Citrus Sinensis ID: 040532

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430------
Protein Sequence
MDRFAIFIIFVAWVSAVFLILGFTLTSTPRLPLFLLSIVLAAVAILGLIFFCVRRKPGSRDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSNVRNTVTSTSSTDKTGDCSINQVTISILEAR
Secondary Structure (PSIPRED)
cccEEEEEEEEccccEEEEEccccccccccccEEEHHHHHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHcccccccccccHHHHHHHccccccccccccHHHHHHHHccccccccccccccccccEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHcccccccccccccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccHHHHcccccccccccccHHHEEEEEEcccccccccccccccHHHHHHHHcccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccccccEEEcccccccccccccccccccccEEEEEcccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEEcccccEEEEEEccccccccHHHEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEccccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccEEEEEEEcccccccEEHccccccccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEcccccccEcccccEEccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHccccHHHEEcccHccccccHHHHHHHHHHHHHEEcccHcccccHHHEEEEccccccccccccccEEEEEcccccccccccccccccccEEEEEEEccc
Coil and Loop (DISEMBL)
MDRFAIFIIFVAWVSAVFLILGFtltstprlpLFLLSIVLAAVAILGLIFFCvrrkpgsrdkredLMTFDLDLnlkannvnielplnsklierskkkevdqlplfsfssvstatntfsdtnklgeggfgpvykgvlrkgdEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGccidkdekiliyeympnksldfflfdptkrilLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASnilldkdmnpkisdfgmaricggnelqantsrivgtygymspeyaLEGIFSIKSDVFSFGVLLLEIVSgkkntglyrtdslNLLGYVWDLwtsnrtleliddpvledeyssKQVLLRYVNIALLCVqesaddrptmNDVVSMLTNeaaalhppkqpafsnvrntvtstsstdktgdcsinQVTISILEAR
Flexible Loop (DISEMBL)
MDRFAIFIIFVAWVSAVFLILGFTLTSTPRLPLFLLSIVLAAVAILGLIFFCVrrkpgsrdkREDLMTFdldlnlkannvnielplnsklierskkkevdqlplfsfssvstatntfsdtnklgeggfgpvYKGVLRKGDEIAVKrlsgrseqglreMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSgkkntglyrtdSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVqesaddrpTMNDVVSMLTNEAAAlhppkqpafsnvRNTVTstsstdktgdcsinqvtisilear
Low Complexity Region (SEG)
MDRFAIFIIFVAWVSAVFLILGFTLTSTPRLPlfllsivlaavailgliffCVRRKPGSRDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFsnvrntvtstsstDKTGDCSINQVTISILEAR
Disordered region (IsUnstruct)
***FAIFIIFVAWVSAVFLILGFTLTSTPRLPLFLLSIVLAAVAILGLIFFCVRRK********DLMTFDLDLNLKANNVNIELPLNSKLI**********LPLFSFSSV*****TF**TNKLGEGGFGPVYKGVLRKGDEIAV******************SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQE**************************************************************
Disordered Region (DISOPRED)
*DRFAIFIIFVAWVSAV***************LFLLSIVLAAVAILGLIFFCVRRKP******************************************DQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAF***********************VTISILEAR
Disordered Region (DISEMBL)
MDRFAIFIIFVAWVSAVFLILGFTLTSTPRLPLFLLSIVLAAVAILGLIFFCVRRKPGSRDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSNV************TGDCSINQVTISILEAR
Disordered Region (DISPRO)
*DRFAIFIIFVAWVSAVFLILGFTLTSTPRLPLFLLSIVLAAVAILGLIFFCVRRKPGSRD*************************************VDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSNVRN*************CSINQVTISILEA*
Transmembrane Helix (TMHMM)
iiiiHHHHHHHHHHHHHHHHHHHHHHHoooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHHHooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooHHHHHHHHHHHHHHHHHHHHiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiHHHHHHHHHHHHHHHHHHHoooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDRFAIFIIFVAWVSAVFLILGFTLTSTPRLPLFLLSIVLAAVAILGLIFFCVRRKPGSRDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSNVRNTVTSTSSTDKTGDCSINQVTISILEAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	436	2.2.26 [Sep-21-2011]
Q9LW83	850	G-type lectin S-receptor-	yes	no	0.770	0.395	0.599	1e-114
O81906	849	G-type lectin S-receptor-	no	no	0.779	0.400	0.582	1e-114
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.915	0.478	0.5	1e-112
O64793	818	G-type lectin S-receptor-	no	no	0.892	0.475	0.530	1e-111
Q9S972	847	Receptor-like serine/thre	no	no	0.784	0.403	0.592	1e-110
Q39086	843	Receptor-like serine/thre	no	no	0.745	0.385	0.608	1e-110
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.883	0.457	0.507	1e-109
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.793	0.406	0.574	1e-108
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.935	0.482	0.504	1e-107
Q9SY89	842	Putative G-type lectin S-	no	no	0.763	0.395	0.570	1e-107

>sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2

 Score =  413 bits (1061), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 205/342 (59%), Positives = 261/342 (76%), Gaps = 6/342 (1%)

Query: 100 DQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMK 159
           ++L +FSF SV+ AT+ FSD NKLGEGGFGPVYKG L  G+E+A+KRLS  S QGL E K
Sbjct: 510 NELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFK 569

Query: 160 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI 219
           NEA +IAK+QH NLV+LLGCC++KDEK+LIYEYMPNKSLD+FLFDP ++I+LDW  R +I
Sbjct: 570 NEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRI 629

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           +EGI QGLLYLH+YSR+++IHRD+KA NILLD+DMNPKISDFGMARI G  E +ANT R+
Sbjct: 630 MEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRV 689

Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS--LNLLGYVWDLW 337
            GT+GYMSPEY  EG+FS KSDVFSFGVL+LEI+ G+KN   +      LNL+ +VW+L+
Sbjct: 690 AGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLF 749

Query: 338 TSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA-AAL 396
             NR  E+I DP L D       +LR V +ALLCVQ++ADDRP+M DVVSM+  +   AL
Sbjct: 750 KENRVREVI-DPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNAL 808

Query: 397 HPPKQPAFSN--VRNTVTSTSSTDKTGDCSINQVTISILEAR 436
             PK+PAF +   R++        +  + S N+VTI+++EAR
Sbjct: 809 SLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850

Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  410 bits (1055), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 201/345 (58%), Positives = 262/345 (75%), Gaps = 5/345 (1%)

Query: 95  KKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG 154
           K     +LP+FS ++++ ATN F   N+LG GGFGPVYKGVL  G EIAVKRLSG+S QG
Sbjct: 507 KAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQG 566

Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV 214
           + E KNE  +IAK+QH+NLVRLLGCC + +EK+L+YEYMPNKSLDFFLFD TK+ L+DW 
Sbjct: 567 VDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWK 626

Query: 215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 274
            R  IIEGIA+GLLYLH+ SR+RIIHRDLK SN+LLD +MNPKISDFGMARI GGN+ +A
Sbjct: 627 LRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEA 686

Query: 275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVW 334
           NT R+VGTYGYMSPEYA+EG+FS+KSDV+SFGVLLLEIVSGK+NT L  ++  +L+GY W
Sbjct: 687 NTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAW 746

Query: 335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA 394
            L+T  R+ EL+D  +      SK+  LR +++A+LCVQ+SA +RP M  V+ ML ++ A
Sbjct: 747 YLYTHGRSEELVDPKIRVT--CSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTA 804

Query: 395 ALHPPKQPAFSNV-RNTVTSTSSTDKTGD--CSINQVTISILEAR 436
            L  P+QP F++  RN++    + D +     S N++T +++  R
Sbjct: 805 TLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  406 bits (1043), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 207/414 (50%), Positives = 285/414 (68%), Gaps = 15/414 (3%)

Query: 25  LTSTPRLPLFLLSIVLAAVAILGLIFFCVRRKPGSRDKREDLMTFDLDLNLKANNVNIEL 84
           L+   R+ L L+S++ AAV +L +I FCV R+    ++           +  AN   +  
Sbjct: 433 LSGKRRVLLILISLI-AAVMLLTVILFCVVRERRKSNRHR---------SSSANFAPVPF 482

Query: 85  PLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAV 144
             +        K    +LPLF  +++  ATN FS  NKLG GGFGPVYKGVL+   EIAV
Sbjct: 483 DFDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAV 542

Query: 145 KRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD 204
           KRLS  S QG+ E KNE  +I+K+QH+NLVR+LGCC++ +EK+L+YEY+PNKSLD+F+F 
Sbjct: 543 KRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFH 602

Query: 205 PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
             +R  LDW  R++I+ GIA+G+LYLHQ SR+RIIHRDLKASNILLD +M PKISDFGMA
Sbjct: 603 EEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMA 662

Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT 324
           RI GGN+++  TSR+VGT+GYM+PEYA+EG FSIKSDV+SFGVL+LEI++GKKN+  +  
Sbjct: 663 RIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHE- 721

Query: 325 DSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMND 384
           +S NL+G++WDLW +    E+ID+ + ++ Y  ++V ++ + I LLCVQE+A DR  M+ 
Sbjct: 722 ESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREV-MKCIQIGLLCVQENASDRVDMSS 780

Query: 385 VVSMLTNEAAALHPPKQPAFSNVRNTVTSTSST--DKTGDCSINQVTISILEAR 436
           VV ML + A  L  PK PAF++ R       +    +TG  S+N VT S ++ R
Sbjct: 781 VVIMLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTG-ISVNDVTFSDIQGR 833

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3

 Score =  402 bits (1032), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 215/405 (53%), Positives = 287/405 (70%), Gaps = 16/405 (3%)

Query: 37  SIVLAAVAILGLIFFCVRRKPGSRDKREDLMTFDLDLNLKANNVNIELPLNSKLI-ERSK 95
           +++++ V +L +I F  RR    R       T D ++ L+      EL ++   I +R++
Sbjct: 425 TVLVSMVFLLTMIGFIRRRILSLRFGS----TIDQEMLLR------ELGIDRSCIHKRNE 474

Query: 96  KKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGL 155
           +K  ++L +FSF SV +AT+ FSD NKLGEGGFGPVYKG L  G+E+A+KRLS  S QGL
Sbjct: 475 RKSNNELQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLASGQGL 534

Query: 156 REMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVT 215
            E KNEA +IAK+QH NLV++LGCCI+KDEK+LIYEYM NKSLD+FLFDP ++ +LDW  
Sbjct: 535 VEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVLDWTL 594

Query: 216 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 275
           R +I+EGI QGLLYLH+YSR+++IHRD+KASNILLD+DMNPKISDFG+ARI G  E +AN
Sbjct: 595 RFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARIFGAEETRAN 654

Query: 276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR--TDSLNLLGYV 333
           T R+ GT+GYMSPEY  EG+FS KSDVFSFGVL+LEI+ G+KN   +      LNL+ +V
Sbjct: 655 TKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLEGPLNLIVHV 714

Query: 334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 393
           W+L+  N+  E+ID  + +      QV LR V +ALLCVQE+A+DRP+M DVVSM+  E 
Sbjct: 715 WNLFKENKIREVIDLSLRDSALDYPQV-LRCVQVALLCVQENAEDRPSMLDVVSMIYGEG 773

Query: 394 -AALHPPKQPAFSN-VRNTVTSTSSTDKTGDCSINQVTISILEAR 436
             AL  PK+PAF +  R +        +  +     +TI++LEAR
Sbjct: 774 NNALSLPKEPAFYDGPRRSFPEMKVEPQEPENVSASITITVLEAR 818

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  398 bits (1022), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 208/351 (59%), Positives = 259/351 (73%), Gaps = 9/351 (2%)

Query: 94  SKKKEVD--QLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS 151
           SK+ + D  +LPL  + +++ ATN FS  NKLG+GGFG VYKG+L  G EIAVKRLS  S
Sbjct: 498 SKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMS 557

Query: 152 EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILL 211
            QG  E  NE  +IAK+QH NLVRLLGCC+DK EK+LIYEY+ N SLD  LFD T+   L
Sbjct: 558 SQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNL 617

Query: 212 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
           +W  R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M PKISDFGMARI G  E
Sbjct: 618 NWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREE 677

Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLL 330
            +ANT R+VGTYGYMSPEYA++GIFS+KSDVFSFGVLLLEI+SGK+N G Y ++  LNLL
Sbjct: 678 TEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLL 737

Query: 331 GYVWDLWTSNRTLELIDDPVLEDEYSSK---QVLLRYVNIALLCVQESADDRPTMNDVVS 387
           G+VW  W   + LE++ DP+  D  SS+     +LR + I LLCVQE A+DRP M+ V+ 
Sbjct: 738 GFVWRHWKEGKELEIV-DPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMV 796

Query: 388 MLTNEAAALHPPKQPAFSNVR--NTVTSTSSTDKTGDCSINQVTISILEAR 436
           ML +E  A+  PK+P F   R    V S+SST +  +C++NQVT+S+++AR
Sbjct: 797 MLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  397 bits (1020), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 202/332 (60%), Positives = 248/332 (74%), Gaps = 7/332 (2%)

Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQH 170
           +TATN FS+ NKLG+GGFG VYKG L  G EIAVKRLS  S QG  E  NE  +IAK+QH
Sbjct: 513 ATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQH 572

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
            NLVRLLGCC+DK EK+LIYEY+ N SLD  LFD T+   L+W  R  II GIA+GLLYL
Sbjct: 573 INLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYL 632

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
           HQ SR RIIHRDLKASN+LLDK+M PKISDFGMARI G  E +ANT R+VGTYGYMSPEY
Sbjct: 633 HQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEY 692

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYVWDLWTSNRTLELIDDP 349
           A++GIFS+KSDVFSFGVLLLEI+SGK+N G Y ++  LNLLG+VW  W     LE++ DP
Sbjct: 693 AMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIV-DP 751

Query: 350 VLEDEYSSK---QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSN 406
           +  D  SSK     +LR + I LLCVQE A+DRP M+ V+ ML +E  A+  PK+P F  
Sbjct: 752 INIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCI 811

Query: 407 VRNTVT--STSSTDKTGDCSINQVTISILEAR 436
            R+ +   S+SST +  +C++NQ+T+S+++AR
Sbjct: 812 GRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  394 bits (1012), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 203/400 (50%), Positives = 278/400 (69%), Gaps = 15/400 (3%)

Query: 38  IVLAAVAILGLIFFCVRRKPGSRDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKK 97
           +++AAV +L       +R   ++D+  +LM   ++             L S     S + 
Sbjct: 457 MLIAAVCVLLACRKYKKRPAPAKDRSAELMFKRME------------ALTSDNESASNQI 504

Query: 98  EVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLRE 157
           ++ +LPLF F  ++T+T++FS  NKLG+GGFGPVYKG L +G EIAVKRLS +S QGL E
Sbjct: 505 KLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEE 564

Query: 158 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV 217
           + NE  VI+K+QH+NLV+LLGCCI+ +E++L+YEYMP KSLD +LFDP K+ +LDW TR 
Sbjct: 565 LMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRF 624

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
            I+EGI +GLLYLH+ SR++IIHRDLKASNILLD+++NPKISDFG+ARI   NE +ANT 
Sbjct: 625 NIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTR 684

Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYVWDL 336
           R+VGTYGYMSPEYA+EG FS KSDVFS GV+ LEI+SG++N+  ++ + +LNLL Y W L
Sbjct: 685 RVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWKL 744

Query: 337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 396
           W       L  DP + D+   K++  + V+I LLCVQE A+DRP +++V+ MLT E  +L
Sbjct: 745 WNDGEAASLA-DPAVFDKCFEKEI-EKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSL 802

Query: 397 HPPKQPAFSNVRNTVTSTSSTDKTGDCSINQVTISILEAR 436
             PKQPAF   R    + SS   +   SIN V+++ +  R
Sbjct: 803 ADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  392 bits (1006), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 204/355 (57%), Positives = 262/355 (73%), Gaps = 9/355 (2%)

Query: 89  KLIERSKKKEVDQ----LPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAV 144
           +LIE  + K+ D     +P F   ++  AT+ FS+ NKLG+GGFGPVYKG+     EIAV
Sbjct: 500 ELIESGRFKQDDSQGIDVPSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAV 559

Query: 145 KRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD 204
           KRLS  S QGL E KNE  +IAK+QH+NLVRLLG C+  +EK+L+YEYMP+KSLDFF+FD
Sbjct: 560 KRLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFD 619

Query: 205 PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
                 LDW  R  II GIA+GLLYLHQ SR+RIIHRDLK SNILLD++MNPKISDFG+A
Sbjct: 620 RKLCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLA 679

Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT 324
           RI GG+E  ANT+R+VGTYGYMSPEYALEG+FS KSDVFSFGV+++E +SGK+NTG +  
Sbjct: 680 RIFGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEP 739

Query: 325 D-SLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMN 383
           + SL+LLG+ WDLW + R +EL+D  +   E    +  L+ +N+ LLCVQE  +DRPTM+
Sbjct: 740 EKSLSLLGHAWDLWKAERGIELLDQAL--QESCETEGFLKCLNVGLLCVQEDPNDRPTMS 797

Query: 384 DVVSML-TNEAAALHPPKQPAFSNVR-NTVTSTSSTDKTGDCSINQVTISILEAR 436
           +VV ML ++EAA L  PKQPAF   R  + +  SS+ K   CS N++TI++ + R
Sbjct: 798 NVVFMLGSSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTITLEDGR 852

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  390 bits (1002), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 212/420 (50%), Positives = 295/420 (70%), Gaps = 12/420 (2%)

Query: 22  GFTLTSTPRLPLFLLSIVLAAVAILGLIFFCVRRKPGSRDKREDLMTFDLDLNLKANNVN 81
           G   +   RL L L+S++ A V +L + F C  RK   R +   L          + ++ 
Sbjct: 433 GNGASGKKRLVLILISLI-AVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLE 491

Query: 82  IELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDE 141
               L  +L ++S+ +E   LPLF  S+++TATN F+  NKLG GGFGPVYKGVL+ G E
Sbjct: 492 DSFIL-EELEDKSRSRE---LPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGME 547

Query: 142 IAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF 201
           IAVKRLS  S QG+ E KNE  +I+K+QH+NLVR+LGCC++ +EK+L+YEY+PNKSLD+F
Sbjct: 548 IAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYF 607

Query: 202 LFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF 261
           +F   +R  LDW  R+ II GI +G+LYLHQ SR+RIIHRDLKASN+LLD +M PKI+DF
Sbjct: 608 IFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADF 667

Query: 262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGL 321
           G+ARI GGN+++ +T+R+VGTYGYMSPEYA++G FSIKSDV+SFGVL+LEI++GK+N+  
Sbjct: 668 GLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAF 727

Query: 322 YRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT 381
           Y  +SLNL+ ++WD W +   +E+ID  + E+ Y   +V ++ ++I LLCVQE++ DRP 
Sbjct: 728 YE-ESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEV-MKCLHIGLLCVQENSSDRPD 785

Query: 382 MNDVVSMLTNEAAALHPPKQPAFS--NVRNTVTSTSSTD-KTGDCS--INQVTISILEAR 436
           M+ VV ML + A  L  PK PAF+    RNT T  SS +  +G+ S  IN VT++ ++ R
Sbjct: 786 MSSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1

 Score =  390 bits (1002), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 191/335 (57%), Positives = 249/335 (74%), Gaps = 2/335 (0%)

Query: 102 LPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNE 161
           LP+FSF SV++AT  F++ NKLG+GGFG VYKG   +G EIAVKRLSG+S+QGL E KNE
Sbjct: 510 LPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNE 569

Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             +IAK+QH+NLVRLLGCCI+ +EK+L+YEYMPNKSLD FLFD +K+  LDW  R ++I 
Sbjct: 570 ILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIG 629

Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
           GIA+GLLYLH+ SR++IIHRDLKASNILLD +MNPKISDFGMARI    +  ANT R+VG
Sbjct: 630 GIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVG 689

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR 341
           TYGYM+PEYA+EGIFS KSDV+SFGVL+LEIVSG+KN     TD  +L+GY W LW+  +
Sbjct: 690 TYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGK 749

Query: 342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQ 401
           T E+I DP+++D     +  +R +++ +LC Q+S   RP M  V+ ML ++ + L PP+Q
Sbjct: 750 TKEMI-DPIVKDTRDVTEA-MRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQ 807

Query: 402 PAFSNVRNTVTSTSSTDKTGDCSINQVTISILEAR 436
           P F +  N+     + D     S+N VT + +  R
Sbjct: 808 PTFHSFLNSGDIELNFDGHDVASVNDVTFTTIVGR 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	436
359484155	865	PREDICTED: receptor-like serine/threonin	0.917	0.462	0.660	1e-145
297742753	637	unnamed protein product [Vitis vinifera]	0.917	0.627	0.660	1e-144
359493705	830	PREDICTED: receptor-like serine/threonin	0.848	0.445	0.681	1e-140
302143120	674	unnamed protein product [Vitis vinifera]	0.848	0.548	0.681	1e-140
296090091	674	unnamed protein product [Vitis vinifera]	0.850	0.550	0.684	1e-139
356514857	834	PREDICTED: G-type lectin S-receptor-like	0.864	0.452	0.658	1e-139
302143114	457	unnamed protein product [Vitis vinifera]	0.846	0.807	0.663	1e-135
359493709	894	PREDICTED: receptor-like serine/threonin	0.809	0.394	0.690	1e-135
224138268	818	predicted protein [Populus trichocarpa]	0.894	0.476	0.616	1e-134
359493703	1658	PREDICTED: uncharacterized protein LOC10	0.848	0.223	0.671	1e-134

>gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  520 bits (1339), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 271/410 (66%), Positives = 322/410 (78%), Gaps = 10/410 (2%)

Query: 27  STPRLPLFLLSIVLAAVAILGLIFFCVRRKPGSRDKREDLMTFDLDLNLKANNVNIELPL 86
           S+ +  ++L+ + LA       + + +RR+   R K E+L+ FDL  +  + + N EL  
Sbjct: 466 SSSKWKVWLI-VTLAISVTSAFVIWGIRRR--LRRKGENLLLFDL--SNSSVDTNYELSE 520

Query: 87  NSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKR 146
            SKL    +KKEVD LP+FSF+SVS ATN FS  NKLGEGGFGPVYKG  +KG E+AVKR
Sbjct: 521 TSKLWS-GEKKEVD-LPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEVAVKR 578

Query: 147 LSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT 206
           LS RS QG  E+KNE  +IAK+QHKNLV+L G CI+KDEKILIYEYMPNKSLDFFLFDPT
Sbjct: 579 LSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPT 638

Query: 207 KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 266
           K  +L+W TRV II+G+AQGLLYLHQYSR+RIIHRDLKASNILLDKDMNP+ISDFGMARI
Sbjct: 639 KHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARI 698

Query: 267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
            GGNE +A T+ IVGTYGYMSPEYALEG+FS KSDVFSFGVLLLEI+SGKKNTG Y+TDS
Sbjct: 699 FGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDS 757

Query: 327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
           LNLLGY WDLW  +R  EL+ DP LE+   +  +LLRY+NI LLCVQESADDRPTM+DVV
Sbjct: 758 LNLLGYAWDLWKDSRGQELM-DPGLEETLPT-HILLRYINIGLLCVQESADDRPTMSDVV 815

Query: 387 SMLTNEAAALHPPKQPAFSNVRNTVTSTSSTDKTGDCSINQVTISILEAR 436
           SML NE+  L  PKQPAFSN+R+ V    S +K   CS+N VT+S++EAR
Sbjct: 816 SMLGNESVRLPSPKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 865

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera]

 Score =  518 bits (1334), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 271/410 (66%), Positives = 322/410 (78%), Gaps = 10/410 (2%)

Query: 27  STPRLPLFLLSIVLAAVAILGLIFFCVRRKPGSRDKREDLMTFDLDLNLKANNVNIELPL 86
           S+ +  ++L+ + LA       + + +RR+   R K E+L+ FDL  +  + + N EL  
Sbjct: 238 SSSKWKVWLI-VTLAISVTSAFVIWGIRRR--LRRKGENLLLFDL--SNSSVDTNYELSE 292

Query: 87  NSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKR 146
            SKL    +KKEVD LP+FSF+SVS ATN FS  NKLGEGGFGPVYKG  +KG E+AVKR
Sbjct: 293 TSKLWS-GEKKEVD-LPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEVAVKR 350

Query: 147 LSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT 206
           LS RS QG  E+KNE  +IAK+QHKNLV+L G CI+KDEKILIYEYMPNKSLDFFLFDPT
Sbjct: 351 LSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPT 410

Query: 207 KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 266
           K  +L+W TRV II+G+AQGLLYLHQYSR+RIIHRDLKASNILLDKDMNP+ISDFGMARI
Sbjct: 411 KHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARI 470

Query: 267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
            GGNE +A T+ IVGTYGYMSPEYALEG+FS KSDVFSFGVLLLEI+SGKKNTG Y+TDS
Sbjct: 471 FGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDS 529

Query: 327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
           LNLLGY WDLW  +R  EL+ DP LE+   +  +LLRY+NI LLCVQESADDRPTM+DVV
Sbjct: 530 LNLLGYAWDLWKDSRGQELM-DPGLEETLPT-HILLRYINIGLLCVQESADDRPTMSDVV 587

Query: 387 SMLTNEAAALHPPKQPAFSNVRNTVTSTSSTDKTGDCSINQVTISILEAR 436
           SML NE+  L  PKQPAFSN+R+ V    S +K   CS+N VT+S++EAR
Sbjct: 588 SMLGNESVRLPSPKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 637

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  504 bits (1298), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 257/377 (68%), Positives = 305/377 (80%), Gaps = 7/377 (1%)

Query: 60  RDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSD 119
           R K EDL+ FD      + + + EL   ++L  R +K+EVD LP+FSF+SVS +TN FS 
Sbjct: 461 RRKGEDLLVFDF--GNSSEDTSYELDETNRLW-RGEKREVD-LPMFSFASVSASTNNFSI 516

Query: 120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            NKLGEGGFG VYKG  ++  E+AVKRLS RS+QG  E+KNEA +IAK+QHKNLV++LG 
Sbjct: 517 ENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGY 576

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           CI++DEKILIYEYM NKSLDFFLFDPTK  +L+W TRV IIEG+AQGLLYLHQYSR+RII
Sbjct: 577 CIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKTRVHIIEGVAQGLLYLHQYSRLRII 636

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDLKASNILLDKDMNPKISDFGMARI GGNE +  T+ IVGTYGYMSPEYALEG+FS K
Sbjct: 637 HRDLKASNILLDKDMNPKISDFGMARIFGGNESKV-TNHIVGTYGYMSPEYALEGLFSTK 695

Query: 300 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQ 359
           SDVFSFGVLLLEI+SGKKNTG Y+TDSLNLLGY WDLW  +R LEL+ DP LE+   +  
Sbjct: 696 SDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGLELM-DPGLEETLPT-H 753

Query: 360 VLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSNVRNTVTSTSSTDK 419
           +LLRY+N+ LLCVQESADDRPTM+DVVSML NE+  L  PKQPAFSN+R+ V    S ++
Sbjct: 754 ILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNR 813

Query: 420 TGDCSINQVTISILEAR 436
              CS+N VT+S++EAR
Sbjct: 814 PEVCSLNGVTLSVMEAR 830

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143120|emb|CBI20415.3| unnamed protein product [Vitis vinifera]

 Score =  503 bits (1296), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 257/377 (68%), Positives = 305/377 (80%), Gaps = 7/377 (1%)

Query: 60  RDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSD 119
           R K EDL+ FD      + + + EL   ++L  R +K+EVD LP+FSF+SVS +TN FS 
Sbjct: 305 RRKGEDLLVFDF--GNSSEDTSYELDETNRLW-RGEKREVD-LPMFSFASVSASTNNFSI 360

Query: 120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            NKLGEGGFG VYKG  ++  E+AVKRLS RS+QG  E+KNEA +IAK+QHKNLV++LG 
Sbjct: 361 ENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGY 420

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           CI++DEKILIYEYM NKSLDFFLFDPTK  +L+W TRV IIEG+AQGLLYLHQYSR+RII
Sbjct: 421 CIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKTRVHIIEGVAQGLLYLHQYSRLRII 480

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDLKASNILLDKDMNPKISDFGMARI GGNE +  T+ IVGTYGYMSPEYALEG+FS K
Sbjct: 481 HRDLKASNILLDKDMNPKISDFGMARIFGGNESKV-TNHIVGTYGYMSPEYALEGLFSTK 539

Query: 300 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQ 359
           SDVFSFGVLLLEI+SGKKNTG Y+TDSLNLLGY WDLW  +R LEL+ DP LE+   +  
Sbjct: 540 SDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGLELM-DPGLEETLPT-H 597

Query: 360 VLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSNVRNTVTSTSSTDK 419
           +LLRY+N+ LLCVQESADDRPTM+DVVSML NE+  L  PKQPAFSN+R+ V    S ++
Sbjct: 598 ILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNR 657

Query: 420 TGDCSINQVTISILEAR 436
              CS+N VT+S++EAR
Sbjct: 658 PEVCSLNGVTLSVMEAR 674

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296090091|emb|CBI39910.3| unnamed protein product [Vitis vinifera]

 Score =  502 bits (1292), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 258/377 (68%), Positives = 303/377 (80%), Gaps = 6/377 (1%)

Query: 60  RDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSD 119
           R K EDL+ FD   N   +    EL   ++L  R +KKEVD LP+FSF+SVS +TN F +
Sbjct: 304 RRKGEDLLLFDFG-NSSEDTSCYELGETNRLW-RGEKKEVD-LPMFSFASVSASTNNFCN 360

Query: 120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            NKLGEGGFG VYKG  ++  E+AVKRLS RS+QG  E+KNEA +IAK+QHKNLV++LG 
Sbjct: 361 ENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGY 420

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           CI++DEKILIYEYM NKSLDFFLFDPTK  +L+W T V IIEG+AQGLLYLHQYSR+RII
Sbjct: 421 CIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKTWVHIIEGVAQGLLYLHQYSRMRII 480

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDLKASNILLDKDMNPKISDFGMARI GGNE +A T+ IVGTYGYMSPEYALEG+FS K
Sbjct: 481 HRDLKASNILLDKDMNPKISDFGMARIFGGNEPKA-TNHIVGTYGYMSPEYALEGLFSTK 539

Query: 300 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQ 359
           SDVFSFGVLL+EI+SGKKNTG Y+TDSLNLLGY WDLW  +R  EL+ DP LE E S   
Sbjct: 540 SDVFSFGVLLMEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGQELM-DPGLE-ETSPTH 597

Query: 360 VLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSNVRNTVTSTSSTDK 419
           +LLRY+N+ LLCVQESADDRPTM+DVVSML NE+  L  PKQPAFSN+R+ V    S ++
Sbjct: 598 ILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNR 657

Query: 420 TGDCSINQVTISILEAR 436
            G  S+N VT+S++EAR
Sbjct: 658 PGIYSLNGVTLSVMEAR 674

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356514857|ref|XP_003526119.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300-like [Glycine max]

 Score =  501 bits (1289), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 257/390 (65%), Positives = 303/390 (77%), Gaps = 13/390 (3%)

Query: 51  FCVRRKPGSRDKREDLMTFDLDLNLKANNVNI-ELPLNSKLIERSKKKEVDQLPLFSFSS 109
           +  RR+   R K EDL+ F + +++K  +  + E    +K+    KKKEV +LPLFSF S
Sbjct: 454 YWTRRQ---RRKGEDLLRFHVSMSMKVEDSELAEAHRGAKV----KKKEV-KLPLFSFVS 505

Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ 169
           V+ ATN FSD NKLGEGGFGPVYKG+L  GDE+AVKRLS RS QG  E++NEA +IAK+Q
Sbjct: 506 VAAATNNFSDANKLGEGGFGPVYKGILLNGDEVAVKRLSRRSGQGWEELRNEALLIAKLQ 565

Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H NLVRLLGCCID+DEK+LIYE MPNKSLD FLFD TKR +LDW TRV+II+GIAQG+LY
Sbjct: 566 HNNLVRLLGCCIDRDEKMLIYELMPNKSLDVFLFDATKRRMLDWGTRVRIIDGIAQGILY 625

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           LHQYSR RIIHRDLKASNILLD +MNPKISDFGMARI G NELQANT+RIVGTYGYMSPE
Sbjct: 626 LHQYSRFRIIHRDLKASNILLDTNMNPKISDFGMARIFGDNELQANTNRIVGTYGYMSPE 685

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
           YA+EG+FSIKSDVFSFGVLLLEI+SGKKNTG Y+T+S NLLGY WDLWT+N  ++L+ DP
Sbjct: 686 YAMEGLFSIKSDVFSFGVLLLEILSGKKNTGFYQTNSFNLLGYAWDLWTNNSGMDLM-DP 744

Query: 350 VLEDE---YSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSN 406
            L+D     SS   + RYVNI LLCVQES  DRPTM+DVVSM+ N+  AL  PK PAF N
Sbjct: 745 ALDDSDTTSSSMHTVPRYVNIGLLCVQESPADRPTMSDVVSMIGNDTVALPSPKPPAFLN 804

Query: 407 VRNTVTSTSSTDKTGDCSINQVTISILEAR 436
           VR    S          S+N +T +++EAR
Sbjct: 805 VRGNQNSILPASMPESFSLNLITDTMVEAR 834

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143114|emb|CBI20409.3| unnamed protein product [Vitis vinifera]

 Score =  487 bits (1254), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 250/377 (66%), Positives = 300/377 (79%), Gaps = 8/377 (2%)

Query: 60  RDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSD 119
           R K EDL+ FD   +  + + + EL   ++L  R +KKEVD LP+FSF+SVS +TN FS 
Sbjct: 89  RRKGEDLLVFDFGNS--SEDTSYELGETNRLW-RGEKKEVD-LPMFSFASVSASTNNFSI 144

Query: 120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            NKLGEGGFG VYKG L++G E+AVKRLS RS+QG  E+KNEA +IAK+QHKNLV++LG 
Sbjct: 145 ENKLGEGGFGSVYKGKLQRGYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGY 204

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           CI++DEKILIYEYM NKSLDFFLFDP KR +L+W  RV+IIEG+AQGLLYLHQYSR+R+I
Sbjct: 205 CIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWEMRVRIIEGVAQGLLYLHQYSRLRVI 264

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDLKASNILLDKDMNPKISDFGMARI GGNE +A T  IVGTYGYMSPEY L G+FS K
Sbjct: 265 HRDLKASNILLDKDMNPKISDFGMARIFGGNESKA-TKHIVGTYGYMSPEYVLRGLFSTK 323

Query: 300 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQ 359
           SDVFSFGVLLLEI+SGKK T  Y + SLNLLGY WDLW +N+  ELI DPVL +E S + 
Sbjct: 324 SDVFSFGVLLLEILSGKKITEFYHSGSLNLLGYAWDLWKNNKGQELI-DPVL-NEISLRH 381

Query: 360 VLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSNVRNTVTSTSSTDK 419
           ++LRY+N+ALLCVQESADDRPTM DVVSML  E   L  P +PAFSN+ +++   +S D+
Sbjct: 382 IMLRYINVALLCVQESADDRPTMFDVVSMLVKENVLLSSPNEPAFSNL-SSMKPHASQDR 440

Query: 420 TGDCSINQVTISILEAR 436
              CS+N VT+S + AR
Sbjct: 441 LEICSLNDVTLSSMGAR 457

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493709|ref|XP_002281056.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  486 bits (1252), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 248/359 (69%), Positives = 290/359 (80%), Gaps = 6/359 (1%)

Query: 60  RDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSD 119
           R K EDL+ FD   N   +    EL   ++L  R +KKEVD LP+FSF SVS +TN F  
Sbjct: 464 RRKGEDLLVFDFG-NSSEDTSCYELGETNRLW-RGEKKEVD-LPMFSFVSVSASTNNFCI 520

Query: 120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            NKLGEGGFG VYKG  ++G E+AVKRLS RS+QG  E+KNEA +IAK+QHKNLV++LG 
Sbjct: 521 ENKLGEGGFGSVYKGKSQRGYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGY 580

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           CI++DEKILIYEYM NKSLDFFLFDP KR +L+W TRV+IIEG+AQGLLYLHQYSR+R+I
Sbjct: 581 CIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWETRVRIIEGVAQGLLYLHQYSRLRVI 640

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDLKASNILLDKDMNPKISDFGMARI GGNE +A T  IVGTYGYMSPEYALEG+FS K
Sbjct: 641 HRDLKASNILLDKDMNPKISDFGMARIFGGNESKA-TKHIVGTYGYMSPEYALEGLFSTK 699

Query: 300 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQ 359
           SDVFSFGVLLLEI+SGKKNTG Y+TDSLNLLGY WDLW  +R  EL+ DP LE+   +  
Sbjct: 700 SDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGQELM-DPGLEETLPT-H 757

Query: 360 VLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSNVRNTVTSTSSTD 418
           +LLRY+N+ LLCVQESADDRPTM+DVVSML NE+  L  PKQPAFSN+R+    + S++
Sbjct: 758 ILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGTHKSLSSN 816

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224138268|ref|XP_002326560.1| predicted protein [Populus trichocarpa] gi|222833882|gb|EEE72359.1| predicted protein [Populus trichocarpa]

 Score =  486 bits (1250), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 252/409 (61%), Positives = 301/409 (73%), Gaps = 19/409 (4%)

Query: 35  LLSIVLAAVAI-LGLIFFCVR------RKPGSRDKREDLMTFDLDLNLKANNVNIELPLN 87
           +L++V+    I  GL  +C           G  D  E+L+ FD D    + N    +P  
Sbjct: 422 ILAVVIPVTLITFGLFIYCCYLRKSKLHHKGEEDTSENLLFFDFDTCPNSTN---NVP-- 476

Query: 88  SKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL 147
           S +  R K  E   LPLFS+ SVS  T  FS  +KLGEGGFGPVYKG L  G E+AVKRL
Sbjct: 477 SSVDNRRKNVE---LPLFSYESVSAVTEQFS--HKLGEGGFGPVYKGKLSNGVEVAVKRL 531

Query: 148 SGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK 207
           S RS QGL E +NE  VIA++QH+NLVRLLGCCI++DEKILIYEYMPNKSLDFFLFD  K
Sbjct: 532 SKRSGQGLEEFRNETMVIARLQHRNLVRLLGCCIERDEKILIYEYMPNKSLDFFLFDANK 591

Query: 208 RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC 267
           R +LDW +RV+IIEGIAQGLLYLH+YSR+RIIHRDLK SNILLD +MNPKISDFGMARI 
Sbjct: 592 RQILDWGSRVRIIEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARIF 651

Query: 268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 327
           G +E +ANT +I GTYGYMSPEYA++G+FSIKSDVFSFGVLLLEIVSG+KNTG Y  DSL
Sbjct: 652 GDSETEANTKKIAGTYGYMSPEYAMDGLFSIKSDVFSFGVLLLEIVSGRKNTGFYHRDSL 711

Query: 328 NLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
           NLLG+ W  W S+R L+L+ DPVL D   S  VLLR++NI LLCVQES  DRPTM+DV S
Sbjct: 712 NLLGHAWKSWNSSRALDLM-DPVLGDP-PSTSVLLRHINIGLLCVQESPADRPTMSDVFS 769

Query: 388 MLTNEAAALHPPKQPAFSNVRNTVTSTSSTDKTGDCSINQVTISILEAR 436
           M+ NE A L  PKQPAF+  RN   ++SST   G  S+N VT+++++AR
Sbjct: 770 MIVNEHAPLPAPKQPAFATGRNMGDTSSSTSSAGFPSVNNVTVTMMDAR 818

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493703|ref|XP_002281224.2| PREDICTED: uncharacterized protein LOC100245158 [Vitis vinifera]

 Score =  486 bits (1250), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 253/377 (67%), Positives = 298/377 (79%), Gaps = 7/377 (1%)

Query: 60   RDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSD 119
            R K EDL+ FD   + +  N   EL   ++L  R +KKEVD LP+FSF+SVS +TN F  
Sbjct: 1289 RRKGEDLLVFDFGNSSEDTNC-YELGETNRLW-RDEKKEVD-LPMFSFASVSASTNNFCI 1345

Query: 120  TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
             NKLGEGGFG VYKG  ++G E+AVKRLS RS+QG  E+KNEA +IAK+QHKNLV++LG 
Sbjct: 1346 ENKLGEGGFGSVYKGKSQRGYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGY 1405

Query: 180  CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
            CI++DEKILIYEYM NKSLDFFLFDP KR +L+W TRV IIEG+AQGLLYLHQYSR+R+I
Sbjct: 1406 CIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWETRVHIIEGVAQGLLYLHQYSRLRVI 1465

Query: 240  HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
            HRDLKASNILLDKDMNPKISDFGMARI GGNE +A T  IVGTYGYMSPEY L G+FS K
Sbjct: 1466 HRDLKASNILLDKDMNPKISDFGMARIFGGNESKA-TKHIVGTYGYMSPEYVLRGLFSTK 1524

Query: 300  SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQ 359
            SDVFSFGVLLLEI+SGKK T  Y +DSLNLLGY WDLW SNR  ELI DPVL +E S + 
Sbjct: 1525 SDVFSFGVLLLEILSGKKITEFYHSDSLNLLGYAWDLWKSNRGQELI-DPVL-NEISLRH 1582

Query: 360  VLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSNVRNTVTSTSSTDK 419
            +LLRY+N+ALLCVQESADDRPTM+DVVSML  E   L  P +PAF N+ +++   +S D+
Sbjct: 1583 ILLRYINVALLCVQESADDRPTMSDVVSMLVKENVLLSSPNEPAFLNL-SSMKPHASQDR 1641

Query: 420  TGDCSINQVTISILEAR 436
               CS+N VT+S + AR
Sbjct: 1642 LEICSLNDVTLSSMGAR 1658

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	436
TAIR|locus:2093397	850	CES101 "CALLUS EXPRESSION OF R	0.788	0.404	0.588	1.2e-104
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.715	0.367	0.622	1.3e-102
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.786	0.406	0.58	4.2e-102
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.860	0.442	0.544	3.8e-101
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.766	0.393	0.575	1.7e-100
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.862	0.442	0.536	8.2e-99
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.772	0.400	0.560	2.8e-98
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.756	0.488	0.55	6.8e-95
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.832	0.463	0.527	6.8e-95
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.770	0.412	0.542	6.8e-95

TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)]

 Score = 1036 (369.7 bits), Expect = 1.2e-104, P = 1.2e-104
 Identities = 206/350 (58%), Positives = 262/350 (74%)

Query:    92 ERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS 151
             +RS +   ++L +FSF SV+ AT+ FSD NKLGEGGFGPVYKG L  G+E+A+KRLS  S
Sbjct:   502 KRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLAS 561

Query:   152 EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILL 211
              QGL E KNEA +IAK+QH NLV+LLGCC++KDEK+LIYEYMPNKSLD+FLFDP ++I+L
Sbjct:   562 GQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVL 621

Query:   212 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
             DW  R +I+EGI QGLLYLH+YSR+++IHRD+KA NILLD+DMNPKISDFGMARI G  E
Sbjct:   622 DWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQE 681

Query:   272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS--LNL 329
              +ANT R+ GT+GYMSPEY  EG+FS KSDVFSFGVL+LEI+ G+KN   +      LNL
Sbjct:   682 SKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNL 741

Query:   330 LGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
             + +VW+L+  NR  E+ID P L D       +LR V +ALLCVQ++ADDRP+M DVVSM+
Sbjct:   742 IVHVWNLFKENRVREVID-PSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMI 800

Query:   390 TNEAA-ALHPPKQPAFXXXXXXXXXXXXXD--KTGDCSINQVTISILEAR 436
               +   AL  PK+PAF             +  +  + S N+VTI+++EAR
Sbjct:   801 YGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1017 (363.1 bits), Expect = 1.3e-102, P = 1.3e-102
 Identities = 196/315 (62%), Positives = 247/315 (78%)

Query:    90 LIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSG 149
             +IE  K     +LP+FS ++++ ATN F   N+LG GGFGPVYKGVL  G EIAVKRLSG
Sbjct:   503 MIE-GKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSG 561

Query:   150 RSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI 209
             +S QG+ E KNE  +IAK+QH+NLVRLLGCC + +EK+L+YEYMPNKSLDFFLFD TK+ 
Sbjct:   562 KSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQA 621

Query:   210 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 269
             L+DW  R  IIEGIA+GLLYLH+ SR+RIIHRDLK SN+LLD +MNPKISDFGMARI GG
Sbjct:   622 LIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGG 681

Query:   270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL 329
             N+ +ANT R+VGTYGYMSPEYA+EG+FS+KSDV+SFGVLLLEIVSGK+NT L  ++  +L
Sbjct:   682 NQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSL 741

Query:   330 LGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
             +GY W L+T  R+ EL+D  +      SK+  LR +++A+LCVQ+SA +RP M  V+ ML
Sbjct:   742 IGYAWYLYTHGRSEELVDPKIRVT--CSKREALRCIHVAMLCVQDSAAERPNMASVLLML 799

Query:   390 TNEAAALHPPKQPAF 404
              ++ A L  P+QP F
Sbjct:   800 ESDTATLAAPRQPTF 814

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
 Identities = 203/350 (58%), Positives = 250/350 (71%)

Query:    93 RSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE 152
             + KK E  +LPL    +++TATN FS+ NKLG+GGFG VYKG L  G EIAVKRLS  S 
Sbjct:   495 KEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSS 554

Query:   153 QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLD 212
             QG  E  NE  +IAK+QH NLVRLLGCC+DK EK+LIYEY+ N SLD  LFD T+   L+
Sbjct:   555 QGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLN 614

Query:   213 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 272
             W  R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M PKISDFGMARI G  E 
Sbjct:   615 WQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREET 674

Query:   273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLG 331
             +ANT R+VGTYGYMSPEYA++GIFS+KSDVFSFGVLLLEI+SGK+N G Y ++  LNLLG
Sbjct:   675 EANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLG 734

Query:   332 YVWDLWTSNRTLELIDDPVLEDEYSSK---QVLLRYVNIALLCVQESADDRPTMNDVVSM 388
             +VW  W     LE++D P+  D  SSK     +LR + I LLCVQE A+DRP M+ V+ M
Sbjct:   735 FVWRHWKEGNELEIVD-PINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVM 793

Query:   389 LTNEAAALHPPKQPAFXXXXX--XXXXXXXXDKTGDCSINQVTISILEAR 436
             L +E  A+  PK+P F                +  +C++NQ+T+S+++AR
Sbjct:   794 LGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1003 (358.1 bits), Expect = 3.8e-101, P = 3.8e-101
 Identities = 210/386 (54%), Positives = 267/386 (69%)

Query:    60 RDKRE-DLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVD--QLPLFSFSSVSTATNT 116
             + KR   + T  +DL    +++  EL   S+    SK+ + D  +LPL  + +++ ATN 
Sbjct:   464 KQKRSITIQTPIVDLVRSQDSLMNELVKASRSYT-SKENKTDYLELPLMEWKALAMATNN 522

Query:   117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
             FS  NKLG+GGFG VYKG+L  G EIAVKRLS  S QG  E  NE  +IAK+QH NLVRL
Sbjct:   523 FSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRL 582

Query:   177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
             LGCC+DK EK+LIYEY+ N SLD  LFD T+   L+W  R  II GIA+GLLYLHQ SR 
Sbjct:   583 LGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRC 642

Query:   237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
             RIIHRDLKASN+LLDK+M PKISDFGMARI G  E +ANT R+VGTYGYMSPEYA++GIF
Sbjct:   643 RIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIF 702

Query:   297 SIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYVWDLWTSNRTLELIDDPVLEDEY 355
             S+KSDVFSFGVLLLEI+SGK+N G Y ++  LNLLG+VW  W   + LE++D P+  D  
Sbjct:   703 SMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVD-PINIDAL 761

Query:   356 SSK---QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAF--XXXXXX 410
             SS+     +LR + I LLCVQE A+DRP M+ V+ ML +E  A+  PK+P F        
Sbjct:   762 SSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLE 821

Query:   411 XXXXXXXDKTGDCSINQVTISILEAR 436
                     +  +C++NQVT+S+++AR
Sbjct:   822 VDSSSSTQRDDECTVNQVTLSVIDAR 847

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 997 (356.0 bits), Expect = 1.7e-100, P = 1.7e-100
 Identities = 194/337 (57%), Positives = 248/337 (73%)

Query:   101 QLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKN 160
             +L ++S   + TAT+ FSD+NKLGEGGFGPVY G L  G+E+AVKRL   S QGL E KN
Sbjct:   514 ELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKN 573

Query:   161 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII 220
             E  +IAK+QH+NLVRLLGCCI ++EKIL+YEYMPNKSLD FLF+P K+ LLDW  R  II
Sbjct:   574 EVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDII 633

Query:   221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             EGIA+GLLYLH+ SR+R++HRDLKASNILLD DM PKISDFGMAR+ GG++ Q NT+R+V
Sbjct:   634 EGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVV 693

Query:   281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY-RTDSLNLLGYVWDLWTS 339
             GT+GYMSPEYA+EGIFS+KSDV+ FGVL+LEI++GK+    +   DSLN+ GY W  W  
Sbjct:   694 GTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNE 753

Query:   340 NRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP 399
             +   ELID PV+    S +QVL R ++IALLCVQ+ AD+RP +  V+ ML+N++++L  P
Sbjct:   754 DNAAELID-PVIRASCSVRQVL-RCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNP 811

Query:   400 KQPAFXXXXXXXXXXXXXDKTGDCSINQVTISILEAR 436
             + P               +K    SI  VT++ L  R
Sbjct:   812 RPPTLMLRGREIESSKSSEKDRSHSIGTVTMTQLHGR 848

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 981 (350.4 bits), Expect = 8.2e-99, P = 8.2e-99
 Identities = 207/386 (53%), Positives = 266/386 (68%)

Query:    60 RDKREDLM-TFDLDLNLKANNVNI-ELPLNSKL-IERSKKKEVDQLPLFSFSSVSTATNT 116
             + KR  L+ T  +D  L++ ++ + E+ ++S+  I R    +  +LPL  F  V+ ATN 
Sbjct:   466 KQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATNN 525

Query:   117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
             FS+ NKLG+GGFG VYKG L  G E+AVKRLS  S QG  E KNE  +IA++QH NLVRL
Sbjct:   526 FSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRL 585

Query:   177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
             L CC+D  EK+LIYEY+ N SLD  LFD ++   L+W  R  II GIA+GLLYLHQ SR 
Sbjct:   586 LACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRF 645

Query:   237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
             RIIHRDLKASNILLDK M PKISDFGMARI G +E +ANT ++VGTYGYMSPEYA++GIF
Sbjct:   646 RIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIF 705

Query:   297 SIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYVWDLWTSNRTLELIDDPVLEDEY 355
             S+KSDVFSFGVLLLEI+S K+N G Y +D  LNLLG VW  W   + LE+ID P++ D  
Sbjct:   706 SMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIID-PIITDSS 764

Query:   356 SS--KQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFXXXXXXXXX 413
             S+  +  +LR + I LLCVQE A+DRPTM+ V+ ML +E+  +  PK P +         
Sbjct:   765 STFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDT 824

Query:   414 XXXXDKTGD---CSINQVTISILEAR 436
                  K  D    ++NQ+T+S+L+AR
Sbjct:   825 DSSSSKQRDDESWTVNQITVSVLDAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 976 (348.6 bits), Expect = 2.8e-98, P = 2.8e-98
 Identities = 190/339 (56%), Positives = 246/339 (72%)

Query:    98 EVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLRE 157
             +   LP+FSF SV++AT  F++ NKLG+GGFG VYKG   +G EIAVKRLSG+S+QGL E
Sbjct:   506 DTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEE 565

Query:   158 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV 217
              KNE  +IAK+QH+NLVRLLGCCI+ +EK+L+YEYMPNKSLD FLFD +K+  LDW  R 
Sbjct:   566 FKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRW 625

Query:   218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
             ++I GIA+GLLYLH+ SR++IIHRDLKASNILLD +MNPKISDFGMARI    +  ANT 
Sbjct:   626 EVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTI 685

Query:   278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW 337
             R+VGTYGYM+PEYA+EGIFS KSDV+SFGVL+LEIVSG+KN     TD  +L+GY W LW
Sbjct:   686 RVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLW 745

Query:   338 TSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALH 397
             +  +T E+ID P+++D     + + R +++ +LC Q+S   RP M  V+ ML ++ + L 
Sbjct:   746 SQGKTKEMID-PIVKDTRDVTEAM-RCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLP 803

Query:   398 PPKQPAFXXXXXXXXXXXXXDKTGDCSINQVTISILEAR 436
             PP+QP F             D     S+N VT + +  R
Sbjct:   804 PPRQPTFHSFLNSGDIELNFDGHDVASVNDVTFTTIVGR 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
 Identities = 187/340 (55%), Positives = 243/340 (71%)

Query:   105 FSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASV 164
             F F ++  ATN F +TNKLG+GGFG VYKG+   G ++AVKRLS  S QG RE  NE  V
Sbjct:   339 FDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIV 398

Query:   165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
             +AK+QH+NLVRLLG C+++DE+IL+YE++PNKSLD+F+FD T + LLDW  R +II GIA
Sbjct:   399 VAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIA 458

Query:   225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
             +G+LYLHQ SR+ IIHRDLKA NILL  DMN KI+DFGMARI G ++ +ANT RIVGTYG
Sbjct:   459 RGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYG 518

Query:   285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL---NLLGYVWDLWTSNR 341
             YMSPEYA+ G FS+KSDV+SFGVL+LEI+SGKKN+ +Y+ D     NL+ Y W LW++  
Sbjct:   519 YMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWSNGS 578

Query:   342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQ 401
              LEL+D P   D Y   +V  R ++IALLCVQE A+DRPTM+ +V MLT  + AL  P++
Sbjct:   579 PLELVD-PSFRDNYRINEVS-RCIHIALLCVQEEAEDRPTMSAIVQMLTTSSIALAVPQR 636

Query:   402 PAFXXXXXXXXXXXXXDK-----TGDCSINQVTISILEAR 436
             P F             D+     +  CS++  +I+ +  R
Sbjct:   637 PGFFFRSSKHEQVGLVDRLSINTSALCSVDDASITNVTPR 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
 Identities = 194/368 (52%), Positives = 255/368 (69%)

Query:    72 DLNLKANNVNIE-LPLNSKLIERSKKKEVD-QLPLFSFSSVSTATNTFSDTNKLGEGGFG 129
             DL ++  +  IE L   S  +   K++E D +LP     +VS AT+ FS  NKLG+GGFG
Sbjct:   418 DLYVRLASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFG 477

Query:   130 PVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 189
             PVYKG L  G E+AVKRLS  S QG+ E KNE  +IAK+QH+NLV++LG C+D++E++LI
Sbjct:   478 PVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLI 537

Query:   190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 249
             YEY PNKSLD F+FD  +R  LDW  RV+II+GIA+G+LYLH+ SR+RIIHRDLKASN+L
Sbjct:   538 YEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVL 597

Query:   250 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 309
             LD DMN KISDFG+AR  GG+E +ANT+R+VGTYGYMSPEY ++G FS+KSDVFSFGVL+
Sbjct:   598 LDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLV 657

Query:   310 LEIVSGKKNTGLYRTD-SLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIA 368
             LEIVSG++N G    +  LNLLG+ W  +  ++  E+ID+ V E      +VL R ++I 
Sbjct:   658 LEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVL-RVIHIG 716

Query:   369 LLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFXXXXXXXXXXXXXDKTGDCSINQV 428
             LLCVQ+   DRP M+ VV ML++E   L P +QP F                   S N  
Sbjct:   717 LLCVQQDPKDRPNMSVVVLMLSSEMLLLDP-RQPGFFNERNLLFSDTVSINLEIPSNNFQ 775

Query:   429 TISILEAR 436
             T+S+++ R
Sbjct:   776 TMSVIDPR 783

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
 Identities = 186/343 (54%), Positives = 247/343 (72%)

Query:    95 KKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG 154
             +++++D LP+F   ++S AT+ FS  N LG GGFGPVYKG L  G EIAVKRLS  S QG
Sbjct:   479 EEEDLD-LPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQG 537

Query:   155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV 214
             + E KNE  +IAK+QH+NLVRLLGCCI  +E +LIYEYMPNKSLDFF+FD  +   LDW 
Sbjct:   538 VEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWK 597

Query:   215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 274
              R+ II G+A+G+LYLHQ SR+RIIHRDLKA N+LLD DMNPKISDFG+A+  GG++ ++
Sbjct:   598 KRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSES 657

Query:   275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYV 333
             +T+R+VGTYGYM PEYA++G FS+KSDVFSFGVL+LEI++GK N G    D  LNLLG+V
Sbjct:   658 STNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHV 717

Query:   334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 393
             W +W  +R +E+ ++  LE+     +VL R +++ALLCVQ+  +DRPTM  VV M  +++
Sbjct:   718 WKMWVEDREIEVPEEEWLEETSVIPEVL-RCIHVALLCVQQKPEDRPTMASVVLMFGSDS 776

Query:   394 AALHPPKQPAFXXXXXXXXXXXXXDKTGDCSINQVTISILEAR 436
             +  HP  QP F                   S N+V+I++L+ R
Sbjct:   777 SLPHPT-QPGFFTNRNVPDISSSLSLR---SQNEVSITMLQGR 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	436
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-58
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-56
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-56
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-47
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-36
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-36
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-34
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-34
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-34
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-32
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-31
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-31
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-31
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-30
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-30
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-28
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-28
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-27
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-27
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-26
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-26
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-26
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-25
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-24
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-24
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-24
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-24
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-24
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-23
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-23
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-23
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-22
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-22
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-22
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-22
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-22
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-21
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-21
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-20
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-20
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-20
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-19
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-19
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-19
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-19
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-18
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-17
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-13
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-10
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	9e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-08
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	3e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	8e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	8e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	7e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.001
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.003

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  192 bits (491), Expect = 1e-58
 Identities = 96/294 (32%), Positives = 138/294 (46%), Gaps = 56/294 (19%)

Query: 121 NKLGEGGFGPVYKGVLRKGD----EIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVR 175
            KLGEG FG VYKG L+  D    E+AVK L    SE+  ++   EA V+ K+ H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL------FDPTKRILLDWVTRVQIIEGIAQGLLY 229
           LLG C +++   L+ EYM    L  +L      F   ++  L     +     IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG----- 284
           L      + +HRDL A N L+ +D+  KISDFG++R     ++  +      T G     
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIR 172

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGLYRTDSLNLLGYVWDLW 337
           +M+PE   +GIF+ KSDV+SFGVLL EI +       G  N  +                
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY------------- 219

Query: 338 TSNRTLELIDDPVLED-EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
                  L     L   EY   ++   Y  + L C Q   +DRPT +++V  L 
Sbjct: 220 -------LRKGYRLPKPEYCPDEL---Y-ELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  186 bits (475), Expect = 2e-56
 Identities = 88/281 (31%), Positives = 135/281 (48%), Gaps = 42/281 (14%)

Query: 122 KLGEGGFGPVYKGVLRKGD-----EIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
           KLGEG FG VYKG L+        E+AVK L    SEQ + E   EA ++ K+ H N+V+
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           LLG C +++   ++ EYM    L  +L     ++       +     IA+G+ YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL--SLSDLLSFALQIARGMEYLE---S 120

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL A N L+ +++  KISDFG++R    ++        +    +M+PE   EG 
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKEGK 179

Query: 296 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLWTSNRTLELIDD------ 348
           F+ KSDV+SFGVLL EI +               LG   +   ++   LE + +      
Sbjct: 180 FTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLEYLKNGYRLPQ 224

Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           P         ++     ++ L C  E  +DRPT +++V +L
Sbjct: 225 P----PNCPPEL----YDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  185 bits (472), Expect = 6e-56
 Identities = 90/281 (32%), Positives = 135/281 (48%), Gaps = 41/281 (14%)

Query: 122 KLGEGGFGPVYKGVLRKGD-----EIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
           KLGEG FG VYKG L+        E+AVK L    SEQ + E   EA ++ K+ H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           LLG C +++  +++ EYMP   L  +L    +   L     +     IA+G+ YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL A N L+ +++  KISDFG++R    ++        +    +M+PE   EG 
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPESLKEGK 180

Query: 296 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLWTSNRTLELIDD------ 348
           F+ KSDV+SFGVLL EI +               LG   +   ++   LE +        
Sbjct: 181 FTSKSDVWSFGVLLWEIFT---------------LGEEPYPGMSNAEVLEYLKKGYRLPK 225

Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           P         ++      + L C  E  +DRPT +++V +L
Sbjct: 226 P----PNCPPEL----YKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  184 bits (470), Expect = 1e-55
 Identities = 96/282 (34%), Positives = 138/282 (48%), Gaps = 43/282 (15%)

Query: 122 KLGEGGFGPVYKGVLRKGDE-----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
           KLGEG FG VYKG L+   E     +AVK L  G SE+   E   EAS++ K+ H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           LLG C   +   ++ EYMP   L  FL        L     +Q+   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEG 294
              +HRDL A N L+ +++  KISDFG++R I   +  +      +    +M+PE   +G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDG 179

Query: 295 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLWTSNRTLELIDD----- 348
            F+ KSDV+SFGVLL EI +               LG   +   ++   LEL++D     
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLELLEDGYRLP 224

Query: 349 -PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
            P    E    ++   Y  + L C     +DRPT +++V  L
Sbjct: 225 RP----ENCPDEL---Y-ELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  172 bits (438), Expect = 2e-51
 Identities = 74/194 (38%), Positives = 108/194 (55%), Gaps = 11/194 (5%)

Query: 123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREM-KNEASVIAKVQHKNLVRLLGCC 180
           LGEGGFG VY    +K G ++A+K +       L E    E  ++ K+ H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            D++   L+ EY    SL   L +   +  L     ++I+  I +GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 241 RDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-EGIFSI 298
           RDLK  NILLD D    K++DFG++++   ++    T  IVGT  YM+PE  L +G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 299 KSDVFSFGVLLLEI 312
           KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  167 bits (426), Expect = 4e-49
 Identities = 73/199 (36%), Positives = 106/199 (53%), Gaps = 12/199 (6%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           KLG G FG VYK   +  G  +AVK L       +  +  + E  ++ ++ H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              DKD   L+ EY     L  +L   ++   L      +I   I +GL YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSN---GI 119

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FS 297
           IHRDLK  NILLD++   KI+DFG+A+    +   ++ +  VGT  YM+PE  L G  + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 298 IKSDVFSFGVLLLEIVSGK 316
            K DV+S GV+L E+++GK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  163 bits (414), Expect = 2e-47
 Identities = 72/204 (35%), Positives = 106/204 (51%), Gaps = 15/204 (7%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLV 174
           +    KLGEG FG VY    +K G  +A+K +  +  +  RE +  E  ++ K++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QIIEGIAQGLLYLHQ 232
           RL     D+D+  L+ EY     L F L     R+  D       QI+  +     YLH 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDL-FDLLKKRGRLSEDEARFYLRQILSALE----YLHS 115

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
                I+HRDLK  NILLD+D + K++DFG+AR     E     +  VGT  YM+PE  L
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLL 169

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGK 316
              +    D++S GV+L E+++GK
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  149 bits (379), Expect = 3e-42
 Identities = 73/207 (35%), Positives = 112/207 (54%), Gaps = 23/207 (11%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
             LG G FG VY  + +  G+ +AVK   LSG SE+ L  ++ E  +++ +QH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 178 GCCIDKDEK-ILIY-EYMPNKSLDFFL--F----DPTKRILLDWVTRVQIIEGIAQGLLY 229
           G   D+++  + I+ EY+   SL   L  F    +P  R      TR QI+EG+A    Y
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY----TR-QILEGLA----Y 116

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           LH      I+HRD+K +NIL+D D   K++DFG A+  G  E    T  + GT  +M+PE
Sbjct: 117 LH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGK 316
                 +   +D++S G  ++E+ +GK
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  134 bits (339), Expect = 1e-36
 Identities = 71/204 (34%), Positives = 109/204 (53%), Gaps = 15/204 (7%)

Query: 117 FSDTNKLGEGGFGPVYKG-VLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           F    K+G+GGFG VYK    R G E+A+K +   S++   ++ NE  ++ K +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI---IEGIAQGLLYLHQ 232
             G  + KDE  ++ E+    SL   L   T + L    T  QI    + + +GL YLH 
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTL----TESQIAYVCKELLKGLEYLHS 116

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
                IIHRD+KA+NILL  D   K+ DFG++     +    NT  +VGT  +M+PE   
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNT--MVGTPYWMAPEVIN 170

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGK 316
              +  K+D++S G+  +E+  GK
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  132 bits (335), Expect = 6e-36
 Identities = 74/199 (37%), Positives = 106/199 (53%), Gaps = 18/199 (9%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRL---SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           KLG G FG V+ G      ++AVK L   +   E  L+E    A ++ K++H  LV+L  
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQE----AQIMKKLRHDKLVQLYA 68

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
            C +++   ++ EYM   SL  FL     + L      V +   IA+G+ YL        
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SRNY 124

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 295
           IHRDL A NIL+ +++  KI+DFG+AR+   +E  A       I  T    +PE A  G 
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGR 180

Query: 296 FSIKSDVFSFGVLLLEIVS 314
           F+IKSDV+SFG+LL EIV+
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  128 bits (324), Expect = 2e-34
 Identities = 75/268 (27%), Positives = 124/268 (46%), Gaps = 34/268 (12%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            LG+G  G VYK   +  G   A+K++     E+  +++  E   +   +   +V+  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRI---LLDWVTRVQIIEGIAQGLLYLHQYSRV 236
              + E  ++ EYM   SL   L     +I   +L ++ R QI+    +GL YLH     
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLL-KKVGKIPEPVLAYIAR-QIL----KGLDYLHTKRH- 120

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            IIHRD+K SN+L++     KI+DFG++++      Q NT   VGT  YMSPE      +
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPERIQGESY 177

Query: 297 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI---DDPVLED 353
           S  +D++S G+ LLE   GK     +         + ++L      ++ I     P L  
Sbjct: 178 SYAADIWSLGLTLLECALGK-----FPFLPPGQPSF-FEL------MQAICDGPPPSLPA 225

Query: 354 EYSSKQVLLRYVNIALLCVQESADDRPT 381
           E  S +    +++    C+Q+    RP+
Sbjct: 226 EEFSPE-FRDFIS---ACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  127 bits (321), Expect = 6e-34
 Identities = 67/203 (33%), Positives = 109/203 (53%), Gaps = 16/203 (7%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           F+   KLG G FG V++G+ +    +A+K L        ++ + E   + +++HK+L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI-----LLDWVTRVQIIEGIAQGLLYLH 231
              C   +   +I E M   SL  FL  P  ++     L+D   +V      A+G+ YL 
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV------AEGMAYLE 121

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
           +      IHRDL A NIL+ +D+  K++DFG+AR+   +   ++  +I   Y + +PE A
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAA 176

Query: 292 LEGIFSIKSDVFSFGVLLLEIVS 314
             G FS KSDV+SFG+LL E+ +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  127 bits (321), Expect = 8e-34
 Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 32/290 (11%)

Query: 121 NKLGEGGFGPVYKGVL-----RKGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLV 174
            +LGEG FG V            G+++AVK L+    EQ   + + E  ++  + H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 175 RLLGCCIDKDEKI--LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           +  G C     +   LI EY+P+ SL  +L     R  ++    +     I +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEY 290
               R IHRDL A NIL++ +   KISDFG+A++     +            + Y +PE 
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-- 348
                FS  SDV+SFGV L E+ +    +     + L ++G         R LEL+ +  
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243

Query: 349 -----PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 393
                P   DE           ++  LC +    DRP+  D++ ++    
Sbjct: 244 RLPRPPSCPDE---------VYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  124 bits (312), Expect = 1e-32
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 30/218 (13%)

Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVR 175
           LGEG FG V+ G     +       +AVK L   +    R+  + EA ++   QH+N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRIL---------LDWVTRVQIIEGIA 224
             G C + D  I+++EYM +  L+ FL    P    L         L     +QI   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT-- 282
            G++YL   +    +HRDL   N L+  D+  KI DFGM+R    +    +  R+ G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185

Query: 283 --YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 317
               +M PE  +   F+ +SDV+SFGV+L EI + GK+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  122 bits (307), Expect = 8e-32
 Identities = 74/212 (34%), Positives = 110/212 (51%), Gaps = 23/212 (10%)

Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLVR 175
           LGEG FG VYKG L   +E      +A+K L   +E  ++ E + EA +++ +QH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLF-------------DPTKRILLDWVTRVQIIEG 222
           LLG C  +    +++EY+ +  L  FL              D T +  LD    + I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           IA G+ YL   S    +HRDL A N L+ + +  KISDFG++R     +     S+ +  
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
             +M PE  L G F+ +SD++SFGV+L EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (305), Expect = 1e-31
 Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 15/194 (7%)

Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           +G+G FG V  G  R G ++AVK L        +    EASV+  ++H NLV+LLG  + 
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRD 242
            +   ++ EYM   SL  +L     R ++    ++     + +G+ YL +      +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 243 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEGIFSIKS 300
           L A N+L+ +D+  K+SDFG+A+       +A+  +  G     + +PE   E  FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180

Query: 301 DVFSFGVLLLEIVS 314
           DV+SFG+LL EI S
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 1e-31
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 15/201 (7%)

Query: 121 NKLGEGGFGPVYKGV-LRKGDEIAVKRLS--GRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           + +G G FG VYKG+ L  GD +A+K++S     E+ L+ +  E  ++  ++H N+V+ +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           G     D   +I EY  N SL   +  F P    L   V     +  + QGL YLH+   
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---VAV--YVYQVLQGLAYLHEQG- 119

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
             +IHRD+KA+NIL  KD   K++DFG+A           +  +VGT  +M+PE      
Sbjct: 120 --VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSG 175

Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
            S  SD++S G  ++E+++G 
Sbjct: 176 ASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  120 bits (304), Expect = 1e-31
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 25/209 (11%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEI--AVKR--LSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
            ++G+G FG VY  V RK D     +K   LS  SE+   +  NE  ++ K+ H N+++ 
Sbjct: 6   KQIGKGSFGKVYL-VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-------ILLDWVTRVQIIEGIAQGLLY 229
                +K +  ++ EY     L   +    K         +LDW   VQ+       L Y
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQL----CLALKY 118

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           LH  SR +I+HRD+K  NI L  +   K+ DFG++++       A T  +VGT  Y+SPE
Sbjct: 119 LH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE 173

Query: 290 YALEGI-FSIKSDVFSFGVLLLEIVSGKK 317
              +   ++ KSD++S G +L E+ + K 
Sbjct: 174 -LCQNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  119 bits (301), Expect = 3e-31
 Identities = 76/207 (36%), Positives = 115/207 (55%), Gaps = 17/207 (8%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDE--IAVKR--LSGRSEQGLREMKNEASVIAKVQHKN 172
           F   NK+G+G FG V+K V+RK D+   A+K+  LS  + +   E  +EA V+AK+    
Sbjct: 2   FEILNKIGKGSFGVVFK-VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLD---WVTRVQIIEGIAQGLLY 229
           ++R     +DK +  ++ EY  N  L   L     R L +   W   +QI+ G+A    +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           LH     +I+HRD+K+ N+ LD   N KI D G+A++   N   ANT  IVGT  Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGK 316
              +  ++ KSDV++ GV+L E  +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 4e-31
 Identities = 70/206 (33%), Positives = 115/206 (55%), Gaps = 21/206 (10%)

Query: 123 LGEGGFGPVYKGVLR-KGD----EIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRL 176
           LG G FG VYKGV   +G+     +A+K L   +  +  +E+ +EA V+A V H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYLHQ 232
           LG C+   +  LI + MP   L  ++ +    I    LL+W  +      IA+G+ YL +
Sbjct: 75  LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
               R++HRDL A N+L+    + KI+DFG+A++   +E + +         +M+ E  L
Sbjct: 128 ---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 293 EGIFSIKSDVFSFGVLLLEIVS-GKK 317
             I++ KSDV+S+GV + E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  119 bits (299), Expect = 6e-31
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L       + E   EA+V+ +++H NLV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL + +    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 185

Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 186 SDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  118 bits (299), Expect = 9e-31
 Identities = 83/279 (29%), Positives = 140/279 (50%), Gaps = 40/279 (14%)

Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V +G L+   +    +A+K L +G S++   +   EAS++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        ++I EYM N SLD FL +   +        V ++ GIA G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS--RIVGTYGYMSPEYALEGI 295
            +HRDL A NIL++ ++  K+SDFG++R    +E    T   +I     + +PE      
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRK 184

Query: 296 FSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD----PV 350
           F+  SDV+SFG+++ E++S G++    Y           WD  ++   ++ ++D    P 
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP---Y-----------WD-MSNQDVIKAVEDGYRLPP 229

Query: 351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
             D       L +   + L C Q+  ++RPT + +VS L
Sbjct: 230 PMD---CPSALYQ---LMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  118 bits (299), Expect = 2e-30
 Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 25/208 (12%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           + +  K+GEG  G VYK   R  G E+A+K++  R  Q    + NE  ++   +H N+V 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG-IA-------QGL 227
                +  DE  ++ EYM   SL       T   ++     V++ E  IA       QGL
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSL-------TD--IITQ-NFVRMNEPQIAYVCREVLQGL 129

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YLH      +IHRD+K+ NILL KD + K++DFG A      + + N+  +VGT  +M+
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMA 184

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           PE      +  K D++S G++ +E+  G
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 3e-30
 Identities = 74/207 (35%), Positives = 100/207 (48%), Gaps = 27/207 (13%)

Query: 121 NKLGEGGFGPVYKGVLR--KGDEI--AVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG G FG V KGV     G E+  AVK L       G +E   EASV+A++ H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLH 231
           L+G C   +  +L+ E  P   L  +L      P   +      +V      A G+ YL 
Sbjct: 61  LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-LAHQV------AMGMAYLE 112

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTY--GYMS 287
                  +HRDL A N+LL      KISDFGM+R    G +  +A T+   G +   + +
Sbjct: 113 S---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---GRWPLKWYA 166

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVS 314
           PE    G FS KSDV+S+GV L E  S
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 4e-30
 Identities = 65/196 (33%), Positives = 103/196 (52%), Gaps = 12/196 (6%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG G FG V++G+      +AVK L   +    ++   EA ++ K++H  L++L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 182 DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 241
            ++   ++ E M   SL  +L     R L      + +   +A G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 242 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFSI 298
           DL A N+L+ ++   K++DFG+AR+   +  +A      G      + +PE AL   FSI
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183

Query: 299 KSDVFSFGVLLLEIVS 314
           KSDV+SFG+LL EIV+
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  116 bits (293), Expect = 7e-30
 Identities = 86/291 (29%), Positives = 129/291 (44%), Gaps = 47/291 (16%)

Query: 121 NKLGEGGFGPVYKGVL--RKGD----EIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNL 173
             LG G FG VY+G+   R GD    ++AVK L    SEQ   +   EA +++K  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------PTKRILLDWVTRVQIIEGIAQG 226
           VRL+G   ++  + ++ E M    L  FL +       P+   + D +        +A+G
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL---FCARDVAKG 128

Query: 227 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTY 283
             YL +      IHRD+ A N LL         KI+DFGMAR            R +   
Sbjct: 129 CKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL 343
            +M PE  L+GIF+ K+DV+SFGVLL EI S               LGY+   +      
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS---------------LGYM--PYPGRTNQ 228

Query: 344 ELIDDPV----LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           E+++       L+        + R   I   C Q + +DRP    ++  + 
Sbjct: 229 EVMEFVTGGGRLDPPKGCPGPVYR---IMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  116 bits (291), Expect = 7e-30
 Identities = 68/197 (34%), Positives = 103/197 (52%), Gaps = 10/197 (5%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE--QGLRE-MKNEASVIAKVQHKNLVRLLG 178
           K+G+G FG VYKGVL+   E+AVK  + RS     L+     EA ++ +  H N+V+L+G
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVK--TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
            C+ K    ++ E +P  SL  FL     R+ +     +Q+    A G+ YL   +    
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKN---C 114

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           IHRDL A N L+ ++   KISDFGM+R   G     +         + +PE    G ++ 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 299 KSDVFSFGVLLLEIVSG 315
           +SDV+S+G+LL E  S 
Sbjct: 175 ESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  111 bits (280), Expect = 3e-28
 Identities = 70/197 (35%), Positives = 109/197 (55%), Gaps = 15/197 (7%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQHKNLVRLLG 178
           KLG G FG V+ G      ++A+K L    +QG    +    EA+++ ++QH  LVRL  
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 179 CCIDKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
             + ++   +I EYM N SL DF       ++ ++    + +   IA+G+ ++    R  
Sbjct: 69  V-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIE---RKN 122

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
            IHRDL+A+NIL+ + +  KI+DFG+AR+   NE  A          + +PE    G F+
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFT 181

Query: 298 IKSDVFSFGVLLLEIVS 314
           IKSDV+SFG+LL EIV+
Sbjct: 182 IKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  111 bits (280), Expect = 3e-28
 Identities = 74/210 (35%), Positives = 110/210 (52%), Gaps = 22/210 (10%)

Query: 123 LGEGGFGPVYKG----VLRKGDE---IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLV 174
           LG G FG VY+G    +L  G     +AVK L  G ++Q  +E   EA +++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYL 230
           +LLG C+  + + +I E M    L  +L D         LL     + I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 231 HQYSRVRIIHRDLKASNILL-----DKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYG 284
            Q   +  IHRDL A N L+     D D   KI DFG+AR I   +  +     ++    
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +M+PE  L+G F+ +SDV+SFGVL+ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  111 bits (280), Expect = 3e-28
 Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 18/200 (9%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           KLGEG +G VYK + ++ G  +A+K +    E+ L+E+  E S++ +     +V+  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 181 IDKDEKILIYEYMPNKS-LDFFLFDPTKRILLDWVTRVQI---IEGIAQGLLYLHQYSRV 236
               +  ++ EY    S  D  +   T + L    T  +I   +    +GL YLH     
Sbjct: 68  FKNTDLWIVMEYCGAGSVSD--IMKITNKTL----TEEEIAAILYQTLKGLEYLHS---N 118

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
           + IHRD+KA NILL+++   K++DFG++        + NT  ++GT  +M+PE   E  +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGY 176

Query: 297 SIKSDVFSFGVLLLEIVSGK 316
           + K+D++S G+  +E+  GK
Sbjct: 177 NNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  111 bits (279), Expect = 7e-28
 Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 33/227 (14%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK-----NEASVIAKV 168
           + F     +GEG F  V     ++   E A+K L  R  Q ++E K      E  V+ ++
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58

Query: 169 -QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
             H  +++L     D++    + EY PN  L  ++    K   LD          I   L
Sbjct: 59  NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLAL 115

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL--------------- 272
            YLH      IIHRDLK  NILLDKDM+ KI+DFG A++   N                 
Sbjct: 116 EYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 273 ---QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
              +   +  VGT  Y+SPE   E      SD+++ G ++ ++++GK
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  110 bits (278), Expect = 8e-28
 Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 24/205 (11%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEI-AVK--RLSGRSE---QGLREMKNEASVIAKVQHKNLV 174
            +LG G  G V K + R   +I AVK  RL        Q LRE+     ++ K     +V
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD----ILHKCNSPYIV 62

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
              G   +  +  +  EYM   SLD  L +   RI    + +  I   + +GL YLH   
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLH--E 118

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL---QANTSRIVGTYGYMSPEYA 291
           + +IIHRD+K SNIL++     K+ DFG++      +L    A T   VGT  YM+PE  
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG-----QLVNSLAKTF--VGTSSYMAPERI 171

Query: 292 LEGIFSIKSDVFSFGVLLLEIVSGK 316
               +S+KSD++S G+ L+E+ +G+
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 8e-28
 Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLL 177
           LG+G FG V   V +K      A+K L  +     + +     E ++++++ H  +V+L 
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 178 GCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                 +EK+ L+ EY P   L   L    +    +   R    E I   L YLH    +
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAE-IVLALEYLH---SL 112

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            II+RDLK  NILLD D + K++DFG+A+       + NT    GT  Y++PE  L   +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGY 170

Query: 297 SIKSDVFSFGVLLLEIVSGK 316
               D +S GVLL E+++GK
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  110 bits (276), Expect = 9e-28
 Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 17/210 (8%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           ++G G FG V+ G   +  ++A+K  R    SE+   +   EA V+ K+ H  LV+L G 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGV 67

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C ++    L++E+M +  L  +L    +R      T + +   + +G+ YL   +   +I
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIF 296
           HRDL A N L+ ++   K+SDFGM R    ++  ++T    GT     + SPE      +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKY 178

Query: 297 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
           S KSDV+SFGVL+ E+ S  K     R++S
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  110 bits (276), Expect = 1e-27
 Identities = 77/269 (28%), Positives = 132/269 (49%), Gaps = 38/269 (14%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLS-----GRSEQGLREMKNEASVIAKVQHKNLVRL 176
           LG G FG VY+G+ L  GD  AVK +S        ++ +++++ E ++++K+QH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 177 LGCCIDKDEKILIY-EYMPNKSLDFFL--FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           LG   + ++ + I+ E +P  SL   L  +      ++   TR QI+ G+     YLH  
Sbjct: 68  LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLH-- 119

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL- 292
            R   +HRD+K +NIL+D +   K++DFGMA+        +      G+  +M+PE    
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE 352
           +G + + +D++S G  +LE+ +GK          L  +  V+ +  S     + D   L 
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWS-----QLEGVAAVFKIGRSKELPPIPDH--LS 228

Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPT 381
           DE           +  L C+Q     RPT
Sbjct: 229 DEAK---------DFILKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  110 bits (276), Expect = 1e-27
 Identities = 82/284 (28%), Positives = 125/284 (44%), Gaps = 36/284 (12%)

Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVR 175
           LG G FG V+    +  +E      + VK L    ++    E + E  +  K+ HKN+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL------FDPTKRILLDWVTRVQIIEGIAQGLLY 229
           LLG C + +   +I EY     L  FL       +  K   L    +V +   IA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           L   S  R +HRDL A N L+      K+S   +++    +E     + ++    +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
              E  FS KSDV+SFGVL+ E+ +  +    GL   + LN L            LEL  
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ--------AGKLEL-- 238

Query: 348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
            PV E   S    L+        C   +  DRP+ +++VS L  
Sbjct: 239 -PVPEGCPSRLYKLM------TRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  109 bits (274), Expect = 2e-27
 Identities = 91/273 (33%), Positives = 137/273 (50%), Gaps = 32/273 (11%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG G FG V+ G      ++AVK L   +   ++    EA+++  +QH  LVRL    +
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV-V 70

Query: 182 DKDEKI-LIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
            K+E I +I EYM   SL DF   D   ++LL     +     IA+G+ Y+    R   I
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYI 125

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL+A+N+L+ + +  KI+DFG+AR+   NE  A          + +PE    G F+IK
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIK 184

Query: 300 SDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDL-WTSNRTLELIDDPVLEDEYS 356
           SDV+SFG+LL EIV+  K    G+  +D ++ L   + +    N   EL D         
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD--------- 235

Query: 357 SKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
                     I   C +E A++RPT + + S+L
Sbjct: 236 ----------IMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 3e-27
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 29/210 (13%)

Query: 121 NKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSE------QGLREMKNEASVIAKVQHKNL 173
            ++GEG +G VYK    + G+ +A+K++   +E        +RE+K    ++ K++H N+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLRHPNI 60

Query: 174 VRLLGCCIDKDEK--ILIYEYMPNKSLDF--FLFDPTKRILLDWVTRV--QIIEGIAQGL 227
           VRL      K +    +++EYM +   D    L  P  +     +     Q++EG+    
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQ--- 114

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YLH      I+HRD+K SNIL++ D   K++DFG+AR          T+R++ T  Y  
Sbjct: 115 -YLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169

Query: 288 PEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
           PE  L    +  + D++S G +L E+  GK
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 4e-27
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 29/212 (13%)

Query: 123 LGEGGFGPVYKGVLR---KGD---EIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLVR 175
           LG+G FG VY+G+ +   KG+    +A+K ++  +    R E  NEASV+ +    ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 176 LLGCCIDKDEKILIYEYM-------------PNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
           LLG        +++ E M             P    +  L  PT +  +           
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE------ 127

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           IA G+ YL      + +HRDL A N ++ +D+  KI DFGM R     +      + +  
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
             +M+PE   +G+F+ KSDV+SFGV+L E+ +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 7e-27
 Identities = 74/226 (32%), Positives = 117/226 (51%), Gaps = 39/226 (17%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRL-SGRSEQG-----LREMKNEASVIAKVQ 169
           +    KLGEG +G VYK   +K  EI A+K++     E+G     LRE+    S++ +++
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREI----SLLKELK 56

Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL------FDPT--KRILLDWVTRVQIIE 221
           H N+V+LL     + +  L++EY  +  L  +L        P   K I+       Q++ 
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMY------QLLR 109

Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
           G+A    Y H     RI+HRDLK  NIL+++D   K++DFG+AR   G  L+  T  +V 
Sbjct: 110 GLA----YCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV- 160

Query: 282 TYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
           T  Y +PE  L    +S   D++S G +  E+++GK    L+  DS
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK---PLFPGDS 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (276), Expect = 7e-27
 Identities = 79/325 (24%), Positives = 130/325 (40%), Gaps = 22/325 (6%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGLREMKNEASVIAKVQH-KNLVRLL 177
           KLGEG FG VY    RK   +A+K L+ + E   + +     E  ++A + H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
               D+    L+ EY+   SL+  L    ++  L     + I+  I   L YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 238 IIHRDLKASNILLDKDMN-PKISDFGMARICGGN----ELQANTSRIVGTYGYMSPEYAL 292
           IIHRD+K  NILLD+D    K+ DFG+A++         + A  S  VGT GYM+PE  L
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 293 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
                  S  SD++S G+ L E++     TGL   +                 L      
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELL-----TGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSNVRN 409
                 + + +     ++    + +   +R + +  +S        L            +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296

Query: 410 TVTSTSSTDKTGDCSINQVTISILE 434
           +     S   + +  I+ +    + 
Sbjct: 297 SAPLRLSLPPSLEALISSLNSLAIS 321

Length = 384

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 80/273 (29%), Positives = 124/273 (45%), Gaps = 33/273 (12%)

Query: 123 LGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LG G FG V+ G  R   ++A+K  R    SE    E   EA V+ K+ H NLV+L G C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYGVC 68

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             +    ++ EYM N  L  +L +   ++  +W+  + +   + + + YL        IH
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FIH 123

Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFS 297
           RDL A N L+ +D   K+SDFG+AR    ++  ++     GT     +  PE      FS
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFS 179

Query: 298 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSS 357
            KSDV+SFGVL+ E+ S  K                ++ ++++  +E +        Y  
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMP--------------YERFSNSEVVESVSAGYR--LYRP 223

Query: 358 KQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           K        I   C  E  +DRP    ++S LT
Sbjct: 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  106 bits (266), Expect = 3e-26
 Identities = 71/213 (33%), Positives = 113/213 (53%), Gaps = 30/213 (14%)

Query: 121 NKLGEGGFGPVYKGV-LRKGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           NK+G G FG VY  V L  G+ +AVK  R+     + ++E+ +E  V+  ++H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLYLHQYS 234
           G  + +++  +  EY    +L+  L     RIL + V RV   Q++EG+A    YLH + 
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLA----YLHSH- 118

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-------VGTYGYMS 287
              I+HRD+K +NI LD +   K+ DFG A       L+ NT+ +        GT  YM+
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVK-----LKNNTTTMGEEVQSLAGTPAYMA 171

Query: 288 PEYALEGIFSIK---SDVFSFGVLLLEIVSGKK 317
           PE    G        +D++S G ++LE+ +GK+
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  106 bits (265), Expect = 4e-26
 Identities = 84/283 (29%), Positives = 143/283 (50%), Gaps = 47/283 (16%)

Query: 123 LGEGGFGPVYKGVL----RKGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V++G+L    RK   +A+K L  G +E+  ++  +EAS++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        ++I EYM N +LD +L D            V ++ GIA G+ YL   S + 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYA 291
            +HRDL A NIL++ ++  K+SDFG++R+     L+ +      T G      + +PE  
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 292 LEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-- 348
               F+  SDV+SFG+++ E++S G++                WD+ +++  ++ I+D  
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP--------------YWDM-SNHEVMKAINDGF 227

Query: 349 --PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
             P   D  S+   L+      L C Q+    RP   D+V++L
Sbjct: 228 RLPAPMDCPSAVYQLM------LQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  106 bits (266), Expect = 4e-26
 Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 22/215 (10%)

Query: 122 KLGEGGFGPVY----KGVLRKGDE--IAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +LGEG FG V+      +L + D+  +AVK L   SE   ++ + EA ++  +QH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRIL----------LDWVTRVQIIEGI 223
             G C +    ++++EYM +  L+ FL    P  +IL          L     + I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 283
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +   
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 317
            +M PE  L   F+ +SD++SFGV+L EI + GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  105 bits (264), Expect = 5e-26
 Identities = 73/197 (37%), Positives = 109/197 (55%), Gaps = 15/197 (7%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLS--GRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           KLG G FG V+ G      ++AVK L     S +   E   EA ++ K++H  LV+L   
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKLRHDKLVQLYAV 69

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
            + ++   ++ EYM   SL  FL D   R L      V +   +A G+ Y+    R+  I
Sbjct: 70  -VSEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYI 124

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEGIFS 297
           HRDL+++NIL+   +  KI+DFG+AR+   NE    T+R    +   + +PE AL G F+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFT 181

Query: 298 IKSDVFSFGVLLLEIVS 314
           IKSDV+SFG+LL E+V+
Sbjct: 182 IKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  105 bits (263), Expect = 1e-25
 Identities = 81/281 (28%), Positives = 124/281 (44%), Gaps = 48/281 (17%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRS-----EQGLREMKNEASVIAKVQHKNLV 174
           ++LGEG  G V K  L+    I A+K ++        +Q LRE++    +    +   +V
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSCKSPYIV 62

Query: 175 RLLGCCID-KDEKILI-YEYMPNKSLDFFLFDPTKR-------ILLDWVTRVQIIEGIAQ 225
           +  G  +D     I I  EY    SLD       KR       +L       +I E + +
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG------KIAESVLK 116

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           GL YLH     +IIHRD+K SNILL +    K+ DFG++    G  + +      GT  Y
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFY 169

Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK---KNTGLYRTDSLNLLGYVWDLWTSNRT 342
           M+PE      +SI SDV+S G+ LLE+   +      G      + LL Y+     +   
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPN 225

Query: 343 LELIDDPVLEDEYSS--KQVLLRYVNIALLCVQESADDRPT 381
            EL D+P    ++S   K  + +       C+++    RPT
Sbjct: 226 PELKDEPGNGIKWSEEFKDFIKQ-------CLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  103 bits (259), Expect = 2e-25
 Identities = 68/193 (35%), Positives = 106/193 (54%), Gaps = 13/193 (6%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
            +GEG FG V +G    G ++AVK +  + +   +    E +V+ K+ HKNLVRLLG  +
Sbjct: 13  IIGEGEFGAVLQGEY-TGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 182 DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 241
                I++ E M   +L  FL     R L+  +  +Q    +A+G+ YL      +++HR
Sbjct: 70  HNGLYIVM-ELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124

Query: 242 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 301
           DL A NIL+ +D   K+SDFG+AR+     +  + S++     + +PE      FS KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKSD 179

Query: 302 VFSFGVLLLEIVS 314
           V+S+GVLL E+ S
Sbjct: 180 VWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  103 bits (257), Expect = 4e-25
 Identities = 67/193 (34%), Positives = 105/193 (54%), Gaps = 7/193 (3%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70

Query: 182 DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 241
            ++   ++ EYM   SL  FL     +  L     V +   IA G+ Y+    R+  +HR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 242 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 301
           DL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185

Query: 302 VFSFGVLLLEIVS 314
           V+SFG+LL E+ +
Sbjct: 186 VWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  102 bits (256), Expect = 7e-25
 Identities = 70/194 (36%), Positives = 105/194 (54%), Gaps = 9/194 (4%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG G FG V+     K  ++AVK +   S   +     EA+V+  +QH  LV+L    +
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 70

Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            K+   +I E+M   SL DF   D   +  L  +  +     IA+G+ ++ Q +    IH
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAFIEQRN---YIH 125

Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+   +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 184

Query: 301 DVFSFGVLLLEIVS 314
           DV+SFG+LL+EIV+
Sbjct: 185 DVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  101 bits (252), Expect = 2e-24
 Identities = 76/273 (27%), Positives = 136/273 (49%), Gaps = 35/273 (12%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLS------GRSEQGLREMKNEASVIAKVQHKNLV 174
             LG+G +G VY G+  +G  IAVK++         +E+   +++ E  ++  ++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           + LG C+D +   +  E++P  S+   L  F P    +    T+ QI++G+A    YLH 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHN 120

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RIC--GGNELQANTSRIV-GTYGYMSP 288
                ++HRD+K +N++L  +   K+ DFG A R+   G +   +N  + + GT  +M+P
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD 348
           E   E  +  KSD++S G  + E+ +GK    L   D L  + Y+     ++R L     
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPP--LASMDRLAAMFYI----GAHRGLM---- 227

Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPT 381
           P L D +S+       ++    C+     +RP+
Sbjct: 228 PRLPDSFSAAA-----IDFVTSCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  100 bits (252), Expect = 2e-24
 Identities = 81/280 (28%), Positives = 121/280 (43%), Gaps = 38/280 (13%)

Query: 122 KLGEGGFGPVYKG----VLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           KLG+G FG V +G       K   +AVK L S +    + +   EA+++  + H+NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV-QIIEGIAQGLLYLHQYSR 235
            G  +      ++ E  P  SL   L        L  ++ +      IA G+ YL     
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFL--ISTLCDYAVQIANGMRYLESK-- 116

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYA 291
            R IHRDL A NILL  D   KI DFG+ R    NE    ++ +    V  + + +PE  
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH--LKV-PFAWCAPESL 172

Query: 292 LEGIFSIKSDVFSFGVLLLEIVS-GKKN-TGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
               FS  SDV+ FGV L E+ + G++   GL  +  L  +         ++  E ++ P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---------DKEGERLERP 223

Query: 350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
               E           N+ L C   +  DRPT   +   L
Sbjct: 224 ----EACP----QDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  101 bits (252), Expect = 3e-24
 Identities = 65/205 (31%), Positives = 111/205 (54%), Gaps = 23/205 (11%)

Query: 123 LGEGGFGPVYKGVL----RKGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V +G L    ++   +A+K L SG +E+  R+  +EAS++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        ++I E+M N +LD FL     +  +  +  V ++ GIA G+ YL + + V 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLSEMNYV- 128

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--------YMSPE 289
             HRDL A NIL++ ++  K+SDFG++R      L+ +TS    T          + +PE
Sbjct: 129 --HRDLAARNILVNSNLVCKVSDFGLSRF-----LEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVS 314
                 F+  SDV+S+G+++ E++S
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (252), Expect = 3e-24
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 27/208 (12%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLS-GRSEQGLRE----MKNEASVIAKVQHKNLVRL 176
           LG+G FG VY    +  G E+AVK++         ++    ++ E  ++  +QH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 177 LGCCIDKDEKILIY-EYMPNKSLDFFLFDPTKRILLDWVTR---VQIIEGIAQGLLYLHQ 232
            GC  D DE + I+ EYMP  S+   L       L + VTR    QI+EG+     YLH 
Sbjct: 70  YGCLRD-DETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVE----YLH- 121

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR----ICGGNELQANTSRIVGTYGYMSP 288
                I+HRD+K +NIL D   N K+ DFG ++    IC           + GT  +MSP
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS---GTGMKSVTGTPYWMSP 176

Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E      +  K+DV+S G  ++E+++ K
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  100 bits (251), Expect = 3e-24
 Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 38/276 (13%)

Query: 123 LGEGGFGP--VYKGVLRKGD-------EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNL 173
           LG+G FG   +Y+   R  D       E+ + RLS   E+  R+  NE  +++ +QH N+
Sbjct: 8   LGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNI 61

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +      +D +  ++  EY    +L +      K  L +    +  +  I   + Y+H+ 
Sbjct: 62  IAYYNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               I+HRD+K  NI L K    K+ DFG+++I G     A T  +VGT  YMSPE    
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQG 175

Query: 294 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED 353
             ++ KSD+++ G +L E+++ K+       D+ N L  V  +   N T  +        
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRT-----FDATNPLNLVVKIVQGNYTPVV-------S 223

Query: 354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
            YSS+ + L +       +Q+  + RPT ++V+   
Sbjct: 224 VYSSELISLVHS-----LLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  101 bits (252), Expect = 4e-24
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 41/224 (18%)

Query: 123 LGEGGFGPVYK----GVLRKGDE--IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +G+G FG V++    G+L       +AVK L    S     + + EA+++A+  H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFD-------------------PTKRILLDWVTR 216
           LLG C       L++EYM    L+ FL                         + L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 217 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR------ICGGN 270
           + I + +A G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R          +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           E  A   R      +M PE      ++ +SDV+++GV+L EI S
Sbjct: 190 ENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  100 bits (251), Expect = 5e-24
 Identities = 71/217 (32%), Positives = 111/217 (51%), Gaps = 31/217 (14%)

Query: 122 KLGEGGFGPVYKGVL------RKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLV 174
           +LGE  FG VYKG L       +   +A+K L  ++E  LRE  K+EA + +++QH N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLF-------------DPTKRILLDWVTRVQIIE 221
            LLG    +    +I+ Y  +  L  FL              D T +  L+    V I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
            IA G+ +L  +    ++H+DL   N+L+   +N KISD G+ R        A+  +++G
Sbjct: 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR----EVYAADYYKLMG 184

Query: 282 T----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                  +MSPE  + G FSI SD++S+GV+L E+ S
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =   99 bits (249), Expect = 6e-24
 Identities = 77/284 (27%), Positives = 141/284 (49%), Gaps = 49/284 (17%)

Query: 123 LGEGGFGPVYKGVLR----KGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V  G L+    +   +A+K L +G +E+  R+  +EAS++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL     V 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYLSDMGYV- 128

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYA 291
             HRDL A NIL++ ++  K+SDFG++R+   +   A T+R     G      + +PE  
Sbjct: 129 --HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAI 181

Query: 292 LEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-- 348
               F+  SDV+S+G+++ E++S G++                W++ ++   ++ I++  
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP--------------YWEM-SNQDVIKAIEEGY 226

Query: 349 ---PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
                ++   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 227 RLPAPMDCPAALHQLMLD-------CWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  100 bits (250), Expect = 8e-24
 Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 26/214 (12%)

Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRLSG-RSEQGLREMKNEASVIAKV-QHKNLV 174
           LGEG FG V K      D       +AVK L    +E+ L ++ +E  ++  + +HKN++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE-- 221
            LLG C  +    ++ EY  + +L  FL            D   R   + +T+  ++   
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP-RPPEETLTQKDLVSFA 138

Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             +A+G+ +L      + IHRDL A N+L+ +D   KI+DFG+AR     +    T+   
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++ +SDV+SFGVLL EI +
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 121 NKLGEGGFGPVYKGVLRKGD--EIAVKRLS-GRSEQGLREM-KNEASVIAKVQHKNLVRL 176
             +G+G FG V K V RK D   +  K +  G   +  ++   +E +++ +++H N+VR 
Sbjct: 6   ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64

Query: 177 LGCCIDKD-EKILIY-EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH--- 231
               ID+  + + I  EY     L   +    K     ++    I   + Q LL L+   
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECH 122

Query: 232 --QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
                   ++HRDLK +NI LD + N K+ DFG+A+I G +   A T   VGT  YMSPE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPE 180

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGK 316
                 +  KSD++S G L+ E+ +  
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 99.2 bits (247), Expect = 1e-23
 Identities = 82/276 (29%), Positives = 128/276 (46%), Gaps = 43/276 (15%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +LG G FG V  G  R   ++A+K  +    SE    E   EA V+ K+ H+ LV+L G 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGV 67

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE---GIAQGLLYL--HQYS 234
           C  +    ++ EYM N  L  +L +  KR         Q++E    + +G+ YL   Q+ 
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRF-----QPSQLLEMCKDVCEGMAYLESKQF- 121

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYA 291
               IHRDL A N L+D     K+SDFG++R    +E  ++    VG+     +  PE  
Sbjct: 122 ----IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVL 173

Query: 292 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL 351
           L   FS KSDV++FGVL+ E+ S  K                ++ + ++ T+E +   + 
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYSLGKMP--------------YERFNNSETVEKVSQGL- 218

Query: 352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
              Y       +   I   C  E A++RPT   ++S
Sbjct: 219 -RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 99.6 bits (248), Expect = 1e-23
 Identities = 85/285 (29%), Positives = 129/285 (45%), Gaps = 36/285 (12%)

Query: 123 LGEGGFG--------PVYKGVLRKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNL 173
           LGEG FG        P   G    G+ +AVK L     Q      K E +++  + H+N+
Sbjct: 12  LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 174 VRLLGCCIDKDEKI--LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII---EGIAQGLL 228
           V+  GCC ++  K   LI EY+P  SL  +L  P  ++ L      Q++   + I +G+ 
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNL-----AQLLLFAQQICEGMA 121

Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNE---LQANTSRIVGTYG 284
           YLH       IHRDL A N+LLD D   KI DFG+A+ +  G+E   ++ +    V  Y 
Sbjct: 122 YLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY- 177

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE 344
             + E   E  FS  SDV+SFGV L E+++   +          ++G      T  R +E
Sbjct: 178 --AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235

Query: 345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           L++          K        +   C +  A  RPT   ++ +L
Sbjct: 236 LLERG--MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 99.9 bits (249), Expect = 2e-23
 Identities = 80/273 (29%), Positives = 135/273 (49%), Gaps = 37/273 (13%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLS---GRSEQGLREMKNEASVIAKVQHKN 172
           F+D  ++G G FG VY     + +E+ A+K++S    +S +  +++  E   + +++H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
            +   GC + +    L+ EY    + D  + +  K+ L + V    I  G  QGL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQE-VEIAAICHGALQGLAYLHS 133

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
           + R   IHRD+KA NILL +    K++DFG A +       AN+   VGT  +M+PE  L
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVIL 184

Query: 293 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
              EG +  K DV+S G+  +E+   K    L+  ++++ L ++      N      D P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHI----AQN------DSP 232

Query: 350 VLE-DEYSSKQVLLRYVNIALLCVQESADDRPT 381
            L  +++S       + N    C+Q+   DRP+
Sbjct: 233 TLSSNDWS-----DYFRNFVDSCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 99.4 bits (247), Expect = 2e-23
 Identities = 80/272 (29%), Positives = 136/272 (50%), Gaps = 35/272 (12%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS---GRSEQGLREMKNEASVIAKVQHKN 172
           FSD  ++G G FG VY    +R  + +A+K++S    +S +  +++  E   + K++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
            ++  GC + +    L+ EY    + D  L +  K+ L + V    +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 133

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
           ++   +IHRD+KA NILL +    K+ DFG A I       A  +  VGT  +M+PE  L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184

Query: 293 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
              EG +  K DV+S G+  +E+   ++   L+  ++++ L ++      N +      P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES------P 232

Query: 350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPT 381
            L+  + S+     + N    C+Q+   DRPT
Sbjct: 233 ALQSGHWSEY----FRNFVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 98.2 bits (244), Expect = 2e-23
 Identities = 69/194 (35%), Positives = 106/194 (54%), Gaps = 9/194 (4%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G      ++A+K L   +         EA ++ K++H  LV L    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAV-V 70

Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ E+M   SL DF      K + L  +  V +   IA G+ Y+    R+  IH
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL--VDMAAQIADGMAYIE---RMNYIH 125

Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+  ++  KI+DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 184

Query: 301 DVFSFGVLLLEIVS 314
           DV+SFG+LL E+V+
Sbjct: 185 DVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 98.5 bits (245), Expect = 3e-23
 Identities = 80/287 (27%), Positives = 130/287 (45%), Gaps = 38/287 (13%)

Query: 122 KLGEGGFGPVY----KGVLRKGDE--IAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +LGEG FG V+      +    D+  +AVK L   +    ++ + EA ++  +QH+++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRILLDWVTR-----------VQIIEG 222
             G C D D  I+++EYM +  L+ FL    P   IL+D   R           + I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R     +        +  
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT 342
             +M PE  +   F+ +SDV+SFGV+L EI +  K      +++      V +  T  R 
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-----VIECITQGRV 243

Query: 343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           LE             K+V     +I L C Q     R  + ++  +L
Sbjct: 244 LE-------RPRVCPKEVY----DIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 97.3 bits (242), Expect = 8e-23
 Identities = 88/301 (29%), Positives = 138/301 (45%), Gaps = 59/301 (19%)

Query: 123 LGEGGFGPVYKGVL-----RKG-DEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
           LGEG FG V K        R G   +AVK L    S   LR++ +E +++ +V H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL----------------------FDPTKRILLDW 213
           L G C      +LI EY    SL  FL                       +P +R L   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL--- 124

Query: 214 VTRVQIIE---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 270
            T   +I     I++G+ YL   + ++++HRDL A N+L+ +    KISDFG++R     
Sbjct: 125 -TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLN 328
           +     S+      +M+ E   + I++ +SDV+SFGVLL EIV+  G    G+      N
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240

Query: 329 LLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM 388
           LL          +T   ++ P    E  S+++     N+ L C ++  D RPT  D+   
Sbjct: 241 LL----------KTGYRMERP----ENCSEEMY----NLMLTCWKQEPDKRPTFADISKE 282

Query: 389 L 389
           L
Sbjct: 283 L 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 97.2 bits (242), Expect = 8e-23
 Identities = 75/285 (26%), Positives = 137/285 (48%), Gaps = 45/285 (15%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVK------RLSGRSEQGLREM----KNEASVIAKVQHK 171
           +G+G +G VY  + +  G+ +AVK       ++GR +   ++M    ++E   +  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 172 NLVRLLGCCIDKDEKILIY-EYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQ 225
           N+V+ LG     +E + I+ EY+P  S+   L     F+     L+ + T  Q++EG+A 
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ---LVRFFTE-QVLEGLA- 122

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
              YLH      I+HRDLKA N+L+D D   KISDFG+++             + G+  +
Sbjct: 123 ---YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176

Query: 286 MSPE--YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL 343
           M+PE  ++    +S K D++S G ++LE+ +G++            +  ++ L       
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS-----DEEAIAAMFKLGNKRSA- 230

Query: 344 ELIDDPVLEDEYSS-KQVLLRYVNIALLCVQESADDRPTMNDVVS 387
                P+  D   +   V L ++N    C   + D+RPT  +++ 
Sbjct: 231 ----PPIPPDVSMNLSPVALDFLNA---CFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 97.9 bits (243), Expect = 8e-23
 Identities = 81/278 (29%), Positives = 141/278 (50%), Gaps = 37/278 (13%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS---GRSEQGLREMKNEASVIAKVQHKN 172
           F+D  ++G G FG VY    +R  + +A+K++S    +S +  +++  E   + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
            +   GC + +    L+ EY    + D  L +  K+ L + V    I  G  QGL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAITHGALQGLAYLHS 143

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
           ++   +IHRD+KA NILL +    K++DFG A I       AN+   VGT  +M+PE  L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANS--FVGTPYWMAPEVIL 194

Query: 293 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
              EG +  K DV+S G+  +E+   ++   L+  ++++ L ++      N +      P
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES------P 242

Query: 350 VLE-DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
            L+ +E+S       + N    C+Q+   DRPT  +++
Sbjct: 243 TLQSNEWSD-----YFRNFVDSCLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.9 bits (242), Expect = 9e-23
 Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 17/205 (8%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLV 174
           F+    +G+G FG VYK +  R    +A+K +    +E  + +++ E   +++ +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           +  G  +   +  +I EY    S      D  K   LD      I+  +  GL YLH+  
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYA 291
               IHRD+KA+NILL ++ + K++DFG++      +L +  S+    VGT  +M+PE  
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 292 LEGIFSIKSDVFSFGVLLLEIVSGK 316
            +  +  K+D++S G+  +E+  G+
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 96.5 bits (240), Expect = 1e-22
 Identities = 68/210 (32%), Positives = 114/210 (54%), Gaps = 24/210 (11%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKR--LSGRSEQG-------LREMKNEASVIAKVQHKN 172
           +G G FG VY G+    G+ +AVK+  L   S          L  +  E +++ ++QH+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           +V+ LG  +D D   +  EY+P  S+   L  +   +  L+        +  I +GL YL
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILKGLNYL 122

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSR--IVGTYGYM 286
           H  +R  IIHRD+K +NIL+D     KISDFG+++    N L    N +R  + G+  +M
Sbjct: 123 H--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +PE   +  ++ K+D++S G L++E+++GK
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 21/204 (10%)

Query: 123 LGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 178 GCCID--KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           G C    +    L+ EY+P  SL  +L    +R  LD    +     I +G+ YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYL---GS 126

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSPEY 290
            R +HRDL   NIL++ +   KI DFG+ ++   ++      +   S I     + +PE 
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYAPES 182

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVS 314
             E  FS+ SDV+SFGV+L E+ +
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 97.1 bits (241), Expect = 1e-22
 Identities = 79/291 (27%), Positives = 135/291 (46%), Gaps = 37/291 (12%)

Query: 122 KLGEGGFGPVY----KGVLRKGDEI--AVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +LGEG FG V+      +  + D+I  AVK L   S+   ++   EA ++  +QH+++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRIL--------LDWVTRVQIIEGIAQ 225
             G C++ D  I+++EYM +  L+ FL    P   ++        L     + I + IA 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           G++YL   +    +HRDL   N L+ +++  KI DFGM+R     +        +    +
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL 345
           M PE  +   F+ +SDV+S GV+L EI +  K                W   ++N  +E 
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------------WYQLSNNEVIEC 234

Query: 346 IDD-PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 395
           I    VL+   +  +      ++ L C Q     R  + ++ S+L N A A
Sbjct: 235 ITQGRVLQRPRTCPK---EVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 91/306 (29%), Positives = 133/306 (43%), Gaps = 89/306 (29%)

Query: 54  RRKPGSRDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTA 113
           RR+P            DL L L   + ++ +PL               LP  S SS S++
Sbjct: 25  RRRP------------DLTLPLPQRDPSLAVPL--------------PLPPPSSSSSSSS 58

Query: 114 TNTFSDT--------------NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLR-E 157
           +++ S +              N++G G  G VYK + R  G   A+K + G  E  +R +
Sbjct: 59  SSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ 118

Query: 158 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD-------FFLFDPTKRIL 210
           +  E  ++  V H N+V+         E  ++ E+M   SL+        FL D      
Sbjct: 119 ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD------ 172

Query: 211 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 270
              V R QI+ GIA    YLH   R  I+HRD+K SN+L++   N KI+DFG++RI    
Sbjct: 173 ---VAR-QILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221

Query: 271 ELQANTSRIVGTYGYMSPE-------------YALEGIFSIKSDVFSFGVLLLEIVSGKK 317
               N+S  VGT  YMSPE             YA         D++S GV +LE   G+ 
Sbjct: 222 MDPCNSS--VGTIAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILEFYLGRF 271

Query: 318 NTGLYR 323
             G+ R
Sbjct: 272 PFGVGR 277

Length = 353

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 82/296 (27%), Positives = 134/296 (45%), Gaps = 40/296 (13%)

Query: 122 KLGEGGFGPVYKGVLR---KGD---EIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLV 174
           +LG+G FG VY+G  R   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLF-------DPTKRILLDWVTRVQIIEGIAQGL 227
           RLLG        +++ E M +  L  +L        +   R        +Q+   IA G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YL+     + +HRDL A N ++  D   KI DFGM R     +      + +    +M+
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKN--TGLYRTDSLNLLGYVWDLWTSNRTLEL 345
           PE   +G+F+  SD++SFGV+L EI S  +    GL     L                 +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF---------------V 234

Query: 346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQ 401
           +D   L+   +  +   R  ++  +C Q +   RPT  ++V++L ++   LHP   
Sbjct: 235 MDGGYLDQPDNCPE---RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD---LHPSFP 284

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 96.6 bits (240), Expect = 3e-22
 Identities = 68/210 (32%), Positives = 113/210 (53%), Gaps = 24/210 (11%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDE-----IAVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTYG 284
           + YL +    R++HRDL A N+L+    + KI+DFG+A++ G +E    A   ++     
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIK 176

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 95.8 bits (238), Expect = 3e-22
 Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 23/213 (10%)

Query: 122 KLGEGGFGPVYKGVL-----RKGDEIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVR 175
           +LGE  FG +YKG L          +A+K L    + Q   E + EAS++A++ H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLF--------------DPTKRILLDWVTRVQIIE 221
           LLG    +    +++EY+    L  FL               D T +  LD    + I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
            IA G+ YL  +     +H+DL A NIL+ + ++ KISD G++R     +      + + 
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
              +M PE  + G FS  SD++SFGV+L EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 94.9 bits (236), Expect = 5e-22
 Identities = 61/211 (28%), Positives = 109/211 (51%), Gaps = 26/211 (12%)

Query: 123 LGEGGFGPVYKGVLRKGD----EIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           LGEG FG V +G L + D    ++AVK  +L   +   + E  +EA+ +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 177 LGCCIDKDEK------ILIYEYMPNKSLDFFLF-----DPTKRILLDWVTRVQIIEGIAQ 225
           +G C +          ++I  +M +  L  FL         +++ L   T ++ +  IA 
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ--TLLKFMVDIAL 124

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNEL-QANTSRIVGTY 283
           G+ YL   S    IHRDL A N +L +DM   ++DFG+++ I  G+   Q   +++    
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PV 179

Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
            +++ E   + +++ KSDV++FGV + EI +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 95.1 bits (236), Expect = 6e-22
 Identities = 71/220 (32%), Positives = 119/220 (54%), Gaps = 22/220 (10%)

Query: 123 LGEGGFGPVYKGVLRKGDE-----IAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRL 176
           LG G FG VYKG+     E     +A+K L+  +  +   E  +EA ++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYLHQ 232
           LG C+    + L+ + MP+  L  ++ +    I    LL+W  +      IA+G++YL +
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
               R++HRDL A N+L+    + KI+DFG+AR+  G+E + N         +M+ E   
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 293 EGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL 330
              F+ +SDV+S+GV + E+++  GK   G+   +  +LL
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 37/223 (16%)

Query: 122 KLGEGGFGPVY---------------KGVLRKGDE--IAVKRL-SGRSEQGLREMKNEAS 163
           KLGEG FG V+                          +AVK L    S+    +   E  
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTR-- 216
           +++++   N+ RLLG C       +I EYM N  L+ FL                ++   
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 217 -VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 275
            + +   IA G+ YL     +  +HRDL   N L+ K+   KI+DFGM+R    N   ++
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSD 184

Query: 276 TSRIVGT----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
             R+ G       +M+ E  L G F+ KSDV++FGV L EI++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.1 bits (231), Expect = 1e-21
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 7/193 (3%)

Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLVRLLGCCI 181
           LG+G FG V+KG L+    +AVK       Q L+ +  +EA ++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 182 DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 241
            +    ++ E +P    DF  F   K+  L     V+     A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 242 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 301
           DL A N L+ ++   KISDFGM+R        ++  + +    + +PE    G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESD 176

Query: 302 VFSFGVLLLEIVS 314
           V+S+G+LL E  S
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 26/209 (12%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLS------GRSEQGLREMKNEASVIAKVQHKNLVR 175
           LG G F   Y+   ++ G  +AVK+++         E+ +  ++ E  ++A++ H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +LG   +     L  E+M   S+   L  +   K  ++     +   E + +GL YLH+ 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122

Query: 234 SRVRIIHRDLKASNILLDKD-MNPKISDFGMA-----RICGGNELQANTSRIVGTYGYMS 287
              +IIHRD+K +N+L+D      +I+DFG A     +  G  E Q    +++GT  +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE      +    DV+S G +++E+ + K
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 63/308 (20%)

Query: 122 KLGEGGFGPVY----KGVLRKGDE-------------IAVKRLSGRSEQGLR-EMKNEAS 163
           KLGEG FG V+    +G+ +  D+             +AVK L   + +  R +   E  
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL--------FDPTKRILLDWVT 215
           ++++++  N++RLL  CI  D   +I EYM N  L+ FL         +    + + + T
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 216 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 275
            + +   IA G+ YL   S +  +HRDL   N L+ K+   KI+DFGM+R     +    
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD 335
             R V    +MS E  L G F+  SDV++FGV L EI++                     
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT--------------------- 227

Query: 336 LWTSNRTLELIDDPVLED--EY---SSKQVLL--------RYVNIALLCVQESADDRPTM 382
           L       +L D+ V+E+  E+     +QV L            + L C + +A +RP+ 
Sbjct: 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF 287

Query: 383 NDVVSMLT 390
            ++ + L 
Sbjct: 288 QEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 92.3 bits (229), Expect = 3e-21
 Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 14/203 (6%)

Query: 122 KLGEGGFGPVYKGVLR---KGDEIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLVRLL 177
           +LG G FG V KGV +   K  ++A+K L   +E+ +R EM  EA ++ ++ +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G C + +  +L+ E      L+ FL      I +  V  V+++  ++ G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNV--VELMHQVSMGMKYLEGKN--- 115

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEGI 295
            +HRDL A N+LL      KISDFG+++  G ++     +R  G +   + +PE      
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRK 174

Query: 296 FSIKSDVFSFGVLLLEIVS-GKK 317
           FS +SDV+S+G+ + E  S G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 92.6 bits (230), Expect = 3e-21
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 11/198 (5%)

Query: 123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG+GGFG V    ++  G   A K+L  +     +G +   NE  ++ KV  + +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               KD+  L+   M    L + +++  +    +        + I  GL +LHQ    RI
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQ---RRI 116

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           ++RDLK  N+LLD   N +ISD G+A        +    R  GT GYM+PE     ++  
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-AGTPGYMAPEVLQGEVYDF 173

Query: 299 KSDVFSFGVLLLEIVSGK 316
             D F+ G  L E+++G+
Sbjct: 174 SVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.4 bits (229), Expect = 4e-21
 Identities = 60/203 (29%), Positives = 109/203 (53%), Gaps = 13/203 (6%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLS-GRSEQGLREMKNEASVIAKVQHKNLV 174
           F+   ++G+G FG VYKG+  +  E+ A+K +    +E  + +++ E +V+++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 175 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           R  G  +   +  +I EY+   S LD     P +   +       I+  I +GL YLH  
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSE 120

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R IHRD+KA+N+LL +  + K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175

Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +  K+D++S G+  +E+  G+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 91.6 bits (227), Expect = 5e-21
 Identities = 64/193 (33%), Positives = 106/193 (54%), Gaps = 13/193 (6%)

Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI- 181
           +G+G FG V  G  R G+++AVK +  +++   +    EASV+ +++H NLV+LLG  + 
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 182 DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 241
           +K    ++ EYM   SL  +L     R +L     ++    + + + YL   +    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 242 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 301
           DL A N+L+ +D   K+SDFG+ +     +   +T ++     + +PE   E  FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTKSD 181

Query: 302 VFSFGVLLLEIVS 314
           V+SFG+LL EI S
Sbjct: 182 VWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 11/198 (5%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +LG G FG V+ G  R   ++A+K       SE+   E   EA V+ K+ H  LV+L G 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYGV 67

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    ++ E+M N  L  +L     ++  D +  + + + + +G+ YL + S    I
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERNS---FI 122

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+      K+SDFGM R    +E   ++S       +  PE      +S K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 300 SDVFSFGVLLLEIVSGKK 317
           SDV+SFGVL+ E+ +  K
Sbjct: 182 SDVWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 78/278 (28%), Positives = 137/278 (49%), Gaps = 37/278 (13%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQ---GLREMKNEASVIAKVQHKN 172
           F   +++G G FG VY       +E+ AVK++S   +Q     +++  E   + +++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
            +   GC + +    L+ EY    + D  L +  K+ L + V    I  G  QGL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAITHGALQGLAYLHS 139

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
           ++   +IHRD+KA NILL +    K++DFG A         AN+   VGT  +M+PE  L
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANS--FVGTPYWMAPEVIL 190

Query: 293 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
              EG +  K DV+S G+  +E+   ++   L+  ++++ L ++      N      D P
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQN------DSP 238

Query: 350 VLE-DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
            L+ +E++       +V+    C+Q+   +RP   +++
Sbjct: 239 TLQSNEWTDS--FRGFVD---YCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 21/204 (10%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           LG+G +G VY    L     IA+K +  R  + ++ +  E ++ + ++H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 182 DKDEKILIYEYMPNKSLDFFL---FDPTK--RILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
           +     +  E +P  SL   L   + P K     + + T+ QI+E    GL YLH     
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILE----GLKYLHD---N 127

Query: 237 RIIHRDLKASNILLDKDMNP-KISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEG 294
           +I+HRD+K  N+L++      KISDFG + R+ G N     T    GT  YM+PE   +G
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKG 184

Query: 295 I--FSIKSDVFSFGVLLLEIVSGK 316
              +   +D++S G  ++E+ +GK
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 90.5 bits (224), Expect = 2e-20
 Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 20/202 (9%)

Query: 123 LGEGGFGPVYKGVLRKGDE-----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYLHQ 232
           LG C+    + L+ + MP   L  ++ +   RI    LL+W  +      IA+G+ YL +
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
              VR++HRDL A N+L+    + KI+DFG+AR+   +E + +         +M+ E  L
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 293 EGIFSIKSDVFSFGVLLLEIVS 314
              F+ +SDV+S+GV + E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)

Query: 120 TNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
             +LG+G FG VYK   ++     A K +   SE+ L +   E  ++++ +H N+V L  
Sbjct: 10  IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE 69

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               +++  ++ E+    +LD  +    +R L +   R  +   + + L +LH +   ++
Sbjct: 70  AYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KV 124

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS- 297
           IHRDLKA NILL  D + K++DFG++     + LQ   +  +GT  +M+PE      F  
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDT-FIGTPYWMAPEVVACETFKD 182

Query: 298 ----IKSDVFSFGVLLLEI 312
                K+D++S G+ L+E+
Sbjct: 183 NPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 16/205 (7%)

Query: 121 NKLGEGGFGPVYKGV-LRKGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
             +G G    VY  + L   +++A+KR+   + +  + E++ E   +++  H N+V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRIL----LDWVTRVQIIEGIAQGLLYLHQYS 234
             +  DE  L+  Y+   SL     D  K       LD      +++ + +GL YLH   
Sbjct: 67  SFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSR-IVGTYGYMSPEYAL 292
           +   IHRD+KA NILL +D + KI+DFG+ A +  G +      +  VGT  +M+PE   
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 293 EGI-FSIKSDVFSFGVLLLEIVSGK 316
           +   +  K+D++SFG+  +E+ +G 
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 67/208 (32%), Positives = 115/208 (55%), Gaps = 19/208 (9%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQG-----LREMKNEASVIAKVQH 170
           F    KLGEG +  VYKG  R   EI A+K +   +E+G     +RE+    S++ +++H
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREI----SLMKELKH 57

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           +N+VRL      +++ +L++EYM +K L  ++     R  LD  T       + +G+ + 
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPE 289
           H+    R++HRDLK  N+L++K    K++DFG+AR  G   +  NT S  V T  Y +P+
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPD 170

Query: 290 YALEG-IFSIKSDVFSFGVLLLEIVSGK 316
             L    +S   D++S G ++ E+++G+
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 20/203 (9%)

Query: 122 KLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQ------GLREMKNEASVIAKVQHKNLV 174
           K+GEG +G VYK   +   EI A+K++  R E        LRE+K    ++ ++ H N++
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           +LL     K +  L++E+M     D +     ++  L        +  + QGL + H + 
Sbjct: 62  KLLDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-E 293
              I+HRDLK  N+L++ +   K++DFG+AR  G        +  V T  Y +PE  L +
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGD 173

Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +S   D++S G +  E++S +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 70/230 (30%), Positives = 109/230 (47%), Gaps = 43/230 (18%)

Query: 122 KLGEGGFGPV---------------YKGVLRKGDE--IAVKRLSGRSEQGLR-EMKNEAS 163
           KLGEG FG V               +   +RKG    +AVK L   + +  R +   E  
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLD----------- 212
           ++++++  N++RLLG C+D+D   +I EYM N  L+ FL   +   L D           
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128

Query: 213 --------WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
                   + + + +   IA G+ YL   S +  +HRDL   N L+ +++  KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           R     +      R V    +M+ E  L G F+  SDV++FGV L EI+ 
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 89.7 bits (222), Expect = 5e-20
 Identities = 74/223 (33%), Positives = 112/223 (50%), Gaps = 38/223 (17%)

Query: 116 TFSDTNKLGEGGFGPVYKGVLRK-GDEI--AVKRLSG-RSEQGLREMKNEASVIAKV-QH 170
            F D   +GEG FG V + +++K G ++  A+K L    SE   R+   E  V+ K+  H
Sbjct: 5   KFEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDP------------TKRILL 211
            N++ LLG C ++    +  EY P  +L  FL        DP            T + LL
Sbjct: 63  PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 212 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
            + + V      A G+ YL   S  + IHRDL A N+L+ +++  KI+DFG++R   G E
Sbjct: 123 QFASDV------ATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEE 170

Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +    +       +M+ E     +++ KSDV+SFGVLL EIVS
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 89.3 bits (221), Expect = 5e-20
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 34/221 (15%)

Query: 122 KLGEGGFGPVY----KGVLR-----------KGDEIAVKRLSGRSEQGLR-EMKNEASVI 165
           KLGEG FG V+    +G+             +   +AVK L     +  R +   E  ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG--- 222
           +++++ N++RLLG C+  D   +I EYM N  L+ FL   ++R +    T    I     
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL---SQREIESTFTHANNIPSVSI 128

Query: 223 ---------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 273
                    IA G+ YL   + +  +HRDL   N L+      KI+DFGM+R     +  
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               R V    +M+ E  L G F+  SDV++FGV L E+ +
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 30/207 (14%)

Query: 126 GGFGPVYKGVLRK---GDEIAVKRLSGRSEQG---LREMKNEASVIAKVQHKNLVRLLGC 179
           G +G V+  + +K   GD  A+K +          + ++  E  ++++ Q   +V+L   
Sbjct: 4   GAYGRVF--LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS 61

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRIL-----LDWVTRVQIIEGIAQGLLYLHQYS 234
              K    L+ EY+P   L          +L     LD       I  I   L YLH   
Sbjct: 62  FQGKKNLYLVMEYLPGGDL--------ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFG------MARICGGNELQANTSRIVGTYGYMSP 288
              IIHRDLK  NIL+D + + K++DFG      + R    N+ +    RIVGT  Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSG 315
           E  L    S   D +S G +L E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 88.4 bits (219), Expect = 7e-20
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 19/203 (9%)

Query: 123 LGEGGFGPVYKGVLRKGD-------EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +G G FG V+    RK D       +I V++++          +NE  V+  + H N++ 
Sbjct: 8   VGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLA---AQNECQVLKLLSHPNIIE 63

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
                ++    +++ EY P  +L  ++       LLD  T   I+    Q LL LH    
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDT---ILHFFVQILLALHHVHT 119

Query: 236 VRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 294
             I+HRDLK  NILLDK  M  KI DFG+++I      ++    +VGT  Y+SPE     
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGK 176

Query: 295 IFSIKSDVFSFGVLLLEIVSGKK 317
            ++ KSD+++ G +L E+ S K+
Sbjct: 177 PYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 88.6 bits (219), Expect = 9e-20
 Identities = 70/232 (30%), Positives = 117/232 (50%), Gaps = 46/232 (19%)

Query: 123 LGEGGFGPVYKGVLRKGDEI---AVKRLS----GRSEQGLREMKNEASVIAKVQHKNLVR 175
           LGEG FG V +G L + D I   AVK +      RSE  + +  +EA  + +  H N++R
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE--MEDFLSEAVCMKEFDHPNVMR 64

Query: 176 LLGCCIDKDEK------ILIYEYMPNKSLDFFL----------FDPTKRILLDWVTRVQI 219
           L+G C+   E       ++I  +M +  L  FL          + PT+         V+ 
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQ-------MLVKF 117

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNEL-QANTS 277
           +  IA G+ YL   S    IHRDL A N +L+++MN  ++DFG++ +I  G+   Q   +
Sbjct: 118 MTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA 174

Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGLY 322
           ++     +++ E   + +++ KSDV+SFGV + EI +       G +N+ +Y
Sbjct: 175 KM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 23/206 (11%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            ++G G +G VYK       E+ A+K +          ++ E S++ + +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 180 CIDKDEKILIYEYMPNKSLDFF---LFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
            + +D+  ++ EY    SL         P   + + +V R  +     +GL YLH+  + 
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHETGK- 122

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALE 293
             IHRD+K +NILL +D + K++DFG++      +L A  ++    +GT  +M+PE A  
Sbjct: 123 --IHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 294 ---GIFSIKSDVFSFGVLLLEIVSGK 316
              G +  K D+++ G+  +E+   +
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 68/238 (28%), Positives = 110/238 (46%), Gaps = 49/238 (20%)

Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ------GLREMKNEAS 163
            +    +    KLGEG FG VYK    K G  +A+K++   +E+       LRE+K    
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK---- 59

Query: 164 VIAKVQHKNLVRLLGCCIDKDEKIL-----IYEYMPNKSLDF--FLFDPT--------KR 208
           ++ K++H N+V L+   +++ +K       +Y   P    D    L +P+        K 
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC 119

Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI-- 266
            +L      Q++EGI     YLH+     I+HRD+KA+NIL+D     KI+DFG+AR   
Sbjct: 120 YML------QLLEGIN----YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166

Query: 267 -------CGGNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
                   GG       + +V T  Y  PE  L E  ++   D++  G +  E+ + +
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 87.7 bits (217), Expect = 1e-19
 Identities = 66/201 (32%), Positives = 100/201 (49%), Gaps = 19/201 (9%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMK--------NEASVIAKVQHKNL 173
           +LG+G FG VY    +K      +RL    E  + E+          EA +++K+ H  +
Sbjct: 7   RLGKGSFGTVYLVKDKKAVA--EERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
           V+     +++D   +I EY   + LD  L     T + L    +  Q+ E   Q LL +H
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL----SENQVCEWFIQLLLGVH 120

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
              + RI+HRDLKA NI L  ++  KI DFG++R+  G+   A T    GT  YMSPE  
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEAL 177

Query: 292 LEGIFSIKSDVFSFGVLLLEI 312
               +  KSD++S G +L E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 68/223 (30%), Positives = 113/223 (50%), Gaps = 28/223 (12%)

Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEA 162
           L +  SV      ++   K+G+G  G VY  + +  G E+A+K+++ + +     + NE 
Sbjct: 8   LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEI 67

Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            V+ + +H N+V  L   +  DE  ++ EY+   SL             D VT   + EG
Sbjct: 68  LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT------------DVVTETCMDEG 115

Query: 223 -IA-------QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQ 273
            IA       Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q
Sbjct: 116 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQ 169

Query: 274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +  S +VGT  +M+PE      +  K D++S G++ +E+V G+
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 88.2 bits (218), Expect = 1e-19
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 122 KLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLV 174
           +LG+G FG VY+G+ +    DE    +A+K ++  +    R E  NEASV+ +    ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLF-------DPTKRILLDWVTRVQIIEGIAQGL 227
           RLLG        ++I E M    L  +L        +   +        +Q+   IA G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YL+     + +HRDL A N ++ +D   KI DFGM R     +      + +    +MS
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVS 314
           PE   +G+F+  SDV+SFGV+L EI +
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 72/218 (33%), Positives = 111/218 (50%), Gaps = 46/218 (21%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQ------GLREMKNEASVIAKVQHKNL 173
           N++ EG +G VY+   +K  EI A+K+L    E+       LRE+    +++ K+QH N+
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI----NILLKLQHPNI 66

Query: 174 VRL----LGCCIDKDEKILIY---EYMPN--KSL-----DFFLFDPTKRILLDWVTRVQI 219
           V +    +G  +DK     IY   EY+ +  KSL       FL    K ++L      Q+
Sbjct: 67  VTVKEVVVGSNLDK-----IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML------QL 115

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           + G+A    +LH      I+HRDLK SN+LL+     KI DFG+AR  G   L+  T  +
Sbjct: 116 LSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLV 167

Query: 280 VGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L    +S   D++S G +  E+++ K
Sbjct: 168 V-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 54/182 (29%), Positives = 92/182 (50%), Gaps = 32/182 (17%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQG------LREMKNEASVIAKVQHKNLV 174
           ++GEG  G V+K   R+ G+ +A+K+++ R  +G      LRE+K     +   QH  +V
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62

Query: 175 RLLGCCIDKDEKILIYEYMPN------KSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGL 227
           +LL         +L+ EYMP+      +  +  L +   K  +        +++G+A   
Sbjct: 63  KLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMR------MLLKGVA--- 113

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            Y+H      I+HRDLK +N+L+  D   KI+DFG+AR+    E +  + + V T  Y +
Sbjct: 114 -YMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRA 168

Query: 288 PE 289
           PE
Sbjct: 169 PE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 45/218 (20%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVK--RLSGRSEQG-------LREMKNEASVIAKVQH 170
            KLGEG +  VYK   ++ G  +A+K  +L  R E         LRE+K    ++ +++H
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK----LLQELKH 61

Query: 171 KNLVRLLGCCIDKDEKILIYEYMP--------NKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            N++ LL     K    L++E+M         +KS+     D  K  +L        +  
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYML------MTL-- 112

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQANTSRIV 280
             +GL YLH      I+HRDLK +N+L+  D   K++DFG+AR  G    ++   T ++V
Sbjct: 113 --RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---THQVV 164

Query: 281 GTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGK 316
            T  Y +PE  L G   + +  D++S G +  E++   
Sbjct: 165 -TRWYRAPEL-LFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 123 LGEGGFGPVYKGVLRKGDEI--AVKRLSGRS--EQGLREM-KNEASVIAKVQHKNLVRLL 177
           LG GGFG V   V  K      A+K +  R   E G +E   +E  ++ +  H  +V+L 
Sbjct: 1   LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59

Query: 178 GCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
                KD+K +  + EY     L   L D   R L D  T    I  +     YLH    
Sbjct: 60  --RTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG- 113

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
             II+RDLK  N+LLD +   K+ DFG A+     +    T    GT  Y++PE  L   
Sbjct: 114 --IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKG 168

Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +    D +S G+LL E+++G+
Sbjct: 169 YDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 29/209 (13%)

Query: 125 EGGFGPVYKGVLRKGD-----EIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           EG FG ++ G+L         E+ VK +    SE  +  +  E+ ++  + H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 179 CCI-DKDEKILIYEYMPNKSLDFFLFDP-----TKRILLDWVTRVQIIEGIAQGLLYLHQ 232
            CI D +   ++Y YM   +L  FL             L     V +   IA G+ YLH+
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARI-------CGGNELQANTSRIVGTYGY 285
                +IH+D+ A N ++D+++  KI+D  ++R        C G+    N +R V    +
Sbjct: 136 R---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD----NENRPVK---W 185

Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           M+ E  +   +S  SDV+SFGVLL E+++
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 33/210 (15%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVK--RLSGRSE----QGLREMKNEASVIAKVQHKNLV 174
           K+GEG +G VYK      G+ +A+K  RL    E      +RE+    S++ ++ H N+V
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREI----SLLKELNHPNIV 61

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL---FDPTKRILLDWVTRVQIIEG----IAQGL 227
           RLL     +++  L++E+     LD  L    D +    LD      +I+     + QG+
Sbjct: 62  RLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLD----PPLIKSYLYQLLQGI 112

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            Y H +   R++HRDLK  N+L+D++   K++DFG+AR   G  ++  T  +V T  Y +
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRA 167

Query: 288 PEYALEG-IFSIKSDVFSFGVLLLEIVSGK 316
           PE  L    +S   D++S G +  E+V+ +
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 39/213 (18%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMK-------------NEASVIAKV 168
           KLG+G +G VYK          VKRLS      L+E+              NE  ++A V
Sbjct: 7   KLGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV 56

Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRIL---LDWVTRVQIIEGI 223
            H N++      +D ++  ++ EY P   L   +      ++++     W   +Q++ G 
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG- 115

Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 283
              L  LH+    +I+HRDLK++NILL  +   KI D G++++   N   A T   +GT 
Sbjct: 116 ---LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQ--IGTP 165

Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
            YM+PE      +S KSD++S G LL E+ +  
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 123 LGEGGFGPVYKGVLRKGD---EIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKNLVRLL 177
           +GEG FG V K  ++K     + A+KR+    S+   R+   E  V+ K+  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFL-------FDPTKRI------LLDWVTRVQIIEGIA 224
           G C  +    L  EY P+ +L  FL        DP   I       L     +     +A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
           +G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG++R   G E+    +       
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 188

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 87.3 bits (216), Expect = 2e-19
 Identities = 66/204 (32%), Positives = 109/204 (53%), Gaps = 24/204 (11%)

Query: 123 LGEGGFGPVYKGV-LRKGDEI----AVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRL 176
           LG G FG V+KG+ + +GD I    A+K +  RS  Q  +E+ +    +  + H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFL------FDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           LG C     + L+ +  P  SL   +       DP  + LL+W  +      IA+G+ YL
Sbjct: 75  LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQ------IAKGMYYL 125

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
            ++   R++HR+L A NILL  D   +I+DFG+A +   ++ +   S       +M+ E 
Sbjct: 126 EEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVS 314
            L G ++ +SDV+S+GV + E++S
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 24/220 (10%)

Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLREMKNEASVIAKV-QH 170
            T  F     +GEG +G VYK   +K  ++ A+K +    ++   E+K E +++ K   H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNH 62

Query: 171 KNLVRLLGCCIDKDEKI------LIYEYMPNKS---LDFFLFDPTKRILLDWVTRVQIIE 221
            N+    G  I K+         L+ E     S   L   L    KR+  +W+    I+ 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILR 120

Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
              +GL YLH+    ++IHRD+K  NILL K+   K+ DFG++        + NT   +G
Sbjct: 121 ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IG 175

Query: 282 TYGYMSPE-----YALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  +M+PE        +  +  +SDV+S G+  +E+  GK
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 23/202 (11%)

Query: 123 LGEGGFGPVYKGVLRKGDEIAVKR---LSGRSE---QGLREMKNEASVIAKVQHKNLVRL 176
           LG G  G V K        +  K+   +  +S    Q LRE++    ++ + +   +V  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIVSF 68

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            G  ++++   +  E+M   SLD       P   I ++ + +  I   + +GL YL  Y+
Sbjct: 69  YGAFLNENNICMCMEFMDCGSLDRIYKKGGP---IPVEILGK--IAVAVVEGLTYL--YN 121

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 294
             RI+HRD+K SNIL++     K+ DFG++    G  + +     VGT  YMSPE    G
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGG 177

Query: 295 IFSIKSDVFSFGVLLLEIVSGK 316
            +++KSDV+S G+ ++E+  GK
Sbjct: 178 KYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 32/212 (15%)

Query: 117 FSDTNKLGEGGFGPVYKG-VLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
             +  K+GEG  G V        G ++AVK++  R +Q    + NE  ++   QH N+V 
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE-GIA-------QGL 227
           +    +  DE  ++ E++   +L             D VT  ++ E  IA       + L
Sbjct: 81  MYSSYLVGDELWVVMEFLEGGALT------------DIVTHTRMNEEQIATVCLAVLKAL 128

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYG 284
            +LH      +IHRD+K+ +ILL  D   K+SDFG    C   ++     R   +VGT  
Sbjct: 129 SFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGF---CA--QVSKEVPRRKSLVGTPY 180

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +M+PE      +  + D++S G++++E+V G+
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 68/220 (30%), Positives = 114/220 (51%), Gaps = 25/220 (11%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ------GLREMKNEASVIAKVQ 169
           ++   K+GEG +G VYKG  +K G  +A+K++   SE+       +RE+    S++ ++Q
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI----SLLKELQ 57

Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDF--FLFDPTKRILLDWVTRVQIIEGIAQGL 227
           H N+V L    + +    LI+E++   S+D   +L    K   +D       +  I QG+
Sbjct: 58  HPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
           L+ H     R++HRDLK  N+L+D     K++DFG+AR   G  ++  T  +V T  Y +
Sbjct: 115 LFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVV-TLWYRA 169

Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
           PE  L    +S   D++S G +  E+ + K    L+  DS
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKKP---LFHGDS 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 85.6 bits (212), Expect = 7e-19
 Identities = 73/286 (25%), Positives = 132/286 (46%), Gaps = 38/286 (13%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---------EAS 163
              F    K+G+G F  VYK + L  G  +A+K++       + EM +         E  
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ------IFEMMDAKARQDCLKEID 54

Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRILLDWVTRVQIIE 221
           ++ ++ H N+++ L   I+ +E  ++ E      L   +  F   KR L+   T  +   
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFV 113

Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
            +   L ++H     RI+HRD+K +N+ +      K+ D G+ R        A++  +VG
Sbjct: 114 QLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVG 168

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR 341
           T  YMSPE   E  ++ KSD++S G LL E+ + +     +  D +NL    + L    +
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL----YSLC---K 218

Query: 342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
            +E  D P L  ++ S++  LR  ++   C+    + RP ++ V+ 
Sbjct: 219 KIEKCDYPPLPADHYSEE--LR--DLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 15/198 (7%)

Query: 122 KLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGL---REMKNEASVIAKVQHKNLVRLL 177
           ++G+GG+G V+    +   EI A+KR+       L   R +  E  ++   + + LV+LL
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
               D +   L  EY+P    DF        +L +   R  + E     +  LH+     
Sbjct: 68  YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALHELG--- 121

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
            IHRDLK  N L+D   + K++DFG+++  G     AN+  +VG+  YM+PE      + 
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY-ANS--VVGSPDYMAPEVLRGKGYD 176

Query: 298 IKSDVFSFGVLLLEIVSG 315
              D +S G +L E + G
Sbjct: 177 FTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 86.3 bits (213), Expect = 7e-19
 Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 12/215 (5%)

Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEA 162
           L S  SV      ++   K+G+G  G VY  + +  G E+A+K+++ + +     + NE 
Sbjct: 8   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67

Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 68  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 281
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 177

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  +M+PE      +  K D++S G++ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 86.6 bits (214), Expect = 8e-19
 Identities = 70/215 (32%), Positives = 111/215 (51%), Gaps = 26/215 (12%)

Query: 123 LGEGGFGPVYK----GVLRKGDE----IAVKRLSGR-SEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V +    G+ +   +    +AVK L    +++ L ++ +E  ++  + +HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTK--RILLDWVTRVQI 219
           ++ LLG C  +    +I EY    +L  FL           FD TK     L +   V  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              +A+G+ YL   SR R IHRDL A N+L+ +D   KI+DFG+AR     +    TS  
Sbjct: 140 AYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +M+PE   + +++ +SDV+SFG+L+ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 85.1 bits (210), Expect = 9e-19
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 7/195 (3%)

Query: 122 KLGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLVRLLGC 179
           ++G G FG V+ G LR  +  +AVK         L+ +   EA ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  K    ++ E +  +  DF  F  T+   L     +Q++E  A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ +    KISDFGM+R        +          + +PE    G +S +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 300 SDVFSFGVLLLEIVS 314
           SDV+SFG+LL E  S
Sbjct: 177 SDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 85.5 bits (211), Expect = 9e-19
 Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 36/216 (16%)

Query: 123 LGEGGFGPVYKGVLRKGD---EIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKNLVRLL 177
           +GEG FG V K  ++K     + A+KR+    S+   R+   E  V+ K+  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFL-------FDP------------TKRILLDWVTRVQ 218
           G C  +    L  EY P+ +L  FL        DP            + + LL +   V 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV- 121

Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
                A+G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG++R   G E+    + 
Sbjct: 122 -----ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 170

Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 56/203 (27%), Positives = 109/203 (53%), Gaps = 13/203 (6%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLS-GRSEQGLREMKNEASVIAKVQHKNLV 174
           F+   ++G+G FG V+KG+  +  ++ A+K +    +E  + +++ E +V+++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 175 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +  G  +   +  +I EY+   S LD     P      D      +++ I +GL YLH  
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSE 120

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
            +   IHRD+KA+N+LL +  + K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 175

Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +  K+D++S G+  +E+  G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLS-GRSEQGLREMKNEASVIAKVQHKNLV 174
           F+   K+G+G FG V+KG+  +  ++ A+K +    +E  + +++ E +V+++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 175 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 120

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
            +   IHRD+KA+N+LL +    K++DFG+A      +++ N    VGT  +M+PE   +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQ 175

Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +  K+D++S G+  +E+  G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 72/284 (25%), Positives = 129/284 (45%), Gaps = 43/284 (15%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQH---K 171
           +     +G G +G VY+G  +  G  +A+K ++  +    + +++ E +++++++     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
           N+ +  G  +      +I EY    S+   +    K   +       II  +   L Y+H
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH 118

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSP 288
              +V +IHRD+KA+NIL+    N K+ DFG+A       L  N+S+    VGT  +M+P
Sbjct: 119 ---KVGVIHRDIKAANILVTNTGNVKLCDFGVAA-----LLNQNSSKRSTFVGTPYWMAP 170

Query: 289 EYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           E   EG  +  K+D++S G+ + E+ +G  N      D+              R + LI 
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATG--NPPYSDVDAF-------------RAMMLIP 215

Query: 348 D---PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM 388
               P LED   SK  LLR       C+ E   +R +  +++  
Sbjct: 216 KSKPPRLEDNGYSK--LLR--EFVAACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 61/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)

Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEA 162
           L S  SV      ++   K+G+G  G VY  + +  G E+A+++++ + +     + NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68

Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 281
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 178

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 62/197 (31%), Positives = 106/197 (53%), Gaps = 13/197 (6%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +LG+G FG VYK   ++ G   A K +  +SE+ L +   E  ++A   H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
               +  ++ E+ P  ++D  + +   R L +   +V I   + + L YLH    ++IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133

Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGI 295
           RDLKA N+LL  D + K++DFG++       LQ   S  +GT  +M+PE  +     +  
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRDS-FIGTPYWMAPEVVMCETMKDTP 191

Query: 296 FSIKSDVFSFGVLLLEI 312
           +  K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 16/202 (7%)

Query: 123 LGEGGFGPVYKGV---LRKGD---EIAVKRLSGRSEQGLRE-MKNEASVIAKV-QHKNLV 174
           LG G FG V +     L K D   ++AVK L   +    RE + +E  +++ +  H+N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            LLG C      ++I EY     L  FL    +   L     +     +A+G+ +L   +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAL 292
               IHRDL A N+LL      KI DFG+AR  +   N +    +R+     +M+PE   
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIF 216

Query: 293 EGIFSIKSDVFSFGVLLLEIVS 314
             +++ +SDV+S+G+LL EI S
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 30/214 (14%)

Query: 119 DTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKN---EASVIAKVQH-KNL 173
           D  ++G G FG V K + +  G  +AVKR+  RS    +E K    +  V+ +      +
Sbjct: 8   DLGEIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYI 65

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFF---LFDPTKRILLDWVTRVQIIEGIA----QG 226
           V+  G    + +  +  E M + SLD F   +++  K ++ +     +I+  IA    + 
Sbjct: 66  VKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-----EILGKIAVATVKA 119

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           L YL +   ++IIHRD+K SNILLD++ N K+ DFG   I G        +R  G   YM
Sbjct: 120 LNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYM 174

Query: 287 SPE----YALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +PE     A +G + ++SDV+S G+ L E+ +GK
Sbjct: 175 APERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.0 bits (207), Expect = 3e-18
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 27/209 (12%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRL-----SGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           LG+G FG VY    +  G E+A K++     S  + + +  ++ E  ++  +QH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 177 LGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKR--ILLDWVTRVQIIEGIAQGLLYLHQ 232
            GC  D+ EK L    EYMP  S+     D  K    L + VTR +    I +G+ YLH 
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTR-KYTRQILEGMSYLHS 124

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMS 287
                I+HRD+K +NIL D   N K+ DFG ++    IC  G  +++    + GT  +MS
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS----VTGTPYWMS 177

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE      +  K+DV+S G  ++E+++ K
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 84.0 bits (207), Expect = 4e-18
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 12/215 (5%)

Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEA 162
           L +  S+      ++   K+G+G  G V+  + +  G E+A+K+++ + +     + NE 
Sbjct: 8   LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67

Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            V+ ++++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 68  LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 281
             Q L +LH     ++IHRD+K+ N+LL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 177

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  +M+PE      +  K D++S G++ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 26/215 (12%)

Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K    +  ++AVK L S  +E+ L ++ +E  ++  + +HKN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTK--RILLDWVTRVQI 219
           ++ LLG C       +I EY    +L  +L           ++PT+     L +   V  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 66/201 (32%), Positives = 95/201 (47%), Gaps = 17/201 (8%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLL 177
           LG+G FG V    L+  DE+ AVK L       +  +     E  V+A   +H  L +L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
            C   KD    + EY+    L F +         +   R    E I  GL +LH+     
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAE-IVLGLQFLHERG--- 116

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALEGI 295
           II+RDLK  N+LLD + + KI+DFGM +  I GG      TS   GT  Y++PE      
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTPDYIAPEILSYQP 172

Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +    D ++ GVLL E+++G+
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 83.4 bits (207), Expect = 6e-18
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 32/209 (15%)

Query: 122 KLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQ-----GLREMKNEASVIAKVQHKNLVR 175
           +LG+G FG VY    ++  E+ A+K++  +         LRE+K   S+    +H N+V+
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVK---SLRKLNEHPNIVK 62

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ--Y 233
           L     + DE   ++EYM   +L + L    K           II  I QGL ++H+  +
Sbjct: 63  LKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-----IVGTYGYMSP 288
                 HRDLK  N+L+      KI+DFG+AR     E++   SR      V T  Y +P
Sbjct: 121 -----FHRDLKPENLLVSGPEVVKIADFGLAR-----EIR---SRPPYTDYVSTRWYRAP 167

Query: 289 EYALE-GIFSIKSDVFSFGVLLLEIVSGK 316
           E  L    +S   D+++ G ++ E+ + +
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 66/207 (31%), Positives = 112/207 (54%), Gaps = 27/207 (13%)

Query: 121 NKLGEGGFGPVYKGV-LRKGDEIAVKRLSGR-SEQG-----LREMKNEASVIAKVQ---H 170
            ++GEG +G VYK   L  G  +A+K++    SE+G     LRE+    +++ +++   H
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI----ALLKQLESFEH 60

Query: 171 KNLVRLLGCC--IDKDEKI---LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
            N+VRLL  C     D ++   L++E++ ++ L  +L    K  L     +  ++  + +
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLR 118

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           G+ +LH +   RI+HRDLK  NIL+  D   KI+DFG+ARI       A TS +V T  Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTS-VVVTLWY 172

Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEI 312
            +PE  L+  ++   D++S G +  E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 33/217 (15%)

Query: 123 LGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG+GGFG V    +R  G   A K+L+ +     +G      E  ++AKV  + +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFD--------PTKRILLDWVTRVQIIEGIAQGLLYL 230
               K +  L+   M    L + +++        P  R         QII     GL +L
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF---YTAQII----SGLEHL 113

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL---QANTSRIVGTYGYMS 287
           HQ    RII+RDLK  N+LLD D N +ISD G+A      EL   Q+ T    GT G+M+
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAV-----ELKDGQSKTKGYAGTPGFMA 165

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT 324
           PE      +    D F+ GV L E+++ +   G +R 
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAAR---GPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 122 KLGEGGFGPVYKGV--LRKGDEI--AVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRL 176
            +GEG FG VY+GV    + ++I  AVK     +   +RE    EA ++ +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
           +G   + +   ++ E  P   L  +L     +  LD  + +     ++  L YL      
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEGI 295
           R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE      
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRR 184

Query: 296 FSIKSDVFSFGVLLLEIVS-GKK 317
           F+  SDV+ FGV + EI+  G K
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVK 207

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 67/206 (32%), Positives = 112/206 (54%), Gaps = 20/206 (9%)

Query: 122 KLGEGGFGPVYKGVLR--KGDE-IAVKRLSGRS-EQGLR-EMKNEASVIAKVQHKNLVRL 176
           +LG G FG V KG+ +  K ++ +AVK L   + +  L+ E+  EA+V+ ++ +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
           +G C + +  +L+ E      L+ FL    K +    +T  +++  ++ G+ YL + +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL-QKNKHVTEKNIT--ELVHQVSMGMKYLEETN-- 115

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI- 295
             +HRDL A N+LL      KISDFG+++  G +E   N  +      +    YA E + 
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMN 171

Query: 296 ---FSIKSDVFSFGVLLLEIVS-GKK 317
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 65/228 (28%), Positives = 118/228 (51%), Gaps = 24/228 (10%)

Query: 122 KLGEGGFGPVYKGV-LRKGDE-IAVKRLSGR-SEQGLR-EMKNEASVIAKVQ---HKNLV 174
           ++GEG +G V+K   L+ G   +A+KR+  +  E+G+      E +V+  ++   H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 175 RLLGCCI----DKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           RL   C     D++ K+ L++E++      +    P   +  +  T   ++  + +GL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE--TIKDMMFQLLRGLDF 125

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V T  Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPE 179

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYVWDL 336
             L+  ++   D++S G +  E+   K    L+R  S ++ LG + D+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDV 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.4 bits (202), Expect = 3e-17
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 31/205 (15%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLREMK------NEASVIAKVQHKNLVR 175
           LG G FG V     +   +  A+K LS   +  + ++K      NE  ++  ++H  LV 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILS---KAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L G   D     L+ EY+P   L F     + R     V R    + +   L YLH    
Sbjct: 66  LYGSFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEP-VARFYAAQ-VVLALEYLHSLD- 121

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
             I++RDLK  N+LLD D   KI+DFG A+      ++  T  + GT  Y++PE     I
Sbjct: 122 --IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPE-----I 169

Query: 296 FSIK-----SDVFSFGVLLLEIVSG 315
              K      D ++ G+L+ E+++G
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.1 bits (208), Expect = 3e-17
 Identities = 69/284 (24%), Positives = 127/284 (44%), Gaps = 22/284 (7%)

Query: 109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAK 167
           +++   ++  + N +  G  G  YKG   K   +  VK +       +     E + + K
Sbjct: 684 TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPSS--EIADMGK 739

Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
           +QH N+V+L+G C  +    LI+EY+  K+L   L +      L W  R +I  GIA+ L
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKAL 793

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            +LH      ++  +L    I++D    P +             L    ++   +  Y++
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVA 846

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT-SNRTLELI 346
           PE       + KSD++ FG++L+E+++GK           +++   W  +  S+  L++ 
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVE--WARYCYSDCHLDMW 904

Query: 347 DDPVLEDEYSSKQ-VLLRYVNIALLCVQESADDRPTMNDVVSML 389
            DP +  + S  Q  ++  +N+AL C       RP  NDV+  L
Sbjct: 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.5 bits (198), Expect = 4e-17
 Identities = 70/281 (24%), Positives = 130/281 (46%), Gaps = 32/281 (11%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS---GRSEQGLREMKNEASVIAKVQHKN 172
           F    K+G G F  VY+   L  G  +A+K++        +   +   E  ++ ++ H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRILLD---WVTRVQIIEGIAQGL 227
           +++     I+ +E  ++ E      L   +  F   KR++ +   W   VQ+   +    
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE--- 120

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
              H +SR R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YMS
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           PE   E  ++ KSD++S G LL E+ + +     +  D +N       L++  + +E  D
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMN-------LYSLCKKIEQCD 224

Query: 348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM 388
            P L  ++ S++ L + VN   +C+    + RP +  V  +
Sbjct: 225 YPPLPSDHYSEE-LRQLVN---MCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 18/216 (8%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QIIEGIAQGLLYLH 231
           V+LL     +++  L++E++      F    P   I L  +     Q+++G+A    + H
Sbjct: 62  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FCH 117

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
            +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEIL 172

Query: 292 L-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
           L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.7 bits (199), Expect = 5e-17
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 20/204 (9%)

Query: 123 LGEGGFGPVY------KGVLRKGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVR 175
           LGEG FG V       +G    G+++AVK L        + ++K E  ++  + H+N+V+
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 176 LLGCCI-DKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL--H 231
             G C  D    I LI E++P+ SL  +L  P  +  ++   +++    I +G+ YL   
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 290
           QY     +HRDL A N+L++ +   KI DFG+ + I    E       +     + +PE 
Sbjct: 129 QY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVS 314
            ++  F I SDV+SFGV L E+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 80.1 bits (197), Expect = 6e-17
 Identities = 69/278 (24%), Positives = 125/278 (44%), Gaps = 32/278 (11%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS---GRSEQGLREMKNEASVIAKVQHKN 172
           F    K+G G F  VY+   L     +A+K++        +  ++   E  ++ ++ H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRILLD---WVTRVQIIEGIAQGL 227
           +++ L   I+ +E  ++ E      L   +  F   KR++ +   W   VQ+   +    
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE--- 120

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
              H +SR R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YMS
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           PE   E  ++ KSD++S G LL E+ + +     +  D +NL           + +E  D
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLFSLC-------QKIEQCD 224

Query: 348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
            P L  E+ S+    +   +  +C+    D RP +  V
Sbjct: 225 YPPLPTEHYSE----KLRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 70/216 (32%), Positives = 117/216 (54%), Gaps = 34/216 (15%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQ--------GLREMKNEASVIAK 167
           +    K+GEG +G VYK   R  +E IA+K++  R EQ         +RE+    S++ +
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKI--RLEQEDEGVPSTAIREI----SLLKE 57

Query: 168 VQHKNLVRLLGCCIDKDEKI-LIYEYMP---NKSLDFF-LFDPTKRILLDWVTRVQIIEG 222
           +QH N+VRL    +  ++++ L++EY+     K +D    F    R++  ++   QI+ G
Sbjct: 58  MQHGNIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYL--YQILRG 114

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 281
           IA    Y H +   R++HRDLK  N+L+D+  N  K++DFG+AR   G  ++  T  +V 
Sbjct: 115 IA----YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV- 165

Query: 282 TYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGK 316
           T  Y +PE  L    +S   D++S G +  E+V+ K
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.1 bits (197), Expect = 6e-17
 Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 27/209 (12%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRL-----SGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           LG+G FG VY       G E+AVK++     S  + + +  ++ E  ++  + H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 177 LGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKR--ILLDWVTRVQIIEGIAQGLLYLHQ 232
            GC  D  E+ L    E+MP  S+     D  K    L + VTR +    I +G+ YLH 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTR-KYTRQILEGVSYLHS 124

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMS 287
                I+HRD+K +NIL D   N K+ DFG ++    IC  G  +++    + GT  +MS
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----VTGTPYWMS 177

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE      +  K+D++S G  ++E+++ K
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.7 bits (196), Expect = 8e-17
 Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 27/209 (12%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRL-----SGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           LG G FG VY       G E+AVK++     S  + + +  ++ E  ++  ++H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 177 LGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKR--ILLDWVTRVQIIEGIAQGLLYLHQ 232
            GC  D +EK L    EYMP  S+     D  K    L + VTR +    I QG+ YLH 
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTR-RYTRQILQGVSYLHS 124

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMS 287
                I+HRD+K +NIL D   N K+ DFG ++    IC  G  +++    + GT  +MS
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS----VTGTPYWMS 177

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE      +  K+DV+S    ++E+++ K
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 80.1 bits (197), Expect = 8e-17
 Identities = 60/197 (30%), Positives = 106/197 (53%), Gaps = 13/197 (6%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAV-KRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +LG+G FG VYK   ++   +A  K +  +SE+ L +   E  ++A   H N+V+LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             ++   ++ E+    ++D  + +  +R L +   RV + +   + L YLH+    +IIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126

Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGI 295
           RDLKA NIL   D + K++DFG++       +Q   S  +GT  +M+PE  +     +  
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRP 184

Query: 296 FSIKSDVFSFGVLLLEI 312
           +  K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 80.1 bits (197), Expect = 9e-17
 Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 12/197 (6%)

Query: 122 KLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           K+GEG  G V     +  G ++AVK +  R +Q    + NE  ++   QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +  +E  ++ E++   +L     D   +  L+      + E + Q L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 241 RDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           RD+K+ +ILL  D   K+SDFG  A+I   ++       +VGT  +M+PE      +  +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197

Query: 300 SDVFSFGVLLLEIVSGK 316
            D++S G++++E+V G+
Sbjct: 198 VDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 25/212 (11%)

Query: 116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHK 171
           TF     LG+GGFG V    +R  G   A K+L  +     +G     NE  ++ KV  +
Sbjct: 1   TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60

Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD------PTKRILLDWVTRVQIIEGIAQ 225
            +V L      KD   L+   M    L F ++          R +            I  
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-------YAAEICC 113

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYG 284
           GL  LHQ    RI++RDLK  NILLD   + +ISD G+A  +  G  ++      VGT G
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVG 166

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           YM+PE      ++   D ++ G LL E+++G+
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 26/215 (12%)

Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K    K   +AVK L    +++ L ++ +E  ++  + +HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTK--RILLDWVTRVQI 219
           ++ LLG C       ++ EY    +L  +L           FD  K     L +   V  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +M+PE   + +++ +SDV+SFGVLL EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 13/198 (6%)

Query: 124 GEGGFGPVYKGVLRKGDEI-AVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           G+G FG V     R   ++ A+K ++ +    +  +R + NE  ++ ++ H  LV L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
             D++   L+ + +    L + L    K    +   +  I E I   L YLH      II
Sbjct: 69  FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYLHSK---GII 122

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRD+K  NILLD+  +  I+DF +A     + L  +TS   GT GYM+PE      +S+ 
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQGYSVA 179

Query: 300 SDVFSFGVLLLEIVSGKK 317
            D +S GV   E + GK+
Sbjct: 180 VDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 73/293 (24%), Positives = 135/293 (46%), Gaps = 55/293 (18%)

Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRLSGR----------SEQGLREMKNEASVIAK- 167
           LG G FG VYK  +RK +     +A+K ++             ++ + ++ +E ++I + 
Sbjct: 8   LGSGAFGCVYK--VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-DFFL--------FDPTKRILLDWVTRVQ 218
           ++H N+VR     ++ D   ++ + +    L + F         F   +RI   W   VQ
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF-TEERI---WNIFVQ 121

Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
           ++      L YLH+  R  I+HRDL  +NI+L +D    I+DFG+A+           + 
Sbjct: 122 MV----LALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTS 172

Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT 338
           +VGT  Y  PE      +  K+DV++FG +L ++ +       Y T+ L+L         
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTNMLSL--------- 221

Query: 339 SNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           + + +E + +P+ E  YS     +        C+   A+ RP +  V +M+++
Sbjct: 222 ATKIVEAVYEPLPEGMYSEDVTDV-----ITSCLTPDAEARPDIIQVSAMISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 28/216 (12%)

Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLS-GRSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I EY    +L  +L           +D   R+  + +T   ++ 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA-RVPDEQMTFKDLVS 141

Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +    T+ 
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 29/196 (14%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKR-LSGRSEQG-----LREMKNEASVIAK 167
           + +    K+G+G FG V+K   +K  +I A+K+ L    ++G     LRE+K    ++  
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQL 67

Query: 168 VQHKNLVRLLGCCIDKDEK--------ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI 219
           ++H+N+V L+  C  K            L++E+  +  L   L +   +  L  + +V  
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV-- 124

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN---T 276
           ++ +  GL Y+H   R +I+HRD+KA+NIL+ KD   K++DFG+AR    ++       T
Sbjct: 125 MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 277 SRIVGTYGYMSPEYAL 292
           +R+V T  Y  PE  L
Sbjct: 182 NRVV-TLWYRPPELLL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 35/211 (16%)

Query: 123 LGEGGFGPVYKGVLRKGDEI----AVKRLS-----GRSEQGLRE---MKNEASVIAKVQH 170
           +G+G FG VY G L   D      AVK L+        EQ L+E   MK+         H
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKD-------FSH 55

Query: 171 KNLVRLLGCCIDKD-EKILIYEYMPNKSLDFFLFD----PTKRILLDWVTRVQIIEGIAQ 225
            N++ LLG C+  +   +++  YM +  L  F+      PT + L+ +  +V      A+
Sbjct: 56  PNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AK 109

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTY 283
           G+ YL      + +HRDL A N +LD+    K++DFG+AR     E  +  N +      
Sbjct: 110 GMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166

Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
            +M+ E      F+ KSDV+SFGVLL E+++
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 27/187 (14%)

Query: 122 KLGEGGFGPVYKGVLRKGD---EIAVKRLSGRSEQG-------LREMKNEASVIAKVQHK 171
            +G G +G VYK   + G    E A+K+  G  EQ         RE+    +++ +++H+
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREI----ALLRELKHE 62

Query: 172 NLVRLLGCCIDKDEKI--LIYEYMPNKSLDFFLFD-PTKRILLDWVTRVQIIEGIAQGLL 228
           N+V L+   ++  +K   L+++Y  +       F    KR+ +       ++  I  G+ 
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122

Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP----KISDFGMARICGGNELQ--ANTSRIVGT 282
           YLH      ++HRDLK +NIL+  +       KI D G+AR+     L+  A+   +V T
Sbjct: 123 YLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADLDPVVVT 178

Query: 283 YGYMSPE 289
             Y +PE
Sbjct: 179 IWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 77.3 bits (190), Expect = 7e-16
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHK 171
           TF     LG+GGFG V    +R  G   A KRL  +     +G     NE  ++ KV  +
Sbjct: 1   TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60

Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD------PTKRILLDWVTRVQIIEGIAQ 225
            +V L      KD   L+   M    L F +++        +R L            I  
Sbjct: 61  FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-------YAAEILC 113

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYG 284
           GL  LH+ +    ++RDLK  NILLD   + +ISD G+A +I  G  ++      VGT G
Sbjct: 114 GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVG 166

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           YM+PE      +++  D +  G L+ E++ G+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 76.9 bits (189), Expect = 8e-16
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 26/211 (12%)

Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRL 176
           LG+G FG V +  L+  D    ++AVK L     S   + E   EA+ + +  H N+++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 177 LGCCIDKDEK------ILIYEYMPNKSLDFFLFDPTKRI-----LLDWVTRVQIIEGIAQ 225
           +G  +    K      ++I  +M +  L  FL     RI      L   T V+ +  IA 
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL--MSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNEL-QANTSRIVGTY 283
           G+ YL   S    IHRDL A N +L+++M   ++DFG+++ I  G+   Q   S++    
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PV 179

Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
            +++ E   + +++  SDV++FGV + EI++
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 62/226 (27%), Positives = 112/226 (49%), Gaps = 33/226 (14%)

Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQ------GLREMKNEAS 163
               + F    ++GEG +G VYK   +  G+ +A+K++   +E+       +RE+K    
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK---- 58

Query: 164 VIAKVQHKNLVRLLGCCIDKDEKI----------LIYEYMPNKSLDFFLFDPTKRILLDW 213
           ++ ++ H+N+V L     DK + +          L++EYM     D  L    +  L+ +
Sbjct: 59  ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHF 113

Query: 214 VTR--VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
                   ++ + +GL Y H+ +    +HRD+K SNILL+     K++DFG+AR+    E
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 272 LQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
            +  T++++ T  Y  PE  L E  +    DV+S G +L E+ + K
Sbjct: 171 SRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 19/202 (9%)

Query: 122 KLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQ------GLREMKNEASVIAKVQHKNLV 174
            +GEG +G V K   +   EI A+K+     +        LRE+K    V+ +++H+N+V
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVK----VLRQLRHENIV 63

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            L      K    L++EY+    L+  L + +   L     R   I  + Q + Y H   
Sbjct: 64  NLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVR-SYIWQLLQAIAYCH--- 117

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 294
              IIHRD+K  NIL+ +    K+ DFG AR          T   V T  Y +PE  +  
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYRAPELLVGD 176

Query: 295 IFSIKS-DVFSFGVLLLEIVSG 315
               K  DV++ G ++ E++ G
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 25/212 (11%)

Query: 116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHK 171
           TF     LG+GGFG V    +R  G   A K+L  +     +G     NE  ++ KV  +
Sbjct: 1   TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60

Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD------PTKRILLDWVTRVQIIEGIAQ 225
            +V L      KD   L+   M    L F +++        +R +            I  
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-------YAAEITC 113

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYG 284
           GL  LH   R RI++RDLK  NILLD   + +ISD G+A  I  G  ++      VGT G
Sbjct: 114 GLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVG 166

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           YM+PE      ++   D +  G L+ E++ GK
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 11/207 (5%)

Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLR-EMKNEASVIAKVQH 170
           A  ++ +  KLGEG +  VYKG+ R  G  +A+K +S ++E+G+      EAS++  ++H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
            N+V L      K+    ++EYM      + +  P    L  +  R+ + + + +GL Y+
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRLFMFQ-LLRGLAYI 119

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
           H      I+HRDLK  N+L+      K++DFG+AR       Q  +S +V T  Y  P+ 
Sbjct: 120 H---GQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-TLWYRPPDV 174

Query: 291 ALEGI-FSIKSDVFSFGVLLLEIVSGK 316
            L    +S   D++  G + +E++ G+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 21/209 (10%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKG---------DEIAVKRLSGRSEQGLREMKNEASVIAK 167
           +    K+GEG FG   K +L K           EI + ++S +  +   E + E +V++ 
Sbjct: 2   YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSN 55

Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
           ++H N+V+      +     ++ +Y     L +   +  + +L       QI++   Q  
Sbjct: 56  MKHPNIVQYQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLF---PEDQILDWFVQIC 111

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
           L L      +I+HRD+K+ NI L KD   K+ DFG+AR+       A T   +GT  Y+S
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC--IGTPYYLS 169

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE      ++ KSD+++ G +L E+ + K
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 28/205 (13%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           K+GEG  G V    ++  G  +AVK++  R +Q    + NE  ++   QH+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE--------GIAQGLLYLHQ 232
           +  DE  ++ E++   +L             D VT  ++ E         + + L  LH 
Sbjct: 87  LVGDELWVVMEFLEGGALT------------DIVTHTRMNEEQIAAVCLAVLKALSVLHA 134

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYA 291
                +IHRD+K+ +ILL  D   K+SDFG  A++    E+    S +VGT  +M+PE  
Sbjct: 135 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKS-LVGTPYWMAPELI 188

Query: 292 LEGIFSIKSDVFSFGVLLLEIVSGK 316
               +  + D++S G++++E+V G+
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 21/207 (10%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKVQH 170
           F    +LG G  G V K + R    I  ++L           Q +RE+K    V+ +   
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELK----VLHECNS 58

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             +V   G      E  +  E+M   SLD  L     RI  + + ++ I   + +GL YL
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPENILGKISI--AVLRGLTYL 115

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
            +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSPE 
Sbjct: 116 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE- 168

Query: 291 ALEGI-FSIKSDVFSFGVLLLEIVSGK 316
            L+G  ++++SD++S G+ L+E+  G+
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 7e-15
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 33/207 (15%)

Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLRE---MKNEASVIAKVQHKNLVRLLG 178
           +G G FG V+    R  +   A+K ++      L++   + NE  V+ +V H  ++RL  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 179 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
              + D++ L  + EY+P   L  F +        +        E I   L YLH     
Sbjct: 68  -WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALEYLHSKE-- 121

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            I++RDLK  NILLDK+ + K++DFG A+     +L+  T  + GT  Y++PE       
Sbjct: 122 -IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE------- 168

Query: 297 SIKS-------DVFSFGVLLLEIVSGK 316
            I+S       D ++ G+L+ E++ G 
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.3 bits (183), Expect = 8e-15
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 48/224 (21%)

Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQ--------GLREMKNEASVIA 166
            F   N++GEG +G VY+       EI A+K++  R +          LRE+    +++ 
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV--RMDNERDGIPISSLREI----TLLL 61

Query: 167 KVQHKNLVRLLGCCIDK--DEKILIYEY-----------MPNKSLDFFLFDPTKRILLDW 213
            ++H N+V L    + K  D   L+ EY           MP      F     K ++L  
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP----FSESQVKCLML-- 115

Query: 214 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 273
               Q++ G+     YLH+     IIHRDLK SN+LL      KI+DFG+AR   G   +
Sbjct: 116 ----QLLRGLQ----YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAK 163

Query: 274 ANTSRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 316
             T ++V T  Y +PE  L       + D+++ G +L E+++ K
Sbjct: 164 PMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 74.0 bits (181), Expect = 9e-15
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 20/206 (9%)

Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCI 181
           +G G +G VYKG   K  ++A  ++   +     E+K E +++ K   H+N+    G  I
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 182 DK------DEKILIYEYMPNKSLDFFLFDPTKRILLD-WVTRVQIIEGIAQGLLYLHQYS 234
            K      D+  L+ E+    S+   + +     L + W+    I   I +GL +LHQ+ 
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQH- 130

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-- 292
             ++IHRD+K  N+LL ++   K+ DFG++        + NT   +GT  +M+PE     
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACD 186

Query: 293 ---EGIFSIKSDVFSFGVLLLEIVSG 315
              +  +  KSD++S G+  +E+  G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 25/204 (12%)

Query: 123 LGEGGFGPVYKGVL----RKGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           LG G FG + +G L    ++   +A+  L +G S++  R    EA  + +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G     +  +++ EYM N +LD FL     +++   +  + ++ G+A G+ YL   S + 
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL--MGMLPGLASGMKYL---SEMG 127

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYG------YMSPEY 290
            +H+ L A  +L++ D+  KIS F          LQ + S  I  T        + +PE 
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--------RLQEDKSEAIYTTMSGKSPVLWAAPEA 179

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVS 314
                FS  SDV+SFG+++ E++S
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 41/274 (14%)

Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRSEQGL-REMKNEASVIAKVQHKNLVRLLGCC 180
           LG G  G VYK   L     +AVK +       L +++ +E  ++ K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             ++   +  E+M   SLD +     ++I    + R+ +   + +GL YL     ++I+H
Sbjct: 69  FVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAV--AVVKGLTYLWS---LKILH 118

Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K SN+L++     K+ DFG++       + +     VGT  YM+PE      + I S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 301 DVFSFGVLLLEIVSGK-------KNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED 353
           DV+S G+  +E+  G+       KN G      L LL  + D           D PVL  
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLM--PLQLLQCIVDE----------DPPVLPV 222

Query: 354 -EYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
            ++S K     +V+    C+++   +RP   +++
Sbjct: 223 GQFSEK-----FVHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 12/197 (6%)

Query: 122 KLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           K+GEG  G V     +  G ++AVK++  R +Q    + NE  ++    H+N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +  DE  ++ E++   +L     D      ++      +   + + L YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 241 RDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           RD+K+ +ILL  D   K+SDFG  A++    E+    S +VGT  +M+PE      +  +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKS-LVGTPYWMAPEVISRLPYGTE 198

Query: 300 SDVFSFGVLLLEIVSGK 316
            D++S G++++E++ G+
Sbjct: 199 VDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 123 LGEGGFGPV------YKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           LG+GGFG V        G +    ++  KRL  +S + +  ++ E  ++ KV    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE--ILEKVNSPFIVNL 58

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                 K    L+   M    L + +++  +R  L+    +     I  G+L+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGER-GLEMERVIHYSAQITCGILHLHS---M 114

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGI 295
            I++RD+K  N+LLD   N ++SD G+A  +  G       ++  GT GYM+PE   E  
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEILKEEP 170

Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +S   D F+ G  + E+V+G+
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 13/206 (6%)

Query: 116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHK 171
           TF     LG+GGFG V    +R  G   A K+L  +     +G     NE  ++ KV  +
Sbjct: 1   TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60

Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
            +V L      KD   L+   M    L F +++       D    +     +  GL  L 
Sbjct: 61  FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY 290
              R RI++RDLK  NILLD   + +ISD G+A +I  G  ++      VGT GYM+PE 
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEV 172

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGK 316
                ++   D +  G L+ E++ G+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 34/211 (16%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREM---KNEASVIAKVQHKNLVRLLG 178
           K+GEG FG +Y    +   E  V +    ++  ++E    K E  ++AK++H N+V    
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRI------------LLDWVTRVQIIEGIAQG 226
              +     ++ EY     L        KRI            +L W  +      I+ G
Sbjct: 67  SFQENGRLFIVMEYCDGGDL-------MKRINRQRGVLFSEDQILSWFVQ------ISLG 113

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           L ++H     +I+HRD+K+ NI L K+ M  K+ DFG+AR    +   A T   VGT  Y
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTPYY 168

Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +SPE      ++ K+D++S G +L E+ + K
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 28/209 (13%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLREMK---NEASVIAKVQH-KNLVRLL 177
           LG G +G V K        I AVKR+  R+    +E K    +  +  +       V   
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 178 GCCIDKDEKILIYEYMPNKSLDFF---LFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           G    + +  +  E M + SLD F   ++D    I  D + ++ +   I + L YLH  S
Sbjct: 67  GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAV--SIVKALEYLH--S 121

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV--GTYGYMSPE--- 289
           ++ +IHRD+K SN+L++++   K+ DFG   I G   L  + ++ +  G   YM+PE   
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFG---ISG--YLVDSVAKTIDAGCKPYMAPERIN 176

Query: 290 --YALEGIFSIKSDVFSFGVLLLEIVSGK 316
                +G + +KSDV+S G+ ++E+ +G+
Sbjct: 177 PELNQKG-YDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 19/206 (9%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKVQH 170
           F   ++LG G  G V K   +    I  ++L           Q +RE++    V+ +   
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHECNS 62

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             +V   G      E  +  E+M   SLD  L +  KRI  + + +V I   + +GL YL
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSI--AVLRGLAYL 119

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
            +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSPE 
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGK 316
                +S++SD++S G+ L+E+  G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 22/223 (9%)

Query: 107 FSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIA 166
            S++      F     +G G +G VYKG   K  ++A  ++   +E    E+K E +++ 
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67

Query: 167 KV-QHKNLVRLLGCCIDK------DEKILIYEYMPNKSLDFFLFDPTKRILL--DWVTRV 217
           K   H+N+    G  I K      D+  L+ E+    S+   L   TK   L  DW+   
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIA-- 124

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
            I   I +GL +LH +   ++IHRD+K  N+LL ++   K+ DFG++        + NT 
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT- 180

Query: 278 RIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSG 315
             +GT  +M+PE        +  +  +SD++S G+  +E+  G
Sbjct: 181 -FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 19/202 (9%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLREMKNEASVIAKV------QHKNLVR 175
           LG+G FG V+   L+  ++  A+K L  + +  L +   E +++ K       +H  L  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L      K+    + EY+    L F +    K    D          I  GL +LH    
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG- 116

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEG 294
             I++RDLK  NILLD D + KI+DFGM   C  N L  A T    GT  Y++PE  L  
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGM---CKENMLGDAKTCTFCGTPDYIAPEILLGQ 171

Query: 295 IFSIKSDVFSFGVLLLEIVSGK 316
            ++   D +SFGVLL E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 71.7 bits (176), Expect = 8e-14
 Identities = 56/234 (23%), Positives = 105/234 (44%), Gaps = 55/234 (23%)

Query: 121 NKLGEGGFGPVYKGV-LRKGDEIAVKRL------SGRSEQG------------LREMKNE 161
             LGEG +G V K      G  +A+K++      +  ++              LRE+K  
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK-- 72

Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN---KSLD--FFLFDPTKRILLDWVTR 216
             ++ +++H+N++ L+   ++ D   L+ + M +   K +D    L +   + +L     
Sbjct: 73  --IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL----- 125

Query: 217 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN- 275
           +QI+ G+      LH++     +HRDL  +NI ++     KI+DFG+AR  G        
Sbjct: 126 LQILNGLNV----LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 276 ------------TSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
                       TS++V T  Y +PE  +    +    D++S G +  E+++GK
Sbjct: 179 SKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 34/223 (15%)

Query: 107 FSSVSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRL------SGRSEQGLREMK 159
           F +V   TN + D   +G G FG V        G  +A+K++         +++  RE+K
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 160 NEASVIAKVQHKNLVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQ 218
               ++  ++H+N++ L    I   E I  + E +     D        R+L       Q
Sbjct: 62  ----LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDL------HRLLTSRPLEKQ 108

Query: 219 IIE----GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 274
            I+     I +GL Y+H      ++HRDLK SNIL++++ + KI DFG+ARI        
Sbjct: 109 FIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDP 160

Query: 275 NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 316
             +  V T  Y +PE  L    + ++ D++S G +  E++ GK
Sbjct: 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 47/224 (20%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGL-------REMKNEASVIA 166
           + + + + +G G +G V      K    +A+K+LS R  Q         RE++    ++ 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELR----LLK 69

Query: 167 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---- 218
            + H+N++ LL              + P  SL    D +L        L+ + + Q    
Sbjct: 70  HMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD 117

Query: 219 -----IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 273
                ++  I +GL Y+H      IIHRDLK SNI +++D   KI DFG+AR        
Sbjct: 118 DHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----D 169

Query: 274 ANTSRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 316
              +  V T  Y +PE  L  +   ++ D++S G ++ E+++GK
Sbjct: 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 31/207 (14%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLREMKNEASVIAK------VQHKNLVR 175
           LG+G FG V    L++   + AVK L  + +  L++   E ++  K        H  L +
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVL--KKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           L  C    D    + E++    L F +     FD  +        R    E I   L++L
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-------ARFYAAE-ITSALMFL 112

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSP 288
           H      II+RDLK  N+LLD + + K++DFGM +  I  G      TS   GT  Y++P
Sbjct: 113 HDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAP 165

Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSG 315
           E   E ++    D ++ GVLL E++ G
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 44/291 (15%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIA---VKRLSGRS---EQGLREMKNEASVIAKVQHKNLV 174
           +++G G FG V  G   +G   A   VK L   +   EQ L     E     ++ H N++
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVL 58

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL--------FDPTKRILLDWVTRVQIIEGIAQG 226
           + LG CI+    +L+ E+ P   L  +L            K +L       ++   +A G
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASG 112

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           LL+LHQ      IH DL   N  L  D++ KI D+G+A      +             ++
Sbjct: 113 LLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169

Query: 287 SPEYALEGIFSI-------KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS 339
           +PE        +       KS+++S GV + E+ +         +D   +L  V      
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQV----VR 224

Query: 340 NRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
            + ++L   P L+ +YS      R+  +   C  +  + RPT  +V  +LT
Sbjct: 225 EQDIKL-PKPQLDLKYSD-----RWYEVMQFCWLDP-ETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 24/204 (11%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ-------GLREMKNEASVIAKVQHKNL 173
           K+GEG +G V+K   R+ G  +A+K+    SE         LRE++    ++ +++H NL
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFV-ESEDDPVIKKIALREIR----MLKQLKHPNL 62

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V L+     K +  L++EY  +  L+    +P     +      +II    Q + + H++
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKH 119

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
           +    IHRD+K  NIL+ K    K+ DFG ARI  G     + +  V T  Y +PE  L 
Sbjct: 120 N---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPEL-LV 173

Query: 294 G--IFSIKSDVFSFGVLLLEIVSG 315
           G   +    DV++ G +  E+++G
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 20/202 (9%)

Query: 122 KLGEGGFGPVYKGVLRKGDEI-AVKRLS------GRSEQGLREMKNEASVIAKVQHKNLV 174
           K+GEG +G V+K   R+  EI A+KR+       G     LRE+     ++ +++HKN+V
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKELKHKNIV 62

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           RL        +  L++EY  ++ L  + FD +    +D       +  + +GL + H + 
Sbjct: 63  RLYDVLHSDKKLTLVFEYC-DQDLKKY-FD-SCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 294
              ++HRDLK  N+L++K+   K++DFG+AR   G  ++  ++ +V T  Y  P+     
Sbjct: 119 --NVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVRCYSAEVV-TLWYRPPDVLFGA 174

Query: 295 -IFSIKSDVFSFGVLLLEIVSG 315
            ++S   D++S G +  E+ + 
Sbjct: 175 KLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 13/205 (6%)

Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNL 173
           T+   +KLGEG +  VYKG  +  D  +A+K +    E+G       E S++  ++H N+
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V L      +    L++EY+ +K L  +L D    I +  V     +  + +GL Y H  
Sbjct: 67  VTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVK--LFLFQLLRGLNYCH-- 121

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAL 292
            R +++HRDLK  N+L+++    K++DFG+AR      +   T S  V T  Y  P+  L
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILL 177

Query: 293 EGI-FSIKSDVFSFGVLLLEIVSGK 316
               +S + D++  G +  E+ +G+
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKV 168
           + F   ++LG G  G V+K   +    I  ++L           Q +RE++    V+ + 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60

Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
               +V   G      E  +  E+M   SLD  L     RI    + +V I   + +GL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 117

Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 171

Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E      +S++SD++S G+ L+E+  G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 28/213 (13%)

Query: 116 TFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSG--RSEQGLREMKNEASVIAKVQHKN 172
            ++   ++G G +G V   +  R G+++A+K+LS   +SE   +    E +++  +QH+N
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVT-------RVQ-IIEGIA 224
           ++ LL    D     +  +       DF+L  P  +  L  +        +VQ ++  + 
Sbjct: 76  VIGLL----DVFTSAVSGDEFQ----DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML 127

Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
            GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR        A  +  V T  
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRW 179

Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 316
           Y +PE  L  +   ++ D++S G ++ E+++GK
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 27/207 (13%)

Query: 123 LGEGGFGPVYKGVLRK-GDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +G G  G VYK   +K G  +AVK++  +G  E+  R + +   V+       +V+  G 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QIIEGIAQGLLYL---HQYS 234
            I   +  +  E M +  LD  L    KRI       +  ++   I + L YL   H   
Sbjct: 83  FITDSDVFICMELM-STCLDKLL----KRIQGPIPEDILGKMTVAIVKALHYLKEKHG-- 135

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY--- 290
              +IHRD+K SNILLD   N K+ DFG++ R+    + +A T R  G   YM+PE    
Sbjct: 136 ---VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPERIDP 188

Query: 291 -ALEGIFSIKSDVFSFGVLLLEIVSGK 316
                 + I++DV+S G+ L+E+ +G+
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 27/206 (13%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLREMKNEASVIAK------VQHKNLVR 175
           LG+G FG V    L+  +E  A+K L  + +  L +   E +++ +       +H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKAL--KKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           L      K+    + EY+    L F +     FD  +        R    E I  GL +L
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR-------ARFYAAE-IICGLQFL 112

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
           H+     II+RDLK  N+LLDKD + KI+DFGM +     E +A+T    GT  Y++PE 
Sbjct: 113 HKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEI 167

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGK 316
                ++   D +SFGVLL E++ G+
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 31/208 (14%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLREMKNEASVIAK------VQHKNLVR 175
           LG+G FG V    L+  DE+ A+K L  + +  L++   + ++  K       +H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVL--KKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           L  C   KD    + EY+    L F +     FD  +       +R    E +   L++L
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPR-------SRFYAAE-VTLALMFL 112

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSP 288
           H++    +I+RDLK  NILLD + + K++DFGM +  I  G      T+   GT  Y++P
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAP 165

Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E   E  +    D ++ GVL+ E+++G+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 19/196 (9%)

Query: 126 GGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKN----EASVIAKVQHKNLVRLLGCC 180
           G FG VY    R  GD  A+K L         ++ N     A ++ + +   + +L    
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             KD   L+ EY+        L      +  DW    Q I  +  G+  LHQ     IIH
Sbjct: 67  QSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAK--QYIAEVVLGVEDLHQRG---IIH 120

Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK- 299
           RD+K  N+L+D+  + K++DFG++R    N+      + VGT  Y++PE  + G+   K 
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILGVGDDKM 173

Query: 300 SDVFSFGVLLLEIVSG 315
           SD +S G ++ E + G
Sbjct: 174 SDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 63/209 (30%), Positives = 89/209 (42%), Gaps = 34/209 (16%)

Query: 123 LGEGGFGPV----YKG--------VLRKGDEIAVKRLSGRSE-QGLREMKNEASVIAKVQ 169
           LG G FG V    YK          L+KGD IA      R E + L   K         +
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA------RDEVESLMCEKRIFETANSER 60

Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ---G 226
           H  LV L  C   +D    + EY     L          I  D  +  + +   A    G
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDL-------MMHIHTDVFSEPRAVFYAACVVLG 113

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           L YLH+    +I++RDLK  N+LLD +   KI+DFG+ +   G      TS   GT  ++
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFL 168

Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           +PE   E  ++   D +  GVL+ E++ G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 38/95 (40%), Positives = 55/95 (57%), Gaps = 7/95 (7%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 281
           IA GL +LH      II+RDLK  N++LD + + KI+DFGM   C  N     T+R   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM---CKENIFGGKTTRTFCG 163

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 28/210 (13%)

Query: 123 LGEGGFGPVYKGVLRK-GD-------EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           LG+G F  ++KG+ R+ GD       E+ +K L              AS+++++ HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
              G C+  DE I++ EY+   SLD +L      I + W  ++++ + +A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 235 RVRIIHRDLKASNILL-----DKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYM 286
              + H ++ A N+LL      K  NP   K+SD G++      E+     RI     ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171

Query: 287 SPEYALEG-IFSIKSDVFSFGVLLLEIVSG 315
            PE        S+ +D +SFG  L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           F    ++G G +G VYK   +  G+  A+K +     +    ++ E  ++   +H N+V 
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 176 LLGCCIDKDEKILIYEYMPNKSLD--FFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G  + +D+  +  E+    SL   + +  P     + +V+R  +     QGL YLH  
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK 125

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAL 292
            +   +HRD+K +NILL  + + K++DFG+ A+I       A     +GT  +M+PE A 
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMAPEVAA 179

Query: 293 ---EGIFSIKSDVFSFGVLLLEI 312
              +G ++   D+++ G+  +E+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 69.1 bits (170), Expect = 7e-13
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 61/232 (26%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQG-------LREMKNEASVIAKV 168
           +     +G G +G V   V  R G ++A+K++S             LRE+K    ++  +
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS-NVFDDLIDAKRILREIK----LLRHL 56

Query: 169 QHKNLVRLLGCCIDKDEK-----ILIYEYMP---------NKSLD-----FFLFDPTKRI 209
           +H+N++ LL        +      ++ E M           + L      +FL+      
Sbjct: 57  RHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY------ 110

Query: 210 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 269
                   QI+    +GL YLH      +IHRDLK SNIL++ + + KI DFG+AR    
Sbjct: 111 --------QIL----RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155

Query: 270 NELQAN--TSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGK 316
           +E +    T  +V T  Y +PE  L       +I  D++S G +  E+++ K
Sbjct: 156 DEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 19/206 (9%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGRS-EQGLR-EMKNEASVIAKVQ---HKNLVR 175
           ++G G +G VYK      G  +A+K +  ++ E GL      E +++ +++   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 176 LLGCC----IDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           L+  C     D++ K+ L++E++      +    P   +  + +    ++    +GL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFL 124

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
           H      I+HRDLK  NIL+      K++DFG+ARI      Q   + +V T  Y +PE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAPEV 178

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGK 316
            L+  ++   D++S G +  E+   K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 51/227 (22%)

Query: 116 TFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQ-----GLREMKNEASVIAKVQ 169
            + + + +GEG +G V        G ++A+K++S    Q      LRE+K    ++ + +
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFK 61

Query: 170 HKNLVRLLGCCIDKD-----EKILIYEYMP-------------NKSLDFFLFDPTKRILL 211
           H+N++ +L            +  ++ E M              N  + +FL+        
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY-------- 113

Query: 212 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
                 QI+    +GL Y+H      ++HRDLK SN+LL+ + + KI DFG+ARI     
Sbjct: 114 ------QIL----RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160

Query: 272 LQANT-SRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 316
                 +  V T  Y +PE  L      K+ D++S G +L E++S +
Sbjct: 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 67.8 bits (165), Expect = 9e-13
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           ++G G +G VYK   L  G+  AVK +          ++ E  ++ + +H N+V   G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 181 IDKDEKILIYEYMPNKSLD--FFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
           + +++  +  EY    SL   + +  P   + + +V R  +     QGL YLH   +   
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK--- 127

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGI 295
           +HRD+K +NILL  + + K++DFG+A         A     +GT  +M+PE A     G 
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 296 FSIKSDVFSFGVLLLEI 312
           ++   D+++ G+  +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 22/203 (10%)

Query: 122 KLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQ------GLREMKNEASVIAKVQHKNLV 174
            +GEG +G V K   ++  +I A+K+     +        +RE++    ++ +++H+NLV
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLRHENLV 63

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            L+     K    L++E++ +  LD     P     LD     + +  I +G+ + H ++
Sbjct: 64  NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN 120

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALE 293
              IIHRD+K  NIL+ +    K+ DFG AR +    E+  +    V T  Y +PE  + 
Sbjct: 121 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPELLVG 174

Query: 294 GI-FSIKSDVFSFGVLLLEIVSG 315
              +    D+++ G L+ E+++G
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 13/205 (6%)

Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNL 173
           T+    KLGEG +  V+KG  +  +  +A+K +    E+G       E S++  ++H N+
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V L           L++EY+ +K L  ++ D    I+     ++ + + I +GL Y H  
Sbjct: 67  VTLHDIVHTDKSLTLVFEYL-DKDLKQYM-DDCGNIMSMHNVKIFLYQ-ILRGLAYCH-- 121

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAL 292
            R +++HRDLK  N+L+++    K++DFG+AR      +   T S  V T  Y  P+  L
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLL 177

Query: 293 -EGIFSIKSDVFSFGVLLLEIVSGK 316
               +S + D++  G +  E+ SG+
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 19/202 (9%)

Query: 123 LGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAK------VQHKNLVR 175
           LG+G FG V    L+ KG+  AVK L  + +  L +   E +++ K       ++  L  
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKAL--KKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L      K+    + E++    L F + D  +    D          I  GL +LH    
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG- 116

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEYALEG 294
             II+RDLK  N++LD+D + KI+DFGM   C  N    N  S   GT  Y++PE     
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGM---CKENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 295 IFSIKSDVFSFGVLLLEIVSGK 316
            ++   D +SFGVLL E++ G+
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 19/225 (8%)

Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEA 162
           +    S+   T+T+     +G+G +G VYK   +K G   AVK L   S+    E++ E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69

Query: 163 SVIAKV-QHKNLVRLLGCCIDKDEKI-----LIYEYMPNKSLDFFLFDPTKR-ILLDWVT 215
           +++  +  H N+V+  G     D+ +     L+ E     S+   +         LD   
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129

Query: 216 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 275
              I+ G   GL +LH     RIIHRD+K +NILL  +   K+ DFG++       L+ N
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186

Query: 276 TSRIVGTYGYMSPEY-----ALEGIFSIKSDVFSFGVLLLEIVSG 315
           TS  VGT  +M+PE        +  +  + DV+S G+  +E+  G
Sbjct: 187 TS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 36/211 (17%)

Query: 123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVR---- 175
           +G+G +G V     R  G +  +K+L+ R  S +  +  + EA ++++++H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 176 ----------LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
                     ++G C   D    +Y  +  +          +  +++W  +      IA 
Sbjct: 68  WEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLP----ENQVVEWFVQ------IAM 113

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
            L YLH+     I+HRDLK  N+ L +    K+ D G+AR+       A+T  ++GT  Y
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYY 168

Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           MSPE      ++ KSDV++ G  + E+ + K
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 81/267 (30%), Positives = 119/267 (44%), Gaps = 50/267 (18%)

Query: 107 FSSVSTATNTFSDTNK------LGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLRE 157
           F SV  A +TF+   +      +G G  G V   +  VL  G  +AVK+LS       R 
Sbjct: 7   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS-------RP 57

Query: 158 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK-- 207
            +N+    AK  ++ LV LL C   K+   L+  + P KSL+ F        L D     
Sbjct: 58  FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ 114

Query: 208 --RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR 265
              + LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR
Sbjct: 115 VIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Query: 266 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD 325
               N +   T  +V  Y Y +PE  L   +    D++S G ++ E+V G  +     TD
Sbjct: 172 TACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG--SVIFQGTD 226

Query: 326 SLNLLGYVWDLWTSNRTLELIDDPVLE 352
            +       D W  N+ +E +  P  E
Sbjct: 227 HI-------DQW--NKVIEQLGTPSAE 244

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 66.3 bits (161), Expect = 4e-12
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 25/211 (11%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKN 172
           +++    KLGEG +  VYKG  +  G  +A+K +  + E+G       EAS++  ++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFF------LFDPTKRILLDWVTRVQIIEGIAQG 226
           +V L      K+   L++EY+      +       L     ++ L  + R         G
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR---------G 115

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGY 285
           L Y+HQ     I+HRDLK  N+L+      K++DFG+AR      + ++T S  V T  Y
Sbjct: 116 LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWY 169

Query: 286 MSPEYALEGI-FSIKSDVFSFGVLLLEIVSG 315
             P+  L    +S   D++  G + +E++ G
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 46/220 (20%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEI-AVKRLSG------------RSEQGLREMKNEASVIAK 167
            KLG+G +G V+K + R+  E+ A+K++              R    L+E+ +       
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD------- 65

Query: 168 VQHKNLVRLLGCC-IDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
             H N+V+LL     + D+ I L++EYM     +  L    +  +L+ V +  I+  + +
Sbjct: 66  --HPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLK 118

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANT--SRIVGT 282
            L Y+H  S   +IHRDLK SNILL+ D   K++DFG+AR +    E   N   +  V T
Sbjct: 119 ALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 283 YGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGK 316
             Y +PE  L      +G+     D++S G +L E++ GK
Sbjct: 176 RWYRAPEILLGSTRYTKGV-----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 38/94 (40%), Positives = 59/94 (62%), Gaps = 7/94 (7%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIV 280
           +A+G+ +L   SR + IHRDL A NILL ++   KI DFG+AR    +   ++   +R+ 
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237

Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++ +SDV+SFGVLL EI S
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.3 bits (159), Expect = 7e-12
 Identities = 46/142 (32%), Positives = 77/142 (54%), Gaps = 10/142 (7%)

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 166

Query: 291 ALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
             +G+ +   +D FS G +L +++ G      ++T   + +    D  T    +EL D  
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAVELPDSF 222

Query: 350 VLEDEYSSKQVLLRYVNIALLC 371
             E     + +L R VN  L C
Sbjct: 223 SPELRSLLEGLLQRDVNRRLGC 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 64.8 bits (158), Expect = 8e-12
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 31/214 (14%)

Query: 123 LGEGGFGPVYKGVLR---------KGDEIAVKR-LSGRSEQGLREMKNEASVIAKVQHKN 172
           LG+G F  +YKGVLR          G E++V   + G   +        AS+++++ HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           LV+L G C+ +DE I++ EY+    LD FL      + L W  ++ + + +A  L YL  
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 233 YSRVRIIHRDLKASNILLDK-DMNP------KISDFGMARICGGNELQANTSRIVGTYGY 285
               +++H ++   NIL+ +  +N       K+SD G+       E +    RI     +
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER--VERI----PW 170

Query: 286 MSPEYALEGIFSIKS--DVFSFGVLLLEIVSGKK 317
           ++PE    G  S+    D +SFG  LLEI S  +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 69/234 (29%), Positives = 103/234 (44%), Gaps = 45/234 (19%)

Query: 107 FSSVSTATNTF------SDTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLRE 157
           F SV    +TF       +   +G G  G V   Y  V   G  +A+K+LS R  Q +  
Sbjct: 2   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLS-RPFQNVTH 58

Query: 158 MKN---EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPT 206
            K    E  ++  V HKN++ LL              + P KSL+ F        L D  
Sbjct: 59  AKRAYRELVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDAN 106

Query: 207 K----RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 107 LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163

Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G 
Sbjct: 164 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 35/225 (15%)

Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMK----------------NEASVIA 166
           LG+G FG V+           V++++G     L  MK                 E  ++A
Sbjct: 4   LGQGSFGKVF----------LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILA 53

Query: 167 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG 226
           +V H  +V+L      + +  LI +++  +  D F     + +  +   +  + E +A  
Sbjct: 54  EVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALA 110

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           L +LH    + II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165

Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLL 330
           +PE       +  +D +SFGVL+ E+++G     G  R +++ ++
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 9/154 (5%)

Query: 161 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII 220
           EA ++  V H +++R+    +      ++   +P+ S D + +   +   L     + I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
           + I +GL YLH     RIIHRD+K  NI ++      I D G A+      +      + 
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217

Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           GT    +PE      ++ K+D++S G++L E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 39/232 (16%)

Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLR 156
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS       R
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLS-------R 59

Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK- 207
             +N+    AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D    
Sbjct: 60  PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 116

Query: 208 ---RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
              ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173

Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           R  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G 
Sbjct: 174 RTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 20/210 (9%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRS------EQGLREMKNEASVIAK 167
           N F     +GEG +G V K   ++  EI A+K+           E  LRE+K    ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56

Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
           ++ +N+V L      + +  L++EY+    L+     P        V   ++   I Q +
Sbjct: 57  LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG------VPPEKVRSYIYQLI 110

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYM 286
             +H   +  I+HRD+K  N+L+  +   K+ DFG AR +  G+   AN +  V T  Y 
Sbjct: 111 KAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWYR 168

Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           SPE  L   +    D++S G +L E+  G+
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 19/222 (8%)

Query: 107 FSSVSTATNTFSDTNKLGEGGFGPVYKGVLRK--GDEIAVKRLSGRSEQGLREMKNEASV 164
           F S    ++T+     +G+G +G V+K VL K  G + AVK L    +    E++ E ++
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID-EEIEAEYNI 67

Query: 165 I-AKVQHKNLVRLLGCCIDKDEKI-----LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQ 218
           + A   H N+V+  G    KD K      L+ E     S+   +    KR   + +    
Sbjct: 68  LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPI 125

Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
           I   + + L+ L      + IHRD+K +NILL  +   K+ DFG++       L+ NTS 
Sbjct: 126 IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 184

Query: 279 IVGTYGYMSPEY-----ALEGIFSIKSDVFSFGVLLLEIVSG 315
            VGT  +M+PE       L+  +  + DV+S G+  +E+  G
Sbjct: 185 -VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 41/232 (17%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 19  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 77

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 78  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 126 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 177

Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL 330
           V T  Y +PE  L  + ++   D++S G ++ E+++G+  T    TD ++ L
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQL 227

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 30/220 (13%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           + D   LG G  G V+  V    D+ +AVK++     Q ++    E  +I ++ H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 176 LL------GCCIDKDEKIL-----IY---EYMPNKSLDFFLFDPTKRILLDWVTRV--QI 219
           +       G  + +D   L     +Y   EYM     D         +  +       Q+
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM---ETDLANVLEQGPLSEEHARLFMYQL 123

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGN-ELQANTS 277
           +    +GL Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI   +   +   S
Sbjct: 124 L----RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 278 RIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 316
             + T  Y SP   L      K+ D+++ G +  E+++GK
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 40/212 (18%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQ--GLREMKNEASVIAKVQ-HKNL 173
            K+GEG F  V K   RK G   A+K +       EQ   LRE++     + ++  H N+
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQ----ALRRLSPHPNI 60

Query: 174 VRLLGCCIDKDEKIL----------IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGI 223
           +RL+    D+    L          +YE +  +        P KR+   ++   Q++   
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPL----PEKRVKS-YMY--QLL--- 110

Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 283
            + L ++H   R  I HRD+K  NIL+  D   K++DFG  R  G       T  I  T 
Sbjct: 111 -KSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STR 162

Query: 284 GYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVS 314
            Y +PE  L +G +  K D+++ G +  EI+S
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 61/228 (26%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKR-LSGRSEQG-----LREMKNEASVIAKVQHKN-L 173
           K+GEG +G VYK      G  +A+K+      E+G     LRE+    S++  +     +
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI----SLLQMLSESIYI 63

Query: 174 VRLLGC--CIDKDEKILIY---EY-------------------MPNKSLDFFLFDPTKRI 209
           VRLL      +K+ K  +Y   EY                   +P K++  F++      
Sbjct: 64  VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY------ 117

Query: 210 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICG 268
                   Q+++G+A    + H++    ++HRDLK  N+L+DK     KI+D G+ R   
Sbjct: 118 --------QLLKGVA----HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR-AF 161

Query: 269 GNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSG 315
              +++ T  IV T  Y +PE  L    +S   D++S G +  E+   
Sbjct: 162 SIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 15/199 (7%)

Query: 123 LGEGGFGPVYKGVLRKGDEI--AVKRLSGRSEQGLREMKN---EASVIAK-VQHKNLVRL 176
           +G+G FG V      K D    AVK L  ++    +E K+   E +V+ K V+H  LV L
Sbjct: 3   IGKGSFGKVLL-AKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                  D+   + +Y+    L F L    +R   +   R    E IA  L YLH    +
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS---L 115

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            II+RDLK  NILLD   +  ++DFG+ +   G E    TS   GT  Y++PE   +  +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173

Query: 297 SIKSDVFSFGVLLLEIVSG 315
               D +  G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 20/207 (9%)

Query: 121 NKLGEGGFGPVYKGVLRK--GDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           ++LG+G +G VYK VL +  G  +A+K  RL    E    ++  E  ++ K     +V  
Sbjct: 7   DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDF 64

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
            G    +    +  EYM   SLD           +      +I   + +GL +L +    
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-VGTYGYMSPEYALEG- 294
            IIHRD+K +N+L++ +   K+ DFG++    GN L A+ ++  +G   YM+PE    G 
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS----GN-LVASLAKTNIGCQSYMAPERIKSGG 177

Query: 295 -----IFSIKSDVFSFGVLLLEIVSGK 316
                 ++++SDV+S G+ +LE+  G+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 123 LGEGGFGPVYKGVLRKGDEI----AVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLL 177
           +G G +  V    L+K + I     VK+     ++ +  ++ E  V  +   H  LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
            C   +     + EY+    L F +    +R L +   R    E I+  L YLH+     
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG--- 116

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           II+RDLK  N+LLD + + K++D+GM +   G      TS   GT  Y++PE      + 
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 298 IKSDVFSFGVLLLEIVSGK 316
              D ++ GVL+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 37/217 (17%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSG--RSEQGLREMKNEASVIAKVQHKNL 173
           + D  ++G G +G V   +  R G ++A+K+L    +SE   +    E  ++  ++H+N+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLD----FFLFDPTKRILLDWVT--------RVQ-II 220
           + LL              + P+ SLD    F+L  P     L  +         R+Q ++
Sbjct: 77  IGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLV 124

Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             + +GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR     +  +  +  V
Sbjct: 125 YQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYV 176

Query: 281 GTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
            T  Y +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.8 bits (158), Expect = 5e-11
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 51/231 (22%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKR----LSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
            +G+GG G VY          +A+K+    LS       R ++ EA + A + H  +V +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLR-EAKIAADLIHPGIVPV 67

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-----------------TRVQI 219
              C D D    +Y  MP      ++   T + LL  V                   + I
Sbjct: 68  YSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQA 274
              I   + Y+H  S+  ++HRDLK  NILL       I D+G A      E     +  
Sbjct: 119 FHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 275 NTS-----------RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +             +IVGT  YM+PE  L    S  +D+++ GV+L ++++
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 36/95 (37%), Positives = 57/95 (60%), Gaps = 7/95 (7%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 281
           I+ GL +LH   R  II+RDLK  N++LD + + KI+DFGM   C  + +   T+R   G
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGM---CKEHMVDGVTTRTFCG 163

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  Y++PE      +    D +++GVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 39/94 (41%), Positives = 60/94 (63%), Gaps = 7/94 (7%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIV 280
           +A+G+ +L   SR + IHRDL A NILL ++   KI DFG+AR      + ++   +R+ 
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243

Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 62.8 bits (152), Expect = 9e-11
 Identities = 70/231 (30%), Positives = 107/231 (46%), Gaps = 39/231 (16%)

Query: 107 FSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLRE 157
           F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS       R 
Sbjct: 3   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDR--NVAIKKLS-------RP 53

Query: 158 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK-- 207
            +N+    AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D     
Sbjct: 54  FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ 110

Query: 208 --RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR 265
             ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR
Sbjct: 111 VIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Query: 266 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
             G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 168 TAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +GEG FG          D+  A+K +   +S   + + + EA ++AK++H N+V      
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRI-----LLDWVTRVQIIEGIAQGLLYLHQYSR 235
                  ++ EY     L   +     ++     +L W  +      +  G+ ++H+   
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK-- 119

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
            R++HRD+K+ NI L ++   K+ DFG AR+       A T   VGT  Y+ PE      
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMP 176

Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           ++ KSD++S G +L E+ + K
Sbjct: 177 YNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 123 LGEGGFGPVYKGVLRKGDEI----AVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G G +  V    L+K D+I     VK+     ++ +  ++ E  V  +      +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 179 CCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
            C     ++ L+ EY+    L F +    +R L +   R    E I   L +LH+     
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAE-ICIALNFLHERG--- 116

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           II+RDLK  N+LLD D + K++D+GM +   G      TS   GT  Y++PE      + 
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174

Query: 298 IKSDVFSFGVLLLEIVSGK 316
              D ++ GVL+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 35/215 (16%)

Query: 116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           T+   +KLGEG +  VYKG  +  G  +A+K +    E+G     +RE    AS++  ++
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDLK 61

Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL------FDPTK-RILLDWVTRVQIIEG 222
           H N+V L      K    L++EY+ +  L  ++            R+ L      Q++ G
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFL-----FQLLRG 115

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVG 281
           +A    Y HQ    R++HRDLK  N+L+ +    K++DFG+AR      + + T S  V 
Sbjct: 116 LA----YCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVV 165

Query: 282 TYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSG 315
           T  Y  P+  L    +S   D++  G +  E+ +G
Sbjct: 166 TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 7/95 (7%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 281
           IA GL +LH      II+RDLK  N++LD + + KI+DFGM   C  N     T++   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKENMWDGVTTKTFCG 163

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 13/205 (6%)

Query: 116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNL 173
           T+   +KLGEG +  V+KG  +   + +A+K +    E+G       E S++  ++H N+
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V L      +    L++EY+ +  L  +L D    ++     ++ + + + +GL Y H  
Sbjct: 66  VTLHDIIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH-- 120

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAL 292
            + +I+HRDLK  N+L+++    K++DFG+AR      +   T S  V T  Y  P+  L
Sbjct: 121 -KRKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLL 176

Query: 293 EGI-FSIKSDVFSFGVLLLEIVSGK 316
               +S   D++  G +L E+ +G+
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 16/200 (8%)

Query: 123 LGEGGFGPVYKGVLRK---GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRL 176
           LG+G FG V   ++R+   G   A+K L      ++  +     E+ V+   +H  L  L
Sbjct: 3   LGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                 KD    + EY+    L F L    +R+  +  TR    E I   L YLH     
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAE-IVSALDYLHSG--- 114

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
           +I++RDLK  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE   +  +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 297 SIKSDVFSFGVLLLEIVSGK 316
               D +  GV++ E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 18/205 (8%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGD--EIAVKRLSGRS---EQGLREMKNEASVIAKVQHK 171
           F+    LG G FG V     +  D   +A+KR        ++ +  + +E  ++  + H 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91

Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-DPTKRILLDWVTRVQIIEGIAQGLLYL 230
             V L G   D+    L+ E++     +FF F    KR   D    V      AQ +L  
Sbjct: 92  FCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNKRFPND----VGCFYA-AQIVLIF 144

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + I++RDLK  N+LLDKD   K++DFG A++     +   T  + GT  Y++PE 
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEI 199

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L       +D ++ G+ + EI+ G
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 38/94 (40%), Positives = 60/94 (63%), Gaps = 7/94 (7%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIV 280
           +A+G+ +L   SR + IHRDL A NILL ++   KI DFG+AR      + ++  ++R+ 
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238

Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++ +SDV+SFGVLL EI S
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 22/203 (10%)

Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC--- 179
           +G GGFG VY    RK D   +  +    ++ ++  + E   + +    +LV    C   
Sbjct: 2   IGRGGFGEVYG--CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 180 -CID-----KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
            C+       D+   I + M    L + L      +  +   R    E I  GL ++H  
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATE-IILGLEHMHNR 116

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE   +
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEVLQK 169

Query: 294 GI-FSIKSDVFSFGVLLLEIVSG 315
           G  +   +D FS G +L +++ G
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 24/205 (11%)

Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRLSG----RSEQGLREMKNEASVIAKVQHKN 172
           LG+GG+G V++  +RK          A+K L      R+++     K E +++  V+H  
Sbjct: 4   LGKGGYGKVFQ--VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           +V L+       +  LI EY+    L  F+    + I ++      + E I+  L +LHQ
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSE-ISLALEHLHQ 118

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEY 290
                II+RDLK  NILLD   + K++DFG+ +  I  G      T    GT  YM+PE 
Sbjct: 119 QG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEI 171

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            +        D +S G L+ ++++G
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 9/149 (6%)

Query: 122 KLGEGGFGPVYKGVLRKG---DEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           ++G G FG V  G +  G    ++ VK L    S Q   +   EA     +QH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILL--DWVTRVQIIEGIAQGLLYLHQYSR 235
           G C +    +L+ E+ P   L  +L    K  L+  D  T  ++   IA GLL+LH+ + 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMA 264
              IH DL   N LL  D+  KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 35/98 (35%), Positives = 58/98 (59%), Gaps = 7/98 (7%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 280
           +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N +    +R+ 
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL- 276

Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN 318
               +M+PE   + +++++SDV+S+G+LL EI S  K+
Sbjct: 277 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 15/199 (7%)

Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN---EASVIAK-VQHKNLVRL 176
           +G+G FG V     RK D    AVK L  ++    +E  +   E +V+ K ++H  LV L
Sbjct: 3   IGKGSFGKVLLAK-RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                  ++   + +Y+    L F L    +R  L+   R    E +A  + YLH    +
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLHS---L 115

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            II+RDLK  NILLD   +  ++DFG+ +   G E +  TS   GT  Y++PE   +  +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173

Query: 297 SIKSDVFSFGVLLLEIVSG 315
               D +  G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 34/97 (35%), Positives = 56/97 (57%), Gaps = 13/97 (13%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +++ +++ +V  
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274

Query: 283 YG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                  +M+PE     +++ +SDV+S+G+LL EI S
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 38/102 (37%), Positives = 55/102 (53%), Gaps = 7/102 (6%)

Query: 216 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 275
           RV I E I   L +LHQ   + II+RD+K  NILLD + +  ++DFG+++     E +  
Sbjct: 108 RVYIAE-IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163

Query: 276 TSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 315
            S   GT  YM+PE    G        D +S GVL  E+++G
Sbjct: 164 YS-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 43/214 (20%)

Query: 123 LGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGL---REMKNEASVIAKVQHKNLVRL 176
           +G G +G V   Y   LR+  ++AVK+LS R  Q L   R    E  ++  ++H+N++ L
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVKKLS-RPFQSLIHARRTYRELRLLKHMKHENVIGL 79

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFF----LFDPTKRILLDWVTRVQ---------IIEGI 223
           L              + P  S++ F    L        L+ + + Q         +I  +
Sbjct: 80  LDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127

Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 283
            +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR     +     +  V T 
Sbjct: 128 LRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATR 179

Query: 284 GYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
            Y +PE  L  + ++   D++S G ++ E++ GK
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 30/180 (16%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           I +GL YLH      I+HRD+K  N+L++ +   KI DFG+AR+   +E +  T  +V  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 283 YGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS----LNLLGYVWDL 336
           Y Y +PE  L G   ++   D++S G +  E++  +    L++  S    L+L+      
Sbjct: 169 Y-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRRI---LFQAQSPIQQLDLI------ 217

Query: 337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 396
                  +L+  P LE   S+ +    ++    L         P +  + S  T+EA  L
Sbjct: 218 ------TDLLGTPSLEAMRSACEGARAHI----LRGPHKPPSLPVLYTLSSQATHEAVHL 267

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 21/202 (10%)

Query: 121 NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKN------EASVIAKVQHKNL 173
             LG G FG V     +  G+  A+K L    ++ + +MK       E S++ ++ H  +
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCLK---KREILKMKQVQHVAQEKSILMELSHPFI 80

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V ++    D++    + E++    L F       R   D V +    E +     YLH  
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGEL-FTHLRKAGRFPND-VAKFYHAE-LVLAFEYLHSK 137

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               II+RDLK  N+LLD   + K++DFG A+     ++   T  + GT  Y++PE    
Sbjct: 138 D---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPEVIQS 189

Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                  D ++ GVLL E ++G
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 48/198 (24%), Positives = 94/198 (47%), Gaps = 34/198 (17%)

Query: 139 GDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKNLVRLL--GCCIDKDEKILIYEYM 193
           G E+A+K L   + +   +      E ++ A++ H N+V LL  G          ++EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61

Query: 194 PNKSLDFFLFD-------PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS 246
           P ++L   L          T R++L      Q+++ +A        +++  I+HRDLK  
Sbjct: 62  PGRTLREVLAADGALPAGETGRLML------QVLDALA------CAHNQ-GIVHRDLKPQ 108

Query: 247 NILL---DKDMNPKISDFGMARICGG----NELQAN-TSRIVGTYGYMSPEYALEGIFSI 298
           NI++       + K+ DFG+  +  G    +      T+ ++GT  Y +PE       + 
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168

Query: 299 KSDVFSFGVLLLEIVSGK 316
            SD++++G++ LE ++G+
Sbjct: 169 NSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 32/229 (13%)

Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ 169
           +  +T  F   + LGEG FG V +   RK  E    ++     +  R+ K E   + KV+
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVR 183

Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRILLDWVTR---------VQI 219
             +         D+   + I  Y  N++    +  P     LLDW+ +          QI
Sbjct: 184 QADPA-------DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI 236

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKIS-----DFGMARIC--GG 269
           I      L Y H  + + ++H DLK  NIL+   D  ++P  +     D    RIC  GG
Sbjct: 237 IFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294

Query: 270 --NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
             +E  + T+ IV T  Y SPE  L   +   +D++S G ++ E+ +GK
Sbjct: 295 CCDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 17/200 (8%)

Query: 123 LGEGGFGPVYKGVLRKGDEI--AVKRLSGRSEQGLREMK---NEASVIAK-VQHKNLVRL 176
           +G+G FG V      K +E   AVK L  ++    +E K   +E +V+ K V+H  LV L
Sbjct: 3   IGKGSFGKVLLA-RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                  D+   + +Y+    L + L    +R  L+   R    E IA  L YLH    +
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---L 115

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYMSPEYALEGI 295
            I++RDLK  NILLD   +  ++DFG+   C  N E    TS   GT  Y++PE   +  
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGL---CKENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 296 FSIKSDVFSFGVLLLEIVSG 315
           +    D +  G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 2/94 (2%)

Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTY 283
           Q LL +H      +IHRD+K++NILL  +   K+ DFG +++     +  +  R   GT 
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY-AATVSDDVGRTFCGTP 209

Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 317
            Y++PE      +S K+D+FS GVLL E+++ K+
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 57/234 (24%), Positives = 92/234 (39%), Gaps = 57/234 (24%)

Query: 123 LGEGGFGPVYKGVLRKGDEI--AVKRLSGRSEQGLREMKNEASVIA----KVQHKN--LV 174
           +G G FG V+  V  K      A+K L  R    ++     A V A         +  +V
Sbjct: 9   IGRGAFGEVWL-VRDKDTGQVYAMKVL--RKSDMIK-RNQIAHVRAERDILADADSPWIV 64

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG------IAQGLL 228
           +L     D++   L+ EYMP   L            ++ + R  +         IA+ +L
Sbjct: 65  KLYYSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELVL 112

Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA------------------RICGGN 270
            L    ++  IHRD+K  NIL+D D + K++DFG+                    +   N
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 271 ELQANTSR---------IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            L                VGT  Y++PE      + ++ D +S GV+L E++ G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 58.6 bits (141), Expect = 4e-09
 Identities = 66/239 (27%), Positives = 112/239 (46%), Gaps = 48/239 (20%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAV-KRLSGRSEQGLREMKN-----EASVIAKV 168
           N +    K+G G FG V+    ++  E    K +S R   GL+E +      E +V+ ++
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR---GLKEREKSQLVIEVNVMREL 69

Query: 169 QHKNLVRLLGCCIDK-DEKILI-YEYMPNKSLD------FFLFDPTKRILLDWVTRVQII 220
           +HKN+VR +   ++K ++K+ I  E+     L       + +F   +   +  +TR Q++
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR-QLL 128

Query: 221 EGIAQGLLYLHQY----SRVRIIHRDLKASNILLD-------------KDMN----PKIS 259
             +A    Y H      +  R++HRDLK  NI L               ++N     KI 
Sbjct: 129 HALA----YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184

Query: 260 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI--KSDVFSFGVLLLEIVSGK 316
           DFG+++  G   +++     VGT  Y SPE  L    S   KSD+++ G ++ E+ SGK
Sbjct: 185 DFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 17/201 (8%)

Query: 123 LGEGGFGPVYKGVLRKGDEI----AVKRLSGRSEQGLREMKNEASVI-AKVQHKNLVRLL 177
           +G G +  V    L+K   I     +K+     ++ +  ++ E  V      H  LV L 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
            C   +     + E++    L F +    +R L +   R    E I+  L +LH+     
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNFLHERG--- 116

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALEGI 295
           II+RDLK  N+LLD + + K++D+GM +  I  G+     TS   GT  Y++PE      
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIAPEILRGED 172

Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +    D ++ GVL+ E+++G+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 8e-09
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 26/216 (12%)

Query: 106 SFSSVSTATNT-FSDTNKLGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLREMKN 160
           S S  ++     ++  + L  G  G V+    + GDE    + VK ++G    G      
Sbjct: 82  SSSDPASVVRMQYNILSSLTPGSEGEVFVCT-KHGDEQRKKVIVKAVTGGKTPG-----R 135

Query: 161 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-DPTKRILLDWVTRVQI 219
           E  ++  + H+ ++ L+     K    ++   MP    D F + D +  + L+    +Q 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQ- 191

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              + + L YLH      IIHRD+K  NI LD+  N  + DFG A  C  +    +T + 
Sbjct: 192 -RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA--CKLDA-HPDTPQC 244

Query: 280 VGTYGYM---SPEYALEGIFSIKSDVFSFGVLLLEI 312
            G  G +   SPE      +  K+D++S G++L E+
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 60/207 (28%), Positives = 88/207 (42%), Gaps = 28/207 (13%)

Query: 123 LGEGGFGPVYKGVLRKGDE---IAVKRLSG-----RSEQGLREMKNEASVIAKVQHKNLV 174
           +G G FG V   ++R        A+K LS      RS+        E  ++A    + +V
Sbjct: 51  IGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANSEWIV 106

Query: 175 RLLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           +L      +D+K L  + EYMP    D         I   W  R    E +   L  +H 
Sbjct: 107 QL--HYAFQDDKYLYMVMEYMPGG--DLVNLMSNYDIPEKW-ARFYTAE-VVLALDAIHS 160

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
                 IHRD+K  N+LLDK  + K++DFG       N +       VGT  Y+SPE   
Sbjct: 161 MG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLK 216

Query: 293 ----EGIFSIKSDVFSFGVLLLEIVSG 315
               +G +  + D +S GV L E++ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 60/251 (23%), Positives = 104/251 (41%), Gaps = 63/251 (25%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDE---IAVKRLSGRSEQGLRE----MKNEASVIAKVQ 169
           F     +G G FG V   ++RK D     A+K L  +++  +R     +K E  ++A+  
Sbjct: 3   FVKIKTIGIGAFGEVC--LVRKVDTNALYAMKTLR-KADVLMRNQAAHVKAERDILAEAD 59

Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           ++ +V+L     DKD    + +Y+P   +   L      I  + + R  I E +   +  
Sbjct: 60  NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RLGIFEEDLARFYIAE-LTCAIES 116

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG-------------------- 269
           +H   ++  IHRD+K  NIL+D+D + K++DFG+   C G                    
Sbjct: 117 VH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL---CTGFRWTHDSKYYQKGDHHRQDS 170

Query: 270 ----NELQANTSR--------------------IVGTYGYMSPEYALEGIFSIKSDVFSF 305
                E                           +VGT  Y++PE  L   ++   D +S 
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 306 GVLLLEIVSGK 316
           GV+L E++ G+
Sbjct: 231 GVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.2 bits (136), Expect = 9e-09
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQAN-TSRIV 280
           + +GL Y+H      +IHRDLK SN+L+++D   +I DFGMAR +           +  V
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 281 GTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIV 313
            T  Y +PE  L    ++   D++S G +  E++
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 28/184 (15%)

Query: 145 KRLSGRSEQGLR---EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE---YMPNKSL 198
           + ++ R + G R   +++NE   + ++ H+N++++        E+IL  E   YM  +  
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKY 245

Query: 199 DFFL--------FDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL 250
           DF L        FD   R LL   TR  I++ +   + Y+H     ++IHRD+K  NI L
Sbjct: 246 DFDLYSFMYDEAFDWKDRPLL-KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300

Query: 251 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL 310
           + D    + DFG A +    E +A     VGT    SPE      +   +D++S G++LL
Sbjct: 301 NCDGKIVLGDFGTA-MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359

Query: 311 EIVS 314
           +++S
Sbjct: 360 DMLS 363

Length = 501

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 8/156 (5%)

Query: 161 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII 220
           E+ V+   +H  L  L       D    + EY     L F L    +R+  +   R    
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGA 102

Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
           E I   L YLH      +++RDLK  N++LDKD + KI+DFG+ +   G    A      
Sbjct: 103 E-IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 156

Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           GT  Y++PE   +  +    D +  GV++ E++ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 50/235 (21%)

Query: 123 LGEGGFGPVYKGVLRK--GDEIAVKRLSGRSEQGLRE----MKNEASVIAKVQHKNLVRL 176
           +G G FG V + V +K  G   A+K+L  +SE   +E    ++ E  ++A+  +  +V+L
Sbjct: 9   IGRGAFGEV-RLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                D++   LI EY+P   +   L    K    +  TR  I E I    L +    ++
Sbjct: 67  YYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETI----LAIDSIHKL 120

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGM------------ARICGGNELQANTSRI----- 279
             IHRD+K  N+LLD   + K+SDFG+             RI            I     
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 280 -------------------VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
                              VGT  Y++PE  L+  ++ + D +S GV++ E++ G
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 123 LGEGGFGPVYKGVLRK----GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVR 175
           LG+G FG V   +L K    G   A+K L      ++  +     E  V+   +H  L  
Sbjct: 3   LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L       D    + EY     L F L    +R+  +   R    E I   L YLH  S 
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SE 114

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
             +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++PE   +  
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDND 172

Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +    D +  GV++ E++ G+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 20/214 (9%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK---GDEIAVKRLSGR---SEQGLREMKNEASVIAKV 168
             F   + +G G FG V   V+R+   GD  A+K +      +++ +   + E  +++  
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
               + +L     DKD   L+ EY P   L   L +  +    + + +  + E +   + 
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQFDEDMAQFYLAE-LVLAIH 116

Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            +HQ   V   HRD+K  N+L+D+  + K++DFG A     N+   N+   VGT  Y++P
Sbjct: 117 SVHQMGYV---HRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAP 172

Query: 289 EY------ALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E         +G + ++ D +S GV+  E++ G+
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 8/156 (5%)

Query: 161 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII 220
           E+ V+   +H  L  L       D    + EY     L F L    +R+  +   R    
Sbjct: 45  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGA 102

Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
           E I   L YLH      +++RD+K  N++LDKD + KI+DFG+ +   G    A      
Sbjct: 103 E-IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 156

Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           GT  Y++PE   +  +    D +  GV++ E++ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 13/198 (6%)

Query: 123 LGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKN---EASVIAK-VQHKNLVRLL 177
           +G+G FG V        G   AVK L  +     +E K+   E +V+ K V+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
                 ++   + +++    L F L    +R   +   R    E IA  L YLH    + 
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS---IN 116

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           I++RDLK  NILLD   +  ++DFG+ +   G      T+   GT  Y++PE   +  + 
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Query: 298 IKSDVFSFGVLLLEIVSG 315
              D +  G +L E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 6/97 (6%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN--ELQANTSRIV 280
           I  GL Y+H      ++HRDLK  N+L++ D   KI DFG+AR    N  E     +  V
Sbjct: 114 ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 281 GTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 316
            T  Y +PE  L      K+ DV+S G +L E++  K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 2/93 (2%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
            A+ L  L    +  +I+RDLK  NILLD   +  + DFG+ ++   ++ + NT    GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156

Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
             Y++PE  L   ++   D ++ GVLL E+++G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN--TSRIV 280
           IA+ +L L    +  I++RDLK  NILLD   +  + DFG+++      L  N  T+   
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK----ANLTDNKTTNTFC 157

Query: 281 GTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSG 315
           GT  Y++PE  L E  ++   D +S GVL+ E+  G
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 12/169 (7%)

Query: 161 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII 220
           EA ++  + H ++++L G         LI   +P    D + +   KR  +     + I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKR-NIAICDILAIE 188

Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-I 279
             + + + YLH+    RIIHRD+KA NI ++   +  + DFG A  C   ++ AN     
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDINANKYYGW 243

Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN 328
            GT    +PE      +    D++S G++L E+ +   +  L+  D L+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS--LFEKDGLD 290

Length = 391

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 49.2 bits (118), Expect = 3e-08
 Identities = 17/48 (35%), Positives = 28/48 (58%), Gaps = 2/48 (4%)

Query: 391 NEAAALHPPKQPAFSNVRNTVTSTSSTDKTGD--CSINQVTISILEAR 436
           +E   +  PKQP F   R+   + SS+    D   ++NQVT+S+++AR
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 5/93 (5%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 281
           +A+G+ +L   +    +HRDL A N+LL +    KI DFG+AR I   +   +  S  + 
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
              +M+PE   + +++  SDV+S+G+LL EI S
Sbjct: 303 V-KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 28/199 (14%)

Query: 131 VYKGVLRKGDEIAVKRLSGRSEQG----LREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 186
           +YKG+    ++  + R   +  +G    +   +NE   + ++   N++++ G  ID  + 
Sbjct: 36  IYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 187 ----ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRD 242
                LI EY     L   L    K   L + T++ +     +GL  L++Y+     +++
Sbjct: 94  LPRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148

Query: 243 LKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEYALEGIFS--- 297
           L + + L+ ++   KI       IC G E  L +   + V    Y S +  L  IFS   
Sbjct: 149 LTSVSFLVTENYKLKI-------ICHGLEKILSSPPFKNVNFMVYFSYKM-LNDIFSEYT 200

Query: 298 IKSDVFSFGVLLLEIVSGK 316
           IK D++S GV+L EI +GK
Sbjct: 201 IKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 33/100 (33%), Positives = 60/100 (60%), Gaps = 8/100 (8%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 281
           +A+ +L +    ++  +HRD+K  N+LLDK+ + +++DFG   R+     +Q+N +  VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165

Query: 282 TYGYMSPEY--ALE---GIFSIKSDVFSFGVLLLEIVSGK 316
           T  Y+SPE   A+E   G +  + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 10/97 (10%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           + +GL Y+H      ++HRDLK SN+LL+ + + KI DFG+AR    +E     +  V T
Sbjct: 117 LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171

Query: 283 YGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 316
             Y +PE  L   E   +I  DV+S G +  E++  K
Sbjct: 172 RWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 51.3 bits (123), Expect = 8e-08
 Identities = 34/151 (22%), Positives = 56/151 (37%), Gaps = 15/151 (9%)

Query: 118 SDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV--R 175
           S    L  G    VY    +  D   +K    R +   RE   E +++  +  K L   +
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDED-YVLKINPSREKGADRE--REVAILQLLARKGLPVPK 57

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           +L          L+ E++  ++LD    +  + I             +A+ L  LHQ   
Sbjct: 58  VLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPL 107

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARI 266
           + + H DL   NIL+D      I D+  A  
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 61/246 (24%), Positives = 113/246 (45%), Gaps = 39/246 (15%)

Query: 122 KLGEGGFGPVYKGVLRKGDE---IAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRL 176
           K+G G +G VYK   + G +    A+K++ G   S    RE+    +++ +++H N++ L
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREI----ALLRELKHPNVISL 63

Query: 177 LGCCIDK-DEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY----- 229
               +   D K+ L+++Y  +       F    +        VQ+  G+ + LLY     
Sbjct: 64  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDG 120

Query: 230 LHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGN-ELQANTSRIVGTYG 284
           +H      ++HRDLK +NIL+     +    KI+D G AR+     +  A+   +V T+ 
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK----------KNTGLYRTDSL----NL 329
           Y +PE  L      K+ D+++ G +  E+++ +          K +  Y  D L    N+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240

Query: 330 LGYVWD 335
           +G+  D
Sbjct: 241 MGFPAD 246

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 46/218 (21%)

Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMK--NEASVIAK---VQHKNLVRLL 177
           LG G +G V+           V+++SG     L  MK   +A+++ K    +H    R +
Sbjct: 8   LGTGAYGKVF----------LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV 57

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVT-----------------RVQII 220
              I +   ++   Y        F  D    ++LD++                   VQI 
Sbjct: 58  LEHIRQSPFLVTLHYA-------FQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110

Query: 221 EG-IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
            G I   L +LH   ++ II+RD+K  NILLD + +  ++DFG+++    +E++   S  
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-F 166

Query: 280 VGTYGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSG 315
            GT  YM+P+     +G      D +S GVL+ E+++G
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 72/277 (25%), Positives = 119/277 (42%), Gaps = 46/277 (16%)

Query: 67  MTFDLDLNLKANNVNIELPLN--SKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLG 124
           +  DLD      N NI+  LN   K++ + +K ++                 +     +G
Sbjct: 6   LVLDLDFPALRKNKNIDNFLNRYEKIVRKIRKLQMK-------------AEDYDVVKVIG 52

Query: 125 EGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLRE----MKNEASVIAKVQHKNLVRLLGCC 180
            G FG V     +   ++   +L  + E   R        E  ++A      +V+L   C
Sbjct: 53  RGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF--C 110

Query: 181 IDKDEKIL--IYEYMPNKSLDFFLFD---PTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
             +D+K L  + EYMP   L   + +   P K     W          A+ +L L     
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFYT-----AEVVLALDAIHS 160

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY---- 290
           + +IHRD+K  N+LLDK  + K++DFG   ++     ++ +T+  VGT  Y+SPE     
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQ 218

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 327
             +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG--DTPFY-ADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 32/100 (32%), Positives = 60/100 (60%), Gaps = 8/100 (8%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 281
           IA+ +L +H   ++  +HRD+K  N+LLD + + +++DFG   ++     +Q++ +  VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165

Query: 282 TYGYMSPEY--ALE---GIFSIKSDVFSFGVLLLEIVSGK 316
           T  Y+SPE   A+E   G +  + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 63/254 (24%), Positives = 102/254 (40%), Gaps = 65/254 (25%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDE---IAVKRLSGRS---EQGLREMKNEASVIAKVQH 170
           F     LG G FG V   + RK D     A+K L  +       +  +K E  ++A+  +
Sbjct: 3   FVKIKTLGIGAFGEVC--LARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           + +VRL     DKD    + +Y+P   +   L      I  + + R  I E        +
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFPEDLARFYIAELTCA----V 114

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG--------------------- 269
               ++  IHRD+K  NIL+D+D + K++DFG+   C G                     
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL---CTGFRWTHDSKYYQSGDHVRQDSM 171

Query: 270 ---NE---------------LQANTSR---------IVGTYGYMSPEYALEGIFSIKSDV 302
              NE               L+   +R         +VGT  Y++PE  L   ++   D 
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231

Query: 303 FSFGVLLLEIVSGK 316
           +S GV+L E++ G+
Sbjct: 232 WSVGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 46/224 (20%)

Query: 123 LGEGGFGPVYKGVLRKG-------DEIAVKRLSGRSEQGLREMK---------------- 159
           LG+G    +Y G LR         DE+  +          RE++                
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 160 --NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV 217
               AS++++V H +L  + G C+   E I++ E++ +  LD  L     R+ + W  ++
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-----DMNP--KISDFGMARICGGN 270
            + + +A  L YL   +   ++H ++ A NILL +       +P  K+SD G++      
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177

Query: 271 ELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEI 312
           E      RI     +++PE  + G    S  +D +SFG  LLEI
Sbjct: 178 E--ERVERI----PWIAPE-CVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 15/184 (8%)

Query: 142 IAVKR--LSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD 199
           +AVK+  L   S++ L+ ++ E     ++QH N++  +   I   E  ++   M   S +
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87

Query: 200 FFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS 259
             L       L +      I++ +   L Y+H       IHR +KAS+ILL  D    +S
Sbjct: 88  DLLKTHFPEGLPELAIA-FILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLS 143

Query: 260 DFGMAR--ICGGNELQA---NTSRIVGTYGYMSPEY---ALEGIFSIKSDVFSFGVLLLE 311
               +   I  G   +         V    ++SPE     L+G ++ KSD++S G+   E
Sbjct: 144 GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG-YNEKSDIYSVGITACE 202

Query: 312 IVSG 315
           + +G
Sbjct: 203 LANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 73/313 (23%), Positives = 138/313 (44%), Gaps = 48/313 (15%)

Query: 122 KLGEGGFGPVYKGVLRKGD---EIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRL 176
           K+G G +G VYK   + G    E A+K++ G   S    RE+    +++ +++H N++ L
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREI----ALLRELKHPNVIAL 63

Query: 177 LGCCID-KDEKI-LIYEYMPNKSLDFFLFDPT-----KRILLDWVTRVQIIEGIAQGLLY 229
               +   D K+ L+++Y  +       F        K + L       ++  I  G+ Y
Sbjct: 64  QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 230 LHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGN-ELQANTSRIVGTYG 284
           LH      ++HRDLK +NIL+     +    KI+D G AR+     +  A+   +V T+ 
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK----------KNTGLYRTDSLN----L 329
           Y +PE  L      K+ D+++ G +  E+++ +          K +  +  D L+    +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240

Query: 330 LGYVWDL-WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM 388
           +G+  D  W   R +   + P L+ ++        Y N +L+   E    +P  +  V +
Sbjct: 241 MGFPADKDWEDIRKMP--EYPTLQKDFRRTT----YANSSLIKYMEKHKVKP--DSKVFL 292

Query: 389 LTNEAAALHPPKQ 401
           L  +   + P K+
Sbjct: 293 LLQKLLTMDPTKR 305

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           +A G+ +L   +    +HRDL A N+L+ +    KI DFG+AR    +    +       
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
             +M+PE     +++  SDV+SFG+LL EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.9 bits (119), Expect = 8e-07
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 19/159 (11%)

Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
           AS++ +V HK++V L G C+   E I++ E++    LD F+   +  +   W  + ++ +
Sbjct: 55  ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAK 112

Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILL-----DKDMNP--KISDFGMARICGGNELQA 274
            +A  L YL       ++H ++   NILL     D +  P  K+SD G+         Q 
Sbjct: 113 QLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--QE 167

Query: 275 NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEI 312
              RI     +++PE   +    SI +D +SFG  L EI
Sbjct: 168 CVERI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 43/289 (14%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIA---VKRL---SGRSEQGLREMKNEASVIAKVQHKNLVR 175
           ++G G FG V    +     +A   VK L   +   EQ     + +   I  +QH N+++
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI--LQHPNILQ 59

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR-VQIIE------GIAQGLL 228
            LG C++    +L++EY     L  +L          W  R  Q++        IA G+ 
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVT 113

Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           ++H+++    +H DL   N  L  D+  K+ D+G+       +             +++P
Sbjct: 114 HMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170

Query: 289 EYALE---GIFSIK----SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR 341
           E   E   G+ + +    S+V++ GV L E+         + +D   +L +V      ++
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHV----IKDQ 225

Query: 342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
            ++L   P LE  YS      R+  +   C   S + R T  +V  +LT
Sbjct: 226 QVKLF-KPQLELPYSE-----RWYEVLQFC-WLSPEKRATAEEVHRLLT 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 31/210 (14%)

Query: 123 LGEGGFGPVYKGVLRK------GDEIAVKRLSG----RSEQGLREMKNEASVIAKVQHKN 172
           LG G +G V+  ++RK      G   A+K L      +  + +   + E +V+  V+   
Sbjct: 8   LGTGAYGKVF--LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 173 LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
            +  L      + K+ LI +Y+    +   L+        D  +  ++     + +L L 
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALE 119

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
              ++ I++RD+K  NILLD + +  ++DFG+++     E +  T    GT  YM+PE  
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYMAPE-- 176

Query: 292 LEGIFSIKS------DVFSFGVLLLEIVSG 315
              I   K       D +S G+L+ E+++G
Sbjct: 177 ---IIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 49/204 (24%), Positives = 97/204 (47%), Gaps = 17/204 (8%)

Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLRE----MKNEASVIAKVQHKNLVRLLG 178
           +G G FG V    L+  D++   ++  + E   R      + E  V+    ++ +  L  
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D++   L+ +Y     L   L     R+  D + R  +    A+ ++ +    ++  
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYL----AEMVIAIDSVHQLHY 123

Query: 239 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY--ALE-- 293
           +HRD+K  NIL+D + + +++DFG   ++     +Q++ +  VGT  Y+SPE   A+E  
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEDG 181

Query: 294 -GIFSIKSDVFSFGVLLLEIVSGK 316
            G +  + D +S GV + E++ G+
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 23/207 (11%)

Query: 121 NKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           N +G G FG VY+ + +   +++A+K++    +   RE+     ++  + H N++ L   
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDY 127

Query: 180 ----CIDKDEKIL----IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
               C  K+EK +    + E++P     +          L           + + L Y+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 232 QYSRVRIIHRDLKASNILLDKDMNP-KISDFGMAR-ICGGNELQANTSRIVGTYGYMSPE 289
                 I HRDLK  N+L+D + +  K+ DFG A+ +  G   Q + S I   + Y +PE
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVSYICSRF-YRAPE 240

Query: 290 YALEGI-FSIKSDVFSFGVLLLEIVSG 315
             L    ++   D++S G ++ E++ G
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 58/254 (22%), Positives = 99/254 (38%), Gaps = 65/254 (25%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDE---IAVKRLSGR---SEQGLREMKNEASVIAKVQH 170
           F     LG G FG V   +  K D     A+K L  +   +   +  +K E  ++A+  +
Sbjct: 3   FVKIKTLGIGAFGEVC--LACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           + +V+L     DKD    + +Y+P   +   L      +  + + R  I    A+  L +
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMEVFPEVLARFYI----AELTLAI 114

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS------------- 277
               ++  IHRD+K  NIL+D D + K++DFG+   C G     N+              
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL---CTGFRWTHNSKYYQKGSHIRQDSM 171

Query: 278 -----------------------------------RIVGTYGYMSPEYALEGIFSIKSDV 302
                                               +VGT  Y++PE  L   ++   D 
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231

Query: 303 FSFGVLLLEIVSGK 316
           +S GV+L E++ G+
Sbjct: 232 WSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 10/97 (10%)

Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTY 283
           + L Y+H  +   + HRDLK  NIL + D   KI DFG+AR+   +   A   +  V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 284 GYMSPEYALEGIFSIKS----DVFSFGVLLLEIVSGK 316
            Y +PE  L G F  K     D++S G +  E+++GK
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 29/90 (32%), Positives = 50/90 (55%)

Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
           Q +L L +    +++HRDLK++NI L      K+ DFG ++    +      S   GT  
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           Y++PE      +S K+D++S GV+L E+++
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 14/156 (8%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK--GDEIAVKRLSGRSE----QGLREMKNEASVIAKV 168
             F     +G+G FG V + V +K  G   A+K L  +SE      L  +K E  V+A+ 
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLL-KSEMFKKDQLAHVKAERDVLAES 58

Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
               +V L     D     LI E++P   L   L         + VTR  + E +    L
Sbjct: 59  DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECV----L 112

Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
            +    ++  IHRD+K  NIL+D+  + K+SDFG++
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 69/275 (25%), Positives = 114/275 (41%), Gaps = 38/275 (13%)

Query: 65  DLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLG 124
           D + +DLD      N NI+  LN        K  ++++       +      +     +G
Sbjct: 4   DALVYDLDFPALRKNKNIDNFLNRY------KDTINKI-----RDLRMKAEDYEVVKVIG 52

Query: 125 EGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLRE----MKNEASVIAKVQHKNLVRLLGCC 180
            G FG V     +   ++   +L  + E   R        E  ++A      +V+L    
Sbjct: 53  RGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112

Query: 181 IDKDEKILIYEYMPNKSLDFFLFD---PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
            D     ++ EYMP   L   + +   P K     W          A+ +L L     + 
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-----WARFYT-----AEVVLALDAIHSMG 162

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY----AL 292
            IHRD+K  N+LLDK  + K++DFG   ++     ++ +T+  VGT  Y+SPE       
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGG 220

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 327
           +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.4 bits (111), Expect = 1e-05
 Identities = 58/220 (26%), Positives = 86/220 (39%), Gaps = 64/220 (29%)

Query: 122 KLGEGGFGPVY--------KGVLRK--------GDEIAVKRLSGRSEQGLREMKNEASVI 165
           KL +G FG V         K  ++K          E  V +L          MK+     
Sbjct: 23  KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQL----------MKD----- 67

Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-ILLDWVTRVQIIEGIA 224
               + N ++L          +LI +Y+     D  LFD  K+   L      +II  + 
Sbjct: 68  ----NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQLV 119

Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 283
           + L  LH++    IIH D+K  N+L D+  +   + D+G+ +I G        S   GT 
Sbjct: 120 EALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------TPSCYDGTL 170

Query: 284 GYMSPEYALEGIFSIKSDV--FSF-----GVLLLEIVSGK 316
            Y SPE        IK      SF     GVL  E+++GK
Sbjct: 171 DYFSPE-------KIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 18/103 (17%)

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT---------- 276
           L YLH Y    I+HRDLK  N+L+    + K++DFG+++I G   L  N           
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI-GLMSLTTNLYEGHIEKDTR 169

Query: 277 ----SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
                ++ GT  Y++PE  L   +    D ++ G++L E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 54/247 (21%), Positives = 98/247 (39%), Gaps = 65/247 (26%)

Query: 117 FSDTNKLGEGGFGPVY------------KGVLRKGDEIAVKRLSGRSEQGLREMKNEASV 164
           F     +G G FG V               +LRK D +         ++ +  ++ E  +
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML--------EKEQVGHIRAERDI 54

Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           + +     +V++     DK    LI E++P   +   L         D +T  +    IA
Sbjct: 55  LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIA 108

Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG--------------- 269
           + +L +    ++  IHRD+K  N+LLD   + K+SDFG+   C G               
Sbjct: 109 ETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL---CTGLKKAHRTEFYRNLNH 165

Query: 270 ------------NELQANTSR---------IVGTYGYMSPEYALEGIFSIKSDVFSFGVL 308
                       ++ +A T +          VGT  Y++PE  ++  ++   D +S GV+
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225

Query: 309 LLEIVSG 315
           + E++ G
Sbjct: 226 MYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)

Query: 215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 266
             V+ I  +A  L YLH++    IIHRDLK  N+L+  + + K++DFG++++
Sbjct: 105 MAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 55/249 (22%), Positives = 100/249 (40%), Gaps = 65/249 (26%)

Query: 115 NTFSDTNKLGEGGFGPVY------------KGVLRKGDEIAVKRLSGRSEQGLREMKNEA 162
           + F     +G G FG V               +LRK D +  ++++         ++ E 
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVA--------HIRAER 52

Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            ++ +     +V++     DK    LI E++P   +   L    K  L +  T+  I E 
Sbjct: 53  DILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAET 110

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG------------- 269
           +    L +    ++  IHRD+K  N+LLD   + K+SDFG+   C G             
Sbjct: 111 V----LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL---CTGLKKAHRTEFYRNL 163

Query: 270 --------------NELQANTSR---------IVGTYGYMSPEYALEGIFSIKSDVFSFG 306
                         ++ +A T +          VGT  Y++PE  ++  ++   D +S G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 307 VLLLEIVSG 315
           V++ E++ G
Sbjct: 224 VIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 26/113 (23%)

Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA---N 275
           I+ G  +GL YLHQ      IHR++KAS+IL        IS  G+  + G + L +   N
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154

Query: 276 TSRIVGTYGY----------MSPEYALEGI--FSIKSDVFSFGVLLLEIVSGK 316
             +    Y +          +SPE   + +  +++KSD++S G+   E+ +G+
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 45/173 (26%), Positives = 71/173 (41%), Gaps = 28/173 (16%)

Query: 117 FSDTNKLGEGGFGPVYKGVL-----RKGDEIAVKRLS--GRSEQGL--REMKNEASVIAK 167
           F    KLGEG FG VYK  L     +K  +  +K+ +  G  E  +  R  +   +  A 
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193

Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-DF-----FLFDPTKRILLDWVT------ 215
             +  L  +      +DE  L++ Y    +L D      F ++    +L   V       
Sbjct: 194 FVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGK-VQDLPKGL 250

Query: 216 --RVQIIEGIAQGLLY-LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMA 264
               +II+ I + +L+ L       I+HRD+K  NI+  +     KI D G A
Sbjct: 251 ERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 28/117 (23%), Positives = 44/117 (37%), Gaps = 26/117 (22%)

Query: 156 REMKNEASVIAKVQHKNLVRLLGCC------IDKDEKILIYEYMPNKSLDFFLFDPTKRI 209
              + EA ++AK       R  G        +D D  +++ EY+  + L   L    +  
Sbjct: 44  ERTRREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL----EEA 93

Query: 210 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 266
             D +  V    G   G L+     +  I+H DL  SNI+L         DFG+   
Sbjct: 94  RPDLLREV----GRLVGKLH-----KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140

Length = 204

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 9/77 (11%)

Query: 217 VQIIEGIA-QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQA 274
           + +I+G+  Q L  L +  R+ I+HRD+K  N+L+  D   KI DFG A  +C G     
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP 367

Query: 275 NTSRIVGTYGYMSPEYA 291
                   YG + P Y+
Sbjct: 368 -------LYGMLDPRYS 377

Length = 507

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 39.5 bits (93), Expect = 0.003
 Identities = 25/115 (21%), Positives = 48/115 (41%), Gaps = 27/115 (23%)

Query: 158 MKNEASVIAKVQHKNLVRLLGCC------IDKDEKILIYEYMPNKSLDFFLFDPTKRILL 211
            + EA ++      +  R  G        +D +EK ++ EY+  K L        K +L 
Sbjct: 383 TRAEARLL------SEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDL--------KDVLE 428

Query: 212 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 266
                 +++  + + +  LH   +  I+H DL  SN ++  D    + DFG+ + 
Sbjct: 429 G---NPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKY 476

Length = 535

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	436
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.98
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.98
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
PRK10345	210	hypothetical protein; Provisional	99.81
smart00090	237	RIO RIO-like kinase.	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.49
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.4
KOG1243	690	consensus Protein kinase [General function predict	99.36
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.32
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG3087	229	consensus Serine/threonine protein kinase [General	99.25
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.19
COG4248	637	Uncharacterized protein with protein kinase and he	99.17
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.14
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.09
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.01
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.82
PRK09902	216	hypothetical protein; Provisional	98.77
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.74
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.74
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.69
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.68
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.52
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.44
PF01636	239	APH: Phosphotransferase enzyme family This family	98.41
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.39
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.37
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.36
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.29
PLN02876	822	acyl-CoA dehydrogenase	98.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.18
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.14
PRK10593	297	hypothetical protein; Provisional	98.12
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.08
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.04
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.94
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.89
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.85
PRK05231	319	homoserine kinase; Provisional	97.72
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.72
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.72
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.71
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.65
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.56
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.5
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.4
PLN02236	344	choline kinase	97.36
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.28
PLN02756	418	S-methyl-5-thioribose kinase	96.8
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.79
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	96.72
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.72
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.69
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.68
KOG2270	520	consensus Serine/threonine protein kinase involved	96.67
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.46
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.45
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	96.23
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.15
COG2334	331	Putative homoserine kinase type II (protein kinase	96.1
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.08
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.03
PRK12396	409	5-methylribose kinase; Reviewed	95.97
PRK11768	325	serine/threonine protein kinase; Provisional	95.78
PTZ00384	383	choline kinase; Provisional	95.56
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.39

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-55  Score=425.22  Aligned_cols=292  Identities=44%  Similarity=0.767  Sum_probs=252.8

Q ss_pred             CCCccccchhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEE
Q 040532          101 QLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC  180 (436)
Q Consensus       101 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  180 (436)
                      ....|++.++..+|++|...+.||+|+||.||+|...+|..||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56679999999999999999999999999999999998999999988765433145699999999999999999999999


Q ss_pred             EeCCc-cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEe
Q 040532          181 IDKDE-KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  259 (436)
Q Consensus       181 ~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~  259 (436)
                      .+.+. .+|||||+++|+|.++|+..... +++|..+++|+.++|+||+|||+...++|+||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99994 99999999999999999876554 78999999999999999999999988899999999999999999999999


Q ss_pred             eccCceecCCCCcccccccc-cccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCC-CCCcchhHHHHHHh
Q 040532          260 DFGMARICGGNELQANTSRI-VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR-TDSLNLLGYVWDLW  337 (436)
Q Consensus       260 DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~~  337 (436)
                      |||+|+.....  ....... .||.+|+|||+...+..+.|+|||||||+|+||+||+++.+... .....+.+|.+..+
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999654421  1111112 79999999999999999999999999999999999999887554 34445899999988


Q ss_pred             hcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          338 TSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      ...+..+.+|+......+........+..++.+|++.+|.+||+|.||++.|+.+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            8888888888776644444324677899999999999999999999999999666543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-49  Score=380.75  Aligned_cols=263  Identities=30%  Similarity=0.509  Sum_probs=212.9

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC-ccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-EKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  191 (436)
                      ......+.||+|+||+||+|.++....||+|++....  ....++|.+|+.+|.+++|||||+++|+|.+.. ..++|||
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            3445556699999999999999844449999998653  222568999999999999999999999999887 7899999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC-CeEEeeccCceecCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICGGN  270 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~-~~kl~DfGla~~~~~~  270 (436)
                      |+++|+|.++++.. ....+++..++.++.+||+||.|||++++  |+||||||+|||++.++ ++||+|||+++.....
T Consensus       121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            99999999999764 34569999999999999999999999874  99999999999999997 9999999999876543


Q ss_pred             CcccccccccccCCccchhhhc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          271 ELQANTSRIVGTYGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      .  .......||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....     .+..........      .
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~~~~~------R  264 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVVVGGL------R  264 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcCC------C
Confidence            2  2223358999999999999  56899999999999999999999999865332     112222211111      1


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                      +..+..     +...+..++.+||+.||+.||++.+++..|+.+......
T Consensus       265 p~~p~~-----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  265 PPIPKE-----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             CCCCcc-----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            111111     456788899999999999999999999999988765443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=365.29  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=210.7

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc-cEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-KILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e  191 (436)
                      .+.+..+.||+|..|+||++.++. ++.+|+|.+... .+...+++.+|+++++.++|||||.++|+|.+... ..++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            356777899999999999999875 777899999654 45557889999999999999999999999999995 999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||++|||+.++....   .+++...-+++.++++||.|||+ .+   |+||||||+|||++..|++||||||.+..+.+.
T Consensus       159 YMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             hcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            999999999996543   38899999999999999999996 55   999999999999999999999999999876544


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                          .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+........+..+.......++       .+.
T Consensus       233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p-------pP~  301 (364)
T KOG0581|consen  233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP-------PPR  301 (364)
T ss_pred             ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC-------CCC
Confidence                334568999999999999999999999999999999999999998765333334433333322221       122


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ++..    .++.++..++..||++||.+||++.|+++
T Consensus       302 lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  302 LPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            2221    25678999999999999999999999876

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-49  Score=377.92  Aligned_cols=264  Identities=31%  Similarity=0.439  Sum_probs=217.1

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      .......+...+.||+|.||+||.|.++....||+|.++... ...++|.+|+++|++|+|+|||+++++|..++..+||
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence            344445566778999999999999999977799999998753 3346788999999999999999999999998999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      ||||+.|+|.+||.. .++..+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||+|+....
T Consensus       280 tE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             EEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC
Confidence            999999999999976 34456889999999999999999999998   99999999999999999999999999996554


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      +.+.. .....-+..|.|||.+..+.++.|||||||||+||||+| |+.|++...     ..+.+.......++      
T Consensus       356 ~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----n~ev~~~le~GyRl------  423 (468)
T KOG0197|consen  356 DEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----NEEVLELLERGYRL------  423 (468)
T ss_pred             Cceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----HHHHHHHHhccCcC------
Confidence            44433 333345678999999999999999999999999999999 777764432     22222222111111      


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                         +   .+..++..+++++..||+.+|++|||++.+...|+++....
T Consensus       424 ---p---~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  424 ---P---RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             ---C---CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence               1   11226778999999999999999999999999999887543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-49  Score=378.83  Aligned_cols=247  Identities=24%  Similarity=0.395  Sum_probs=210.9

Q ss_pred             cCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      .+|...+.||+|+|+.||++++ ..|+.||+|++.+.   .....+.+.+|+++.++|+|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6789999999999999999998 77999999999763   3455678899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      |+|++++|.+++.   .+.++.+.++..+++||+.||.|||+++   |+|||||..|++|++++++||+|||||..+...
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999985   4556999999999999999999999998   999999999999999999999999999987644


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      .  ......+|||.|.|||++....++..+||||+||+||-|+.|++||+...     +.+.+... ...       +..
T Consensus       172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~I-k~~-------~Y~  236 (592)
T KOG0575|consen  172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNKI-KLN-------EYS  236 (592)
T ss_pred             c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHHH-Hhc-------Ccc
Confidence            2  23455799999999999999999999999999999999999999996432     11111111 111       111


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .+.     ..+....+||.++|+.||.+|||+++|+.
T Consensus       237 ~P~-----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 MPS-----HLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ccc-----ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111     24556788999999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-48  Score=360.91  Aligned_cols=200  Identities=31%  Similarity=0.535  Sum_probs=180.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ...+|...+.||.|+||+||+|+++. +..||||.+...  ..+..+.+..|+.+|+.++|||||.+++++..++..|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            34678888999999999999999764 889999999876  666778889999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC------CCeEEeeccC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD------MNPKISDFGM  263 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~------~~~kl~DfGl  263 (436)
                      ||||+||+|.+|++...   .+++.....++.|+|.||++||+++   |+||||||+||||+..      -.+||+|||+
T Consensus        88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999997544   4899999999999999999999998   9999999999999864      4589999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGL  321 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~  321 (436)
                      |+.+.....   ....+|++-|||||++..+.|+.|+|+||+|+++|+|++|+.||..
T Consensus       162 AR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  162 ARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            998875443   3346999999999999999999999999999999999999999864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-48  Score=391.03  Aligned_cols=265  Identities=31%  Similarity=0.457  Sum_probs=224.2

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCCChh-hHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRSEQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ....+....+.||+|+||+||+|...+      ...||||.++..... ..++|++|+++|..++|||||+|+|+|.+++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            344556667899999999999998543      346999999977554 7789999999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCC-------c----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC
Q 040532          185 EKILIYEYMPNKSLDFFLFDPT-------K----RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD  253 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~  253 (436)
                      ..++|+|||..|+|.+||....       .    +.+++..+.+.|+.|||.||+||-++.   +|||||..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence            9999999999999999985311       1    334889999999999999999999998   9999999999999999


Q ss_pred             CCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 040532          254 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGY  332 (436)
Q Consensus       254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~  332 (436)
                      ..|||+|||+++.....+++.......-+.+|||||.+..++||.+||||||||+|||++| |+.|+.....++      
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------  713 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------  713 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH------
Confidence            9999999999999988888776656667889999999999999999999999999999999 888875433221      


Q ss_pred             HHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          333 VWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                      +.+....++.+..           .++++.++++|+..||+.+|++||+++||-..|+......
T Consensus       714 VIe~i~~g~lL~~-----------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  714 VIECIRAGQLLSC-----------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             HHHHHHcCCcccC-----------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            3333344433222           2237789999999999999999999999999999877543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-48  Score=358.81  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=202.8

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh-------hhHHHHHHHHHHHHHcCCCceeEEeeEEEeC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE-------QGLREMKNEASVIAKVQHKNLVRLLGCCIDK  183 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  183 (436)
                      ...+.|.+.+.||+|+||.|-+|..+ +|+.||||+++....       .......+|+++|++++|||||+++++|...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            35567888999999999999999965 599999999975411       1123467999999999999999999999999


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC---CCeEEee
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISD  260 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~---~~~kl~D  260 (436)
                      +..|+||||++||+|.+.+-.+..   +.+.....+++|++.|+.|||++|   |+||||||+|||+..+   ..+||+|
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence            999999999999999888855433   677778899999999999999999   9999999999999866   6799999


Q ss_pred             ccCceecCCCCcccccccccccCCccchhhhccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh
Q 040532          261 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      ||+|+..+..   ......|||+.|.|||++.+..   +..+.|+||+||+||-+++|.+||.....+. .+        
T Consensus       323 FGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl--------  390 (475)
T KOG0615|consen  323 FGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SL--------  390 (475)
T ss_pred             cchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cH--------
Confidence            9999987633   3345679999999999998654   3458899999999999999999995432211 01        


Q ss_pred             hcCCcceeccCCccc-cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          338 TSNRTLELIDDPVLE-DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       338 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                           .+.+...... ........+.+..++|.+||..||++|||+.|+++
T Consensus       391 -----~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  391 -----KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -----HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                 1111111111 01122347778899999999999999999999876

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-48  Score=342.38  Aligned_cols=261  Identities=25%  Similarity=0.376  Sum_probs=208.8

Q ss_pred             ccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEee-EEEeCCc-cEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLG-CCIDKDE-KIL  188 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~l  188 (436)
                      ..+|+++++||+|+||+||++.. .+|..+|.|.+.-.  +.+..+++..|+.+|++|+|||||++++ .+.++.+ .++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            45688999999999999999994 46899999988732  5566778999999999999999999998 4444555 799


Q ss_pred             EEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCC-CCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          189 IYEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYS-RVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      |||||++|+|..++... ..+..+++...++++.|++.||.++|+.- +..++||||||.||+|+.+|.+||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            99999999999888543 34556899999999999999999999832 12499999999999999999999999999998


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      +....  ......+|||.||+||.+.+..|+.||||||+||++|||..-++||...     ++...-... ...      
T Consensus       178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI-~qg------  243 (375)
T KOG0591|consen  178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKI-EQG------  243 (375)
T ss_pred             hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHH-HcC------
Confidence            76443  2234468999999999999999999999999999999999999998542     222221111 111      


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      +-+.+    +....+..+.+++..|+..||+.||+...++..+...
T Consensus       244 d~~~~----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  244 DYPPL----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             CCCCC----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence            11112    2233677899999999999999999966555555543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4e-46  Score=341.81  Aligned_cols=243  Identities=25%  Similarity=0.358  Sum_probs=199.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..+.|++++.||+|+||+||.++.++ ++.+|+|++++.   ...+.+....|..+|.+++||.||+++..|++.+.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            45789999999999999999999665 888999999765   33456788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      |+||+.||.|...|.+...   +++..+.-++..|+.||.|||+.+   |+||||||+|||||.+|+++|+|||+++..-
T Consensus       103 Vld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            9999999999999965433   788878888889999999999999   9999999999999999999999999998533


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ..  ...+...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+     ...+........       -
T Consensus       177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~k-------~  242 (357)
T KOG0598|consen  177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKGK-------L  242 (357)
T ss_pred             cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcCc-------C
Confidence            22  123444799999999999999999999999999999999999999985432     122222221111       0


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCC
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRP  380 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  380 (436)
                       .....+    .+....+++...|+.||++|.
T Consensus       243 -~~~p~~----ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 -PLPPGY----LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -CCCCcc----CCHHHHHHHHHHhccCHHHhc
Confidence             111111    345678899999999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.4e-46  Score=329.68  Aligned_cols=263  Identities=22%  Similarity=0.342  Sum_probs=207.4

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      +.|+.+.++|+|+||.||+++.++ |+.||||++....  +.-.+-..+|+++|++++|+|+|.++.+|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            357788999999999999999876 9999999997653  3334557899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      ||+..-|+++-....+   ++.....++++|++.|+.|+|+++   ++||||||+|||++.++.+||||||+|+.+....
T Consensus        82 ~~dhTvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            9999887766544333   788999999999999999999998   9999999999999999999999999999876321


Q ss_pred             cccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCc---------chhHHHHHHhhcCC
Q 040532          272 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL---------NLLGYVWDLWTSNR  341 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~~  341 (436)
                        ......+.|.+|+|||.+.+ ..|+...|||++||++.||++|.+-|...++-+.         ++...-.+.+..+.
T Consensus       156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence              22334588999999999998 6799999999999999999999988854332110         11111122222222


Q ss_pred             ccee------ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 TLEL------IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...-      -....++..++.  .+.-+.+++..||+.||.+|++-+|++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~--~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPK--ISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhccc--chHHHHHHHHHHhcCCccccccHHHHhc
Confidence            2221      122233334444  4557889999999999999999998874

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=374.89  Aligned_cols=267  Identities=31%  Similarity=0.467  Sum_probs=221.7

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC--CC----EEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK--GD----EIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      ..+.+..+.||+|+||.||.|...+  |.    .||+|.+... +.+...+|.+|..+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3445667899999999999999654  43    4899999865 566788999999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCC----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          187 ILIYEYMPNKSLDFFLFDPT----KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                      ++++|||++|+|..||.+.+    ....+...+.+.++.+||+|+.||++++   +|||||.++|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999997652    2345889999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      +|+.+...+++.......-..+|||||.+..+.++.|+|||||||+|||++| |..||+..+..     +......... 
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-----~v~~~~~~gg-  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-----EVLLDVLEGG-  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-----HHHHHHHhCC-
Confidence            9998777777666555455679999999999999999999999999999999 78887543321     1111122222 


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCC
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPK  400 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~  400 (436)
                         .++.        ...++..+++++..||+.+|++||++..+++.+..+.....+..
T Consensus       922 ---RL~~--------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~  969 (1025)
T KOG1095|consen  922 ---RLDP--------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI  969 (1025)
T ss_pred             ---ccCC--------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence               1111        12267789999999999999999999999999998887655544

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-45  Score=351.42  Aligned_cols=270  Identities=28%  Similarity=0.464  Sum_probs=217.4

Q ss_pred             ccchhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC
Q 040532          106 SFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK  183 (436)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  183 (436)
                      +..++.+..+...+...||+|+||+||+|.+. | .||||++...  .++..+.|++|+..+++-+|.||+-+.|+|...
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            34566677777888899999999999999997 4 5999999754  556789999999999999999999999999887


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      .. .+|+.+|+|.+|+.+++....  .++..+.+.|+.|+|+||.|||.++   |+|||||+.||++.+++.|||+|||+
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence            77 999999999999999986553  4888999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhcc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      +..-..-.-........|...|||||+++.   .+|+..+||||||+++|||+||..||.....+               
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d---------------  599 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD---------------  599 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh---------------
Confidence            975432211122233457789999999984   46899999999999999999999998632211               


Q ss_pred             CcceeccCCcc-cc-ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          341 RTLELIDDPVL-ED-EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       341 ~~~~~~~~~~~-~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                      +++-.+....+ .. ......++.++.+|+..||..++++||.+.+|+..|+.++.++|.
T Consensus       600 qIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk  659 (678)
T KOG0193|consen  600 QIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK  659 (678)
T ss_pred             heEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence            11111111100 00 111223667899999999999999999999999999999876433

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=346.64  Aligned_cols=265  Identities=27%  Similarity=0.429  Sum_probs=220.4

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhh-HHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      ....+.++||+|-||+|..+....+..||||+++...... ..+|.+|+++|.+++||||++++|+|..++..++++||+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            4456778999999999999999878999999999775444 588999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++|+|..|+..+.... +......+|+.||+.||+||.+.+   ++||||.++|+|+++++++||+|||+++-+...+++
T Consensus       618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999997654322 455667789999999999999998   999999999999999999999999999988888888


Q ss_pred             cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      ....+.+-+.+|||||.+.-++++.++|||+||+++||+++  ...||+....  .+..+....+.........+..+  
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~vven~~~~~~~~~~~~~l~~P--  769 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQVVENAGEFFRDQGRQVVLSRP--  769 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HHHHHhhhhhcCCCCcceeccCC--
Confidence            77777888999999999999999999999999999999866  6678754322  12222222333332222222222  


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                            ..++..+++++.+||..+.++||+++++...|.+..
T Consensus       770 ------~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  770 ------PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             ------CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence                  126678999999999999999999999999997653

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-46  Score=367.01  Aligned_cols=262  Identities=27%  Similarity=0.421  Sum_probs=216.4

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC----CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ....+.++||.|.||+||+|.++.    ...||||.++.. .+++..+|..|+.+|.+++||||++|.|+.......++|
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            344567899999999999999764    346999999865 567788999999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      .|||+||+|+.||.....  .+.+.++..++++||.||.||.+.+   +|||||.++|||++.+..+|++|||+++.+.+
T Consensus       709 TEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            999999999999976554  3889999999999999999999998   99999999999999999999999999998755


Q ss_pred             CC-cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          270 NE-LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       270 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      .. .......-.-+.+|.|||.+...++|.++||||||++|||.++ |.+||-.              ....+-+..+.+
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd--------------mSNQdVIkaIe~  849 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD--------------MSNQDVIKAIEQ  849 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc--------------cchHHHHHHHHh
Confidence            43 1222222233578999999999999999999999999999877 8899622              111121222223


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                      ...++....   ++..|.+|+..||++|-..||.+.+++..|.+++..-..
T Consensus       850 gyRLPpPmD---CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  850 GYRLPPPMD---CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             ccCCCCCCC---CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence            333433322   678899999999999999999999999999998865333

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-45  Score=338.93  Aligned_cols=260  Identities=25%  Similarity=0.405  Sum_probs=206.7

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC--ccEEEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EKILIY  190 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  190 (436)
                      ..+|...+.||+|+||+||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+++|......  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3457778999999999999999765 8999999987654333677999999999999999999999855554  588999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-CCCeEEeeccCceecCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGG  269 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-~~~~kl~DfGla~~~~~  269 (436)
                      ||+++|+|.+++.+...  .+++.....++.|+++||+|||+++   ++||||||+|||++. ++.+||+|||++.....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999976553  5899999999999999999999998   999999999999999 79999999999987654


Q ss_pred             -CCcccccccccccCCccchhhhccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          270 -NELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       270 -~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                       ...........||+.|||||++..+. ...++||||+||++.||+||++||...    .....+..........     
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~~~-----  241 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGREDSL-----  241 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccCCC-----
Confidence             12222333468999999999999643 345999999999999999999998653    1112222222222211     


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                       +.++..     .+....+++.+|++.+|++|||++++++.---..
T Consensus       242 -P~ip~~-----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  242 -PEIPDS-----LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             -CCCCcc-----cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence             111211     4557889999999999999999999998654433

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-44  Score=349.82  Aligned_cols=263  Identities=26%  Similarity=0.384  Sum_probs=205.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCC
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGRS-EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  184 (436)
                      ..++|++.+.||+|+||.||+|.+.      .+..||+|++.... ......+.+|+.++.++ +||||++++++|...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            4568999999999999999999742      25679999997543 34456789999999999 8999999999887654


Q ss_pred             -ccEEEEeecCCCChhhhhcCCCc--------------------------------------------------------
Q 040532          185 -EKILIYEYMPNKSLDFFLFDPTK--------------------------------------------------------  207 (436)
Q Consensus       185 -~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------  207 (436)
                       ..+++|||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             57899999999999988854211                                                        


Q ss_pred             ---cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCC
Q 040532          208 ---RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG  284 (436)
Q Consensus       208 ---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  284 (436)
                         ...+++.....++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               134778888999999999999999988   99999999999999999999999999986543222222223356678


Q ss_pred             ccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHH
Q 040532          285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLR  363 (436)
Q Consensus       285 y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (436)
                      |+|||++.+..++.++|||||||++|||++ |..||.......     .............      .+     ...+..
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~~~~~~~~~------~~-----~~~~~~  305 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQRLKDGTRMR------AP-----ENATPE  305 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHHHHhcCCCCC------CC-----CCCCHH
Confidence            999999999999999999999999999997 999986432211     1111111111100      01     113456


Q ss_pred             HHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          364 YVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       364 l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      +.+++.+||+.||++|||+.|+++.|+++..
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-44  Score=332.96  Aligned_cols=266  Identities=22%  Similarity=0.333  Sum_probs=211.3

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .....+.|+....||.|..++||+|... .++.||||++.-. ...+.+.+.+|+..|..++||||++++..|..+..+|
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            3455678999999999999999999954 4899999999744 3344789999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||.||.+||+.+++...-. ..+++.....|++++++||.|||.+|   .+|||||+.||||+++|.|||+|||.+..+
T Consensus       101 vVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             EeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeee
Confidence            99999999999999865332 23889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCcc--cccccccccCCccchhhhcc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc
Q 040532          268 GGNELQ--ANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL  343 (436)
Q Consensus       268 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  343 (436)
                      ......  ......+||+.|||||++..  ..|+.|+||||||++..||.+|..||..+..-..     ....+..+. .
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-----Ll~tLqn~p-p  250 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-----LLLTLQNDP-P  250 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-----HHHHhcCCC-C
Confidence            433211  12255689999999999664  4599999999999999999999999976543221     111111111 0


Q ss_pred             eeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ... . ........+.....+.+++..||++||.+|||++++++
T Consensus       251 ~~~-t-~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  251 TLL-T-SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             Ccc-c-ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            000 0 01111222335557899999999999999999999875

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=334.51  Aligned_cols=277  Identities=25%  Similarity=0.360  Sum_probs=212.6

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHH--cCCCceeEEeeEEEeCC---
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAK--VQHKNLVRLLGCCIDKD---  184 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~---  184 (436)
                      ..+..++.+..+.||+|.||+||+|.++ |+.||||++...++.   .+.+|.++.+.  |+|+||+.+++.-..++   
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            4566778888999999999999999998 999999999876654   56777777766  59999999999876554   


Q ss_pred             -ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEecccCCCCEEEcCCCCeEE
Q 040532          185 -EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH-----QYSRVRIIHRDLKASNILLDKDMNPKI  258 (436)
Q Consensus       185 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~~~i~H~Dikp~NIll~~~~~~kl  258 (436)
                       .++||.+|.++|||.+||..    ..++....++++..+|+||+|||     .+|+|.|.|||||+.|||+.+++.+.|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence             56899999999999999954    45899999999999999999999     478899999999999999999999999


Q ss_pred             eeccCceecCCC--CcccccccccccCCccchhhhccCC----C--CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 040532          259 SDFGMARICGGN--ELQANTSRIVGTYGYMSPEYALEGI----F--SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL  330 (436)
Q Consensus       259 ~DfGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~  330 (436)
                      +|+|||......  ......+..+||.+|||||++.+..    +  -..+||||||+++||+.-....-+.......+..
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            999999876543  3344566679999999999997543    1  2358999999999999753221111111111111


Q ss_pred             HHHHHHhhcCCcceec----cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          331 GYVWDLWTSNRTLELI----DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       331 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      +++..--..+++.+.+    ..+..+........+..+.+++..||..||.-|-|+--+-+.|.++..
T Consensus       438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            1111100111111111    134455566666788899999999999999999999999999998875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.4e-43  Score=336.28  Aligned_cols=265  Identities=27%  Similarity=0.418  Sum_probs=204.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-----------------CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-----------------GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVR  175 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~  175 (436)
                      .++|++.+.||+|+||.||++.+++                 +..||+|.+... ......++.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4578888999999999999998542                 336999998764 3444567899999999999999999


Q ss_pred             EeeEEEeCCccEEEEeecCCCChhhhhcCCC----------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 040532          176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII  239 (436)
Q Consensus       176 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~  239 (436)
                      +++++.+.+..++||||+++|+|.+++....                ....+++.....++.|++.||.|||+.+   ++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999998874321                1234678889999999999999999998   99


Q ss_pred             ecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhC--CC
Q 040532          240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG--KK  317 (436)
Q Consensus       240 H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg--~~  317 (436)
                      ||||||+|||+++++.+||+|||+++...............++..|+|||.+.++.++.++||||||+++|||+++  ..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999865443332223334567899999999988999999999999999999974  45


Q ss_pred             CCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          318 NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       318 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      ||....  .......................   .     ..++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       241 p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELT--DEQVIENAGEFFRDQGRQVYLFR---P-----PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCC--HHHHHHHHHHHhhhccccccccC---C-----CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            654322  11122222221111110000000   0     0134578999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-44  Score=334.21  Aligned_cols=275  Identities=27%  Similarity=0.378  Sum_probs=211.8

Q ss_pred             CCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHH--cCCCceeEEeeEEEeCC----ccEEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAK--VQHKNLVRLLGCCIDKD----EKILI  189 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv  189 (436)
                      ..+..+.+|+|+||.||+|+++ ++.||||++..   .+.+.|++|-++...  ++|+||++++++-....    +++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            3456688999999999999998 69999999964   444677777777765  58999999999877655    78999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh------CCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ------YSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~------~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      ++|.+.|+|.+||..+    .++|....+++..+++||+|||+      +.+++|+|||||++||||.+|+++.|+|||+
T Consensus       287 t~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            9999999999999643    48999999999999999999996      4467899999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCC-CC-----cccchhhHHHHHHHHHhCCCCCC--CCCCCCcchhHHHHH
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGI-FS-----IKSDVFSFGVLLLEIVSGKKNTG--LYRTDSLNLLGYVWD  335 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~SlGvil~elltg~~p~~--~~~~~~~~~~~~~~~  335 (436)
                      |..+.........-..+||.+|||||++.+.. +.     .+.||||+|.+||||++...-..  ............+-.
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            99887655555555579999999999998643 22     36899999999999999765442  111111111111111


Q ss_pred             HhhcCCcceec----cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          336 LWTSNRTLELI----DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       336 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                      .-+.+++.+.+    ..+.++........+..+.+.+..||..||+-|.|+.=|-+.+.++....+.
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            11111111111    2334444444445677899999999999999999999999999998876665

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=344.06  Aligned_cols=269  Identities=28%  Similarity=0.359  Sum_probs=215.2

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCc
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  185 (436)
                      ....++|...+.||.|+|++|++|+... ++.+|||++.+.   .+.-.+.+..|-+.|.+| .||.|++|+..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3455789999999999999999999654 889999998754   233345678899999999 89999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      +|+|+||+++|+|.+++.+...   +++.....++.+|+.||+|||++|   ||||||||+|||||+||++||+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999976543   889999999999999999999999   9999999999999999999999999999


Q ss_pred             ecCCCCcc---------ccc--ccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHH
Q 040532          266 ICGGNELQ---------ANT--SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVW  334 (436)
Q Consensus       266 ~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  334 (436)
                      .+......         ...  ..++||..|.+||++.++..+..+|+|+|||++|+|+.|++||.......     .+.
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-----iFq  297 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-----IFQ  297 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-----HHH
Confidence            87543221         112  44799999999999999999999999999999999999999996432210     011


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-------HhhccccCCCCCCCC
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM-------LTNEAAALHPPKQPA  403 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~-------L~~~~~~~~~~~~~~  403 (436)
                      ...      .+  +..++..     .+....+|+.+.|..||++|++..++-+.       .+++-...||+-.|+
T Consensus       298 kI~------~l--~y~fp~~-----fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py  360 (604)
T KOG0592|consen  298 KIQ------AL--DYEFPEG-----FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPY  360 (604)
T ss_pred             HHH------Hh--cccCCCC-----CCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCC
Confidence            111      10  1112212     33567889999999999999999888764       244444444444443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.8e-43  Score=307.02  Aligned_cols=282  Identities=23%  Similarity=0.361  Sum_probs=214.9

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChh--hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQ--GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .+|...+.||+|.||.||+|++. .|+.||||+++.....  -.....+|++.|+.++|+||+.++++|.+.+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46778899999999999999965 4999999999755322  13467899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |++ .+|...+.+.  ...+...+..+++.++++|++|+|.+.   |+||||||.|+|++++|.+||+|||+++.+....
T Consensus        82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            996 4788888653  456889999999999999999999998   9999999999999999999999999999887544


Q ss_pred             cccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc---
Q 040532          272 LQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID---  347 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  347 (436)
                      ....  ..+-|..|.|||.+.|. .|+...|+||.|||+.||+-|.+-|..  ..+.+....+...+..+...+..+   
T Consensus       156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG--~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG--DSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC--CchHHHHHHHHHHcCCCCcccCccccc
Confidence            3222  23789999999999875 599999999999999999998866532  222233333333332221111111   


Q ss_pred             -----------CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCCCcccccCc
Q 040532          348 -----------DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSNVRNT  410 (436)
Q Consensus       348 -----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~~~~~~~~~  410 (436)
                                 .+......+  ..+....+++..++..||.+|+++.|+++.  ......|.|..|..-+.+..
T Consensus       232 lpdY~~~~~~P~~~~~~lf~--aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~~~lp~p~~  301 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNNLFP--AASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPPSKLPIPST  301 (318)
T ss_pred             cccHHHHhcCCCCccccccc--cccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCChhhCcCCcc
Confidence                       111111122  245667999999999999999999999874  34444555555544444333

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-44  Score=343.04  Aligned_cols=252  Identities=27%  Similarity=0.414  Sum_probs=209.6

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      .....|....+||+|+.|.||.|... .++.||||++........+-+.+|+.+|+..+|+|||++++.|...++.|.||
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            34466888899999999999999854 48889999998765555567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+.+....    +++.+...|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+...
T Consensus       350 Eym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             eecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            9999999999885433    899999999999999999999999   999999999999999999999999999877644


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      ..  .....+||+.|||||+.....|+.|.||||||++++||+-|++||-.    +..+.. .+-....+       .+.
T Consensus       423 ~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrA-lyLIa~ng-------~P~  488 (550)
T KOG0578|consen  423 QS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRA-LYLIATNG-------TPK  488 (550)
T ss_pred             cC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHH-HHHHhhcC-------CCC
Confidence            32  34456899999999999999999999999999999999999999732    111111 11111111       111


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +   ......+..+.+++.+||+.|+++||++.|+++
T Consensus       489 l---k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  489 L---KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             c---CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            1   112236678999999999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-43  Score=333.81  Aligned_cols=264  Identities=25%  Similarity=0.335  Sum_probs=204.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--CccE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKI  187 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  187 (436)
                      ..+.|+.+++||+|.||.||+|++. .|+.||+|++....  +.......+|+.+|++|+||||++|.+...+.  ...|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            3456888999999999999999954 58999999997553  44456678999999999999999999998876  6889


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      ||+|||++ +|.-++..  ....++..+...++.|++.||+|+|+.+   |+|||||.+|||||.+|.+||+|||||+++
T Consensus       195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            99999987 45555543  2334889999999999999999999999   999999999999999999999999999987


Q ss_pred             CCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ....... ....+-|.+|.|||++.|. .|+.+.|+||.||||.||++|++.+....  +......+......+......
T Consensus       269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t--EveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT--EVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc--HHHHHHHHHHHhCCCChhccc
Confidence            6554332 3345789999999999975 59999999999999999999999885432  122222333333222111110


Q ss_pred             --cC-------------CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          347 --DD-------------PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       347 --~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        +-             +.+...  ....+....+|+..+|..||.+|.|+.++++
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~--~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRET--FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCcccccCCCCcccchHHHH--hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              00             001111  1224456788999999999999999998875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=338.56  Aligned_cols=262  Identities=24%  Similarity=0.347  Sum_probs=205.9

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHH--HHHHHHHHHHcC-CCceeEEeeEEEeCC-ccE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLRE--MKNEASVIAKVQ-HKNLVRLLGCCIDKD-EKI  187 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~  187 (436)
                      .-++|...++||.|.||+||+|+.. .|+.||||+++..-.. +++  -.+|+..|++++ ||||+++.+++.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            4568999999999999999999954 5889999999865332 233  358999999998 999999999999988 899


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +|||||+. +|.+++.+.  +..+++.....|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+|+..
T Consensus        87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            99999965 788888654  567999999999999999999999999   999999999999999999999999999977


Q ss_pred             CCCCcccccccccccCCccchhhhc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee-
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL-  345 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  345 (436)
                      .....   ....+.|.+|+|||++. .+.|+.+.|+|++|||++|+.+-++-|...+.  .+..--+.+.+..+..... 
T Consensus       161 ~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  161 RSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             ccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHHHHhCCCccccch
Confidence            65443   33458899999999987 46799999999999999999999988854331  1111111122211111111 


Q ss_pred             ---------------ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          346 ---------------IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       346 ---------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                                     +....+....+  +.+.+..+++.+|+++||.+|||+.|.++.
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p--~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLP--NASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCc--ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                           11111111112  256788999999999999999999999874

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=341.42  Aligned_cols=267  Identities=29%  Similarity=0.419  Sum_probs=213.3

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecCC----CE-EEEEEcCC---CChhhHHHHHHHHHHHHHcCCCceeEEeeEEE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKG----DE-IAVKRLSG---RSEQGLREMKNEASVIAKVQHKNLVRLLGCCI  181 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  181 (436)
                      ++...++....++||+|+||+||+|.+..+    .. ||+|..+.   .......++.+|+++|++++|||||+++|++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            444455566679999999999999996542    23 89999985   34667889999999999999999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeec
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  261 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~Df  261 (436)
                      .....++|||+|+||+|+++|....+  .++..++..++.+.|+||+|||+++   ++||||.++|+|++.++.+||+||
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF  306 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF  306 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence            99999999999999999999976544  5899999999999999999999998   999999999999999999999999


Q ss_pred             cCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      |+++...  .+........-+..|+|||.+..+.|+.++|||||||++||+++ |..||....     ..+........+
T Consensus       307 GLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-----~~~v~~kI~~~~  379 (474)
T KOG0194|consen  307 GLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK-----NYEVKAKIVKNG  379 (474)
T ss_pred             ccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC-----HHHHHHHHHhcC
Confidence            9987643  11111111135678999999999999999999999999999999 788874322     111111111211


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCC
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP  399 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~  399 (436)
                      .....      +.     ..+..+..++.+||..+|++||+|.++.+.|+.+.....++
T Consensus       380 ~r~~~------~~-----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  380 YRMPI------PS-----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             ccCCC------CC-----CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence            11110      00     13456788889999999999999999999999998776654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.8e-44  Score=341.43  Aligned_cols=261  Identities=26%  Similarity=0.374  Sum_probs=214.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ++|.+.+.||+|+||.||||+.+. .+.||+|.+.+.  .+++.+.+.+|+++++.++||||+.+++.|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            468888999999999999999764 788999999754  56678889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+.| +|..++....+   +++.....++.++..||.|||+..   |+|||+||.|||+++.+.+|+||||+|+....+.
T Consensus        82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9987 99999976554   899999999999999999999998   9999999999999999999999999999776533


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                        .......|||-|||||...++.|+..+|+||+||++|||++|++||-.     ......+.....++        ...
T Consensus       155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~d~--------v~~  219 (808)
T KOG0597|consen  155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILKDP--------VKP  219 (808)
T ss_pred             --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhcCC--------CCC
Confidence              223446899999999999999999999999999999999999999832     11222222222211        111


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhhccccCCCCCCC
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS--MLTNEAAALHPPKQP  402 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~--~L~~~~~~~~~~~~~  402 (436)
                      +     ...+..+.+++...|.+||.+|.+-.+++.  +.++.......+..+
T Consensus       220 p-----~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~  267 (808)
T KOG0597|consen  220 P-----STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQV  267 (808)
T ss_pred             c-----ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccc
Confidence            1     135677899999999999999999999875  344444444444333

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-43  Score=338.73  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=203.4

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC----Ch-hhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR----SE-QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKD  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  184 (436)
                      ...+.|...+.||+|+||+|+.|... .|..||+|.+...    .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            44678999999999999999999865 4899999977653    12 23456778999999998 999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC-CCeEEeeccC
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGM  263 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~-~~~kl~DfGl  263 (436)
                      ..++||||+.+|+|.+++.+   ...+.+.....++.|+++|++|+|+++   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999966   234788999999999999999999999   9999999999999999 9999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCC-CC-cccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGI-FS-IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      +....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||....     ........ ... 
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----~~~l~~ki-~~~-  238 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----VPNLYRKI-RKG-  238 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----HHHHHHHH-hcC-
Confidence            98774  1122344569999999999999877 75 88999999999999999999996521     11111221 111 


Q ss_pred             cceeccCCccccccchHHH-HHHHHHHHHhcccCCCCCCCCHHHHH
Q 040532          342 TLELIDDPVLEDEYSSKQV-LLRYVNIALLCVQESADDRPTMNDVV  386 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPs~~ev~  386 (436)
                            ....+..     . +..+..++.+||..||.+|+++.+++
T Consensus       239 ------~~~~p~~-----~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 ------EFKIPSY-----LLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ------CccCCCC-----cCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                  0111111     2 45788899999999999999999999

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-44  Score=333.04  Aligned_cols=249  Identities=25%  Similarity=0.409  Sum_probs=208.7

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ...|+..+.||+|+||.||+|.+.. ++.||+|++.-. .+.+.+++++|+.+|.+++++||.++++.+..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            4457777999999999999999765 788999999754 55667899999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      ||.+|++.+.+...   ..+++....-+++++..|+.|||.++   .+|||||+.|||+..+|.+|++|||++-.+....
T Consensus        92 y~~gGsv~~lL~~~---~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSG---NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HhcCcchhhhhccC---CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence            99999999998532   23577778889999999999999998   9999999999999999999999999998776544


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      ...  ..++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....               ..+.+-.+.+...
T Consensus       166 ~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h---------------PmrvlflIpk~~P  228 (467)
T KOG0201|consen  166 KRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH---------------PMRVLFLIPKSAP  228 (467)
T ss_pred             hcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC---------------cceEEEeccCCCC
Confidence            332  56799999999999998899999999999999999999999974322               2222333322222


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +....  .++..+.+++..||++||+.||++.++++
T Consensus       229 P~L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  229 PRLDG--DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             Ccccc--ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            21111  36678999999999999999999999875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.4e-42  Score=324.02  Aligned_cols=245  Identities=21%  Similarity=0.298  Sum_probs=197.6

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCCh---hhHHHHHHHHHHHHHcCCCceeEEeeEEEe----CCccEEEEeec
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIYEYM  193 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  193 (436)
                      ..||+|++|.||+|.++ |+.||+|.+.....   ...+.+.+|+.+|.+++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            57999999999999985 89999999975432   225678899999999999999999999877    34678999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      ++|+|.+++...   ..+++.....++.+++.||.|||+. +   ++||||||+||++++++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999653   3478899999999999999999985 5   7899999999999999999999999987654321 


Q ss_pred             ccccccccccCCccchhhhcc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          273 QANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                          ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.....     .+...........      ..
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~------~~  242 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDLIINKNNS------LK  242 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcCCC------CC
Confidence                12367889999999976  6799999999999999999999999864321     1111111111111      01


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                      .+     ...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       243 ~~-----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        243 LP-----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CC-----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            11     014557899999999999999999999999998764

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.7e-42  Score=340.79  Aligned_cols=261  Identities=27%  Similarity=0.390  Sum_probs=204.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEe------cCCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCC
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVL------RKGDEIAVKRLSGRS-EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  184 (436)
                      ..++|++.+.||+|+||.||+|++      ..+..||+|+++... ....+.+.+|+.++..+ +||||++++++|...+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            345789999999999999999974      235679999997542 33456788999999999 8999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCc---------------------------------------------------------
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTK---------------------------------------------------------  207 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  207 (436)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            99999999999999988853211                                                         


Q ss_pred             ---------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          208 ---------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       208 ---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                                     ...+++.....++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||++........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                           124788889999999999999999988   99999999999999999999999999986643322


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      ........++..|+|||.+.+..++.++|||||||++|||++ |..||.....+. ..    .........      ...
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~----~~~~~~~~~------~~~  338 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KF----YKMIKEGYR------MLS  338 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HH----HHHHHhCcc------CCC
Confidence            222222345678999999999999999999999999999998 888875432111 11    111111110      000


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      +..     .+.++.+++.+||+.||++||++.|+++.|++.
T Consensus       339 ~~~-----~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         339 PEC-----APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCC-----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            011     234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=336.00  Aligned_cols=247  Identities=27%  Similarity=0.422  Sum_probs=202.7

Q ss_pred             CCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      ....++-||+|+.|.||+|+++ ++.||||+++.-.       ..+++-|++|+||||+.+.|+|.....+|+|||||..
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             HhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence            3445678999999999999998 8899999986433       3467889999999999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |-|...|...   .++.......|..+||.||.|||.+.   |+|||||+-||||+-+..+||+|||.++.....   ..
T Consensus       197 GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---ST  267 (904)
T KOG4721|consen  197 GQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---ST  267 (904)
T ss_pred             ccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hh
Confidence            9999999643   34788889999999999999999988   999999999999999999999999999876533   22


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .-.+.||..|||||+++..+.+.|.|||||||+||||+||..||...+....     +|.          +....+.-..
T Consensus       268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----IwG----------VGsNsL~Lpv  332 (904)
T KOG4721|consen  268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IWG----------VGSNSLHLPV  332 (904)
T ss_pred             hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EEe----------ccCCcccccC
Confidence            3345899999999999999999999999999999999999999854332111     111          1111111111


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                       ...++..+.-|+.+||+..|.+||++++++..|+-.-.+
T Consensus       333 -PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  333 -PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             -cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence             112566788899999999999999999999999765544

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-43  Score=309.58  Aligned_cols=238  Identities=26%  Similarity=0.365  Sum_probs=199.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      .-++|+..+.||.|+||.|.+++.+. |..+|+|++...   ...+.+...+|..+|+.+.||.++++.+.|.+.+..||
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            34678999999999999999999764 788999999865   34556778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||++||.|..+++...+   +++..+.=++.+|+.||+|||+.+   |++|||||+|||+|.+|.+||+|||.|+...
T Consensus       122 vmeyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EEeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            9999999999999965443   888888899999999999999998   9999999999999999999999999999865


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ..     +-..||||.|+|||++....|..++|.|+|||++|||+.|.+||.....  ..    ..+..-+.       +
T Consensus       196 ~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~----iY~KI~~~-------~  257 (355)
T KOG0616|consen  196 GR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQ----IYEKILEG-------K  257 (355)
T ss_pred             Cc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HH----HHHHHHhC-------c
Confidence            33     4456999999999999999999999999999999999999999954332  11    11111111       1


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCC
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDR  379 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  379 (436)
                      -..+..     .+.++.+|+...|+.|-.+|
T Consensus       258 v~fP~~-----fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 VKFPSY-----FSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ccCCcc-----cCHHHHHHHHHHHhhhhHhh
Confidence            111222     44567889999999998888

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4e-42  Score=337.90  Aligned_cols=263  Identities=26%  Similarity=0.386  Sum_probs=205.5

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  183 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  183 (436)
                      ...++|++.+.||+|+||.||+|...      ++..||+|++... .......+.+|+.+++.+ +|+||++++++|...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            34567899999999999999998842      2357999999754 333456788999999999 899999999999999


Q ss_pred             CccEEEEeecCCCChhhhhcCCC---------------------------------------------------------
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPT---------------------------------------------------------  206 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  206 (436)
                      +..++||||+++|+|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            99999999999999998874321                                                         


Q ss_pred             ----------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccc
Q 040532          207 ----------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  276 (436)
Q Consensus       207 ----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  276 (436)
                                ....+++....+++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++...........
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                      1124778889999999999999999988   999999999999999999999999999765432221112


Q ss_pred             ccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       277 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      ....++..|+|||++.+..++.++|||||||++|||++ |+.||....... .    .........      ....+.. 
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~----~~~~~~~~~------~~~~~~~-  339 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-K----FYKMVKRGY------QMSRPDF-  339 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-H----HHHHHHccc------CccCCCC-
Confidence            22345678999999998899999999999999999997 999985432211 1    111111110      0000111 


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                          .+..+.+++.+||+.||++||++.++++.|+++.
T Consensus       340 ----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         340 ----APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                2356889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6e-42  Score=326.82  Aligned_cols=250  Identities=22%  Similarity=0.302  Sum_probs=199.2

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      ....++|+.++.||+|+||.||+|+-++ |+.+|+|++++..   ..+...++.|-.+|...++|+||+++..|.+.+.+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            4467889999999999999999999654 9999999998753   34567788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ||||||++||++..+|...   ..+++....-++.+++.|++.||+.|   ++||||||+|+|||..|++||+||||+.-
T Consensus       217 YLiMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence            9999999999999998643   34888888888889999999999999   99999999999999999999999999953


Q ss_pred             cCC----------------------CCccc----c-------------------cccccccCCccchhhhccCCCCcccc
Q 040532          267 CGG----------------------NELQA----N-------------------TSRIVGTYGYMSPEYALEGIFSIKSD  301 (436)
Q Consensus       267 ~~~----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~D  301 (436)
                      +..                      .+...    .                   ....+|||.|||||++.+..|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            211                      00000    0                   01247999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCC
Q 040532          302 VFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT  381 (436)
Q Consensus       302 v~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  381 (436)
                      .||||||||||+.|.+||........     ......-...........         ...+..+||.+|+. ||++|..
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T-----~rkI~nwr~~l~fP~~~~---------~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQET-----YRKIVNWRETLKFPEEVD---------LSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHhhhccCCCcCc---------ccHHHHHHHHHHhc-CHHHhcC
Confidence            99999999999999999965432221     111111111111111111         23567889999999 9999976

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-41  Score=321.93  Aligned_cols=257  Identities=31%  Similarity=0.505  Sum_probs=206.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......+.+|+..+.+++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998643      2579999987543 344567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC
Q 040532          188 LIYEYMPNKSLDFFLFDPTK-------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  254 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~  254 (436)
                      ++|||+++++|.+++.....             ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999998854211             145788899999999999999999988   99999999999999999


Q ss_pred             CeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHH
Q 040532          255 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYV  333 (436)
Q Consensus       255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  333 (436)
                      .++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......  +    .
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~----~  235 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--E----V  235 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--H----H
Confidence            999999999986544333222333456788999999998899999999999999999998 99998543211  1    1


Q ss_pred             HHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      ...........      .     ...++..+.+++.+||+.+|.+||++.||++.|++
T Consensus       236 ~~~i~~~~~~~------~-----~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 IEMIRSRQLLP------C-----PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHcCCcCC------C-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11111111110      0     11245678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-41  Score=319.62  Aligned_cols=256  Identities=25%  Similarity=0.368  Sum_probs=203.3

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec----CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++.. +......+.+|+..+.+++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            456888899999999999999854    2568999999865 33445678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            999999999999986532  35889999999999999999999988   9999999999999999999999999876532


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ..... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||......     +.... ......     
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~~~~~-~~~~~~-----  226 (266)
T cd05064         159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----DVIKA-VEDGFR-----  226 (266)
T ss_pred             ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHH-HHCCCC-----
Confidence            22111 1112245678999999999999999999999999999875 99998543211     11111 111100     


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      .+ .+     ..++..+.+++.+||+.+|++||+++++.+.|++.
T Consensus       227 ~~-~~-----~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 LP-AP-----RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CC-CC-----CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            01 11     11455788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-42  Score=337.80  Aligned_cols=247  Identities=25%  Similarity=0.354  Sum_probs=205.6

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      +-|...+.||+|+.|.|-.|++. .|+.+|||++.+.   +......+.+|+-+|+.+.|||++++++++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45888899999999999999965 5999999999765   2333567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|-|.+++....   ++.+.+..++++||+.|+.|+|..+   |+|||+||+|+|||..+++||+|||+|..-..+
T Consensus        92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999986543   4888999999999999999999999   999999999999999999999999999875433


Q ss_pred             CcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ..   -..-||++.|.|||+++|.+| +.++||||+|||||.|+||+.||+.     .++......+ ..+.    +.. 
T Consensus       166 kl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV-~~G~----f~M-  231 (786)
T KOG0588|consen  166 KL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKV-QRGV----FEM-  231 (786)
T ss_pred             cc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHH-HcCc----ccC-
Confidence            32   233499999999999999998 6889999999999999999999962     1222222222 1111    111 


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                             ....+.+..+|+.+|+..||++|.|++||++.
T Consensus       232 -------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  232 -------PSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -------CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                   12256678899999999999999999999874

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.8e-41  Score=335.04  Aligned_cols=266  Identities=24%  Similarity=0.347  Sum_probs=208.7

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcC-CCceeEEeeEEE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQ-HKNLVRLLGCCI  181 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  181 (436)
                      .....++|++.+.||+|+||.||+|.+..      +..||+|++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            34456789999999999999999998532      346999999754 3334567899999999996 999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCCc------------------------------------------------------
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPTK------------------------------------------------------  207 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  207 (436)
                      +.+..++||||+++|+|.+++.....                                                      
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            99999999999999999988753210                                                      


Q ss_pred             ---------------------------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCE
Q 040532          208 ---------------------------------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  248 (436)
Q Consensus       208 ---------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NI  248 (436)
                                                             ...+++.....++.|++.||.|||+.+   ++|+||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence                                                   124678888999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCc
Q 040532          249 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSL  327 (436)
Q Consensus       249 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  327 (436)
                      |+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....+. 
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-  347 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-  347 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence            999999999999999986543332222333456788999999998899999999999999999997 888875432111 


Q ss_pred             chhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          328 NLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                          ............      ...     ...+..+.+++.+||+.+|++||++.+|.+.|+++..
T Consensus       348 ----~~~~~~~~~~~~------~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 ----TFYNKIKSGYRM------AKP-----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ----HHHHHHhcCCCC------CCC-----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                111111111000      000     1145578899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.5e-41  Score=367.36  Aligned_cols=264  Identities=24%  Similarity=0.428  Sum_probs=209.3

Q ss_pred             cCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      ..+...+.||+|+||.||+|+. .+|..||+|++......    ...|++.+++++||||++++++|.+.+..++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            4567778999999999999997 46889999998754322    234688899999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++|+|.+++..      ++|..+..++.|+++||+|||....++++||||||+||+++.++..++. ||.......    
T Consensus       766 ~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        766 EGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             CCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            99999999842      7899999999999999999997655669999999999999999888876 665533211    


Q ss_pred             cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                        .....++..|+|||++.+..++.++|||||||++|||+||+.||............|.............++......
T Consensus       835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence              112367899999999999999999999999999999999999986544444556666654433333223333222222


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      .........++.+++.+||+.+|++||+|+|+++.|++..+.
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            122234566788999999999999999999999999988753

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.2e-41  Score=322.48  Aligned_cols=251  Identities=25%  Similarity=0.334  Sum_probs=198.6

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .|+..+.||+|+||+||+|... +|+.||+|.+....   ......+.+|+.++.+++|+|++++.+++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677889999999999999964 58999999986432   2223457889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++|+|..++.... ...+++.....++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            999999988775422 234889999999999999999999998   9999999999999999999999999998754322


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      .   .....||..|+|||++.+..++.++|||||||++|||++|+.||.......  .............       ...
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~-------~~~  224 (285)
T cd05631         157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KREEVDRRVKEDQ-------EEY  224 (285)
T ss_pred             e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hHHHHHHHhhccc-------ccC
Confidence            1   223478999999999999999999999999999999999999986433211  1111111111100       001


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPT-----MNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~  387 (436)
                      .     ...+..+.+++.+||+.||++||+     ++++++
T Consensus       225 ~-----~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         225 S-----EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             C-----ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            1     113456889999999999999997     777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-42  Score=322.55  Aligned_cols=249  Identities=34%  Similarity=0.544  Sum_probs=193.9

Q ss_pred             CcccCCCCceeEEEEEec-----CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          120 TNKLGEGGFGPVYKGVLR-----KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      .+.||.|.||.||+|.++     .+..|+||.+... .....+.+.+|++.+++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999987     2567999999754 4445788999999999999999999999999888899999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++|+|.+++... ....+++..+..|+.|+++||.|||+.+   ++|+||+++||++++++.+||+|||++.........
T Consensus        84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            999999999654 2345899999999999999999999988   999999999999999999999999999877433332


Q ss_pred             cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                      ...........|+|||.+.+..++.++||||||+++|||++ |+.|+....     ........ ........      +
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-----~~~~~~~~-~~~~~~~~------~  227 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-----NEEIIEKL-KQGQRLPI------P  227 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-----HHHHHHHH-HTTEETTS------B
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccc-ccccccee------c
Confidence            33333456778999999999999999999999999999999 678864332     11111122 22211110      0


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                      .     .++..+.+++.+||+.+|++||++.++++.|
T Consensus       228 ~-----~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  228 D-----NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             T-----TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             c-----chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            0     1345688999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=327.50  Aligned_cols=245  Identities=24%  Similarity=0.284  Sum_probs=198.6

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999976 48899999986432   233466889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++...   ..+++.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            999999999988543   24788899999999999999999998   999999999999999999999999998765322


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                           .....|++.|+|||++.+..++.++|||||||++|||++|+.||.....     ...........        ..
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~--------~~  216 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEKILAGK--------LE  216 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC--------cC
Confidence                 2234689999999999988899999999999999999999999854321     11111111111        01


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPT-----MNDVVSM  388 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~~  388 (436)
                      .+..     ....+.+++.+||+.||.+||+     +.++++.
T Consensus       217 ~~~~-----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         217 FPRH-----LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCcc-----CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            1111     2346789999999999999995     7777644

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.8e-41  Score=325.27  Aligned_cols=263  Identities=22%  Similarity=0.295  Sum_probs=203.5

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .++|++.+.||+|+||.||++.+. +|..+|+|.+... .......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999976 4788999998754 33445679999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++++|.+++....   .+++.....++.|++.||.|||+.+  +++||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            999999999985433   4788999999999999999999853  3999999999999999999999999998765322 


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc--CC-c------
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS--NR-T------  342 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~-~------  342 (436)
                         ......|+..|+|||++.+..++.++|||||||++|||++|+.||...+...  +..........  .. .      
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcc
Confidence               1223468999999999999899999999999999999999999985432211  11000000000  00 0      


Q ss_pred             ------------------------ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          343 ------------------------LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       343 ------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                                              ...+..... ........+..+.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPP-PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCC-cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                    000000000 000011144578999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3e-41  Score=320.26  Aligned_cols=262  Identities=29%  Similarity=0.451  Sum_probs=210.0

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .++|.+.+.||+|+||+||++...      ++..+|+|.+..........+.+|+.++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            457888899999999999999852      24568999998766666678999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCC----------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeE
Q 040532          188 LIYEYMPNKSLDFFLFDPT----------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  257 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~k  257 (436)
                      +||||+++++|.+++....          ....+++.....++.|++.||+|||+.+   ++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999885322          2234899999999999999999999988   99999999999999999999


Q ss_pred             EeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHH
Q 040532          258 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      |+|||++................++..|+|||.+.+..++.++|+|||||++|||++ |..||......     . ....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-----~-~~~~  234 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-----E-VIEC  234 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----H-HHHH
Confidence            999999986543332222233345778999999998889999999999999999998 88887533211     1 1111


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      ........      ...     ..+..+.+++.+||+.+|.+||++.++.+.|+++..+
T Consensus       235 i~~~~~~~------~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 ITQGRVLQ------RPR-----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHcCCcCC------CCC-----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            11111110      011     1334689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.1e-41  Score=320.64  Aligned_cols=261  Identities=29%  Similarity=0.438  Sum_probs=209.9

Q ss_pred             cCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+........+.+.+|+..+++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45777889999999999999843      245689999887666666789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC
Q 040532          189 IYEYMPNKSLDFFLFDPT-------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  255 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~  255 (436)
                      ||||+++++|.+++....             ....+++..++.++.|++.|++|||+.+   ++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985422             1234789999999999999999999998   999999999999999999


Q ss_pred             eEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHH
Q 040532          256 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVW  334 (436)
Q Consensus       256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  334 (436)
                      ++|+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.||......  .    ..
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~----~~  235 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--E----VI  235 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H----HH
Confidence            99999999976544332222333456788999999999999999999999999999999 99997543211  1    11


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      +..........      .     ...+..+.+++.+||+.+|++||++.+|++.|+++...
T Consensus       236 ~~~~~~~~~~~------~-----~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 ECITQGRVLER------P-----RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHhCCCCCCC------C-----ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            11111111110      0     11345688999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.9e-42  Score=331.86  Aligned_cols=245  Identities=23%  Similarity=0.286  Sum_probs=198.4

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      .++|++.+.||+|+||.||+|.+.. |+.||+|++...   .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            3568888999999999999999764 889999998643   223356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+++|+|.+++....   .+++.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999998886432   4788888899999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ..     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....... ....       .
T Consensus       171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i-~~~~-------~  232 (329)
T PTZ00263        171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEKI-LAGR-------L  232 (329)
T ss_pred             Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHHH-hcCC-------c
Confidence            22     234789999999999999999999999999999999999999853211     1111111 1111       0


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPT-----MNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~  387 (436)
                      ..+..     ....+.+++.+||+.||.+||+     ++++++
T Consensus       233 ~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 KFPNW-----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCCCC-----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            01111     2345788999999999999997     577663

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.7e-41  Score=318.62  Aligned_cols=265  Identities=21%  Similarity=0.278  Sum_probs=200.4

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ++|++.+.||+|+||+||+|+++. ++.+|+|++....  ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            468899999999999999999864 7889999987542  2334677899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |++++++..+...   ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            9999888765432   234888999999999999999999988   9999999999999999999999999998654322


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHH----------HHHhhcCC
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV----------WDLWTSNR  341 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----------~~~~~~~~  341 (436)
                      . .......|++.|+|||++.+..++.++|||||||++|||++|+.||....... .+....          ........
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccc
Confidence            1 12223468999999999998889999999999999999999999986432111 000000          00000000


Q ss_pred             cceeccCCcccccc-----chHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 TLELIDDPVLEDEY-----SSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .......+......     .....+..+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000000000     00113456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.2e-42  Score=330.35  Aligned_cols=241  Identities=22%  Similarity=0.278  Sum_probs=193.9

Q ss_pred             cccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCC
Q 040532          121 NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      +.||+|+||.||++..+ +|+.||+|++...   .......+.+|+.++++++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 5889999998753   2334456788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccc
Q 040532          197 SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  276 (436)
Q Consensus       197 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  276 (436)
                      +|..++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  152 (323)
T cd05571          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence            998888543   34789999999999999999999998   9999999999999999999999999987532211  122


Q ss_pred             ccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccc
Q 040532          277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYS  356 (436)
Q Consensus       277 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (436)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..     ...... ...       ....+.   
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~~~~~-~~~-------~~~~p~---  216 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI-LME-------EIRFPR---  216 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----HHHHHH-HcC-------CCCCCC---
Confidence            3357999999999999999999999999999999999999998532211     111111 111       011111   


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          357 SKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       357 ~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                        ..+..+.+++.+||+.||++||     ++.++++
T Consensus       217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 --TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             --CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence              1345688999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.6e-41  Score=319.05  Aligned_cols=258  Identities=29%  Similarity=0.451  Sum_probs=206.1

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCCChh-hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRSEQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      .++|.+.+.||+|+||.||+|...+      +..||+|.+...... ..+.+.+|++++++++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568888999999999999998643      468999999765433 457899999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCC-----------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC
Q 040532          187 ILIYEYMPNKSLDFFLFDPT-----------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  255 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~  255 (436)
                      ++||||+++++|.+++....           ....+++.....++.|++.|+.|||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999986432           2345788899999999999999999998   999999999999999999


Q ss_pred             eEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHH
Q 040532          256 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVW  334 (436)
Q Consensus       256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  334 (436)
                      +||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||......  ...   .
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~---~  235 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVI---E  235 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH---H
Confidence            99999999976543332222233356788999999999999999999999999999998 99997433211  111   1


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      . ........      ...     ..+..+.+++.+||+.||++||++.|+++.|++
T Consensus       236 ~-~~~~~~~~------~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         236 C-ITQGRLLQ------RPR-----TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             H-HHcCCcCC------CCC-----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1 11111100      000     134578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.7e-41  Score=318.67  Aligned_cols=260  Identities=27%  Similarity=0.427  Sum_probs=204.0

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ...++|++.+.||+|+||.||+|.+.      .+..||+|++... ......++.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999999754      2467999998643 2334567889999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCc-------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeE
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTK-------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  257 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~k  257 (436)
                      ..++||||+++++|.+++.....       ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            99999999999999998854221       234678888999999999999999988   99999999999999999999


Q ss_pred             EeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHH
Q 040532          258 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      |+|||++................++..|+|||.+.++.++.++||||||+++|||++ |..||......     .. ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-----~~-~~~  233 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-----QV-LRF  233 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HH-HHH
Confidence            999999876543332222222345778999999998899999999999999999999 67887533211     11 111


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      ........      ...     ..+..+.+++.+||+.+|++||++.|+++.|++
T Consensus       234 ~~~~~~~~------~~~-----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VMEGGLLD------KPD-----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCcCC------CCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            11111100      111     134568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.3e-41  Score=324.35  Aligned_cols=259  Identities=28%  Similarity=0.450  Sum_probs=203.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CC----EEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GD----EIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ..+|+..+.||+|+||.||+|.+.. |+    .||+|.+... .....+.+.+|+.+++.++||||++++++|... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            3568999999999999999998643 33    3899998754 344557789999999999999999999998764 578


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +++||+++|+|.+++....  ..+++...+.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          85 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            9999999999999886533  24788899999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.||......     . ...........   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-----~-~~~~~~~~~~~---  230 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----E-ISSILEKGERL---  230 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----H-HHHHHhCCCCC---
Confidence            54332222222345678999999999999999999999999999998 99997532211     1 11111111100   


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                        + ...     .+...+.+++.+||+.+|++||++.+++..|..+..+
T Consensus       231 --~-~~~-----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         231 --P-QPP-----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             --C-CCC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence              0 000     1334678899999999999999999999999888754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=327.07  Aligned_cols=253  Identities=22%  Similarity=0.334  Sum_probs=202.8

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||.||+|.+.. ++.||+|++...   .......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            468889999999999999999764 889999998743   2233467889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            999999999998543   24788899999999999999999998   99999999999999999999999999976432 


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||......     +..........   .+..+.
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~---~~~~~~  221 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-----ETWENLKYWKE---TLQRPV  221 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-----HHHHHHHhccc---cccCCC
Confidence                223347899999999999999999999999999999999999998543211     11111111111   111111


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ...  .....+..+.+++.+||+.+|.+||++.++++.
T Consensus       222 ~~~--~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 YDD--PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCc--cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            110  001245678899999999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-42  Score=297.42  Aligned_cols=268  Identities=23%  Similarity=0.264  Sum_probs=212.4

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEE-ecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC----
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----  184 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  184 (436)
                      +-...++|++.+.||+|||+-||.++ ..+++.+|+|++...+.++.+...+|++.-++++|||+++++++...+.    
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            44567899999999999999999999 4558899999999888788889999999999999999999999876544    


Q ss_pred             -ccEEEEeecCCCChhhhhcC-CCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          185 -EKILIYEYMPNKSLDFFLFD-PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       185 -~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                       +.|++++|+..|+|.+.+.. ..++..+++.+.++|+.++++||++||+.. ++++||||||.|||+++.+.+++.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence             47999999999999888754 234457999999999999999999999986 469999999999999999999999999


Q ss_pred             CceecCCCCccc-------ccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 040532          263 MARICGGNELQA-------NTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY  332 (436)
Q Consensus       263 la~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~  332 (436)
                      .++...-.....       ......-|..|.|||.+.   +...+.++|||||||++|+|+.|..||+..-..+..+.  
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla--  252 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA--  252 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE--
Confidence            987643211100       011124578899999886   34578999999999999999999999864322111110  


Q ss_pred             HHHHhhcCCcceecc-CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          333 VWDLWTSNRTLELID-DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       333 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                                ..... ....+.. ..  .++.+.+++.+|++.||.+||+..+++..++.+.
T Consensus       253 ----------LAv~n~q~s~P~~-~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  253 ----------LAVQNAQISIPNS-SR--YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----------EeeeccccccCCC-CC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                      11111 1111111 11  5678999999999999999999999999998764

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.9e-41  Score=340.95  Aligned_cols=253  Identities=19%  Similarity=0.209  Sum_probs=204.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC--CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK--GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ..|.+.+.||+|++|.||+|....  +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            348889999999999999998543  577899987666555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          193 MPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      +++|+|.+++... ....++++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999887542 23446888999999999999999999988   9999999999999999999999999998765433


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ............       ...
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~~-------~~~  291 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGKY-------DPF  291 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCC-------CCC
Confidence            22233445799999999999999999999999999999999999999853221     111111111110       001


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +.     ..+..+.+++.+||+.+|++||++.+++.
T Consensus       292 ~~-----~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        292 PC-----PVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             Cc-----cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            11     13456889999999999999999999864

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.4e-41  Score=313.19  Aligned_cols=257  Identities=31%  Similarity=0.461  Sum_probs=206.3

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ..++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            346788899999999999999998888899999987543 2356789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++.... ...+++.....++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        83 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          83 MAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999886432 334788899999999999999999988   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      . ......++..|+|||.+.+..++.++||||||+++|+|+| |+.||......  ...   ... ....     ..+..
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~---~~~-~~~~-----~~~~~  226 (261)
T cd05072         159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVM---SAL-QRGY-----RMPRM  226 (261)
T ss_pred             e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHH---HHH-HcCC-----CCCCC
Confidence            1 1222345678999999998889999999999999999998 89998542211  111   111 1110     00111


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                       .     ..+..+.+++.+|++.+|++||+++++.+.|++.
T Consensus       227 -~-----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         227 -E-----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -C-----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence             0     1345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=325.80  Aligned_cols=239  Identities=22%  Similarity=0.273  Sum_probs=191.1

Q ss_pred             cCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       123 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      ||+|+||.||+|.... ++.||+|++...   .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            6999999999999764 788999998643   234456778999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccccc
Q 040532          199 DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  278 (436)
Q Consensus       199 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  278 (436)
                      .+++....   .+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            99885432   4789999999999999999999998   9999999999999999999999999987533221  12233


Q ss_pred             ccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchH
Q 040532          279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK  358 (436)
Q Consensus       279 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (436)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||....     ............        ...+.     
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~--------~~~~~-----  214 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEP--------LRFPD-----  214 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCC--------CCCCC-----
Confidence            578999999999999999999999999999999999999985322     111111111111        11111     


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          359 QVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       359 ~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .....+.+++.+||+.||++||++.++.+
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e  243 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQE  243 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence            13456889999999999999986443333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=318.67  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=199.7

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--------------hhhHHHHHHHHHHHHHcCCCceeE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--------------EQGLREMKNEASVIAKVQHKNLVR  175 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~  175 (436)
                      ....++|++.+.||+|.||.|-+|+.. +++.||+|++.+..              -...+...+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            345688999999999999999999965 48899999986431              112457899999999999999999


Q ss_pred             EeeEEEe--CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC
Q 040532          176 LLGCCID--KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD  253 (436)
Q Consensus       176 l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~  253 (436)
                      |+.+..+  .+..|||+|||..|.+.+.-   .....++..+.+++++++..||+|||.++   |+||||||+|+||+++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence            9999875  46789999999998875432   22223899999999999999999999999   9999999999999999


Q ss_pred             CCeEEeeccCceecCCC---CcccccccccccCCccchhhhccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 040532          254 MNPKISDFGMARICGGN---ELQANTSRIVGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  326 (436)
Q Consensus       254 ~~~kl~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~elltg~~p~~~~~~~~  326 (436)
                      |++||+|||.+......   .........+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-..  ..
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~--~~  324 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD--FE  324 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--hH
Confidence            99999999999866322   1222334468999999999998743    367899999999999999999998321  11


Q ss_pred             cchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                         .... +.+.        .+++.-...+  ++...+.+||.++|++||++|.+..+|....
T Consensus       325 ---~~l~-~KIv--------n~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  325 ---LELF-DKIV--------NDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ---HHHH-HHHh--------cCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecc
Confidence               1111 1111        1111111111  2456788999999999999999999987655

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=316.24  Aligned_cols=265  Identities=26%  Similarity=0.402  Sum_probs=202.5

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC---------------CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEe
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK---------------GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLL  177 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~  177 (436)
                      .++|++.+.||+|+||.||++....               ...||+|.+... .......+.+|++++.+++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4578999999999999999987642               224899999764 344456789999999999999999999


Q ss_pred             eEEEeCCccEEEEeecCCCChhhhhcCCC---------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCE
Q 040532          178 GCCIDKDEKILIYEYMPNKSLDFFLFDPT---------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  248 (436)
Q Consensus       178 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NI  248 (436)
                      +++...+..++||||+++++|.+++....         ....+++.....++.|++.||+|||+.+   ++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999885421         1124688899999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCCC
Q 040532          249 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDS  326 (436)
Q Consensus       249 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~p~~~~~~~~  326 (436)
                      ++++++.+||+|||++................++..|+|||.+.++.++.++|+||||+++|||++  |..||.....  
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence            999999999999999976543332222233345778999999998899999999999999999998  4556543221  


Q ss_pred             cchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      ......................   ..     ..+..+.+++.+|++.+|++||++.+|++.|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~---~~-----~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQ---TP-----LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCC---CC-----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            1111111111111100000000   00     134578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=331.60  Aligned_cols=246  Identities=24%  Similarity=0.333  Sum_probs=202.4

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCC
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD  184 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  184 (436)
                      .....++|...++||+|+||+|+++..+. ++.+|||.+++.   ...+.+..+.|..++... +||.+++++.+|...+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            34556789999999999999999999775 778999999876   345677888999998888 5999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..|+||||+.||++..+.    ....+++....-++..++.||+|||+++   |++||||.+|||||.+|.+||+|||++
T Consensus       443 ~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             eEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence            999999999999943333    2234888898999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      +.--.  ....++..+||+.|||||++.+..|+.+.|.|||||+||||+.|..||...+.++     .+... .      
T Consensus       516 Ke~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-----~FdsI-~------  581 (694)
T KOG0694|consen  516 KEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-----VFDSI-V------  581 (694)
T ss_pred             cccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHH-h------
Confidence            85332  2235667899999999999999999999999999999999999999996543221     11111 1      


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTM  382 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  382 (436)
                       .+++..+..     .+.+...++.++|..+|++|..+
T Consensus       582 -~d~~~yP~~-----ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 -NDEVRYPRF-----LSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -cCCCCCCCc-----ccHHHHHHHHHHhccCcccccCC
Confidence             122222222     45678889999999999999876

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-41  Score=312.42  Aligned_cols=257  Identities=29%  Similarity=0.428  Sum_probs=206.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ..++|++.+.||+|++|.||+|.+++++.||+|.+.... ...+++.+|+.++++++||||+++++++...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            356788899999999999999998878889999987543 2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++.... ...+++.....++.|++.|+.|||+.+   ++||||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999986533 345789999999999999999999988   99999999999999999999999999987653221


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      . .......+..|+|||.+.+..++.++|+||||+++|||++ |+.||.....     .. ...........     + .
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~-~~~~~~~~~~~-----~-~  225 (261)
T cd05068         159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----AE-VLQQVDQGYRM-----P-C  225 (261)
T ss_pred             c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----HH-HHHHHHcCCCC-----C-C
Confidence            1 1111223457999999998899999999999999999999 8888753221     10 11111111000     0 0


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      .     ...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus       226 ~-----~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         226 P-----PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             C-----CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            0     11345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.4e-41  Score=320.89  Aligned_cols=265  Identities=23%  Similarity=0.308  Sum_probs=195.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .++|++.+.||+|+||+||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999976 588999999875432 223457789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |++ ++|.+++....  ..++...+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 56666654322  34788889999999999999999998   9999999999999999999999999987543221


Q ss_pred             cccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc-------
Q 040532          272 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL-------  343 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  343 (436)
                        .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.........+. ............       
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE-RIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH-HHHHHhCCCChhhccchhh
Confidence              11223468899999999875 4578999999999999999999999964322111111 111100000000       


Q ss_pred             -eecc--------CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          344 -ELID--------DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       344 -~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ....        .............+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             0000        0000000000012245788999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.3e-41  Score=312.40  Aligned_cols=252  Identities=28%  Similarity=0.383  Sum_probs=201.4

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      ++|++.+.||+|+||.||++.++++..+|+|.+.... ...+++.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4577889999999999999998888899999986432 234678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +|+|.+++....  ..+++.....++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||.++........ 
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            999999886432  24789999999999999999999988   999999999999999999999999998765432221 


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                      ......++..|+|||.+.+..++.++|+||||+++|||++ |+.||....     ..............       ..+.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-----~~~~~~~i~~~~~~-------~~~~  224 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NYEVVEMISRGFRL-------YRPK  224 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHCCCCC-------CCCC
Confidence            1122245568999999988889999999999999999999 888874322     11111111111110       0011


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      .     .+..+.+++.+||+.+|++||++.++++.|+
T Consensus       225 ~-----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 L-----ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             C-----CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1     2346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.1e-41  Score=313.74  Aligned_cols=257  Identities=30%  Similarity=0.472  Sum_probs=209.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ...+|+..+.||.|+||.||+|...++..+++|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            45678899999999999999999888899999999876665567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++.... ...+++.....++.|++.|++|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999996543 345789999999999999999999988   99999999999999999999999999976543221


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.....  ......   . .....     .+ .
T Consensus       160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~---~-~~~~~-----~~-~  225 (261)
T cd05148         160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQ---I-TAGYR-----MP-C  225 (261)
T ss_pred             cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHH---H-HhCCc-----CC-C
Confidence            11  12345678999999998889999999999999999998 8888854321  111111   1 11100     00 0


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      .     ..++..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       226 ~-----~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         226 P-----AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             C-----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            0     11345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.2e-41  Score=325.05  Aligned_cols=264  Identities=27%  Similarity=0.383  Sum_probs=205.8

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRS-EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  183 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  183 (436)
                      ...++|++.+.||+|+||.||+|...+      ++.||+|++.... ....+.+..|+.++.++ +|+||++++++|...
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            345689999999999999999997432      4689999987542 33456778899999999 899999999988754


Q ss_pred             -CccEEEEeecCCCChhhhhcCCCc-------------------------------------------------------
Q 040532          184 -DEKILIYEYMPNKSLDFFLFDPTK-------------------------------------------------------  207 (436)
Q Consensus       184 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  207 (436)
                       ...+++|||+++++|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             567899999999999988743211                                                       


Q ss_pred             ---cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCC
Q 040532          208 ---RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG  284 (436)
Q Consensus       208 ---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  284 (436)
                         ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.++|+|||++................++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence               125789999999999999999999988   99999999999999999999999999987543332222333456778


Q ss_pred             ccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHH
Q 040532          285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLR  363 (436)
Q Consensus       285 y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (436)
                      |+|||++.+..++.++|||||||++|||++ |..||.......     ............      ..+     ......
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~~------~~~-----~~~~~~  304 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----EFCRRLKEGTRM------RAP-----EYATPE  304 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-----HHHHHHhccCCC------CCC-----ccCCHH
Confidence            999999999999999999999999999998 999985422111     111111111110      001     113456


Q ss_pred             HHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          364 YVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       364 l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      +.+++.+||+.+|++||++.|+++.|+++..
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=339.43  Aligned_cols=263  Identities=26%  Similarity=0.318  Sum_probs=212.2

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecCC-CEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeE-EEeC---
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKG-DEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGC-CIDK---  183 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~~---  183 (436)
                      +.....++++.+.|.+|||+.||.|++..+ ..+|+|++...++...+.+.+|+++|++|. |+|||.+++. ....   
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            345667788999999999999999998776 999999998888899999999999999996 9999999993 2221   


Q ss_pred             ---CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEee
Q 040532          184 ---DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  260 (436)
Q Consensus       184 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~D  260 (436)
                         -+.+|.||||.+|.|-+++....... +.+.++++|+.++++|+++||.+. ++|+|||||-+||||+.+++.||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence               25579999999999999986543333 899999999999999999999985 6799999999999999999999999


Q ss_pred             ccCceecCCCCcccc-------cccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 040532          261 FGMARICGGNELQAN-------TSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL  330 (436)
Q Consensus       261 fGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~  330 (436)
                      ||.+.-.-.......       .=....|+.|+|||++.   +...+.|+|||+|||+||-|+....||+....      
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------  263 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------  263 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence            999974322221110       00124689999999985   66789999999999999999999999964311      


Q ss_pred             HHHHHHhhcCCcceec-cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          331 GYVWDLWTSNRTLELI-DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       331 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                                  ..++ ....++..   ...+..+..||..||+.||++||++.+|++.+-++...
T Consensus       264 ------------laIlng~Y~~P~~---p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 ------------LAILNGNYSFPPF---PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ------------eeEEeccccCCCC---ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                        1111 11222211   23677899999999999999999999999999887744

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=311.88  Aligned_cols=257  Identities=29%  Similarity=0.445  Sum_probs=204.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC----CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      .++|++.+.||+|+||.||+|.+..    ...||+|.+... .......+.+|+..+++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3568889999999999999998753    357999998754 33445678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      +|||+++++|.+++.....  .+++.....++.|++.|++|||+.+   ++|+||||+||++++++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999999865332  5889999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..||......  ..    ..........    
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~----~~~~~~~~~~----  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DV----IKAVEDGYRL----  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HH----HHHHHcCCCC----
Confidence            2222111222345678999999998899999999999999999998 99887432211  11    1111111000    


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                       +. ..     ..+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus       228 -~~-~~-----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 -PP-PM-----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -CC-CC-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             00 00     1345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-40  Score=320.72  Aligned_cols=240  Identities=27%  Similarity=0.353  Sum_probs=188.5

Q ss_pred             cccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||.||+|.... ++.||+|+++..   .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999754 788999998743   122344556677777654 899999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++....   .+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            99998885432   4788899999999999999999988   9999999999999999999999999997643222  22


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.     ......... .       .+..+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~-~-------~~~~~~~-  218 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILN-D-------RPHFPRW-  218 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHc-C-------CCCCCCC-
Confidence            2345789999999999998999999999999999999999999864321     111111111 1       1111111 


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTMN-DVV  386 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~~-ev~  386 (436)
                          ....+.+++.+||+.+|++||++. +++
T Consensus       219 ----~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         219 ----ISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ----CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                334678899999999999999876 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.5e-41  Score=325.73  Aligned_cols=242  Identities=23%  Similarity=0.278  Sum_probs=194.4

Q ss_pred             cccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCC
Q 040532          121 NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      +.||+|+||.||++..+ +|+.||+|++...   .......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999965 4889999999753   2334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccc
Q 040532          197 SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  276 (436)
Q Consensus       197 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  276 (436)
                      +|..++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            998887543   24889999999999999999999998   9999999999999999999999999987532211  122


Q ss_pred             ccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccc
Q 040532          277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYS  356 (436)
Q Consensus       277 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (436)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..     .........        ....+..  
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~--------~~~~p~~--  217 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILME--------DIKFPRT--  217 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccC--------CccCCCC--
Confidence            3357899999999999889999999999999999999999998543211     111111100        0111111  


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 040532          357 SKQVLLRYVNIALLCVQESADDRP-----TMNDVVSM  388 (436)
Q Consensus       357 ~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~~  388 (436)
                         ....+.+++.+||+.||++||     ++.|+++.
T Consensus       218 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         218 ---LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             ---CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence               345688999999999999997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-41  Score=329.36  Aligned_cols=247  Identities=22%  Similarity=0.274  Sum_probs=199.3

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC--CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK--GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ..++|++.+.||+|+||.||+|.++.  +..||+|++...   .....+.+.+|+.++..++||||+++++++.+.+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            44678899999999999999998654  358999998643   2334567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|.+++....   .+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus       108 lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            9999999999999985433   4888999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ...     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....... .....     
T Consensus       182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~i-~~~~~-----  245 (340)
T PTZ00426        182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----LLIYQKI-LEGII-----  245 (340)
T ss_pred             CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-----HHHHHHH-hcCCC-----
Confidence            422     2234789999999999988899999999999999999999999853221     1111111 11100     


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVSM  388 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~~  388 (436)
                        ..+..     ....+.+++.+|++.+|++|+     +++++++.
T Consensus       246 --~~p~~-----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 --YFPKF-----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --CCCCC-----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              01111     234578899999999999995     78888764

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.5e-41  Score=317.82  Aligned_cols=264  Identities=28%  Similarity=0.404  Sum_probs=208.7

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCI  181 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  181 (436)
                      +....++|+..+.||+|+||.||++....      ...+|+|.+... .......+.+|+.++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            34456678889999999999999998642      357999998754 344456788999999999 8999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCC-------------CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCE
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDP-------------TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  248 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NI  248 (436)
                      .++..+++|||+++|+|..++...             .....+++...+.++.|++.||+|||+.+   ++||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence            999999999999999999988532             22345889999999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCc
Q 040532          249 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSL  327 (436)
Q Consensus       249 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  327 (436)
                      ++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....   
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---  240 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---  240 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---
Confidence            999999999999999987654332222222345678999999988899999999999999999998 8888753221   


Q ss_pred             chhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          328 NLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                        .. ............      .+     ......+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus       241 --~~-~~~~~~~~~~~~------~~-----~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 --EE-LFKLLKEGYRME------KP-----QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HH-HHHHHHcCCcCC------CC-----CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              11 111111111100      00     013456889999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-42  Score=316.36  Aligned_cols=249  Identities=24%  Similarity=0.391  Sum_probs=209.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ...+|++.+.||+|.||.|-+|.. ..|+.||||.+++.   ++++.-.+.+|+++|..|+||||+.++.+|++.+...+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            356799999999999999999996 56999999999754   56667778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||..+|.|.+|+.+..   .+++.+...+++||.+|+.|+|+++   ++|||||.+|||+|+++++||+|||++.++.
T Consensus       131 vMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999996544   4899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ....   ...++|++-|.+||++.+.+| +...|.|||||+||-|+.|..||+..+     ....+.+..          
T Consensus       205 ~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQIs----------  266 (668)
T KOG0611|consen  205 DKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQIS----------  266 (668)
T ss_pred             cccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHhh----------
Confidence            4332   344699999999999999988 678999999999999999999986543     111222211          


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                          .+.|.....+....-||+|||-.||++|-|+.+|....
T Consensus       267 ----~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  267 ----RGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ----cccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                11111111334456699999999999999999998765

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.6e-41  Score=325.96  Aligned_cols=241  Identities=22%  Similarity=0.276  Sum_probs=193.3

Q ss_pred             cccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCC
Q 040532          121 NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      +.||+|+||.||++... +|+.||+|++...   .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999965 4889999998753   2334556788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccc
Q 040532          197 SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  276 (436)
Q Consensus       197 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  276 (436)
                      +|..++...   ..+++.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++.......  ...
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            998887543   24789999999999999999999998   9999999999999999999999999987532211  112


Q ss_pred             ccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccc
Q 040532          277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYS  356 (436)
Q Consensus       277 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (436)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..     ..........        ...+..  
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~~--------~~~p~~--  217 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEE--------IRFPRT--  217 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCC--------CCCCCC--
Confidence            2346899999999999999999999999999999999999998543211     1111111110        011111  


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          357 SKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       357 ~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                         .+..+.+++.+||+.||++||     ++.++++
T Consensus       218 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         218 ---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ---CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence               345678999999999999998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.6e-40  Score=319.29  Aligned_cols=201  Identities=27%  Similarity=0.357  Sum_probs=174.1

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ..++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|++++++++||||++++++|.+++..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            3578999999999999999999976 4778999988754 3344567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|.+++...   ..+++.....++.+++.||.|||+.+  +++|+||||+|||+++++.+||+|||++......
T Consensus        83 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          83 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            999999999998543   24788899999999999999999753  3999999999999999999999999998754322


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY  322 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~  322 (436)
                          ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                122346889999999999888999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.9e-40  Score=313.30  Aligned_cols=264  Identities=24%  Similarity=0.384  Sum_probs=209.6

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-----CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe-CC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-----GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCID-KD  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~  184 (436)
                      ...++|++.+.||+|+||.||+|.+.+     +..|++|++... .......+.+|+.++++++|||++++++++.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            345788899999999999999999765     678999998754 34456778899999999999999999998876 46


Q ss_pred             ccEEEEeecCCCChhhhhcCCCcc-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEe
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKR-----ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  259 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~  259 (436)
                      ..++++||+++++|.+++......     ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998543222     46889999999999999999999988   9999999999999999999999


Q ss_pred             eccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhh
Q 040532          260 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWT  338 (436)
Q Consensus       260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  338 (436)
                      |||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||.....  ....    ....
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~----~~~~  233 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMA----AYLK  233 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHH----HHHH
Confidence            9999986543332222222345678999999998889999999999999999999 9999854221  1111    1111


Q ss_pred             cCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          339 SNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      .....      ...     ..++..+.+++.+||+.+|++||++.++++.|+++.++
T Consensus       234 ~~~~~------~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         234 DGYRL------AQP-----INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             cCCCC------CCC-----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            11100      000     01345688999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-40  Score=314.65  Aligned_cols=257  Identities=30%  Similarity=0.458  Sum_probs=203.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEe-----cCCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVL-----RKGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..|++.+.||+|+||.||+|..     ..+..+++|.+... .......+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999984     23678999999754 33445678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCC--------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC
Q 040532          189 IYEYMPNKSLDFFLFDPT--------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  254 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~  254 (436)
                      ||||+++++|.+++....              ....+++.....++.|++.||+|||+.+   ++|+||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999884221              1234788889999999999999999988   99999999999999999


Q ss_pred             CeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHH
Q 040532          255 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYV  333 (436)
Q Consensus       255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  333 (436)
                      .+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||.....      ..+
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------~~~  235 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------QEV  235 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HHH
Confidence            999999999986543332222233346678999999988889999999999999999998 8888743221      011


Q ss_pred             HHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      ...........      ...     ..+..+.+++.+|++.+|++||++.++.+.|..
T Consensus       236 ~~~~~~~~~~~------~~~-----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 IEMVRKRQLLP------CSE-----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHcCCcCC------CCC-----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11111111110      111     134568889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.2e-40  Score=316.12  Aligned_cols=263  Identities=22%  Similarity=0.307  Sum_probs=196.6

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999975 48899999987442 22235678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++ +|..++....  ..+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-  157 (288)
T cd07871          85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-  157 (288)
T ss_pred             CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence            985 7877775432  34788899999999999999999988   9999999999999999999999999997643222 


Q ss_pred             ccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC-----------
Q 040532          273 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN-----------  340 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------  340 (436)
                       .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......  .............           
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--EELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhccccc
Confidence             11223467899999998875 56899999999999999999999998543211  1111111111000           


Q ss_pred             -CcceeccCCcccc--ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 -RTLELIDDPVLED--EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 -~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       .......+.....  ............+++.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             0000000000000  0000112346789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=310.99  Aligned_cols=256  Identities=26%  Similarity=0.413  Sum_probs=201.3

Q ss_pred             CCCCcccCCCCceeEEEEEecC----CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc-----
Q 040532          117 FSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-----  185 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  185 (436)
                      |++.+.||+|+||.||+|.+..    +..||+|++...  .......+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5677899999999999998653    367999998753  34445788999999999999999999998876554     


Q ss_pred             -cEEEEeecCCCChhhhhcCC---CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeec
Q 040532          186 -KILIYEYMPNKSLDFFLFDP---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  261 (436)
Q Consensus       186 -~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~Df  261 (436)
                       .++++||+++|+|..++...   .....+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             68999999999999887432   22345889999999999999999999988   999999999999999999999999


Q ss_pred             cCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      |+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....  ...   .... ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~---~~~~-~~~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEI---YDYL-RHG  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHH---HHHH-HcC
Confidence            99987654332222222345678999999988889999999999999999999 8888743221  111   1111 111


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      ....      .+     ...+..+.+++.+||+.||++||++.|+++.|+++
T Consensus       232 ~~~~------~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 NRLK------QP-----EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCC------CC-----cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1110      11     11445789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-40  Score=313.93  Aligned_cols=268  Identities=29%  Similarity=0.389  Sum_probs=200.3

Q ss_pred             CCCCcccCCCCceeEEEEEe-----cCCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--CccEE
Q 040532          117 FSDTNKLGEGGFGPVYKGVL-----RKGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKIL  188 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  188 (436)
                      |+..+.||+|+||+||++..     .++..||+|.+.... ......+.+|++++++++||||+++.+++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988653     347789999997643 33456788999999999999999999988764  35789


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      +|||+++++|.+++...    .+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++....
T Consensus        86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999999999988542    3899999999999999999999988   9999999999999999999999999998654


Q ss_pred             CCCccc-ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||+||..|+......-.....................
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            322111 1112245667999999988889999999999999999999999975432211111000000000000000111


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                      .......  ....+..+.+++.+||+.+|++||+++++++.|+++.
T Consensus       239 ~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMRLPC--PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCCCCC--CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1000000  1114467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.5e-41  Score=324.37  Aligned_cols=262  Identities=20%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC-----ccE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKI  187 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  187 (436)
                      +|++.+.||+|+||.||+|... +|+.||+|++...  .......+.+|+.++++++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999965 4889999998643  2233456889999999999999999999886433     469


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||++ ++|..++...   ..+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 6787777543   24889999999999999999999998   999999999999999999999999999764


Q ss_pred             CCCCc-ccccccccccCCccchhhhcc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc-----
Q 040532          268 GGNEL-QANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS-----  339 (436)
Q Consensus       268 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  339 (436)
                      ..... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....  .............     
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPET  231 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHH
Confidence            32211 112233578999999999876  6789999999999999999999999854321  1111111111000     


Q ss_pred             ------CC---cceeccC---CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          340 ------NR---TLELIDD---PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       340 ------~~---~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                            ..   ....+..   ........  .....+.+++.+||+.||++||+++|+++.
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFP--NADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcC--CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                  00   0000000   00000001  123467899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.7e-40  Score=313.08  Aligned_cols=265  Identities=27%  Similarity=0.404  Sum_probs=205.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-----------------CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-----------------GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVR  175 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  175 (436)
                      .++|++.+.||+|+||.||+|....                 +..||+|.+.... ....+.+.+|+.++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4678999999999999999998643                 2458999987653 445678899999999999999999


Q ss_pred             EeeEEEeCCccEEEEeecCCCChhhhhcCCC--------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCC
Q 040532          176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  247 (436)
Q Consensus       176 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~N  247 (436)
                      +++++..++..++++||+++++|..++....        ....+++...+.++.|++.||+|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986533        1235889999999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCC
Q 040532          248 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTD  325 (436)
Q Consensus       248 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~p~~~~~~~  325 (436)
                      |++++++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++  |..||....  
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence            9999999999999999986544333333334456788999999998889999999999999999998  566664322  


Q ss_pred             CcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          326 SLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      .......................        ....+..+.+++.+||+.+|++||++.|+++.|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPR--------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             hHHHHHHHHhccccccccccCCC--------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            11111111111111111110100        01134578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.1e-42  Score=326.02  Aligned_cols=251  Identities=22%  Similarity=0.352  Sum_probs=210.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc-cEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-KILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  190 (436)
                      ++|..++++|+|+||.++..+++. ++.+++|.+.-.  ++...+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            578889999999999999998764 778999998643  34445678899999999999999999999999888 89999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      +||+||++.+.+.+.+ +..+++.....|+.|++.|+.|||+..   |+|||||+.||+++.++.+||+|||+|+.....
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999987644 556899999999999999999999877   999999999999999999999999999987654


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      .  ......+||+.||.||++.+.+|..|+|+|||||++|||++-+++|...+     +...+.......      -.+.
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----m~~Li~ki~~~~------~~Pl  226 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----MSELILKINRGL------YSPL  226 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----hHHHHHHHhhcc------CCCC
Confidence            4  23344689999999999999999999999999999999999999986543     222222222111      1111


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                       +     ...+.++..++..|++.+|..||++.+++..
T Consensus       227 -p-----~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  227 -P-----SMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -C-----ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             1     1255678899999999999999999999876

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.5e-40  Score=314.20  Aligned_cols=259  Identities=29%  Similarity=0.433  Sum_probs=204.5

Q ss_pred             CCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      +|++.+.||+|+||.||+|....      ...+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47788999999999999998532      3568999887553 3445678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCC---------------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCC
Q 040532          189 IYEYMPNKSLDFFLFDPT---------------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  247 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~N  247 (436)
                      ++||+++++|.+++....                     ....+++...+.++.|++.||+|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999998875321                     1235788999999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 040532          248 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  326 (436)
Q Consensus       248 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~  326 (436)
                      |++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999976543322222223345678999999988889999999999999999998 99887432211 


Q ss_pred             cchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                           .++........      .....     ..+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus       237 -----~~~~~~~~~~~------~~~~~-----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 -----RLFNLLKTGYR------MERPE-----NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -----HHHHHHhCCCC------CCCCC-----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                 11121111110      00011     133568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.8e-41  Score=338.44  Aligned_cols=259  Identities=21%  Similarity=0.271  Sum_probs=205.8

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC--
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--  184 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  184 (436)
                      .....++|++.+.||+|+||+||+|... +|+.||+|++...  +......+.+|+..+..++|+|++++.+.+...+  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            4455679999999999999999999864 5899999998653  3455667889999999999999999988775432  


Q ss_pred             ------ccEEEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeE
Q 040532          185 ------EKILIYEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  257 (436)
Q Consensus       185 ------~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~k  257 (436)
                            ..++||||+++|+|.+++... .....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence                  257999999999999988643 22346889999999999999999999988   99999999999999999999


Q ss_pred             EeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh
Q 040532          258 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      |+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....     .........
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~  258 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTL  258 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHh
Confidence            999999987654332223344579999999999999999999999999999999999999985322     111222211


Q ss_pred             hcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          338 TSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ... .     .+ .+.     ..+..+.+++.+||+.+|++||++.++++.
T Consensus       259 ~~~-~-----~~-~~~-----~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        259 AGR-Y-----DP-LPP-----SISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             cCC-C-----CC-CCC-----CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            111 0     00 111     134578899999999999999999998763

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.2e-40  Score=323.58  Aligned_cols=250  Identities=27%  Similarity=0.399  Sum_probs=195.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ...+|+..+.||+|+||+||+|.+. +|+.||+|++.... ......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            3456788899999999999999975 48999999996543 334567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|....       ..++.....++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||++......
T Consensus       152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            999999985432       2456777889999999999999998   999999999999999999999999999865432


Q ss_pred             CcccccccccccCCccchhhhcc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          271 ELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ..  ......||..|+|||.+..     ...+.++|||||||++|||++|+.||......  ++...........     
T Consensus       222 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~-----  292 (353)
T PLN00034        222 MD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICMSQ-----  292 (353)
T ss_pred             cc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhccC-----
Confidence            11  1223478999999998753     23456899999999999999999998632211  1111111110000     


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        .....     ......+.+++.+||+.||++||++.|+++.
T Consensus       293 --~~~~~-----~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 --PPEAP-----ATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --CCCCC-----CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00011     1134578999999999999999999999874

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.9e-40  Score=310.48  Aligned_cols=256  Identities=29%  Similarity=0.430  Sum_probs=204.8

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ...|++.+.||+|++|.||+|.+++ ++.||+|.+... ......+.+|+.++++++||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            3457788999999999999999764 788999998754 33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          84 MTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999885432 335789999999999999999999988   99999999999999999999999999976543322


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      . ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....     ... ........      ....
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~-~~~~~~~~------~~~~  226 (263)
T cd05052         160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQV-YELLEKGY------RMER  226 (263)
T ss_pred             e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHH-HHHHHCCC------CCCC
Confidence            1 1112234568999999998899999999999999999998 8888753221     111 11111110      0011


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      ..     ..+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       227 ~~-----~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         227 PE-----GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CC-----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11     1345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.8e-40  Score=312.20  Aligned_cols=257  Identities=28%  Similarity=0.398  Sum_probs=201.3

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CC----EEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GD----EIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ++|+..+.||+|+||+||+|.+.. |+    .+++|.+.... .....++..|+..+.+++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            467888999999999999999743 43    47888886443 334567888888999999999999999875 456789


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ++||+++|+|.+++....  ..+++.....++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            999999999999986432  34889999999999999999999988   9999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ............++..|+|||.+.++.++.++||||||+++|||++ |+.||......  .    ..+.........   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~----~~~~~~~~~~~~---  231 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--E----VPDLLEKGERLA---  231 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--H----HHHHHHCCCcCC---
Confidence            3332222233456778999999998899999999999999999998 99887533211  1    111111111110   


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      .   ...     +...+.+++.+|+..+|++||++.|+++.|..+..
T Consensus       232 ~---~~~-----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         232 Q---PQI-----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             C---CCC-----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            0   000     23457889999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-40  Score=314.94  Aligned_cols=257  Identities=31%  Similarity=0.438  Sum_probs=202.5

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRSE-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ..|++.+.||+|+||.||+|...+      +..||+|++..... ...+.+.+|..++.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            346778899999999999998642      46799999975533 33467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCC-------------CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC
Q 040532          188 LIYEYMPNKSLDFFLFDP-------------TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  254 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~  254 (436)
                      +++||+++++|..++...             .....+++.....++.|++.||+|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999887421             11234788889999999999999999988   99999999999999999


Q ss_pred             CeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHH
Q 040532          255 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYV  333 (436)
Q Consensus       255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  333 (436)
                      .+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||.....     .++.
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~  236 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDVI  236 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence            999999999876543332222233456788999999998889999999999999999998 7778753221     1111


Q ss_pred             HHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      .. .......      ....     .++..+.+++.+||+.+|++||++++++..|+.
T Consensus       237 ~~-i~~~~~~------~~~~-----~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EM-IRNRQVL------PCPD-----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HH-HHcCCcC------CCCC-----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11 1111110      0111     144568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.8e-40  Score=309.48  Aligned_cols=252  Identities=30%  Similarity=0.434  Sum_probs=201.3

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      ++|++.+.||+|+||+||+|.+.++..+|+|.+.... ...+.+.+|+.++.+++||||+++++++.+.+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4577889999999999999998767779999987543 233678999999999999999999999999889999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +|+|.+++.....  .+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||.++........ 
T Consensus        83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            9999998864322  4889999999999999999999988   999999999999999999999999998765433221 


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......     ...... ......     . ...
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~-~~~~~~-----~-~~~  224 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVEKV-SQGLRL-----Y-RPH  224 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHH-hcCCCC-----C-CCC
Confidence            1112245678999999998889999999999999999999 99887543211     111111 111100     0 000


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      .     .+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       225 ~-----~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 L-----ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             C-----CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            1     2357889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.9e-40  Score=311.77  Aligned_cols=265  Identities=27%  Similarity=0.423  Sum_probs=202.8

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-----------------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-----------------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVR  175 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~  175 (436)
                      .++|++.+.||+|+||.||++...                 ++..+|+|.+... .......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356899999999999999998643                 1346899999754 3444568899999999999999999


Q ss_pred             EeeEEEeCCccEEEEeecCCCChhhhhcCCCc--------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCC
Q 040532          176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK--------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  247 (436)
Q Consensus       176 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~N  247 (436)
                      +++++...+..+++|||+++++|.+++.....        ...+++.....++.|++.||+|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99999999999999999999999998864321        234778889999999999999999998   9999999999


Q ss_pred             EEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCC
Q 040532          248 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTD  325 (436)
Q Consensus       248 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~p~~~~~~~  325 (436)
                      |++++++.++|+|||++................++..|+|||...++.++.++|+|||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999976543322222222345678999999888889999999999999999998  66776432211


Q ss_pred             CcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          326 SLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                        .....................   .     ..++..+.+++.+||+.||++||++.+|++.|++
T Consensus       241 --~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 --QVIENTGEFFRDQGRQVYLPK---P-----ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             --HHHHHHHHHHhhccccccCCC---C-----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence              111111111111110000000   0     1134578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.2e-40  Score=307.88  Aligned_cols=248  Identities=27%  Similarity=0.373  Sum_probs=195.9

Q ss_pred             cccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          121 NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      +.||+|+||.||+|.+. +++.+|+|.+... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999975 5888999988654 344456789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccccc
Q 040532          199 DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  278 (436)
Q Consensus       199 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  278 (436)
                      .+++...  ...+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            9998543  234789999999999999999999988   99999999999999999999999999875443221111111


Q ss_pred             ccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccch
Q 040532          279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSS  357 (436)
Q Consensus       279 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (436)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..||......  .    .........      ......    
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~----~~~~~~~~~------~~~~~~----  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--Q----TREAIEQGV------RLPCPE----  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--H----HHHHHHcCC------CCCCcc----
Confidence            123457999999998889999999999999999998 88887432211  0    111111110      001111    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          358 KQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       358 ~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                       ..+..+.+++.+|++.+|++||++.++.+.|+
T Consensus       220 -~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 -LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             -cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence             13457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.7e-40  Score=309.87  Aligned_cols=255  Identities=26%  Similarity=0.439  Sum_probs=198.2

Q ss_pred             CCCcccCCCCceeEEEEEecCCC---EEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC------Ccc
Q 040532          118 SDTNKLGEGGFGPVYKGVLRKGD---EIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------DEK  186 (436)
Q Consensus       118 ~~~~~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  186 (436)
                      .+.+.||+|+||.||+|++..+.   .+|+|.+...  +....+.+.+|+.+++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            45688999999999999976532   5899988653  345567889999999999999999999987542      245


Q ss_pred             EEEEeecCCCChhhhhcCC---CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          187 ILIYEYMPNKSLDFFLFDP---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      +++|||+++|+|..++...   .....+++.....++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999998876321   22345889999999999999999999988   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      ++...............+++.|+|||...+..++.++||||||+++|||++ |+.||.....  ..    ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~----~~~~~~~~~~  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SE----IYDYLRQGNR  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HH----HHHHHHcCCC
Confidence            987644332222222346678999999998899999999999999999999 7888753211  11    1121222111


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      ..      ...     ..+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       233 ~~------~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 LK------QPP-----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC------CCC-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10      011     1345688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-40  Score=313.04  Aligned_cols=261  Identities=24%  Similarity=0.346  Sum_probs=192.4

Q ss_pred             cCCCCCcccCCCCceeEEEEEec--CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHc---CCCceeEEeeEEEe-----
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR--KGDEIAVKRLSGRS--EQGLREMKNEASVIAKV---QHKNLVRLLGCCID-----  182 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----  182 (436)
                      ++|++.+.||+|+||.||+|.+.  +|..||+|.+....  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            46889999999999999999863  36789999886432  22234556677777665   69999999999863     


Q ss_pred             CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                      ....++||||++ ++|..++.... ...+++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            345789999997 58888775432 234789999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      ++......   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  .+....+.........
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~--~~~~~~i~~~~~~~~~  230 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPGE  230 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCCh
Confidence            99865433   122334689999999999988999999999999999999999999864321  1111111111110000


Q ss_pred             ce----------eccC---CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 LE----------LIDD---PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 ~~----------~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..          ....   .......  ......+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFV--TDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHc--cCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00          0000   0000000  113456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.1e-40  Score=308.65  Aligned_cols=259  Identities=21%  Similarity=0.355  Sum_probs=206.7

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...   .......+.+|+.+++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47889999999999999999965 5889999987542   3344567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          191 EYMPNKSLDFFLFDPT-KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      ||+++++|..++.... +...++......++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999988875322 2345788899999999999999999988   99999999999999999999999999887543


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|||++|+.||.....   +...+.... ....     ..+
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~-~~~~-----~~~  227 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKI-EQCD-----YPP  227 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHH-hcCC-----CCC
Confidence            221  11234678899999999988899999999999999999999999743221   111111111 1100     011


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      .     .....+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       228 ~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 L-----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             C-----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            1     1112445789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-40  Score=324.46  Aligned_cols=262  Identities=17%  Similarity=0.187  Sum_probs=196.0

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ...++|++.+.||+|+||.||++.+. .++.||+|....      ..+.+|+.++++++||||+++++++......++|+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            34468999999999999999999975 478899997532      34678999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      |++. ++|..++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       163 e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        163 PRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             ecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            9995 6777776443   24789999999999999999999998   999999999999999999999999999753321


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC-----cchhHHHHHHhhc-CCc--
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-----LNLLGYVWDLWTS-NRT--  342 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~-~~~--  342 (436)
                      . ........||+.|+|||++.+..++.++|||||||++|||++|+.|+-......     ......+...... ...  
T Consensus       236 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        236 N-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             c-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            1 112233579999999999999999999999999999999999998763221100     0011111110000 000  


Q ss_pred             -------c----e----eccCCc-cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 -------L----E----LIDDPV-LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 -------~----~----~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                             .    .    ....+. ..........+..+.+++.+||+.||++|||+.|+++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                   0    0    000000 0000011124557889999999999999999999985

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.9e-40  Score=311.68  Aligned_cols=259  Identities=31%  Similarity=0.436  Sum_probs=203.1

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      .+++|++.+.||+|++|.||+|.+..      +..|++|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35678999999999999999999753      5678999887543 3345678999999999999999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCc----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC---CeEE
Q 040532          186 KILIYEYMPNKSLDFFLFDPTK----RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPKI  258 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~---~~kl  258 (436)
                      .++||||+++++|.+++.....    ...+++.....++.|++.||+|||+.+   ++|+||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            9999999999999998854321    235889999999999999999999998   99999999999998654   5999


Q ss_pred             eeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHh
Q 040532          259 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      +|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......  ..    ....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~----~~~~  234 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EV----MEFV  234 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHH
Confidence            99999987643332222222234568999999999999999999999999999997 88888543211  11    1111


Q ss_pred             hcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          338 TSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      ......      ....     ..+..+.+++.+|++.+|++||++.+|++.|.+
T Consensus       235 ~~~~~~------~~~~-----~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         235 TGGGRL------DPPK-----GCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HcCCcC------CCCC-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            111100      0011     134568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-40  Score=328.47  Aligned_cols=253  Identities=23%  Similarity=0.342  Sum_probs=195.2

Q ss_pred             CCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .|+..+.||+|+||+||+|.... ++.||+|++...   .......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            57888999999999999998654 789999999653   23345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++|+|.+++....   .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999885432   4788888999999999999999988   9999999999999999999999999975431100


Q ss_pred             c---------------------------------------------ccccccccccCCccchhhhccCCCCcccchhhHH
Q 040532          272 L---------------------------------------------QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFG  306 (436)
Q Consensus       272 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG  306 (436)
                      .                                             .......+||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001234699999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHh--cccCCCCCCCCHHH
Q 040532          307 VLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALL--CVQESADDRPTMND  384 (436)
Q Consensus       307 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RPs~~e  384 (436)
                      |++|||++|+.||........     ............      .+..   ...+.++.+++.+  |+..++..||++.+
T Consensus       236 ~il~elltG~~Pf~~~~~~~~-----~~~i~~~~~~~~------~~~~---~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTET-----QLKVINWENTLH------IPPQ---VKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHH-----HHHHHccccccC------CCCC---CCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            999999999999864332110     011111010000      0100   0133467778877  55666677999999


Q ss_pred             HHHH
Q 040532          385 VVSM  388 (436)
Q Consensus       385 v~~~  388 (436)
                      +++.
T Consensus       302 ~l~h  305 (381)
T cd05626         302 IKAH  305 (381)
T ss_pred             HhcC
Confidence            9874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.2e-40  Score=318.46  Aligned_cols=267  Identities=26%  Similarity=0.368  Sum_probs=208.5

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC--------CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK--------GDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCI  181 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  181 (436)
                      ....+|++.+.||+|+||.||+|....        +..||+|.+... .....+.+.+|+.+++++ +||||+++++++.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            344578999999999999999997421        236899988754 344567889999999999 8999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCE
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPT-------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  248 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NI  248 (436)
                      ..+..++++||+++|+|.+++....             ....+++.....++.|++.||+|||+.+   ++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence            9999999999999999999985421             1234788899999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCc
Q 040532          249 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSL  327 (436)
Q Consensus       249 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  327 (436)
                      ++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....    
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----  241 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----  241 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----
Confidence            999999999999999986543322222222234567999999999999999999999999999998 788874322    


Q ss_pred             chhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          328 NLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                       ..+.... ........      ...     ..+..+.+++.+|++.+|++||++.|+++.|+++......
T Consensus       242 -~~~~~~~-~~~~~~~~------~~~-----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~  299 (334)
T cd05100         242 -VEELFKL-LKEGHRMD------KPA-----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST  299 (334)
T ss_pred             -HHHHHHH-HHcCCCCC------CCC-----CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence             1111111 11111100      000     1345688999999999999999999999999998865443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-40  Score=322.24  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=198.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||+|... +|+.||+|++...   .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999976 4889999999643   2233456789999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++....   .+++.....++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||++......
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999886432   4889999999999999999999998   999999999999999999999999998754321


Q ss_pred             Cccc------------------------------------ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh
Q 040532          271 ELQA------------------------------------NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS  314 (436)
Q Consensus       271 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt  314 (436)
                      ....                                    .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0012368999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 040532          315 GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT---MNDVVS  387 (436)
Q Consensus       315 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~ev~~  387 (436)
                      |..||.....     ................      +...   ..+..+.+++.+|+. +|.+|++   +.|+++
T Consensus       235 G~~Pf~~~~~-----~~~~~~i~~~~~~~~~------~~~~---~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNP-----QETYRKIINWKETLQF------PDEV---PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCH-----HHHHHHHHcCCCccCC------CCCC---CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999854321     1111111111111110      0000   134567889999996 8999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.2e-40  Score=311.97  Aligned_cols=258  Identities=29%  Similarity=0.414  Sum_probs=204.7

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ..+|+..+.||+|+||.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++.+.+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            356778899999999999999742      25678999988777666788999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCc------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC
Q 040532          188 LIYEYMPNKSLDFFLFDPTK------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  255 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~  255 (436)
                      ++|||+++++|.+++.....            ...+++..+..++.|++.|++|||+.+   ++|+||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            99999999999998854321            134788999999999999999999988   999999999999999999


Q ss_pred             eEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHH
Q 040532          256 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVW  334 (436)
Q Consensus       256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  334 (436)
                      +||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |+.||......     +...
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~  235 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-----EAIE  235 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-----HHHH
Confidence            99999999976543332222223345678999999999999999999999999999998 88887432211     1111


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      .. ......      ....     .++..+.+++.+||+.||.+||++.||++.|+.
T Consensus       236 ~~-~~~~~~------~~~~-----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 CI-TQGREL------ERPR-----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HH-HcCccC------CCCC-----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            11 111000      0001     134568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.6e-40  Score=312.92  Aligned_cols=262  Identities=27%  Similarity=0.411  Sum_probs=205.2

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ...++|++.+.||+|+||.||+|..++      +..||+|.+.... ......+.+|+..++.++||||+++++++.+.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            456789999999999999999997542      4579999987543 333456788999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCC-------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeE
Q 040532          185 EKILIYEYMPNKSLDFFLFDPT-------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  257 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~k  257 (436)
                      ..++||||+++|+|.+++....       ......+.....++.|++.||.|||+.+   ++||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            9999999999999999985421       1234567788899999999999999988   99999999999999999999


Q ss_pred             EeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHH
Q 040532          258 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      |+|||+++...............++..|+|||.+.++.++.++|+|||||++|||++ |..||.....     .+.....
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~  234 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKFV  234 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH
Confidence            999999876543332222222345678999999998899999999999999999999 6778743221     1111111


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                      .. .....      ..     ...+..+.+++.+|++.+|++||++.++++.|++..
T Consensus       235 ~~-~~~~~------~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 MD-GGYLD------QP-----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             Hc-CCCCC------CC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11 11000      00     012457899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.4e-40  Score=325.75  Aligned_cols=265  Identities=23%  Similarity=0.356  Sum_probs=206.7

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcC-CCceeEEeeEEE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQ-HKNLVRLLGCCI  181 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  181 (436)
                      .+...++|.+.+.||+|+||.||+|.++      .+..||+|++.... ....+.+.+|+.+|.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3445567888899999999999999864      24579999997542 333457889999999997 999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCC-------------------------------------------------------
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPT-------------------------------------------------------  206 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  206 (436)
                      ..+..++||||+++|+|.++++...                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999885421                                                       


Q ss_pred             ----------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 040532          207 ----------------------------------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS  246 (436)
Q Consensus       207 ----------------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~  246 (436)
                                                              ....+++.....++.|++.||+|||+.+   ++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                    1124677788899999999999999887   999999999


Q ss_pred             CEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 040532          247 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTD  325 (436)
Q Consensus       247 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~  325 (436)
                      |||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986533221112223356788999999998889999999999999999998 88887543211


Q ss_pred             CcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          326 SLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                           .............      ..+.     ..+..+.+++.+||+.+|.+||+++|+++.|+++.
T Consensus       349 -----~~~~~~~~~~~~~------~~p~-----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 -----EQFYNAIKRGYRM------AKPA-----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -----HHHHHHHHcCCCC------CCCC-----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                 1111111111100      0010     13457899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3e-40  Score=315.88  Aligned_cols=264  Identities=25%  Similarity=0.370  Sum_probs=208.6

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec--------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR--------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCI  181 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  181 (436)
                      ...++|++.+.||+|+||.||+|...        ++..||+|.+... .....+.+.+|+.++..+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            44677888999999999999999741        2457999998754 344567889999999999 8999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCE
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPT-------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  248 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NI  248 (436)
                      .....+++|||+++|+|.+++....             ....+++..+..++.|++.||+|||+.+   ++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            9999999999999999999986432             1235788889999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCc
Q 040532          249 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSL  327 (436)
Q Consensus       249 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  327 (436)
                      ++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....    
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----  244 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----  244 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence            999999999999999987654332222223345678999999998889999999999999999998 777764321    


Q ss_pred             chhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          328 NLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                       ...+... ........      ..     ..++..+.+++.+||+.+|++||++.|+++.|+++...
T Consensus       245 -~~~~~~~-~~~~~~~~------~~-----~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         245 -VEELFKL-LKEGHRMD------KP-----ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             -HHHHHHH-HHcCCcCC------CC-----CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence             1111111 11111100      00     11445788999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-41  Score=306.83  Aligned_cols=265  Identities=22%  Similarity=0.328  Sum_probs=204.6

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCC--CChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe-----C
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSG--RSEQGLREMKNEASVIAKVQHKNLVRLLGCCID-----K  183 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~  183 (436)
                      .....|...+.||+|+||.|+.+.+. +|+.||+|++..  ......+...+|+.+|+.++|+||+.+.+.+..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            34556666789999999999999965 489999999973  355567788999999999999999999999875     3


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      +..|+|+|+| +.+|...++...   .++......+++|+++||.|+|+.+   ++||||||+|+|++.+..+||+|||+
T Consensus        99 ~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence            4679999999 668888885433   3888888999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHH-------
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD-------  335 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------  335 (436)
                      |+...........+..+.|..|.|||++.. ..|+.+.||||.|||+.||++|++-|...+.-  +....+..       
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLILELLGTPSE  249 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHHHHhcCCCCH
Confidence            998765423333456688999999999874 67999999999999999999999998654321  11111111       


Q ss_pred             ----HhhcCCcceecc------CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          336 ----LWTSNRTLELID------DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       336 ----~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                          ...++.....+.      ...+...++  +......+++.+||..||.+|+|++|.++
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp--~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFP--NANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcC--CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                111111111111      111111122  24456789999999999999999999886

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.4e-40  Score=298.56  Aligned_cols=278  Identities=23%  Similarity=0.321  Sum_probs=205.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhh--HHHHHHHHHHHHHcCCCceeEEeeEEEeC--CccE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQG--LREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKI  187 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  187 (436)
                      .-+.|+.++.|++|+||.||+|+++. ++.||+|+++...+..  --.-.+|+.+|.+++|||||.+..+....  +..|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            34678999999999999999999765 7789999998653221  12347999999999999999999887643  5689


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +|||||+. +|..++..-.  .++...+...++.|+++|++|||...   |+|||||++|+|++..|.+||+|||+|+.+
T Consensus       154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence            99999976 5666664433  35788899999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc---c
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT---L  343 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~  343 (436)
                      +...  ......+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++-|....  +.+..+.+......+..   .
T Consensus       228 gsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s--E~dQl~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  228 GSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS--EIDQLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             cCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc--hHHHHHHHHHHhCCCccccCC
Confidence            7542  233445789999999999975 59999999999999999999998875432  22222222222221110   0


Q ss_pred             ee--------c---cC--CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCC
Q 040532          344 EL--------I---DD--PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP  402 (436)
Q Consensus       344 ~~--------~---~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~  402 (436)
                      ..        +   ..  ..+...+.....+..-.+++...|..||.+|.|++|.++.  +...+.|-|..|
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P  373 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDP  373 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCCh
Confidence            00        0   00  0011111111133556789999999999999999998763  344444444333

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=310.79  Aligned_cols=259  Identities=27%  Similarity=0.430  Sum_probs=205.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      ..++|++.+.||+|+||.||+|...+      +..||+|.+.... ......+.+|+.++..++||||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            34678889999999999999998653      3679999987553 3445678899999999999999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCC-------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEE
Q 040532          186 KILIYEYMPNKSLDFFLFDPT-------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  258 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl  258 (436)
                      .++||||+++++|..++....       ....+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            999999999999999885422       1234788899999999999999999988   999999999999999999999


Q ss_pred             eeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHh
Q 040532          259 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++|||+| |+.||......  ..    ....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~----~~~~  234 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EV----LKFV  234 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HH----HHHH
Confidence            99999876544333222333456788999999988889999999999999999998 88887532211  11    1111


Q ss_pred             hcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          338 TSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      ......      ..+..     .+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       235 ~~~~~~------~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 IDGGHL------DLPEN-----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             hcCCCC------CCCCC-----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            111111      01111     24578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.1e-40  Score=309.77  Aligned_cols=260  Identities=27%  Similarity=0.410  Sum_probs=203.4

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCC----EEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGD----EIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .++|+..+.||+|+||+||+|.+. +|+    .||+|.+... .......+.+|+.++..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            456888899999999999999854 344    4899998754 34445678899999999999999999999875 4578


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +++||+++|+|.+++....  ..+++.....++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            9999999999999986532  34889999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .............++..|+|||...+..++.++|||||||++|||++ |..||.....  ....    ..........  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~----~~~~~~~~~~--  231 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIP----DLLEKGERLP--  231 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH----HHHHCCCcCC--
Confidence            53322211222245678999999998899999999999999999998 8888753221  1111    1111111000  


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                          ..     ...+..+.+++.+||+.||++||++.++++.|++...+.
T Consensus       232 ----~~-----~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         232 ----QP-----PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ----CC-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                00     113456889999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.6e-40  Score=315.79  Aligned_cols=263  Identities=28%  Similarity=0.392  Sum_probs=206.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC--------CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK--------GDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCID  182 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  182 (436)
                      ..++|.+.+.||+|+||.||++....        +..+|+|.+... .......+.+|+.++..+ +||||+++++++..
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            34679999999999999999997531        346999999754 344456788999999999 79999999999999


Q ss_pred             CCccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEE
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDPTK-------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  249 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIl  249 (436)
                      .+..++||||+++|+|.+++.....             ...+++.+...++.|++.||+|||+.+   ++||||||+||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  172 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  172 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence            9999999999999999999864321             234888999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 040532          250 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLN  328 (436)
Q Consensus       250 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~  328 (436)
                      +++++.+||+|||++................++..|+|||.+.+..++.++|+|||||++|||++ |+.||....     
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-----  247 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----  247 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----
Confidence            99999999999999876543222121222234568999999998889999999999999999998 888874322     


Q ss_pred             hhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          329 LLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      ..+. ...........      ..     ...+..+.+++.+||+.+|++||++.++++.|+++.+.
T Consensus       248 ~~~~-~~~~~~~~~~~------~~-----~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         248 VEEL-FKLLKEGHRMD------KP-----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHH-HHHHHcCCCCC------CC-----CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            1111 11111111100      00     11345788899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-40  Score=321.30  Aligned_cols=241  Identities=24%  Similarity=0.305  Sum_probs=191.9

Q ss_pred             cccCCCCceeEEEEEec----CCCEEEEEEcCCC----ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          121 NKLGEGGFGPVYKGVLR----KGDEIAVKRLSGR----SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +.||+|+||.||++...    .++.||+|++...    .......+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999853    4788999998643    223345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++...   ..+.+.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            9999999888543   24678888889999999999999998   99999999999999999999999999875432221


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...........        ...+
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~~~~--------~~~~  220 (323)
T cd05584         156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKILKGK--------LNLP  220 (323)
T ss_pred             --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC--------CCCC
Confidence              12234789999999999988899999999999999999999999854321     11111111111        0011


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                      ..     ....+.+++.+||+.+|++||     ++.++++
T Consensus       221 ~~-----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         221 PY-----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CC-----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            11     234678999999999999999     7887766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=323.62  Aligned_cols=253  Identities=23%  Similarity=0.330  Sum_probs=202.3

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||+|... +|+.||+|++...   .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999976 5889999998743   1234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998654   34889999999999999999999988   999999999999999999999999999765432


Q ss_pred             C---------------------------cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 040532          271 E---------------------------LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  323 (436)
Q Consensus       271 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~  323 (436)
                      .                           .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0011223468999999999999999999999999999999999999986433


Q ss_pred             CCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 040532          324 TDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT-MNDVVSM  388 (436)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~ev~~~  388 (436)
                      .     ...............   .+....      .+..+.+++.+|++ +|.+||+ +.++++.
T Consensus       235 ~-----~~~~~~i~~~~~~~~---~p~~~~------~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 L-----QETYNKIINWKESLR---FPPDPP------VSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             H-----HHHHHHHhccCCccc---CCCCCC------CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            1     111111111001111   010000      34568889999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-40  Score=321.35  Aligned_cols=244  Identities=24%  Similarity=0.335  Sum_probs=191.4

Q ss_pred             CCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHH---HHcCCCceeEEeeEEEeCCccEEE
Q 040532          117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVI---AKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      |++.+.||+|+||.||+|.++ +|+.||+|++...   .....+.+.+|..++   ++++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999975 4889999999743   223345566666655   456899999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+++++|..++..    ..+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999888743    24899999999999999999999998   99999999999999999999999999864322


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ..  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.....     ...........        .
T Consensus       154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~~i~~~~--------~  218 (324)
T cd05589         154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFDSIVNDE--------V  218 (324)
T ss_pred             CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC--------C
Confidence            11  122345789999999999999999999999999999999999999854321     11111111111        1


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPT-----MNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~  387 (436)
                      ..+..     .+..+.+++.+||+.||++||+     +.++++
T Consensus       219 ~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 RYPRF-----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCC-----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            11111     3456788999999999999994     555554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-40  Score=306.17  Aligned_cols=252  Identities=29%  Similarity=0.413  Sum_probs=200.6

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      .+|++.+.||+|+||.||+|.++.+..+|+|.+..... ....+.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            45788899999999999999987777899999865422 23567889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +++|.+++.....  .+++.....++.|++.|++|||+.+   ++||||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          83 NGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999998864332  5789999999999999999999998   9999999999999999999999999987654322111


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                       .....++..|+|||.+.+..++.++|+||||+++|||++ |+.||......  .   ..... .....      ...+.
T Consensus       158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~---~~~~~-~~~~~------~~~~~  224 (256)
T cd05059         158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--E---VVESV-SAGYR------LYRPK  224 (256)
T ss_pred             -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--H---HHHHH-HcCCc------CCCCC
Confidence             111234457999999998899999999999999999999 78888543211  1   11111 11100      00011


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                           ..+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       225 -----~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         225 -----LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             -----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence                 13457899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.8e-39  Score=304.06  Aligned_cols=260  Identities=22%  Similarity=0.366  Sum_probs=208.8

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|++|.||+|... +|+.||+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999986 6899999988632   2334567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          191 EYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       191 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      ||+++++|..++... .....+++.....++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999888543 22345889999999999999999999988   99999999999999999999999999876543


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....   .+........ .....     .+
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~-~~~~~-----~~  227 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKI-EKCDY-----PP  227 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhh-hcCCC-----CC
Confidence            221  1222467889999999998889999999999999999999999974322   1222111111 11100     00


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                           .+....+..+.+++.+||..+|++||++.++++.|+++.
T Consensus       228 -----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         228 -----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 111124557889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.2e-40  Score=310.57  Aligned_cols=246  Identities=24%  Similarity=0.331  Sum_probs=193.1

Q ss_pred             cCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          123 LGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       123 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      ||+|+||+||++.+. +|+.+|+|.+....   ....+.+..|+.++++++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999975 58899999986432   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccc
Q 040532          199 DFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS  277 (436)
Q Consensus       199 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  277 (436)
                      ..++... .....+++.....++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8877432 23345899999999999999999999998   99999999999999999999999999976543221  122


Q ss_pred             cccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccch
Q 040532          278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSS  357 (436)
Q Consensus       278 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (436)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......... ..       .....     
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~-~~-------~~~~~-----  221 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRIL-ND-------SVTYP-----  221 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhc-cc-------CCCCc-----
Confidence            34689999999999999999999999999999999999999864322110 000000000 00       00011     


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          358 KQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       358 ~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                      ...+..+.+++.+||+.||++||     +++++++
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            11445788999999999999999     5666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.9e-41  Score=322.95  Aligned_cols=242  Identities=22%  Similarity=0.280  Sum_probs=192.8

Q ss_pred             cccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCC
Q 040532          121 NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      +.||+|+||.||++... +|..||+|.+...   .......+.+|+.++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999865 5889999998753   2334456788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          197 SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       197 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      +|..++...   ..+++.....++.|++.||.|||+ .+   ++||||||+|||+++++.+||+|||++.......  ..
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            998887543   248899999999999999999997 56   9999999999999999999999999987532211  11


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+     ... ......       ....+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~-~~i~~~-------~~~~p~~-  218 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLF-ELILME-------EIRFPRT-  218 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHH-HHHhcC-------CCCCCCC-
Confidence            22346899999999999999999999999999999999999998543211     111 111111       0011111 


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRP-----TMNDVVSM  388 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~~  388 (436)
                          ....+.+++.+||+.||++|+     ++.++++.
T Consensus       219 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         219 ----LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ----CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                344688899999999999996     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.2e-40  Score=341.63  Aligned_cols=263  Identities=21%  Similarity=0.281  Sum_probs=205.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||.||+|.+.. |+.||+|++...   .....+.+.+|+.++++++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            578899999999999999999754 889999998753   2333567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCC--------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          191 EYMPNKSLDFFLFDPT--------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                      ||+++++|.+++....        .....++.....++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885311        1223566778899999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCc----------------ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 040532          263 MARICGGNEL----------------QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  326 (436)
Q Consensus       263 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~  326 (436)
                      ++........                ........||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                001123469999999999999999999999999999999999999985422111


Q ss_pred             cchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhhcccc
Q 040532          327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP-TMNDVVSMLTNEAAA  395 (436)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~ev~~~L~~~~~~  395 (436)
                      ..     ..    ...   .......   .....+..+.+++.+|++.||++|| +++++.+.|+.....
T Consensus       239 i~-----~~----~~i---~~P~~~~---p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 IS-----YR----DVI---LSPIEVA---PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hh-----hh----hhc---cChhhcc---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            00     00    000   0000000   0112445688899999999999996 678888888887654

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.1e-40  Score=318.67  Aligned_cols=252  Identities=22%  Similarity=0.325  Sum_probs=199.9

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||++... +|+.||+|++...   .......+.+|+.+++.++||||+++.+++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999965 4889999999753   2234566889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++....  ..+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999986542  34889999999999999999999998   999999999999999999999999999876433


Q ss_pred             CcccccccccccCCccchhhhc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          271 ELQANTSRIVGTYGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ... ......||+.|+|||++.      +..++.++|||||||++|||++|+.||.....     ...............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~  229 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTYNNIMNFQRFLK  229 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHHHHHHcCCCccC
Confidence            221 222346899999999987      45678999999999999999999999854221     111122211111111


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ....         ...+..+.+++..|++ +|.+||++.++++
T Consensus       230 ~~~~---------~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         230 FPED---------PKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCC---------CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            1110         0134568889999998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.9e-39  Score=305.92  Aligned_cols=263  Identities=25%  Similarity=0.392  Sum_probs=202.1

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-----CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--Ccc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-----KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK  186 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  186 (436)
                      .+.|++.+.||+|+||.||++...     ++..||+|.+........+.+.+|++++++++||||+++.+++...  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            357888999999999999999742     4788999999877766678899999999999999999999987543  467


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++|+||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            89999999999999985432  34889999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCccc-ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCc----------chhHHHHH
Q 040532          267 CGGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL----------NLLGYVWD  335 (436)
Q Consensus       267 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~----------~~~~~~~~  335 (436)
                      ........ ......++..|+|||.+.+..++.++|+||||+++|||++|..++......-.          .......+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            64322111 11112234569999999988899999999999999999998876532211000          00000001


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      ......        ..+   .....+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       238 ~~~~~~--------~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNG--------RLP---APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCC--------cCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            110000        000   0111345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.3e-40  Score=305.21  Aligned_cols=254  Identities=30%  Similarity=0.465  Sum_probs=202.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      .++|++.+.||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            457889999999999999999988888899999976433 2357899999999999999999999875 46689999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++++|.+++.... ...+++..+..++.+++.||+|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999999986532 234789999999999999999999988   999999999999999999999999999875433221


Q ss_pred             cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                      . .....++..|+|||.+.+..++.++|+||||+++|||++ |..||.....  ..   ..... ....      ....+
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~---~~~~~-~~~~------~~~~~  225 (260)
T cd05070         159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--RE---VLEQV-ERGY------RMPCP  225 (260)
T ss_pred             c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HH---HHHHH-HcCC------CCCCC
Confidence            1 112235668999999988889999999999999999999 8888853221  11   11111 1110      00011


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                           ...+..+.+++.+|++.+|++|||+.++.+.|++
T Consensus       226 -----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         226 -----QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -----CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 1134568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.7e-40  Score=319.99  Aligned_cols=242  Identities=24%  Similarity=0.328  Sum_probs=192.2

Q ss_pred             cccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||.||+|.... ++.||+|++...   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999999764 789999998753   233345677888888876 799999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++....   .+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            99988885433   4788899999999999999999998   9999999999999999999999999987543222  11


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...........        ...+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~~~~~~i~~~~--------~~~p~~-  218 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----DDLFESILHDD--------VLYPVW-  218 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC--------CCCCCC-
Confidence            2334689999999999999999999999999999999999999864321     11111111111        001111 


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCC-------CHHHHHHH
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRP-------TMNDVVSM  388 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RP-------s~~ev~~~  388 (436)
                          .+..+.+++.+||+.||++||       ++.++++.
T Consensus       219 ----~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         219 ----LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             ----CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                234678899999999999999       77777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.3e-40  Score=306.69  Aligned_cols=255  Identities=23%  Similarity=0.360  Sum_probs=200.7

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++.+++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            457999999999999999999964 5788999999765544556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++....... 
T Consensus        88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06646          88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-  160 (267)
T ss_pred             CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence            9999999988543   34789999999999999999999988   9999999999999999999999999998654221 


Q ss_pred             ccccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          273 QANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                       .......++..|+|||.+.   ...++.++|+|||||++|||++|+.|+........        .....  ......+
T Consensus       161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--------~~~~~--~~~~~~~  229 (267)
T cd06646         161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LFLMS--KSNFQPP  229 (267)
T ss_pred             -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--------heeee--cCCCCCC
Confidence             1122346888999999885   34578899999999999999999999743221100        00000  0000111


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                      ....   ....+..+.+++.+||+.+|++||+++++++.|
T Consensus       230 ~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLKD---KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCcc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1110   111345788999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.7e-40  Score=306.14  Aligned_cols=260  Identities=22%  Similarity=0.350  Sum_probs=206.9

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|++|.||++... ++..+++|.+...   ......++.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46788899999999999999964 6889999987643   2334567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          191 EYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       191 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      ||+++++|.+++... .....+++...+.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999887532 22345889999999999999999999988   99999999999999999999999999876543


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....+   .........      . ...+
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~------~-~~~~  226 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIE------Q-CDYP  226 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhh------c-CCCC
Confidence            221  112346888999999999888999999999999999999999997432211   111111110      0 0011


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                      ...    ....+..+.+++.+||+.+|++|||+.+|++.+++..
T Consensus       227 ~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         227 PLP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CCC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            111    1124557889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.4e-40  Score=310.63  Aligned_cols=259  Identities=26%  Similarity=0.440  Sum_probs=204.1

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      ..++|++.+.||+|+||.||+|...      .+..+|+|.+.... ......+.+|+.++++++|||++++++++.+.+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            3467899999999999999999864      36789999987653 3445678999999999999999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCC-------------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 040532          186 KILIYEYMPNKSLDFFLFDPT-------------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS  246 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~  246 (436)
                      .+++|||+++++|.+++....                   ....+++..++.++.|++.||+|||..+   ++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence            999999999999999985321                   1234788889999999999999999988   999999999


Q ss_pred             CEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 040532          247 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTD  325 (436)
Q Consensus       247 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~  325 (436)
                      ||++++++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||..... 
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-  238 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-  238 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence            99999999999999999876543322222222345667999999998899999999999999999998 7778742211 


Q ss_pred             CcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          326 SLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                          ....... .......      ..     ...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus       239 ----~~~~~~~-~~~~~~~------~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 ----EEVIYYV-RDGNVLS------CP-----DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HHHHHHH-hcCCCCC------CC-----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                1111111 1111100      00     1134578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.7e-40  Score=317.94  Aligned_cols=251  Identities=22%  Similarity=0.264  Sum_probs=195.9

Q ss_pred             CCCCCcccCCCCceeEEEEEec----CCCEEEEEEcCCC----ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCcc
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLSGR----SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  186 (436)
                      +|++.+.||+|+||.||++...    .++.||+|++...    .....+.+..|+.++.++ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788899999999999998853    4788999998642    223345678899999999 599999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||+++|+|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            9999999999999888543   34888999999999999999999998   99999999999999999999999999976


Q ss_pred             cCCCCcccccccccccCCccchhhhccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||........  ...+.......     
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~-----  226 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILKC-----  226 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhcC-----
Confidence            4332211 122347899999999998654 78999999999999999999999864322111  11111111110     


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                        .+.....     ....+.+++.+||+.||++||     +++++++
T Consensus       227 --~~~~~~~-----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 --DPPFPSF-----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             --CCCCCCC-----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence              1111111     344678899999999999999     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.9e-40  Score=322.18  Aligned_cols=255  Identities=22%  Similarity=0.283  Sum_probs=200.3

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ...++|++.+.||+|+||.||++... +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            45678999999999999999999976 4889999998642   2233455788999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|..++...    .++......++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            999999999999988542    3678888889999999999999988   999999999999999999999999999765


Q ss_pred             CCCCcccccccccccCCccchhhhccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL  343 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  343 (436)
                      ..... .......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.....     ..............
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~~~  266 (370)
T cd05596         193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMDHKNSL  266 (370)
T ss_pred             cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCCcC
Confidence            43221 122334799999999998753    378999999999999999999999854321     11112221111111


Q ss_pred             eeccCCccccccchHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 040532          344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADD--RPTMNDVVSM  388 (436)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~ev~~~  388 (436)
                      ..      +..   ...+..+.+++.+||+.+|++  ||++.|+++.
T Consensus       267 ~~------~~~---~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 TF------PDD---IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CC------CCc---CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            11      110   013456888999999999987  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.4e-40  Score=323.34  Aligned_cols=201  Identities=24%  Similarity=0.348  Sum_probs=173.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|+..+.||+|+||+||++... +++.||+|++....   ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999865 48899999996532   233456788999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            999999999998643   34889999999999999999999998   999999999999999999999999998754321


Q ss_pred             Ccc---------------------------------cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCC
Q 040532          271 ELQ---------------------------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK  317 (436)
Q Consensus       271 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~  317 (436)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123479999999999999999999999999999999999999


Q ss_pred             CCCC
Q 040532          318 NTGL  321 (436)
Q Consensus       318 p~~~  321 (436)
                      ||..
T Consensus       235 Pf~~  238 (363)
T cd05628         235 PFCS  238 (363)
T ss_pred             CCCC
Confidence            9854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.7e-40  Score=312.03  Aligned_cols=262  Identities=27%  Similarity=0.381  Sum_probs=204.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-C--CEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-G--DEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468888999999999999998754 3  24788888743 344456789999999999 799999999999999999999


Q ss_pred             EeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCe
Q 040532          190 YEYMPNKSLDFFLFDPT-------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  256 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~  256 (436)
                      +||+++++|.+++....             ....+++.....++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985422             1134788999999999999999999988   9999999999999999999


Q ss_pred             EEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHH
Q 040532          257 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  335 (436)
                      ||+|||++......   ........+..|+|||.+.+..++.++|||||||++|||++ |..||......     .....
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----~~~~~  230 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----ELYEK  230 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHH
Confidence            99999998642211   11111123457999999998889999999999999999998 99998533211     11111


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCC
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP  399 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~  399 (436)
                      . .....      .....     ..+..+.+++.+||+.+|.+||+++++++.|++........
T Consensus       231 ~-~~~~~------~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~  282 (297)
T cd05089         231 L-PQGYR------MEKPR-----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY  282 (297)
T ss_pred             H-hcCCC------CCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence            1 11100      00011     13456889999999999999999999999999988765443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-39  Score=304.59  Aligned_cols=255  Identities=33%  Similarity=0.493  Sum_probs=203.9

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ..+.|++.+.||+|+||.||+|..++++.+|+|.+..... ....+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            4567889999999999999999988899999999875432 3467889999999999999999999864 5678999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++.... ...+++.....++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999885433 345889999999999999999999988   99999999999999999999999999976653222


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      .. .....++..|+|||.+.+..++.++|+||||+++|||++ |+.||.....     .+..... ......     + .
T Consensus       158 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~-~~~~~~-----~-~  224 (260)
T cd05067         158 TA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEVIQNL-ERGYRM-----P-R  224 (260)
T ss_pred             cc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHH-HcCCCC-----C-C
Confidence            11 122345678999999998889999999999999999999 9999853221     1111111 111000     0 0


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      ..     ..+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       225 ~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 PD-----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CC-----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11     134568999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-40  Score=323.03  Aligned_cols=253  Identities=23%  Similarity=0.294  Sum_probs=195.6

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||++... +|+.||+|++...   .....+.+.+|++++.+++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999865 4889999998643   2234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999988543   34788888899999999999999998   999999999999999999999999998633210


Q ss_pred             Cc-------------c--------------------------------cccccccccCCccchhhhccCCCCcccchhhH
Q 040532          271 EL-------------Q--------------------------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSF  305 (436)
Q Consensus       271 ~~-------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~Sl  305 (436)
                      ..             .                                ......+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00             0                                00012468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCC---CCH
Q 040532          306 GVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDR---PTM  382 (436)
Q Consensus       306 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~  382 (436)
                      ||++|||++|..||......     ..............      .+..   ...+..+.+++.+|+. +|.+|   +++
T Consensus       235 Gvil~elltG~~Pf~~~~~~-----~~~~~i~~~~~~~~------~p~~---~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSH-----ETYRKIINWRETLY------FPDD---IHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHH-----HHHHHHHccCCccC------CCCC---CCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            99999999999998543211     11111111111111      1110   0133467889999997 66665   599


Q ss_pred             HHHHHH
Q 040532          383 NDVVSM  388 (436)
Q Consensus       383 ~ev~~~  388 (436)
                      .|+++.
T Consensus       300 ~~~l~h  305 (377)
T cd05629         300 HEIKSH  305 (377)
T ss_pred             HHHhcC
Confidence            888874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.7e-40  Score=319.09  Aligned_cols=241  Identities=25%  Similarity=0.311  Sum_probs=191.4

Q ss_pred             CCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCC-ceeEEeeEEEeCCccEEEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHK-NLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  190 (436)
                      +|++.+.||+|+||.||+|.... ++.||+|++...   .....+.+..|..++..++|+ +|+++.+++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            47888999999999999999764 678999998743   233456778899999999765 6888999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|..++....   .+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999998885432   3788999999999999999999988   999999999999999999999999998643221


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      .  .......||+.|+|||++.+..++.++||||+||++|||+||+.||......     ........ ..       ..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i~~-~~-------~~  219 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQSIME-HN-------VS  219 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHHc-CC-------CC
Confidence            1  1223347899999999999999999999999999999999999998543211     11111111 10       01


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTM  382 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  382 (436)
                      .+..     .+..+.+++.+||+.||.+|++.
T Consensus       220 ~~~~-----~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 YPKS-----LSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCC-----CCHHHHHHHHHHhhcCHHHcCCC
Confidence            1111     33467889999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-39  Score=305.23  Aligned_cols=256  Identities=29%  Similarity=0.427  Sum_probs=203.0

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      .++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.++++++||||+++++.+. .+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            467899999999999999999987777899999975332 2357899999999999999999999874 45679999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++|+|.+++.... ...+++.....++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||.+.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999986432 234788999999999999999999988   999999999999999999999999999866433321


Q ss_pred             cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                       ......++..|+|||...+..++.++|+||||+++|||+| |+.||......     . ..........      ... 
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~-~~~~~~~~~~------~~~-  224 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----E-VLDQVERGYR------MPC-  224 (262)
T ss_pred             -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----H-HHHHHhcCCC------CCC-
Confidence             1122346678999999988899999999999999999999 77787532211     0 1111111100      000 


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                          ....+..+.+++.+|++.+|++||++.++++.|++..
T Consensus       225 ----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         225 ----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence                1124567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=319.20  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=213.9

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecC---CC--EEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRK---GD--EIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      +......+..+.||.|-||.||+|...+   |+  .||||..+.+ .....+.|..|..+|++++||||++++|+|.+ .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            3344455566789999999999999543   43  4899998864 45557889999999999999999999999864 6


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..++|||.++-|.|..||....  ..++......++.||+.||+|||+..   ++||||..+|||+...-.+||+|||++
T Consensus       464 P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence            8899999999999999996544  45888899999999999999999988   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcc
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTL  343 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  343 (436)
                      +.+....++... ...-+..|||||.+.-..++.++|||-|||+|||+++ |.+||....               .....
T Consensus       539 R~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk---------------NsDVI  602 (974)
T KOG4257|consen  539 RYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK---------------NSDVI  602 (974)
T ss_pred             hhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc---------------ccceE
Confidence            998877766544 3355778999999999999999999999999999877 899985432               22222


Q ss_pred             eeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      ..+........  +++|+..++.++.+||+++|.+||.+.++...|+++..
T Consensus       603 ~~iEnGeRlP~--P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  603 GHIENGERLPC--PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEecCCCCCCC--CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            22222211111  22378899999999999999999999999999988775

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.3e-40  Score=319.01  Aligned_cols=236  Identities=26%  Similarity=0.354  Sum_probs=188.8

Q ss_pred             cccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||+||+|..+. ++.||+|++...   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            468999999999999764 789999998643   223445677888888876 699999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++....   .+++.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            99998885433   4889999999999999999999998   9999999999999999999999999987532221  12


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ........ ...       ...+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~-~~~-------~~~~~~-  218 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAIL-NDE-------VVYPTW-  218 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHh-cCC-------CCCCCC-
Confidence            2334789999999999998999999999999999999999999864321     11111111 111       011111 


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCH
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTM  382 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~  382 (436)
                          .+..+.+++.+||+.||++||++
T Consensus       219 ----~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         219 ----LSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             ----CCHHHHHHHHHHcccCHHHCCCC
Confidence                34467899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.3e-40  Score=315.89  Aligned_cols=242  Identities=22%  Similarity=0.350  Sum_probs=190.8

Q ss_pred             cccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||.||+|.... ++.+|+|++...   .......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            469999999999999764 788999998753   233455678899888877 899999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++...   ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            9998887543   24889999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC---CcchhHHHHHHhhcCCcceeccCCccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD---SLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||......   ......+..........       ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-------~~p  225 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-------RIP  225 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-------CCC
Confidence            23357899999999999999999999999999999999999999643211   11122222222221111       111


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTM  382 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  382 (436)
                      ..     ....+.+++.+||+.||++||+.
T Consensus       226 ~~-----~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         226 RS-----LSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CC-----CCHHHHHHHHHHhcCCHHHcCCC
Confidence            11     33467889999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.7e-40  Score=312.08  Aligned_cols=261  Identities=26%  Similarity=0.378  Sum_probs=205.6

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGRS-EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  183 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  183 (436)
                      ...++|++.+.||+|+||.||++...      .+..+|+|+++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            34567899999999999999999742      24579999987543 34456789999999999 799999999999999


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      +..+++|||+++|+|..++.... ...+++.+...++.|++.||+|||+.+   ++|+||||+||+++.++.++++|||+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence            99999999999999999986432 233789999999999999999999988   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      +................++..|+|||.+.+..++.++||||+||++|||++ |..||......     ............
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~  262 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-----SKFYKLIKEGYR  262 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-----HHHHHHHHcCCc
Confidence            976543221111222346778999999999999999999999999999998 89987532211     011111111100


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                            .....     ..+..+.+++.+|++.+|++||++.|+++.|++.
T Consensus       263 ------~~~~~-----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 ------MAQPE-----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------CCCCC-----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  00000     1235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.6e-39  Score=310.92  Aligned_cols=264  Identities=27%  Similarity=0.423  Sum_probs=206.3

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec--------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR--------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCID  182 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  182 (436)
                      ..++|.+.+.||+|+||.||++...        .+..+|+|.+... .......+.+|+.+++++ +||||+++++++.+
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3467888999999999999999742        2456899998754 344466788999999999 69999999999999


Q ss_pred             CCccEEEEeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEE
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDPT-------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  249 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIl  249 (436)
                      .+..+++|||+++|+|.+++....             ....+++.....++.|++.||.|||+.+   ++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence            999999999999999999985432             1235888999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 040532          250 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLN  328 (436)
Q Consensus       250 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~  328 (436)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......  .
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~  244 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--E  244 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence            99999999999999976543222221222234567999999998889999999999999999999 88887432211  1


Q ss_pred             hhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          329 LLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                          ............      ..     ..++..+.+++.+||+.+|++||++.++++.|.++....
T Consensus       245 ----~~~~~~~~~~~~------~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         245 ----LFKLLREGHRMD------KP-----SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             ----HHHHHHcCCCCC------CC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence                111111111110      00     113446889999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.7e-40  Score=309.94  Aligned_cols=261  Identities=24%  Similarity=0.395  Sum_probs=202.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEe-----cCCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--Ccc
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVL-----RKGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK  186 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  186 (436)
                      +.|++.+.||+|+||.||.+..     .++..||+|.+.... ......+.+|+.++++++|||++++.+++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999974     247789999987553 44456789999999999999999999998875  567


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||+++++|..++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            89999999999999985432  24799999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC----------CCcchhHHHHH
Q 040532          267 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT----------DSLNLLGYVWD  335 (436)
Q Consensus       267 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~----------~~~~~~~~~~~  335 (436)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++++.|......          ........ ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  237 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-VR  237 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH-HH
Confidence            5432211 112234567789999999988899999999999999999998766422110          00001101 11


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      ........     + ..     ...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       238 ~~~~~~~~-----~-~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGKRL-----P-RP-----PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCccC-----C-CC-----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111000     0 00     11445789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-40  Score=310.82  Aligned_cols=252  Identities=27%  Similarity=0.329  Sum_probs=198.7

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      +|+..+.||+|+||+||++... +++.||+|++....   ......+.+|+.++++++||||+++.+.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999965 48899999986532   2223456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++|+|..++.... ...+++.....++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999988875432 234889999999999999999999988   9999999999999999999999999997654322


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      .   .....|+..|+|||++.+..++.++||||+|+++|||++|+.||......  .....+.......       ....
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--~~~~~~~~~~~~~-------~~~~  224 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--VKREEVERRVKED-------QEEY  224 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh--hHHHHHHHHhhhc-------cccc
Confidence            1   12347899999999999888999999999999999999999998643211  1111111111000       0001


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVSM  388 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~~  388 (436)
                      .     ...+..+.+++.+||+.||++||     ++.++++.
T Consensus       225 ~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         225 S-----EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             C-----cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            1     11445688999999999999999     78888553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.5e-41  Score=306.53  Aligned_cols=260  Identities=24%  Similarity=0.350  Sum_probs=193.4

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc-----cEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-----KIL  188 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~l  188 (436)
                      -.|...+++|.|+||.||+|.... ++.||||+.-....    .-.+|+.+|+.++|||||++.-+|....+     ..+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            346777899999999999999764 68999999875532    22579999999999999999998876432     358


Q ss_pred             EEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC-CCeEEeeccCcee
Q 040532          189 IYEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARI  266 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~-~~~kl~DfGla~~  266 (436)
                      ||||++. +|.+.+... ..+..++.....-+..||.+||.|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999986 566665432 22345777888889999999999999988   9999999999999955 9999999999998


Q ss_pred             cCCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      +..+...   ....-|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|...+  ..+.+..+...+.-+...++
T Consensus       176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s--~~dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS--SVDQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC--HHHHHHHHHHHhCCCCHHHH
Confidence            7655432   223457789999999975 59999999999999999999999986522  22222223332222211110


Q ss_pred             --cc-------CCcccc----ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 --ID-------DPVLED----EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 --~~-------~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        +.       .+....    .......+.+..+++.++|+.+|.+|.++.|++.
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence              00       011110    0112235678899999999999999999998874

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.8e-40  Score=326.22  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=192.8

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .|+..+.||+|+||+||+|... +++.+|+|++....   ......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999975 47889999987532   2345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++|+|..++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999999988543   24788888899999999999999998   9999999999999999999999999975321100


Q ss_pred             ---------------------------------------------cccccccccccCCccchhhhccCCCCcccchhhHH
Q 040532          272 ---------------------------------------------LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFG  306 (436)
Q Consensus       272 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG  306 (436)
                                                                   ........+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                         00001224689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCC---HH
Q 040532          307 VLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT---MN  383 (436)
Q Consensus       307 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~  383 (436)
                      |++|||++|+.||......     ..............      .+.   ....+....+++.+|+ .+|++|++   +.
T Consensus       236 vil~elltG~~Pf~~~~~~-----~~~~~i~~~~~~~~------~p~---~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPL-----ETQMKVINWQTSLH------IPP---QAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHH-----HHHHHHHccCCCcC------CCC---cccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            9999999999998643211     11111111110000      000   0112345677777765 59999997   77


Q ss_pred             HHHH
Q 040532          384 DVVS  387 (436)
Q Consensus       384 ev~~  387 (436)
                      ++++
T Consensus       301 ei~~  304 (382)
T cd05625         301 EIKA  304 (382)
T ss_pred             HHhc
Confidence            7664

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.8e-39  Score=302.76  Aligned_cols=247  Identities=28%  Similarity=0.411  Sum_probs=194.7

Q ss_pred             ccCCCCceeEEEEEec---CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCC
Q 040532          122 KLGEGGFGPVYKGVLR---KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      .||+|+||.||+|.++   ++..+|+|++....  ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   47789999986542  334577899999999999999999999875 45678999999999


Q ss_pred             ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc-c
Q 040532          197 SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA-N  275 (436)
Q Consensus       197 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~  275 (436)
                      +|.+++...   ..+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.......... .
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            999988543   24889999999999999999999988   9999999999999999999999999998654332211 1


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDE  354 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (436)
                      .....++..|+|||.+....++.++|+||||+++|||++ |+.||.....  ...   . .........      ..+. 
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~---~-~~i~~~~~~------~~~~-  221 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEV---T-QMIESGERM------ECPQ-  221 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHH---H-HHHHCCCCC------CCCC-
Confidence            112234578999999988889999999999999999998 9999854321  111   1 111111110      1111 


Q ss_pred             cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          355 YSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       355 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                          ..+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus       222 ----~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         222 ----RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ----CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                1345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4e-39  Score=304.25  Aligned_cols=249  Identities=24%  Similarity=0.386  Sum_probs=197.8

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|+..+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            35788899999999999999864 5888999998654 334456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|..+.       .+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999996553       2677888899999999999999998   999999999999999999999999999765422  


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcch--hHHHHHHhhcCCcceeccCCc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL--LGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  350 (436)
                        ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..........  .... .......      .+.
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~------~~~  219 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-QCIVDED------PPV  219 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-HHHhccC------CCC
Confidence              1223478999999999998899999999999999999999999986433221111  0111 1101010      111


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ..    ....+..+.+++.+|++.+|++||+++|+++.
T Consensus       220 ~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         220 LP----VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CC----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11    11133468899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.1e-39  Score=307.70  Aligned_cols=247  Identities=24%  Similarity=0.349  Sum_probs=192.6

Q ss_pred             cCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          123 LGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       123 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      ||+|+||+||++..+ +|+.+|+|++....   ......+..|++++++++||||+++.+++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 48999999986431   12234456799999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccccc
Q 040532          199 DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  278 (436)
Q Consensus       199 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  278 (436)
                      ..++.... ...+++.....++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            88875432 234788999999999999999999988   9999999999999999999999999987654322   1123


Q ss_pred             ccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchH
Q 040532          279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK  358 (436)
Q Consensus       279 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (436)
                      ..|+..|+|||++.+..++.++||||+||++|||++|+.||........ ......... ...    .   ...    ..
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~-~~~----~---~~~----~~  220 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTL-EDE----V---KFE----HQ  220 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhh-ccc----c---ccc----cc
Confidence            4688999999999988899999999999999999999999864322111 111111111 000    0   000    01


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          359 QVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       359 ~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                      ..+..+.+++.+||+.||++||+++|+++.+
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            1345688999999999999999998776444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.1e-39  Score=302.48  Aligned_cols=254  Identities=26%  Similarity=0.396  Sum_probs=191.9

Q ss_pred             cccCCCCceeEEEEEecC---CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCC
Q 040532          121 NKLGEGGFGPVYKGVLRK---GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      +.||+|+||.||+|...+   +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   4579999987543 333457889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCC--ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          197 SLDFFLFDPT--KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       197 ~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +|.+++....  .....++.....++.|++.|++|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986432  2234567778889999999999999988   9999999999999999999999999987544333222


Q ss_pred             ccccccccCCccchhhhccC-------CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          275 NTSRIVGTYGYMSPEYALEG-------IFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ......++..|+|||++.+.       .++.++|+||||+++|||++ |+.||.......  ....   ... ..... .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~---~~~-~~~~~-~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTY---TVR-EQQLK-L  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHH---Hhh-cccCC-C
Confidence            23334577889999988642       35789999999999999996 999986433211  1100   011 11111 1


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      ..+.....     ....+.+++..|+ .+|++|||+.||+..|+
T Consensus       231 ~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLP-----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCC-----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111111     2345778999998 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-39  Score=314.72  Aligned_cols=247  Identities=21%  Similarity=0.339  Sum_probs=194.5

Q ss_pred             cccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||.||++.+. +++.||+|+++..   .....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999975 4889999999753   233456688899999998 799999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++...   ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~  152 (329)
T cd05588          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT  152 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence            9998887543   34899999999999999999999998   9999999999999999999999999986422111  12


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC---cchhHHHHHHhhcCCcceeccCCccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS---LNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|+.||.......   .....+..........       ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~p  225 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-------RIP  225 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-------CCC
Confidence            233578999999999999999999999999999999999999996432211   1122222222221110       111


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPT------MNDVVS  387 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs------~~ev~~  387 (436)
                      ..     .+..+.+++.+||+.||.+||+      ++++++
T Consensus       226 ~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         226 RS-----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CC-----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            11     3346788999999999999997      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.2e-40  Score=314.20  Aligned_cols=240  Identities=27%  Similarity=0.360  Sum_probs=189.1

Q ss_pred             cccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||.||+|.+. +|+.||+|++....   .........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 47899999987531   22345567788888765 899999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++...   ..+++.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05620          81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR  152 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence            9998888543   24788899999999999999999998   9999999999999999999999999987432111  12


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     .. .......       .+..+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-----~~-~~~~~~~-------~~~~~~~-  218 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----EL-FESIRVD-------TPHYPRW-  218 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HH-HHHHHhC-------CCCCCCC-
Confidence            23357899999999999999999999999999999999999998543211     11 1111111       1111111 


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTMN-DVV  386 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~~-ev~  386 (436)
                          ....+.+++.+||+.||++||++. ++.
T Consensus       219 ----~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         219 ----ITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                334678899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.2e-41  Score=321.86  Aligned_cols=238  Identities=24%  Similarity=0.285  Sum_probs=190.2

Q ss_pred             cccCCCCceeEEEEEe----cCCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          121 NKLGEGGFGPVYKGVL----RKGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      +.||+|+||.||++..    ..|+.+|+|++....  ......+..|++++++++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999875    247899999997532  2233457789999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +|+|..++...   ..+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.......  .
T Consensus        82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            99999888543   34889999999999999999999998   9999999999999999999999999987643321  1


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDE  354 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (436)
                      ......|++.|+|||.+.+..++.++|||||||++|||++|+.||.....     ...........        ...+..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~i~~~~--------~~~p~~  220 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTMILKAK--------LGMPQF  220 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHHHHcCC--------CCCCCC
Confidence            12234789999999999988899999999999999999999999854321     11111111110        001111


Q ss_pred             cchHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 040532          355 YSSKQVLLRYVNIALLCVQESADDRPTMND  384 (436)
Q Consensus       355 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~e  384 (436)
                           .+..+.+++.+||+.||++||++.+
T Consensus       221 -----~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         221 -----LSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -----CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                 3446788999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.8e-40  Score=317.22  Aligned_cols=241  Identities=26%  Similarity=0.325  Sum_probs=191.3

Q ss_pred             CCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      +|++.+.||+|+||.||+|.... ++.||+|.+....   ......+..|..++..+ +|++|+++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            47788999999999999999764 7789999987532   22344567788888777 5899999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|..++....   .+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999988885432   3788999999999999999999998   999999999999999999999999998754322


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      .  .......||+.|+|||++.+..++.++|||||||++|||+||+.||......  .+   ........        ..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~---~~~i~~~~--------~~  219 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL---FQSIMEHN--------VA  219 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HH---HHHHHhCC--------CC
Confidence            1  1223357899999999999999999999999999999999999998543211  11   11111111        00


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTM  382 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  382 (436)
                      .+.     ..+..+.+++.+|++.+|++|++.
T Consensus       220 ~p~-----~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 YPK-----SMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCC-----cCCHHHHHHHHHHcccCHHhcCCC
Confidence            111     134567889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.9e-40  Score=322.51  Aligned_cols=256  Identities=21%  Similarity=0.270  Sum_probs=199.1

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      ....++|++.+.||+|+||.||++.... ++.+|+|.+...   .......+.+|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            3456789999999999999999999764 788999998642   223345678999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||+++|+|.+++...    .+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++..
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence            9999999999999988532    3788888999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCCccchhhhccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      ...... .......||+.|+|||++.+.    .++.++|+||+||++|||++|+.||.....     .............
T Consensus       192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~  265 (370)
T cd05621         192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGTYSKIMDHKNS  265 (370)
T ss_pred             cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCcc
Confidence            643221 122345799999999999754    378899999999999999999999854321     1111222111111


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADD--RPTMNDVVSM  388 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~ev~~~  388 (436)
                      ...      +.   ....+..+.+++..|++.++.+  ||++.|+++.
T Consensus       266 ~~~------p~---~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 LNF------PE---DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cCC------CC---cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            111      10   0113456778899999865543  8899998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-39  Score=304.14  Aligned_cols=257  Identities=28%  Similarity=0.462  Sum_probs=203.1

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-C---CEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-G---DEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      .++|+..+.||+|+||.||+|.... +   ..+++|.+... .....+.+..|+.++++++|||++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            4567888999999999999999753 3   36999998755 34445778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++++|.+++....  ..+++.....++.|++.|++|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999999985432  34789999999999999999999988   9999999999999999999999999997654


Q ss_pred             CCCcccc-cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          269 GNELQAN-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       269 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ....... ......+..|+|||.+.+..++.++|||||||++|||++ |+.||.....     ....... ....     
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i-~~~~-----  227 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAI-NDGF-----  227 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHH-hcCC-----
Confidence            3221111 111223457999999998889999999999999999997 9999843221     1111111 1110     


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      ..+..      ...+..+.+++.+|++.+|++||++.+|++.|+++
T Consensus       228 ~~~~~------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 RLPAP------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00000      01345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.8e-40  Score=326.90  Aligned_cols=253  Identities=22%  Similarity=0.316  Sum_probs=195.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      +.|++.+.||+|+||.||+|.... ++.||+|++....   ......+.+|+.++++++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            368899999999999999999654 8899999986432   223456889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++...   ..++......++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            999999999998543   24788888899999999999999998   999999999999999999999999997532100


Q ss_pred             C-----------------------------------------cccccccccccCCccchhhhccCCCCcccchhhHHHHH
Q 040532          271 E-----------------------------------------LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL  309 (436)
Q Consensus       271 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil  309 (436)
                      .                                         ........+||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                         00001134699999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCC---CHHHHH
Q 040532          310 LEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP---TMNDVV  386 (436)
Q Consensus       310 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---s~~ev~  386 (436)
                      |||++|+.||......     ..............      .+..   ...+..+.+++.+|+ .+|.+|+   ++.+++
T Consensus       235 yell~G~~Pf~~~~~~-----~~~~~i~~~~~~~~------~~~~---~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         235 YEMLVGQPPFLADTPA-----ETQLKVINWETTLH------IPSQ---AKLSREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             eehhhCCCCCCCCCHH-----HHHHHHhccCcccc------CCCC---CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            9999999998643211     11111111110000      0000   013345677888876 5999999   788887


Q ss_pred             HH
Q 040532          387 SM  388 (436)
Q Consensus       387 ~~  388 (436)
                      +.
T Consensus       300 ~h  301 (376)
T cd05598         300 AH  301 (376)
T ss_pred             CC
Confidence            55

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-39  Score=317.52  Aligned_cols=263  Identities=27%  Similarity=0.381  Sum_probs=202.4

Q ss_pred             ccCCCCCcccCCCCceeEEEEEe------cCCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeC-C
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVL------RKGDEIAVKRLSGRS-EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK-D  184 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  184 (436)
                      .++|++.+.||+|+||.||+|.+      ..++.||+|++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45799999999999999999974      236789999997543 33456788999999999 689999999988654 4


Q ss_pred             ccEEEEeecCCCChhhhhcCCCc---------------------------------------------------------
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTK---------------------------------------------------------  207 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  207 (436)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            56899999999999988753210                                                         


Q ss_pred             -------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccccccc
Q 040532          208 -------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV  280 (436)
Q Consensus       208 -------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  280 (436)
                             ...+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   123678888999999999999999988   9999999999999999999999999997653322222222234


Q ss_pred             ccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHH
Q 040532          281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQ  359 (436)
Q Consensus       281 gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (436)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||.......     ............      ..+..     
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~~------~~~~~-----  306 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKEGTRM------RAPDY-----  306 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----HHHHHHhccCCC------CCCCC-----
Confidence            5678999999998899999999999999999997 888875432110     011111111110      00111     


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          360 VLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       360 ~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      ....+.+++.+||+.+|++||++.|+++.|+.+.+.
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            234688999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-39  Score=299.04  Aligned_cols=250  Identities=34%  Similarity=0.503  Sum_probs=202.8

Q ss_pred             cccCCCCceeEEEEEecC----CCEEEEEEcCCCChh-hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK----GDEIAVKRLSGRSEQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||.||+|....    +..+++|.+...... ..+.+.+|+..+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999764    778999999865433 367889999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCc------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          196 KSLDFFLFDPTK------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       196 g~L~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      ++|.+++.....      ...+++.....++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999866421      256899999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ...........++..|+|||.+....++.++||||+|+++|||++ |..||.....     ... ..........     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~-~~~~~~~~~~-----  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEV-LEYLRKGYRL-----  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHH-HHHHHcCCCC-----
Confidence            432222334467889999999998889999999999999999999 5888854421     111 1111111100     


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                       ...     ...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus       227 -~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 -PKP-----EYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCC-----ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             001     113457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.7e-40  Score=315.59  Aligned_cols=240  Identities=27%  Similarity=0.366  Sum_probs=189.2

Q ss_pred             cccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||+||+|.+.. ++.||+|++....   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            468999999999999764 7889999987531   22334566777888764 899999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++...   ..+++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++.......  ..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            9999888543   24788899999999999999999988   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||.....     ....... ...       .+..+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~i-~~~-------~~~~~~~-  218 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQSI-RMD-------NPCYPRW-  218 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHH-HhC-------CCCCCcc-
Confidence            2334689999999999998999999999999999999999999854321     1111111 111       1111111 


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTMN-DVV  386 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~~-ev~  386 (436)
                          ....+.+++.+||+.||++||++. ++.
T Consensus       219 ----~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         219 ----LTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ----CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                234678899999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.5e-39  Score=303.85  Aligned_cols=256  Identities=27%  Similarity=0.450  Sum_probs=201.5

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-C---CEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-G---DEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      +.|++.+.||+|+||.||+|.+.. +   ..||+|.+... .......+..|+.++++++||||+++.+++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            347788999999999999999753 3   35999999764 445567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+++++|.+++....  ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999999986432  34789999999999999999999988   99999999999999999999999999876543


Q ss_pred             CCccccccccc---ccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          270 NELQANTSRIV---GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       270 ~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ...........   .+..|+|||.+.+..++.++||||||+++|||++ |..||.....  .+...++    ....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i----~~~~----  228 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAI----EQDY----  228 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHH----HcCC----
Confidence            22211111111   2457999999998899999999999999999886 9999743221  1111111    1110    


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                       ..+..      ...+..+.+++.+||+.+|.+||++.+++..|++.
T Consensus       229 -~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 -RLPPP------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -cCCCc------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             00000      11345678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.6e-39  Score=298.60  Aligned_cols=247  Identities=26%  Similarity=0.364  Sum_probs=197.0

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCChh
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD  199 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  199 (436)
                      +.||+|+||.||+|...++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999998888999999987653 333457889999999999999999999999999999999999999999


Q ss_pred             hhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccc
Q 040532          200 FFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI  279 (436)
Q Consensus       200 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  279 (436)
                      +++....  ..+++.....++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||++......... .....
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            9885432  34789999999999999999999988   999999999999999999999999998754332211 11122


Q ss_pred             cccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchH
Q 040532          280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK  358 (436)
Q Consensus       280 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (436)
                      .++..|+|||++.+..++.++||||||+++|||++ |..||......     .. .........      .....     
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~~-~~~~~~~~~------~~~~~-----  217 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----QA-REQVEKGYR------MSCPQ-----  217 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----HH-HHHHHcCCC------CCCCC-----
Confidence            34567999999998889999999999999999998 88888532211     11 111111100      00011     


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       359 ~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      ..+..+.+++.+|++.+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            13457899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.6e-39  Score=301.32  Aligned_cols=254  Identities=30%  Similarity=0.440  Sum_probs=201.1

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      .++|++.+.||+|++|.||+|.+..+..+|+|.+..... ..+.+.+|+.++++++|||++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            356888899999999999999988777899998865432 2357889999999999999999999875 46689999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          83 GKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999986532 234789999999999999999999988   999999999999999999999999999876433221


Q ss_pred             cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                       ......++..|+|||...+..++.++|+||||+++|||+| |+.||......  ..    .........      ....
T Consensus       159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~----~~~~~~~~~------~~~~  225 (260)
T cd05069         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EV----LEQVERGYR------MPCP  225 (260)
T ss_pred             -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HH----HHHHHcCCC------CCCC
Confidence             1122345678999999998889999999999999999999 88887532211  11    111111100      0001


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                           ...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       226 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         226 -----QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 1134578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.9e-40  Score=315.88  Aligned_cols=241  Identities=26%  Similarity=0.336  Sum_probs=192.4

Q ss_pred             cccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||+||+|.+.. ++.||+|++...   .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999764 788999998743   233455677888999888 799999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++....   .+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.......  ..
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            99988875432   4889999999999999999999988   9999999999999999999999999986532211  11


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....|+..|+|||++.+..++.++|+|||||++|||++|+.||.....     ....... ....       ...+.  
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i-~~~~-------~~~~~--  217 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSI-LEDE-------VRYPR--  217 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHH-HcCC-------CCCCC--
Confidence            2234689999999999999999999999999999999999999853321     1111111 1111       01111  


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTM-----NDVVS  387 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~-----~ev~~  387 (436)
                         ..+..+.+++.+||+.||++||++     .++++
T Consensus       218 ---~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         218 ---WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ---cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence               134568899999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-39  Score=301.76  Aligned_cols=257  Identities=31%  Similarity=0.459  Sum_probs=205.8

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ...++|++.+.||+|+||.||+|..+++..+|+|.+.... ...+++.+|+.++++++|+|++++++++......++|||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            3457899999999999999999998878889999987543 234678999999999999999999999998899999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++++|.+++.... ...+++.....++.+++.|+.|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        82 ~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          82 YMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             ccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999999986533 234889999999999999999999988   9999999999999999999999999998765322


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      .. ......++..|+|||.+.+..++.++|+||||+++|||++ |+.||.....  ..   ..........      .+ 
T Consensus       158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~---~~~~~~~~~~------~~-  224 (261)
T cd05034         158 YT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--RE---VLEQVERGYR------MP-  224 (261)
T ss_pred             hh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HH---HHHHHHcCCC------CC-
Confidence            11 1112234568999999998889999999999999999999 8998843211  11   1111111000      00 


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      ...     ..+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       225 ~~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 RPP-----NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCC-----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            000     124468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.9e-39  Score=307.93  Aligned_cols=253  Identities=23%  Similarity=0.393  Sum_probs=203.7

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      .....+|+..+.||+|++|.||+|... +++.+++|.+........+.+.+|+.+++.++|||++++++.+......++|
T Consensus        16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            344568999999999999999999864 5889999999766555567788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+++++|.+++...    .+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            9999999999988532    3788899999999999999999998   99999999999999999999999999875432


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ..  .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||......    ..+ .......       .+
T Consensus       169 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~~~-~~~~~~~-------~~  234 (296)
T cd06654         169 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RAL-YLIATNG-------TP  234 (296)
T ss_pred             cc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----HhH-HHHhcCC-------CC
Confidence            22  1122346888999999999888999999999999999999999998543211    001 1111100       00


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...   ........+.+++.+||..+|++||++.++++
T Consensus       235 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         235 ELQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCC---CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            000   01113456888999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.3e-40  Score=318.37  Aligned_cols=237  Identities=24%  Similarity=0.291  Sum_probs=186.0

Q ss_pred             cccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHH-HHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||+||+|... +|+.||+|++....   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 48899999986431   222334445544 56778999999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++...   ..+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (323)
T cd05575          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT  152 (323)
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence            9998888543   34788899999999999999999998   9999999999999999999999999986532211  12


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+     ............        ...... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~--------~~~~~~-  218 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNKP--------LRLKPN-  218 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCC--------CCCCCC-
Confidence            233478999999999999999999999999999999999999985432     111111111111        001111 


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCHH
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTMN  383 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~~  383 (436)
                          .+..+.+++.+||+.||.+||++.
T Consensus       219 ----~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 ----ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ----CCHHHHHHHHHHhhcCHHhCCCCC
Confidence                245688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.2e-39  Score=300.50  Aligned_cols=250  Identities=28%  Similarity=0.387  Sum_probs=202.4

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|+..+.||+|++|.||+|... +++.|++|.+...  .......+.+|+.++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            3677789999999999999975 4889999998643  344567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++.... ...+++.....++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999986532 345889999999999999999999988   99999999999999999999999999886653321


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                        ......|++.|+|||+..+..++.++|+||||+++|||++|+.||......     ...... .....      +...
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~-~~~~~------~~~~  222 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----ALILKI-IRGVF------PPVS  222 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH-HcCCC------CCCc
Confidence              122346788999999999988999999999999999999999998543311     111111 11100      0111


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      .     .....+.+++.+||+.+|++||++.++++.
T Consensus       223 ~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         223 Q-----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             c-----ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1     144578999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.9e-39  Score=310.22  Aligned_cols=259  Identities=29%  Similarity=0.403  Sum_probs=202.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CC--EEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GD--EIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ++|++.+.||+|+||.||+|.+++ +.  .+++|.+... .......+.+|+.++.++ +||||+++++++..++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            567888999999999999999753 43  4688877653 344556788999999999 899999999999999999999


Q ss_pred             EeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCe
Q 040532          190 YEYMPNKSLDFFLFDPT-------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  256 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~  256 (436)
                      |||+++++|.+++....             ....+++.....++.|++.|++|||+.+   ++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999886432             1235789999999999999999999988   9999999999999999999


Q ss_pred             EEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHH
Q 040532          257 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  335 (436)
                      ||+|||++.....   ........++..|+|||.+.+..++.++|||||||++|||+| |..||......     +....
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~  235 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEK  235 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHHHH
Confidence            9999999863221   111111234567999999988889999999999999999998 99998532211     11111


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                      . .......      ..     ...+..+.+++.+||+.+|++||++.+++..|+.+....
T Consensus       236 ~-~~~~~~~------~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         236 L-PQGYRLE------KP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             H-hcCCcCC------CC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1 1110000      00     013346889999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-39  Score=297.85  Aligned_cols=266  Identities=22%  Similarity=0.305  Sum_probs=199.5

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChh--hHHHHHHHHHHHHHcCCCc-eeEEeeEEEeCC------
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQ--GLREMKNEASVIAKVQHKN-LVRLLGCCIDKD------  184 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------  184 (436)
                      ..|+.+++||+|+||+||+|+.+ +|+.||+|++.-..+.  ......+|+.++++++|+| |+++.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            45677788999999999999965 4889999999755331  2345689999999999999 999999999877      


Q ss_pred             ccEEEEeecCCCChhhhhcCCCcc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKR-ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      ..++|+||++ .+|..++...... ..++......+++|+++||+|||+++   |+||||||+|||++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            7789999995 5787777543321 34667889999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC-
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-  341 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  341 (436)
                      |+...-..  ......++|..|+|||++.+. .|+...||||+|||++||++++.-|.....  .+....+......+. 
T Consensus       167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNE  242 (323)
T ss_pred             HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCc
Confidence            98654222  123344789999999999987 699999999999999999999988754332  222222222222211 


Q ss_pred             --cceec---cCC-ccccccch-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          342 --TLELI---DDP-VLEDEYSS-------KQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       342 --~~~~~---~~~-~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        .....   +-. ........       +.......+++.+||+.+|.+|.|++..++.
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence              11111   000 11111100       0111367889999999999999999998875

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.1e-39  Score=311.22  Aligned_cols=242  Identities=23%  Similarity=0.349  Sum_probs=191.5

Q ss_pred             cccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||+||++.... ++.+|+|++...   .....+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999754 788999999754   233456688999999888 699999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++...   ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            9998887543   24899999999999999999999998   9999999999999999999999999987532111  12


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC-CcchhHHHHHHhhcCCcceeccCCccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYVWDLWTSNRTLELIDDPVLEDE  354 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (436)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.........       ...+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~p~~  225 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-------IRIPRF  225 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-------CCCCCC
Confidence            23357899999999999999999999999999999999999999643321 1222222222221111       011111


Q ss_pred             cchHHHHHHHHHHHHhcccCCCCCCCCH
Q 040532          355 YSSKQVLLRYVNIALLCVQESADDRPTM  382 (436)
Q Consensus       355 ~~~~~~~~~l~~li~~cl~~~p~~RPs~  382 (436)
                           .+..+.+++.+||+.||++||++
T Consensus       226 -----~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         226 -----LSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -----CCHHHHHHHHHHhccCHHHcCCC
Confidence                 23457889999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.1e-39  Score=299.12  Aligned_cols=250  Identities=24%  Similarity=0.411  Sum_probs=202.7

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .++|+..+.||+|+||.||+|...+ ++.+++|.+.....  .+.+.+|++++++++|||++++++++......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678999999999999999999875 78999999875433  57899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++...  ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            9999999998542  235899999999999999999999988   99999999999999999999999999886543321


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........    . ... ...      ....  
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~-~~~-~~~------~~~~--  218 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----I-FMI-PNK------PPPT--  218 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----h-hhh-ccC------CCCC--
Confidence              12233578899999999988999999999999999999999999864321110    0 000 000      0000  


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ..........+.+++.+||+.+|++||++.|+++
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         219 -LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence             0011123456889999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.9e-39  Score=299.46  Aligned_cols=248  Identities=26%  Similarity=0.393  Sum_probs=193.8

Q ss_pred             ccCCCCceeEEEEEec---CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCC
Q 040532          122 KLGEGGFGPVYKGVLR---KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS  197 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  197 (436)
                      .||+|+||.||+|.+.   .+..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999864   35569999997653 334567899999999999999999999875 457899999999999


Q ss_pred             hhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc-ccc
Q 040532          198 LDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ-ANT  276 (436)
Q Consensus       198 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~  276 (436)
                      |.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......... ...
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            99988543  235889999999999999999999988   999999999999999999999999999755432211 111


Q ss_pred             ccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       277 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      ....++..|+|||.+....++.++||||||+++|||++ |..||......     +. .........      ...+.  
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~-~~~~~~~~~------~~~~~--  221 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EV-MSFIEQGKR------LDCPA--  221 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HH-HHHHHCCCC------CCCCC--
Confidence            11234578999999988889999999999999999996 99998533211     11 111111111      00111  


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                         ..+..+.+++.+||..+|++||++.+|.+.|+..
T Consensus       222 ---~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         222 ---ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence               1345788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.2e-39  Score=305.37  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=199.1

Q ss_pred             CCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      .|++.+.||+|+||.||+|.+.. +..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            36778899999999999999764 77889999977666667788999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +++|..++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......  .
T Consensus        86 ~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          86 GGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            99998887542  235889999999999999999999988   9999999999999999999999999987643221  1


Q ss_pred             ccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          275 NTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ......++..|+|||.+.     +..++.++|+|||||++|||++|+.||.....     ............ ....   
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~-~~~~---  229 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEP-PTLA---  229 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-----HHHHHHHhhcCC-CCCC---
Confidence            223346889999999884     34578899999999999999999999854321     111111111110 0000   


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       .+     ...+..+.+++.+||+.+|.+||++.++++
T Consensus       230 -~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         230 -QP-----SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -Cc-----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00     113456889999999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-39  Score=300.32  Aligned_cols=251  Identities=28%  Similarity=0.412  Sum_probs=204.5

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      .++|++.+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+|++++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            457888999999999999999876 88999999986644 4577899999999999999999999999989999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++++|.+++..... ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.++....... 
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999999864332 25899999999999999999999998   99999999999999999999999999976532211 


Q ss_pred             cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                          ....+..|+|||.+.++.++.++|+||||+++|||++ |..||......     + ...........      ...
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~-~~~~~~~~~~~------~~~  221 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----D-VVPHVEKGYRM------EAP  221 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----H-HHHHHhcCCCC------CCc
Confidence                2234567999999988889999999999999999997 99887543211     1 11111111000      000


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                           ...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus       222 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         222 -----EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -----cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                 11345788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.3e-39  Score=303.05  Aligned_cols=254  Identities=23%  Similarity=0.355  Sum_probs=189.4

Q ss_pred             cccCCCCceeEEEEEecC---CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCC
Q 040532          121 NKLGEGGFGPVYKGVLRK---GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      +.||+|+||+||+|....   ...+++|.+.... ......+.+|+..++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997543   3468899876543 334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCc--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          197 SLDFFLFDPTK--RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       197 ~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +|.+++.....  ....++.....++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865432  223467778899999999999999998   9999999999999999999999999986543322222


Q ss_pred             ccccccccCCccchhhhcc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          275 NTSRIVGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ......++..|+|||++..       ..++.++|||||||++|||++ |..||......     +......... ... .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~~~~-~~~-~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-----QVLKQVVREQ-DIK-L  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHHhhcc-Ccc-C
Confidence            2233356778999998753       356889999999999999999 77777432211     1111111111 111 1


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      ..+....     .....+.+++..|+ .||++||++++|++.|.
T Consensus       231 ~~~~~~~-----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDL-----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcccc-----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111111     13345677888888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4e-39  Score=306.28  Aligned_cols=252  Identities=25%  Similarity=0.420  Sum_probs=201.5

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .+.|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+..+++++|||++++.+.+..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            4679999999999999999999765 889999999877777778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|..++....  ..+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.++|+|||++....... 
T Consensus        91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            99999988775432  34889999999999999999999988   9999999999999999999999999987543221 


Q ss_pred             ccccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          273 QANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                       .......++..|+|||.+.     ...++.++|+|||||++|||++|+.||.....     ............      
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~------  232 (292)
T cd06644         165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEP------  232 (292)
T ss_pred             -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHHhcCCC------
Confidence             1122346788999999885     34478899999999999999999999854321     111111111110      


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       +...   .....+..+.+++.+||+.+|++||++.++++
T Consensus       233 -~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 -PTLS---QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -ccCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             0000   01113456888999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-39  Score=300.69  Aligned_cols=252  Identities=27%  Similarity=0.398  Sum_probs=200.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-----hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-----EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ++|+..+.||+|++|.||++... +++.+|+|.+....     ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46889999999999999999865 48899999886432     1234578899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      |+||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            99999999999888543   24788889999999999999999998   9999999999999999999999999997654


Q ss_pred             CCCcccc-cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQAN-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.....     ............      
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~------  224 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-----MAAIFKIATQPT------  224 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-----HHHHHHHhccCC------
Confidence            3221111 1234578899999999998899999999999999999999999853211     111111111111      


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ....+.     .....+.+++.+||..+|++||++.++++.
T Consensus       225 ~~~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         225 NPQLPS-----HVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCCc-----cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            011111     134568889999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.2e-40  Score=317.26  Aligned_cols=242  Identities=23%  Similarity=0.266  Sum_probs=186.8

Q ss_pred             cccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHH-HHHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEA-SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||+||+|.+.. ++.+|+|++....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999999764 6789999986432   12223344444 456778999999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++....   .+.......++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~  152 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT  152 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence            99998885432   3677888889999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...........        .....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~--------~~~~~--  217 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNKP--------LQLKP--  217 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCC--------cCCCC--
Confidence            2345799999999999999999999999999999999999999853221     11111111111        00011  


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                         ..+..+.+++.+||+.+|.+||++.+.+..
T Consensus       218 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         218 ---NITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             ---CCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence               134467889999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-38  Score=297.22  Aligned_cols=249  Identities=29%  Similarity=0.391  Sum_probs=198.9

Q ss_pred             cccCCCCceeEEEEEecC--C--CEEEEEEcCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK--G--DEIAVKRLSGRSE-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|+..+++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998753  3  3689999987655 566789999999999999999999999988 888999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc-c
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ-A  274 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~  274 (436)
                      ++|..++..... ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865432 45899999999999999999999988   999999999999999999999999999876442211 1


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......     +............      ... 
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~~------~~~-  223 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKIDKEGERL------ERP-  223 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhcCCcC------CCC-
Confidence            1122356788999999998899999999999999999999 99997532211     1111111111000      000 


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                          ...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       224 ----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         224 ----EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                113457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.3e-39  Score=302.00  Aligned_cols=257  Identities=28%  Similarity=0.445  Sum_probs=202.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC----CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..+|++.+.||+|+||.||+|.+..    +..+|+|.+.... ......+.+|+.++.+++||||+++.+++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            3568888999999999999998642    3369999987542 3445688999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++++|.+++....  ..+++.....++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999999986432  34788999999999999999999988   9999999999999999999999999998664


Q ss_pred             CCCccc-ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          269 GNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       269 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ...... ......++..|+|||.+.+..++.++|+||||+++||+++ |..||......  +....    .....  .  
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~----~~~~~--~--  227 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKA----IEEGY--R--  227 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHH----HhCCC--c--
Confidence            322111 1111233567999999998889999999999999999887 99997543211  11111    11110  0  


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                       .+. .     ...+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus       228 -~~~-~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -LPA-P-----MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -CCC-C-----CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence             010 0     01345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.7e-39  Score=316.50  Aligned_cols=257  Identities=21%  Similarity=0.268  Sum_probs=199.4

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      .....++|++.+.||+|+||.||++..+. ++.+|+|++...   .......+.+|..+++.++||||+++++++.+.+.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            44556899999999999999999999764 788999998642   22334567889999999999999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++||||+++|+|..++...    .++......++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            99999999999999988532    3678888899999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccCCccchhhhccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      ....... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....     ............
T Consensus       191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~  264 (371)
T cd05622         191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNHKN  264 (371)
T ss_pred             EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCC
Confidence            7643221 122345799999999998754    378999999999999999999999854221     111222211111


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADD--RPTMNDVVSM  388 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~ev~~~  388 (436)
                      .......         ...+..+.+++..|+..++.+  ||++.|+++.
T Consensus       265 ~~~~~~~---------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         265 SLTFPDD---------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             cccCCCc---------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1111110         113456788999999844433  7889988875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2e-39  Score=306.62  Aligned_cols=262  Identities=26%  Similarity=0.397  Sum_probs=203.9

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-----CCCEEEEEEcCCCChh-hHHHHHHHHHHHHHcCCCceeEEeeEEEe--CCcc
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-----KGDEIAVKRLSGRSEQ-GLREMKNEASVIAKVQHKNLVRLLGCCID--KDEK  186 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  186 (436)
                      ..|+..+.||+|+||.||+|.+.     .+..+|+|.+...... ..+.+.+|++.++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999854     3678999999865443 46789999999999999999999999887  5578


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      +++|||+++++|.+++.....  .+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999999865332  4889999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcc---------hhHHHHHH
Q 040532          267 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN---------LLGYVWDL  336 (436)
Q Consensus       267 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~---------~~~~~~~~  336 (436)
                      ....... .......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.........         ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            6532211 1111224456799999998888999999999999999999999987543221110         00011111


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      ......        ...   ...++..+.+++.+||+.+|++||++.|++++|+.+
T Consensus       239 ~~~~~~--------~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGER--------LPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCc--------CCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111100        000   011345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-41  Score=288.52  Aligned_cols=249  Identities=25%  Similarity=0.321  Sum_probs=204.3

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..++|++.+.||+|.||.||.|+.+. +-.||+|++.+..   .....++.+|+++-..|+||||++++++|.++...||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            34678999999999999999999654 6789999986542   2234678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ++||.++|++...|.... ...+++.....+..|+|.|+.|+|..+   ++||||||+|+|++.++.+|++|||-+..-.
T Consensus       100 ilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            999999999999887432 234788888999999999999999988   9999999999999999999999999986533


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                          .......+||..|.+||...+..++...|+|++|++.||++.|.+||.....+  ..   +.....    .+...+
T Consensus       176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--et---YkrI~k----~~~~~p  242 (281)
T KOG0580|consen  176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--ET---YKRIRK----VDLKFP  242 (281)
T ss_pred             ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--HH---HHHHHH----ccccCC
Confidence                22344569999999999999999999999999999999999999999643311  11   111111    111111


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                               ...+....++|.+|+..+|.+|.+..|++.
T Consensus       243 ---------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  243 ---------STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ---------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence                     114557889999999999999999999875

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.5e-40  Score=317.66  Aligned_cols=240  Identities=23%  Similarity=0.288  Sum_probs=187.1

Q ss_pred             cccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHH-HHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||+||+|... +|+.+|+|++...   .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999965 4889999998643   2223344555554 46778999999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++...   ..+++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++.......  ..
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  152 (325)
T cd05604          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT  152 (325)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence            9998887543   34889999999999999999999998   9999999999999999999999999987532111  12


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+     ............ .       ....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~~~~~-~-------~~~~--  217 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNILHKP-L-------VLRP--  217 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHHHcCC-c-------cCCC--
Confidence            234578999999999999999999999999999999999999985422     111111111111 0       0011  


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTMNDVV  386 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~  386 (436)
                         ..+..+.+++.+|++.+|.+||++.+.+
T Consensus       218 ---~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         218 ---GASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ---CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence               1234677899999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-39  Score=318.48  Aligned_cols=264  Identities=19%  Similarity=0.232  Sum_probs=199.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec---CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR---KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ...+|++.+.||+|+||.||++...   .+..||+|.+...     ....+|+.++++++||||+++++++......++|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            4567999999999999999999754   2567999988653     2346899999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      ||++. ++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++.....
T Consensus       165 ~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        165 MPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99996 567777632   235899999999999999999999998   99999999999999999999999999986654


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC-cchhHHHHHHhhcCCcc-----
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYVWDLWTSNRTL-----  343 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~-----  343 (436)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+..........     
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            433333344579999999999999999999999999999999999999985433221 11111111110000000     


Q ss_pred             ------------eeccC-CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          344 ------------ELIDD-PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       344 ------------~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                                  ..... ...+...........+.+++.+||..||++||++.|++..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                        00000 0000000001123467889999999999999999999875

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-39  Score=296.94  Aligned_cols=248  Identities=29%  Similarity=0.427  Sum_probs=197.9

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCChh
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD  199 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  199 (436)
                      +.||+|+||.||++.+.+++.|++|.+..... .....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999987799999999876533 35578899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccc
Q 040532          200 FFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI  279 (436)
Q Consensus       200 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  279 (436)
                      +++....  ..+++.....++.+++.|++|||+.+   ++||||||+||+++.++.++|+|||++...............
T Consensus        81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9885432  24788899999999999999999988   999999999999999999999999999765432222221222


Q ss_pred             cccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchH
Q 040532          280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK  358 (436)
Q Consensus       280 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (436)
                      ..+..|+|||.+.++.++.++|+||||+++|||+| |..||......  ..    ........      ....+     .
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~----~~~~~~~~------~~~~~-----~  218 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QT----RERIESGY------RMPAP-----Q  218 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HH----HHHHhcCC------CCCCC-----c
Confidence            34567999999998899999999999999999999 78887433211  11    11111110      00001     1


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       359 ~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      ..+..+.+++.+|++.+|.+||++.|+++.|+
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            13457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-38  Score=296.07  Aligned_cols=249  Identities=33%  Similarity=0.476  Sum_probs=196.0

Q ss_pred             cccCCCCceeEEEEEecC----CCEEEEEEcCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK----GDEIAVKRLSGRSE-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||.||+|.+..    +..+|+|.+..... ...+.+.+|+.++++++|||++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998532    26899999986543 34567899999999999999999999875 5567999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc-
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA-  274 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-  274 (436)
                      ++|.+++....   .+++..+..++.|++.||+|||..+   ++|+||||+||+++.++.+||+|||+++......... 
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999986543   4889999999999999999999988   9999999999999999999999999998664332211 


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....  .....+    ........      ...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~----~~~~~~~~------~~~  221 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAM----LESGERLP------RPE  221 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHH----HHcCCcCC------CCC
Confidence            1111234567999999998899999999999999999998 9999854321  111111    11111100      011


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                           ..+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       222 -----~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         222 -----ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                 13456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.2e-39  Score=303.14  Aligned_cols=263  Identities=25%  Similarity=0.329  Sum_probs=196.3

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|++.+.||+|++|.||+|... +++.||+|.+....  ......+.+|+.++++++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999975 48899999986432  22346678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      ++ ++|..++........+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 578777755444456899999999999999999999988   9999999999999999999999999987654321 


Q ss_pred             ccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh-------hcCC---
Q 040532          273 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW-------TSNR---  341 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~---  341 (436)
                       .......+++.|+|||.+.+. .++.++||||||+++|||+||+.||....... ..........       ....   
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhH
Confidence             112223568899999988754 47899999999999999999999986432110 0000000000       0000   


Q ss_pred             ----cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 ----TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                          .............  ....+.++.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSA--VKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHh--cCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                0000000000000  0113456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-39  Score=302.54  Aligned_cols=259  Identities=28%  Similarity=0.438  Sum_probs=204.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CC----EEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GD----EIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ..+|++.+.||+|+||.||+|.+++ |.    .+|+|.+.... ......+.+|+..+++++|||++++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            3567888999999999999998653 33    58999887653 3445778899999999999999999999887 7889


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +|+||+++|+|.+++....  ..+++.....++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++...
T Consensus        85 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            9999999999999986533  23889999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .............++..|+|||.+....++.++|+||||+++||+++ |+.||.....     .++. ........   .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~-~~~~~~~~---~  230 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIP-DLLEKGER---L  230 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHH-HHHhCCCC---C
Confidence            53322111112234568999999988889999999999999999998 9999854321     1111 11111110   0


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                         ..+..     +...+.+++.+||..+|++||++.++++.|++..++
T Consensus       231 ---~~~~~-----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         231 ---PQPPI-----CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             ---CCCCC-----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence               00000     234678899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.9e-39  Score=302.63  Aligned_cols=252  Identities=28%  Similarity=0.436  Sum_probs=198.8

Q ss_pred             CCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhH--HHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGL--REMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      |+..+.||+|+||+||++.... ++.+|+|.+........  ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5677899999999999999775 56899999987654432  23456999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++++|.+++.   ....+++..+..++.|+++||.+||+.+   ++|+||||+||++++++.++|+|||.+.....  ..
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence            9999999986   3345899999999999999999999998   99999999999999999999999999986421  12


Q ss_pred             cccccccccCCccchhhhc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          274 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                      .......++..|+|||.+. +..++.++|+||+|+++|+|++|..||.....  .+............ ...        
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~-~~~--------  221 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKRP-LPS--------  221 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHTH-HHH--------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhccccc-ccc--------
Confidence            2333457889999999998 78899999999999999999999999864410  11111111111000 000        


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...........+.+++.+||+.||++||++.++++
T Consensus       222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000001257899999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6e-39  Score=299.02  Aligned_cols=249  Identities=29%  Similarity=0.406  Sum_probs=198.7

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe-CCccEEEEeec
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILIYEYM  193 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  193 (436)
                      .+|++.+.||+|+||.||++... |..+|+|.+.....  .+.+.+|+.++++++|+|++++++++.. .+..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999876 88899999865432  4578899999999999999999997654 45689999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++++|.+++.... ...+++.....++.|++.||+|||+++   ++||||||+||++++++.+||+|||++.......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            9999999886432 234788999999999999999999988   9999999999999999999999999987543221  


Q ss_pred             cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                         ....++..|+|||.+.+..++.++|||||||++|||++ |+.||....     ........ ....      .....
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~-~~~~------~~~~~  221 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRV-EKGY------KMDAP  221 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH-hcCC------CCCCC
Confidence               12234568999999998889999999999999999998 888875322     11111111 1110      00111


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      .     ..+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus       222 ~-----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         222 D-----GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             C-----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            1     1345788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-38  Score=305.74  Aligned_cols=261  Identities=23%  Similarity=0.303  Sum_probs=199.7

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|++++.+++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999965 4778899988754 333456688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      +++++|.+++...   ..+++.....++.|++.||.|||+ .+   ++|+||||+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999998643   347889999999999999999997 45   999999999999999999999999998654322 


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc--------
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--------  343 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  343 (436)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..  ....+...........        
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccC
Confidence               122346889999999998888999999999999999999999998533211  1111000000000000        


Q ss_pred             ---------------eeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          344 ---------------ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       344 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                                     +.+.... ....+....+..+.+++.+||+.+|++||++.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                           0000000 0000011134568899999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.1e-39  Score=305.00  Aligned_cols=252  Identities=24%  Similarity=0.384  Sum_probs=203.4

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ...++|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++||
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            34578999999999999999999964 58999999997655555567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|.+++..    ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999998853    23788899999999999999999988   999999999999999999999999998765432


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      ..  ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..........     .....       ..+.
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----~~~~~-------~~~~  234 (297)
T cd06656         169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATN-------GTPE  234 (297)
T ss_pred             cc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----eeccC-------CCCC
Confidence            21  1223468889999999998889999999999999999999999985432111000     00000       0000


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..   ........+.+++.+||+.+|++||++.++++
T Consensus       235 ~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 LQ---NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00   01123456788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-39  Score=300.26  Aligned_cols=250  Identities=30%  Similarity=0.418  Sum_probs=194.9

Q ss_pred             cccCCCCceeEEEEEecC-CC--EEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK-GD--EIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||.||+|.+.+ +.  .+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999754 33  4788988753 344556788999999999 899999999999999999999999999


Q ss_pred             CChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          196 KSLDFFLFDPT-------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       196 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                      |+|.+++....             ....+++.....++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999885432             1234788999999999999999999988   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      ++.....   .........+..|+|||++....++.++|+||||+++|||++ |..||.....     ....... ....
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~-~~~~  228 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKL-PQGY  228 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHHH-hCCC
Confidence            9853221   111111233567999999988889999999999999999997 9999843221     1111111 1110


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                      ...      ..     ......+.+++.+|++.+|.+||++.+++..|+++.
T Consensus       229 ~~~------~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 RLE------KP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCC------CC-----CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            000      00     013346889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-40  Score=317.08  Aligned_cols=262  Identities=29%  Similarity=0.438  Sum_probs=214.1

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .++....+...-.+||-|.||.||.|.|+. .-.||||.++.. ....++|..|+.+|+.++|||+|+++|+|..+...|
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            344444555666789999999999999986 567999999864 455789999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +|+|||.+|+|.+||.+.. +..++....+.++.||.+||+||...+   ++||||.++|+|+.++..+|++|||+++++
T Consensus       340 IiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence            9999999999999997643 344677788999999999999999988   999999999999999999999999999988


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ....+.. .....-...|.|||.+....++.|+|||+|||+|||+.| |-.||..-     ++. .++..+..+..++  
T Consensus       416 tgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlS-qVY~LLEkgyRM~--  486 (1157)
T KOG4278|consen  416 TGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLS-QVYGLLEKGYRMD--  486 (1157)
T ss_pred             cCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHH-HHHHHHhcccccc--
Confidence            7655433 222344678999999999999999999999999999998 66776432     221 2233333222111  


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                               ....|+..+++|++.||+.+|.+||+++|+-+.++...
T Consensus       487 ---------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  487 ---------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             ---------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                     11227788999999999999999999999999888765

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-38  Score=319.18  Aligned_cols=264  Identities=18%  Similarity=0.223  Sum_probs=195.9

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ....|.+.+.||+|+||.||+|.+.. ++.||+|....      ..+.+|++++++++|+||+++++++..++..++|||
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35579999999999999999999765 78899996432      245789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      ++. ++|..++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       241 ~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        241 KYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             ccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            995 67777764322  25899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCC-CCCCCC-CcchhHHHHHHhhcCCc-----ce
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT-GLYRTD-SLNLLGYVWDLWTSNRT-----LE  344 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~-~~~~~~-~~~~~~~~~~~~~~~~~-----~~  344 (436)
                      .........||..|+|||++.+..++.++|||||||++|||++|..++ ...... .......+.........     ..
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            222223457999999999999999999999999999999999988654 221111 11111111111111000     00


Q ss_pred             ecc---------------CCccc-cccc-hHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          345 LID---------------DPVLE-DEYS-SKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       345 ~~~---------------~~~~~-~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ...               .+... ..+. .......+.+|+.+||+.||.+|||+.|+++.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000               00000 0000 00122367889999999999999999999864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=325.58  Aligned_cols=255  Identities=28%  Similarity=0.421  Sum_probs=209.6

Q ss_pred             CCCcccCCCCceeEEEEEec-CCC----EEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          118 SDTNKLGEGGFGPVYKGVLR-KGD----EIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       118 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ...++||+|+||+||+|.+- +|+    +||+|++... ..+...++.+|+-.|.+++|||+++++|+|..+. ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            44578999999999999853 343    6899998754 4555688999999999999999999999998776 889999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |++.|+|.++++..  +..+.....+.|..|||+||.|||.+.   ++||||..+|||+.+-..+|+.|||+++......
T Consensus       778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            99999999999764  345888999999999999999999988   9999999999999999999999999999887665


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      .........-.+.|||-|.+....|+.++|||||||++||++| |..|+.....++      +.+.+..++.        
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------I~dlle~geR--------  918 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------IPDLLEKGER--------  918 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------hhHHHhcccc--------
Confidence            5554444455778999999999999999999999999999998 888875433221      2222222211        


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      ++   ....++.+++-++.+||..|+..||+++++...+++...+
T Consensus       919 Ls---qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  919 LS---QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             CC---CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            11   1112677899999999999999999999999999887754

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.7e-39  Score=314.27  Aligned_cols=263  Identities=24%  Similarity=0.281  Sum_probs=194.5

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC-----
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  184 (436)
                      ..++|++.+.||+|+||.||++.+. .|..||+|++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999975 4889999998643  3334567889999999999999999999986543     


Q ss_pred             -ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          185 -EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       185 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                       ..++||||++++ |...+..     .+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~-l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDAN-LCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCcC-HHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             468999999765 4444421     2678888899999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhH------------
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG------------  331 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~------------  331 (436)
                      +.......   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... .+..            
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~  245 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEF  245 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHH
Confidence            97543221   1223468999999999999999999999999999999999999996432110 0000            


Q ss_pred             ------HHHHHhhcCCcc------eeccCCcccc-ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          332 ------YVWDLWTSNRTL------ELIDDPVLED-EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       332 ------~~~~~~~~~~~~------~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                            .+..........      +.......+. ..........+.+++.+||+.||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  000000000000      0000000000 00011123567899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.5e-39  Score=298.80  Aligned_cols=255  Identities=30%  Similarity=0.452  Sum_probs=203.5

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ..++|++.+.||+|+||.||++.++++..+++|.+.... ...+.+.+|+.++++++|+|++++.+++.+ ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            456789999999999999999998778889999887543 335678899999999999999999999877 778999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            99999999986532 335788899999999999999999988   99999999999999999999999999976543222


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      . ......++..|+|||.+....++.++|+||||+++|+|++ |+.||.....  ....    .........     .. 
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~----~~~~~~~~~-----~~-  224 (260)
T cd05073         158 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVI----RALERGYRM-----PR-  224 (260)
T ss_pred             c-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHH----HHHhCCCCC-----CC-
Confidence            1 1122345677999999998889999999999999999999 8888753221  1111    111111110     00 


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      .     ...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       225 ~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 P-----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             c-----ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0     1134568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.4e-39  Score=301.80  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=200.1

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .++|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            457888899999999999999865 4889999998766555556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++....   .+++.....++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          88 CGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            99999999885432   4889999999999999999999998   9999999999999999999999999987654221 


Q ss_pred             ccccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          273 QANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                       .......|+..|+|||.+.   ...++.++|+|||||++|+|++|+.||....... .    ........     ...+
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~----~~~~~~~~-----~~~~  229 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-A----LFLMTKSN-----FQPP  229 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-h----HHhhhccC-----CCCC
Confidence             1223347899999999875   4568899999999999999999999974322110 0    00000000     0011


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .....   ...+..+.+++.+||+.+|++||++.++++
T Consensus       230 ~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KLKDK---MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccccc---CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            11100   012346788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.4e-39  Score=307.46  Aligned_cols=263  Identities=23%  Similarity=0.350  Sum_probs=196.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|+..+.||+|+||+||+|... .++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999976 47889999987442 22234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++ +|..++....  ..+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++........
T Consensus        86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            986 6776664432  34788889999999999999999988   99999999999999999999999999876432221


Q ss_pred             ccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhh-----------cC
Q 040532          273 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT-----------SN  340 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~  340 (436)
                        ......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||.......  ..........           ..
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED--ELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHhhhcch
Confidence              1223467899999998875 468999999999999999999999986433211  1111111100           00


Q ss_pred             CcceeccCCcccc---ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 RTLELIDDPVLED---EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ........+....   .......+..+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000000000   0000113456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-38  Score=308.99  Aligned_cols=255  Identities=20%  Similarity=0.243  Sum_probs=195.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||++..+. ++.+|+|++...   .......+.+|..++..++|+||+++.+++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            368889999999999999999765 678999998642   2223445788999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++....  ..+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999986432  24788889999999999999999998   999999999999999999999999998754322


Q ss_pred             CcccccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          271 ELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||....     ................ 
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~-  228 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKERFQ-  228 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCCcccc-
Confidence            21 1222347999999999986     3468899999999999999999999985322     1112222211111110 


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADD--RPTMNDVVSM  388 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~ev~~~  388 (436)
                           .+...  ...+..+.+++.+|+..++++  |+++.|+++.
T Consensus       229 -----~p~~~--~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 -----FPAQV--TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -----CCCcc--ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                 11100  113456788999988654443  6888888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.5e-39  Score=324.25  Aligned_cols=261  Identities=18%  Similarity=0.293  Sum_probs=189.3

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--------
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--------  183 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  183 (436)
                      ..++|++.+.||+|+||.||+|... .++.||+|++....    ....+|+.++++++||||+++.+++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            4567999999999999999999975 48899999886532    2345799999999999999999887532        


Q ss_pred             CccEEEEeecCCCChhhhhcC-CCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC-CeEEeec
Q 040532          184 DEKILIYEYMPNKSLDFFLFD-PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDF  261 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~-~~kl~Df  261 (436)
                      ...++||||+++ +|..++.. ......+++.....++.|++.||+|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            135689999986 55554432 223345889999999999999999999998   99999999999999664 7999999


Q ss_pred             cCceecCCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          262 GMARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      |+++......   ......||+.|+|||++.+. .++.++|||||||++|||++|.+||......  +............
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p  290 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTP  290 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCC
Confidence            9998654322   12234689999999998764 6899999999999999999999998543211  1111111111100


Q ss_pred             Cc----------cee----ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 RT----------LEL----IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ~~----------~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..          ...    .....+.... ....+.++.+++.+||+.||.+|||+.|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVF-PKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHh-ccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00          000    0000000000 0113457889999999999999999999884

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.8e-39  Score=299.93  Aligned_cols=239  Identities=22%  Similarity=0.357  Sum_probs=187.5

Q ss_pred             cccCCCCceeEEEEEecC-------------CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          121 NKLGEGGFGPVYKGVLRK-------------GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      +.||+|+||.||+|+...             ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2258999987655555567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC-------eEEee
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-------PKISD  260 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~-------~kl~D  260 (436)
                      +||||+++++|..++....  ..+++.....++.|+++||+|||+.+   ++||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999998885432  34788999999999999999999988   999999999999987664       89999


Q ss_pred             ccCceecCCCCcccccccccccCCccchhhhc-cCCCCcccchhhHHHHHHHHH-hCCCCCCCCCCCCcchhHHHHHHhh
Q 040532          261 FGMARICGGNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIV-SGKKNTGLYRTDSLNLLGYVWDLWT  338 (436)
Q Consensus       261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~  338 (436)
                      ||++......      ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+.......      ......
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~  223 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------KERFYE  223 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------HHHHHh
Confidence            9998654321      2235778899999887 466899999999999999998 5777764321110      001111


Q ss_pred             cCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          339 SNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                      .. . .     ...   +   ....+.+++.+||+.||.+||++.++++.|
T Consensus       224 ~~-~-~-----~~~---~---~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 GQ-C-M-----LVT---P---SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             cC-c-c-----CCC---C---ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            00 0 0     000   0   234678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.3e-39  Score=301.45  Aligned_cols=251  Identities=31%  Similarity=0.486  Sum_probs=197.4

Q ss_pred             cccCCCCceeEEEEEecC-------CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          121 NKLGEGGFGPVYKGVLRK-------GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +.||+|+||.||+|+..+       +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998653       2578999886543 33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCC----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC-----CeEEeeccC
Q 040532          193 MPNKSLDFFLFDPT----KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-----NPKISDFGM  263 (436)
Q Consensus       193 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~-----~~kl~DfGl  263 (436)
                      +++++|.+++....    ....+++.....++.|++.||+|||+.+   ++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986422    2234788999999999999999999988   99999999999999877     899999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      +................++..|+|||.+.++.++.++||||||+++|||++ |+.||.....  .+..   .. ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~---~~-~~~~~~  231 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVL---QH-VTAGGR  231 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHH---HH-HhcCCc
Confidence            976543332222223345678999999999999999999999999999998 9999853221  1111   11 111100


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      .      ..     ....+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       232 ~------~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         232 L------QK-----PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             c------CC-----cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            0      00     11145678899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.1e-39  Score=312.63  Aligned_cols=241  Identities=24%  Similarity=0.324  Sum_probs=190.5

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  190 (436)
                      +|+..+.||+|+||+||+|... +|+.||+|++...   .....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677889999999999999965 4889999998743   2233456778888888885 577888999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|..++....   .+++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++......
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999998885432   4889999999999999999999988   999999999999999999999999998753322


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      .  .......||+.|+|||++.+..++.++|+||+||++|||++|+.||......     ..........        ..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i~~~~--------~~  219 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-----ELFQSIMEHN--------VS  219 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCC--------CC
Confidence            1  1223346899999999999989999999999999999999999998543211     1111111111        00


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTM  382 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  382 (436)
                      .+.     ..+..+.+++.+||+.+|.+|++.
T Consensus       220 ~p~-----~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 YPK-----SLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCc-----cCCHHHHHHHHHHcccCHhhCCCC
Confidence            111     133467889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=304.19  Aligned_cols=253  Identities=25%  Similarity=0.406  Sum_probs=202.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .++|++.+.||.|+||.||++.+. ++..+|+|.+........+.+..|++++++++|||++++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467899999999999999999975 4889999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|..++....  ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            99999999885432  34889999999999999999999998   9999999999999999999999999987543221 


Q ss_pred             ccccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          273 QANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                       .......++..|+|||.+.     ...++.++|+||||+++|||++|+.||......     ..........       
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~-------  224 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVLLKILKSE-------  224 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----HHHHHHhcCC-------
Confidence             1122346888999999885     344778999999999999999999998543211     1111111110       


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      .+...   .....+..+.+++.+||+.+|.+||++.++++.
T Consensus       225 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         225 PPTLD---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCCcC---CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            00000   011134568899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.5e-39  Score=302.48  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=197.3

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeC------
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK------  183 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------  183 (436)
                      .+++.|+..+.||+|+||.||+|.... ++.+|+|++.... .....+..|+.++.++ +|+|++++.+++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            456788999999999999999999754 7889999986543 2335788999999998 799999999998763      


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      ...+++|||+++++|.+++.... ...+++.....++.|++.|++|||+.+   ++|+||||+||++++++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            35789999999999999886532 335889999999999999999999988   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhh
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT  338 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  338 (436)
                      +.......  .......|+..|+|||++.     +..++.++|||||||++|||++|+.||......    ... .....
T Consensus       158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~-~~~~~  230 (272)
T cd06637         158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RAL-FLIPR  230 (272)
T ss_pred             ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHH-HHHhc
Confidence            87653221  1223346889999999986     345788999999999999999999998532211    101 00000


Q ss_pred             cCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          339 SNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ..     ......     ...+..+.+++.+||..+|.+||++.++++
T Consensus       231 -~~-----~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 -NP-----APRLKS-----KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -CC-----CCCCCC-----CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             00     000011     113456889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.7e-39  Score=309.12  Aligned_cols=255  Identities=20%  Similarity=0.242  Sum_probs=195.5

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||++... +++.||+|.+...   .......+.+|..++..++|+||+++.+++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999976 4788999998642   2233456788999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|..++....  ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999986532  24788889999999999999999988   999999999999999999999999999765433


Q ss_pred             CcccccccccccCCccchhhhcc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          271 ELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      .. .......||+.|+|||++.+     +.++.++|||||||++|||++|+.||....     ................ 
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~-  228 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHEERFQ-  228 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-----HHHHHHHHHcCCCccc-
Confidence            22 12223469999999999875     567899999999999999999999985322     1111111111111000 


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADD--RPTMNDVVSM  388 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~ev~~~  388 (436)
                           .+...  ...+..+.+++.+|+..++.+  |++++++++.
T Consensus       229 -----~p~~~--~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 -----FPSHI--TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -----CCCcc--ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                 11111  113456888999999865544  4578777653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.4e-39  Score=315.44  Aligned_cols=263  Identities=23%  Similarity=0.303  Sum_probs=195.3

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC-----ccE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKI  187 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  187 (436)
                      +|++.+.||+|+||.||++.+. +|+.||+|++...  .......+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999964 5899999998653  2334567889999999999999999999998776     779


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +|+||+. ++|..++...   ..+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus        81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 4676666432   34889999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc----
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT----  342 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  342 (436)
                      ..... .......++..|+|||.+.+. .++.++||||+||++|||++|+.||......  .....+.........    
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHH
Confidence            43221 112233678899999998874 4799999999999999999999998643311  111111110000000    


Q ss_pred             ----------cee-ccCCccccc-cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          343 ----------LEL-IDDPVLEDE-YSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       343 ----------~~~-~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                                ... ...+..... .........+.+++.+||+.||++|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                      000 000000000 0001124567899999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-39  Score=314.10  Aligned_cols=237  Identities=22%  Similarity=0.280  Sum_probs=184.6

Q ss_pred             cccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHH-HHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||.||+|... +|+.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 47889999986432   222334455544 67888999999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      ++|...+...   ..++......++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (321)
T cd05603          81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET  152 (321)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence            9998877542   34778888899999999999999988   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+     ............        ...+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~--------~~~~~~-  218 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHKP--------LQLPGG-  218 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcCC--------CCCCCC-
Confidence            233578999999999998899999999999999999999999985422     111111111110        011111 


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCHH
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTMN  383 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~~  383 (436)
                          ....+.+++.+||+.+|.+||+..
T Consensus       219 ----~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         219 ----KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ----CCHHHHHHHHHHccCCHhhcCCCC
Confidence                234678899999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=320.74  Aligned_cols=253  Identities=30%  Similarity=0.393  Sum_probs=205.4

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC--CC--EEEEEEcCCCChh-hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK--GD--EIAVKRLSGRSEQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      +.....++||+|+||.|++|.|..  |+  .||||++...... ...+|.+|+..|.+|+|+|+++|+|+..+ ....||
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            445566889999999999999864  44  4899999876543 56899999999999999999999999887 788999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      ||.++.|+|.+.|++ .....+.......++.|||.||.||.+++   +|||||..+|+||-....+||+|||+.+-++.
T Consensus       189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999987 44556788889999999999999999998   99999999999999999999999999998876


Q ss_pred             CCcccc-cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          270 NELQAN-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       270 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ++.... .....-...|+|||.+....++.++|||+|||++|||+| |..||-.-..               -.+++.+|
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---------------~qIL~~iD  329 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---------------IQILKNID  329 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---------------HHHHHhcc
Confidence            543332 222345668999999999999999999999999999999 5677633211               11222222


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                      +...-.  ..+.+++++++++.+||..+|.+||++..+.+.+
T Consensus       330 ~~erLp--RPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLP--RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCC--CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            211111  1122788999999999999999999999998544

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=300.46  Aligned_cols=248  Identities=24%  Similarity=0.429  Sum_probs=202.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|+..+.||.|++|.||+|.+. +++.+|+|.+.... ......+.+|+.+++.++|+|++++.+++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999975 48899999987543 44456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++...    .+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999988543    5889999999999999999999988   9999999999999999999999999998765332 


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                       .......++..|+|||.+.+..++.++||||||+++|+|+||+.||......     ...... ...      ..+...
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~-~~~------~~~~~~  219 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLFLI-PKN------NPPSLE  219 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHHHh-hhc------CCCCCc
Confidence             1223346788999999999888999999999999999999999998543211     011111 111      011111


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..    ..+..+.+++.+||..+|++||+++++++
T Consensus       220 ~~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 GN----KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cc----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11    13456888999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.2e-39  Score=298.27  Aligned_cols=250  Identities=22%  Similarity=0.295  Sum_probs=200.8

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      +|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++|+|++++.+.+..++..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999975 4888999998643 3445577889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++++|.+++... ....++......++.|++.||.|||+.+   ++|+||||+||++++++.++++|||++........ 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999998887542 2334788899999999999999999988   99999999999999999999999999976543221 


Q ss_pred             cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                       ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....     .......... ....      ..+.
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~-~~~~------~~~~  222 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQ-GSYK------PLPS  222 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhc-CCCC------CCCc
Confidence             1223468889999999998889999999999999999999999985322     1111111111 1100      0111


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                           ..+..+.+++.+||+.||++||++.+++..
T Consensus       223 -----~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 -----HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -----ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                 133467889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.2e-39  Score=297.63  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=200.8

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      ..|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46778899999999999999987788999999875432 23568899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +++|.+++....  ..+++.....++.+++.|++|||+.+   ++|+||||+||+++.++.++|+|||++..........
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            999999885432  24788999999999999999999988   9999999999999999999999999987654332211


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                       .....++..|+|||.+.++.++.++||||||+++|||++ |..||.....     ....... ...  ......    .
T Consensus       158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~-~~~--~~~~~~----~  224 (256)
T cd05112         158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETI-NAG--FRLYKP----R  224 (256)
T ss_pred             -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHH-hCC--CCCCCC----C
Confidence             122235678999999998889999999999999999998 8888753221     1111111 111  000001    1


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      .     .+..+.+++.+||+.+|++||++.++++.|.
T Consensus       225 ~-----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 L-----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             C-----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            1     2356889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-38  Score=299.28  Aligned_cols=249  Identities=28%  Similarity=0.472  Sum_probs=198.0

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh---------hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE---------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      +|.+.+.||+|++|.||+|... +++.+|+|.+.....         ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677889999999999999865 478899998864321         123568899999999999999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++++||+++++|..++...   ..+++.....++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999999998543   34788889999999999999999988   9999999999999999999999999998


Q ss_pred             ecCCCCccc----ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          266 ICGGNELQA----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       266 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      .........    ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.....    .. .+..... . 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~-~~~~~~~-~-  227 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQ-AIFKIGE-N-  227 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HH-HHHHHhc-c-
Confidence            765322111    11223578899999999988899999999999999999999999854321    10 1111100 0 


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                          . .+....     ..+..+.+++.+||+.+|.+||++.|+++
T Consensus       228 ----~-~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ----A-SPEIPS-----NISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ----C-CCcCCc-----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                0 011111     13456889999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3e-38  Score=296.41  Aligned_cols=256  Identities=25%  Similarity=0.390  Sum_probs=198.9

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ..++++.....||+|+||.||+|.+. ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34555666678999999999999965 47789999988776666778999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-CCCeEEeeccCceecCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGG  269 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-~~~~kl~DfGla~~~~~  269 (436)
                      ||+++++|.+++.........++.....++.|++.||+|||+.+   ++||||||+||+++. ++.++|+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999999999865322212377888899999999999999988   999999999999986 67999999999876543


Q ss_pred             CCcccccccccccCCccchhhhccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ...  ......++..|+|||.+.+..  ++.++|+||||+++|+|++|+.||..........    ...   . ...  .
T Consensus       162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~~---~-~~~--~  229 (268)
T cd06624         162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FKV---G-MFK--I  229 (268)
T ss_pred             CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hhh---h-hhc--c
Confidence            221  122235788999999987643  7899999999999999999999985422111000    000   0 000  0


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .+..+     ......+.+++.+||+.+|++||++.|+++
T Consensus       230 ~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         230 HPEIP-----ESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CCCCC-----cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            01111     113456889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.1e-39  Score=305.88  Aligned_cols=259  Identities=28%  Similarity=0.443  Sum_probs=201.6

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CC----EEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GD----EIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .++|+..+.||+|+||.||+|.+.. |.    .+|+|.+.... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCce
Confidence            3567788999999999999998643 43    47999887543 3334578899999999999999999999865 4567


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +++||+++|+|.+++....  ..+++.....++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            9999999999999885432  24788899999999999999999988   999999999999999999999999999866


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.||.....  ...    ..........   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~----~~~~~~~~~~---  230 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REI----PDLLEKGERL---  230 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHH----HHHHHCCCCC---
Confidence            43332222223345678999999998899999999999999999997 8888753211  111    1111111110   


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                         ....     .....+.+++.+||..+|++||++.++++.|..+..+
T Consensus       231 ---~~~~-----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 ---PQPP-----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             ---CCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence               0000     1234688899999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.3e-38  Score=299.12  Aligned_cols=257  Identities=23%  Similarity=0.343  Sum_probs=203.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCC----CEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKG----DEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      .++|++.+.||+|+||.||+|.+.+.    ..|++|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            45688889999999999999986432    468999887654 4556789999999999999999999998865 56789


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++++|.+++....  ..+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            999999999999986432  24789999999999999999999988   9999999999999999999999999998664


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ....... ....++..|+|||.+....++.++||||||+++|||++ |..||......  ..   .... ......    
T Consensus       159 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~---~~~~-~~~~~~----  227 (270)
T cd05056         159 DESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DV---IGRI-ENGERL----  227 (270)
T ss_pred             cccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HH---HHHH-HcCCcC----
Confidence            4322211 12234568999999988889999999999999999986 99998543211  11   1111 111100    


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                        ...     ...+..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus       228 --~~~-----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 --PMP-----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             --CCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence              011     1134578899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.8e-39  Score=317.97  Aligned_cols=252  Identities=22%  Similarity=0.311  Sum_probs=193.9

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|+..+.||+|+||+||++... .++.||+|++...   .......+.+|..++.+++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999976 4889999998643   2333567888999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            999999999998543   34788999999999999999999998   999999999999999999999999998754211


Q ss_pred             Ccc---------------------------------cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCC
Q 040532          271 ELQ---------------------------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK  317 (436)
Q Consensus       271 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~  317 (436)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            000                                 00113469999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 040532          318 NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT---MNDVVS  387 (436)
Q Consensus       318 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~ev~~  387 (436)
                      ||......     ..............      .+...   ..+..+.+++.+|+ .+|.+|++   +.|+++
T Consensus       235 Pf~~~~~~-----~~~~~i~~~~~~~~------~p~~~---~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         235 PFCSETPQ-----ETYRKVMNWKETLV------FPPEV---PISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCHH-----HHHHHHHcCCCcee------cCCCC---CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            98543211     11111111111110      11110   02345777888876 49999986   455543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.8e-39  Score=306.39  Aligned_cols=251  Identities=24%  Similarity=0.412  Sum_probs=202.1

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ...+|+..+.||.|++|.||+|... +|+.|++|.+........+.+.+|+..++.++|||++++++++...+..++|+|
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            3456899999999999999999864 588999999876554555778899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++++|..++...    .+++.++..++.+++.|++|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        97 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          97 YLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             ecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            99999999988532    3789999999999999999999998   9999999999999999999999999987654322


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      .  ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.......     ......... .      +..
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----~~~~~~~~~-~------~~~  235 (296)
T cd06655         170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIATNG-T------PEL  235 (296)
T ss_pred             c--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcC-C------ccc
Confidence            1  1223468889999999998889999999999999999999999985432111     111111110 0      000


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..   ....+..+.+++.+||..+|++||++.++++
T Consensus       236 ~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         236 QN---PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CC---cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            00   0113456888999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=307.24  Aligned_cols=255  Identities=20%  Similarity=0.256  Sum_probs=195.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||++.... ++.||+|++...   .....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            468889999999999999999754 889999998642   2233456889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|..++...  ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999998542  234788899999999999999999998   999999999999999999999999998765432


Q ss_pred             CcccccccccccCCccchhhhcc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          271 ELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ... ......||+.|+|||++..     ..++.++|||||||++|||++|+.||....     ..+..............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~~~~  229 (331)
T cd05597         156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKEHFQF  229 (331)
T ss_pred             CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC-----HHHHHHHHHcCCCcccC
Confidence            211 1222468999999999873     457889999999999999999999985321     11111121111111110


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCC--CCCCCHHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESA--DDRPTMNDVVSM  388 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p--~~RPs~~ev~~~  388 (436)
                            ....  ...+..+.+++.+|+..++  ..||++.++++.
T Consensus       230 ------~~~~--~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 ------PPDV--TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ------CCcc--CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                  1110  0134567788888776533  347889888876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.2e-38  Score=296.60  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=205.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+..++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999964 47889999987542 33567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++........+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999865433345889999999999999999999988   99999999999999999999999999876654322


Q ss_pred             cc--ccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          273 QA--NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       273 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ..  ......|+..|+|||.+... .++.++|+||||+++|||++|+.||.......     .........       ..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~~~~~~-------~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----VLMLTLQND-------PP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-----hHHHHhcCC-------CC
Confidence            21  22334688999999998877 78999999999999999999999985432211     111111111       11


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...........+..+.+++.+||+.||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11111111124567889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-38  Score=298.85  Aligned_cols=251  Identities=25%  Similarity=0.432  Sum_probs=199.0

Q ss_pred             CCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCC------hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS------EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      +|+..+.||+|+||+||+|...+|+.+|+|.+....      ......+.+|++.+++++|+||+++.+++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998889999999886432      22345688999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      +||+++++|.+++....   .+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999985432   3788888999999999999999988   99999999999999999999999999876432


Q ss_pred             CCc----ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          270 NEL----QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       270 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ...    ........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..    .. ..........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~-~~~~~~~~~~---  226 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AA-MFYIGAHRGL---  226 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HH-HHHhhhccCC---
Confidence            111    11122346888999999999888999999999999999999999998543211    00 0010000000   


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        .+.....     ....+.+++.+||+.+|++||++.++++
T Consensus       227 --~~~~~~~-----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 --MPRLPDS-----FSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --CCCCCCC-----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              0111111     3456889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-38  Score=311.90  Aligned_cols=263  Identities=23%  Similarity=0.272  Sum_probs=195.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC-----
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  184 (436)
                      ..++|+..+.||+|+||.||++.+. .++.||+|++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999865 4888999999753  3334567788999999999999999999886543     


Q ss_pred             -ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          185 -EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       185 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                       ..++||||++++ +...+..     .+++.....++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~~-l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhccc-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence             468999999764 5444422     3778888999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHH-----------
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY-----------  332 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~-----------  332 (436)
                      ++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||...+... .+...           
T Consensus       166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~  241 (355)
T cd07874         166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEF  241 (355)
T ss_pred             cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence            97654322   1223468999999999999899999999999999999999999986432110 00000           


Q ss_pred             -------HHHHhhcCCcce-e-----ccCCccc-cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          333 -------VWDLWTSNRTLE-L-----IDDPVLE-DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       333 -------~~~~~~~~~~~~-~-----~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                             ............ .     ..+...+ ...........+.+++.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   000000000000 0     0000000 000011123567899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.3e-38  Score=304.66  Aligned_cols=197  Identities=24%  Similarity=0.407  Sum_probs=159.1

Q ss_pred             CcccCCCCceeEEEEEec---CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe--CCccEEEEeecC
Q 040532          120 TNKLGEGGFGPVYKGVLR---KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIYEYMP  194 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  194 (436)
                      .++||+|+||+||+|...   .++.+|+|.+.....  ...+.+|+.++++++||||+++++++..  +...+++|||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            368999999999999865   367899999875432  2456889999999999999999998865  345789999986


Q ss_pred             CCChhhhhcCC------CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE----cCCCCeEEeeccCc
Q 040532          195 NKSLDFFLFDP------TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMA  264 (436)
Q Consensus       195 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll----~~~~~~kl~DfGla  264 (436)
                      + +|..++...      .....+++.....++.|++.||.|||+.+   ++||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 666665321      12235888999999999999999999998   9999999999999    45678999999999


Q ss_pred             eecCCCCcc-cccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 040532          265 RICGGNELQ-ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLY  322 (436)
Q Consensus       265 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~  322 (436)
                      +........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876433211 122345789999999999874 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-38  Score=302.22  Aligned_cols=262  Identities=23%  Similarity=0.331  Sum_probs=190.0

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHc---CCCceeEEeeEEEeC-----C
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKV---QHKNLVRLLGCCIDK-----D  184 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~  184 (436)
                      +|++.+.||+|+||+||+|... +|+.||+|.+....  ......+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999976 48899999987432  11123455677766655   799999999988653     3


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..+++|||+++ +|..++.... ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            46899999985 7777775422 234789999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      .......   ......+|..|+|||++.+..++.++||||+||++|||++|++||......  +................
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~  230 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIGLPPEDD  230 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--HHHHHHHHHhCCCChhh
Confidence            7654322   122346789999999999889999999999999999999999998543211  11111111110000000


Q ss_pred             ------e----ccCCccc-cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          345 ------L----IDDPVLE-DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       345 ------~----~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                            .    ....... ...........+.+++.+||+.||++|||+.|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                  0    0000000 00000113456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.9e-38  Score=295.46  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=203.0

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|+..+.||.|+||.||.+... +++.+++|.+...  +......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788899999999999999864 4888999988643  345567788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++.... ...+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999886532 345789999999999999999999988   99999999999999999999999999986643331


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                        ......++..|+|||.+.+..++.++|+||||+++|||++|..||....     ............ ...      ..
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~-~~~------~~  222 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIVQGN-YTP------VV  222 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCC-CCC------Cc
Confidence              2233468899999999988889999999999999999999999985322     111122211111 000      00


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                           ...+..+.+++.+||+.+|++||++.++++.
T Consensus       223 -----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         223 -----SVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -----cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                 1134568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-38  Score=302.35  Aligned_cols=251  Identities=27%  Similarity=0.359  Sum_probs=197.0

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .|+..+.||+|+||+||++... .++.+|+|.+....   ......+.+|+.++++++|+|++.+.+.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3667789999999999999976 47899999986432   2223457789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999998885422 234888999999999999999999988   9999999999999999999999999987643222


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......  .............      . ..
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~~~~~~------~-~~  224 (285)
T cd05630         157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVQ------E-EY  224 (285)
T ss_pred             ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhhhhhhh------h-hc
Confidence               1123468999999999999999999999999999999999999986432111  0001111100000      0 00


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPT-----MNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~  387 (436)
                      ..     .....+.+++.+||+.||++||+     +.|+++
T Consensus       225 ~~-----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 SE-----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             Cc-----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            11     13446789999999999999999     778876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.8e-38  Score=296.76  Aligned_cols=251  Identities=26%  Similarity=0.374  Sum_probs=192.2

Q ss_pred             cccCCCCceeEEEEEecC----CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe-CCccEEEEeecC
Q 040532          121 NKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILIYEYMP  194 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  194 (436)
                      +.||+|+||.||+|.+.+    +..+|+|.+... .....+.+.+|+.+++.++|||++++++++.. ++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998532    356999998643 34456788899999999999999999998764 556789999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc-
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ-  273 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-  273 (436)
                      +++|.+++.....  ..++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999864322  3577788899999999999999987   999999999999999999999999999755432211 


Q ss_pred             -cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          274 -ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       274 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                       .......++..|+|||.+.+..++.++||||||+++|||++|+ .||....     ............       ....
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~~~~~-------~~~~  223 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVYLLQGR-------RLLQ  223 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHhcCC-------CCCC
Confidence             1112234567899999998888999999999999999999964 4553211     111111111111       0000


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                      ..     ..+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       224 ~~-----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         224 PE-----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CC-----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            11     12346889999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=296.69  Aligned_cols=254  Identities=22%  Similarity=0.371  Sum_probs=203.3

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .++|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357888999999999999999975 4788999999876555678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++....  ..++......++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            99999999885432  34889999999999999999999988   9999999999999999999999999987654321 


Q ss_pred             ccccccccccCCccchhhhccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          273 QANTSRIVGTYGYMSPEYALEG---IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                       .......++..|+|||.+.+.   .++.++|+||||+++|||++|+.||.......    . ...... ..    ....
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~----~-~~~~~~-~~----~~~~  224 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR----A-LFLISK-SN----FPPP  224 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----H-HHHHHh-cc----CCCc
Confidence             112234678899999998776   78999999999999999999999985432110    0 001000 00    0000


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...   .....+..+.+++.+||+.+|.+||++.+++.
T Consensus       225 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 KLK---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccc---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            100   11224567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-38  Score=302.31  Aligned_cols=250  Identities=26%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             CCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      |+..+.||+|+||+||+|.+. +++.+|+|.+....   ......+.+|+.++++++|+|++.+.+++..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667788999999999999975 48899999986532   22334577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++.... ...+++.....++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999988875432 235899999999999999999999988   9999999999999999999999999987653222 


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                        ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||........ .. ..........       ....
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~-~~~~~~~~~~-------~~~~  225 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-RE-EVDRRVLETE-------EVYS  225 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHhhhccc-------cccC
Confidence              11234689999999999988999999999999999999999999854321100 00 0011000000       0011


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPT-----MNDVVS  387 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~  387 (436)
                           ...+..+.+++..|++.||++||+     +.+++.
T Consensus       226 -----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         226 -----AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -----ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                 113446788999999999999999     556655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-38  Score=300.22  Aligned_cols=239  Identities=23%  Similarity=0.340  Sum_probs=186.2

Q ss_pred             ccCCCCceeEEEEEecC-------------------------CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEE
Q 040532          122 KLGEGGFGPVYKGVLRK-------------------------GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRL  176 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  176 (436)
                      .||+|+||.||+|.+..                         ...|++|.+..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997421                         13489999876544445678899999999999999999


Q ss_pred             eeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC--
Q 040532          177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM--  254 (436)
Q Consensus       177 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~--  254 (436)
                      ++++.+.+..++||||+++|+|..++....  ..+++..+..++.|+++||+|||+.+   ++||||||+|||+++++  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            999999999999999999999998886432  34788899999999999999999988   99999999999998644  


Q ss_pred             -----CeEEeeccCceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHH-hCCCCCCCCCCCCc
Q 040532          255 -----NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIV-SGKKNTGLYRTDSL  327 (436)
Q Consensus       255 -----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~ell-tg~~p~~~~~~~~~  327 (436)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....... 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-  229 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-  229 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence                 3799999987543211      12356788999998875 56899999999999999995 6888875332111 


Q ss_pred             chhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          328 NLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                       ....    ....        ......     ....+.+++.+||+.+|++||++.++++.|+
T Consensus       230 -~~~~----~~~~--------~~~~~~-----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 -KERF----YEKK--------HRLPEP-----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -HHHH----HHhc--------cCCCCC-----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence             1111    0100        001111     1235788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2e-38  Score=300.33  Aligned_cols=261  Identities=24%  Similarity=0.372  Sum_probs=200.0

Q ss_pred             cchhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEE---
Q 040532          107 FSSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCI---  181 (436)
Q Consensus       107 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~---  181 (436)
                      +..+....++|++.+.||+|+||.||++... .++.+|+|.+..... ....+.+|+.++.++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            4456677889999999999999999999875 478899998865322 235678899999999 7999999999885   


Q ss_pred             --eCCccEEEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEE
Q 040532          182 --DKDEKILIYEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  258 (436)
Q Consensus       182 --~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl  258 (436)
                        .++..++||||+++++|.+++... .....+++.....++.|++.||.|||+.+   ++||||||+||++++++.++|
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              334679999999999999887532 22345788899999999999999999988   999999999999999999999


Q ss_pred             eeccCceecCCCCcccccccccccCCccchhhhcc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHH
Q 040532          259 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV  333 (436)
Q Consensus       259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  333 (436)
                      +|||++........  ......|+..|+|||.+..     ..++.++||||+||++|||++|+.|+.......     ..
T Consensus       166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~~  238 (286)
T cd06638         166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----AL  238 (286)
T ss_pred             ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----HH
Confidence            99999876543221  1223468899999998753     457889999999999999999999985432110     00


Q ss_pred             HHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ..... ..      ......   .......+.+++.+||+.+|++||++.|+++.
T Consensus       239 ~~~~~-~~------~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         239 FKIPR-NP------PPTLHQ---PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hhccc-cC------CCcccC---CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00000 00      000000   00123468899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.8e-38  Score=299.00  Aligned_cols=257  Identities=26%  Similarity=0.385  Sum_probs=202.7

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCCChh-hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRSEQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ++|+..+.||+|+||.||+|+.+.      .+.+++|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            568888999999999999999642      457999988765433 4577899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCcc------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKR------ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  261 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~Df  261 (436)
                      +||||+++|+|.+++......      ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998654322      25899999999999999999999988   999999999999999999999999


Q ss_pred             cCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      |++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......  .   .+.. ....
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~---~~~~-~~~~  234 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--E---VLNR-LQAG  234 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--H---HHHH-HHcC
Confidence            99865432221 12223356778999999988888999999999999999999 77787432211  1   1111 1111


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      .....     ...     ..+..+.+++.+||+.+|++||++.|++..|++
T Consensus       235 ~~~~~-----~~~-----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         235 KLELP-----VPE-----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CcCCC-----CCC-----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            11000     001     134578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-38  Score=301.82  Aligned_cols=252  Identities=23%  Similarity=0.374  Sum_probs=199.3

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|++.+.||+|+||.||++... .|..+|+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999976 5889999988754 344457788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      +++++|..++........+++.....++.+++.||.|||+. +   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999998886543334589999999999999999999974 5   9999999999999999999999999987553221


Q ss_pred             cccccccccccCCccchhhhccCC------CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                          .....++..|+|||.+.+..      ++.++|+|||||++|+|++|+.||......  .......... ...    
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~-~~~----  226 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLSAIV-DGD----  226 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHHHHh-hcC----
Confidence                22235788999999986543      588999999999999999999998542211  1111111110 000    


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        .+...     ......+.+++.+||+.+|++||++.+++.
T Consensus       227 --~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 --PPTLP-----SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             --CCCCC-----cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence              01111     114557889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.8e-38  Score=297.21  Aligned_cols=256  Identities=25%  Similarity=0.417  Sum_probs=198.3

Q ss_pred             CCCCcccCCCCceeEEEEEec----CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC------
Q 040532          117 FSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------  184 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  184 (436)
                      |.+.+.||+|+||.||+|.+.    .++.||+|++...  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999854    3678999998754  3445677889999999999999999999886543      


Q ss_pred             ccEEEEeecCCCChhhhhcCC---CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeec
Q 040532          185 EKILIYEYMPNKSLDFFLFDP---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  261 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~Df  261 (436)
                      ..++++||+++|+|..++...   .+...+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            236889999999998876432   12234788899999999999999999988   999999999999999999999999


Q ss_pred             cCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      |+++...............++..|++||.+.+..++.++||||||+++|||++ |+.||.....  .....+   .....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~---~~~~~  232 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNY---LIKGN  232 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHH---HHcCC
Confidence            99986543332222222345678999999998889999999999999999999 8888753221  111111   11111


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      .. .      ...     ..+..+.+++.+|++.+|++||++.++++.|+++
T Consensus       233 ~~-~------~~~-----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 RL-K------QPP-----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cC-C------CCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00 0      000     1345788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=308.23  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=209.0

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCCh---hhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCc
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSE---QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDE  185 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  185 (436)
                      ......|++.+.||+|.||.||+++.+. |+.+|+|.+.+...   .+...+.+|+.+|+++. |||||.+.++|++.+.
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            3455678888999999999999999876 99999999976532   34568999999999998 9999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC----CCeEEeec
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNPKISDF  261 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~----~~~kl~Df  261 (436)
                      .++|||++.||.|.+.+...    .+++.....++.|++.++.|||+.+   ++||||||+|+|+...    +.+|++||
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            99999999999998888654    2899999999999999999999998   9999999999999733    57999999


Q ss_pred             cCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      |++.....   .......+||+.|+|||++.+..|+..+||||+|+++|.|++|..||..........     .. ...+
T Consensus       184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i-~~~~  254 (382)
T KOG0032|consen  184 GLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AI-LRGD  254 (382)
T ss_pred             CCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HH-HcCC
Confidence            99998765   234455799999999999999999999999999999999999999985443221111     11 1111


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .  .+..+    .+  ...+....+++..|+..||..|+|+.++++
T Consensus       255 ~--~f~~~----~w--~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  255 F--DFTSE----PW--DDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             C--CCCCC----Cc--cccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            1  11111    11  125667889999999999999999999998

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=317.90  Aligned_cols=259  Identities=26%  Similarity=0.420  Sum_probs=204.7

Q ss_pred             ccCCCCceeEEEEEecCC-CEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCChhh
Q 040532          122 KLGEGGFGPVYKGVLRKG-DEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF  200 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  200 (436)
                      +||+|.||+||-|++.+. ..+|||.+...+....+-+.+|+.+-++++|.|||+++|.+.+++..-+.||-++||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            699999999999998764 4689999988777777889999999999999999999999999998889999999999999


Q ss_pred             hhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-CCCCeEEeeccCceecCCCCcccccccc
Q 040532          201 FLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRI  279 (436)
Q Consensus       201 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~  279 (436)
                      +|...=+...-++.+.--+.+||++||.|||.+.   |+|||||-+|+|++ -.|.+||+|||.++.+..  ....+..+
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence            9965333222366777788999999999999998   99999999999997 678999999999987653  33445567


Q ss_pred             cccCCccchhhhccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccch
Q 040532          280 VGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSS  357 (436)
Q Consensus       280 ~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (436)
                      .||..|||||++..++  |+.++|||||||++.||.||++||-.......       .++.-   -.....+..+     
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-------AMFkV---GmyKvHP~iP-----  801 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-------AMFKV---GMYKVHPPIP-----  801 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-------hhhhh---cceecCCCCc-----
Confidence            8999999999998654  89999999999999999999999843322110       00000   0111122222     


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhhccccCCCCC
Q 040532          358 KQVLLRYVNIALLCVQESADDRPTMNDVVS--MLTNEAAALHPPK  400 (436)
Q Consensus       358 ~~~~~~l~~li~~cl~~~p~~RPs~~ev~~--~L~~~~~~~~~~~  400 (436)
                      .+.+.+...++.+|+.++|.+||++.+++.  +|..-.++..|+.
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~l  846 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKL  846 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCC
Confidence            336778899999999999999999999986  3443333333333

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=312.19  Aligned_cols=246  Identities=30%  Similarity=0.493  Sum_probs=199.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ...|+.++.||.|+||.||.|.+. +.+.||||+..-.   +...++++..|+.+|.+++|||++.+.|+|..+...|||
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            345777899999999999999965 4778999998643   445578999999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      ||||- ||-.+++.-  .++++.+.....|+.+.+.||+|||+++   .+|||||+.|||+++.|.|||+|||.+.... 
T Consensus       105 MEYCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-  177 (948)
T KOG0577|consen  105 MEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-  177 (948)
T ss_pred             HHHHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC-
Confidence            99994 566666632  2345888899999999999999999998   9999999999999999999999999986543 


Q ss_pred             CCcccccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          270 NELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                           ..+.++|||.|||||++.   .+.|+-++||||||+++.||.-.++|.  ++...+.   -.+....+       
T Consensus       178 -----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl--FnMNAMS---ALYHIAQN-------  240 (948)
T KOG0577|consen  178 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMS---ALYHIAQN-------  240 (948)
T ss_pred             -----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc--cCchHHH---HHHHHHhc-------
Confidence                 344569999999999997   578999999999999999999999985  2222111   11221111       


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +.+.+.    ..+.+..+..++..||++-|.+|||.+++++
T Consensus       241 esPtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  241 ESPTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCCCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            223332    2335667899999999999999999987653

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=287.99  Aligned_cols=252  Identities=25%  Similarity=0.371  Sum_probs=200.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      .++.|++.+.||+|.|+.||++... .|+.+|+|.+...  +..+.+++.+|+.+-+.++||||+++.+...+....|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            3567888899999999999999865 4888998887533  344678899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---CCCeEEeeccCcee
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARI  266 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~~~~kl~DfGla~~  266 (436)
                      +|+++|++|-.-+-   .+...++...-..++||+.+|.|.|..+   |+|||+||+|+++-.   .--+||+|||++..
T Consensus        89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            99999999955442   2244778888899999999999999998   999999999999963   33589999999998


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ......   ....+|||.|||||+++..+|+..+|||+.||+||-|+.|..||-.  .+...+.+.+.    ...  -.+
T Consensus       163 l~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~--~~~~rlye~I~----~g~--yd~  231 (355)
T KOG0033|consen  163 VNDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--EDQHRLYEQIK----AGA--YDY  231 (355)
T ss_pred             eCCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC--ccHHHHHHHHh----ccc--cCC
Confidence            773332   2345899999999999999999999999999999999999999832  22222222111    110  001


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +.+    .+..  .+++..+|+++||..||.+|.|+.|.++
T Consensus       232 ~~~----~w~~--is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  232 PSP----EWDT--VTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCc----ccCc--CCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            111    1222  5667889999999999999999987653

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.3e-38  Score=294.87  Aligned_cols=253  Identities=22%  Similarity=0.344  Sum_probs=188.2

Q ss_pred             ccCCCCceeEEEEEecCC---CEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCC
Q 040532          122 KLGEGGFGPVYKGVLRKG---DEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS  197 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  197 (436)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+..++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975433   346777776443 3445788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccc
Q 040532          198 LDFFLFDPTK-RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  276 (436)
Q Consensus       198 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  276 (436)
                      |..++..... ....+......++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9998865321 234567777899999999999999988   999999999999999999999999998643222222222


Q ss_pred             ccccccCCccchhhhcc-------CCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          277 SRIVGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       277 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ....++..|+|||++..       ..++.++||||||+++|||+++ ..||.....     ........... .....+ 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~~~-~~~~~~-  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVIKDQ-QVKLFK-  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhhc-ccccCC-
Confidence            34467889999998753       2457899999999999999975 566643211     11122222111 111111 


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      +.....     ....+.+++..|| .+|++||++++|++.|.
T Consensus       232 ~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111111     2346778999999 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=296.69  Aligned_cols=251  Identities=25%  Similarity=0.411  Sum_probs=209.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ..+-|.++++||+|+||.||+|.++. |+.+|+|.+...  .+.+++..|+.+|++++.|++|+++|.+.....+++|||
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            34558889999999999999999764 999999998754  446889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      ||..|+..+.+.-  .++++.+.+...+++.-++||+|||...   -+|||||+.|||++-+|.+||+|||.+-.+... 
T Consensus       109 YCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-  182 (502)
T KOG0574|consen  109 YCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-  182 (502)
T ss_pred             hcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh-
Confidence            9999999999864  3456999999999999999999999987   899999999999999999999999999765432 


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                       ....+...||+.|||||++..-.|..++||||||++..||.-|++||..-.               .-+..-.+.....
T Consensus       183 -MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH---------------PMRAIFMIPT~PP  246 (502)
T KOG0574|consen  183 -MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH---------------PMRAIFMIPTKPP  246 (502)
T ss_pred             -HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc---------------ccceeEeccCCCC
Confidence             223445689999999999999999999999999999999999999974321               1111222222222


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +........+.++.++++.||-++|++|-|+.++++
T Consensus       247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            223334456778999999999999999999987765

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.8e-38  Score=295.98  Aligned_cols=248  Identities=24%  Similarity=0.437  Sum_probs=201.3

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ..|+..+.||+|+||.||+|.+. .+..||+|.+... .......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45778899999999999999975 4788999998754 345567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++..    ..+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++++|||++........
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999998853    23788889999999999999999988   99999999999999999999999999976543221


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                        ......++..|+|||.+.+..++.++|+||||+++|||++|+.||.......     ... .....      ..+.  
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~-~~~~~------~~~~--  220 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VLF-LIPKN------NPPT--  220 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hhh-hhhcC------CCCC--
Confidence              1223467889999999998889999999999999999999999985322110     000 00000      0111  


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                         .....+..+.+++.+||+.+|++||++.++++.
T Consensus       221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         221 ---LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ---CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence               112256678899999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=8.4e-38  Score=295.91  Aligned_cols=264  Identities=23%  Similarity=0.325  Sum_probs=198.5

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ++|+..+.||+|++|.||+|.+. +|+.||+|++....  ....+.+.+|+.++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999976 48899999986432  2223567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++++|..+.....   .+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999999988764332   3899999999999999999999988   9999999999999999999999999998765432


Q ss_pred             cccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHH----------HHhhcC
Q 040532          272 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVW----------DLWTSN  340 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~  340 (436)
                      .  ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||........ +.....          ..+...
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcccc
Confidence            1  1222357789999999876 4578999999999999999999999864332110 000000          000000


Q ss_pred             CcceeccCCccccccc----hHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 RTLELIDDPVLEDEYS----SKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ........+.......    ....+..+.+++.+||+.+|++||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000000000000000    0113456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-38  Score=295.21  Aligned_cols=238  Identities=26%  Similarity=0.429  Sum_probs=188.2

Q ss_pred             cccCCCCceeEEEEEecCCC-----------EEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          121 NKLGEGGFGPVYKGVLRKGD-----------EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999986533           4788887654333 5788999999999999999999999988 788999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC-------CeEEeecc
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-------NPKISDFG  262 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~-------~~kl~DfG  262 (436)
                      |||+++|+|.+++.....  .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999865332  5889999999999999999999988   99999999999999887       79999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccC--CCCcccchhhHHHHHHHHHhC-CCCCCCCCCCCcchhHHHHHHhhc
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNLLGYVWDLWTS  339 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~  339 (436)
                      ++.....      .....++..|+|||.+.+.  .++.++|+||||+++|||++| ..|+......  ....    ....
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~----~~~~  221 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKER----FYQD  221 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHH----HHhc
Confidence            9876432      1223566789999998876  789999999999999999994 6666443211  1100    0000


Q ss_pred             CCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          340 NRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      .        ......     ....+.+++.+||+.+|.+||++.++++.|+
T Consensus       222 ~--------~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 Q--------HRLPMP-----DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             C--------CCCCCC-----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0        000000     1156889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-39  Score=284.78  Aligned_cols=251  Identities=25%  Similarity=0.350  Sum_probs=199.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC-----Ch---hhHHHHHHHHHHHHHc-CCCceeEEeeEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR-----SE---QGLREMKNEASVIAKV-QHKNLVRLLGCCID  182 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  182 (436)
                      .-+.|...+.||+|..+.|-++..+. |+..|+|++...     ++   .-.+.-..|+.+|+++ .||||+.+.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            34567778899999999999988664 788999988532     11   2234566899999998 69999999999999


Q ss_pred             CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                      +...++|+|.|+.|.|.++|...   ..+++....+|++|+..|++|||..+   |+||||||+|||+|++.++||+|||
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence            99999999999999999999543   45899999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhcc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALE------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      +++.+.....   ....+|||+|+|||.+..      ..|+...|+|++|||||-|+.|.+||=.  ...+-.       
T Consensus       169 Fa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--RkQmlM-------  236 (411)
T KOG0599|consen  169 FACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--RKQMLM-------  236 (411)
T ss_pred             eeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--HHHHHH-------
Confidence            9998765443   234599999999999873      2478899999999999999999999821  000000       


Q ss_pred             hhcCCcceeccCCcccc-ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          337 WTSNRTLELIDDPVLED-EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                            +..+.....+- .....+.+....+++.+||+.||.+|.|++|++.
T Consensus       237 ------LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  237 ------LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ------HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                  11111111110 0011236677899999999999999999999985

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.1e-38  Score=332.44  Aligned_cols=258  Identities=26%  Similarity=0.357  Sum_probs=199.2

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--C
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--D  184 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~  184 (436)
                      .....++|++.+.||+|+||+||+|.+.. +..+|+|.+...  .......+..|+.++.+++||||++++++|.+.  .
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            34556789999999999999999999764 678899988643  344456789999999999999999999988654  4


Q ss_pred             ccEEEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEecccCCCCEEEcC-------
Q 040532          185 EKILIYEYMPNKSLDFFLFDPT-KRILLDWVTRVQIIEGIAQGLLYLHQYSR----VRIIHRDLKASNILLDK-------  252 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~i~H~Dikp~NIll~~-------  252 (436)
                      ..|+||||+++|+|..++.... ....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            6789999999999999886422 22458999999999999999999998542    34999999999999964       


Q ss_pred             ----------CCCeEEeeccCceecCCCCcccccccccccCCccchhhhcc--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 040532          253 ----------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTG  320 (436)
Q Consensus       253 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~  320 (436)
                                .+.+||+|||++........   .....||+.|+|||++.+  ..++.++|||||||++|||+||+.||.
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                      33589999999976543221   223478999999999864  458899999999999999999999985


Q ss_pred             CCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          321 LYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...    ......... ...        +..+.    ...+..+.+|+..||+.+|.+||++.|++.
T Consensus       245 ~~~----~~~qli~~l-k~~--------p~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        245 KAN----NFSQLISEL-KRG--------PDLPI----KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cCC----cHHHHHHHH-hcC--------CCCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            322    111111111 111        00100    012456889999999999999999999984

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-38  Score=294.87  Aligned_cols=256  Identities=21%  Similarity=0.279  Sum_probs=204.2

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ...+.|+.++.||+|.-|+||++.+++ +..+|+|++.+..   .+.....+.|.++|+.++||.+..|++.++.+...|
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            345678889999999999999999875 5789999997653   334566788999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      ++||||+||+|..+.+.+. ...+++..+.=++..++.||+|||-.|   ||.|||||+||||.++|++-|+||.|+..+
T Consensus       154 l~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999999998886644 345778888888889999999999999   999999999999999999999999998654


Q ss_pred             CCCC---------------------------------c---------------------ccccccccccCCccchhhhcc
Q 040532          268 GGNE---------------------------------L---------------------QANTSRIVGTYGYMSPEYALE  293 (436)
Q Consensus       268 ~~~~---------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~  293 (436)
                      ....                                 .                     .......+||-.|.|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            2100                                 0                     001123579999999999999


Q ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhccc
Q 040532          294 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQ  373 (436)
Q Consensus       294 ~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  373 (436)
                      ...+.+.|+|+|||++|||+.|+.||........     +......        +..++.. +  +.+..+.+||++.|.
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-----l~NIv~~--------~l~Fp~~-~--~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-----LRNIVGQ--------PLKFPEE-P--EVSSAAKDLIRKLLV  373 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-----HHHHhcC--------CCcCCCC-C--cchhHHHHHHHHHhc
Confidence            9999999999999999999999999965543221     1111111        1111111 1  256778999999999


Q ss_pred             CCCCCCCC----HHHHHH
Q 040532          374 ESADDRPT----MNDVVS  387 (436)
Q Consensus       374 ~~p~~RPs----~~ev~~  387 (436)
                      +||++|..    +.||-+
T Consensus       374 KdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  374 KDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             cChhhhhccccchHHhhc
Confidence            99999998    666654

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.2e-38  Score=295.36  Aligned_cols=253  Identities=26%  Similarity=0.383  Sum_probs=202.8

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|+..+.||+|++|.||++.++ +++.+++|.+.... ......+.+|++++++++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778899999999999999976 48899999987653 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      +++++|.+++....  ..++......++.|++.||+|||+ .+   ++|+||||+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999986532  458889999999999999999999 77   9999999999999999999999999986543211


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      .    ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....................       .+..
T Consensus       156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~  224 (265)
T cd06605         156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-------PPRL  224 (265)
T ss_pred             h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-------CCCC
Confidence            1    1146888999999999989999999999999999999999998644322222222222211111       1111


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..    ...+..+.+++.+||..+|++||++.++++
T Consensus       225 ~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 PS----GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             Ch----hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            11    113456889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.5e-38  Score=302.20  Aligned_cols=263  Identities=22%  Similarity=0.352  Sum_probs=196.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888999999999999999875 47889999986442 22234677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      ++ ++|..++....  ..+++.....++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++....... 
T Consensus        86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  158 (301)
T cd07873          86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  158 (301)
T ss_pred             cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence            97 57877775432  24788899999999999999999988   9999999999999999999999999987543221 


Q ss_pred             ccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc-----------C
Q 040532          273 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS-----------N  340 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~  340 (436)
                       .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+..  ............           .
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhcc
Confidence             112223568899999988754 4788999999999999999999998643321  111111111000           0


Q ss_pred             CcceeccCCccccc---cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 RTLELIDDPVLEDE---YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ........+.....   ......+..+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000000000000   000113456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.3e-39  Score=299.89  Aligned_cols=240  Identities=25%  Similarity=0.412  Sum_probs=188.5

Q ss_pred             cccCCCCceeEEEEEecC--------CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          121 NKLGEGGFGPVYKGVLRK--------GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +.||+|+||.||+|....        ...+++|.+........+.+.+|..+++.++|||++++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999998643        234888888765555567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC--------eEEeeccCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--------PKISDFGMA  264 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~--------~kl~DfGla  264 (436)
                      +++|+|..++.....  .+++.....++.|++.||+|||+.+   ++||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999865332  5788999999999999999999988   999999999999987765        699999988


Q ss_pred             eecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCC-CCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      .....      .....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+......     ... ......  
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-----~~~-~~~~~~--  221 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-----KKL-QFYEDR--  221 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-----HHH-HHHHcc--
Confidence            65432      122457888999999986 45799999999999999999995 454321110     000 011100  


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                            ...+..     ....+.+++.+||+.+|++|||++++++.|.
T Consensus       222 ------~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ------HQLPAP-----KWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------ccCCCC-----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  011111     2346889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.6e-38  Score=309.25  Aligned_cols=262  Identities=23%  Similarity=0.268  Sum_probs=194.5

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC------
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------  183 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  183 (436)
                      ..++|++.+.||+|+||.||++... .++.||+|++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999965 4788999999753  233456788999999999999999999987643      


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      ...++||||+++ +|..++..     .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            346999999976 55555532     2678888999999999999999988   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH-------
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL-------  336 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------  336 (436)
                      ++......   ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+..  .....+...       
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~  247 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPE  247 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHH
Confidence            97654322   122346899999999999999999999999999999999999998643311  000000000       


Q ss_pred             ------------hhcCC-cce-----eccCCcccc-ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          337 ------------WTSNR-TLE-----LIDDPVLED-EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       337 ------------~~~~~-~~~-----~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                                  ..... ...     .......+. ..........+.+++.+||+.||++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                        00000 000     000000000 00001123467899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3e-38  Score=296.46  Aligned_cols=254  Identities=23%  Similarity=0.403  Sum_probs=200.1

Q ss_pred             CCCCCcccCCCCceeEEEEEecC--CCEEEEEEcCCC----------ChhhHHHHHHHHHHHHH-cCCCceeEEeeEEEe
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK--GDEIAVKRLSGR----------SEQGLREMKNEASVIAK-VQHKNLVRLLGCCID  182 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  182 (436)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999765  678999987532          23344567788888875 799999999999999


Q ss_pred             CCccEEEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcCCCCeEEee
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISD  260 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~~~~~kl~D  260 (436)
                      ++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+   ++|+||+|+||++++++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999998887431 223458889999999999999999996 55   99999999999999999999999


Q ss_pred             ccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          261 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      ||++.......   ......++..|+|||.+.+..++.++|+||||+++|||++|+.||....     ......... ..
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~-~~  228 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----MLSLATKIV-EA  228 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HHHHHHHHh-hc
Confidence            99998754432   2233468889999999998889999999999999999999999974322     111111111 11


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      ..     .+....     ..+..+.+++.+||+.||++||++.|+..++++
T Consensus       229 ~~-----~~~~~~-----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         229 VY-----EPLPEG-----MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             cC-----CcCCcc-----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            00     000110     134568899999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.4e-38  Score=304.08  Aligned_cols=259  Identities=18%  Similarity=0.255  Sum_probs=192.5

Q ss_pred             CCcccCCC--CceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          119 DTNKLGEG--GFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       119 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      +.++||+|  +||+||++..+ +|+.||+|++...  .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78999999875 5889999999754  2334466788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc-
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-  272 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-  272 (436)
                      ++|+|.+++.... ...+++.....++.|++.||+|||+.+   ++||||||+|||++.++.++++||+.......... 
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999885432 224789999999999999999999988   99999999999999999999999987543321110 


Q ss_pred             ----ccccccccccCCccchhhhcc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          273 ----QANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       273 ----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                          ........++..|+|||++.+  ..++.++|||||||++|||++|+.||.......     ........ ......
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~-~~~~~~  231 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-----MLLEKLNG-TVPCLL  231 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-----HHHHHhcC-Cccccc
Confidence                001122356778999999976  458999999999999999999999986432111     00000000 000000


Q ss_pred             c-------------------C-----C----ccc------cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          347 D-------------------D-----P----VLE------DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       347 ~-------------------~-----~----~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +                   .     .    ...      ...........+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            0                   0     0    000      00001123457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.3e-38  Score=293.92  Aligned_cols=250  Identities=26%  Similarity=0.418  Sum_probs=193.4

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-----ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--Ccc
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-----SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK  186 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  186 (436)
                      .+|+..+.||+|+||.||+|... .+..|++|++...     .......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47889999999999999999875 4889999988643     123345688999999999999999999988763  466


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++++||+++++|.+++....   .+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999885432   3788889999999999999999988   99999999999999999999999999876


Q ss_pred             cCCCCc-ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          267 CGGNEL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       267 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ...... ........++..|+|||.+.+..++.++|+|||||++|||++|+.||.....     ...........     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----~~~~~~~~~~~-----  225 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----MAAIFKIATQP-----  225 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----HHHHHHHhcCC-----
Confidence            532211 1112224578899999999988899999999999999999999999854321     11111111111     


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ..+..+.     .....+.+++ +||..+|++||+++|+++
T Consensus       226 -~~~~~~~-----~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 -TNPQLPS-----HISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -CCCCCch-----hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence             0111111     1234556666 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.4e-38  Score=290.81  Aligned_cols=247  Identities=28%  Similarity=0.449  Sum_probs=199.2

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-----hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-----EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     ....+.+.+|+.+++.++|+|++++.+++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 68999999886432     33457789999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      +||+++++|.+++....   .+++.....++.|++.|++|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999985432   4788999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCcccccccccccCCccchhhhccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ..   ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.....     .............      
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~------  220 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----VAAVFKIGRSKEL------  220 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----HHHHHHHHhcccC------
Confidence            32   123346888999999988766 89999999999999999999999854321     1111111110110      


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +....     .....+.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 PPIPD-----HLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCcCC-----CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            11111     13456788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=294.79  Aligned_cols=357  Identities=22%  Similarity=0.311  Sum_probs=254.1

Q ss_pred             eeeeeeccCCCChh-hHHHHHHHHHHHHHHHHhhheeccCCCCccccccchhccccccccCC----------cccccCcc
Q 040532           19 LILGFTLTSTPRLP-LFLLSIVLAAVAILGLIFFCVRRKPGSRDKREDLMTFDLDLNLKANN----------VNIELPLN   87 (436)
Q Consensus        19 ~~~~~~~~s~~~~~-~~i~~~~~~~v~i~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~p~~   87 (436)
                      +-+.++++.+.... ++.+++.++++.+++++.+|.+.+.+++.+..+.........+....          .+.-.|..
T Consensus       173 ~~~~v~~p~s~~~~f~V~v~va~a~v~lva~il~c~~~~s~Kr~~~~~~i~tSs~~~l~~~qps~~st~y~~P~t~tpi~  252 (563)
T KOG1024|consen  173 LRENVVPPASGLVTFIVGVIVALALVSLVALILYCAKGPSKKRSNGVHLIKTSSFQRLPTIQPSAHSTIYVTPSTITPIY  252 (563)
T ss_pred             ccccccCCCcccEEEeeeHHHHHHHHHHHHHHHHHHhcccchhhccCcccchhhhhcCCcCCccccCCcccCCCcccccc
Confidence            33444444444444 44445555566677777888877766655544443332222111000          01111111


Q ss_pred             hhHHhhhhccccCC-CC---ccccchhhhhccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCC-ChhhHH
Q 040532           88 SKLIERSKKKEVDQ-LP---LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGR-SEQGLR  156 (436)
Q Consensus        88 ~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~  156 (436)
                      +....++......+ -|   .-...++.....+++....+.+|.||.||+|.+.+      .+.|.+|.++.. ++.+..
T Consensus       253 sap~~r~~~ns~~~~~p~e~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~  332 (563)
T KOG1024|consen  253 SAPLTRSSPNSEYEHEPEEFNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVN  332 (563)
T ss_pred             CCCcccCCCCccccCChHHHhhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHH
Confidence            11111111111110 01   01234455566778888899999999999997553      445788888754 566677


Q ss_pred             HHHHHHHHHHHcCCCceeEEeeEEEeC-CccEEEEeecCCCChhhhhc-----CCCccCCCCHHHHHHHHHHHHHHHHHH
Q 040532          157 EMKNEASVIAKVQHKNLVRLLGCCIDK-DEKILIYEYMPNKSLDFFLF-----DPTKRILLDWVTRVQIIEGIAQGLLYL  230 (436)
Q Consensus       157 ~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~~L  230 (436)
                      .+..|.-.+..+.|||+..+.+++.+. ...+.++.++.-|+|..||.     +......+...+...++.|++.|++||
T Consensus       333 ~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl  412 (563)
T KOG1024|consen  333 LLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL  412 (563)
T ss_pred             HHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH
Confidence            888999999999999999999998865 46688999999999999997     555566788899999999999999999


Q ss_pred             hhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHH
Q 040532          231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL  310 (436)
Q Consensus       231 H~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~  310 (436)
                      |+++   ++|.||..+|++||+..++||+|=.+++.+-..++..-....-.+..||+||.+....|+.++|||||||+||
T Consensus       413 h~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllW  489 (563)
T KOG1024|consen  413 HNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLW  489 (563)
T ss_pred             HhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHH
Confidence            9999   9999999999999999999999999999887777776555556678999999999999999999999999999


Q ss_pred             HHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          311 EIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       311 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                      ||+| |+.|+..-+..+  ...+..            +...+....   +++.++..++.-||+..|++||+++|++.-|
T Consensus       490 ELmtlg~~PyaeIDPfE--m~~ylk------------dGyRlaQP~---NCPDeLf~vMacCWallpeeRPsf~Qlv~cL  552 (563)
T KOG1024|consen  490 ELMTLGKLPYAEIDPFE--MEHYLK------------DGYRLAQPF---NCPDELFTVMACCWALLPEERPSFSQLVICL  552 (563)
T ss_pred             HHHhcCCCCccccCHHH--HHHHHh------------ccceecCCC---CCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence            9998 888875433221  111111            122222222   2677899999999999999999999999999


Q ss_pred             hhcccc
Q 040532          390 TNEAAA  395 (436)
Q Consensus       390 ~~~~~~  395 (436)
                      ++...+
T Consensus       553 seF~~q  558 (563)
T KOG1024|consen  553 SEFHTQ  558 (563)
T ss_pred             HHHHHH
Confidence            887643

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-38  Score=308.72  Aligned_cols=259  Identities=22%  Similarity=0.317  Sum_probs=193.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC------
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------  183 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  183 (436)
                      ..++|+..+.||+|+||+||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999965 47889999987542  22345677899999999999999999987643      


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      ...++++|++ +++|..++..    ..+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence            3458999987 7788877642    24889999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC-
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-  341 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  341 (436)
                      +......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......  +............. 
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~  237 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGTPSP  237 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCCH
Confidence            9865422     223478999999999877 56899999999999999999999998543211  10000000000000 


Q ss_pred             ----------c---ceec---cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          342 ----------T---LELI---DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       342 ----------~---~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                                .   ...+   ..........  .....+.+++.+||+.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFR--GANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhcc--CCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                      0   0000   0000000000  012346789999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.4e-38  Score=292.89  Aligned_cols=251  Identities=33%  Similarity=0.501  Sum_probs=200.0

Q ss_pred             CCCCcccCCCCceeEEEEEecC-----CCEEEEEEcCCCChh-hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          117 FSDTNKLGEGGFGPVYKGVLRK-----GDEIAVKRLSGRSEQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      +++.+.||.|+||.||++...+     +..||+|.+...... ..+.+..|+..+.+++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3566889999999999999764     378999999765433 5678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|.+++..... ..+++.....++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999854322 12789999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ...... ...++..|+|||.+.+..++.++|+||+|+++++|++ |..||....     ........ ......      
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~-~~~~~~------  223 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-----NEEVLEYL-KKGYRL------  223 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH-hcCCCC------
Confidence            222211 2236789999999988889999999999999999998 777764321     11111111 111110      


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                      ....     ..+..+.+++.+|+..+|++|||+.|+++.|
T Consensus       224 ~~~~-----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 PKPE-----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCC-----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0011     1345788999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.8e-38  Score=292.86  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=198.8

Q ss_pred             CCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-CccEEEEe
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-DEKILIYE  191 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  191 (436)
                      +|++.+.||+|++|.||++.... ++.+|+|.+...  .....+.+.+|++++++++|+|++++.+.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            47888999999999999999754 788999998643  234456788999999999999999999887643 45789999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++++|.+++.... ...+++.+...++.+++.|+++||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999998886432 335889999999999999999999988   9999999999999999999999999998664322


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                        .......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+     .......... ...      +..
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~-~~~------~~~  222 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIE-GKL------PPM  222 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHh-cCC------CCC
Confidence              12233468899999999999999999999999999999999999985322     1111111111 111      001


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .     ......+.+++.+|++.+|++||++.++++
T Consensus       223 ~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         223 P-----KDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             c-----cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1     114457889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.5e-38  Score=298.44  Aligned_cols=248  Identities=26%  Similarity=0.449  Sum_probs=199.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ..|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34667788999999999999865 47789999987543 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++..    ..+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            999999988843    24788999999999999999999988   99999999999999999999999999876543221


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                        ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.......  .   ... .....      .+...
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~---~~~-~~~~~------~~~~~  222 (277)
T cd06642         157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--V---LFL-IPKNS------PPTLE  222 (277)
T ss_pred             --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--H---Hhh-hhcCC------CCCCC
Confidence              1222357889999999998889999999999999999999999975322111  0   000 00000      01111


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                           ...+..+.+++.+||+.+|++||++.++++.
T Consensus       223 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         223 -----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             -----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                 1134568899999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5e-38  Score=297.52  Aligned_cols=255  Identities=25%  Similarity=0.362  Sum_probs=203.1

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .++|++.+.||+|+||+||++... +|+.+|+|++... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            356888899999999999999975 4888999988654 23445778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      |+++++|.+++...   ..+++.....++.+++.||.|||+ .+   ++|+||+|+||++++++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            99999999887542   247899999999999999999997 45   999999999999999999999999998654221


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC------cchhHHHHHHhhcCCcce
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS------LNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~  344 (436)
                          ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.......      .....+........    
T Consensus       158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  229 (284)
T cd06620         158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----  229 (284)
T ss_pred             ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence                1223478999999999988889999999999999999999999986543211      11112222211111    


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                         .+...    ....+..+.+++.+|++.||++||++.|+++..
T Consensus       230 ---~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 ---PPRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ---CCCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence               01111    111445688999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=311.86  Aligned_cols=197  Identities=26%  Similarity=0.385  Sum_probs=170.1

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-C-----CceeEEeeEEEeCCcc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-H-----KNLVRLLGCCIDKDEK  186 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~  186 (436)
                      ..+|.+++.||+|+||.|-+|.+.. ++.||||+++.. ..-..+...|+.+|..++ |     -|+|+++++|...++.
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            3478999999999999999999765 899999999865 334566788999999996 4     3899999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC--CCCeEEeeccCc
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNPKISDFGMA  264 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~--~~~~kl~DfGla  264 (436)
                      |+|+|.+ ..+|.+++..+.. ..++......++.||+.||.+||+.+   |||+||||+||||.+  ...+||+|||.|
T Consensus       264 ciVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence            9999998 5689999976443 34889999999999999999999998   999999999999974  347999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGL  321 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~  321 (436)
                      +......+     ....+..|+|||++.|.+|+.+.||||||||++||++|.+-|..
T Consensus       339 c~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  339 CFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             cccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            87654333     33567889999999999999999999999999999999877754

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7e-38  Score=298.51  Aligned_cols=262  Identities=23%  Similarity=0.319  Sum_probs=197.2

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChh-----hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      +|+..+.||+|++|.||+|... +|+.||+|.+......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999975 4889999999754322     234567899999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+ +++|..++....  ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999986533  35899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC--------
Q 040532          270 NELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN--------  340 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------  340 (436)
                      ...  ......++..|+|||.+.+ ..++.++|+|||||++|||++|..+|.....  ..............        
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHHHHHHHHcCCCchhhhhhc
Confidence            321  1122356778999998865 4578999999999999999999877643221  11111111100000        


Q ss_pred             -Ccceec---cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 -RTLELI---DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 -~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ......   .................+.+++.+||+.+|++||++.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence             000000   00000000001123567889999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-37  Score=292.27  Aligned_cols=254  Identities=25%  Similarity=0.405  Sum_probs=196.9

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC----------hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS----------EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      +|...+.||+|+||.||+|... +|+.+|+|.+....          ....+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999865 48899999885321          112346788999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998654   34888899999999999999999988   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      ................++..|+|||.+....  ++.++|+||||+++|||++|..||.....     .............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~  230 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMFKLGNKRSA  230 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHHHhhccccC
Confidence            7644322112223346788999999988654  78999999999999999999999843211     1111111111100


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                            ...... .....+..+.+++.+||+.+|++||++.++++
T Consensus       231 ------~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         231 ------PPIPPD-VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             ------CcCCcc-ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence                  000000 01114567889999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.5e-37  Score=298.88  Aligned_cols=196  Identities=25%  Similarity=0.415  Sum_probs=158.1

Q ss_pred             cccCCCCceeEEEEEecC---CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe--CCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK---GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  195 (436)
                      ..||+|+||+||+|...+   +..||+|.+.....  ...+.+|+.++++++||||+++++++..  +...++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            579999999999999653   56899999875432  2457889999999999999999999864  4567899999976


Q ss_pred             CChhhhhcC------CCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE----cCCCCeEEeeccCce
Q 040532          196 KSLDFFLFD------PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMAR  265 (436)
Q Consensus       196 g~L~~~l~~------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll----~~~~~~kl~DfGla~  265 (436)
                       +|.+++..      ......+++.....++.|++.||.|||+.+   ++||||||+|||+    ++++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             55555421      112235788899999999999999999998   9999999999999    566789999999998


Q ss_pred             ecCCCCcc-cccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 040532          266 ICGGNELQ-ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLY  322 (436)
Q Consensus       266 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~  322 (436)
                      ........ .......+|..|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            76433221 122334689999999998764 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-37  Score=292.78  Aligned_cols=260  Identities=26%  Similarity=0.355  Sum_probs=199.9

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--CccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  190 (436)
                      ++|+..+.||.|++|.||++.+. .++.+|+|.+.... ......+.+|++++++++||||+++++++.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35778899999999999999975 47889999987543 34456789999999999999999999998654  3679999


Q ss_pred             eecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          191 EYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       191 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      ||+++++|.+++... .....++......++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999998876431 22345788899999999999999999988   99999999999999999999999999865432


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ..    .....++..|+|||.+.+..++.++||||||+++|+|++|+.||................. ............
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  232 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI-VNMPNPELKDEP  232 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH-hcCCchhhccCC
Confidence            21    1223578899999999999999999999999999999999999875432111111111111 111111111110


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .     .....+..+.+++.+||+.+|++|||+.|+++
T Consensus       233 ~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         233 G-----NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             C-----CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0     00113457889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.7e-38  Score=292.66  Aligned_cols=247  Identities=29%  Similarity=0.428  Sum_probs=196.8

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      ++|++.+.||+|+||.||++... ++.+|+|.+.....  .+.+.+|+.++++++|||++++++++.. +..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEecccC-CCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence            56888899999999999999764 78899999875432  3578899999999999999999999865 45799999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +++|.+++.... ...+++.....++.|++.|+.|||+.+   ++||||||+||+++.++.+||+|||++......    
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            999999986533 234788999999999999999999988   999999999999999999999999998754321    


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                       ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||.....     ... ..........      ... 
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~-~~~~~~~~~~------~~~-  219 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEV-KECVEKGYRM------EPP-  219 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHH-HHHHhCCCCC------CCC-
Confidence             111234567999999988899999999999999999998 8888754321     111 1111111100      000 


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                          ...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       220 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         220 ----EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ----CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                1134568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.3e-38  Score=297.03  Aligned_cols=261  Identities=25%  Similarity=0.358  Sum_probs=200.4

Q ss_pred             ccchhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeC
Q 040532          106 SFSSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  183 (436)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  183 (436)
                      ...++....++|++.+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34455667889999999999999999999975 488899999865422 235677899999998 899999999998754


Q ss_pred             C-----ccEEEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeE
Q 040532          184 D-----EKILIYEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  257 (436)
Q Consensus       184 ~-----~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~k  257 (436)
                      +     ..++||||+++++|.+++... .....+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence            3     579999999999999887532 12345789999999999999999999988   99999999999999999999


Q ss_pred             EeeccCceecCCCCcccccccccccCCccchhhhccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 040532          258 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY  332 (436)
Q Consensus       258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~  332 (436)
                      |+|||++.........  .....|+..|+|||.+...     .++.++|+|||||++|||++|+.||......     ..
T Consensus       169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----~~  241 (291)
T cd06639         169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----KT  241 (291)
T ss_pred             Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----HH
Confidence            9999998765432211  1224678899999988643     3688999999999999999999998532210     01


Q ss_pred             HHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          333 VWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +..... .......         ........+.+++.+||+.+|++||++.|+++
T Consensus       242 ~~~~~~-~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         242 LFKIPR-NPPPTLL---------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHHhc-CCCCCCC---------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111111 1000000         01113346889999999999999999999976

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.9e-38  Score=299.20  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=197.8

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ++|+..+.||+|+||.||+|.+++ ++.+|+|++....  ....+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            468888999999999999999864 8899999986432  2234568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++++|..+.....   .+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999999988764322   3789999999999999999999988   9999999999999999999999999987654332


Q ss_pred             cccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHH----------HHhhcC
Q 040532          272 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVW----------DLWTSN  340 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~  340 (436)
                        .......++..|+|||.+.+ ..++.++||||||+++|||++|++||....... .......          ......
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccc
Confidence              11223467889999999875 447889999999999999999998885322100 0000000          000000


Q ss_pred             CcceeccCCccccc----cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 RTLELIDDPVLEDE----YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ........+.....    ......+..+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00000000000000    000124567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1e-37  Score=296.81  Aligned_cols=252  Identities=24%  Similarity=0.402  Sum_probs=202.8

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ..++|.+.+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++|||++++++.+...+..++|+|
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            3478999999999999999999864 578899999875544555778899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++++|.+++...    .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        97 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          97 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             cCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            99999999988542    3678899999999999999999998   9999999999999999999999999987654332


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      .  ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||........     +.......       .+..
T Consensus       170 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-----~~~~~~~~-------~~~~  235 (293)
T cd06647         170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNG-------TPEL  235 (293)
T ss_pred             c--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-----eeehhcCC-------CCCC
Confidence            2  12234688899999999888899999999999999999999999854321110     00000000       0001


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      .   ........+.+++.+||+.+|++||++.+++..
T Consensus       236 ~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         236 Q---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0   111234568899999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-38  Score=294.27  Aligned_cols=255  Identities=26%  Similarity=0.409  Sum_probs=199.5

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCC-----
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD-----  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----  184 (436)
                      ..+++|++.+.||+|++|.||+|..+ +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            45688999999999999999999975 478899999876543 346789999999999 7999999999997654     


Q ss_pred             -ccEEEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          185 -EKILIYEYMPNKSLDFFLFDPT-KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       185 -~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                       ..++||||+++++|.+++.... ....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             3799999999999998875422 2345889999999999999999999988   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhcc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      ++.......  .......++..|+|||.+..     ..++.++||||||+++|+|++|+.||......     .......
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~  231 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-----RALFKIP  231 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-----HHHHHhh
Confidence            987654322  11223468889999998863     34678999999999999999999998532111     0111111


Q ss_pred             hcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          338 TSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...       .+..   .........+.+++.+||..||++|||+.++++
T Consensus       232 ~~~-------~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RNP-------PPTL---KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ccC-------CCCC---CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            100       0000   111124457889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.6e-38  Score=305.91  Aligned_cols=193  Identities=23%  Similarity=0.296  Sum_probs=163.5

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ....+|++.+.||+|+||.||+|.... ++.||+|.....      ....|+.++++++||||+++++++......++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            345679999999999999999999764 678999975432      2356899999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+. ++|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 5777776432  235889999999999999999999998   999999999999999999999999998753221


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCC
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT  319 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~  319 (436)
                         .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               1222346899999999999999999999999999999999966554

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.3e-38  Score=297.16  Aligned_cols=263  Identities=21%  Similarity=0.306  Sum_probs=193.7

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|+..+.||+|+||.||+|... +|+.+|+|.+....  ......+.+|+.++++++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999975 48899999986432  22235677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++ +|..++....  ..+++.....++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  153 (284)
T cd07839          81 CDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  153 (284)
T ss_pred             CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence            975 6666654322  34899999999999999999999998   9999999999999999999999999987654221 


Q ss_pred             ccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC---------Cc
Q 040532          273 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN---------RT  342 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~  342 (436)
                       .......++..|+|||.+.+. .++.++|||||||++|||+||+.|+....... .............         ..
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHHHhCCCChHHhHHhhhc
Confidence             112223578899999998765 47899999999999999999998863222111 1111111110000         00


Q ss_pred             ceeccCCcccccc----chHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 LELIDDPVLEDEY----SSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 ~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .............    .....+..+.+++.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000000000000    00113457789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7.1e-38  Score=316.81  Aligned_cols=263  Identities=22%  Similarity=0.236  Sum_probs=189.9

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCC------CceeEEeeEEEe
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQH------KNLVRLLGCCID  182 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~  182 (436)
                      +....++|++.+.||+|+||+||+|.+.. ++.||||+++... .....+..|+.++..++|      .+++.+.+++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            34456889999999999999999999754 7789999996532 223456678888877754      458899998876


Q ss_pred             C-CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcCCC------
Q 040532          183 K-DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDM------  254 (436)
Q Consensus       183 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~~~------  254 (436)
                      . ...++|||++ +++|.+++...   ..+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++      
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence            5 4678999988 66777777543   348899999999999999999997 47   99999999999998765      


Q ss_pred             ----------CeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 040532          255 ----------NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  324 (436)
Q Consensus       255 ----------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~  324 (436)
                                .+||+|||.+....     ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                      49999999875422     122345799999999999999999999999999999999999999964332


Q ss_pred             CCcchhHHHHHH--------------------hhcCCcce-eccCCcc----c-cccchHHHHHHHHHHHHhcccCCCCC
Q 040532          325 DSLNLLGYVWDL--------------------WTSNRTLE-LIDDPVL----E-DEYSSKQVLLRYVNIALLCVQESADD  378 (436)
Q Consensus       325 ~~~~~~~~~~~~--------------------~~~~~~~~-~~~~~~~----~-~~~~~~~~~~~l~~li~~cl~~~p~~  378 (436)
                      .  +....+...                    +....... .......    . ...........+.+|+.+||+.||++
T Consensus       351 ~--~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        351 L--EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             H--HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            1  111111000                    00000000 0000000    0 00000011345779999999999999


Q ss_pred             CCCHHHHHH
Q 040532          379 RPTMNDVVS  387 (436)
Q Consensus       379 RPs~~ev~~  387 (436)
                      |||++|+++
T Consensus       429 R~ta~e~L~  437 (467)
T PTZ00284        429 RLNARQMTT  437 (467)
T ss_pred             CCCHHHHhc
Confidence            999999986

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.9e-38  Score=292.19  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=200.6

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|+..+.||+|+||.+|++... +|+.+|+|.+...  ......++.+|+.++++++||||+++.+++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788899999999999999865 4889999998643  334456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++.... ...+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999988885422 234788899999999999999999988   99999999999999999999999999976543221


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                      .  .....|++.|+|||.+.+..++.++|+||||+++++|++|+.||....     ..+.+........       +...
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~~-------~~~~  222 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIRGSY-------PPVS  222 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHhcCCC-------CCCc
Confidence            1  122357889999999998889999999999999999999999975321     1112222211110       0011


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                           ......+.+++.+||+.+|++||++.+|++
T Consensus       223 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         223 -----SHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -----ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 113456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=293.04  Aligned_cols=247  Identities=24%  Similarity=0.428  Sum_probs=198.0

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcC---CCceeEEeeEEEeCCccEEEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  190 (436)
                      .|+..+.||+|+||.||+|.+. +++.+|+|.+... .......+.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4778899999999999999964 5889999998754 3344567889999999996   999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|.+++...    .+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999988542    5889999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ..  ......|+..|+|||.+.++ .++.++|+||||+++|+|++|+.||......     ...... ...      ..+
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~-~~~------~~~  220 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLI-PKS------KPP  220 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhcc-ccC------CCC
Confidence            31  12234688899999988754 4689999999999999999999998543211     010000 000      011


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .+...    ..+..+.+++.+||+.||++||++.++++
T Consensus       221 ~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         221 RLEDN----GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11111    13456889999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.8e-38  Score=296.18  Aligned_cols=258  Identities=24%  Similarity=0.397  Sum_probs=198.9

Q ss_pred             cchhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEe--
Q 040532          107 FSSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCID--  182 (436)
Q Consensus       107 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--  182 (436)
                      +.+.....+.|++.+.||+|+||.||+|.+. .++.+|+|.+.... .....+..|+.++.++ +|+|++++++++..  
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            3444556788999999999999999999975 47889999986543 3345688899999998 79999999999863  


Q ss_pred             ----CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEE
Q 040532          183 ----KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  258 (436)
Q Consensus       183 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl  258 (436)
                          .+..+++|||+++|+|.+++.... ...+++.....++.|++.|+.|||+.+   ++|+||+|+||++++++.++|
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence                456799999999999999885432 234778888899999999999999988   999999999999999999999


Q ss_pred             eeccCceecCCCCcccccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHH
Q 040532          259 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV  333 (436)
Q Consensus       259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  333 (436)
                      +|||++.......  .......|+..|+|||.+.     +..++.++|+|||||++|||++|+.||.......    . .
T Consensus       163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~----~-~  235 (282)
T cd06636         163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR----A-L  235 (282)
T ss_pred             eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh----h-h
Confidence            9999987543211  1223346889999999886     3467889999999999999999999985322110    0 0


Q ss_pred             HHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ... ...      .....    .....+..+.+++.+||+.||.+||++.|+++
T Consensus       236 ~~~-~~~------~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 FLI-PRN------PPPKL----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhH-hhC------CCCCC----cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            000 000      00000    11124457899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7e-38  Score=297.46  Aligned_cols=264  Identities=24%  Similarity=0.333  Sum_probs=194.5

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|+..+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999976 478999999865422 1224567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++ +|..++.....  .+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 88887754332  5788999999999999999999988   99999999999999999999999999875432211


Q ss_pred             ccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc--------
Q 040532          273 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--------  343 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  343 (436)
                        ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....... ................        
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhhhhhhc
Confidence              1122246788999998875 458899999999999999999999985432111 1111111110000000        


Q ss_pred             --------eeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          344 --------ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       344 --------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                              ....................+.+++.+||+.+|++||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                    00000000000001001256788999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.2e-38  Score=301.26  Aligned_cols=251  Identities=23%  Similarity=0.369  Sum_probs=199.4

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .+.|.....||+|+||.||++... ++..||+|.+........+.+.+|+..+++++|+|++++++.+...+..++||||
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            344555677999999999999865 4889999998765555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++...    .+++.....++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++....... 
T Consensus       101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-  172 (292)
T cd06658         101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-  172 (292)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-
Confidence            9999999887432    3788999999999999999999998   9999999999999999999999999987543222 


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                       .......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.....     ....... ...     . .....
T Consensus       173 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~-~~~-----~-~~~~~  239 (292)
T cd06658         173 -PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-----LQAMRRI-RDN-----L-PPRVK  239 (292)
T ss_pred             -ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH-Hhc-----C-CCccc
Confidence             112234688999999999888899999999999999999999999853221     1111111 100     0 00000


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ..   ......+.+++.+|+..+|.+|||++++++.
T Consensus       240 ~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         240 DS---HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cc---cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            00   0133467889999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.8e-38  Score=300.79  Aligned_cols=256  Identities=18%  Similarity=0.267  Sum_probs=200.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|+..+.||+|+||.||++.... ++.|++|.+....   ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            468888999999999999999764 7889999987543   233457889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            999999999998543   24788899999999999999999988   999999999999999999999999998642111


Q ss_pred             Cc-------------ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh
Q 040532          271 EL-------------QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       271 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      ..             ........++..|+|||.+.+..++.++|+||||+++|||++|..||.....     ........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~~~~  229 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQVI  229 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence            00             0011123578899999999888899999999999999999999999853211     11111111


Q ss_pred             hcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          338 TSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      ...     ...+....     ..+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       230 ~~~-----~~~~~~~~-----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SDD-----IEWPEGDE-----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hcc-----cCCCCccc-----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            111     00011000     134568899999999999999998777777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-37  Score=291.34  Aligned_cols=250  Identities=26%  Similarity=0.376  Sum_probs=194.5

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC-----ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--Ccc
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR-----SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK  186 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  186 (436)
                      ++|++.+.||+|+||.||+|...+ |..||+|.+...     .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            468888999999999999999754 889999987532     123456788999999999999999999988764  456


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      +++|||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            7999999999999988543   23778888999999999999999998   99999999999999999999999999876


Q ss_pred             cCCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          267 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       267 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ....... .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.....    ... ........     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~-~~~~~~~~-----  225 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAA-IFKIATQP-----  225 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHH-HHHHhcCC-----
Confidence            5322111 112234688899999999888899999999999999999999999853211    111 11111110     


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ..+..     .......+.+++.+|+. +|++||+++|+++
T Consensus       226 -~~~~~-----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 -TNPVL-----PPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -CCCCC-----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence             01111     11244567889999995 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=308.52  Aligned_cols=240  Identities=22%  Similarity=0.286  Sum_probs=184.0

Q ss_pred             cCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHc---CCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          123 LGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKV---QHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       123 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      ||+|+||+||+|... +|+.||+|++....   .........|..++.+.   +||||+++++.+...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999975 48899999986431   22233445666666655   699999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|..++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            9998888543   34789999999999999999999998   9999999999999999999999999987532221  12


Q ss_pred             cccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccc
Q 040532          276 TSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDE  354 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (436)
                      .....||..|+|||++.+. .++.++|||||||++|||++|+.||.....     ....... ....       ..... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i-~~~~-------~~~~~-  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNI-AFGK-------VRFPK-  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHH-HcCC-------CCCCC-
Confidence            2335789999999998765 479999999999999999999999853221     1111111 1111       00111 


Q ss_pred             cchHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 040532          355 YSSKQVLLRYVNIALLCVQESADDRPT----MNDVVS  387 (436)
Q Consensus       355 ~~~~~~~~~l~~li~~cl~~~p~~RPs----~~ev~~  387 (436)
                         ......+.+++.+||+.||.+||+    +.++++
T Consensus       219 ---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 ---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence               113346788999999999999994    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.9e-38  Score=301.21  Aligned_cols=249  Identities=23%  Similarity=0.347  Sum_probs=197.9

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      .|.....||+|+||.||+|... +++.||+|.+........+.+.+|+..+..++|||++++++++..++..++++||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            3444567999999999999875 588999999875544445678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +++|..++..    ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.......  .
T Consensus       102 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~  172 (297)
T cd06659         102 GGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P  172 (297)
T ss_pred             CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence            9999887743    23789999999999999999999988   9999999999999999999999999987543322  1


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDE  354 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (436)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......  ..   ... .......      .... 
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~---~~~-~~~~~~~------~~~~-  239 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QA---MKR-LRDSPPP------KLKN-  239 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH---HHH-HhccCCC------Cccc-
Confidence            122346889999999999888999999999999999999999998532211  10   111 1111000      0000 


Q ss_pred             cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          355 YSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       355 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        .......+.+++.+||+.+|++||++.++++.
T Consensus       240 --~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         240 --AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             --cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              01133467889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=299.89  Aligned_cols=253  Identities=21%  Similarity=0.272  Sum_probs=199.6

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCCh---hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSE---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|+..+.||+|++|.||+|...+ ++.+|+|.+.....   ...+.+.+|++.++.++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368888999999999999999765 89999999975432   24567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+.+++|.+++... ....+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999988643 2345889999999999999999999988   999999999999999999999999998754321


Q ss_pred             Ccc---------------------------cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 040532          271 ELQ---------------------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  323 (436)
Q Consensus       271 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~  323 (436)
                      ...                           .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01123467889999999998889999999999999999999999985432


Q ss_pred             CCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 040532          324 TDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT----MNDVVS  387 (436)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs----~~ev~~  387 (436)
                      ...     .........        ......   ...+..+.+++.+||+.+|++||+    +.|++.
T Consensus       237 ~~~-----~~~~~~~~~--------~~~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDE-----TFSNILKKE--------VTFPGS---PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHH-----HHHHHhcCC--------ccCCCc---cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            211     111111110        001110   014567899999999999999999    555544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.4e-37  Score=288.91  Aligned_cols=253  Identities=24%  Similarity=0.452  Sum_probs=199.3

Q ss_pred             CCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCCC------hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRS------EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      +|+..+.||+|++|.||+|.. .+++.+|+|.+....      ....+.+.+|+..+++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999986 458899999986432      2235678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC-CeEEeeccCceec
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARIC  267 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~-~~kl~DfGla~~~  267 (436)
                      |+||+++++|.+++...   .++++.....++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999999988543   24788999999999999999999998   99999999999998776 5999999998766


Q ss_pred             CCCCcc--cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          268 GGNELQ--ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       268 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ......  .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......  .............     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~-----  227 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASAT-----  227 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhccC-----
Confidence            433211  1122346788999999998888999999999999999999999998543221  1111111111000     


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ..+..     .......+.+++.+|++.+|++||++.++++
T Consensus       228 -~~~~~-----~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 -TAPSI-----PEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -CCCCC-----chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence             00111     1124567889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.2e-37  Score=291.31  Aligned_cols=252  Identities=27%  Similarity=0.464  Sum_probs=200.7

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh--hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|+..+.||+|+||.||+|... +++.+++|.+.....  ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999865 588999999876533  3677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++...   ..+++.....++.++++||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            9999999998643   23788889999999999999999988   99999999999999999999999999987654332


Q ss_pred             ccc--cccccccCCccchhhhccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          273 QAN--TSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       273 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ...  .....++..|+|||.+.+..   ++.++||||||+++|||++|+.||...+..    ......... ..      
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~~~~~~~~~-~~------  223 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----FQIMFHVGA-GH------  223 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----HHHHHHHhc-CC------
Confidence            111  12346788999999998766   899999999999999999999998543211    111111111 10      


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .+..+..   ......+.+++.+||+.+|++||++.+++.
T Consensus       224 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 KPPIPDS---LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCcc---cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111111   112456788999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.5e-37  Score=294.52  Aligned_cols=254  Identities=26%  Similarity=0.434  Sum_probs=204.7

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ...++.|+..+.||+|++|.||+|.++ ++..+++|++..... ....+.+|++.+++++|+|++++++++...+..+++
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            345677899999999999999999987 588999999976544 456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      +||+++++|.+++....  ..+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            99999999999986533  35899999999999999999999988   99999999999999999999999999865443


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......     ..... .....      .
T Consensus       169 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~------~  234 (286)
T cd06614         169 EKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-----ALFLI-TTKGI------P  234 (286)
T ss_pred             chh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-HhcCC------C
Confidence            221  1223357889999999998889999999999999999999999985332110     01111 01100      0


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...   .....+..+.+++.+|++.+|.+||++.++++
T Consensus       235 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         235 PLK---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCc---chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            000   01113456889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.1e-38  Score=297.44  Aligned_cols=243  Identities=26%  Similarity=0.341  Sum_probs=196.9

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|++|.||++.+. +++.+|+|.+...   .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888899999999999999976 4889999998643   2234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|.+++...   ..++......++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999988543   34889999999999999999999988   999999999999999999999999998765433


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                           .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....     .. ........       ...
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~-~~~~~~~~-------~~~  216 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQ-IYEKILEG-------KVR  216 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HH-HHHHHhcC-------Ccc
Confidence                 2234688999999999888889999999999999999999999854321     00 11111111       011


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVV  386 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~  386 (436)
                      .+..     ....+.+++.+||+.+|.+||     +++|++
T Consensus       217 ~~~~-----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         217 FPSF-----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             CCcc-----CCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            1111     235688999999999999999     556655

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.8e-37  Score=287.03  Aligned_cols=253  Identities=26%  Similarity=0.386  Sum_probs=205.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSE-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|++.+.||+|++|.||+|.... ++.+++|++..... .....+.+|+..+.+++|+|++++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            367888999999999999999875 89999999876543 4467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      +++++|.+++...   ..++......++.|+++|++|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999998643   458999999999999999999999 87   9999999999999999999999999998764332


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      ...  ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....  ....+......... .      +..
T Consensus       155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~-~------~~~  223 (264)
T cd06623         155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDGP-P------PSL  223 (264)
T ss_pred             Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcCC-C------CCC
Confidence            221  234678899999999988899999999999999999999999855432  11111111111111 0      111


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ...    ..+..+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~----~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 PAE----EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             Ccc----cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            110    034578899999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.6e-37  Score=293.94  Aligned_cols=262  Identities=24%  Similarity=0.334  Sum_probs=199.6

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|++.+.||+|++|.||+|.+. +|+.||+|++....  ......+.+|+.++++++|||++++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999975 58899999987543  33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      + +++|.+++....  ..+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999998885433  45899999999999999999999988   99999999999999999999999999986643321


Q ss_pred             ccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc---------
Q 040532          273 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT---------  342 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  342 (436)
                       .......++..|+|||.+.+. .++.++||||+|+++|||++|.++|.....  ................         
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCc
Confidence             112234688899999988754 468999999999999999999877743221  1111111111110000         


Q ss_pred             --ceeccCCc-----cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          343 --LELIDDPV-----LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       343 --~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        ...+..+.     .....  ......+.+++.+||+.+|++||+++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIF--PDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             chhhcccCCCCCcchHHHhC--CCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              00000000     00000  1134678899999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-38  Score=296.46  Aligned_cols=263  Identities=24%  Similarity=0.365  Sum_probs=200.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ++|+..+.||+|++|.||+|.+++ ++.||+|.+...  .....+.+.+|++++++++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            368888999999999999999764 789999998643  23334678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |++++++..+....   ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99998887665432   23789999999999999999999988   9999999999999999999999999988765433


Q ss_pred             cccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh-----------hc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW-----------TS  339 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~  339 (436)
                      . .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......  +.........           ..
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhccc
Confidence            2 122234678899999999888 7899999999999999999999998643211  1000000000           00


Q ss_pred             CCcceecc--CC----ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          340 NRTLELID--DP----VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       340 ~~~~~~~~--~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ........  ..    .....+ ....+..+.+++.+||..+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRY-PGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCCcHHHHHhc-CCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00000000  00    000000 1113567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-37  Score=289.38  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=199.3

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|+..+.||+|++|.||++... +++.+|+|.+...  .......+.+|+.++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788899999999999999865 4788999998654  334467889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC-CCeEEeeccCceecCCCC
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNE  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~-~~~kl~DfGla~~~~~~~  271 (436)
                      +++++|.+++.... ...+++..+..++.+++.||.|||+++   ++|+||+|+||+++++ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999986432 345789999999999999999999988   9999999999999865 457999999998764332


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                         ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.     ........... ...      .
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~-~~~------~  221 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIMSGT-FAP------I  221 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHHhcC-CCC------C
Confidence               12234678899999999988899999999999999999999999854321     11111111111 000      0


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..     ..+..+.+++.+||+.+|++|||+.|+++
T Consensus       222 ~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 SD-----RYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CC-----CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11     13456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-37  Score=295.54  Aligned_cols=266  Identities=24%  Similarity=0.314  Sum_probs=193.9

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh-hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++++|++.+.||+|+||.||+|... +|+.+|+|.+..... .....+.+|+.+++.++|+||+++.+++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999865 488999999865432 22345678999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||++ +++..++....  ..+.+.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 56655553322  23677888899999999999999988   999999999999999999999999998754322


Q ss_pred             CcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC---------
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN---------  340 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------  340 (436)
                      ..  ......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ .....+......         
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhh
Confidence            11  12223578899999998764 578899999999999999999999864332111 100011100000         


Q ss_pred             ---Ccceecc----CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 ---RTLELID----DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ---~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                         .......    ................+.+++.+|++.||++|||+.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence               0000000    0000000000012346788999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.3e-37  Score=284.74  Aligned_cols=251  Identities=27%  Similarity=0.451  Sum_probs=204.1

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--CccEEEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIY  190 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  190 (436)
                      +|+..+.||+|++|.||+|... ++..+++|.+....  ....+.+.+|+..+++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999976 58899999987654  34567889999999999999999999999988  8899999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999986533   5899999999999999999999987   999999999999999999999999999876554


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      ..........++..|+|||.+.+...+.++||||||+++++|++|..||....    +..............      ..
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~------~~  224 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIGSSGEP------PE  224 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhccccCCC------cC
Confidence            32112233468889999999988889999999999999999999999986543    111111111110000      01


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .+     ...+..+.+++.+|++.+|++||++.++++
T Consensus       225 ~~-----~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 IP-----EHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CC-----cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11     113457899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.8e-37  Score=289.86  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=199.4

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe--CCccEEEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIY  190 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  190 (436)
                      +|++.+.||.|+||.||++... +|+.+|+|.+...  .....+.+.+|+.++++++|||++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999865 4788999998643  34445678899999999999999999998764  34568999


Q ss_pred             eecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          191 EYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYS--RVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       191 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      ||+++++|..++... .....+++...+.++.|++.||.|||..+  ..+++|+||+|+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999888542 22346899999999999999999999332  233999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ......  .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....     .... ........     
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~-~~~~~~~~-----  227 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQLA-SKIKEGKF-----  227 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----HHHH-HHHhcCCC-----
Confidence            543321  2234688999999999988899999999999999999999999864331     1111 11111110     


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                       +...     ...+..+.+++.+|++.+|++||++.+|++.
T Consensus       228 -~~~~-----~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 -RRIP-----YRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -CCCc-----cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             1111     1244578899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.2e-37  Score=285.59  Aligned_cols=249  Identities=29%  Similarity=0.483  Sum_probs=202.5

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      .|+..+.||+|++|.||++... +++.+++|++..........+.+|+..+++++|+|++++.+++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677889999999999999976 588999999987655556789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +++|.+++....  ..+++.....++.|++.||.+||..+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999886532  35899999999999999999999987   99999999999999999999999999876553321  


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDE  354 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (436)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......     ........ . .     .+.... 
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~-~-----~~~~~~-  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KALFKIAT-N-G-----PPGLRN-  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHHh-c-C-----CCCcCc-
Confidence             23346888999999999888999999999999999999999998543211     01111100 0 0     001110 


Q ss_pred             cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          355 YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       355 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        ....+..+.+++.+||+.||++|||+.|+++
T Consensus       220 --~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 --PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             --ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              0002456889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=313.86  Aligned_cols=252  Identities=24%  Similarity=0.410  Sum_probs=204.8

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCC-EEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .+.|.+...||.|+||.||+|..+... ..|.|.+...+....+++.-|+++|..++||+||++++.|...+.++++.||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            456788889999999999999987533 3577888888888899999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      |.||-.+..+..-.  ..+.+.+...+++|++.||.|||++.   |+|||||+.|||++-+|.++|+|||.+.....  .
T Consensus       111 C~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t  183 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T  183 (1187)
T ss_pred             cCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--H
Confidence            99999988875433  35888999999999999999999998   99999999999999999999999999865321  1


Q ss_pred             ccccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          273 QANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ......+.|||.|||||+..     ..+|+.++||||||++|.||..+.+|-..     .+....+......+       
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-----lnpMRVllKiaKSe-------  251 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-----LNPMRVLLKIAKSE-------  251 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-----cchHHHHHHHhhcC-------
Confidence            12233468999999999886     46799999999999999999999998422     22222223322222       


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ++.+.   .+...+..+.+++.+||.+||..||+++++++
T Consensus       252 PPTLl---qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  252 PPTLL---QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             CCccc---CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            12111   12235667899999999999999999998874

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.5e-37  Score=289.92  Aligned_cols=248  Identities=25%  Similarity=0.436  Sum_probs=199.7

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +-|+..+.||+|+||.||+|... ++..+|+|.+... .......+.+|+..+.+++||||+++++++..++..++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34777889999999999999864 5789999998644 234456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|..++..    ..+++.....++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            999999988853    24789999999999999999999988   99999999999999999999999999876543221


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                        ......++..|+|||.+.+..++.++|+|||||++|+|++|..||......     ...... ....      .+...
T Consensus       157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~-~~~~------~~~~~  222 (277)
T cd06641         157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFLI-PKNN------PPTLE  222 (277)
T ss_pred             --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHHH-hcCC------CCCCC
Confidence              122346788999999998888899999999999999999999998532211     111111 1110      01111


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      .     ..+..+.+++.+||+.+|++||++.++++.
T Consensus       223 ~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 G-----NYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             c-----ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1     134568889999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-37  Score=295.65  Aligned_cols=268  Identities=20%  Similarity=0.295  Sum_probs=195.4

Q ss_pred             CCCCCcccCCCCceeEEEEEecC---CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--CccE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK---GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKI  187 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  187 (436)
                      +|++.+.||+|++|.||+|....   +..||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788999999999999999754   7899999997632   33345678899999999999999999999988  7889


Q ss_pred             EEEeecCCCChhhhhcCC-C-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC----CCCeEEeec
Q 040532          188 LIYEYMPNKSLDFFLFDP-T-KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK----DMNPKISDF  261 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~-~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~----~~~~kl~Df  261 (436)
                      +||||+++ ++..++... . ....++......++.|++.||+|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999986 454444321 1 2235888999999999999999999998   999999999999999    999999999


Q ss_pred             cCceecCCCCc-ccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcch-------hHH
Q 040532          262 GMARICGGNEL-QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL-------LGY  332 (436)
Q Consensus       262 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~-------~~~  332 (436)
                      |++........ ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||..........       ...
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986543322 1122334678899999988764 57899999999999999999999986544322000       000


Q ss_pred             HHHHhhc------------CCcce---eccCCccccccc----hH--HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          333 VWDLWTS------------NRTLE---LIDDPVLEDEYS----SK--QVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       333 ~~~~~~~------------~~~~~---~~~~~~~~~~~~----~~--~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +......            .....   ............    ..  .....+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000            00000   000000000000    00  13346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.7e-37  Score=292.09  Aligned_cols=251  Identities=24%  Similarity=0.390  Sum_probs=191.3

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHH-HHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASV-IAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ++|++.+.||+|+||.||++.+. +|+.||+|++.... ......+..|+.. ++..+|||++++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999976 48999999987542 2223445556654 566789999999999999999999999


Q ss_pred             ecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          192 YMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       192 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |++ |+|..++... .....+++.....++.|++.||+|||+. +   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 6777766432 2335689999999999999999999986 6   99999999999999999999999999876532


Q ss_pred             CCcccccccccccCCccchhhhcc----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          270 NELQANTSRIVGTYGYMSPEYALE----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ..   ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||......    ........... .   
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~-~---  225 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQLKQVVEEP-S---  225 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHHHHHHHhcC-C---
Confidence            21   1122367889999998865    44688999999999999999999998532211    11111111110 0   


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                         +..    .....+..+.+++.+||+.+|++||++.++++
T Consensus       226 ---~~~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 ---PQL----PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ---CCC----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               000    01113456889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-38  Score=300.42  Aligned_cols=257  Identities=24%  Similarity=0.353  Sum_probs=201.0

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcC--CCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCcc
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLS--GRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  186 (436)
                      +......|+++++||+||.+.||++...+.+.+|+|++.  ..+.+..+.+.+|+.+|.++ .|.+|+++++|-..++..
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            345567899999999999999999998777888888775  34667788999999999999 499999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ||||||- ..+|..+|..... ....| .+..+..|++.|+.++|.++   |||.||||.|+|+- .|.+||+|||.|..
T Consensus       436 YmvmE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANA  508 (677)
T ss_pred             EEEeecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcc
Confidence            9999986 4578888865433 22334 66788999999999999999   99999999999995 46899999999998


Q ss_pred             cCCCCcccccccccccCCccchhhhccCC-----------CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGI-----------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  335 (436)
                      +............+||..||+||.+....           .+.++||||+|||||+|+.|+.||+.+...       ...
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-------~aK  581 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-------IAK  581 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-------HHH
Confidence            87766666666779999999999986422           467899999999999999999999653211       111


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .      ..+.+ +...-.++.......+.+++..||+.||++||+..++++
T Consensus       582 l------~aI~~-P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  582 L------HAITD-PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             H------HhhcC-CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            1      11111 100001110001123888999999999999999999986

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.7e-37  Score=292.70  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=198.3

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      .|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|||++++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555679999999999999864 588999999876555555678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +++|.+++..    ..+++.....++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||.+.......  .
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--P  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--c
Confidence            9999998865    23788999999999999999999998   9999999999999999999999999886543221  1


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDE  354 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (436)
                      ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||....     ........... .      .+.....
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~~~~~~~~~~~-~------~~~~~~~  238 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----PLQAMKRIRDN-L------PPKLKNL  238 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHHHHhc-C------CCCCccc
Confidence            1223468899999999998889999999999999999999999974321     11111111111 0      0011000


Q ss_pred             cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          355 YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       355 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                         ...+..+.+++.+||+.+|++||++.++++
T Consensus       239 ---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 ---HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ---ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence               113457899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-38  Score=295.53  Aligned_cols=250  Identities=22%  Similarity=0.300  Sum_probs=207.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      +.+-|...+.||+|.|..|-+|++- .|..||||++.+.  +......+..|+..|+.++|||||+++.+.......|||
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            3456888999999999999999853 5999999999865  334456788999999999999999999999889999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-CCCCeEEeeccCceecC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICG  268 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-~~~~~kl~DfGla~~~~  268 (436)
                      +|.-++|+|.+|+.+...+  +.+....+++.||..|+.|+|+.+   ++||||||+|+.+- +-|-+||+|||++..+.
T Consensus        96 LELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            9999999999999776554  888899999999999999999999   99999999999875 66899999999997765


Q ss_pred             CCCcccccccccccCCccchhhhccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFS-IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ....   ....+|+..|.|||++.+..|+ ++.||||||||||.|++|+.||+.....+              .+..++|
T Consensus       171 PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------------TLTmImD  233 (864)
T KOG4717|consen  171 PGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------------TLTMIMD  233 (864)
T ss_pred             Ccch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--------------hhhhhhc
Confidence            4432   2335899999999999999885 67899999999999999999997654221              1122222


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      -+    +..+...+.++.+||..||..||.+|.+.+|++..
T Consensus       234 CK----YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  234 CK----YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             cc----ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            11    11223366789999999999999999999998753

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.5e-37  Score=294.34  Aligned_cols=248  Identities=29%  Similarity=0.459  Sum_probs=195.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..+.|+..+.||+|+||+||+|... +|+.||+|.+...   .....+.+.+|+.+++.++|||++++.+++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            3456889999999999999999975 4889999988643   23344678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      |+||+++ ++.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        93 v~e~~~g-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          93 VMEYCLG-SASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             EHHhhCC-CHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            9999974 5655553222  24889999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCcccccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          269 GNELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ..      ....++..|+|||.+.   ...++.++||||||+++|||+||+.||.....     ...........     
T Consensus       167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-----~~~~~~~~~~~-----  230 (307)
T cd06607         167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQND-----  230 (307)
T ss_pred             CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-----HHHHHHHhcCC-----
Confidence            22      2236788999999874   35688999999999999999999999743221     11111111110     


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        .+..    .....+..+.+++.+||+.+|++||++.++++.
T Consensus       231 --~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 --SPTL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --CCCC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              0111    111244578999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.6e-38  Score=304.74  Aligned_cols=246  Identities=24%  Similarity=0.373  Sum_probs=194.6

Q ss_pred             CCCCcccCCCCceeEEEEEecC-CCEEEEEEcC----CCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc--cEEE
Q 040532          117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLS----GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE--KILI  189 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv  189 (436)
                      .+....||+|+|-+||+|.+.. |-.||--.++    ..++...+.|..|+.+|+.|+||||++++.++.+...  ..+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            3556789999999999999764 6666533222    1245667899999999999999999999999987665  6789


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-CCCeEEeeccCceecC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICG  268 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-~~~~kl~DfGla~~~~  268 (436)
                      +|.+..|+|..|+.+...   ++.....+|++||++||.|||++. |||+|||||.+||+|+. .|.|||+|+|||....
T Consensus       122 TEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            999999999999976554   788899999999999999999985 67999999999999985 5899999999998765


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ...    .....|||.|||||+.. ..|+...||||||++|+||+|+..||.    +..+-.+.+..+ ..+.....+..
T Consensus       198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs----EC~n~AQIYKKV-~SGiKP~sl~k  267 (632)
T KOG0584|consen  198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS----ECTNPAQIYKKV-TSGIKPAALSK  267 (632)
T ss_pred             ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh----hhCCHHHHHHHH-HcCCCHHHhhc
Confidence            332    22358999999999655 889999999999999999999999973    233333333333 33222111111


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                           .     ...++.++|.+|+.. .+.|||+.|++.
T Consensus       268 -----V-----~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  268 -----V-----KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -----c-----CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                 0     123578899999999 999999999986

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.7e-37  Score=289.11  Aligned_cols=264  Identities=25%  Similarity=0.367  Sum_probs=197.5

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      +|+..+.||.|++|.||+|.+. +|..||+|++.... ......+.+|+.++++++|||++++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999976 48899999987543 223456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++ +|.+++........+++.....++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            85 78777755444456899999999999999999999988   9999999999999999999999999987543221  


Q ss_pred             cccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC---------cc
Q 040532          274 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR---------TL  343 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  343 (436)
                      .......++..|++||.+.+. .++.++|+||||+++|+|++|+.||......  ..............         ..
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhHHHHhcCc
Confidence            111223568899999988764 5789999999999999999999998643321  11111111100000         00


Q ss_pred             eeccC-Ccccc---ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          344 ELIDD-PVLED---EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       344 ~~~~~-~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..... +....   .......+..+.+++.+|++.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000 00000   0000123456789999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.9e-37  Score=292.04  Aligned_cols=263  Identities=23%  Similarity=0.318  Sum_probs=196.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh--hhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--CccEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE--QGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILI  189 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  189 (436)
                      ++|+..+.||+|+||.||+|.++ +++.+++|.+.....  .....+.+|+.++.+++||||+++.+++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999976 488899999875432  2234567899999999999999999998877  789999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      +||+++ +|..++....  ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999975 8888775432  25899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhh----------
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT----------  338 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----------  338 (436)
                      ..  .......++..|+|||.+.+. .++.++|+||+|+++|||++|+.||......  ....-+.....          
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI--DQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchHHHHHh
Confidence            32  112223578899999988764 4689999999999999999999998643211  11100000000          


Q ss_pred             -c----C-CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          339 -S----N-RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       339 -~----~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       .    . .......................+.+++.+||+.+|++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence             0    0 00000000000111111112456789999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.5e-37  Score=290.78  Aligned_cols=262  Identities=22%  Similarity=0.318  Sum_probs=194.5

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|+..+.||+|++|.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999875 48899999986432  22335788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +. ++|..++.... ...+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-  154 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  154 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence            96 57877775432 335889999999999999999999988   9999999999999999999999999987554221 


Q ss_pred             ccccccccccCCccchhhhccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc---------
Q 040532          273 QANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT---------  342 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  342 (436)
                       .......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...... ................         
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHH
Confidence             1122235678899999887644 688999999999999999999998543211 1111111000000000         


Q ss_pred             -----ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 -----LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                           ............  .......+.+++.+||+.||++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFSKV--VPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHHHH--cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                 000000000000  0113346788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.8e-36  Score=281.97  Aligned_cols=242  Identities=26%  Similarity=0.368  Sum_probs=193.7

Q ss_pred             cCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       123 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      ||.|++|.||++.... ++.+|+|.+....   ....+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6999999999999764 8899999986532   23446789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccccc
Q 040532          199 DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  278 (436)
Q Consensus       199 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  278 (436)
                      .+++....   .++...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            99985432   3788999999999999999999988   9999999999999999999999999998664332   1223


Q ss_pred             ccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchH
Q 040532          279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK  358 (436)
Q Consensus       279 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (436)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....+.   ............      ....+..    
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~------~~~~~~~----  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDILKGNG------KLEFPNY----  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHhccCC------CCCCCcc----
Confidence            467889999999988889999999999999999999999986543211   111111111010      0111111    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 040532          359 QVLLRYVNIALLCVQESADDRPT-----MNDVVS  387 (436)
Q Consensus       359 ~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~  387 (436)
                       ....+.+++.+||+.+|++||+     +.|+++
T Consensus       219 -~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 -IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             -cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence             2457899999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-37  Score=289.10  Aligned_cols=247  Identities=24%  Similarity=0.315  Sum_probs=199.4

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      +|++.+.||.|+||.||+|.+. +++.+|+|.+....   ....+.+.+|++.+++++||||+++++++......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999976 48899999997532   2346788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++++|.+++...   .++++.....++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999988543   35889999999999999999999988   9999999999999999999999999987654332


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......   ...........       .....
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~-------~~~~~  221 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET-------ADVLY  221 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc-------ccccC
Confidence               122346788999999999888999999999999999999999998654322   11111111110       00111


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTM--NDVV  386 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~--~ev~  386 (436)
                      +.     ..+..+.+++.+||+.+|.+||++  .|++
T Consensus       222 ~~-----~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         222 PA-----TWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cc-----cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11     134578899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.3e-37  Score=290.96  Aligned_cols=265  Identities=21%  Similarity=0.283  Sum_probs=193.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCc-----
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDE-----  185 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----  185 (436)
                      ++|+..+.||+|+||.||+|.+. +|+.||+|.+....  ......+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999975 48899999886432  222356788999999995 6999999999887665     


Q ss_pred             cEEEEeecCCCChhhhhcCCCc--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-CCCeEEeecc
Q 040532          186 KILIYEYMPNKSLDFFLFDPTK--RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFG  262 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-~~~~kl~DfG  262 (436)
                      .++||||+++ +|..++.....  ...+++.....++.|++.||.|||+.+   ++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 67777643221  346899999999999999999999988   999999999999998 8999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      ++........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....... .+.. +........
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~-~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLH-IFKLLGTPT  232 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHH-HHHHhCCCC
Confidence            9876533211  1122356788999998875 457899999999999999999999985422110 0000 000000000


Q ss_pred             c--c-ee------ccCCccccc---cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 T--L-EL------IDDPVLEDE---YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~--~-~~------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .  . ..      ...+.....   .........+.+++.+||+.||.+||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0  0 00      000000000   000124567889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-37  Score=288.90  Aligned_cols=261  Identities=23%  Similarity=0.332  Sum_probs=194.5

Q ss_pred             CCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      |+..+.||.|++|+||+|.++ +|..||+|++....  ......+.+|++.+++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999975 58999999987542  222356788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      + ++|..++..... ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++.......  
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--  153 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--  153 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence            5 688888754331 35899999999999999999999987   9999999999999999999999999987543221  


Q ss_pred             cccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC-----------C
Q 040532          274 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN-----------R  341 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~  341 (436)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....... .+...........           .
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchh
Confidence            111223568899999988764 57899999999999999999999985432110 1111100000000           0


Q ss_pred             cceec---cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 TLELI---DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .....   ........  ....+..+.+++.+|++.+|++||+++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         233 YKPTFPKWARQDLSKV--VPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhcccccccchhhh--cCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00000   00000000  1113357889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.4e-36  Score=288.15  Aligned_cols=253  Identities=26%  Similarity=0.443  Sum_probs=192.2

Q ss_pred             CCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|+..+.||+|+||.||++.... ++.+|+|.+.... ......+.+|+..+.++. |+||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            45667889999999999999754 7899999987542 344567889999999996 99999999999999999999999


Q ss_pred             cCCCChhhhh---cCCCccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          193 MPNKSLDFFL---FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       193 ~~~g~L~~~l---~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ++. ++..+.   .. .....+++.....++.+++.||+|||+. +   ++||||||+||+++.++.+||+|||++....
T Consensus        85 ~~~-~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          85 MDI-SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ccC-CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            864 443332   21 1224588999999999999999999975 5   9999999999999999999999999987543


Q ss_pred             CCCcccccccccccCCccchhhhccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEG---IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ....   .....|+..|+|||.+.+.   .++.++||||||+++|||++|+.||....    .............     
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~-----  227 (288)
T cd06616         160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGD-----  227 (288)
T ss_pred             cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCC-----
Confidence            3221   1223578899999998866   68999999999999999999999985432    1111111111100     


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        .+...... ....+..+.+++.+||+.+|++||++.++++.
T Consensus       228 --~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 --PPILSNSE-EREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             --CCcCCCcC-CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              11111111 01245678999999999999999999998874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1e-36  Score=287.52  Aligned_cols=241  Identities=25%  Similarity=0.354  Sum_probs=188.1

Q ss_pred             cCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          123 LGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       123 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      ||+|+||+||++..+ +|+.+|+|.+....   ......+.+|+.++++++|||++++.+.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 48899999986432   22344567899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccccc
Q 040532          199 DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  278 (436)
Q Consensus       199 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  278 (436)
                      .+++..... ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+......   .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence            988865332 35889999999999999999999998   999999999999999999999999998765321   11223


Q ss_pred             ccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchH
Q 040532          279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK  358 (436)
Q Consensus       279 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (436)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ .. ..    ..... .  ......     .
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-~~----~~~~~-~--~~~~~~-----~  219 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KE-EL----KRRTL-E--MAVEYP-----D  219 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HH-HH----Hhccc-c--ccccCC-----c
Confidence            3678899999999888899999999999999999999999854332111 00 00    00000 0  000111     1


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHH
Q 040532          359 QVLLRYVNIALLCVQESADDRPTMND  384 (436)
Q Consensus       359 ~~~~~l~~li~~cl~~~p~~RPs~~e  384 (436)
                      .....+.+++.+||+.+|++||+.++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCc
Confidence            13456889999999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.1e-37  Score=285.81  Aligned_cols=249  Identities=24%  Similarity=0.366  Sum_probs=198.6

Q ss_pred             CCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|+..+.||+|+||.||+|..+. |..+|+|.+...  .....+.+.+|+.++++++|+|++++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            47788999999999999999764 788999998653  223346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC-CeEEeeccCceecCCCC
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICGGNE  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~  271 (436)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999886432 234789999999999999999999988   99999999999999886 46999999987654322


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      .  ......|+..|+|||...+..++.++|+||||+++|||++|+.||....     ............ .     ... 
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~-~-----~~~-  222 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGY-F-----API-  222 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhccc-C-----CCC-
Confidence            1  1122357889999999988889999999999999999999999985322     122222221111 0     000 


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .     ...+..+.+++.+|++.+|++||++.|+++
T Consensus       223 ~-----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 S-----PNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             C-----CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0     113456889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.3e-36  Score=285.50  Aligned_cols=242  Identities=24%  Similarity=0.291  Sum_probs=184.3

Q ss_pred             ccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHH---HcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          122 KLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIA---KVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      .||+|+||.||++... +++.+|+|.+....   ......+.+|..++.   ..+|||++.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 48899999886432   111223344443333   3479999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +++|..++...   ..+++.....++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            99999888543   24899999999999999999999998   9999999999999999999999999987543221   


Q ss_pred             ccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                       .....|+..|+|||.+.+ ..++.++|+||+||++|||++|..||.........   ...... ..      ....+. 
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~-~~------~~~~~~-  219 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMT-LT------VNVELP-  219 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHh-hc------CCcCCc-
Confidence             122368999999998864 55899999999999999999999998643321111   111110 00      011111 


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVSM  388 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~~  388 (436)
                          ...+..+.+++.+||+.||++||     ++.++++.
T Consensus       220 ----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         220 ----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                11345788999999999999999     58888774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-37  Score=296.62  Aligned_cols=270  Identities=21%  Similarity=0.312  Sum_probs=197.8

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC-----cc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EK  186 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  186 (436)
                      +++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+.++++++||||+++++++...+     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            568999999999999999999865 4889999998643 2334466788999999999999999999876543     46


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++++||+++ +|..++..    ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            899999975 67666632    24889999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCccc-ccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc--
Q 040532          267 CGGNELQA-NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT--  342 (436)
Q Consensus       267 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  342 (436)
                      ........ ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+.  ................  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQED  233 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHH
Confidence            54322211 1223468899999998765 4689999999999999999999999854321  0111111111110000  


Q ss_pred             ---------ceecc----CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhcc
Q 040532          343 ---------LELID----DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEA  393 (436)
Q Consensus       343 ---------~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~--L~~~~  393 (436)
                               .....    .+..+...........+.+++.+||+.+|++||++.|+++.  ++...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                     00000    00000000001134568899999999999999999999986  55544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8e-37  Score=290.50  Aligned_cols=246  Identities=23%  Similarity=0.332  Sum_probs=196.0

Q ss_pred             CCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCC
Q 040532          118 SDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       118 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      .....||+|+||.||++..+ +|+.||+|.+..........+.+|+.++++++|+|++++++.+...+..++||||++++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            33467999999999999875 58899999987655555677899999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccc
Q 040532          197 SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  276 (436)
Q Consensus       197 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  276 (436)
                      +|.+++...    .+++.....++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||++.......  ...
T Consensus       103 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~  173 (292)
T cd06657         103 ALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR  173 (292)
T ss_pred             cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccc
Confidence            999887432    3788999999999999999999988   9999999999999999999999999987554322  112


Q ss_pred             ccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccc
Q 040532          277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYS  356 (436)
Q Consensus       277 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (436)
                      ....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......  ...   .. .....      .......  
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~---~~-~~~~~------~~~~~~~--  239 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAM---KM-IRDNL------PPKLKNL--  239 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH---HH-HHhhC------CcccCCc--
Confidence            2346788999999998888999999999999999999999998532211  111   11 11000      0000000  


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          357 SKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       357 ~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ...+..+.+++.+||+.+|.+||++.++++
T Consensus       240 -~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         240 -HKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             -ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence             113446788999999999999999999887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.6e-36  Score=294.48  Aligned_cols=265  Identities=25%  Similarity=0.360  Sum_probs=197.1

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCC--c
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD--E  185 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~--~  185 (436)
                      ...++|++.+.||+|+||.||+|.+. +|+.+|+|++...  .......+.+|+.+++++ +||||+++++++...+  .
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            34678999999999999999999976 4788999988642  233445677899999999 9999999999986543  5


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++||||++ ++|..++...    .+++.....++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            799999997 5888777442    4788899999999999999999988   9999999999999999999999999998


Q ss_pred             ecCCCCcc---cccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh----
Q 040532          266 ICGGNELQ---ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW----  337 (436)
Q Consensus       266 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----  337 (436)
                      ........   .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......  .........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~  233 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLEKIIEVIGPPS  233 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCC
Confidence            65433221   12233468899999998765 457899999999999999999999985432111  000000000    


Q ss_pred             -------hc---CCcceecc---CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          338 -------TS---NRTLELID---DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       338 -------~~---~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                             ..   ........   ........  ...+..+.+++.+||+.+|++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELL--PKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhc--cCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                   00   00000000   00000000  1134578899999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-38  Score=291.67  Aligned_cols=249  Identities=29%  Similarity=0.389  Sum_probs=202.3

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ...+.|+.-++||+|+||.||-++.+. |+.+|.|++.+..   .....-..+|-.+|.+++.+.||.+--+|+..+.++
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            445778888999999999999998654 8999999886432   233345678999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +|+..|+||+|..++++..+ ..+++...+-++.+|+.||++||...   ||.||+||+|||+|+.|+++|+|+|+|..+
T Consensus       262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999999977554 45899999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      .......   ..+||.+|||||++.+..|+...|.||+||++|||+-|+.||........               .+.++
T Consensus       338 ~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---------------~eEvd  399 (591)
T KOG0986|consen  338 PEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---------------REEVD  399 (591)
T ss_pred             CCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---------------HHHHH
Confidence            6544322   23899999999999999999999999999999999999999865332110               00111


Q ss_pred             CCccc--cccchHHHHHHHHHHHHhcccCCCCCCCCHH
Q 040532          348 DPVLE--DEYSSKQVLLRYVNIALLCVQESADDRPTMN  383 (436)
Q Consensus       348 ~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  383 (436)
                      ...+.  ..++ ...+++...+....|+.||++|..-+
T Consensus       400 rr~~~~~~ey~-~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  400 RRTLEDPEEYS-DKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHhcchhhcc-cccCHHHHHHHHHHHccCHHHhccCC
Confidence            11111  1122 23667788899999999999997543

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5e-37  Score=286.80  Aligned_cols=246  Identities=24%  Similarity=0.355  Sum_probs=195.4

Q ss_pred             cCCCCceeEEEEEecC-CCEEEEEEcCCCCh---hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGRSE---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       123 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      ||+|+||.||++.+.. |+.+++|.+.....   ...+.+.+|++++++++|||++++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999875 89999999875432   4456788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc------
Q 040532          199 DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL------  272 (436)
Q Consensus       199 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~------  272 (436)
                      .+++....   .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99886433   4899999999999999999999988   99999999999999999999999999875433211      


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                      ........++..|+|||...+..++.++|+||||+++|+|++|+.||.....     ......... ... .      ..
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~-~------~~  221 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQNILN-GKI-E------WP  221 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhc-CCc-C------CC
Confidence            1122334678899999999988899999999999999999999999854321     111111111 000 0      00


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      ...   ..+..+.+++.+||+.+|++||++.++.+.|+
T Consensus       222 ~~~---~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         222 EDV---EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ccc---cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            000   02456889999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=281.65  Aligned_cols=247  Identities=28%  Similarity=0.435  Sum_probs=201.2

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh--hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|++.+.||+|++|.||++... +++.+++|.+.....  ...+.+.+|++++.+++|||++++.+++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999876 478999999976543  4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++...   ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999988543   34899999999999999999999988   99999999999999999999999999987654332


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                      .  .....++..|+|||...+..++.++|+||+|+++|+|++|+.||.....    .. ..+......       .+..+
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~-~~~~~~~~~-------~~~~~  220 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MA-ALFRIVQDD-------HPPLP  220 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HH-HHHHHhccC-------CCCCC
Confidence            1  2234678899999999888889999999999999999999999853321    11 111111100       11111


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .     ..+..+.+++.+||+.+|++||++.++++
T Consensus       221 ~-----~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         221 E-----GISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             C-----CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            1     13456889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2e-36  Score=288.05  Aligned_cols=262  Identities=16%  Similarity=0.179  Sum_probs=183.1

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCC----CEEEEEEcCCCChhhH-----------HHHHHHHHHHHHcCCCceeEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKG----DEIAVKRLSGRSEQGL-----------REMKNEASVIAKVQHKNLVRL  176 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l  176 (436)
                      ...++|++.+.||+|+||+||+|...++    ..+|+|..........           .....+...+..++|+|++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            3457899999999999999999997653    4566665432221110           011223344556689999999


Q ss_pred             eeEEEeCC----ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC
Q 040532          177 LGCCIDKD----EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK  252 (436)
Q Consensus       177 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~  252 (436)
                      ++++....    ..++++|++.. ++.+.+...   ...++.....++.|++.||+|||+.+   ++||||||+|||++.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~  161 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG  161 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence            99776544    33677787643 455554322   12467778899999999999999988   999999999999999


Q ss_pred             CCCeEEeeccCceecCCCCcc-----cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCc
Q 040532          253 DMNPKISDFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL  327 (436)
Q Consensus       253 ~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~  327 (436)
                      ++.++|+|||+++........     .......||+.|+|||...+..++.++|||||||++|||++|+.||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            999999999999865432211     112234699999999999999999999999999999999999999965432211


Q ss_pred             chhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          328 NLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      .......+...      .+......    ....+..+.+++..|++.+|++||++.++++.|+
T Consensus       242 ~~~~~~~~~~~------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHAAKCDFIK------RLHEGKIK----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHhHHHHHH------Hhhhhhhc----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            10000000000      00000000    0113456889999999999999999999998763

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=313.16  Aligned_cols=266  Identities=28%  Similarity=0.399  Sum_probs=211.7

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecC--------CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK--------GDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGC  179 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~  179 (436)
                      .+...++..+.+.||+|.||.|++|....        ...||||.++.. ...+.+.+..|+++|+.+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            44455555667799999999999998441        346999999865 445678899999999999 69999999999


Q ss_pred             EEeCCccEEEEeecCCCChhhhhcCCC-------c----c--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 040532          180 CIDKDEKILIYEYMPNKSLDFFLFDPT-------K----R--ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS  246 (436)
Q Consensus       180 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~  246 (436)
                      |..++..++|.||+..|+|..++....       .    .  ..+.....+.++.|||.|++||++..   ++||||.++
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence            999999999999999999999997654       0    0  24888999999999999999999987   999999999


Q ss_pred             CEEEcCCCCeEEeeccCceecCCCCccccc-ccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 040532          247 NILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRT  324 (436)
Q Consensus       247 NIll~~~~~~kl~DfGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~  324 (436)
                      |||++++..+||+|||+++........... +...-+..|||||.+....|+.++||||||++|||++| |..||.....
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            999999999999999999976655544322 21113557999999999999999999999999999999 7788743110


Q ss_pred             CCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          325 DSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                          ..+. .+....+...+.           +..+..++++++..||+.+|++||++.++++.++....
T Consensus       528 ----~~~l-~~~l~~G~r~~~-----------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  528 ----TEEL-LEFLKEGNRMEQ-----------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             ----HHHH-HHHHhcCCCCCC-----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence                1111 223333322111           11156689999999999999999999999999999654

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.1e-36  Score=293.45  Aligned_cols=262  Identities=24%  Similarity=0.302  Sum_probs=195.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC-----
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  184 (436)
                      ..++|+..+.||+|+||.||+|... +|+.||+|.+...  .......+.+|+.++++++||||+++++++....     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999965 5889999998643  3334466788999999999999999999886443     


Q ss_pred             -ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          185 -EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       185 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                       ..++||||+++ +|...+...     ++......++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence             46899999965 676666321     778888999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHH--------
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD--------  335 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------  335 (436)
                      +........   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..  .....+..        
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~  239 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI--DQWNKIIEQLGTPSDE  239 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhcCCCCHH
Confidence            986543221   22236788999999999999999999999999999999999998543211  00000000        


Q ss_pred             -----------HhhcCC------cceeccCCcccc--ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          336 -----------LWTSNR------TLELIDDPVLED--EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       336 -----------~~~~~~------~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                                 ......      ......+.....  ..........+.+++.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                       000000      000000000000  00011234567899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.2e-36  Score=288.96  Aligned_cols=251  Identities=29%  Similarity=0.463  Sum_probs=196.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      +.|+..+.||+|+||.||+|... ++..+|+|.+...   .......+.+|+.++++++|||++++++++.+++..++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            44778899999999999999965 4889999998643   2334567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++ ++.+++...  ...+++..+..++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||++..... 
T Consensus       105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            99975 666665432  234889999999999999999999988   99999999999999999999999999865432 


Q ss_pred             CcccccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          271 ELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                           .....++..|+|||.+.   ++.++.++|||||||++|||++|+.||.....     ............      
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~------  241 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES------  241 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHhccC------
Confidence                 12236788999999874   45688999999999999999999999743211     011111111110      


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                       +..    ........+.+++.+||+.+|.+||++.++++.+-...
T Consensus       242 -~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         242 -PTL----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             -CCC----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence             000    01113456889999999999999999999998664433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-36  Score=309.25  Aligned_cols=270  Identities=20%  Similarity=0.260  Sum_probs=186.2

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC--CCEEEEE------------------EcCCCChhhHHHHHHHHHHHHHcCCC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK--GDEIAVK------------------RLSGRSEQGLREMKNEASVIAKVQHK  171 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~  171 (436)
                      ...++|++.+.||+|+||+||++..+.  +...+.|                  .+. ........+.+|+.+|++++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence            345789999999999999999987542  2112222                  111 1222345688999999999999


Q ss_pred             ceeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCc--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEE
Q 040532          172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK--RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  249 (436)
Q Consensus       172 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIl  249 (436)
                      ||+++++++...+..|+|+|++.+ +|..++.....  ...........++.|++.||.|||+++   |+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            999999999999999999999965 55555533211  112334566789999999999999988   999999999999


Q ss_pred             EcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCC-CCCCCCCC-c
Q 040532          250 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN-TGLYRTDS-L  327 (436)
Q Consensus       250 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p-~~~~~~~~-~  327 (436)
                      ++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.+ +....... .
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            99999999999999987643221 122235799999999999999999999999999999999998754 33221111 1


Q ss_pred             chhHHHHHHhhc-CC-------cceeccCC-------ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          328 NLLGYVWDLWTS-NR-------TLELIDDP-------VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       328 ~~~~~~~~~~~~-~~-------~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .+.......... ..       ..+.+...       ..............+.+++.+||+.||++|||+.|+++
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111111100000 00       00000000       00000001112345677899999999999999999986

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-37  Score=301.29  Aligned_cols=272  Identities=25%  Similarity=0.344  Sum_probs=205.3

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC------cc
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------EK  186 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~  186 (436)
                      ..|...+.||+|+||.||+|+.+ .|+.||||.++... ....+...+|+++|++++|+|||++++.-....      ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            45677789999999999999955 59999999998643 334567889999999999999999999855433      45


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc--CCCC--eEEeecc
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMN--PKISDFG  262 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~--~~~~--~kl~DfG  262 (436)
                      .+|||||.+|||...|..+.+...+++.+.+.++.++..||.|||+++   |+||||||.||++-  ++|+  -||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            899999999999999999999889999999999999999999999888   99999999999994  3343  6999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      .|+-++.+.   .....+||..|.+||.... +.|+..+|.|||||++|+..||..||....+... .....+...+...
T Consensus       170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~-~~~~~~~~~tkkp  245 (732)
T KOG4250|consen  170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN-NKEIMWHIITKKP  245 (732)
T ss_pred             ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc-cchhhhhhhccCC
Confidence            999877655   3455689999999999984 8899999999999999999999999976554421 1111222222211


Q ss_pred             --cceeccCC---------cccc-ccchHHHHHHHHHHHHhcccCCCCCCC--CHHHHHHHHhhcc
Q 040532          342 --TLELIDDP---------VLED-EYSSKQVLLRYVNIALLCVQESADDRP--TMNDVVSMLTNEA  393 (436)
Q Consensus       342 --~~~~~~~~---------~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RP--s~~ev~~~L~~~~  393 (436)
                        ........         .++. ..-.......+-+.+..+|..+|.+|.  .+.+....+.++.
T Consensus       246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence              11111110         0110 001122334556777788888999998  5555544444443

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.7e-36  Score=280.56  Aligned_cols=250  Identities=23%  Similarity=0.383  Sum_probs=203.1

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|++.+.||+|++|.||++.+. +++.+++|++....  ......+.+|++++++++|||++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999976 48899999997543  34567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          193 MPNKSLDFFLFDPT-KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      +++++|..++.... ....+++.....++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999886532 2356899999999999999999999998   9999999999999999999999999998764432


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                        .......|++.|+|||...+..++.++|+||+|+++++|++|+.||....     ......... ....      ..+
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~-~~~~------~~~  223 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKIL-KGQY------PPI  223 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHh-cCCC------CCC
Confidence              12223468889999999998889999999999999999999999985432     111111111 1111      011


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +.     .....+.+++.+||..+|++||++.++++
T Consensus       224 ~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 PS-----QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CC-----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11     13456889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.3e-36  Score=281.16  Aligned_cols=245  Identities=23%  Similarity=0.300  Sum_probs=188.8

Q ss_pred             hhccCCCCCccc--CCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKL--GEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  187 (436)
                      ...++|++.+.+  |+|+||.||++..+ ++..+|+|.+.......     .|......+ +|||++++++.+...+..+
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            344566676766  99999999999965 47889999986532111     122222222 7999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC-CeEEeeccCcee
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARI  266 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~-~~kl~DfGla~~  266 (436)
                      +||||+++++|.+++....   .+++.....++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||++..
T Consensus        86 iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~  159 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI  159 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence            9999999999999985432   5899999999999999999999998   99999999999999988 999999999876


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ....      ....++..|+|||.+.+..++.++||||||+++|||++|+.||............+....   .....  
T Consensus       160 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~--  228 (267)
T PHA03390        160 IGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLP--  228 (267)
T ss_pred             cCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCC--
Confidence            5422      123578899999999988899999999999999999999999874333222222221111   00000  


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT-MNDVVS  387 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~ev~~  387 (436)
                         ..      ...+..+.+++.+||+.+|.+||+ ++|+++
T Consensus       229 ---~~------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        229 ---FI------KNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---cc------cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence               00      124567899999999999999996 688873

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-36  Score=291.61  Aligned_cols=264  Identities=24%  Similarity=0.330  Sum_probs=193.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh--hhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--CccEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE--QGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKIL  188 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  188 (436)
                      .++|+..+.||+|+||.||+|.+. +|+.||+|.+.....  .....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467899999999999999999975 489999999864321  1123456899999999999999999998765  45799


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++ +|.+++....  ..+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 6777765432  35889999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC--c---
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR--T---  342 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~---  342 (436)
                      ....  ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.....  ......+........  .   
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChhhchh
Confidence            3321  1122245778999999875 4579999999999999999999999854321  111111111111000  0   


Q ss_pred             ------ceecc--CCcccc-ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 ------LELID--DPVLED-EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 ------~~~~~--~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                            .....  ...... ..........+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                  00000  000000 0000112456788999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.3e-36  Score=283.61  Aligned_cols=259  Identities=21%  Similarity=0.259  Sum_probs=190.5

Q ss_pred             CCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeC--CccEEEEe
Q 040532          117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDK--DEKILIYE  191 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  191 (436)
                      |++.+.||+|+||.||+|... +++.+|+|+++... ........+|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567789999999999999965 48899999987542 222234457888898885 99999999999987  88899999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++ ++.+++....  ..+++.....++.|++.||+|||+.+   ++||||+|+||+++. +.+||+|||++.......
T Consensus        81 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9975 6766664322  35899999999999999999999988   999999999999999 999999999997654322


Q ss_pred             cccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhh-----------c
Q 040532          272 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT-----------S  339 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~  339 (436)
                      .   .....++..|+|||.+.+ +.++.++|+|||||++|||++|+.||...+.  .+..........           .
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcc
Confidence            1   122357889999997754 5578999999999999999999999854321  111111111110           0


Q ss_pred             CCcceeccCCccccc--cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          340 NRTLELIDDPVLEDE--YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       340 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...............  ......+..+.+++.+||+++|++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000000000000000  001124578899999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=285.50  Aligned_cols=261  Identities=23%  Similarity=0.317  Sum_probs=197.6

Q ss_pred             CCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh--hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      |+..+.||+|++|.||+|... +|+.+++|++.....  .....+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999975 588899999875432  24567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++ ++..++....  ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            76 7777765432  35889999999999999999999998   9999999999999999999999999998765433  


Q ss_pred             cccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC--Cc--------
Q 040532          274 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN--RT--------  342 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~--------  342 (436)
                      .......++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||......  +............  ..        
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI--DQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCchHhcccchhhh
Confidence            112223577889999998876 7899999999999999999999998543211  1110000000000  00        


Q ss_pred             ----ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 ----LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                          ..................+..+.+++.+||+.||.+||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                000000000000011224567899999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.6e-36  Score=282.19  Aligned_cols=248  Identities=27%  Similarity=0.364  Sum_probs=200.9

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|++.+.||+|++|.||++... +++.+++|.+...  .......+.+|+.++++++|+||+++.+++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999865 4788999998753  334456778999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          193 MPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      +++++|..++... .....+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999887542 22345889999999999999999999988   999999999999999999999999999776543 


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                         ......++..|+|||.+.+..++.++|+||+|+++|||++|+.||...+..     ..... ......      +..
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~------~~~  221 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLRYK-VQRGKY------PPI  221 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HhcCCC------CCC
Confidence               112235788999999999988999999999999999999999998543311     11111 111110      001


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .     ......+.+++.+|++.+|++||++.++++
T Consensus       222 ~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         222 P-----PIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             c-----hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1     124567899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=282.42  Aligned_cols=244  Identities=24%  Similarity=0.263  Sum_probs=187.6

Q ss_pred             cccCCCCceeEEEEEec-CCCEEEEEEcCCCCh---hhHHHHHHHHHHH-HHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE---QGLREMKNEASVI-AKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||.||+|... +|+.||+|.+.....   .....+..|...+ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999975 488999999875432   2223344555444 445899999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      ++|..++...   ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....      
T Consensus        82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            9999998543   24788999999999999999999988   99999999999999999999999999875432      


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....++..|+|||.+.+..++.++||||||+++|||++|..||.....     ....... ......   .....    
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~-~~~~~~---~~~~~----  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNI-LSRRIN---WPEEV----  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH-HhcccC---CCCcc----
Confidence            2234678899999999888899999999999999999999999853221     1111111 111000   00000    


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                       ...++..+.+++.+||+.+|++||++.++.+.|+
T Consensus       217 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         217 -KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             -cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence             0114457889999999999999998876655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.1e-36  Score=286.62  Aligned_cols=264  Identities=24%  Similarity=0.314  Sum_probs=192.4

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ++|+..+.||+|++|+||+|.++ +|+.||+|.+....  ......+.+|++++++++|||++++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999976 58899999986432  2234568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-CCCeEEeeccCceecCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGN  270 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-~~~~kl~DfGla~~~~~~  270 (436)
                      |+++ +|..++.... ...+++.....++.|++.||+|||+.+   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLDL-DLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             cccc-cHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9964 6666653322 233577888899999999999999988   999999999999985 567999999999765322


Q ss_pred             CcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC--c-----
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR--T-----  342 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~-----  342 (436)
                      .  .......+++.|+|||.+.+. .++.++||||+|+++|+|+||+.||......+  .............  .     
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  232 (294)
T PLN00009        157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIFRILGTPNEETWPGVT  232 (294)
T ss_pred             c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhhccccc
Confidence            1  112233578899999988764 57899999999999999999999986432110  0000000000000  0     


Q ss_pred             --ceecc-CCccccc---cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 --LELID-DPVLEDE---YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 --~~~~~-~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        ..... .+.....   ......+..+.+++.+|++.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00000 0000000   000113456789999999999999999999986

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.7e-36  Score=287.13  Aligned_cols=267  Identities=24%  Similarity=0.322  Sum_probs=195.9

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC----
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  184 (436)
                      ...++|++.+.||+|+||.||+|..+. |+.||+|.+....  ......+.+|+.++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            456789999999999999999999764 8899999986532  223356778999999999999999999987654    


Q ss_pred             ------ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEE
Q 040532          185 ------EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  258 (436)
Q Consensus       185 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl  258 (436)
                            ..++|+||+++ ++..++...  ...+++.....++.|++.||+|||+.+   ++|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  67999999987 555555432  235899999999999999999999988   999999999999999999999


Q ss_pred             eeccCceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh
Q 040532          259 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      +|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....  .......+....
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~~~~~~~~~~~  234 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--ELAQLELISRLC  234 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHh
Confidence            99999976543322 11122345778999998865 357899999999999999999999985422  111111112211


Q ss_pred             hcCCcce---e--------ccCCc-cccc--cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          338 TSNRTLE---L--------IDDPV-LEDE--YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       338 ~~~~~~~---~--------~~~~~-~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .......   .        .+... ....  ......+..+.+++.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1110000   0        00000 0000  000013457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.6e-37  Score=296.15  Aligned_cols=252  Identities=21%  Similarity=0.299  Sum_probs=206.2

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      .+...+.|.+.+.||+|.|++|..|++. .|..||+|.+.+.  +....+.+.+|+++|..++|||||+++.+......+
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            3455678999999999999999999965 4889999999865  334456689999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      |+||||+.+|.+.+++.....   +.+.....++.|+.+|++|+|+++   |+|||||++||||+++.++||+|||++..
T Consensus       131 ylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             EEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccccee
Confidence            999999999999999976544   555888899999999999999998   99999999999999999999999999988


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      +.....   ....+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+...-..          .....+.. 
T Consensus       205 ~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~----------Lr~rvl~g-  270 (596)
T KOG0586|consen  205 FDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE----------LRPRVLRG-  270 (596)
T ss_pred             eccccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc----------ccchheee-
Confidence            764432   344599999999999998776 689999999999999999999985422110          01111111 


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        ....+..     ...++.++++++|-.+|.+|++++++.+.
T Consensus       271 --k~rIp~~-----ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  271 --KYRIPFY-----MSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             --eecccce-----eechhHHHHHHhhccCccccCCHHHhhhh
Confidence              1111111     33467789999999999999999998764

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7e-36  Score=282.64  Aligned_cols=261  Identities=26%  Similarity=0.376  Sum_probs=196.1

Q ss_pred             CCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--CccEEEEe
Q 040532          117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIYE  191 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  191 (436)
                      |++.+.||+|++|.||+|...+ |+.+|+|++....  ......+.+|+.++++++|||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            5677899999999999999764 7899999998652  33346788999999999999999999999988  78999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++ +|..++....  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9985 7877775432  35889999999999999999999988   9999999999999999999999999998765432


Q ss_pred             cccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc------e
Q 040532          272 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL------E  344 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~  344 (436)
                      . .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......  ................      .
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchhhcccccc
Confidence            1 11222356788999998765 45789999999999999999999998543321  1111111111100000      0


Q ss_pred             e-----c-c----CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          345 L-----I-D----DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       345 ~-----~-~----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .     . .    ......... ..++..+.+++.+||+.+|.+||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFK-HLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhhhccccccchhHHHHHhc-ccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0     0 0    000000000 002567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.8e-36  Score=287.50  Aligned_cols=264  Identities=20%  Similarity=0.215  Sum_probs=192.3

Q ss_pred             CCcccCCCCceeEEEEEecCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCC
Q 040532          119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       119 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      +.+.+|.|+++.||++.. +++.||+|++...  .....+.+.+|+..+++++|+||+++++++.+.+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344556666666666655 4899999998754  4455678999999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc----
Q 040532          197 SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL----  272 (436)
Q Consensus       197 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~----  272 (436)
                      +|.+++..... ..+++.....++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||.+........    
T Consensus        85 ~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99999865322 34788888999999999999999998   99999999999999999999999999875432211    


Q ss_pred             -ccccccccccCCccchhhhcc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH----hhcCC----
Q 040532          273 -QANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL----WTSNR----  341 (436)
Q Consensus       273 -~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~----  341 (436)
                       ........++..|+|||.+.+  ..++.++|+|||||++|||++|+.||....... .........    .....    
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhhh
Confidence             111122356778999999876  358899999999999999999999986432111 010000000    00000    


Q ss_pred             ---cce---eccCC---ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          342 ---TLE---LIDDP---VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       342 ---~~~---~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                         ...   ....+   ..............+.+++.+||+.||++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence               000   00000   000011122345678899999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-36  Score=280.09  Aligned_cols=250  Identities=26%  Similarity=0.366  Sum_probs=195.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-----ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--Ccc
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-----SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK  186 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  186 (436)
                      .+|++.+.||+|+||.||+|.+. +++.+|+|.+...     .......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999965 4889999987532     233456788999999999999999999998764  357


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++++||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            8999999999999888543   23788889999999999999999998   99999999999999999999999999976


Q ss_pred             cCCCCc-ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          267 CGGNEL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       267 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ...... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....    .. .+......+.    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~-~~~~~~~~~~----  226 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MA-AIFKIATQPT----  226 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HH-HHHHHHcCCC----
Confidence            532111 1112234688899999999988899999999999999999999999853211    11 1111111110    


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        .+..+     ......+.+++.+|++ +|..||+..++++
T Consensus       227 --~~~~p-----~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 --KPMLP-----DGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --CCCCC-----cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence              11111     1144568899999999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-36  Score=293.93  Aligned_cols=268  Identities=20%  Similarity=0.302  Sum_probs=197.6

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-----Cc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE  185 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  185 (436)
                      .++|.+.+.||+|+||+||+|... .++.||+|.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457899999999999999999965 4889999998753  233345677899999999999999999988654     24


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++|+||+. ++|..++...   ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 6787777543   34889999999999999999999988   9999999999999999999999999997


Q ss_pred             ecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc-----
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS-----  339 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  339 (436)
                      ......  .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+..  ............     
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~  232 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITELLGSPSEED  232 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCChHH
Confidence            654322  11223357889999998875 46899999999999999999999998543211  111111111000     


Q ss_pred             ------CCcceeccC----CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhc
Q 040532          340 ------NRTLELIDD----PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM--LTNE  392 (436)
Q Consensus       340 ------~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~--L~~~  392 (436)
                            .........    ............+..+.+++.+||+.+|++||+++++++.  ++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                  000000000    0000000011245678899999999999999999999877  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.8e-36  Score=293.75  Aligned_cols=266  Identities=19%  Similarity=0.306  Sum_probs=196.6

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEe----CCcc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEK  186 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  186 (436)
                      .++|++.+.||+|++|.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            467899999999999999999965 48999999987542  2334667889999999999999999998764    3457


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||+. ++|..++...   ..+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            89999996 5888887543   23899999999999999999999988   99999999999999999999999999976


Q ss_pred             cCCCCccc--ccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhh-----
Q 040532          267 CGGNELQA--NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT-----  338 (436)
Q Consensus       267 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----  338 (436)
                      ........  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..  .....+.....     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~  234 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEE  234 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhH
Confidence            54322111  1123468889999998865 45899999999999999999999998543211  00111011000     


Q ss_pred             ------cCCcceeccCCccccccc----hHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          339 ------SNRTLELIDDPVLEDEYS----SKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       339 ------~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                            .+................    ....+..+.+++.+||+.+|.+||++++++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                  000000000000000000    01135678999999999999999999998873

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.7e-36  Score=286.68  Aligned_cols=267  Identities=22%  Similarity=0.312  Sum_probs=192.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc----
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE----  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  185 (436)
                      .-++|+..+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.++++++||||+++++++.....    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457899999999999999999975 48899999886432  2223456789999999999999999999876543    


Q ss_pred             ----cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeec
Q 040532          186 ----KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  261 (436)
Q Consensus       186 ----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~Df  261 (436)
                          .++||||+.+ +|..++....  ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.+||+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence                4999999975 6766664322  24789999999999999999999988   999999999999999999999999


Q ss_pred             cCceecCCCCcc--cccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhh
Q 040532          262 GMARICGGNELQ--ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT  338 (436)
Q Consensus       262 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  338 (436)
                      |++.........  .......++..|+|||.+.+. .++.++|+||||+++|||++|+.||.....  ......+.....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~~~~~~~~  241 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLTLISQLCG  241 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhC
Confidence            999765432211  112234577889999988764 478899999999999999999999854321  111111111110


Q ss_pred             c--------CCcceeccCCcccc--------ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          339 S--------NRTLELIDDPVLED--------EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       339 ~--------~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .        .......+......        ..........+.+++.+||+.||.+||+++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0        00000000000000        0000001235678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.8e-36  Score=288.58  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=192.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  189 (436)
                      ..++|++.+.||+|++|.||+|.++. ++.||+|.+.... ......+..|+..+.+.. ||||+++++++.+....+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            34678889999999999999999875 8899999997542 233455667777777774 99999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      |||+++ ++..+.....  ..+++.....++.|++.||+|||+ .+   ++||||+|+||++++++.+||+|||++....
T Consensus        93 ~e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          93 MELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eeccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            999854 6666654322  258899999999999999999997 45   9999999999999999999999999987653


Q ss_pred             CCCcccccccccccCCccchhhhccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ....   .....++..|+|||.+.+..    ++.++|+||||+++|||++|+.||.....+    .+......... .  
T Consensus       167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~-~--  236 (296)
T cd06618         167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEVLTKILQEE-P--  236 (296)
T ss_pred             CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHHHHHHhcCC-C--
Confidence            3221   12235778999999987553    789999999999999999999998542211    11111111111 0  


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                          +..+..   ......+.+++.+||+.+|++||++.++++.
T Consensus       237 ----~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 ----PSLPPN---EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ----CCCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                000000   0134568899999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=326.15  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=206.1

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      .++..+-+|+-...||.|.||.||.|... +|+..|+|-++..  .......+.+|+.++..++|||+|+.+|+-.+.+.
T Consensus      1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred             HhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence            34566678888899999999999999954 4888999988643  23345668899999999999999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++.||||++|+|.+.+....   ..++.....+..|++.|++|||++|   ||||||||.||+|+.+|.+|++|||.|.
T Consensus      1309 v~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence            999999999999999985433   2566667778899999999999999   9999999999999999999999999999


Q ss_pred             ecCCCC--cccccccccccCCccchhhhccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          266 ICGGNE--LQANTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       266 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      .+..+.  ....-....||+.|||||++.+..   ...++||||+||+..||+||++||...+.+      |.....   
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~aIMy~--- 1453 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WAIMYH--- 1453 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hHHHhH---
Confidence            876553  222334568999999999998644   567899999999999999999998665432      111110   


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        ......|..+..     .+..-.+++.+||+.||++|+++.|+++.
T Consensus      1454 --V~~gh~Pq~P~~-----ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 --VAAGHKPQIPER-----LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             --HhccCCCCCchh-----hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence              000112222221     55667889999999999999999877654

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-36  Score=286.82  Aligned_cols=249  Identities=27%  Similarity=0.363  Sum_probs=200.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  189 (436)
                      ++|.+.+.||+|++|.||+|... +|+.+|+|++...   .......+.+|..++.+++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999975 5899999998653   2334467889999999998 99999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+++++|.+++....   .+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999986432   5899999999999999999999988   99999999999999999999999999986543


Q ss_pred             CCcc------------------cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 040532          270 NELQ------------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG  331 (436)
Q Consensus       270 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~  331 (436)
                      ....                  .......++..|+|||...+..++.++|+||||++++++++|+.||.....     ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~  229 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-----YL  229 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-----HH
Confidence            3211                  122234578899999999888899999999999999999999999864331     11


Q ss_pred             HHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 040532          332 YVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTM----NDVVS  387 (436)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~----~ev~~  387 (436)
                      .........        ...+.     ..+..+.+++.+||+.+|++||++    +++++
T Consensus       230 ~~~~~~~~~--------~~~~~-----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 TFQKILKLE--------YSFPP-----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHhcC--------CCCCC-----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            111111000        00111     124568899999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-36  Score=292.28  Aligned_cols=264  Identities=22%  Similarity=0.308  Sum_probs=199.3

Q ss_pred             CCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC-----ccE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKI  187 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  187 (436)
                      +|++.+.||+|++|.||+|.... ++.+|+|++....  ....+.+.+|+..+++++||||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            47888999999999999999764 8899999987643  344567899999999999999999999988775     779


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      ++|||+++ +|..++....   .+++.....++.+++.||+|||+.+   ++||||||+||++++++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999984 7877775432   5899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCc-ccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc------
Q 040532          268 GGNEL-QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS------  339 (436)
Q Consensus       268 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  339 (436)
                      ..... ........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.......  ....+......      
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcCCCChhHh
Confidence            54321 0112234678899999999887 78999999999999999999999985443211  01011110000      


Q ss_pred             -----CCcceeccCCcccccc----chHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          340 -----NRTLELIDDPVLEDEY----SSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       340 -----~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                           ......+.........    .....+..+.+++.+||+.+|++||++.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 0000000000000000    001134578899999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-36  Score=282.24  Aligned_cols=261  Identities=22%  Similarity=0.279  Sum_probs=193.2

Q ss_pred             CCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCCh-hhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEEeec
Q 040532          117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSE-QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      |++.+.||+|++|+||+|...+ ++.|++|++..... .......+|+..+++++ |||++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5677899999999999999764 78899999865422 22234567899999998 999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                       +|+|.+++.... ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             788888775433 235899999999999999999999988   99999999999999999999999999976543221 


Q ss_pred             cccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcc-----------hhHHHHHHhhcCC
Q 040532          274 ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN-----------LLGYVWDLWTSNR  341 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~-----------~~~~~~~~~~~~~  341 (436)
                        .....++..|+|||.+.+ ..++.++|+||||++++||++|+.||.........           ...|.........
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              122467889999998754 45789999999999999999999998543211100           0000000000000


Q ss_pred             cceec---cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 TLELI---DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .....   ..........  .....+.+++.+||+.+|++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIP--NASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcc--cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000   0000000000  12356889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=278.75  Aligned_cols=261  Identities=23%  Similarity=0.330  Sum_probs=192.5

Q ss_pred             CCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC--hhhHHHHHHHHHHHHHc---CCCceeEEeeEEEeCCc-----
Q 040532          117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--EQGLREMKNEASVIAKV---QHKNLVRLLGCCIDKDE-----  185 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  185 (436)
                      |++.+.||+|+||.||+|..+. ++.+|+|++....  ......+.+|+.++.++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5677899999999999999875 8999999997432  22234566787777666   59999999999998776     


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .+++|||+++ +|.+++.... ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 7877775422 234899999999999999999999988   9999999999999999999999999997


Q ss_pred             ecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      .......   .....++..|+|||.+.+..++.++|+|||||++|||++|+.||......  ....-+.+..........
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  230 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEEW  230 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHhc
Confidence            7643321   12235788999999999989999999999999999999999887543211  111111111000000000


Q ss_pred             cc-----CCccc----c--ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 ID-----DPVLE----D--EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~-----~~~~~----~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..     .....    .  ..........+.+++.+||+.||++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00     00000    0  0001123466789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1e-35  Score=287.68  Aligned_cols=257  Identities=22%  Similarity=0.278  Sum_probs=190.3

Q ss_pred             cccCCC--CceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEG--GFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      ..||+|  +||+||++.+. .|+.||+|++...  .....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456766  99999999975 5899999998743  334457788999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc--
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--  273 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~--  273 (436)
                      ++|.+++..... ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.++++||+.+.........  
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999998865322 24788899999999999999999988   999999999999999999999999865432211100  


Q ss_pred             ---cccccccccCCccchhhhccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC-------
Q 040532          274 ---ANTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-------  341 (436)
Q Consensus       274 ---~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  341 (436)
                         .......++..|+|||++.+.  .++.++|||||||++|||++|+.||........     .........       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~  234 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-----LLQKLKGPPYSPLDIT  234 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-----HHHHhcCCCCCCcccc
Confidence               001112345679999999764  478999999999999999999999864321110     000000000       


Q ss_pred             -------------------cce---------eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 -------------------TLE---------LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 -------------------~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                                         ..+         .+...... ..........+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                               000         00000000 0112235667899999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=270.97  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=195.7

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  190 (436)
                      .+..+.+..||.|+.|+||++..++ |...|||..... +....+.+...++++...+ +|+||+.+|+|..+...++.|
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            3556677889999999999999775 788999999765 4455677888888887775 999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      |.|. ..++.++..-.  .++++...=++...+.+||.||..++  +|+|||+||+|||+|+.|++|+||||++-.+..+
T Consensus       171 elMs-~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  171 ELMS-TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHH-HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence            9884 34555554322  24777778888999999999998876  5999999999999999999999999999766543


Q ss_pred             CcccccccccccCCccchhhhcc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ..   .+...|-+.|||||.+.-   ..|+.++||||||++++||.||+.||..-+.+   +. ....... +      .
T Consensus       246 kA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---Fe-~ltkvln-~------e  311 (391)
T KOG0983|consen  246 KA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---FE-VLTKVLN-E------E  311 (391)
T ss_pred             cc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---HH-HHHHHHh-c------C
Confidence            32   233478899999999873   46899999999999999999999998543221   11 1111111 1      1


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ++.++...   ..+..+.+++..||++|+.+||...++++
T Consensus       312 PP~L~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  312 PPLLPGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCCCCccc---CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            23333221   15678999999999999999999998875

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.2e-35  Score=278.65  Aligned_cols=241  Identities=25%  Similarity=0.311  Sum_probs=184.2

Q ss_pred             ccCCCCceeEEEEEec-CCCEEEEEEcCCCCh---hhHHHHHHHH---HHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          122 KLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE---QGLREMKNEA---SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      .||+|+||.||+|... +++.||+|.+.....   .....+..|.   ..+....||||+.+.+++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 488999999865321   1112233343   34444579999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +++|..++...   ..+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.++|+|||++.......   
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            99999888542   35899999999999999999999988   9999999999999999999999999987543221   


Q ss_pred             ccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                       .....|+..|+|||.+.++ .++.++|+||+|+++|||++|+.||..........   .......       .....+.
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~-------~~~~~~~  220 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLT-------MAVELPD  220 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---HHHHhhc-------cCCCCCC
Confidence             1233689999999998754 68999999999999999999999986432211110   0010000       0111111


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                      .     .+..+.+++.+|+..+|.+||     ++.++++
T Consensus       221 ~-----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         221 S-----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             c-----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1     245788999999999999999     8989875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=287.69  Aligned_cols=263  Identities=21%  Similarity=0.305  Sum_probs=194.4

Q ss_pred             ccCCC-CCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhh--------------HHHHHHHHHHHHHcCCCceeEEe
Q 040532          114 TNTFS-DTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQG--------------LREMKNEASVIAKVQHKNLVRLL  177 (436)
Q Consensus       114 ~~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~  177 (436)
                      .++|. +.+.||+|+||+||+|.+. .++.||+|.+.......              ...+.+|+.++++++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            45565 4577999999999999965 58899999986432111              12467899999999999999999


Q ss_pred             eEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeE
Q 040532          178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  257 (436)
Q Consensus       178 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~k  257 (436)
                      +++...+..++||||++ |+|.+++...   ..+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            99999999999999997 5788877432   34788999999999999999999988   99999999999999999999


Q ss_pred             EeeccCceecCCCCc------------ccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 040532          258 ISDFGMARICGGNEL------------QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  324 (436)
Q Consensus       258 l~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~  324 (436)
                      |+|||++........            ........++..|+|||.+.+. .++.++|+||||+++|||++|+.||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999986652111            1111223467889999998764 468999999999999999999999864432


Q ss_pred             CCcchhHHHHHHhhcCCcc---eec-----------cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          325 DSLNLLGYVWDLWTSNRTL---ELI-----------DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~---~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .  .....+..........   ...           .........  ...+..+.+++.+||+.+|++||+++|++.
T Consensus       240 ~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        240 I--DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIF--PNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             H--HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhC--cCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1  1111121211111100   000           000000000  113456889999999999999999999986

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5e-36  Score=287.24  Aligned_cols=264  Identities=24%  Similarity=0.356  Sum_probs=191.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC------
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------  184 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  184 (436)
                      .++|++.+.||+|+||.||+|... +++.+|+|++....  ......+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999975 48899999886432  222345678999999999999999999876543      


Q ss_pred             --ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          185 --EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       185 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                        ..++|+||+++ ++...+...  ...+++.....++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              35899999976 455555432  234899999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCccc---------ccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 040532          263 MARICGGNELQA---------NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY  332 (436)
Q Consensus       263 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~  332 (436)
                      ++..........         ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.....  ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~--~~~~~~  238 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD--IDQLHL  238 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence            997654322111         11223567889999988754 578999999999999999999999854321  111111


Q ss_pred             HHHHhhcCCc---------cee-------ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          333 VWDLWTSNRT---------LEL-------IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       333 ~~~~~~~~~~---------~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..........         ...       ...+.......  .....+.+++.+||+.+|++|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG--KLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcc--cCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1111110000         000       00000100011  12356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.2e-35  Score=284.69  Aligned_cols=248  Identities=30%  Similarity=0.445  Sum_probs=193.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      .+.|+..+.||+|+||.||+|... +++.+|+|.+...   ......++.+|+.+++.++|+|++++.+++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            445777889999999999999975 4788999988632   334456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+. |++.+++....  ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          94 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            99997 56766654322  34788999999999999999999988   99999999999999999999999999876432


Q ss_pred             CCcccccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          270 NELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .      ....++..|+|||.+.   ...++.++|||||||++|+|++|+.||......  .   ......... .    
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~---~~~~~~~~~-~----  231 (308)
T cd06634         168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--S---ALYHIAQNE-S----  231 (308)
T ss_pred             c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--H---HHHHHhhcC-C----
Confidence            1      2236788999999975   355788999999999999999999997432211  0   111111100 0    


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                        +..    ........+.+++.+||+.+|++||++.++++.-
T Consensus       232 --~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 --PAL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --CCc----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence              000    0111445688999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-35  Score=284.64  Aligned_cols=244  Identities=28%  Similarity=0.471  Sum_probs=190.7

Q ss_pred             CCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      |...+.||+|+||+||+|... .|+.|++|++...   .......+.+|+.+++.++|||++++.+++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999964 4889999998643   233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +.+ ++.+++...  ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.+||+|||++....    
T Consensus       103 ~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            964 666665432  234889999999999999999999988   9999999999999999999999999985432    


Q ss_pred             ccccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          273 QANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                        ......|+..|+|||.+.   ...++.++||||||+++|||++|..||.....     ...........       .+
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~-------~~  238 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQND-------SP  238 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcC-------CC
Confidence              122346888999999984   45688899999999999999999999743221     11111111111       00


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ...    ....+..+.+++.+||+.+|.+||++.++++.
T Consensus       239 ~~~----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 TLQ----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000    01123457889999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-37  Score=275.93  Aligned_cols=242  Identities=24%  Similarity=0.293  Sum_probs=195.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      .-++|..+++||+|.||.|-+++-+ .|+.+|+|++++.   .......-..|-++|+..+||.+..+.-.|+..+..|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3467999999999999999999865 4889999999865   34445566789999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||..||.|...|...   ..+++....-+-..|..||.|||+.+   |+.||||.+|.|+|++|++||+|||+++.--
T Consensus       246 VMeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999998887543   33677776777788999999999988   9999999999999999999999999987421


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                        ......+..+|||.|+|||++....|+.+.|.|.+||+||||++|+.||-..+  ...+...+.           +.+
T Consensus       320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d--h~kLFeLIl-----------~ed  384 (516)
T KOG0690|consen  320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD--HEKLFELIL-----------MED  384 (516)
T ss_pred             --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc--hhHHHHHHH-----------hhh
Confidence              22334566799999999999999999999999999999999999999984322  222221111           111


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCC
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRP  380 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  380 (436)
                      -..+..     .+.+...|+.-.|.+||.+|.
T Consensus       385 ~kFPr~-----ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  385 LKFPRT-----LSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ccCCcc-----CCHHHHHHHHHHhhcChHhhc
Confidence            112221     344567788999999999995

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.9e-36  Score=283.67  Aligned_cols=251  Identities=22%  Similarity=0.280  Sum_probs=193.5

Q ss_pred             CCCCCcccCCCCceeEEEEEec----CCCEEEEEEcCCCC----hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCcc
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLSGRS----EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  186 (436)
                      +|++.+.||+|+||.||.+...    +|..||+|++....    ....+.+.+|+.++.++ +|+||+++.+++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4778899999999999999863    58899999987532    12345678899999999 599999999999999899


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++|+||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||+|+|||+++++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999999988543   34788888999999999999999988   99999999999999999999999999976


Q ss_pred             cCCCCcccccccccccCCccchhhhccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ....... ......|+..|+|||.+.+.  .++.++||||||+++|+|++|+.||..... ...............    
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~----  228 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE----  228 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC----
Confidence            5432211 12234688899999998753  467899999999999999999999853221 111111111111111    


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                          +..+.     .....+.+++.+||+.+|++||     +..+++.
T Consensus       229 ----~~~~~-----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 ----PPYPQ-----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ----CCCCc-----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                01111     1345678999999999999997     5555544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.7e-36  Score=285.24  Aligned_cols=255  Identities=23%  Similarity=0.281  Sum_probs=197.9

Q ss_pred             CCCCCcccCCCCceeEEEEEec----CCCEEEEEEcCCCC----hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCcc
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLSGRS----EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  186 (436)
                      +|++.+.||+|++|.||++...    ++..+|+|.+....    ....+.+.+|+.++.++ +||||+++.+.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3677889999999999999843    46789999986432    22345678999999999 599999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||+++++|..++...   ..+++.....++.|+++||.|||+.+   ++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999999888542   34788899999999999999999988   99999999999999999999999999876


Q ss_pred             cCCCCcccccccccccCCccchhhhccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ....... ......|+..|+|||.+.+..  .+.++|+||||+++|||++|..||....... ............     
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-----  227 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKS-----  227 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHcc-----
Confidence            5433211 122346788999999987665  7889999999999999999999985322111 111111111111     


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                         ....+..     ....+.+++.+||+.+|++|||+.++.+.|..
T Consensus       228 ---~~~~~~~-----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 ---KPPFPKT-----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ---CCCCCcc-----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence               0111111     33467889999999999999999988887765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-35  Score=288.71  Aligned_cols=265  Identities=22%  Similarity=0.279  Sum_probs=192.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC---------
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK---------  183 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------  183 (436)
                      ..+|++.+.||.|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            468999999999999999999975 4889999998766555567788999999999999999999876543         


Q ss_pred             -----CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-CCCCeE
Q 040532          184 -----DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPK  257 (436)
Q Consensus       184 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-~~~~~k  257 (436)
                           ...++||||++ ++|..++..    ..+++.....++.|++.||.|||+.+   ++||||||+||+++ +++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 34689999997 578777743    23788999999999999999999998   99999999999998 456789


Q ss_pred             EeeccCceecCCCCccc-ccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 040532          258 ISDFGMARICGGNELQA-NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       258 l~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  335 (436)
                      ++|||++.......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~  234 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILES  234 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence            99999997653321111 1122357889999998764 567889999999999999999999985332100 00000000


Q ss_pred             Hhhc-----CC----cceec----cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          336 LWTS-----NR----TLELI----DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       336 ~~~~-----~~----~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ....     ..    .....    .....+...........+.+++.+||+.||.+||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0000     00    00000    00000000000113356789999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-35  Score=289.14  Aligned_cols=264  Identities=24%  Similarity=0.362  Sum_probs=193.1

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC------
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------  184 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  184 (436)
                      .++|...+.||+|+||.||+|... +|+.||+|++...  .......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            467888999999999999999965 5899999998653  2223456789999999999999999999987543      


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..++|+||+.. +|..+..     ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            35899999964 6665542     23788899999999999999999998   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh------
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW------  337 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------  337 (436)
                      .....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....  ...........      
T Consensus       165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~  237 (342)
T cd07879         165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGPE  237 (342)
T ss_pred             cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHH
Confidence            75432     1223467889999999876 4688999999999999999999999864321  11110001000      


Q ss_pred             -----hcCCcceeccC-Cccccc-cc--hHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhcc
Q 040532          338 -----TSNRTLELIDD-PVLEDE-YS--SKQVLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEA  393 (436)
Q Consensus       338 -----~~~~~~~~~~~-~~~~~~-~~--~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~--L~~~~  393 (436)
                           ........... +..... ..  .......+.+++.+||+.||++||++.+++..  ++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                 00000000000 000000 00  00133467899999999999999999999854  65544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.4e-35  Score=286.63  Aligned_cols=263  Identities=24%  Similarity=0.348  Sum_probs=195.2

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe-CCcc
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEK  186 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  186 (436)
                      -..+++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.++.+++|||++++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346788999999999999999999865 5889999988643  22334677899999999999999999999876 5578


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++++||+ +++|..++..    ..++......++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            8999998 5688877743    23677888899999999999999998   99999999999999999999999999875


Q ss_pred             cCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh--------
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW--------  337 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------  337 (436)
                      ....     .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......  .......+..        
T Consensus       158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence            4321     122357888999998766 56899999999999999999999998543211  0000000000        


Q ss_pred             ---hcCCcceeccCCccccccch----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          338 ---TSNRTLELIDDPVLEDEYSS----KQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       338 ---~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                         ..................+.    ......+.+++.+||+.+|++||++.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               00000011000000000000    1134578899999999999999999998664

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-35  Score=287.06  Aligned_cols=258  Identities=23%  Similarity=0.352  Sum_probs=193.8

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC----
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  184 (436)
                      ...++|++.+.||+|+||.||+|... +|..||+|++...  .......+.+|+.++++++||||+++.+++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            35678999999999999999999865 5889999998643  2333456889999999999999999999987654    


Q ss_pred             --ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          185 --EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       185 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                        ..++||||+ +++|..++..    ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence              348999998 7788877743    24789999999999999999999988   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc--
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS--  339 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  339 (436)
                      ++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.....     ..........  
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-----~~~~~~~~~~~~  233 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH-----LDQLMEIMKVTG  233 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcC
Confidence            98754321     223357889999999876 4588999999999999999999999864321     1111111000  


Q ss_pred             ------------CCcceeccC-Cccc-cc--cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          340 ------------NRTLELIDD-PVLE-DE--YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       340 ------------~~~~~~~~~-~~~~-~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                                  ......... +... ..  .........+.+++.+|++.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                        000000000 0000 00  000113446789999999999999999999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-35  Score=288.62  Aligned_cols=263  Identities=23%  Similarity=0.321  Sum_probs=194.9

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--  183 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--  183 (436)
                      ++....++|++.+.||+|+||.||+|... +|+.||+|++...  .....+.+.+|+.++.+++||||+++.+++...  
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            34566788999999999999999999864 5889999998753  223345678899999999999999999988643  


Q ss_pred             ----CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEe
Q 040532          184 ----DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  259 (436)
Q Consensus       184 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~  259 (436)
                          ...+++++++ +++|.+++...    .+++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence                2357788876 78888777432    3789999999999999999999998   9999999999999999999999


Q ss_pred             eccCceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhh
Q 040532          260 DFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT  338 (436)
Q Consensus       260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  338 (436)
                      |||++.....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......  ...........
T Consensus       163 dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~  235 (345)
T cd07877         163 DFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVG  235 (345)
T ss_pred             cccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC
Confidence            9999875432     1223467889999998876 56889999999999999999999998543211  11000000000


Q ss_pred             c--CCcce---------------eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          339 S--NRTLE---------------LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       339 ~--~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      .  .....               ............  .....+.+++.+|++.+|.+||++.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFI--GANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcC--CCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0  00000               000000000000  123467899999999999999999998865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.3e-35  Score=284.64  Aligned_cols=273  Identities=22%  Similarity=0.260  Sum_probs=193.9

Q ss_pred             CCCCCcccCCCCceeEEEEEecC---CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeC----Cc
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK---GDEIAVKRLSGR--SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK----DE  185 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  185 (436)
                      +|++.+.||+|+||.||++....   +..+|+|++...  .....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            47778899999999999999653   678999998643  222345678899999999 599999999875432    34


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++++||+. ++|..++...   ..+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888886 5788777432   34889999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcc--cccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCc----------chhHH
Q 040532          266 ICGGNELQ--ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL----------NLLGY  332 (436)
Q Consensus       266 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~----------~~~~~  332 (436)
                      ........  .......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+....          .....
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            65432211  11223468899999998776 4689999999999999999999999864321100          00000


Q ss_pred             HHHHhhcCC-----cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCC
Q 040532          333 VWDLWTSNR-----TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP  399 (436)
Q Consensus       333 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~  399 (436)
                      .........     ...............  .....+.+++.+|++.+|++|||+.++++.  ....++..|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~t~~~ll~~--~~~~~~~~~  301 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFP--NANPLALDLLEKLLAFDPTKRISVEEALEH--PYLAIWHDP  301 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCC--CCCHHHHHHHHHHccCCcccCCCHHHHhcC--hhhhhhcCc
Confidence            000000000     000000000010000  124568899999999999999999998642  344444444

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-35  Score=277.45  Aligned_cols=259  Identities=26%  Similarity=0.356  Sum_probs=196.6

Q ss_pred             CCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      |+..+.||+|++|.||+|+... ++.+|+|.+....  ....+.+..|+.++++++|+|++++.+++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            5567889999999999999764 8999999997653  333467788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      + ++|.+++....  ..+++..+..++.+++.||.|||+.+   ++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 58988886532  34889999999999999999999998   99999999999999999999999999876543221 


Q ss_pred             cccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC------------
Q 040532          274 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN------------  340 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------  340 (436)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......  .............            
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHHHhCCCcHHHHHhhcccc
Confidence             12223457789999998876 7899999999999999999999998543211  1111111110000            


Q ss_pred             ---CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 ---RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                         ...............  ......+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVL--PRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccCccchHHhc--ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence               000000000000000  112457899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-35  Score=286.68  Aligned_cols=259  Identities=24%  Similarity=0.352  Sum_probs=195.3

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc---
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE---  185 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  185 (436)
                      ...++|+..+.||+|++|.||+|.+.. ++.||+|++...  .......+.+|+.++++++|||++++.+++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            346789999999999999999999764 788999998653  23334667889999999999999999998876554   


Q ss_pred             ---cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          186 ---KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       186 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                         .++|+||+ +++|.+++..    ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence               79999998 5688888753    24899999999999999999999988   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc--
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS--  339 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  339 (436)
                      ++......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....  .............  
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~  236 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGTPD  236 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCC
Confidence            98765322     223367888999998875 3678999999999999999999999854321  1111111111000  


Q ss_pred             ---------CCcceecc------CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          340 ---------NRTLELID------DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       340 ---------~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                               ......+.      .........  ..+..+.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFS--GANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhc--cCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                     00000000      000000000  13567889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4e-36  Score=268.70  Aligned_cols=272  Identities=21%  Similarity=0.315  Sum_probs=197.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-----CCEEEEEEcCCCChh--hHHHHHHHHHHHHHcCCCceeEEeeEEEe-CCc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-----GDEIAVKRLSGRSEQ--GLREMKNEASVIAKVQHKNLVRLLGCCID-KDE  185 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  185 (436)
                      ...|+..+.||+|.||.||+|...+     ...+|+|+++.....  .-....+|+.+++.++|||++.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3568888999999999999996433     236899999865221  12456899999999999999999999988 778


Q ss_pred             cEEEEeecCCCChhhhhc--CCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC----CCeEEe
Q 040532          186 KILIYEYMPNKSLDFFLF--DPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNPKIS  259 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~--~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~----~~~kl~  259 (436)
                      .++++||.+...+ ..++  ...+...++.....+|+.||+.|+.|||++-   |+||||||.|||+..+    |.|||+
T Consensus       103 v~l~fdYAEhDL~-~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEHDLW-HIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhhhHH-HHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            8999999987544 4442  2233356888999999999999999999998   9999999999999877    999999


Q ss_pred             eccCceecCCCCcc-cccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCC-------cchh
Q 040532          260 DFGMARICGGNELQ-ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-------LNLL  330 (436)
Q Consensus       260 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-------~~~~  330 (436)
                      |||+++.+...-.. ......+-|..|.|||.+.+. .||.+.|||+.|||+.||+|-++-|.......       .+.+
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999987654322 234456789999999999985 58999999999999999999888775432111       1112


Q ss_pred             HHHHHHhhcCCcceeccCCccccc-----------cch----------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          331 GYVWDLWTSNRTLELIDDPVLEDE-----------YSS----------KQVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~----------~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                      +.+.+....+......+-...+..           +.+          ..-.....+|+.++|+.||-+|.|+++.++.-
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            222222222211111111000000           000          00112357899999999999999999988754

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.5e-36  Score=307.94  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=188.6

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe------
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCID------  182 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------  182 (436)
                      +...++|+.++.||+||||.||+++.+ +|..+|||++.-. +......+.+|+.+|++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345678899999999999999999965 6999999999755 44556778999999999999999999842100      


Q ss_pred             --------------------------------------------------------------------------------
Q 040532          183 --------------------------------------------------------------------------------  182 (436)
Q Consensus       183 --------------------------------------------------------------------------------  182 (436)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------C--------CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHH
Q 040532          183 -------------------------K--------DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY  229 (436)
Q Consensus       183 -------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~  229 (436)
                                               +        ...|+=||||+..++++++..+....  .....++++++|+.||.|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                     0        11266789998888888886543211  356778999999999999


Q ss_pred             HhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC----C------------CCcccccccccccCCccchhhhcc
Q 040532          230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG----G------------NELQANTSRIVGTYGYMSPEYALE  293 (436)
Q Consensus       230 LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~  293 (436)
                      +|++|   ++||||||.||++|++..|||+|||+++...    .            .......+..+||.-|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99999   9999999999999999999999999998721    0            001112344689999999999986


Q ss_pred             C---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHh
Q 040532          294 G---IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALL  370 (436)
Q Consensus       294 ~---~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  370 (436)
                      .   .|+.|+|+||+|++++||+.   ||+.    .++-...+.. ++...+...      .....+  ....-.++|++
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T----sMERa~iL~~-LR~g~iP~~------~~f~~~--~~~~e~slI~~  853 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGT----SMERASILTN-LRKGSIPEP------ADFFDP--EHPEEASLIRW  853 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCc----hHHHHHHHHh-cccCCCCCC------cccccc--cchHHHHHHHH
Confidence            4   49999999999999999985   3532    1111111111 111111110      001111  23344679999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 040532          371 CVQESADDRPTMNDVVS  387 (436)
Q Consensus       371 cl~~~p~~RPs~~ev~~  387 (436)
                      +++.||++|||+.|++.
T Consensus       854 Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HhcCCCccCCCHHHHhh
Confidence            99999999999999875

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.5e-35  Score=275.17  Aligned_cols=249  Identities=27%  Similarity=0.362  Sum_probs=192.3

Q ss_pred             CCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC-----ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR-----SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      +|.+.+.||+|+||.||++.+.. +..+++|.++..     .......+..|+.++++++|||++++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998654 444555555421     222334567899999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          190 YEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      +||+++++|..++... .....+++.....++.|++.||.|||+.+   ++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999887532 22345899999999999999999999988   999999999999975 569999999987654


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ....  ......|+..|+|||...+..++.++|+||||+++|+|++|..||....     .......... ..      .
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~-~~------~  222 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVE-GP------T  222 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHc-CC------C
Confidence            3221  1223457889999999988888999999999999999999999984321     1111111111 10      1


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +...     ...+..+.+++.+||+.+|++||++.|+++
T Consensus       223 ~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 PSLP-----ETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCc-----chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            1111     124557889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=306.13  Aligned_cols=257  Identities=23%  Similarity=0.270  Sum_probs=204.9

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      .+.....+|.+++.||+|+||.|..++.+. ++.+|.|++++-   .......|..|-++|..-+.+-|+.+.-+|.+..
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            455667899999999999999999999865 778899999752   2334467899999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ++|+||||++||+|-.++.+..   .+++.-+.-++..+.-||.-||+.|   +|||||||+|||||..|++||+|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence            9999999999999999997655   3677666677778999999999999   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhc----c-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYAL----E-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS  339 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  339 (436)
                      ..+..+. .......+|||.|.+||++.    + +.|+..+|.||+||++|||+.|..||-.     ..+++.+......
T Consensus       223 lkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-----dslveTY~KIm~h  296 (1317)
T KOG0612|consen  223 LKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-----DSLVETYGKIMNH  296 (1317)
T ss_pred             HhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-----HHHHHHHHHHhch
Confidence            8776443 34455679999999999997    3 5699999999999999999999999832     2333333333333


Q ss_pred             CCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 040532          340 NRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT---MNDVVS  387 (436)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~ev~~  387 (436)
                      .......+.         ...+....+||++.+. +|+.|..   .+++-.
T Consensus       297 k~~l~FP~~---------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  297 KESLSFPDE---------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hhhcCCCcc---------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            222222211         1155677888888664 6888887   666643

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-35  Score=271.77  Aligned_cols=236  Identities=25%  Similarity=0.326  Sum_probs=190.8

Q ss_pred             cCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       123 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      ||+|+||.||++.... ++.+++|.+....   ......+..|+.++++++|||++++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999999764 8899999987542   23456789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccccc
Q 040532          199 DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  278 (436)
Q Consensus       199 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  278 (436)
                      .+++....   .+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            99985433   4789999999999999999999988   9999999999999999999999999997754332  12233


Q ss_pred             ccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchH
Q 040532          279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK  358 (436)
Q Consensus       279 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (436)
                      ..++..|+|||...+...+.++|+||||+++|+|++|+.||...+.     ......... .       ....+..    
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~-~-------~~~~~~~----  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILK-D-------PLRFPEF----  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhc-C-------CCCCCCC----
Confidence            4678899999999888889999999999999999999999854321     111111111 0       1111111    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHH
Q 040532          359 QVLLRYVNIALLCVQESADDRPTMND  384 (436)
Q Consensus       359 ~~~~~l~~li~~cl~~~p~~RPs~~e  384 (436)
                       .+..+.+++.+||..||++||++.+
T Consensus       216 -~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 -LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -CCHHHHHHHHHHhcCCHhhCCCccc
Confidence             2456788999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=271.67  Aligned_cols=257  Identities=26%  Similarity=0.391  Sum_probs=194.7

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .+.+.+..||.|+||+|++-.++. |+..|||+++.. .+.+..++..|.+...+- ++||||+++|++..++..|+.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            445667889999999999998764 899999999865 446667788888766554 79999999999999999999999


Q ss_pred             ecCCCChhhhhcC--CCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          192 YMPNKSLDFFLFD--PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       192 ~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      .|+ .||+.+...  ......+++...-+|..-...||.||....  .|+|||+||+|||++..|.+||||||.+-.+..
T Consensus       144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            995 466544321  112234777777778878899999998755  499999999999999999999999999865533


Q ss_pred             CCcccccccccccCCccchhhhcc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          270 NELQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      +-   ..+...|-..|||||.+..  ..|+.+|||||||++|||+.||+.|+..++.    ..+.+....       .-+
T Consensus       221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv-------~gd  286 (361)
T KOG1006|consen  221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVV-------IGD  286 (361)
T ss_pred             HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHH-------cCC
Confidence            22   2223467788999999873  3489999999999999999999999865432    111112211       112


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      .+.+.......+.+..+..++..|+.+|-++||...++.++
T Consensus       287 pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  287 PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            33333333333456678999999999999999999988754

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=288.99  Aligned_cols=258  Identities=23%  Similarity=0.386  Sum_probs=207.4

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEe---
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCID---  182 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---  182 (436)
                      ..+...++.|++.+.||+|.+|.||+++.. +|+.+|+|+....... .+++..|.++++.. .|||++.++|++..   
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            344556778999999999999999999954 5888999998765433 35678899999887 79999999999875   


Q ss_pred             --CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEee
Q 040532          183 --KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  260 (436)
Q Consensus       183 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~D  260 (436)
                        ++.+|||||||.+||..++..+.. +..+.|.....|++.++.|+.+||...   ++|||||-.|||++.++.|||+|
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence              467899999999999999987655 566999999999999999999999887   99999999999999999999999


Q ss_pred             ccCceecCCCCcccccccccccCCccchhhhcc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 040532          261 FGMARICGGNELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  335 (436)
                      ||++..++..  ........||+.|||||++..     ..|+.++|+||||++..||--|.+|+.....           
T Consensus       167 FGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----------  233 (953)
T KOG0587|consen  167 FGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----------  233 (953)
T ss_pred             eeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----------
Confidence            9999876532  233445689999999999974     3478899999999999999999999743221           


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                         -..+..+...+. +.......-..++.++|..||.+|.++||++.++++
T Consensus       234 ---mraLF~IpRNPP-PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  234 ---MRALFLIPRNPP-PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ---hhhhccCCCCCC-ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence               111112221221 122223446788999999999999999999988764

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.4e-34  Score=301.41  Aligned_cols=145  Identities=27%  Similarity=0.417  Sum_probs=130.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||+|.+. .++.||+|++...   .......+..|+.++..++||||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999976 4889999998653   2334567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      ||+++++|..++....   .+++...+.++.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999985432   3788889999999999999999988   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=264.38  Aligned_cols=255  Identities=24%  Similarity=0.303  Sum_probs=196.8

Q ss_pred             cccCCCCceeEEEEE-ecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          121 NKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      +.||+|+|+.|--+. ..+|..+|||++.+..........+|++++.+++ |+||+.++++|+++...|||||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            579999999999988 5669999999998876667788999999999995 99999999999999999999999999999


Q ss_pred             hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC---eEEeeccCceecCCCC----
Q 040532          199 DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFGMARICGGNE----  271 (436)
Q Consensus       199 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~---~kl~DfGla~~~~~~~----  271 (436)
                      ...+.+   +..+++.++.++..+|+.||.|||..|   |.|||+||+|||......   +|||||.+..-...+.    
T Consensus       164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            888754   344889999999999999999999998   999999999999976554   7999998875432211    


Q ss_pred             -cccccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC-----cchhHHHHHHhhcC
Q 040532          272 -LQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-----LNLLGYVWDLWTSN  340 (436)
Q Consensus       272 -~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~  340 (436)
                       ........+|+..|||||+..     ...|+.+.|.||||||+|-|++|.+||....+.+     ...-......    
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~----  313 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK----  313 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH----
Confidence             112233457889999999875     2358999999999999999999999996543221     1111110000    


Q ss_pred             CcceeccC--CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 RTLELIDD--PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       +.+.+.+  ..++.. ....++....+++...+..++.+|.++.+++.
T Consensus       314 -LFesIQEGkYeFPdk-dWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  314 -LFESIQEGKYEFPDK-DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             -HHHHHhccCCcCChh-hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence             1111111  111111 11236667788999999999999999998876

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.4e-34  Score=264.03  Aligned_cols=220  Identities=18%  Similarity=0.133  Sum_probs=174.6

Q ss_pred             CCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCChhhhhcC
Q 040532          126 GGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD  204 (436)
Q Consensus       126 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  204 (436)
                      |.+|.||++.+. +++.+|+|++....     .+.+|...+....|||++++++++.+.+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999975 47899999997643     233455555666899999999999999999999999999999988854


Q ss_pred             CCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCC
Q 040532          205 PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG  284 (436)
Q Consensus       205 ~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  284 (436)
                      ..   .+++.....++.|++.||.|||+.+   ++||||||+||+++.++.++++|||.+......     .....++..
T Consensus        79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence            32   3889999999999999999999988   999999999999999999999999987654322     122345678


Q ss_pred             ccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHH
Q 040532          285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRY  364 (436)
Q Consensus       285 y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  364 (436)
                      |+|||...+..++.++|+||+|+++|||++|+.|+.......           ...   ..+   ..+.     .....+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~---~~~---~~~~-----~~~~~~  205 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTH---TTL---NIPE-----WVSEEA  205 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccc---ccc---CCcc-----cCCHHH
Confidence            999999988889999999999999999999998764221100           000   000   0111     134568


Q ss_pred             HHHHHhcccCCCCCCCCHH
Q 040532          365 VNIALLCVQESADDRPTMN  383 (436)
Q Consensus       365 ~~li~~cl~~~p~~RPs~~  383 (436)
                      .+++.+|++.||++||++.
T Consensus       206 ~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         206 RSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHccCCHHHhcCCC
Confidence            8999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=280.97  Aligned_cols=240  Identities=23%  Similarity=0.263  Sum_probs=192.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      .+..|.....+|.|+|+.|-++.+.. ++..++|++....    .+..+|..++... +|||++++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            46778888899999999999998654 7889999997652    2346677666666 7999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE-cCCCCeEEeeccCceecCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-DKDMNPKISDFGMARICGG  269 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll-~~~~~~kl~DfGla~~~~~  269 (436)
                      |.+.++-+.+-+....    .....+..|+.+|+.|+.|||.+|   ++||||||+|||+ ++.++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999998866664322    222677789999999999999998   9999999999999 5999999999999987654


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      .     ....+-|..|.|||++....|+.++|+||||++||+|++|+.||.....+ .             ++...+..+
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~-------------ei~~~i~~~  529 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-I-------------EIHTRIQMP  529 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-H-------------HHHHhhcCC
Confidence            3     22235678999999999999999999999999999999999998654322 0             111111122


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...     ...+....+|+.+||+.||.+||+|.++..
T Consensus       530 ~~s-----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 KFS-----ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ccc-----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            111     225667899999999999999999999865

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-35  Score=277.35  Aligned_cols=242  Identities=24%  Similarity=0.357  Sum_probs=193.8

Q ss_pred             CcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCC
Q 040532          120 TNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      .+.||+|.||+||-|+++ +|+.||||++.+.  ..+....+++|+.+|.+++||.||.+...|+..+..+.|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            478999999999999975 4999999999754  3344478899999999999999999999999999999999999777


Q ss_pred             ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---CCCeEEeeccCceecCCCCcc
Q 040532          197 SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       197 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~~~~kl~DfGla~~~~~~~~~  273 (436)
                      -|...|.....+  +++..-.-+..||+.||.|||.++   |+|+||||+|||+.+   ..++||||||.|+.++.....
T Consensus       649 MLEMILSsEkgR--L~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILSSEKGR--LPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHHhhccc--chHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            777666544333  777777778889999999999998   999999999999964   457999999999998765433


Q ss_pred             cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                         ...+||+.|+|||++..+.|...-|+||.|||+|--++|..||....+-        .+...   ....+-+     
T Consensus       724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--------ndQIQ---NAaFMyP-----  784 (888)
T KOG4236|consen  724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--------NDQIQ---NAAFMYP-----  784 (888)
T ss_pred             ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--------hHHhh---ccccccC-----
Confidence               3358999999999999999999999999999999999999998542211        11111   1111111     


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDV  385 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev  385 (436)
                      ..+..+......++|...|+..-.+|-+....
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~  816 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKS  816 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence            12234466778899999999999999887643

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=273.06  Aligned_cols=263  Identities=28%  Similarity=0.368  Sum_probs=200.0

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-------hhhHHHHHHHHHHHHHcCCCceeEEeeE
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-------EQGLREMKNEASVIAKVQHKNLVRLLGC  179 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~  179 (436)
                      ..-....++|-.+.+||+|+|+.||+|.+- ..+.||+|+-.-+.       +.-.+...+|..+-+.|+||.||+++++
T Consensus       456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            334456677888999999999999999964 36778999754321       1223456789999999999999999999


Q ss_pred             EEe-CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---CCC
Q 040532          180 CID-KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMN  255 (436)
Q Consensus       180 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~~~  255 (436)
                      +.- .+..|-|+|||+|.+|+.||...   ..+++.++..|+.||..||.||.... +||+|-||||.|||+-.   -|.
T Consensus       536 fslDtdsFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  536 FSLDTDSFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             eeeccccceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccce
Confidence            875 55778999999999999999643   35899999999999999999999874 67999999999999953   578


Q ss_pred             eEEeeccCceecCCCCccc-----ccccccccCCccchhhhccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 040532          256 PKISDFGMARICGGNELQA-----NTSRIVGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  326 (436)
Q Consensus       256 ~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~  326 (436)
                      +||+|||+++.+....+..     -++...||.+|++||++.-+    +.+.|.||||.|||+|..+.|++||+......
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ  691 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ  691 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence            9999999999887655432     23445799999999998743    36889999999999999999999997533211


Q ss_pred             cchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 040532          327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV  386 (436)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~  386 (436)
                              +.+..+.++..-. -   ...+.+..+.+...+|++||++.-++|....++.
T Consensus       692 --------dILqeNTIlkAtE-V---qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 --------DILQENTILKATE-V---QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             --------HHHhhhchhccee-c---cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                    1111221111100 0   0111122455678899999999999998877664

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.8e-33  Score=258.51  Aligned_cols=238  Identities=29%  Similarity=0.364  Sum_probs=191.5

Q ss_pred             CceeEEEEEecC-CCEEEEEEcCCCChhh-HHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCChhhhhcC
Q 040532          127 GFGPVYKGVLRK-GDEIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD  204 (436)
Q Consensus       127 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  204 (436)
                      +||.||+|.... |+.+++|++....... .+.+.+|++.+++++|+|++++.+++......++++||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999874 8999999998665443 67899999999999999999999999999999999999999999998854


Q ss_pred             CCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCC
Q 040532          205 PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG  284 (436)
Q Consensus       205 ~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  284 (436)
                      ...   +++.....++.+++.++.+||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            332   788999999999999999999988   9999999999999999999999999998765432   2233467889


Q ss_pred             ccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHH
Q 040532          285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRY  364 (436)
Q Consensus       285 y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  364 (436)
                      |++||.+.+..++.++|+||||+++++|++|..||...... .    .............         ..........+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~----~~~~~~~~~~~~~---------~~~~~~~~~~~  217 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-L----ELFKKIGKPKPPF---------PPPEWKISPEA  217 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-H----HHHHHHhccCCCC---------ccccccCCHHH
Confidence            99999999888899999999999999999999998542111 0    1111111111000         00000033568


Q ss_pred             HHHHHhcccCCCCCCCCHHHHHH
Q 040532          365 VNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       365 ~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            89999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-34  Score=235.08  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=193.5

Q ss_pred             CCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +|.-.++||+|.||+|++|+.++ ++.||+|+++-.  ++.......+|+-+++.++|.|||+++++...+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45667899999999999999654 788999998643  222345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      |+. +|..+...-.  ..++.....+++.|+++||.|.|+++   +.|||+||.|.|++.+|++|++|||+++.++-.. 
T Consensus        83 cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-  155 (292)
T ss_pred             hhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence            964 5555543222  23788899999999999999999998   9999999999999999999999999998765432 


Q ss_pred             ccccccccccCCccchhhhccCC-CCcccchhhHHHHHHHHHhCCCC-CCCCCCCCcchhHHHHHHh--hcCCc------
Q 040532          273 QANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKN-TGLYRTDSLNLLGYVWDLW--TSNRT------  342 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~--~~~~~------  342 (436)
                       ...+..+-|..|.+|.++.+.+ |+...|+||-||++.|+.....| |...+. ..++...++..-  .+++.      
T Consensus       156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccccCCccccC
Confidence             1223346789999999999865 89999999999999999885555 433221 122333322221  11111      


Q ss_pred             ceeccCCccccccchHHHHHH----HHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 LELIDDPVLEDEYSSKQVLLR----YVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~----l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .+...-+..+....-.+..+.    =.+++.+.+.-+|.+|.++++.++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            111112222222222223332    357888889999999999988764

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-34  Score=252.76  Aligned_cols=251  Identities=20%  Similarity=0.240  Sum_probs=191.6

Q ss_pred             hccCCCCC-cccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeC----Cc
Q 040532          113 ATNTFSDT-NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK----DE  185 (436)
Q Consensus       113 ~~~~~~~~-~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  185 (436)
                      .+++|++. ++||-|-.|.|..+..+. |+.+|+|++...     ...++|+++--.. .|||||.++++|.+.    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45566554 579999999999998764 889999999754     2346777765555 699999999998753    45


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---CCCeEEeecc
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFG  262 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~~~~kl~DfG  262 (436)
                      +.+|||.|+||.|..-+.+. +...+.+.++..|++||+.|+.|||+.+   |.||||||+|+|.+.   |-.+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            67899999999998877543 3456889999999999999999999998   999999999999974   5568999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      +|+.-..+   ......+-|+.|.|||++...+|+...|+||+||+||-|++|.+||-...+...  .         +..
T Consensus       210 FAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--s---------pgM  275 (400)
T KOG0604|consen  210 FAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--S---------PGM  275 (400)
T ss_pred             cccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--C---------hhH
Confidence            99864421   223345779999999999999999999999999999999999999843222110  0         000


Q ss_pred             ceeccC--CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 LELIDD--PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 ~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...+..  ..++.. ...+.++...++|+.+|..+|.+|.|+.+++.
T Consensus       276 k~rI~~gqy~FP~p-EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  276 KRRIRTGQYEFPEP-EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HhHhhccCccCCCh-hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            111111  111110 12336677889999999999999999999875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=281.57  Aligned_cols=247  Identities=28%  Similarity=0.405  Sum_probs=189.4

Q ss_pred             CCCCCcccCCCCcee-EEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEeec
Q 040532          116 TFSDTNKLGEGGFGP-VYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      -|...+.+|.|+.|+ ||+|... |+.||||++-...   .+-.++|+..|+.- +|||||++++.-.+.+..|+..|.|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            355567889999975 7999997 8999999986543   34568999999988 6999999999998999999999999


Q ss_pred             CCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---C--CCeEEeeccCceec
Q 040532          194 PNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---D--MNPKISDFGMARIC  267 (436)
Q Consensus       194 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~--~~~kl~DfGla~~~  267 (436)
                      . .+|++++... ...........+.++.|+++||++||+.+   |+||||||.||||+.   +  .+++|+|||+++.+
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            5 5899998663 11111222456788999999999999988   999999999999975   3  56899999999987


Q ss_pred             CCCCc-ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          268 GGNEL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       268 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ..... ........||.+|+|||++.+..-+.++||||+||++|+.++| .+||+..-..+.+       ..........
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-------Il~~~~~L~~  734 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-------ILTGNYTLVH  734 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-------hhcCccceee
Confidence            65432 2235566899999999999999889999999999999999996 8999753221111       1111111111


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +.        ...++  ...+||.+|++++|..||++.+|+.
T Consensus       735 L~--------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 LE--------PLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ec--------cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            11        11111  5678999999999999999999863

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=6.1e-33  Score=284.16  Aligned_cols=261  Identities=19%  Similarity=0.197  Sum_probs=166.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-----CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeE------EE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-----GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC------CI  181 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~  181 (436)
                      ..++|+..+.||+|+||.||+|.+.+     +..||+|++.......  ....+  .+....+.++..+...      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--IWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--HHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45789999999999999999999754     5889999986543221  11111  1222222222222211      24


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCCcc-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccC
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPTKR-----------------ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  244 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dik  244 (436)
                      .....++|+||+++++|.+++......                 ..........++.|++.||+|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            556789999999999999888543211                 01122345679999999999999988   9999999


Q ss_pred             CCCEEEcC-CCCeEEeeccCceecCCCCcccccccccccCCccchhhhccC----------------------CCCcccc
Q 040532          245 ASNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG----------------------IFSIKSD  301 (436)
Q Consensus       245 p~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  301 (436)
                      |+|||+++ ++.+||+|||+++....... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999995 68999999999976543221 122345789999999976422                      2345679


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc----eeccCCcc---cc-ccchHHHHHHHHHHHHhccc
Q 040532          302 VFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL----ELIDDPVL---ED-EYSSKQVLLRYVNIALLCVQ  373 (436)
Q Consensus       302 v~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---~~-~~~~~~~~~~l~~li~~cl~  373 (436)
                      ||||||++|||+++..+++.      .+..........+...    ........   .. ............+|+.+||+
T Consensus       362 VwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            99999999999997765321      1111100000000000    00000000   00 00000011234589999999


Q ss_pred             CCCCCCCCHHHHHH
Q 040532          374 ESADDRPTMNDVVS  387 (436)
Q Consensus       374 ~~p~~RPs~~ev~~  387 (436)
                      .||++|||+.|+++
T Consensus       436 ~dP~kR~ta~e~L~  449 (566)
T PLN03225        436 FKGRQRISAKAALA  449 (566)
T ss_pred             CCcccCCCHHHHhC
Confidence            99999999999987

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-32  Score=274.17  Aligned_cols=265  Identities=21%  Similarity=0.238  Sum_probs=179.7

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEe-----------------cCCCEEEEEEcCCCChhhHHH--------------HHH
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVL-----------------RKGDEIAVKRLSGRSEQGLRE--------------MKN  160 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~  160 (436)
                      ...++|++.++||+|+||+||+|.+                 .+++.||||++........++              ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3567899999999999999999964                 235679999987543322222              334


Q ss_pred             HHHHHHHcCCCce-----eEEeeEEEe--------CCccEEEEeecCCCChhhhhcCCCc--------------------
Q 040532          161 EASVIAKVQHKNL-----VRLLGCCID--------KDEKILIYEYMPNKSLDFFLFDPTK--------------------  207 (436)
Q Consensus       161 e~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------  207 (436)
                      |+.++.+++|.++     ++++++|..        .+..++||||+++++|.++++....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777876654     667777653        3567999999999999998864211                    


Q ss_pred             -cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCcc
Q 040532          208 -RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM  286 (436)
Q Consensus       208 -~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~  286 (436)
                       ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........ .......+++.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCccee
Confidence             113466778899999999999999988   99999999999999999999999999975433211 1111224578999


Q ss_pred             chhhhccCC--------------------C--CcccchhhHHHHHHHHHhCCC-CCCCCCCCCcchhH--HHHHHhhcCC
Q 040532          287 SPEYALEGI--------------------F--SIKSDVFSFGVLLLEIVSGKK-NTGLYRTDSLNLLG--YVWDLWTSNR  341 (436)
Q Consensus       287 aPE~~~~~~--------------------~--~~~~Dv~SlGvil~elltg~~-p~~~~~~~~~~~~~--~~~~~~~~~~  341 (436)
                      |||.+....                    +  ..+.|+||+||++++|++|.. |+.....-...+..  .....+....
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~  457 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK  457 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence            999886422                    1  134799999999999999875 55321110000000  0000000000


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCC---CCCCCHHHHHH
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESA---DDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPs~~ev~~  387 (436)
                      ..    .....   ..........+++.++|..+|   .+|+|++|+++
T Consensus       458 ~~----~~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        458 GQ----KYDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cc----CCCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            00    00010   011134567889999999765   68999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=259.03  Aligned_cols=269  Identities=21%  Similarity=0.253  Sum_probs=200.7

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCC--C----ceeEEeeEE
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQH--K----NLVRLLGCC  180 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~  180 (436)
                      ......+++|.+...+|+|.||.|..+.++. +..||+|+++.-. .-.+..+-|+++|.++.+  |    -++.+.++|
T Consensus        82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            3344558999999999999999999999765 6789999987542 223556789999999942  2    478888999


Q ss_pred             EeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC--------
Q 040532          181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--------  252 (436)
Q Consensus       181 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~--------  252 (436)
                      .-.+..++|+|.+ |-|+.+++..+ +-.+++......|+.|++++++|||+.+   ++|-||||+|||+.+        
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEec
Confidence            9999999999998 56888888653 3456888999999999999999999998   999999999999932        


Q ss_pred             ------------CCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 040532          253 ------------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG  320 (436)
Q Consensus       253 ------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~  320 (436)
                                  +..+|++|||.|+.....     .+..+.|..|.|||++.+-.++..+||||+||||.|+.||..-|+
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence                        345899999999864322     244688999999999999999999999999999999999999886


Q ss_pred             CCCCCCc-chhHHH--------------HHHhhcCCc-----------ceecc--CCccccccchHHHHHHHHHHHHhcc
Q 040532          321 LYRTDSL-NLLGYV--------------WDLWTSNRT-----------LELID--DPVLEDEYSSKQVLLRYVNIALLCV  372 (436)
Q Consensus       321 ~~~~~~~-~~~~~~--------------~~~~~~~~~-----------~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl  372 (436)
                      ..+..+. .+.+.+              ...+..+++           ....+  .+..........+...+.+|+.+||
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            5442110 000000              000011100           00000  0111111122335567999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 040532          373 QESADDRPTMNDVVS  387 (436)
Q Consensus       373 ~~~p~~RPs~~ev~~  387 (436)
                      ..||.+|+|+.|++.
T Consensus       391 ~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  391 EFDPARRITLREALS  405 (415)
T ss_pred             ccCccccccHHHHhc
Confidence            999999999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-35  Score=253.77  Aligned_cols=266  Identities=21%  Similarity=0.354  Sum_probs=190.6

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChh--hHHHHHHHHHHHHHcCCCceeEEeeEEEe--------
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ--GLREMKNEASVIAKVQHKNLVRLLGCCID--------  182 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  182 (436)
                      .+.|.-..++|+|.||+||+|+.++ |+.||+|++...+++  .-....+|+++|..++|+|++.++..|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            3456667899999999999999765 778899876543221  12456899999999999999999988864        


Q ss_pred             CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                      ....|+||++|+. +|.-+|.+..  ..++..+..+++.++..||.|+|...   |+|||+||.|+||+.++.+||+|||
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence            2346899999976 5666665432  23788899999999999999999887   9999999999999999999999999


Q ss_pred             CceecCCCC--cccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhh-
Q 040532          263 MARICGGNE--LQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT-  338 (436)
Q Consensus       263 la~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-  338 (436)
                      +++.+....  ........+.|..|.+||.+.+. .|+.+.|+|.-||++.||+||.+-++...  +......+..... 
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is~LcGs  247 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLISQLCGS  247 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHHHHhcc
Confidence            997665432  22233445679999999999874 59999999999999999999987764321  1111111111111 


Q ss_pred             --cCCcce--------eccCC-ccccccc-hHHHH------HHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          339 --SNRTLE--------LIDDP-VLEDEYS-SKQVL------LRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       339 --~~~~~~--------~~~~~-~~~~~~~-~~~~~------~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        .+...+        .+..+ ...+.+. -++..      ....+++..++..||.+|+++.+++.
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence              111111        11001 1111110 01111      24678999999999999999988765

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=264.47  Aligned_cols=242  Identities=27%  Similarity=0.364  Sum_probs=189.1

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  187 (436)
                      ...+|..+.+||+|+||.|.+|..+. .+.+|||++++.   ...+.+--..|-++|... +-|.++++..+|..-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            34568888999999999999998764 566899999865   223344456677777766 5788999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+.||+|-..+....+   +.+..+.-++..||-||-+||+++   |+.||||.+|||+|.+|++||+|||+++.-
T Consensus       427 FVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999999877755433   566677778889999999999999   999999999999999999999999998742


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      -..  ...+...+||+.|+|||++..++|+.++|.|||||+||||+.|++||+..+.+  .+.+-+.+   ..       
T Consensus       501 i~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--elF~aI~e---hn-------  566 (683)
T KOG0696|consen  501 IFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQAIME---HN-------  566 (683)
T ss_pred             ccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHH---cc-------
Confidence            211  22345579999999999999999999999999999999999999999654322  12111111   11       


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCC
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRP  380 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  380 (436)
                       .    .+ .+..+.+...++...+.+.|.+|.
T Consensus       567 -v----sy-PKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 -V----SY-PKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -C----cC-cccccHHHHHHHHHHhhcCCcccc
Confidence             0    01 112445667788888999999985

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=2.1e-32  Score=264.61  Aligned_cols=204  Identities=25%  Similarity=0.365  Sum_probs=169.6

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      .-|..++.||-|+||+|.++...+ ...+|.|.+.+.+   .......+.|-++|...+.+-||+|+-.|.+++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            457778899999999999998544 5568999997653   344567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC-
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG-  269 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~-  269 (436)
                      ||++||++-.+|-.-.   .+++..+.-++..+++|+++.|..|   ++||||||+|||||.+|++||+||||+.-+.. 
T Consensus       709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999988874322   3666666667778999999999998   99999999999999999999999999964321 


Q ss_pred             --------CCccc-------------------------------ccccccccCCccchhhhccCCCCcccchhhHHHHHH
Q 040532          270 --------NELQA-------------------------------NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL  310 (436)
Q Consensus       270 --------~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~  310 (436)
                              .+...                               .....+||+.|+|||++....|+..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                    00000                               001247999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCC
Q 040532          311 EIVSGKKNTGLYRT  324 (436)
Q Consensus       311 elltg~~p~~~~~~  324 (436)
                      ||+.|+.||-....
T Consensus       863 em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTP  876 (1034)
T ss_pred             HHhhCCCCccCCCC
Confidence            99999999965443

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=248.40  Aligned_cols=251  Identities=22%  Similarity=0.346  Sum_probs=199.3

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCC
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD  184 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  184 (436)
                      .....++|..+++||+|+|..|..+.+.+ .+.+|+|++++.   ..++.+-.+.|-.+..+. +||.+|.+..+|..+.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            34456789999999999999999999765 667899998753   445566678888888887 7999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      .+++|.||++||+|-..+....   .+++..+.-+...|.-||.|||+.|   |+.||||.+|+|+|..|++||+|+|++
T Consensus       325 rlffvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchh
Confidence            9999999999999977775433   3888888888889999999999999   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCC--CCCcchhHHHHHHhhcCCc
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR--TDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~  342 (436)
                      +.--.  ....++..+||+.|.|||++++..|....|.|++||+|+||+.|+.||+...  ..+.+-.++.....-+.++
T Consensus       399 ke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi  476 (593)
T KOG0695|consen  399 KEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI  476 (593)
T ss_pred             hcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence            74221  1234556799999999999999999999999999999999999999998654  3333444454444333221


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCC
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP  380 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  380 (436)
                       .      .+..     .+.....++..-|++||.+|.
T Consensus       477 -r------iprs-----lsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 -R------IPRS-----LSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -c------ccce-----eehhhHHHHHHhhcCCcHHhc
Confidence             1      1111     222344577788899998884

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-33  Score=267.02  Aligned_cols=243  Identities=23%  Similarity=0.299  Sum_probs=196.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCC-EEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGD-EIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      -.+++....||-|+||.|=+...++.. .+|+|++++.   +..+.+.+..|-++|..++.|.||+++..|.++...|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            345667788999999999999877543 3788888654   445567788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      ||-|-||.+...|.+..   .++..+..-++..+.+|++|||.++   |+.|||||+|.+++.+|-+||.|||+|+.+..
T Consensus       499 mEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            99999999999986543   3677777778888999999999999   99999999999999999999999999998765


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ..   .+-.++||+.|.|||++.....+.++|.||||+++|||++|.+||...+.-  .-...         ++.-++.-
T Consensus       573 g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--ktYn~---------ILkGid~i  638 (732)
T KOG0614|consen  573 GR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--KTYNL---------ILKGIDKI  638 (732)
T ss_pred             CC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--HHHHH---------HHhhhhhh
Confidence            43   334569999999999999999999999999999999999999999765432  11111         12222222


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCC
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPT  381 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  381 (436)
                      ..+..     ......+++.+.+..+|.+|..
T Consensus       639 ~~Pr~-----I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 EFPRR-----ITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hcccc-----cchhHHHHHHHHHhcCcHhhhc
Confidence            22222     3345677899999999999976

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=231.52  Aligned_cols=209  Identities=26%  Similarity=0.351  Sum_probs=168.8

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCcc
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  186 (436)
                      .+...+.......||+|++|.|-+-++. +|...|+|++... ..+......+|+++..+. .+|.+|.++|........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            4445556666788999999999888754 5889999999754 344456778888877665 799999999999999999


Q ss_pred             EEEEeecCCCChhhhhcC-CCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          187 ILIYEYMPNKSLDFFLFD-PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      ++.||.|+ .||+.+..+ ...+..+++...=+|+..+.+||.|||++-  .++|||+||+|||++.+|++|+||||.+-
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999995 567665432 233455888888999999999999999875  59999999999999999999999999997


Q ss_pred             ecCCCCcccccccccccCCccchhhhcc----CCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALE----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  324 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~  324 (436)
                      .+.++-..   +...|-..|||||.+..    ..|+-++||||||+++.||.+++.||+.+..
T Consensus       198 ~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  198 YLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             eehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            76543211   12357778999998863    3589999999999999999999999865543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=7.3e-30  Score=228.86  Aligned_cols=211  Identities=36%  Similarity=0.573  Sum_probs=183.4

Q ss_pred             cCCCCceeEEEEEecC-CCEEEEEEcCCCChh-hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCChhh
Q 040532          123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF  200 (436)
Q Consensus       123 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  200 (436)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++||+++++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999865 889999999865432 35678999999999999999999999999999999999999999999


Q ss_pred             hhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-CCCeEEeeccCceecCCCCcccccccc
Q 040532          201 FLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNELQANTSRI  279 (436)
Q Consensus       201 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~  279 (436)
                      ++....  ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            986432  34789999999999999999999998   999999999999999 89999999999987643321  12224


Q ss_pred             cccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchH
Q 040532          280 VGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK  358 (436)
Q Consensus       280 ~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (436)
                      .+...|++||..... .++.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            577889999998877 789999999999999999                                              


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          359 QVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       359 ~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                         ..+.+++..|++.+|++||++.++++.+
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence               3578899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.1e-31  Score=230.76  Aligned_cols=259  Identities=17%  Similarity=0.301  Sum_probs=193.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeC--CccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDK--DEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~l  188 (436)
                      ..++|++.+++|+|.+++|+.|.. .+.++++||.+++-..   ..+++|+.+|..+. ||||+.+++...+.  ....|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            457899999999999999999983 4588999999976433   57899999999997 99999999998764  45579


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-CCCeEEeeccCceec
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARIC  267 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-~~~~kl~DfGla~~~  267 (436)
                      ++||+++.++..+..      .+........+.++++||.|+|+.|   |.|||+||.|+++|. ...++|+|+|+|.++
T Consensus       113 iFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            999999998876652      2666778889999999999999999   999999999999994 567999999999887


Q ss_pred             CCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc---
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL---  343 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  343 (436)
                      ......   +..+.+..|.-||.+.. +.|+.+-|+|||||++..|+..+.||-.......+++.. ......+++.   
T Consensus       184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI-akVLGt~el~~Yl  259 (338)
T KOG0668|consen  184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI-AKVLGTDELYAYL  259 (338)
T ss_pred             CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH-HHHhChHHHHHHH
Confidence            544322   22356677889998875 558999999999999999999999984433332233322 1111111111   


Q ss_pred             ------------eeccC---Cccccccc---hHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          344 ------------ELIDD---PVLEDEYS---SKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       344 ------------~~~~~---~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                                  .++..   ........   ..-...+..+++.+.|..|-.+|||+.|...
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                        11111   11111100   1112356789999999999999999998753

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=1.8e-31  Score=253.16  Aligned_cols=208  Identities=21%  Similarity=0.265  Sum_probs=177.1

Q ss_pred             cchhhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcC------CCceeEEeeE
Q 040532          107 FSSVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQ------HKNLVRLLGC  179 (436)
Q Consensus       107 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~  179 (436)
                      +.-.+....+|.+....|+|-|++|.+|.+.. |+.||||++..+.. -...=..|+++|++|+      --|+++++-.
T Consensus       424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            33445667889999999999999999999765 88999999987533 3345578999999995      2489999999


Q ss_pred             EEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC-CCeEE
Q 040532          180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKI  258 (436)
Q Consensus       180 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~-~~~kl  258 (436)
                      |...+++|||||-+ .-+|.+.|........+....+..++.|+.-||..|..++   |+|.||||+|||+++. ..+||
T Consensus       503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeee
Confidence            99999999999987 5688999988777777899999999999999999999998   9999999999999965 56899


Q ss_pred             eeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 040532          259 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  323 (436)
Q Consensus       259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~  323 (436)
                      ||||.|.....+....    ...+..|.|||++.|-+|+...|+||.||+||||.||+..|....
T Consensus       579 CDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  579 CDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             ccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            9999998776554332    234567999999999999999999999999999999999886543

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-30  Score=225.73  Aligned_cols=283  Identities=17%  Similarity=0.296  Sum_probs=203.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeE-EEeCCccEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGC-CIDKDEKILI  189 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv  189 (436)
                      ..+.|.+.+.||+|.||.+.++.++. ...+++|-+.... ....+|.+|...--.| .|.||+.-++. |+..+.++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            35679999999999999999999875 5678999887543 3357899998876666 58999987764 5566777899


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc--CCCCeEEeeccCceec
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNPKISDFGMARIC  267 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~--~~~~~kl~DfGla~~~  267 (436)
                      +||++.|+|..-+..    ..+.+.....++.|+++|+.|||+.+   +||||||.+||||-  +..++||||||+.+..
T Consensus       101 qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence            999999999877644    23778888999999999999999998   99999999999994  4458999999998765


Q ss_pred             CCCCcccccccccccCCccchhhhccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEG-----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      +.....     .--+..|.+||.....     .....+|+|.||++++.++||+.||+.....+...  |-+..+..+..
T Consensus       174 g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y--~~~~~w~~rk~  246 (378)
T KOG1345|consen  174 GTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY--WEWEQWLKRKN  246 (378)
T ss_pred             Cceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH--HHHHHHhcccC
Confidence            432211     1235579999987642     24678999999999999999999998544433333  33334443333


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH-----hhccccCCCCCCCCcccccCccccCCCC
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML-----TNEAAALHPPKQPAFSNVRNTVTSTSST  417 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  417 (436)
                      ...      +..+..  .++.+.++..+-+..+|++|-...++.++-     +..+.....+.+..+-+.+.+..+.+.+
T Consensus       247 ~~~------P~~F~~--fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee~~~tn~d~~S~iysrq  318 (378)
T KOG1345|consen  247 PAL------PKKFNP--FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEEDYYTNIDTASKIYSRQ  318 (378)
T ss_pred             ccC------chhhcc--cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhhccccccCCcchhhhcC
Confidence            222      212222  556778899999999999995555544443     3344445555555555555544444444


Q ss_pred             C
Q 040532          418 D  418 (436)
Q Consensus       418 ~  418 (436)
                      +
T Consensus       319 ~  319 (378)
T KOG1345|consen  319 T  319 (378)
T ss_pred             c
Confidence            3

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=7.2e-29  Score=225.65  Aligned_cols=198  Identities=32%  Similarity=0.458  Sum_probs=171.3

Q ss_pred             CCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChh-hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      |+..+.||+|++|+||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999875 889999999876544 56789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +++|..++......  +++.....++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            99999988543321  788899999999999999999997   99999999999999999999999999987654321 1


Q ss_pred             ccccccccCCccchhhh-ccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 040532          275 NTSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSGKKNTG  320 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltg~~p~~  320 (436)
                      ......++..|++||.. ....++.++|+|+||++++||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22334677889999998 66678889999999999999999999984

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.5e-31  Score=232.54  Aligned_cols=264  Identities=22%  Similarity=0.332  Sum_probs=190.6

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-----CccE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DEKI  187 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  187 (436)
                      +.+..+.||-|+||.||..++. +|+.||+|++..-  +-.+-+.+.+|+.+|..++|.|++..++...-.     ++.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4456688999999999999864 6999999998653  233456788999999999999999998876543     2557


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      .++|.|. .+|...+-...   .++.....-+++||++||.|||+.+   |.||||||.|.|++.+..+||||||+++..
T Consensus       134 V~TELmQ-SDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHH-hhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            8888885 45666664433   3777777888999999999999998   999999999999999999999999999875


Q ss_pred             CCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc----
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT----  342 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  342 (436)
                      ...+ .......+-|..|.|||++++. .|+.+.||||.|||+.||+..+.-|+....  .+.++.+.+....+..    
T Consensus       207 e~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs~EaMr  283 (449)
T KOG0664|consen  207 DQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPSQEAMK  283 (449)
T ss_pred             chhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCcHHHHH
Confidence            5333 2233344678899999999975 599999999999999999988877754332  1122222222221111    


Q ss_pred             -----------ceeccCCcccccc---chHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 040532          343 -----------LELIDDPVLEDEY---SSKQVLLRYVNIALLCVQESADDRPTMNDVVSML  389 (436)
Q Consensus       343 -----------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L  389 (436)
                                 ..-...+..+..+   .......+...+...++..||++|.+.++.+..+
T Consensus       284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                       0011112111111   1111223455678889999999999998877654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1e-30  Score=254.70  Aligned_cols=253  Identities=23%  Similarity=0.367  Sum_probs=202.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ..++|+.+..+|+|.||.||++++. +++..|+|.++-.......-++.|+-+++.++||||+.++|.+...+..+++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3567888999999999999999965 488999999987766677788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      ||.+|+|++.-+-.   .++++.+...+++...+|++|||+++   -+|||||-.|||+++.|.+|++|||.+-.++.. 
T Consensus        93 ycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-  165 (829)
T ss_pred             ecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-
Confidence            99999998876533   35888999999999999999999998   799999999999999999999999998765432 


Q ss_pred             cccccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          272 LQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                       -.....+.||+.|||||+..   .+.|...+|+|++|+...|+---++|.  +  +.+.....+...      ....+.
T Consensus       166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl--f--dlhpmr~l~LmT------kS~~qp  234 (829)
T KOG0576|consen  166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL--F--DLHPMRALFLMT------KSGFQP  234 (829)
T ss_pred             -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc--c--ccchHHHHHHhh------ccCCCC
Confidence             22334468999999999885   466999999999999999997777663  1  111111111111      111223


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV  386 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~  386 (436)
                      +.+.+...   -.+.+.+++..|+.++|++||+++.++
T Consensus       235 p~lkDk~k---ws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  235 PTLKDKTK---WSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             CcccCCcc---chHHHHHHHHHHhcCCCccCCChhhhe
Confidence            33332222   345688899999999999999998654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-30  Score=247.46  Aligned_cols=195  Identities=26%  Similarity=0.382  Sum_probs=165.6

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCCh--------hhHHHHHHHHHHHHHcC---CCceeEEeeEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSE--------QGLREMKNEASVIAKVQ---HKNLVRLLGCCID  182 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  182 (436)
                      ..|+..+.+|.|+||.|+.|.++. ...|+||.+.+..-        ...-..-.|+.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            448889999999999999999875 56789998875421        11122446999999997   9999999999999


Q ss_pred             CCccEEEEeecC-CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeec
Q 040532          183 KDEKILIYEYMP-NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  261 (436)
Q Consensus       183 ~~~~~lv~e~~~-~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~Df  261 (436)
                      ++.+|++||-.. +-+|.+++....   .+++.....|++|++.|+++||+++   |+|||||-+|+.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            999999999875 447777774433   4899999999999999999999999   999999999999999999999999


Q ss_pred             cCceecCCCCcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCC
Q 040532          262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNT  319 (436)
Q Consensus       262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~  319 (436)
                      |.+......    .+..++||..|.|||++.|.+| +..-|||++|++||-++....||
T Consensus       715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            999765433    3455689999999999999887 56789999999999999988886

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.8e-29  Score=233.72  Aligned_cols=131  Identities=24%  Similarity=0.315  Sum_probs=106.8

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-----C---CceeEEeeEEEe---
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-----H---KNLVRLLGCCID---  182 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~---  182 (436)
                      ++|.+.++||.|.|++||++.+.. .+.||+|+.+.. ..-.+....|+++|++++     |   .+||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            789999999999999999999765 567999998753 233456789999999983     3   479999999986   


Q ss_pred             -CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE
Q 040532          183 -KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  250 (436)
Q Consensus       183 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll  250 (436)
                       +.+.+||+|++. .+|..++.... -.-++...+.+|++|++.||.|||...  +|+|-||||+|||+
T Consensus       157 NG~HVCMVfEvLG-dnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVLG-DNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhhh-hHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             457799999994 45555553322 223888999999999999999999876  69999999999999

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-29  Score=225.58  Aligned_cols=264  Identities=25%  Similarity=0.301  Sum_probs=192.1

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC----
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  184 (436)
                      +...+|..++.+|.|.- .|..+.+. .+++||+|++...  .....+...+|..++..++|+|+++++.+|.-..    
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            34567888889999998 67777644 3889999988643  3344577889999999999999999999987543    


Q ss_pred             --ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          185 --EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       185 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                        +.|+|||+|.. +|...+.     ..++-.+...++.|+++|+.|||+.+   |+||||||+||++..+..+||.|||
T Consensus        93 ~~e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   93 FQEVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHhHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccch
Confidence              56999999954 5655553     12667788899999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC-CC---------c-----
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT-DS---------L-----  327 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~-~~---------~-----  327 (436)
                      +++.-...   -..+..+.|..|.|||++.+..+...+||||+||++.||++|+.-|...+- +.         .     
T Consensus       164 ~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F  240 (369)
T KOG0665|consen  164 LARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF  240 (369)
T ss_pred             hhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence            99764332   234445788999999999998899999999999999999999987753210 00         0     


Q ss_pred             --chhHHHHHHhhcC------CcceeccCCcccccc-chHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          328 --NLLGYVWDLWTSN------RTLELIDDPVLEDEY-SSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       328 --~~~~~~~~~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        ++...+.......      ...+.+.+....... .++.......+++.+||-.||++|.+.+++++.
T Consensus       241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence              0011111111100      001111111111111 011123456789999999999999999999874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.2e-28  Score=229.72  Aligned_cols=267  Identities=23%  Similarity=0.359  Sum_probs=199.6

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec----CCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCC
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD  184 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  184 (436)
                      .....+.|...++||+|.|++||++.+.    ....||+|.+...+..  ..+.+|+++|..+ -+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3455678999999999999999999854    3678999999765443  5689999999999 5999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-CCCCeEEeeccC
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGM  263 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-~~~~~kl~DfGl  263 (436)
                      ...+|+||+++....++...      ++......+++.+..||.++|+.|   |+||||||+|+|.+ ..+.-.|.|||+
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999999998854      667888999999999999999999   99999999999998 456779999999


Q ss_pred             ceecCCC-------C---------------------------ccc--------ccccccccCCccchhhhcc-CCCCccc
Q 040532          264 ARICGGN-------E---------------------------LQA--------NTSRIVGTYGYMSPEYALE-GIFSIKS  300 (436)
Q Consensus       264 a~~~~~~-------~---------------------------~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~  300 (436)
                      +......       .                           +..        ......||++|.|||++.. ...+.+.
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            9721100       0                           000        0012359999999999985 4578999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH---------hhcCC--cce---------------ec--------
Q 040532          301 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL---------WTSNR--TLE---------------LI--------  346 (436)
Q Consensus       301 Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---------~~~~~--~~~---------------~~--------  346 (436)
                      ||||.|||++.+++++.||-....+...+...+.-+         ...+.  ..+               .+        
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            999999999999999999855444433332221100         00111  000               00        


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +.+...........+..+++++.+|+..||.+|.|+++.++
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            00001111112223447889999999999999999999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=6.8e-28  Score=258.56  Aligned_cols=195  Identities=19%  Similarity=0.231  Sum_probs=135.4

Q ss_pred             cCC-CceeEEeeEE-------EeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 040532          168 VQH-KNLVRLLGCC-------IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII  239 (436)
Q Consensus       168 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~  239 (436)
                      ++| +||++++++|       .+....+.++||+ +++|.+++...  ...+++..+..++.||++||.|||+++   |+
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            445 5777777776       2334567788887 56999999643  234899999999999999999999998   99


Q ss_pred             ecccCCCCEEEcCC-------------------CCeEEeeccCceecCCCCc--------------ccccccccccCCcc
Q 040532          240 HRDLKASNILLDKD-------------------MNPKISDFGMARICGGNEL--------------QANTSRIVGTYGYM  286 (436)
Q Consensus       240 H~Dikp~NIll~~~-------------------~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~  286 (436)
                      ||||||+||||+..                   +.+|++|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999654                   4456666666643211000              00011235788999


Q ss_pred             chhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHH
Q 040532          287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVN  366 (436)
Q Consensus       287 aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  366 (436)
                      |||++.+..++.++|||||||+||||++|..|+....    .   ..... ...    .. ++    ...  ........
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~---~~~~~-~~~----~~-~~----~~~--~~~~~~~~  243 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----R---TMSSL-RHR----VL-PP----QIL--LNWPKEAS  243 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----H---HHHHH-HHh----hc-Ch----hhh--hcCHHHHH
Confidence            9999999999999999999999999999888753210    0   00010 000    00 00    000  01233567


Q ss_pred             HHHhcccCCCCCCCCHHHHHH
Q 040532          367 IALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       367 li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ++.+||+++|.+||++.|+++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            888999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=1.8e-26  Score=202.52  Aligned_cols=168  Identities=20%  Similarity=0.120  Sum_probs=125.1

Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|.+++...  +..+++..++.++.|++.||+|||+.+         ||+|||++.++.+|+  ||++.......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            6788888542  235899999999999999999999875         999999999999999  99987654321    


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                         ..||+.|+|||++.+..++.++|||||||++|||+||+.||.........+    ...........   .   ....
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~---~---~~~~  130 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL----EILLNGMPADD---P---RDRS  130 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH----HHHHHHhccCC---c---cccc
Confidence               257899999999999999999999999999999999999985432211111    11111110000   0   0000


Q ss_pred             chHHHHH--HHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          356 SSKQVLL--RYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       356 ~~~~~~~--~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                      .......  .+.+++.+||+.+|.+||++.|+++.+....
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            1111222  6899999999999999999999999887654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=3.1e-25  Score=213.30  Aligned_cols=177  Identities=19%  Similarity=0.226  Sum_probs=134.6

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec--CCCEEEEEEcCCC-----ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR--KGDEIAVKRLSGR-----SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK  183 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  183 (436)
                      ....++|+..+.||+|+||+||+|.++  +++.+|||++...     .....+.+.+|+++|++++|+|+++.+..   .
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence            445678999999999999999999875  4777899987533     22335678999999999999999853322   2


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccc-CCCCEEEcCCCCeEEeecc
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL-KASNILLDKDMNPKISDFG  262 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Di-kp~NIll~~~~~~kl~DfG  262 (436)
                      +..++||||+++++|....  ..     .   ...++.++++||.|||+.+   |+|||| ||+|||++.++.+||+|||
T Consensus        91 ~~~~LVmE~~~G~~L~~~~--~~-----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLAR--PH-----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CCcEEEEEccCCCCHHHhC--cc-----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence            5679999999999996321  11     1   1467889999999999998   999999 9999999999999999999


Q ss_pred             CceecCCCCcccc------cccccccCCccchhhhccCC------CCcccchh
Q 040532          263 MARICGGNELQAN------TSRIVGTYGYMSPEYALEGI------FSIKSDVF  303 (436)
Q Consensus       263 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~  303 (436)
                      +++.+........      -....+++.|+|||.+....      .+..+|-|
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            9997654321111      12456888899999886432      23346666

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.8e-23  Score=199.85  Aligned_cols=263  Identities=21%  Similarity=0.215  Sum_probs=194.4

Q ss_pred             CCCCCcccCCCCceeEEEEEecCC--CEEEEEEcCCCChhhHHHHHHHHHHHHHcCC----CceeEEeeEE-EeCCccEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRKG--DEIAVKRLSGRSEQGLREMKNEASVIAKVQH----KNLVRLLGCC-IDKDEKIL  188 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l  188 (436)
                      +|.+.+.||+|+||.||.+...+.  ..+|+|.-..........+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997654  4788887765433222267888999988863    6888888888 47778899


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC-----CCeEEeeccC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-----MNPKISDFGM  263 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~-----~~~kl~DfGl  263 (436)
                      ||+.+ |.+|.++..... ...++..+...++.|++.+|++||+.|   ++||||||.|+++...     ..+.+.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99987 788988775444 455899999999999999999999999   9999999999999854     4699999999


Q ss_pred             ce--ecCCCCc----cc-c-cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 040532          264 AR--ICGGNEL----QA-N-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       264 a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  335 (436)
                      ++  .......    .. . .....||..|+++....+...+.+.|+||++.++.|++.|..||........  ..-+..
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~~~  251 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKFEK  251 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHHHH
Confidence            98  3221111    11 1 2234599999999999999999999999999999999999999854332111  000000


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                      .....    ....  ..     ...+..+.++...+-..+...+|....+...|++.....
T Consensus       252 ~~~~~----~~~~--~~-----~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  252 DPRKL----LTDR--FG-----DLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             Hhhhh----cccc--cc-----CCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            00000    0000  00     002334555666666688999999999999998877654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=1.4e-22  Score=193.79  Aligned_cols=262  Identities=28%  Similarity=0.375  Sum_probs=196.6

Q ss_pred             CCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCCh---hhHHHHHHHHHHHHHcCCC-ceeEEeeEEEeCCccEEEEee
Q 040532          117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGLREMKNEASVIAKVQHK-NLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  192 (436)
                      |...+.||.|+||.||++...  ..+++|.+.....   .....+.+|...+..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567788999999999999987  7889999875432   2467899999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC-CeEEeeccCceecCCCC
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICGGNE  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~  271 (436)
                      +.++++..++........+.......++.|++.++.|+|..+   ++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966643321125788899999999999999999998   99999999999999988 79999999998654433


Q ss_pred             ccc----ccccccccCCccchhhhcc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          272 LQA----NTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       272 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ...    ......|+..|+|||.+.+   ..+....|+||+|++++++++|..|+......  ................ 
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~-  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPTP-  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCCc-
Confidence            221    2345689999999999987   57889999999999999999999996543321  0011111111111100 


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      .... ....... ......+.+++..|+..+|..|.+..+....
T Consensus       234 ~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLAS-PLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccc-ccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0000 0000000 1123467889999999999999998887764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=8.2e-25  Score=193.05  Aligned_cols=249  Identities=22%  Similarity=0.357  Sum_probs=186.9

Q ss_pred             CCCcccCCCCceeEEEEEecCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          118 SDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       118 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      ....+|.+...|+.|+|+++ |..+++|++...  .....++|..|.-.|+-+.||||+++++.|.......++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34457888999999999998 666777877643  222236789999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      |+|...|++.. ....+..+..+++.++|+|++|||+..+. |.---|.+..+++|++.+++|+- +-+++.      -.
T Consensus       272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarism-ad~kfs------fq  342 (448)
T KOG0195|consen  272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQ  342 (448)
T ss_pred             hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheec-ccceee------ee
Confidence            99999998754 34567789999999999999999998732 44557999999999999988752 111111      01


Q ss_pred             cccccccCCccchhhhccCCC---CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIF---SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                      .....-.+.||+||.+...+.   -.++|+|||++++|||.|...||.....-+-..     .     -.++-+...+. 
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----k-----ialeglrv~ip-  411 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----K-----IALEGLRVHIP-  411 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----h-----hhhccccccCC-
Confidence            111133578999999986653   467999999999999999999996543221100     0     00111111111 


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                           +..+..+.+++.-|+..||.+||.+..++-.|++.
T Consensus       412 -----pgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  412 -----PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             -----CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                 12556789999999999999999999999998864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=4.5e-24  Score=218.33  Aligned_cols=254  Identities=20%  Similarity=0.253  Sum_probs=186.0

Q ss_pred             CCCcccCCCCceeEEEEEecC-CCEEEEEEcC----C-CChhhH-HHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          118 SDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLS----G-RSEQGL-REMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       118 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~----~-~~~~~~-~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ...+.+|.|++|.|+...... ....+.|.+.    . ..+... ..+..|+-+-..+.|||++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            456789999999777776432 3334444332    1 122211 22556777777889999999888887777666669


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      |||++ +|..++...   ..+....+..++.|+..|+.|+|+.|   +.|||+|++|++++.+|.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 888887553   23778888999999999999999999   999999999999999999999999999876443


Q ss_pred             Ccc--cccccccccCCccchhhhccCCCCc-ccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          271 ELQ--ANTSRIVGTYGYMSPEYALEGIFSI-KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       271 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ...  ......+|+..|+|||.+.+..|.. ..||||.|+++..|.+|+.||...........    .. .......   
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----~~-~~~~~~~---  545 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----TN-NYSDQRN---  545 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh----hh-ccccccc---
Confidence            322  4455678999999999999998865 58999999999999999999976654332210    00 0000000   


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ............+.....++.++|+.+|.+|-|+++|++
T Consensus       546 -~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 -IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             -cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence             001111122335566788999999999999999999876

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=8.5e-23  Score=183.04  Aligned_cols=172  Identities=16%  Similarity=0.161  Sum_probs=134.4

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCCh---hhHHH------HHHHHHHHHHcCCCceeEEeeEEEe
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGLRE------MKNEASVIAKVQHKNLVRLLGCCID  182 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~------~~~e~~~l~~l~h~niv~l~~~~~~  182 (436)
                      ...++|+..+.||.|+||.||.... ++..+|+|.+.....   .....      +.+|+..+.+++|++|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4578899999999999999999766 477899999975422   22222      5789999999999999999988664


Q ss_pred             C--------CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC
Q 040532          183 K--------DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  254 (436)
Q Consensus       183 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~  254 (436)
                      .        +..+++|||++|.+|.++..       ++.    ....+++.++..+|..+   ++|||+||+||+++.++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence            3        35789999999999977631       222    34568999999999998   99999999999999988


Q ss_pred             CeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHH
Q 040532          255 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV  313 (436)
Q Consensus       255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ell  313 (436)
                       ++|+|||..........              ...++....+..++|+||||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence             99999998764321110              011345566778999999999987664

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=4.6e-22  Score=172.94  Aligned_cols=269  Identities=19%  Similarity=0.271  Sum_probs=198.7

Q ss_pred             hhccCCCCCcccCCCCceeEEEEE-ecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCC-CceeEEeeEEEeCCccEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv  189 (436)
                      ...+.|.++++||+|+||.+|.|. ..+|..||||.=+.....  ..+..|..+.+.+++ ..|..+..+..+.....+|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            345789999999999999999998 456999999987654322  356788899998864 6777778888888999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC---CCeEEeeccCcee
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISDFGMARI  266 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~---~~~kl~DfGla~~  266 (436)
                      ||.+ |.+|.++..-...+  ++..+.+-++-|++.-++|+|..+   ++||||||+|.|..-+   ..+.++|||+|+.
T Consensus        90 MdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             eecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence            9998 78898877433332  677888999999999999999998   9999999999999743   4589999999997


Q ss_pred             cCCCCc-----ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          267 CGGNEL-----QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       267 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      +.+...     ........||.+|.+--...+...+.+.|+=|+|.+|..+--|..||+.........   -.+...+.+
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q---KyEkI~EkK  240 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ---KYEKISEKK  240 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH---HHHHHHHhh
Confidence            754322     223455689999999887777888999999999999999999999997543222110   011111111


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                      ..       .+...-+...+.++.-.+..|=..--++-|...-+.+.+.-+...+..
T Consensus       241 ~s-------~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~  290 (341)
T KOG1163|consen  241 MS-------TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH  290 (341)
T ss_pred             cC-------CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence            10       000111223455677778888888888888887777776665554443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.6e-21  Score=176.83  Aligned_cols=271  Identities=17%  Similarity=0.222  Sum_probs=203.3

Q ss_pred             hhccCCCCCcccCCCCceeEEEEE-ecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ...-.|.+.++||+|+||..+.|+ +-+++.||||.=...++  ..++..|....+.| ..++|...+-+..++....||
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            456689999999999999999998 44699999997654443  25678888888888 578888888888888888999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-----CCCeEEeeccCc
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-----DMNPKISDFGMA  264 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-----~~~~kl~DfGla  264 (436)
                      +|.+ |.||.++..-...  .++..+...++.|++.-++|+|++.   +|.|||||+|+||..     ...+.++|||+|
T Consensus       103 idLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence            9998 7888887632222  3788999999999999999999998   999999999999964     345899999999


Q ss_pred             eecCCCCc-----ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc
Q 040532          265 RICGGNEL-----QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS  339 (436)
Q Consensus       265 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  339 (436)
                      +.+.+...     ........||.+||+-....+.+.+.+.|+=|+|-++...+-|..||+....+.....   .+.+.+
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k---YeKIGe  253 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK---YEKIGE  253 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH---HHHhcc
Confidence            97755432     2234556799999999888899999999999999999999999999976543321110   111111


Q ss_pred             CCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCC
Q 040532          340 NRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPK  400 (436)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~  400 (436)
                      .+       ...+-..-+...+.++..-+.-.=..+-.+-|..+-+.+.+.+.+.......
T Consensus       254 ~K-------r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~  307 (449)
T KOG1165|consen  254 TK-------RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETD  307 (449)
T ss_pred             cc-------ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcc
Confidence            11       1111111223345566666666566777889999988888888776544443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=2.3e-23  Score=213.65  Aligned_cols=251  Identities=21%  Similarity=0.238  Sum_probs=179.7

Q ss_pred             CCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCC-hhhHHHHHHHHHH--HHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS-EQGLREMKNEASV--IAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++...+.||++.|-.|.+|+++.|. |+||++-+.. .-..+.+.++++-  ...++|||.+++.-+-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5677789999999999999999887 9999986554 3334444443333  4556999999998887777777899999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC-C
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN-E  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~-~  271 (436)
                      +.+ +|.+-+.   .+..+...+...|+.|++.|+..+|..+   |+|||||.+||||+.-+.+.|+||..-+...-. +
T Consensus       103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            865 5655553   3455788899999999999999999999   999999999999999999999999877643321 1


Q ss_pred             ccccccccc----ccCCccchhhhccCC-----------CCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHH
Q 040532          272 LQANTSRIV----GTYGYMSPEYALEGI-----------FSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       272 ~~~~~~~~~----gt~~y~aPE~~~~~~-----------~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  335 (436)
                      .......+.    .-.+|.|||.+....           .+++.||||+||+++||++ |+++|...     ++..+-..
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~  250 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSG  250 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhcc
Confidence            111122222    234799999886411           5788999999999999998 57777431     11111000


Q ss_pred             -HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          336 -LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       336 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                       ....+..++.+.             ...+.+++..|++.||++|.++++.++.-.+.
T Consensus       251 ~~~~~e~~Le~Ie-------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  251 NADDPEQLLEKIE-------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             CccCHHHHHHhCc-------------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence             000000111111             12467899999999999999999999885443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=4.3e-22  Score=176.30  Aligned_cols=139  Identities=15%  Similarity=0.135  Sum_probs=107.0

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChh--h------------------------HHHHHHHHHHHHHcCCCce
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQ--G------------------------LREMKNEASVIAKVQHKNL  173 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni  173 (436)
                      .+.||+|++|.||+|...+|+.||+|+++.....  .                        ......|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998653211  0                        0122359999999987766


Q ss_pred             eEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEecccCCCCEEEcC
Q 040532          174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL-HQYSRVRIIHRDLKASNILLDK  252 (436)
Q Consensus       174 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~i~H~Dikp~NIll~~  252 (436)
                      .....+.  ....++||||++++++......   ...++......++.|++.+|.++ |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            4333222  2234899999999877544322   23478889999999999999999 6877   99999999999998 


Q ss_pred             CCCeEEeeccCceec
Q 040532          253 DMNPKISDFGMARIC  267 (436)
Q Consensus       253 ~~~~kl~DfGla~~~  267 (436)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=3.7e-21  Score=170.79  Aligned_cols=140  Identities=19%  Similarity=0.214  Sum_probs=110.1

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChh--------------------------hHHHHHHHHHHHHHcCCCce
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQ--------------------------GLREMKNEASVIAKVQHKNL  173 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni  173 (436)
                      .+.||+|++|.||+|.+.+|+.||||+++.....                          ....+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998754211                          01224678999999999987


Q ss_pred             eEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcC
Q 040532          174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDK  252 (436)
Q Consensus       174 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~  252 (436)
                      .....+...  ..++||||++++++......   ...++......++.|++.++.++|+ .+   ++||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544443332  35899999998865433211   1236778889999999999999999 87   99999999999999 


Q ss_pred             CCCeEEeeccCceecC
Q 040532          253 DMNPKISDFGMARICG  268 (436)
Q Consensus       253 ~~~~kl~DfGla~~~~  268 (436)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=2.7e-21  Score=189.46  Aligned_cols=220  Identities=24%  Similarity=0.371  Sum_probs=163.7

Q ss_pred             HHHcCCCceeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccC
Q 040532          165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  244 (436)
Q Consensus       165 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dik  244 (436)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..  ....+++.-...+.++++.||+|||...  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            3568999999999999999999999999999999999976  3345899999999999999999999865  23999999


Q ss_pred             CCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCC-------CCcccchhhHHHHHHHHHhCCC
Q 040532          245 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-------FSIKSDVFSFGVLLLEIVSGKK  317 (436)
Q Consensus       245 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~SlGvil~elltg~~  317 (436)
                      +.|+++|....+||+|||+.................-..-|.|||.+.+..       .+.++|+||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999987764311111111112334699999998632       4677999999999999999999


Q ss_pred             CCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          318 NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       318 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      ||+........ .+.+.......  ...+ .+...   ...+....+..++.+||..+|.+||+++++-..++.....
T Consensus       157 ~~~~~~~~~~~-~eii~~~~~~~--~~~~-rP~i~---~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  157 PFDLRNLVEDP-DEIILRVKKGG--SNPF-RPSIE---LLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccccCCh-HHHHHHHHhcC--CCCc-Ccchh---hhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            99764332221 12222221101  0000 11111   1112444688999999999999999999999999887754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=5.6e-21  Score=176.43  Aligned_cols=233  Identities=19%  Similarity=0.254  Sum_probs=149.9

Q ss_pred             CCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCC----------CceeEEeeEEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQH----------KNLVRLLGCCI  181 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~  181 (436)
                      .+...+.||.|+++.||.+++.. |+.+|+|.+...   .....+++++|.-....+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            34556789999999999999875 899999988533   23346777777765555322          22332222221


Q ss_pred             ---------eCC--------ccEEEEeecCCCChhhhhc---C-CCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040532          182 ---------DKD--------EKILIYEYMPNKSLDFFLF---D-PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH  240 (436)
Q Consensus       182 ---------~~~--------~~~lv~e~~~~g~L~~~l~---~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H  240 (436)
                               ...        +.+++|+-+ .++|..++.   . ......+....+..+..|+.+.+++||+.|   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                     111        235677776 567766642   1 111233556677888899999999999999   999


Q ss_pred             cccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccC--------CCCcccchhhHHHHHHHH
Q 040532          241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG--------IFSIKSDVFSFGVLLLEI  312 (436)
Q Consensus       241 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~SlGvil~el  312 (436)
                      +||+|+|++++++|.+.|+||+.....+.....     ...+..|.+||.....        .++.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999987764422111     2345779999977542        478899999999999999


Q ss_pred             HhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCC
Q 040532          313 VSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDR  379 (436)
Q Consensus       313 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  379 (436)
                      .+|..||+..........                   .....   .+.++.+..||..+|+.||.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~-------------------~f~~C---~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW-------------------DFSRC---RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG-------------------GGTTS---S---HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc-------------------cchhc---CCcCHHHHHHHHHHccCCcccC
Confidence            999999976543221100                   11111   1467789999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=6.6e-20  Score=161.00  Aligned_cols=184  Identities=18%  Similarity=0.142  Sum_probs=138.6

Q ss_pred             CCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChh----hHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEEee
Q 040532          118 SDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQ----GLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       118 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .+...|++|+||+||.+.. .+.+++.+.+......    ....+.+|+++|+++. |+++.+++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999998766 5888888887654321    1235789999999995 5788888886    456999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccc-CCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL-KASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Di-kp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      ++|.+|...+..          ....++.|++.+|.++|.+|   |+|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999998643311          11357789999999999998   999999 7999999999999999999998654333


Q ss_pred             cc----c--c-----cccccccCCccchhhhccC-CC-CcccchhhHHHHHHHHHhCCCCC
Q 040532          272 LQ----A--N-----TSRIVGTYGYMSPEYALEG-IF-SIKSDVFSFGVLLLEIVSGKKNT  319 (436)
Q Consensus       272 ~~----~--~-----~~~~~gt~~y~aPE~~~~~-~~-~~~~Dv~SlGvil~elltg~~p~  319 (436)
                      ..    .  .     ......++.|++|+...-- .. -...+.++-|.-+|.++|++.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            10    0  0     0112357788888755422 22 35678999999999999999874

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=2.5e-20  Score=194.86  Aligned_cols=201  Identities=18%  Similarity=0.207  Sum_probs=164.4

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC---CCceeEEeeEEEeCCc
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDE  185 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~  185 (436)
                      +.+.....|.+.+.||+|+||+||+|...+|+.||+|+=++.+..+   |.--.+++.+|+   -+.|+.+..++.-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            3455667889999999999999999998889999999987765432   222334444554   3445556666677888


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-------CCCCeEE
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-------KDMNPKI  258 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-------~~~~~kl  258 (436)
                      .++|+||.+.|+|.+++.   ....+++...+.+..|++..+++||..+   ||||||||+|.||.       +..-++|
T Consensus       769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence            999999999999999996   3445899999999999999999999999   99999999999994       2345899


Q ss_pred             eeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCC
Q 040532          259 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  318 (436)
Q Consensus       259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p  318 (436)
                      +|||.+..+..-.....+...++|-.+-.+|+..|..++..+|.|.++-+++-|+.|+..
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            999999766543333455566889999999999999999999999999999999999854

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=2.4e-21  Score=189.94  Aligned_cols=225  Identities=23%  Similarity=0.289  Sum_probs=171.1

Q ss_pred             ccCCCCceeEEEEE----ecCCCEEEEEEcCCCChhh--HHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEEeecC
Q 040532          122 KLGEGGFGPVYKGV----LRKGDEIAVKRLSGRSEQG--LREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      .+|+|+||.|+.+.    .+.|.-+|.|.+.+.....  ......|..++..++ ||.++++.-.+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999865    2336778888886543211  124567888888886 9999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +|.+...+.+..   .............++-+++++|+.+   ++|||+|++||+++.+|++++.|||+++..-...   
T Consensus        81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---  151 (612)
T ss_pred             cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence            998876664433   2555666666777899999999998   9999999999999999999999999997643222   


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDE  354 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (436)
                         ..+||..|||||++.  ....++|.||||++++||+||..||..      +.   ..         .++..    ..
T Consensus       152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~---~~---------~Il~~----~~  204 (612)
T KOG0603|consen  152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DT---MK---------RILKA----EL  204 (612)
T ss_pred             ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HH---HH---------HHhhh----cc
Confidence               228999999999988  567899999999999999999999854      00   00         01100    01


Q ss_pred             cchHHHHHHHHHHHHhcccCCCCCCCCH
Q 040532          355 YSSKQVLLRYVNIALLCVQESADDRPTM  382 (436)
Q Consensus       355 ~~~~~~~~~l~~li~~cl~~~p~~RPs~  382 (436)
                      ....+.......++..++..+|.+|--.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            1112245566778888888899888754

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=3e-19  Score=159.62  Aligned_cols=136  Identities=21%  Similarity=0.293  Sum_probs=105.4

Q ss_pred             CCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-----CCCceeEEeeEEEeCC---ccE-E
Q 040532          118 SDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV-----QHKNLVRLLGCCIDKD---EKI-L  188 (436)
Q Consensus       118 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l  188 (436)
                      ...+.||+|+||.||.  +......+||+.........+.+.+|+.+++++     +||||++++|++..+.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999996  433333479988765444557789999999999     5799999999998864   323 7


Q ss_pred             EEee--cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEecccCCCCEEEcC----CCCeEEeec
Q 040532          189 IYEY--MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL-LYLHQYSRVRIIHRDLKASNILLDK----DMNPKISDF  261 (436)
Q Consensus       189 v~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~i~H~Dikp~NIll~~----~~~~kl~Df  261 (436)
                      |+||  +++++|.+++.+..    +++.  ..++.+++.++ +|||+++   |+||||||+|||++.    ++.++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  56899999995421    4444  35677788777 9999998   999999999999974    347999995


Q ss_pred             cCc
Q 040532          262 GMA  264 (436)
Q Consensus       262 Gla  264 (436)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            443

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=1.6e-18  Score=158.62  Aligned_cols=144  Identities=16%  Similarity=0.149  Sum_probs=110.6

Q ss_pred             ccCCCCCcccCCCCceeEEEEE--ecCCCEEEEEEcCCCChh------------------------hHHHHHHHHHHHHH
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQ------------------------GLREMKNEASVIAK  167 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~  167 (436)
                      +..|++.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+..|+..+.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3457888999999999999998  457999999998743210                        11235689999999


Q ss_pred             cCCC--ceeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCC
Q 040532          168 VQHK--NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKA  245 (436)
Q Consensus       168 l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp  245 (436)
                      +.+.  .+.++++.    ...++||||+++++|......   ...........++.|++.++.+||..+  .++||||||
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp  177 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE  177 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence            9753  33344432    245899999999888665422   123455667899999999999999876  499999999


Q ss_pred             CCEEEcCCCCeEEeeccCceec
Q 040532          246 SNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       246 ~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||+++ ++.++|+|||.+...
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhcc
Confidence            999999 889999999998654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2e-18  Score=155.97  Aligned_cols=134  Identities=20%  Similarity=0.308  Sum_probs=113.0

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCCh--------hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE--------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      +.||+|++|.||+|.. .|..+++|+......        .....+.+|+..+..++|+++.....++.+.+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 478899998654321        1124577899999999999988877777788889999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++|++|.+++...      .. ....++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999887432      12 77899999999999999998   99999999999999 78899999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=1.4e-19  Score=174.42  Aligned_cols=174  Identities=26%  Similarity=0.350  Sum_probs=130.7

Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..|+.|++|...+|.+++.........++.....++.|++.|+.|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999766666667889999999999999999   55   999999999999999999999999998


Q ss_pred             eecCCCC----cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhc
Q 040532          265 RICGGNE----LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTS  339 (436)
Q Consensus       265 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  339 (436)
                      .......    ........+||..||+||.+.+..|+.++||||||++|+|+++ -...+.              ..   
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e--------------r~---  466 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE--------------RI---  466 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH--------------HH---
Confidence            7655433    1223455689999999999999999999999999999999987 222211              00   


Q ss_pred             CCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 040532          340 NRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMND  384 (436)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e  384 (436)
                       .....+++..++.....  .-..-+.++.+++.+.|.+||++.+
T Consensus       467 -~t~~d~r~g~ip~~~~~--d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  467 -ATLTDIRDGIIPPEFLQ--DYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             -HhhhhhhcCCCChHHhh--cCcHHHHHHHHhcCCCcccCchHHH
Confidence             01112222222211100  0112356889999999999994433

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=5.8e-18  Score=151.40  Aligned_cols=140  Identities=19%  Similarity=0.194  Sum_probs=109.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChh----------------------hHHHHHHHHHHHHHcCC
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQ----------------------GLREMKNEASVIAKVQH  170 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h  170 (436)
                      ....|.+.+.||+|+||.||++...+|+.||||++......                      .......|...+..+.|
T Consensus        13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   92 (198)
T cd05144          13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE   92 (198)
T ss_pred             cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence            33457888999999999999999888999999987543210                      11235678899999987


Q ss_pred             Cc--eeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCE
Q 040532          171 KN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  248 (436)
Q Consensus       171 ~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NI  248 (436)
                      ++  +...++    ....++||||+++++|......         .....++.+++.++.++|+.+   ++||||||+||
T Consensus        93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Ni  156 (198)
T cd05144          93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNI  156 (198)
T ss_pred             cCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccE
Confidence            74  444433    3456899999999998765421         234578889999999999988   99999999999


Q ss_pred             EEcCCCCeEEeeccCceecC
Q 040532          249 LLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       249 ll~~~~~~kl~DfGla~~~~  268 (436)
                      ++++++.++|+|||++....
T Consensus       157 ll~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         157 LVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EEcCCCcEEEEECCccccCC
Confidence            99999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=4.2e-18  Score=152.41  Aligned_cols=130  Identities=24%  Similarity=0.379  Sum_probs=106.6

Q ss_pred             ccCCCCceeEEEEEecCCCEEEEEEcCCCC----h----hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRS----E----QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      .||+|++|.||+|.+. |..+++|......    .    .....+.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4899999999999964 7889999865431    1    11355778999999999887666555666777789999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      +|++|.+++....          ..++.+++.+|.+||+.+   ++|+|++|+||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999988774311          078999999999999998   99999999999999 88999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=7e-18  Score=173.23  Aligned_cols=139  Identities=19%  Similarity=0.313  Sum_probs=112.9

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcC-CC-C------hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLS-GR-S------EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK  183 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~-~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  183 (436)
                      .....|...+.||+|+||+||+|.+... .+++|+.. .. .      ....+.+.+|++++.+++|++++....++...
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            3345556788999999999999987644 44444322 11 1      11235688999999999999999888888887


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      ...++||||+++++|.+++.           ....++.+++.+|.+||+.+   ++||||||+|||+ +++.++|+|||+
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence            88899999999999988773           34678999999999999998   9999999999999 678999999999


Q ss_pred             cee
Q 040532          264 ARI  266 (436)
Q Consensus       264 a~~  266 (436)
                      ++.
T Consensus       474 a~~  476 (535)
T PRK09605        474 GKY  476 (535)
T ss_pred             ccc
Confidence            865

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=7e-18  Score=156.76  Aligned_cols=199  Identities=22%  Similarity=0.284  Sum_probs=137.3

Q ss_pred             CCCceeEEeeEEEe---------------------------CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHH
Q 040532          169 QHKNLVRLLGCCID---------------------------KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE  221 (436)
Q Consensus       169 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~  221 (436)
                      +|||||++.++|.+                           ....|+||.-++. +|..++....    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            59999999988753                           2234788887754 6777775433    45667778899


Q ss_pred             HHHHHHHHHhhCCCCCeEecccCCCCEEEc--CCC--CeEEeeccCceecCCCC----cccccccccccCCccchhhhcc
Q 040532          222 GIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDM--NPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYALE  293 (436)
Q Consensus       222 ~ia~~l~~LH~~~~~~i~H~Dikp~NIll~--~~~--~~kl~DfGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~  293 (436)
                      |+++|+.|||+++   +.|||+|++|||+.  +|+  .+.++|||.+.-.....    +.......-|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999999   99999999999994  333  47899999875433211    1111222357788999998864


Q ss_pred             CC------CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHH
Q 040532          294 GI------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNI  367 (436)
Q Consensus       294 ~~------~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  367 (436)
                      .+      .-.|+|.|+.|.+.||+++...||-.  ..++-+...   .+.+.+      -+.++..     ++..+.++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~r---~Yqe~q------LPalp~~-----vpp~~rql  489 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDTR---TYQESQ------LPALPSR-----VPPVARQL  489 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheechh---hhhhhh------CCCCccc-----CChHHHHH
Confidence            32      23689999999999999999999843  111111100   011111      1222222     45567889


Q ss_pred             HHhcccCCCCCCCCHHHHHHHHhh
Q 040532          368 ALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       368 i~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                      +...|+.||++|++..-....|.-
T Consensus       490 V~~lL~r~pskRvsp~iAANvl~L  513 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVLNL  513 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHHHH
Confidence            999999999999998766666643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=2.8e-16  Score=133.39  Aligned_cols=135  Identities=21%  Similarity=0.244  Sum_probs=114.5

Q ss_pred             CCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCC--CceeEEeeEEEeCCccEEEEeecCCC
Q 040532          119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       119 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      +.+.||+|.++.||++... +..+++|.......  ...+.+|...+..++|  .++.++++++...+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            3577999999999999986 47899999876543  4578899999999976  58899998888888899999999988


Q ss_pred             ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          197 SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       197 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      .+..+          +......++.++++++++||.....+++|+|++|+||++++++.+++.|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          4556678899999999999987555699999999999999999999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2.5e-16  Score=139.38  Aligned_cols=137  Identities=18%  Similarity=0.241  Sum_probs=97.9

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChh--hHHH----------------------HHHHHHHHHHcCCCc--e
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQ--GLRE----------------------MKNEASVIAKVQHKN--L  173 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i  173 (436)
                      .+.||+|+||+||+|...+|+.||||++......  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999998653211  1111                      135666666664432  3


Q ss_pred             eEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcC
Q 040532          174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDK  252 (436)
Q Consensus       174 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~  252 (436)
                      .+.+++    ...++||||++++.+.........   .. .....++.+++.++.++|. .+   ++|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444432    346899999999654321111100   11 5567899999999999999 77   99999999999999 


Q ss_pred             CCCeEEeeccCceecC
Q 040532          253 DMNPKISDFGMARICG  268 (436)
Q Consensus       253 ~~~~kl~DfGla~~~~  268 (436)
                      ++.++++|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=2.5e-17  Score=169.60  Aligned_cols=212  Identities=20%  Similarity=0.301  Sum_probs=141.2

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ....+|..++.+-.|+||.||...++. .+.+|.|+ +++.-     +.+-  ++.....|.+|                
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee----------------
Confidence            445788999999999999999998875 56678743 22211     1110  22233344443                


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                           |+-...+....   +++..        ++.+++|||+.+   |+|||+||+|.+|+.-|++|++|||+++.....
T Consensus       136 -----gDc~tllk~~g---~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----GDCATLLKNIG---PLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----chhhhhcccCC---CCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                 33333332211   12211        277899999998   999999999999999999999999999753211


Q ss_pred             C-------------cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh
Q 040532          271 E-------------LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       271 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      .             ..-.....+||+.|.|||++..+.|+...|+|++|+|+||.+-|+.||.....+  .+..   .+.
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe--elfg---~vi  271 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFG---QVI  271 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH--HHHh---hhh
Confidence            0             001223458999999999999999999999999999999999999998543222  1111   111


Q ss_pred             hcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCC
Q 040532          338 TSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT  381 (436)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  381 (436)
                      ...-  .      ....  ......+..+++.+.|+.+|..|--
T Consensus       272 sd~i--~------wpE~--dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  272 SDDI--E------WPEE--DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hhhc--c------cccc--CcCCCHHHHHHHHHHHHhChHhhcc
Confidence            1110  0      0000  0113456788999999999999953

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=1.1e-17  Score=171.53  Aligned_cols=256  Identities=19%  Similarity=0.250  Sum_probs=190.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC--CCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK--GDEIAVKRLSGRS--EQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  188 (436)
                      ...|.+.+.||+|+|+.|-......  ...+|.|.+....  .........|..+-..+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4457777889999999998887643  4456777665443  333445566777777776 9999999999999999999


Q ss_pred             EEeecCCCChhhhhc-CCCccCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEecccCCCCEEEcCCC-CeEEeeccCce
Q 040532          189 IYEYMPNKSLDFFLF-DPTKRILLDWVTRVQIIEGIAQGLLYLH-QYSRVRIIHRDLKASNILLDKDM-NPKISDFGMAR  265 (436)
Q Consensus       189 v~e~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~i~H~Dikp~NIll~~~~-~~kl~DfGla~  265 (436)
                      .++|.+++++...+. ...  ...+....-..+.|+..++.|+| ..+   +.|+|+||+|.+++..+ ..+++|||+|.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence            999999999977773 222  12455566678999999999999 777   99999999999999999 99999999999


Q ss_pred             ecCC-CCcccccccccc-cCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          266 ICGG-NELQANTSRIVG-TYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       266 ~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      .+.. +.........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+............|          
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~----------  243 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW----------  243 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee----------
Confidence            8766 444445555678 9999999998884 45778999999999999999999987655433222211          


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                         .....................++.+++..+|+.|.+.+++..
T Consensus       244 ---~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  244 ---KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ---cccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence               111100001111113345677888999999999999887643

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=2.6e-15  Score=137.74  Aligned_cols=134  Identities=20%  Similarity=0.230  Sum_probs=103.6

Q ss_pred             cccC-CCCceeEEEEEecCCCEEEEEEcCCCC-------------hhhHHHHHHHHHHHHHcCCCce--eEEeeEEEeCC
Q 040532          121 NKLG-EGGFGPVYKGVLRKGDEIAVKRLSGRS-------------EQGLREMKNEASVIAKVQHKNL--VRLLGCCIDKD  184 (436)
Q Consensus       121 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~  184 (436)
                      ..|| .|+.|+||.+... +..+++|++....             ......+.+|+.++.+++|+++  ...+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4687 8899999999876 7789999885321             1123457889999999998774  66776654432


Q ss_pred             c----cEEEEeecCC-CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEe
Q 040532          185 E----KILIYEYMPN-KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  259 (436)
Q Consensus       185 ~----~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~  259 (436)
                      .    .++|||++++ .+|.+++...    .++..    .+.+++.++.+||..|   |+|+||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    2599999997 6888887432    23432    3578999999999998   9999999999999999999999


Q ss_pred             eccCcee
Q 040532          260 DFGMARI  266 (436)
Q Consensus       260 DfGla~~  266 (436)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9999864

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1.2e-14  Score=144.66  Aligned_cols=141  Identities=23%  Similarity=0.273  Sum_probs=100.4

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHH----------------------------------------HHH
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLR----------------------------------------EMK  159 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~  159 (436)
                      .+.||.|++|.||+|++++|+.||||+.++.......                                        ++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3679999999999999999999999998765321100                                        234


Q ss_pred             HHHHHHHHc----CCCceeEEeeEEE-eCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHH-HHHHHhhC
Q 040532          160 NEASVIAKV----QHKNLVRLLGCCI-DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ-GLLYLHQY  233 (436)
Q Consensus       160 ~e~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~~  233 (436)
                      +|+..+.++    +|.+-+.+-.++. ..+..++||||++|++|.++.......  .   ....++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence            455555554    2333333333333 355679999999999998776421111  1   23456666665 46788988


Q ss_pred             CCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       234 ~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      |   ++|+|+||.||+++++++++++|||++..++
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8   9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=1.5e-14  Score=131.76  Aligned_cols=205  Identities=21%  Similarity=0.238  Sum_probs=138.9

Q ss_pred             HHHHHcCCCceeEEeeEEEeCC-----ccEEEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 040532          163 SVIAKVQHKNLVRLLGCCIDKD-----EKILIYEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRV  236 (436)
Q Consensus       163 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  236 (436)
                      .-|-++.|.|+|++..|+.+..     ...++.||+..|++..+|.+. .....+......+|+-||..||.|||+.. +
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence            4455667999999999887643     357899999999999999653 23445777888899999999999999985 6


Q ss_pred             CeEecccCCCCEEEcCCCCeEEeeccCceecC--CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh
Q 040532          237 RIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS  314 (436)
Q Consensus       237 ~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt  314 (436)
                      +|+|+++..+.|++..++-+|+.----.....  ............+.++|.|||.-.....+.++|||+||+...||.-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            79999999999999999888875321111100  0011112223356789999998776777889999999999999988


Q ss_pred             CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          315 GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       315 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      +..--..  .+..-....     ........+.+.             .-..++..|++..|..||+|++++..
T Consensus       278 lEiq~tn--seS~~~~ee-----~ia~~i~~len~-------------lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  278 LEIQSTN--SESKVEVEE-----NIANVIIGLENG-------------LQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             heeccCC--Ccceeehhh-----hhhhheeeccCc-------------cccCcCcccccCCCCCCcchhhhhcC
Confidence            7643111  110000000     000000000010             11347789999999999999987643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=1.1e-13  Score=136.20  Aligned_cols=251  Identities=22%  Similarity=0.283  Sum_probs=176.5

Q ss_pred             hccCCCCCcccCC--CCceeEEEEEe---cCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCC
Q 040532          113 ATNTFSDTNKLGE--GGFGPVYKGVL---RKGDEIAVKRLSGR--SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  184 (436)
                      ..+.|...+.+|.  |.+|.+|.+..   .++..+|+|+-+..  .+..-..=.+|+.....+ .|+|.++....+..++
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3456777888999  99999999986   34788999985432  122212224566666666 4999999888888999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEecccCCCCEEEcCC-CCeEEe
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ----GLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKIS  259 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~i~H~Dikp~NIll~~~-~~~kl~  259 (436)
                      ..++-+|++. .+|..+.+...+  .++....+..+.+..+    |+.++|+.+   ++|-|+||.||+..++ ..++++
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             cceeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence            9999999986 667666544332  3566677777777777    999999988   9999999999999999 899999


Q ss_pred             eccCceecCCCCccccc---ccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 040532          260 DFGMARICGGNELQANT---SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       260 DfGla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      |||+...+.........   ....|...|++||. ..+.++.++|+|++|.++.+..+|-......-...          
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----------  334 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS----------  334 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCCC----------
Confidence            99999988766533322   22367788999995 45678999999999999999998876532210000          


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      |...+      ....+..+.. ....++...+..+++.+|-.|++.+.+..
T Consensus       335 W~~~r------~~~ip~e~~~-~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  335 WSQLR------QGYIPLEFCE-GGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccc------cccCchhhhc-CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            01111      1001111110 02234455888999999999988776543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=5.7e-13  Score=115.83  Aligned_cols=129  Identities=24%  Similarity=0.205  Sum_probs=97.0

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeE-EeeEEEeCCccEEEEeecCCCChh
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR-LLGCCIDKDEKILIYEYMPNKSLD  199 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g~L~  199 (436)
                      +.|+.|.++.||++... +..+++|....... ....+..|+..+..+.+.++++ ++.+  ..+..++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence            56899999999999876 78899999865432 1234678999999886555443 4333  334568999999998875


Q ss_pred             hhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          200 FFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS--RVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       200 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      ...           ......+.+++++|+.||..+  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            420           011245678999999999876  23469999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.40  E-value=1.8e-12  Score=130.87  Aligned_cols=147  Identities=17%  Similarity=0.183  Sum_probs=95.3

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhh----------------------------------HH--
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQG----------------------------------LR--  156 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~--  156 (436)
                      -..|+. +.||+|++|+||+|++++ |+.||||+.++.-...                                  .+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 789999999999999987 9999999997542110                                  11  


Q ss_pred             ----HHHHHHHHHHHc----CCCceeEEeeEEEe-CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHH-H
Q 040532          157 ----EMKNEASVIAKV----QHKNLVRLLGCCID-KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ-G  226 (436)
Q Consensus       157 ----~~~~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~-~  226 (436)
                          ++.+|+.-+.++    .+.+.+.+-.++.+ ....++||||++|+.+.++..-...+  .+..   .++...+. -
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~---~la~~~v~~~  272 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMK---LLAERGVEVF  272 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHH---HHHHHHHHHH
Confidence                133344444444    24444444444443 56778999999999997642111111  1111   12221111 1


Q ss_pred             HHHHhhCCCCCeEecccCCCCEEEcCCC----CeEEeeccCceecCC
Q 040532          227 LLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDFGMARICGG  269 (436)
Q Consensus       227 l~~LH~~~~~~i~H~Dikp~NIll~~~~----~~kl~DfGla~~~~~  269 (436)
                      +..+...|   ++|+|+||.||+++.++    ++++.|||++..++.
T Consensus       273 ~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            23334456   99999999999999888    999999999987653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.36  E-value=1.1e-11  Score=123.41  Aligned_cols=165  Identities=15%  Similarity=0.202  Sum_probs=125.2

Q ss_pred             cCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHH
Q 040532          137 RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR  216 (436)
Q Consensus       137 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~  216 (436)
                      .++.+|.|...+..+....+...+-++.|+.++||||+++++.+..++..|+|+|-+.  .|..++.+      +.....
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v  106 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV  106 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence            3578888888876655445667888999999999999999999999999999999874  45555533      234556


Q ss_pred             HHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCC
Q 040532          217 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF  296 (436)
Q Consensus       217 ~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  296 (436)
                      ..-+.||+.||.|||..+  .++|++|.-..|+++..|+.||++|-++........  .......-..|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            677889999999998655  499999999999999999999999988765432221  111112223466776544222 


Q ss_pred             CcccchhhHHHHHHHHHhC
Q 040532          297 SIKSDVFSFGVLLLEIVSG  315 (436)
Q Consensus       297 ~~~~Dv~SlGvil~elltg  315 (436)
                       -..|.|-|||+++|++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             456999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.32  E-value=5.8e-11  Score=104.45  Aligned_cols=136  Identities=14%  Similarity=0.103  Sum_probs=97.2

Q ss_pred             CcccCCCCceeEEEEEecC-------CCEEEEEEcCCCC----------------------hhhHHHH----HHHHHHHH
Q 040532          120 TNKLGEGGFGPVYKGVLRK-------GDEIAVKRLSGRS----------------------EQGLREM----KNEASVIA  166 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~e~~~l~  166 (436)
                      ...||.|--+.||.|...+       +..+|||+.+...                      ......+    .+|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998653       4789999764210                      0011223    37999999


Q ss_pred             HcC--CCceeEEeeEEEeCCccEEEEeecCCCChhh-hhcCCCccCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEecc
Q 040532          167 KVQ--HKNLVRLLGCCIDKDEKILIYEYMPNKSLDF-FLFDPTKRILLDWVTRVQIIEGIAQGLLYL-HQYSRVRIIHRD  242 (436)
Q Consensus       167 ~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~i~H~D  242 (436)
                      ++.  .-++..++++    ...++||||+.++.+.. .+.+    ..++......+..+++.+|..| |..+   ++|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            984  2455555543    56799999998754421 2221    1244455667889999999999 7777   99999


Q ss_pred             cCCCCEEEcCCCCeEEeeccCceec
Q 040532          243 LKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       243 ikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      |++.||+++ ++.+.|+|||.+...
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999997 467999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=6.8e-11  Score=100.61  Aligned_cols=131  Identities=22%  Similarity=0.329  Sum_probs=102.5

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCC---hh-----hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS---EQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ..+++|+-+.+|.+.+. |..+++|.-.+..   +.     ......+|+.++.+++--.|-...-+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45789999999999875 5557777543321   11     123467899999998766665555566778888999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++|..|.+++...          ...++..+-.-+.-||..+   |+|+||.++||++.++. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888543          2467778888899999998   99999999999998776 99999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=7.4e-11  Score=107.06  Aligned_cols=142  Identities=18%  Similarity=0.259  Sum_probs=108.4

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCCh-hhHHHHHHHHHHHHHcCC--CceeEEeeEEEeCC---ccEEEEeecC
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE-QGLREMKNEASVIAKVQH--KNLVRLLGCCIDKD---EKILIYEYMP  194 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~  194 (436)
                      +.|+.|..+.+|++...+|..+++|....... .....+..|..++..+++  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987678999999865432 134578899999999965  34566676665532   5689999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS----------------------------------------  234 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------------------  234 (436)
                      +.++...+..    ..++......++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988765421    23566777788888888888888521                                        


Q ss_pred             -------------CCCeEecccCCCCEEEcC--CCCeEEeeccCcee
Q 040532          235 -------------RVRIIHRDLKASNILLDK--DMNPKISDFGMARI  266 (436)
Q Consensus       235 -------------~~~i~H~Dikp~NIll~~--~~~~kl~DfGla~~  266 (436)
                                   ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245899999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.25  E-value=1.2e-10  Score=98.73  Aligned_cols=143  Identities=22%  Similarity=0.313  Sum_probs=108.9

Q ss_pred             CCcccCCCCceeEEEEEecCCCEEEEEEcCCCC--------hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS--------EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       119 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ....+-+|+-+.|+++.+. |+...||.-....        .-.....++|++.|.+++--.|....-++.+.....++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578899999999999987 8888888543221        112356788999999997666666666777888889999


Q ss_pred             eecCC-CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC---CeEEeeccCcee
Q 040532          191 EYMPN-KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPKISDFGMARI  266 (436)
Q Consensus       191 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~---~~kl~DfGla~~  266 (436)
                      ||+++ .++.+++....... ........++..+-+.+.-||..+   ++||||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 46677765433322 222333688899999999999988   99999999999997554   358999999854

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.19  E-value=2.2e-11  Score=120.16  Aligned_cols=248  Identities=19%  Similarity=0.174  Sum_probs=173.2

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec--CCCEEEEEEcCCCChhhHHHH--HHHHHHHHHc-CCCceeEEeeEEEeCCc
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR--KGDEIAVKRLSGRSEQGLREM--KNEASVIAKV-QHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l-~h~niv~l~~~~~~~~~  185 (436)
                      .....+|..+..||.|.|+.|+....+  ++..+++|.+.+......+++  ..|+.+...+ .|.++++....+.....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            345567888999999999999998744  477899998876543332332  3455555555 58888888887777788


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC-CCeEEeeccCc
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMA  264 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~-~~~kl~DfGla  264 (436)
                      .|+=-|||+++++.....-   ...++....+.+..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||.+
T Consensus       341 ~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             ccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence            8899999999988665522   223667778899999999999999887   9999999999999886 88899999998


Q ss_pred             eecCCCCcccccccccccCCcc--chhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          265 RICGGNELQANTSRIVGTYGYM--SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      ..+....     ......-+++  +|+......+..+.|+||||.-+.|.++|..--...                 ...
T Consensus       415 t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-----------------~~~  472 (524)
T KOG0601|consen  415 TRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-----------------VQS  472 (524)
T ss_pred             cccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc-----------------ccc
Confidence            6422111     1112233444  555555677899999999999999999987532110                 001


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      ..+. .......   ......+..+...+...++..||.+.++....+
T Consensus       473 ~~i~-~~~~p~~---~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  473 LTIR-SGDTPNL---PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             eeee-cccccCC---CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            1111 1111110   012245667888889999999999888766543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.17  E-value=2.4e-09  Score=101.52  Aligned_cols=269  Identities=14%  Similarity=0.107  Sum_probs=165.0

Q ss_pred             CCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeE----E--EeCCc-cEEE
Q 040532          118 SDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGC----C--IDKDE-KILI  189 (436)
Q Consensus       118 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~----~--~~~~~-~~lv  189 (436)
                      ...+.||+|+-+.+|-.-.- +. .+.|++.........+   ....|... .||-+-.=+.+    .  -+++. .-+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            34567999999999975321 22 3568877654432222   22233333 46543331111    0  11222 4577


Q ss_pred             EeecCCCCh-hhhhcC---CCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          190 YEYMPNKSL-DFFLFD---PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       190 ~e~~~~g~L-~~~l~~---~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      |+.+.+.-- ..++..   .+.-...+|...++.++.++.+.+-||..|   .+-||++++|+|+++++.+.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            777766532 222221   122335789999999999999999999999   8999999999999999999999865443


Q ss_pred             ecCCCCcccccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCCCC--CCCc-chhHHHHH-
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYR--TDSL-NLLGYVWD-  335 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg-~~p~~~~~--~~~~-~~~~~~~~-  335 (436)
                      ...   ........+|...|.+||...     +..-+...|-|.+|+++++++.| ++||..-.  .+.. .+-.-+.. 
T Consensus       166 i~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 INA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             ecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            332   122233357889999999776     23456789999999999999887 89986422  1111 11101111 


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCC--CCCCCCHHHHHHHHhhccccCCC
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQES--ADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~--p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                      .+..... .....+..+...+-...+..+..+..+|+...  +.-||+++..+..|..+.+++.+
T Consensus       243 ~f~ya~~-~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         243 RFAYASD-QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             eeeechh-ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            1110000 11111111222333345567788888998753  66899999999988887766543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.14  E-value=2.3e-09  Score=104.09  Aligned_cols=170  Identities=21%  Similarity=0.334  Sum_probs=129.0

Q ss_pred             CceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe----CCccEEEEeecCC-CChhh
Q 040532          127 GFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIYEYMPN-KSLDF  200 (436)
Q Consensus       127 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~  200 (436)
                      .-.+.|++..+ +|..+++|+++............-++.++++.|+|+|++.+++..    +...++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34688999854 699999999965543333334556788999999999999998872    4467899999986 46765


Q ss_pred             hhcCC------------CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          201 FLFDP------------TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       201 ~l~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      +....            ..+...++...|.++.|++.||.++|+.|   +.-+-|.+.+|+++++.+++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            54322            12334677899999999999999999999   9999999999999999999999888876543


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  318 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p  318 (436)
                      .+.              .+|  +.+   -.+-|.=.||.+++.|.||...
T Consensus       445 ~d~--------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDP--------------TEP--LES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC--------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            322              011  111   1356888999999999999644

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.09  E-value=3.2e-11  Score=125.26  Aligned_cols=252  Identities=19%  Similarity=0.191  Sum_probs=167.6

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      ....+.+.+.+-+-+|.++.+..+.-.. |...+.|.....   .....+....+-.++-..++|-++...--+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            3455667777888999999999876432 444444433221   111122333333344334567777766666667888


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      +|+++|..+++|...|+...   ..+..........+.+++++||...   +.|+|++|.|.+...++..+++|||....
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence            99999999999988886544   2333344455556788999999886   89999999999999999999999984432


Q ss_pred             cCCC-------------------------Ccc----cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCC
Q 040532          267 CGGN-------------------------ELQ----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK  317 (436)
Q Consensus       267 ~~~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~  317 (436)
                      .+..                         ...    .......||+.|.+||...+......+|.|++|++++|.++|.+
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            2110                         000    01223468999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHH
Q 040532          318 NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMN  383 (436)
Q Consensus       318 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  383 (436)
                      ||.......               ..+.+.....+-.............++...+..+|.+|-.+.
T Consensus      1034 p~na~tpq~---------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQ---------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcchhh---------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            986433211               111111111111111122344566788888888999997665

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.04  E-value=5.5e-09  Score=97.07  Aligned_cols=133  Identities=19%  Similarity=0.153  Sum_probs=95.7

Q ss_pred             eeEEEEEecCCCEEEEEEcCCCChhh-H----------HHHHHHHHHHHHcCC--CceeEEeeEEEe-----CCccEEEE
Q 040532          129 GPVYKGVLRKGDEIAVKRLSGRSEQG-L----------REMKNEASVIAKVQH--KNLVRLLGCCID-----KDEKILIY  190 (436)
Q Consensus       129 g~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~e~~~l~~l~h--~niv~l~~~~~~-----~~~~~lv~  190 (436)
                      ..|.+.... |+.+.||+.....-.. .          ..+.+|...+.++..  -....++++...     ....++|+
T Consensus        36 rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            346676664 7889999875443111 1          137789998888842  233344445443     23468999


Q ss_pred             eecCCC-ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-------CCCeEEeecc
Q 040532          191 EYMPNK-SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-------DMNPKISDFG  262 (436)
Q Consensus       191 e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-------~~~~kl~DfG  262 (436)
                      |++++. +|.+++..... ...+......++.+++..+.-||..|   ++|+|++++|||++.       ++.+.++||+
T Consensus       115 e~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        115 EDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             eeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            999986 88888743221 23455677789999999999999999   999999999999985       4689999999


Q ss_pred             Ccee
Q 040532          263 MARI  266 (436)
Q Consensus       263 la~~  266 (436)
                      .+..
T Consensus       191 r~~~  194 (268)
T PRK15123        191 RAQI  194 (268)
T ss_pred             cccc
Confidence            8753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=5.2e-09  Score=91.75  Aligned_cols=125  Identities=24%  Similarity=0.296  Sum_probs=82.3

Q ss_pred             eEEEEEecCCCEEEEEEcCCCC--------------------------hhhHHHHHHHHHHHHHcCCC--ceeEEeeEEE
Q 040532          130 PVYKGVLRKGDEIAVKRLSGRS--------------------------EQGLREMKNEASVIAKVQHK--NLVRLLGCCI  181 (436)
Q Consensus       130 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  181 (436)
                      .||.|...+|..+|+|..+...                          ........+|.+.|.++..-  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            4899999889999999764321                          01123467899999999755  45555544  


Q ss_pred             eCCccEEEEeecC--CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeEecccCCCCEEEcCCCCeEE
Q 040532          182 DKDEKILIYEYMP--NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY-LHQYSRVRIIHRDLKASNILLDKDMNPKI  258 (436)
Q Consensus       182 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~i~H~Dikp~NIll~~~~~~kl  258 (436)
                        ....+||||++  |..+..+....     ++......++.+++..+.. +|..|   ++|||+.+.||+++++ .+.+
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              35689999999  65555443221     1123445677777775555 56777   9999999999999988 9999


Q ss_pred             eeccCceec
Q 040532          259 SDFGMARIC  267 (436)
Q Consensus       259 ~DfGla~~~  267 (436)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.82  E-value=5.6e-08  Score=87.93  Aligned_cols=134  Identities=21%  Similarity=0.235  Sum_probs=96.3

Q ss_pred             CCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCC----------------------hhhHHHHHHHHHHHHHcCCC--c
Q 040532          117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS----------------------EQGLREMKNEASVIAKVQHK--N  172 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--n  172 (436)
                      ..+...||.|--+.||.|...+|.++|+|.=+...                      .......++|.++|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            44567899999999999999999999999432110                      11233467899999998644  6


Q ss_pred             eeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC
Q 040532          173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK  252 (436)
Q Consensus       173 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~  252 (436)
                      +.+.+++    +...+||||++|-.|...-        ++....-.++..|+.-+.-+-..|   ++|||+++-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            6666654    4558999999997764332        122233344555555555555666   999999999999999


Q ss_pred             CCCeEEeeccCce
Q 040532          253 DMNPKISDFGMAR  265 (436)
Q Consensus       253 ~~~~kl~DfGla~  265 (436)
                      +|.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999997654

>PRK09902 hypothetical protein; Provisional

Probab=98.77  E-value=1.9e-07  Score=82.52  Aligned_cols=139  Identities=17%  Similarity=0.143  Sum_probs=102.0

Q ss_pred             cCCCCceeEEEEEecCCCEEEEEEcCCC---C---hhhHHHHHHHHHHHHHcC--CCceeEEeeEEEeCC----ccEEEE
Q 040532          123 LGEGGFGPVYKGVLRKGDEIAVKRLSGR---S---EQGLREMKNEASVIAKVQ--HKNLVRLLGCCIDKD----EKILIY  190 (436)
Q Consensus       123 lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~  190 (436)
                      -|+||.+-|++-... |+.+.+|+-...   +   +.....|.+|...+.++.  .-.+.+...+.....    ..+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            367888999998776 668999987521   1   334568999999999984  233444442222211    247999


Q ss_pred             eecCC-CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC--eEEeeccCcee
Q 040532          191 EYMPN-KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--PKISDFGMARI  266 (436)
Q Consensus       191 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~--~kl~DfGla~~  266 (436)
                      |-+++ -+|.+++.+.. ..+.+...+..++.+++..+.-||..|   +.|+|+.+.||+++.++.  ++++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 58887774422 123567778899999999999999999   999999999999986666  99999987654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.74  E-value=7.9e-08  Score=96.74  Aligned_cols=140  Identities=19%  Similarity=0.277  Sum_probs=93.4

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCChhh------------------------------HH----------HHHH
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG------------------------------LR----------EMKN  160 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~  160 (436)
                      +.|+.++-|.||+|++++|+.||||+.++.-...                              .+          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6799999999999999999999999887652110                              01          1333


Q ss_pred             HHHHHHHc----C-CCceeEEeeEEE-eCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHH-HHHHhhC
Q 040532          161 EASVIAKV----Q-HKNLVRLLGCCI-DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG-LLYLHQY  233 (436)
Q Consensus       161 e~~~l~~l----~-h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~-l~~LH~~  233 (436)
                      |..-+.++    + .+++. +=.++. -.+...|+|||++|-.+.+.......+  .+   +..++..++++ +..+=..
T Consensus       211 EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d---~k~ia~~~~~~f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--ID---RKELAELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhc
Confidence            44444444    2 34433 333333 367889999999999998874222221  33   22333333332 2233334


Q ss_pred             CCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       234 ~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |   +.|.|.+|.||+++.++++.+.|||+...++.
T Consensus       285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             C---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            5   99999999999999999999999999876543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.74  E-value=1e-07  Score=85.50  Aligned_cols=106  Identities=25%  Similarity=0.270  Sum_probs=82.0

Q ss_pred             HHHHHHHHHHHHcC--CCceeEEeeEEEeCC----ccEEEEeecCCC-ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHH
Q 040532          156 REMKNEASVIAKVQ--HKNLVRLLGCCIDKD----EKILIYEYMPNK-SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL  228 (436)
Q Consensus       156 ~~~~~e~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~  228 (436)
                      ....+|...+..+.  .-...+.+++.....    ..++|+|++++. +|.+++.....   .+......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            45678888877774  333445555555432    348999999985 78888854222   455677889999999999


Q ss_pred             HHhhCCCCCeEecccCCCCEEEcCCC---CeEEeeccCceec
Q 040532          229 YLHQYSRVRIIHRDLKASNILLDKDM---NPKISDFGMARIC  267 (436)
Q Consensus       229 ~LH~~~~~~i~H~Dikp~NIll~~~~---~~kl~DfGla~~~  267 (436)
                      -||..|   ++|+|+++.|||++.+.   .+.++||+.++..
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999   99999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.69  E-value=7.5e-09  Score=104.03  Aligned_cols=150  Identities=20%  Similarity=0.314  Sum_probs=100.4

Q ss_pred             HHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccccc-------ccccccCCccchhhhcc
Q 040532          221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-------SRIVGTYGYMSPEYALE  293 (436)
Q Consensus       221 ~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~  293 (436)
                      .+++.|+.|+|...  ++||++|.|++|.+++.+..||+.|+.+............       .-......|.|||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34569999999865  6999999999999999999999999988654431111100       01124557999999999


Q ss_pred             CCCCcccchhhHHHHHHHHHhCCCC-CCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcc
Q 040532          294 GIFSIKSDVFSFGVLLLEIVSGKKN-TGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCV  372 (436)
Q Consensus       294 ~~~~~~~Dv~SlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  372 (436)
                      ...+.++|+||+|+++|.+..|..+ +.......    .+-..        ...++.....  ...+.+.++.+=+.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~----~~~~~--------~~~~~~~~~~--~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL----SYSFS--------RNLLNAGAFG--YSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcc----hhhhh--------hccccccccc--ccccCcHHHHHHHHHHh
Confidence            8889999999999999999965544 32211110    00000        0000100000  11235667888888999


Q ss_pred             cCCCCCCCCHHHHH
Q 040532          373 QESADDRPTMNDVV  386 (436)
Q Consensus       373 ~~~p~~RPs~~ev~  386 (436)
                      ..++..||++.++.
T Consensus       250 ~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLL  263 (700)
T ss_pred             cCCcccCcchhhhh
Confidence            99999999776654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.68  E-value=4.1e-07  Score=82.74  Aligned_cols=132  Identities=20%  Similarity=0.203  Sum_probs=84.8

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCc--eeEEeeEEEeCCccEEEEeecCCCC-
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKN--LVRLLGCCIDKDEKILIYEYMPNKS-  197 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~-  197 (436)
                      ..||+|..+.||+.   .|..+++|.......  .....+|.++++.+..-.  +.+.+++..+.+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56899999999984   255688898875432  245688999999885433  4556777667777789999999963 


Q ss_pred             hhhhhcCCCccCCCCHHHHHHHHHHHHHH---------------------------------------HHHHhhC-CCCC
Q 040532          198 LDFFLFDPTKRILLDWVTRVQIIEGIAQG---------------------------------------LLYLHQY-SRVR  237 (436)
Q Consensus       198 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~---------------------------------------l~~LH~~-~~~~  237 (436)
                      +...+..       +......++..+++.                                       ..+|... ....
T Consensus        82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            2211110       000111111111111                                       2222211 2335


Q ss_pred             eEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          238 IIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       238 i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      ++|+|+.|.||++++++ +.++||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            79999999999999888 9999999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.52  E-value=1.8e-06  Score=76.67  Aligned_cols=139  Identities=16%  Similarity=0.158  Sum_probs=91.1

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHH---------HHHHHHHHHcC---CCceeEEeeE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREM---------KNEASVIAKVQ---HKNLVRLLGC  179 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~---h~niv~l~~~  179 (436)
                      ...++|...+.+-......|.+-..+ |..+++|..+.......+.|         .+.+..+.+++   ......++.+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            34567777777777777777776665 78899998876543222222         23333333332   2233332322


Q ss_pred             EEe-----CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC
Q 040532          180 CID-----KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  254 (436)
Q Consensus       180 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~  254 (436)
                      ...     ....+++|||++|..|.++..       ++.    .+...+.+++.-||..|   +.|+|.+|.|+++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence            222     234568999999988865431       222    24456778899999999   99999999999999655


Q ss_pred             CeEEeeccCcee
Q 040532          255 NPKISDFGMARI  266 (436)
Q Consensus       255 ~~kl~DfGla~~  266 (436)
                       +++.||+..+.
T Consensus       173 -i~iID~~~k~~  183 (229)
T PF06176_consen  173 -IRIIDTQGKRM  183 (229)
T ss_pred             -EEEEECccccc
Confidence             99999987643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.44  E-value=4e-06  Score=77.33  Aligned_cols=139  Identities=15%  Similarity=0.131  Sum_probs=85.1

Q ss_pred             cCCCCc-eeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEEeecCCCChhh
Q 040532          123 LGEGGF-GPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDF  200 (436)
Q Consensus       123 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  200 (436)
                      |-.|.. ..||+.... +..+++|......   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444555 789999765 5788899886543   245678888888873 4445567777766667899999999988764


Q ss_pred             hh-------------------cCCC-ccCCCCH--HHHHHHHH--------------------HHHHHHHHHhh----CC
Q 040532          201 FL-------------------FDPT-KRILLDW--VTRVQIIE--------------------GIAQGLLYLHQ----YS  234 (436)
Q Consensus       201 ~l-------------------~~~~-~~~~l~~--~~~~~i~~--------------------~ia~~l~~LH~----~~  234 (436)
                      ..                   +... ...+...  ........                    .+...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   1100 0001110  00000000                    01111222211    12


Q ss_pred             CCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          235 RVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       235 ~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3459999999999999998778999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.41  E-value=3e-06  Score=77.28  Aligned_cols=142  Identities=23%  Similarity=0.240  Sum_probs=83.4

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCC--ceeEEeeEEEe---CCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHK--NLVRLLGCCID---KDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~  195 (436)
                      +.|+.|..+.||+....+ ..+++|.....  .....+.+|..++..+...  .+.+++.....   ....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            568999999999999886 69999997654  4456778888888888432  34455554432   3346899999999


Q ss_pred             CChhh----------------hh---cCC-CccCCCCHHH---------HHHH------------HHHHHH-HHHHHhh-
Q 040532          196 KSLDF----------------FL---FDP-TKRILLDWVT---------RVQI------------IEGIAQ-GLLYLHQ-  232 (436)
Q Consensus       196 g~L~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~l~~LH~-  232 (436)
                      ..+..                .+   +.. ..........         ....            ...+.. .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            98877                11   010 0000011100         0000            111222 2333332 


Q ss_pred             ---CCCCCeEecccCCCCEEEc-CCCCeEEeeccCce
Q 040532          233 ---YSRVRIIHRDLKASNILLD-KDMNPKISDFGMAR  265 (436)
Q Consensus       233 ---~~~~~i~H~Dikp~NIll~-~~~~~kl~DfGla~  265 (436)
                         .....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               2345699999999999999 66666899998864

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.39  E-value=7.1e-06  Score=73.73  Aligned_cols=134  Identities=19%  Similarity=0.225  Sum_probs=91.0

Q ss_pred             ccCCCCceeEEEEEecCCCEEEEEEcCCCChhh------------------------HHHHHHHHHHHHHcC--CCceeE
Q 040532          122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG------------------------LREMKNEASVIAKVQ--HKNLVR  175 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~e~~~l~~l~--h~niv~  175 (436)
                      .|.+|.-+.||+|...++..+|+|++.......                        ..-...|..-|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            567788889999998889999999986432110                        011235666677663  444444


Q ss_pred             EeeEEEeCCccEEEEeecCCCCh-hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcCC
Q 040532          176 LLGCCIDKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKD  253 (436)
Q Consensus       176 l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~~  253 (436)
                      .+++.    ...|||||+..... .-.|.    ..++.......+..++++.+.-|-. .+   +||+||+.=|||+. +
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~  202 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-D  202 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-C
Confidence            55443    44799999965421 11111    1123333566677788888888776 55   99999999999999 8


Q ss_pred             CCeEEeeccCceec
Q 040532          254 MNPKISDFGMARIC  267 (436)
Q Consensus       254 ~~~kl~DfGla~~~  267 (436)
                      +.+.++|||-|...
T Consensus       203 ~~p~iID~~QaV~~  216 (268)
T COG1718         203 GEPYIIDVSQAVTI  216 (268)
T ss_pred             CeEEEEECcccccc
Confidence            89999999988654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.37  E-value=3.3e-06  Score=84.96  Aligned_cols=140  Identities=17%  Similarity=0.245  Sum_probs=89.6

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCChhh-------------------------------HH------HHHHHHH
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-------------------------------LR------EMKNEAS  163 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~e~~  163 (436)
                      +.||..+.|.||+|++++|+.||||+-++.-+..                               .+      +|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6799999999999999999999999887652110                               01      1223333


Q ss_pred             HHH----HcCCCc---eeEEeeEEEe-CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHH-hhCC
Q 040532          164 VIA----KVQHKN---LVRLLGCCID-KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL-HQYS  234 (436)
Q Consensus       164 ~l~----~l~h~n---iv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~  234 (436)
                      -..    .+.|-+   -|.+=.++.+ .....|+||||+|..+.+...-...  .++..   .++..+.++...+ =..|
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~---~i~~~l~~~~~~qIf~~G  321 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPH---DILNKLVEAYLEQIFKTG  321 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHH---HHHHHHHHHHHHHHHhcC
Confidence            222    234555   2223333433 4577999999999988766432121  13443   3333343332221 2234


Q ss_pred             CCCeEecccCCCCEEEcC----CCCeEEeeccCceecC
Q 040532          235 RVRIIHRDLKASNILLDK----DMNPKISDFGMARICG  268 (436)
Q Consensus       235 ~~~i~H~Dikp~NIll~~----~~~~kl~DfGla~~~~  268 (436)
                         ++|+|-+|.||+++.    ++++.+.|||+.....
T Consensus       322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence               999999999999983    6789999999987654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.36  E-value=9.1e-08  Score=95.41  Aligned_cols=191  Identities=18%  Similarity=0.120  Sum_probs=137.8

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCc-eeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKN-LVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  190 (436)
                      ..+.-+....-+++|+++.++|.+....+....+.+...     ....-++++|.+++||| .+..++-+..++..++++
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            334445556678999999999988665555556655443     34567899999999999 666676666777888999


Q ss_pred             eecCCC-ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          191 EYMPNK-SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       191 e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      +++..+ +-.....  .....+...+...+.+.-+++++++|+..   =+|+|    ||+..+ +..+..||+....+..
T Consensus       314 ~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  314 RICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             hhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCc
Confidence            999887 2211110  11112334444556666788999999864   48888    777766 6789999999876654


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG  320 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~  320 (436)
                      ..   ......+++.|+|||+..+..+..+.|+|++|+-..+|--|-+|-.
T Consensus       384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            32   2334578999999999999999999999999988778877776643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.29  E-value=6.5e-06  Score=70.02  Aligned_cols=132  Identities=22%  Similarity=0.290  Sum_probs=91.0

Q ss_pred             CCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      ..+..+.|++|++|.||+|.+. |..+|+|+-...++  ...+..|+++|..++-.++-+=+-.+   +..++.|||.+|
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G   96 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcC
Confidence            3456688999999999999998 66899998775543  36789999999999876665433222   223455999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccC-CCCEEEcCCCCeEEeeccCcee
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK-ASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dik-p~NIll~~~~~~kl~DfGla~~  266 (436)
                      -.|...-...      +    .+-...++..---|...|   |-|+.|+ |...+|-.++.+.|+||..|+.
T Consensus        97 ~~L~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8886554211      1    122333455544455556   9999987 4555555555999999999863

>PLN02876 acyl-CoA dehydrogenase

Probab=98.23  E-value=2.5e-05  Score=84.61  Aligned_cols=79  Identities=16%  Similarity=0.367  Sum_probs=57.7

Q ss_pred             CcccCCCCceeEEEEEecCC---CEEEEEEcCCCC-hhhHHHHHHHHHHHHHcC-CCce--eEEeeEEEeC---CccEEE
Q 040532          120 TNKLGEGGFGPVYKGVLRKG---DEIAVKRLSGRS-EQGLREMKNEASVIAKVQ-HKNL--VRLLGCCIDK---DEKILI  189 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  189 (436)
                      .+.++.|.+..+|+.....+   ..+++|+..... ......+.+|..+|+.+. |+++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999876643   467888765432 123356889999999995 6654  7777777664   457899


Q ss_pred             EeecCCCCh
Q 040532          190 YEYMPNKSL  198 (436)
Q Consensus       190 ~e~~~~g~L  198 (436)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998754

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.18  E-value=1.1e-05  Score=71.11  Aligned_cols=104  Identities=20%  Similarity=0.232  Sum_probs=82.1

Q ss_pred             HHHHHHHHHcCC-CceeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 040532          159 KNEASVIAKVQH-KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR  237 (436)
Q Consensus       159 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~  237 (436)
                      ..|.-++..+++ +++.+++|+|    ..++|.||...+++...-..-..-...+|..+.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457888888876 6999999998    44789999998766421000011123689999999999999999999865556


Q ss_pred             eEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          238 IIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       238 i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      +.-.|++++|+-+++++++|+.|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            99999999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.14  E-value=2.8e-05  Score=71.29  Aligned_cols=73  Identities=14%  Similarity=0.256  Sum_probs=45.6

Q ss_pred             cccCCCCce-eEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCC---ceeEEeeEEEeC---CccEEEEeec
Q 040532          121 NKLGEGGFG-PVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHK---NLVRLLGCCIDK---DEKILIYEYM  193 (436)
Q Consensus       121 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~  193 (436)
                      +.++.|+.. .||+.    +..+++|......  ....+.+|.+.+..+...   .+.+.++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777766 58875    3457778765422  235788999999887521   233333332221   2348899999


Q ss_pred             CCCChh
Q 040532          194 PNKSLD  199 (436)
Q Consensus       194 ~~g~L~  199 (436)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            998774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.12  E-value=6.2e-05  Score=71.53  Aligned_cols=77  Identities=12%  Similarity=0.123  Sum_probs=56.4

Q ss_pred             CCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCC---CceeEEeeEEEeC---CccEEEEee
Q 040532          119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQH---KNLVRLLGCCIDK---DEKILIYEY  192 (436)
Q Consensus       119 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e~  192 (436)
                      ..+.||.|..+.||+....++ .+++|..+....  ...+..|...|+.+.-   ..+.++++++...   +..++|||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSFST--PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEeccccc--chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            346799999999999987655 467777543212  2478899999988842   4677788777543   568999999


Q ss_pred             cCCCCh
Q 040532          193 MPNKSL  198 (436)
Q Consensus       193 ~~~g~L  198 (436)
                      ++++++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.08  E-value=3.3e-05  Score=71.85  Aligned_cols=138  Identities=14%  Similarity=0.096  Sum_probs=78.6

Q ss_pred             ccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCcee-EEeeEEEeCCccEEEEeecCCCChhh
Q 040532          122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYEYMPNKSLDF  200 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~~  200 (436)
                      .+..|-...+|+... +++.+++|..........-+..+|..+++.+....+. +++..+    ..++|+||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence            356688889999874 4778889876543222112357788888888543332 233332    2479999999877642


Q ss_pred             h-----------------hcCCC-ccCCCCHHHH-HHHHHH---------HHHHHHHHhhC-----CCCCeEecccCCCC
Q 040532          201 F-----------------LFDPT-KRILLDWVTR-VQIIEG---------IAQGLLYLHQY-----SRVRIIHRDLKASN  247 (436)
Q Consensus       201 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~~l~~LH~~-----~~~~i~H~Dikp~N  247 (436)
                      .                 ++... ...+++.... .....+         +...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111 1111222111 111111         11112222111     12358999999999


Q ss_pred             EEEcCCCCeEEeeccCce
Q 040532          248 ILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       248 Ill~~~~~~kl~DfGla~  265 (436)
                      |++++++ +.++||..+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999877 7899999874

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.04  E-value=7e-05  Score=68.59  Aligned_cols=74  Identities=19%  Similarity=0.344  Sum_probs=48.9

Q ss_pred             cccCCCCceeEEEEEecC--CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeEEEeCCccEEEEeecCCCC
Q 040532          121 NKLGEGGFGPVYKGVLRK--GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEYMPNKS  197 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  197 (436)
                      +.|..|-...+|+....+  ++.+++|........ ..+..+|+.++..+...++ .++++.+.    ..++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            567888889999998764  678999987643222 1233578888888854333 33333322    248999999977


Q ss_pred             hh
Q 040532          198 LD  199 (436)
Q Consensus       198 L~  199 (436)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            63

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.94  E-value=0.00017  Score=63.46  Aligned_cols=125  Identities=22%  Similarity=0.370  Sum_probs=89.8

Q ss_pred             cCCCCCcccCCCCc-eeEEEEEecCCCEEEEEEcCC---CC-----------h-------hhHHHHHHHHHHHHHcC---
Q 040532          115 NTFSDTNKLGEGGF-GPVYKGVLRKGDEIAVKRLSG---RS-----------E-------QGLREMKNEASVIAKVQ---  169 (436)
Q Consensus       115 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~-----------~-------~~~~~~~~e~~~l~~l~---  169 (436)
                      ..++.++.||.|.- |.||++... |+.+|+|.+..   ..           +       ...+.|..|.+...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78889999999999 999999997 88999999321   10           0       11235778888888874   


Q ss_pred             CCce--eEEeeEEEeCC------------------ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHH
Q 040532          170 HKNL--VRLLGCCIDKD------------------EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY  229 (436)
Q Consensus       170 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~  229 (436)
                      +.++  |+++|+..-..                  ...+|.||.+...            .+.    .+-+.++.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            4455  89999874321                  1246777775542            112    2334567777888


Q ss_pred             HhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       230 LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      +|..+   |+-+|+++.|..     .-+|+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99998   999999999976     3489999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.89  E-value=0.00022  Score=63.15  Aligned_cols=128  Identities=18%  Similarity=0.246  Sum_probs=88.4

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCC----------------hhhHHHHHHHHHHHHHcC------CCceeEEe
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS----------------EQGLREMKNEASVIAKVQ------HKNLVRLL  177 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~l~  177 (436)
                      ...||+|+.-.||.  +.+....+||+.....                .....+..+|+....++.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46799999999987  4445667889887654                223455667777666665      88999999


Q ss_pred             eEEEeCCccEEEEeecCC------CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc
Q 040532          178 GCCIDKDEKILIYEYMPN------KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  251 (436)
Q Consensus       178 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~  251 (436)
                      |+.+.+...-+|+|.+.+      -+|.+++.+.    .++. ...+.   +-.-..||-..+   |+.+|++|+||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999998743      2455666322    2343 33333   334455666666   99999999999996


Q ss_pred             CCC----CeEEee
Q 040532          252 KDM----NPKISD  260 (436)
Q Consensus       252 ~~~----~~kl~D  260 (436)
                      ...    .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            332    466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.85  E-value=0.00031  Score=68.98  Aligned_cols=75  Identities=16%  Similarity=0.263  Sum_probs=54.1

Q ss_pred             cccCCCCceeEEEEEecCC-CEEEEEEcCCC------C-hhhHHHHHHHHHHHHHcC---CCceeEEeeEEEeCCccEEE
Q 040532          121 NKLGEGGFGPVYKGVLRKG-DEIAVKRLSGR------S-EQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  189 (436)
                      +.||.|.+..||++...+| +.++||.-.+.      + +...+....|.+.|..+.   ..++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5789999999999998876 48999985421      1 223456777888888762   2356666665  44667999


Q ss_pred             EeecCCCC
Q 040532          190 YEYMPNKS  197 (436)
Q Consensus       190 ~e~~~~g~  197 (436)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998743

>PRK05231 homoserine kinase; Provisional

Probab=97.72  E-value=0.00064  Score=65.36  Aligned_cols=142  Identities=17%  Similarity=0.153  Sum_probs=77.4

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-----CCceeEEe-e--EEEeCCccEEEEe
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-----HKNLVRLL-G--CCIDKDEKILIYE  191 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e  191 (436)
                      .+.++.|...++|+....+| .+++|++.....   +.+..|..++..+.     .|.++.-. |  +....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            35677788889999887655 688898762222   23334555555542     33333211 0  1223456789999


Q ss_pred             ecCCCChhh-----h------h---cCCCc--------cCCCCH-HHHHH------------HH-HHHHHHHHHHhhC--
Q 040532          192 YMPNKSLDF-----F------L---FDPTK--------RILLDW-VTRVQ------------II-EGIAQGLLYLHQY--  233 (436)
Q Consensus       192 ~~~~g~L~~-----~------l---~~~~~--------~~~l~~-~~~~~------------i~-~~ia~~l~~LH~~--  233 (436)
                      |++|..+..     .      +   +....        ...+.| .....            .+ ..+...++.+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999875421     1      1   11000        001111 11111            11 1111122333211  


Q ss_pred             --CCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          234 --SRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       234 --~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                        -+.+++|+|++|.||+++++...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              23469999999999999977666899999874

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.72  E-value=0.00045  Score=66.06  Aligned_cols=143  Identities=17%  Similarity=0.176  Sum_probs=82.0

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCC--ceeEEeeE------EEeCCccEEEEe
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHK--NLVRLLGC------CIDKDEKILIYE  191 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e  191 (436)
                      .+.++.|....+|+....+| .+++|+......  .+....|..++..+...  .+.+++..      ....+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45678888889999876544 677898755321  23445666777666322  23333321      112345689999


Q ss_pred             ecCCCChhhh--------------hcCCCcc---------CCCCHHHHH------------HHHHHHHHHHHHHhh----
Q 040532          192 YMPNKSLDFF--------------LFDPTKR---------ILLDWVTRV------------QIIEGIAQGLLYLHQ----  232 (436)
Q Consensus       192 ~~~~g~L~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~ia~~l~~LH~----  232 (436)
                      |++|..+...              ++.....         ..-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998654211              1110000         001111110            011123344555542    


Q ss_pred             CCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       233 ~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      ..+..++|+|+++.||++++++.+.|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223569999999999999998877899999864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.72  E-value=0.00038  Score=66.09  Aligned_cols=142  Identities=15%  Similarity=0.119  Sum_probs=85.2

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCC--ceeEEeeE------EEeCCccEEEEe
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHK--NLVRLLGC------CIDKDEKILIYE  191 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e  191 (436)
                      .+.+..|....+|+.... +..+++|+.....   ...+..|+.++..+.+.  .+.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            456788888899998765 4578889886522   24566788887777432  23444331      123445689999


Q ss_pred             ecCCCChhhh----h----------cCC----Cc----cCCCCHHHHH----------HHHHHHHHHHHHHhh----CCC
Q 040532          192 YMPNKSLDFF----L----------FDP----TK----RILLDWVTRV----------QIIEGIAQGLLYLHQ----YSR  235 (436)
Q Consensus       192 ~~~~g~L~~~----l----------~~~----~~----~~~l~~~~~~----------~i~~~ia~~l~~LH~----~~~  235 (436)
                      |++|..+...    .          +..    ..    .....|....          .....+..++.++..    ..+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9999876430    0          100    00    0111221110          011123334455443    123


Q ss_pred             CCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          236 VRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       236 ~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      ..++|+|+.|.||++++++.+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            459999999999999998778999998874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.71  E-value=0.00031  Score=66.98  Aligned_cols=140  Identities=28%  Similarity=0.332  Sum_probs=82.4

Q ss_pred             cccCCCCceeEEEEEecC-------CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCcee-EEeeEEEeCCccEEEEee
Q 040532          121 NKLGEGGFGPVYKGVLRK-------GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~  192 (436)
                      +.+..|-...+|+....+       ++.+++|+...... ...+..+|..++..+....+. ++++++.    ..+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            456667777899988654       47899999765432 224557888888887533332 3444432    2468999


Q ss_pred             cCCCChhhh-h----------------cCCCccC------CCC--HHHHHH--------------------------HHH
Q 040532          193 MPNKSLDFF-L----------------FDPTKRI------LLD--WVTRVQ--------------------------IIE  221 (436)
Q Consensus       193 ~~~g~L~~~-l----------------~~~~~~~------~l~--~~~~~~--------------------------i~~  221 (436)
                      ++|..+... +                +......      ..+  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998876431 1                1111000      011  101100                          111


Q ss_pred             HHHHHHHHHhh------CCCCCeEecccCCCCEEEcCC----CCeEEeeccCce
Q 040532          222 GIAQGLLYLHQ------YSRVRIIHRDLKASNILLDKD----MNPKISDFGMAR  265 (436)
Q Consensus       222 ~ia~~l~~LH~------~~~~~i~H~Dikp~NIll~~~----~~~kl~DfGla~  265 (436)
                      .+...+.++..      .....++|+|+.+.||+++++    +.+.++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22223334432      134569999999999999985    889999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.65  E-value=0.00019  Score=77.04  Aligned_cols=199  Identities=19%  Similarity=0.205  Sum_probs=137.4

Q ss_pred             HHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE----EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHH
Q 040532          155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI----LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL  230 (436)
Q Consensus       155 ~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L  230 (436)
                      ......|...+.+..|+|++.++.|..++...-    +..+++...++...+..-   ...+....+.+..++.+|+.|+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHH
Confidence            444556788888899999999999887654332    445778777777666432   3477888888999999999999


Q ss_pred             hhCCCCCeEecccCCC---CEEEcCCCCeEEe--eccCceecCCCCcccccccccccCCccchhhhccCCCCc--ccchh
Q 040532          231 HQYSRVRIIHRDLKAS---NILLDKDMNPKIS--DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI--KSDVF  303 (436)
Q Consensus       231 H~~~~~~i~H~Dikp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dv~  303 (436)
                      |+..   ..|.-+..+   +--.+.++.+..+  ||+.+..........   ....+..+.+||......++.  ..|+|
T Consensus       303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHH
Confidence            9985   666655555   5555677777777  998887665433221   123455678888777665544  47999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHH
Q 040532          304 SFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMN  383 (436)
Q Consensus       304 SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  383 (436)
                      .+|.....+..|..+-.....                 ....+     ...     ....+......|+..++++|++..
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~-----------------~~~~l-----~~~-----~~~~~~d~~~~~~~~~~~~Rl~~~  429 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAV-----------------PVSLL-----DVL-----STSELLDALPKCLDEDSEERLSAL  429 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccc-----------------hhhhh-----ccc-----cchhhhhhhhhhcchhhhhccchh
Confidence            999999999998865322110                 00000     000     111356678899999999999999


Q ss_pred             HHHHHH
Q 040532          384 DVVSML  389 (436)
Q Consensus       384 ev~~~L  389 (436)
                      +++...
T Consensus       430 ~ll~~~  435 (1351)
T KOG1035|consen  430 ELLTHP  435 (1351)
T ss_pred             hhhhch
Confidence            998765

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.56  E-value=0.0014  Score=61.62  Aligned_cols=70  Identities=14%  Similarity=0.040  Sum_probs=42.0

Q ss_pred             cCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-C-Cc-eeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-H-KN-LVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       123 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~n-iv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      .++|-...|+.....+|..+++|.-..  ......+.+|.++|+.+. + |- +.++..    .+.-+++|++++|..+
T Consensus        19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~----~~~~~~~y~~i~G~p~   91 (276)
T cd05152          19 NESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPVQVPDWRV----HTPELIAYPKLPGVPA   91 (276)
T ss_pred             cCCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCCCCCceee----ecCceEEEeccCCCcc
Confidence            455656677776555688899998753  233456789999998884 2 21 111111    1223567777776554

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.50  E-value=0.0018  Score=61.51  Aligned_cols=136  Identities=18%  Similarity=0.260  Sum_probs=85.9

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCC--CChhhHHHHHHHHHHHHHcCC--CceeEEeeEEEeCC--ccEEEEeecC
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSG--RSEQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKD--EKILIYEYMP  194 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~  194 (436)
                      +.+-.|..-.+|..... ++++++. ...  ..........+|+.+|+.+.-  .-+-..+++|.++.  ..+.||+|++
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            34434444455665554 7778888 331  233445677889999988743  34445666776665  6699999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHH-HHHHHHHHHHhhC----------------------------------------
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQII-EGIAQGLLYLHQY----------------------------------------  233 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~-~~ia~~l~~LH~~----------------------------------------  233 (436)
                      |......+....    ..    .+.+ ..++..|+-||+-                                        
T Consensus       109 Ge~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         109 GEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             ceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            854432221100    00    1112 2445555555531                                        


Q ss_pred             ---------------CCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          234 ---------------SRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       234 ---------------~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                                     +...++|||+++.|++++.+.-+-+.||+++..
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                           134599999999999999888899999999865

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.40  E-value=0.001  Score=62.53  Aligned_cols=73  Identities=16%  Similarity=0.233  Sum_probs=47.1

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC---CCceeEEeeEEEeCCccEEEEeecCCC
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      .+.++.|....+|+.. .+++.+.||.-..   .....|..|..-|+.|.   --.+.+.+++....+..+|++||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4568889999999988 4588899998762   22246778888888873   445777888877777889999999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.36  E-value=0.002  Score=62.56  Aligned_cols=140  Identities=17%  Similarity=0.208  Sum_probs=80.5

Q ss_pred             cccCCCCceeEEEEEecC-----CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCcee-EEeeEEEeCCccEEEEeecC
Q 040532          121 NKLGEGGFGPVYKGVLRK-----GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~  194 (436)
                      +.+-.|-.-.+|+....+     ++.+++|+.........+ -.+|..++..+...++. ++++.+..    ..|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC----ceEEEeeC
Confidence            445557788999987532     367999988765433332 36788888888543333 34454422    26899998


Q ss_pred             CCChhhh-----------------hcCCC--c-cCCCCHHHHHHHHHH-----------------HHHHHHHH----hh-
Q 040532          195 NKSLDFF-----------------LFDPT--K-RILLDWVTRVQIIEG-----------------IAQGLLYL----HQ-  232 (436)
Q Consensus       195 ~g~L~~~-----------------l~~~~--~-~~~l~~~~~~~i~~~-----------------ia~~l~~L----H~-  232 (436)
                      +.++...                 ++...  . ..+..+....++..+                 +...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8777421                 11111  0 101112222222211                 11112222    11 


Q ss_pred             CCCCCeEecccCCCCEEEcC-CCCeEEeeccCce
Q 040532          233 YSRVRIIHRDLKASNILLDK-DMNPKISDFGMAR  265 (436)
Q Consensus       233 ~~~~~i~H~Dikp~NIll~~-~~~~kl~DfGla~  265 (436)
                      .....++|+|+++.||++++ ++.+.++||..+.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            22345999999999999986 4789999998874

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.28  E-value=0.0004  Score=64.91  Aligned_cols=133  Identities=15%  Similarity=0.161  Sum_probs=91.1

Q ss_pred             CCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCC-----------------Chh-----hHHHHHHHHHHHHHcC-CC-
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR-----------------SEQ-----GLREMKNEASVIAKVQ-HK-  171 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----------------~~~-----~~~~~~~e~~~l~~l~-h~-  171 (436)
                      -+.+.++||-|.-+.+|.+-+.+|++.++|.-+-.                 ...     +.-...+|...|+.+. |- 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            45677899999999999999999999998842110                 000     1123456888888874 22 


Q ss_pred             ceeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc
Q 040532          172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  251 (436)
Q Consensus       172 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~  251 (436)
                      -+.+.+++    +..++|||++.+-.|...-+-      .+.   ..+...+..-+.-|..+|   ++|+|..--||+++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~---~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDP---PTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec------CCh---HHHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence            23334443    445899999988877543211      122   233444445556666777   99999999999999


Q ss_pred             CCCCeEEeeccCc
Q 040532          252 KDMNPKISDFGMA  264 (436)
Q Consensus       252 ~~~~~kl~DfGla  264 (436)
                      +++.++++||--.
T Consensus       237 dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  237 DDDKIVVIDFPQM  249 (465)
T ss_pred             cCCCEEEeechHh
Confidence            9999999999644

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.80  E-value=0.025  Score=55.55  Aligned_cols=73  Identities=14%  Similarity=0.156  Sum_probs=51.0

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCC----Ch---hhHHHHHHHHHHHHHcC---CCceeEEeeEEEeCCccEEE
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR----SE---QGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv  189 (436)
                      .+.||.|....||+.... +..++||+-...    +.   ........|...|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            467899999999998875 567999986521    11   13344455677776653   246777787765  567889


Q ss_pred             EeecCC
Q 040532          190 YEYMPN  195 (436)
Q Consensus       190 ~e~~~~  195 (436)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.79  E-value=0.013  Score=56.56  Aligned_cols=140  Identities=16%  Similarity=0.240  Sum_probs=78.2

Q ss_pred             cccCCCCceeEEEEEecC----CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCcee-EEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK----GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.|..|-.-.+|+....+    +..|++|+........ -+-.+|..+++.+..-++- ++++++. ++   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            345557777889887543    2378899886544322 2336788888888644443 3454442 22   58999987


Q ss_pred             CChhhh-----------------hcCCC---ccCCCCHHHHHHHHHH----------------------HHHHHHHHh--
Q 040532          196 KSLDFF-----------------LFDPT---KRILLDWVTRVQIIEG----------------------IAQGLLYLH--  231 (436)
Q Consensus       196 g~L~~~-----------------l~~~~---~~~~l~~~~~~~i~~~----------------------ia~~l~~LH--  231 (436)
                      ..+..-                 ++...   ...+.-+....++..+                      +..-+..+.  
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            766321                 11111   0111112222222111                      111111111  


Q ss_pred             --h-CCCCCeEecccCCCCEEEcC-CCCeEEeeccCce
Q 040532          232 --Q-YSRVRIIHRDLKASNILLDK-DMNPKISDFGMAR  265 (436)
Q Consensus       232 --~-~~~~~i~H~Dikp~NIll~~-~~~~kl~DfGla~  265 (436)
                        . ..+.-++|+|+.+.|||+++ ++.++++||..|-
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence              1 11234899999999999975 5789999999874

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=96.72  E-value=0.0016  Score=42.93  Aligned_cols=43  Identities=49%  Similarity=0.736  Sum_probs=36.0

Q ss_pred             ccCCCCCCCCcccccCccccCCCCCCC--CCCccccceecccccC
Q 040532          394 AALHPPKQPAFSNVRNTVTSTSSTDKT--GDCSINQVTISILEAR  436 (436)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  436 (436)
                      ..+|.|++|.|...+...-..++..+.  ..|++|.||+|.+++|
T Consensus         4 ~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    4 ATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             ccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            468999999999888866666665555  7899999999999998

; GO: 0004674 protein serine/threonine kinase activity

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.72  E-value=0.021  Score=55.18  Aligned_cols=73  Identities=16%  Similarity=0.275  Sum_probs=49.0

Q ss_pred             ccCCCCceeEEEEEecCC-CEEEEEEcCC-------CChhhHHHHHHHHHHHHHcC--CCc-eeEEeeEEEeCCccEEEE
Q 040532          122 KLGEGGFGPVYKGVLRKG-DEIAVKRLSG-------RSEQGLREMKNEASVIAKVQ--HKN-LVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~  190 (436)
                      .||-|....||++...+| +.|+||.-.+       .-+...+...-|...|+...  .|. +.+++.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            579999999999998654 5899997531       11334456667888887663  343 333443  3556667999


Q ss_pred             eecCCC
Q 040532          191 EYMPNK  196 (436)
Q Consensus       191 e~~~~g  196 (436)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.69  E-value=0.025  Score=54.04  Aligned_cols=31  Identities=26%  Similarity=0.374  Sum_probs=27.8

Q ss_pred             CCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          235 RVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       235 ~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      +..++|+|+.++|+++++++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            3469999999999999999999999998875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.68  E-value=0.00046  Score=76.00  Aligned_cols=160  Identities=13%  Similarity=-0.015  Sum_probs=112.2

Q ss_pred             HHHHHHHHHHcCCCceeEEeeEEEe--CCccEEEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHhhC-
Q 040532          158 MKNEASVIAKVQHKNLVRLLGCCID--KDEKILIYEYMPNKSLDFFLFDPT-KRILLDWVTRVQIIEGIAQGLLYLHQY-  233 (436)
Q Consensus       158 ~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~-  233 (436)
                      ...|.+.++...|+++.....-...  +.+.+.+++|+.+|.+...+.+.. +..+++..-......+......-.|.. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3345555566788887766544333  346689999999999988775543 333344433333333334444444433 


Q ss_pred             -CCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHH
Q 040532          234 -SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI  312 (436)
Q Consensus       234 -~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el  312 (436)
                       +....+|+++|+-|.+|..+.++|++++|+.+....  .....+...+++.|++|++...-.++.++|+|..|+-+|+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence             234589999999999999999999999999983221  12223334678889999998888999999999999999999


Q ss_pred             HhCCCCC
Q 040532          313 VSGKKNT  319 (436)
Q Consensus       313 ltg~~p~  319 (436)
                      -.|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8888775

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.67  E-value=0.021  Score=54.65  Aligned_cols=140  Identities=16%  Similarity=0.154  Sum_probs=92.3

Q ss_pred             CCcccCCCCceeEEEEEecCCCEEEEEEcCCCC-------------------------hh-hHHHHHHHHHHHHHcCCCc
Q 040532          119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS-------------------------EQ-GLREMKNEASVIAKVQHKN  172 (436)
Q Consensus       119 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------------------~~-~~~~~~~e~~~l~~l~h~n  172 (436)
                      +...|..|--+.||.|.-.+|..+|||+++..-                         .. -.--...|+.-|.+++...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            446788899999999999999999999764220                         00 0111345777777775433


Q ss_pred             eeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC
Q 040532          173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK  252 (436)
Q Consensus       173 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~  252 (436)
                      |....-...  ....|||+|+.....   -....+...++...+..+-.+++.-|.-|.+.+  ++||.||.--|+|+.+
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd  300 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD  300 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence            222111111  133789999963322   222223344676777788888888888886655  4999999999999854


Q ss_pred             CCCeEEeeccCcee
Q 040532          253 DMNPKISDFGMARI  266 (436)
Q Consensus       253 ~~~~kl~DfGla~~  266 (436)
                       |.+.++|-+-+..
T Consensus       301 -G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 -GKLYIIDVSQSVE  313 (520)
T ss_pred             -CEEEEEEcccccc
Confidence             5789999876643

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.46  E-value=0.05  Score=48.76  Aligned_cols=74  Identities=19%  Similarity=0.302  Sum_probs=50.6

Q ss_pred             ccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHc---CCCceeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV---QHKNLVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      .+--|.--..|...+. ..++.+|+-..   .....|..|+.-|..+   +.-++.+.+.+-.+.+..|+|+||++-+.+
T Consensus        23 ~v~gG~inea~~v~dg-~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          23 EVSGGDINEAWRLRDG-TDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccCCccccceeEeecC-CcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            3444444445554443 67899997532   3345677777766666   445677788888888999999999998877


Q ss_pred             h
Q 040532          199 D  199 (436)
Q Consensus       199 ~  199 (436)
                      +
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            6

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.45  E-value=0.007  Score=54.39  Aligned_cols=30  Identities=40%  Similarity=0.560  Sum_probs=21.5

Q ss_pred             CeEecccCCCCEEE-cCCCCeEEeeccCcee
Q 040532          237 RIIHRDLKASNILL-DKDMNPKISDFGMARI  266 (436)
Q Consensus       237 ~i~H~Dikp~NIll-~~~~~~kl~DfGla~~  266 (436)
                      .++|+|+.|.||++ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            49999999999999 8899999999988753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=96.23  E-value=0.0038  Score=50.03  Aligned_cols=35  Identities=23%  Similarity=0.450  Sum_probs=24.0

Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHHhhheeccCCC
Q 040532           25 LTSTPRLPLFLLSIVLAAVAILGLIFFCVRRKPGS   59 (436)
Q Consensus        25 ~~s~~~~~~~i~~~~~~~v~i~~~~~~~~~r~~~~   59 (436)
                      ..+.+.++++|+|+++++++++++++||.||++|+
T Consensus        60 ~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk   94 (122)
T PF01102_consen   60 RFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK   94 (122)
T ss_dssp             SSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred             CccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence            34667778888888888887777777777766554

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.15  E-value=0.081  Score=50.46  Aligned_cols=29  Identities=28%  Similarity=0.359  Sum_probs=25.2

Q ss_pred             CCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          236 VRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       236 ~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .+++|||+.+.||+++. +.+.+.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            46999999999999998 678999998753

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.10  E-value=0.08  Score=50.84  Aligned_cols=139  Identities=20%  Similarity=0.229  Sum_probs=80.1

Q ss_pred             cCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC---CCc---eeEEeeEEE--eCC--ccEEEEee
Q 040532          123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ---HKN---LVRLLGCCI--DKD--EKILIYEY  192 (436)
Q Consensus       123 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~n---iv~l~~~~~--~~~--~~~lv~e~  192 (436)
                      |.+ .-..+|+....+|.. ++|.....  ....++..|...|..+.   .+=   +...-|-..  -..  ..+-+++|
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            444 456789988876766 88888765  22356677788887773   111   222222111  123  56789999


Q ss_pred             cCCCChhh-hh--------------c----CCC--c---cCCCCHHH-------------HHHHHHHHHHHHHHHhh---
Q 040532          193 MPNKSLDF-FL--------------F----DPT--K---RILLDWVT-------------RVQIIEGIAQGLLYLHQ---  232 (436)
Q Consensus       193 ~~~g~L~~-~l--------------~----~~~--~---~~~l~~~~-------------~~~i~~~ia~~l~~LH~---  232 (436)
                      ++|..+.. ..              +    +..  .   .....|..             ......++...+..+..   
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99988873 11              0    000  0   11122320             01122233333444432   


Q ss_pred             -CCC---CCeEecccCCCCEEEcCCCC-eEEeeccCce
Q 040532          233 -YSR---VRIIHRDLKASNILLDKDMN-PKISDFGMAR  265 (436)
Q Consensus       233 -~~~---~~i~H~Dikp~NIll~~~~~-~kl~DfGla~  265 (436)
                       .-+   ..++|+|+.|.||+++.+.. +-+.||+-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence             111   22999999999999998885 8999999764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.08  E-value=0.034  Score=49.53  Aligned_cols=115  Identities=19%  Similarity=0.194  Sum_probs=70.3

Q ss_pred             CceeEEEEEecCCCEEEEEEcCCCChh-hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCChhhhhcCC
Q 040532          127 GFGPVYKGVLRKGDEIAVKRLSGRSEQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP  205 (436)
Q Consensus       127 ~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~  205 (436)
                      +-++.-.+..+-| +..+|++....-. ...-+..+.++++++.  .|+++..-  +.-..-++.|+|-....       
T Consensus        74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------  141 (308)
T PF07387_consen   74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------  141 (308)
T ss_pred             CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence            3444444444333 3556666543222 2345678889998875  46776622  23344588998843211       


Q ss_pred             CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          206 TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       206 ~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                            ..   ..+..-=.++|.-.|+.+ ...+|||-.|+||+-|+.|.+||.|=+.
T Consensus       142 ------~~---~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  142 ------NF---SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ------ch---hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence                  00   111111145677778543 3599999999999999999999999765

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.03  E-value=0.024  Score=54.14  Aligned_cols=110  Identities=15%  Similarity=0.230  Sum_probs=72.7

Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..|++|++. |+++...       ....+.+...++.+.+..+.-+...-  +.-|||+.-.||||+ +|++.|+||-++
T Consensus       300 y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         300 YLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             EEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence            345666665 4444211       22568889999999999888887755  689999999999999 999999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCC
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK  316 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~  316 (436)
                      +....+..       ......--|-.+. +.-+..-|||-+   |--|+.|+
T Consensus       369 Rl~~~q~~-------isy~rldhp~lF~-G~dd~QFeIYrl---Mr~l~~g~  409 (488)
T COG5072         369 RLSYSQGI-------ISYNRLDHPDLFN-GVDDYQFEIYRL---MRRLLKGR  409 (488)
T ss_pred             ecccCCce-------eeccccCchhhhc-CccceeeeHHHH---HHHHhcCc
Confidence            86433221       1111233454444 333667777764   33444444

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.97  E-value=0.022  Score=55.64  Aligned_cols=74  Identities=12%  Similarity=0.197  Sum_probs=51.0

Q ss_pred             CcccCCCCceeEEEEEecC-CCEEEEEEcCC------CChhhHHHHHHHHHHHHHcC--CCc-eeEEeeEEEeCCccEEE
Q 040532          120 TNKLGEGGFGPVYKGVLRK-GDEIAVKRLSG------RSEQGLREMKNEASVIAKVQ--HKN-LVRLLGCCIDKDEKILI  189 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv  189 (436)
                      .+.||-|.-.-||++.+.+ ++.|+||.-.+      .-+-..++..-|.+.|+...  .|. +.+++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4678999999999999753 56899996532      11334566777888888763  443 4445443  55667789


Q ss_pred             EeecCC
Q 040532          190 YEYMPN  195 (436)
Q Consensus       190 ~e~~~~  195 (436)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.78  E-value=0.21  Score=48.08  Aligned_cols=72  Identities=11%  Similarity=0.058  Sum_probs=44.7

Q ss_pred             CCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCC--CceeEEe---e--EEEeCCccEEEEeecCCCCh
Q 040532          126 GGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQH--KNLVRLL---G--CCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       126 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~---~--~~~~~~~~~lv~e~~~~g~L  198 (436)
                      +.-..||+....+|..+++|...... .....+..|...+..+..  -.++...   |  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            34467999988778889999886432 233556777777776631  1122211   2  12234566789999988754

>PTZ00384 choline kinase; Provisional

Probab=95.56  E-value=0.094  Score=51.59  Aligned_cols=74  Identities=18%  Similarity=0.284  Sum_probs=45.6

Q ss_pred             cccCCCCceeEEEEEecCC--CE-----EEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeE-EeeEEEeCCccEEEEee
Q 040532          121 NKLGEGGFGPVYKGVLRKG--DE-----IAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR-LLGCCIDKDEKILIYEY  192 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~  192 (436)
                      +.|..|-...+|++...++  ..     |.++......... -+-.+|..+++.+...++-+ +++.+.    .++++||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence            4566688899999975432  22     4444432222222 23367889999986555544 444442    3699999


Q ss_pred             cCCCChh
Q 040532          193 MPNKSLD  199 (436)
Q Consensus       193 ~~~g~L~  199 (436)
                      ++|..|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9998774

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.39  E-value=0.11  Score=47.79  Aligned_cols=79  Identities=19%  Similarity=0.196  Sum_probs=55.9

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec-CCCCh
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM-PNKSL  198 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~-~~g~L  198 (436)
                      ...+..|..+.|+.+...+|.+.++|......... .+ ......|+..+-...|++++.-  .....+++|.+ ++.+|
T Consensus         7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~-~E-~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L   82 (253)
T PF04655_consen    7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE-HE-ARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSL   82 (253)
T ss_pred             CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch-hh-hhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCch
Confidence            34567899999999999889999999987543221 11 1122457777888889999764  34567888998 55577


Q ss_pred             hhhh
Q 040532          199 DFFL  202 (436)
Q Consensus       199 ~~~l  202 (436)
                      .+..
T Consensus        83 ~~~~   86 (253)
T PF04655_consen   83 ASLP   86 (253)
T ss_pred             hhcc
Confidence            6554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	436
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-52
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-51
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-44
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-44
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-43
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-42
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-42
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-40
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-24
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-24
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-23
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-23
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-22
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-22
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-22
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-22
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-22
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-22
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-22
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-22
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-22
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-22
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-22
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-22
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-22
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-22
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-22
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-21
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-21
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-21
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-21
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-21
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-21
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-21
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-21
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-21
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-21
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-21
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-21
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-20
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-20
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-20
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-20
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-20
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-20
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-20
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-20
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-20
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-20
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-20
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-20
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-20
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-20
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-20
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-20
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-20
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-20
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-20
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-20
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-20
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-19
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-19
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-19
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-19
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-19
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-19
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-19
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-19
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-19
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-19
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-19
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-19
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-19
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-18
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-18
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-18
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-18
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-18
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-18
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-18
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-18
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-18
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-18
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-18
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-18
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-18
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-18
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-18
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-18
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-18
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-18
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-18
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-18
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-18
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-18
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-18
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-17
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-16
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-14
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-14
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-14
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-11
3soa_A	444	Full-Length Human Camkii Length = 444		3e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		9e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-05
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-05
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  201 bits (511), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 119/309 (38%), Positives = 179/309 (57%), Gaps = 8/309 (2%)
Query: 92  ERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS 151
           E   +  + QL  FS   +  A++ FS+ N LG GGFG VYKG L  G  +AVKRL    
Sbjct: 15  EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 74
Query: 152 EQGLR-EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-PTKRI 209
            QG   + + E  +I+   H+NL+RL G C+   E++L+Y YM N S+   L + P  + 
Sbjct: 75  XQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 134
Query: 210 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 269
            LDW  R +I  G A+GL YLH +   +IIHRD+KA+NILLD++    + DFG+A++   
Sbjct: 135 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 194
Query: 270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR---TDS 326
            +     + + GT G+++PEY   G  S K+DVF +GV+LLE+++G++   L R    D 
Sbjct: 195 KDXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 253
Query: 327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
           + LL +V  L    + LE + D  L+  Y  ++V  + + +ALLC Q S  +RP M++VV
Sbjct: 254 VMLLDWVKGL-LKEKKLEALVDVDLQGNYKDEEV-EQLIQVALLCTQSSPMERPKMSEVV 311
Query: 387 SMLTNEAAA 395
            ML  +  A
Sbjct: 312 RMLEGDGLA 320

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  197 bits (502), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 117/309 (37%), Positives = 179/309 (57%), Gaps = 8/309 (2%)
Query: 92  ERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL-SGR 150
           E   +  + QL  FS   +  A++ F + N LG GGFG VYKG L  G  +AVKRL   R
Sbjct: 7   EEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEER 66
Query: 151 SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-PTKRI 209
           ++ G  + + E  +I+   H+NL+RL G C+   E++L+Y YM N S+   L + P  + 
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 210 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 269
            LDW  R +I  G A+GL YLH +   +IIHRD+KA+NILLD++    + DFG+A++   
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR---TDS 326
            +     + + G  G+++PEY   G  S K+DVF +GV+LLE+++G++   L R    D 
Sbjct: 187 KDXHVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
           + LL +V  L    + LE + D  L+  Y  ++V  + + +ALLC Q S  +RP M++VV
Sbjct: 246 VMLLDWVKGL-LKEKKLEALVDVDLQGNYKDEEV-EQLIQVALLCTQSSPMERPKMSEVV 303
Query: 387 SMLTNEAAA 395
            ML  +  A
Sbjct: 304 RMLEGDGLA 312

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 114/281 (40%), Positives = 173/281 (61%), Gaps = 17/281 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKN 172
           ATN F     +G G FG VYKGVLR G ++A+KR +  S QG+ E + E   ++  +H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD---PTKRILLDWVTRVQIIEGIAQGLLY 229
           LV L+G C +++E ILIY+YM N +L   L+    PT  + + W  R++I  G A+GL Y
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEICIGAARGLHY 154
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIV-GTYGYMS 287
           LH  +   IIHRD+K+ NILLD++  PKI+DFG+++   G EL Q +   +V GT GY+ 
Sbjct: 155 LHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXVVKGTLGYID 209
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKN--TGLYRTDSLNLLGYVWDLWTSNRTLEL 345
           PEY ++G  + KSDV+SFGV+L E++  +      L R + +NL  +  +   +N  LE 
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVES-HNNGQLEQ 267
Query: 346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
           I DP L D+   +  L ++ + A+ C+  S++DRP+M DV+
Sbjct: 268 IVDPNLADKIRPES-LRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  175 bits (443), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 114/281 (40%), Positives = 173/281 (61%), Gaps = 17/281 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKN 172
           ATN F     +G G FG VYKGVLR G ++A+KR +  S QG+ E + E   ++  +H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD---PTKRILLDWVTRVQIIEGIAQGLLY 229
           LV L+G C +++E ILIY+YM N +L   L+    PT  + + W  R++I  G A+GL Y
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEICIGAARGLHY 154
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIV-GTYGYMS 287
           LH  +   IIHRD+K+ NILLD++  PKI+DFG+++   G EL Q +   +V GT GY+ 
Sbjct: 155 LHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLXXVVKGTLGYID 209
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKN--TGLYRTDSLNLLGYVWDLWTSNRTLEL 345
           PEY ++G  + KSDV+SFGV+L E++  +      L R + +NL  +  +   +N  LE 
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVES-HNNGQLEQ 267
Query: 346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
           I DP L D+   +  L ++ + A+ C+  S++DRP+M DV+
Sbjct: 268 IVDPNLADKIRPES-LRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 114/303 (37%), Positives = 159/303 (52%), Gaps = 22/303 (7%)
Query: 105 FSFSSVSTATNTFSD------TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREM 158
           FSF  +   TN F +       NK+GEGGFG VYKG +     +AVK+L+   +    E+
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 159 KN----EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL--DFFLFDPTKRILLD 212
           K     E  V+AK QH+NLV LLG   D D+  L+Y YMPN SL       D T    L 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LS 131
Query: 213 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 272
           W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR       
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY 332
               SRIVGT  YM+PE AL G  + KSD++SFGV+LLEI++G      +R   L L   
Sbjct: 189 TVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 333 VWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE 392
                      + ID  + + + +S + +    ++A  C+ E  + RP +  V  +L   
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMY---SVASQCLHEKKNKRPDIKKVQQLLQEM 304
Query: 393 AAA 395
            A+
Sbjct: 305 TAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 158/303 (52%), Gaps = 22/303 (7%)
Query: 105 FSFSSVSTATNTFSD------TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREM 158
           FSF  +   TN F +       NK+GEGGFG VYKG +     +AVK+L+   +    E+
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 159 KN----EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL--DFFLFDPTKRILLD 212
           K     E  V+AK QH+NLV LLG   D D+  L+Y YMPN SL       D T    L 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LS 125
Query: 213 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 272
           W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR       
Sbjct: 126 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY 332
                RIVGT  YM+PE AL G  + KSD++SFGV+LLEI++G      +R   L L   
Sbjct: 183 XVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 241
Query: 333 VWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE 392
                      + ID  + + + +S + +    ++A  C+ E  + RP +  V  +L   
Sbjct: 242 EEIEDEEKTIEDYIDKKMNDADSTSVEAMY---SVASQCLHEKKNKRPDIKKVQQLLQEM 298
Query: 393 AAA 395
            A+
Sbjct: 299 TAS 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 158/303 (52%), Gaps = 22/303 (7%)
Query: 105 FSFSSVSTATNTFSD------TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREM 158
           FSF  +   TN F +       NK+GEGGFG VYKG +     +AVK+L+   +    E+
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 159 KN----EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL--DFFLFDPTKRILLD 212
           K     E  V+AK QH+NLV LLG   D D+  L+Y YMPN SL       D T    L 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LS 131
Query: 213 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 272
           W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR       
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY 332
                RIVGT  YM+PE AL G  + KSD++SFGV+LLEI++G      +R   L L   
Sbjct: 189 TVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 333 VWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE 392
                      + ID  + + + +S + +    ++A  C+ E  + RP +  V  +L   
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMY---SVASQCLHEKKNKRPDIKKVQQLLQEM 304
Query: 393 AAA 395
            A+
Sbjct: 305 TAS 307

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 114/303 (37%), Positives = 153/303 (50%), Gaps = 22/303 (7%)
Query: 105 FSFSSVSTATNTFSD------TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREM 158
           FSF  +   TN F +       NK GEGGFG VYKG +     +AVK+L+   +    E+
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 159 KN----EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL--DFFLFDPTKRILLD 212
           K     E  V AK QH+NLV LLG   D D+  L+Y Y PN SL       D T    L 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP--LS 122
Query: 213 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 272
           W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR       
Sbjct: 123 WHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY 332
               SRIVGT  Y +PE AL G  + KSD++SFGV+LLEI++G      +R   L L   
Sbjct: 180 XVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 238
Query: 333 VWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE 392
                      + ID     ++  S  V   Y ++A  C+ E  + RP +  V  +L   
Sbjct: 239 EEIEDEEKTIEDYIDKKX--NDADSTSVEAXY-SVASQCLHEKKNKRPDIKKVQQLLQEX 295
Query: 393 AAA 395
            A+
Sbjct: 296 TAS 298

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 135/270 (50%), Gaps = 24/270 (8%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            +LG G FG V+ G      ++AVK L   +   ++    EA+++  +QH  LVRL    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 181 IDKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
             ++   +I EYM   SL DF   D   ++LL     +     IA+G+ Y+    R   I
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYI 132
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL+A+N+L+ + +  KI+DFG+AR+   NE  A          + +PE    G F+IK
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIK 191
Query: 300 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQ 359
           SDV+SFG+LL EIV+  K     RT++  +      L    R   + + P   DE     
Sbjct: 192 SDVWSFGILLYEIVTYGKIPYPGRTNADVMTA----LSQGYRMPRVENCP---DE----- 239
Query: 360 VLLRYVNIALLCVQESADDRPTMNDVVSML 389
                 +I  +C +E A++RPT + + S+L
Sbjct: 240 ----LYDIMKMCWKEKAEERPTFDYLQSVL 265

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 76/211 (36%), Positives = 115/211 (54%), Gaps = 31/211 (14%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSE----QGLREMKNEASVIAKVQHKNLVRLLG 178
           +G GGFG VY+     GDE+AVK      +    Q +  ++ EA + A ++H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYLHQYS 234
            C+ +    L+ E+     L+  L    KRI    L++W  +      IA+G+ YLH  +
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQ------IARGMNYLHDEA 125
Query: 235 RVRIIHRDLKASNILL-----DKDMNP---KISDFGMARICGGNELQANTS-RIVGTYGY 285
            V IIHRDLK+SNIL+     + D++    KI+DFG+AR     E    T     G Y +
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAW 180
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           M+PE     +FS  SDV+S+GVLL E+++G+
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 88/273 (32%), Positives = 136/273 (49%), Gaps = 32/273 (11%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG G FG V+ G      ++AVK L   +   ++    EA+++  +QH  LVRL     
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   +I E+M   SL DF   D   ++LL     +     IA+G+ Y+    R   IH
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+N+L+ + +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIKS 191
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLL--GYVWDLWTSNRTLELIDDPVLEDEYS 356
           +V+SFG+LL EIV+  K    G    D ++ L  GY        R   + + P   DE  
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGY--------RMPRMENCP---DE-- 238
Query: 357 SKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
                    +I  +C +E A++RPT + + S+L
Sbjct: 239 -------LYDIMKMCWKEKAEERPTFDYLQSVL 264

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVR
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 73  LY-AVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGT 186
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 237
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP 402
           + Y     L+R      LC +E  +DRPT + + S+L +   A     QP
Sbjct: 238 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L   S         EA+++ ++QH+ LVR
Sbjct: 20  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 78
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 79  LY-AVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 135
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 136 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGT 192
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 243
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP 402
           + Y     L+R      LC +E  +DRPT + + S+L +   A     QP
Sbjct: 244 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 283

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVR
Sbjct: 24  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 82
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 83  LY-AVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 139
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 140 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGT 196
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 197 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 247
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP 402
           + Y     L+R      LC +E  +DRPT + + S+L +   A     QP
Sbjct: 248 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 287

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVR
Sbjct: 22  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 80
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 81  LY-AVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 137
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 138 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGT 194
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 195 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 245
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP 402
           + Y     L+R      LC +E  +DRPT + + S+L +   A     QP
Sbjct: 246 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 285

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVR
Sbjct: 23  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 81
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 82  LY-AVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 138
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 139 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGT 195
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 196 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 246
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP 402
           + Y     L+R      LC +E  +DRPT + + S+L +   A     QP
Sbjct: 247 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLEDFFTATEGQFQP 286

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 140/279 (50%), Gaps = 29/279 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVR
Sbjct: 16  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 74
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 75  LYAV-VTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 131
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 132 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGT 188
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 189 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 239
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           + Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 240 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLED 268

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 140/279 (50%), Gaps = 29/279 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVR
Sbjct: 20  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 79  LYAV-VTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 135
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 136 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGT 192
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 243
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           + Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 244 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLED 272

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 140/279 (50%), Gaps = 29/279 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L   S         EA+++ ++QH+ LVR
Sbjct: 19  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 77
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 78  LYAV-VTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 134
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 135 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGT 191
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 192 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 242
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           + Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 243 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLED 271

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 140/279 (50%), Gaps = 29/279 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVR
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 73  LYAV-VTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGT 186
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 237
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           + Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 238 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLED 266

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 140/279 (50%), Gaps = 29/279 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVR
Sbjct: 9   TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 67
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 68  LYAV-VTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 124
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 125 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGT 181
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 182 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 232
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           + Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 233 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLED 261

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 140/279 (50%), Gaps = 29/279 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVR
Sbjct: 15  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 73
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 74  LYAV-VTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 130
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 131 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGT 187
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 238
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           + Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 239 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLED 267

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 140/279 (50%), Gaps = 29/279 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVR
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 73  LYAV-VTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGT 186
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 237
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           + Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 238 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLED 266

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 91/326 (27%), Positives = 159/326 (48%), Gaps = 39/326 (11%)
Query: 75  LKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKG 134
           L   N +++LP     ++    ++  Q  +  F+    ATN   D   +G G FG V  G
Sbjct: 7   LHFGNGHLKLPGLRTFVDPHTFEDPTQT-VHEFAKELDATNISID-KVVGAGEFGEVCSG 64
Query: 135 VLR----KGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 189
            L+    K   +A+K L  G +E+  R+   EAS++ +  H N++RL G        +++
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 249
            EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S +  +HRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL 179
Query: 250 LDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIFSIKSDVFSFGVL 308
           ++ ++  K+SDFG+AR+   +   A T+R       + SPE      F+  SDV+S+G++
Sbjct: 180 INSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 309 LLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-----PVLEDEYSSKQVLLR 363
           L E++S  +                W++ ++   ++ +D+     P ++   +  Q++L 
Sbjct: 240 LWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD 285
Query: 364 YVNIALLCVQESADDRPTMNDVVSML 389
                  C Q+  ++RP    +VS+L
Sbjct: 286 -------CWQKDRNNRPKFEQIVSIL 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 90/326 (27%), Positives = 159/326 (48%), Gaps = 39/326 (11%)
Query: 75  LKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKG 134
           L   N +++LP     ++    ++  Q  +  F+    ATN   D   +G G FG V  G
Sbjct: 7   LHFGNGHLKLPGLRTFVDPHTYEDPTQT-VHEFAKELDATNISID-KVVGAGEFGEVCSG 64
Query: 135 VLR----KGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 189
            L+    K   +A+K L  G +E+  R+   EAS++ +  H N++RL G        +++
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 249
            EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S +  +HRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL 179
Query: 250 LDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIFSIKSDVFSFGVL 308
           ++ ++  K+SDFG++R+   +   A T+R       + SPE      F+  SDV+S+G++
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 309 LLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-----PVLEDEYSSKQVLLR 363
           L E++S  +                W++ ++   ++ +D+     P ++   +  Q++L 
Sbjct: 240 LWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD 285
Query: 364 YVNIALLCVQESADDRPTMNDVVSML 389
                  C Q+  ++RP    +VS+L
Sbjct: 286 -------CWQKDRNNRPKFEQIVSIL 304

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 303
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 412
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 413 --------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/326 (27%), Positives = 159/326 (48%), Gaps = 39/326 (11%)
Query: 75  LKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKG 134
           L   N +++LP     ++    ++  Q  +  F+    ATN   D   +G G FG V  G
Sbjct: 7   LHFGNGHLKLPGLRTFVDPHTFEDPTQT-VHEFAKELDATNISID-KVVGAGEFGEVCSG 64
Query: 135 VLR----KGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 189
            L+    K   +A+K L  G +E+  R+   EAS++ +  H N++RL G        +++
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 249
            EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S +  +HRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGFVHRDLAARNIL 179
Query: 250 LDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIFSIKSDVFSFGVL 308
           ++ ++  K+SDFG++R+   +   A T+R       + SPE      F+  SDV+S+G++
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 309 LLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-----PVLEDEYSSKQVLLR 363
           L E++S  +                W++ ++   ++ +D+     P ++   +  Q++L 
Sbjct: 240 LWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD 285
Query: 364 YVNIALLCVQESADDRPTMNDVVSML 389
                  C Q+  ++RP    +VS+L
Sbjct: 286 -------CWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/326 (27%), Positives = 159/326 (48%), Gaps = 39/326 (11%)
Query: 75  LKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKG 134
           L   N +++LP     ++    ++  Q  +  F+    ATN   D   +G G FG V  G
Sbjct: 5   LHFGNGHLKLPGLRTYVDPHTYEDPTQT-VHEFAKELDATNISID-KVVGAGEFGEVCSG 62
Query: 135 VLR----KGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 189
            L+    K   +A+K L  G +E+  R+   EAS++ +  H N++RL G        +++
Sbjct: 63  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 122
Query: 190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 249
            EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S +  +HRDL A NIL
Sbjct: 123 TEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL 177
Query: 250 LDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIFSIKSDVFSFGVL 308
           ++ ++  K+SDFG++R+   +   A T+R       + SPE      F+  SDV+S+G++
Sbjct: 178 INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 237
Query: 309 LLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-----PVLEDEYSSKQVLLR 363
           L E++S  +                W++ ++   ++ +D+     P ++   +  Q++L 
Sbjct: 238 LWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD 283
Query: 364 YVNIALLCVQESADDRPTMNDVVSML 389
                  C Q+  ++RP    +VS+L
Sbjct: 284 -------CWQKDRNNRPKFEQIVSIL 302

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 303
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 412
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 413 --------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/326 (27%), Positives = 159/326 (48%), Gaps = 39/326 (11%)
Query: 75  LKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKG 134
           L   N +++LP     ++    ++  Q  +  F+    ATN   D   +G G FG V  G
Sbjct: 7   LHFGNGHLKLPGLRTYVDPHTYEDPTQT-VHEFAKELDATNISID-KVVGAGEFGEVCSG 64
Query: 135 VLR----KGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 189
            L+    K   +A+K L  G +E+  R+   EAS++ +  H N++RL G        +++
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 249
            EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S +  +HRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL 179
Query: 250 LDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIFSIKSDVFSFGVL 308
           ++ ++  K+SDFG++R+   +   A T+R       + SPE      F+  SDV+S+G++
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 309 LLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-----PVLEDEYSSKQVLLR 363
           L E++S  +                W++ ++   ++ +D+     P ++   +  Q++L 
Sbjct: 240 LWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD 285
Query: 364 YVNIALLCVQESADDRPTMNDVVSML 389
                  C Q+  ++RP    +VS+L
Sbjct: 286 -------CWQKDRNNRPKFEQIVSIL 304

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY-AVV 331
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 386
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 495
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 496 --------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 532

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 75
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 130
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 189
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 190 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 239
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 240 --------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 276

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/326 (27%), Positives = 159/326 (48%), Gaps = 39/326 (11%)
Query: 75  LKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKG 134
           L   N +++LP     ++    ++  Q  +  F+    ATN   D   +G G FG V  G
Sbjct: 7   LHFGNGHLKLPGLRTFVDPHTFEDPTQT-VHEFAKELDATNISID-KVVGAGEFGEVCSG 64
Query: 135 VLR----KGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 189
            L+    K   +A+K L  G +E+  R+   EAS++ +  H N++RL G        +++
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 249
            EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S +  +HRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL 179
Query: 250 LDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIFSIKSDVFSFGVL 308
           ++ ++  K+SDFG++R+   +   A T+R       + SPE      F+  SDV+S+G++
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 309 LLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-----PVLEDEYSSKQVLLR 363
           L E++S  +                W++ ++   ++ +D+     P ++   +  Q++L 
Sbjct: 240 LWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD 285
Query: 364 YVNIALLCVQESADDRPTMNDVVSML 389
                  C Q+  ++RP    +VS+L
Sbjct: 286 -------CWQKDRNNRPKFEQIVSIL 304

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 303
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 412
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 413 --------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 135/286 (47%), Gaps = 31/286 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           +LG G FG V+ G      ++A+K L   +         EA ++ K++H  LV+L    +
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLY-AVV 73
Query: 182 DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 241
            ++   ++ EYM   SL  FL D   R L      V +   +A G+ Y+    R+  IHR
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 242 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 301
           DL+++NIL+   +  KI+DFG+AR+   NE  A          + +PE AL G F+IKSD
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSD 188
Query: 302 VFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD----PVLEDEYSS 357
           V+SFG+LL E+V+     G      +N          +   LE ++     P  +D   S
Sbjct: 189 VWSFGILLTELVT----KGRVPYPGMN----------NREVLEQVERGYRMPCPQDCPIS 234
Query: 358 KQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
              L+      + C ++  ++RPT   + S L +   A  P  QP 
Sbjct: 235 LHELM------IHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPG 274

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 147/297 (49%), Gaps = 38/297 (12%)
Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLS-GRSEQGLREM 158
           +  F+    ATN   D   +G G FG V  G L+    K   +A+K L  G +E+  R+ 
Sbjct: 35  VHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 159 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQ 218
             EAS++ +  H N++RL G        +++ EYM N SLD FL     +  +  +  V 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVG 151
Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
           ++ GIA G+ YL   S +  +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 279 IVG-TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW 337
                  + SPE      F+  SDV+S+G++L E++S  +                W++ 
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEM- 254
Query: 338 TSNRTLELIDD-----PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           ++   ++ +D+     P ++   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 255 SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/326 (27%), Positives = 158/326 (48%), Gaps = 39/326 (11%)
Query: 75  LKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKG 134
           L   N +++LP     ++    ++  Q  +  F+    ATN   D   +G G FG V  G
Sbjct: 7   LHFGNGHLKLPGLRTFVDPHTFEDPTQT-VHEFAKELDATNISID-KVVGAGEFGEVCSG 64
Query: 135 VLR----KGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 189
            L+    K   +A+K L  G +E+  R+   EAS++ +  H N++RL G        +++
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 249
            EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S +  +HRDL A NIL
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL 179
Query: 250 LDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIFSIKSDVFSFGVL 308
           ++ ++  K+SDFG+ R+   +   A T+R       + SPE      F+  SDV+S+G++
Sbjct: 180 INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 309 LLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-----PVLEDEYSSKQVLLR 363
           L E++S  +                W++ ++   ++ +D+     P ++   +  Q++L 
Sbjct: 240 LWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD 285
Query: 364 YVNIALLCVQESADDRPTMNDVVSML 389
                  C Q+  ++RP    +VS+L
Sbjct: 286 -------CWQKDRNNRPKFEQIVSIL 304

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 72
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKS 186
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 187 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 236
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 237 --------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 273

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 147/297 (49%), Gaps = 38/297 (12%)
Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLS-GRSEQGLREM 158
           +  F+    ATN   D   +G G FG V  G L+    K   +A+K L  G +E+  R+ 
Sbjct: 23  VHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 81
Query: 159 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQ 218
             EAS++ +  H N++RL G        +++ EYM N SLD FL     +  +  +  V 
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVG 139
Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
           ++ GIA G+ YL   S +  +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R
Sbjct: 140 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 196
Query: 279 IVGT-YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW 337
                  + SPE      F+  SDV+S+G++L E++S  +                W++ 
Sbjct: 197 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEM- 242
Query: 338 TSNRTLELIDD-----PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           ++   ++ +D+     P ++   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 243 SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 292

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 147/297 (49%), Gaps = 38/297 (12%)
Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLS-GRSEQGLREM 158
           +  F+    ATN   D   +G G FG V  G L+    K   +A+K L  G +E+  R+ 
Sbjct: 6   VHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 159 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQ 218
             EAS++ +  H N++RL G        +++ EYM N SLD FL     +  +  +  V 
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVG 122
Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
           ++ GIA G+ YL   S +  +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R
Sbjct: 123 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179
Query: 279 IVGT-YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW 337
                  + SPE      F+  SDV+S+G++L E++S  +                W++ 
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEM- 225
Query: 338 TSNRTLELIDD-----PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           ++   ++ +D+     P ++   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 226 SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 275

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 140/279 (50%), Gaps = 29/279 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           T     +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVR
Sbjct: 10  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 68
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + + 
Sbjct: 69  LY-AVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 125
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
              IHR+L+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G 
Sbjct: 126 --YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGT 182
Query: 296 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLE 352
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   E
Sbjct: 183 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 233
Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           + Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 234 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLED 262

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAV-V 82
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 246
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 247 --------LMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 71
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 126
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 185
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 186 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 235
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 236 --------LMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 272

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 133/277 (48%), Gaps = 27/277 (9%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG V+ G     D++A+K  R    SE+   E   EA V+ K+ H  LV+L G
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYG 69
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
            C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL + S   +
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---V 124
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           IHRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S 
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSS 183
Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           KSDV+SFGVL+ E+ S  K     R++S      V D+ T  R             Y  +
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDISTGFRL------------YKPR 227
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 395
                   I   C +E  +DRP  + ++  L   AA+
Sbjct: 228 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAIAAS 264

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 73
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 128
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 187
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 188 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 237
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 238 --------LMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 274

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQL--VDMSAQIASGMAYVE---RMNYVH 134
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 193
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 243
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 244 --------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 246
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 247 --------LMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 136/272 (50%), Gaps = 35/272 (12%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS---GRSEQGLREMKNEASVIAKVQHKN 172
           FSD  ++G G FG VY    +R  + +A+K++S    +S +  +++  E   + K++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
            ++  GC + +    L+ EY    + D  L +  K+ L + V    +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 133
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
           ++   +IHRD+KA NILL +    K+ DFG A I       A  +  VGT  +M+PE  L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVIL 184
Query: 293 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
              EG +  K DV+S G+  +E+   ++   L+  ++++ L ++      N +      P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES------P 232
Query: 350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPT 381
            L+  + S+     + N    C+Q+   DRPT
Sbjct: 233 ALQSGHWSEY----FRNFVDSCLQKIPQDRPT 260

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQL--VDMSAQIASGMAYVE---RMNYVH 134
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAALYGRFTIKS 193
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 243
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 244 --------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 246
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 247 --------LMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 246
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 247 --------LMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 246
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 247 --------LMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 140/278 (50%), Gaps = 36/278 (12%)
Query: 123 LGEGGFGPVYKGVLR-----KGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           +G G FG VYKG+L+     K   +A+K L +G +E+   +   EA ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
            G        ++I EYM N +LD FL +      +  +  V ++ GIA G+ YL   + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSV--LQLVGMLRGIAAGMKYL---ANM 166
Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYMSPEYALEGI 295
             +HRDL A NIL++ ++  K+SDFG++R+   + E    TS       + +PE      
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 296 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD----PVL 351
           F+  SDV+SFG+++ E+++  +                W+L +++  ++ I+D    P  
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERP-------------YWEL-SNHEVMKAINDGFRLPTP 272
Query: 352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
            D  S+   L+      + C Q+    RP   D+VS+L
Sbjct: 273 MDCPSAIYQLM------MQCWQQERARRPKFADIVSIL 304

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 136/272 (50%), Gaps = 35/272 (12%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS---GRSEQGLREMKNEASVIAKVQHKN 172
           FSD  ++G G FG VY    +R  + +A+K++S    +S +  +++  E   + K++H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
            ++  GC + +    L+ EY    + D  L +  K+ L + V    +  G  QGL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 172
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
           ++   +IHRD+KA NILL +    K+ DFG A I       A  +  VGT  +M+PE  L
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 223
Query: 293 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
              EG +  K DV+S G+  +E+   ++   L+  ++++ L ++      N +      P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES------P 271
Query: 350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPT 381
            L+  + S+     + N    C+Q+   DRPT
Sbjct: 272 ALQSGHWSEY----FRNFVDSCLQKIPQDRPT 299

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 6/201 (2%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLR--EMKNEASVIAKVQHKNLVRLLGC 179
           K+G G FG V++     G ++AVK L  +     R  E   E +++ +++H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
                   ++ EY+   SL   L     R  LD   R+ +   +A+G+ YLH  +   I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP-IV 161
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDLK+ N+L+DK    K+ DFG++R+     L +  +   GT  +M+PE   +   + K
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA--AGTPEWMAPEVLRDEPSNEK 219
Query: 300 SDVFSFGVLLLEIVSGKKNTG 320
           SDV+SFGV+L E+ + ++  G
Sbjct: 220 SDVYSFGVILWELATLQQPWG 240

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 135/285 (47%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L             EA V+ K++H+ LV+L    +
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 249
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 304
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+ R+   NE  A          + +PE AL G F+IKS
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 363
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 364 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 413
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 414 --------LMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQXQPG 450

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    ++ EYMP  +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRE-CNREEVTAVVLLYMATQISSAMEYL---EKKNFI 152
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNTFSIK 211
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 212 SDVWAFGVLLWEIAT 226

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 6/201 (2%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLR--EMKNEASVIAKVQHKNLVRLLGC 179
           K+G G FG V++     G ++AVK L  +     R  E   E +++ +++H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
                   ++ EY+   SL   L     R  LD   R+ +   +A+G+ YLH  +   I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIV 161
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HR+LK+ N+L+DK    K+ DFG++R+     L + ++   GT  +M+PE   +   + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNEK 219
Query: 300 SDVFSFGVLLLEIVSGKKNTG 320
           SDV+SFGV+L E+ + ++  G
Sbjct: 220 SDVYSFGVILWELATLQQPWG 240

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 246
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 247 --------LMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 136/285 (47%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM    L DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 246
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 247 --------LMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 136/285 (47%), Gaps = 29/285 (10%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 182 DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   ++ EYM    L DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 301 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           DV+SFG+LL E+ +  +    G+   + L+ +   + +       E + D          
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 246
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
                   +   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 247 --------LMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 138/278 (49%), Gaps = 37/278 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V  G L+   +    +A+K L +G +++  R+  +EAS++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        ++I EYM N SLD FL     R  +  +  V ++ GI  G+ YL   S V 
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSAV- 153
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 296
             HRDL A NIL++ ++  K+SDFGM+R+   +   A T+R       + +PE      F
Sbjct: 154 --HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 297 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-----PVL 351
           +  SDV+S+G+++ E++S  +                WD+ ++   ++ I++     P +
Sbjct: 212 TSASDVWSYGIVMWEVMSYGERP-------------YWDM-SNQDVIKAIEEGYRLPPPM 257
Query: 352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           +   +  Q++L        C Q+   DRP    +V+ML
Sbjct: 258 DCPIALHQLMLD-------CWQKERSDRPKFGQIVNML 288

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 141/291 (48%), Gaps = 29/291 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
            T     +LG G  G V+ G      ++AVK L  +          EA+++ ++QH+ LV
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           RL    + ++   +I EYM N SL  FL  P+  I L     + +   IA+G+ ++ + +
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 294
               IHRDL+A+NIL+   ++ KI+DFG+AR+    E  A          + +PE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPI-KWTAPEAINYG 185
Query: 295 IFSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVL 351
            F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++  D   
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCP 236
Query: 352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP 402
           E+ Y     L+R      LC +E  +DRPT + + S+L +   A     QP
Sbjct: 237 EELYQ----LMR------LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 89/326 (27%), Positives = 158/326 (48%), Gaps = 39/326 (11%)
Query: 75  LKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKG 134
           L   N +++LP     ++    ++  Q  +  F+    ATN   D   +G G FG V  G
Sbjct: 7   LHFGNGHLKLPGLRTFVDPHTFEDPTQT-VHEFAKELDATNISID-KVVGAGEFGEVCSG 64
Query: 135 VLR----KGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 189
            L+    K   +A+K L  G +E+  R+   EAS++ +  H N++RL G        +++
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 249
            E M N SLD FL     +  +  +  V ++ GIA G+ YL   S +  +HRDL A NIL
Sbjct: 125 TEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGAVHRDLAARNIL 179
Query: 250 LDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIFSIKSDVFSFGVL 308
           ++ ++  K+SDFG++R+   +   A T+R       + SPE      F+  SDV+S+G++
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 309 LLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-----PVLEDEYSSKQVLLR 363
           L E++S  +                W++ ++   ++ +D+     P ++   +  Q++L 
Sbjct: 240 LWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD 285
Query: 364 YVNIALLCVQESADDRPTMNDVVSML 389
                  C Q+  ++RP    +VS+L
Sbjct: 286 -------CWQKDRNNRPKFEQIVSIL 304

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 89/326 (27%), Positives = 158/326 (48%), Gaps = 39/326 (11%)
Query: 75  LKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKG 134
           L   N +++LP     ++    ++  Q  +  F+    ATN   D   +G G FG V  G
Sbjct: 7   LHFGNGHLKLPGLRTYVDPHTYEDPTQT-VHEFAKELDATNISID-KVVGAGEFGEVCSG 64
Query: 135 VLR----KGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 189
            L+    K   +A+K L  G +E+  R+   EAS++ +  H N++RL G        +++
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 249
            E M N SLD FL     +  +  +  V ++ GIA G+ YL   S +  +HRDL A NIL
Sbjct: 125 TEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL 179
Query: 250 LDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIFSIKSDVFSFGVL 308
           ++ ++  K+SDFG++R+   +   A T+R       + SPE      F+  SDV+S+G++
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 309 LLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-----PVLEDEYSSKQVLLR 363
           L E++S  +                W++ ++   ++ +D+     P ++   +  Q++L 
Sbjct: 240 LWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD 285
Query: 364 YVNIALLCVQESADDRPTMNDVVSML 389
                  C Q+  ++RP    +VS+L
Sbjct: 286 -------CWQKDRNNRPKFEQIVSIL 304

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 138/278 (49%), Gaps = 37/278 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V  G L+   +    +A+K L +G +++  R+  +EAS++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        ++I EYM N SLD FL     R  +  +  V ++ GI  G+ YL   S V 
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSYV- 138
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 296
             HRDL A NIL++ ++  K+SDFGM+R+   +   A T+R       + +PE      F
Sbjct: 139 --HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 297 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-----PVL 351
           +  SDV+S+G+++ E++S  +                WD+ ++   ++ I++     P +
Sbjct: 197 TSASDVWSYGIVMWEVMSYGERP-------------YWDM-SNQDVIKAIEEGYRLPPPM 242
Query: 352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           +   +  Q++L        C Q+   DRP    +V+ML
Sbjct: 243 DCPIALHQLMLD-------CWQKERSDRPKFGQIVNML 273

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 138/278 (49%), Gaps = 37/278 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V  G L+   +    +A+K L +G +++  R+  +EAS++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        ++I EYM N SLD FL     R  +  +  V ++ GI  G+ YL   S V 
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSYV- 132
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 296
             HRDL A NIL++ ++  K+SDFGM+R+   +   A T+R       + +PE      F
Sbjct: 133 --HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 297 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-----PVL 351
           +  SDV+S+G+++ E++S  +                WD+ ++   ++ I++     P +
Sbjct: 191 TSASDVWSYGIVMWEVMSYGERP-------------YWDM-SNQDVIKAIEEGYRLPPPM 236
Query: 352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           +   +  Q++L        C Q+   DRP    +V+ML
Sbjct: 237 DCPIALHQLMLD-------CWQKERSDRPKFGQIVNML 267

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 146/297 (49%), Gaps = 38/297 (12%)
Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLS-GRSEQGLREM 158
           +  F+    ATN   D   +G G FG V  G L+    K   +A+K L  G +E+  R+ 
Sbjct: 6   VHEFAKELDATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 159 KNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQ 218
             EAS++ +  H N++RL G        +++ E M N SLD FL     +  +  +  V 
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVG 122
Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
           ++ GIA G+ YL   S +  +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R
Sbjct: 123 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179
Query: 279 IVGT-YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW 337
                  + SPE      F+  SDV+S+G++L E++S  +                W++ 
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEM- 225
Query: 338 TSNRTLELIDD-----PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           ++   ++ +D+     P ++   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 226 SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 275

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            KLG G FG V+     K  ++AVK +   S   +     EA+V+  +QH  LV+L    
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAV 78
Query: 181 IDKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           + K+   +I E+M   SL DF   D   +  L     +     IA+G+ ++ Q +    I
Sbjct: 79  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YI 133
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL+A+NIL+   +  KI+DFG+AR+   NE  A          + +PE    G F+IK
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIK 192
Query: 300 SDVFSFGVLLLEIVS 314
           SDV+SFG+LL+EIV+
Sbjct: 193 SDVWSFGILLMEIVT 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 120 TNKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
             ++G G FG V+ G     D++A+K  R    SE+   E   EA V+ K+ H  LV+L 
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLY 66
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL +     
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +IHRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYS 180
Query: 298 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSS 357
            KSDV+SFGVL+ E+ S  K     R++S      V D+ T  R             Y  
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDISTGFRL------------YKP 224
Query: 358 KQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 395
           +        I   C +E  +DRP  + ++  L   A +
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 120 TNKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
             ++G G FG V+ G     D++A+K  R    SE+   E   EA V+ K+ H  LV+L 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLY 68
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL +     
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 123
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +IHRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYS 182
Query: 298 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSS 357
            KSDV+SFGVL+ E+ S  K     R++S      V D+ T  R             Y  
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDISTGFRL------------YKP 226
Query: 358 KQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 395
           +        I   C +E  +DRP  + ++  L   A +
Sbjct: 227 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 264

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 137
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 196
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 197 SDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 122 KLGEGGFGPVY----KGVLRKGDE--IAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +LGEG FG V+      +L + D+  +AVK L   SE   ++ + EA ++  +QH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRIL----------LDWVTRVQIIEGI 223
             G C +    ++++EYM +  L+ FL    P  ++L          L     + +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 283
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +   
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL 343
            +M PE  L   F+ +SDV+SFGV+L EI +  K      +++  +     D  T  R L
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-----DCITQGREL 256
Query: 344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP 399
           E             +        I   C Q     R ++ DV + L  +A A  PP
Sbjct: 257 E-----------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL--QALAQAPP 299

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 122 KLGEGGFGPVY----KGVLRKGDE--IAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +LGEG FG V+      +L + D+  +AVK L   SE   ++ + EA ++  +QH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRIL----------LDWVTRVQIIEGI 223
             G C +    ++++EYM +  L+ FL    P  ++L          L     + +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 283
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +   
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL 343
            +M PE  L   F+ +SDV+SFGV+L EI +  K      +++  +     D  T  R L
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-----DCITQGREL 250
Query: 344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP 399
           E             +        I   C Q     R ++ DV + L  +A A  PP
Sbjct: 251 E-----------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL--QALAQAPP 293

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            KLG G FG V+     K  ++AVK +   S   +     EA+V+  +QH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAV 251
Query: 181 IDKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           + K+   +I E+M   SL DF   D   +  L     +     IA+G+ ++ Q +    I
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YI 306
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL+A+NIL+   +  KI+DFG+AR+   NE  A          + +PE    G F+IK
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIK 365
Query: 300 SDVFSFGVLLLEIVS 314
           SDV+SFG+LL+EIV+
Sbjct: 366 SDVWSFGILLMEIVT 380

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 120 TNKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
             ++G G FG V+ G     D++A+K  R    SE+   E   EA V+ K+ H  LV+L 
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLY 71
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL +     
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 126
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +IHRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYS 185
Query: 298 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSS 357
            KSDV+SFGVL+ E+ S  K     R++S      V D+ T  R             Y  
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDISTGFRL------------YKP 229
Query: 358 KQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 395
           +        I   C +E  +DRP  + ++  L   A +
Sbjct: 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G FG VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 131
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 135
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 194
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 122 KLGEGGFGPVY----KGVLRKGDEI--AVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +LGEG FG V+      +  + D+I  AVK L   S+   ++   EA ++  +QH+++V+
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRIL--------LDWVTRVQIIEGIAQ 225
             G C++ D  I+++EYM +  L+ FL    P   ++        L     + I + IA 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           G++YL   +    +HRDL   N L+ +++  KI DFGM+R     +        +    +
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL 345
           M PE  +   F+ +SDV+S GV+L EI +  K                W   ++N  +E 
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------------WYQLSNNEVIEC 242
Query: 346 IDDP-VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 395
           I    VL+   +  Q +     + L C Q     R  +  + ++L N A A
Sbjct: 243 ITQGRVLQRPRTCPQEVY---ELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 134
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 193
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 135
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 194
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 146
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 205
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 206 SDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 122 KLGEGGFGPVY----KGVLRKGDE--IAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +LGEG FG V+      +L + D+  +AVK L   SE   ++ + EA ++  +QH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRIL----------LDWVTRVQIIEGI 223
             G C +    ++++EYM +  L+ FL    P  ++L          L     + +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 283
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL 343
            +M PE  L   F+ +SDV+SFGV+L EI +  K    Y+  +   +    D  T  R L
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-WYQLSNTEAI----DCITQGREL 279
Query: 344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP 399
           E             +        I   C Q     R ++ DV + L  +A A  PP
Sbjct: 280 E-----------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL--QALAQAPP 322

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 131
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 119/220 (54%), Gaps = 22/220 (10%)
Query: 123 LGEGGFGPVYKGVLRKGDE-----IAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRL 176
           LG G FG VYKG+     E     +A+K L+  +  +   E  +EA ++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYLHQ 232
           LG C+    + L+ + MP+  L  ++ +    I    LL+W  +      IA+G++YL +
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
               R++HRDL A N+L+    + KI+DFG+AR+  G+E + N         +M+ E   
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 293 EGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL 330
              F+ +SDV+S+GV + E+++  GK   G+   +  +LL
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 13/201 (6%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG  +   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 14  QRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   I
Sbjct: 72  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGI 295
           IHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      +  
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +S +SDV++FG++L E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 13/201 (6%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG  +   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 16  QRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   I
Sbjct: 74  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 127
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGI 295
           IHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      +  
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +S +SDV++FG++L E+++G+
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQ 208

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 119/220 (54%), Gaps = 22/220 (10%)
Query: 123 LGEGGFGPVYKGVLRKGDE-----IAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRL 176
           LG G FG VYKG+     E     +A+K L+  +  +   E  +EA ++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYLHQ 232
           LG C+    + L+ + MP+  L  ++ +    I    LL+W  +      IA+G++YL +
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
               R++HRDL A N+L+    + KI+DFG+AR+  G+E + N         +M+ E   
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 293 EGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL 330
              F+ +SDV+S+GV + E+++  GK   G+   +  +LL
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 13/201 (6%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG    GD +AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   I
Sbjct: 77  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGI 295
           IHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      +  
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +S +SDV++FG++L E+++G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 13/201 (6%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG    GD +AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   I
Sbjct: 77  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGI 295
           IHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      +  
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +S +SDV++FG++L E+++G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 21/205 (10%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG    GD +AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 34  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   I
Sbjct: 92  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL-- 292
           IHRDLK++NI L +D+  KI DFG+A    R  G ++ +    ++ G+  +M+PE     
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQ 201
Query: 293 -EGIFSIKSDVFSFGVLLLEIVSGK 316
            +  +S +SDV++FG++L E+++G+
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 131
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 21/205 (10%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG    GD +AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   I
Sbjct: 72  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL-- 292
           IHRDLK++NI L +D+  KI DFG+A    R  G ++ +    ++ G+  +M+PE     
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQ 181
Query: 293 -EGIFSIKSDVFSFGVLLLEIVSGK 316
            +  +S +SDV++FG++L E+++G+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 13/201 (6%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG    GD +AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 41  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   I
Sbjct: 99  YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGI 295
           IHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      +  
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +S +SDV++FG++L E+++G+
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQ 233

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 111/203 (54%), Gaps = 19/203 (9%)
Query: 123 LGEGGFGPVYKGVLR----KGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V +G L+    K   +A+K L  G +E+  RE  +EAS++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII---EGIAQGLLYLHQYS 234
           G   +    +++ E+M N +LD FL     R+     T +Q++    GIA G+ YL + S
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASGMRYLAEMS 138
Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG---TYGYMSPEYA 291
            V   HRDL A NIL++ ++  K+SDFG++R    N      +  +G      + +PE  
Sbjct: 139 YV---HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS 314
               F+  SD +S+G+++ E++S
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 13/201 (6%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG    GD +AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   I
Sbjct: 100 YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGI 295
           IHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      +  
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +S +SDV++FG++L E+++G+
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ 234

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 134
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A          + +PE      FSIK
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYNKFSIK 193
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 110/200 (55%), Gaps = 13/200 (6%)
Query: 123 LGEGGFGPVYKGVLR----KGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V +G L+    K   +A+K L  G +E+  RE  +EAS++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G   +    +++ E+M N +LD FL     +  +  +  V ++ GIA G+ YL + S V 
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYLAEMSYV- 138
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG---TYGYMSPEYALEG 294
             HRDL A NIL++ ++  K+SDFG++R    N      +  +G      + +PE     
Sbjct: 139 --HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 295 IFSIKSDVFSFGVLLLEIVS 314
            F+  SD +S+G+++ E++S
Sbjct: 197 KFTSASDAWSYGIVMWEVMS 216

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 135
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ ++   K++DFG++R+  G+   A          + +PE      FSIK
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYNKFSIK 194
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 21/205 (10%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG    GD +AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               K +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   I
Sbjct: 100 YST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL-- 292
           IHRDLK++NI L +D+  KI DFG+A    R  G ++ +    ++ G+  +M+PE     
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQ 209
Query: 293 -EGIFSIKSDVFSFGVLLLEIVSGK 316
            +  +S +SDV++FG++L E+++G+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 130/277 (46%), Gaps = 27/277 (9%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG V+ G     D++A+K  R    SE+   E   EA V+ K+ H  LV+L G
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYG 70
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
            C+++    L+ E+M +  L  +L   T+R L    T + +   + +G+ YL +     +
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           IHRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S 
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSS 184
Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSK 358
           KSDV+SFGVL+ E+ S  K     R++S      V D+ T  R             Y  +
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDISTGFRL------------YKPR 228
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 395
                   I   C +E  +DRP  + ++  L   A +
Sbjct: 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 120 TNKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
             ++G G FG V+ G     D++A+K +     SE    E   EA V+ K+ H  LV+L 
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIE---EAEVMMKLSHPKLVQLY 88
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL +     
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 143
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +IHRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYS 202
Query: 298 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSS 357
            KSDV+SFGVL+ E+ S  K     R++S      V D+ T  R             Y  
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDISTGFRL------------YKP 246
Query: 358 KQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA 395
           +        I   C +E  +DRP  + ++  L   A +
Sbjct: 247 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 284

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 115/219 (52%), Gaps = 33/219 (15%)
Query: 121 NKLGEGGFGPVYKGVL------RKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNL 173
            +LGE  FG VYKG L       +   +A+K L  ++E  LRE  ++EA + A++QH N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 174 VRLLGCCIDKDEKI-LIYEYMPNKSLDFFLF-------------DPTKRILLDWVTRVQI 219
           V LLG  + KD+ + +I+ Y  +  L  FL              D T +  L+    V +
Sbjct: 92  VCLLGV-VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           +  IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R        A+  ++
Sbjct: 151 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 203
Query: 280 VGT----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +G       +M+PE  + G FSI SD++S+GV+L E+ S
Sbjct: 204 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 115/219 (52%), Gaps = 33/219 (15%)
Query: 121 NKLGEGGFGPVYKGVL------RKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNL 173
            +LGE  FG VYKG L       +   +A+K L  ++E  LRE  ++EA + A++QH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 174 VRLLGCCIDKDEKI-LIYEYMPNKSLDFFLF-------------DPTKRILLDWVTRVQI 219
           V LLG  + KD+ + +I+ Y  +  L  FL              D T +  L+    V +
Sbjct: 75  VCLLGV-VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           +  IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R        A+  ++
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 186
Query: 280 VGT----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +G       +M+PE  + G FSI SD++S+GV+L E+ S
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 135
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 191
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 192 ESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 134
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 190
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI--DHIKLLQYTSQICKGMEYL--- 133
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 189
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 161
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 217
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 136
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 192
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 193 ESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 133
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 189
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 129
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 185
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 186 ESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 128
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 184
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 185 ESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 109/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 379
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HR+L A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 438
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 439 SDVWAFGVLLWEIAT 453

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 130
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 186
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 137/274 (50%), Gaps = 29/274 (10%)
Query: 123 LGEGGFGPVYKGVLR----KGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V  G L+    +   +A+K L  G +E+  R+   EAS++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        +++ EYM N SLD FL     +  +  +  V ++ GI+ G+ YL   S + 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--IQLVGMLRGISAGMKYL---SDMG 144
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 296
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + +PE      F
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKF 204
Query: 297 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV-LEDEY 355
           +  SDV+S+G+++ E+VS  +                W++ T+   ++ +++   L    
Sbjct: 205 TSASDVWSYGIVMWEVVSYGERP-------------YWEM-TNQDVIKAVEEGYRLPSPM 250
Query: 356 SSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
                L +   + L C Q+  + RP  +++V+ML
Sbjct: 251 DCPAALYQ---LMLDCWQKERNSRPKFDEIVNML 281

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 130
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 186
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 137
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 193
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 194 ESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 148
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 204
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG  +   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 14  QRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
                   I + ++    SL   L     +   + +  + I    AQG+ YLH  S   I
Sbjct: 72  YSTAPQLAI-VTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGI 295
           IHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      +  
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +S +SDV++FG++L E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +KLG G +G VY+GV +K    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HR+L A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 399
Query: 300 SDVFSFGVLLLEIVS 314
           SDV++FGVLL EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 130
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++   ++      +   S I     + +P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WYAP 186
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 148
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 288
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 204
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 74  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAEG 126
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 127 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 184 ALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 122 KLGEGGFGPVYKGVL------RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +LGEG FG V+          +    +AVK L   +    ++ + EA ++  +QH+++V+
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRILLDWVTR-----------VQIIEG 222
             G C D D  I+++EYM +  L+ FL    P   IL+D   R           + I   
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R     +        +  
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN 318
             +M PE  +   F+ +SDV+SFGV+L EI +  K 
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 130
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 131 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 77  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 80  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 132
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 87  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 139
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 140 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 197 ALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 123
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 124 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKG 130
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 131 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 133
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 134 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 83  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 135
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 136 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 192
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 193 ALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 132
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 132
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 110/202 (54%), Gaps = 19/202 (9%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G  G V  G LR   +    +A+K L +G +E+  R+  +EAS++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        +++ EYM N SLD FL     +  +  +  V ++ G+  G+ YL   S + 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAL 292
            +HRDL A N+L+D ++  K+SDFG++R+   +   A T+    T G     + +PE   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPEAIA 227
Query: 293 EGIFSIKSDVFSFGVLLLEIVS 314
              FS  SDV+SFGV++ E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 132
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 136
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 102 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 154
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 155 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 212 ALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 122 KLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 177 LGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            G C     +   LI E++P  SL  +L    +RI  D +  +Q    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 134
Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 289
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 190
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVS 314
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 110/202 (54%), Gaps = 19/202 (9%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G  G V  G LR   +    +A+K L +G +E+  R+  +EAS++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        +++ EYM N SLD FL     +  +  +  V ++ G+  G+ YL   S + 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAL 292
            +HRDL A N+L+D ++  K+SDFG++R+   +   A T+    T G     + +PE   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPEAIA 227
Query: 293 EGIFSIKSDVFSFGVLLLEIVS 314
              FS  SDV+SFGV++ E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V    Y  +    G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G C     +   LI EY+P  SL  +L    +RI  D +  +Q    I +G+ YL   
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 131
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSP 288
              R IHR+L   NIL++ +   KI DFG+ ++   ++      +   S I     + +P
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----WYAP 187
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 188 ESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 111/205 (54%), Gaps = 21/205 (10%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG    GD +AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 18  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               K +  ++ ++    SL   L     +  +  +  + I    A+G+ YLH  S   I
Sbjct: 76  YST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKL--IDIARQTARGMDYLHAKS---I 129
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL-- 292
           IHRDLK++NI L +D   KI DFG+A    R  G ++ +    ++ G+  +M+PE     
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRMQ 185
Query: 293 -EGIFSIKSDVFSFGVLLLEIVSGK 316
               +S +SDV++FG++L E+++G+
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 133
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         +M
Sbjct: 134 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         +M
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         +M
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 130/275 (47%), Gaps = 29/275 (10%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V  G L+   +    +A+K L SG +E+  R+  +EAS++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        ++I E+M N SLD FL     +  +  +  V ++ GIA G+ YL   + + 
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 155
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG---TYGYMSPEYALEG 294
            +HRDL A NIL++ ++  K+SDFG++R    +      +  +G      + +PE     
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 295 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDE 354
            F+  SDV+S+G+++ E++S  +                WD+   +    +  D  L   
Sbjct: 216 KFTSASDVWSYGIVMWEVMSYGERP-------------YWDMTNQDVINAIEQDYRLPPP 262
Query: 355 YSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
                 L +   + L C Q+  + RP    +V+ L
Sbjct: 263 MDCPSALHQ---LMLDCWQKDRNHRPKFGQIVNTL 294

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         +M
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 103/195 (52%), Gaps = 19/195 (9%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            KLG G FG V+     K  ++AVK +   S   +     EA+V+  +QH  LV+L    
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAV 245
Query: 181 IDKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           + K+   +I E+M   SL DF   D   +  L     +     IA+G+ ++ Q +    I
Sbjct: 246 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YI 300
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL+A+NIL+   +  KI+DFG+AR+     ++           + +PE    G F+IK
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAINFGSFTIK 349
Query: 300 SDVFSFGVLLLEIVS 314
           SDV+SFG+LL+EIV+
Sbjct: 350 SDVWSFGILLMEIVT 364

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 111/205 (54%), Gaps = 21/205 (10%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG    GD +AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               K +  ++ ++    SL   L     +  +  +  + I    A+G+ YLH  S   I
Sbjct: 88  YST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKL--IDIARQTARGMDYLHAKS---I 141
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL-- 292
           IHRDLK++NI L +D   KI DFG+A    R  G ++ +    ++ G+  +M+PE     
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQ 197
Query: 293 -EGIFSIKSDVFSFGVLLLEIVSGK 316
               +S +SDV++FG++L E+++G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         +M
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 136
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         +M
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+ + +G+++    A+  L    S +  +E+ +EA V+A V +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 111 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 163
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 164 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 220
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 221 ALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     L  G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 136
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     L  G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 84  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 136
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEI----AVKRL-SGRSEQGLREMKNEASVIAKVQH 170
           F     L  G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQG 226
            ++ RLLG C+    + LI + MP   L  ++ +    I    LL+W  +      IA+G
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 100/348 (28%), Positives = 148/348 (42%), Gaps = 60/348 (17%)
Query: 60  RDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSD 119
           R K ++L    ++L      +       SKL  R+     D  P +SF+  +++ +   +
Sbjct: 3   RRKHQELQAMQMELQSPEYKL-------SKL--RTSTIMTDYNPNYSFAGKTSSISDLKE 53
Query: 120 TNK--------LGEGGFGPVYKGVLRKGD------EIAVKRLSGR-SEQGLREMKNEASV 164
             +        LG G FG VY+G +          ++AVK L    SEQ   +   EA +
Sbjct: 54  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 113
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRILLDWVTRVQII 220
           I+K  H+N+VR +G  +    + ++ E M    L  FL +    P++   L  +  + + 
Sbjct: 114 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 173
Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTS 277
             IA G  YL +      IHRD+ A N LL         KI DFGMAR    +  +A+  
Sbjct: 174 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYY 226
Query: 278 RIVGT----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV 333
           R  G       +M PE  +EGIF+ K+D +SFGVLL EI S               LGY+
Sbjct: 227 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYM 271
Query: 334 WDLWTSNR-TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP 380
                SN+  LE +      D    K        I   C Q   +DRP
Sbjct: 272 PYPSKSNQEVLEFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRP 317

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 93/315 (29%), Positives = 137/315 (43%), Gaps = 51/315 (16%)
Query: 93  RSKKKEVDQLPLFSFSSVSTATNTFSDTNK--------LGEGGFGPVYKGVLRKGD---- 140
           R+     D  P +SF+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 60
Query: 141 --EIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 197
             ++AVK L    SEQ   +   EA +I+K+ H+N+VR +G  +    + ++ E M    
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 198 LDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 250
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 177
Query: 251 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 306
                 KI DFGMAR    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 178 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 307 VLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TLELIDDPVLEDEYSSKQVLLRYV 365
           VLL EI S               LGY+     SN+  LE +      D    K       
Sbjct: 234 VLLWEIFS---------------LGYMPYPSKSNQEVLEFVTSGGRMD--PPKNCPGPVY 276
Query: 366 NIALLCVQESADDRP 380
            I   C Q   +DRP
Sbjct: 277 RIMTQCWQHQPEDRP 291

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 135/291 (46%), Gaps = 36/291 (12%)
Query: 122 KLGEGGFGPVYKGVLR---KGD---EIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLV 174
           +LG+G FG VY+G  R   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTK-----RILLDWVTRVQIIEGIAQGL 227
           RLLG        +++ E M +  L  +L    P       R        +Q+   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YL+     + +HRDL A N ++  D   KI DFGM R     +      + +    +M+
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           PE   +G+F+  SD++SFGV+L EI S              L    +   ++ + L+ + 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS--------------LAEQPYQGLSNEQVLKFVM 246
Query: 348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP 398
           D    D+        R  ++  +C Q + + RPT  ++V++L ++   LHP
Sbjct: 247 DGGYLDQ--PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD---LHP 292

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 110/205 (53%), Gaps = 21/205 (10%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG    GD +AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
                 +  ++ ++    SL   L     +  +  +  + I    A+G+ YLH  S   I
Sbjct: 88  YST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKL--IDIARQTARGMDYLHAKS---I 141
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL-- 292
           IHRDLK++NI L +D   KI DFG+A    R  G ++ +    ++ G+  +M+PE     
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQ 197
Query: 293 -EGIFSIKSDVFSFGVLLLEIVSGK 316
               +S +SDV++FG++L E+++G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 93/315 (29%), Positives = 136/315 (43%), Gaps = 51/315 (16%)
Query: 93  RSKKKEVDQLPLFSFSSVSTATNTFSDTNK--------LGEGGFGPVYKGVLRKGD---- 140
           R+     D  P +SF+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 7   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 66
Query: 141 --EIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 197
             ++AVK L    SEQ   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 67  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 126
Query: 198 LDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 250
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 127 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 183
Query: 251 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 306
                 KI DFGMAR    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 184 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 239
Query: 307 VLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TLELIDDPVLEDEYSSKQVLLRYV 365
           VLL EI S               LGY+     SN+  LE +      D    K       
Sbjct: 240 VLLWEIFS---------------LGYMPYPSKSNQEVLEFVTSGGRMD--PPKNCPGPVY 282
Query: 366 NIALLCVQESADDRP 380
            I   C Q   +DRP
Sbjct: 283 RIMTQCWQHQPEDRP 297

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 93/315 (29%), Positives = 136/315 (43%), Gaps = 51/315 (16%)
Query: 93  RSKKKEVDQLPLFSFSSVSTATNTFSDTNK--------LGEGGFGPVYKGVLRKGD---- 140
           R+     D  P +SF+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 60
Query: 141 --EIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 197
             ++AVK L    SEQ   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 198 LDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 250
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 177
Query: 251 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 306
                 KI DFGMAR    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 178 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 307 VLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TLELIDDPVLEDEYSSKQVLLRYV 365
           VLL EI S               LGY+     SN+  LE +      D    K       
Sbjct: 234 VLLWEIFS---------------LGYMPYPSKSNQEVLEFVTSGGRMD--PPKNCPGPVY 276
Query: 366 NIALLCVQESADDRP 380
            I   C Q   +DRP
Sbjct: 277 RIMTQCWQHQPEDRP 291

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 36/291 (12%)
Query: 122 KLGEGGFGPVYKGVLR---KGD---EIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLV 174
           +LG+G FG VY+G  R   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTK-----RILLDWVTRVQIIEGIAQGL 227
           RLLG        +++ E M +  L  +L    P       R        +Q+   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YL+     + +HRDL A N ++  D   KI DFGM R     +      + +    +M+
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           PE   +G+F+  SD++SFGV+L EI S              L    +   ++ + L+ + 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS--------------LAEQPYQGLSNEQVLKFVM 246
Query: 348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP 398
           D    D+        R  ++  +C Q +   RPT  ++V++L ++   LHP
Sbjct: 247 DGGYLDQ--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD---LHP 292

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 36/291 (12%)
Query: 122 KLGEGGFGPVYKGVLR---KGD---EIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLV 174
           +LG+G FG VY+G  R   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTK-----RILLDWVTRVQIIEGIAQGL 227
           RLLG        +++ E M +  L  +L    P       R        +Q+   IA G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YL+     + +HRDL A N ++  D   KI DFGM R     +      + +    +M+
Sbjct: 141 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           PE   +G+F+  SD++SFGV+L EI S              L    +   ++ + L+ + 
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITS--------------LAEQPYQGLSNEQVLKFVM 243
Query: 348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP 398
           D    D+        R  ++  +C Q +   RPT  ++V++L ++   LHP
Sbjct: 244 DGGYLDQ--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD---LHP 289

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           + ++G G FG VYKG       + + ++   + +  +  +NE +V+ K +H N++  +G 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG- 99
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
            + KD   ++ ++    SL   L    +         + I    AQG+ YLH  +   II
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYKHLH--VQETKFQMFQLIDIARQTAQGMDYLHAKN---II 154
Query: 240 HRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL--- 292
           HRD+K++NI L + +  KI DFG+A    R  G  +++  T  ++    +M+PE      
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL----WMAPEVIRMQD 210
Query: 293 EGIFSIKSDVFSFGVLLLEIVSGK 316
              FS +SDV+S+G++L E+++G+
Sbjct: 211 NNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 107/200 (53%), Gaps = 13/200 (6%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V  G L+   +    +A+K L SG +E+  R+  +EAS++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        ++I E+M N SLD FL     +  +  +  V ++ GIA G+ YL   + + 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 129
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG---TYGYMSPEYALEG 294
            +HR L A NIL++ ++  K+SDFG++R    +      +  +G      + +PE     
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 295 IFSIKSDVFSFGVLLLEIVS 314
            F+  SDV+S+G+++ E++S
Sbjct: 190 KFTSASDVWSYGIVMWEVMS 209

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 123 LGEGGFGPVYKGVLRKGD------EIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVR 175
           LG G FG VY+G +          ++AVK L    SEQ   +   EA +I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLH 231
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 232 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 284
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TL 343
           +M PE  +EGIF+ K+D +SFGVLL EI S               LGY+     SN+  L
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVL 270
Query: 344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP 380
           E +      D    K        I   C Q   +DRP
Sbjct: 271 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRP 305

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 123/277 (44%), Gaps = 43/277 (15%)
Query: 123 LGEGGFGPVYKGVLRKGD------EIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVR 175
           LG G FG VY+G +          ++AVK L    SEQ   +   EA +I+K+ H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLH 231
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 232 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 284
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TL 343
           +M PE  +EGIF+ K+D +SFGVLL EI S               LGY+     SN+  L
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVL 270
Query: 344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP 380
           E +      D    K        I   C Q   +DRP
Sbjct: 271 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRP 305

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 92/315 (29%), Positives = 135/315 (42%), Gaps = 51/315 (16%)
Query: 93  RSKKKEVDQLPLFSFSSVSTATNTFSDTNK--------LGEGGFGPVYKGVLRKGD---- 140
           R+     D  P + F+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 17  RTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 76
Query: 141 --EIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 197
             ++AVK L    SEQ   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 77  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 136
Query: 198 LDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 250
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 137 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 193
Query: 251 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 306
                 KI DFGMAR    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 194 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 249
Query: 307 VLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TLELIDDPVLEDEYSSKQVLLRYV 365
           VLL EI S               LGY+     SN+  LE +      D    K       
Sbjct: 250 VLLWEIFS---------------LGYMPYPSKSNQEVLEFVTSGGRMD--PPKNCPGPVY 292
Query: 366 NIALLCVQESADDRP 380
            I   C Q   +DRP
Sbjct: 293 RIMTQCWQHQPEDRP 307

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 123 LGEGGFGPVYKGVLRKGD------EIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVR 175
           LG G FG VY+G +          ++AVK L    SEQ   +   EA +I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLH 231
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 232 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 284
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TL 343
           +M PE  +EGIF+ K+D +SFGVLL EI S               LGY+     SN+  L
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVL 255
Query: 344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP 380
           E +      D    K        I   C Q   +DRP
Sbjct: 256 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRP 290

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 36/291 (12%)
Query: 122 KLGEGGFGPVYKGVLR---KGD---EIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLV 174
           +LG+G FG VY+G  R   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTK-----RILLDWVTRVQIIEGIAQGL 227
           RLLG        +++ E M +  L  +L    P       R        +Q+   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YL+     + +HRDL A N ++  D   KI DFGM R     +      + +    +M+
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           PE   +G+F+  SD++SFGV+L EI S              L    +   ++ + L+ + 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS--------------LAEQPYQGLSNEQVLKFVM 246
Query: 348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP 398
           D    D+        R  ++  +C Q +   RPT  ++V++L ++   LHP
Sbjct: 247 DGGYLDQ--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD---LHP 292

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 127/279 (45%), Gaps = 24/279 (8%)
Query: 123 LGEGGFG--------PVYKGVLRKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNL 173
           LGEG FG        P   G    G+ +AVK L        R   K E  ++  + H+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 174 VRLLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
           ++  GCC D+ EK L  + EY+P  SL  +L  P   I L     +   + I +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGL--AQLLLFAQQICEGMAYLH 134
Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 290
                  IHR+L A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 135 S---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV 350
             E  F   SDV+SFGV L E+++   ++    T  L L+G      T  R  EL++   
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG- 250
Query: 351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
            E      +      ++   C +  A  RPT  +++ +L
Sbjct: 251 -ERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 123 LGEGGFGPVYKGVLRKGD------EIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVR 175
           LG G FG VY+G +          ++AVK L    SEQ   +   EA +I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLH 231
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 232 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 284
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TL 343
           +M PE  +EGIF+ K+D +SFGVLL EI S               LGY+     SN+  L
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVL 255
Query: 344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP 380
           E +      D    K        I   C Q   +DRP
Sbjct: 256 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRP 290

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 127/279 (45%), Gaps = 24/279 (8%)
Query: 123 LGEGGFG--------PVYKGVLRKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNL 173
           LGEG FG        P   G    G+ +AVK L        R   K E  ++  + H+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 174 VRLLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
           ++  GCC D+ EK L  + EY+P  SL  +L  P   I L     +   + I +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGL--AQLLLFAQQICEGMAYLH 134
Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 290
                  IHR+L A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 135 A---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV 350
             E  F   SDV+SFGV L E+++   ++    T  L L+G      T  R  EL++   
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG- 250
Query: 351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
            E      +      ++   C +  A  RPT  +++ +L
Sbjct: 251 -ERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 92/315 (29%), Positives = 134/315 (42%), Gaps = 51/315 (16%)
Query: 93  RSKKKEVDQLPLFSFSSVSTATNTFSDTNK--------LGEGGFGPVYKGVLRKGD---- 140
           R+     D  P + F+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 18  RTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 77
Query: 141 --EIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 197
             ++AVK L    SEQ   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 78  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 137
Query: 198 LDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 250
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 138 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 194
Query: 251 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 306
                 KI DFGMAR    +  +A   R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 195 GPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 250
Query: 307 VLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TLELIDDPVLEDEYSSKQVLLRYV 365
           VLL EI S               LGY+     SN+  LE +      D    K       
Sbjct: 251 VLLWEIFS---------------LGYMPYPSKSNQEVLEFVTSGGRMD--PPKNCPGPVY 293
Query: 366 NIALLCVQESADDRP 380
            I   C Q   +DRP
Sbjct: 294 RIMTQCWQHQPEDRP 308

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASV 164
            A    + + +LG+G FG VY+GV +    DE    +A+K ++  +    R E  NEASV
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-------TRV 217
           + +    ++VRLLG        ++I E M    L  +L      +  + V         +
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 123 LGEGGFGPVYKGVLRKGD------EIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVR 175
           LG G FG VY+G +          ++AVK L    SEQ   +   EA +I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLH 231
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 232 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 284
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TL 343
           +M PE  +EGIF+ K+D +SFGVLL EI S               LGY+     SN+  L
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVL 270
Query: 344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP 380
           E +      D    K        I   C Q   +DRP
Sbjct: 271 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRP 305

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASVI 165
           A    + + +LG+G FG VY+GV +    DE    +A+K ++  +    R E  NEASV+
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-------TRVQ 218
            +    ++VRLLG        ++I E M    L  +L      +  + V         +Q
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
           +   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      +
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
            +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           F    KLGEG +G VYK + ++ G  +A+K++   S+  L+E+  E S++ +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
             G      +  ++ EY    S+   +    K +  D +    I++   +GL YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEYLH---F 143
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
           +R IHRD+KA NILL+ + + K++DFG+A      +  A  + ++GT  +M+PE   E  
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIG 201
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           ++  +D++S G+  +E+  GK
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 92/315 (29%), Positives = 136/315 (43%), Gaps = 51/315 (16%)
Query: 93  RSKKKEVDQLPLFSFSSVSTATNTFSDTNK--------LGEGGFGPVYKGVLRKGD---- 140
           R+     D  P +SF+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 60
Query: 141 --EIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 197
             ++AVK L    SEQ   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 198 LDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 250
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 177
Query: 251 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 306
                 KI DFGMA+    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 178 GPGRVAKIGDFGMAQ----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 307 VLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TLELIDDPVLEDEYSSKQVLLRYV 365
           VLL EI S               LGY+     SN+  LE +      D    K       
Sbjct: 234 VLLWEIFS---------------LGYMPYPSKSNQEVLEFVTSGGRMD--PPKNCPGPVY 276
Query: 366 NIALLCVQESADDRP 380
            I   C Q   +DRP
Sbjct: 277 RIMTQCWQHQPEDRP 291

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 36/291 (12%)
Query: 122 KLGEGGFGPVYKGVLR---KGD---EIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLV 174
           +LG+G FG VY+G  R   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTK-----RILLDWVTRVQIIEGIAQGL 227
           RLLG        +++ E M +  L  +L    P       R        +Q+   IA G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YL+     + +HRDL A N ++  D   KI DFGM R     +      + +    +M+
Sbjct: 143 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           PE   +G+F+  SD++SFGV+L EI S              L    +   ++ + L+ + 
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITS--------------LAEQPYQGLSNEQVLKFVM 245
Query: 348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP 398
           D    D+        R  ++  +C Q +   RPT  ++V++L ++   LHP
Sbjct: 246 DGGYLDQ--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD---LHP 291

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 123 LGEGGFGPVYKGVLRKGD------EIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVR 175
           LG G FG VY+G +          ++AVK L    SEQ   +   EA +I+K  H+N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLH 231
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 232 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 284
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 202
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TL 343
           +M PE  +EGIF+ K+D +SFGVLL EI S               LGY+     SN+  L
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVL 247
Query: 344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP 380
           E +      D    K        I   C Q   +DRP
Sbjct: 248 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRP 282

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 92/315 (29%), Positives = 134/315 (42%), Gaps = 51/315 (16%)
Query: 93  RSKKKEVDQLPLFSFSSVSTATNTFSDTNK--------LGEGGFGPVYKGVLRKGD---- 140
           R+     D  P + F+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 41  RTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 100
Query: 141 --EIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 197
             ++AVK L    SEQ   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 101 PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 198 LDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 250
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 217
Query: 251 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 306
                 KI DFGMAR    +  +A   R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 218 GPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273
Query: 307 VLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TLELIDDPVLEDEYSSKQVLLRYV 365
           VLL EI S               LGY+     SN+  LE +      D    K       
Sbjct: 274 VLLWEIFS---------------LGYMPYPSKSNQEVLEFVTSGGRMD--PPKNCPGPVY 316
Query: 366 NIALLCVQESADDRP 380
            I   C Q   +DRP
Sbjct: 317 RIMTQCWQHQPEDRP 331

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 131/293 (44%), Gaps = 51/293 (17%)
Query: 123 LGEGGFGPVYKGVL-----RKG-DEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
           LGEG FG V K        R G   +AVK L    S   LR++ +E +V+ +V H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-------------RILLDWVTRVQIIEG 222
           L G C      +LI EY    SL  FL +  K                LD      +  G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 223 --------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 274
                   I+QG+ YL   + ++++HRDL A NIL+ +    KISDFG++R     +   
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGY 332
             S+      +M+ E   + I++ +SDV+SFGVLL EIV+  G    G+      NLL  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-- 265
Query: 333 VWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
                 +   +E  D+   E+ Y           + L C ++  D RP   D+
Sbjct: 266 -----KTGHRMERPDN-CSEEMY----------RLMLQCWKQEPDKRPVFADI 302

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 135/268 (50%), Gaps = 39/268 (14%)
Query: 138 KGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 196
           K +++A+KR++  + +  + E+  E   +++  H N+V      + KDE  L+ + +   
Sbjct: 34  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 93
Query: 197 SLDFFLFDPTKRIL---------LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN 247
           S+     D  K I+         LD  T   I+  + +GL YLH+  +   IHRD+KA N
Sbjct: 94  SV----LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGN 146
Query: 248 ILLDKDMNPKISDFGM-ARICGGNELQANTSR--IVGTYGYMSPEYALEGI--FSIKSDV 302
           ILL +D + +I+DFG+ A +  G ++  N  R   VGT  +M+PE  +E +  +  K+D+
Sbjct: 147 ILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADI 205
Query: 303 FSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLL 362
           +SFG+  +E+ +G      Y    + +L           TL+  D P LE     K++L 
Sbjct: 206 WSFGITAIELATGAAPYHKYPPMKVLML-----------TLQ-NDPPSLETGVQDKEMLK 253
Query: 363 RY----VNIALLCVQESADDRPTMNDVV 386
           +Y      +  LC+Q+  + RPT  +++
Sbjct: 254 KYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 130/293 (44%), Gaps = 51/293 (17%)
Query: 123 LGEGGFGPVYKGVL-----RKG-DEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
           LGEG FG V K        R G   +AVK L    S   LR++ +E +V+ +V H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-------------RILLDWVTRVQIIEG 222
           L G C      +LI EY    SL  FL +  K                LD      +  G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 223 --------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 274
                   I+QG+ YL + S   ++HRDL A NIL+ +    KISDFG++R     +   
Sbjct: 151 DLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGY 332
             S+      +M+ E   + I++ +SDV+SFGVLL EIV+  G    G+      NLL  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-- 265
Query: 333 VWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
                 +   +E  D+   E+ Y           + L C ++  D RP   D+
Sbjct: 266 -----KTGHRMERPDN-CSEEMY----------RLMLQCWKQEPDKRPVFADI 302

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 133/291 (45%), Gaps = 36/291 (12%)
Query: 122 KLGEGGFGPVYKGVLR---KGD---EIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLV 174
           +LG+G FG VY+G  R   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTK-----RILLDWVTRVQIIEGIAQGL 227
           RLLG        +++ E M +  L  +L    P       R        +Q+   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YL+     + +HRDL A N ++  D   KI DFGM R            + +    +M+
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           PE   +G+F+  SD++SFGV+L EI S              L    +   ++ + L+ + 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS--------------LAEQPYQGLSNEQVLKFVM 246
Query: 348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP 398
           D    D+        R  ++  +C Q +   RPT  ++V++L ++   LHP
Sbjct: 247 DGGYLDQ--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD---LHP 292

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASV 164
            A    + + +LG+G FG VY+GV +    DE    +A+K ++  +    R E  NEASV
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-------TRV 217
           + +    ++VRLLG        ++I E M    L  +L      +  + V         +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 131/293 (44%), Gaps = 51/293 (17%)
Query: 123 LGEGGFGPVYKGVL-----RKG-DEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
           LGEG FG V K        R G   +AVK L    S   LR++ +E +V+ +V H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-------------RILLDWVTRVQIIEG 222
           L G C      +LI EY    SL  FL +  K                LD      +  G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 223 --------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 274
                   I+QG+ YL   + ++++HRDL A NIL+ +    KISDFG++R     +   
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGY 332
             S+      +M+ E   + I++ +SDV+SFGVLL EIV+  G    G+      NLL  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-- 265
Query: 333 VWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
                 +   +E  D+   E+ Y           + L C ++  D RP   D+
Sbjct: 266 -----KTGHRMERPDN-CSEEMY----------RLMLQCWKQEPDKRPVFADI 302

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 135/268 (50%), Gaps = 39/268 (14%)
Query: 138 KGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 196
           K +++A+KR++  + +  + E+  E   +++  H N+V      + KDE  L+ + +   
Sbjct: 39  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98
Query: 197 SLDFFLFDPTKRIL---------LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN 247
           S+     D  K I+         LD  T   I+  + +GL YLH+  +   IHRD+KA N
Sbjct: 99  SV----LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGN 151
Query: 248 ILLDKDMNPKISDFGM-ARICGGNELQANTSR--IVGTYGYMSPEYALEGI--FSIKSDV 302
           ILL +D + +I+DFG+ A +  G ++  N  R   VGT  +M+PE  +E +  +  K+D+
Sbjct: 152 ILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADI 210
Query: 303 FSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLL 362
           +SFG+  +E+ +G      Y    + +L           TL+  D P LE     K++L 
Sbjct: 211 WSFGITAIELATGAAPYHKYPPMKVLML-----------TLQ-NDPPSLETGVQDKEMLK 258
Query: 363 RY----VNIALLCVQESADDRPTMNDVV 386
           +Y      +  LC+Q+  + RPT  +++
Sbjct: 259 KYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 125/279 (44%), Gaps = 24/279 (8%)
Query: 123 LGEGGFG--------PVYKGVLRKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNL 173
           LGEG FG        P   G    G+ +AVK L       LR   + E  ++  + H+++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 174 VRLLGCCIDKDEKI--LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
           V+  GCC D+ EK   L+ EY+P  SL  +L     R  +     +   + I +G+ YLH
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 290
                  IHR L A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 129 A---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV 350
             E  F   SDV+SFGV L E+++   +     T    L+G+     T  R  EL++   
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERG- 244
Query: 351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
            E      +      ++   C +  A  RPT  ++V +L
Sbjct: 245 -ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 282

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 125/279 (44%), Gaps = 24/279 (8%)
Query: 123 LGEGGFG--------PVYKGVLRKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNL 173
           LGEG FG        P   G    G+ +AVK L       LR   + E  ++  + H+++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 174 VRLLGCCIDKDEKI--LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
           V+  GCC D+ EK   L+ EY+P  SL  +L     R  +     +   + I +G+ YLH
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 290
                  IHR L A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 130 A---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV 350
             E  F   SDV+SFGV L E+++   +     T    L+G+     T  R  EL++   
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERG- 245
Query: 351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
            E      +      ++   C +  A  RPT  ++V +L
Sbjct: 246 -ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 283

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASV 164
            A    + + +LG+G FG VY+GV +    DE    +A+K ++  +    R E  NEASV
Sbjct: 12  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-------TRV 217
           + +    ++VRLLG        ++I E M    L  +L      +  + V         +
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 189 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASV 164
            A    + + +LG+G FG VY+GV +    DE    +A+K ++  +    R E  NEASV
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-------TRV 217
           + +    ++VRLLG        ++I E M    L  +L      +  + V         +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASV 164
            A    + + +LG+G FG VY+GV +    DE    +A+K ++  +    R E  NEASV
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-------TRV 217
           + +    ++VRLLG        ++I E M    L  +L      +  + V         +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASV 164
            A    + + +LG+G FG VY+GV +    DE    +A+K ++  +    R E  NEASV
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-------TRV 217
           + +    ++VRLLG        ++I E M    L  +L      +  + V         +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 36/291 (12%)
Query: 122 KLGEGGFGPVYKGVLR---KGD---EIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLV 174
           +LG+G FG VY+G  R   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTK-----RILLDWVTRVQIIEGIAQGL 227
           RLLG        +++ E M +  L  +L    P       R        +Q+   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YL+     + +HR+L A N ++  D   KI DFGM R     +      + +    +M+
Sbjct: 144 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           PE   +G+F+  SD++SFGV+L EI S              L    +   ++ + L+ + 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS--------------LAEQPYQGLSNEQVLKFVM 246
Query: 348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP 398
           D    D+        R  ++  +C Q + + RPT  ++V++L ++   LHP
Sbjct: 247 DGGYLDQ--PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD---LHP 292

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASV 164
            A    + + +LG+G FG VY+GV +    DE    +A+K ++  +    R E  NEASV
Sbjct: 13  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-------TRV 217
           + +    ++VRLLG        ++I E M    L  +L      +  + V         +
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 133 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 190 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 36/291 (12%)
Query: 122 KLGEGGFGPVYKGVLR---KGD---EIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLV 174
           +LG+G FG VY+G  R   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTK-----RILLDWVTRVQIIEGIAQGL 227
           RLLG        +++ E M +  L  +L    P       R        +Q+   IA G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YL+     + +HR+L A N ++  D   KI DFGM R     +      + +    +M+
Sbjct: 145 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           PE   +G+F+  SD++SFGV+L EI S              L    +   ++ + L+ + 
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEITS--------------LAEQPYQGLSNEQVLKFVM 247
Query: 348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP 398
           D    D+        R  ++  +C Q + + RPT  ++V++L ++   LHP
Sbjct: 248 DGGYLDQ--PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD---LHP 293

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 110/203 (54%), Gaps = 21/203 (10%)
Query: 123 LGEGGFGPVYKGVLR---KGD-EIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG V  G L+   K D  +A+K L  G +E+  R+   EAS++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G        +++ E+M N +LD FL     +  +  +  V ++ GIA G+ YL   + + 
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV--IQLVGMLRGIAAGMRYL---ADMG 165
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYA 291
            +HRDL A NIL++ ++  K+SDFG++R+     ++ +   +  T G      + +PE  
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRV-----IEDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS 314
               F+  SDV+S+G+++ E++S
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMS 243

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASV 164
            A    + + +LG+G FG VY+GV +    DE    +A+K ++  +    R E  NEASV
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-------TRV 217
           + +    ++VRLLG        ++I E M    L  +L      +  + V         +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASV 164
            A    + + +LG+G FG VY+GV +    DE    +A+K ++  +    R E  NEASV
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-------TRV 217
           + +    ++VRLLG        ++I E M    L  +L      +  + V         +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASV 164
            A    + + +LG+G FG VY+GV +    DE    +A+K ++  +    R E  NEASV
Sbjct: 44  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-------TRV 217
           + +    ++VRLLG        ++I E M    L  +L      +  + V         +
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 221 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 38/276 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           +G G FG V K   R  D +A+K++   SE+  +    E   +++V H N+V+L G C++
Sbjct: 17  VGRGAFGVVCKAKWRAKD-VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 183 KDEKILIYEYMPNKSLDFFLF--DP----TKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                L+ EY    SL   L   +P    T    + W  +       +QG+ YLH     
Sbjct: 74  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 125
Query: 237 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
            +IHRDLK  N+LL       KI DFG A      ++Q + +   G+  +M+PE      
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSN 180
Query: 296 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY 355
           +S K DVFS+G++L E+++ +K        +  ++   W +    R       P++++  
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGTRP------PLIKNLP 231
Query: 356 SSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
              + L+        C  +    RP+M ++V ++T+
Sbjct: 232 KPIESLM------TRCWSKDPSQRPSMEEIVKIMTH 261

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 38/276 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           +G G FG V K   R  D +A+K++   SE+  +    E   +++V H N+V+L G C++
Sbjct: 16  VGRGAFGVVCKAKWRAKD-VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 183 KDEKILIYEYMPNKSLDFFLF--DP----TKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                L+ EY    SL   L   +P    T    + W  +       +QG+ YLH     
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 124
Query: 237 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
            +IHRDLK  N+LL       KI DFG A      ++Q + +   G+  +M+PE      
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 296 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY 355
           +S K DVFS+G++L E+++ +K        +  ++   W +    R       P++++  
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGTRP------PLIKNLP 230
Query: 356 SSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
              + L+        C  +    RP+M ++V ++T+
Sbjct: 231 KPIESLM------TRCWSKDPSQRPSMEEIVKIMTH 260

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 116/213 (54%), Gaps = 16/213 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK-NEASVIAKVQ 169
           ++++ F    KLG G +  VYKG+ +  G  +A+K +   SE+G       E S++ +++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPN---KSLDFFLFDPTKRIL-LDWVTRVQIIEGIAQ 225
           H+N+VRL      +++  L++E+M N   K +D      T R L L+ V   Q    + Q
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--QLLQ 119
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYG 284
           GL + H+    +I+HRDLK  N+L++K    K+ DFG+AR  G   +  NT S  V T  
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG---IPVNTFSSEVVTLW 173
Query: 285 YMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGK 316
           Y +P+  +    +S   D++S G +L E+++GK
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 117 FSDTNKLGEGGFGPVYKG-VLRKGDEIAVKRLSGRS--EQGL-REMKNEASVIAKVQHKN 172
           F   N LG+G F  VY+   +  G E+A+K +  ++  + G+ + ++NE  +  +++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           ++ L     D +   L+ E   N  ++ +L +  K    +       +  I  G+LYLH 
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIITGMLYLHS 130
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
           +    I+HRDL  SN+LL ++MN KI+DFG+A        +  T  + GT  Y+SPE A 
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIAT 185
Query: 293 EGIFSIKSDVFSFGVLLLEIVSGK 316
                ++SDV+S G +   ++ G+
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK--GDE----IAVKRLSGRSEQGLR-EMKNEASV 164
            A    + + +LG+G FG VY+GV +    DE    +A+K ++  +    R E  NEASV
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWV-------TRV 217
           + +    ++VRLLG        ++I E M    L  +L      +  + V         +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q+   IA G+ YL+     + +HRDL A N  + +D   KI DFGM R     +      
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEA 162
           L S  SV      ++   K+G+G  G VY  + +  G E+A+++++ + +     + NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 281
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSEMVG 178
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEA 162
           L S  SV      ++   K+G+G  G VY  + +  G E+A+++++ + +     + NE 
Sbjct: 10  LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 69
Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 125
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 281
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 126 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVG 179
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 127/271 (46%), Gaps = 31/271 (11%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            +LG G FG V  G  R   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLH 143
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSI 298
           RDL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP--VLEDEYS 356
           KSD+++FGVL+ EI             SL  + Y  + +T++ T E I     +     +
Sbjct: 201 KSDIWAFGVLMWEIY------------SLGKMPY--ERFTNSETAEHIAQGLRLYRPHLA 246
Query: 357 SKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
           S++V      I   C  E AD+RPT   ++S
Sbjct: 247 SEKV----YTIMYSCWHEKADERPTFKILLS 273

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEA 162
           L S  SV      ++   K+G+G  G VY  + +  G E+A+++++ + +     + NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 281
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 178
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            +LG G FG V  G  R   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLH 123
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSI 298
           RDL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS 
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP--VLEDEYS 356
           KSD+++FGVL+ EI S  K                ++ +T++ T E I     +     +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMP--------------YERFTNSETAEHIAQGLRLYRPHLA 226
Query: 357 SKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
           S++V      I   C  E AD+RPT   ++S
Sbjct: 227 SEKVY----TIMYSCWHEKADERPTFKILLS 253

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 127/271 (46%), Gaps = 31/271 (11%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            +LG G FG V  G  R   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSI 298
           RDL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS 
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP--VLEDEYS 356
           KSD+++FGVL+ EI             SL  + Y  + +T++ T E I     +     +
Sbjct: 185 KSDIWAFGVLMWEIY------------SLGKMPY--ERFTNSETAEHIAQGLRLYRPHLA 230
Query: 357 SKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
           S++V      I   C  E AD+RPT   ++S
Sbjct: 231 SEKVY----TIMYSCWHEKADERPTFKILLS 257

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEA 162
           L S  SV      ++   K+G+G  G VY  + +  G E+A+++++ + +     + NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 281
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVG 178
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            +LG G FG V  G  R   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLH 128
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSI 298
           RDL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS 
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP--VLEDEYS 356
           KSD+++FGVL+ EI S  K                ++ +T++ T E I     +     +
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMP--------------YERFTNSETAEHIAQGLRLYRPHLA 231
Query: 357 SKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
           S++V      I   C  E AD+RPT   ++S
Sbjct: 232 SEKV----YTIMYSCWHEKADERPTFKILLS 258

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 127/281 (45%), Gaps = 28/281 (9%)
Query: 123 LGEGGFG--------PVYKGVLRKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNL 173
           LGEG FG        P   G    G+ +AVK L   +    R   K E  ++  + H+++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 174 VRLLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
           ++  GCC D     L  + EY+P  SL  +L  P   I L     +   + I +G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGL--AQLLLFAQQICEGMAYLH 151
Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 290
                  IHRDL A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID--D 348
             E  F   SDV+SFGV L E+++   ++    T  L L+G      T  R  EL++  +
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
            +   +    +V     N    C +  A  RPT  +++ +L
Sbjct: 269 RLPRPDKCPAEVYHLMKN----CWETEASFRPTFENLIPIL 305

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 127/271 (46%), Gaps = 31/271 (11%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            +LG G FG V  G  R   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLH 143
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSI 298
           RDL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP--VLEDEYS 356
           KSD+++FGVL+ EI             SL  + Y  + +T++ T E I     +     +
Sbjct: 201 KSDIWAFGVLMWEIY------------SLGKMPY--ERFTNSETAEHIAQGLRLYRPHLA 246
Query: 357 SKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
           S++V      I   C  E AD+RPT   ++S
Sbjct: 247 SEKV----YTIMYSCWHEKADERPTFKILLS 273

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKGVLRKGDE-----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYLHQ 232
           LG C+    + L+ + MP   L   + +   R+    LL+W  +      IA+G+ YL  
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLED 137
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
              VR++HRDL A N+L+    + KI+DFG+AR+   +E + +         +M+ E  L
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 293 EGIFSIKSDVFSFGVLLLEIVS 314
              F+ +SDV+S+GV + E+++
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMT 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 127/271 (46%), Gaps = 31/271 (11%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            +LG G FG V  G  R   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLH 134
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSI 298
           RDL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS 
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP--VLEDEYS 356
           KSD+++FGVL+ EI             SL  + Y  + +T++ T E I     +     +
Sbjct: 192 KSDIWAFGVLMWEIY------------SLGKMPY--ERFTNSETAEHIAQGLRLYRPHLA 237
Query: 357 SKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
           S++V      I   C  E AD+RPT   ++S
Sbjct: 238 SEKVY----TIMYSCWHEKADERPTFKILLS 264

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 111/196 (56%), Gaps = 19/196 (9%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           +G+G FG V  G  R G+++AVK +  +++   +    EASV+ +++H NLV+LLG  ++
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 183 KDEKI-LIYEYMPNKSLDFFLFDPTKRILL-DWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +   + ++ EYM   SL  +L    + +L  D + +  +   + + + YL   +    +H
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FVH 131
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT--YGYMSPEYALEGIFSI 298
           RDL A N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   E  FS 
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREAAFST 184
Query: 299 KSDVFSFGVLLLEIVS 314
           KSDV+SFG+LL EI S
Sbjct: 185 KSDVWSFGILLWEIYS 200

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 27/269 (10%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            +LG G FG V  G  R   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLH 128
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL A N L++     K+SDFG++R    +E  ++         +  PE  +   FS KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYSKFSSKS 187
Query: 301 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP--VLEDEYSSK 358
           D+++FGVL+ EI             SL  + Y  + +T++ T E I     +     +S+
Sbjct: 188 DIWAFGVLMWEIY------------SLGKMPY--ERFTNSETAEHIAQGLRLYRPHLASE 233
Query: 359 QVLLRYVNIALLCVQESADDRPTMNDVVS 387
           +V      I   C  E AD+RPT   ++S
Sbjct: 234 KV----YTIMYSCWHEKADERPTFKILLS 258

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 96/196 (48%), Gaps = 7/196 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG V+ G LR  +  +AVK         L+ +   EA ++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
            C  K    ++ E +  +  DF  F  T+   L   T +Q++   A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           IHRDL A N L+ +    KISDFGM+R        A+         + +PE    G +S 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 299 KSDVFSFGVLLLEIVS 314
           +SDV+SFG+LL E  S
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 96/196 (48%), Gaps = 7/196 (3%)
Query: 121 NKLGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG V+ G LR  +  +AVK         L+ +   EA ++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
            C  K    ++ E +  +  DF  F  T+   L   T +Q++   A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           IHRDL A N L+ +    KISDFGM+R        A+         + +PE    G +S 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 299 KSDVFSFGVLLLEIVS 314
           +SDV+SFG+LL E  S
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 88/333 (26%), Positives = 153/333 (45%), Gaps = 53/333 (15%)
Query: 73  LNLKANNVNIEL-PLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPV 131
           L++ +N V+I+L  LN +L++  +   +           S+    F++   +G G FG V
Sbjct: 3   LHMGSNTVHIDLSALNPELVQAVQHVVIGP---------SSLIVHFNEV--IGRGHFGCV 51
Query: 132 YKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLLGCCI-DKDE 185
           Y G L   D      AVK L+  ++ G + +   E  ++    H N++ LLG C+  +  
Sbjct: 52  YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 111
Query: 186 KILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 241
            +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L   +  + +HR
Sbjct: 112 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL---ASKKFVHR 162
Query: 242 DLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYALEGIFSIK 299
           DL A N +LD+    K++DFG+AR     E  +  N +       +M+ E      F+ K
Sbjct: 163 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK 222
Query: 300 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDDPVLEDEYSS 357
           SDV+SFGVLL E+++     G      +N       L    R L  E   DP+ E     
Sbjct: 223 SDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE----- 273
Query: 358 KQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
                    + L C    A+ RP+ +++VS ++
Sbjct: 274 ---------VMLKCWHPKAEMRPSFSELVSRIS 297

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 123 LGEGGFGPVYKGVLRKGD---EIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKNLVRLL 177
           +GEG FG V K  ++K     + A+KR+    S+   R+   E  V+ K+  H N++ LL
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFL-------FDPTKRIL------LDWVTRVQIIEGIA 224
           G C  +    L  EY P+ +L  FL        DP   I       L     +     +A
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
           +G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG++R   G E+    +       
Sbjct: 143 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 196
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 197 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 123 LGEGGFGPVYKGVLRKGD---EIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKNLVRLL 177
           +GEG FG V K  ++K     + A+KR+    S+   R+   E  V+ K+  H N++ LL
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFL-------FDPTKRIL------LDWVTRVQIIEGIA 224
           G C  +    L  EY P+ +L  FL        DP   I       L     +     +A
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
           +G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG++R   G E+    +       
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 206
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 207 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 178 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 263
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 264 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 291

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 178 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 168
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 283
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 284 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 311

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 111/196 (56%), Gaps = 19/196 (9%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           +G+G FG V  G  R G+++AVK +  +++   +    EASV+ +++H NLV+LLG  ++
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 183 KDEKI-LIYEYMPNKSLDFFLFDPTKRILL-DWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +   + ++ EYM   SL  +L    + +L  D + +  +   + + + YL   +    +H
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FVH 125
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT--YGYMSPEYALEGIFSI 298
           RDL A N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   E  FS 
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 299 KSDVFSFGVLLLEIVS 314
           KSDV+SFG+LL EI S
Sbjct: 179 KSDVWSFGILLWEIYS 194

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 178 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 264
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 265 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 111/196 (56%), Gaps = 19/196 (9%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           +G+G FG V  G  R G+++AVK +  +++   +    EASV+ +++H NLV+LLG  ++
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 183 KDEKI-LIYEYMPNKSLDFFLFDPTKRILL-DWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +   + ++ EYM   SL  +L    + +L  D + +  +   + + + YL   +    +H
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FVH 140
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT--YGYMSPEYALEGIFSI 298
           RDL A N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   E  FS 
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 299 KSDVFSFGVLLLEIVS 314
           KSDV+SFG+LL EI S
Sbjct: 194 KSDVWSFGILLWEIYS 209

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 178 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 264
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 265 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 111/196 (56%), Gaps = 19/196 (9%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           +G+G FG V  G  R G+++AVK +  +++   +    EASV+ +++H NLV+LLG  ++
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 183 KDEKI-LIYEYMPNKSLDFFLFDPTKRILL-DWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +   + ++ EYM   SL  +L    + +L  D + +  +   + + + YL   +    +H
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FVH 312
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT--YGYMSPEYALEGIFSI 298
           RDL A N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   E  FS 
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 299 KSDVFSFGVLLLEIVS 314
           KSDV+SFG+LL EI S
Sbjct: 366 KSDVWSFGILLWEIYS 381

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLS-GRSEQGLREMKNEASVIAKVQHKNLV 174
           F+  +++G+G FG VYKG+     E+ A+K +    +E  + +++ E +V+++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 175 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           R  G  +   +  +I EY+   S LD     P +   +       I+  I +GL YLH  
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHS- 134
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R IHRD+KA+N+LL +  + K++DFG+A      +++ N    VGT  +M+PE   +
Sbjct: 135 --ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 190
Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +  K+D++S G+  +E+  G+
Sbjct: 191 SAYDFKADIWSLGITAIELAKGE 213

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAV-KRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           LG+G FG   K   R+  E+ V K L    E+  R    E  V+  ++H N+++ +G  +
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV-L 76
Query: 182 DKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            KD+++  I EY+   +L   +     +    W  RV   + IA G+ YLH    + IIH
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR------------IVGTYGYMSP 288
           RDL + N L+ ++ N  ++DFG+AR+    + Q    R            +VG   +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVS 314
           E      +  K DVFSFG++L EI+ 
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIG 217

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 178 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 263
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 264 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 291

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 178 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 141
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 256
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 257 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 284

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 178 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 147
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 262
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 263 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 290

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 178 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 144
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 260 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 287

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 178 GCCI-DKDEKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 167
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 282
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 283 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 310

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 178 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 146
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 261
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 262 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 89/330 (26%), Positives = 149/330 (45%), Gaps = 55/330 (16%)
Query: 77  ANNVNIEL-PLNSKLIERSKKKEVDQLPLF-SFSSVSTATNTFSDTNKLGEGGFGPVYKG 134
           AN V+I+L  LN +L++  +   +    L   F+ V            +G G FG VY G
Sbjct: 2   ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEV------------IGRGHFGCVYHG 49
Query: 135 VLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKD-EKIL 188
            L   D      AVK L+  ++ G + +   E  ++    H N++ LLG C+  +   ++
Sbjct: 50  TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 109
Query: 189 IYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK 244
           +  YM +  L  F+     +PT + L+ +  +V      A+G+ +L   +  + +HRDL 
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL---ASKKFVHRDLA 160
Query: 245 ASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYALEGIFSIKSDV 302
           A N +LD+    K++DFG+AR     E  +  N +       +M+ E      F+ KSDV
Sbjct: 161 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDV 220
Query: 303 FSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDDPVLEDEYSSKQV 360
           +SFGVLL E+++     G      +N       L    R L  E   DP+ E        
Sbjct: 221 WSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE-------- 268
Query: 361 LLRYVNIALLCVQESADDRPTMNDVVSMLT 390
                 + L C    A+ RP+ +++VS ++
Sbjct: 269 ------VMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 104
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           C  D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 105 CFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 156
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 157 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 214 KSACKSSDLWALGCIIYQLVAG 235

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 178 GCCIDKD-EKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 147
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 262
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 263 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 290

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/330 (26%), Positives = 149/330 (45%), Gaps = 55/330 (16%)
Query: 77  ANNVNIEL-PLNSKLIERSKKKEVDQLPLF-SFSSVSTATNTFSDTNKLGEGGFGPVYKG 134
           AN V+I+L  LN +L++  +   +    L   F+ V            +G G FG VY G
Sbjct: 61  ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEV------------IGRGHFGCVYHG 108
Query: 135 VLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLLGCCI-DKDEKIL 188
            L   D      AVK L+  ++ G + +   E  ++    H N++ LLG C+  +   ++
Sbjct: 109 TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168
Query: 189 IYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK 244
           +  YM +  L  F+     +PT + L+ +  +V      A+G+ +L   +  + +HRDL 
Sbjct: 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL---ASKKFVHRDLA 219
Query: 245 ASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYALEGIFSIKSDV 302
           A N +LD+    K++DFG+AR     E  +  N +       +M+ E      F+ KSDV
Sbjct: 220 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDV 279
Query: 303 FSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDDPVLEDEYSSKQV 360
           +SFGVLL E+++     G      +N       L    R L  E   DP+ E        
Sbjct: 280 WSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE-------- 327
Query: 361 LLRYVNIALLCVQESADDRPTMNDVVSMLT 390
                 + L C    A+ RP+ +++VS ++
Sbjct: 328 ------VMLKCWHPKAEMRPSFSELVSRIS 351

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K    +  ++AVK L S  +E+ L ++ +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTR--VQI 219
           ++ LLG C       +I EY    +L  +L           F+P+        ++  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 178 GCCI-DKDEKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 265
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 266 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 293

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 178 GCCI-DKDEKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 264
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 265 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 117/221 (52%), Gaps = 25/221 (11%)
Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDE-IAVKRL-----SGRSE--QGLREMKNEA 162
           + A N      ++G+GGFG V+KG L K    +A+K L      G +E  +  +E + E 
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            +++ + H N+V+L G   +     ++ E++P   L   L D    I   W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLD 130
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMN----PKISDFGMARICGGNELQANTS 277
           IA G+ Y+ Q     I+HRDL++ NI L   D N     K++DFG+++     +   + S
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVS 184
Query: 278 RIVGTYGYMSPEY--ALEGIFSIKSDVFSFGVLLLEIVSGK 316
            ++G + +M+PE   A E  ++ K+D +SF ++L  I++G+
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 178 GCCI-DKDEKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 290
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDD 348
                F+ KSDV+SFGVLL E+++     G      +N       L    R L  E   D
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 265
Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
           P+ E              + L C    A+ RP+ +++VS ++
Sbjct: 266 PLYE--------------VMLKCWHPKAEMRPSFSELVSRIS 293

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 123 LGEGGFGPVYKGVLRKGD---EIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKNLVRLL 177
           +GEG FG V K  ++K     + A+KR+    S+   R+   E  V+ K+  H N++ LL
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFL-------FDPTKRIL------LDWVTRVQIIEGIA 224
           G C  +    L  EY P+ +L  FL        DP   I       L     +     +A
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
           +G+ YL   S+ + IHR+L A NIL+ ++   KI+DFG++R   G E+    +       
Sbjct: 150 RGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 203
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 204 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 109 SVSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAK 167
           SV      ++   K+G+G  G VY  + +  G E+A+++++ + +     + NE  V+ +
Sbjct: 15  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
            ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +     Q L
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 130
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYM 286
            +LH     ++IHR++K+ NILL  D + K++DFG  A+I      Q+  S +VGT  +M
Sbjct: 131 EFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWM 184
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +PE      +  K D++S G++ +E++ G+
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 35/273 (12%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            +LG G FG V  G  +   ++AVK +   S     E   EA  + K+ H  LV+  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             +    ++ EY+ N  L  +L    K   L+    +++   + +G+ +L  +   + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFS 297
           RDL A N L+D+D+  K+SDFGM R    ++  ++    VGT     + +PE      +S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFHYFKYS 183
Query: 298 IKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTL--ELIDDPVLEDE 354
            KSDV++FG+L+ E+ S GK    LY    + L      +   +R     L  D + +  
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-----KVSQGHRLYRPHLASDTIYQIM 238
Query: 355 YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
           YS              C  E  + RPT   ++S
Sbjct: 239 YS--------------CWHELPEKRPTFQQLLS 257

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 106/217 (48%), Gaps = 36/217 (16%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLG-- 178
           +G G +G VYKG L   DE  +AVK  S  + Q     KN   V   ++H N+ R +   
Sbjct: 21  IGRGRYGAVYKGSL---DERPVAVKVFSFANRQNFINEKNIYRV-PLMEHDNIARFIVGD 76
Query: 179 ---CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH---- 231
                  + E +L+ EY PN SL  +L   T     DWV+  ++   + +GL YLH    
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELP 132
Query: 232 --QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL----QANTSRI--VGTY 283
              + +  I HRDL + N+L+  D    ISDFG++    GN L    + + + I  VGT 
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 284 GYMSPEYALEGIFSIKS--------DVFSFGVLLLEI 312
            YM+PE  LEG  +++         D+++ G++  EI
Sbjct: 193 RYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K    +  ++AVK L S  +E+ L ++ +E  ++  + +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTR--VQI 219
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 116/221 (52%), Gaps = 25/221 (11%)
Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDE-IAVKRL-----SGRSE--QGLREMKNEA 162
           + A N      ++G+GGFG V+KG L K    +A+K L      G +E  +  +E + E 
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            +++ + H N+V+L G   +     ++ E++P   L   L D    I   W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLD 130
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMN----PKISDFGMARICGGNELQANTS 277
           IA G+ Y+ Q     I+HRDL++ NI L   D N     K++DFG ++     +   + S
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVS 184
Query: 278 RIVGTYGYMSPEY--ALEGIFSIKSDVFSFGVLLLEIVSGK 316
            ++G + +M+PE   A E  ++ K+D +SF ++L  I++G+
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K    +  ++AVK L S  +E+ L ++ +E  ++  + +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTR--VQI 219
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 122 KLGEGGFGPVYKGVLR---KGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +LG G FG V +GV R   K  ++A+K L   +E+    EM  EA ++ ++ +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G C   +  +L+ E      L  FL    + I +  V   +++  ++ G+ YL + +   
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA--ELLHQVSMGMKYLEEKN--- 130
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEGI 295
            +HRDL A N+LL      KISDFG+++  G ++    T+R  G +   + +PE      
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 189
Query: 296 FSIKSDVFSFGVLLLEIVS 314
           FS +SDV+S+GV + E +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K    +  ++AVK L S  +E+ L ++ +E  ++  + +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTR--VQI 219
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K    +  ++AVK L S  +E+ L ++ +E  ++  + +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTR--VQI 219
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K    +  ++AVK L S  +E+ L ++ +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTR--VQI 219
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K    +  ++AVK L S  +E+ L ++ +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTR--VQI 219
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K    +  ++AVK L S  +E+ L ++ +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTR--VQI 219
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 112/203 (55%), Gaps = 11/203 (5%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE-QGLREMK-NEASVIAKVQHKNLV 174
           +    K+GEG +G VYK    +G  +A+KR+   +E +G+      E S++ ++ H N+V
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            L+     +    L++E+M  K L   L D  K  L D   ++ + + + +G+ + HQ+ 
Sbjct: 83  SLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQH- 138
Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-E 293
             RI+HRDLK  N+L++ D   K++DFG+AR   G  +++ T  +V T  Y +P+  +  
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV-TLWYRAPDVLMGS 194
Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +S   D++S G +  E+++GK
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K    +  ++AVK L S  +E+ L ++ +E  ++  + +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTR--VQI 219
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 112/203 (55%), Gaps = 11/203 (5%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE-QGLREMK-NEASVIAKVQHKNLV 174
           +    K+GEG +G VYK    +G  +A+KR+   +E +G+      E S++ ++ H N+V
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            L+     +    L++E+M  K L   L D  K  L D   ++ + + + +G+ + HQ+ 
Sbjct: 83  SLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQH- 138
Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-E 293
             RI+HRDLK  N+L++ D   K++DFG+AR   G  +++ T  +V T  Y +P+  +  
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV-TLWYRAPDVLMGS 194
Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +S   D++S G +  E+++GK
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 100 TFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 151
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
              S  SD+++ G ++ ++V+G
Sbjct: 209 KSASKSSDLWALGCIIYQLVAG 230

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLS-GRSEQGLREMKNEASVIAKVQHKNLV 174
           F+   K+G+G FG V+KG+  +  ++ A+K +    +E  + +++ E +V+++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 175 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 123
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
            +   IHRD+KA+N+LL +    K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 178
Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +  K+D++S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 116/221 (52%), Gaps = 25/221 (11%)
Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDE-IAVKRL-----SGRSE--QGLREMKNEA 162
           + A N      ++G+GGFG V+KG L K    +A+K L      G +E  +  +E + E 
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            +++ + H N+V+L G   +     ++ E++P   L   L D    I   W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLD 130
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMN----PKISDFGMARICGGNELQANTS 277
           IA G+ Y+ Q     I+HRDL++ NI L   D N     K++DF +++     +   + S
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVS 184
Query: 278 RIVGTYGYMSPEY--ALEGIFSIKSDVFSFGVLLLEIVSGK 316
            ++G + +M+PE   A E  ++ K+D +SF ++L  I++G+
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLS-GRSEQGLREMKNEASVIAKVQHKNLV 174
           F+   K+G+G FG V+KG+  +  ++ A+K +    +E  + +++ E +V+++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 175 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 143
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
            +   IHRD+KA+N+LL +    K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 198
Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +  K+D++S G+  +E+  G+
Sbjct: 199 SAYDSKADIWSLGITAIELARGE 221

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 113/212 (53%), Gaps = 13/212 (6%)
Query: 108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLS-GRSEQGLREMKNEASVI 165
           ++++     F+   ++G+G FG V+KG+  +  ++ A+K +    +E  + +++ E +V+
Sbjct: 16  NNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL 75
Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRILLDWVTRVQIIEGIA 224
           ++     + +  G  +   +  +I EY+   S LD     P      D      +++ I 
Sbjct: 76  SQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEIL 130
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
           +GL YLH   +   IHRD+KA+N+LL +  + K++DFG+A      +++ NT   VGT  
Sbjct: 131 KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPF 185
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +M+PE   +  +  K+D++S G+  +E+  G+
Sbjct: 186 WMAPEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 74
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 75  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 126
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 127 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 184 KSACKSSDLWALGCIIYQLVAG 205

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 77
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 78  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 129
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 130 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 187 KSACKSSDLWALGCIIYQLVAG 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 76
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 77  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 128
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 129 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 186 KSACKSSDLWALGCIIYQLVAG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 76  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 127
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 128 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 185 KSACKSSDLWALGCIIYQLVAG 206

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 25/210 (11%)
Query: 123 LGEGGFGPVYKGVLRKGD----EIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           LGEG FG V +G L++ D    ++AVK  +L   S++ + E  +EA+ +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 177 LGCCIDKDEK-----ILIYEYMPNKSLDFFLF-----DPTKRILLDWVTRVQIIEGIAQG 226
           LG CI+   +     ++I  +M    L  +L         K I L   T ++ +  IA G
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ--TLLKFMVDIALG 159
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYG 284
           + YL   S    +HRDL A N +L  DM   ++DFG+++    G    Q   +++     
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVK 214
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +++ E   + +++ KSDV++FGV + EI +
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 81
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 82  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 133
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 134 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 191 KSACKSSDLWALGCIIYQLVAG 212

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 122 KLGEGGFGPVYKGVLR---KGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +LG G FG V +GV R   K  ++A+K L   +E+    EM  EA ++ ++ +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G C   +  +L+ E      L  FL    + I +  V   +++  ++ G+ YL + +   
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV--AELLHQVSMGMKYLEEKN--- 456
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEGI 295
            +HR+L A N+LL      KISDFG+++  G ++    T+R  G +   + +PE      
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 515
Query: 296 FSIKSDVFSFGVLLLEIVS-GKK 317
           FS +SDV+S+GV + E +S G+K
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQK 538

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 149
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 207 KSACKSSDLWALGCIIYQLVAG 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 97  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 148
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 149 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 206 KSACKSSDLWALGCIIYQLVAG 227

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           K+GEG  G V     +  G ++AVK +  R +Q    + NE  ++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +  +E  ++ E++   +L     D   ++ L+      + E + Q L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K+ +ILL  D   K+SDFG       +        +VGT  +M+PE     +++ + 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 301 DVFSFGVLLLEIVSGK 316
           D++S G++++E+V G+
Sbjct: 223 DIWSLGIMVIEMVDGE 238

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 149
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 207 KSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 101 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 152
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 153 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 210 KSACKSSDLWALGCIIYQLVAG 231

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 136/304 (44%), Gaps = 47/304 (15%)
Query: 115 NTFSDTNKLGEGGFGPVYKGV---LRKGD---EIAVKRLSGRSEQGLRE-MKNEASVIAK 167
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 168 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVT 215
           + QH+N+V LLG C      ++I EY     L  FL           ++P+        +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 216 R--VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNE 271
           R  +     +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N 
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG 331
           +    +R+     +M+PE   + +++++SDV+S+G+LL EI             SL L  
Sbjct: 223 IVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNP 268
Query: 332 YVWDLWTSNRTLELIDD--PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           Y   +  +++  +L+ D   + +  ++ K +     +I   C       RPT   + S L
Sbjct: 269 YP-GILVNSKFYKLVKDGYQMAQPAFAPKNIY----SIMQACWALEPTHRPTFQQICSFL 323
Query: 390 TNEA 393
             +A
Sbjct: 324 QEQA 327

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 151
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 209 KSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 97  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 148
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 149 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 206 KSACKSSDLWALGCIIYQLVAG 227

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 133/298 (44%), Gaps = 41/298 (13%)
Query: 115 NTFSDTNKLGEGGFGPVYKGV---LRKGD---EIAVKRLSGRSEQGLRE-MKNEASVIAK 167
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 168 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDPTKRILLDWVTRVQI 219
           + QH+N+V LLG C      ++I EY     L  FL        D      L+    +  
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTS 277
              +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N +    +
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW 337
           R+     +M+PE   + +++++SDV+S+G+LL EI             SL L  Y   + 
Sbjct: 215 RL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNPYP-GIL 259
Query: 338 TSNRTLELIDD--PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 393
            +++  +L+ D   + +  ++ K +     +I   C       RPT   + S L  +A
Sbjct: 260 VNSKFYKLVKDGYQMAQPAFAPKNIY----SIMQACWALEPTHRPTFQQICSFLQEQA 313

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 101 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 152
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 153 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 210 KSACKSSDLWALGCIIYQLVAG 231

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 33/229 (14%)
Query: 115 NTFSDTNKLGEGGFGPVYK----GVL--RKGDEIAVKRLSGRSEQGLR-EMKNEASVIAK 167
           N       +GEG FG V++    G+L       +AVK L   +   ++ + + EA+++A+
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILL-----DWVTRVQ---- 218
             + N+V+LLG C       L++EYM    L+ FL   +   +      D  TR +    
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 219 ------------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR- 265
                       I   +A G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 266 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           I   +  +A+ +  +    +M PE      ++ +SDV+++GV+L EI S
Sbjct: 224 IYSADYYKADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 149
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 207 KSACKSSDLWALGCIIYQLVAG 228

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 135/294 (45%), Gaps = 45/294 (15%)
Query: 123 LGEGGFGPVYKGV---LRKGD---EIAVKRLSGRSEQGLRE-MKNEASVIAKV-QHKNLV 174
           LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ + QH+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL--------FDPTKRILLDWVTRVQIIE---GI 223
            LLG C      ++I EY     L  FL         DP   I    ++   ++     +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVG 281
           AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N +    +R+  
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL-- 228
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR 341
              +M+PE   + +++++SDV+S+G+LL EI             SL L  Y   +  +++
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNPYP-GILVNSK 275
Query: 342 TLELIDD--PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 393
             +L+ D   + +  ++ K +     +I   C       RPT   + S L  +A
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIY----SIMQACWALEPTHRPTFQQICSFLQEQA 325

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I EY    +L  +L           +D   R+  + +T   ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQMTFKDLVS 161
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +   NT+ 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 151
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 209 KSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGP-VYKGVLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F   V    L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 149
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 207 KSACKSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 151
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 209 KSACKSSDLWALGCIIYQLVAG 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 151
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 209 KSAXKSSDLWALGCIIYQLVAG 230

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 134/294 (45%), Gaps = 45/294 (15%)
Query: 123 LGEGGFGPVYKGV---LRKGD---EIAVKRLSGRSEQGLRE-MKNEASVIAKV-QHKNLV 174
           LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ + QH+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL--------FDPTKRILLDWVTRVQIIE---GI 223
            LLG C      ++I EY     L  FL         DP   I     +   ++     +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVG 281
           AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N +    +R+  
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL-- 228
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR 341
              +M+PE   + +++++SDV+S+G+LL EI             SL L  Y   +  +++
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNPYP-GILVNSK 275
Query: 342 TLELIDD--PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 393
             +L+ D   + +  ++ K +     +I   C       RPT   + S L  +A
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIY----SIMQACWALEPTHRPTFQQICSFLQEQA 325

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 111/222 (50%), Gaps = 35/222 (15%)
Query: 123 LGEGGFGPVYK----GVLRKGD--EIAVKRLSGRSEQGLRE-MKNEASVIAKV-QHKNLV 174
           LG G FG V      G+ + G   ++AVK L  +++   RE + +E  ++ ++  H+N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRI-------LLDWV 214
            LLG C       LI+EY     L  +L             ++  KR+       +L + 
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNEL 272
             +     +A+G+ +L   S    +HRDL A N+L+      KI DFG+AR  +   N +
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +R+     +M+PE   EGI++IKSDV+S+G+LL EI S
Sbjct: 230 VRGNARL--PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 151
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 209 KSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 123 LGEGGFGPVYKG-VLRKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V     L    E A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 102
Query: 179 CCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              D ++      Y  N  L  ++     FD T        TR    E I   L YLH  
Sbjct: 103 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVSALEYLHGK 154
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E
Sbjct: 155 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 SD+++ G ++ ++V+G
Sbjct: 212 KSACKSSDLWALGCIIYQLVAG 233

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 133/298 (44%), Gaps = 41/298 (13%)
Query: 115 NTFSDTNKLGEGGFGPVYKGV---LRKGD---EIAVKRLSGRSEQGLRE-MKNEASVIAK 167
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 168 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDPTKRILLDWVTRVQI 219
           + QH+N+V LLG C      ++I EY     L  FL        D      L+    +  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTS 277
              +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N +    +
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW 337
           R+     +M+PE   + +++++SDV+S+G+LL EI             SL L  Y   + 
Sbjct: 223 RL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNPYP-GIL 267
Query: 338 TSNRTLELIDD--PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 393
            +++  +L+ D   + +  ++ K +     +I   C       RPT   + S L  +A
Sbjct: 268 VNSKFYKLVKDGYQMAQPAFAPKNIY----SIMQACWALEPTHRPTFQQICSFLQEQA 321

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            +LG+G FG VYK   ++ G   A K +  +SE+ L +   E  ++A   H  +V+LLG 
Sbjct: 17  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII-EGIAQGLLYLHQYSRVRI 238
                +  ++ E+ P  ++D  + +   R L +   ++Q++   + + L +LH     RI
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTE--PQIQVVCRQMLEALNFLHSK---RI 130
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPEYAL---- 292
           IHRDLKA N+L+  + + +++DFG++       L+    R   +GT  +M+PE  +    
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 293 -EGIFSIKSDVFSFGVLLLEIVS 314
            +  +  K+D++S G+ L+E+  
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQ 209

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 107/200 (53%), Gaps = 15/200 (7%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAV-KRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +LG+G FG VYK   ++   +A  K +  +SE+ L +   E  ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII-EGIAQGLLYLHQYSRVRII 239
             ++   ++ E+    ++D  + +  +R L +  +++Q++ +     L YLH     +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTE--SQIQVVCKQTLDALNYLHDN---KII 157
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EG 294
           HRDLKA NIL   D + K++DFG++       +Q   S  +GT  +M+PE  +     + 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAK-NTRXIQRRDS-FIGTPYWMAPEVVMCETSKDR 215
Query: 295 IFSIKSDVFSFGVLLLEIVS 314
            +  K+DV+S G+ L+E+  
Sbjct: 216 PYDYKADVWSLGITLIEMAE 235

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 120/233 (51%), Gaps = 18/233 (7%)
Query: 113 ATNTF---SDTNKLGEGGFGPVYK-GVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV 168
           A N+F   S T  LG G FG V+K      G ++A K +  R  +   E+KNE SV+ ++
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
            H NL++L      K++ +L+ EY+    L   + D +    L  +  +  ++ I +G+ 
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIR 201
Query: 229 YLHQYSRVRIIHRDLKASNIL-LDKDMNP-KISDFGMARICGGNE-LQANTSRIVGTYGY 285
           ++HQ   + I+H DLK  NIL +++D    KI DFG+AR     E L+ N     GT  +
Sbjct: 202 HMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN----FGTPEF 254
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSL-NLLGYVWDL 336
           ++PE       S  +D++S GV+   ++SG     G    ++L N+L   WDL
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL 307

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAV-KRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +LG+G FG VYK   ++   +A  K +  +SE+ L +   E  ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII-EGIAQGLLYLHQYSRVRII 239
             ++   ++ E+    ++D  + +  +R L +  +++Q++ +     L YLH     +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTE--SQIQVVCKQTLDALNYLHDN---KII 157
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EG 294
           HRDLKA NIL   D + K++DFG++               +GT  +M+PE  +     + 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 295 IFSIKSDVFSFGVLLLEIV 313
            +  K+DV+S G+ L+E+ 
Sbjct: 216 PYDYKADVWSLGITLIEMA 234

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            +LG+G FG VYK   ++ G   A K +  +SE+ L +   E  ++A   H  +V+LLG 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII-EGIAQGLLYLHQYSRVRI 238
                +  ++ E+ P  ++D  + +   R L +   ++Q++   + + L +LH     RI
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTE--PQIQVVCRQMLEALNFLHSK---RI 138
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPEYAL---- 292
           IHRDLKA N+L+  + + +++DFG++       L+    R   +GT  +M+PE  +    
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 293 -EGIFSIKSDVFSFGVLLLEIVS 314
            +  +  K+D++S G+ L+E+  
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQ 217

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLS-GRSEQGLREMKNEASVIAKVQHKNLV 174
           F+   K+G+G FG V+KG+  +  ++ A+K +    +E  + +++ E +V+++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 175 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 138
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
            +   IHRD+KA+N+LL +    K++DFG+A      +++ N    VGT  +M+PE   +
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 193
Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +  K+D++S G+  +E+  G+
Sbjct: 194 SAYDSKADIWSLGITAIELARGE 216

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAV-KRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +LG+G FG VYK   ++   +A  K +  +SE+ L +   E  ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII-EGIAQGLLYLHQYSRVRII 239
             ++   ++ E+    ++D  + +  +R L +  +++Q++ +     L YLH     +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTE--SQIQVVCKQTLDALNYLHDN---KII 157
Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EG 294
           HRDLKA NIL   D + K++DFG++               +GT  +M+PE  +     + 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 295 IFSIKSDVFSFGVLLLEIVS 314
            +  K+DV+S G+ L+E+  
Sbjct: 216 PYDYKADVWSLGITLIEMAE 235

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLS-GRSEQGLREMKNEASVIAKVQHKNLV 174
           F+   K+G+G FG V+KG+  +  ++ A+K +    +E  + +++ E +V+++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 175 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 123
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
            +   IHRD+KA+N+LL +    K++DFG+A      +++ N    VGT  +M+PE   +
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 178
Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +  K+D++S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 116 TFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSG---RSEQGLREMKNEASVIAKVQHK 171
            F    K+G G F  VY+   L  G  +A+K++        +   +   E  ++ ++ H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRILLD---WVTRVQIIEGIAQG 226
           N+++     I+ +E  ++ E      L   +  F   KR++ +   W   VQ+   +   
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE-- 150
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
               H +SR R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YM
Sbjct: 151 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 203
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI 346
           SPE   E  ++ KSD++S G LL E+ + +     +  D +N       L++  + +E  
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMN-------LYSLCKKIEQC 253
Query: 347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
           D P L  ++ S++ L + VN   +C+    + RP +  V
Sbjct: 254 DYPPLPSDHYSEE-LRQLVN---MCINPDPEKRPDVTYV 288

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 136/311 (43%), Gaps = 54/311 (17%)
Query: 115 NTFSDTNKLGEGGFGPVYKGV---LRKGD---EIAVKRLSGRSEQGLRE-MKNEASVIAK 167
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 168 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG---- 222
           + QH+N+V LLG C      ++I EY     L  FL    + +L   +   Q  EG    
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 223 ----------------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR- 265
                           +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 266 -ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT 324
            +   N +    +R+     +M+PE   + +++++SDV+S+G+LL EI            
Sbjct: 208 IMNDSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----------- 254
Query: 325 DSLNLLGYVWDLWTSNRTLELIDD--PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTM 382
            SL L  Y   +  +++  +L+ D   + +  ++ K +     +I   C       RPT 
Sbjct: 255 -SLGLNPYP-GILVNSKFYKLVKDGYQMAQPAFAPKNI----YSIMQACWALEPTHRPTF 308
Query: 383 NDVVSMLTNEA 393
             + S L  +A
Sbjct: 309 QQICSFLQEQA 319

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRL-------SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+ A  R         G +    R + +E  ++  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 175 RLLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDPTKRILLDWVTRVQIIE---GIA 224
            LLG C      ++ I E+    +L  +L      F P K +  D++T   +I     +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
           +G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +              
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++     DF        I L  +     +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAF 118
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 122
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL- 292
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLG 177
Query: 293 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I EY    +L  +L           +D   R+  + +T   ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYD-INRVPEEQMTFKDLVS 161
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +    T+ 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I EY    +L  +L           +D   R+  + +T   ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQMTFKDLVS 161
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +    T+ 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I EY    +L  +L           +D   R+  + +T   ++ 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQMTFKDLVS 161
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +    T+ 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I EY    +L  +L           +D   R+  + +T   ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQMTFKDLVS 161
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +    T+ 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 122
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLG 177
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 121
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  L 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLG 176
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 129
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL- 292
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  L 
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLG 184
Query: 293 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 215

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 121
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  L 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLG 176
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 119
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 174
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 122
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLG 177
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 126
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  L 
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLG 181
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 212

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++     DF        I L  +     +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAF 121
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRL-------SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+ A  R         G +    R + +E  ++  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 175 RLLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDPTKRILLDWVTRVQIIE---GIA 224
            LLG C      ++ I E+    +L  +L      F P K +  D++T   +I     +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
           +G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +              
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 121 NKLGEGGFGPVY---KGVLRKGDEIAVKRL---SGRSEQGLREMKNEASVIAKVQHKNLV 174
           +KLG GG   VY     +L    ++A+K +       E+ L+  + E    +++ H+N+V
Sbjct: 17  DKLGGGGMSTVYLAEDTILNI--KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            ++    + D   L+ EY+   +L  ++        L   T +     I  G+ + H   
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD-- 129
Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 294
            +RI+HRD+K  NIL+D +   KI DFG+A+      L   T+ ++GT  Y SPE A   
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGE 187
Query: 295 IFSIKSDVFSFGVLLLEIVSGK 316
                +D++S G++L E++ G+
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGE 209

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 129
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  L 
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLG 184
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 215

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I EY    +L  +L           +D   R+  + +T   ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQMTFKDLVS 207
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +    T+ 
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++     DF        I L  +     +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAF 120
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 175
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 210

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I EY    +L  +L           +D   R+  + +T   ++ 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQMTFKDLVS 161
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +    T+ 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLSFCHSH 122
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLG 177
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 112/214 (52%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL + H +
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  L 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLG 176
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLS-GRSEQGLREMK-NEASVIAKVQHKNLV 174
           +    K+GEG +G VYK     G+  A+K++   + ++G+      E S++ +++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRIL------LDWVTRVQIIEGIAQGLL 228
           +L      K   +L++E++             K++L      L+ VT    +  +  G+ 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQD---------LKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           Y H     R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  IV T  Y +P
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIV-TLWYRAP 169
Query: 289 EYAL-EGIFSIKSDVFSFGVLLLEIVSG 315
           +  +    +S   D++S G +  E+V+G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 120/237 (50%), Gaps = 24/237 (10%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKG--VLRKGDEIAVKRL---SGRSEQGLREMKNEASV--I 165
           A   +    ++GEG +G V+K   +   G  +A+KR+   +G     L  ++  A +  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 166 AKVQHKNLVRLLGCCI----DKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII 220
              +H N+VRL   C     D++ K+ L++E++ ++ L  +L D      +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 180
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYVWDL 336
            T  Y +PE  L+  ++   D++S G +  E+   K    L+R  S ++ LG + D+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDV 234

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 110/224 (49%), Gaps = 35/224 (15%)
Query: 110 VSTATNTFSDTNK----LGEGGFGPVYKGVLRK----GDEIAVKRLSGRSEQGLREMKNE 161
           V  +T  FSD  K    LG+G FG V   +L K    G E AVK +S R    +++  ++
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKTDK 70
Query: 162 ASVIAKVQ------HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRILLDWV 214
            S++ +VQ      H N+++L     DK    L+ E      L    FD    R     V
Sbjct: 71  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEV 126
Query: 215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNE 271
              +II  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++      E
Sbjct: 127 DAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---E 180
Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
                   +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 181 ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I EY    +L  +L           +D   R+  + +T   ++ 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQMTFKDLVS 148
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +    T+ 
Sbjct: 149 CTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I EY    +L  +L           +D   R+  + +T   ++ 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQMTFKDLVS 153
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +    T+ 
Sbjct: 154 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I EY    +L  +L           +D   R+  + +T   ++ 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQMTFKDLVS 150
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +    T+ 
Sbjct: 151 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I EY    +L  +L           +D   R+  + +T   ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQMTFKDLVS 161
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   +I+DFG+AR     +    T+ 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLS-GRSEQGLREMK-NEASVIAKVQHKNLV 174
           +    K+GEG +G VYK     G+  A+K++   + ++G+      E S++ +++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRIL------LDWVTRVQIIEGIAQGLL 228
           +L      K   +L++E++             K++L      L+ VT    +  +  G+ 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQD---------LKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           Y H     R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  +V T  Y +P
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEVV-TLWYRAP 169
Query: 289 EYAL-EGIFSIKSDVFSFGVLLLEIVSG 315
           +  +    +S   D++S G +  E+V+G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 120/237 (50%), Gaps = 24/237 (10%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKG--VLRKGDEIAVKRL---SGRSEQGLREMKNEASV--I 165
           A   +    ++GEG +G V+K   +   G  +A+KR+   +G     L  ++  A +  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 166 AKVQHKNLVRLLGCCI----DKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII 220
              +H N+VRL   C     D++ K+ L++E++ ++ L  +L D      +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 180
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYVWDL 336
            T  Y +PE  L+  ++   D++S G +  E+   K    L+R  S ++ LG + D+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDV 234

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLS-GRSEQGLREMK-NEASVIAKVQHKNLV 174
           +    K+GEG +G VYK     G+  A+K++   + ++G+      E S++ +++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRIL------LDWVTRVQIIEGIAQGLL 228
           +L      K   +L++E++             K++L      L+ VT    +  +  G+ 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQD---------LKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           Y H     R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  +V T  Y +P
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEVV-TLWYRAP 169
Query: 289 EYAL-EGIFSIKSDVFSFGVLLLEIVSG 315
           +  +    +S   D++S G +  E+V+G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 110/224 (49%), Gaps = 35/224 (15%)
Query: 110 VSTATNTFSDTNK----LGEGGFGPVYKGVLRK----GDEIAVKRLSGRSEQGLREMKNE 161
           V  +T  FSD  K    LG+G FG V   +L K    G E AVK +S R    +++  ++
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKTDK 76
Query: 162 ASVIAKVQ------HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRILLDWV 214
            S++ +VQ      H N+++L     DK    L+ E      L    FD    R     V
Sbjct: 77  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEV 132
Query: 215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNE 271
              +II  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++      E
Sbjct: 133 DAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFE 186
Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
                   +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 187 ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 120/237 (50%), Gaps = 24/237 (10%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKG--VLRKGDEIAVKRL---SGRSEQGLREMKNEASV--I 165
           A   +    ++GEG +G V+K   +   G  +A+KR+   +G     L  ++  A +  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 166 AKVQHKNLVRLLGCCI----DKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII 220
              +H N+VRL   C     D++ K+ L++E++ ++ L  +L D      +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 180
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYVWDL 336
            T  Y +PE  L+  ++   D++S G +  E+   K    L+R  S ++ LG + D+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDV 234

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 110/224 (49%), Gaps = 35/224 (15%)
Query: 110 VSTATNTFSDTNK----LGEGGFGPVYKGVLRK----GDEIAVKRLSGRSEQGLREMKNE 161
           V  +T  FSD  K    LG+G FG V   +L K    G E AVK +S R    +++  ++
Sbjct: 40  VQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKTDK 93
Query: 162 ASVIAKVQ------HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRILLDWV 214
            S++ +VQ      H N+++L     DK    L+ E      L    FD    R     V
Sbjct: 94  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEV 149
Query: 215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNE 271
              +II  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++      E
Sbjct: 150 DAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---E 203
Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
                   +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 204 ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 110/224 (49%), Gaps = 35/224 (15%)
Query: 110 VSTATNTFSDTNK----LGEGGFGPVYKGVLRK----GDEIAVKRLSGRSEQGLREMKNE 161
           V  +T  FSD  K    LG+G FG V   +L K    G E AVK +S R    +++  ++
Sbjct: 41  VQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKTDK 94
Query: 162 ASVIAKVQ------HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRILLDWV 214
            S++ +VQ      H N+++L     DK    L+ E      L    FD    R     V
Sbjct: 95  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEV 150
Query: 215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNE 271
              +II  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++      E
Sbjct: 151 DAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---E 204
Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
                   +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 205 ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRL-------SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+ A  R         G +    R + +E  ++  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 175 RLLGCCIDKDEKILIY----------EYMPNKSLDFFLFDPTKRILLDWVTRVQIIE--- 221
            LLG C      +++            Y+ +K  +F  + P + +  D++T   +I    
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKP-EDLYKDFLTLEHLIXYSF 155
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
            +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +           
Sbjct: 156 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
              +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 32/208 (15%)
Query: 123 LGEGGFGPVYKGV-LRKGDEI-------AVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           LG G FG V+KGV + +G+ I        ++  SGR  Q  + + +    I  + H ++V
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIV 96
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR--------ILLDWVTRVQIIEGIAQG 226
           RLLG C     + L+ +Y+P  SL     D  ++        +LL+W  +      IA+G
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKG 145
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL ++    ++HR+L A N+LL      +++DFG+A +   ++ Q   S       +M
Sbjct: 146 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 202
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E    G ++ +SDV+S+GV + E+++
Sbjct: 203 ALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 123 LGEGGFGPVYKGVLR-------KGDEIAVKRLSGRSE-QGLREMKNEASVIAKVQHKNLV 174
           LGEG FG V   + R        G+++AVK L   S    + ++K E  ++  + H+N+V
Sbjct: 29  LGEGHFGKVE--LCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 175 RLLGCCI-DKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           +  G C  D    I LI E++P+ SL  +L  P  +  ++   +++    I +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL-- 142
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEY 290
               + +HRDL A N+L++ +   KI DFG+ +    ++        R    + Y +PE 
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 200
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVS 314
            ++  F I SDV+SFGV L E+++
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 32/208 (15%)
Query: 123 LGEGGFGPVYKGV-LRKGDEI-------AVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           LG G FG V+KGV + +G+ I        ++  SGR  Q  + + +    I  + H ++V
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIV 78
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR--------ILLDWVTRVQIIEGIAQG 226
           RLLG C     + L+ +Y+P  SL     D  ++        +LL+W  +      IA+G
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKG 127
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL ++    ++HR+L A N+LL      +++DFG+A +   ++ Q   S       +M
Sbjct: 128 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           + E    G ++ +SDV+S+GV + E+++
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 118
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+      +AVK L  G +    R + +E  ++  + H  N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 175 RLLGCCIDKDEKILIY----------EYMPNKSLDFFLFDPTKRILLDWVTRVQIIE--- 221
            LLG C      +++            Y+ +K  +F  +   + +  D++T   +I    
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
            +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +           
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
              +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 123 LGEGGFGPVYKGVLR-------KGDEIAVKRLSGRSE-QGLREMKNEASVIAKVQHKNLV 174
           LGEG FG V   + R        G+++AVK L   S    + ++K E  ++  + H+N+V
Sbjct: 17  LGEGHFGKVE--LCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 175 RLLGCCI-DKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           +  G C  D    I LI E++P+ SL  +L  P  +  ++   +++    I +G+ YL  
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL-- 130
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEY 290
               + +HRDL A N+L++ +   KI DFG+ +    ++        R    + Y +PE 
Sbjct: 131 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 188
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVS 314
            ++  F I SDV+SFGV L E+++
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+   RL   +E        E S++ ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 122
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLG 177
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+   RL   +E        E S++ ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 121
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE  L 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLG 176
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 121
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE  L 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPEILLG 176
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 118
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           K+GEG  G V    +R  G  +AVK++  R +Q    + NE  ++   QH+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +  DE  ++ E++   +L     D      ++      +   + Q L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 299
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 300 SDVFSFGVLLLEIVSGK 316
            D++S G++++E+V G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 121
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 120
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 175
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 210

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 118
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 121 NKLGEGGFGPVYKGVLRKG---------DEIAVKRLSGRSEQGLREMKNEASVIAKVQHK 171
            K+GEG FG   K +L K           EI + R+S +  +   E + E +V+A ++H 
Sbjct: 30  QKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKERE---ESRREVAVLANMKHP 83
Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
           N+V+      +     ++ +Y     L F   +  K +L       QI++   Q  L L 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDL-FKRINAQKGVLFQ---EDQILDWFVQICLALK 139
Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
                +I+HRD+K+ NI L KD   ++ DFG+AR+       A     +GT  Y+SPE  
Sbjct: 140 HVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC--IGTPYYLSPEIC 197
Query: 292 LEGIFSIKSDVFSFGVLLLEIVSGK 316
               ++ KSD+++ G +L E+ + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  + A + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 119
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 174
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 120
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 175
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 210

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           K+GEG  G V    +R  G  +AVK++  R +Q    + NE  ++   QH+N+V +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +  DE  ++ E++   +L     D      ++      +   + Q L  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 299
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 300 SDVFSFGVLLLEIVSGK 316
            D++S G++++E+V G+
Sbjct: 206 VDIWSLGIMVIEMVDGE 222

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           K+GEG  G V    +R  G  +AVK++  R +Q    + NE  ++   QH+N+V +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +  DE  ++ E++   +L     D      ++      +   + Q L  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 299
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 300 SDVFSFGVLLLEIVSGK 316
            D++S G++++E+V G+
Sbjct: 201 VDIWSLGIMVIEMVDGE 217

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 120
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 175
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 210

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 121
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE  L 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPEILLG 176
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           K+GEG  G V    +R  G  +AVK++  R +Q    + NE  ++   QH+N+V +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +  DE  ++ E++   +L     D      ++      +   + Q L  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 150
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 299
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 300 SDVFSFGVLLLEIVSGK 316
            D++S G++++E+V G+
Sbjct: 208 VDIWSLGIMVIEMVDGE 224

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 119
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 174
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 122
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 177
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 212

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 118
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 121
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 108/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I  Y    +L  +L           +D   R+  + +T   ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYD-INRVPEEQMTFKDLVS 161
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +    T+ 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +     +  + QGL + H +
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSH 123
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE  L 
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPEILLG 178
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
              +S   D++S G +  E+V+ +    L+  DS
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 16/219 (7%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-DPTKRILLDWVTRVQIIEGIAQGLL 228
           H N+V+LL     +++  L++E++   S+D   F D +    +        +  + QGL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAP 175
Query: 289 EYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
           E  L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 53/233 (22%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           F +   +G GGFG V+K   R  G    ++R+   +E+  RE+K     +AK+ H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVK----ALAKLDHVNIVH 69
Query: 176 LLGCCIDKDEKILIYEYMP---NKSLDFFLFDPT---------------------KRILL 211
             GC          ++Y P   + SL+   +DP                      K  L 
Sbjct: 70  YNGCWDG-------FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLE 122
Query: 212 DWVTR-----------VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD 260
            W+ +           +++ E I +G+ Y+H     ++IHRDLK SNI L      KI D
Sbjct: 123 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGD 179
Query: 261 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 313
           FG+      +      +R  GT  YMSPE      +  + D+++ G++L E++
Sbjct: 180 FGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 16/219 (7%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-DPTKRILLDWVTRVQIIEGIAQGLL 228
           H N+V+LL     +++  L++E++   S+D   F D +    +        +  + QGL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAP 173
Query: 289 EYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
           E  L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 110 VSTATNTFSDTNK----LGEGGFGPVYKGVLRK----GDEIAVKRLSGRSEQGLREMKNE 161
           V  +T  FSD  K    LG+G FG V   +L K    G E AVK +S R    +++  ++
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKTDK 70
Query: 162 ASVIAKVQ------HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRILLDWV 214
            S++ +VQ      H N+ +L     DK    L+ E      L    FD    R     V
Sbjct: 71  ESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEV 126
Query: 215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNE 271
              +II  +  G+ Y H   + +I+HRDLK  N+LL+   KD N +I DFG++      E
Sbjct: 127 DAARIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---E 180
Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
                   +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 181 ASKKXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           LG+G +G VY G  L     IA+K +  R  +  + +  E ++   ++HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 182 DKDEKILIYEYMPNKSLDFFL---FDPTK--RILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
           +     +  E +P  SL   L   + P K     + + T+ QI+E    GL YLH     
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLHDN--- 141
Query: 237 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
           +I+HRD+K  N+L++      KISDFG ++   G  +   T    GT  YM+PE   +G 
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 199
Query: 296 --FSIKSDVFSFGVLLLEIVSGK 316
             +   +D++S G  ++E+ +GK
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 112/235 (47%), Gaps = 23/235 (9%)
Query: 94  SKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQ 153
           S  + +D++ L   S++      F     +G G +G VYKG   K  ++A  ++   +  
Sbjct: 6   SPARSLDEIDL---SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62
Query: 154 GLREMKNEASVIAKV-QHKNLVRLLGCCIDK------DEKILIYEYMPNKSLDFFLFDPT 206
              E+K E +++ K   H+N+    G  I K      D+  L+ E+    S+   + +  
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 207 KRILLD-WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR 265
              L + W+    I   I +GL +LHQ+   ++IHRD+K  N+LL ++   K+ DFG++ 
Sbjct: 123 GNTLKEEWI--AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 266 ICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSG 315
                  + NT   +GT  +M+PE        +  +  KSD++S G+  +E+  G
Sbjct: 178 QLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLV 174
           F     LG GGFG V++   +  D   A+KR+   + +  RE +  E   +AK++H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE------------G 222
           R     ++K+    +    P   L   +    K  L DW+     IE             
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--------- 273
           IA+ + +LH      ++HRDLK SNI    D   K+ DFG+      +E +         
Sbjct: 127 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 274 -ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 313
            A  +  VGT  YMSPE      +S K D+FS G++L E++
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           K+GEG  G V    +R  G  +AVK++  R +Q    + NE  ++   QH+N+V +    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE--------GIAQGLLYLHQ 232
           +  DE  ++ E++   +L             D VT  ++ E         + Q L  LH 
Sbjct: 218 LVGDELWVVMEFLEGGALT------------DIVTHTRMNEEQIAAVCLAVLQALSVLHA 265
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYA 291
                +IHRD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE  
Sbjct: 266 QG---VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELI 319
Query: 292 LEGIFSIKSDVFSFGVLLLEIVSGK 316
               +  + D++S G++++E+V G+
Sbjct: 320 SRLPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 108/216 (50%), Gaps = 28/216 (12%)
Query: 123 LGEGGFGPVY--------KGVLRKGDEIAVKRLSG-RSEQGLREMKNEASVIAKV-QHKN 172
           LGEG FG V         K   ++   +AVK L    +E+ L ++ +E  ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRILLDWVTRVQIIE 221
           ++ LLG C       +I  Y    +L  +L           +D   R+  + +T   ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYD-INRVPEEQMTFKDLVS 161
Query: 222 ---GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     +    T+ 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                 +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           LG+G +G VY G  L     IA+K +  R  +  + +  E ++   ++HKN+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 182 DKDEKILIYEYMPNKSLDFFL---FDPTK--RILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
           +     +  E +P  SL   L   + P K     + + T+ QI+E    GL YLH     
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLHDN--- 127
Query: 237 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
           +I+HRD+K  N+L++      KISDFG ++   G  +   T    GT  YM+PE   +G 
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 185
Query: 296 --FSIKSDVFSFGVLLLEIVSGK 316
             +   +D++S G  ++E+ +GK
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGK 208

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 25/217 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLLGCCI 181
           +G+G +G V++G   +G+ +AVK  S R E+   RE +   +V+  ++H+N++  +   +
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 72
Query: 182 ----DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH-----Q 232
                  +  LI  Y    SL    +D  +   LD V+ ++I+  IA GL +LH      
Sbjct: 73  TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 290
             +  I HRDLK+ NIL+ K+    I+D G+A +     N+L    +  VGT  YM+PE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 291 ALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGL 321
             E I         + D+++FG++L E+     + G+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 14/218 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQ 169
           +   F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H N+V+LL     +++  L++E++      F        I L  +     +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAF 121
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 25/217 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLLGCCI 181
           +G+G +G V++G   +G+ +AVK  S R E+   RE +   +V+  ++H+N++  +   +
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 72
Query: 182 ----DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH-----Q 232
                  +  LI  Y    SL    +D  +   LD V+ ++I+  IA GL +LH      
Sbjct: 73  TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 290
             +  I HRDLK+ NIL+ K+    I+D G+A +     N+L    +  VGT  YM+PE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 291 ALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGL 321
             E I         + D+++FG++L E+     + G+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 25/217 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLLGCCI 181
           +G+G +G V++G   +G+ +AVK  S R E+   RE +   +V+  ++H+N++  +   +
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 101
Query: 182 ----DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH-----Q 232
                  +  LI  Y    SL    +D  +   LD V+ ++I+  IA GL +LH      
Sbjct: 102 TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 290
             +  I HRDLK+ NIL+ K+    I+D G+A +     N+L    +  VGT  YM+PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 217
Query: 291 ALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGL 321
             E I         + D+++FG++L E+     + G+
Sbjct: 218 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 254

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           K+GEG  G V    +R  G  +AVK++  R +Q    + NE  ++   QH+N+V +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE--------GIAQGLLYLHQ 232
           +  DE  ++ E++   +L             D VT  ++ E         + Q L  LH 
Sbjct: 141 LVGDELWVVMEFLEGGALT------------DIVTHTRMNEEQIAAVCLAVLQALSVLHA 188
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYA 291
                +IHRD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE  
Sbjct: 189 QG---VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELI 242
Query: 292 LEGIFSIKSDVFSFGVLLLEIVSGK 316
               +  + D++S G++++E+V G+
Sbjct: 243 SRLPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 123 LGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQG--LREMKNEASVIAKVQHKNLVRLLGC 179
           LG+G FG V K   R    E AVK ++  S +      +  E  ++ K+ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPT-KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
             D     ++ E      L    FD   KR         +II+ +  G+ Y+H+++   I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 239 IHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRI--VGTYGYMSPEYALE 293
           +HRDLK  NILL   +KD + KI DFG++  C     Q NT     +GT  Y++PE  L 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLS-TC----FQQNTKMKDRIGTAYYIAPE-VLR 196
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
           G +  K DV+S GV+L  ++SG
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 73  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 126
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 187 VDVWSCGIVLTAMLAGE 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           F +   +G GGFG V+K   R  G    +KR+   +E+  RE+K     +AK+ H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK----ALAKLDHVNIVH 68
Query: 176 LLGCC--IDKDEK--------------ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI 219
             GC    D D +               +  E+    +L+ ++ +  +   LD V  +++
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
            E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      +       R 
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRXRS 181
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 313
            GT  YMSPE      +  + D+++ G++L E++
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 104/194 (53%), Gaps = 19/194 (9%)
Query: 123 LGEGGFGPVYKGV-LRKGDEIAVK----RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           LGEG FG V        G ++A+K    ++  +S+   R ++ E S +  ++H ++++L 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 70
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
                KDE I++ EY  N+  D+ +    +R  +      +  + I   + Y H++   +
Sbjct: 71  DVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---K 123
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGIF 296
           I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ +     G+  Y +PE     ++
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKLY 179
Query: 297 S-IKSDVFSFGVLL 309
           +  + DV+S GV+L
Sbjct: 180 AGPEVDVWSCGVIL 193

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAV----KRLSGRSEQGLREMKNEASVIAKVQH 170
           NTF     LG+GGFG V    +R   ++      ++   +  +G     NE  ++ KV  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           + +V L      KD   L+   M    L F ++   +    +        E I  GL  L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDL 302
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE 289
           H   R RI++RDLK  NILLD   + +ISD G+A  +  G  ++      VGT GYM+PE
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPE 355
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGK 316
                 ++   D ++ G LL E+++G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 123 LGEGGFGPVYKGVLRKGD-EIAVKR---LSGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G G +G   K + RK D +I V +       +E   + + +E +++ +++H N+VR   
Sbjct: 14  IGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 179 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTK-RILLDWVTRVQIIEGIAQGLLYLHQYSR 235
             ID+    L  + EY     L   +   TK R  LD    ++++  +   L   H+ S 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 236 --VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               ++HRDLK +N+ LD   N K+ DFG+ARI   +   A T   VGT  YMSPE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNR 190
Query: 294 GIFSIKSDVFSFGVLLLEIVS 314
             ++ KSD++S G LL E+ +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 104/194 (53%), Gaps = 19/194 (9%)
Query: 123 LGEGGFGPVYKGV-LRKGDEIAVK----RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           LGEG FG V        G ++A+K    ++  +S+   R ++ E S +  ++H ++++L 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 80
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
                KDE I++ EY  N+  D+ +    +R  +      +  + I   + Y H++   +
Sbjct: 81  DVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---K 133
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGIF 296
           I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ +     G+  Y +PE     ++
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKLY 189
Query: 297 S-IKSDVFSFGVLL 309
           +  + DV+S GV+L
Sbjct: 190 AGPEVDVWSCGVIL 203

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAV----KRLSGRSEQGLREMKNEASVIAKVQH 170
           NTF     LG+GGFG V    +R   ++      ++   +  +G     NE  ++ KV  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           + +V L      KD   L+   M    L F ++   +    +        E I  GL  L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDL 302
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE 289
           H   R RI++RDLK  NILLD   + +ISD G+A  +  G  ++      VGT GYM+PE
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPE 355
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGK 316
                 ++   D ++ G LL E+++G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 188
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 104/194 (53%), Gaps = 19/194 (9%)
Query: 123 LGEGGFGPVYKGV-LRKGDEIAVK----RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           LGEG FG V        G ++A+K    ++  +S+   R ++ E S +  ++H ++++L 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 79
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
                KDE I++ EY  N+  D+ +    +R  +      +  + I   + Y H++   +
Sbjct: 80  DVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---K 132
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGIF 296
           I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ +     G+  Y +PE     ++
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKLY 188
Query: 297 S-IKSDVFSFGVLL 309
           +  + DV+S GV+L
Sbjct: 189 AGPEVDVWSCGVIL 202

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 104/194 (53%), Gaps = 19/194 (9%)
Query: 123 LGEGGFGPVYKGV-LRKGDEIAVK----RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           LGEG FG V        G ++A+K    ++  +S+   R ++ E S +  ++H ++++L 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 74
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
                KDE I++ EY  N+  D+ +    +R  +      +  + I   + Y H++   +
Sbjct: 75  DVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---K 127
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGIF 296
           I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ +     G+  Y +PE     ++
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKLY 183
Query: 297 S-IKSDVFSFGVLL 309
           +  + DV+S GV+L
Sbjct: 184 AGPEVDVWSCGVIL 197

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 123 LGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQG--LREMKNEASVIAKVQHKNLVRLLGC 179
           LG+G FG V K   R    E AVK ++  S +      +  E  ++ K+ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPT-KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
             D     ++ E      L    FD   KR         +II+ +  G+ Y+H+++   I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 239 IHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRI--VGTYGYMSPEYALE 293
           +HRDLK  NILL   +KD + KI DFG++  C     Q NT     +GT  Y++PE  L 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLS-TC----FQQNTKMKDRIGTAYYIAPE-VLR 196
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
           G +  K DV+S GV+L  ++SG
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 123 LGEGGFGPVYKGVLRKGD-EIAVKR---LSGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G G +G   K + RK D +I V +       +E   + + +E +++ +++H N+VR   
Sbjct: 14  IGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 179 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTK-RILLDWVTRVQIIEGIAQGLLYLHQYSR 235
             ID+    L  + EY     L   +   TK R  LD    ++++  +   L   H+ S 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 236 --VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               ++HRDLK +N+ LD   N K+ DFG+ARI   +E  A     VGT  YMSPE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMNR 190
Query: 294 GIFSIKSDVFSFGVLLLEIVS 314
             ++ KSD++S G LL E+ +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 123 LGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQG--LREMKNEASVIAKVQHKNLVRLLGC 179
           LG+G FG V K   R    E AVK ++  S +      +  E  ++ K+ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPT-KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
             D     ++ E      L    FD   KR         +II+ +  G+ Y+H+++   I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 239 IHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRI--VGTYGYMSPEYALE 293
           +HRDLK  NILL   +KD + KI DFG++  C     Q NT     +GT  Y++PE  L 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLS-TC----FQQNTKMKDRIGTAYYIAPE-VLR 196
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
           G +  K DV+S GV+L  ++SG
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLREMKNEASVIAK 167
            +      F     LG+G FG V+    +K ++  A+K L  + +  L +   E +++ K
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVECTMVEK 69
Query: 168 ------VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
                  +H  L  +      K+    + EY+    L + +    K    D         
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAA 126
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIV 280
            I  GL +LH      I++RDLK  NILLDKD + KI+DFGM   C  N L  A T+   
Sbjct: 127 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNEFC 180
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           GT  Y++PE  L   ++   D +SFGVLL E++ G+
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 119/236 (50%), Gaps = 23/236 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS-GRSEQGLR-EMKNEASVIAKVQ 169
           AT+ +    ++G G +G VYK      G  +A+K +     E+GL      E +++ +++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 170 ---HKNLVRLLGCC----IDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
              H N+VRL+  C     D++ K+ L++E++ ++ L  +L D      L   T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
              +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q   + +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVV 173
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYVWDL 336
           T  Y +PE  L+  ++   D++S G +  E+   K    L+  +S  + LG ++DL
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP---LFCGNSEADQLGKIFDL 226

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLREMKNEASVIAK------VQHKNLVR 175
           LG+G FG V+    +K ++  A+K L  + +  L +   E +++ K       +H  L  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           +      K+    + EY+    L + +    K    D          I  GL +LH    
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG- 138
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEG 294
             I++RDLK  NILLDKD + KI+DFGM   C  N L  A T+   GT  Y++PE  L  
Sbjct: 139 --IVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNXFCGTPDYIAPEILLGQ 193
Query: 295 IFSIKSDVFSFGVLLLEIVSGK 316
            ++   D +SFGVLL E++ G+
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+      +AVK L  G +    R + +E  ++  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 175 RLLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDPTK----RILLDWVTRVQIIE-- 221
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+      +AVK L  G +    R + +E  ++  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 175 RLLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDPTKR----ILLDWVTRVQIIE-- 221
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+      +AVK L  G +    R + +E  ++  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 175 RLLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDPTK----RILLDWVTRVQIIE-- 221
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+      +AVK L  G +    R + +E  ++  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 175 RLLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDPTK----RILLDWVTRVQIIE-- 221
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKV 168
           + F   ++LG G  G V K   R    I  ++L           Q +RE++    V+ + 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
               +V   G      E  +  E+M   SLD  L +  KRI  + + +V I   + +GL 
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSI--AVLRGLA 128
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YM+P
Sbjct: 129 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMAP 182
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E      +S++SD++S G+ L+E+  G+
Sbjct: 183 ERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+      +AVK L  G +    R + +E  ++  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 175 RLLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDPTK----RILLDWVTRVQIIE-- 221
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 113/220 (51%), Gaps = 34/220 (15%)
Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ------GLREMKNEASVIA 166
            + +    K+G+G FG V+K   RK G ++A+K++   +E+       LRE+K    ++ 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQ 72
Query: 167 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--------- 217
            ++H+N+V L+  C  K        Y   K+  + +FD  +  L   ++ V         
Sbjct: 73  LLKHENVVNLIEICRTKAS-----PYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 218 -QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---ICGGNELQ 273
            ++++ +  GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR   +   ++  
Sbjct: 128 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 274 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 312
              +R+V T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 126 GGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC-----C 180
           G FG V+K  L   + +AVK    + +Q  +  + E   +  ++H+N+++ +G       
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-------Y 233
           +D D   LI  +    SL  FL    K  ++ W     I E +A+GL YLH+        
Sbjct: 93  VDVD-LWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
            +  I HRD+K+ N+LL  ++   I+DFG+A      +   +T   VGT  YM+PE  LE
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VLE 206
Query: 294 GIFSIKSDVF------SFGVLLLEIVS 314
           G  + + D F      + G++L E+ S
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           K+GEG  G V     +  G ++AVK++  R +Q    + NE  ++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +  DE  ++ E++   +L     D      ++      +   + + L YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 299
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 300 SDVFSFGVLLLEIVSGK 316
            D++S G++++E++ G+
Sbjct: 222 VDIWSLGIMVIEMIDGE 238

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 15/220 (6%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           ++LG+G FG V    Y  +    G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 176 LLGCCID--KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G      + E  L+ EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 127
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYA 291
              R +HRDL A NIL++ + + KI+DFG+A++   ++      R  G     + +PE  
Sbjct: 128 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DXXVVREPGQSPIFWYAPESL 186
Query: 292 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG 331
            + IFS +SDV+SFGV+L E+ +    +     + L ++G
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 226

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+      +AVK L  G +    R + +E  ++  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 175 RLLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDPTK----RILLDWVTRVQIIE-- 221
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 118/236 (50%), Gaps = 23/236 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS-GRSEQGLR-EMKNEASVIAKVQ 169
           AT+ +    ++G G +G VYK      G  +A+K +     E+GL      E +++ +++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 170 ---HKNLVRLLGCC----IDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
              H N+VRL+  C     D++ K+ L++E++ ++ L  +L D      L   T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
              +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q     +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDPVVV 173
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYVWDL 336
           T  Y +PE  L+  ++   D++S G +  E+   K    L+  +S  + LG ++DL
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP---LFCGNSEADQLGKIFDL 226

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           LGEG  G V   V R  +E +AVK +   R+      +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            + + + L  EY     L F   +P   I +      +    +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITH 127
Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 301 -DVFSFGVLLLEIVSGK 316
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 123 LGEGGFGPVYKGVLRKGD-EIAVKR---LSGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G G +G   K + RK D +I V +       +E   + + +E +++ +++H N+VR   
Sbjct: 14  IGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 179 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTK-RILLDWVTRVQIIEGIAQGLLYLHQYSR 235
             ID+    L  + EY     L   +   TK R  LD    ++++  +   L   H+ S 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 236 --VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               ++HRDLK +N+ LD   N K+ DFG+ARI   N   +     VGT  YMSPE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPEQMNR 190
Query: 294 GIFSIKSDVFSFGVLLLEIVS 314
             ++ KSD++S G LL E+ +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 110/212 (51%), Gaps = 34/212 (16%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ------GLREMKNEASVIAKVQHKNLV 174
           K+G+G FG V+K   RK G ++A+K++   +E+       LRE+K    ++  ++H+N+V
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 80
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV----------QIIEGIA 224
            L+  C  K        Y   K   + +FD  +  L   ++ V          ++++ + 
Sbjct: 81  NLIEICRTKASP-----YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---ICGGNELQANTSRIVG 281
            GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR   +   ++     +R+V 
Sbjct: 136 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 282 TYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 312
           T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   +   L   +K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 177
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+      +AVK L  G +    R + +E  ++  + H  N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 175 RLLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDPTK----RILLDWVTRVQIIE-- 221
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+      +AVK L  G +    R + +E  ++  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 175 RLLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDPTK----RILLDWVTRVQIIE-- 221
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRL--SGRSEQGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I A+K L  +   + G+  +++ E  + + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 149 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 198
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHK-NLV 174
           LG G FG V +      D+      +AVK L  G +    R + +E  ++  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 175 RLLGCCIDKDEKIL-IYEYMPNKSLDFFL------FDPTK----RILLDWVTRVQIIE-- 221
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 106 SFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNE 161
           +  S   A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             + + ++H N++RL G   D     LI EY P   L     +  K    D       I 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYIT 118
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--- 278
            +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   
Sbjct: 119 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAA 168
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 112/220 (50%), Gaps = 34/220 (15%)
Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ------GLREMKNEASVIA 166
            + +    K+G+G FG V+K   RK G ++A+K++   +E+       LRE+K    ++ 
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQ 71
Query: 167 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--------- 217
            ++H+N+V L+  C  K        Y   K   + +FD  +  L   ++ V         
Sbjct: 72  LLKHENVVNLIEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 126
Query: 218 -QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---ICGGNELQ 273
            ++++ +  GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR   +   ++  
Sbjct: 127 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 274 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 312
              +R+V T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 184 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 112/220 (50%), Gaps = 34/220 (15%)
Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ------GLREMKNEASVIA 166
            + +    K+G+G FG V+K   RK G ++A+K++   +E+       LRE+K    ++ 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQ 72
Query: 167 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--------- 217
            ++H+N+V L+  C  K        Y   K   + +FD  +  L   ++ V         
Sbjct: 73  LLKHENVVNLIEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 218 -QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---ICGGNELQ 273
            ++++ +  GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR   +   ++  
Sbjct: 128 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 274 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 312
              +R+V T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 172
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDTLCGTLDY 173
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 173
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 172
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 125 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDY 174
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTELCGTLDY 172
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 118/236 (50%), Gaps = 23/236 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS-GRSEQGLR-EMKNEASVIAKVQ 169
           AT+ +    ++G G +G VYK      G  +A+K +     E+GL      E +++ +++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 170 ---HKNLVRLLGCC----IDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
              H N+VRL+  C     D++ K+ L++E++ ++ L  +L D      L   T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
              +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q     +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVV 173
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYVWDL 336
           T  Y +PE  L+  ++   D++S G +  E+   K    L+  +S  + LG ++DL
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP---LFCGNSEADQLGKIFDL 226

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 175
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P  ++   L   +K    D       I  +A  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALS 121
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 122 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 171
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 172
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRL--SGRSEQGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I A+K L  +   + G+  +++ E  + + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 149 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDY 198
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P  ++   L   +K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALS 122
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDY 172
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 123 LGEGGFGPVYKGVL--RKGDEIAVKRLSGRSEQGL---REMKNEASVIAKVQHKNLVRLL 177
           LGEG FG VY+GV    KG++I V   + + +  L    +  +EA ++  + H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I+++   +I E  P   L  +L     +  L  +T V     I + + YL     + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 129
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+   NIL+      K+ DFG++R I   +  +A+ +R+     +MSPE      F
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 187
Query: 297 SIKSDVFSFGVLLLEIVSGKKNTGLY 322
           +  SDV+ F V + EI+S  K    +
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPFFW 213

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 37/288 (12%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           ++LG+G FG V    Y  +    G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 176 LLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G       + L  + EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 130
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSP 288
              R +HRDL A NIL++ + + KI+DFG+A++   ++      +   S I     + +P
Sbjct: 131 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 186
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL----- 343
           E   + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+   +R L     
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEE 246
Query: 344 --ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
              L   P    E            +  LC   S  DRP+ + +   L
Sbjct: 247 GQRLPAPPACPAEVH---------ELMKLCWAPSPQDRPSFSALGPQL 285

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 177
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRL--SGRSEQGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I A+K L  +   + G+  +++ E  + + +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 140 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 189
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P  ++   L   +K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALS 122
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDY 172
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P  ++   L   +K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALS 122
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTXLCGTLDY 172
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 26/219 (11%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGD----EIAVKRLSGR--SEQGLREMKNEASVIAKV 168
             F+    LG+G FG V +  L++ D    ++AVK L     +   + E   EA+ + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 169 QHKNLVRLLGCCIDKDEK------ILIYEYMPNKSLDFFLFDPTKRIL-----LDWVTRV 217
            H ++ +L+G  +    K      ++I  +M +  L  FL     RI      L   T V
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL--ASRIGENPFNLPLQTLV 140
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQAN 275
           + +  IA G+ YL   S    IHRDL A N +L +DM   ++DFG++R    G    Q  
Sbjct: 141 RFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
            S++     +++ E   + ++++ SDV++FGV + EI++
Sbjct: 198 ASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 107 FSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEA 162
             S   A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E 
Sbjct: 3   LGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            + + ++H N++RL G   D     LI EY P  ++   L   +K    D       I  
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITE 119
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---I 279
           +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   +
Sbjct: 120 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDL 169
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
            GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 37/288 (12%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           ++LG+G FG V    Y  +    G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 176 LLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G       + L  + EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 143
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSP 288
              R +HRDL A NIL++ + + KI+DFG+A++   ++      +   S I     + +P
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 199
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL----- 343
           E   + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+   +R L     
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 344 --ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
              L   P    E            +  LC   S  DRP+ + +   L
Sbjct: 260 GQRLPAPPACPAEVH---------ELMKLCWAPSPQDRPSFSALGPQL 298

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKVQHKN 172
           F     LG+G FG VY    R+   I   ++  +++    G+  +++ E  + + ++H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           ++RL G   D     LI EY P   L     +  K    D       I  +A  L Y H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPE 289
               R+IHRD+K  N+LL  +   KI+DFG +       + A +SR   + GT  Y+ PE
Sbjct: 131 ---KRVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPE 180
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSG 315
                +   K D++S GVL  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 13/160 (8%)
Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-----DFFLFDPTKRILL 211
           + KNE  +I  ++++  +   G   + DE  +IYEYM N S+      FF+ D      +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 212 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
                  II+ +     Y+H  +   I HRD+K SNIL+DK+   K+SDFG +      +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 272 LQANTSRIVGTYGYMSPE-YALEGIFS-IKSDVFSFGVLL 309
           ++   SR  GTY +M PE ++ E  ++  K D++S G+ L
Sbjct: 207 IKG--SR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 177
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P  ++   L   +K    D       I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALS 125
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDY 175
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKVQHKN 172
           F     LG+G FG VY    R+   I   ++  +++    G+  +++ E  + + ++H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           ++RL G   D     LI EY P   L     +  K    D       I  +A  L Y H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPE 289
               R+IHRD+K  N+LL  +   KI+DFG +       + A +SR   + GT  Y+ PE
Sbjct: 131 ---KRVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRDTLCGTLDYLPPE 180
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSG 315
                +   K D++S GVL  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P  ++   L   +K    D       I  +A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALS 126
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 127 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 176
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P  ++   L   +K    D       I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALS 125
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 175
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 115 NTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSG--RSEQGLREMKNEASVIAKVQHK 171
            T+     +G G +G V   +  R G+++A+K+LS   +SE   +    E  ++  +QH+
Sbjct: 42  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 101
Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQIIEGIAQ-- 225
           N++ LL              + P  SL    DF+L  P  +  L  +  ++  E   Q  
Sbjct: 102 NVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYL 149
Query: 226 ------GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
                 GL Y+H      ++HRDLK  N+ +++D   KI DFG+AR        A  +  
Sbjct: 150 VYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGY 201
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 202 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRL--SGRSEQGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I A+K L  +   + G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   +   L   +K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLXGTLDY 177
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 123 LGEGGFGPVYKGVL--RKGDEIAVKRLSGRSEQGL---REMKNEASVIAKVQHKNLVRLL 177
           LGEG FG VY+GV    KG++I V   + + +  L    +  +EA ++  + H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I+++   +I E  P   L  +L     +  L  +T V     I + + YL     + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 145
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+   NIL+      K+ DFG++R I   +  +A+ +R+     +MSPE      F
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 203
Query: 297 SIKSDVFSFGVLLLEIVSGKKNTGLY 322
           +  SDV+ F V + EI+S  K    +
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPFFW 229

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 115 NTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSG--RSEQGLREMKNEASVIAKVQHK 171
            T+     +G G +G V   +  R G+++A+K+LS   +SE   +    E  ++  +QH+
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQIIEGIAQ-- 225
           N++ LL              + P  SL    DF+L  P  +  L  +  ++  E   Q  
Sbjct: 84  NVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL 131
Query: 226 ------GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
                 GL Y+H      ++HRDLK  N+ +++D   KI DFG+AR        A  +  
Sbjct: 132 VYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGY 183
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIA 166
           SS     + F     LG+G FG V    +++ GD  AVK L  + +  L++   E ++  
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL--KKDVILQDDDVECTMTE 73
Query: 167 KV------QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII 220
           K        H  L +L  C    D    + E++    L F +     R   +   R    
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAA 131
Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSR 278
           E I   L++LH      II+RDLK  N+LLD + + K++DFGM +  IC G      T+ 
Sbjct: 132 E-IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG----VTTAT 183
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
             GT  Y++PE   E ++    D ++ GVLL E++ G 
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +G+G FG VY G  R   E+A++   +   +E  L+  K E     + +H+N+V  +G C
Sbjct: 41  IGKGRFGQVYHG--RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +      +I      ++L   + D   +I+LD     QI + I +G+ YLH      I+H
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILH 153
Query: 241 RDLKASNILLDKDMNPK--ISDFGMARICGGNELQANTSRIVGTYGY-----------MS 287
           +DLK+ N+  D   N K  I+DFG+  I G  +      ++    G+           +S
Sbjct: 154 KDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI 346
           P+   + + FS  SDVF+ G +  E+ +       ++T     +  +W + T  +     
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHA---REWPFKTQPAEAI--IWQMGTGMK----- 260
Query: 347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
             P L      K++     +I L C     ++RPT   ++ ML
Sbjct: 261 --PNLSQIGMGKEI----SDILLFCWAFEQEERPTFTKLMDML 297

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 123 LGEGGFGPVYKGVL--RKGDEIAVKRLSGRSEQGL---REMKNEASVIAKVQHKNLVRLL 177
           LGEG FG VY+GV    KG++I V   + + +  L    +  +EA ++  + H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I+++   +I E  P   L  +L     +  L  +T V     I + + YL     + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 133
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+   NIL+      K+ DFG++R I   +  +A+ +R+     +MSPE      F
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 191
Query: 297 SIKSDVFSFGVLLLEIVSGKKN 318
           +  SDV+ F V + EI+S  K 
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQ 213

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 121 NKLGEGGFGPV----YKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           ++LG+G FG V    Y  +    G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 176 LLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
             G       + L  + EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 131
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSP 288
              R +HRDL A NIL++ + + KI+DFG+A++   ++      +   S I     + +P
Sbjct: 132 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 187
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG 331
           E   + IFS +SDV+SFGV+L E+ +    +     + L ++G
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 230

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 111/215 (51%), Gaps = 23/215 (10%)
Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKR--LSGRSEQ-------GLREMK 159
           V +    +   + LGEG F  VYK   +  ++I A+K+  L  RSE         LRE+K
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 160 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI 219
               ++ ++ H N++ LL     K    L++++M    L+  + D +  +    +    +
Sbjct: 65  ----LLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYML 119
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           +    QGL YLHQ+    I+HRDLK +N+LLD++   K++DFG+A+  G    +A   ++
Sbjct: 120 M--TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYXHQV 173
Query: 280 VGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIV 313
           V T  Y +PE      ++ +  D+++ G +L E++
Sbjct: 174 V-TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKV 168
           + F   ++LG G  G V+K   +    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
               +V   G      E  +  E+M   SLD  L     RI    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKV 168
           + F   ++LG G  G V+K   +    +  ++L           Q +RE++    V+ + 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 123
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
               +V   G      E  +  E+M   SLD  L     RI    + +V I   + +GL 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 180
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 181 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 234
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E      +S++SD++S G+ L+E+  G+
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAV----KRLSGRSEQGLREMKNEASVIAKVQHKN 172
           F D   LG GGFG V+   ++   ++       +   +  +G +    E  ++AKV  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-----PTKRILLDWVTRVQIIEGIAQGL 227
           +V L      K +  L+   M    + + +++     P  +         QI+     GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYM 286
            +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    GT G+M
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFM 356
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +PE  L   +    D F+ GV L E+++ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 106/201 (52%), Gaps = 19/201 (9%)
Query: 123 LGEGGFGPV-----YKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           LGEG FG V     YK   +   +   ++L  +S+  +R ++ E S +  ++H ++++L 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
                  + +++ EY   +  D+ +    KR+  D   R    + I   + Y H++   +
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRR--FFQQIICAIEYCHRH---K 128
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGIF 296
           I+HRDLK  N+LLD ++N KI+DFG++ I   GN L+ +     G+  Y +PE     ++
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVINGKLY 184
Query: 297 S-IKSDVFSFGVLLLEIVSGK 316
           +  + DV+S G++L  ++ G+
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGR 205

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P  ++   L   +K    D       I  +A  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALS 119
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 120 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 169
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 104 LFSFSSVSTATNTFSDTNKLGEGGFGPVY---KGVLRKGDEIAVKRLSGRSEQGLREMKN 160
           +F  S     +  +    KLG G +G V      V      I + R +  S     ++  
Sbjct: 26  MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 161 EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRILLDWVTRVQI 219
           E +V+  + H N+++L     DK    L+ E      L    FD    R+  + V    I
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVI 141
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANT 276
           I+ +  G+ YLH+++   I+HRDLK  N+LL   +KD   KI DFG++ +    E Q   
Sbjct: 142 IKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKM 195
Query: 277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
              +GT  Y++PE  L   +  K DV+S GV+L  +++G
Sbjct: 196 KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAV----KRLSGRSEQGLREMKNEASVIAKVQHKN 172
           F D   LG GGFG V+   ++   ++       +   +  +G +    E  ++AKV  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-----PTKRILLDWVTRVQIIEGIAQGL 227
           +V L      K +  L+   M    + + +++     P  +         QI+     GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYM 286
            +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    GT G+M
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFM 356
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +PE  L   +    D F+ GV L E+++ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAV----KRLSGRSEQGLREMKNEASVIAKVQHKN 172
           F D   LG GGFG V+   ++   ++       +   +  +G +    E  ++AKV  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-----PTKRILLDWVTRVQIIEGIAQGL 227
           +V L      K +  L+   M    + + +++     P  +         QI+     GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYM 286
            +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    GT G+M
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFM 356
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +PE  L   +    D F+ GV L E+++ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKV 168
           + F   ++LG G  G V+K   +    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
               +V   G      E  +  E+M   SLD  L     RI    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAV----KRLSGRSEQGLREMKNEASVIAKVQHKN 172
           F D   LG GGFG V+   ++   ++       +   +  +G +    E  ++AKV  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-----PTKRILLDWVTRVQIIEGIAQGL 227
           +V L      K +  L+   M    + + +++     P  +         QI+     GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYM 286
            +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    GT G+M
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFM 356
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +PE  L   +    D F+ GV L E+++ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           Y H     R+IHRD+K  N+LL      KI+DFG +  C     +  T  + GT  Y+ P
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTT--LSGTLDYLPP 176
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E     +   K D++S GVL  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKV 168
           + F   ++LG G  G V+K   +    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
               +V   G      E  +  E+M   SLD  L     RI    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKV 168
           + F   ++LG G  G V+K   +    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
               +V   G      E  +  E+M   SLD  L     RI    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKV 168
           + F   ++LG G  G V+K   +    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
               +V   G      E  +  E+M   SLD  L     RI    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLR-EMKNEASVIAKVQHKN 172
           + F   ++LG G  G V+K   +  G  +A K +    +  +R ++  E  V+ +     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           +V   G      E  +  E+M   SLD  L     RI    + +V I   + +GL YL +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLTYLRE 141
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
             + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSPE   
Sbjct: 142 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 195
Query: 293 EGIFSIKSDVFSFGVLLLEIVSGKKNTG 320
              +S++SD++S G+ L+E+  G+   G
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGRYPIG 223

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRL--SGRSEQGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I A+K L  +   + G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 177
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE         K D++S GVL  E + GK
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKV 168
           + F   ++LG G  G V+K   +    +  ++L           Q +RE++    V+ + 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 88
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
               +V   G      E  +  E+M   SLD  L     RI    + +V I   + +GL 
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 145
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 146 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 199
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E      +S++SD++S G+ L+E+  G+
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKV 168
           + F   ++LG G  G V+K   +    +  ++L           Q +RE++    V+ + 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 64
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
               +V   G      E  +  E+M   SLD  L     RI    + +V I   + +GL 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 121
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  +    +  VGT  YMSP
Sbjct: 122 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDEMANEFVGTRSYMSP 175
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E      +S++SD++S G+ L+E+  G+
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKVQHKN 172
           F     LG+G FG VY    +K   I   ++  +S+   +G+  +++ E  + A + H N
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           ++RL     D+    LI EY P   L   L    K    D      I+E +A  L+Y H 
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYCHG 141
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
               ++IHRD+K  N+LL      KI+DFG +       L+  T  + GT  Y+ PE   
Sbjct: 142 ---KKVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKT--MCGTLDYLPPEMIE 194
Query: 293 EGIFSIKSDVFSFGVLLLEIVSG 315
             + + K D++  GVL  E++ G
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVG 217

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI++FG +       + A +SR   + GT  Y
Sbjct: 125 YCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTLCGTLDY 174
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    ++   I   ++  +++    G+  +++ E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     R+IHRD+K  N+LL      KI++FG +       + A +SR   + GT  Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTLCGTLDY 175
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLLGC 179
            ++G+G +G V+ G  R G+++AVK      E    RE +   +V+  ++H+N++  +  
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVL--MRHENILGFIAA 99
Query: 180 CIDKD----EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ--- 232
            I       +  LI +Y  N SL    +D  K   LD  + +++      GL +LH    
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 233 --YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSP 288
               +  I HRDLK+ NIL+ K+    I+D G+A   I   NE+    +  VGT  YM P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 289 EYALEGI------FSIKSDVFSFGVLLLEIV 313
           E   E +        I +D++SFG++L E+ 
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 114/232 (49%), Gaps = 25/232 (10%)
Query: 106 SFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDE-IAVKRLS-GRSEQGLREMK-NEA 162
           S +  +T+ + +    KLGEG +G VYK +    +E +A+KR+     E+G+      E 
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV 84
Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP--TKRILLDWVTRVQII 220
           S++ ++QH+N++ L           LI+EY  N    +   +P  + R++  ++   Q+I
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL--YQLI 142
Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNP--KISDFGMARICGGNELQAN 275
            G+     + H  SR R +HRDLK  N+LL   D    P  KI DFG+AR   G  ++  
Sbjct: 143 NGVN----FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQF 194
Query: 276 TSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
           T  I+ T  Y  PE  L    +S   D++S   +  E++     T L+  DS
Sbjct: 195 THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML---MKTPLFPGDS 242

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 33/225 (14%)
Query: 112 TATNTFSDTNKLGE----GGFGPVYKGV-LRKGDEIAVKRLSG---RSEQGLREMKNEAS 163
           T  +  SD  +LGE    GG   V+    LR   ++AVK L     R        + EA 
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR------- 216
             A + H  +V       D  E        P   L + + +    + L  +         
Sbjct: 65  NAAALNHPAIV----AVYDTGEA-----ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 217 ---VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNE 271
              +++I    Q L + HQ     IIHRD+K +NIL+      K+ DFG+AR     GN 
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNS 172
Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +   T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 173 VX-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 112/217 (51%), Gaps = 22/217 (10%)
Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR----SEQGL--REMKNEAS 163
           S   + +    +LG G F  V K   +  G E A K +  R    S +G+   E++ E +
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGI 223
           ++ +++H N++ L     +K + +LI E +    L  FL +  + +  D  T  Q ++ I
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEAT--QFLKQI 117
Query: 224 AQGLLYLHQYSRVRIIHRDLKASNI-LLDKDM-NPKIS--DFGMA-RICGGNELQANTSR 278
             G+ YLH     RI H DLK  NI LLDK++ NP+I   DFG+A +I  GNE +     
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----N 170
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           I GT  +++PE        +++D++S GV+   ++SG
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKV 168
           A   F     LG+G FG VY    +    I   ++  +++    G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 285
           Y H     ++IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KKVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDY 172
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 17/209 (8%)
Query: 123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKNLVRLLG 178
           LG G FG V+    R  G   A+K L       L+++++   E  +++ V H  ++R+ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D  +  +I +Y+    L F L   ++R   + V +    E +   L YLH      I
Sbjct: 74  TFQDAQQIFMIMDYIEGGEL-FSLLRKSQR-FPNPVAKFYAAE-VCLALEYLHSKD---I 127
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           I+RDLK  NILLDK+ + KI+DFG A+      +   T  + GT  Y++PE      ++ 
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAPEVVSTKPYNK 182
Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSL 327
             D +SFG+L+ E+++G   T  Y ++++
Sbjct: 183 SIDWWSFGILIYEMLAGY--TPFYDSNTM 209

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 122 KLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKN-EASVIAKVQHKNLVRL--- 176
           +LG GGFG V + + +  G+++A+K+         RE    E  ++ K+ H N+V     
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 177 ---LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              L      D  +L  EY     L  +L        L       ++  I+  L YLH+ 
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 234 SRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
              RIIHRDLK  NI+L    + +  KI D G A+     EL    +  VGT  Y++PE 
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPEL 195
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
             +  +++  D +SFG L  E ++G
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 122 KLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKN-EASVIAKVQHKNLVRL--- 176
           +LG GGFG V + + +  G+++A+K+         RE    E  ++ K+ H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 177 ---LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
              L      D  +L  EY     L  +L        L       ++  I+  L YLH+ 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 234 SRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
              RIIHRDLK  NI+L    + +  KI D G A+     EL    +  VGT  Y++PE 
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPEL 194
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
             +  +++  D +SFG L  E ++G
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 113 ATNTFSDT----NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVI 165
           A+  FSD      +LG+G F  V + V +  G E A K ++ +  S +  ++++ EA + 
Sbjct: 23  ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82
Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
            K+QH N+VRL     ++    L+++ +    L     D   R           I+ I +
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILE 139
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSR---- 278
            + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N S     
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVNDSEAWHG 189
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
             GT GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 22/206 (10%)
Query: 122 KLGEGGFGPVYKGVLR-KGDEIAVKRLSGR----SEQGL--REMKNEASVIAKVQHKNLV 174
           +LG G F  V K   +  G E A K +  R    S +G+   E++ E +++ +++H N++
Sbjct: 19  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            L     +K + +LI E +    L  FL +  + +  D  T  Q ++ I  G+ YLH   
Sbjct: 79  TLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEAT--QFLKQILDGVHYLHSK- 134
Query: 235 RVRIIHRDLKASNI-LLDKDM-NPKIS--DFGMA-RICGGNELQANTSRIVGTYGYMSPE 289
             RI H DLK  NI LLDK++ NP+I   DFG+A +I  GNE +     I GT  +++PE
Sbjct: 135 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFGTPEFVAPE 188
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSG 315
                   +++D++S GV+   ++SG
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 116/241 (48%), Gaps = 26/241 (10%)
Query: 111 STATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASV----- 164
           S AT+ +    ++G G +G VYK      G  +A+K +   +  G       ++V     
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 165 ---IAKVQHKNLVRLLGCC----IDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTR 216
              +   +H N+VRL+  C     D++ K+ L++E++ ++ L  +L D      L   T 
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETI 122
Query: 217 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT 276
             ++    +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q   
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMAL 176
Query: 277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYVWD 335
           + +V T  Y +PE  L+  ++   D++S G +  E+   K    L+  +S  + LG ++D
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP---LFCGNSEADQLGKIFD 233
Query: 336 L 336
           L
Sbjct: 234 L 234

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 33/225 (14%)
Query: 112 TATNTFSDTNKLGE----GGFGPVYKGV-LRKGDEIAVKRLSG---RSEQGLREMKNEAS 163
           T  +  SD  +LGE    GG   V+    LR   ++AVK L     R        + EA 
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR------- 216
             A + H  +V       D  E        P   L + + +    + L  +         
Sbjct: 65  NAAALNHPAIV----AVYDTGEA-----ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 217 ---VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNE 271
              +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN 
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +   T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 173 VT-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNL 173
           T+   +KLGEG +  VYKG  +  D  +A+K +    E+G       E S++  ++H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V L      +    L++EY+ +K L  +L D    I +  V     +  + +GL Y H  
Sbjct: 63  VTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKL--FLFQLLRGLAYCH-- 117
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAL 292
            R +++HRDLK  N+L+++    K++DFG+AR      +   T    V T  Y  P+  L
Sbjct: 118 -RQKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 293 EGI-FSIKSDVFSFGVLLLEIVSGK 316
               +S + D++  G +  E+ +G+
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 112/217 (51%), Gaps = 22/217 (10%)
Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR----SEQGL--REMKNEAS 163
           S   + +    +LG G F  V K   +  G E A K +  R    S +G+   E++ E +
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGI 223
           ++ +++H N++ L     +K + +LI E +    L  FL +  + +  D  T  Q ++ I
Sbjct: 82  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEAT--QFLKQI 138
Query: 224 AQGLLYLHQYSRVRIIHRDLKASNI-LLDKDM-NPKIS--DFGMA-RICGGNELQANTSR 278
             G+ YLH     RI H DLK  NI LLDK++ NP+I   DFG+A +I  GNE +     
Sbjct: 139 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----N 191
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           I GT  +++PE        +++D++S GV+   ++SG
Sbjct: 192 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 33/225 (14%)
Query: 112 TATNTFSDTNKLGE----GGFGPVYKGV-LRKGDEIAVKRLSG---RSEQGLREMKNEAS 163
           T  +  SD  +LGE    GG   V+    LR   ++AVK L     R        + EA 
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR------- 216
             A + H  +V       D  E        P   L + + +    + L  +         
Sbjct: 65  NAAALNHPAIV----AVYDTGEA-----ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 217 ---VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNE 271
              +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN 
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +   T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 173 VT-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 115 NTFSDTNKLGEGGFGPVYKGV---LRKGDE---IAVKRLSGRSEQGLRE-MKNEASVIAK 167
           N  S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 168 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSL--------DFFLFDPTKRILLDWVTRVQ 218
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 219 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 159 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 210
Query: 272 LQANTSRIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           ++ +++ +V         +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 211 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 115 NTFSDTNKLGEGGFGPVYKGV---LRKGDE---IAVKRLSGRSEQGLRE-MKNEASVIAK 167
           N  S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 168 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSL--------DFFLFDPTKRILLDWVTRVQ 218
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 219 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 194
Query: 272 LQANTSRIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           ++ +++ +V         +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 33/225 (14%)
Query: 112 TATNTFSDTNKLGE----GGFGPVYKGV-LRKGDEIAVKRLSG---RSEQGLREMKNEAS 163
           T  +  SD  +LGE    GG   V+    LR   ++AVK L     R        + EA 
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR------- 216
             A + H  +V       D  E        P   L + + +    + L  +         
Sbjct: 65  NAAALNHPAIV----AVYDTGEA-----ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 217 ---VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNE 271
              +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN 
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +   T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 173 VT-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 114 TNTFSDT----NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIA 166
           +  FSD      +LG+G F  V + V +  G E A K ++ +  S +  ++++ EA +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 167 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG 226
           K+QH N+VRL     ++    L+++ +    L     D   R           I+ I + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILES 117
Query: 227 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSR----I 279
           + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N S      
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVNDSEAWHGF 167
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            GT GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 115 NTFSDTNKLGEGGFGPVYKGV---LRKGDE---IAVKRLSGRSEQGLRE-MKNEASVIAK 167
           N  S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 168 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSL--------DFFLFDPTKRILLDWVTRVQ 218
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 219 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 161 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 212
Query: 272 LQANTSRIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           ++ +++ +V         +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 213 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 33/233 (14%)
Query: 104 LFSFSSVSTATNTFSDTNKLGE----GGFGPVYKGV-LRKGDEIAVKRLSG---RSEQGL 155
           L    S  T  +  SD  +LGE    GG   V+    LR   ++AVK L     R     
Sbjct: 14  LVPRGSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFY 73
Query: 156 REMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVT 215
              + EA   A + H  +V       D  E        P   L + + +    + L  + 
Sbjct: 74  LRFRREAQNAAALNHPAIV----AVYDTGEA-----ETPAGPLPYIVMEYVDGVTLRDIV 124
Query: 216 R----------VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR 265
                      +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR
Sbjct: 125 HTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 181
Query: 266 ICG--GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
                GN +   T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 182 AIADSGNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQH 170
           ++ +    +LG+G F  V + V +  G E A K ++ +  S +  ++++ EA +  K+QH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
            N+VRL     ++    L+++ +    L     D   R           I+ I + + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 231 HQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSR----IVGTY 283
           H      I+HR+LK  N+LL    K    K++DFG+A       ++ N S       GT 
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVNDSEAWHGFAGTP 170
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 171 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 114 TNTFSDT----NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIA 166
           +  FSD      +LG+G F  V + V +  G E A K ++ +  S +  ++++ EA +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 167 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG 226
           K+QH N+VRL     ++    L+++ +    L     D   R           I+ I + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILES 117
Query: 227 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSR----I 279
           + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N S      
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVNDSEAWHGF 167
Query: 280 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            GT GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 123 LGEGGFGPVY--KGVLR--KGDEIAVKRLSGRSEQGLRE---MKNEASVIAKVQHKNLVR 175
           LG+G FG V+  + V R   G   A+K L  ++   +R+    K E  ++A V H  +V+
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLK-KATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L      + +  LI +++  +  D F     + +  +   +  + E +A GL +LH    
Sbjct: 95  LHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALGLDHLHS--- 148
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
           + II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM+PE      
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEVVNRQG 206
Query: 296 FSIKSDVFSFGVLLLEIVSG 315
            S  +D +S+GVL+ E+++G
Sbjct: 207 HSHSADWWSYGVLMFEMLTG 226

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 217 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 274
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN +  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT- 174
Query: 275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 115 NTFSDTNKLGEGGFGPVYKGV---LRKGDE---IAVKRLSGRSEQGLRE-MKNEASVIAK 167
           N  S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 168 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSL--------DFFLFDPTKRILLDWVTRVQ 218
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 219 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--G 269
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR      
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           N +    +R+     +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 223 NYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 29/223 (13%)
Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQ 169
           ST   T      +G+G FG V++G  R G+E+AVK  S R E+   RE +   +V+  ++
Sbjct: 5   STIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LR 61
Query: 170 HKNLVRLLGCCIDKDEKI-----LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           H+N++  +    +KD        L+ +Y  + SL    FD   R  +     +++    A
Sbjct: 62  HENILGFIAA-DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTA 116
Query: 225 QGLLYLHQ-----YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTS 277
            GL +LH        +  I HRDLK+ NIL+ K+    I+D G+A       + +    +
Sbjct: 117 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 176
Query: 278 RIVGTYGYMSPEYALEGIFSIK-------SDVFSFGVLLLEIV 313
             VGT  YM+PE  L+   ++K       +D+++ G++  EI 
Sbjct: 177 HRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 115 NTFSDTNKLGEGGFGPVYKGV---LRKGDE---IAVKRLSGRSEQGLRE-MKNEASVIAK 167
           N  S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 168 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSL--------DFFLFDPTKRILLDWVTRVQ 218
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 219 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 217
Query: 272 LQANTSRIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           ++ +++ +V         +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 121 NKLGEGGFGPVYKGVLR----KGDEIAVKRLSG---RSEQGLREMKNEASVIAKVQHKNL 173
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 291
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS 314
               FS  SD + FGV L E+ +
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNL 173
           + D   +G G +G V   V  R G ++A+K+L    +SE   +    E  ++  ++H+N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 174 VRLLGCCIDK---DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQ-IIEGIAQGLLY 229
           + LL         D+    Y  MP    D       +++  D   R+Q ++  + +GL Y
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED---RIQFLVYQMLKGLRY 143
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           +H      IIHRDLK  N+ +++D   KI DFG+AR     +  +     V T  Y +PE
Sbjct: 144 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPE 195
Query: 290 YALEGI-FSIKSDVFSFGVLLLEIVSGK 316
             L  + ++   D++S G ++ E+++GK
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLLGCCI 181
           +G+G +G V++G L  G+ +AVK  S R EQ   RE +   +V+  ++H N++  +   +
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVL--LRHDNILGFIASDM 72
Query: 182 ----DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH-----Q 232
                  +  LI  Y  + SL  FL    +R  L+    +++    A GL +LH      
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 290
             +  I HRD K+ N+L+  ++   I+D G+A +   G + L    +  VGT  YM+PE 
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 291 ALEGIF-----SIK-SDVFSFGVLLLEIV 313
             E I      S K +D+++FG++L EI 
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 121 NKLGEGGFGPVYKGVLR----KGDEIAVKRLSG---RSEQGLREMKNEASVIAKVQHKNL 173
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYA 291
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 186
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS 314
               FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVK-----RLSGRSEQGLREMKNEASVI 165
           + T+ +     +G+G F  V + V L  G E A K     +LS R  Q L   + EA + 
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKL---EREARIC 57
Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
             ++H N+VRL     ++    L+++ +    L     D   R           I+ I +
Sbjct: 58  RLLKHSNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILE 114
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGT 282
            +L+ HQ     ++HRDLK  N+LL    K    K++DFG+A    G+  Q       GT
Sbjct: 115 AVLHCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD--QQAWFGFAGT 169
Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 170 PGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 123 LGEGGFGPV--YKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               +    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +HRDLKA N+LLD DMN KI+DFG +     GN+L A            +P YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCG---------APPYAAPELFQ 185
Query: 298 IKS------DVFSFGVLLLEIVSG 315
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 123 LGEGGFGPV--YKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 15  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI---IEGIAQGLLYLHQYSR 235
               +    L+ EY     +  +L      +   W+   +       I   + Y HQ   
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYL------VAHGWMKEKEARAKFRQIVSAVQYCHQKF- 126
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEG 294
             I+HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   
Sbjct: 127 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYAAPE 175
Query: 295 IFSIKS------DVFSFGVLLLEIVSG 315
           +F  K       DV+S GV+L  +VSG
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 121 NKLGEGGFGPVYKGVLR-KGDEIAVK---RLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           + LG G FG V  G     G ++AVK   R   RS   + +++ E   +   +H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                   +  ++ EY+    L  ++    K   LD     ++ + I  G+ Y H++   
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            ++HRDLK  N+LLD  MN KI+DFG++ +    E    +    G+  Y +PE     ++
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISGRLY 192
Query: 297 S-IKSDVFSFGVLLLEIVSG 315
           +  + D++S GV+L  ++ G
Sbjct: 193 AGPEVDIWSSGVILYALLCG 212

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 121 NKLGEGGFGPVYKGVLR----KGDEIAVKRLSG---RSEQGLREMKNEASVIAKVQHKNL 173
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYA 291
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 196
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS 314
               FS  SD + FGV L E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 126 GGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD- 184
           G FG V+K  L   D +AVK    + +Q  +  + E      ++H+NL++ +        
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 185 ---EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ--------Y 233
              E  LI  +    SL  +L    K  ++ W     + E +++GL YLH+         
Sbjct: 84  LEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
            +  I HRD K+ N+LL  D+   ++DFG+A      +   +T   VGT  YM+PE  LE
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-VLE 198
Query: 294 GIFSIKSDVF------SFGVLLLEIVS 314
           G  + + D F      + G++L E+VS
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 121 NKLGEGGFGPVYKGVLR----KGDEIAVKRLSG---RSEQGLREMKNEASVIAKVQHKNL 173
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 291
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS 314
               FS  SD + FGV L E+ +
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 121 NKLGEGGFGPVYKGVLR----KGDEIAVKRLSG---RSEQGLREMKNEASVIAKVQHKNL 173
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 291
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS 314
               FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRS----EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D D   ++ E    +SL        ++ L +   R  + + I  G  YLH   R R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 142
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           IHRDLK  N+ L++D+  KI DFG+A     +  +  T  + GT  Y++PE   +   S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 299 KSDVFSFGVLLLEIVSGK 316
           + DV+S G ++  ++ GK
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 121 NKLGEGGFGPVYKGVLR----KGDEIAVKRLSG---RSEQGLREMKNEASVIAKVQHKNL 173
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 291
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS 314
               FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 128
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 182 AFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +++   +G G FG V++  L + DE+A+K++     Q  R    E  ++  V+H N+V 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL----QDKRFKNRELQIMRIVKHPNVVD 96
Query: 176 LLGCCI---DKDEKI---LIYEYMPN----KSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           L        DK +++   L+ EY+P      S  +     T  +LL  +   Q++  +A 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA- 155
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYG 284
              Y+H    + I HRD+K  N+LLD      K+ DFG A+I    E   N S I   Y 
Sbjct: 156 ---YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSXICSRY- 206
Query: 285 YMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           Y +PE       ++   D++S G ++ E++ G+
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 33/280 (11%)
Query: 119 DTNKLGEGGFGPVYKGVLRKGDEI-AVKRL-SGRSEQGLREMKNEASVIAKVQH-KNLVR 175
           D  ++G G +G V K V +   +I AVKR+ S   E+  +++  +  V+ +      +V+
Sbjct: 26  DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL--HQY 233
             G    + +  +  E M   S  F  F      +LD V   +I+  I    +    H  
Sbjct: 86  FYGALFREGDCWICMELM---STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---- 289
             ++IIHRD+K SNILLD+  N K+ DFG   I G        +R  G   YM+PE    
Sbjct: 143 ENLKIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDP 199
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS---NRTLELI 346
            A    + ++SDV+S G+ L E+ +G+               + +  W S     T  + 
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGR---------------FPYPKWNSVFDQLTQVVK 244
Query: 347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
            DP        ++    ++N   LC+ +    RP   +++
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRS----EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D D   ++ E    +SL        ++ L +   R  + + I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 138
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           IHRDLK  N+ L++D+  KI DFG+A     +  +  T  + GT  Y++PE   +   S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 299 KSDVFSFGVLLLEIVSGK 316
           + DV+S G ++  ++ GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 121 NKLGEGGFGPVYKGVLR----KGDEIAVKRLSG---RSEQGLREMKNEASVIAKVQHKNL 173
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 291
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 196
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS 314
               FS  SD + FGV L E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRS----EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D D   ++ E    +SL        ++ L +   R  + + I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 138
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           IHRDLK  N+ L++D+  KI DFG+A     +  +  T  + GT  Y++PE   +   S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 299 KSDVFSFGVLLLEIVSGK 316
           + DV+S G ++  ++ GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 123 LGEGGFGPV--YKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               +    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYAAPELFQ 185
Query: 298 IKS------DVFSFGVLLLEIVSG 315
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 26/280 (9%)
Query: 109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV 168
           ++    N FS    +G GGFG VY    RK D   +  +    ++ ++  + E   + + 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYG--CRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 169 QHKNLVRLLGC----CID-----KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI 219
              +LV    C    C+       D+   I + M    L + L      +  +   R   
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYA 298
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
            E I  GL ++H      +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  
Sbjct: 299 AE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS-- 350
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT 338
           VGT+GYM+PE   +G+ +   +D FS G +L +++ G      ++T   + +    D  T
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT 406
Query: 339 SNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADD 378
               +EL D    E     + +L R VN  L C+   A +
Sbjct: 407 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 446

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 107/233 (45%), Gaps = 43/233 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS   +++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG 171
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S GV++ E++ G
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 121 NKLGEGGFGPVYKGV-LRKGDEIAVK-----RLSGRSEQGLREMKNEASVIAKVQHKNLV 174
            +LG+G F  V + V +  G E A K     +LS R  Q   +++ EA +   ++H N+V
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHPNIV 84
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           RL     ++    LI++ +    L     D   R           I+ I + +L+ HQ  
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQ-- 139
Query: 235 RVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
            + ++HRDLK  N+LL    K    K++DFG+A    G   Q       GT GY+SPE  
Sbjct: 140 -MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGYLSPEVL 196
Query: 292 LEGIFSIKSDVFSFGVLLLEIVSG 315
            +  +    D+++ GV+L  ++ G
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVG 220

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 123 LGEGGFGPV--YKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               +    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYAAPELFQ 185
Query: 298 IKS------DVFSFGVLLLEIVSG 315
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 26/280 (9%)
Query: 109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV 168
           ++    N FS    +G GGFG VY    RK D   +  +    ++ ++  + E   + + 
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVYG--CRKADTGKMYAMKCLDKKRIKMKQGETLALNER 239
Query: 169 QHKNLVRLLGC----CID-----KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI 219
              +LV    C    C+       D+   I + M    L + L      +  +   R   
Sbjct: 240 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYA 297
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
            E I  GL ++H      +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  
Sbjct: 298 AE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS-- 349
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT 338
           VGT+GYM+PE   +G+ +   +D FS G +L +++ G      ++T   + +    D  T
Sbjct: 350 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT 405
Query: 339 SNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADD 378
               +EL D    E     + +L R VN  L C+   A +
Sbjct: 406 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 445

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQH 170
           T   T      +G+G FG V++G  R G+E+AVK  S R E+   RE +   +V+  ++H
Sbjct: 39  TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRH 95
Query: 171 KNLVRLLGCCIDKDEKI-----LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           +N++  +    +KD        L+ +Y  + SL    FD   R  +     +++    A 
Sbjct: 96  ENILGFIAA-DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTAS 150
Query: 226 GLLYLHQ-----YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSR 278
           GL +LH        +  I HRDLK+ NIL+ K+    I+D G+A       + +    + 
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 279 IVGTYGYMSPEYALEGIFSIK-------SDVFSFGVLLLEIV 313
            VGT  YM+PE  L+   ++K       +D+++ G++  EI 
Sbjct: 211 RVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 107/233 (45%), Gaps = 43/233 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS   +++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG 171
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S GV++ E++ G
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRS----EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D D   ++ E    +SL        ++ L +   R  + + I  G  YLH   R R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 160
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 295
           IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 215
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
            S + DV+S G ++  ++ GK
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGK 236

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQH 170
           T   T      +G+G FG V++G  R G+E+AVK  S R E+   RE +   +V+  ++H
Sbjct: 1   TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRH 57
Query: 171 KNLVRLLGCCIDKDEKI-----LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           +N++  +    +KD        L+ +Y  + SL    FD   R  +     +++    A 
Sbjct: 58  ENILGFIAA-DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTAS 112
Query: 226 GLLYLHQ-----YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSR 278
           GL +LH        +  I HRDLK+ NIL+ K+    I+D G+A       + +    + 
Sbjct: 113 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 172
Query: 279 IVGTYGYMSPEYALEGIFSIK-------SDVFSFGVLLLEIV 313
            VGT  YM+PE  L+   ++K       +D+++ G++  EI 
Sbjct: 173 RVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQH 170
           T   T      +G+G FG V++G  R G+E+AVK  S R E+   RE +   +V+  ++H
Sbjct: 26  TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRH 82
Query: 171 KNLVRLLGCCIDKDEKI-----LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           +N++  +    +KD        L+ +Y  + SL    FD   R  +     +++    A 
Sbjct: 83  ENILGFIAA-DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTAS 137
Query: 226 GLLYLHQ-----YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSR 278
           GL +LH        +  I HRDLK+ NIL+ K+    I+D G+A       + +    + 
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 197
Query: 279 IVGTYGYMSPEYALEGIFSIK-------SDVFSFGVLLLEIV 313
            VGT  YM+PE  L+   ++K       +D+++ G++  EI 
Sbjct: 198 RVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRS----EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D D   ++ E    +SL        ++ L +   R  + + I  G  YLH   R R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 162
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 295
           IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
            S + DV+S G ++  ++ GK
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 26/280 (9%)
Query: 109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV 168
           ++    N FS    +G GGFG VY    RK D   +  +    ++ ++  + E   + + 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYG--CRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 169 QHKNLVRLLGC----CID-----KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI 219
              +LV    C    C+       D+   I + M    L + L      +  +   R   
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYA 298
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
            E I  GL ++H      +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  
Sbjct: 299 AE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS-- 350
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT 338
           VGT+GYM+PE   +G+ +   +D FS G +L +++ G      ++T   + +    D  T
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT 406
Query: 339 SNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADD 378
               +EL D    E     + +L R VN  L C+   A +
Sbjct: 407 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 446

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 26/280 (9%)
Query: 109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV 168
           ++    N FS    +G GGFG VY    RK D   +  +    ++ ++  + E   + + 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYG--CRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 169 QHKNLVRLLGC----CID-----KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI 219
              +LV    C    C+       D+   I + M    L + L      +  +   R   
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYA 298
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
            E I  GL ++H      +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  
Sbjct: 299 AE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS-- 350
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT 338
           VGT+GYM+PE   +G+ +   +D FS G +L +++ G      ++T   + +    D  T
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT 406
Query: 339 SNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADD 378
               +EL D    E     + +L R VN  L C+   A +
Sbjct: 407 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 446

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 41/232 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           +   + +G G +G V     ++ G +IAVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 111
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P  SL    D +L        L+ + + Q         +
Sbjct: 112 VIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 159
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 160 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 211
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL 330
           V T  Y +PE  L  + +++  D++S G ++ E+++G+  T    TD +N L
Sbjct: 212 VATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR--TLFPGTDHINQL 261

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 33/225 (14%)
Query: 108 SSVSTATN------TFSDTNKLGEGGFGPV--YKGVLRKGDEIAVKRL--SGRSEQGLRE 157
           +S+++AT+       +     +G+G F  V   + VL  G E+AVK +  +  +   L++
Sbjct: 2   NSITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVL-TGREVAVKIIDKTQLNPTSLQK 60
Query: 158 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV 217
           +  E  ++  + H N+V+L      +    L+ EY     +  +L    +  + +   R 
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARA 118
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANT 276
           +  + I   + Y HQ     I+HRDLKA N+LLD DMN KI+DFG +     GN+L    
Sbjct: 119 KFRQ-IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC 174
Query: 277 SRIVGTYGYMSPEYALEGIFSIKS------DVFSFGVLLLEIVSG 315
                     SP YA   +F  K       DV+S GV+L  +VSG
Sbjct: 175 G---------SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRS----EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D D   ++ E    +SL        ++ L +   R  + + I  G  YLH   R R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 136
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 295
           IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
            S + DV+S G ++  ++ GK
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 29/223 (13%)
Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQ 169
            T   T      +G+G FG V++G  R G+E+AVK  S R E+   RE +   +V+  ++
Sbjct: 2   GTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LR 58
Query: 170 HKNLVRLLGCCIDKDEKI-----LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           H+N++  +    +KD        L+ +Y  + SL    FD   R  +     +++    A
Sbjct: 59  HENILGFIAA-DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTA 113
Query: 225 QGLLYLHQ-----YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTS 277
            GL +LH        +  I HRDLK+ NIL+ K+    I+D G+A       + +    +
Sbjct: 114 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 173
Query: 278 RIVGTYGYMSPEYALEGIFSIK-------SDVFSFGVLLLEIV 313
             VGT  YM+PE  L+   ++K       +D+++ G++  EI 
Sbjct: 174 HRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 29/211 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLLGCCI 181
           +G+G FG V++G  R G+E+AVK  S R E+   RE +   +V+  ++H+N++  +    
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 66
Query: 182 DKD-----EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ---- 232
           +KD     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 233 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 289
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 290 YALEGIFSIK-------SDVFSFGVLLLEIV 313
             L+   ++K       +D+++ G++  EI 
Sbjct: 183 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 114 TNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAV-----KRLSGRSEQGLREMKNEASVIAK 167
           T  +    +LG+G F  V + V +  G E A      K+LS R  Q L   + EA +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL---EREARICRL 66
Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
           ++H N+VRL     ++    LI++ +    L     D   R           I+ I + +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAV 123
Query: 228 LYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
           L+ HQ     ++HR+LK  N+LL    K    K++DFG+A    G   Q       GT G
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPG 178
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           Y+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL----RKGDEIAVKRLSGRSE-QGLREMKNEASVIAKVQH 170
           T SD   +G+G FG VY G      +   + A+K LS  +E Q +     E  ++  + H
Sbjct: 23  THSD-RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 171 KNLVRLLGCCIDKDE-KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
            N++ L+G  +  +    ++  YM +  L  F+  P +   +  +    +   +A+G+ Y
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEY 139
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL----QANTSRIVGTYGY 285
           L   +  + +HRDL A N +LD+    K++DFG+AR     E     Q   +R+   +  
Sbjct: 140 L---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT- 195
Query: 286 MSPEYALEGI----FSIKSDVFSFGVLLLEIVS 314
                ALE +    F+ KSDV+SFGVLL E+++
Sbjct: 196 -----ALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 79  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 127 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGF 178
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 106/231 (45%), Gaps = 39/231 (16%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLR 156
            F SV  A +TF+          +G G  G V   +  VL  G  +AVK+LS       R
Sbjct: 9   QFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS-------R 59
Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP--- 205
             +N+    AK  ++ LV LL C   K+   L+  + P K+L+ F        L D    
Sbjct: 60  PFQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 116
Query: 206 -TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
               + LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 117 QVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           R    N +   T  +V  Y Y +PE  L   ++   D++S G ++ E+V G
Sbjct: 174 RTACTNFMM--TPYVVTRY-YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGF 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 127
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 128 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 180
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 123 LGEGGFGPV--YKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G+G F  V   + +L  G E+A+K +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 23  IGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               +    LI EY     +  +L    +    +  ++ + I    Q   Y HQ    RI
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQK---RI 135
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +HRDLKA N+LLD DMN KI+DFG +     G +L A            +P YA   +F 
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG---------APPYAAPELFQ 186
Query: 298 IKS------DVFSFGVLLLEIVSG 315
            K       DV+S GV+L  +VSG
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 107 FSSVSTATNTFSDTN---KLGEGGFGPVYKGVLRKGDE------IAVKRLSGRSEQGLRE 157
           F  ++T T    D     +LG+G F  V + V +   +      I  K+LS R  Q L  
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKL-- 77
Query: 158 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV 217
            + EA +   ++H N+VRL     ++    L+++ +    L     D   R         
Sbjct: 78  -EREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADAS 133
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQA 274
             I  I + + ++HQ+    I+HRDLK  N+LL    K    K++DFG+A    G   Q 
Sbjct: 134 HCIHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE--QQ 188
Query: 275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
                 GT GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 189 AWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGF 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 12  YYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 128
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 128
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 127
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDMNP---KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++     KI DFG+A +I  GNE +     I GT 
Sbjct: 128 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 180
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 128
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 128
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 128
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 123 LGEGGFGPV--YKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G+G F  V   + +L  G E+AV+ +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               +    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYAAPELFQ 185
Query: 298 IKS------DVFSFGVLLLEIVSG 315
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 128
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 79  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 127 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 178
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKR-LSGRSEQGLREMK-NEASVIAKVQ 169
           +   + +   +GEG +G V K   +  G  +A+K+ L    ++ ++++   E  ++ +++
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           H+NLV LL  C  K    L++E++ +  LD     P     LD+    + +  I  G+ +
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGF 139
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSP 288
            H ++   IIHRD+K  NIL+ +    K+ DFG AR +    E+  +    V T  Y +P
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATRWYRAP 193
Query: 289 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           E  +  + +    DV++ G L+ E+  G+
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 128
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 128
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRS----EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG+GGF   Y+       E+   ++  +S         +M  E ++   + + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D D   ++ E    +SL        ++ + +   R  + + I QG+ YLH     R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 295
           IHRDLK  N+ L+ DM+ KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
            S + D++S G +L  ++ GK
Sbjct: 203 HSFEVDIWSLGCILYTLLVGK 223

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEI----AVKRLSGRSEQGLREMKNEAS 163
           +S S     F     +G G +  V    L+K D I     VK+     ++ +  ++ E  
Sbjct: 13  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 72
Query: 164 VIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
           V  +   H  LV L  C   +     + EY+    L F +    +R L +   R    E 
Sbjct: 73  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE- 129
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           I+  L YLH+     II+RDLK  N+LLD + + K++D+GM +   G      TS   GT
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 184
Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
             Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRS----EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG+GGF   Y+       E+   ++  +S         +M  E ++   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D D   ++ E    +SL        ++ + +   R  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           IHRDLK  N+ L+ DM+ KI DFG+A     +  +  T  + GT  Y++PE   +   S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSF 221
Query: 299 KSDVFSFGVLLLEIVSGK 316
           + D++S G +L  ++ GK
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 34/209 (16%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMK----------------NEASVIA 166
           LG+G FG V+           VK++SG   + L  MK                 E  ++ 
Sbjct: 32  LGQGSFGKVF----------LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 167 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG 226
           +V H  +V+L      + +  LI +++  +  D F     + +  +   +  + E +A  
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALA 138
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           L +LH      II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           +PE       +  +D +SFGVL+ E+++G
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 89  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 188
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRL----SGRSEQGLR-EMKNEASVIAKVQHKNL 173
           +  +LG G FG V KG  +    +    +    +  ++  L+ E+  EA+V+ ++ +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + 
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE- 145
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPE 289
                +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE
Sbjct: 146 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APE 200
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVS-GKK 317
                 FS KSDV+SFGVL+ E  S G+K
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRL----SGRSEQGLR-EMKNEASVIAKVQHKNL 173
           +  +LG G FG V KG  +    +    +    +  ++  L+ E+  EA+V+ ++ +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + 
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE- 145
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPE 289
                +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE
Sbjct: 146 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APE 200
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVS-GKK 317
                 FS KSDV+SFGVL+ E  S G+K
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS----EQGLREMKNEAS 163
           +S S     F     +G G +  V    L+K D I   R+  +     ++ +  ++ E  
Sbjct: 45  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104
Query: 164 VIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
           V  +   H  LV L  C   +     + EY+    L F +    +R L +   R    E 
Sbjct: 105 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE- 161
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           I+  L YLH+     II+RDLK  N+LLD + + K++D+GM +   G      TS   GT
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 216
Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
             Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 39/231 (16%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLR 156
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS       R
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------R 59
Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP--- 205
             +N+    AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D    
Sbjct: 60  PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 116
Query: 206 -TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
              ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           R  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 174 RTAGTSFMM--TPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRL------SGRSEQGLREMKNEASVIAKVQ 169
           +    K+GEG +G V+K   R+  EI A+KR+       G     LRE+     ++ +++
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKELK 59
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           HKN+VRL        +  L++E+  ++ L  + FD     L   + +  + + + +GL +
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDLDPEIVKSFLFQ-LLKGLGF 116
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H  +   ++HRDLK  N+L++++   K++DFG+AR   G  ++  ++ +V T  Y  P+
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLADFGLAR-AFGIPVRCYSAEVV-TLWYRPPD 171
Query: 290 YALEG-IFSIKSDVFSFGVLLLEIVSGKK 317
                 ++S   D++S G +  E+ +  +
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRS----EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG+GGF   Y+       E+   ++  +S         +M  E ++   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D D   ++ E    +SL        ++ + +   R  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 295
           IHRDLK  N+ L+ DM+ KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
            S + D++S G +L  ++ GK
Sbjct: 219 HSFEVDIWSLGCILYTLLVGK 239

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++  
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 66
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPT 206
            +    E  ++  V HKN++ LL              + P K+L+ F        L D  
Sbjct: 67  AKRAYRELVLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 114
Query: 207 K----RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LXQVIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFG 171
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGD-EIAVKRLS------GRS-------EQGLREMKNE 161
           ++    KLG G +G V     + G  E A+K +       GR        E+   E+ NE
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRILLDWVTRVQII 220
            S++  + H N+++L     DK    L+ E+     L    F+    R   D      I+
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAANIM 152
Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISDFGMARICGGNELQANTS 277
           + I  G+ YLH+++   I+HRD+K  NILL+     +N KI DFG++     +       
Sbjct: 153 KQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLR 206
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
             +GT  Y++PE  L+  ++ K DV+S GV++  ++ G
Sbjct: 207 DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 12  YYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 128
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 123 LGEGGFGPV--YKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G+G F  V   + +L  G E+AV+ +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               +    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG---------SPPYAAPELFQ 185
Query: 298 IKS------DVFSFGVLLLEIVSG 315
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRS----EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG+GGF   Y+       E+   ++  +S         +M  E ++   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D D   ++ E    +SL        ++ + +   R  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 295
           IHRDLK  N+ L+ DM+ KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
            S + D++S G +L  ++ GK
Sbjct: 219 HSFEVDIWSLGCILYTLLVGK 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 103 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 151 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 202
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 111/225 (49%), Gaps = 42/225 (18%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRL------SGRSEQGLREMKNEASVIAKVQ-HKNL 173
           KLG+G +G V+K + R+ G+ +AVK++      S  +++  RE+     ++ ++  H+N+
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREI----MILTELSGHENI 71
Query: 174 VRLLGCC-IDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
           V LL     D D  + L+++YM        L    +  +L+ V +  ++  + + + YLH
Sbjct: 72  VNLLNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-------RICGGNELQANT-------- 276
                 ++HRD+K SNILL+ + + K++DFG++       R+     L  N         
Sbjct: 127 SGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 277 ----SRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 316
               +  V T  Y +PE  L      K  D++S G +L EI+ GK
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRL----SGRSEQGLR-EMKNEASVIAKVQHKNL 173
           +  +LG G FG V KG  +    +    +    +  ++  L+ E+  EA+V+ ++ +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + 
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE- 129
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYA 291
                +HRDL A N+LL      KISDFG+++    +E     ++  G +   + +PE  
Sbjct: 130 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NXYKAQTHGKWPVKWYAPECI 186
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS-GKK 317
               FS KSDV+SFGVL+ E  S G+K
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 101
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 102 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 150 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 201
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 202 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 72  QHPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 128
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 34/209 (16%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMK----------------NEASVIA 166
           LG+G FG V+           VK++SG   + L  MK                 E  ++ 
Sbjct: 32  LGQGSFGKVF----------LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 167 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG 226
           +V H  +V+L      + +  LI +++  +  D F     + +  +   +  + E +A  
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALA 138
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           L +LH      II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           +PE       +  +D +SFGVL+ E+++G
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 123 LGEGGFGPV--YKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G+G F  V   + +L  G E+A+K +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 20  IGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               +    LI EY     +  +L    +    +  ++ + I    Q   Y HQ    RI
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQK---RI 132
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +HRDLKA N+LLD DMN KI+DFG +     G +L              SP YA   +F 
Sbjct: 133 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCG---------SPPYAAPELFQ 183
Query: 298 IKS------DVFSFGVLLLEIVSG 315
            K       DV+S GV+L  +VSG
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 123 LGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           +G+G F  V + + R+ G + AVK     + +        ++K EAS+   ++H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI----IEGIAQGLLYLHQ 232
           L          +++E+M    L    F+  KR    +V    +    +  I + L Y H 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 233 YSRVRIIHRDLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            +   IIHRD+K  N+LL    N    K+ DFG+A   G + L A     VGT  +M+PE
Sbjct: 149 NN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPE 203
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSG 315
                 +    DV+  GV+L  ++SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRL----SGRSEQGLR-EMKNEASVIAKVQHKNL 173
           +  +LG G FG V KG  +    +    +    +  ++  L+ E+  EA+V+ ++ +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + 
Sbjct: 89  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE- 143
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYA 291
                +HRDL A N+LL      KISDFG+++    +E     ++  G +   + +PE  
Sbjct: 144 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHGKWPVKWYAPECI 200
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS-GKK 317
               FS KSDV+SFGVL+ E  S G+K
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQK 227

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 34/209 (16%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMK----------------NEASVIA 166
           LG+G FG V+           VK++SG   + L  MK                 E  ++ 
Sbjct: 33  LGQGSFGKVF----------LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 82
Query: 167 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG 226
           +V H  +V+L      + +  LI +++  +  D F     + +  +   +  + E +A  
Sbjct: 83  EVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALA 139
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           L +LH      II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM
Sbjct: 140 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 194
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           +PE       +  +D +SFGVL+ E+++G
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 117 FSDT-NKLGEGGFGPVYK-----GVLRKGDEIAVKRLSGRSEQGL--REMKNEASVIAKV 168
           + DT  +LG G F  V K       L+   +   KR +  S +G+   +++ E S++ ++
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           QH N++ L     +K + ILI E +    L  FL    ++  L      + ++ I  G+ 
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVY 128
Query: 229 YLHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTY 283
           YLH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            +++PE        +++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 94/168 (55%), Gaps = 16/168 (9%)
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRILLD 212
           + ++  E +++ K+ H N+V+L+    D +E  L  ++E +    +   +  PT + L +
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSE 136
Query: 213 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNE 271
              R    + + +G+ YLH     +IIHRD+K SN+L+ +D + KI+DFG++    G + 
Sbjct: 137 DQARF-YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 272 LQANTSRIVGTYGYMSPEYALE--GIFSIKS-DVFSFGVLLLEIVSGK 316
           L +NT   VGT  +M+PE   E   IFS K+ DV++ GV L   V G+
Sbjct: 193 LLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRL----SGRSEQGLR-EMKNEASVIAKVQHKNL 173
           +  +LG G FG V KG  +    +    +    +  ++  L+ E+  EA+V+ ++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + 
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE- 125
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYA 291
                +HRDL A N+LL      KISDFG+++    +E     ++  G +   + +PE  
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHGKWPVKWYAPECI 182
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS-GKK 317
               FS KSDV+SFGVL+ E  S G+K
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQK 209

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 105/231 (45%), Gaps = 39/231 (16%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLR 156
            F SV  A +TF+          +G G  G V   +  VL  G  +AVK+LS       R
Sbjct: 7   QFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS-------R 57
Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP--- 205
             +N+    AK  ++ LV LL C   K+   L+  + P K+L+ F        L D    
Sbjct: 58  PFQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 114
Query: 206 -TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
               + LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 115 QVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 171
Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           R    N +   T  +V  Y Y +PE  L   +    D++S G ++ E+V G
Sbjct: 172 RTASTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + +   +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 34  YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 92
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 93  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 140
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 141 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 192
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 193 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 90  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGY 189
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRL----SGRSEQGLR-EMKNEASVIAKVQHKNL 173
           +  +LG G FG V KG  +    +    +    +  ++  L+ E+  EA+V+ ++ +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + 
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE- 129
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYA 291
                +HRDL A N+LL      KISDFG+++    +E     ++  G +   + +PE  
Sbjct: 130 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHGKWPVKWYAPECI 186
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS-GKK 317
               FS KSDV+SFGVL+ E  S G+K
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 90  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGY 189
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 90  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGY 189
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 16/207 (7%)
Query: 119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRL----SGRSEQGLR-EMKNEASVIAKVQHKNL 173
           +  +LG G FG V KG  +    +    +    +  ++  L+ E+  EA+V+ ++ +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + 
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEES 136
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYA 291
           +    +HRDL A N+LL      KISDFG+++    +E     ++  G +   + +PE  
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHGKWPVKWYAPECI 192
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS-GKK 317
               FS KSDV+SFGVL+ E  S G+K
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 106/233 (45%), Gaps = 43/233 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS   +++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPT 206
            +    E  ++  V HKN++ LL              + P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 207 K----RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 39/231 (16%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLR 156
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS       R
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------R 59
Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK- 207
             +N+    AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D    
Sbjct: 60  PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLS 116
Query: 208 ---RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
              ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLA 173
Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           R  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 174 RTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRL----SGRSEQGLR-EMKNEASVIAKVQHKNL 173
           +  +LG G FG V KG  +    +    +    +  ++  L+ E+  EA+V+ ++ +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + 
Sbjct: 69  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE- 123
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYA 291
                +HRDL A N+LL      KISDFG+++    +E     ++  G +   + +PE  
Sbjct: 124 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHGKWPVKWYAPECI 180
Query: 292 LEGIFSIKSDVFSFGVLLLEIVS-GKK 317
               FS KSDV+SFGVL+ E  S G+K
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQK 207

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 116/255 (45%), Gaps = 48/255 (18%)
Query: 84  LPLNSKLIERSKKKEVDQLPLFSFS----SVSTATNTFSDTNKLGEGGFGPVYKGV-LRK 138
           +P  S ++E S+++     P F       ++      + + + +G G +G V      + 
Sbjct: 15  VPRGSHMLEMSQER-----PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKT 69
Query: 139 GDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 195
           G  +AVK+LS R  Q +   K    E  ++  ++H+N++ LL              + P 
Sbjct: 70  GLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPA 116
Query: 196 KSL----DFFLFDPTKRILLDWVTRVQ---------IIEGIAQGLLYLHQYSRVRIIHRD 242
           +SL    D +L        L+ + + Q         +I  I +GL Y+H      IIHRD
Sbjct: 117 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRD 173
Query: 243 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSD 301
           LK SN+ +++D   KI DFG+AR           +  V T  Y +PE  L  + ++   D
Sbjct: 174 LKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVD 228
Query: 302 VFSFGVLLLEIVSGK 316
           ++S G ++ E+++G+
Sbjct: 229 IWSVGCIMAELLTGR 243

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLR 156
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS       R
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------R 59
Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP--- 205
             +N+    AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D    
Sbjct: 60  PFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLX 116
Query: 206 -TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
              ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 117 QVIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA 173
Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           R  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 174 RTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRA 190
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 77
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 138 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRA 191
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 192 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLR 156
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS       R
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-------R 52
Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP--- 205
             +N+    AK  ++ LV L+ C   K+   L+  + P K+L+ F        L D    
Sbjct: 53  PFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLX 109
Query: 206 -TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
              ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 110 QVIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA 166
Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           R  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 167 RTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 88  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGY 187
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 103 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR    +E+       
Sbjct: 151 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT-DDEMXGX---- 202
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 106/233 (45%), Gaps = 43/233 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS   +++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG 171
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRA 190
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 95
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 156 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRA 209
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 210 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 88
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 149 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRA 202
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++  
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 66
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P K+L+ F        L D  
Sbjct: 67  AKRAYRELVLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 114
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LXQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFG 171
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     QG      E  ++ K+ H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRA 190
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 106/233 (45%), Gaps = 43/233 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS   +++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG 171
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 39/231 (16%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLR 156
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS       R
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------R 59
Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP--- 205
             +N+    AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D    
Sbjct: 60  PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 116
Query: 206 -TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
              ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           R  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 174 RTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 84
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 145 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRA 198
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 199 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 123 LGEGGFGPVYKGVLRKGDEI----AVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLL 177
           +G G +  V    L+K D I     VK+     ++ +  ++ E  V  +   H  LV L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
            C   +     + EY+    L F +    +R L +   R    E I+  L YLH+     
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG--- 126
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           II+RDLK  N+LLD + + K++D+GM +   G      TS   GT  Y++PE      + 
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 184
Query: 298 IKSDVFSFGVLLLEIVSGK 316
              D ++ GVL+ E+++G+
Sbjct: 185 FSVDWWALGVLMFEMMAGR 203

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 79
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 80  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 128 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 179
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 123 LGEGGFGPVYKGVLRKGDEI----AVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLL 177
           +G G +  V    L+K D I     VK+     ++ +  ++ E  V  +   H  LV L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
            C   +     + EY+    L F +    +R L +   R    E I+  L YLH+     
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG--- 130
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           II+RDLK  N+LLD + + K++D+GM +   G      TS   GT  Y++PE      + 
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 188
Query: 298 IKSDVFSFGVLLLEIVSGK 316
              D ++ GVL+ E+++G+
Sbjct: 189 FSVDWWALGVLMFEMMAGR 207

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRA 190
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 39/231 (16%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLR 156
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS       R
Sbjct: 10  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------R 60
Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP--- 205
             +N+    AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D    
Sbjct: 61  PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 117
Query: 206 -TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
              ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 118 QVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174
Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           R  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 175 RTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++  
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 66
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P K+L+ F        L D  
Sbjct: 67  AKRAYRELVLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 114
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFG 171
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     QG      E  ++ K+ H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRA 190
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGX 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 79  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 127 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 178
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 39/231 (16%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLR 156
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS       R
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------R 59
Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP--- 205
             +N+    AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D    
Sbjct: 60  PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLS 116
Query: 206 -TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
              ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           R  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 174 RTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 88  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 187
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 123 LGEGGFGPVYKGVLRK-GD-------EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           LG+G F  ++KGV R+ GD       E+ +K L              AS+++K+ HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
              G C+  DE IL+ E++   SLD +L      I + W  ++++ + +A  + +L + +
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT 133
Query: 235 RVRIIHRDLKASNILL-----DKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYM 286
              +IH ++ A NILL      K  NP   K+SD G++      ++       V      
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           +P+       ++ +D +SFG  L EI SG
Sbjct: 191 NPKN-----LNLATDKWSFGTTLWEICSG 214

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 79
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 80  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 128 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 179
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 110
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRA 224
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 89
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 150 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRA 203
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 204 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 88  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 187
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 85  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 184
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 81
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 82  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 129
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 130 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 181
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 182 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 80
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 81  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 128
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 129 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 180
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 181 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 88
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 149 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRA 202
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     QG      E  ++ K+ H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRA 190
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 81
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 142 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRA 195
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 196 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 85  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 184
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 90  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 189
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 88  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGY 187
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRA 190
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 104
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 165 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRA 218
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 219 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 89  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 188
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           +A+G+ +L   S  + IHRDL A NILL ++   KI DFG+AR    N            
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
             +M+PE   + I+S KSDV+S+GVLL EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 93
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 94  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 142 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 193
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 194 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 85  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 184
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 80
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 141 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRA 194
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 195 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 95  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 143 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 194
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 195 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 95  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 143 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 194
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 195 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 89  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 188
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 93
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 94  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 142 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGY 193
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 194 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 110
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRA 224
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 103 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 151 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 202
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 101
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 102 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 150 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 201
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 202 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVKR-LSGRSEQGLREMK-NEASVIAKVQHKNL 173
           +    K+GEG +G V+K   R  G  +A+K+ L    +  ++++   E  ++ +++H NL
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V LL     K    L++EY  +  L     D  +R + + + +  I     Q + + H++
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVK-SITWQTLQAVNFCHKH 121
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL- 292
           +    IHRD+K  NIL+ K    K+ DFG AR+  G     +    V T  Y SPE  + 
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELLVG 176
Query: 293 EGIFSIKSDVFSFGVLLLEIVSG 315
           +  +    DV++ G +  E++SG
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 112
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 173 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRA 226
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 227 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 28/227 (12%)
Query: 117 FSDTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKV 168
           +++ + +GEG +G V   Y  V +    +A+K++S    Q      LRE+K    ++ + 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLRF 78
Query: 169 QHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I 
Sbjct: 79  RHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQIL 134
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTY 283
           +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T 
Sbjct: 135 RGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 284 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
            Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++  
Sbjct: 3   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 60
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P K+L+ F        L D  
Sbjct: 61  AKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 108
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 109 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 165
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 166 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     +G G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EYMP   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 85  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGY 184
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++  
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 59
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P K+L+ F        L D  
Sbjct: 60  AKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 107
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 108 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 165 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++  
Sbjct: 8   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 65
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P K+L+ F        L D  
Sbjct: 66  AKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 113
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 114 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 170
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 171 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++  
Sbjct: 3   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 60
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P K+L+ F        L D  
Sbjct: 61  AKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 108
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 109 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 165
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 166 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 114
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 175 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRA 228
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 229 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 28/227 (12%)
Query: 117 FSDTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKV 168
           +++ + +GEG +G V   Y  V +    +A+K++S    Q      LRE+K    ++ + 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLRF 78
Query: 169 QHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I 
Sbjct: 79  RHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQIL 134
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTY 283
           +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T 
Sbjct: 135 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 284 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
            Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHK 171
           N   +  ++G G  G V+K   RK G  IAVK  R SG  E+  R + +   V+      
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 172 NLVRLLGCCIDKDEKILIYEYMPN--KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
            +V+  G  I   +  +  E M    + L   +  P    +L  +T       I + L Y
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVA-----IVKALYY 139
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           L +  +  +IHRD+K SNILLD+    K+ DFG   I G         R  G   YM+PE
Sbjct: 140 LKE--KHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRSAGCAAYMAPE 194
Query: 290 Y-----ALEGIFSIKSDVFSFGVLLLEIVSGK 316
                   +  + I++DV+S G+ L+E+ +G+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++  
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 66
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P K+L+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 114
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++  
Sbjct: 10  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 67
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P K+L+ F        L D  
Sbjct: 68  AKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 115
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 116 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 172
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 173 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 28/227 (12%)
Query: 117 FSDTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKV 168
           +++ + +GEG +G V   Y  V +    +A+K++S    Q      LRE+K    ++ + 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLRF 78
Query: 169 QHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I 
Sbjct: 79  RHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQIL 134
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTY 283
           +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T 
Sbjct: 135 RGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 284 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
            Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 28/227 (12%)
Query: 117 FSDTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKV 168
           +++ + +GEG +G V   Y  V +    +A+K++S    Q      LRE+K    ++ + 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLRF 78
Query: 169 QHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I 
Sbjct: 79  RHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQIL 134
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTY 283
           +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T 
Sbjct: 135 RGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 284 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
            Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 104/266 (39%), Gaps = 72/266 (27%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGD-EIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLV 174
           F     +G GGFG V++   +  D   A+KR+   + +  RE +  E   +AK++H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 175 RLLGCCIDKDEKILIYE----YMPNKSLDFFLFDPT------------------------ 206
           R     ++   +    E    ++ ++S D+ L  P+                        
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 207 -----------------KRILLDWVTR------------VQIIEGIAQGLLYLHQYSRVR 237
                            K  L DW+ R            + I   IA+ + +LH      
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--- 184
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ----------ANTSRIVGTYGYMS 287
           ++HRDLK SNI    D   K+ DFG+      +E +          A     VGT  YMS
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMS 244
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIV 313
           PE      +S K D+FS G++L E++
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 105
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 106 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR    +E+       
Sbjct: 154 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT-DDEMXG----Y 205
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 206 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++  
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 66
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P K+L+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 114
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS   +++  
Sbjct: 3   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 60
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P KSL+ F        L D  
Sbjct: 61  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 108
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 109 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 165
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 166 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     +G G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EYMP   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L+E++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+++D+    K++DFG+A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 89  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGY 188
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 116 TFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           +++DT  +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+V
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 155
Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           RL        EK       L+ +Y+P             +  L  +     +  + + L 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +
Sbjct: 216 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRA 269
Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE       ++   DV+S G +L E++ G+
Sbjct: 270 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 111/227 (48%), Gaps = 28/227 (12%)
Query: 117 FSDTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKV 168
           +++ + +GEG +G V   Y  V +    +A+K++S    Q      LRE+K    ++ + 
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLRF 98
Query: 169 QHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           +H+N++ +        I++ + + +  ++     D +    T+ +  D +     +  I 
Sbjct: 99  RHENIIGINDIIRAPTIEQMKDVYLVTHL--MGADLYKLLKTQHLSNDHI--CYFLYQIL 154
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTY 283
           +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T 
Sbjct: 155 RGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 284 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
            Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRL----SGRSEQGLR-EMKNEASVIAKVQHKNL 173
           +  +LG G FG V KG  +    +    +    +  ++  L+ E+  EA+V+ ++ +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + 
Sbjct: 433 VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEES 488
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPE 289
           +    +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE
Sbjct: 489 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APE 542
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVS 314
                 FS KSDV+SFGVL+ E  S
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 28/227 (12%)
Query: 117 FSDTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKV 168
           +++ + +GEG +G V   Y  V +    +A+K++S    Q      LRE+K    ++ + 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLRF 80
Query: 169 QHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I 
Sbjct: 81  RHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQIL 136
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTY 283
           +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T 
Sbjct: 137 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 284 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
            Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFF--LFDPTKRILLDWVTRVQ-----------I 219
           ++ LL              + P +SL+ F  ++  T  +  D    V+           +
Sbjct: 79  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL 126
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  
Sbjct: 127 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 178
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 119 DTNKLGEGGFGPVYKGVLRKGDEIAVKRL----SGRSEQGLR-EMKNEASVIAKVQHKNL 173
           +  +LG G FG V KG  +    +    +    +  ++  L+ E+  EA+V+ ++ +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + 
Sbjct: 434 VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE- 488
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPE 289
                +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE
Sbjct: 489 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APE 543
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVS 314
                 FS KSDV+SFGVL+ E  S
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLL 177
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL--PIKWMAPESINFRRF 189
Query: 297 SIKSDVFSFGVLLLEIV 313
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++  
Sbjct: 10  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 67
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P K+L+ F        L D  
Sbjct: 68  AKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 115
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 116 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 172
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 173 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 105/233 (45%), Gaps = 43/233 (18%)
Query: 107 FSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQGL 155
           F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++   
Sbjct: 48  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHA 105
Query: 156 REMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK 207
           +    E  ++  V HKN++ LL              + P K+L+ F        L D   
Sbjct: 106 KRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANL 153
Query: 208 ----RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM 263
               ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+
Sbjct: 154 CQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210
Query: 264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 211 ARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 28/227 (12%)
Query: 117 FSDTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKV 168
           +++ + +GEG +G V   Y  V +    +A+K++S    Q      LRE+K    ++ + 
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLRF 86
Query: 169 QHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I 
Sbjct: 87  RHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQIL 142
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTY 283
           +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T 
Sbjct: 143 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 284 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
            Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 246

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 28/227 (12%)
Query: 117 FSDTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKV 168
           +++ + +GEG +G V   Y  V +    +A+K++S    Q      LRE+K    ++ + 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLRF 78
Query: 169 QHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I 
Sbjct: 79  RHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQIL 134
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTY 283
           +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T 
Sbjct: 135 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 284 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
            Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 123 LGEGGFGPV--YKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  +   + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               +    L+ EY     +  +L    +    +   + + I    Q   Y HQ     I
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCHQKF---I 134
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE-YALEGIF 296
           +HRDLKA N+LLD D N KI+DFG +     GN+L A      G   Y +PE +  +   
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPELFQGKKYD 190
Query: 297 SIKSDVFSFGVLLLEIVSG 315
             + DV+S GV+L  +VSG
Sbjct: 191 GPEVDVWSLGVILYTLVSG 209

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
            F SV    +TF+      +   +G G  G V   Y  VL +   +A+K+LS   +++  
Sbjct: 47  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTH 104
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDP- 205
            +    E  ++  V HKN++ LL              + P K+L+ F        L D  
Sbjct: 105 AKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDAN 152
Query: 206 ---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 153 LCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 209
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 210 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 28/227 (12%)
Query: 117 FSDTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKV 168
           +++ + +GEG +G V   Y  V +    +A+K++S    Q      LRE+K    ++ + 
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLRF 98
Query: 169 QHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I 
Sbjct: 99  RHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQIL 154
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTY 283
           +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T 
Sbjct: 155 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 284 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
            Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 16/211 (7%)
Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK---RLSGRSEQGLREMKNEASVI 165
           V        DT  LG G FG V  G  +  G ++AVK   R   RS   + ++K E   +
Sbjct: 8   VKIGHYVLGDT--LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
              +H ++++L        +  ++ EY+    L  ++    K   ++ +   ++ + I  
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILS 122
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
            + Y H++    ++HRDLK  N+LLD  MN KI+DFG++ +    E   ++    G+  Y
Sbjct: 123 AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNY 176
Query: 286 MSPEYALEGIFS-IKSDVFSFGVLLLEIVSG 315
            +PE     +++  + D++S GV+L  ++ G
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 123 LGEGGFGPVYKGVLRK-GD-------EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           LG+G F  ++KGV R+ GD       E+ +K L              AS+++K+ HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
              G C   DE IL+ E++   SLD +L      I + W  ++++ + +A  + +L + +
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT 133
Query: 235 RVRIIHRDLKASNILL-----DKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYM 286
              +IH ++ A NILL      K  NP   K+SD G++      ++       V      
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           +P+       ++ +D +SFG  L EI SG
Sbjct: 191 NPKN-----LNLATDKWSFGTTLWEICSG 214

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLR 156
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS       R
Sbjct: 14  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------R 64
Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK- 207
             +N+    AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D    
Sbjct: 65  PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 121
Query: 208 ---RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
              ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 122 QVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 178
Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           R  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 179 RTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI D+G+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRL------SGRSEQGLREMKNEASVIAKVQ 169
           +    K+GEG +G V+K   R+  EI A+KR+       G     LRE+     ++ +++
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKELK 59
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           HKN+VRL        +  L++E+  ++ L  + FD     L   + +  + + + +GL +
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDLDPEIVKSFLFQ-LLKGLGF 116
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            H  +   ++HRDLK  N+L++++   K+++FG+AR   G  ++  ++ +V T  Y  P+
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV-TLWYRPPD 171
Query: 290 YALEG-IFSIKSDVFSFGVLLLEIVSGKK 317
                 ++S   D++S G +  E+ +  +
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 37/217 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN--EASVIAKVQHKNL 173
           + + + +G G +G V      + G  +AVK+LS   +  +   +   E  ++  ++H+N+
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------II 220
           + LL              + P +SL    D +L        L+ + + Q         +I
Sbjct: 96  IGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           +  V
Sbjct: 144 YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYV 195
Query: 281 GTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
            T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEI--AVKRLSGRSEQGLREMKN---EASVIAK-VQHKNLVRL 176
           +G+G FG V      K +E+  AVK L  ++    +E K+   E +V+ K V+H  LV L
Sbjct: 46  IGKGSFGKVLLA-RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                  D+   + +Y+    L + L    +R  L+   R    E IA  L YLH    +
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---L 158
Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYMSPEYALEGI 295
            I++RDLK  NILLD   +  ++DFG+   C  N E  + TS   GT  Y++PE   +  
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGL---CKENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 296 FSIKSDVFSFGVLLLEIVSG 315
           +    D +  G +L E++ G
Sbjct: 216 YDRTVDWWCLGAVLYEMLYG 235

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 39/231 (16%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGLR 156
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS       R
Sbjct: 11  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-------R 61
Query: 157 EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK- 207
             +N+    AK  ++ LV L+ C   K+   L+  + P KSL+ F        L D    
Sbjct: 62  PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 118
Query: 208 ---RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
              ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+A
Sbjct: 119 QVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 175
Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           R  G + +       V T  Y +PE  L   +    D++S G ++ E++ G
Sbjct: 176 RTAGTSFMMVP---FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 26/226 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           +++ + +GEG +G V      L K   +A+K++S    Q      LRE+K    ++ + +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIK----ILLRFR 83
Query: 170 HKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQILR 139
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYG 284
           GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
           Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 26/226 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           +++ + +GEG +G V      L K   +A+K++S    Q      LRE+K    ++ + +
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIK----ILLRFR 84
Query: 170 HKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I +
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQILR 140
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYG 284
           GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  
Sbjct: 141 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
           Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 243

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 26/226 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           +++ + +GEG +G V      L K   +A+K++S    Q      LRE+K    ++ + +
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIK----ILLRFR 85
Query: 170 HKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I +
Sbjct: 86  HENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQILR 141
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYG 284
           GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  
Sbjct: 142 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
           Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 244

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 26/226 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           +++ + +GEG +G V      L K   +A+K++S    Q      LRE+K    ++ + +
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIK----ILLRFR 76
Query: 170 HKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I +
Sbjct: 77  HENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQILR 132
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYG 284
           GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  
Sbjct: 133 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
           Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 235

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 26/226 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           +++ + +GEG +G V      L K   +A+K++S    Q      LRE+K    ++ + +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIK----ILLRFR 83
Query: 170 HKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQILR 139
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYG 284
           GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
           Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 111/233 (47%), Gaps = 29/233 (12%)
Query: 100 DQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVK-------RLSGRS 151
           D+LP   +++       +   + +G G    V + V R  G E AVK       RLS   
Sbjct: 81  DELP--DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQ 138
Query: 152 EQGLRE-MKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI 209
            + +RE  + E  ++ +V  H +++ L+          L+++ M    L  +L   T+++
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKV 195
Query: 210 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICG 268
            L       I+  + + + +LH  +   I+HRDLK  NILLD +M  ++SDFG +  +  
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
Query: 269 GNELQANTSRIVGTYGYMSPEY------ALEGIFSIKSDVFSFGVLLLEIVSG 315
           G +L+     + GT GY++PE            +  + D+++ GV+L  +++G
Sbjct: 253 GEKLR----ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 26/226 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           +++ + +GEG +G V      L K   +A+K++S    Q      LRE+K    ++ + +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYXQRTLREIK----ILLRFR 83
Query: 170 HKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQILR 139
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYG 284
           GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
           Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 26/226 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           +++ + +GEG +G V      L K   +A+K++S    Q      LRE+K    ++ + +
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIK----ILLRFR 77
Query: 170 HKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I +
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQILR 133
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYG 284
           GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  
Sbjct: 134 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
           Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 236

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 26/226 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           +++ + +GEG +G V      L K   +A+K++S    Q      LRE+K    ++ + +
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIK----ILLRFR 77
Query: 170 HKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I +
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQILR 133
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYG 284
           GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  
Sbjct: 134 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
           Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 236

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 137/281 (48%), Gaps = 45/281 (16%)
Query: 122 KLGEGGFGPVYK-GVLRKGDEIAVKRLSG--RSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +LG G +G V K   +  G  +AVKR+     S++  R + +    +  V     V   G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 179 CCIDKDEKILIYEYMPNKSLDFF---LFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
               + +  +  E M + SLD F   + D  + I  D + ++ +   I + L +LH  S+
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHLH--SK 172
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-VGTYGYMSPEYALEG 294
           + +IHRD+K SN+L++     K+ DFG++    G  + +    I  G   YM+PE     
Sbjct: 173 LSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDSVAKTIDAGCKPYMAPERINPE 228
Query: 295 I----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS--NRTLELIDD 348
           +    +S+KSD++S G+ ++E               L +L + +D W +   +  +++++
Sbjct: 229 LNQKGYSVKSDIWSLGITMIE---------------LAILRFPYDSWGTPFQQLKQVVEE 273
Query: 349 PVLE---DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
           P  +   D++S++     +V+    C+++++ +RPT  +++
Sbjct: 274 PSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPELM 309

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVK---RLSGRSEQGLREMKNEASVI 165
           V        DT  LG G FG V  G  +  G ++AVK   R   RS   + ++K E   +
Sbjct: 8   VKIGHYVLGDT--LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
              +H ++++L        +  ++ EY+    L  ++    K   ++ +   ++ + I  
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILS 122
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
            + Y H++    ++HRDLK  N+LLD  MN KI+DFG++ +    E    +    G+  Y
Sbjct: 123 AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNY 176
Query: 286 MSPEYALEGIFS-IKSDVFSFGVLLLEIVSG 315
            +PE     +++  + D++S GV+L  ++ G
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKVQH 170
           + F     LG+G FG VY    ++   I   ++  +S+   +G+  +++ E  + + ++H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
            N++R+     D+    L+ E+ P   L   L    K    D       +E +A  L Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYC 130
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMS 287
           H+    ++IHRD+K  N+L+      KI+DFG +       + A + R   + GT  Y+ 
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLP 180
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           PE         K D++  GVL  E + G
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 110/227 (48%), Gaps = 28/227 (12%)
Query: 117 FSDTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKV 168
           +++ + +GEG +G V   Y  V +    +A+K++S    Q      LRE+K    ++   
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLAF 80
Query: 169 QHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I 
Sbjct: 81  RHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQIL 136
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTY 283
           +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T 
Sbjct: 137 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 284 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
            Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS   +++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPT 206
            +    E  ++  V HKN++ LL              + P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 207 K----RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +      +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 172 LARTAGTSFMM--EPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLL 177
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 297 SIKSDVFSFGVLLLEIV 313
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLL 177
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES---KR 159
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 217
Query: 297 SIKSDVFSFGVLLLEIV 313
           +  SDV+ FGV + EI+
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +LG G FG V++   R  G+  A K +    E     ++ E   ++ ++H  LV L    
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            D +E ++IYE+M    L   + D   ++  D    V+ +  + +GL ++H+ +    +H
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENN---YVH 172
Query: 241 RDLKASNILL--DKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
            DLK  NI+    +    K+ DFG+ A +     ++  T    GT  + +PE A      
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVG 228
Query: 298 IKSDVFSFGVLLLEIVSG 315
             +D++S GVL   ++SG
Sbjct: 229 YYTDMWSVGVLSYILLSG 246

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DF +AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLL 177
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 297 SIKSDVFSFGVLLLEIV 313
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L+E++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+++D+    +++DFG+A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 111 STATNT-----FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NE 161
           S A NT     F     LG G FG V     ++ G+  A+K L  +    L++++   NE
Sbjct: 25  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             ++  V    LV+L     D     ++ EY+P   +    F   +RI        +   
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY- 139
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
             AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + G
Sbjct: 140 -AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG 193
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 105 FSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEI--AVKRLSGRSEQGLREMKNEA 162
           F  S+       ++  N +G G +G V K  ++KG  I  A K++     + +   K E 
Sbjct: 16  FQGSTKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI 74
Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
            ++  + H N++RL     D  +  L+ E      L  F     KR+  +     +I++ 
Sbjct: 75  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL--FERVVHKRVFRE-SDAARIMKD 131
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILL--DKDMNP-KISDFGM-ARICGGNELQANTSR 278
           +   + Y H   ++ + HRDLK  N L   D   +P K+ DFG+ AR   G  ++     
Sbjct: 132 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--- 185
Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            VGT  Y+SP+  LEG++  + D +S GV++  ++ G
Sbjct: 186 -VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLL 177
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 569
Query: 297 SIKSDVFSFGVLLLEIV 313
           +  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +LG G FG V++   R  G+  A K +    E     ++ E   ++ ++H  LV L    
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            D +E ++IYE+M    L   + D   ++  D    V+ +  + +GL ++H+ +    +H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENN---YVH 278
Query: 241 RDLKASNILL--DKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
            DLK  NI+    +    K+ DFG+ A +     ++  T    GT  + +PE A      
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVG 334
Query: 298 IKSDVFSFGVLLLEIVSG 315
             +D++S GVL   ++SG
Sbjct: 335 YYTDMWSVGVLSYILLSG 352

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLL 177
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 191
Query: 297 SIKSDVFSFGVLLLEIV 313
           +  SDV+ FGV + EI+
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI        +     AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY--AAQIVLTF 155
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 110/227 (48%), Gaps = 28/227 (12%)
Query: 117 FSDTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKV 168
           +++ + +GEG +G V   Y  V +    +A+K++S    Q      LRE+K    ++   
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLAF 80
Query: 169 QHKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I 
Sbjct: 81  RHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQIL 136
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTY 283
           +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T 
Sbjct: 137 RGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 284 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
            Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI     +        AQ +L  
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRI--GRFSEPHARFYAAQIVLTF 140
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEI 195
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE---QGL-REMKNEASVIAKVQH 170
           + F     LG+G FG VY    ++   I   ++  +S+   +G+  +++ E  + + ++H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
            N++R+     D+    L+ E+ P   L   L    K    D       +E +A  L Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYC 131
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMS 287
           H+    ++IHRD+K  N+L+      KI+DFG +       + A + R   + GT  Y+ 
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLP 181
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           PE         K D++  GVL  E + G
Sbjct: 182 PEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLL 177
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 194
Query: 297 SIKSDVFSFGVLLLEIV 313
           +  SDV+ FGV + EI+
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 109/226 (48%), Gaps = 26/226 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           +++ + +GEG +G V      L K   +A+K++S    Q      LRE+K    ++ + +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIK----ILLRFR 83
Query: 170 HKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQILR 139
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYG 284
           GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +          V T  
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
           Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 109/226 (48%), Gaps = 26/226 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           +++ + +GEG +G V      L K   +A+K++S    Q      LRE+K    ++ + +
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIK----ILLRFR 84
Query: 170 HKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I +
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQILR 140
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYG 284
           GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +          V T  
Sbjct: 141 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
           Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 243

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLL 177
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 75  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 186
Query: 297 SIKSDVFSFGVLLLEIV 313
           +  SDV+ FGV + EI+
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 123 LGEGGFGPVYKGVLRK------GDEIAVKRLSG----RSEQGLREMKNEASVIAKVQHKN 172
           LG+GG+G V++  +RK      G   A+K L      R+ +     K E +++ +V+H  
Sbjct: 25  LGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           +V L+       +  LI EY+    L  F+    + I ++      + E I+  L +LHQ
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISMALGHLHQ 139
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEY 290
                II+RDLK  NI+L+   + K++DFG+ +  I  G      T    GT  YM+PE 
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHTFCGTIEYMAPEI 192
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            +    +   D +S G L+ ++++G
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 110/226 (48%), Gaps = 26/226 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           +++ + +GEG +G V      L K   +A++++S    Q      LRE+K    ++ + +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKV-RVAIRKISPFEHQTYCQRTLREIK----ILLRFR 83
Query: 170 HKNLVRL----LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQILR 139
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYG 284
           GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
           Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 123 LGEGGFGPVYKGVLRK------GDEIAVKRLSG----RSEQGLREMKNEASVIAKVQHKN 172
           LG+GG+G V++  +RK      G   A+K L      R+ +     K E +++ +V+H  
Sbjct: 25  LGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           +V L+       +  LI EY+    L  F+    + I ++      + E I+  L +LHQ
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISMALGHLHQ 139
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEY 290
                II+RDLK  NI+L+   + K++DFG+ +  I  G      T    GT  YM+PE 
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHXFCGTIEYMAPEI 192
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            +    +   D +S G L+ ++++G
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLL 177
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 192
Query: 297 SIKSDVFSFGVLLLEIV 313
           +  SDV+ FGV + EI+
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLL 177
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+ A N+L+      K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 297 SIKSDVFSFGVLLLEIV 313
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 111 STATNT-----FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NE 161
           S A NT     F     LG G FG V     ++ G+  A+K L  +    L++++   NE
Sbjct: 25  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             ++  V    LV+L     D     ++ EY+P   +    F   +RI     +      
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRI--GRFSEPHARF 138
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
             AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + G
Sbjct: 139 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG 193
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 54/240 (22%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQG-----LREMKNEASVIAKVQ 169
           +++ + +GEG +G V      L K   +A+K++S    Q      LRE+K    ++ + +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKV-RVAIKKISPFEHQTYCQRTLREIK----ILLRFR 83
Query: 170 HKNLV------------RLLGCCIDKD------EKILIYEYMPNKSLDFFLFDPTKRILL 211
           H+N++            ++    I +D       K+L  +++ N  + +FL+        
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQ------- 136
Query: 212 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
                      I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   + 
Sbjct: 137 -----------ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 272 LQAN-TSRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
                 +  V T  Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     +G G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 106 SFSSVSTATNTFS------DTNKLGEGGFGPV---YKGVLRKGDEIAVKRLSG--RSEQG 154
           +F SV    +TF+      +   +G G  G V   Y  +L +   +A+K+LS   +++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPT 206
            +    E  ++  V HKN++ LL              + P KSL+ F        L D  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 207 K----RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG 262
                ++ LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +AR  G + +      +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 172 LARTAGTSFMM--EPEVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLV 174
           F     LG G F  V     +  G   AVK +  ++ +G    ++NE +V+ K++H+N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            L       +   L+ + +    L   + +       D  T   +I  +   + YLH   
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST---LIRQVLDAVYYLH--- 137
Query: 235 RVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
           R+ I+HRDLK  N+L    D++    ISDFG++++ G  ++    S   GT GY++PE  
Sbjct: 138 RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDV---MSTACGTPGYVAPEVL 194
Query: 292 LEGIFSIKSDVFSFGVLLLEIVSG 315
            +  +S   D +S GV+   ++ G
Sbjct: 195 AQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI        +     AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 155
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI        +     AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 155
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEI 210
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 111 STATNT-----FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NE 161
           S A NT     F     LG G FG V     ++ G+  A+K L  +    L++++   NE
Sbjct: 33  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             ++  V    LV+L     D     ++ EY P   +    F   +RI        +   
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY- 147
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
             AQ +L       + +I+RDLK  N+++D+    K++DFG A+   G      T  + G
Sbjct: 148 -AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCG 201
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+ R           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSG-RSEQGLREMKNEASVIAKVQ 169
           T  + F    KLG G FG V+    R  G E  +K ++  RS+  + +++ E  V+  + 
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           H N++++     D     ++ E      L +  +    +   L      ++++ +   L 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP----KISDFGMARICGGNELQANTSRIVGTYG 284
           Y H      ++H+DLK  NIL  +D +P    KI DFG+A +   +E   N +   GT  
Sbjct: 139 YFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTAL 191
Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           YM+PE     + + K D++S GV++  +++G
Sbjct: 192 YMAPEVFKRDV-TFKCDIWSAGVVMYFLLTG 221

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 111 STATNT-----FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NE 161
           S A NT     F     LG G FG V     ++ G+  A+K L  +    L++++   NE
Sbjct: 33  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             ++  V    LV+L     D     ++ EY+P   +    F   +RI        +   
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY- 147
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
             AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + G
Sbjct: 148 -AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG 201
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 111 STATNT-----FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NE 161
           S A NT     F     LG G FG V     ++ G+  A+K L  +    L++++   NE
Sbjct: 33  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             ++  V    LV+L     D     ++ EY+P   +    F   +RI        +   
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY- 147
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
             AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + G
Sbjct: 148 -AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG 201
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 111 STATNT-----FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NE 161
           S A NT     F     LG G FG V     ++ G+  A+K L  +    L++++   NE
Sbjct: 33  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             ++  V    LV+L     D     ++ EY+P   +    F   +RI        +   
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY- 147
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
             AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + G
Sbjct: 148 -AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG 201
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 121 NKLGEGGFGPVYKGVLRKGDEI--AVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           N +G G +G V K  ++KG  I  A K++     + +   K E  ++  + H N++RL  
Sbjct: 15  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D  +  L+ E      L  F     KR+  +     +I++ +   + Y H   ++ +
Sbjct: 74  TFEDNTDIYLVMELCTGGEL--FERVVHKRVFRE-SDAARIMKDVLSAVAYCH---KLNV 127
Query: 239 IHRDLKASNILL--DKDMNP-KISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEG 294
            HRDLK  N L   D   +P K+ DFG+ AR   G  ++      VGT  Y+SP+  LEG
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK----VGTPYYVSPQ-VLEG 182
Query: 295 IFSIKSDVFSFGVLLLEIVSG 315
           ++  + D +S GV++  ++ G
Sbjct: 183 LYGPECDEWSAGVMMYVLLCG 203

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI  FG+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 111/243 (45%), Gaps = 38/243 (15%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           F +   LG+G FG V K          A+K++   +E+ L  + +E  ++A + H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-RILLDWVTRV----------QIIEGIA 224
                +++   +     +  KS  F   +  + R L D +             ++   I 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---------------ICGG 269
           + L Y+H      IIHRDLK  NI +D+  N KI DFG+A+               + G 
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 270 NELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 327
           ++   N +  +GT  Y++ E  L+G   ++ K D++S G++  E++    +TG+ R + L
Sbjct: 184 SD---NLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY-PFSTGMERVNIL 238
Query: 328 NLL 330
             L
Sbjct: 239 KKL 241

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 123 LGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLL 177
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G  I ++   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +HRD+ A N+L+      K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 569
Query: 297 SIKSDVFSFGVLLLEIV 313
           +  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 111 STATNT-----FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NE 161
           S A NT     F     LG G FG V     ++ G+  A+K L  +    L++++   NE
Sbjct: 53  SPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             ++  V    LV+L     D     ++ EY+P   +    F   +RI        +   
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY- 167
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
             AQ +L       + +I+RDLK  N+L+D+    +++DFG A+      ++  T  + G
Sbjct: 168 -AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 221
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           + D   LG GG G V+  V    D+ +A+K++     Q ++    E  +I ++ H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 176 L--------------LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
           +              +G   + +   ++ EYM     +     P    LL+   R+ + +
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP----LLEEHARLFMYQ 128
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGN-ELQANTSRI 279
            + +GL Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI   +   + + S  
Sbjct: 129 -LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 280 VGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 316
           + T  Y SP   L      K+ D+++ G +  E+++GK
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 141/295 (47%), Gaps = 47/295 (15%)
Query: 109 SVSTATNTFSDTNKLGEGGFGPVYK-GVLRKGDEIAVKRLSG--RSEQGLREMKNEASVI 165
           S+    +      +LG G +G V K   +  G  +AVKR+     S++  R + +    +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF---LFDPTKRILLDWVTRVQIIEG 222
             V     V   G    + +  +  E M + SLD F   + D  + I  D + ++ +   
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--S 117
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV-- 280
           I + L +LH  S++ +IHRD+K SN+L++     K+ DFG++       L  + ++ +  
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAKDIDA 170
Query: 281 GTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL 336
           G   YM+PE     +    +S+KSD++S G+ ++E               L +L + +D 
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE---------------LAILRFPYDS 215
Query: 337 WTS--NRTLELIDDPVLE---DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
           W +   +  +++++P  +   D++S++     +V+    C+++++ +RPT  +++
Sbjct: 216 WGTPFQQLKQVVEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPELM 265

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 114 TNTFSDTNKLGEGGFGPVY------KGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAK 167
           ++ +    KLG G +G V        G  R    I    ++  S  G   + +E +V+ +
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSG--ALLDEVAVLKQ 77
Query: 168 VQHKNLVRLLGCCIDKDEKILIYE-YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG 226
           + H N+++L     DK    L+ E Y   +  D  +     R     V    I++ +  G
Sbjct: 78  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----RQKFSEVDAAVIMKQVLSG 133
Query: 227 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTY 283
             YLH+++   I+HRDLK  N+LL+   +D   KI DFG++      E+       +GT 
Sbjct: 134 TTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGKMKERLGTA 187
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            Y++PE  L   +  K DV+S GV+L  ++ G
Sbjct: 188 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
             +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
             +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             L +L     D     ++ EY P   +    F   +RI        +     AQ +L  
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFY--AAQIVLTF 155
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN---EASVIAKVQHKN 172
           + + + +G G +G V      + G  +AVK+LS R  Q +   K    E  ++  ++H+N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRILLDWVTRVQ---------I 219
           ++ LL              + P +SL    D +L        L+ + + Q         +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           I  I +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR           +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDDEMTGY 182
Query: 280 VGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 10/218 (4%)
Query: 117 FSDTNKLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQGL-REMKNEASVIAKVQHKNL 173
           ++    +GEG +G V      +RK   +A+K++S    Q   +    E  ++ + +H+N+
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRK-TRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           + +         + +   Y+    ++  L+   K   L        +  I +GL Y+H  
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHS- 162
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEYAL 292
               ++HRDLK SN+L++   + KI DFG+ARI           +  V T  Y +PE  L
Sbjct: 163 --ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 293 EGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 328
                 KS D++S G +L E++S +    G +  D LN
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
             +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
             +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 123 LGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGL---REMKNEASVIAKVQHKNLVRL 176
           +G G +G V   Y   LR+  ++AVK+LS R  Q L   R    E  ++  ++H+N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 177 L-----GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQ-IIEGIAQGLLYL 230
           L        I+   ++ +   +    L+  +     + L D    VQ ++  + +GL Y+
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KSQALSD--EHVQFLVYQLLRGLKYI 147
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
           H      IIHRDLK SN+ +++D   +I DFG+AR     +     +  V T  Y +PE 
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEI 199
Query: 291 ALEGI-FSIKSDVFSFGVLLLEIVSGK 316
            L  + ++   D++S G ++ E++ GK
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY P   +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+++D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 43/214 (20%)
Query: 123 LGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGL---REMKNEASVIAKVQHKNLVRL 176
           +G G +G V   Y   LR+  ++AVK+LS R  Q L   R    E  ++  ++H+N++ L
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 177 LGCCIDKDEKILIYEYMPNKSL-DF---FLFDPTKRILLDWVTRVQ---------IIEGI 223
           L              + P  S+ DF   +L        L+ + + Q         ++  +
Sbjct: 85  LDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL 132
Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 283
            +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR     +     +  V T 
Sbjct: 133 LRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATR 184
Query: 284 GYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
            Y +PE  L  + ++   D++S G ++ E++ GK
Sbjct: 185 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 111 STATNT-----FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NE 161
           S A NT     F     LG G FG V     ++ G+  A+K L  +    L++++   NE
Sbjct: 33  SPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             +   V    LV+L     D     ++ EY P   +    F   +RI        +   
Sbjct: 93  KRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM----FSHLRRIGRFSEPHARFY- 147
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
             AQ +L       + +I+RDLK  N+L+D+    K++DFG A+   G      T  + G
Sbjct: 148 -AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCG 201
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 91/178 (51%), Gaps = 19/178 (10%)
Query: 147 LSGRSEQGLREMK-NEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD 204
            S    Q LRE    E  ++ KV  H N+++L           L+++ M    L  +L  
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 115
Query: 205 PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
            T+++ L      +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +
Sbjct: 116 -TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 265 -RICGGNELQANTSRIVGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSG 315
            ++  G +L++    + GT  Y++PE     +      +  + D++S GV++  +++G
Sbjct: 172 CQLDPGEKLRS----VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             L +L     D     ++ EY P   +    F   +RI        +     AQ +L  
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 155
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVK-----RLSGRSEQGLREMKNEASVI 165
           + T+ +    +LG+G F  V + + +  G E A K     +LS R  Q L   + EA + 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKL---EREARIC 57
Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
             ++H N+VRL     ++    L+++ +    L     D   R           I+ I +
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILE 114
Query: 226 GLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT 282
            + + H      I+HRDLK  N+LL    K    K++DFG+A    G+  Q       GT
Sbjct: 115 SVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD--QQAWFGFAGT 169
Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             L +L     D     ++ EY P   +    F   +RI        +     AQ +L  
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 155
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 114 TNTFSDTNKLGEGGFGPVY------KGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAK 167
           ++ +    KLG G +G V        G  R    I    ++  S  G   + +E +V+ +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA--LLDEVAVLKQ 60
Query: 168 VQHKNLVRLLGCCIDKDEKILIYE-YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG 226
           + H N+++L     DK    L+ E Y   +  D  +     R     V    I++ +  G
Sbjct: 61  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----RQKFSEVDAAVIMKQVLSG 116
Query: 227 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTY 283
             YLH+++   I+HRDLK  N+LL+   +D   KI DFG++      E+       +GT 
Sbjct: 117 TTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGKMKERLGTA 170
Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            Y++PE  L   +  K DV+S GV+L  ++ G
Sbjct: 171 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 112 TATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVK-----RLSGRSEQGLREMKNEASVI 165
           + T+ +    +LG+G F  V + + +  G E A K     +LS R  Q L   + EA + 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKL---EREARIC 57
Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
             ++H N+VRL     ++    L+++ +    L     D   R           I+ I +
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILE 114
Query: 226 GLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT 282
            + + H      I+HRDLK  N+LL    K    K++DFG+A    G+  Q       GT
Sbjct: 115 SVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD--QQAWFGFAGT 169
Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
            GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +LG G FG V++ V +  G     K ++         +KNE S++ ++ H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLD--WVTRVQIIEGIAQ---GLLYLHQYSR 235
            DK E +LI E++        LFD   RI  +   ++  ++I  + Q   GL ++H++S 
Sbjct: 118 EDKYEMVLILEFLSGGE----LFD---RIAAEDYKMSEAEVINYMRQACEGLKHMHEHS- 169
Query: 236 VRIIHRDLKASNILLD--KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
             I+H D+K  NI+ +  K  + KI DFG+A     +E+   T+    T  + +PE    
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDR 224
Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
                 +D+++ GVL   ++SG
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSG 246

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 19/178 (10%)
Query: 147 LSGRSEQGLREMK-NEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD 204
            S    Q LRE    E  ++ KV  H N+++L           L+++ M    L  +L  
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 115
Query: 205 PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
            T+++ L      +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +
Sbjct: 116 -TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 265 -RICGGNELQANTSRIVGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSG 315
            ++  G +L+     + GT  Y++PE     +      +  + D++S GV++  +++G
Sbjct: 172 CQLDPGEKLR----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 57/95 (60%), Gaps = 7/95 (7%)
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 281
           I+ GL +LH+     II+RDLK  N++LD + + KI+DFGM   C  + +   T+R   G
Sbjct: 129 ISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKEHMMDGVTTREFCG 182
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  Y++PE      +    D +++GVLL E+++G+
Sbjct: 183 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 43/214 (20%)
Query: 123 LGEGGFGPV---YKGVLRKGDEIAVKRLSGRSEQGL---REMKNEASVIAKVQHKNLVRL 176
           +G G +G V   Y   LR+  ++AVK+LS R  Q L   R    E  ++  ++H+N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 177 LGCCIDKDEKILIYEYMPNKSL-DF---FLFDPTKRILLDWVTRVQ---------IIEGI 223
           L              + P  S+ DF   +L        L+ + + Q         ++  +
Sbjct: 93  LDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL 140
Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 283
            +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR     +     +  V T 
Sbjct: 141 LRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATR 192
Query: 284 GYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
            Y +PE  L  + ++   D++S G ++ E++ GK
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK---GDEIAVKRLSGR---SEQGLREMKNEASVIAKV 168
           N F     LG+G FG V   ++R+   G   A+K L      ++  +     E+ V+   
Sbjct: 5   NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H  L  L       D    + EY     L F L    +R+  +   R    E I   L 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALE 119
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YLH      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++P
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 174
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E   +  +    D +  GV++ E++ G+
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 19/178 (10%)
Query: 147 LSGRSEQGLREMK-NEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD 204
            S    Q LRE    E  ++ KV  H N+++L           L+++ M    L  +L  
Sbjct: 45  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 102
Query: 205 PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
            T+++ L      +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +
Sbjct: 103 -TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 158
Query: 265 -RICGGNELQANTSRIVGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSG 315
            ++  G +L+     + GT  Y++PE     +      +  + D++S GV++  +++G
Sbjct: 159 CQLDPGEKLR----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 46/247 (18%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           F +   LG+G FG V K          A+K++   +E+ L  + +E  ++A + H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 176 LLGCCID-------------KDEKILIYEYMPNKSLDFFLFDPTKRILLD--WVTRVQII 220
                ++             K    +  EY  N +L   +         D  W    QI+
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--------------- 265
           E ++    Y+H      IIHRDLK  NI +D+  N KI DFG+A+               
Sbjct: 127 EALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 266 ICGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYR 323
           + G ++   N +  +GT  Y++ E  L+G   ++ K D++S G++  E++    +TG+ R
Sbjct: 180 LPGSSD---NLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY-PFSTGMER 234
Query: 324 TDSLNLL 330
            + L  L
Sbjct: 235 VNILKKL 241

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLR------EMKNEASVIAKVQHKNLV 174
           +LG G F  V K   +  G E A K +  R  +  R      E++ E S++ +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            L     ++ + +LI E +    L  FL    ++  L        I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 235 RVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPE 289
             +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++PE
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAPE 188
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSG 315
                   +++D++S GV+   ++SG
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK---GDEIAVKRLSGR---SEQGLREMKNEASVIAKV 168
           N F     LG+G FG V   ++R+   G   A+K L      ++  +     E+ V+   
Sbjct: 10  NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H  L  L       D    + EY     L F L    +R+  +   R    E I   L 
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALE 124
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YLH      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++P
Sbjct: 125 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 179
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E   +  +    D +  GV++ E++ G+
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK---GDEIAVKRLSGR---SEQGLREMKNEASVIAKV 168
           N F     LG+G FG V   ++R+   G   A+K L      ++  +     E+ V+   
Sbjct: 5   NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H  L  L       D    + EY     L F L    +R+  +   R    E I   L 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALE 119
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YLH      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++P
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 174
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E   +  +    D +  GV++ E++ G+
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK---GDEIAVKRLSGR---SEQGLREMKNEASVIAKV 168
           N F     LG+G FG V   ++R+   G   A+K L      ++  +     E+ V+   
Sbjct: 5   NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H  L  L       D    + EY     L F L    +R+  +   R    E I   L 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALE 119
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YLH      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++P
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 174
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E   +  +    D +  GV++ E++ G+
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLR------EMKNEASVIAKVQHKNLV 174
           +LG G F  V K   +  G E A K +  R  +  R      E++ E S++ +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            L     ++ + +LI E +    L  FL    ++  L        I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 235 RVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPE 289
             +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++PE
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAPE 188
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSG 315
                   +++D++S GV+   ++SG
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 16/215 (7%)
Query: 108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRK---GDEIAVKRLSGR---SEQGLREMKNE 161
           +      N F     LG+G FG V   ++R+   G   A+K L      ++  +     E
Sbjct: 1   ARAKVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 58
Query: 162 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
           + V+   +H  L  L       D    + EY     L F L    +R+  +   R    E
Sbjct: 59  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE 116
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
            I   L YLH      +++RD+K  N++LDKD + KI+DFG+ +   G    A      G
Sbjct: 117 -IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 170
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  Y++PE   +  +    D +  GV++ E++ G+
Sbjct: 171 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 107 FSSVSTATNTFSDTNK-LGEGGFGPVYKGVLRK-GDEIAVKRLSGRSE-QGLR-EMKNEA 162
           F S+    N +  T+K LG G F  V + + +  G E A K L  R   Q  R E+ +E 
Sbjct: 20  FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEI 79
Query: 163 SVIAKVQH-KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
           +V+   +    ++ L     +  E ILI EY     + F L  P    ++     +++I+
Sbjct: 80  AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIK 138
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP----KISDFGMARICGGNELQANTS 277
            I +G+ YLHQ +   I+H DLK  NILL   + P    KI DFGM+R  G         
Sbjct: 139 QILEGVYYLHQNN---IVHLDLKPQNILL-SSIYPLGDIKIVDFGMSRKIGH---ACELR 191
Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVL 308
            I+GT  Y++PE       +  +D+++ G++
Sbjct: 192 EIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK---GDEIAVKRLSGR---SEQGLREMKNEASVIAKV 168
           N F     LG+G FG V   ++R+   G   A+K L      ++  +     E+ V+   
Sbjct: 5   NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H  L  L       D    + EY     L F L    +R+  +   R    E I   L 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALE 119
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YLH      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++P
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 174
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E   +  +    D +  GV++ E++ G+
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLR------EMKNEASVIAKVQHKNLV 174
           +LG G F  V K   +  G E A K +  R  +  R      E++ E S++ +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            L     ++ + +LI E +    L  FL    ++  L        I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 235 RVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPE 289
             +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++PE
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAPE 188
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSG 315
                   +++D++S GV+   ++SG
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLR------EMKNEASVIAKVQHKNLV 174
           +LG G F  V K   +  G E A K +  R  +  R      E++ E S++ +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            L     ++ + +LI E +    L  FL    ++  L        I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 235 RVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPE 289
             +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++PE
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAPE 188
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSG 315
                   +++D++S GV+   ++SG
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLR------EMKNEASVIAKVQHKNLV 174
           +LG G F  V K   +  G E A K +  R  +  R      E++ E S++ +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            L     ++ + +LI E +    L  FL    ++  L        I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 235 RVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPE 289
             +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++PE
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAPE 188
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSG 315
                   +++D++S GV+   ++SG
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK---GDEIAVKRLSGR---SEQGLREMKNEASVIAKV 168
           N F     LG+G FG V   ++R+   G   A+K L      ++  +     E+ V+   
Sbjct: 5   NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL 228
           +H  L  L       D    + EY     L F L    +R+  +   R    E I   L 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALE 119
Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           YLH      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++P
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 174
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E   +  +    D +  GV++ E++ G+
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           TF     LG G F  V+    R  G   A+K +          ++NE +V+ K++H+N+V
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQ----IIEGIAQGLLYL 230
            L           L+ + +    L    FD   RIL   V   +    +I+ +   + YL
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGEL----FD---RILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 231 HQYSRVRIIHRDLKASNIL-LDKDMNPKI--SDFGMARICGGNELQANTSRIVGTYGYMS 287
           H+     I+HRDLK  N+L L  + N KI  +DFG++++    E     S   GT GY++
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVA 175
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           PE   +  +S   D +S GV+   ++ G
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR---SEQGLREMKNEASVIAK 167
           N F     LG+G FG V   +L K    G   A+K L      ++  +     E  V+  
Sbjct: 10  NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 123
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 124 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 179
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE   +  +    D +  GV++ E++ G+
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 28/205 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLVRLLGCC 180
           LG G F  V     ++  + +A+K ++ ++ +G    M+NE +V+ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 181 IDKDEKILIYEYMPNKSL-------DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
                  LI + +    L        F+      R++       Q+++ +     YLH  
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK----YLHD- 134
Query: 234 SRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
             + I+HRDLK  N+L   LD+D    ISDFG++++    +  +  S   GT GY++PE 
Sbjct: 135 --LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEV 189
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
             +  +S   D +S GV+   ++ G
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLR------EMKNEASVIAKVQHKNL 173
            +LG G F  V K   +  G E A K +  R  +  R      E++ E S++ +V H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           + L     ++ + +LI E +    L  FL    ++  L        I+ I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 234 SRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSP 288
              +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++P
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAP 187
Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSG 315
           E        +++D++S GV+   ++SG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR---SEQGLREMKNEASVIAK 167
           N F     LG+G FG V   +L K    G   A+K L      ++  +     E  V+  
Sbjct: 8   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 121
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 122 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 177
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE   +  +    D +  GV++ E++ G+
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 33/211 (15%)
Query: 122 KLGEGGFGPVYKGVLRKGD-EIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLG 178
           ++G G F  VYKG+  +   E+A   L  R  ++   +  K EA  +  +QH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 179 C---------CIDKDEKILIYEYMPNKSLDFFL--FDPTK-RILLDWVTRVQIIEGIAQG 226
                     CI     +L+ E   + +L  +L  F   K ++L  W  +      I +G
Sbjct: 93  SWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKG 141
Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGY 285
           L +LH  +   IIHRDLK  NI +       KI D G+A +   +  +A    ++GT  +
Sbjct: 142 LQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEF 196
Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
            +PE   E  +    DV++FG   LE  + +
Sbjct: 197 XAPE-XYEEKYDESVDVYAFGXCXLEXATSE 226

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR---SEQGLREMKNEASVIAK 167
           N F     LG+G FG V   +L K    G   A+K L      ++  +     E  V+  
Sbjct: 9   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 122
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 123 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 178
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE   +  +    D +  GV++ E++ G+
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFXEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 15  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 73
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 74  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 129
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 130 IGRFXEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 187
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 188 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFXEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFXEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 23/230 (10%)
Query: 93  RSKKKEVDQLPLFSFSSV-STATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR 150
           R +  E  Q P +  S   S    +F   ++LG G +G V+K   ++ G   AVKR    
Sbjct: 34  RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR---- 89
Query: 151 SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRI 209
           S    R  K+ A  +A+V     V    CC+  ++    +E      L   L  P+ ++ 
Sbjct: 90  SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ---AWEEGGILYLQTELCGPSLQQH 146
Query: 210 LLDW---VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM--- 263
              W   +   Q+   +   LL L       ++H D+K +NI L      K+ DFG+   
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 313
               G  E+Q    R      YM+PE  L+G +   +DVFS G+ +LE+ 
Sbjct: 207 LGTAGAGEVQEGDPR------YMAPEL-LQGSYGTAADVFSLGLTILEVA 249

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR---SEQGLREMKNEASVIAK 167
           N F     LG+G FG V   +L K    G   A+K L      ++  +     E  V+  
Sbjct: 148 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 261
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLA 317
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE   +  +    D +  GV++ E++ G+
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 21/229 (9%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 I--LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 266
           I    +   R    + I     YLH    + +I+RDLK  N+L+D+    +++DFG A+ 
Sbjct: 135 IGRFAEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
             G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 191 VKG-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR---SEQGLREMKNEASVIAK 167
           N F     LG+G FG V   +L K    G   A+K L      ++  +     E  V+  
Sbjct: 151 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 208 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 264
Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 265 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLA 320
Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE   +  +    D +  GV++ E++ G+
Sbjct: 321 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 41  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 99
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 100 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 155
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 156 IGRFXEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--- 210
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
              ++  T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 211 --RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 123 LGEGGFGPVYKGVLRKGDE---IAVKRLSGRSEQGLREMKN---EASVIAKVQHKNLVRL 176
           +G+G FG V   +++K D     A+K ++ +      E++N   E  ++  ++H  LV L
Sbjct: 23  IGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                D+++  ++ + +    L + L    + +     T    I  +   L YL      
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMALDYLQNQ--- 134
Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY--ALEG 294
           RIIHRD+K  NILLD+  +  I+DF +A +    E Q  T  + GT  YM+PE   + +G
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKPYMAPEMFSSRKG 191
Query: 295 I-FSIKSDVFSFGVLLLEIVSGKK 317
             +S   D +S GV   E++ G++
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 7   AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 65
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 66  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 121
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 122 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK 179
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 180 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 21  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 79
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 80  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 135
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 136 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 193
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 194 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 123 LGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           +G+G F  V + + R+ G + AVK     + +        ++K EAS+   ++H ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI----IEGIAQGLLYLHQ 232
           L          +++E+M    L    F+  KR    +V    +    +  I + L Y H 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 233 YSRVRIIHRDLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            +   IIHRD+K   +LL    N    K+  FG+A   G + L A     VGT  +M+PE
Sbjct: 149 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPE 203
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSG 315
                 +    DV+  GV+L  ++SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 28/205 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLVRLLGCC 180
           LG G F  V     ++  + +A+K ++  + +G    M+NE +V+ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 181 IDKDEKILIYEYMPNKSL-------DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
                  LI + +    L        F+      R++       Q+++ +     YLH  
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK----YLHD- 134
Query: 234 SRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
             + I+HRDLK  N+L   LD+D    ISDFG++++    +  +  S   GT GY++PE 
Sbjct: 135 --LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEV 189
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
             +  +S   D +S GV+   ++ G
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 115 NTFSDTNKLGEGGFGPVY-KGVLRKGDEIAVKRLSGRSEQGLREMK---NEASVIAKVQH 170
           + F     LG G FG V     +  G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             LV+L     D     ++ EY+    +    F   +RI        +     AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 28/205 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLVRLLGCC 180
           LG G F  V     ++  + +A+K ++  + +G    M+NE +V+ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 181 IDKDEKILIYEYMPNKSL-------DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
                  LI + +    L        F+      R++       Q+++ +     YLH  
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK----YLHD- 134
Query: 234 SRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
             + I+HRDLK  N+L   LD+D    ISDFG++++    +  +  S   GT GY++PE 
Sbjct: 135 --LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEV 189
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
             +  +S   D +S GV+   ++ G
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 28/205 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLR-EMKNEASVIAKVQHKNLVRLLGCC 180
           LG G F  V     ++  + +A+K ++  + +G    M+NE +V+ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 181 IDKDEKILIYEYMPNKSL-------DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
                  LI + +    L        F+      R++       Q+++ +     YLH  
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK----YLHD- 134
Query: 234 SRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
             + I+HRDLK  N+L   LD+D    ISDFG++++    +  +  S   GT GY++PE 
Sbjct: 135 --LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEV 189
Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSG 315
             +  +S   D +S GV+   ++ G
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 45/230 (19%)
Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           F +   LG+G FG V K          A+K++   +E+ L  + +E  ++A + H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 176 LLGCCID-------------KDEKILIYEYMPNKSLDFFLFDPTKRILLD--WVTRVQII 220
                ++             K    +  EY  N++L   +         D  W    QI+
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--------------- 265
           E ++    Y+H      IIHR+LK  NI +D+  N KI DFG+A+               
Sbjct: 127 EALS----YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 266 ICGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIV 313
           + G ++   N +  +GT  Y++ E  L+G   ++ K D +S G++  E +
Sbjct: 180 LPGSSD---NLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 123 LGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           +G+G F  V + + R+ G + AVK     + +        ++K EAS+   ++H ++V L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI----IEGIAQGLLYLHQ 232
           L          +++E+M    L    F+  KR    +V    +    +  I + L Y H 
Sbjct: 94  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 150
Query: 233 YSRVRIIHRDLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
            +   IIHRD+K   +LL    N    K+  FG+A   G + L A     VGT  +M+PE
Sbjct: 151 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPE 205
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSG 315
                 +    DV+  GV+L  ++SG
Sbjct: 206 VVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 23/226 (10%)
Query: 106 SFSSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSG------RSEQGLREM 158
           SF       + +     +G G +G V     R  G ++A+K++         +++ LRE+
Sbjct: 45  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 104
Query: 159 KNEASVIAKVQHKNLVRL---LGCCIDKDEKILIYEYMPNKSLDFF-LFDPTKRILLDWV 214
           K    ++   +H N++ +   L   +   E   +Y  +     D   +   ++ + L+ V
Sbjct: 105 K----ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV 160
Query: 215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-IC-GGNEL 272
                +  + +GL Y+H     ++IHRDLK SN+L++++   KI DFGMAR +C    E 
Sbjct: 161 R--YFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 215
Query: 273 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKK 317
           Q   +  V T  Y +PE  L    ++   D++S G +  E+++ ++
Sbjct: 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 35/231 (15%)
Query: 107 FSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASV 164
           F S+S     +S   ++G GG   V++ +  K    A+K   L     Q L   +NE + 
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 165 IAKVQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
           + K+Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKN 135
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI--- 279
           + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +   
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKD 186
Query: 280 --VGTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 316
             VGT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 187 SQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 41/223 (18%)
Query: 121 NKLGEGGFGPV--YKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            KLGEGGF  V   +G L  G   A+KR+    +Q   E + EA +     H N++RL+ 
Sbjct: 35  QKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 179 CCI----DKDEKILIYEYMPNKSLDFFLFDPTKRI--LLDWVTRVQIIE---GIAQGLLY 229
            C+     K E  L+  +    +    L++  +R+    +++T  QI+    GI +GL  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGT----LWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFG-MARICGGNE-------LQANTSRIVG 281
           +H        HRDLK +NILL  +  P + D G M + C   E       LQ   ++   
Sbjct: 150 IHAKGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC- 205
Query: 282 TYGYMSPEYALEGIFSIKS--------DVFSFGVLLLEIVSGK 316
           T  Y +PE     +FS++S        DV+S G +L  ++ G+
Sbjct: 206 TISYRAPE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 41  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 99
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 100 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 155
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 156 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--- 210
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
              ++  T  + GT  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 211 --RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 53/234 (22%)
Query: 108 SSVSTATNTFSDTNKLGEGGFGP-VYKGVLRKGDEIAVKRL-------SGRSEQGLREMK 159
           S V     +F   + LG G  G  VY+G+    D +AVKR+       + R  Q LRE  
Sbjct: 17  SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESD 75
Query: 160 NEASVIAKVQHKNLVRLLGCCIDKDEKI----------LIYEYMPNKSLDFFLFDPTKRI 209
                    +H N++R    C +KD +            + EY+  K       +P    
Sbjct: 76  ---------EHPNVIRYF--CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP---- 120
Query: 210 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-----DKDMNPKISDFGMA 264
                  + +++    GL +LH    + I+HRDLK  NIL+        +   ISDFG+ 
Sbjct: 121 -------ITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
Query: 265 -RICGGNELQANTSRIVGTYGYMSPEYALEGIF---SIKSDVFSFGVLLLEIVS 314
            ++  G    +  S + GT G+++PE   E      +   D+FS G +   ++S
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 23/226 (10%)
Query: 106 SFSSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSG------RSEQGLREM 158
           SF       + +     +G G +G V     R  G ++A+K++         +++ LRE+
Sbjct: 46  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 105
Query: 159 KNEASVIAKVQHKNLVRL---LGCCIDKDEKILIYEYMPNKSLDFF-LFDPTKRILLDWV 214
           K    ++   +H N++ +   L   +   E   +Y  +     D   +   ++ + L+ V
Sbjct: 106 K----ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV 161
Query: 215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-IC-GGNEL 272
                +  + +GL Y+H     ++IHRDLK SN+L++++   KI DFGMAR +C    E 
Sbjct: 162 R--YFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 216
Query: 273 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKK 317
           Q   +  V T  Y +PE  L    ++   D++S G +  E+++ ++
Sbjct: 217 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  L   ++   D ++ GVL+ ++ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 281
           IA GL +L       II+RDLK  N++LD + + KI+DFGM   C  N     T++   G
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKENIWDGVTTKXFCG 504
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 281
           IA GL +L       II+RDLK  N++LD + + KI+DFGM   C  N     T++   G
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKENIWDGVTTKXFCG 183
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           T  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+++D+    +++DFG A+   
Sbjct: 135 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 34/230 (14%)
Query: 108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NEAS 163
            S ST+ + +  ++ LG+G    V++G  +K GD  A+K  +  S   LR +     E  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFE 59
Query: 164 VIAKVQHKNLVRLLGCCIDKD----EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI 219
           V+ K+ HKN+V+L    I+++     K+LI E+ P  SL   L +P+    L     + +
Sbjct: 60  VLKKLNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQAN 275
           +  +  G+ +L +     I+HR++K  NI+     D     K++DFG AR     EL+ +
Sbjct: 118 LRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-----ELEDD 169
Query: 276 TS--RIVGTYGYMSPEYALEGI--------FSIKSDVFSFGVLLLEIVSG 315
                + GT  Y+ P+     +        +    D++S GV      +G
Sbjct: 170 EQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ--GLREMKNEASVIA 166
           V   ++ F   + LGEG +G V     +  G+ +A+K++    +    LR ++ E  ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 167 KVQHKNLVRLLG-----CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             +H+N++ +          + +E  +I E M          D  + I    ++   I  
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT--------DLHRVISTQMLSDDHIQY 116
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL--------Q 273
            I Q L  +       +IHRDLK SN+L++ + + K+ DFG+ARI   +          Q
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 274 ANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEI 312
           +  +  V T  Y +PE  L    +S   DV+S G +L E+
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT  Y++P   L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ--GLREMKNEASVIA 166
           V   ++ F   + LGEG +G V     +  G+ +A+K++    +    LR ++ E  ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 167 KVQHKNLVRLLG-----CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             +H+N++ +          + +E  +I E M          D  + I    ++   I  
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT--------DLHRVISTQMLSDDHIQY 116
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL--------Q 273
            I Q L  +       +IHRDLK SN+L++ + + K+ DFG+ARI   +          Q
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 274 ANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEI 312
           +  +  V T  Y +PE  L    +S   DV+S G +L E+
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 34/230 (14%)
Query: 108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMK---NEAS 163
            S ST+ + +  ++ LG+G    V++G  +K GD  A+K  +  S   LR +     E  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS--FLRPVDVQMREFE 59
Query: 164 VIAKVQHKNLVRLLGCCIDKD----EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI 219
           V+ K+ HKN+V+L    I+++     K+LI E+ P  SL   L +P+    L     + +
Sbjct: 60  VLKKLNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQAN 275
           +  +  G+ +L +     I+HR++K  NI+     D     K++DFG AR     EL+ +
Sbjct: 118 LRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-----ELEDD 169
Query: 276 TS--RIVGTYGYMSPEYALEGI--------FSIKSDVFSFGVLLLEIVSG 315
                + GT  Y+ P+     +        +    D++S GV      +G
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKNEASVIAKVQHK 171
           ++ F   ++LG G    VY+   +KG +   A+K L    ++ +  ++ E  V+ ++ H 
Sbjct: 52  SDFFEVESELGRGATSIVYR-CKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHP 108
Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP-------TKRILLDWVTRVQIIEGIA 224
           N+++L        E  L+ E +    L    FD        ++R   D V   QI+E +A
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVK--QILEAVA 162
Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARICGGNELQANTSRIVG 281
               YLH+     I+HRDLK  N+L      D   KI+DFG+++I    E Q     + G
Sbjct: 163 ----YLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCG 212
Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           T GY +PE      +  + D++S G++   ++ G
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQ--GLREMKNEASVIA 166
           V   ++ F   + LGEG +G V     +  G+ +A+K++    +    LR ++ E  ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 167 KVQHKNLVRLLG-----CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             +H+N++ +          + +E  +I E M          D  + I    ++   I  
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT--------DLHRVISTQMLSDDHIQY 116
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL--------Q 273
            I Q L  +       +IHRDLK SN+L++ + + K+ DFG+ARI   +          Q
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 274 ANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEI 312
           +     V T  Y +PE  L    +S   DV+S G +L E+
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           KL E   G ++KG   +G++I VK L  R  S +  R+   E   +    H N++ +LG 
Sbjct: 17  KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 180 CIDKD--EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           C         LI  +MP  SL   L + T   ++D    V+    +A+G+ +LH    + 
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEPL- 133
Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY---ALEG 294
           I    L + ++++D+DM  +IS   MA +    +    +   +    +++PE      E 
Sbjct: 134 IPRHALNSRSVMIDEDMTARIS---MADV----KFSFQSPGRMYAPAWVAPEALQKKPED 186
Query: 295 IFSIKSDVFSFGVLLLEIVS 314
                +D++SF VLL E+V+
Sbjct: 187 TNRRSADMWSFAVLLWELVT 206

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 16/198 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           +G G FG       ++ +E+   +   R E+    +K E      ++H N+VR     + 
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QIIEGIAQGLLYLHQYSRVRIIH 240
                ++ EY     L F       R   D       Q+I G++    Y H    +++ H
Sbjct: 87  PTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YCHA---MQVCH 138
Query: 241 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           RDLK  N LLD    P  KI DFG ++    + L +     VGT  Y++PE  L+  +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 299 K-SDVFSFGVLLLEIVSG 315
           K +DV+S GV L  ++ G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           +G G FG       ++ +E+   +   R E+    +K E      ++H N+VR     + 
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QIIEGIAQGLLYLHQYSRVRIIH 240
                ++ EY     L F       R   D       Q+I G++    Y H    +++ H
Sbjct: 87  PTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YAHA---MQVAH 138
Query: 241 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           RDLK  N LLD    P  KI+DFG ++    + L +     VGT  Y++PE  L+  +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYIAPEVLLKKEYDG 195
Query: 299 K-SDVFSFGVLLLEIVSG 315
           K +DV+S GV L  ++ G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 35/231 (15%)
Query: 107 FSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASV 164
           F S+S     +S   ++G GG   V++ +  K    A+K   L     Q L   +NE + 
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 165 IAKVQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
           + K+Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKN 135
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI--- 279
           + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +   +   
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDXXXVVKD 186
Query: 280 --VGTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 316
             VGT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 187 SQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 17/227 (7%)
Query: 94  SKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS 151
           +K KE D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  + 
Sbjct: 20  AKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 152 EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              L++++   NE  ++  V    LV+L     D     ++ EY+    +    F   +R
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR 134
Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           I        +     AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   
Sbjct: 135 IGRFSEPHARFY--AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           G      T  + GT   ++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 193 G-----RTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 131/284 (46%), Gaps = 53/284 (18%)
Query: 122 KLGEGGFGPVYKG-VLRKGDEIAVKRLSG--RSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +LG G +G V K   +  G   AVKR+     S++  R + +       V     V   G
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 179 CCIDKDEKILIYEYMPNKSLDFF---LFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
               ++  + I   + + SLD F   + D  + I  D + ++ +   I + L +LH  S+
Sbjct: 101 ALF-REGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHLH--SK 155
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMA---------RICGGNELQANTSRIVGTYGYM 286
           + +IHRD+K SN+L++     K  DFG++          I  G +      RI       
Sbjct: 156 LSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERI------- 208
Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS--NRTLE 344
           +PE   +G +S+KSD++S G+  +E               L +L + +D W +   +  +
Sbjct: 209 NPELNQKG-YSVKSDIWSLGITXIE---------------LAILRFPYDSWGTPFQQLKQ 252
Query: 345 LIDDPVLE---DEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
           ++++P  +   D++S++     +V+    C+++++ +RPT  ++
Sbjct: 253 VVEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPEL 291

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 16/198 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           +G G FG       ++ +E+   +   R E+    +K E      ++H N+VR     + 
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QIIEGIAQGLLYLHQYSRVRIIH 240
                ++ EY     L F       R   D       Q+I G++    Y H    +++ H
Sbjct: 86  PTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YCHA---MQVCH 137
Query: 241 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           RDLK  N LLD    P  KI DFG ++    + L +     VGT  Y++PE  L+  +  
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 194
Query: 299 K-SDVFSFGVLLLEIVSG 315
           K +DV+S GV L  ++ G
Sbjct: 195 KVADVWSCGVTLYVMLVG 212

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAK 167
           +S     +S   ++G GG   V++ +  K    A+K   L     Q L   +NE + + K
Sbjct: 7   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 66
Query: 168 VQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 67  LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 122
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 280
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 123 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 173
Query: 281 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 316
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 174 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCC 180
           LGEG F    K V +K ++  AVK +S R E   ++   E + +   + H N+V+L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQ-IIEGIAQGLLYLHQYSRVRII 239
            D+    L+ E +    L    F+  K+      T    I+  +   + ++H    V ++
Sbjct: 76  HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVV 128
Query: 240 HRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
           HRDLK  N+L    + ++  KI DFG AR+   +     T     T  Y +PE   +  +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQNGY 186
Query: 297 SIKSDVFSFGVLLLEIVSGK 316
               D++S GV+L  ++SG+
Sbjct: 187 DESCDLWSLGVILYTMLSGQ 206

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAK 167
           +S     +S   ++G GG   V++ +  K    A+K   L     Q L   +NE + + K
Sbjct: 3   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 62
Query: 168 VQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 63  LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 118
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 280
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 119 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 169
Query: 281 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 316
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 170 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAK 167
           +S     +S   ++G GG   V++ +  K    A+K   L     Q L   +NE + + K
Sbjct: 51  ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 168 VQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 111 LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 166
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 280
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 167 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 217
Query: 281 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 316
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 218 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLRE----MKNEASVIAKVQHKNLVRLLG 178
           +G G FG V     +   ++   +L  + E   R        E  ++A      +V+L  
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 141
Query: 179 CCIDKDEKIL--IYEYMPNKSLDFFL--FDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            C  +D+K L  + EYMP   L   +  +D  ++    W          A+ +L L    
Sbjct: 142 -CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDAIH 191
Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE---- 289
            + +IHRD+K  N+LLDK  + K++DFG   ++     +  +T+  VGT  Y+SPE    
Sbjct: 192 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA--VGTPDYISPEVLKS 249
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 327
              +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY-ADSL 284

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAK 167
           +S     +S   ++G GG   V++ +  K    A+K   L     Q L   +NE + + K
Sbjct: 4   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 168 VQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 64  LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 119
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 280
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 120 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 170
Query: 281 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 316
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 171 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 87/195 (44%), Gaps = 10/195 (5%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           LG G FG V++ V     +  + +           +K E S++   +H+N++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRD 242
            +E ++I+E++    LD F    T    L+    V  +  + + L +LH ++   I H D
Sbjct: 73  MEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFD 127
Query: 243 LKASNILLD--KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           ++  NI+    +    KI +FG AR     +   N   +     Y +PE     + S  +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 301 DVFSFGVLLLEIVSG 315
           D++S G L+  ++SG
Sbjct: 185 DMWSLGTLVYVLLSG 199

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAK 167
           +S     +S   ++G GG   V++ +  K    A+K   L     Q L   +NE + + K
Sbjct: 51  ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 168 VQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 111 LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 166
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 280
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 167 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 217
Query: 281 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 316
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 218 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--------SEQGLREMKNEASV 164
           +  +S  + LG G FG V+  V + K  E+ VK +            +  L ++  E ++
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-DPTKRI---LLDWVTRVQII 220
           +++V+H N++++L    ++    L+ E      LD F F D   R+   L  ++ R Q++
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFIDRHPRLDEPLASYIFR-QLV 140
Query: 221 EGIAQGLLYLHQYSRVR-IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
             +         Y R++ IIHRD+K  NI++ +D   K+ DFG A      +L       
Sbjct: 141 SAVG--------YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTF 189
Query: 280 VGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIV 313
            GT  Y +PE  +   +   + +++S GV L  +V
Sbjct: 190 CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 10/151 (6%)
Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCC 180
           L EGGF  VY+   +  G E A+KRL    E+  R +  E   + K+  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 181 -IDKDE------KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
            I K+E      + L+   +    L  FL     R  L   T ++I     + + ++H+ 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR- 154
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
            +  IIHRDLK  N+LL      K+ DFG A
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCC 180
           LGEG    V   + L    E AVK +  +       +  E  ++ + Q H+N++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++D   L++E M   S+   L    KR   + +    +++ +A  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 241 RDLKASNILLDK--DMNP-KISDFGMARICGGNELQANTSRI--------VGTYGYMSPE 289
           RDLK  NIL +    ++P KI DFG+     G +L  + S I         G+  YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLG---SGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 290 ----YALEG-IFSIKSDVFSFGVLLLEIVSG 315
               ++ E  I+  + D++S GV+L  ++SG
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 108/246 (43%), Gaps = 33/246 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRL-----SGRSEQGL------REMKNEASVIAKVQHK 171
           +  G +G V  GV  +G  +A+KR+      GR+   L      + +  E  ++    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSL--DFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           N++ L    +  +E  +   Y+  + +  D       +RI++        +  I  GL  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           LH+     ++HRDL   NILL  + +  I DF +AR    +   AN +  V    Y +PE
Sbjct: 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPE 203
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NLLGYVWDLWTSNRTLELID 347
             ++   F+   D++S G ++ E+ + K    L+R  +  N L         N+ +E++ 
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRK---ALFRGSTFYNQL---------NKIVEVVG 251
Query: 348 DPVLED 353
            P +ED
Sbjct: 252 TPKIED 257

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 119/273 (43%), Gaps = 42/273 (15%)
Query: 103 PLFSFSSV--STATNTFSDTNKLGEGGFGPVYKGVLRKG-DEIAVKRLSGR--SEQGLRE 157
           PL S  SV      + +  +  LG G  G V     RK   ++A+K +S R  +    RE
Sbjct: 2   PLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 61
Query: 158 ------MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--KRI 209
                 ++ E  ++ K+ H  ++++     D ++  ++ E M    L    FD     + 
Sbjct: 62  ADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKR 116
Query: 210 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARI 266
           L +   ++   + +   + YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I
Sbjct: 117 LKEATCKLYFYQMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 172
Query: 267 CGGNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYR 323
            G   L      + GT  Y++PE  +      ++   D +S GV+L   +SG      +R
Sbjct: 173 LGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229
Query: 324 TD----------SLNLLGYVWDLWTSNRTLELI 346
           T             N +  VW    S + L+L+
Sbjct: 230 TQVSLKDQITSGKYNFIPEVW-AEVSEKALDLV 261

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 108/246 (43%), Gaps = 33/246 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRL-----SGRSEQGL------REMKNEASVIAKVQHK 171
           +  G +G V  GV  +G  +A+KR+      GR+   L      + +  E  ++    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSL--DFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           N++ L    +  +E  +   Y+  + +  D       +RI++        +  I  GL  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           LH+     ++HRDL   NILL  + +  I DF +AR    +   AN +  V    Y +PE
Sbjct: 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPE 203
Query: 290 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NLLGYVWDLWTSNRTLELID 347
             ++   F+   D++S G ++ E+ + K    L+R  +  N L         N+ +E++ 
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRK---ALFRGSTFYNQL---------NKIVEVVG 251
Query: 348 DPVLED 353
            P +ED
Sbjct: 252 TPKIED 257

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLRE----MKNEASVIAKVQHKNLVRLLG 178
           +G G FG V     +   ++   +L  + E   R        E  ++A      +V+L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG-----IAQGLLYLHQY 233
              D     ++ EYMP   L            ++ ++   + E       A+ +L L   
Sbjct: 137 AFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVLALDAI 184
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---- 289
             +  IHRD+K  N+LLDK  + K++DFG   +    E        VGT  Y+SPE    
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 327
              +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 120 TNKLGEGGFGPVYKGVLRKG-DEIAVKRLSGR--SEQGLRE------MKNEASVIAKVQH 170
           +  LG G  G V     RK   ++A+K +S R  +    RE      ++ E  ++ K+ H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--KRILLDWVTRVQIIEGIAQGLL 228
             ++++     D ++  ++ E M    L    FD     + L +   ++   + +   + 
Sbjct: 75  PCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQ 128
Query: 229 YLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 182
Query: 286 MSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD----------SLNLLGY 332
           ++PE  +      ++   D +S GV+L   +SG      +RT             N +  
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242
Query: 333 VWDLWTSNRTLELI 346
           VW    S + L+L+
Sbjct: 243 VW-AEVSEKALDLV 255

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLRE----MKNEASVIAKVQHKNLVRLLG 178
           +G G FG V     +   ++   +L  + E   R        E  ++A      +V+L  
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG-----IAQGLLYLHQY 233
              D     ++ EYMP   L            ++ ++   + E       A+ +L L   
Sbjct: 142 AFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVLALDAI 189
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---- 289
             +  IHRD+K  N+LLDK  + K++DFG   +    E        VGT  Y+SPE    
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 327
              +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 283

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 120 TNKLGEGGFGPVYKGVLRKG-DEIAVKRLSGR--SEQGLRE------MKNEASVIAKVQH 170
           +  LG G  G V     RK   ++A+K +S R  +    RE      ++ E  ++ K+ H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--KRILLDWVTRVQIIEGIAQGLL 228
             ++++     D ++  ++ E M    L    FD     + L +   ++   + +   + 
Sbjct: 75  PCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQ 128
Query: 229 YLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 182
Query: 286 MSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD----------SLNLLGY 332
           ++PE  +      ++   D +S GV+L   +SG      +RT             N +  
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242
Query: 333 VWDLWTSNRTLELI 346
           VW    S + L+L+
Sbjct: 243 VW-AEVSEKALDLV 255

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLRE----MKNEASVIAKVQHKNLVRLLG 178
           +G G FG V     +   ++   +L  + E   R        E  ++A      +V+L  
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG-----IAQGLLYLHQY 233
              D     ++ EYMP   L            ++ ++   + E       A+ +L L   
Sbjct: 142 AFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVLALDAI 189
Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---- 289
             +  IHRD+K  N+LLDK  + K++DFG   +    E        VGT  Y+SPE    
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 327
              +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 283

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 120 TNKLGEGGFGPVYKGVLRKG-DEIAVKRLSGR--SEQGLRE------MKNEASVIAKVQH 170
           +  LG G  G V     RK   ++A+K +S R  +    RE      ++ E  ++ K+ H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--KRILLDWVTRVQIIEGIAQGLL 228
             ++++     D ++  ++ E M    L    FD     + L +   ++   + +   + 
Sbjct: 75  PCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQ 128
Query: 229 YLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 182
Query: 286 MSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD----------SLNLLGY 332
           ++PE  +      ++   D +S GV+L   +SG      +RT             N +  
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242
Query: 333 VWDLWTSNRTLELI 346
           VW    S + L+L+
Sbjct: 243 VW-AEVSEKALDLV 255

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 120 TNKLGEGGFGPVYKGVLRKG-DEIAVKRLSGR--SEQGLRE------MKNEASVIAKVQH 170
           +  LG G  G V     RK   ++A+K +S R  +    RE      ++ E  ++ K+ H
Sbjct: 14  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 73
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--KRILLDWVTRVQIIEGIAQGLL 228
             ++++     D ++  ++ E M    L    FD     + L +   ++   + +   + 
Sbjct: 74  PCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQ 127
Query: 229 YLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 181
Query: 286 MSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD----------SLNLLGY 332
           ++PE  +      ++   D +S GV+L   +SG      +RT             N +  
Sbjct: 182 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 241
Query: 333 VWDLWTSNRTLELI 346
           VW    S + L+L+
Sbjct: 242 VW-AEVSEKALDLV 254

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 57/286 (19%)
Query: 96  KKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVY--KGVLRKGDE--IAVKRLSGRS 151
           KK++++L    + +V   +N F   +K+GEG F  VY     L+ G E  IA+K L   S
Sbjct: 6   KKDIEKL----YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS 61
Query: 152 EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS----LDFFLFDPTK 207
                  + +   +A  Q  N++ +  C    D  ++   Y+ ++S    L+   F   +
Sbjct: 62  HPIRIAAELQCLTVAGGQ-DNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVR 120
Query: 208 RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMAR- 265
             +L+          + + L  +HQ+    I+HRD+K SN L ++ +    + DFG+A+ 
Sbjct: 121 EYMLN----------LFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167
Query: 266 -------------------ICGGNELQANTSR------IVGTYGYMSPEYALEGIFSIKS 300
                               C  N+     SR        GT G+ +PE   +      +
Sbjct: 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTA 227
Query: 301 -DVFSFGVLLLEIVSGKKNTGLYR-TDSLNLLGYVWDLWTSNRTLE 344
            D++S GV+ L ++SG+     Y+ +D L  L  +  +  S  T++
Sbjct: 228 IDMWSAGVIFLSLLSGR--YPFYKASDDLTALAQIMTIRGSRETIQ 271

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 123 LGEGGFGPVYKGVL------RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           LGEG +G V K VL      R+  +I  K+   R   G   +K E  ++ +++HKN+++L
Sbjct: 13  LGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 177 LGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTR--VQIIEGIAQGLLYLHQ 232
           +    +++++   ++ EY      +     P KR  +        Q+I+G    L YLH 
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG----LEYLHS 127
Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA- 291
                I+H+D+K  N+LL      KIS  G+A                G+  +  PE A 
Sbjct: 128 QG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 292 -LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL 329
            L+     K D++S GV L  I      TGLY  +  N+
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNIT-----TGLYPFEGDNI 218

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 16/198 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           +G G FG       ++ +E+   +   R E+    +K E      ++H N+VR     + 
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QIIEGIAQGLLYLHQYSRVRIIH 240
                ++ EY     L F       R   D       Q+I G++    Y H    +++ H
Sbjct: 87  PTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YCHA---MQVCH 138
Query: 241 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           RDLK  N LLD    P  KI  FG ++    + L +     VGT  Y++PE  L+  +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 299 K-SDVFSFGVLLLEIVSG 315
           K +DV+S GV L  ++ G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 29/222 (13%)
Query: 120 TNKLGEGGFGPVYKGVLRKG-DEIAVKRLSGR--SEQGLRE------MKNEASVIAKVQH 170
           +  LG G  G V     RK   ++A++ +S R  +    RE      ++ E  ++ K+ H
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 213
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--KRILLDWVTRVQIIEGIAQGLL 228
             ++++     D ++  ++ E M    L    FD     + L +   ++   + +   + 
Sbjct: 214 PCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQ 267
Query: 229 YLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 268 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 321
Query: 286 MSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT 324
           ++PE  +      ++   D +S GV+L   +SG      +RT
Sbjct: 322 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 363

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 35/228 (15%)
Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAK 167
           +S     +S   ++G GG   V++ +  K    A+K   L     Q L   +NE + + K
Sbjct: 51  ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 168 VQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 111 LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 166
Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 280
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 167 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 217
Query: 281 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 316
           G   YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 218 GAVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 22/201 (10%)
Query: 123 LGEGGFG--PVYKGVLRKGDEIAVK---RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G G FG   + +  L K + +AVK   R +   E   RE+ N  S+    +H N+VR  
Sbjct: 28  IGSGNFGVARLMRDKLTK-ELVAVKYIERGAAIDENVQREIINHRSL----RHPNIVRFK 82
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
              +      +I EY     L   + +   R   D        + +  G+ Y H    ++
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARF--FFQQLLSGVSYCHS---MQ 136
Query: 238 IIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
           I HRDLK  N LLD    P  KI DFG ++    + L +     VGT  Y++PE  L   
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRQE 193
Query: 296 FSIK-SDVFSFGVLLLEIVSG 315
           +  K +DV+S GV L  ++ G
Sbjct: 194 YDGKIADVWSCGVTLYVMLVG 214

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 32/230 (13%)
Query: 109 SVSTATNTFSDTNKL-----GEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEA 162
           S  +    F D  KL     GEG +  V   V L+ G E AVK +  ++      +  E 
Sbjct: 2   STDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREV 61
Query: 163 SVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
             + + Q +KN++ L+    D     L++E +   S+   L    K+   +     +++ 
Sbjct: 62  ETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVR 118
Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNP-KISDFGMARICGGNELQANTSR 278
            +A  L +LH      I HRDLK  NIL +  + ++P KI DF +     G +L  + + 
Sbjct: 119 DVAAALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLG---SGMKLNNSCTP 172
Query: 279 I--------VGTYGYMSPE----YALEGIFSIK-SDVFSFGVLLLEIVSG 315
           I         G+  YM+PE    +  +  F  K  D++S GV+L  ++SG
Sbjct: 173 ITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 29/222 (13%)
Query: 120 TNKLGEGGFGPVYKGVLRKG-DEIAVKRLSGR--SEQGLRE------MKNEASVIAKVQH 170
           +  LG G  G V     RK   ++A++ +S R  +    RE      ++ E  ++ K+ H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT--KRILLDWVTRVQIIEGIAQGLL 228
             ++++     D ++  ++ E M    L    FD     + L +   ++   + +   + 
Sbjct: 200 PCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQ 253
Query: 229 YLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 307
Query: 286 MSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT 324
           ++PE  +      ++   D +S GV+L   +SG      +RT
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 16/198 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID 182
           +G G FG       ++ +E+   +   R E+    +K E      ++H N+VR     + 
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QIIEGIAQGLLYLHQYSRVRIIH 240
                ++ EY     L F       R   D       Q+I G++    Y H    +++ H
Sbjct: 87  PTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YCHA---MQVCH 138
Query: 241 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           RDLK  N LLD    P  KI  FG ++    + L +     VGT  Y++PE  L+  +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYIAPEVLLKKEYDG 195
Query: 299 K-SDVFSFGVLLLEIVSG 315
           K +DV+S GV L  ++ G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 108/258 (41%), Gaps = 49/258 (18%)
Query: 100 DQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMK 159
           D++  FS+       N F    K+G+G FG V         +    ++    ++  R  K
Sbjct: 20  DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK 79
Query: 160 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR--- 216
            EA ++ K+Q+ ++       +    K + Y++M        +F+P    L + +TR   
Sbjct: 80  IEADILKKIQNDDINNNNI--VKYHGKFMYYDHMC------LIFEPLGPSLYEIITRNNY 131
Query: 217 ---------VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC 267
                    +  IE I + L YL + S   + H DLK  NILLD     K S   + R+ 
Sbjct: 132 NGFHIEDIKLYCIE-ILKALNYLRKMS---LTHTDLKPENILLDDPYFEK-SLITVRRVT 186
Query: 268 GGNELQANTSR---------------------IVGTYGYMSPEYALEGIFSIKSDVFSFG 306
            G ++Q   ++                     I+ T  Y +PE  L   + + SD++SFG
Sbjct: 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246
Query: 307 VLLLEIVSGKKNTGLYRT 324
            +L E+ +G   + L+RT
Sbjct: 247 CVLAELYTG---SLLFRT 261

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCC 180
           LGEG    V   + L    E AVK +  +       +  E  ++ + Q H+N++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++D   L++E M   S+   L    KR   + +    +++ +A  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 241 RDLKASNILLDK--DMNP-KISDFGMARICGGNELQANTSRI--------VGTYGYMSPE 289
           RDLK  NIL +    ++P KI DF +     G +L  + S I         G+  YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLG---SGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 290 ----YALEG-IFSIKSDVFSFGVLLLEIVSG 315
               ++ E  I+  + D++S GV+L  ++SG
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLRE----MKNEASVIAKVQHKNLVRLLG 178
           +G G FG V    L+  D++   ++  + E   R      + E  V+     K +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D +   L+ +Y     L   L    +  L + + R  +    A+ ++ +    ++  
Sbjct: 142 AFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYL----AEMVIAIDSVHQLHY 196
Query: 239 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE--YALE-- 293
           +HRD+K  NIL+D + + +++DFG   ++     +Q++ +  VGT  Y+SPE   A+E  
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEGG 254
Query: 294 -GIFSIKSDVFSFGVLLLEIVSGK 316
            G +  + D +S GV + E++ G+
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 102/221 (46%), Gaps = 36/221 (16%)
Query: 123 LGEGGFGPVYKGVLRKGDE-IAVKRLSGRSEQ--GLREMKNEASVIAKVQHKNLVRLLGC 179
           +G G +G VY    +  ++ +A+K+++   E     + +  E +++ +++   ++RL   
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 180 CIDKD----EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
            I  D    +++ I   + +  L      P   I L       I+  +  G  ++H+   
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG- 149
Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGG-------NELQAN------------- 275
             IIHRDLK +N LL++D + K+ DFG+AR           N+L+ N             
Sbjct: 150 --IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 276 -TSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVS 314
            TS +V T  Y +PE   L+  ++   D++S G +  E+++
Sbjct: 208 LTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 113/246 (45%), Gaps = 39/246 (15%)
Query: 122 KLGEGGFGPVYKGVLRKGDE---IAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRL 176
           K+G G +G VYK   + G +    A+K++ G   S    RE+    +++ +++H N++ L
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREI----ALLRELKHPNVISL 83
Query: 177 LGCCIDK-DEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY----- 229
               +   D K+ L+++Y  +       F    +        VQ+  G+ + LLY     
Sbjct: 84  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDG 140
Query: 230 LHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGN-ELQANTSRIVGTYG 284
           +H      ++HRDLK +NIL+     +    KI+D G AR+     +  A+   +V T+ 
Sbjct: 141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200
Query: 285 YMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK----------KNTGLYRTDSL----NL 329
           Y +PE  L      K+ D+++ G +  E+++ +          K +  Y  D L    N+
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260
Query: 330 LGYVWD 335
           +G+  D
Sbjct: 261 MGFPAD 266

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKN------EASVIAKVQ----HK 171
           LG+GGFG V+ G  L    ++A+K +      G   + +      E +++ KV     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLL 228
            ++RLL     ++  +L+ E  P  + D F +   K  L +  +R    Q++  I     
Sbjct: 99  GVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ---- 153
Query: 229 YLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
             H +SR  ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  
Sbjct: 154 --HCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSP 206
Query: 288 PEY-ALEGIFSIKSDVFSFGVLLLEIVSG 315
           PE+ +     ++ + V+S G+LL ++V G
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 12  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           ++RLL      D  +LI E  P    D F F   +  L + + R      + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN 128
Query: 233 YSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
                ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE+ 
Sbjct: 129 XG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWI 181
Query: 292 LEGIFSIKS-DVFSFGVLLLEIVSG 315
               +  +S  V+S G+LL ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 56/99 (56%), Gaps = 6/99 (6%)
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           I + +L +    ++  +HRD+K  N+LLD + + +++DFG   +   ++    +S  VGT
Sbjct: 181 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 239
Query: 283 YGYMSPE--YALE---GIFSIKSDVFSFGVLLLEIVSGK 316
             Y+SPE   A+E   G +  + D +S GV + E++ G+
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 44  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 157
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 158 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 210
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 31  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 90  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 144
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 145 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 197
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 45  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 158
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 159 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 211
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 45  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 158
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 159 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 211
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 44  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 157
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 158 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 210
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 44  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 157
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 158 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 210
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 15  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           ++RLL      D  +LI E  P    D F F   +  L + + R      + + + + H 
Sbjct: 74  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN 131
Query: 233 YSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
                ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE+ 
Sbjct: 132 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWI 184
Query: 292 LEGIFSIKS-DVFSFGVLLLEIVSG 315
               +  +S  V+S G+LL ++V G
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 31  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 90  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 144
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 145 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 197
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 45  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 158
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 159 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 211
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 44  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 157
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 158 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 210
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 45  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 158
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 159 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 211
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 12  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           ++RLL      D  +LI E  P    D F F   +  L + + R      + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN 128
Query: 233 YSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
                ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE+ 
Sbjct: 129 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWI 181
Query: 292 LEGIFSIKS-DVFSFGVLLLEIVSG 315
               +  +S  V+S G+LL ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 59  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 118 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 172
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 173 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 225
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 59  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 118 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 172
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 173 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 225
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 17  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 76  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 130
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 131 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 183
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 12  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           ++RLL      D  +LI E  P    D F F   +  L + + R      + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN 128
Query: 233 YSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
                ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE+ 
Sbjct: 129 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWI 181
Query: 292 LEGIFSIKS-DVFSFGVLLLEIVSG 315
               +  +S  V+S G+LL ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 17  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 76  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 130
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 131 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 183
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 32  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 91  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 145
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 146 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 198
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKR----LSGR--SEQGLREMKNEAS 163
           S  T  F +  K+G G FG V+K V R  G   A+KR    L+G    +  LRE+   A 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE-- 221
           +    QH ++VR      + D  ++  EY    SL   + +  +  ++ +    ++ +  
Sbjct: 65  L---GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYR--IMSYFKEAELKDLL 119
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP 256
             + +GL Y+H  S   ++H D+K SNI + +   P
Sbjct: 120 LQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIP 152

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 40/215 (18%)
Query: 123 LGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMK--NEASVIAKV---QHKNLVRLL 177
           LG G +G V+           V+++SG     L  MK   +A+++ K    +H    R +
Sbjct: 62  LGTGAYGKVF----------LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG----------- 226
              I +   ++   Y        F  +    ++LD++   ++   ++Q            
Sbjct: 112 LEHIRQSPFLVTLHYA-------FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 227 ----LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
               +L L    ++ II+RD+K  NILLD + +  ++DFG+++    +E +       GT
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGT 223
Query: 283 YGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 315
             YM+P+    G        D +S GVL+ E+++G
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKR----LSGR--SEQGLREMKNEAS 163
           S  T  F +  K+G G FG V+K V R  G   A+KR    L+G    +  LRE+   A 
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE-- 221
           +    QH ++VR      + D  ++  EY    SL   + +  +  ++ +    ++ +  
Sbjct: 67  L---GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYR--IMSYFKEAELKDLL 121
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP 256
             + +GL Y+H  S   ++H D+K SNI + +   P
Sbjct: 122 LQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIP 154

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 16  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 75  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 129
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 130 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 182
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKR----LSGR--SEQGLREMKNEAS 163
           S  T  F +  K+G G FG V+K V R  G   A+KR    L+G    +  LRE+   A 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE-- 221
           +    QH ++VR      + D  ++  EY    SL   + +  +  ++ +    ++ +  
Sbjct: 65  L---GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYR--IMSYFKEAELKDLL 119
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP 256
             + +GL Y+H  S   ++H D+K SNI + +   P
Sbjct: 120 LQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIP 152

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 56/99 (56%), Gaps = 6/99 (6%)
Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           I + +L +    ++  +HRD+K  N+LLD + + +++DFG   +   ++    +S  VGT
Sbjct: 197 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 255
Query: 283 YGYMSPE--YALE---GIFSIKSDVFSFGVLLLEIVSGK 316
             Y+SPE   A+E   G +  + D +S GV + E++ G+
Sbjct: 256 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 13/104 (12%)
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP------KISDFGMARICGGNE 271
           QI + +  GL Y+H+  R  IIH D+K  N+L++   +P      KI+D G A  C  +E
Sbjct: 135 QISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190
Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
              N+   + T  Y SPE  L   +   +D++S   L+ E+++G
Sbjct: 191 HYTNS---IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKR----LSGR--SEQGLREMKNEAS 163
           S  T  F +  K+G G FG V+K V R  G   A+KR    L+G    +  LRE+   A 
Sbjct: 3   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 62
Query: 164 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE-- 221
           +    QH ++VR      + D  ++  EY    SL   + +  +  ++ +    ++ +  
Sbjct: 63  L---GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYR--IMSYFKEAELKDLL 117
Query: 222 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP 256
             + +GL Y+H  S   ++H D+K SNI + +   P
Sbjct: 118 LQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIP 150

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 13/104 (12%)
Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP------KISDFGMARICGGNE 271
           QI + +  GL Y+H+  R  IIH D+K  N+L++   +P      KI+D G A  C  +E
Sbjct: 135 QISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190
Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
              N+   + T  Y SPE  L   +   +D++S   L+ E+++G
Sbjct: 191 HYTNS---IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 32  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 91  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 145
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 146 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 198
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 32  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 91  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 145
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 146 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 198
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 64  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 123 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 177
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 178 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 230
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 231 EWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 123 LGEGGFGPVYKGVLRKGDE--IAVKRLSGRSEQGLREMKN------EASVIAKVQH--KN 172
           LG GGFG VY G+ R  D   +A+K +         E+ N      E  ++ KV      
Sbjct: 17  LGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLY 229
           ++RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     +
Sbjct: 76  VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 130
Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            H      ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  P
Sbjct: 131 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 183
Query: 289 EYALEGIFSIKS-DVFSFGVLLLEIVSG 315
           E+     +  +S  V+S G+LL ++V G
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCG 211
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	436
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-146
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-142
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-124
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-95
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-81
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-65
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-64
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-63
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-63
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-60
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-59
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-57
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-55
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-53
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-52
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-52
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-51
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-51
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-50
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-50
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-49
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-49
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-48
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-48
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-48
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-47
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-47
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-47
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-47
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-47
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-47
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-47
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-47
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-47
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-47
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-47
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-47
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-46
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-46
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-46
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-46
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-46
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-46
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-46
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-46
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-46
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-45
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-45
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-45
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-45
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-45
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-45
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-45
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-44
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-44
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-44
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-44
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-44
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-44
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-44
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-43
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-43
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-43
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-42
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-42
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-42
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-37
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-34
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-32
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-32
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-32
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-27
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-23
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-06

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  418 bits (1077), Expect = e-146
 Identities = 115/305 (37%), Positives = 161/305 (52%), Gaps = 18/305 (5%)

Query: 101 QLPLFSFSSVSTATNTFSD------TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR---- 150
           +   FSF  +   TN F +       NK+GEGGFG VYKG +     +AVK+L+      
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69

Query: 151 SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRIL 210
           +E+  ++   E  V+AK QH+NLV LLG   D D+  L+Y YMPN SL   L        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 211 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 270
           L W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL 330
                TSRIVGT  YM+PE  L G  + KSD++SFGV+LLEI++G      +R     LL
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 244

Query: 331 GYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
               ++    +T+E   D  + D   S  V     ++A  C+ E  + RP +  V  +L 
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMND-ADSTSV-EAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

Query: 391 NEAAA 395
              A+
Sbjct: 303 EMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  408 bits (1050), Expect = e-142
 Identities = 118/309 (38%), Positives = 178/309 (57%), Gaps = 8/309 (2%)

Query: 92  ERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS 151
           E   +  + QL  FS   +  A++ FS+ N LG GGFG VYKG L  G  +AVKRL    
Sbjct: 7   EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66

Query: 152 EQGL-REMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-RI 209
            QG   + + E  +I+   H+NL+RL G C+   E++L+Y YM N S+   L +  + + 
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126

Query: 210 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 269
            LDW  R +I  G A+GL YLH +   +IIHRD+KA+NILLD++    + DFG+A++   
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186

Query: 270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT---DS 326
            +    T  + GT G+++PEY   G  S K+DVF +GV+LLE+++G++   L R    D 
Sbjct: 187 KDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245

Query: 327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
           + LL +V  L    +   L+ D  L+  Y  ++V  + + +ALLC Q S  +RP M++VV
Sbjct: 246 VMLLDWVKGLLKEKKLEALV-DVDLQGNYKDEEV-EQLIQVALLCTQSSPMERPKMSEVV 303

Query: 387 SMLTNEAAA 395
            ML  +  A
Sbjct: 304 RMLEGDGLA 312

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  362 bits (931), Expect = e-124
 Identities = 106/287 (36%), Positives = 167/287 (58%), Gaps = 7/287 (2%)

Query: 105 FSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASV 164
                +  ATN F     +G G FG VYKGVLR G ++A+KR +  S QG+ E + E   
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRIL-LDWVTRVQIIEGI 223
           ++  +H +LV L+G C +++E ILIY+YM N +L   L+      + + W  R++I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 283
           A+GL YLH  +   IIHRD+K+ NILLD++  PKI+DFG+++     +    ++ + GT 
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205

Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR-TDSLNLLGYVWDLWTSNRT 342
           GY+ PEY ++G  + KSDV+SFGV+L E++  +         + +NL  +      +N  
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-ESHNNGQ 264

Query: 343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           LE I DP L D+   +  L ++ + A+ C+  S++DRP+M DV+  L
Sbjct: 265 LEQIVDPNLADKIRPES-LRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  288 bits (740), Expect = 2e-95
 Identities = 68/308 (22%), Positives = 120/308 (38%), Gaps = 27/308 (8%)

Query: 105 FSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASV 164
               ++   +           G FG V+K  L   + +AVK    + +Q   + + E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVYS 71

Query: 165 IAKVQHKNLVRLLGCCI----DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQII 220
           +  ++H+N+++ +G          +  LI  +    SL  FL        + W     I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIA 127

Query: 221 EGIAQGLLYLHQ-------YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 273
           E +A+GL YLH+         +  I HRD+K+ N+LL  ++   I+DFG+A      +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 274 ANTSRIVGTYGYMSPEYALEGI-----FSIKSDVFSFGVLLLEIVSGKKN-TGLYRTDSL 327
            +T   VGT  YM+PE     I       ++ D+++ G++L E+ S      G      L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 328 NLLGYVWDLWTSNRTLELID----DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMN 383
                +    +     E++      PVL D +     +         C    A+ R +  
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 384 DVVSMLTN 391
            V   +T 
Sbjct: 308 CVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  252 bits (644), Expect = 6e-81
 Identities = 75/334 (22%), Positives = 129/334 (38%), Gaps = 44/334 (13%)

Query: 105 FSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASV 164
            + S  S   +       +G G +G VYKG L     +AVK  S  + Q      NE ++
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ---NFINEKNI 58

Query: 165 --IAKVQHKNLVRLLGCCI-----DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV 217
             +  ++H N+ R +          + E +L+ EY PN SL  +L   T     DWV+  
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114

Query: 218 QIIEGIAQGLLYLHQ------YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN- 270
           ++   + +GL YLH       + +  I HRDL + N+L+  D    ISDFG++    GN 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 271 -----ELQANTSRIVGTYGYMSPEYALEGIFSI--------KSDVFSFGVLLLEIVSGKK 317
                E        VGT  YM+PE  LEG  ++        + D+++ G++  EI     
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 318 NTGLYRTDSLNLLGYVWDLWTSNRTLELIDD-------PVLEDEYSSKQVLLR-YVNIAL 369
           +     +     + +  ++       ++          P   + +    + +R       
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 370 LCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
            C  + A+ R T       +          K  +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  210 bits (537), Expect = 3e-65
 Identities = 73/285 (25%), Positives = 133/285 (46%), Gaps = 26/285 (9%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLG 178
            K+G G FG V++     G ++AVK L  +    + + E   E +++ +++H N+V  +G
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
                    ++ EY+   SL   L     R  LD   R+ +   +A+G+ YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           +HR+LK+ N+L+DK    K+ DFG++R+     L + ++   GT  +M+PE   +   + 
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNE 218

Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD--PVLEDEYS 356
           KSDV+SFGV+L E+ + ++    +   +LN    V  +    + LE+  +  P +     
Sbjct: 219 KSDVYSFGVILWELATLQQ---PW--GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA--- 270

Query: 357 SKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQ 401
               ++        C       RP+   ++ +L     +  PP  
Sbjct: 271 ----IIEG------CWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  207 bits (528), Expect = 7e-64
 Identities = 68/282 (24%), Positives = 112/282 (39%), Gaps = 33/282 (11%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
             LG+G FG   K   R+ G+ + +K L    E+  R    E  V+  ++H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
                    I EY+   +L   +     +    W  RV   + IA G+ YLH  +   II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHSMN---II 130

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR------------IVGTYGYMS 287
           HRDL + N L+ ++ N  ++DFG+AR+    + Q    R            +VG   +M+
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           PE      +  K DVFSFG++L EI+                       +        ++
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN---------------ADPDYLPRTMDFGLN 235

Query: 348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
                D Y        +  I + C     + RP+   +   L
Sbjct: 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  206 bits (526), Expect = 1e-63
 Identities = 71/283 (25%), Positives = 121/283 (42%), Gaps = 26/283 (9%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
             +G G FG V K   R   ++A+K++   SE   +    E   +++V H N+V+L G C
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           ++     L+ EY    SL   L              +      +QG+ YLH      +IH
Sbjct: 71  LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 241 RDLKASNILLDKDMN-PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           RDLK  N+LL       KI DFG A      ++Q + +   G+  +M+PE      +S K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183

Query: 300 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQ 359
            DVFS+G++L E+++ +K    +          +W +    R   LI +           
Sbjct: 184 CDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTR-PPLIKN----------- 228

Query: 360 VLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP 402
           +     ++   C  +    RP+M ++V ++T+         +P
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  197 bits (502), Expect = 2e-60
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 37/283 (13%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQ----GLREMKNEASVIAKVQHKNLVRL 176
             +G GGFG VY+     GDE+AVK      ++     +  ++ EA + A ++H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
            G C+ +    L+ E+     L+  L        +     V     IA+G+ YLH  + V
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 237 RIIHRDLKASNILLDKDMNP--------KISDFGMARICGGNELQANTSRIVGTYGYMSP 288
            IIHRDLK+SNIL+ + +          KI+DFG+AR       +       G Y +M+P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAP 183

Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD 348
           E     +FS  SDV+S+GVLL E+++G+     +    ++ L   + +  +   L +   
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEV---PF--RGIDGLAVAYGVAMNKLALPIPST 238

Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
                          +  +   C       RP+  +++  LT 
Sbjct: 239 -----------CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  196 bits (500), Expect = 6e-60
 Identities = 67/286 (23%), Positives = 131/286 (45%), Gaps = 39/286 (13%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQG-------LREMKNEASVIAKVQHKN 172
            ++G+GGFG V+KG L K    +A+K L     +G        +E + E  +++ + H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           +V+L G   +     ++ E++P   L   L D      + W  +++++  IA G+ Y+  
Sbjct: 85  IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQN 140

Query: 233 YSRVRIIHRDLKASNILLDK-----DMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
                I+HRDL++ NI L        +  K++DFG+++     +   + S ++G + +M+
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMA 194

Query: 288 PE--YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL 345
           PE   A E  ++ K+D +SF ++L  I++G+     +   S   + ++  +        +
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINMIREEGLRPTI 251

Query: 346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
            +D              R  N+  LC       RP  + +V  L+ 
Sbjct: 252 PED-----------CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  196 bits (500), Expect = 7e-60
 Identities = 69/274 (25%), Positives = 127/274 (46%), Gaps = 25/274 (9%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            ++G G FG VYKG      ++AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
                 +  ++ ++    SL   L     +   +    + I    A+G+ YLH      I
Sbjct: 88  YST-APQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KSI 141

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---YALEGI 295
           IHRDLK++NI L +D   KI DFG+A             ++ G+  +M+PE         
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 296 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY 355
           +S +SDV++FG++L E+++G+     Y   + N    +  +   + + +L        + 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQL---PYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCPK- 256

Query: 356 SSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
                  R   +   C+++  D+RP+   +++ +
Sbjct: 257 -------RMKRLMAECLKKKRDERPSFPRILAEI 283

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  194 bits (495), Expect = 2e-59
 Identities = 59/277 (21%), Positives = 112/277 (40%), Gaps = 35/277 (12%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLG 178
            KL E   G ++KG  + G++I VK L  R  S +  R+   E   +    H N++ +LG
Sbjct: 16  TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 179 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
            C          I  +MP  SL   L + T  ++ D    V+    +A+G+ +LH    +
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLHTLEPL 133

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-- 294
            I    L + ++++D+DM  +IS   +            +   +    +++PE AL+   
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPE-ALQKKP 184

Query: 295 --IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE 352
                  +D++SF VLL E+V+ +     +    L+ +     +        +       
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREV---PF--ADLSNMEIGMKVALEGLRPTIPPG---- 235

Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
                  +      +  +C+ E    RP  + +V +L
Sbjct: 236 -------ISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  189 bits (481), Expect = 8e-57
 Identities = 67/296 (22%), Positives = 123/296 (41%), Gaps = 38/296 (12%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
             +G+G FG VY G      E+A++ +     +E  L+  K E     + +H+N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
            C+      +I      ++L   + D   +I+LD     QI + I +G+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI---VGTYGYMSPE------ 289
           +H+DLK+ N+  D +    I+DFG+  I G  +      ++    G   +++PE      
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 290 ---YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI 346
                 +  FS  SDVF+ G +  E+ + +     ++  +      +W + T  +   L 
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREW---PFK--TQPAEAIIWQMGTGMK-PNLS 264

Query: 347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP 402
              + ++            +I L C     ++RPT   ++ ML            P
Sbjct: 265 QIGMGKE----------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  185 bits (472), Expect = 1e-55
 Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 41/299 (13%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASV--IAKVQHKNLVRLLG 178
             +G+G +G V++G  + G+ +AVK  S R E+       E  +     ++H+N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69

Query: 179 CCIDKDEKI----LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH--- 231
             +          LI  Y    SL  +L    +   LD V+ ++I+  IA GL +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 232 --QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI---CGGNELQANTSRIVGTYGYM 286
                +  I HRDLK+ NIL+ K+    I+D G+A +           N  R VGT  YM
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYM 184

Query: 287 SPE------YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN 340
           +PE               + D+++FG++L E+     + G+            +D+  ++
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP----PFYDVVPND 240

Query: 341 RTLELIDD--------PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
            + E +          P + + + S   L     +   C  ++   R T   +   LT 
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  184 bits (470), Expect = 6e-55
 Identities = 74/299 (24%), Positives = 123/299 (41%), Gaps = 41/299 (13%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASV--IAKVQHKNLVRLLG 178
            ++G+G +G V+ G  R G+++AVK      E        E  +     ++H+N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIA 98

Query: 179 CCIDKDEKI----LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH--- 231
             I          LI +Y  N SL  +L    K   LD  + +++      GL +LH   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 232 --QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMS 287
                +  I HRDLK+ NIL+ K+    I+D G+A       NE+    +  VGT  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 288 PEYALEGI-------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN 340
           PE  L+           I +D++SFG++L E+     + G+     L     V     S+
Sbjct: 215 PE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP----SD 269

Query: 341 RTLELIDD--------PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
            + E + +        P   + +SS + L +   +   C   +   R T   V   L  
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (455), Expect = 8e-53
 Identities = 71/300 (23%), Positives = 123/300 (41%), Gaps = 43/300 (14%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASV--IAKVQHKNLVRLLG 178
             +G+G FG V++G  R G+E+AVK  S R E+       EA +     ++H+N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103

Query: 179 CCIDKDEKI----LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-- 232
                +       L+ +Y  + SL  +L     R  +     +++    A GL +LH   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 233 ---YSRVRIIHRDLKASNILLDKDMNPKISDFGMARI---CGGNELQANTSRIVGTYGYM 286
                +  I HRDLK+ NIL+ K+    I+D G+A            A   R VGT  YM
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYM 218

Query: 287 SPEYALEGI-------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS 339
           +PE  L+            ++D+++ G++  EI       G++    L     V     S
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP----S 273

Query: 340 NRTLELIDD--------PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           + ++E +          P + + + S + L     I   C   +   R T   +   L+ 
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  176 bits (449), Expect = 5e-52
 Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 46/295 (15%)

Query: 121 NKLGEGGFGPVYKGVL-----RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V            G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLY 229
             G C     +   LI EY+P  SL  +L    +RI    LL + +       I +G+ Y
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGMEY 160

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG----- 284
           L      R IHRDL   NIL++ +   KI DFG+ ++     L  +              
Sbjct: 161 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEYYKVKEPGESPI 212

Query: 285 -YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLWTSNRT 342
            + +PE   E  FS+ SDV+SFGV+L E+ +  + +     + + ++G            
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272

Query: 343 LELIDD------PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           +EL+ +      P    +    ++   Y  I   C   + + RP+  D+   +  
Sbjct: 273 IELLKNNGRLPRP----DGCPDEI---Y-MIMTECWNNNVNQRPSFRDLALRVDQ 319

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  175 bits (447), Expect = 5e-52
 Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 46/295 (15%)

Query: 121 NKLGEGGFGPVYKGVLR-----KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +LG+G FG V            G+ +AVK+L   +E+ LR+ + E  ++  +QH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLY 229
             G C     +   LI EY+P  SL  +L    +RI    LL + +       I +G+ Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGMEY 129

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG----- 284
           L      R IHRDL   NIL++ +   KI DFG+ ++     L  +              
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEFFKVKEPGESPI 181

Query: 285 -YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLWTSNRT 342
            + +PE   E  FS+ SDV+SFGV+L E+ +  + +     + + ++G            
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241

Query: 343 LELIDD------PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           +EL+ +      P    +    ++   Y  I   C   + + RP+  D+   +  
Sbjct: 242 IELLKNNGRLPRP----DGCPDEI---Y-MIMTECWNNNVNQRPSFRDLALRVDQ 288

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  176 bits (448), Expect = 3e-51
 Identities = 73/282 (25%), Positives = 115/282 (40%), Gaps = 43/282 (15%)

Query: 122 KLGEGGFGPVYKGVLRKGD-EIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           ++G G FG V+ G LR  +  +AVK            +   EA ++ +  H N+VRL+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  K    ++ E +       FL   T+   L   T +Q++   A G+ YL        I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N L+ +    KISDFGM+R        A+         + +PE    G +S +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

Query: 300 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV--WDLWTSNRTLELIDD------PVL 351
           SDV+SFG+LL E  S               LG     +  ++ +T E ++       P L
Sbjct: 296 SDVWSFGILLWETFS---------------LGASPYPN-LSNQQTREFVEKGGRLPCPEL 339

Query: 352 --EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
             +  +           +   C       RP+ + +   L +
Sbjct: 340 CPDAVF----------RLMEQCWAYEPGQRPSFSTIYQELQS 371

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  174 bits (443), Expect = 4e-51
 Identities = 80/321 (24%), Positives = 138/321 (42%), Gaps = 47/321 (14%)

Query: 121 NKLGEGGFGPVYKGVLR-----KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           ++LG+G FG V            G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 176 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLY 229
             G       +   L+ EY+P+  L  FL     R+    LL + +       I +G+ Y
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QICKGMEY 142

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG----- 284
           L      R +HRDL A NIL++ + + KI+DFG+A++     L  +    V         
Sbjct: 143 LGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL-----LPLDKDYYVVREPGQSPI 194

Query: 285 -YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRT 342
            + +PE   + IFS +SDV+SFGV+L E+ +   K+      + L ++G   D+   +R 
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS-AEFLRMMGCERDVPALSRL 253

Query: 343 LELIDD------PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL 396
           LEL+++      P         +V   +  +  LC   S  DRP+ + +   L    +  
Sbjct: 254 LELLEEGQRLPAP----PACPAEV---H-ELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305

Query: 397 HPPKQPAFSNVRNTVTSTSST 417
              +  AF+        + S 
Sbjct: 306 RGCETHAFTAHPEGKHHSLSF 326

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  172 bits (438), Expect = 1e-50
 Identities = 64/294 (21%), Positives = 118/294 (40%), Gaps = 48/294 (16%)

Query: 121 NKLGEGGFGPVYKGVL-----RKGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLV 174
             LGEG FG V            G+++AVK L        + ++K E  ++  + H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 175 RLLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLL 228
           +  G C +       LI E++P+ SL  +L     +I     L +         I +G+ 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV------QICKGMD 140

Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG---- 284
           YL      + +HRDL A N+L++ +   KI DFG+ +      ++ +             
Sbjct: 141 YL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----IETDKEYYTVKDDRDSP 192

Query: 285 --YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNR 341
             + +PE  ++  F I SDV+SFGV L E+++    ++         +        T  R
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ-MTVTR 251

Query: 342 TLELIDD------PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
            +  + +      P         +V   Y  +   C +    +R +  +++   
Sbjct: 252 LVNTLKEGKRLPCP----PNCPDEV---Y-QLMRKCWEFQPSNRTSFQNLIEGF 297

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  171 bits (436), Expect = 3e-50
 Identities = 82/290 (28%), Positives = 124/290 (42%), Gaps = 38/290 (13%)

Query: 121 NKLGEGGFGPVYKGVLR-----KGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLV 174
             LGEG FG V            G+ +AVK L +    Q     K E  ++  + H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 175 RLLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           +  GCC D       L+ EY+P  SL  +L     R  +     +   + I +G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMS 287
                 IHRDL A N+LLD D   KI DFG+A+              V   G     + +
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYA 205

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID 347
           PE   E  F   SDV+SFGV L E+++   ++    T  L L+G      T  R  EL++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265

Query: 348 D------PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
                  P    +    +V   Y ++   C +  A  RPT  +++ +L  
Sbjct: 266 RGERLPRP----DKCPAEV---Y-HLMKNCWETEASFRPTFENLIPILKT 307

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  169 bits (430), Expect = 3e-49
 Identities = 78/295 (26%), Positives = 130/295 (44%), Gaps = 64/295 (21%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE-----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLV 174
             LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYL 230
           RLLG C+      LI + MP   L  ++ +    I    LL+W         IA+G+ YL
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 133

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----Y 285
                 R++HRDL A N+L+    + KI+DFG+A++ G  E + +        G     +
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185

Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLWTSNRTLE 344
           M+ E  L  I++ +SDV+S+GV + E+++                G   +D   ++    
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT---------------FGSKPYDGIPASEISS 230

Query: 345 LIDD------PVL--EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           +++       P +   D Y           I   C    AD RP   +++   + 
Sbjct: 231 ILEKGERLPQPPICTIDVY----------MIMRKCWMIDADSRPKFRELIIEFSK 275

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  169 bits (429), Expect = 5e-49
 Identities = 82/318 (25%), Positives = 145/318 (45%), Gaps = 58/318 (18%)

Query: 122 KLGEGGFGPVYKGVLRKGDE-----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +G G FG VYKG+L+         +A+K L +G +E+   +   EA ++ +  H N++R
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L G        ++I EYM N +LD FL +         +  V ++ GIA G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYL---AN 165

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPE 289
           +  +HRDL A NIL++ ++  K+SDFG++R+   +     T+      G      + +PE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPE 220

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV--WDLWTSNRTLELID 347
                 F+  SDV+SFG+++ E+++                G    W+  +++  ++ I+
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT---------------YGERPYWE-LSNHEVMKAIN 264

Query: 348 D------PVL--EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP 399
           D      P+      Y           + + C Q+    RP   D+VS+L     A    
Sbjct: 265 DGFRLPTPMDCPSAIY----------QLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314

Query: 400 KQPAFSNVRNTVTSTSST 417
           K  A  + R ++   S++
Sbjct: 315 KTLADFDPRVSIRLPSTS 332

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  167 bits (424), Expect = 2e-48
 Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 21/205 (10%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
             +G G  G V  G LR   +    +A+K L +G +E+  R+  +EAS++ +  H N++R
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L G        +++ EYM N SLD FL     +     +  V ++ G+  G+ YL   S 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---SD 169

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPE 289
           +  +HRDL A N+L+D ++  K+SDFG++R+   +   A T+      G      + +PE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPIRWTAPE 224

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVS 314
                 FS  SDV+SFGV++ E+++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  167 bits (426), Expect = 4e-48
 Identities = 86/326 (26%), Positives = 144/326 (44%), Gaps = 51/326 (15%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
             +G G FG V  G L+   +    +A+K L  G +E+  R+   EAS++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L G        +++ EYM N SLD FL     +     +  V ++ GIA G+ YL   S 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYL---SD 165

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAL 292
           +  +HRDL A NIL++ ++  K+SDFG+ R+   +   A T+R  G      + SPE   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIA 223

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLWTSNRTLELIDD--- 348
              F+  SDV+S+G++L E++S                G   +   ++   ++ +D+   
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS---------------YGERPYWEMSNQDVIKAVDEGYR 268

Query: 349 ---PVL--EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
              P+      Y           + L C Q+  ++RP    +VS+L          K   
Sbjct: 269 LPPPMDCPAALY----------QLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIIT 318

Query: 404 FSNVR--NTVTSTSSTDKTGDCSINQ 427
            +  R  N +   S+ D T   +   
Sbjct: 319 SAAARPSNLLLDQSNVDITTFRTTGD 344

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  164 bits (417), Expect = 6e-48
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            ++G G FG V+ G     D++A+K +  G   +   +   EA V+ K+ H  LV+L G 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C+++    L+ E+M +  L  +L   T+R L    T + +   + +G+ YL       +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIF 296
           HRDL A N L+ ++   K+SDFGM R    ++  ++T    GT     + SPE      +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRY 182

Query: 297 SIKSDVFSFGVLLLEIVS 314
           S KSDV+SFGVL+ E+ S
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  164 bits (417), Expect = 1e-47
 Identities = 80/310 (25%), Positives = 123/310 (39%), Gaps = 77/310 (24%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNL 173
            +LGE  FG VYKG L           +A+K L          E ++EA + A++QH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRILLDWVTRVQII 220
           V LLG         +I+ Y  +  L  FL              D T +  L+    V ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
             IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R     E+ A     +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKL 186

Query: 281 GTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-- 333
                    +M+PE  + G FSI SD++S+GV+L E+ S                G    
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------------YGLQPY 231

Query: 334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYV------------NIALLCVQESADDRPT 381
                SN+  +++           + +  R V             + + C  E    RP 
Sbjct: 232 CGY--SNQ--DVV-----------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPR 276

Query: 382 MNDVVSMLTN 391
             D+ S L  
Sbjct: 277 FKDIHSRLRA 286

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  163 bits (416), Expect = 1e-47
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 62/302 (20%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE------IAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
            +LGEG FG V+               +AVK L   +    ++ + EA ++  +QH+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRILLDWVTRVQIIE 221
           +  G C D D  I+++EYM +  L+ FL                  +  L     + I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
            IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R     ++ +     VG
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVG 192

Query: 282 TYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WD 335
            +      +M PE  +   F+ +SDV+SFGV+L EI +                G   W 
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------YGKQPWF 237

Query: 336 LWTSNRTLELIDD------PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
             ++   +E I        P        K+V   Y ++ L C Q     R  + ++  +L
Sbjct: 238 QLSNTEVIECITQGRVLERP----RVCPKEV---Y-DVMLGCWQREPQQRLNIKEIYKIL 289

Query: 390 TN 391
             
Sbjct: 290 HA 291

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  163 bits (416), Expect = 2e-47
 Identities = 71/289 (24%), Positives = 115/289 (39%), Gaps = 53/289 (18%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
             +G G FG VY G L   D      AVK L        + +   E  ++    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 176 LLGCCIDKDEKIL-IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           LLG C+  +   L +  YM +  L  F+ +            +     +A+G+ YL   +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL---A 145

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSP 288
             + +HRDL A N +LD+    K++DFG+AR    +        +    G      +M+ 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMAL 201

Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV--WDLWTSNRTLELI 346
           E      F+ KSDV+SFGVLL E+++                G     D   +      +
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT---------------RGAPPYPD-VNTFDITVYL 245

Query: 347 DD------PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
                   P    EY    +   Y  + L C    A+ RP+ +++VS +
Sbjct: 246 LQGRRLLQP----EYCPDPL---Y-EVMLKCWHPKAEMRPSFSELVSRI 286

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  167 bits (425), Expect = 3e-47
 Identities = 62/197 (31%), Positives = 105/197 (53%), Gaps = 17/197 (8%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
             +G+G FG V  G   +G+++AVK +   +    +    EASV+ +++H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 181 IDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           +++   + ++ EYM   SL  +L    +  +L     ++    + + + YL        +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYALEGIFS 297
           HRDL A N+L+ +D   K+SDFG+ +       +A++++  G       +PE   E  FS
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364

Query: 298 IKSDVFSFGVLLLEIVS 314
            KSDV+SFG+LL EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  162 bits (413), Expect = 3e-47
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 15/198 (7%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            +LG G FG V  G  R   ++A+K +  G   +   E   EA V+  + H+ LV+L G 
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           C  +    +I EYM N  L  +L     R        +++ + + + + YL      + +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIF 296
           HRDL A N L++     K+SDFG++R    +E  ++     G+     +  PE  +   F
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKF 198

Query: 297 SIKSDVFSFGVLLLEIVS 314
           S KSD+++FGVL+ EI S
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  164 bits (416), Expect = 4e-47
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 31/217 (14%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE------IAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
            +LGEG FG V+               +AVK L   SE   ++ + EA ++  +QH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFL------------FDPTKRILLDWVTRVQIIEG 222
           R  G C +    ++++EYM +  L+ FL             +      L     + +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           +A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     ++ +     VG 
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGG 218

Query: 283 YG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                  +M PE  L   F+ +SDV+SFGV+L EI +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  162 bits (413), Expect = 4e-47
 Identities = 66/290 (22%), Positives = 112/290 (38%), Gaps = 57/290 (19%)

Query: 122 KLGEGGFGPVYKGVLRKGDE---IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +LG G FG V +GV R   +   +A+K L  G  +    EM  EA ++ ++ +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 178 GCCIDKDEKILI-YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
           G C  + E +++  E      L  FL    +   +      +++  ++ G+ YL      
Sbjct: 77  GVC--QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEK 129

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEY 290
             +HRDL A N+LL      KISDFG+++  G ++                   + +PE 
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPEC 184

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLWTSNRTLELIDD- 348
                FS +SDV+S+GV + E +S                G   +        +  I+  
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALS---------------YGQKPYKKMKGPEVMAFIEQG 229

Query: 349 -----PVL--EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
                P     + Y           +   C     +DRP    V   +  
Sbjct: 230 KRMECPPECPPELY----------ALMSDCWIYKWEDRPDFLTVEQRMRA 269

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  162 bits (411), Expect = 6e-47
 Identities = 69/199 (34%), Positives = 107/199 (53%), Gaps = 15/199 (7%)

Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +KLG G +G VY+GV +K    +AVK L     E    E   EA+V+ +++H NLV+LLG
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLG 76

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
            C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNF 132

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGI 295
           IHRDL A N L+ ++   K++DFG++R+  G+   A+     G      + +PE      
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA----GAKFPIKWTAPESLAYNK 188

Query: 296 FSIKSDVFSFGVLLLEIVS 314
           FSIKSDV++FGVLL EI +
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  162 bits (412), Expect = 7e-47
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 19/205 (9%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
             +G+G FG VY G      +     A+K L      Q +     E  ++  + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 176 LLGCCIDKDEKILI-YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           L+G  +  +    +   YM +  L  F+  P +   +     +     +A+G+ YL   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL---A 141

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 289
             + +HRDL A N +LD+    K++DFG+AR     E     S     +      + + E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY---YSVQQHRHARLPVKWTALE 198

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVS 314
                 F+ KSDV+SFGVLL E+++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  163 bits (414), Expect = 7e-47
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 34/217 (15%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE---IAVKRL-SGRSEQGLREMKNEASVIAKV-QHKNLVR 175
           + +GEG FG V K  ++K       A+KR+    S+   R+   E  V+ K+  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRILLDWVTRVQIIEG 222
           LLG C  +    L  EY P+ +L  FL                +    L     +     
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS----- 277
           +A+G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG++R  G       T      
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 205

Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           R      +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 206 R------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  166 bits (422), Expect = 9e-47
 Identities = 81/282 (28%), Positives = 125/282 (44%), Gaps = 49/282 (17%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            KLG G FG V+     K  ++AVK +  G           EA+V+  +QH  LV+L   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV--EAFLAEANVMKTLQHDKLVKLHAV 251

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
              K+   +I E+M   SL  FL              +     IA+G+ ++    +   I
Sbjct: 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNYI 306

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIF 296
           HRDL+A+NIL+   +  KI+DFG+AR+   NE  A      G      + +PE    G F
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSF 362

Query: 297 SIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD------P 349
           +IKSDV+SFG+LL+EIV+ G+               Y     ++   +  ++       P
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRI-------------PY-PG-MSNPEVIRALERGYRMPRP 407

Query: 350 VL--EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
               E+ Y          NI + C +   ++RPT   + S+L
Sbjct: 408 ENCPEELY----------NIMMRCWKNRPEERPTFEYIQSVL 439

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  161 bits (409), Expect = 9e-47
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 15/197 (7%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +LG G FG V  G  +   ++AVK +  G   +   E   EA  + K+ H  LV+  G C
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             +    ++ EY+ N  L  +L   +    L+    +++   + +G+ +L      + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127

Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFS 297
           RDL A N L+D+D+  K+SDFGM R    ++  ++     GT     + +PE      +S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYS 183

Query: 298 IKSDVFSFGVLLLEIVS 314
            KSDV++FG+L+ E+ S
Sbjct: 184 SKSDVWAFGILMWEVFS 200

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  161 bits (409), Expect = 1e-46
 Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 17/197 (8%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
             +G+G FG V  G   +G+++AVK +   +    +    EASV+ +++H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 181 IDKDEKILI-YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           +++   + I  EYM   SL  +L     R +L     ++    + + + YL        +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYALEGIFS 297
           HRDL A N+L+ +D   K+SDFG+ +       +A++++  G       +PE   E  FS
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 192

Query: 298 IKSDVFSFGVLLLEIVS 314
            KSDV+SFG+LL EI S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  166 bits (423), Expect = 1e-46
 Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 39/278 (14%)

Query: 121 NKLGEGGFGPVYKGVLRKGD-EIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           +KLG G +G VY+GV +K    +AVK L     E    E   EA+V+ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLG 283

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
            C  +    +I E+M   +L  +L +  ++  +  V  + +   I+  + YL    +   
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 339

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           IHR+L A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSI
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 398

Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-TLELIDD------PVL 351
           KSDV++FGVLL EI +                G             EL++       P  
Sbjct: 399 KSDVWAFGVLLWEIAT---------------YGMSPYPGIDLSQVYELLEKDYRMERP-- 441

Query: 352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
             E   ++V   Y  +   C Q +  DRP+  ++    
Sbjct: 442 --EGCPEKV---Y-ELMRACWQWNPSDRPSFAEIHQAF 473

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  161 bits (410), Expect = 1e-46
 Identities = 66/300 (22%), Positives = 115/300 (38%), Gaps = 72/300 (24%)

Query: 122 KLGEGGFGPVYKGVLRKGD--------EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNL 173
            LG+G F  ++KGV R+          E+ +K L              AS+++K+ HK+L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V   G C+  DE IL+ E++   SLD +L      I + W   +++ + +A  + +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFL--- 129

Query: 234 SRVRIIHRDLKASNILLDKDMNP--------KISDFGMARICGGNELQANTSRIVGTYGY 285
               +IH ++ A NILL ++ +         K+SD G++              ++     
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177

Query: 286 ------MSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLW 337
                 + PE        ++ +D +SFG  L EI S                G       
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS---------------GGDKPLSAL 222

Query: 338 TSNRTLELIDD------PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
            S R L+  +D      P   +            N+   C+    D RP+   ++  L +
Sbjct: 223 DSQRKLQFYEDRHQLPAPKAAELA----------NLINNCMDYEPDHRPSFRAIIRDLNS 272

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  160 bits (408), Expect = 2e-46
 Identities = 72/197 (36%), Positives = 106/197 (53%), Gaps = 13/197 (6%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            +LG G FG V+ G      ++AVK L  G           EA+++ ++QH+ LVRL   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAV 76

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
              ++   +I EYM N SL  FL  P   I L     + +   IA+G+ ++        I
Sbjct: 77  VT-QEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYALEGIFS 297
           HRDL+A+NIL+   ++ KI+DFG+AR+   NE    T+R    +     +PE    G F+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFT 188

Query: 298 IKSDVFSFGVLLLEIVS 314
           IKSDV+SFG+LL EIV+
Sbjct: 189 IKSDVWSFGILLTEIVT 205

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  162 bits (411), Expect = 2e-46
 Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 30/209 (14%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE-----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLV 174
             LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYL 230
           RLLG C+      LI + MP   L  ++ +    I    LL+W         IA+G+ YL
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 133

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----Y 285
                 R++HRDL A N+L+    + KI+DFG+A++ G  E + +        G     +
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185

Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  163 bits (413), Expect = 3e-46
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 19/205 (9%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVR 175
             +G G FG VY G L   D      AVK L        + +   E  ++    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 176 LLGCCIDKDEKIL-IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           LLG C+  +   L +  YM +  L  F+ + T    +     +     +A+G+ +L   +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---A 209

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 289
             + +HRDL A N +LD+    K++DFG+AR     E  +  ++   T       +M+ E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMALE 266

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVS 314
                 F+ KSDV+SFGVLL E+++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  161 bits (409), Expect = 4e-46
 Identities = 71/213 (33%), Positives = 98/213 (46%), Gaps = 27/213 (12%)

Query: 121 NKLGEGGFGPVYKGVLRKGD------EIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNL 173
             LG G FG VY+G +          ++AVK L    SEQ   +   EA +I+K  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLY 229
           VR +G  +    + ++ E M    L  FL      P++   L  +  + +   IA G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 230 LHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGY- 285
           L        IHRD+ A N LL         KI DFGMAR     ++   +    G     
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAML 207

Query: 286 ----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  160 bits (407), Expect = 6e-46
 Identities = 72/324 (22%), Positives = 126/324 (38%), Gaps = 58/324 (17%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE----IAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLV 174
             LG+G FG V +  L++ D     +AVK L     +   + E   EA+ + +  H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 175 RLLGCCIDKDEKI------LIYEYMPNKSLDFFLFD---PTKRILLDWVTRVQIIEGIAQ 225
           +L+G  +    K       +I  +M +  L  FL           L   T V+ +  IA 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG- 284
           G+ YL   S    IHRDL A N +L +DM   ++DFG++R     ++ +      G    
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASK 200

Query: 285 ----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGLYRTDSLNLLGYV 333
               +++ E   + ++++ SDV++FGV + EI++       G +N  +Y         Y+
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN--------YL 252

Query: 334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA 393
                    L+    P        ++V   Y ++   C       RP+   +   L N  
Sbjct: 253 ----IGGNRLKQ---P----PECMEEV---Y-DLMYQCWSADPKQRPSFTCLRMELENIL 297

Query: 394 AALHPPKQPAFSNVRNTVTSTSST 417
             L            N   +    
Sbjct: 298 GHLSVLSTSQDPLYINIERAHHHH 321

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  160 bits (407), Expect = 7e-46
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 27/213 (12%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNL 173
            +LG+G FG VY+GV +   +      +A+K +    S +   E  NEASV+ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDPTKRILLDWVTRVQIIEGIAQG 226
           VRLLG        ++I E M    L  +L        +            +Q+   IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY- 285
           + YL   +  + +HRDL A N ++ +D   KI DFGM R     ++        G  G  
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLL 202

Query: 286 ----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  161 bits (409), Expect = 1e-45
 Identities = 71/213 (33%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 121 NKLGEGGFGPVYKGVLRKGD------EIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNL 173
             LG G FG VY+G +          ++AVK L    SEQ   +   EA +I+K  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFL----FDPTKRILLDWVTRVQIIEGIAQGLLY 229
           VR +G  +    + ++ E M    L  FL      P++   L  +  + +   IA G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 230 LHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGY- 285
           L        IHRD+ A N LL         KI DFGMAR     ++        G     
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAML 248

Query: 286 ----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  159 bits (405), Expect = 1e-45
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 27/213 (12%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE----IAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLV 174
             LGEG FG V +G L++ D     +AVK +     S++ + E  +EA+ +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 175 RLLGCCIDKD-----EKILIYEYMPNKSLDFFL---FDPTKRILLDWVTRVQIIEGIAQG 226
           RLLG CI+       + ++I  +M    L  +L      T    +   T ++ +  IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-- 284
           + YL   S    +HRDL A N +L  DM   ++DFG+++     ++ +      G     
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKM 211

Query: 285 ---YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
              +++ E   + +++ KSDV++FGV + EI +
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  158 bits (403), Expect = 1e-45
 Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 27/211 (12%)

Query: 122 KLGEGGFGPVYKGVLRKGD----EIAVKRL---SGRSEQGLREMKNEASVIAKVQHKNLV 174
           KLG+G FG V +G           +AVK L        + + +   E + +  + H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYL 230
           RL G  +    K+ + E  P  SL   L           L  +         +A+G+ YL
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMGYL 137

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMS 287
                 R IHRDL A N+LL      KI DFG+ R    N+              + + +
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCA 192

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 317
           PE      FS  SD + FGV L E+ + G++
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  158 bits (402), Expect = 1e-45
 Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 70/296 (23%)

Query: 122 KLGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRL 176
            LGEG FG VY+GV          +AVK      +     +  +EA ++  + H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
           +G   +++   +I E  P   L  +L      + +  +T V     I + + YL     +
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL---ESI 132

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY----------- 285
             +HRD+   NIL+      K+ DFG++R     +             Y           
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-------------YYKASVTRLPIK 179

Query: 286 -MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLWTSNRTL 343
            MSPE      F+  SDV+ F V + EI+S                G   +    +   +
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILS---------------FGKQPFFWLENKDVI 224

Query: 344 ELIDD------PVL--EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
            +++       P L     Y           +   C      DRP   ++V  L++
Sbjct: 225 GVLEKGDRLPKPDLCPPVLY----------TLMTRCWDYDPSDRPRFTELVCSLSD 270

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  159 bits (405), Expect = 1e-45
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 30/209 (14%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE-----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLV 174
             LG G FG V+KGV     E     + +K +      Q  + + +    I  + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYL 230
           RLLG C       L+ +Y+P  SL   +      +    LL+W         IA+G+ YL
Sbjct: 79  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYYL 131

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----Y 285
                  ++HR+L A N+LL      +++DFG+A +   ++ Q   S            +
Sbjct: 132 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKW 183

Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           M+ E    G ++ +SDV+S+GV + E+++
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMT 212

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  157 bits (400), Expect = 3e-45
 Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 38/211 (18%)

Query: 122 KLGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRL 176
            +GEG FG V++G+    +     +A+K   +  S+    +   EA  + +  H ++V+L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 177 LGCCIDKDEKILI-YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           +G   +    + I  E      L  FL      + L   + +     ++  L YL     
Sbjct: 82  IGVITE--NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYL---ES 134

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY---------- 285
            R +HRD+ A N+L+  +   K+ DFG++R    +              Y          
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------------YYKASKGKLPI 181

Query: 286 --MSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
             M+PE      F+  SDV+ FGV + EI+ 
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILM 212

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  164 bits (417), Expect = 3e-45
 Identities = 66/298 (22%), Positives = 114/298 (38%), Gaps = 49/298 (16%)

Query: 122 KLGEGGFGPVYKGVLRKGDE---IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +LG G FG V +GV R   +   +A+K L  G  +    EM  EA ++ ++ +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G C   +  +L+ E      L  FL    +   +      +++  ++ G+ YL       
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEG 294
            +HR+L A N+LL      KISDFG+++  G ++                + +PE     
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFR 514

Query: 295 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLWTSNRTLELIDD----- 348
            FS +SDV+S+GV + E +S                G   +        +  I+      
Sbjct: 515 KFSSRSDVWSYGVTMWEALS---------------YGQKPYKKMKGPEVMAFIEQGKRME 559

Query: 349 -PVL--EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
            P     + Y           +   C     +DRP    V   +     +L    +  
Sbjct: 560 CPPECPPELY----------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  155 bits (395), Expect = 1e-44
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 23/204 (11%)

Query: 122 KLGEGGFGPVYKGVLRKGD---EIAVKRL-SGRSEQGLR-EMKNEASVIAKVQHKNLVRL 176
           +LG G FG V KG  +       +AVK L +  ++  L+ E+  EA+V+ ++ +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
           +G C + +  +L+ E      L+ +L    +   +     ++++  ++ G+ YL      
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EES 136

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEY 290
             +HRDL A N+LL      KISDFG+++    +E                   + +PE 
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVS 314
                FS KSDV+SFGVL+ E  S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  161 bits (409), Expect = 2e-44
 Identities = 81/292 (27%), Positives = 132/292 (45%), Gaps = 41/292 (14%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            ++   I + EYM   SL  FL        L     V +   IA G+ Y+    R+  +H
Sbjct: 332 SEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445

Query: 301 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLWTSNRTLELIDD------PVL-- 351
           DV+SFG+LL E+ +                G V +    +   L+ ++       P    
Sbjct: 446 DVWSFGILLTELTT---------------KGRVPYPGMVNREVLDQVERGYRMPCPPECP 490

Query: 352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
           E  +          ++   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 491 ESLH----------DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  159 bits (403), Expect = 3e-44
 Identities = 82/293 (27%), Positives = 132/293 (45%), Gaps = 43/293 (14%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            KLG+G FG V+ G       +A+K L  G           EA V+ K++H+ LV+L   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
             ++   I + EYM   SL  FL        L     V +   IA G+ Y+    R+  +
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 302

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IK
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361

Query: 300 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV-WDLWTSNRTLELIDD------PVL- 351
           SDV+SFG+LL E+ +                G V +    +   L+ ++       P   
Sbjct: 362 SDVWSFGILLTELTT---------------KGRVPYPGMVNREVLDQVERGYRMPCPPEC 406

Query: 352 -EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
            E  +          ++   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 407 PESLH----------DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  155 bits (395), Expect = 3e-44
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 35/221 (15%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
             LG G FG V +      D+      +AVK L  G +    R + +E  ++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 173 LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFL-------------FDPTKRILLDWVTRVQ 218
           +V LLG C      + +I E+    +L  +L              +   +  L     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR     ++  +   
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDY 204

Query: 279 IVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +          +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  156 bits (396), Expect = 3e-44
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 24/214 (11%)

Query: 121 NKLGEGGFGPVYKGV---LRKGDE---IAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
             LG G FG V +     L K D    +AVK L S         + +E  +++ + QH+N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--------FDPTKRILLDWVTRVQIIE--- 221
           +V LLG C      ++I EY     L  FL         DP   I     +   ++    
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIV 280
            +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR I   +      +  +
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               +M+PE   + +++++SDV+S+G+LL EI S
Sbjct: 229 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  155 bits (394), Expect = 4e-44
 Identities = 82/312 (26%), Positives = 130/312 (41%), Gaps = 77/312 (24%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNL 173
             LGEG FG V K              +AVK L    S   LR++ +E +V+ +V H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFL---------------------FDPTKRILLD 212
           ++L G C      +LI EY    SL  FL                      D      L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 213 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNE 271
               +     I+QG+ YL   + ++++HRDL A NIL+ +    KISDFG++R +   + 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 272 LQANTS-----RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNT 319
               +      +      +M+ E   + I++ +SDV+SFGVLL EIV+       G    
Sbjct: 206 YVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259

Query: 320 GLYRTDSLNLL--GYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESAD 377
            L+      LL  G+             ++ P    +  S+++   Y  + L C ++  D
Sbjct: 260 RLFN-----LLKTGHR------------MERP----DNCSEEM---Y-RLMLQCWKQEPD 294

Query: 378 DRPTMNDVVSML 389
            RP   D+   L
Sbjct: 295 KRPVFADISKDL 306

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  155 bits (393), Expect = 8e-44
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 36/222 (16%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE--------IAVKRL-SGRSEQGLREMKNEASVIAKV-QH 170
             LGEG FG V        D+        +AVK L    +E+ L ++ +E  ++  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRILLDWVTRV 217
           KN++ LLG C       +I EY    +L  +L              +      + +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
                +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     ++     
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 212

Query: 278 RIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               T G     +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  155 bits (393), Expect = 1e-43
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNL 173
             +GEG FG V++              +AVK L    S     + + EA+++A+  + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFL---------------------FDPTKRILLD 212
           V+LLG C       L++EYM    L+ FL                             L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 213 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 272
              ++ I   +A G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R      +
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NI 224

Query: 273 QANTSRIVGTYGY-----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
            +                M PE      ++ +SDV+++GV+L EI S
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  153 bits (390), Expect = 1e-43
 Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 28/218 (12%)

Query: 121 NKLGEGGFGPVYKGV---LRKGDE---IAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
             LG G FG V +     L K D    +AVK L           + +E  V++ +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL---------------FDPTKRILLDWVTRV 217
           +V LLG C      ++I EY     L  FL                     + LD    +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANT 276
                +A+G+ +L   +    IHRDL A NILL      KI DFG+AR I   +      
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
           +  +    +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 206 NARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  155 bits (393), Expect = 2e-43
 Identities = 76/308 (24%), Positives = 127/308 (41%), Gaps = 70/308 (22%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE--------IAVKRL-SGRSEQGLREMKNEASVIAKV-QH 170
             LGEG FG V        D+        +AVK L    +E+ L ++ +E  ++  + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRILLDWVTRV 217
           KN++ LLG C       +I EY    +L  +L              +      + +   V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
                +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     ++     
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 258

Query: 278 RIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGLYRTD 325
               T G     +M+PE   + +++ +SDV+SFGVL+ EI +       G     L++  
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-- 316

Query: 326 SLNLL--GYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMN 383
              LL  G+             +D P       + ++   Y  +   C       RPT  
Sbjct: 317 ---LLKEGHR------------MDKP----ANCTNEL---Y-MMMRDCWHAVPSQRPTFK 353

Query: 384 DVVSMLTN 391
            +V  L  
Sbjct: 354 QLVEDLDR 361

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  153 bits (388), Expect = 1e-42
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 36/222 (16%)

Query: 121 NKLGEGGFGPVYKGVLRKGD--------EIAVKRL-SGRSEQGLREMKNEASVIAKV-QH 170
             LGEG FG V        D        ++AVK L S  +E+ L ++ +E  ++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRILLDWVTRV 217
           KN++ LLG C       +I EY    +L  +L                     L     V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
                +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     ++     
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 246

Query: 278 RIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
               T G     +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  150 bits (382), Expect = 5e-42
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 43/228 (18%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
             LG G FG V         +      +AVK L           + +E  ++ ++  H+N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL------FDPTKRILLDWVTRVQIIEG---- 222
           +V LLG C       LI+EY     L  +L      F   +    +     +  +     
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 223 ----------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNE 271
                     +A+G+ +L        +HRDL A N+L+      KI DFG+AR I   + 
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 272 LQANTS-----RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
                +     +      +M+PE   EGI++IKSDV+S+G+LL EI S
Sbjct: 228 YVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  156 bits (395), Expect = 7e-42
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 122 KLGEGGFGPVYKGVLRKGDE----IAVKRL-SGRSEQGLREMKNEASVIAKVQHKNLVRL 176
            +GEG FG V++G+    +     +A+K   +  S+    +   EA  + +  H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
           +G    ++   +I E      L  FL    ++  LD  + +     ++  L YL      
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESK 510

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
           R +HRD+ A N+L+  +   K+ DFG++R    +     +   +    +M+PE      F
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRF 569

Query: 297 SIKSDVFSFGVLLLEIVS 314
           +  SDV+ FGV + EI+ 
Sbjct: 570 TSASDVWMFGVCMWEILM 587

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  147 bits (374), Expect = 7e-41
 Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 46/277 (16%)

Query: 122 KLGEGGFGPVYKGVLRKGD--EIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           K+GEG FG     V    D  +  +K   +S  S +   E + E +V+A ++H N+V+  
Sbjct: 31  KIGEGSFGKAIL-VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRIL-----LDWVTRVQIIEGIAQGLLYLHQ 232
               +     ++ +Y     L   +      +      LDW   VQI       L ++H 
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF--VQI----CLALKHVHD 143

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
               +I+HRD+K+ NI L KD   ++ DFG+AR+       A     +GT  Y+SPE   
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPE-IC 197

Query: 293 EGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI---DD 348
           E   ++ KSD+++ G +L E+ + K     +   S+  L            +  I     
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH---AFEAGSMKNL------------VLKIISGSF 242

Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
           P +   YS     LR  ++     + +  DRP++N +
Sbjct: 243 PPVSLHYSYD---LR--SLVSQLFKRNPRDRPSVNSI 274

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  144 bits (366), Expect = 4e-40
 Identities = 62/276 (22%), Positives = 117/276 (42%), Gaps = 38/276 (13%)

Query: 122 KLGEGGFGPVYKGVLRKGD--EIAVKRL---SGRSEQGLREMKNEASVIAKVQHKNLVRL 176
           K+G G F  VY+      D   +A+K++        +   +   E  ++ ++ H N+++ 
Sbjct: 39  KIGRGQFSEVYR-AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-------ILLDWVTRVQIIEGIAQGLLY 229
               I+ +E  ++ E      L   +    K+        +  +   VQ+       L +
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF--VQL----CSALEH 151

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           +H     R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
              E  ++ KSD++S G LL E+ + +     +  D +NL           +  +    P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLC------KKIEQCDYPP 257

Query: 350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
           +  D YS +   LR   +  +C+    + RP +  V
Sbjct: 258 LPSDHYSEE---LR--QLVNMCINPDPEKRPDVTYV 288

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  142 bits (360), Expect = 3e-39
 Identities = 65/289 (22%), Positives = 112/289 (38%), Gaps = 48/289 (16%)

Query: 122 KLGEGGFGPVYKGVLRKGD--EIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            LG GGFG V++    K D    A+KR+     E    ++  E   +AK++H  +VR   
Sbjct: 12  CLGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 179 CCIDKDE---------KILIY---EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG 226
             ++K+          K+ +Y   +    ++L  ++         +    + I   IA+ 
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT---------- 276
           + +LH      ++HRDLK SNI    D   K+ DFG+      +E +             
Sbjct: 131 VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL 336
           +  VGT  YMSPE      +S K D+FS G++L E+        LY   +          
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--------LYPFSTQMERVRTLTD 239

Query: 337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
             + +       P L  +    +       +    +  S  +RP   ++
Sbjct: 240 VRNLKF------PPLFTQKYPCE-----YVMVQDMLSPSPMERPEAINI 277

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  138 bits (351), Expect = 3e-38
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 122 KLGEGGFGPVYKGVLRKGD--EIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
            +G G +G   K + RK D   +  K       +E   + + +E +++ +++H N+VR  
Sbjct: 13  TIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 178 GCCIDKDEKIL--IYEYMPNKSLDFFLFDPTKR-------ILLDWVTRVQIIEGIAQGLL 228
              ID+    L  + EY     L   +   TK         +L  +   Q+       L 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM--TQL----TLALK 125

Query: 229 YLHQ--YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
             H+       ++HRDLK +N+ LD   N K+ DFG+ARI   +   A T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           SPE      ++ KSD++S G LL E+ +  
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  138 bits (349), Expect = 7e-38
 Identities = 63/283 (22%), Positives = 116/283 (40%), Gaps = 52/283 (18%)

Query: 121 NKLGEGGFGPVYKGVLRKGD--EIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
             +G GGFG V+K    + D     +KR+   +E    + + E   +AK+ H N+V   G
Sbjct: 17  ELIGSGGFGQVFK-AKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNG 71

Query: 179 CCIDKDEKI----------------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG 222
           C    D                   +  E+    +L+ ++ +  +   LD V  +++ E 
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQ 130

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      N+ +       GT
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTR--SKGT 184

Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT 342
             YMSPE      +  + D+++ G++L E++        + T                  
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKF--------------- 227

Query: 343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
              + D ++ D +  K    +   +    + +  +DRP  +++
Sbjct: 228 FTDLRDGIISDIFDKK---EK--TLLQKLLSKKPEDRPNTSEI 265

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  137 bits (348), Expect = 1e-37
 Identities = 58/259 (22%), Positives = 95/259 (36%), Gaps = 26/259 (10%)

Query: 71  LDLNLKANNVNIE---LPLNSKLIERSKKKEVDQLPLFSFSSVSTATNT-FSDTNKLGEG 126
             ++L   N+  +        ++  R +  E  Q P +  S   +     F   ++LG G
Sbjct: 9   SGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHG 68

Query: 127 GFGPVYKGVLRKGDEI-AVK--RLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCID 182
            +G V+K   ++   + AVK      R  +       E     KV QH   VRL     +
Sbjct: 69  SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128

Query: 183 KDEKILIYEYMPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
                L  E     SL          +    +  ++            L +LH      +
Sbjct: 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYL--RDT----LLALAHLHSQ---GL 178

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           +H D+K +NI L      K+ DFG+    G            G   YM+PE  L+G +  
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-GEV--QEGDPRYMAPE-LLQGSYGT 234

Query: 299 KSDVFSFGVLLLEIVSGKK 317
            +DVFS G+ +LE+    +
Sbjct: 235 AADVFSLGLTILEVACNME 253

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  137 bits (346), Expect = 2e-37
 Identities = 56/233 (24%), Positives = 103/233 (44%), Gaps = 17/233 (7%)

Query: 92  ERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVK--RLS 148
           ER+++++  +        +S          ++G G F  VYKG+      E+A    +  
Sbjct: 3   ERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR 62

Query: 149 GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK----ILIYEYMPNKSLDFFLFD 204
             ++   +  K EA ++  +QH N+VR         +     +L+ E M + +L  +L  
Sbjct: 63  KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-- 120

Query: 205 PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGM 263
             +  ++           I +GL +LH      IIHRDLK  NI +     + KI D G+
Sbjct: 121 -KRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178

Query: 264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           A +   +        ++GT  +M+PE   E  +    DV++FG+ +LE+ + +
Sbjct: 179 ATLKRAS----FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  135 bits (341), Expect = 4e-36
 Identities = 62/239 (25%), Positives = 107/239 (44%), Gaps = 22/239 (9%)

Query: 83  ELPLNSKLIERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEI 142
           EL L+ +  +R +     +  +          + F   ++LG G  G V+K   +    +
Sbjct: 6   ELELDEQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLV 60

Query: 143 -AVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF 200
            A K +          ++  E  V+ +     +V   G      E  +  E+M   SLD 
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 201 FLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD 260
            L     RI    + +  +   + +GL YL    + +I+HRD+K SNIL++     K+ D
Sbjct: 121 VL-KKAGRIPEQILGK--VSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCD 175

Query: 261 FGMARICGGNEL---QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           FG++      +L    AN+   VGT  YMSPE      +S++SD++S G+ L+E+  G+
Sbjct: 176 FGVSG-----QLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  133 bits (337), Expect = 4e-36
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 11/199 (5%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           LG+G +G VY G  L     IA+K +  R  +  + +  E ++   ++HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 182 DKDEKILIY-EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           + +  I I+ E +P  SL   L      +  +  T     + I +GL YLH     +I+H
Sbjct: 90  E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 241 RDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI--FS 297
           RD+K  N+L++      KISDFG ++   G      T    GT  YM+PE   +G   + 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYG 203

Query: 298 IKSDVFSFGVLLLEIVSGK 316
             +D++S G  ++E+ +GK
Sbjct: 204 KAADIWSLGCTIIEMATGK 222

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  133 bits (337), Expect = 5e-36
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 25/227 (11%)

Query: 106 SFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKR--LSGRSEQGLREMKNEAS 163
            F S+S     +S   ++G GG   V++ +  K    A+K   L     Q L   +NE +
Sbjct: 19  YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78

Query: 164 VIAKVQHKNL--VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE 221
            + K+Q  +   +RL    I      ++ E   N  L+ +L    K+  +D   R    +
Sbjct: 79  YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWK 134

Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 281
            + + +  +HQ+    I+H DLK +N L+      K+ DFG+A     +         VG
Sbjct: 135 NMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 190

Query: 282 TYGYMSPEYALEGI------------FSIKSDVFSFGVLLLEIVSGK 316
           T  YM PE A++ +             S KSDV+S G +L  +  GK
Sbjct: 191 TVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  133 bits (337), Expect = 7e-36
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 21/212 (9%)

Query: 122 KLGEGGFGPVYKGVLRK--GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           KLGEGGF  V   V     G   A+KR+    +Q   E + EA +     H N++RL+  
Sbjct: 36  KLGEGGFSYVDL-VEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 180 CIDKDEK----ILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           C+ +        L+  +    +L +       K   L     + ++ GI +GL  +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-- 152

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV-------GTYGYMS 287
                HRDLK +NILL  +  P + D G       +   +  +  +        T  Y +
Sbjct: 153 -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211

Query: 288 PE-YALEGIFSI--KSDVFSFGVLLLEIVSGK 316
           PE ++++    I  ++DV+S G +L  ++ G+
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  133 bits (336), Expect = 3e-35
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 25/212 (11%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKR--LSGRSEQGLREMKNEASVIAKVQHKNL--VRL 176
            ++G GG   V++ +  K    A+K   L     Q L   +NE + + K+Q  +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
               I      ++ E   N  L+ +L    K+ +  W  +    + + + +  +HQ+   
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKS-YWKNMLEAVHTIHQH--- 174

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI- 295
            I+H DLK +N L+  D   K+ DFG+A     +         VG   YM PE A++ + 
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMS 232

Query: 296 -----------FSIKSDVFSFGVLLLEIVSGK 316
                       S KSDV+S G +L  +  GK
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  132 bits (333), Expect = 4e-35
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 25/212 (11%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKR--LSGRSEQGLREMKNEASVIAKVQHKNL--VRL 176
            ++G GG   V++ +  K    A+K   L     Q L   +NE + + K+Q  +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
               I      ++ E   N  L+ +L    K+  +D   R    + + + +  +HQ+   
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 127

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI- 295
            I+H DLK +N L+      K+ DFG+A     +         VGT  YM PE A++ + 
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMS 185

Query: 296 -----------FSIKSDVFSFGVLLLEIVSGK 316
                       S KSDV+S G +L  +  GK
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (329), Expect = 8e-35
 Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 37/231 (16%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKN 172
            + F +   LG+G FG V K          A+K++   +E+ L  + +E  ++A + H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFF---------LFD--PTKRILLD----WVTRV 217
           +VR     +++   +     +  KS  F          L+D   ++ +       W    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC---------- 267
           QI+E ++    Y+H      IIHRDLK  NI +D+  N KI DFG+A+            
Sbjct: 124 QILEALS----YIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 268 --GGNELQANTSRIVGTYGYMSPE-YALEGIFSIKSDVFSFGVLLLEIVSG 315
                    N +  +GT  Y++ E     G ++ K D++S G++  E++  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  128 bits (324), Expect = 3e-34
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 22/220 (10%)

Query: 109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSG-RSEQGLREMKNEASVIA 166
           S+    +      +LG G +G V K       +I AVKR+    + Q  + +  +  +  
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 167 K-VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL---FDPTKRILLDWVTRVQIIEG 222
           + V     V   G    + +  +  E M + SLD F     D  + I  D + +  I   
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVS 117

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQANTSRIV 280
           I + L +LH  S++ +IHRD+K SN+L++     K+ DFG   I G   +++  +     
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG---ISGYLVDDVAKDID--A 170

Query: 281 GTYGYMSPE----YALEGIFSIKSDVFSFGVLLLEIVSGK 316
           G   YM+PE       +  +S+KSD++S G+ ++E+   +
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (321), Expect = 2e-33
 Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 22/204 (10%)

Query: 121 NKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            ++G G FG V++    + G + AVK++     +       E    A +    +V L G 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 180 CIDKDEKILIY-EYMPNKSLDFFL--FDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
              +   + I+ E +   SL   +            +    Q +EG    L YLH     
Sbjct: 119 VR-EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-QALEG----LEYLHT---R 169

Query: 237 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAL 292
           RI+H D+KA N+LL  D +   + DFG A     + L  +      I GT  +M+PE  +
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGK 316
                 K D++S   ++L +++G 
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGC 253

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  126 bits (318), Expect = 3e-33
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 22/222 (9%)

Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLRE-MKNEASVIAKV 168
           ST+ + +  ++ LG+G    V++G  +K GD  A+K  +  S     +    E  V+ K+
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 169 QHKNLVRLLGC--CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG 226
            HKN+V+L           K+LI E+ P  SL   L +P+    L     + ++  +  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 227 LLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           + +L +     I+HR++K  NI+     D     K++DFG AR    +E    +  + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGT 178

Query: 283 YGYMSPE--------YALEGIFSIKSDVFSFGVLLLEIVSGK 316
             Y+ P+           +  +    D++S GV      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  125 bits (315), Expect = 5e-33
 Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 26/209 (12%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           ++   K+G+G  G VY  + +  G E+A+++++ + +     + NE  V+ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG-IA-------QGL 227
            L   +  DE  ++ EY+   SL             D VT   + EG IA       Q L
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSL------------TDVVTETCMDEGQIAAVCRECLQAL 129

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            +LH     ++IHRD+K+ NILL  D + K++DFG        + + +T  +VGT  +M+
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 184

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE      +  K D++S G++ +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  126 bits (319), Expect = 1e-32
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 22/222 (9%)

Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLRE-MKNEASVIAKV 168
           ST+ + +  ++ LG+G    V++G  +K GD  A+K  +  S     +    E  V+ K+
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 169 QHKNLVRLLGC--CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG 226
            HKN+V+L           K+LI E+ P  SL   L +P+    L     + ++  +  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 227 LLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           + +L +     I+HR++K  NI+     D     K++DFG AR    +E    +  + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGT 178

Query: 283 YGYMSPE--------YALEGIFSIKSDVFSFGVLLLEIVSGK 316
             Y+ P+           +  +    D++S GV      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  124 bits (314), Expect = 1e-32
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 26/209 (12%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
                K+GEG  G V        G ++AVK +  R +Q    + NE  ++   QH N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG-IA-------QGL 227
           +    +  +E  ++ E++   +L             D V++V++ E  IA       Q L
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGAL------------TDIVSQVRLNEEQIATVCEAVLQAL 154

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            YLH      +IHRD+K+ +ILL  D   K+SDFG       +  +  +  +VGT  +M+
Sbjct: 155 AYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMA 209

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE     +++ + D++S G++++E+V G+
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  124 bits (314), Expect = 2e-32
 Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 32/241 (13%)

Query: 91  IERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRL-S 148
           IE S K ++     + F++         D  ++G G +G V K V +   +I AVKR+ S
Sbjct: 3   IESSGKLKISPEQHWDFTA-----EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS 57

Query: 149 GRSEQGLREMKNEASVIAK-VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK 207
              E+  +++  +  V+ +      +V+  G    + +  +  E M + S D F     K
Sbjct: 58  TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----K 112

Query: 208 RILLDWVTRV------QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF 261
            +       +      +I     + L +L     ++IIHRD+K SNILLD+  N K+ DF
Sbjct: 113 YVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDF 170

Query: 262 GMARICGGNELQANTSR--IVGTYGYMSPE----YALEGIFSIKSDVFSFGVLLLEIVSG 315
           G   I G  +L  + ++    G   YM+PE     A    + ++SDV+S G+ L E+ +G
Sbjct: 171 G---ISG--QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

Query: 316 K 316
           +
Sbjct: 226 R 226

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  124 bits (313), Expect = 2e-32
 Identities = 69/334 (20%), Positives = 113/334 (33%), Gaps = 93/334 (27%)

Query: 122 KLGEGGFGPVYKGVLRKGDEI--AVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            +G GGFG V++    K D+   A+KR+     E    ++  E   +AK++H  +VR   
Sbjct: 13  CMGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71

Query: 179 C------------------------CIDKDEKILIYEYMPNKSLDFFLFDPT-------- 206
                                            +    +  + +D F    T        
Sbjct: 72  AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131

Query: 207 -------------KRILLDWVTR------------VQIIEGIAQGLLYLHQYSRVRIIHR 241
                        K  L DW+ R            + I   IA+ + +LH      ++HR
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHR 188

Query: 242 DLKASNILLDKDMNPKISDFGMARICGGNELQANTS----------RIVGTYGYMSPEYA 291
           DLK SNI    D   K+ DFG+      +E +                VGT  YMSPE  
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248

Query: 292 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL 351
               +S K D+FS G++L E++     T + R   +  +          R L+       
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFS-TQMERVRIITDV----------RNLKFPLLF-- 295

Query: 352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
             +   ++       +    +  S  +RP   D+
Sbjct: 296 -TQKYPQE-----HMMVQDMLSPSPTERPEATDI 323

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (309), Expect = 3e-32
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 17/201 (8%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRS--EQGLRE-MKNEASVIAKVQHKNLVRLLG 178
           LG+G F  VY+   +  G E+A+K +  ++  + G+ + ++NE  +  +++H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D +   L+ E   N  +         +   +   R   +  I  G+LYLH +    I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSH---GI 133

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 295
           +HRDL  SN+LL ++MN KI+DFG+A      +L+    +   + GT  Y+SPE A    
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSA 188

Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
             ++SDV+S G +   ++ G+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGR 209

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  123 bits (311), Expect = 4e-32
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 22/203 (10%)

Query: 123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--EQGLRE-MKNEASVIAKVQHKNLVRLLG 178
           LG+GGF   ++       +  A K +      +   RE M  E S+   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKR--ILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
              D D   ++ E    +SL     +  KR   L +   R   +  I  G  YLH+    
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN--- 160

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALE 293
           R+IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSK 215

Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
              S + DV+S G ++  ++ GK
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGK 238

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  122 bits (307), Expect = 1e-31
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 20/212 (9%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRL-SGRSEQGLREMKNEASVIAK-VQHK 171
           N   +  ++G G  G V+K   RK   + AVK++    +++  + +  +  V+ K     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
            +V+  G  I   +  +  E M     +         I    + +  +   I + L YL 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLK 141

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQANTSRIVGTYGYMSPE 289
              +  +IHRD+K SNILLD+    K+ DFG   I G   ++   + S   G   YM+PE
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRS--AGCAAYMAPE 194

Query: 290 -----YALEGIFSIKSDVFSFGVLLLEIVSGK 316
                   +  + I++DV+S G+ L+E+ +G+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (306), Expect = 1e-31
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 22/203 (10%)

Query: 123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--EQGLRE-MKNEASVIAKVQHKNLVRLLG 178
           LG+GGF   ++       +  A K +      +   RE M  E S+   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKR--ILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
              D D   ++ E    +SL     +  KR   L +   R   +  I  G  YLH+    
Sbjct: 83  FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN--- 134

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALE 293
           R+IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSK 189

Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
              S + DV+S G ++  ++ GK
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGK 212

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  121 bits (306), Expect = 1e-31
 Identities = 65/233 (27%), Positives = 112/233 (48%), Gaps = 21/233 (9%)

Query: 92  ERSKKKEVDQLPLFSFSSVSTATN---TFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRL 147
           E  + +   +  L      S        F    KLGEG +G VYK +    G  +A+K++
Sbjct: 3   ETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62

Query: 148 SGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-DFFLFDPT 206
               E  L+E+  E S++ +    ++V+  G      +  ++ EY    S+ D  +    
Sbjct: 63  P--VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD--IIRLR 118

Query: 207 KRILLDWVTRVQI---IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM 263
            + L    T  +I   ++   +GL YLH     R IHRD+KA NILL+ + + K++DFG+
Sbjct: 119 NKTL----TEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV 171

Query: 264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           A        + NT  ++GT  +M+PE   E  ++  +D++S G+  +E+  GK
Sbjct: 172 AGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  120 bits (303), Expect = 3e-31
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 11/199 (5%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLS---GRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           KLG GG   VY         ++A+K +       E+ L+  + E    +++ H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
               + D   L+ EY+   +L  ++        L   T +     I  G+ + H    +R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           I+HRD+K  NIL+D +   KI DFG+A+      L   T+ ++GT  Y SPE A      
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATD 190

Query: 298 IKSDVFSFGVLLLEIVSGK 316
             +D++S G++L E++ G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  120 bits (303), Expect = 5e-31
 Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 23/217 (10%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGC 179
            L EGGF  VY+   +  G E A+KRL    E+  R +  E   + K+  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 180 CIDKDEK-------ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
                E+        L+   +    L  FL     R  L   T ++I     + + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI----------VGT 282
             +  IIHRDLK  N+LL      K+ DFG A         + +++             T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 283 YGYMSPE-YALEGIFSI--KSDVFSFGVLLLEIVSGK 316
             Y +PE   L   F I  K D+++ G +L  +   +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  119 bits (301), Expect = 7e-31
 Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 11/202 (5%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLV 174
           F+   K+G+G FG V+KG+  R    +A+K +    +E  + +++ E +V+++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           +  G  +   +  +I EY+   S      D  +   LD      I+  I +GL YLH   
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH--- 136

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 294
             + IHRD+KA+N+LL +    K++DFG+A      +++ NT   VGT  +M+PE   + 
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194

Query: 295 IFSIKSDVFSFGVLLLEIVSGK 316
            +  K+D++S G+  +E+  G+
Sbjct: 195 AYDSKADIWSLGITAIELARGE 216

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  123 bits (310), Expect = 1e-30
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 17/206 (8%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLL-- 177
           +LG GGFG V + + +  G+++A+K+         RE    E  ++ K+ H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 178 ----GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
                     D  +L  EY     L  +L        L       ++  I+  L YLH+ 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 234 SRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
              RIIHRDLK  NI+L    + +  KI D G A+     EL       VGT  Y++PE 
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEF--VGTLQYLAPEL 194

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGK 316
             +  +++  D +SFG L  E ++G 
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGF 220

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  118 bits (298), Expect = 2e-30
 Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 19/209 (9%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +    +LG+G FG VYK   ++ G   A K +  +SE+ L +   E  ++A   H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI---IEGIAQGLLYLHQ 232
           LLG      +  ++ E+ P  ++D  +     R L    T  QI      + + L +LH 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGL----TEPQIQVVCRQMLEALNFLHS 135

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE--- 289
               RIIHRDLKA N+L+  + + +++DFG++        + ++   +GT  +M+PE   
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190

Query: 290 --YALEGIFSIKSDVFSFGVLLLEIVSGK 316
                +  +  K+D++S G+ L+E+   +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  119 bits (299), Expect = 3e-30
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 31/219 (14%)

Query: 122 KLGEGGFGPVY---------------KGVLRKGDEIAVKRLSGRSEQGLRE-MKNEASVI 165
            L +G F  +                K +L K  +         S +   +  KNE  +I
Sbjct: 38  TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-----DFFLFDPTKRILLDWVTRVQII 220
             ++++  +   G   + DE  +IYEYM N S+      FF+ D      +       II
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
           + +     Y+H  +   I HRD+K SNIL+DK+   K+SDFG +      +++   S   
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GS--R 211

Query: 281 GTYGYMSPEYALEGIFSI---KSDVFSFGVLLLEIVSGK 316
           GTY +M PE       S    K D++S G+ L  +    
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  116 bits (293), Expect = 7e-30
 Identities = 51/240 (21%), Positives = 87/240 (36%), Gaps = 46/240 (19%)

Query: 108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKR--LSGRSEQGLREMKNEASV 164
              S  T  F +  K+G G FG V+K V R  G   A+KR           +    E   
Sbjct: 4   GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63

Query: 165 IAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-------ILLDWVTR 216
            A + QH ++VR      + D  ++  EY    SL   + +  +         L D +  
Sbjct: 64  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL-- 121

Query: 217 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-------------------K 257
           +Q+     +GL Y+H    + ++H D+K SNI + +   P                   K
Sbjct: 122 LQV----GRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 258 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           I D G            +     G   +++ E   E      K+D+F+  + ++     +
Sbjct: 175 IGDLGHVTRIS------SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  115 bits (289), Expect = 2e-29
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLRE-MKNEASVIAKVQHKNLVRL 176
             LG+G FG VY    ++    +A+K L      + G+   ++ E  + + ++H N++RL
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
            G   D     LI EY P  ++ +       +   +  T    I  +A  L Y H     
Sbjct: 75  YGYFHDATRVYLILEYAPLGTV-YRELQKLSK-FDEQRTA-TYITELANALSYCHSK--- 128

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
           R+IHRD+K  N+LL      KI+DFG +     +        + GT  Y+ PE     + 
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPEMIEGRMH 184

Query: 297 SIKSDVFSFGVLLLEIVSGK 316
             K D++S GVL  E + GK
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  115 bits (290), Expect = 3e-29
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 25/209 (11%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLS---GRSEQGLREMKNEASVIAKVQHKNLVRLL 177
            LG GG   V+    LR   ++AVK L     R        + EA   A + H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 178 GCCIDKDEKILIY----EYMPNKSLDFFLFDPTKRIL-----LDWVTRVQIIEGIAQGLL 228
                +     +     EY+   +L        + I+     +     +++I    Q L 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTL--------RDIVHTEGPMTPKRAIEVIADACQALN 130

Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 287
           + H   +  IIHRD+K +NI++      K+ DFG+AR I         T+ ++GT  Y+S
Sbjct: 131 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 288 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE A       +SDV+S G +L E+++G+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  119 bits (299), Expect = 4e-29
 Identities = 43/203 (21%), Positives = 80/203 (39%), Gaps = 24/203 (11%)

Query: 122 KLGEGGFGPVYKGV-LR-KGDEIAVKRLSGRSEQGLREM-KNEASVIAKVQHKNLVRLL- 177
            +  GG G +Y  +     G  + +K L    +   + M   E   +A+V H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 178 -GCCIDKDEKILIY---EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
                D+    + Y   EY+  +SL            L     +  +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
             + +++ DLK  NI+L ++   K+ D G                + GT G+ +PE    
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251

Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
           G  ++ +D+++ G  L  +    
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDL 273

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  114 bits (288), Expect = 5e-29
 Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 11/199 (5%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGR--SEQGLRE-MKNEASVIAKVQHKNLVRLL 177
            +G GG G VY+     +   +A+K +S    S+   R  M+ EA    ++Q  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
                  +  +    +    L   L    ++  L     V I+  I   L   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
             HRD+K  NIL+  D    + DFG+A      +L       VGT  YM+PE   E   +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHAT 213

Query: 298 IKSDVFSFGVLLLEIVSGK 316
            ++D+++   +L E ++G 
Sbjct: 214 YRADIYALTCVLYECLTGS 232

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  115 bits (290), Expect = 5e-29
 Identities = 68/235 (28%), Positives = 109/235 (46%), Gaps = 25/235 (10%)

Query: 92  ERSKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS-- 148
              +   +    +            FSD  ++G G FG VY    +R  + +A+K++S  
Sbjct: 31  AGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS 90

Query: 149 -GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK 207
             +S +  +++  E   + K++H N ++  GC + +    L+ EY    + D  L +  K
Sbjct: 91  GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHK 148

Query: 208 RILLDWVTRVQI---IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
           + L      V+I     G  QGL YLH +    +IHRD+KA NILL +    K+ DFG A
Sbjct: 149 KPL----QEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201

Query: 265 RICGGNELQANTSRIVGTYGYMSPE---YALEGIFSIKSDVFSFGVLLLEIVSGK 316
                    AN+   VGT  +M+PE      EG +  K DV+S G+  +E+   K
Sbjct: 202 ----SIMAPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  116 bits (293), Expect = 1e-28
 Identities = 65/245 (26%), Positives = 103/245 (42%), Gaps = 42/245 (17%)

Query: 93  RSKKKEVDQLPLFSFSSVSTATNTFSDT----NKLGEGGFGPVYKGVLRK-GDEIAVK-- 145
           R        L       +++     S+      KLG G +G V     +    E A+K  
Sbjct: 11  RENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70

Query: 146 ---RLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL 202
               +S  S   L     E +V+  + H N+++L     DK    L+ E      L    
Sbjct: 71  RKTSVSTSSNSKLL---EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL---- 123

Query: 203 FDPTKRILLDWVTR--------VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---D 251
           FD    I    + R          II+ +  G+ YLH+++   I+HRDLK  N+LL   +
Sbjct: 124 FD---EI----IHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKE 173

Query: 252 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 311
           KD   KI DFG++ +    +        +GT  Y++PE  L   +  K DV+S GV+L  
Sbjct: 174 KDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFI 229

Query: 312 IVSGK 316
           +++G 
Sbjct: 230 LLAGY 234

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  114 bits (288), Expect = 1e-28
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 29/206 (14%)

Query: 116 TFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
           T S T  LG G FG V+K      G ++A K +  R  +   E+KNE SV+ ++ H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR---------VQIIEGIAQ 225
           +L      K++ +L+ EY+        LFD   RI    +           +  ++ I +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFD---RI----IDESYNLTELDTILFMKQICE 198

Query: 226 GLLYLHQYSRVRIIHRDLKASNILL-DKDMNP-KISDFGMARICGGNELQANTSRIVGTY 283
           G+ ++HQ     I+H DLK  NIL  ++D    KI DFG+AR     E         GT 
Sbjct: 199 GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTP 252

Query: 284 GYMSPEYALEGIFSIKSDVFSFGVLL 309
            +++PE       S  +D++S GV+ 
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  115 bits (290), Expect = 1e-28
 Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 21/211 (9%)

Query: 116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLV 174
           +F   + LG G  G +    +    ++AVKR+     +       E  ++ +  +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           R      D+  + +  E       ++      K      +  + +++    GL +LH   
Sbjct: 82  RYFCTEKDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHSL- 137

Query: 235 RVRIIHRDLKASNILL-----DKDMNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSP 288
              I+HRDLK  NIL+        +   ISDFG+ +    G    +  S + GT G+++P
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 289 EYALEGIF----SIKSDVFSFGVLLLEIVSG 315
           E  L        +   D+FS G +   ++S 
Sbjct: 196 EM-LSEDCKENPTYTVDIFSAGCVFYYVISE 225

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  113 bits (284), Expect = 3e-28
 Identities = 23/249 (9%), Positives = 53/249 (21%), Gaps = 43/249 (17%)

Query: 103 PLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREM 158
                S +S           L  G    V+     +  ++ A+K  +     S   L  +
Sbjct: 50  ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109

Query: 159 KNEASVIAKVQHKNLVRLLGCC--------------------------IDKDEKILIYEY 192
                  A++  ++                                        +L+   
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169

Query: 193 MP---NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 249
                        F    R     +    +   + +    L       ++H      N+ 
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLF 226

Query: 250 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL--EGIFSIKSDVFSFGV 307
           +  D    + D       G                Y   E+       F+   + +  G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281

Query: 308 LLLEIVSGK 316
            +  +    
Sbjct: 282 SIYRVWCLF 290

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  112 bits (281), Expect = 4e-28
 Identities = 60/221 (27%), Positives = 109/221 (49%), Gaps = 22/221 (9%)

Query: 111 STATNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLS-GRSEQGLREMKNEASVIAKV 168
           S   + +     +G G    V       K +++A+KR++  + +  + E+  E   +++ 
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70

Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIE--GIA-- 224
            H N+V      + KDE  L+ + +   S+     D  K I+     +  +++   IA  
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 225 -----QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSR 278
                +GL YLH   +   IHRD+KA NILL +D + +I+DFG+ A +  G ++  N  R
Sbjct: 127 LREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183

Query: 279 --IVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
              VGT  +M+PE   +   +  K+D++SFG+  +E+ +G 
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (279), Expect = 5e-28
 Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 27/201 (13%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           KLG G FG V+    R  G E  +K ++  RS+  + +++ E  V+  + H N++++   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR--------VQIIEGIAQGLLYLH 231
             D     ++ E      L     +   RI+               ++++ +   L Y H
Sbjct: 89  FEDYHNMYIVMETCEGGEL----LE---RIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 232 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
                 ++H+DLK  NIL          KI DFG+A +   +E   N     GT  YM+P
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALYMAP 195

Query: 289 EYALEGIFSIKSDVFSFGVLL 309
           E   +   + K D++S GV++
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVM 215

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  114 bits (288), Expect = 6e-28
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 33/210 (15%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRL 176
             LG+G FG V     +  G E AVK +S R    +     +  E  ++ ++ H N+++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR--------VQIIEGIAQGLL 228
                DK    L+ E      L    FD    I    ++R         +II  +  G+ 
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGEL----FD---EI----ISRKRFSEVDAARIIRQVLSGIT 140

Query: 229 YLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           Y+H+     I+HRDLK  N+LL    KD N +I DFG++     ++        +GT  Y
Sbjct: 141 YMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYY 194

Query: 286 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           ++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  112 bits (282), Expect = 1e-27
 Identities = 46/222 (20%), Positives = 86/222 (38%), Gaps = 18/222 (8%)

Query: 108 SSVSTATNTFSDTNKLGEG--GFGPVYKGV-LRKGDEIAVKR--LSGRSEQGLREMKNEA 162
           SS       +     +G+G      V        G+ + V+R  L   S + +  ++ E 
Sbjct: 18  SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77

Query: 163 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRVQIIE 221
            V     H N+V      I  +E  ++  +M   S  D  L        ++ +    I++
Sbjct: 78  HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQ 135

Query: 222 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT----- 276
           G+ + L Y+H       +HR +KAS+IL+  D    +S          +  +        
Sbjct: 136 GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 277 SRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGK 316
              V    ++SPE   + +  +  KSD++S G+   E+ +G 
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  109 bits (276), Expect = 1e-27
 Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 30/200 (15%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            +G G +G V   V +      A K++     + +   K E  ++  + H N++RL    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR--------VQIIEGIAQGLLYLHQ 232
            D  +  L+ E          LF+   R+    V +         +I++ +   + Y H+
Sbjct: 76  EDNTDIYLVMELCTGGE----LFE---RV----VHKRVFRESDAARIMKDVLSAVAYCHK 124

Query: 233 YSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
                + HRDLK  N L      D   K+ DFG+A      ++       VGT  Y+SP+
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ 178

Query: 290 YALEGIFSIKSDVFSFGVLL 309
             LEG++  + D +S GV++
Sbjct: 179 -VLEGLYGPECDEWSAGVMM 197

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  110 bits (276), Expect = 2e-27
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 38/205 (18%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            LG+G FG V K   R    E AVK         +    +     E  ++ K+ H N+++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNIMK 85

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR--------VQIIEGIAQGL 227
           L     D     ++ E          LFD    I    + R         +II+ +  G+
Sbjct: 86  LFEILEDSSSFYIVGELYTGGE----LFD---EI----IKRKRFSEHDAARIIKQVFSGI 134

Query: 228 LYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
            Y+H+++   I+HRDLK  NILL   +KD + KI DFG++     N         +GT  
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAY 188

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLL 309
           Y++PE  L G +  K DV+S GV+L
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVIL 212

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  113 bits (284), Expect = 2e-27
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 32/209 (15%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLL 177
             LG+G FG V K   R    E AVK ++      +    +  E  ++ K+ H N+++L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR--------VQIIEGIAQGLLY 229
               D     ++ E      L    FD    I    + R         +II+ +  G+ Y
Sbjct: 88  EILEDSSSFYIVGELYTGGEL----FD---EI----IKRKRFSEHDAARIIKQVFSGITY 136

Query: 230 LHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           +H++    I+HRDLK  NILL   +KD + KI DFG++     N         +GT  Y+
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYI 190

Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
           +PE  L G +  K DV+S GV+L  ++SG
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  109 bits (275), Expect = 2e-27
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 14/198 (7%)

Query: 123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLRE-MKNEASVIAKVQHKNLVRLLG 178
           LG+G FG VY    ++    +A+K L      ++G+   ++ E  + + ++H N++R+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D+    L+ E+ P   L +       R   +  +    +E +A  L Y H+    ++
Sbjct: 82  YFHDRKRIYLMLEFAPRGEL-YKELQKHGR-FDEQRSA-TFMEELADALHYCHER---KV 135

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           IHRD+K  N+L+      KI+DFG +           T    GT  Y+ PE         
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTM--CGTLDYLPPEMIEGKTHDE 191

Query: 299 KSDVFSFGVLLLEIVSGK 316
           K D++  GVL  E + G 
Sbjct: 192 KVDLWCAGVLCYEFLVGM 209

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  110 bits (278), Expect = 2e-27
 Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 37/209 (17%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +G+G F  V + + R+ G + AVK     + +        ++K EAS+   ++H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV------------QIIEGI 223
           LL          +++E+M        L      I    V R               +  I
Sbjct: 91  LLETYSSDGMLYMVFEFMDGAD----LCF---EI----VKRADAGFVYSEAVASHYMRQI 139

Query: 224 AQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIV 280
            + L Y H      IIHRD+K   +LL   +     K+  FG+A   G + L A     V
Sbjct: 140 LEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RV 194

Query: 281 GTYGYMSPEYALEGIFSIKSDVFSFGVLL 309
           GT  +M+PE      +    DV+  GV+L
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  111 bits (279), Expect = 3e-27
 Identities = 56/235 (23%), Positives = 93/235 (39%), Gaps = 33/235 (14%)

Query: 91  IERSKKKEVDQLPLFSFSSVSTATNTFSDT----NKLGEGGFGPVYKGVLRK-GDEIAVK 145
           I    K   D    +    V     +  D      +LG G FG V++ V +  G     K
Sbjct: 23  INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 82

Query: 146 RLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP 205
            ++         +KNE S++ ++ H  L+ L     DK E +LI E++        LFD 
Sbjct: 83  FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE----LFD- 137

Query: 206 TKRILLDWVTR---------VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-DKDMN 255
             RI                +  +    +GL ++H++    I+H D+K  NI+   K  +
Sbjct: 138 --RI----AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKAS 188

Query: 256 P-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 309
             KI DFG+A     +E+         T  + +PE          +D+++ GVL 
Sbjct: 189 SVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 6e-27
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 22/237 (9%)

Query: 94  SKKKEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSE 152
           +       L     S++      F     +G G +G VYKG   K G   A+K +   + 
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTG 61

Query: 153 QGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI------LIYEYMPNKSL-DFFLFD 204
               E+K E +++ K   H+N+    G  I K+         L+ E+    S+ D  L  
Sbjct: 62  DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIK 119

Query: 205 PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
            TK   L       I   I +GL +LHQ+   ++IHRD+K  N+LL ++   K+ DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176

Query: 265 RICGGNELQANTSRIVGTYGYMSPE-----YALEGIFSIKSDVFSFGVLLLEIVSGK 316
                   + NT   +GT  +M+PE        +  +  KSD++S G+  +E+  G 
Sbjct: 177 AQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  112 bits (281), Expect = 6e-27
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 25/228 (10%)

Query: 94  SKKKEVDQLPLFSFSSVSTATNTFSDT----NKLGEGGFGPVYKGVLRK-GDEIAVKRLS 148
                 D    +    V    +   D      +LG G FG V++   R  G+  A K + 
Sbjct: 132 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 191

Query: 149 GRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR 208
              E     ++ E   ++ ++H  LV L     D +E ++IYE+M        LF+   +
Sbjct: 192 TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFE---K 244

Query: 209 ILLDWVT-----RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-DKDMNP-KISDF 261
           +  +         V+ +  + +GL ++H+ +    +H DLK  NI+   K  N  K+ DF
Sbjct: 245 VADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDF 301

Query: 262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 309
           G+       +   +     GT  + +PE A        +D++S GVL 
Sbjct: 302 GLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (271), Expect = 8e-27
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 37/205 (18%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +LG+G F  V + V +  G E A K     +LS R  Q L     EA +  K+QH N+VR
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVR 69

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--------QIIEGIAQGL 227
           L     ++    L+++ +        LF+    I    V R           I+ I + +
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGE----LFE---DI----VAREFYSEADASHCIQQILESI 118

Query: 228 LYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
            Y H      I+HR+LK  N+LL    K    K++DFG+A     +E         GT G
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPG 172

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLL 309
           Y+SPE   +  +S   D+++ GV+L
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  108 bits (272), Expect = 9e-27
 Identities = 64/218 (29%), Positives = 118/218 (54%), Gaps = 26/218 (11%)

Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQG-----LREMKNEASVI 165
           ++++ F    KLG G +  VYKG+ +      A+K +   SE+G     +RE+    S++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREI----SLM 57

Query: 166 AKVQHKNLVRLLGCCIDKDEKILIYEYMPN---KSLDFFLFDPTKRILLDWVTR---VQI 219
            +++H+N+VRL      +++  L++E+M N   K +D      T R L   + +    Q+
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 279
           ++G+A    + H+    +I+HRDLK  N+L++K    K+ DFG+AR   G  +   +S +
Sbjct: 118 LQGLA----FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEV 169

Query: 280 VGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
           V T  Y +P+  +    +S   D++S G +L E+++GK
Sbjct: 170 V-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  108 bits (272), Expect = 1e-26
 Identities = 28/223 (12%), Positives = 66/223 (29%), Gaps = 24/223 (10%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRSEQGLREMKNEASVIAK 167
           +      + LGEG F  VY+             +  +K     +             +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL---FDPTKRILLDWVTRVQIIEGIA 224
                 ++     + ++  +L+ E     +L   +    +  ++++   +     +  + 
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR-ML 182

Query: 225 QGLLYLHQYSRVRIIHRDLKASNILL-----------DKDMNPKISDFGMARICGGNELQ 273
             +  +H      IIH D+K  N +L           D      + D G +         
Sbjct: 183 YMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
              +    T G+   E      ++ + D F     +  ++ G 
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  107 bits (270), Expect = 2e-26
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 33/210 (15%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQ------GLREMKNEASVIAKVQHKNLV 174
            K+GEG +G VYK    +G  +A+KR+   +E        +RE+    S++ ++ H N+V
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI----SLLKELHHPNIV 82

Query: 175 RLLGCCIDKDEKILIYEYMPN---KSLD--FFLFDPT--KRILLDWVTRVQIIEGIAQGL 227
            L+     +    L++E+M     K LD        +  K  L       Q++ G+A   
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLY------QLLRGVA--- 133

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            + HQ+   RI+HRDLK  N+L++ D   K++DFG+AR   G  +++ T  +V T  Y +
Sbjct: 134 -HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRA 187

Query: 288 PEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
           P+  +    +S   D++S G +  E+++GK
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  110 bits (277), Expect = 2e-26
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 43/220 (19%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLS-------------GRSEQGLREMKNEASVIA 166
            KLG G +G V     +    E A+K +                 E+   E+ NE S++ 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 167 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR--------VQ 218
            + H N+++L     DK    L+ E+         LF+   +I    + R          
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFE---QI----INRHKFDECDAAN 150

Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQAN 275
           I++ I  G+ YLH++    I+HRD+K  NILL   +  +N KI DFG++     +     
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-- 205

Query: 276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 315
               +GT  Y++PE  L+  ++ K DV+S GV++  ++ G
Sbjct: 206 -RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  107 bits (269), Expect = 2e-26
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 30/200 (15%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            LG G F  V+    R  G   A+K +          ++NE +V+ K++H+N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR--------VQIIEGIAQGLLYLHQ 232
                  L+ + +        LFD   RI    + R          +I+ +   + YLH+
Sbjct: 76  ESTTHYYLVMQLVSGGE----LFD---RI----LERGVYTEKDASLVIQQVLSAVKYLHE 124

Query: 233 YSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
                I+HRDLK  N+L    +++    I+DFG++++     +        GT GY++PE
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGYVAPE 177

Query: 290 YALEGIFSIKSDVFSFGVLL 309
              +  +S   D +S GV+ 
Sbjct: 178 VLAQKPYSKAVDCWSIGVIT 197

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  108 bits (271), Expect = 2e-26
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 37/205 (18%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +LG+G F  V + V +  G E A K     +LS R  Q L     EA +  K+QH N+VR
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVR 92

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--------QIIEGIAQGL 227
           L     ++    L+++ +        LF+    I    V R           I+ I + +
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGE----LFE---DI----VAREFYSEADASHCIQQILESI 141

Query: 228 LYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
            Y H      I+HR+LK  N+LL    K    K++DFG+A     +E         GT G
Sbjct: 142 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPG 195

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLL 309
           Y+SPE   +  +S   D+++ GV+L
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVIL 220

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  107 bits (269), Expect = 2e-26
 Identities = 61/198 (30%), Positives = 88/198 (44%), Gaps = 10/198 (5%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLG 178
           LGEG F  V            A+K L  R    E  +  +  E  V++++ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D ++      Y  N  L                TR    E I   L YLH      I
Sbjct: 98  TFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDET-CTRFYTAE-IVSALEYLHGKG---I 151

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           IHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E     
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211

Query: 299 KSDVFSFGVLLLEIVSGK 316
            SD+++ G ++ ++V+G 
Sbjct: 212 SSDLWALGCIIYQLVAGL 229

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (271), Expect = 4e-26
 Identities = 31/233 (13%), Positives = 66/233 (28%), Gaps = 43/233 (18%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLS---GRSEQGLREMKNEASVIAKVQH-------- 170
           LG+       +      G+   V             +++MK E   +  ++         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 171 --------KNLVRLLGCCIDKDEK-----------ILIYEYMPNKSLDFF--LFD-PTKR 208
                    +LV+          +             +Y  M +    F   L    +  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
             L    R+Q+   + + L  LH Y    ++H  L+  +I+LD+     ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-D 261

Query: 269 GNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGK 316
           G    +   R        +            + +   D ++ G+ +  I    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  107 bits (268), Expect = 5e-26
 Identities = 52/207 (25%), Positives = 84/207 (40%), Gaps = 36/207 (17%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLRE-MKNEASVIAKVQHKNLV 174
           +LG G F  V K   +  G E A K     +         RE ++ E S++ +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR--------VQIIEGIAQG 226
            L     ++ + +LI E +        LFD    +      +           I+ I  G
Sbjct: 79  TLHDVYENRTDVVLILELVSGGE----LFD---FL----AQKESLSEEEATSFIKQILDG 127

Query: 227 LLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           + YLH      I H DLK  NI+L        + K+ DFG+A              I GT
Sbjct: 128 VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGT 181

Query: 283 YGYMSPEYALEGIFSIKSDVFSFGVLL 309
             +++PE        +++D++S GV+ 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  105 bits (264), Expect = 5e-26
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 38/208 (18%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLREM-KNEASVIAKVQHKNLV 174
           +LG G F  V K   +  G E A K     RLS       RE  + E +++ +++H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLD---------WVTRVQIIEGIAQ 225
            L     +K + +LI E +        LFD    +               + QI++G+  
Sbjct: 72  TLHDIFENKTDVVLILELVSGGE----LFD---FLAEKESLTEDEATQFLK-QILDGVH- 122

Query: 226 GLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVG 281
              YLH     RI H DLK  NI+L      +   K+ DFG+A              I G
Sbjct: 123 ---YLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFG 173

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLL 309
           T  +++PE        +++D++S GV+ 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  106 bits (266), Expect = 6e-26
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 38/208 (18%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLRE-MKNEASVIAKVQHKNLV 174
           +LG G F  V K   +  G E A K     +         RE ++ E S++ +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLD---------WVTRVQIIEGIAQ 225
            L     ++ + +LI E +        LFD    +               + QI++G+  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGE----LFD---FLAQKESLSEEEATSFIK-QILDGVN- 129

Query: 226 GLLYLHQYSRVRIIHRDLKASNILL-DKDMNP---KISDFGMARICGGNELQANTSRIVG 281
              YLH      I H DLK  NI+L DK++     K+ DFG+A              I G
Sbjct: 130 ---YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLL 309
           T  +++PE        +++D++S GV+ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  107 bits (270), Expect = 8e-26
 Identities = 50/221 (22%), Positives = 80/221 (36%), Gaps = 32/221 (14%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGC 179
             LG G  G V      +G  +AVKR+             E  ++ +   H N++R    
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYYCS 77

Query: 180 CIDKDEKILIYEYMPNKSLDFFL---FDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                   +  E       D             L      + ++  IA G+ +LH    +
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134

Query: 237 RIIHRDLKASNILLD-------------KDMNPKISDFGMARICGGNE--LQANTSRIVG 281
           +IIHRDLK  NIL+              +++   ISDFG+ +     +   + N +   G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194

Query: 282 TYGYMSPEYALEGIFSI-------KSDVFSFGVLLLEIVSG 315
           T G+ +PE   E              D+FS G +   I+S 
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  105 bits (264), Expect = 9e-26
 Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 42/213 (19%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVK--------RLSGRSEQGLREM-KNEASVIAKV-QH 170
            LG G    V + + +    E AVK          S    Q LRE    E  ++ KV  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--------QIIEG 222
            N+++L           L+++ M    L    FD    +      +V        +I+  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGEL----FD---YL----TEKVTLSEKETRKIMRA 132

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 282
           + + +  LH+     I+HRDLK  NILLD DMN K++DFG +      E       + GT
Sbjct: 133 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 186

Query: 283 YGYMSPE------YALEGIFSIKSDVFSFGVLL 309
             Y++PE            +  + D++S GV++
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  105 bits (265), Expect = 1e-25
 Identities = 43/201 (21%), Positives = 80/201 (39%), Gaps = 32/201 (15%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            LG G FG V++ V          K +  +       +K E S++   +H+N++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLD----------WVTRVQIIEGIAQGLLYL 230
              +E ++I+E++        +F+   RI                  Q+ E +     +L
Sbjct: 71  ESMEELVMIFEFISGLD----IFE---RINTSAFELNEREIVSYVH-QVCEALQ----FL 118

Query: 231 HQYSRVRIIHRDLKASNILL--DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           H ++   I H D++  NI+    +    KI +FG AR     +       +     Y +P
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172

Query: 289 EYALEGIFSIKSDVFSFGVLL 309
           E     + S  +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  104 bits (263), Expect = 1e-25
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 23/205 (11%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQ------GLREMKNEASVIAKVQHKNLV 174
            K+GEG +G VYK     G+  A+K++    E        +RE+    S++ +++H N+V
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI----SILKELKHSNIV 63

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QIIEGIAQGLLYLHQ 232
           +L      K   +L++E++  + L   L      +          Q++ GIA    Y H 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YCHD 118

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
               R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  IV T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLM 173

Query: 293 -EGIFSIKSDVFSFGVLLLEIVSGK 316
               +S   D++S G +  E+V+G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  104 bits (262), Expect = 1e-25
 Identities = 51/207 (24%), Positives = 103/207 (49%), Gaps = 24/207 (11%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQ------GLREMKNEASVIAKVQHKNL 173
            K+GEG +G V+K   R+  EI A+KR+    +        LRE+     ++ +++HKN+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKELKHKNI 63

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QIIEGIAQGLLYLH 231
           VRL        +  L++E+   + L  +       +  + V     Q+++G+     + H
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG----FCH 118

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
                 ++HRDLK  N+L++++   K+++FG+AR   G  ++  ++ +V T  Y  P+  
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVL 173

Query: 292 L-EGIFSIKSDVFSFGVLLLEIVSGKK 317
               ++S   D++S G +  E+ +  +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  106 bits (265), Expect = 1e-25
 Identities = 36/239 (15%), Positives = 72/239 (30%), Gaps = 54/239 (22%)

Query: 123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQG----------------LREMKNEAS-- 163
           LG+       +   ++ G+   V                          LR +KN+    
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 164 ----------VIAKVQHKNLVRLLGCCIDKDEK--ILIYEYMPNKSLDFF--LFD-PTKR 208
                     ++   Q K ++R+     D        +Y  M +    F   L    +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
             L    R+Q+   + + L  LH Y    ++H  L+  +I+LD+     ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 269 GNELQANTSRIVGTYGYMSPEYAL-----------EGIFSIKSDVFSFGVLLLEIVSGK 316
                        + G+  PE                + +   D ++ G+++  I    
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  105 bits (263), Expect = 2e-25
 Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 38/208 (18%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLRE-MKNEASVIAKVQHKNLV 174
           +LG G F  V K   +  G + A K     R         RE ++ E S++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLD---------WVTRVQIIEGIAQ 225
            L     +K + ILI E +        LFD    +               + QI+ G+  
Sbjct: 78  TLHEVYENKTDVILILELVAGGE----LFD---FLAEKESLTEEEATEFLK-QILNGVY- 128

Query: 226 GLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVG 281
              YLH      I H DLK  NI+L          KI DFG+A              I G
Sbjct: 129 ---YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLL 309
           T  +++PE        +++D++S GV+ 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  105 bits (265), Expect = 2e-25
 Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 47/287 (16%)

Query: 53  VRRKPG--SRDKREDLMTFDLDLNLKANNVNIELPLNSKLIERSKKKEVDQLPLFSFSSV 110
           +R  P      +R  + +   D +  AN +     LN    + ++      +        
Sbjct: 26  IRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPD 85

Query: 111 STATNTFSDT----NKLGEGGFGPVYKGVLRK-GDEIAVK-------RLSGRSEQGLREM 158
             A   F       + +G G    V + V R  G E AVK       RLS    + +RE 
Sbjct: 86  WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145

Query: 159 -KNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR 216
            + E  ++ +V  H +++ L+          L+++ M    L    FD    +      +
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FD---YL----TEK 194

Query: 217 V--------QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           V         I+  + + + +LH      I+HRDLK  NILLD +M  ++SDFG +    
Sbjct: 195 VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251

Query: 269 GNELQANTSRIVGTYGYMSPE------YALEGIFSIKSDVFSFGVLL 309
             E       + GT GY++PE            +  + D+++ GV+L
Sbjct: 252 PGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  104 bits (262), Expect = 3e-25
 Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 23/211 (10%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQG-----LREMKNEASVIAKV 168
            T+   +KLGEG +  VYKG  +  D + A+K +    E+G     +RE+    S++  +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREV----SLLKDL 57

Query: 169 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QIIEGIAQG 226
           +H N+V L      +    L++EY+ +K L  +L D    I +  V     Q++ G+A  
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA-- 114

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
             Y H+    +++HRDLK  N+L+++    K++DFG+AR       +   + +V T  Y 
Sbjct: 115 --YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYR 167

Query: 287 SPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
            P+  L    +S + D++  G +  E+ +G+
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  103 bits (258), Expect = 8e-25
 Identities = 48/245 (19%), Positives = 83/245 (33%), Gaps = 54/245 (22%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
            +G+G +G V   +  +     A+K     ++   + + +  +K E  ++ K+ H N+ R
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 176 LLGCCIDKDEKILIYEYM-------------------------PNKSLDFFLFDPTKRIL 210
           L     D+    L+ E                             +       +      
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 211 LDWVTRV------------QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--DKDMNP 256
                R              I+  I   L YLH      I HRD+K  N L   +K    
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209

Query: 257 KISDFGMARICGGNELQANT--SRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLE 311
           K+ DFG+++             +   GT  +++PE  L      +  K D +S GVLL  
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSAGVLLHL 268

Query: 312 IVSGK 316
           ++ G 
Sbjct: 269 LLMGA 273

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  104 bits (261), Expect = 9e-25
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 44/224 (19%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNL 173
              +++   +G G FG V++  L + DE+A+K++        RE++    ++  V+H N+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94

Query: 174 VRLLGC----CIDKDEKI--LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG----- 222
           V L          KDE    L+ EY+P +++         R    +    Q +       
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVP-ETV--------YRASRHYAKLKQTMPMLLIKL 145

Query: 223 ----IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTS 277
               + + L Y+H    + I HRD+K  N+LLD      K+ DFG A+I      + N S
Sbjct: 146 YMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200

Query: 278 RIVGTYGYMSPEYALEGIF-----SIKSDVFSFGVLLLEIVSGK 316
            I   Y Y +PE     IF     +   D++S G ++ E++ G+
Sbjct: 201 YICSRY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  103 bits (258), Expect = 9e-25
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 26/201 (12%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQH-KNLVRLL 177
           +LG G F  V + + +  G E A K L  R   +    E+ +E +V+   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR------VQIIEGIAQGLLYLH 231
               +  E ILI EY     +    F      L +          +++I+ I +G+ YLH
Sbjct: 96  EVYENTSEIILILEYAAGGEI----FS---LCLPELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 232 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           Q     I+H DLK  NILL       + KI DFGM+R  G          I+GT  Y++P
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAP 202

Query: 289 EYALEGIFSIKSDVFSFGVLL 309
           E       +  +D+++ G++ 
Sbjct: 203 EILNYDPITTATDMWNIGIIA 223

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  104 bits (261), Expect = 1e-24
 Identities = 60/266 (22%), Positives = 109/266 (40%), Gaps = 60/266 (22%)

Query: 86  LNSKLIERSKKKEVDQ----------LPLFSFSSV-----STATNTFSDT----NKLGEG 126
           +N++L+ + K++ ++             +F F  +     S       D       LG G
Sbjct: 87  VNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSG 146

Query: 127 GFGPVYKGVLRK-GDEIAVKRLS--------GRSEQGLREMKNEASVIAKVQHKNLVRLL 177
             G V     RK   ++A++ +S         R       ++ E  ++ K+ H  ++++ 
Sbjct: 147 ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG--------IAQGLLY 229
               D ++  ++ E M    L    FD   ++    V   ++ E         +   + Y
Sbjct: 207 NF-FDAEDYYIVLELMEGGEL----FD---KV----VGNKRLKEATCKLYFYQMLLAVQY 254

Query: 230 LHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           LH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y+
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYL 308

Query: 287 SPE---YALEGIFSIKSDVFSFGVLL 309
           +PE         ++   D +S GV+L
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVIL 334

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  103 bits (258), Expect = 1e-24
 Identities = 57/192 (29%), Positives = 100/192 (52%), Gaps = 26/192 (13%)

Query: 110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVK--RLSGRSEQ-------GLREMK 159
           V +    +   + LGEG F  VYK   +  ++I A+K  +L  RSE         LRE+K
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 160 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR--V 217
               ++ ++ H N++ LL     K    L++++M    L+  + D +  +    +    +
Sbjct: 65  ----LLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYML 119

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
             ++G+     YLHQ+    I+HRDLK +N+LLD++   K++DFG+A+   G+  +A T 
Sbjct: 120 MTLQGLE----YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171

Query: 278 RIVGTYGYMSPE 289
           ++V T  Y +PE
Sbjct: 172 QVV-TRWYRAPE 182

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (261), Expect = 1e-24
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 36/205 (17%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVK-----RLSGRSEQGLREMKNEASVIAKVQHKNLVR 175
           +LG+G F  V + V    G E A       +LS R  Q L     EA +   ++H N+VR
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLLKHPNIVR 74

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR--------VQIIEGIAQGL 227
           L     ++    LI++ +        LF+    I    V R           I+ I + +
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGE----LFE---DI----VAREYYSEADASHCIQQILEAV 123

Query: 228 LYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
           L+ HQ     ++HR+LK  N+LL    K    K++DFG+A    G +         GT G
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPG 178

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLL 309
           Y+SPE   +  +    D+++ GV+L
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  105 bits (263), Expect = 1e-24
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 11/206 (5%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGR---SEQGLREMKNEASVIAKVQH 170
           NTF     LG+GGFG V    +R   ++ A K+L  +     +G     NE  ++ KV  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           + +V L      KD   L+   M    L F ++   +    +        E I  GL  L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDL 302

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
           H+    RI++RDLK  NILLD   + +ISD G+A      +        VGT GYM+PE 
Sbjct: 303 HRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEV 356

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGK 316
                ++   D ++ G LL E+++G+
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQ 382

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  104 bits (261), Expect = 2e-24
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 12/208 (5%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGR---SEQGLREMKNEASVIAKVQH 170
           + F D   LG GGFG V+   ++   ++ A K+L+ +     +G +    E  ++AKV  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR--ILLDWVTRVQIIEGIAQGLL 228
           + +V L      K +  L+   M    + + +++  +      +        + I  GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLE 303

Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
           +LHQ     II+RDLK  N+LLD D N +ISD G+A      + +       GT G+M+P
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAP 358

Query: 289 EYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           E  L   +    D F+ GV L E+++ +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  101 bits (254), Expect = 2e-24
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 41/211 (19%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLS--------GRSEQGLREMKNEASVIAKVQHKN 172
            LG G  G V     RK   ++A+K +S         R       ++ E  ++ K+ H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--------QIIEGIA 224
           ++++     D ++  ++ E M    L    FD   ++    V                + 
Sbjct: 77  IIKIKNF-FDAEDYYIVLELMEGGEL----FD---KV----VGNKRLKEATCKLYFYQML 124

Query: 225 QGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVG 281
             + YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + G
Sbjct: 125 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 178

Query: 282 TYGYMSPE---YALEGIFSIKSDVFSFGVLL 309
           T  Y++PE         ++   D +S GV+L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  101 bits (253), Expect = 3e-24
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 30/211 (14%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLS----GRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           LGEG +G V + +        AVK L      R   G   +K E  ++ +++HKN+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 178 GCCIDKDEKILIY---EYMPNKSLDFFLFDPTKRILLDWVTR---VQIIEGIAQGLLYLH 231
              +  +EK  +Y   EY      +     P KR            Q+I+G+     YLH
Sbjct: 73  DV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLE----YLH 126

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI----CGGNELQANTSRIVGTYGYMS 287
                 I+H+D+K  N+LL      KIS  G+A         +  +  TS+  G+  +  
Sbjct: 127 SQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR--TSQ--GSPAFQP 179

Query: 288 PEYA--LEGIFSIKSDVFSFGVLLLEIVSGK 316
           PE A  L+     K D++S GV L  I +G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  101 bits (254), Expect = 4e-24
 Identities = 59/239 (24%), Positives = 112/239 (46%), Gaps = 39/239 (16%)

Query: 101 QLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQ------ 153
           Q            +  +    K+G+G FG V+K   RK  +  A+K++   +E+      
Sbjct: 4   QYDSVECPFCDEVSK-YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 62

Query: 154 GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI--------LIYEYMPN--KSLDFFLF 203
            LRE+K    ++  ++H+N+V L+  C  K            L++++  +    L   L 
Sbjct: 63  ALREIK----ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL---LS 115

Query: 204 DPTKRILLDWVTRV--QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF 261
           +   +  L  + RV   ++ G+     Y+H+    +I+HRD+KA+N+L+ +D   K++DF
Sbjct: 116 NVLVKFTLSEIKRVMQMLLNGLY----YIHRN---KILHRDMKAANVLITRDGVLKLADF 168

Query: 262 GMARICG---GNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
           G+AR       ++    T+R+V T  Y  PE  L E  +    D++  G ++ E+ +  
Sbjct: 169 GLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  100 bits (252), Expect = 7e-24
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQ------GLREMKNEASVIAK 167
             + +   +GEG +G V K   +    I A+K+     +        +RE+K    ++ +
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK----LLKQ 80

Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QIIEGIAQ 225
           ++H+NLV LL  C  K    L++E++ + ++   L      +    V +   QII GI  
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIG- 138

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
              + H +    IIHRD+K  NIL+ +    K+ DFG AR       +     +  T  Y
Sbjct: 139 ---FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWY 190

Query: 286 MSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
            +PE  + +  +    DV++ G L+ E+  G+
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  100 bits (250), Expect = 9e-24
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 38/215 (17%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQ------GLREMKNEASVIAKVQHKNL 173
            KLGEG +G VYK +    +E  A+KR+    E+       +RE+    S++ ++QH+N+
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV----SLLKELQHRNI 95

Query: 174 VRLLGCCIDKDEKILIYEYMPN---KSLD---FFLFDPTKRILLDWVTRVQIIEGIAQGL 227
           + L           LI+EY  N   K +D          K  L       Q+I G+    
Sbjct: 96  IELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLY------QLINGVN--- 146

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNP-----KISDFGMARICGGNELQANTSRIVGT 282
            + H     R +HRDLK  N+LL           KI DFG+AR   G  ++  T  I+ T
Sbjct: 147 -FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-T 200

Query: 283 YGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
             Y  PE  L    +S   D++S   +  E++   
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 48/202 (23%), Positives = 78/202 (38%), Gaps = 32/202 (15%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
             +G G +    + + +    E AVK +         E      ++   QH N++ L   
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPNIITLKDV 84

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--------QIIEGIAQGLLYLH 231
             D     ++ E M    L     D   +I    + +          ++  I + + YLH
Sbjct: 85  YDDGKYVYVVTELMKGGEL----LD---KI----LRQKFFSEREASAVLFTITKTVEYLH 133

Query: 232 QYSRVRIIHRDLKASNILL-DKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMS 287
                 ++HRDLK SNIL  D+  NP   +I DFG A+          T     T  +++
Sbjct: 134 A---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVA 188

Query: 288 PEYALEGIFSIKSDVFSFGVLL 309
           PE      +    D++S GVLL
Sbjct: 189 PEVLERQGYDAACDIWSLGVLL 210

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 37/210 (17%)

Query: 123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCC 180
           LGEG    V   +      E AVK +  +       +  E  ++ + Q H+N++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--------QIIEGIAQGLLYLHQ 232
            ++D   L++E M   S+          I      R          +++ +A  L +LH 
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LS---HI----HKRRHFNELEASVVVQDVASALDFLHN 129

Query: 233 YSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSR-----IVGTYG 284
                I HRDLK  NIL    ++    KI DF +      N   +  S        G+  
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186

Query: 285 YMSPE-----YALEGIFSIKSDVFSFGVLL 309
           YM+PE          I+  + D++S GV+L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  100 bits (250), Expect = 2e-23
 Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 47/224 (20%)

Query: 122 KLGEGGFGPVYKGVLRK---GDEIAVKRLS--GRSEQGLREMKNEASVIAKVQHKNLVRL 176
           K+G G +G VYK   +      + A+K++   G S    RE+     ++ +++H N++ L
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA----LLRELKHPNVISL 83

Query: 177 LGCCIDK-DEKI-LIYEYM-------------PNKSLDFFLFDPT--KRILLDWVTRVQI 219
               +   D K+ L+++Y                 +           K +L       QI
Sbjct: 84  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY------QI 137

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP----KISDFGMARICG--GNELQ 273
           ++GI     YLH      ++HRDLK +NIL+  +       KI+D G AR+       L 
Sbjct: 138 LDGIH----YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190

Query: 274 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
                +V T+ Y +PE  L    ++   D+++ G +  E+++ +
Sbjct: 191 DLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  100 bits (251), Expect = 2e-23
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 45/225 (20%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKN 172
             +++DT  +G G FG VY+  L   G+ +A+K++        RE++    ++ K+ H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108

Query: 173 LVRLLGCCIDKDEKI------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG---- 222
           +VRL        EK       L+ +Y+P +++         R+   +    Q +      
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETV--------YRVARHYSRAKQTLPVIYVK 159

Query: 223 -----IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT 276
                + + L Y+H      I HRD+K  N+LLD D    K+ DFG A+     E   N 
Sbjct: 160 LYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 214

Query: 277 SRIVGTYGYMSPEYALEGIFSIKS-----DVFSFGVLLLEIVSGK 316
           S I   Y Y +PE     IF         DV+S G +L E++ G+
Sbjct: 215 SYICSRY-YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 98.1 bits (245), Expect = 3e-23
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 53/232 (22%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLS--------------------------GRSEQGL 155
           +G+G +G V            A+K LS                           +    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 156 REMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY---EYMPNKSLDFFLFD-PTKRILL 211
            ++  E +++ K+ H N+V+L+   +D   +  +Y   E +    +     + PT + L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 212 DWVTRV---QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
           +   R     +I+GI     YLH     +IIHRD+K SN+L+ +D + KI+DFG++    
Sbjct: 136 EDQARFYFQDLIKGIE----YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 269 GNELQANTSRIVGTYGYMSPEYALEGIFSI----KSDVFSFGVLLLEIVSGK 316
           G++   + +  VGT  +M+PE +L     I      DV++ GV L   V G+
Sbjct: 189 GSDALLSNT--VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 31/200 (15%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +LG G    VY+   +      A+K L    ++  + ++ E  V+ ++ H N+++L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR--------VQIIEGIAQGLLYLHQ 232
               E  L+ E +        LFD   RI    V +           ++ I + + YLH+
Sbjct: 118 ETPTEISLVLELVTGGE----LFD---RI----VEKGYYSERDAADAVKQILEAVAYLHE 166

Query: 233 YSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
                I+HRDLK  N+L      D   KI+DFG+++I     L      + GT GY +PE
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPE 220

Query: 290 YALEGIFSIKSDVFSFGVLL 309
                 +  + D++S G++ 
Sbjct: 221 ILRGCAYGPEVDMWSVGIIT 240

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 98.4 bits (246), Expect = 4e-23
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 34/217 (15%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQ------GLREMKNEASVIAK 167
             +    K+GEG +G V+K   R   +I A+K+     +        LRE++    ++ +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIR----MLKQ 58

Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPN---KSLD----FFLFDPTKRILLDWVTRVQII 220
           ++H NLV LL     K    L++EY  +     LD           K I        Q +
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW------QTL 112

Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 280
           + +     + H++     IHRD+K  NIL+ K    K+ DFG AR+  G         + 
Sbjct: 113 QAVN----FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA 164

Query: 281 GTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
            T  Y SPE  + +  +    DV++ G +  E++SG 
Sbjct: 165 -TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 98.1 bits (245), Expect = 5e-23
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 32/201 (15%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGC 179
            LGEG F    K V +K     AVK +S R E   +    E + +   + H N+V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEV 74

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--------QIIEGIAQGLLYLH 231
             D+    L+ E +    L    F+   RI      +          I+  +   + ++H
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FE---RI----KKKKHFSETEASYIMRKLVSAVSHMH 123

Query: 232 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 288
               V ++HRDLK  N+L    + ++  KI DFG AR+   +     T     T  Y +P
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178

Query: 289 EYALEGIFSIKSDVFSFGVLL 309
           E   +  +    D++S GV+L
Sbjct: 179 ELLNQNGYDESCDLWSLGVIL 199

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 97.7 bits (244), Expect = 6e-23
 Identities = 57/220 (25%), Positives = 104/220 (47%), Gaps = 44/220 (20%)

Query: 121 NKLGEGGFGPVYKGV-LRKGDEI-AVKRLSGRSEQ------GLRE---MKNEASVIAKVQ 169
            ++GEG +G V+K   L+ G    A+KR+  ++ +       +RE   +++    +   +
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH----LETFE 72

Query: 170 HKNLVRLL----GCCIDKDEKI-LIYEYMP--------NKSLDFFLFDPTKRILLDWVTR 216
           H N+VRL         D++ K+ L++E++                  +  K ++      
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF----- 127

Query: 217 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT 276
            Q++ G+     +LH +   R++HRDLK  NIL+      K++DFG+ARI       A T
Sbjct: 128 -QLLRGLD----FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALT 177

Query: 277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           S +V T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 178 SVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 97.3 bits (243), Expect = 8e-23
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 46/232 (19%)

Query: 111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQG---------LRE--- 157
           S AT+ +    ++G G +G VYK          A+K +   +  G         +RE   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 158 MKNEASVIAKVQHKNLVRLL----GCCIDKDEKI-LIYEYMP--------NKSLDFFLFD 204
           ++     +   +H N+VRL+        D++ K+ L++E++                  +
Sbjct: 65  LRR----LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120

Query: 205 PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 264
             K ++       Q + G+     +LH      I+HRDLK  NIL+      K++DFG+A
Sbjct: 121 TIKDLMR------QFLRGLD----FLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 167

Query: 265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           RI       A T  +V T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 168 RIYSYQ--MALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 97.0 bits (242), Expect = 9e-23
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 30/210 (14%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLS-------GRSEQGL---REMKNEASVIAKVQHK 171
           LG+GGFG V+ G  L    ++A+K +              +    E+     V A   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR---VQIIEGIAQGLL 228
            ++RLL     ++  +L+ E  P  + D F +   K  L +  +R    Q++  I     
Sbjct: 99  GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ---- 153

Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 287
           + H      ++HRD+K  NIL+D      K+ DFG   +              GT  Y  
Sbjct: 154 HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT--DF--DGTRVYSP 206

Query: 288 PEYALEGI--FSIKSDVFSFGVLLLEIVSG 315
           PE+ +      ++ + V+S G+LL ++V G
Sbjct: 207 PEW-ISRHQYHALPATVWSLGILLYDMVCG 235

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 97.4 bits (243), Expect = 9e-23
 Identities = 54/213 (25%), Positives = 84/213 (39%), Gaps = 36/213 (16%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRL------SGRSEQGLREMKNEASVIAKVQHK--NL 173
           LG GGFG VY G+ +     +A+K +                +  E  ++ KV      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTR---VQIIEGIAQGLLYL 230
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 165

Query: 231 HQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           H      ++HRD+K  NIL+D +    K+ DFG   +              GT  Y  PE
Sbjct: 166 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DF--DGTRVYSPPE 218

Query: 290 YALEGIFSIK------SDVFSFGVLLLEIVSGK 316
                           + V+S G+LL ++V G 
Sbjct: 219 -----WIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 35/209 (16%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGC 179
           +G+G F  V     +  G E+A+K +     +   L+++  E  ++  + H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFD--PTKRILLDWVTRV---QIIEGIAQGLLYLHQYS 234
              +    LI EY     +    FD       + +   R    QI+  +     Y HQ  
Sbjct: 83  IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCHQK- 133

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEYALE 293
             RI+HRDLKA N+LLD DMN KI+DFG +     G +L  +     G   Y +PE    
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAF--CGAPPYAAPE---- 183

Query: 294 GIFS------IKSDVFSFGVLLLEIVSGK 316
            +F        + DV+S GV+L  +VSG 
Sbjct: 184 -LFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 54/240 (22%), Positives = 94/240 (39%), Gaps = 53/240 (22%)

Query: 106 SFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVK------RLSGRSEQGLREM 158
           +        + F      G+G FG V  G  +  G  +A+K      R   R    L+ M
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE---LQIM 70

Query: 159 KNEASVIAKVQHKNLVRLLGCCIDKDEK-------ILIYEYMPNKSLDFFLFDPTKRILL 211
           +     +A + H N+V+L        E+        ++ EY+P  +L         R   
Sbjct: 71  Q----DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTL--------HRCCR 117

Query: 212 DWVTRVQIIEG---------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDF 261
           ++  R               + + +  LH  S   + HRD+K  N+L+++     K+ DF
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDF 176

Query: 262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS-----DVFSFGVLLLEIVSGK 316
           G A+    +E   N + I   Y Y +PE     IF  +      D++S G +  E++ G+
Sbjct: 177 GSAKKLSPSE--PNVAYICSRY-YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 39/211 (18%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V     + +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRI-----LLDWVTRV---QIIEGIAQGLLYLHQ 232
            + + + L  EY     L    FD   RI     + +   +    Q++ G+     YLH 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FD---RIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEY 290
                I HRD+K  N+LLD+  N KISDFG+A +      E   N     GT  Y++PE 
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPE- 177

Query: 291 ALEGIFSIK------SDVFSFGVLLLEIVSG 315
               +   +       DV+S G++L  +++G
Sbjct: 178 ----LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.8 bits (246), Expect = 2e-22
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 18/210 (8%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEI-AVKRLSGR---SEQGLREMKNEASVIAKVQH 170
           N FS    +G GGFG VY        ++ A+K L  +    +QG     NE  +++ V  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 171 KN---LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
            +   +V +       D+   I + M    L + L      +  +   R    E I  GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAE-IILGL 305

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            ++H      +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+
Sbjct: 306 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMA 358

Query: 288 PEYALEGIFSIKS-DVFSFGVLLLEIVSGK 316
           PE   +G+    S D FS G +L +++ G 
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 39/211 (18%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLLGCC 180
           LGEG +G V   V     + +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRI-----LLDWVTRV---QIIEGIAQGLLYLHQ 232
            + + + L  EY     L    FD   RI     + +   +    Q++ G+     YLH 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FD---RIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEY 290
                I HRD+K  N+LLD+  N KISDFG+A +      E   N     GT  Y++PE 
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPE- 177

Query: 291 ALEGIFSIK------SDVFSFGVLLLEIVSG 315
               +   +       DV+S G++L  +++G
Sbjct: 178 ----LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 95.2 bits (237), Expect = 6e-22
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 36/212 (16%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVK--------RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           LG G FG V+  V   K  E+ VK              +  L ++  E +++++V+H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV---QIIEGIAQGLLYL 230
           +++L    ++    L+ E   +  LD F F      L + +      Q++  +     YL
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIFRQLVSAVG----YL 146

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPE 289
                  IIHRD+K  NI++ +D   K+ DFG  A +  G      T    GT  Y +PE
Sbjct: 147 RLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTF--CGTIEYCAPE 199

Query: 290 YALEGIFSIKS------DVFSFGVLLLEIVSG 315
                +           +++S GV L  +V  
Sbjct: 200 -----VLMGNPYRGPELEMWSLGVTLYTLVFE 226

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 49/203 (24%), Positives = 78/203 (38%), Gaps = 34/203 (16%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGC 179
            LG G  G V +   R+ G + A+K L         + + E     +     ++V +L  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90

Query: 180 CIDKDEKI----LIYEYMPNKSLDFFLFDPTKRILLDWVTR------VQIIEGIAQGLLY 229
             +         +I E M    L    F    RI              +I+  I   + +
Sbjct: 91  YENMHHGKRCLLIIMECMEGGEL----FS---RIQERGDQAFTEREAAEIMRDIGTAIQF 143

Query: 230 LHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           LH      I HRD+K  N+L    +KD   K++DFG A+    N LQ        T  Y+
Sbjct: 144 LHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYV 196

Query: 287 SPEYALEGIFSIKSDVFSFGVLL 309
           +PE      +    D++S GV++
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIM 219

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 34/209 (16%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRS--EQGLRE-MKNEASVIAKVQHKNLVRLLG 178
           LG G FG V  G     G ++AVK L+ +      +   +K E   +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFD--PTKRILLDWVTRV---QIIEGIAQGLLYLHQY 233
                 +  ++ EY+    L    FD       + +   R    QI+  +     Y H++
Sbjct: 79  VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCHRH 130

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               ++HRDLK  N+LLD  MN KI+DFG++ +    E    TS   G+  Y +PE    
Sbjct: 131 ---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPE---- 180

Query: 294 GIFS------IKSDVFSFGVLLLEIVSGK 316
            + S       + D++S GV+L  ++ G 
Sbjct: 181 -VISGRLYAGPEVDIWSCGVILYALLCGT 208

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 51/217 (23%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGR--SEQGLRE-MKNEASVIAKVQHKNLVRLLG 178
           LGEG FG V      +   ++A+K +S +   +  +   ++ E S +  ++H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 179 CCIDKDEKILIYEYMPNKSLDFF--------LFD--PTKRILLDWVTRV---QIIEGIAQ 225
                      Y+ +   +            LFD    K+ + +   R    QII  I  
Sbjct: 75  -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
              Y H++   +I+HRDLK  N+LLD ++N KI+DFG++ I         TS   G+  Y
Sbjct: 123 ---YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS--CGSPNY 173

Query: 286 MSPEYALEGIFS------IKSDVFSFGVLLLEIVSGK 316
            +PE     + +       + DV+S G++L  ++ G+
Sbjct: 174 AAPE-----VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 89.6 bits (222), Expect = 7e-20
 Identities = 37/93 (39%), Positives = 55/93 (59%), Gaps = 5/93 (5%)

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 281
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR I    +        + 
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL- 257

Query: 282 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 314
              +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 35/160 (21%), Positives = 57/160 (35%), Gaps = 19/160 (11%)

Query: 121 NKLGEGGFGPVYKGVLRKGDE------IAVKRL-SGRSEQGLREMKNEASVIAKV-QHKN 172
             LG G FG V +      D+      +AVK L  G +    R + +E  ++  +  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 173 LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
           +V LLG C      + +I E+    +L  +L             R + +    +G  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
               V  I  DLK     +    +   S F   +     E
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 34/209 (16%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVK---RLSGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
           LG G FG V  G     G ++AVK   R   RS   + +++ E   +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFD--PTKRILLDWVTRV---QIIEGIAQGLLYLHQY 233
                 +  ++ EY+    L    FD       L +  +R    QI+ G+     Y H++
Sbjct: 84  VISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCHRH 135

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
               ++HRDLK  N+LLD  MN KI+DFG++ +    E    TS   G+  Y +PE    
Sbjct: 136 ---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPE---- 185

Query: 294 GIFS------IKSDVFSFGVLLLEIVSGK 316
            + S       + D++S GV+L  ++ G 
Sbjct: 186 -VISGRLYAGPEVDIWSSGVILYALLCGT 213

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 46/223 (20%), Positives = 84/223 (37%), Gaps = 40/223 (17%)

Query: 108 SSVSTATNTFSDT-----NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNE 161
           S +    N   D        LG G  G V +   ++  ++ A+K L    +      + E
Sbjct: 50  SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARRE 104

Query: 162 ASVIAKVQ-HKNLVRLLGCCIDKDEKI----LIYEYMPNKSLDFFLFDPTKRILLDWVTR 216
             +  +     ++VR++    +         ++ E +    L    F    RI       
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FS---RIQDRGDQA 157

Query: 217 ------VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARIC 267
                  +I++ I + + YLH  +   I HRD+K  N+L      +   K++DFG A+  
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214

Query: 268 -GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 309
              N L         T  Y++PE      +    D++S GV++
Sbjct: 215 TSHNSLT----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.5 bits (217), Expect = 6e-19
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 19/204 (9%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLRE---MKNEASVIAKVQHKNLVRLLG 178
           +G G FG V    L+  D++ A+K L+        E    + E  V+     K +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D +   L+ +Y     L   L    +  L + + R  + E +   +  +HQ      
Sbjct: 142 AFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDSVHQLH---Y 196

Query: 239 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +HRD+K  NIL+D + + +++DFG   ++     +Q++    VGT  Y+SPE  L+ +  
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPE-ILQAMEG 253

Query: 298 IKS------DVFSFGVLLLEIVSG 315
            K       D +S GV + E++ G
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYG 277

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 15/197 (7%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLRE---MKNEASVIAKVQHKNLVRLLG 178
           LG G FG V     ++     A+K L  +    L++     NE  ++  V    LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D     ++ EY+    +   L         +   R    + I     YLH      +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQ-IVLTFEYLHSLD---L 162

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           I+RDLK  N+L+D+    +++DFG A+   G      T  + GT   ++PE  L   ++ 
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNK 217

Query: 299 KSDVFSFGVLLLEIVSG 315
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLS----GRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           +G+G FG V         ++ A+K ++        + +R +  E  ++  ++H  LV L 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLEHPFLVNLW 81

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
               D+++  ++ + +    L  +          +   ++ I E +   L YL      R
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEE-TVKLFICE-LVMALDYLQNQ---R 135

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           IIHRD+K  NILLD+  +  I+DF +A +          + + GT  YM+PE     +FS
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPE-----MFS 187

Query: 298 IKS--------DVFSFGVLLLEIVSGK 316
            +         D +S GV   E++ G+
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGR 214

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 19/199 (9%), Positives = 58/199 (29%), Gaps = 41/199 (20%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRL---SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
             G       ++ +      ++A+  +       +  L+E  +    ++++    + R+L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
                +   +++ E++   SL               V  ++ ++ +A      H   R  
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           +       S + +  D +  ++                          M          +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA-------N 180

Query: 298 IKSDVFSFGVLLLEIVSGK 316
            + D+   G  L  ++  +
Sbjct: 181 PQDDIRGIGASLYALLVNR 199

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 23/207 (11%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLS-----GRSEQGLREMKNEASVIAKVQHKNLVRL 176
           +G G F  V    +++  ++ A+K ++      R E  +   + E  V+     + + +L
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE--VSCFREERDVLVNGDRRWITQL 126

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                D++   L+ EY     L   L    +RI  +   R  + E I   +  +H+    
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLAE-IVMAIDSVHRLG-- 182

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE------ 289
             +HRD+K  NILLD+  + +++DFG   ++     +++     VGT  Y+SPE      
Sbjct: 183 -YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGTPDYLSPEILQAVG 239

Query: 290 -YALEGIFSIKSDVFSFGVLLLEIVSG 315
                G +  + D ++ GV   E+  G
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYG 266

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 40/210 (19%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           +G G FG           + +AVK +  R       ++ E      ++H N+VR     +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 182 DKDEKILIYEYMPNKSLDFFLFDPTKRI-----LLDWVTRV---QIIEGIAQGLLYLHQY 233
                 +I EY     L    ++   RI       +   R    Q++ G++    Y H  
Sbjct: 87  TPTHLAIIMEYASGGEL----YE---RICNAGRFSEDEARFFFQQLLSGVS----YCH-- 133

Query: 234 SRVRIIHRDLKASNILLDKD--MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
             ++I HRDLK  N LLD       KI DFG ++    +     ++  VGT  Y++PE  
Sbjct: 134 -SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST--VGTPAYIAPE-- 187

Query: 292 LEGIFSIK------SDVFSFGVLLLEIVSG 315
              +   +      +DV+S GV L  ++ G
Sbjct: 188 ---VLLRQEYDGKIADVWSCGVTLYVMLVG 214

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 81.8 bits (203), Expect = 2e-17
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 15/197 (7%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLRE---MKNEASVIAKVQHKNLVRLLG 178
           LG G FG V+    R      A+K L       L++     +E  +++ V H  ++R+ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D  +  +I +Y+    L F L   ++R     V +    E +   L YLH      I
Sbjct: 74  TFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNP-VAKFYAAE-VCLALEYLHSKD---I 127

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
           I+RDLK  NILLDK+ + KI+DFG A+      +   T  + GT  Y++PE      ++ 
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNK 182

Query: 299 KSDVFSFGVLLLEIVSG 315
             D +SFG+L+ E+++G
Sbjct: 183 SIDWWSFGILIYEMLAG 199

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 49/255 (19%), Positives = 99/255 (38%), Gaps = 69/255 (27%)

Query: 112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQH 170
           T++  +S    LG G FG V +    + G   A+K++        RE+     ++  + H
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59

Query: 171 KNLVRLLGCCIDKDEKI--------------------------------------LIYEY 192
            N+++L+       ++                                       +I EY
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEG---------IAQGLLYLHQYSRVRIIHRDL 243
           +P  +L         ++L  ++   + I           + + + ++H    + I HRD+
Sbjct: 120 VP-DTL--------HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDI 167

Query: 244 KASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSD 301
           K  N+L++ KD   K+ DFG A+       + + + I   + Y +PE  L    ++   D
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSID 224

Query: 302 VFSFGVLLLEIVSGK 316
           ++S G +  E++ GK
Sbjct: 225 LWSIGCVFGELILGK 239

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 15/200 (7%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLS-----GRSEQGLREMKNEASVIAKVQHKNLVRL 176
           LG+G FG V     +      A+K L       + E  +     E  V+   +H  L  L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVLQNSRHPFLTAL 213

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                  D    + EY     L F L    +R+  +   R    E I   L YLH  S  
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEK 268

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +++RDLK  N++LDKD + KI+DFG+ +    +     T    GT  Y++PE   +  +
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDY 326

Query: 297 SIKSDVFSFGVLLLEIVSGK 316
               D +  GV++ E++ G+
Sbjct: 327 GRAVDWWGLGVVMYEMMCGR 346

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 48/223 (21%), Positives = 84/223 (37%), Gaps = 38/223 (17%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAK--------- 167
           ++    +  G +G V  GV  +G  +A+KR+      G        S + K         
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 168 --VQHKNLVRLLGCCI----DKDEKI-LIYEYMPN------KSLDFFLFDPTKRILLDWV 214
               H N++ L    +        K+ L+ E M              +     +  +   
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM--- 140

Query: 215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 274
               I+     GL  LH+     ++HRDL   NILL  + +  I DF +AR    +    
Sbjct: 141 --YHIL----LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA--- 188

Query: 275 NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 316
           N +  V    Y +PE  ++   F+   D++S G ++ E+ + K
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.9 bits (200), Expect = 8e-17
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 18/202 (8%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLSGRSEQGLRE---MKNEASVIAKVQHKNLVRLLG 178
           +G G FG V     +   ++ A+K LS        +      E  ++A      +V+L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              D     ++ EYMP   L   L      +   W  R    E +   L  +H       
Sbjct: 137 AFQDDRYLYMVMEYMPGGDL-VNLMS-NYDVPEKW-ARFYTAE-VVLALDAIHSMG---F 189

Query: 239 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE----YALE 293
           IHRD+K  N+LLDK  + K++DFG   ++     ++ +T+  VGT  Y+SPE       +
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGD 247

Query: 294 GIFSIKSDVFSFGVLLLEIVSG 315
           G +  + D +S GV L E++ G
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVG 269

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 49/217 (22%), Positives = 93/217 (42%), Gaps = 41/217 (18%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQG-LREMKNEASVIAK--VQHKN 172
           +    KLG G +  V++ + +   +++ VK L    ++   RE+K     I +      N
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK-----ILENLRGGPN 92

Query: 173 LVRLLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           ++ L     D   +   L++E++ N            + L D+  R  + E I + L Y 
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE-ILKALDYC 146

Query: 231 HQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           H  S   I+HRD+K  N+++D +    ++ D+G+A     +  Q    R+   Y +  PE
Sbjct: 147 H--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGPE 200

Query: 290 ---------YALEGIFSIKSDVFSFGVLLLEIVSGKK 317
                    Y+L        D++S G +L  ++  K+
Sbjct: 201 LLVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 16/201 (7%)

Query: 123 LGEGGFGPVY---KGVLRKGDEI-AVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRL 176
           LG+G FG V+   K       ++ A+K L   +   +     K E  ++ +V H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 177 LGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
                  + K+ LI +++    L F           + V +  + E +A  L +LH    
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFTEEDV-KFYLAE-LALALDHLHSLG- 146

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
             II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM+PE      
Sbjct: 147 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRG 202

Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
            +  +D +SFGVL+ E+++G 
Sbjct: 203 HTQSADWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 77.2 bits (191), Expect = 7e-16
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 20/204 (9%)

Query: 123 LGEGGFGPVY---KGVLRKGDEI-AVKRLS-----GRSEQGLREMKNEASVIAKVQHKNL 173
           LG+GG+G V+   K       +I A+K L        ++      K E +++ +V+H  +
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD-TAHTKAERNILEEVKHPFI 83

Query: 174 VRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           V L+        K+ LI EY+    L F   +     + D      + E I+  L +LHQ
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMED-TACFYLAE-ISMALGHLHQ 139

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
                II+RDLK  NI+L+   + K++DFG+ +    +    +T    GT  YM+PE  +
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILM 194

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGK 316
               +   D +S G L+ ++++G 
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGA 218

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 78.3 bits (193), Expect = 8e-16
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 41/219 (18%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSG---------RSEQGLREMKNEASVIA 166
           + +   +G G  G V           +A+K+LS          R+    RE+     ++ 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA---YRELV----LMK 116

Query: 167 KVQHKNLVRLL-----GCCIDKDEKI-LIYEYMP---NKSLDFFLFDPTKRILLDWVTRV 217
            V HKN++ LL        +++ + + L+ E M     + +   L       LL      
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL-----Y 171

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q++     G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +    +
Sbjct: 172 QML----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MT 221

Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
             V T  Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.5 bits (193), Expect = 8e-16
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 21/203 (10%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLS-----GRSEQGLREMKNEASVIAKV-QHKNLVR 175
           LG+G FG V     +  DE+ AVK L         +  +     E  V+A   +   L +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPGKPPFLTQ 406

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L  C    D    + EY+    L  +      R            E IA GL +L     
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEP-HAVFYAAE-IAIGLFFLQSKG- 462

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALE 293
             II+RDLK  N++LD + + KI+DFGM +  I  G      T    GT  Y++PE    
Sbjct: 463 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAY 516

Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +    D ++FGVLL E+++G+
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQ 539

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 76.9 bits (190), Expect = 9e-16
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 16/200 (8%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLS-----GRSEQGLREMKNEASVIAKVQHKNLVRL 176
           LG+G FG V     +      A+K L       + E        E+ V+   +H  L  L
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV--AHTVTESRVLQNTRHPFLTAL 70

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                  D    + EY     L F L    +R+  +   R    E I   L YLH     
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD-- 125

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            +++RD+K  N++LDKD + KI+DFG+ +    +     T    GT  Y++PE   +  +
Sbjct: 126 -VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDY 182

Query: 297 SIKSDVFSFGVLLLEIVSGK 316
               D +  GV++ E++ G+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 41/222 (18%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSG---------RSEQGLREMKNEAS 163
              + +   +G G  G V           +A+K+LS          R+    RE+     
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA---YRELV---- 76

Query: 164 VIAKVQHKNLVRLL------GCCIDKDEKILIYEYMP---NKSLDFFLFDPTKRILLDWV 214
           ++  V HKN++ LL          +  +  ++ E M     + +   L       LL   
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL--- 133

Query: 215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 274
              Q++     G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +  
Sbjct: 134 --YQML----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184

Query: 275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
                V T  Y +PE  L   +    D++S G ++ E++ G 
Sbjct: 185 PY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 39/203 (19%), Positives = 79/203 (38%), Gaps = 51/203 (25%)

Query: 117 FSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQG------LREMKNEASVIAKVQ 169
           +   + +G G +G V +     +   +A+K++    E        LRE+     ++ ++ 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILNRLN 110

Query: 170 HKNLVRLLGCCI----DKDEKI-LIYEYMP---------NKSLD-----FFLFDPTKRIL 210
           H ++V++L   I    +K +++ ++ E               L        L+       
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY------- 163

Query: 211 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 270
                   ++     G+ Y+H      I+HRDLK +N L+++D + K+ DFG+AR     
Sbjct: 164 -------NLL----VGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209

Query: 271 ELQANTSRIVGTYGYMSPEYALE 293
           E   +   I      M+      
Sbjct: 210 ENGNSQLPISPREDDMNLVTFPH 232

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 74.6 bits (184), Expect = 6e-15
 Identities = 53/220 (24%), Positives = 103/220 (46%), Gaps = 38/220 (17%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSG------RSEQGLREMKNEASVIA 166
             T+     +G G +G V   + ++ G+++A+K+LS        +++  RE+     ++ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78

Query: 167 KVQHKNLVRLL-----GCCIDKDEKI-LIYEYMP---NKSLDFFLFDPTKRILLDWVTRV 217
            +QH+N++ LL        +       L+  +M     K +     +   + L+      
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-----Y 133

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
           Q++    +GL Y+H      ++HRDLK  N+ +++D   KI DFG+AR        A  +
Sbjct: 134 QML----KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMT 181

Query: 278 RIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 316
             V T  Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 54/229 (23%), Positives = 104/229 (45%), Gaps = 51/229 (22%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQG-----LREMKNEASVIAK 167
              +++ + +GEG +G V           +A+K++S    Q      LRE+K    ++ +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81

Query: 168 VQHKNLVRLLGC----CIDKDEKI-LIYEYMP--------NKSLD-----FFLFDPTKRI 209
            +H+N++ +        I++ + + ++ + M          + L      +FL+      
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY------ 135

Query: 210 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 269
                   QI+    +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   
Sbjct: 136 --------QIL----RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180

Query: 270 NELQANT-SRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 316
           +       +  V T  Y +PE  L    ++   D++S G +L E++S +
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 21/203 (10%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLS-----GRSEQGLREMKNEASVIAKV-QHKNLVR 175
           LG+G FG V    +++  ++ AVK L         +        E  +++    H  L +
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDV--ECTMTEKRILSLARNHPFLTQ 88

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L  C    D    + E++    L  F    ++R       R    E I   L++LH    
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEAR-ARFYAAE-IISALMFLHDKG- 144

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPEYALE 293
             II+RDLK  N+LLD + + K++DFGM    IC G      T+   GT  Y++PE   E
Sbjct: 145 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDYIAPEILQE 198

Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
            ++    D ++ GVLL E++ G 
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGH 221

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLS-----GRSEQGLREMKNEASVIAKV-QHKNLVR 175
           +G G +  V    L+K D I A+K +         +     ++ E  V  +   H  LV 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDI--DWVQTEKHVFEQASNHPFLVG 74

Query: 176 LLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           L   C   + ++  + EY+    L F +    +R L +   R    E I+  L YLH+  
Sbjct: 75  LH-SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAE-ISLALNYLHERG 130

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAL 292
              II+RDLK  N+LLD + + K++D+GM +  +  G+     TS   GT  Y++PE   
Sbjct: 131 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILR 183

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGK 316
              +    D ++ GVL+ E+++G+
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGR 207

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 23/204 (11%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLS-----GRSEQGLREMKNEASVIAKV-QHKNLVR 175
           LG+G FG V     +  DE+ AVK L         +  +     E  V+A   +   L +
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPGKPPFLTQ 85

Query: 176 LLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           L   C    +++  + EY+    L  +      R            E IA GL +L    
Sbjct: 86  LH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPH-AVFYAAE-IAIGLFFLQSK- 140

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAL 292
              II+RDLK  N++LD + + KI+DFGM +  I  G      T    GT  Y++PE   
Sbjct: 141 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIA 194

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGK 316
              +    D ++FGVLL E+++G+
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQ 218

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 73.0 bits (178), Expect = 2e-14
 Identities = 38/212 (17%), Positives = 64/212 (30%), Gaps = 47/212 (22%)

Query: 97  KEVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRL--------S 148
            E  Q     FS     T       K+GEG FG V++ +      +A+K +        +
Sbjct: 3   GECSQKGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVN 60

Query: 149 GRSEQGLREMKNEASV---------IAKVQHKNLVRLLG--CCIDKDEKILIYEYM---- 193
           G  ++   E+  E  +             + +  + L    C       +L+  +     
Sbjct: 61  GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120

Query: 194 ----PNKSLDFF----------------LFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
                N   DFF                  +  +  L    T   I+  +   L      
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA- 179

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR 265
             +R  HRDL   N+LL K    K+      +
Sbjct: 180 -SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 23/204 (11%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLS-----GRSEQGLREMKNEASVIAKV-QHKNLVR 175
           +G G +  V    L+K D I A++ +         +  +  ++ E  V  +   H  LV 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED--IDWVQTEKHVFEQASNHPFLVG 117

Query: 176 LLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           L   C   + ++  + EY+    L F +    +R L +   R    E I+  L YLH+  
Sbjct: 118 LH-SCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAE-ISLALNYLHERG 173

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAL 292
              II+RDLK  N+LLD + + K++D+GM +  +  G+     TS   GT  Y++PE   
Sbjct: 174 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILR 226

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGK 316
              +    D ++ GVL+ E+++G+
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGR 250

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 24/217 (11%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQG----LREMKNEASVIAKVQHK 171
           + D   LG GG G V+  V       +A+K++     Q     LRE+K    +I ++ H 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK----IIRRLDHD 68

Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEG--------- 222
           N+V++         ++        +    ++        L  V     +           
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ 128

Query: 223 IAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANT-SRIV 280
           + +GL Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI   +       S  +
Sbjct: 129 LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185

Query: 281 GTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
            T  Y SP   L    ++   D+++ G +  E+++GK
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 24/208 (11%)

Query: 123 LGEGGFGPVY---KGVLRKGDEI-AVKRLS-----GRSEQGLREMKNEASVIAKVQHKN- 172
           LG G +G V+   K       ++ A+K L       +++      + E  V+  ++    
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT-TEHTRTERQVLEHIRQSPF 120

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           LV L      + +  LI +Y+    L F      +R     V ++ + E I   L +LH+
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEV-QIYVGE-IVLALEHLHK 177

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEY 290
                II+RD+K  NILLD + +  ++DFG+++  +    E         GT  YM+P+ 
Sbjct: 178 LG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER---AYDFCGTIEYMAPDI 231

Query: 291 ALEGIFSIKSDV--FSFGVLLLEIVSGK 316
              G       V  +S GVL+ E+++G 
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 71.1 bits (175), Expect = 8e-14
 Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 17/200 (8%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLS-----GRSEQGLREMKNEASVIAKV-QHKNLVR 175
           LG+G FG V+    +K ++  A+K L         +        E  V++   +H  L  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLTH 82

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           +      K+    + EY+    L  +      +  L         E I  GL +LH    
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLS-RATFYAAE-IILGLQFLHSKG- 138

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
             I++RDLK  NILLDKD + KI+DFGM +     + + NT    GT  Y++PE  L   
Sbjct: 139 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQK 194

Query: 296 FSIKSDVFSFGVLLLEIVSG 315
           ++   D +SFGVLL E++ G
Sbjct: 195 YNHSVDWWSFGVLLYEMLIG 214

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.1 bits (175), Expect = 9e-14
 Identities = 54/239 (22%), Positives = 101/239 (42%), Gaps = 64/239 (26%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQG-----LREMKNEASVIAK 167
           ++ F   + LGEG +G V     +  G+ +A+K++    +       LRE+K    ++  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65

Query: 168 VQHKNLVRLLGC----CIDKDEKI-LIYEYMP--------NKSLD-----FFLFDPTKRI 209
            +H+N++ +         +   ++ +I E M          + L      +F++      
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY------ 119

Query: 210 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 269
                   Q +    + +  LH      +IHRDLK SN+L++ + + K+ DFG+ARI   
Sbjct: 120 --------QTL----RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII-- 162

Query: 270 NELQANTSRIVGTYGYMSPEY-------ALEGIFSIKS-----DVFSFGVLLLEIVSGK 316
           +E  A+ S   G    M  E+       A E + +        DV+S G +L E+   +
Sbjct: 163 DESAADNSEPTGQQSGMV-EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 44/223 (19%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGRS---EQGLREMK-----NEASVIAKVQ--H 170
           KLG G F  V+    +     +A+K + G     E    E+K     N+A    +     
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 171 KNLVRLLGC-----------CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQI 219
            ++++LL              +       ++E +    L        + I L +V +  I
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVM-------VFEVLGENLLALIKKYEHRGIPLIYVKQ--I 136

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP------KISDFGMARICGGNELQ 273
            + +  GL Y+H   R  IIH D+K  N+L++   +P      KI+D G A  C  +E  
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE-- 190

Query: 274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
            + +  + T  Y SPE  L   +   +D++S   L+ E+++G 
Sbjct: 191 -HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 34/158 (21%), Positives = 63/158 (39%), Gaps = 30/158 (18%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGC 179
            LG G  G V +   ++  ++ A+K L         + + E  +  +  Q  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79

Query: 180 CIDKDEKI----LIYEYMPNKSLDFFLFDPTKRILLDWVTR------VQIIEGIAQGLLY 229
             +         ++ E +    L    F    RI              +I++ I + + Y
Sbjct: 80  YENLYAGRKCLLIVMECLDGGEL----FS---RIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 230 LHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMA 264
           LH    + I HRD+K  N+L      +   K++DFG A
Sbjct: 133 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 49/226 (21%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSG---------RSEQGLREMKNEAS 163
              + + + +G G +G V      K G  +AVK+LS          R+    RE++    
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELR---- 80

Query: 164 VIAKVQHKNLVRLL-----GCCIDKDEKI-LIYEYMPN------KSLDFFLFDPTKRILL 211
           ++  ++H+N++ LL        +++   + L+   M        K     L D   + L+
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLI 138

Query: 212 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
                 QI+    +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 139 -----YQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 181

Query: 272 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 316
                +  V T  Y +PE  L    ++   D++S G ++ E+++G+
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 17/201 (8%)

Query: 123 LGEGGFGPVYKGVLRKGDEI-AVKRLS-----GRSEQGLREMKNEASVIAK-VQHKNLVR 175
           +G+G FG V     +  +   AVK L       + E+  + + +E +V+ K V+H  LV 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEE--KHIMSERNVLLKNVKHPFLVG 103

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           L       D+   + +Y+    L F+     +  L     R    E IA  L YLH  + 
Sbjct: 104 LHFSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPR-ARFYAAE-IASALGYLHSLN- 159

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
             I++RDLK  NILLD   +  ++DFG+ +    +    +T    GT  Y++PE   +  
Sbjct: 160 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEVLHKQP 215

Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           +    D +  G +L E++ G 
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGL 236

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 38/204 (18%), Positives = 74/204 (36%), Gaps = 51/204 (25%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQG------LREMKNEASVIAKVQ 169
           +   + +G G +G VY    +     +A+K+++   E        LRE+     ++ +++
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILNRLK 83

Query: 170 HKNLVRLLGCCIDKDEKI-----LIYEYMP---------NKSLD-----FFLFDPTKRIL 210
              ++RL    I  D        ++ E               L        L+       
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY------- 136

Query: 211 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 270
                   ++     G  ++H+     IIHRDLK +N LL++D + K+ DFG+AR     
Sbjct: 137 -------NLL----LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182

Query: 271 ELQANTSRIVGTYGYMSPEYALEG 294
           +     + +            L+ 
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKK 206

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 54/230 (23%), Positives = 102/230 (44%), Gaps = 57/230 (24%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSG------RSEQGLREMKNEASVIA 166
              + D   +G G +G V   V  + G ++A+K+L         +++  RE++    ++ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79

Query: 167 KVQHKNLVRLL------GCCIDKDEKILIYEYMP--------NKSLD-----FFLFDPTK 207
            ++H+N++ LL          D  +  L+  +M         ++ L      F ++    
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY---- 135

Query: 208 RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC 267
                     Q++    +GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR  
Sbjct: 136 ----------QML----KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ- 177

Query: 268 GGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 316
                 +  +  V T  Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 178 ----ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 57/248 (22%), Positives = 99/248 (39%), Gaps = 78/248 (31%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSG------------RSEQGLREMKNEAS 163
           +    KLG+G +G V+K + R+ G+ +AVK++              R    L E+     
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG--- 67

Query: 164 VIAKVQHKNLVRLLGCCI-DKDEKI-LIYEYMP--------NKSLD-----FFLFDPTKR 208
                 H+N+V LL     D D  + L+++YM            L+     + ++     
Sbjct: 68  ------HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY----- 116

Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 268
                    Q+I    + + YLH      ++HRD+K SNILL+ + + K++DFG++R   
Sbjct: 117 ---------QLI----KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160

Query: 269 GNELQANTSRIVGTYGYMSP--------EY-------ALEGIFSIKS-----DVFSFGVL 308
                 N   +       +         +Y       A E +          D++S G +
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220

Query: 309 LLEIVSGK 316
           L EI+ GK
Sbjct: 221 LGEILCGK 228

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 34/149 (22%), Positives = 72/149 (48%), Gaps = 13/149 (8%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV-RLLGC 179
           K+G G FG +Y G  ++  +E+A+K  + +++    ++  E+ +   +Q    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
            ++ D  +L+ + +   SL+  LF+   R  L   T + + + +   + ++H  S    +
Sbjct: 72  GVEGDYNVLVMDLL-GPSLE-DLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS---FL 125

Query: 240 HRDLKASNILLDKDMNPK---ISDFGMAR 265
           HRD+K  N L+          I DFG+A+
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 47/218 (21%), Positives = 95/218 (43%), Gaps = 30/218 (13%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQH- 170
            + +   + +G+G FG V K     + + +A+K +  ++++      + E  ++  +   
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEVRLLELMNKH 110

Query: 171 -----KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-----ILLDWVTRVQII 220
                  +V L    + ++   L++E      L + L+D  +      + L+   +    
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRK--FA 163

Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSR 278
           + +   LL+L     + IIH DLK  NILL        KI DFG +  C   +      +
Sbjct: 164 QQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQ---RIYQ 217

Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
            + +  Y SPE  L   + +  D++S G +L+E+ +G+
Sbjct: 218 YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 36/149 (24%), Positives = 70/149 (46%), Gaps = 13/149 (8%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV-RLLGC 179
           K+G G FG +Y G  +  G+E+A+K    +++    ++  E+ +   +Q    +  +  C
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
             + D  +++ E +   SL+  LF+   R      T + + + +   + Y+H  +    I
Sbjct: 74  GAEGDYNVMVMELL-GPSLE-DLFNFCSRK-FSLKTVLLLADQMISRIEYIHSKN---FI 127

Query: 240 HRDLKASNILLDKDMNPK---ISDFGMAR 265
           HRD+K  N L+          I DFG+A+
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 35/154 (22%), Positives = 64/154 (41%), Gaps = 21/154 (13%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQH-KNLVRLLGC 179
           K+G G FG +  G  L   + +A+K    +S     ++  E     ++     + ++   
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRIL-LDWVTRV--QIIEGIAQGLLYLHQYSRV 236
                   ++ E +   SL+  LFD   R   L  V  +  Q+I  +     Y+H  +  
Sbjct: 74  GPCGKYNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLISRME----YVHSKN-- 125

Query: 237 RIIHRDLKASNILLDKDMNPK-----ISDFGMAR 265
            +I+RD+K  N L+ +  N       I DF +A+
Sbjct: 126 -LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 41/211 (19%), Positives = 86/211 (40%), Gaps = 28/211 (13%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV-RLLGC 179
           ++GEG FG +++G  L    ++A+K    RS+    ++++E      +     +  +   
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRIL-LDWVTRV--QIIEGIAQGLLYLHQYSRV 236
             +    +L+ + +   SL+  L D   R   +  V     Q++  +      +H+ S  
Sbjct: 75  GQEGLHNVLVIDLLG-PSLED-LLDLCGRKFSVKTVAMAAKQMLARVQ----SIHEKS-- 126

Query: 237 RIIHRDLKASNILLDKDMNPK-----ISDFGMARI-----CGGNELQANTSRIVGTYGYM 286
            +++RD+K  N L+ +  +       + DFGM +         +        + GT  YM
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185

Query: 287 SPEYALEGIF-SIKSDVFSFGVLLLEIVSGK 316
           S      G   S + D+ + G + +  + G 
Sbjct: 186 SI-NTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 34/210 (16%)

Query: 123 LGEGGFGPVYKGV-LRKGDEIAVKRLSGRS---EQGLREMK-----NEASVIAKVQHKNL 173
           +G+G FG V K    +    +A+K +        Q   E++      +     K    N+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD---KDNTMNV 161

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-----ILLDWVTRVQIIEGIAQGLL 228
           + +L     ++   + +E      L   L++  K+       L  V +      I Q L 
Sbjct: 162 IHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLD 214

Query: 229 YLHQYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYM 286
            LH+    RIIH DLK  NILL +      K+ DFG +  C  ++        + +  Y 
Sbjct: 215 ALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQ---RVYTYIQSRFYR 266

Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +PE  L   + +  D++S G +L E+++G 
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 51/266 (19%), Positives = 96/266 (36%), Gaps = 90/266 (33%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREM-KNEASVIAKVQ--------HK 171
           KLG G F  V+    ++    +A+K +  +S +   E   +E  ++  V+         +
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 172 NLVRLLGC-----------CIDKDEKILIYEYMPNKSLDFFLFD-PTKRILLDWVTRVQI 219
            +V+LL             C       +++E +    L  ++     + + L  V   +I
Sbjct: 102 MVVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWIIKSNYQGLPLPCVK--KI 151

Query: 220 IEGIAQGLLYLHQYSRVRIIHRDLKASNILL----------------------------- 250
           I+ + QGL YLH  ++ RIIH D+K  NILL                             
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209

Query: 251 --------------------DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                                + +  KI+D G A       +  + +  + T  Y S E 
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW-----VHKHFTEDIQTRQYRSLEV 264

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGK 316
            +   ++  +D++S   +  E+ +G 
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGD 290

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 46/226 (20%), Positives = 89/226 (39%), Gaps = 40/226 (17%)

Query: 122 KLGEGGFGPVYKGVLRKGDEI------AVKRLSGRSEQGLREMK-----NEASVIAKVQH 170
            +G+GGFG +Y   +   + +       VK     +     E+K      +   I K   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 171 KNLVRLLG----------CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--Q 218
              ++ LG              K  + +I +      L        KR     V ++  +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLR 160

Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI--SDFGMA-RICGGNELQAN 275
           I++ +     Y+H++     +H D+KASN+LL+     ++   D+G+A R C     +A 
Sbjct: 161 ILDILE----YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213

Query: 276 TSR----IVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGK 316
            +       GT  + S + A  G+  S + D+   G  +++ ++G 
Sbjct: 214 AADPKRCHDGTIEFTSID-AHNGVAPSRRGDLEILGYCMIQWLTGH 258

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 31/167 (18%), Positives = 65/167 (38%), Gaps = 32/167 (19%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIA---VKRLSGRSEQGLREMK-----NEASVIAKVQHKN 172
           K+G GGFG +Y      K ++ A   VK     +     E+K      +   I K   + 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 173 LVRLLG----------CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRV--QII 220
            +  LG              +  + ++ E +    L   +           V ++  +++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKKSTVLQLGIRML 161

Query: 221 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI--SDFGMAR 265
           + +     Y+H+      +H D+KA+N+LL      ++  +D+G++ 
Sbjct: 162 DVLE----YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 23/171 (13%), Positives = 56/171 (32%), Gaps = 35/171 (20%)

Query: 121 NKLGEGGFGPVYKGV---------LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHK 171
           +       G +Y+             +  + ++K L  +  +   E          +Q  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 172 NLVRLLGC---CI---------DKDEKILIYEYMPNKSL-DFFLFDPTKRILLDWVTRV- 217
              +L       I             + L+   +  +SL       P   +    V +V 
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA 165

Query: 218 -QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI--SDFGMAR 265
            ++++ +     +LH+      +H ++ A NI +D +   ++  + +G A 
Sbjct: 166 CRLLDALE----FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.3 bits (127), Expect = 1e-07
 Identities = 51/403 (12%), Positives = 118/403 (29%), Gaps = 86/403 (21%)

Query: 48  LIFFCVRRKPGSRDKR--EDLMTFDLD-LNLKANNVNIELPLNSKLIERSKKKEVDQLPL 104
            +F+ +  K     ++  E+++  +   L         +  + +++    + +  +   +
Sbjct: 66  RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125

Query: 105 FSFSSVSTATNTFSDTNKL------------GEGGFGPVYKGVLRKGDEIAVKRLSGRSE 152
           F+  +VS           L            G  G G   K  +      A+      S 
Sbjct: 126 FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWV------ALDVC--LSY 174

Query: 153 QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI-----LIYEYMPNKSLDFFLFDPTK 207
           +   +M  +   +           L  C   +  +     L+Y+  PN +      D + 
Sbjct: 175 KVQCKMDFKIFWLN----------LKNCNSPETVLEMLQKLLYQIDPNWTS---RSDHSS 221

Query: 208 RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI----SDFGM 263
            I L    R+  I+   + LL    Y    ++  +++ +      +++ KI        +
Sbjct: 222 NIKL----RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277

Query: 264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFS---------IKSDVFSFGVLLLEIVS 314
                          +      ++P+     +           +  +V +     L I++
Sbjct: 278 TDFLSAATTTH--ISLDHHSMTLTPDEVKS-LLLKYLDCRPQDLPREVLTTNPRRLSIIA 334

Query: 315 GKKNTGLYRTDSLNLLGYVWDLW----------TSNRTLELIDDPVLEDEYSSKQVLLRY 364
                GL            WD W              +L +++       +    V    
Sbjct: 335 ESIRDGLAT----------WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPS 384

Query: 365 VNI--ALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFS 405
            +I   LL +      +  +  VV+ L   +     PK+   S
Sbjct: 385 AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 56/236 (23%), Positives = 91/236 (38%), Gaps = 62/236 (26%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQH-----KNLV 174
           K+G+G FG V     +      AVK +  R+ +      K EA ++ K+Q+      N+V
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 175 RLLGC-------CI--DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           +  G        C+  +     L YE +     ++  F   + I      +      I +
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGPSL-YEII--TRNNYNGF-HIEDI------K-LYCIEILK 148

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNP-------------------------KISD 260
            L YL    ++ + H DLK  NILLD                              K+ D
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 261 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           FG A     ++       I+ T  Y +PE  L   + + SD++SFG +L E+ +G 
Sbjct: 206 FGCA--TFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 55/230 (23%), Positives = 86/230 (37%), Gaps = 54/230 (23%)

Query: 122 KLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHK------N 172
            LGEG FG V + +   R   ++A+K +  R+    RE  + E +V+ K++ K       
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARLEINVLKKIKEKDKENKFL 83

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-----ILLDWVTRV--QIIEGIAQ 225
            V +           + +E      L    F+  K        L  V  +  Q+      
Sbjct: 84  CVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA--- 135

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNP-------------------KISDFGMARI 266
            L +LH     ++ H DLK  NIL                          +++DFG A  
Sbjct: 136 -LRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189

Query: 267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
              +E   + + IV T  Y  PE  LE  ++   DV+S G +L E   G 
Sbjct: 190 TFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 54/230 (23%), Positives = 88/230 (38%), Gaps = 54/230 (23%)

Query: 122 KLGEGGFGPVYKGV--LRKGDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHK------N 172
            LGEG FG V + +     G  +AVK +  ++     E  ++E  V+  +          
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-----ILLDWVTRV--QIIEGIAQ 225
            V++L          +++E      L    +D  K        LD + ++  QI + +  
Sbjct: 79  CVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN- 132

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNP-------------------KISDFGMARI 266
              +LH     ++ H DLK  NIL  +                       K+ DFG A  
Sbjct: 133 ---FLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-- 184

Query: 267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
              +E   + S +V T  Y +PE  L   +S   DV+S G +L+E   G 
Sbjct: 185 TYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	436
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.7
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.16
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.77
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.71
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.6
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.58
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.43
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.42
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.16
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.16
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.13
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.94
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.78
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.73
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.59
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.52
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.48
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.45
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.43
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.38
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.22
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.17
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.87
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.78
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.66
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.62
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	95.37
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	95.22
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.21
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.27
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	86.8
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.87
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.94
1iij_A	35	ERBB-2 receptor protein-tyrosine kinase; alpha-hel	82.96
2klu_A	70	T-cell surface glycoprotein CD4; cell membrane, di	82.63
1afo_A	40	Glycophorin A; integral membrane protein, transmem	82.42

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7e-59  Score=439.63  Aligned_cols=263  Identities=28%  Similarity=0.428  Sum_probs=217.3

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .++|.+.+.||+|+||+||+|++.      ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            456788899999999999999864      36789999998877777889999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCC----------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeE
Q 040532          188 LIYEYMPNKSLDFFLFDPT----------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  257 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~k  257 (436)
                      +|||||++|+|.+++....          ....+++..+..++.|+++||+|||+++   |+||||||+|||+++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence            9999999999999996432          2346999999999999999999999988   99999999999999999999


Q ss_pred             EeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHH
Q 040532          258 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      |+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.....     .+.....
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~~~~i  243 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVIECI  243 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHH
Confidence            999999987654444334444579999999999999999999999999999999999 8999854321     1122222


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                       .......      .+.     .++..+.+++.+||+.||++|||++||.+.|+++.+..
T Consensus       244 -~~~~~~~------~p~-----~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          244 -TQGRVLQ------RPR-----TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             -HHTCCCC------CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             -HcCCCCC------CCc-----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence             2221111      111     14557899999999999999999999999999987654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-57  Score=436.59  Aligned_cols=262  Identities=29%  Similarity=0.406  Sum_probs=209.7

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .++|.+.++||+|+||+||+|+++      ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            456777889999999999999864      36789999998877777889999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCc------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC
Q 040532          188 LIYEYMPNKSLDFFLFDPTK------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  255 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~  255 (436)
                      +|||||++|+|.+++.....            ..++++.+++.++.|+++||+|||+.+   |+||||||+||||++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence            99999999999999865421            246899999999999999999999988   999999999999999999


Q ss_pred             eEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHH
Q 040532          256 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVW  334 (436)
Q Consensus       256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  334 (436)
                      +||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.....     .+...
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~~~  271 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TEAID  271 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----HHHHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence            99999999987655444444455689999999999999999999999999999999999 8999854321     11111


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      .. ......      ..+.     .++..+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus       272 ~i-~~g~~~------~~p~-----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 CI-TQGREL------ERPR-----ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HH-HHTCCC------CCCT-----TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HH-HcCCCC------CCcc-----cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            11 111111      1111     1445789999999999999999999999999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.5e-57  Score=425.63  Aligned_cols=267  Identities=26%  Similarity=0.426  Sum_probs=208.7

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      +...+++++.+.||+|+||+||+|+++  ..||||+++..  +....+.|.+|+.+|++++|||||++++++.+ +..++
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            445577888999999999999999976  35999998743  45567889999999999999999999998864 57899


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      |||||++|+|.+++....  ..+++..+..++.|+|+||+|||+++   |+||||||+||||++++++||+|||+|+...
T Consensus       109 VmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            999999999999996543  34899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCccchhhhcc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ...........+||+.|||||++.+   +.|+.++|||||||++|||+||+.||.....     ...+.........   
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-----~~~~~~~~~~~~~---  255 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-----RDQIIFMVGRGYA---  255 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHTTCC---
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhcCCC---
Confidence            4333333445689999999999974   4589999999999999999999999854321     1111222111110   


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCC
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALH  397 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~  397 (436)
                        .+......  ..++..+.+++.+||+.||++||||.||++.|+.+...++
T Consensus       256 --~p~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          256 --SPDLSKLY--KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             --CCCSTTSC--TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             --CCCccccc--ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence              11111111  1145678999999999999999999999999998876554

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1e-57  Score=433.51  Aligned_cols=257  Identities=29%  Similarity=0.423  Sum_probs=210.4

Q ss_pred             CCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ++++.+.||+|+||+||+|.+.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4566789999999999999863      36789999997543 3345789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC
Q 040532          189 IYEYMPNKSLDFFLFDPT-------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  255 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~  255 (436)
                      |||||++|+|.++|....             ....+++..+..++.|+|+||+|||+++   |+||||||+||||+++++
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence            999999999999996432             1346899999999999999999999998   999999999999999999


Q ss_pred             eEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHH
Q 040532          256 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVW  334 (436)
Q Consensus       256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  334 (436)
                      +||+|||+++.....+.........||+.|||||++.++.|+.++|||||||++|||+| |+.||.....     .+...
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-----~~~~~  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDVVE  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----HHHHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence            99999999987654444444455689999999999999999999999999999999999 8999854321     11222


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                       .........      .+     ..++..+.+++.+||+.||++||||.||++.|+..
T Consensus       259 -~i~~~~~~~------~p-----~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          259 -MIRNRQVLP------CP-----DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -HHHTTCCCC------CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -HHHcCCCCC------Cc-----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence             222221111      11     11456789999999999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-55  Score=421.52  Aligned_cols=265  Identities=20%  Similarity=0.218  Sum_probs=211.4

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .+.|+..+.||+|+||+||+|++.. |+.||||+++....     ..+|+.+|++++|||||++++++.+++..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            3567788899999999999999754 89999999975422     24799999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC-CeEEeeccCceecCCCC
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICGGNE  271 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~  271 (436)
                      |++|+|.+++...   ..+++.....++.|++.||+|||+++   |+||||||+||||+.++ ++||+|||+|+......
T Consensus       132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999543   35899999999999999999999998   99999999999999987 69999999999775432


Q ss_pred             cc---cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          272 LQ---ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       272 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ..   ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.......  +.   ...........    
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~---~~i~~~~~~~~----  276 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LC---LKIASEPPPIR----  276 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CH---HHHHHSCCGGG----
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HH---HHHHcCCCCch----
Confidence            21   12234579999999999999999999999999999999999999996433221  11   11111111000    


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCCCc
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAF  404 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~~~  404 (436)
                       ..+     ..++..+.+++.+||+.||++|||+.|+++.|.........-+.|-.
T Consensus       277 -~~~-----~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~  326 (336)
T 4g3f_A          277 -EIP-----PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK  326 (336)
T ss_dssp             -GSC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred             -hcC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence             011     11456788999999999999999999999999888876655444433

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-55  Score=423.50  Aligned_cols=250  Identities=24%  Similarity=0.341  Sum_probs=206.5

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ...|+..+.||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            467999999999999999999976 4899999999754444446688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      |++|+|.+++..    ..+++.....++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+...... 
T Consensus       153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  224 (346)
T 4fih_A          153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  224 (346)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred             CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence            999999999853    24899999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||....     ........ .....      +...
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i-~~~~~------~~~~  291 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----PLKAMKMI-RDNLP------PRLK  291 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHH-HHSSC------CCCS
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHH-HcCCC------CCCC
Confidence             22344689999999999999999999999999999999999999985321     11111111 11100      0011


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .   ....+..+.+|+.+||+.||++|||++|+++
T Consensus       292 ~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 N---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             C---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0   1114557889999999999999999999876

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.3e-55  Score=423.38  Aligned_cols=250  Identities=23%  Similarity=0.356  Sum_probs=202.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...  .....+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999975 4899999999754  44556789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      ||++|+|.+++... +...+++.....++.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+......
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999998543 2345788999999999999999999998   9999999999999999999999999998654221


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                        ......+||+.|||||++.+..|+.++|||||||++|||+||+.||....     ..+..........       +..
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~~~-------~~~  245 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLKIISGSF-------PPV  245 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTCC-------CCC
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHcCCC-------CCC
Confidence              12234579999999999999999999999999999999999999995422     2222223222211       011


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..     ..+..+.+|+.+||+.||++|||++|+++
T Consensus       246 ~~-----~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 SL-----HYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             Cc-----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11     13457889999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.6e-55  Score=422.43  Aligned_cols=269  Identities=27%  Similarity=0.364  Sum_probs=218.9

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCC-CceeEEeeE
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQH-KNLVRLLGC  179 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~l~~~  179 (436)
                      ..++...++|++.+.||+|+||+||+|.+..      ++.||||++... .....+.|.+|+.+|.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            3455667889999999999999999998653      357999999765 34456789999999999965 899999999


Q ss_pred             EEeC-CccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCC
Q 040532          180 CIDK-DEKILIYEYMPNKSLDFFLFDPTK-------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKA  245 (436)
Q Consensus       180 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp  245 (436)
                      |.+. +..++|||||++|+|.++|....+             ...+++..+..++.|||+||+|||+++   |+||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence            9765 568999999999999999964321             345899999999999999999999998   99999999


Q ss_pred             CCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 040532          246 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRT  324 (436)
Q Consensus       246 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~  324 (436)
                      +|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987765444444455689999999999999999999999999999999998 8999864332


Q ss_pred             CCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          325 DSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      .     ..+......+....      .+..     ++.++.+++.+||+.||++|||+.||++.|++++++
T Consensus       294 ~-----~~~~~~i~~g~~~~------~p~~-----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          294 D-----EEFCRRLKEGTRMR------APDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             S-----HHHHHHHHHTCCCC------CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H-----HHHHHHHHcCCCCC------CCcc-----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            1     11222222221111      1111     345788999999999999999999999999998764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.9e-56  Score=418.19  Aligned_cols=248  Identities=25%  Similarity=0.306  Sum_probs=207.8

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||+|++. +|+.||+|++...   .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            56999999999999999999975 4899999999643   2233567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      |||++|+|.+++...   ..+++.....++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999999999999543   34899999999999999999999998   999999999999999999999999999987654


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      .........+||+.|||||++.+..|+.++||||+||++|||+||+.||...+     ............        ..
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~~~--------~~  252 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EGLIFAKIIKLE--------YD  252 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTC--------CC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCC--------CC
Confidence            44444556789999999999999999999999999999999999999995422     112222222211        11


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV  386 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~  386 (436)
                      .+..     .+.++.+|+.+||+.||++|||++|++
T Consensus       253 ~p~~-----~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          253 FPEK-----FFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCTT-----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCcc-----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            1111     344688999999999999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.8e-54  Score=409.40  Aligned_cols=270  Identities=24%  Similarity=0.320  Sum_probs=203.7

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC----ccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----EKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  190 (436)
                      ++|.+.+.||+|+||+||+|+++ |+.||||++....... ..+..|+..+.+++|||||+++++|.+.+    ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            45677789999999999999985 8999999996543221 22345666667889999999999998764    468999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY-----SRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      |||++|+|.+++...    .+++..+.+++.|+++||+|||++     +.++|+||||||+||||++++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            999999999999542    489999999999999999999986     23459999999999999999999999999998


Q ss_pred             ecCCCCc--ccccccccccCCccchhhhccC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcch--------
Q 040532          266 ICGGNEL--QANTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL--------  329 (436)
Q Consensus       266 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~--------  329 (436)
                      .......  .......+||+.|||||++.+.      .++.++|||||||++|||+||+.|++.........        
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            7654322  1223345799999999999764      36789999999999999999998875433221111        


Q ss_pred             -hHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          330 -LGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       330 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                       ............     ..+..+......+.+..+.+++.+||+.||++||||.||++.|+++.++
T Consensus       237 ~~~~~~~~~~~~~-----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          237 SVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHhccc-----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence             111111111111     1122233333334667899999999999999999999999999987653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-54  Score=424.92  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=207.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .+.|+..+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+..|+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            467999999999999999999976 4899999999765544556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      |++|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+|+.+.... 
T Consensus       230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            999999999853    23899999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||....     .......... ...      +...
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~-~~~------~~~~  368 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----PLKAMKMIRD-NLP------PRLK  368 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHH-SCC------CCCS
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHc-CCC------CCCc
Confidence             22344689999999999999999999999999999999999999985321     1111111111 110      0000


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .   ....+..+.+|+.+||+.||++|||+.|+++
T Consensus       369 ~---~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 N---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             C---TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0   0113457889999999999999999999876

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1e-53  Score=401.65  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=196.2

Q ss_pred             CCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe----CCccEEEE
Q 040532          118 SDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIY  190 (436)
Q Consensus       118 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  190 (436)
                      +..+.||+|+||+||+|.+.. +..||+|++...  .....+.|.+|+.+|++++|||||+++++|.+    .+..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            566789999999999999764 889999998643  45556789999999999999999999999875    24579999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-CCCCeEEeeccCceecCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGG  269 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-~~~~~kl~DfGla~~~~~  269 (436)
                      |||++|+|.+++..   ...+++..+..++.|++.||+|||+++ ++|+||||||+||||+ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999954   335899999999999999999999875 3599999999999998 479999999999976432


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      .    .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||....    +... +.........     ..
T Consensus       185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~----~~~~-~~~~i~~~~~-----~~  249 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQ-IYRRVTSGVK-----PA  249 (290)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHH-HHHHHTTTCC-----CG
T ss_pred             C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC----cHHH-HHHHHHcCCC-----CC
Confidence            2    2334589999999998864 69999999999999999999999985322    1111 1122121111     11


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .....     .+.++.+++.+||+.||++|||++|+++
T Consensus       250 ~~~~~-----~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 SFDKV-----AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGC-----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCcc-----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111     2346889999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.7e-54  Score=401.22  Aligned_cols=245  Identities=22%  Similarity=0.336  Sum_probs=189.5

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|++....   ......+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999975 48999999996542   233567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+ +|+|.+++...   ..+++.....++.|++.||+|||+++   |+||||||+|||+++++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 67888887543   34899999999999999999999998   999999999999999999999999999875432


Q ss_pred             CcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      .   .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||....     ............        .
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~i~~~~--------~  229 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKNISNGV--------Y  229 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTC--------C
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCC--------C
Confidence            2   2234589999999999998876 579999999999999999999995321     122222221111        1


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..+..     .+..+.+++.+||+.||++|||++|+++
T Consensus       230 ~~p~~-----~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 TLPKF-----LSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCCTT-----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCC-----CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11111     3456889999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.8e-54  Score=406.59  Aligned_cols=247  Identities=22%  Similarity=0.272  Sum_probs=194.8

Q ss_pred             cCCCCCcccCCCCceeEEEEEec----CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ++|++.+.||+|+||+||+|+..    .++.||+|+++...  ......+.+|+.+|++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999853    36789999996532  2223467889999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      |||||++|+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999999543   35899999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ...  ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+     ..+.........        
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~~--------  242 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-----RKETMTMILKAK--------  242 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCC--------
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-----HHHHHHHHHcCC--------
Confidence            322  22334589999999999999999999999999999999999999995422     112222222111        


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTM-----NDVVS  387 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~ev~~  387 (436)
                      ...+..     .+.++.+++.+||+.||++|||+     +|+++
T Consensus       243 ~~~p~~-----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 LGMPQF-----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CCCCTT-----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CCCCCc-----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            111111     34568899999999999999984     56653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-52  Score=397.78  Aligned_cols=251  Identities=24%  Similarity=0.350  Sum_probs=189.7

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc-------
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-------  185 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-------  185 (436)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45888999999999999999975 4889999998644 44455778999999999999999999999876543       


Q ss_pred             -----cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEee
Q 040532          186 -----KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  260 (436)
Q Consensus       186 -----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~D  260 (436)
                           .|+|||||++|+|.+++.........++...+.++.|++.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                 5899999999999999976554445677778899999999999999998   99999999999999999999999


Q ss_pred             ccCceecCCCCcc----------cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 040532          261 FGMARICGGNELQ----------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL  330 (436)
Q Consensus       261 fGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~  330 (436)
                      ||+|+........          ......+||+.|||||++.+..|+.++|||||||++|||++   ||...    .+..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~----~~~~  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ----MERV  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH----HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc----cHHH
Confidence            9999876543211          11233579999999999999999999999999999999996   65321    1111


Q ss_pred             HHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          331 GYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...... ...         ..+..  .........+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~-~~~---------~~p~~--~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 RTLTDV-RNL---------KFPPL--FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHH-HTT---------CCCHH--HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHH-hcC---------CCCCC--CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111 111         11111  1123445678999999999999999999976

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-48  Score=374.05  Aligned_cols=287  Identities=34%  Similarity=0.611  Sum_probs=237.3

Q ss_pred             cccchhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          105 FSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ++..++...+++|+..+.||+|+||+||+|.+++|+.||+|++........+.+.+|+.++++++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            44556777889999999999999999999998889999999998776666788999999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTK-RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      ..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999865432 335899999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC-CcchhHHHHHHhhcCCc
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~  342 (436)
                      +................||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ......|..........
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            98754433333334456899999999999999999999999999999999999998754432 23444554444444443


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                      ...++......  .....+..+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       266 ~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          266 EQIVDPNLADK--IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             CSSSSSSCTTC--SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHhcChhhccc--cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            33333322221  22347788999999999999999999999999999887543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=388.26  Aligned_cols=264  Identities=19%  Similarity=0.279  Sum_probs=201.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe------C
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCID------K  183 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~  183 (436)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||++...  .....+.+.+|+.+|++++|||||++++++..      .
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            3468999999999999999999975 5899999999754  34445678899999999999999999998764      3


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      +..|+|||||+ |+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence            56799999996 6788888543   35899999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCC--cccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          264 ARICGGNE--LQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       264 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      |+.+....  ........+||+.|||||++.+. .++.++||||+||++|||++|+.||...+  ..+....+.......
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--YVHQLQLIMMVLGTP  282 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHHHHHCCC
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhcCCC
Confidence            98764322  12233456899999999998875 46999999999999999999999995432  112222222211111


Q ss_pred             Ccc--eecc---------------CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 RTL--ELID---------------DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ~~~--~~~~---------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...  ....               ...+....  ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVY--PGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHS--TTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhC--CCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            100  0000               00000000  013456889999999999999999999876

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.8e-49  Score=384.19  Aligned_cols=200  Identities=25%  Similarity=0.393  Sum_probs=171.3

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec----CCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCc
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  185 (436)
                      ....+.|++.+.||+|+||+||+|+.+    .++.||+|++.....  ...+.+|+++|..+ +||||+++++++.+.+.
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            345688999999999999999999853    367899999876533  35678999999998 69999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC-CCeEEeeccCc
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMA  264 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~-~~~kl~DfGla  264 (436)
                      .|+||||+++|+|.+++.      .+++.....++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||+|
T Consensus        95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            999999999999999883      2789999999999999999999998   9999999999999976 79999999999


Q ss_pred             eecCCCCcc--------------------------cccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCC
Q 040532          265 RICGGNELQ--------------------------ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKK  317 (436)
Q Consensus       265 ~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~  317 (436)
                      +........                          ......+||+.|+|||++.+. .|+.++||||+||++|||+||+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            865432211                          012234799999999999876 48999999999999999999999


Q ss_pred             CCCC
Q 040532          318 NTGL  321 (436)
Q Consensus       318 p~~~  321 (436)
                      ||..
T Consensus       246 Pf~~  249 (361)
T 4f9c_A          246 PFYK  249 (361)
T ss_dssp             SSSC
T ss_pred             CCCC
Confidence            9843

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2e-48  Score=400.18  Aligned_cols=252  Identities=22%  Similarity=0.318  Sum_probs=208.8

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .++|++.+.||+|+||+||+|.++ +|+.||+|++........+.+.+|+.+|++++|||||++++++.+.+..|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999976 4899999999877777778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC--CCeEEeeccCceecCCC
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD--MNPKISDFGMARICGGN  270 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~--~~~kl~DfGla~~~~~~  270 (436)
                      |++|+|.+++....  ..+++.....++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999999885432  34889999999999999999999998   9999999999999854  89999999999987543


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      ..   ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.....     .............   +....
T Consensus       311 ~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----~~~~~~i~~~~~~---~~~~~  379 (573)
T 3uto_A          311 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRNVKSCDWN---MDDSA  379 (573)
T ss_dssp             SE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHTTCCC---CCSGG
T ss_pred             Cc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHhCCCC---CCccc
Confidence            32   2335899999999999999999999999999999999999999854321     1111221111100   00000


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                          .  ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       380 ----~--~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          380 ----F--SGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ----G--TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----c--cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0  113456889999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.1e-48  Score=370.27  Aligned_cols=292  Identities=38%  Similarity=0.664  Sum_probs=235.2

Q ss_pred             cCCCCccccchhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCCh-hhHHHHHHHHHHHHHcCCCceeEEe
Q 040532           99 VDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE-QGLREMKNEASVIAKVQHKNLVRLL  177 (436)
Q Consensus        99 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~  177 (436)
                      ......++..++....++|+..+.||+|+||+||+|...+|+.||+|++..... .....+.+|+.++++++||||++++
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence            345567888899999999999999999999999999988899999999976432 2233688999999999999999999


Q ss_pred             eEEEeCCccEEEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCe
Q 040532          178 GCCIDKDEKILIYEYMPNKSLDFFLFDPT-KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  256 (436)
Q Consensus       178 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~  256 (436)
                      +++.+.+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+...++++||||||+|||+++++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            99999999999999999999999987643 34458999999999999999999999922239999999999999999999


Q ss_pred             EEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCC---CCCCcchhHHH
Q 040532          257 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY---RTDSLNLLGYV  333 (436)
Q Consensus       257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~---~~~~~~~~~~~  333 (436)
                      ||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...   .........|.
T Consensus       174 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            99999999876543322 223346999999999999999999999999999999999999999632   22333444554


Q ss_pred             HHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                      .............+..... .. ....+..+.+++.+||+.||++|||+.|+++.|++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQG-NY-KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTT-SC-CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HHHhhchhhhhhcChhhcc-cc-CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            4444444333333322222 22 2346788999999999999999999999999998743

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.4e-48  Score=394.59  Aligned_cols=250  Identities=24%  Similarity=0.279  Sum_probs=198.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC------ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR------SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      .-++|++.+.||+|+||+||+|+... |+.||+|++.+.      ..........++.+++.++|||||+++++|.+.+.
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence            34679999999999999999999764 899999998632      12222233445666777799999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .|+|||||+||+|..++...   ..+++..+..++.||+.||+|||+++   |+||||||+||||+.+|++||+|||+|+
T Consensus       267 lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence            99999999999999999543   34899999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ......    ....+||+.|||||++.+ ..|+.++|+||+||++|||++|+.||.......  ............    
T Consensus       341 ~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~~i~~~~----  410 (689)
T 3v5w_A          341 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMA----  410 (689)
T ss_dssp             ECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHHHHHHCC----
T ss_pred             ecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhhcCCC----
Confidence            765432    234589999999999975 579999999999999999999999996433221  111111111111    


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT-----MNDVVS  387 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~  387 (436)
                          ...+..     .+..+.+|+.+||+.||++|++     ++|+.+
T Consensus       411 ----~~~p~~-----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 ----VELPDS-----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ----CCCCTT-----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ----CCCCcc-----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                111111     3456889999999999999998     577654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-46  Score=359.37  Aligned_cols=272  Identities=26%  Similarity=0.411  Sum_probs=209.0

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      ......++|++.+.||+|+||+||+|.+. |+.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            34456678999999999999999999875 889999999754  344567889999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||+++|+|.+++........+++..++.++.|++.||+|||+.+ ++++||||||+|||++.++.+||+|||+++.
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            999999999999999976554445899999999999999999999875 3499999999999999999999999999975


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....     ..............   
T Consensus       189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-----~~~~~~~~~~~~~~---  258 (309)
T 3p86_A          189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-----AQVVAAVGFKCKRL---  258 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-----HHHHHHHHHSCCCC---
T ss_pred             ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcCCCC---
Confidence            43322  122335789999999999999999999999999999999999999864321     11111111111111   


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCC
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPK  400 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~  400 (436)
                         ..+..     .+..+.+++.+||+.||++|||+.++++.|+.+.+...+|.
T Consensus       259 ---~~~~~-----~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          259 ---EIPRN-----LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             ---CCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred             ---CCCcc-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence               11111     34568899999999999999999999999999987655544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-45  Score=352.27  Aligned_cols=285  Identities=39%  Similarity=0.585  Sum_probs=226.6

Q ss_pred             CCccccchhhhhccCCCCC------cccCCCCceeEEEEEecCCCEEEEEEcCCC----ChhhHHHHHHHHHHHHHcCCC
Q 040532          102 LPLFSFSSVSTATNTFSDT------NKLGEGGFGPVYKGVLRKGDEIAVKRLSGR----SEQGLREMKNEASVIAKVQHK  171 (436)
Q Consensus       102 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~  171 (436)
                      .+.+++.++...+++|...      +.||+|+||+||+|..+ ++.||+|++...    .....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3456677777777777766      89999999999999975 889999998643    234467899999999999999


Q ss_pred             ceeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc
Q 040532          172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  251 (436)
Q Consensus       172 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~  251 (436)
                      ||+++++++.+.+..++||||+++++|.+++........+++..+..++.|++.||.|||+.+   ++||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence            999999999999999999999999999999876555567999999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 040532          252 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG  331 (436)
Q Consensus       252 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~  331 (436)
                      +++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|+.||....... ....
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~  245 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLD  245 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHH
Confidence            999999999999987654333333344578999999998764 58999999999999999999999987544322 1222


Q ss_pred             HHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          332 YVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      +.....................  .....+..+.+++.+||+.||++||++.++++.|+++.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCSC--CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHhhhhhhhhhhhccccccc--cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            2222222221111111111211  123367789999999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=359.35  Aligned_cols=265  Identities=26%  Similarity=0.410  Sum_probs=215.8

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            467888999999999999999975 4889999999877777788999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++........
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999998643  234899999999999999999999998   99999999999999999999999999987654322


Q ss_pred             cc------------ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          273 QA------------NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       273 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      ..            ......||+.|+|||++.+..++.++||||||+++|||++|..|+.....................
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY  243 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence            11            111357999999999999999999999999999999999999998654332211110000000000


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                                .+     ..++..+.+++.+||+.||++|||+.++++.|+++...+..
T Consensus       244 ----------~~-----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          244 ----------CP-----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             ----------CC-----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ----------CC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence                      00     01234578899999999999999999999999998876544

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.8e-46  Score=365.91  Aligned_cols=265  Identities=26%  Similarity=0.391  Sum_probs=215.7

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec--------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR--------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCC  180 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  180 (436)
                      ....++|++.+.||+|+||+||+|.+.        ++..||+|++... .....+.+.+|+.+++++ +||||+++++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            345678999999999999999999853        2457999999765 344567899999999999 899999999999


Q ss_pred             EeCCccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCC
Q 040532          181 IDKDEKILIYEYMPNKSLDFFLFDPTK-------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  247 (436)
Q Consensus       181 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~N  247 (436)
                      .+.+..++||||+++|+|.+++.....             ...+++..+..++.|++.||+|||+++   |+||||||+|
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N  233 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN  233 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence            999999999999999999999864321             234789999999999999999999998   9999999999


Q ss_pred             EEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 040532          248 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  326 (436)
Q Consensus       248 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~  326 (436)
                      ||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... 
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-  312 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-  312 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            9999999999999999987665443333444567889999999999999999999999999999999 99998643221 


Q ss_pred             cchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                       .+.    .........      ..+.     .++..+.+++.+||+.||++||++.|+++.|+.+...
T Consensus       313 -~~~----~~~~~~~~~------~~~~-----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          313 -ELF----KLLKEGHRM------DKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             -GHH----HHHHTTCCC------CCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHH----HHHhcCCCC------CCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence             111    111111110      0111     1345788999999999999999999999999998753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=367.42  Aligned_cols=284  Identities=26%  Similarity=0.355  Sum_probs=222.9

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEec--------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEe
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLR--------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLL  177 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~  177 (436)
                      .......++|++.+.||+|+||+||+|.+.        .+..||+|++... .......+.+|+.+++++ +||||++++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            334566788999999999999999999853        2357999999765 445567899999999999 999999999


Q ss_pred             eEEEeCCccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccC
Q 040532          178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTK-------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  244 (436)
Q Consensus       178 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dik  244 (436)
                      +++.+.+..++||||+++|+|.+++.....             ...+++..+..++.|++.||+|||+.+   |+|||||
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk  218 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA  218 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence            999999999999999999999999864321             235899999999999999999999998   9999999


Q ss_pred             CCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 040532          245 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYR  323 (436)
Q Consensus       245 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~  323 (436)
                      |+|||+++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987655443334444567889999999999999999999999999999999 999985432


Q ss_pred             CCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCCC
Q 040532          324 TDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA  403 (436)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~~  403 (436)
                      .     ... ...........      ....     ++..+.+++.+||+.||++|||+.|+++.|+.+.........+.
T Consensus       299 ~-----~~~-~~~~~~~~~~~------~~~~-----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~  361 (382)
T 3tt0_A          299 V-----EEL-FKLLKEGHRMD------KPSN-----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY  361 (382)
T ss_dssp             H-----HHH-HHHHHTTCCCC------CCSS-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred             H-----HHH-HHHHHcCCCCC------CCcc-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence            1     111 12212211111      0111     34568899999999999999999999999999998877776665


Q ss_pred             cccccCcc
Q 040532          404 FSNVRNTV  411 (436)
Q Consensus       404 ~~~~~~~~  411 (436)
                      +.......
T Consensus       362 ~~~~~~~~  369 (382)
T 3tt0_A          362 YHHHHHHD  369 (382)
T ss_dssp             --------
T ss_pred             CCcccccc
Confidence            54444433

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-46  Score=361.91  Aligned_cols=271  Identities=23%  Similarity=0.325  Sum_probs=213.2

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc----c
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE----K  186 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~  186 (436)
                      ....++|++.+.||+|+||+||+|++. ++.||||++..... .......|+.++++++||||+++++++.+...    .
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            345578999999999999999999987 89999999975433 33455678999999999999999999988554    5


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC----------CCCCeEecccCCCCEEEcCCCCe
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY----------SRVRIIHRDLKASNILLDKDMNP  256 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------~~~~i~H~Dikp~NIll~~~~~~  256 (436)
                      ++||||+++|+|.+++...    .+++..+..++.|++.||+|||+.          +   ++||||||+|||++.++.+
T Consensus        98 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCE
T ss_pred             EEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeE
Confidence            9999999999999999542    389999999999999999999988          6   9999999999999999999


Q ss_pred             EEeeccCceecCCCCcccccccccccCCccchhhhccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCc-chh
Q 040532          257 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NLL  330 (436)
Q Consensus       257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~  330 (436)
                      ||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||+||+.||........ ...
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            99999999877654443344446799999999999863     467789999999999999999999865432211 110


Q ss_pred             ---------HHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          331 ---------GYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       331 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                               ..........     ...+...........+..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHK-----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhccCCchhhhhhhhhcc-----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                     0011111111     11122222223334667799999999999999999999999999987653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.7e-46  Score=354.20  Aligned_cols=252  Identities=23%  Similarity=0.380  Sum_probs=206.9

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ...++|+..+.||+|+||+||+|.+. +|+.||+|++........+.+.+|+.++++++||||+++++++...+..++||
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            35678999999999999999999964 58899999987554444567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++...    .+++.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        97 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            999999999998542    4889999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      ..  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ............. .    ..
T Consensus       170 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~-~----~~  237 (297)
T 3fxz_A          170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGTP-E----LQ  237 (297)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHHCSC-C----CS
T ss_pred             cc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC-C----CC
Confidence            22  23345799999999999999999999999999999999999999854321     1111111111110 0    00


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..     ...+..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 NP-----EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CG-----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             Cc-----cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            01     113456889999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=355.45  Aligned_cols=264  Identities=27%  Similarity=0.403  Sum_probs=211.8

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec----CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      ...++|++.+.||+|+||+||+|.+.    .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            34578899999999999999999974    2456999999865 455567899999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999999996533  34899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCc-ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          267 CGGNEL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       267 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ...... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......     ...... ...... 
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~~~-~~~~~~-  273 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DVISSV-EEGYRL-  273 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHHH-HTTCCC-
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHH-HcCCCC-
Confidence            654322 112223356778999999999999999999999999999999 99998543211     111111 111000 


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCC
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALH  397 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~  397 (436)
                           ....     .++..+.+++.+||+.||++||++.++++.|+.+....+
T Consensus       274 -----~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          274 -----PAPM-----GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             -----CCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             -----CCCC-----CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence                 0011     134578899999999999999999999999999986543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.1e-46  Score=357.45  Aligned_cols=250  Identities=24%  Similarity=0.302  Sum_probs=206.1

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|++...  .....+.+.+|+.++++++||||+++++++...+..++
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            3457899999999999999999997 46899999998643  44556778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++|+|.+++...   ..+++.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++....
T Consensus        92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            99999999999988543   34889999999999999999999998   9999999999999999999999999997654


Q ss_pred             CCCcccccccccccCCccchhhhccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFS-IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ...   .....+||+.|+|||++.+..+. .++||||+||++|||++|+.||....     .............      
T Consensus       166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~------  231 (328)
T 3fe3_A          166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRERVLRGKY------  231 (328)
T ss_dssp             SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCC------
T ss_pred             CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC------
Confidence            332   23345799999999999988764 79999999999999999999985432     1111122211110      


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        ..+..     .+..+.+++.+||+.||.+|||++|+++.
T Consensus       232 --~~p~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 --RIPFY-----MSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             --CCCTT-----SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             --CCCCC-----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              11111     23467889999999999999999999863

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-45  Score=352.91  Aligned_cols=267  Identities=30%  Similarity=0.421  Sum_probs=217.3

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEE
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCI  181 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  181 (436)
                      ......++|.+.+.||+|+||.||+|.+.      ++..||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            34456788999999999999999999862      3578999999764 4555678999999999999999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCCc---------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPTK---------------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH  240 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H  240 (436)
                      +.+..++||||+++++|.+++.....                     ...+++..++.++.|++.||+|||+++   ++|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence            99999999999999999999864322                     234789999999999999999999998   999


Q ss_pred             cccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 040532          241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNT  319 (436)
Q Consensus       241 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~  319 (436)
                      |||||+||++++++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987755443333444567889999999999999999999999999999999 99998


Q ss_pred             CCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          320 GLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      ......  ...    .........      ....     ..+..+.+++.+||+.||++||++.|+++.|+++...
T Consensus       254 ~~~~~~--~~~----~~~~~~~~~------~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          254 PGIPPE--RLF----NLLKTGHRM------ERPD-----NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             TTCCGG--GHH----HHHHTTCCC------CCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCHH--HHH----HHhhcCCcC------CCCc-----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            543321  111    111111110      0111     1345788999999999999999999999999988753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.1e-46  Score=366.69  Aligned_cols=264  Identities=26%  Similarity=0.343  Sum_probs=213.8

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      ......++|++.+.||+|+||+||+|.+. +++.||+|.+... .....+.+.+|+.+|++++||||+++++++.+.+..
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            34455678899999999999999999986 5889999999754 334456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus       188 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            9999999999999998642  234889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ..............++..|+|||.+.++.++.++|||||||++|||+| |..||......      ............  
T Consensus       263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~------~~~~~~~~~~~~--  334 (377)
T 3cbl_A          263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ------QTREFVEKGGRL--  334 (377)
T ss_dssp             CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH------HHHHHHHTTCCC--
T ss_pred             cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC--
Confidence            544332222222345778999999999999999999999999999998 99998543211      111111111110  


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                          ..+.     .++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       335 ----~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          335 ----PCPE-----LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             ----CCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCC-----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                0111     134568899999999999999999999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.5e-45  Score=347.84  Aligned_cols=269  Identities=26%  Similarity=0.398  Sum_probs=208.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEe-----cCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--Cc
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVL-----RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DE  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  185 (436)
                      ..++|++.+.||+|+||+||+|.+     .+++.||+|++........+.+.+|+.++++++||||+++++++...  ..
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            457789999999999999999984     24889999999887777778899999999999999999999998654  45


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             eEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            899999999999999986533  24899999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC-------C---cchhHHHH
Q 040532          266 ICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-------S---LNLLGYVW  334 (436)
Q Consensus       266 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~-------~---~~~~~~~~  334 (436)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||+||..|+.....+       .   ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            76443221 2222335777899999999999999999999999999999999987543210       0   00000111


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCC
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALH  397 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~  397 (436)
                      .........      ..+     ..++..+.+++.+||+.||++|||+.|+++.|+++...++
T Consensus       243 ~~~~~~~~~------~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          243 ELLKNNGRL------PRP-----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHHHTTCCC------CCC-----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHhccCcC------CCC-----cCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            111111100      001     1134578999999999999999999999999999876553

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-45  Score=347.01  Aligned_cols=267  Identities=25%  Similarity=0.397  Sum_probs=209.6

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      .++|++.+.||+|+||+||+|.+. ++.||+|++....  ..+.+.+|+.++++++||||+++++++.  +..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            457888899999999999999986 7889999997543  3467899999999999999999999876  4589999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC-eEEeeccCceecCCCCc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-PKISDFGMARICGGNEL  272 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~-~kl~DfGla~~~~~~~~  272 (436)
                      ++|+|.+++........+++...+.++.|+++||+|||+.+..+++||||||+||+++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999976555456788999999999999999999943334999999999999998887 799999999754322  


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......   ....+...... ..      ...
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~-~~------~~~  226 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA---FRIMWAVHNGT-RP------PLI  226 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH---HHHHHHHHTTC-CC------CCB
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH---HHHHHHHhcCC-CC------Ccc
Confidence               223368999999999999999999999999999999999999986433221   11111111111 10      111


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCCCcc
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFS  405 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~~~~  405 (436)
                      ..     .+..+.+++.+||+.||++|||+.++++.|+.+....+...+|...
T Consensus       227 ~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~  274 (307)
T 2eva_A          227 KN-----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY  274 (307)
T ss_dssp             TT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCC
T ss_pred             cc-----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcccc
Confidence            11     3456889999999999999999999999999999888777665443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.6e-45  Score=352.61  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=204.1

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999976 58899999986543 2234668899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++|+|.+++....   .+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999986433   4899999999999999999999998   9999999999999999999999999998764333


Q ss_pred             cccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      .........||+.|+|||++.+..+ +.++|||||||++|||++|+.||............+    .......       
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~----~~~~~~~-------  228 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----KEKKTYL-------  228 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH----HTTCTTS-------
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH----hcccccC-------
Confidence            3333345689999999999988775 789999999999999999999996544332211111    1111000       


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                       . .  ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       229 -~-~--~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 -N-P--WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -T-T--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -C-c--cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             0 0  01134567889999999999999999999764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1e-45  Score=355.15  Aligned_cols=267  Identities=25%  Similarity=0.414  Sum_probs=197.6

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecCCC----EEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGD----EIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK  183 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  183 (436)
                      .....++|++.+.||+|+||+||+|.+....    .||+|++...  .....+.+.+|+.++++++||||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            4456788999999999999999999976532    7999999754  344567899999999999999999999999887


Q ss_pred             Ccc------EEEEeecCCCChhhhhcCC---CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC
Q 040532          184 DEK------ILIYEYMPNKSLDFFLFDP---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  254 (436)
Q Consensus       184 ~~~------~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~  254 (436)
                      ...      ++||||+++|+|.+++...   .....+++..+..++.|++.||+|||+.+   ++||||||+|||+++++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence            665      9999999999999988532   22235899999999999999999999998   99999999999999999


Q ss_pred             CeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHH
Q 040532          255 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYV  333 (436)
Q Consensus       255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  333 (436)
                      .+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |+.||......  ...   
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~---  249 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIY---  249 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH---
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHH---
Confidence            999999999987654443333334467889999999999999999999999999999999 89998643321  111   


Q ss_pred             HHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                      ....... ...      ...     ..+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus       250 ~~~~~~~-~~~------~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          250 NYLIGGN-RLK------QPP-----ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HHHHTTC-CCC------CCT-----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHhcCC-CCC------CCC-----ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1111111 000      011     13456889999999999999999999999999998653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.8e-45  Score=358.63  Aligned_cols=270  Identities=27%  Similarity=0.365  Sum_probs=215.9

Q ss_pred             cchhhhhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEee
Q 040532          107 FSSVSTATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLG  178 (436)
Q Consensus       107 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~  178 (436)
                      ........++|++.+.||+|+||.||+|.+.      +++.||||++... .....+.+.+|+.++.++ +||||+++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            3445667789999999999999999999742      3578999999764 344557799999999999 7999999999


Q ss_pred             EEEeCCc-cEEEEeecCCCChhhhhcCCCc--------------------------------------------------
Q 040532          179 CCIDKDE-KILIYEYMPNKSLDFFLFDPTK--------------------------------------------------  207 (436)
Q Consensus       179 ~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------  207 (436)
                      ++.+.+. .++||||+++|+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            9987654 8999999999999999865432                                                  


Q ss_pred             -------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          208 -------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       208 -------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                                   ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..........
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                         122889999999999999999999998   9999999999999999999999999998765443333


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                      ......||+.|+|||++.+..++.++||||||+++|||+| |+.||.......     .............      .+.
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~~~~~~~~------~~~  319 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKEGTRMR------APD  319 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-----HHHHHHHHTCCCC------CCT
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-----HHHHHHHcCCCCC------CCC
Confidence            3444578899999999999999999999999999999998 999985433221     1112112111111      111


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      .     .+..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       320 ~-----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          320 Y-----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             T-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            1     334688999999999999999999999999988753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.4e-44  Score=343.33  Aligned_cols=264  Identities=26%  Similarity=0.355  Sum_probs=205.0

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHH--cCCCceeEEeeEEEeC----Cc
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAK--VQHKNLVRLLGCCIDK----DE  185 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~  185 (436)
                      ...++|++.+.||+|+||+||+|.+. |+.||+|++...   ....+..|.+++..  ++||||+++++++...    ..
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEEC-CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            45678999999999999999999984 899999999653   23456677777777  7999999999987653    35


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEecccCCCCEEEcCCCCeE
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH--------QYSRVRIIHRDLKASNILLDKDMNPK  257 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~i~H~Dikp~NIll~~~~~~k  257 (436)
                      .++||||+++|+|.+++..    ..+++..+..++.|++.||+|||        +.+   ++||||||+|||++.++.+|
T Consensus        81 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred             eEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence            7899999999999999943    24899999999999999999999        666   99999999999999999999


Q ss_pred             EeeccCceecCCCCcc--cccccccccCCccchhhhccC------CCCcccchhhHHHHHHHHHhC----------CCCC
Q 040532          258 ISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSG----------KKNT  319 (436)
Q Consensus       258 l~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltg----------~~p~  319 (436)
                      |+|||+++........  .......||+.|+|||++.+.      .++.++|||||||++|||+||          +.||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            9999999865433221  122334799999999999876      456799999999999999999          7777


Q ss_pred             CCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          320 GLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      ............. .........     .+..+........+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       234 ~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPSFEDM-RKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCCHHHH-HHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcchhhh-hHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            5433332222222 111111111     111122222233677899999999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=357.14  Aligned_cols=269  Identities=26%  Similarity=0.400  Sum_probs=215.9

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEE
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCI  181 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  181 (436)
                      .+....++|++.+.||+|+||.||+|.+..      ++.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            345667899999999999999999999753      478999999865 3445678999999999999999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCCc---------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPTK---------------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH  240 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H  240 (436)
                      +.+..++||||+++|+|.+++.....                     ...+++..++.++.|++.||.|||+.+   ++|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence            99999999999999999999864321                     246899999999999999999999998   999


Q ss_pred             cccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 040532          241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNT  319 (436)
Q Consensus       241 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~  319 (436)
                      |||||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999987654333233344568899999999999999999999999999999999 99998


Q ss_pred             CCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCC
Q 040532          320 GLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALH  397 (436)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~  397 (436)
                      .....     ...... ........      ...     ..+..+.+++.+||+.||++||++.++++.|+++.....
T Consensus       278 ~~~~~-----~~~~~~-~~~~~~~~------~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          278 YGMAH-----EEVIYY-VRDGNILA------CPE-----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             TTSCH-----HHHHHH-HHTTCCCC------CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CCCCh-----HHHHHH-HhCCCcCC------CCC-----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            54321     111111 11111111      111     134578899999999999999999999999999886544

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=344.16  Aligned_cols=275  Identities=21%  Similarity=0.309  Sum_probs=216.5

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC--ccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~  187 (436)
                      ...++|++.+.||+|+||+||+|.+.. |+.||+|++.... ....+.+.+|+.++++++||||+++++++...+  ..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            456789999999999999999999765 8899999997532 233567889999999999999999999998765  669


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE----cCCCCeEEeeccC
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGM  263 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll----~~~~~~kl~DfGl  263 (436)
                      +||||+++++|.+++........+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            99999999999999977655556899999999999999999999998   9999999999999    7888899999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhc--------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYAL--------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  335 (436)
                      ++.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||......... ......
T Consensus       163 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~  238 (319)
T 4euu_A          163 ARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYK  238 (319)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC-HHHHHH
T ss_pred             ceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh-HHHHHH
Confidence            987654332   22347899999999987        467899999999999999999999998654332221 222222


Q ss_pred             HhhcCC--cceecc----------CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          336 LWTSNR--TLELID----------DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       336 ~~~~~~--~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                      ......  ......          ................+.+++.+||+.||++|||++|+++...+..
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            222111  011000          0011111223446778899999999999999999999999988765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-45  Score=344.36  Aligned_cols=259  Identities=28%  Similarity=0.407  Sum_probs=211.8

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ...++|++.+.||+|+||+||+|.+.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             eChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            34567899999999999999999998889999999986532 23678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             CCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             eCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            999999999986533  34899999999999999999999998   9999999999999999999999999998654322


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      . .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.....     ............       ..
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-----~~~~~~~~~~~~-------~~  227 (269)
T 4hcu_A          161 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDISTGFR-------LY  227 (269)
T ss_dssp             H-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTCC-------CC
T ss_pred             c-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHhcCcc-------CC
Confidence            1 22233456788999999999999999999999999999999 9999854321     111111111110       00


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      .+..     .+..+.+++.+||+.||++||++.++++.|+++..
T Consensus       228 ~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          228 KPRL-----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCc-----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            1111     23468899999999999999999999999998764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.2e-45  Score=350.83  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=204.0

Q ss_pred             CCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            666778999999999999976 5999999999866555567889999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      ++|.+++...    .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........  .
T Consensus       127 ~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  197 (321)
T 2c30_A          127 GALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  197 (321)
T ss_dssp             CBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence            9999998542    4899999999999999999999998   99999999999999999999999999987654321  2


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccccc
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEY  355 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (436)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....     ........... .      +....  
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~-~------~~~~~--  263 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----VQAMKRLRDSP-P------PKLKN--  263 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSS-C------CCCTT--
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCC-C------CCcCc--
Confidence            2345799999999999999999999999999999999999999854221     11111111111 0      00000  


Q ss_pred             chHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          356 SSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       356 ~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                       ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       264 -~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          264 -SHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             11134568899999999999999999999873

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.4e-45  Score=341.98  Aligned_cols=260  Identities=27%  Similarity=0.379  Sum_probs=212.2

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ...++|++.+.||+|+||+||+|.++++..||+|++..... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            45678999999999999999999998888999999976432 23678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           84 YISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             ccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999998543  234899999999999999999999998   9999999999999999999999999998765443


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      ... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......     ...........       ..
T Consensus       159 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~-------~~  225 (268)
T 3sxs_A          159 YVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLKVSQGHR-------LY  225 (268)
T ss_dssp             EEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHHTTCC-------CC
T ss_pred             hhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHHHHcCCC-------CC
Confidence            222 223456778999999999899999999999999999999 99998543321     11111111110       00


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      .+..     .+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       226 ~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          226 RPHL-----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCTT-----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCc-----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            0111     234688999999999999999999999999988653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.9e-45  Score=359.03  Aligned_cols=261  Identities=29%  Similarity=0.439  Sum_probs=200.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec----CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ..++|++.+.||+|+||+||+|.+.    ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            4568999999999999999999875    4678999999765 4555678999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|.+++....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       123 lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            9999999999999996532  34899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          268 GGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       268 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ...... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.....     ...... .....  . 
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~~~~-i~~~~--~-  268 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKA-VDEGY--R-  268 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHHHHH-HHTTE--E-
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-HHcCC--C-
Confidence            533211 11222345778999999999999999999999999999998 9999854321     111111 11110  0 


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                        .+. .     ..++..+.+++.+||+.||++||++.++++.|+++...
T Consensus       269 --~~~-~-----~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          269 --LPP-P-----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             --CCC-C-----TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --CCC-C-----ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence              000 0     11345788999999999999999999999999988754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.1e-46  Score=356.98  Aligned_cols=276  Identities=24%  Similarity=0.341  Sum_probs=210.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEe-----cCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe--CCcc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVL-----RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEK  186 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  186 (436)
                      .++|++.+.||+|+||.||+|.+     ..++.||+|++........+.+.+|+.++++++||||+++++++..  ....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            46788999999999999999984     3478899999988777777889999999999999999999999874  4567


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            89999999999999986422  24899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCc-ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC---------cchhHHHHHH
Q 040532          267 CGGNEL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS---------LNLLGYVWDL  336 (436)
Q Consensus       267 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~---------~~~~~~~~~~  336 (436)
                      ...... ........||..|+|||.+.+..++.++||||||+++|+|++|+.||.....+.         ..........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            654332 122333468888999999999999999999999999999999999975322110         0000111111


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCCCcc
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFS  405 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~~~~  405 (436)
                      ......      ....     ...+..+.+++.+||+.||++|||+.|+++.|+.+......-..++..
T Consensus       257 ~~~~~~------~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~  314 (327)
T 3lxl_A          257 LEEGQR------LPAP-----PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT  314 (327)
T ss_dssp             HHTTCC------CCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------------
T ss_pred             hhcccC------CCCC-----CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccccc
Confidence            111110      0001     114457889999999999999999999999999998766554444333

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2e-45  Score=369.53  Aligned_cols=268  Identities=30%  Similarity=0.424  Sum_probs=217.2

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .......++|++.+.||+|+||+||+|.++++..||||++.... ...+.+.+|+.+|++++||||+++++++. .+..+
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            44566778899999999999999999999888899999998643 34578999999999999999999999986 66789


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            9999999999999996432 234788999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ...... ......++..|+|||.+....++.++|||||||++|||+| |+.||.....     ...........+.    
T Consensus       335 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~i~~~~~~----  404 (454)
T 1qcf_A          335 EDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEVIRALERGYRM----  404 (454)
T ss_dssp             CCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHHHHHTCCC----
T ss_pred             CCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCCC----
Confidence            432211 1223356788999999999999999999999999999999 9999854321     1111111111110    


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCC
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP  399 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~  399 (436)
                        + .+     ..++..+.+++.+||+.||++|||+++|++.|+++.....+.
T Consensus       405 --~-~~-----~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~  449 (454)
T 1qcf_A          405 --P-RP-----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ  449 (454)
T ss_dssp             --C-CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred             --C-CC-----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence              0 01     114457899999999999999999999999999998765544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5e-45  Score=345.90  Aligned_cols=265  Identities=23%  Similarity=0.348  Sum_probs=208.7

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ...++|++.+.||+|+||+||+|.+. .+..||+|.+...   .....+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            34678999999999999999999965 4889999998543   3445678899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++++|.+++...   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        88 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             EEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            999999999999998543   35899999999999999999999998   999999999999999999999999999765


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     ........... ....  
T Consensus       162 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~-~~~~--  232 (294)
T 4eqm_A          162 SETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-----VSIAIKHIQDS-VPNV--  232 (294)
T ss_dssp             --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----HHHHHHHHSSC-CCCH--
T ss_pred             ccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhhcc-CCCc--
Confidence            43221 223335799999999999999999999999999999999999999854321     11111111111 0000  


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhhccccC
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRP-TMNDVVSMLTNEAAAL  396 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~ev~~~L~~~~~~~  396 (436)
                          . .......+..+.+++.+||+.||++|| ++.++.+.|+......
T Consensus       233 ----~-~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          233 ----T-TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             ----H-HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             ----c-hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence                0 000111345788999999999999998 8999999999887543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-45  Score=353.97  Aligned_cols=270  Identities=26%  Similarity=0.358  Sum_probs=211.9

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCI  181 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  181 (436)
                      .....++|++.+.||+|+||+||+|.+.      .+..||+|++... .....+.+.+|+.++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3445688999999999999999999962      3567999999754 233456789999999999 8999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCCcc--------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPTKR--------------------ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR  241 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~  241 (436)
                      ..+..++||||+++|+|.+++......                    ..+++..+..++.|++.||+|||+.+   ++||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            999999999999999999998654321                    34789999999999999999999998   9999


Q ss_pred             ccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 040532          242 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTG  320 (436)
Q Consensus       242 Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~  320 (436)
                      ||||+|||++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986644333233334467889999999999999999999999999999998 999986


Q ss_pred             CCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          321 LYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                      ......     ............      .....     .+..+.+++.+||+.||.+||++.++++.|+.+....+.
T Consensus       277 ~~~~~~-----~~~~~~~~~~~~------~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          277 GIPVDA-----NFYKLIQNGFKM------DQPFY-----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             TCCCSH-----HHHHHHHTTCCC------CCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             cCCcHH-----HHHHHHhcCCCC------CCCCC-----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            443221     111221211110      00111     345688999999999999999999999999998865443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.6e-45  Score=343.87  Aligned_cols=262  Identities=27%  Similarity=0.379  Sum_probs=210.9

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ......++|++.+.||+|+||+||+|.+.++..||+|++...... .+++.+|+.++.+++||||+++++++.+.+..++
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            345567789999999999999999999988889999999865322 3678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        97 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             EECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            999999999999996532  34899999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      .... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......     ...... ....  .   
T Consensus       172 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~-~~~~--~---  239 (283)
T 3gen_A          172 DDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHI-AQGL--R---  239 (283)
T ss_dssp             CHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHH-HTTC--C---
T ss_pred             cccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHHHHH-hccc--C---
Confidence            3221 12223356788999999999999999999999999999998 99998643321     111111 1110  0   


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                       ...+..     .+..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus       240 -~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          240 -LYRPHL-----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             -CCCCTT-----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCc-----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence             000111     23468899999999999999999999999998764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.3e-45  Score=366.92  Aligned_cols=271  Identities=27%  Similarity=0.421  Sum_probs=214.0

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ......++|++.+.||+|+||+||+|.++++..||||++..... ..+.+.+|+.+|++++||||+++++++.+ +..++
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            34556678899999999999999999998888899999986432 34678999999999999999999999876 77899


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++|+|.+++... ....+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++...
T Consensus       256 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            99999999999999532 2235889999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....     ....... ......    
T Consensus       332 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~i-~~~~~~----  400 (452)
T 1fmk_A          332 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQV-ERGYRM----  400 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHH-HTTCCC----
T ss_pred             CCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH-HcCCCC----
Confidence            33221 2223356789999999999999999999999999999999 8999854321     1111111 111100    


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCCC
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA  403 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~~  403 (436)
                        ..+     ..++..+.+++.+||+.||++|||++++++.|+++....+++..|.
T Consensus       401 --~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~  449 (452)
T 1fmk_A          401 --PCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG  449 (452)
T ss_dssp             --CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred             --CCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccccc
Confidence              001     1144578899999999999999999999999999998877766554

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1e-44  Score=350.04  Aligned_cols=268  Identities=25%  Similarity=0.368  Sum_probs=216.2

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec--------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR--------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCC  180 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  180 (436)
                      ....++|++.+.||+|+||+||+|.+.        ++..||+|++... .....+.+.+|+.+++++ +||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            345678999999999999999999863        3678999999765 445567899999999999 899999999999


Q ss_pred             EeCCccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCC
Q 040532          181 IDKDEKILIYEYMPNKSLDFFLFDPTK-------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  247 (436)
Q Consensus       181 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~N  247 (436)
                      .+.+..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence            999999999999999999999865432             234889999999999999999999998   9999999999


Q ss_pred             EEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 040532          248 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  326 (436)
Q Consensus       248 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~  326 (436)
                      |+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....  
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--  265 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  265 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--
Confidence            9999999999999999987765443333344467889999999999999999999999999999999 9999854321  


Q ss_pred             cchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                         ....... .......      ...     ..+..+.+++.+||+.||.+||++.|+++.|+++......
T Consensus       266 ---~~~~~~~-~~~~~~~------~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          266 ---EELFKLL-KEGHRMD------KPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             ---HHHHHHH-HHTCCCC------CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             ---HHHHHHH-hcCCCCC------CCc-----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence               1111111 1111100      111     1345688999999999999999999999999999865444

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.7e-45  Score=346.74  Aligned_cols=268  Identities=26%  Similarity=0.372  Sum_probs=216.4

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEe------cCCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHc-CCCceeEEeeEEE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVL------RKGDEIAVKRLSGRS-EQGLREMKNEASVIAKV-QHKNLVRLLGCCI  181 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  181 (436)
                      .....++|++.+.||+|+||+||+|.+      ..++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            344567899999999999999999985      236789999997653 34567899999999999 9999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCCc---------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCC
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPTK---------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS  246 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~  246 (436)
                      +.+..++||||+++|+|.+++.....               ...+++..+..++.|++.||+|||+.+   ++||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence            99999999999999999999864332               225899999999999999999999998   999999999


Q ss_pred             CEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 040532          247 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTD  325 (436)
Q Consensus       247 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~  325 (436)
                      ||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99999999999999999987655433333334467889999999999999999999999999999999 99998643322


Q ss_pred             CcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          326 SLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                      .     ...........      .....     ..+..+.+++.+||+.||.+|||+.|+++.|++.....
T Consensus       255 ~-----~~~~~~~~~~~------~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          255 S-----KFYKMIKEGFR------MLSPE-----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             H-----HHHHHHHHTCC------CCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             h-----HHHHHhccCCC------CCCcc-----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            1     11111111110      00011     13456889999999999999999999999999987654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=359.18  Aligned_cols=264  Identities=30%  Similarity=0.393  Sum_probs=211.4

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ...++|++.+.||+|+||+||+|.+.      .+..||||++... .......+.+|+.++++++||||+++++++.+..
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            34577899999999999999999953      3568999999754 4555667899999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCC----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC---CeE
Q 040532          185 EKILIYEYMPNKSLDFFLFDPT----KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPK  257 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~---~~k  257 (436)
                      ..++||||+++|+|.+++....    ....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999986432    2245899999999999999999999998   99999999999999555   599


Q ss_pred             EeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHH
Q 040532          258 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      |+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.....     .......
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----~~~~~~i  299 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEFV  299 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHHH
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH
Confidence            999999975433222233334568899999999999999999999999999999998 9999854321     1111111


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                       .......      ...     .++..+.+++.+||+.||++||++.++++.|+.+...
T Consensus       300 -~~~~~~~------~~~-----~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          300 -TSGGRMD------PPK-----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             -HTTCCCC------CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -HcCCCCC------CCc-----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence             1111100      011     1345688999999999999999999999999887754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=347.52  Aligned_cols=252  Identities=19%  Similarity=0.275  Sum_probs=205.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ..++|++.+.||+|+||+||+|.+.. ++.+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            35689999999999999999999764 7889999997543 344678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC--CCCeEEeeccCceecCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNPKISDFGMARICGG  269 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~--~~~~kl~DfGla~~~~~  269 (436)
                      |+++|+|.+++....  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.  ++.+||+|||++.....
T Consensus        82 ~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             eCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            999999999985432  34899999999999999999999998   999999999999997  78999999999987654


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ...   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....     .............       
T Consensus       157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~-------  221 (321)
T 1tki_A          157 GDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIENIMNAEYT-------  221 (321)
T ss_dssp             TCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTCCC-------
T ss_pred             CCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHcCCCC-------
Confidence            322   2334789999999999988899999999999999999999999854321     1111221111110       


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       .. .......+..+.+++.+||+.||++|||+.|+++
T Consensus       222 -~~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          222 -FD-EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -CC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CC-hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             00 0000113457889999999999999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.4e-45  Score=352.32  Aligned_cols=259  Identities=28%  Similarity=0.438  Sum_probs=202.6

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CC----EEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GD----EIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .++|+..+.||+|+||+||+|.+.. ++    +||+|.+... .....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence            4678999999999999999999653 43    3688988643 334457899999999999999999999999875 478


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +|+||+++|+|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            9999999999999986533  34899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .............+|..|+|||.+.+..++.++|||||||++|||+| |+.||.......  ..    ..........  
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~----~~~~~~~~~~--  239 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS----SILEKGERLP--  239 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH----HHHHTTCCCC--
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HH----HHHHcCCCCC--
Confidence            55443333344467889999999999999999999999999999999 999986433221  11    1111111000  


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                          ....     ++..+.+++.+||+.||++||++.|+++.|+.+...
T Consensus       240 ----~~~~-----~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          240 ----QPPI-----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ----CCTT-----BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ----CCcc-----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                0111     344688999999999999999999999999987653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5e-44  Score=341.80  Aligned_cols=266  Identities=23%  Similarity=0.320  Sum_probs=204.0

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .+...++|++.+.||+|+||+||+|.+.+|+.||+|++....  ......+.+|+.++++++||||+++++++.+.+..+
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   95 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT   95 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence            344567899999999999999999999889999999997542  223467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++ +|.+++....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        96 lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           96 LVFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             EEEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             EEEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceec
Confidence            99999985 6766665432  34889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce--
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE--  344 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  344 (436)
                      ....  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......  +................  
T Consensus       170 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          170 GIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--DQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             TSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--THHHHHHHHHCCCCTTTSG
T ss_pred             CCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHHCCCChHHhh
Confidence            4322  12233478999999999876 56899999999999999999999999654322  22222222211111100  


Q ss_pred             --------------eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          345 --------------LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       345 --------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                                    ..........  ....+.++.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSI--IPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHH--STTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhccchhhhcccccccCCcHHHh--CcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                          0000000000  0113356889999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.3e-44  Score=339.51  Aligned_cols=271  Identities=16%  Similarity=0.209  Sum_probs=215.5

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ...++|++.+.||+|+||.||+|.. .+|+.||+|++.....  .+.+.+|+..+.++ +|+|++++++++.+....++|
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            3467899999999999999999996 4588999999865432  24578899999999 799999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC-----eEEeeccCc
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-----PKISDFGMA  264 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~-----~kl~DfGla  264 (436)
                      |||+ +++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.     +||+|||++
T Consensus        85 ~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            9999 999999986432  34899999999999999999999998   999999999999987776     999999999


Q ss_pred             eecCCCCcc-----cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCc-chhHHHHHHhh
Q 040532          265 RICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NLLGYVWDLWT  338 (436)
Q Consensus       265 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~  338 (436)
                      .........     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .....+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            876543221     123445799999999999999999999999999999999999999975432221 11111111111


Q ss_pred             cCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCC
Q 040532          339 SNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQ  401 (436)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~  401 (436)
                      .......           ....+..+.+++.+||+.||++||++.+|++.|+++.........
T Consensus       239 ~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~  290 (298)
T 1csn_A          239 STPLREL-----------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED  290 (298)
T ss_dssp             HSCHHHH-----------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred             CccHHHH-----------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCC
Confidence            0100000           001345789999999999999999999999999999887665443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-44  Score=348.24  Aligned_cols=252  Identities=24%  Similarity=0.344  Sum_probs=200.8

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc------
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE------  185 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------  185 (436)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467889999999999999999986 6899999999754 33456789999999999999999999999876542      


Q ss_pred             ---------------------------------------------------cEEEEeecCCCChhhhhcCCCccCCCCHH
Q 040532          186 ---------------------------------------------------KILIYEYMPNKSLDFFLFDPTKRILLDWV  214 (436)
Q Consensus       186 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~  214 (436)
                                                                         .++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               68999999999999999876655567778


Q ss_pred             HHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc----------cccccccccCC
Q 040532          215 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ----------ANTSRIVGTYG  284 (436)
Q Consensus       215 ~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~~  284 (436)
                      .++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++.........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            88999999999999999998   999999999999999999999999999876543211          12233579999


Q ss_pred             ccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHH
Q 040532          285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRY  364 (436)
Q Consensus       285 y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  364 (436)
                      |+|||.+.+..++.++||||||+++|||++|..|+..       ........ ...         ..+  .........+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~~~~-~~~---------~~~--~~~~~~~~~~  302 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRIITDV-RNL---------KFP--LLFTQKYPQE  302 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHHHHH-HTT---------CCC--HHHHHHCHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHHHHh-hcc---------CCC--cccccCChhH
Confidence            9999999999999999999999999999998776310       00000110 111         111  1112244567


Q ss_pred             HHHHHhcccCCCCCCCCHHHHHH
Q 040532          365 VNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       365 ~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .+++.+||+.||++|||+.|+++
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCCCcCCCHHHHhh
Confidence            89999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.8e-45  Score=351.57  Aligned_cols=278  Identities=27%  Similarity=0.386  Sum_probs=210.2

Q ss_pred             ccCC-CCCcccCCCCceeEEEEEec-----CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--C
Q 040532          114 TNTF-SDTNKLGEGGFGPVYKGVLR-----KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--D  184 (436)
Q Consensus       114 ~~~~-~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~  184 (436)
                      .++| ++.+.||+|+||+||++.+.     +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.  .
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            3445 89999999999999888642     4788999999865 345567899999999999999999999999884  5


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..++||||+++++|.+++...    .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             eEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccc
Confidence            678999999999999998543    3899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc
Q 040532          265 RICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL  343 (436)
Q Consensus       265 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  343 (436)
                      ......... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||............+...........
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence            877543321 2233346788899999999999999999999999999999999998542211000000000000000000


Q ss_pred             eeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCC
Q 040532          344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPK  400 (436)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~  400 (436)
                      +.+........  ...++..+.+++.+||+.||++|||+.|+++.|+.+.....++.
T Consensus       262 ~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~  316 (318)
T 3lxp_A          262 ELLERGERLPR--PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA  316 (318)
T ss_dssp             HHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred             HHHhcccCCCC--CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence            00100000000  01134578999999999999999999999999999887765544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.3e-45  Score=350.97  Aligned_cols=268  Identities=21%  Similarity=0.301  Sum_probs=202.2

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc-
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK-  186 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-  186 (436)
                      ...++|++.+.||+|+||+||+|.+ .+++.||+|++...   .......+.+|+.++.+++||||+++++++...... 
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence            4567899999999999999999996 45889999999754   334456789999999999999999999998876654 


Q ss_pred             ---EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          187 ---ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       187 ---~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                         ++||||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             cccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence               9999999999999998542   34899999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          264 ARICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       264 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      +......... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....     .............
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~  237 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPI  237 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCC
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCCCC
Confidence            9866443221 223335689999999999999999999999999999999999999854321     1111222221111


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHH-HHHHHHhhccccCCCC
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMN-DVVSMLTNEAAALHPP  399 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-ev~~~L~~~~~~~~~~  399 (436)
                      ..         .......+..+.+++.+||+.||++||+.. ++...|.......++.
T Consensus       238 ~~---------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~  286 (311)
T 3ork_A          238 PP---------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPE  286 (311)
T ss_dssp             CH---------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCS
T ss_pred             Cc---------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCC
Confidence            00         000111345688999999999999999654 5556666665444333

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.5e-45  Score=349.80  Aligned_cols=270  Identities=27%  Similarity=0.405  Sum_probs=217.4

Q ss_pred             cccchhhhhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEe
Q 040532          105 FSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLL  177 (436)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~  177 (436)
                      +...+.....++|++.+.||+|+||.||+|.+.      .++.||+|.+... .......+.+|+.++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            444566777889999999999999999999865      2678999999754 344456789999999999999999999


Q ss_pred             eEEEeCCccEEEEeecCCCChhhhhcCCC-------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE
Q 040532          178 GCCIDKDEKILIYEYMPNKSLDFFLFDPT-------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  250 (436)
Q Consensus       178 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll  250 (436)
                      +++.+.+..++||||+++|+|.+++....       ....+++..++.++.|++.||.|||+.+   ++||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence            99999999999999999999999985421       1234789999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 040532          251 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNL  329 (436)
Q Consensus       251 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~  329 (436)
                      +.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....     
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----  246 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----  246 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----
Confidence            9999999999999976543333233334467889999999999999999999999999999999 8888854321     


Q ss_pred             hHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          330 LGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      .... ..........      ...     ..+..+.+++.+||+.||++|||+.|+++.|++...
T Consensus       247 ~~~~-~~~~~~~~~~------~~~-----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          247 EQVL-RFVMEGGLLD------KPD-----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHH-HHHHTTCCCC------CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHH-HHHHcCCcCC------CCC-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1111 1111111110      011     134568899999999999999999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2e-44  Score=351.09  Aligned_cols=253  Identities=23%  Similarity=0.293  Sum_probs=205.1

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh------hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ...+.|++.+.||+|+||+||+|... +|+.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            34678999999999999999999976 488999999875422      13567899999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC----CeEEee
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISD  260 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~----~~kl~D  260 (436)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++    .+||+|
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            999999999999999999543   34899999999999999999999998   99999999999998877    799999


Q ss_pred             ccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          261 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      ||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ...........
T Consensus       163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----~~~~~~i~~~~  234 (361)
T 2yab_A          163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANITAVS  234 (361)
T ss_dssp             CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHTTC
T ss_pred             cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcC
Confidence            99998765432   22345799999999999999999999999999999999999999854221     11111111111


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .        ...... ....+..+.+++.+||..||++|||+.|+++
T Consensus       235 ~--------~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          235 Y--------DFDEEF-FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             C--------CCCHHH-HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             C--------CCCchh-ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0        000000 0113456889999999999999999999885

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.9e-44  Score=338.82  Aligned_cols=265  Identities=26%  Similarity=0.432  Sum_probs=199.9

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .+...++|++.+.||+|+||+||+|.+.  ..||+|++...  .....+.+.+|+.++++++||||+++++++ .....+
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            3455778999999999999999999875  35999998754  445567899999999999999999999965 566789


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        96 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccc
Confidence            9999999999999985433  34899999999999999999999998   999999999999999999999999999765


Q ss_pred             CCCCcccccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      .............||+.|+|||.+.   +..++.++||||||+++|||++|+.||......     ..............
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~  245 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----DQIIEMVGRGSLSP  245 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-----HHHHHHHHHTSCCC
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-----HHHHHHhcccccCc
Confidence            4333233334457899999999987   567889999999999999999999998543221     11112211111111


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      ...  ...     ..++..+.+++.+||+.||++||++.++++.|+++.+
T Consensus       246 ~~~--~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          246 DLS--KVR-----SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CTT--SSC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             chh--hcc-----ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            100  001     1134578999999999999999999999999998864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.6e-44  Score=344.82  Aligned_cols=267  Identities=18%  Similarity=0.184  Sum_probs=211.5

Q ss_pred             hccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ..++|++.+.||+|+||+||+|.. .+|+.||+|++......  +.+.+|+.+++++ +||||+++++++...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            457899999999999999999996 45889999998754322  4578999999999 9999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC-----eEEeeccCce
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-----PKISDFGMAR  265 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~-----~kl~DfGla~  265 (436)
                      ||+ +++|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||+++
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           85 ELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            999 99999998643  235899999999999999999999998   999999999999998887     9999999998


Q ss_pred             ecCCCCccc-----ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          266 ICGGNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       266 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      .........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~~~~  236 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQKIGDTK  236 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHHHHhhh
Confidence            764332211     1234579999999999999999999999999999999999999997543222  111111110000


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                      ..     .+   ........+ .+.+++..||+.||.+||++.++++.|+++......
T Consensus       237 ~~-----~~---~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          237 RA-----TP---IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             HH-----SC---HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cc-----CC---HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            00     00   000000123 789999999999999999999999999988766543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-44  Score=337.71  Aligned_cols=255  Identities=29%  Similarity=0.461  Sum_probs=197.1

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCCh----hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE----QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..++|++.+.||+|+||+||+|.+. |+.||+|++.....    ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            3567899999999999999999986 89999999875422    235678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC--------CCCeEEee
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--------DMNPKISD  260 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~--------~~~~kl~D  260 (436)
                      ||||+++++|.+++..    ..+++.....++.|++.||+|||+.+..+++||||||+||+++.        ++.+||+|
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999999843    24899999999999999999999987556899999999999986        77899999


Q ss_pred             ccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          261 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      ||++.......    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......     ..........
T Consensus       160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~  230 (271)
T 3dtc_A          160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-----AVAYGVAMNK  230 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-----HHHHHHHTSC
T ss_pred             CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHhhhcCC
Confidence            99997654322    22347899999999999999999999999999999999999998543211     1111111111


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      ...      ....     ..+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       231 ~~~------~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          231 LAL------PIPS-----TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCC------CCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCC------CCCc-----ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            100      0111     1345688999999999999999999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2e-44  Score=338.75  Aligned_cols=270  Identities=32%  Similarity=0.461  Sum_probs=214.0

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      +.....++|++.+.||+|+||+||+|..+++..||+|.+.... ...+.+.+|+.++++++||||+++++++. .+..++
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   84 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI   84 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence            3455667899999999999999999998888899999997643 23467899999999999999999999976 456899


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             EEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            999999999999985422 235899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....     ....... .....     
T Consensus       161 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~~-~~~~~-----  228 (279)
T 1qpc_A          161 DNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNL-ERGYR-----  228 (279)
T ss_dssp             SSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHH-HTTCC-----
T ss_pred             Ccccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----HHHHHHH-hcccC-----
Confidence            43322 2233457789999999998999999999999999999999 8999854321     1111111 11100     


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCC
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP  402 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~  402 (436)
                       .....     ..+..+.+++.+||+.||++|||+.++++.|+++......+.+|
T Consensus       229 -~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~  277 (279)
T 1qpc_A          229 -MVRPD-----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP  277 (279)
T ss_dssp             -CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC------
T ss_pred             -CCCcc-----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCCC
Confidence             00111     13457889999999999999999999999999998776665544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=345.68  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=204.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh------hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      ..+.|++.+.||+|+||.||+|... +|+.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            4567899999999999999999976 488999999865321      135778999999999999999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC----CeEEeec
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDF  261 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~----~~kl~Df  261 (436)
                      .++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++    .+||+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999998543   34899999999999999999999998   99999999999999887    8999999


Q ss_pred             cCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      |++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     ............
T Consensus       163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~~~~~~~  234 (326)
T 2y0a_A          163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANVSAVNY  234 (326)
T ss_dssp             TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHHTCC
T ss_pred             CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHHHhcCC
Confidence            9998765332   22335799999999999999999999999999999999999999853221     111111111110


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                              ...... ....+..+.+++.+||+.||++|||+.|+++
T Consensus       235 --------~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 --------EFEDEY-FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             --------CCCHHH-HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --------CcCccc-cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                    000000 0113456889999999999999999999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.6e-44  Score=366.62  Aligned_cols=263  Identities=27%  Similarity=0.419  Sum_probs=214.7

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .......+|++.+.||+|+||.||+|.++. +..||||.+.... ...+.+.+|+.+|++++||||++++++|.+.+..+
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence            344556778889999999999999999875 7889999997643 23578999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       293 lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence            9999999999999986432 235889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ...... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||......  ...    .........   
T Consensus       369 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~---  438 (495)
T 1opk_A          369 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY----ELLEKDYRM---  438 (495)
T ss_dssp             TTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH----HHHHTTCCC---
T ss_pred             cCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcCCCC---
Confidence            543322 2233456789999999999999999999999999999999 99998643321  111    111111100   


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                         ..+     ..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       439 ---~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          439 ---ERP-----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ---CCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ---CCC-----CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence               001     1134578899999999999999999999999998864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9e-45  Score=350.42  Aligned_cols=248  Identities=22%  Similarity=0.269  Sum_probs=202.8

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      .++|++.+.||+|+||+||+|... +|+.||+|++...   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            357889999999999999999976 4899999999643   123356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+++|+|..++...   ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9999999999888542   34889999999999999999999998   99999999999999999999999999975432


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ..  ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+.     ...........        .
T Consensus       158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~--------~  222 (337)
T 1o6l_A          158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEE--------I  222 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC--------C
T ss_pred             CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC--------C
Confidence            21  123345799999999999999999999999999999999999999854221     11111111111        1


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                      ..+..     .+..+.+++.+||+.||++||     ++.|+++
T Consensus       223 ~~p~~-----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCTT-----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCC-----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            11111     345688999999999999999     8998876

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.4e-44  Score=360.15  Aligned_cols=255  Identities=27%  Similarity=0.392  Sum_probs=208.0

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC-ccEEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-EKILI  189 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv  189 (436)
                      ....++|++.+.||+|+||+||+|.++ |+.||||+++...  ..+.+.+|+.+|++++||||+++++++.+.. ..++|
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            345678889999999999999999987 7899999998654  3467999999999999999999999988765 68999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+++|+|.+++... ....+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++....
T Consensus       266 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999643 2234789999999999999999999998   99999999999999999999999999986432


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      .     .....++..|+|||.+.+..++.++||||||+++|||+| |+.||......  ...   ... ......     
T Consensus       342 ~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~---~~i-~~~~~~-----  405 (450)
T 1k9a_A          342 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVV---PRV-EKGYKM-----  405 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THH---HHH-HTTCCC-----
T ss_pred             c-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH---HHH-HcCCCC-----
Confidence            1     112256889999999999999999999999999999998 99998644322  111   111 111100     


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                       ..+     ..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       406 -~~p-----~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          406 -DAP-----DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             -CCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCC-----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence             011     1144578999999999999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.4e-45  Score=350.14  Aligned_cols=259  Identities=25%  Similarity=0.379  Sum_probs=204.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCE----EEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDE----IAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .++|++.+.||+|+||+||+|.+.. ++.    ||+|.+.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            4578899999999999999999654 443    8888875432 233356788999999999999999999886 56789


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        91 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            9999999999999986542  34788899999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .............+|..|+|||.+.+..++.++||||||+++|||+| |+.||.......  .    ...........  
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~~~--  237 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--V----PDLLEKGERLA--  237 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--H----HHHHHTTCBCC--
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--H----HHHHHcCCCCC--
Confidence            65444334445578889999999999999999999999999999999 999986433211  1    11111111110  


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                          ....     .+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus       238 ----~~~~-----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          238 ----QPQI-----CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ----CCTT-----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ----CCCc-----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                0001     223567899999999999999999999999988754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-44  Score=339.70  Aligned_cols=260  Identities=22%  Similarity=0.327  Sum_probs=199.0

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecC----CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      ....++|++.+.||+|+||+||+|.+..    +..||+|.+... .....+.+.+|+.++++++||||+++++++ .++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~   89 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP   89 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCc
Confidence            4456789999999999999999998753    456999998764 344567789999999999999999999997 4567


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++||||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             cEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence            89999999999999998643  234889999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......  ...   ... ...... 
T Consensus       165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~---~~i-~~~~~~-  236 (281)
T 1mp8_A          165 YMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVI---GRI-ENGERL-  236 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH---HHH-HTTCCC-
T ss_pred             ccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHH---HHH-HcCCCC-
Confidence            76543221 1223356788999999999999999999999999999997 89998643321  111   111 111100 


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                           ....     ..+..+.+++.+||+.||++||++.|+++.|+++..
T Consensus       237 -----~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          237 -----PMPP-----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             -----CCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                 0111     134578899999999999999999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.8e-44  Score=343.56  Aligned_cols=271  Identities=26%  Similarity=0.393  Sum_probs=203.8

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEecC----CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEE
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCI  181 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  181 (436)
                      ..+....++|.+.+.||+|+||+||+|.+..    +..||+|++...  .....+.+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            3455667889999999999999999998643    447999999754  4455678999999999999999999999998


Q ss_pred             eCCc-----cEEEEeecCCCChhhhhcCC---CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC
Q 040532          182 DKDE-----KILIYEYMPNKSLDFFLFDP---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD  253 (436)
Q Consensus       182 ~~~~-----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~  253 (436)
                      +.+.     .++||||+++++|.+++...   .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence            7653     49999999999999988422   23346899999999999999999999998   9999999999999999


Q ss_pred             CCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 040532          254 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGY  332 (436)
Q Consensus       254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~  332 (436)
                      +.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||......  ...  
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~--  259 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMY--  259 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH--
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHH--
Confidence            9999999999987654433333334467889999999999999999999999999999999 88888543321  111  


Q ss_pred             HHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          333 VWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                       ... ......      ....     ..+..+.+++.+||+.||++||++.++++.|+++...++.
T Consensus       260 -~~~-~~~~~~------~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~  312 (313)
T 3brb_A          260 -DYL-LHGHRL------KQPE-----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD  312 (313)
T ss_dssp             -HHH-HTTCCC------CCBT-----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             -HHH-HcCCCC------CCCc-----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence             111 111100      0111     1345688999999999999999999999999999876653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.5e-44  Score=348.53  Aligned_cols=279  Identities=16%  Similarity=0.160  Sum_probs=209.7

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCCChhhHH-----------HHHHHHHHHHHcCCCcee
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRSEQGLR-----------EMKNEASVIAKVQHKNLV  174 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~niv  174 (436)
                      ...++|++.+.||+|+||+||+|.+..      ++.||+|++.........           .+..|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            355689999999999999999999765      468999998765432111           123455566677899999


Q ss_pred             EEeeEEEeC----CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE
Q 040532          175 RLLGCCIDK----DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  250 (436)
Q Consensus       175 ~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll  250 (436)
                      ++++++...    ...++||||+ +++|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill  185 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL  185 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence            999998875    3479999999 99999998643  235899999999999999999999998   9999999999999


Q ss_pred             c--CCCCeEEeeccCceecCCCCccc-----ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 040532          251 D--KDMNPKISDFGMARICGGNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  323 (436)
Q Consensus       251 ~--~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~  323 (436)
                      +  .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  88999999999998765332111     1233459999999999999999999999999999999999999986422


Q ss_pred             CCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCCC
Q 040532          324 TDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA  403 (436)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~~  403 (436)
                      ... ........... ......++... .    ....+..+.+++..||+.+|++||++.++++.|+++...........
T Consensus       266 ~~~-~~~~~~~~~~~-~~~~~~~~~~~-~----~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~  338 (364)
T 3op5_A          266 KDP-KYVRDSKIRYR-ENIASLMDKCF-P----AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGK  338 (364)
T ss_dssp             TCH-HHHHHHHHHHH-HCHHHHHHHHS-C----TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             cCH-HHHHHHHHHhh-hhHHHHHHHhc-c----cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCc
Confidence            211 11111111111 11111111100 0    01134578899999999999999999999999999998776665433

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-43  Score=339.70  Aligned_cols=276  Identities=24%  Similarity=0.334  Sum_probs=207.8

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHc--CCCceeEEeeEEEeC--
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV--QHKNLVRLLGCCIDK--  183 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~--  183 (436)
                      .......++|++.+.||+|+||.||+|.++ |+.||+|++.....   ..+..|.+++...  +||||+++++++...  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            344566789999999999999999999987 89999999864322   3445555655554  899999999999887  


Q ss_pred             --CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEecccCCCCEEEcCCCCe
Q 040532          184 --DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS-----RVRIIHRDLKASNILLDKDMNP  256 (436)
Q Consensus       184 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~i~H~Dikp~NIll~~~~~~  256 (436)
                        ...++||||+++|+|.+++...    .+++..+..++.|++.||+|||+..     .++++||||||+|||++.++.+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence              6789999999999999998532    4889999999999999999999880     1129999999999999999999


Q ss_pred             EEeeccCceecCCCCccc--ccccccccCCccchhhhccCCCCcc------cchhhHHHHHHHHHhC----------CCC
Q 040532          257 KISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYALEGIFSIK------SDVFSFGVLLLEIVSG----------KKN  318 (436)
Q Consensus       257 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlGvil~elltg----------~~p  318 (436)
                      ||+|||++..........  ......||+.|+|||++.+..++.+      +|||||||++|||+||          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999998765432211  1234579999999999987766655      9999999999999999          555


Q ss_pred             CCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCC
Q 040532          319 TGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALH  397 (436)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~  397 (436)
                      |............ ..........     .+..+.......++..+.+++.+||+.||++|||+.|+++.|+++....+
T Consensus       262 ~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          262 YHDLVPSDPSYED-MREIVCIKKL-----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             TTTTSCSSCCHHH-HHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             HhhhcCCCCchhh-hHHHHhhhcc-----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            5433222221111 1111111111     11122222233577889999999999999999999999999999886543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.1e-44  Score=349.48  Aligned_cols=255  Identities=22%  Similarity=0.337  Sum_probs=205.5

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ....++|++.+.||+|+||.||+|.+. +|+.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            345678999999999999999999975 4889999999754  3455678899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC---CCeEEeeccCc
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISDFGMA  264 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~---~~~kl~DfGla  264 (436)
                      +||||+++|+|.+++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.+   +.+||+|||++
T Consensus       105 lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EEECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            999999999998888543   34899999999999999999999998   9999999999999865   45999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      .......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     ........... . .
T Consensus       179 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~~~~i~~~~-~-~  248 (362)
T 2bdw_A          179 IEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQIKAGA-Y-D  248 (362)
T ss_dssp             BCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTC-C-C
T ss_pred             eEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhCC-C-C
Confidence            8765332   12335799999999999998999999999999999999999999854221     11111111111 0 0


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                       ...+.    .  ...+..+.+++.+||+.||++||++.|+++.
T Consensus       249 -~~~~~----~--~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 -YPSPE----W--DTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -CCTTG----G--GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -CCccc----c--cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00000    0  1134578899999999999999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.1e-44  Score=349.56  Aligned_cols=247  Identities=20%  Similarity=0.323  Sum_probs=199.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..++|.+.+.||+|+||+||+|.+ .+|+.||+|++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            346899999999999999999997 458899999986431   1123568899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+ +|+|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||++....
T Consensus        87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            99999 67887777432   34899999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ....   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......               ....+.
T Consensus       160 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------------~~~~i~  221 (336)
T 3h4j_B          160 DGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------------LFKKVN  221 (336)
T ss_dssp             TSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------------CBCCCC
T ss_pred             CCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHH
Confidence            3322   233479999999999988776 789999999999999999999985432111               111111


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .....   .....+..+.+++.+||+.||.+|||++|+++
T Consensus       222 ~~~~~---~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          222 SCVYV---MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             SSCCC---CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             cCCCC---CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11000   01113456889999999999999999999976

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=348.59  Aligned_cols=259  Identities=28%  Similarity=0.431  Sum_probs=200.3

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CC----EEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GD----EIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .++|++.+.||+|+||+||+|.+.. ++    +||+|.+... .....+.+.+|+.++++++||||+++++++... ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence            4679999999999999999999653 44    3688887643 334467889999999999999999999999865 488


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +|+||+++|+|.+++....  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            9999999999999986433  34889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......  ..    .........   
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~----~~~~~~~~~---  238 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS----SILEKGERL---  238 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH----HHHHTTCCC---
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcCCCC---
Confidence            54433333334467889999999999999999999999999999999 999986433221  11    111111100   


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                         .....     .+..+.+++.+||+.||++||++.|+++.|+++...
T Consensus       239 ---~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          239 ---PQPPI-----CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---CCCTT-----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---CCCcc-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence               00111     334688999999999999999999999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6e-44  Score=350.86  Aligned_cols=255  Identities=22%  Similarity=0.298  Sum_probs=208.1

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ...+.|++.+.||+|+||+||+|... +|+.||+|.+..........+.+|+.++++++||||+++++++.+.+..++||
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            34578999999999999999999976 48899999998776666678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC--CCCeEEeeccCceecC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNPKISDFGMARICG  268 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~--~~~~kl~DfGla~~~~  268 (436)
                      ||+++|+|.+++....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||++....
T Consensus       128 E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          128 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence            9999999999886432  34899999999999999999999998   999999999999974  5789999999998765


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .............   ...
T Consensus       203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~i~~~~~~---~~~  271 (387)
T 1kob_A          203 PDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQNVKRCDWE---FDE  271 (387)
T ss_dssp             TTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHHCCCC---CCS
T ss_pred             CCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC---CCc
Confidence            4322   2234789999999999999999999999999999999999999854321     1111111111100   001


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ...      ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       272 ~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          272 DAF------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             STT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccc------ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            110      1134578899999999999999999999873

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-44  Score=336.68  Aligned_cols=267  Identities=25%  Similarity=0.379  Sum_probs=214.1

Q ss_pred             hccCCCCCc-ccCCCCceeEEEEEec---CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          113 ATNTFSDTN-KLGEGGFGPVYKGVLR---KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       113 ~~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ..++|.+.+ .||+|+||.||+|.+.   ++..||+|++... .....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            345666666 8999999999999854   4778999999864 445567899999999999999999999999 566789


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        86 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence            999999999999998643  335899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          268 GGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       268 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......  ..   . ........   
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~---~-~~i~~~~~---  231 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EV---M-AFIEQGKR---  231 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HH---H-HHHHTTCC---
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HH---H-HHHhcCCc---
Confidence            543321 22233456889999999998999999999999999999998 99998543221  11   1 11111111   


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCC
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP  402 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~  402 (436)
                         ...+.     ..+..+.+++.+||+.||++||++.++++.|+++..+...+..+
T Consensus       232 ---~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~  280 (287)
T 1u59_A          232 ---MECPP-----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG  280 (287)
T ss_dssp             ---CCCCT-----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred             ---CCCCC-----CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence               01111     13457889999999999999999999999999998776655443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1e-43  Score=337.75  Aligned_cols=264  Identities=22%  Similarity=0.356  Sum_probs=206.1

Q ss_pred             ccCCCCCcccCCCCceeEEEEEe-----cCCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--Cc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVL-----RKGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DE  185 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  185 (436)
                      .+.|++.+.||+|+||.||+|.+     .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            45688899999999999999983     34889999999754 333457889999999999999999999999876  56


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            799999999999999985422  34899999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC---------CCcchhHHHHH
Q 040532          266 ICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT---------DSLNLLGYVWD  335 (436)
Q Consensus       266 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~---------~~~~~~~~~~~  335 (436)
                      ........ .......||..|+|||.+.+..++.++||||||+++|||++|+.|+.....         ...........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            76544321 223345688889999999999999999999999999999999988532210         00000011111


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                      ........      ...     ...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       255 ~~~~~~~~------~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          255 TLKEGKRL------PCP-----PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHTTCCC------CCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhccCCC------CCC-----CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11111100      001     113457889999999999999999999999999865

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=344.12  Aligned_cols=255  Identities=24%  Similarity=0.328  Sum_probs=198.4

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCC--CceeEEeeEEEeCCcc
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKDEK  186 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~  186 (436)
                      ....++|++.+.||+|+||+||++...+++.||+|++...  .....+.+.+|+.++.+++|  |||+++++++.+.+..
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            4456789999999999999999999988999999998643  44556788999999999976  9999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||| +.+++|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|||++..
T Consensus        85 ~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EEEEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence            99999 5688999998643   34889999999999999999999998   99999999999997 57899999999987


Q ss_pred             cCCCCcccccccccccCCccchhhhcc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALE-----------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  335 (436)
                      ..............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....    .......
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~  232 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QISKLHA  232 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHHHHH
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----HHHHHHH
Confidence            654433333344579999999999875           6789999999999999999999999853221    1111111


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ........      ..+..     ....+.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~------~~~~~-----~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          233 IIDPNHEI------EFPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHCTTSCC------CCCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhcCCccc------CCccc-----CCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            11111111      01111     12467899999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.6e-44  Score=341.61  Aligned_cols=269  Identities=27%  Similarity=0.373  Sum_probs=215.3

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEe------cCCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeE
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVL------RKGDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGC  179 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~  179 (436)
                      .......++|++.+.||+|+||+||+|.+      .+++.||+|++... .....+.+.+|+.++.++ +||||++++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            34455678899999999999999999984      23678999999765 344557789999999999 79999999999


Q ss_pred             EEeCC-ccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCC
Q 040532          180 CIDKD-EKILIYEYMPNKSLDFFLFDPTK-------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKA  245 (436)
Q Consensus       180 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp  245 (436)
                      +...+ ..++||||+++++|.+++.....             ...+++..+..++.|++.||.|||+.+   ++||||||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp  176 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  176 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence            88755 48999999999999999865432             223788999999999999999999998   99999999


Q ss_pred             CCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 040532          246 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRT  324 (436)
Q Consensus       246 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~  324 (436)
                      +||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus       177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~  256 (316)
T 2xir_A          177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  256 (316)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence            999999999999999999987654433333344567889999999999999999999999999999998 9999854332


Q ss_pred             CCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          325 DSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      ..     .............      ....     .+..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       257 ~~-----~~~~~~~~~~~~~------~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          257 DE-----EFCRRLKEGTRMR------APDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             SH-----HHHHHHHHTCCCC------CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hH-----HHHHHhccCccCC------CCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            21     1111111111110      1111     234688999999999999999999999999998754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=349.89  Aligned_cols=276  Identities=21%  Similarity=0.309  Sum_probs=217.0

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC--ccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~  187 (436)
                      ...++|++.+.||+|+||+||+|.+.. |+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+  ..+
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            456789999999999999999999765 8999999997532 233567789999999999999999999998765  669


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE----cCCCCeEEeeccC
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGM  263 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll----~~~~~~kl~DfGl  263 (436)
                      +||||+++|+|.+++........+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            99999999999999976555555899999999999999999999998   9999999999999    7788899999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhcc--------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALE--------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  335 (436)
                      ++......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||......... ......
T Consensus       163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~  238 (396)
T 4eut_A          163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYK  238 (396)
T ss_dssp             CEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-HHHHHH
T ss_pred             ceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-HHHHHH
Confidence            98765432   2233579999999999875        56788999999999999999999999654432222 222222


Q ss_pred             HhhcCCc--ceecc----------CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          336 LWTSNRT--LELID----------DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       336 ~~~~~~~--~~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      .......  .....          ................+.+++.+||+.||++||++.|+++.+++++.
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            2222110  00000          00011111224467788999999999999999999999999988764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-44  Score=335.49  Aligned_cols=258  Identities=28%  Similarity=0.401  Sum_probs=210.8

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ..++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            4567889999999999999999998888999999986533 236789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           85 MEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             CTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             CCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            99999999986432  34789999999999999999999998   99999999999999999999999999976543221


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                       .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....     ............       ...
T Consensus       160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~i~~~~~-------~~~  226 (267)
T 3t9t_A          160 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDISTGFR-------LYK  226 (267)
T ss_dssp             -HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTCC-------CCC
T ss_pred             -cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHHHhcCCc-------CCC
Confidence             12223457788999999999999999999999999999999 8999854321     111111111110       000


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      +..     .+..+.+++.+||+.||++||++.++++.|+++..
T Consensus       227 ~~~-----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          227 PRL-----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Ccc-----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            111     23468899999999999999999999999998864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.1e-44  Score=349.03  Aligned_cols=255  Identities=22%  Similarity=0.315  Sum_probs=203.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-----ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-----SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      ..+.|++.+.||+|+||+||+|.+. +|+.||+|++...     .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3567899999999999999999975 4899999998532     112356789999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC---eEEeecc
Q 040532          187 ILIYEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFG  262 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~---~kl~DfG  262 (436)
                      ++||||+++++|.+++... .....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999998777432 22335889999999999999999999998   999999999999986655   9999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....   .   ............
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~---~~~~~i~~~~~~  250 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---E---RLFEGIIKGKYK  250 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---H---HHHHHHHHTCCC
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---H---HHHHHHHcCCCC
Confidence            9987654322  1233479999999999999999999999999999999999999985421   1   111111111100


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .       .....  ...+..+.+++.+||+.||++|||+.|+++
T Consensus       251 ~-------~~~~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 M-------NPRQW--SHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             C-------CHHHH--TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C-------Ccccc--ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0       00000  113457889999999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-43  Score=334.33  Aligned_cols=256  Identities=26%  Similarity=0.486  Sum_probs=202.3

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChh---h----HHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQ---G----LREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++......   .    .+.+.+|+.++++++||||+++++++.+. 
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   95 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-   95 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence            4578999999999999999999975 5889999999654221   1    16789999999999999999999998554 


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC-----eEEe
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-----PKIS  259 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~-----~kl~  259 (436)
                       .++||||+++|+|.+++....  ..+++.....++.|++.||+|||+.+ ++++||||||+||+++.++.     +||+
T Consensus        96 -~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           96 -PRMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             -TEEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             -CeEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence             479999999999988886533  35899999999999999999999875 34999999999999988776     9999


Q ss_pred             eccCceecCCCCcccccccccccCCccchhhhc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh
Q 040532          260 DFGMARICGGNELQANTSRIVGTYGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      |||+++....     ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||...........   ....
T Consensus       172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~  243 (287)
T 4f0f_A          172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI---NMIR  243 (287)
T ss_dssp             CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH---HHHH
T ss_pred             CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH---HHHh
Confidence            9999975332     223357899999999984  45678999999999999999999999865443222111   1111


Q ss_pred             hcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          338 TSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      .....      +....     ..+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       244 ~~~~~------~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 EEGLR------PTIPE-----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HSCCC------CCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ccCCC------CCCCc-----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11110      11111     1345788999999999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.8e-44  Score=356.38  Aligned_cols=254  Identities=22%  Similarity=0.296  Sum_probs=203.5

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ...++|++.+.||+|+||+||+|... +|+.+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            45677999999999999999999865 58899999987543  3445678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc---CCCCeEEeeccCce
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMAR  265 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~---~~~~~kl~DfGla~  265 (436)
                      ||||+++|+|.+.+...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++   +++.+||+|||++.
T Consensus        88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999998888543   34899999999999999999999998   99999999999998   56789999999997


Q ss_pred             ecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      .......  ......||+.|+|||++.+..++.++||||+||++|+|++|..||.....     .............   
T Consensus       162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~---  231 (444)
T 3soa_A          162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----HRLYQQIKAGAYD---  231 (444)
T ss_dssp             CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTCCC---
T ss_pred             EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHhCCCC---
Confidence            6653321  22345799999999999999999999999999999999999999853221     1111111111100   


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...+..      ...+..+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          232 FPSPEW------DTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCTTTT------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCcccc------ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            001100      113457889999999999999999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2e-44  Score=347.61  Aligned_cols=267  Identities=26%  Similarity=0.360  Sum_probs=213.2

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCI  181 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  181 (436)
                      .....++|++.+.||+|+||+||+|.+..      +..||+|.+... .....+.+.+|+.++.++ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            44556889999999999999999999653      247999999765 344567789999999999 8999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCC-----------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPT-----------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  250 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll  250 (436)
                      +.+..++||||+++|+|.+++....           ....+++..+..++.|++.||+|||+.+   ++||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence            9999999999999999999885421           1235789999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 040532          251 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNL  329 (436)
Q Consensus       251 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~  329 (436)
                      +.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......   
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---  274 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---  274 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---
Confidence            9999999999999986543332222333467889999999999999999999999999999999 889985432211   


Q ss_pred             hHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          330 LGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                        ............      ..+..     .+..+.+++.+||+.||.+|||+.|+++.|++....
T Consensus       275 --~~~~~~~~~~~~------~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          275 --KFYKLVKDGYQM------AQPAF-----APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             --HHHHHHHHTCCC------CCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHhcCCCC------CCCCC-----CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence              111111111100      00111     234688999999999999999999999999987653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.8e-44  Score=336.56  Aligned_cols=261  Identities=23%  Similarity=0.339  Sum_probs=198.3

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCCh--hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|++.+.||+|+||+||+|....|+.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888999999999999999998799999999975432  2246788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +++ +|.+++....  ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....... 
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            986 8888775432  34889999999999999999999998   9999999999999999999999999997654322 


Q ss_pred             ccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc---ee---
Q 040532          273 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL---EL---  345 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~---  345 (436)
                       .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....  .................   ..   
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHHCCCChhhchhhhcc
Confidence             112234689999999999764 589999999999999999999999864321  11111111111111000   00   


Q ss_pred             ---------ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 ---------IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                               .........  ....+..+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESF--LKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGT--CCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccCccHHHH--hhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                     000000000  0113456889999999999999999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=352.23  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=198.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  187 (436)
                      ..++|++.+.||+|+||+||+|+.+. |+.||+|++...   .....+.+.+|..++..+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            34689999999999999999999764 889999999743   223456678999999998 7999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|..++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            999999999999988543   34899999999999999999999998   999999999999999999999999999754


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...........       
T Consensus       175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~-------  240 (353)
T 3txo_A          175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDE-------  240 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC-------
T ss_pred             ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC-------
Confidence            3222  223345799999999999998999999999999999999999999854321     11122221111       


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTM------NDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~ev~~  387 (436)
                       ...+..     .+..+.+++.+||+.||++||++      .|+++
T Consensus       241 -~~~p~~-----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 -VVYPTW-----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -CCCCTT-----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -CCCCCC-----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence             111111     33468889999999999999998      66664

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.6e-43  Score=335.09  Aligned_cols=264  Identities=20%  Similarity=0.280  Sum_probs=199.5

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|++...  .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46889999999999999999976 4889999999644  33345778899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |++++.+..+...   ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9987555544432   234899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccCCccchhhhccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce---ecc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE---LID  347 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  347 (436)
                        .......||+.|+|||++.+.. ++.++|||||||++|||++|+.|+-..... ......+...........   ...
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhhhhhhcc
Confidence              2223347899999999998766 899999999999999999998885322111 111111122111110000   000


Q ss_pred             ------CCccc----cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 ------DPVLE----DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ------~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                            .+...    ........+..+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                  00000    00000113457889999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=334.07  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=194.7

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh--------------------------hhHHHHHHHHHHHH
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE--------------------------QGLREMKNEASVIA  166 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  166 (436)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            467999999999999999999975 488899999865421                          12356889999999


Q ss_pred             HcCCCceeEEeeEEEe--CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccC
Q 040532          167 KVQHKNLVRLLGCCID--KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  244 (436)
Q Consensus       167 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dik  244 (436)
                      +++||||+++++++.+  .+..++||||+++++|.+++.    ...+++.....++.|++.||+|||+.+   ++|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  567899999999999987653    235899999999999999999999998   9999999


Q ss_pred             CCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCC---CCcccchhhHHHHHHHHHhCCCCCCC
Q 040532          245 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGL  321 (436)
Q Consensus       245 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~  321 (436)
                      |+|||++.++.+||+|||++........  ......||+.|+|||.+.+..   ++.++|||||||++|||++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987654322  123347999999999988655   47889999999999999999999853


Q ss_pred             CCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          322 YRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..     ............ . ..   +.. .     ..+..+.+++.+||+.||++||++.|+++
T Consensus       243 ~~-----~~~~~~~~~~~~-~-~~---~~~-~-----~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ER-----IMCLHSKIKSQA-L-EF---PDQ-P-----DIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SS-----HHHHHHHHHHCC-C-CC---CSS-S-----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cc-----HHHHHHHHhccc-C-CC---CCc-c-----ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            22     111111111111 0 00   000 0     13456889999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.4e-44  Score=368.57  Aligned_cols=271  Identities=27%  Similarity=0.425  Sum_probs=218.1

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .......++|++.+.||+|+||+||+|.++++..||||++.... ...+.+.+|+.+|++++||||+++++++.+ +..+
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            34456677889999999999999999999888889999998643 234679999999999999999999999876 6789


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|.+++... ....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++..
T Consensus       338 lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            999999999999999532 2234889999999999999999999998   999999999999999999999999999765


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ..... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.....     .+..... .......  
T Consensus       414 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----~~~~~~i-~~~~~~~--  484 (535)
T 2h8h_A          414 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQV-ERGYRMP--  484 (535)
T ss_dssp             CCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----HHHHHHH-HTTCCCC--
T ss_pred             CCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH-HcCCCCC--
Confidence            43221 12223356788999999999999999999999999999999 8999854321     1111111 1111000  


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCC
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP  402 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~  402 (436)
                          ...     .++..+.+++.+||+.||++|||+.+|++.|+++.....+..++
T Consensus       485 ----~~~-----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~  531 (535)
T 2h8h_A          485 ----CPP-----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  531 (535)
T ss_dssp             ----CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC
T ss_pred             ----CCC-----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccCc
Confidence                011     13457889999999999999999999999999998877766544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.5e-44  Score=354.21  Aligned_cols=260  Identities=19%  Similarity=0.236  Sum_probs=205.1

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ......++|++.+.||+|+||+||+|+++. ++.||+|++....   ......+.+|..++.+++||||++++++|.+.+
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            345567889999999999999999999775 7889999986421   111234789999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhh
Confidence            9999999999999999996532  34899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS  339 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  339 (436)
                      +....... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||.....     ..........
T Consensus       223 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-----~~~~~~i~~~  296 (437)
T 4aw2_A          223 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNH  296 (437)
T ss_dssp             EECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTH
T ss_pred             hhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-----hHHHHhhhhc
Confidence            87654332 2223358999999999997     46689999999999999999999999854321     1111111111


Q ss_pred             CCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 040532          340 NRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADD--RPTMNDVVS  387 (436)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~ev~~  387 (436)
                      .....      .+....  ..+..+.+++.+||..+|++  ||+++|+++
T Consensus       297 ~~~~~------~p~~~~--~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          297 KERFQ------FPTQVT--DVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHCC------CCSSCC--CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ccccc------CCcccc--cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            00000      010000  03456888999999888888  999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-44  Score=343.14  Aligned_cols=245  Identities=24%  Similarity=0.303  Sum_probs=202.3

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      .++|++.+.||+|+||+||+|... +|+.||+|++....   ....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            357889999999999999999976 58999999986431   12346788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+++|+|.+++...   ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            9999999999998643   34889999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      .     ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||....     ............        .
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~--------~  220 (318)
T 1fot_A          159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNAE--------L  220 (318)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHCC--------C
T ss_pred             c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCC--------C
Confidence            2     233579999999999999999999999999999999999999985422     111222222111        0


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                      ..+..     .+..+.+++.+||+.||++||     +++|+++
T Consensus       221 ~~p~~-----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 RFPPF-----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CCCTT-----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCC-----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            11111     334688999999999999999     8888874

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=348.07  Aligned_cols=246  Identities=26%  Similarity=0.346  Sum_probs=196.4

Q ss_pred             CcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          120 TNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      .+.||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            567999999999999975 4889999999887766678899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE--cCCCCeEEeeccCceecCCCCccccc
Q 040532          199 DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--DKDMNPKISDFGMARICGGNELQANT  276 (436)
Q Consensus       199 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll--~~~~~~kl~DfGla~~~~~~~~~~~~  276 (436)
                      .+++...  ...+++.....++.|++.||+|||+.+   |+||||||+|||+  ++++.+||+|||++........   .
T Consensus       174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~  245 (373)
T 2x4f_A          174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L  245 (373)
T ss_dssp             HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred             HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence            8887542  234889999999999999999999998   9999999999999  5678899999999987654332   2


Q ss_pred             ccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccc
Q 040532          277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYS  356 (436)
Q Consensus       277 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (436)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ..............   ..    ... 
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~~~~~~---~~----~~~-  312 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----AETLNNILACRWDL---ED----EEF-  312 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTCCCS---CS----GGG-
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhccCCC---Ch----hhh-
Confidence            234699999999999999999999999999999999999999854321     11112221111100   00    000 


Q ss_pred             hHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          357 SKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       357 ~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ...+..+.+++.+||+.||.+||++.|+++
T Consensus       313 -~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          313 -QDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             113457889999999999999999999987

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.8e-44  Score=337.64  Aligned_cols=264  Identities=28%  Similarity=0.423  Sum_probs=215.2

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ......++|++.+.||+|+||+||+|.+.. +..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            445567889999999999999999999765 7889999997643 34578899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        86 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999998643 2345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......  ...    .........   
T Consensus       162 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~----~~~~~~~~~---  231 (288)
T 3kfa_A          162 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY----ELLEKDYRM---  231 (288)
T ss_dssp             CSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH----HHHHTTCCC---
T ss_pred             cCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHhccCCC---
Confidence            54332 22233457888999999999999999999999999999999 99998643321  111    111111000   


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                         ....     ..+..+.+++.+||+.||++||++.++++.|+++...
T Consensus       232 ---~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          232 ---ERPE-----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             ---CCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCC-----CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence               0011     1345788999999999999999999999999987653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=346.41  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=202.8

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..++|++.+.||+|+||.||++.... ++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            34679999999999999999999764 7889999986431   2235678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++|+|..++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        93 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             EECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999999998653   34899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCccchhhhcc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ...   .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.......  ............     
T Consensus       167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~~~-----  236 (384)
T 4fr4_A          167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFETTV-----  236 (384)
T ss_dssp             TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHHHCC-----
T ss_pred             CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhhcc-----
Confidence            332   2334579999999999974   458999999999999999999999996433222  111111111111     


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT-MNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~ev~~  387 (436)
                         ...+..     .+..+.+++.+||+.||++||+ ++++.+
T Consensus       237 ---~~~p~~-----~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 ---VTYPSA-----WSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---CCCCTT-----SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---cCCCCc-----CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               011111     3456889999999999999998 666654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.9e-43  Score=346.09  Aligned_cols=274  Identities=17%  Similarity=0.233  Sum_probs=206.1

Q ss_pred             hhhhccCCCCCcccCCC--CceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          110 VSTATNTFSDTNKLGEG--GFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      .....++|++.+.||+|  +||+||+|.+. +|+.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            34456789999999999  99999999976 5899999999743  3455677889999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             EEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccc
Confidence            9999999999999999986432 234899999999999999999999998   999999999999999999999999998


Q ss_pred             eecCCCC-----cccccccccccCCccchhhhcc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh
Q 040532          265 RICGGNE-----LQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       265 ~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      .......     .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||......... ........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~  254 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTV  254 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH-HHC-----
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHhcCCC
Confidence            7542211     1111223478999999999987  57999999999999999999999999653322110 00000000


Q ss_pred             ----hc-----CC-------------cceecc----C---CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          338 ----TS-----NR-------------TLELID----D---PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       338 ----~~-----~~-------------~~~~~~----~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                          ..     ..             ......    .   ............+..+.+++.+||+.||++|||+.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                00     00             000000    0   0000000111234568899999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-44  Score=342.08  Aligned_cols=255  Identities=24%  Similarity=0.375  Sum_probs=203.5

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-C-------CEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-G-------DEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ..++|++.+.||+|+||+||+|.+.. +       ..||+|++........+.+.+|+.++++++||||+++++++.+.+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            35678899999999999999998654 3       469999997766666788999999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC--------e
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--------P  256 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~--------~  256 (436)
                      ..++||||+++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.        +
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999996432  33889999999999999999999998   999999999999998887        9


Q ss_pred             EEeeccCceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCC-CCCCCCCcchhHHHH
Q 040532          257 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNT-GLYRTDSLNLLGYVW  334 (436)
Q Consensus       257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~-~~~~~~~~~~~~~~~  334 (436)
                      ||+|||++.....      .....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+ ....     .... .
T Consensus       161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~-~  228 (289)
T 4fvq_A          161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRK-L  228 (289)
T ss_dssp             EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHH-H
T ss_pred             eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHHH-H
Confidence            9999999864322      122357889999999987 67899999999999999999965543 2211     1111 1


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCC
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALH  397 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~  397 (436)
                      ......        ......     .+..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       229 ~~~~~~--------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          229 QFYEDR--------HQLPAP-----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             HHHHTT--------CCCCCC-----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             HHhhcc--------CCCCCC-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            111111        011111     12347789999999999999999999999999886433

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=339.65  Aligned_cols=247  Identities=22%  Similarity=0.258  Sum_probs=193.0

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  187 (436)
                      ...++|+..+.||+|+||+||+|.+. +|+.||||++...  ..........|+..+.++ +||||+++++++.+++..+
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            34478999999999999999999986 5899999998653  333344555666666555 9999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+ +++|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       134 lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            999999 66887777543  235899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ....   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....         .+........     
T Consensus       208 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~~~~~~-----  269 (311)
T 3p1a_A          208 GTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQLRQGYL-----  269 (311)
T ss_dssp             C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHHTTTCC-----
T ss_pred             ccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHhccCC-----
Confidence            5332   2233468999999998875 78999999999999999999977652210         0111111110     


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                          .... ....+..+.+++.+||+.||++|||+.|+++
T Consensus       270 ----~~~~-~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 ----PPEF-TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ----CHHH-HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----Cccc-ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                0000 0113457899999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.2e-43  Score=334.88  Aligned_cols=267  Identities=25%  Similarity=0.353  Sum_probs=208.0

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecC----CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe-CC
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCID-KD  184 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~  184 (436)
                      .....+|++.+.||+|+||+||+|.+.+    +..+|+|.+... .....+.+.+|+.++++++||||+++++++.. ++
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            3445678889999999999999998643    235899998764 44556789999999999999999999998654 56


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a  175 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA  175 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred             ceEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccc
Confidence            7799999999999999996533  34789999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcc--cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          265 RICGGNELQ--ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       265 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      .........  .......+|+.|+|||.+.+..++.++||||||+++|||++| .+||......  ...   ........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~---~~~~~~~~  250 (298)
T 3f66_A          176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DIT---VYLLQGRR  250 (298)
T ss_dssp             CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THH---HHHHTTCC
T ss_pred             ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHH---HHHhcCCC
Confidence            866543221  122334678899999999999999999999999999999995 5555432221  111   11111110


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCC
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP  399 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~  399 (436)
                             ...+..     .+..+.+++.+||+.||++||++.|+++.|+++.....+.
T Consensus       251 -------~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~  296 (298)
T 3f66_A          251 -------LLQPEY-----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  296 (298)
T ss_dssp             -------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred             -------CCCCcc-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence                   000111     2346889999999999999999999999999998766543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=340.26  Aligned_cols=272  Identities=22%  Similarity=0.247  Sum_probs=210.4

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe----CC
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID----KD  184 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~  184 (436)
                      +....++|++.+.||+|+||.||++.. .+|+.||+|++........+.+.+|+.++++++||||+++++++..    ..
T Consensus        24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            445567899999999999999999997 4589999999977666777889999999999999999999999873    34


Q ss_pred             ccEEEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          185 EKILIYEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      ..++||||+++|+|.+++... .....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCc
Confidence            678999999999999888542 12345899999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCccc-------ccccccccCCccchhhhccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHH
Q 040532          264 ARICGGNELQA-------NTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV  333 (436)
Q Consensus       264 a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  333 (436)
                      +..........       ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||............. 
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-  259 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-  259 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH-
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH-
Confidence            87653211100       112235799999999987554   6899999999999999999999984321111111110 


Q ss_pred             HHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCC
Q 040532          334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP  399 (436)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~  399 (436)
                         ....     ...+..      ...+..+.+++.+||+.||.+||++.++++.|+.+....+++
T Consensus       260 ---~~~~-----~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  311 (317)
T 2buj_A          260 ---VQNQ-----LSIPQS------PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ  311 (317)
T ss_dssp             ---HHCC-------CCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred             ---hhcc-----CCCCcc------ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence               0000     000000      113457889999999999999999999999999887554444

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.2e-43  Score=347.25  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=198.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  187 (436)
                      ..++|++.+.||+|+||+||+|+.+. ++.||+|++...   .....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            45679999999999999999999765 778999998743   223345678899999887 8999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|..++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       130 lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            999999999999888543   34899999999999999999999998   999999999999999999999999999753


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC---cchhHHHHHHhhcCCcce
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS---LNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  344 (436)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ...............   
T Consensus       204 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---  278 (396)
T 4dc2_A          204 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---  278 (396)
T ss_dssp             CCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred             ccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence            2221  22344589999999999999999999999999999999999999996432211   111122222211111   


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTM  382 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  382 (436)
                          ...+..     .+..+.+++.+||+.||++||++
T Consensus       279 ----~~~p~~-----~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 ----IRIPRS-----LSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ----CCCCTT-----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ----cCCCCc-----CCHHHHHHHHHHhcCCHhHcCCC
Confidence                111111     34568899999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=344.40  Aligned_cols=276  Identities=24%  Similarity=0.258  Sum_probs=199.7

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEe---
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCCID---  182 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~---  182 (436)
                      ..+.....+|++.+.||+|+||.||+|.+. +|+.||+|++........+.+.+|+.++.++. ||||+++++++..   
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            344556678999999999999999999975 58899999997776666788999999999996 9999999999853   


Q ss_pred             -----CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeE
Q 040532          183 -----KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  257 (436)
Q Consensus       183 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~k  257 (436)
                           ....++||||++ |+|.+++........+++..+..++.|++.||+|||+.+ ++++||||||+|||++.++.+|
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEE
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEE
Confidence                 334689999996 688887754333445899999999999999999999875 3499999999999999999999


Q ss_pred             EeeccCceecCCCCccc----------ccccccccCCccchhhh---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 040532          258 ISDFGMARICGGNELQA----------NTSRIVGTYGYMSPEYA---LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  324 (436)
Q Consensus       258 l~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~  324 (436)
                      |+|||++..........          ......||+.|+|||++   .+..++.++||||||+++|||++|+.||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            99999998765332111          11134689999999998   466789999999999999999999999853221


Q ss_pred             CCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCCCc
Q 040532          325 DSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAF  404 (436)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~~~  404 (436)
                      ..     ..    .     .....+. ...     ....+.+++.+||+.||++||++.|+++.|+.+..........+.
T Consensus       259 ~~-----~~----~-----~~~~~~~-~~~-----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~  318 (337)
T 3ll6_A          259 LR-----IV----N-----GKYSIPP-HDT-----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI  318 (337)
T ss_dssp             ---------------------CCCCT-TCC-----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred             HH-----hh----c-----CcccCCc-ccc-----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccH
Confidence            10     00    0     0000000 011     123477899999999999999999999999999877655544443


Q ss_pred             c
Q 040532          405 S  405 (436)
Q Consensus       405 ~  405 (436)
                      .
T Consensus       319 ~  319 (337)
T 3ll6_A          319 T  319 (337)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=345.51  Aligned_cols=261  Identities=12%  Similarity=0.117  Sum_probs=210.0

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEE------ecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC---CCceeEEee
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGV------LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ---HKNLVRLLG  178 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~  178 (436)
                      .+.....++|++.+.||+|+||+||+|.      ...++.||+|++.....   .++..|..++.+++   |+||+.+++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            4455667889999999999999999994      34588999999976543   46778888888886   999999999


Q ss_pred             EEEeCCccEEEEeecCCCChhhhhcCC--CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC----
Q 040532          179 CCIDKDEKILIYEYMPNKSLDFFLFDP--TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK----  252 (436)
Q Consensus       179 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~----  252 (436)
                      ++...+..++||||+++|+|.+++...  .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence            999999999999999999999998532  12345899999999999999999999988   999999999999998    


Q ss_pred             -------CCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 040532          253 -------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD  325 (436)
Q Consensus       253 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~  325 (436)
                             ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   8999999999997654332233344557999999999999999999999999999999999999998432111


Q ss_pred             CcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHHhhccccC
Q 040532          326 SLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDR-PTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Ps~~ev~~~L~~~~~~~  396 (436)
                      .                 ... ....... .   ....+.+++..|++.+|.+| |++.++.+.|++.....
T Consensus       292 ~-----------------~~~-~~~~~~~-~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          292 E-----------------CKP-EGLFRRL-P---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             E-----------------EEE-CSCCTTC-S---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             c-----------------eee-chhcccc-C---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            0                 000 1111111 1   23457789999999999999 67899999998887653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-43  Score=333.95  Aligned_cols=265  Identities=24%  Similarity=0.314  Sum_probs=208.3

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-C---CEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc-EE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-G---DEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK-IL  188 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~l  188 (436)
                      ..|...+.||+|+||+||+|.+.+ +   ..+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            346667899999999999998543 2   36999999764 345567889999999999999999999999876665 99


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+.+|+|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus       101 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999999996533  34789999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCc--ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          269 GNEL--QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       269 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ....  ........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.... ........    ......    
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~----~~~~~~----  246 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHF----LAQGRR----  246 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHH----HHTTCC----
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHH----hhcCCC----
Confidence            3321  122233467889999999999999999999999999999999665542211 11111111    111110    


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCC
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPK  400 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~  400 (436)
                        ......     .+..+.+++.+||+.||++|||+.++++.|+++...+.+..
T Consensus       247 --~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~  293 (298)
T 3pls_A          247 --LPQPEY-----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH  293 (298)
T ss_dssp             --CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred             --CCCCcc-----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence              000111     33468899999999999999999999999999988766544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.9e-43  Score=342.30  Aligned_cols=214  Identities=29%  Similarity=0.347  Sum_probs=184.6

Q ss_pred             ccCCCCccccchhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-----CC
Q 040532           98 EVDQLPLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-----HK  171 (436)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~  171 (436)
                      +......+++.......++|++.+.||+|+||+||+|.+. +++.||+|++... ......+..|+.+++.++     ||
T Consensus        18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~   96 (360)
T 3llt_A           18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNN   96 (360)
T ss_dssp             --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred             cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCC
Confidence            3344556777778888999999999999999999999974 5889999999753 344567788999999996     99


Q ss_pred             ceeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc
Q 040532          172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  251 (436)
Q Consensus       172 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~  251 (436)
                      ||+++++++...+..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++
T Consensus        97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~  171 (360)
T 3llt_A           97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLD  171 (360)
T ss_dssp             GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred             CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEc
Confidence            9999999999999999999999 999999886432 234889999999999999999999998   99999999999997


Q ss_pred             C-------------------------CCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHH
Q 040532          252 K-------------------------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFG  306 (436)
Q Consensus       252 ~-------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG  306 (436)
                      .                         ++.+||+|||++......     .....||+.|+|||++.+..++.++||||||
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  246 (360)
T 3llt_A          172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFG  246 (360)
T ss_dssp             CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred             cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence            5                         789999999999864432     2334789999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCC
Q 040532          307 VLLLEIVSGKKNTGLY  322 (436)
Q Consensus       307 vil~elltg~~p~~~~  322 (436)
                      |++|||++|+.||...
T Consensus       247 ~il~ell~g~~pf~~~  262 (360)
T 3llt_A          247 CVLAELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHHHHHSSCSCCCS
T ss_pred             HHHHHHHHCCCCCCCC
Confidence            9999999999999643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.4e-43  Score=330.62  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=205.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3467889999999999999999976 5889999998643 3344577899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            999999999998543   34899999999999999999999998   999999999999999999999999999865433


Q ss_pred             CcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ..........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||............+     ......    ..
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~----~~  229 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKTY----LN  229 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH-----HTTCTT----ST
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh-----hhcccc----cC
Confidence            32223344578999999999987765 789999999999999999999996544322211111     111000    00


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .      ....+..+.+++.+||+.||++|||+.|+++
T Consensus       230 ~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 P------WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             T------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            0      0113456889999999999999999999876

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=342.36  Aligned_cols=264  Identities=28%  Similarity=0.442  Sum_probs=205.1

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-----CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-----GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      ...++|+..+.||+|+||+||+|.+..     +..||+|.+... .......+.+|+.++++++||||+++++++.+.+.
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            345678888999999999999998653     235999999764 44456678999999999999999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence            99999999999999998643  234899999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCc-ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcc
Q 040532          266 ICGGNEL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTL  343 (436)
Q Consensus       266 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  343 (436)
                      ....... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....     ....... ......
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~~~-~~~~~~  269 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAI-NDGFRL  269 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHH-HTTCCC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHH-HCCCcC
Confidence            7653321 112222356788999999999999999999999999999999 9999854321     1111111 111100


Q ss_pred             eeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCC
Q 040532          344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALH  397 (436)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~  397 (436)
                           + ...     ..+..+.+++.+||+.||++||++.++++.|+++.....
T Consensus       270 -----~-~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          270 -----P-TPM-----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             -----C-CCT-----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             -----C-Ccc-----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                 0 011     134568899999999999999999999999999886543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=344.66  Aligned_cols=254  Identities=21%  Similarity=0.285  Sum_probs=190.7

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      .....++|++.+.||+|+||+||+|.+.. ++.||+|++....  ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            44567889999999999999999999864 7889999997543  23568899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---CCCeEEeeccCce
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMAR  265 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~~~~kl~DfGla~  265 (436)
                      ||||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+|||++.   ++.+||+|||++.
T Consensus       126 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             EECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            99999999999988643   34899999999999999999999998   999999999999975   8899999999998


Q ss_pred             ecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ....... .... . 
T Consensus       200 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~i~-~~~~-~-  269 (349)
T 2w4o_A          200 IVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ----FMFRRIL-NCEY-Y-  269 (349)
T ss_dssp             ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH----HHHHHHH-TTCC-C-
T ss_pred             ccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH----HHHHHHH-hCCC-c-
Confidence            654322   1233478999999999999999999999999999999999999985432211    0111111 1110 0 


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...+..      ...+..+.+++.+||+.||++|||+.|+++
T Consensus       270 ~~~~~~------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          270 FISPWW------DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CCTTTT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCchh------hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000000      113456889999999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-44  Score=345.73  Aligned_cols=263  Identities=19%  Similarity=0.230  Sum_probs=201.9

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-----ChhhHHHHHHHHHHHHHcCCCceeEEeeEEE
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-----SEQGLREMKNEASVIAKVQHKNLVRLLGCCI  181 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  181 (436)
                      .++....++|++.+.||+|+||+||+|... ++..||+|++...     .....+.+.+|+.++++++||||+++++++.
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   98 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE   98 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence            345667788999999999999999999975 4788999998532     3345678999999999999999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCC-------------------------------------ccCCCCHHHHHHHHHHHH
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPT-------------------------------------KRILLDWVTRVQIIEGIA  224 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia  224 (436)
                      +.+..++||||+++|+|.+++....                                     ....+++.....++.|++
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A           99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            9999999999999999999884210                                     011235677888999999


Q ss_pred             HHHHHHhhCCCCCeEecccCCCCEEEcCCC--CeEEeeccCceecCCCC--cccccccccccCCccchhhhcc--CCCCc
Q 040532          225 QGLLYLHQYSRVRIIHRDLKASNILLDKDM--NPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEYALE--GIFSI  298 (436)
Q Consensus       225 ~~l~~LH~~~~~~i~H~Dikp~NIll~~~~--~~kl~DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~  298 (436)
                      .||+|||+.+   ++||||||+||+++.++  .+||+|||++.......  .........||+.|+|||.+.+  ..++.
T Consensus       179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            9999999998   99999999999998776  89999999998653321  1112334579999999999975  67899


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCC
Q 040532          299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADD  378 (436)
Q Consensus       299 ~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~  378 (436)
                      ++||||||+++|||++|+.||.....     .+............   ..+..      ...+..+.+++.+||+.||.+
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~---~~~~~------~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVND-----ADTISQVLNKKLCF---ENPNY------NVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCT---TSGGG------GGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhccccc---CCccc------ccCCHHHHHHHHHHcCCChhH
Confidence            99999999999999999999854321     11122222211110   00000      113456889999999999999


Q ss_pred             CCCHHHHHH
Q 040532          379 RPTMNDVVS  387 (436)
Q Consensus       379 RPs~~ev~~  387 (436)
                      ||++.|+++
T Consensus       322 Rps~~~~l~  330 (345)
T 3hko_A          322 RFDAMRALQ  330 (345)
T ss_dssp             SCCHHHHHH
T ss_pred             CCCHHHHhc
Confidence            999999987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=343.00  Aligned_cols=268  Identities=17%  Similarity=0.175  Sum_probs=200.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec----CCCEEEEEEcCCCChhh-----------HHHHHHHHHHHHHcCCCceeEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLSGRSEQG-----------LREMKNEASVIAKVQHKNLVRLL  177 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~  177 (436)
                      ..++|++.+.||+|+||+||+|.+.    .+..+|+|+........           ...+.+|+..+..++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            4578999999999999999999975    47789999987653211           12356788889999999999999


Q ss_pred             eEEEe----CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC
Q 040532          178 GCCID----KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD  253 (436)
Q Consensus       178 ~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~  253 (436)
                      +++..    ....++||||+ +++|.+++....   .+++..++.++.|++.||+|||+.+   |+||||||+|||++.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence            99988    67889999999 999999986433   5899999999999999999999998   9999999999999988


Q ss_pred             C--CeEEeeccCceecCCCCcc-----cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 040532          254 M--NPKISDFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  326 (436)
Q Consensus       254 ~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~  326 (436)
                      +  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999876432211     11234579999999999999999999999999999999999999985322221


Q ss_pred             cchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      .......... ... ......     ........+..+.+++.+||+.||++||++.++++.|++...
T Consensus       268 ~~~~~~~~~~-~~~-~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 VAVQTAKTNL-LDE-LPQSVL-----KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHH-HHT-TTHHHH-----HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHHHhh-ccc-ccHHHH-----hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1111111111 110 000000     000000134578999999999999999999999999988664

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.6e-43  Score=327.54  Aligned_cols=256  Identities=22%  Similarity=0.340  Sum_probs=206.8

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC--CccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  188 (436)
                      ..++|++.+.||+|+||+||+|.++ ++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.  +..++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            4567899999999999999999986 889999999754  345567899999999999999999999999887  67899


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++++||||||+||+++.++.++|+|||+.....
T Consensus        87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             eecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999997533 335899999999999999999999865 349999999999999999999999999875422


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCc---ccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSI---KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                             .....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||.....     ..............  
T Consensus       165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~--  230 (271)
T 3kmu_A          165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----MEIGMKVALEGLRP--  230 (271)
T ss_dssp             -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----HHHHHHHHHSCCCC--
T ss_pred             -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----HHHHHHHHhcCCCC--
Confidence                   22346899999999998765544   79999999999999999999854321     11111221111111  


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                          .....     .+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       231 ----~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          231 ----TIPPG-----ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ----CCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ----CCCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                11111     34568899999999999999999999999998764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7e-43  Score=337.87  Aligned_cols=270  Identities=24%  Similarity=0.309  Sum_probs=212.1

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHH--cCCCceeEEeeEEEeCC--
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAK--VQHKNLVRLLGCCIDKD--  184 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~--  184 (436)
                      ......++|++.+.||+|+||+||+|.+. |+.||+|++...   ....+.+|.+++..  ++||||+++++++....  
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            34556788999999999999999999985 899999999643   33567889999988  78999999999998876  


Q ss_pred             --ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEecccCCCCEEEcCCC
Q 040532          185 --EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH--------QYSRVRIIHRDLKASNILLDKDM  254 (436)
Q Consensus       185 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~i~H~Dikp~NIll~~~~  254 (436)
                        ..++||||+++|+|.+++...    .+++..++.++.|++.||+|||        +.+   ++||||||+|||++.++
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred             cceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence              789999999999999998532    4889999999999999999999        666   99999999999999999


Q ss_pred             CeEEeeccCceecCCCCccc--ccccccccCCccchhhhccC------CCCcccchhhHHHHHHHHHhC----------C
Q 040532          255 NPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSG----------K  316 (436)
Q Consensus       255 ~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltg----------~  316 (436)
                      .+||+|||++..........  ......||+.|+|||++.+.      .++.++||||||+++|||+||          .
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            99999999998765433211  23345799999999999865      334789999999999999999          6


Q ss_pred             CCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          317 KNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      .||............+.... .....     .+..+........+..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       265 ~p~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          265 LPYYDLVPSDPSVEEMRKVV-CEQKL-----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CTTTTTSCSSCCHHHHHHHH-TTSCC-----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCccccCcCcccHHHHHHHH-HHHHh-----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            67654333222222222221 11111     112222222334677899999999999999999999999999998764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.8e-43  Score=342.62  Aligned_cols=255  Identities=20%  Similarity=0.262  Sum_probs=194.6

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ...++|++.+.||+|+||+||++... +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            34678999999999999999999976 5889999999754322 256889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC--eEEeeccCceecC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--PKISDFGMARICG  268 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~--~kl~DfGla~~~~  268 (436)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|||+++...
T Consensus        96 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           96 EYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            999999999988542   24899999999999999999999998   999999999999987765  9999999987432


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIK-SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ..   .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||....... ..............  .   
T Consensus       170 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~~--~---  240 (361)
T 3uc3_A          170 LH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVKY--S---  240 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTCC--C---
T ss_pred             cc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCCC--C---
Confidence            22   12233479999999999988887655 899999999999999999996543221 12222222211110  0   


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                         .+..   ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       241 ---~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          241 ---IPDD---IRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ---CCTT---SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ---CCCc---CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence               0000   0123568899999999999999999999874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-43  Score=333.11  Aligned_cols=252  Identities=20%  Similarity=0.271  Sum_probs=203.5

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ...++|++.+.||+|+||+||+|.+.. +..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            345779999999999999999999765 6789999987654445678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE---cCCCCeEEeeccCceec
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARIC  267 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll---~~~~~~kl~DfGla~~~  267 (436)
                      ||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++||||||+||++   +.++.+||+|||++...
T Consensus        86 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           86 ELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             eccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            999999998888542   34899999999999999999999998   9999999999999   78899999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ....   ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......     ............     
T Consensus       160 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-----  225 (277)
T 3f3z_A          160 KPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-----EVMLKIREGTFT-----  225 (277)
T ss_dssp             CTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCC-----
T ss_pred             cCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhCCCC-----
Confidence            5432   22334789999999988654 899999999999999999999998543211     111111111100     


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                         .... .....+..+.+++.+||+.||++||++.++++
T Consensus       226 ---~~~~-~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          226 ---FPEK-DWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ---CCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---CCch-hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0000 00013457889999999999999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=347.50  Aligned_cols=264  Identities=27%  Similarity=0.400  Sum_probs=199.4

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC--C--CEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe-CCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK--G--DEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~  187 (436)
                      ...|++.+.||+|+||+||+|.+.+  +  ..||+|.+... .....+.+.+|+.++++++||||+++++++.. ++..+
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            3457778899999999999998642  2  35899998754 34556789999999999999999999998765 45789


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|.+++....  ..+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus       168 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence            9999999999999996533  34788999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCccc--ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          268 GGNELQA--NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       268 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      .......  ......+|+.|+|||.+.+..++.++||||||+++|||+| |.+||......  +....   . ...... 
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~---~-~~~~~~-  315 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY---L-LQGRRL-  315 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHH---H-HTTCCC-
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHH---H-HcCCCC-
Confidence            4332211  2233457789999999999999999999999999999999 66777543222  11111   1 111100 


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCC
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP  399 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~  399 (436)
                           ..+.     .++..+.+++.+||+.||++||++.|+++.|+++...+...
T Consensus       316 -----~~p~-----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          316 -----LQPE-----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             -----CCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             -----CCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence                 0011     13456889999999999999999999999999998776543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.8e-43  Score=336.22  Aligned_cols=270  Identities=21%  Similarity=0.333  Sum_probs=203.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++...   .......+.+|+.++++++||||+++++++.+.+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            4467999999999999999999964 5899999999753   34556788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          189 IYEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      ||||+++++|.+++... .....+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            99999999999988532 12345889999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      .....  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....   ......... ......    
T Consensus       187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~-~~~~~~----  256 (310)
T 2wqm_A          187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKI-EQCDYP----  256 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C---CHHHHHHHH-HTTCSC----
T ss_pred             cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---hHHHHHHHh-hcccCC----
Confidence            43221  12234689999999999999999999999999999999999999853221   111121111 111110    


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCC
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQ  401 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~  401 (436)
                       .....     ..+..+.+++.+||+.||++||++.++++.|+++.+...++.+
T Consensus       257 -~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          257 -PLPSD-----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE  304 (310)
T ss_dssp             -CCCTT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred             -CCccc-----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence             00001     1345688999999999999999999999999999877666543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.3e-43  Score=345.02  Aligned_cols=254  Identities=23%  Similarity=0.332  Sum_probs=198.5

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcC--CCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQ--HKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~  187 (436)
                      ...+.|++.+.||+|+||+||+|...+++.||||++...  .....+.+.+|+.++.+++  ||||+++++++...+..+
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            345679999999999999999999888999999998643  4455678999999999996  599999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||| +.+++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||+++..
T Consensus       133 lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             EEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            9999 67889999986433   4888899999999999999999998   99999999999995 589999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhcc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALE-----------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      ............+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....    ........
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~~~  280 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QISKLHAI  280 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHHHHHHH
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH----HHHHHHHH
Confidence            54333223344579999999999875           3689999999999999999999999854221    11111222


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ........      .+..     .+..+.+++.+||+.||++||++.|+++.
T Consensus       281 ~~~~~~~~------~~~~-----~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          281 IDPNHEIE------FPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HCTTSCCC------CCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hCccccCC------CCcc-----chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            11111100      1111     13468899999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.2e-44  Score=346.47  Aligned_cols=246  Identities=22%  Similarity=0.276  Sum_probs=203.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3467999999999999999999976 48999999986432   2235678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++|+|.+++...   ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       119 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999998643   24899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ..     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....     ............ .      
T Consensus       193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~~-~------  255 (350)
T 1rdq_E          193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIVSGK-V------  255 (350)
T ss_dssp             SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCC-C------
T ss_pred             CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----HHHHHHHHHcCC-C------
Confidence            32     233579999999999999999999999999999999999999985422     111122221111 0      


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPT-----MNDVVS  387 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~  387 (436)
                       ..+..     .+..+.+++.+||+.||++||+     ++|+++
T Consensus       256 -~~p~~-----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 -RFPSH-----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCCTT-----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCC-----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence             11111     3456889999999999999998     788765

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.3e-43  Score=335.40  Aligned_cols=263  Identities=26%  Similarity=0.365  Sum_probs=207.8

Q ss_pred             hhhhccCCCCCc-ccCCCCceeEEEEEec---CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC
Q 040532          110 VSTATNTFSDTN-KLGEGGFGPVYKGVLR---KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK  183 (436)
Q Consensus       110 ~~~~~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  183 (436)
                      +....++|++.+ .||+|+||+||+|.+.   .++.||+|++....  ....+.+.+|+.++++++||||+++++++ ..
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            344556788887 9999999999999643   36789999997542  33357899999999999999999999998 66


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      +..++||||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCc
Confidence            7889999999999999998643   34889999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          264 ARICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       264 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      +......... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......  .    .........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~----~~~~~~~~~  237 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--E----VTAMLEKGE  237 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--H----HHHHHHTTC
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--H----HHHHHHcCC
Confidence            9876543321 12222356788999999999899999999999999999999 99998643221  1    111111111


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                      ..      ....     ..+..+.+++.+||+.||++||++.++++.|+++....
T Consensus       238 ~~------~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          238 RM------GCPA-----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             CC------CCCT-----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CC------CCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            11      1111     13457889999999999999999999999999987553

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.4e-44  Score=348.42  Aligned_cols=249  Identities=26%  Similarity=0.358  Sum_probs=201.1

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCcc
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  186 (436)
                      ...++|++.+.||+|+||.||+|+.+. |+.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            345789999999999999999999764 8899999996431   22345678899999887 999999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||+++|+|..++...   ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999998542   34899999999999999999999998   99999999999999999999999999975


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .....  ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.....     ...........      
T Consensus       168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~------  234 (345)
T 1xjd_A          168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHSIRMDN------  234 (345)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC------
T ss_pred             cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCC------
Confidence            43222  123445899999999999999999999999999999999999999854321     11111111111      


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMN-DVV  386 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-ev~  386 (436)
                        ...+..     .+..+.+++.+||+.||++||++. +++
T Consensus       235 --~~~p~~-----~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 --PFYPRW-----LEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --CCCCTT-----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --CCCCcc-----cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence              111111     345688999999999999999997 554

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.6e-43  Score=340.48  Aligned_cols=249  Identities=22%  Similarity=0.344  Sum_probs=200.0

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  188 (436)
                      .++|++.+.||+|+||.||+|+.+. ++.||+|++...   .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            3578899999999999999999764 788999999743   344566788999999998 89999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++|+|..++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            99999999999988542   34899999999999999999999998   9999999999999999999999999997543


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC---cchhHHHHHHhhcCCccee
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS---LNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~  345 (436)
                      ...  ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.......   ................   
T Consensus       162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---  236 (345)
T 3a8x_A          162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---  236 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred             CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence            221  12334589999999999999999999999999999999999999996432111   0111112222111110   


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTM  382 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  382 (436)
                          ..+..     .+..+.+++.+||+.||++||++
T Consensus       237 ----~~p~~-----~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 ----RIPRS-----LSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ----CCCTT-----SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ----CCCCC-----CCHHHHHHHHHHhcCCHhHCCCC
Confidence                11111     34568899999999999999995

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.8e-43  Score=335.88  Aligned_cols=266  Identities=25%  Similarity=0.358  Sum_probs=188.3

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .++|++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999975 48899999987543 2234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCC---CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          192 YMPNKSLDFFLFDP---TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       192 ~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      |++ |+|.+++...   .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5888877432   12235889999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC--cc-e
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR--TL-E  344 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~-~  344 (436)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....  ......+........  .. .
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND--EEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCTTTCGG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChhHhhh
Confidence            322  12233478999999999986 4689999999999999999999999864322  111111222111100  00 0


Q ss_pred             eccCC------------ccc---cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          345 LIDDP------------VLE---DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       345 ~~~~~------------~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ....+            .+.   ........+..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            00000            000   00000013457889999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-42  Score=329.16  Aligned_cols=269  Identities=20%  Similarity=0.271  Sum_probs=210.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEE-EeCCccEEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC-IDKDEKILIY  190 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  190 (436)
                      ..++|++.+.||+|+||+||+|.+ .+|+.||+|++......  +.+.+|+.++++++|++++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            467899999999999999999996 45889999998654332  4688999999999988866666555 5566779999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE---cCCCCeEEeeccCceec
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARIC  267 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll---~~~~~~kl~DfGla~~~  267 (436)
                      ||+ +++|.+++....  ..+++..+..++.|++.||+|||+++   ++||||||+|||+   ++++.+||+|||++...
T Consensus        85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 999999986322  34899999999999999999999998   9999999999999   48899999999999876


Q ss_pred             CCCCcc-----cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC-cchhHHHHHHhhcCC
Q 040532          268 GGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYVWDLWTSNR  341 (436)
Q Consensus       268 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~  341 (436)
                      ......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ......+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            543321     11234579999999999999999999999999999999999999997543222 122211111111000


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCC
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPK  400 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~  400 (436)
                      . ..     .     ....+..+.+++.+||+.||++||++.++++.|+++........
T Consensus       239 ~-~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~  286 (296)
T 3uzp_A          239 I-EV-----L-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             H-HH-----H-----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred             h-HH-----H-----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence            0 00     0     01134568899999999999999999999999999987765543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-43  Score=332.67  Aligned_cols=260  Identities=26%  Similarity=0.371  Sum_probs=205.7

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecC----CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      ....++|++.+.||+|+||+||+|.+..    +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   86 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP   86 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence            3456789999999999999999998643    235999999765 44556789999999999999999999999764 56


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++||||+++++|.+++...  ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             CEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence            79999999999999998542  234889999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......  ......    ...... 
T Consensus       162 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~----~~~~~~-  233 (281)
T 3cc6_A          162 YIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVL----EKGDRL-  233 (281)
T ss_dssp             CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHH----HHTCCC-
T ss_pred             cccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHH----hcCCCC-
Confidence            66543221 1223457889999999999999999999999999999998 99998543221  111111    111100 


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                           .....     .+..+.+++.+||+.||++||++.|+++.|+++..
T Consensus       234 -----~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          234 -----PKPDL-----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             -----CCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCC-----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                 00111     33568899999999999999999999999998764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=344.85  Aligned_cols=269  Identities=13%  Similarity=0.121  Sum_probs=210.3

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC---------CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeE---------
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK---------GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVR---------  175 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  175 (436)
                      .++|++.+.||+|+||+||+|.+..         ++.||+|++...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            5789999999999999999999764         788999999754     35789999999999999987         


Q ss_pred             ------EeeEEEe-CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCE
Q 040532          176 ------LLGCCID-KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  248 (436)
Q Consensus       176 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NI  248 (436)
                            +++++.. ++..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6677776 67789999999 999999996432 345899999999999999999999998   99999999999


Q ss_pred             EEcCCC--CeEEeeccCceecCCCCcc-----cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 040532          249 LLDKDM--NPKISDFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGL  321 (436)
Q Consensus       249 ll~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~  321 (436)
                      |++.++  .+||+|||+++........     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  9999999999865432211     112334799999999999999999999999999999999999999865


Q ss_pred             CCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCC
Q 040532          322 YRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP  399 (436)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~  399 (436)
                      ...................  ............     .+..+.+++.+||+.||++||++.++++.|+++.......
T Consensus       271 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKP--GPFVGPCGHWIR-----PSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSC--CCEECTTSCEEC-----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCcCHHHHHHHHHhccCCh--hhhhhhccccCC-----CcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence            4322222222222111111  111111110011     2457889999999999999999999999999998776544

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-43  Score=341.57  Aligned_cols=249  Identities=23%  Similarity=0.290  Sum_probs=193.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEe----cCCCEEEEEEcCCCC----hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVL----RKGDEIAVKRLSGRS----EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ..++|++.+.||+|+||.||++..    .+|+.||+|++....    ......+.+|+.++++++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            346799999999999999999986    468999999997642    233456789999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..++||||+++++|.+++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999999988542   34788999999999999999999998   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      +......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....     ...........    
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~----  237 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----KKTIDKILKCK----  237 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTC----
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhCC----
Confidence            7543221  122335799999999999999999999999999999999999999854321     11112221111    


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                          ...+..     .+..+.+++.+||+.||++||     ++.|+++
T Consensus       238 ----~~~p~~-----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ----LNLPPY-----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----CCCCTT-----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----CCCCCC-----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                011111     345688999999999999999     6777765

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.8e-43  Score=330.04  Aligned_cols=269  Identities=20%  Similarity=0.273  Sum_probs=205.4

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEE-EeCCccEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC-IDKDEKILI  189 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv  189 (436)
                      ...++|++.+.||+|+||+||+|.+ .+++.||+|++......  ..+.+|+.++.+++|++++..+..+ .+.+..++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3467899999999999999999996 45889999987644322  3578899999999988777666655 566778999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE---cCCCCeEEeeccCcee
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARI  266 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll---~~~~~~kl~DfGla~~  266 (436)
                      |||+ +++|.+++....  ..+++..+..++.|++.||.|||+.+   ++||||||+|||+   ++++.+||+|||++..
T Consensus        84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            9999 999999986322  24899999999999999999999998   9999999999999   7899999999999987


Q ss_pred             cCCCCcc-----cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCc-chhHHHHHHhhcC
Q 040532          267 CGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NLLGYVWDLWTSN  340 (436)
Q Consensus       267 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~  340 (436)
                      .......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            6543221     122345789999999999999999999999999999999999999975443221 1111111110000


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCC
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP  399 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~  399 (436)
                      .. ..     .     ....+..+.+++.+||+.||++||++.++++.|+++.......
T Consensus       238 ~~-~~-----~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~  285 (296)
T 4hgt_A          238 PI-EV-----L-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             CH-HH-----H-----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             hh-hh-----h-----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence            00 00     0     0012457889999999999999999999999999998765543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.2e-43  Score=332.99  Aligned_cols=263  Identities=24%  Similarity=0.297  Sum_probs=198.7

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ++|++.+.||+|+||+||+|.+.. |+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            578899999999999999999764 8999999986543  3335678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++++|..++....   .+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999998875433   3899999999999999999999998   9999999999999999999999999998765322


Q ss_pred             cccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH-----------hhc
Q 040532          272 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL-----------WTS  339 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~  339 (436)
                      .  ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  ........           ...
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHT
T ss_pred             c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhccccccccccccc
Confidence            1  1233478999999999986 568999999999999999999999986533211  11111111           111


Q ss_pred             CCcceeccCCccccc----cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          340 NRTLELIDDPVLEDE----YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       340 ~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .........+.....    ......+..+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            110000000000000    000124456889999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.2e-43  Score=353.92  Aligned_cols=248  Identities=22%  Similarity=0.348  Sum_probs=204.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3567999999999999999999976 58999999996432   1234678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++|+|.+++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        94 v~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           94 VMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EEECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999998643   34899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ....   ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....     ......... ...     
T Consensus       168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~~i~~-~~~-----  233 (476)
T 2y94_A          168 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLFKKICD-GIF-----  233 (476)
T ss_dssp             TTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHHHHHHT-TCC-----
T ss_pred             cccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhc-CCc-----
Confidence            4322   233479999999999998765 7899999999999999999999854221     111122111 110     


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        ..+..     .+..+.+++.+||+.||++|||+.|+++
T Consensus       234 --~~p~~-----~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 --YTPQY-----LNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             --CCCTT-----CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --CCCcc-----CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence              01111     2346889999999999999999999987

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.3e-44  Score=343.26  Aligned_cols=274  Identities=25%  Similarity=0.362  Sum_probs=200.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHH--HHHcCCCceeEEeeEEEe-----CCc
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASV--IAKVQHKNLVRLLGCCID-----KDE  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~  185 (436)
                      ..++|++.+.||+|+||+||+|... ++.||+|++.....   ..+..|.++  +..++||||+++++.+..     ...
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            4578999999999999999999874 89999999964432   334444444  445899999999986543     224


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC---------CCCCeEecccCCCCEEEcCCCCe
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY---------SRVRIIHRDLKASNILLDKDMNP  256 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------~~~~i~H~Dikp~NIll~~~~~~  256 (436)
                      .++||||+++|+|.+++....    .++.....++.|++.||+|||+.         +   |+||||||+|||++.++.+
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred             EEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence            589999999999999985432    48889999999999999999998         6   9999999999999999999


Q ss_pred             EEeeccCceecCCCCc------ccccccccccCCccchhhhcc-------CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 040532          257 KISDFGMARICGGNEL------QANTSRIVGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  323 (436)
Q Consensus       257 kl~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~elltg~~p~~~~~  323 (436)
                      ||+|||++........      ........||+.|+|||++.+       ..++.++|||||||++|||++|+.|+....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            9999999987653321      112223469999999999986       456789999999999999999987753322


Q ss_pred             CCCc-c--h---------hHHHHHHhhcCCcceeccCCcccc-ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          324 TDSL-N--L---------LGYVWDLWTSNRTLELIDDPVLED-EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       324 ~~~~-~--~---------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      .... .  .         .............     .+..+. .......+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ-----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC-----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhccccc-----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            1111 0  0         0000111111110     111111 1112235667999999999999999999999999999


Q ss_pred             hccccCCCCCCC
Q 040532          391 NEAAALHPPKQP  402 (436)
Q Consensus       391 ~~~~~~~~~~~~  402 (436)
                      ++...+......
T Consensus       315 ~ll~~~~~~~~~  326 (336)
T 3g2f_A          315 ELMMIWERNKSV  326 (336)
T ss_dssp             HHHHCCCC----
T ss_pred             HHHHHHHhcccC
Confidence            999887766544

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=331.97  Aligned_cols=250  Identities=24%  Similarity=0.402  Sum_probs=182.8

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            3467899999999999999999974 58999999986432   1224678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            999999999999986532  35899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ....  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........     ....     .   ...
T Consensus       164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~-----~---~~~  228 (278)
T 3cok_A          164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNKV-----V---LAD  228 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------C-----C---SSC
T ss_pred             CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHHH-----h---hcc
Confidence            3221  12234689999999999988899999999999999999999999864332110     0000     0   001


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...+..     .+..+.+++.+||+.||++||++.++++
T Consensus       229 ~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 YEMPSF-----LSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCCTT-----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCCccc-----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            111111     3456889999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=336.79  Aligned_cols=267  Identities=26%  Similarity=0.392  Sum_probs=210.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEe-----cCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC--c
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVL-----RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--E  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~  185 (436)
                      ..++|++.+.||+|+||.||+|.+     .+|+.||+|++........+.+.+|+.++++++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            356788999999999999999983     358899999998777677788999999999999999999999987654  6


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence            799999999999999986432  34889999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC-------Cc---chhHHHH
Q 040532          266 ICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-------SL---NLLGYVW  334 (436)
Q Consensus       266 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~-------~~---~~~~~~~  334 (436)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||+||..|+......       ..   .......
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            76543321 1122345677899999999999999999999999999999999987532100       00   0000011


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      ........      ....     ..++..+.+++.+||+.||++||++.|+++.|+++...
T Consensus       274 ~~~~~~~~------~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          274 ELLKNNGR------LPRP-----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHTTCC------CCCC-----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhhcCCC------CCCC-----CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            11111110      0001     11345788999999999999999999999999988654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.5e-43  Score=330.31  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=203.8

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ..++|++.+.||+|+||.||+|.+.. |+.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            45789999999999999999999754 889999998643  445567889999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC---eEEeeccCcee
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFGMARI  266 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~---~kl~DfGla~~  266 (436)
                      |||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++.   +||+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            9999999998887543   34899999999999999999999998   999999999999986655   99999999987


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ......   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....     ........... . .. 
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~-~-~~-  226 (284)
T 3kk8_A          158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQIKAGA-Y-DY-  226 (284)
T ss_dssp             CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTC-C-CC-
T ss_pred             cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----hHHHHHHHhcc-c-cC-
Confidence            653322   2335789999999999999999999999999999999999999854221     11111111111 0 00 


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..+..      ...+..+.+++.+||+.||++|||+.|+++
T Consensus       227 ~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 PSPEW------DTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CTTTT------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             Cchhh------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00000      013456889999999999999999999987

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.2e-43  Score=336.79  Aligned_cols=253  Identities=23%  Similarity=0.296  Sum_probs=204.7

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh------hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ...++|++.+.||+|+||.||+|.+. +|+.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            34567999999999999999999976 488999999865321      13577899999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC----CeEEee
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISD  260 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~----~~kl~D  260 (436)
                      ..++||||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++    .+||+|
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence            999999999999999999653   34889999999999999999999998   99999999999999888    799999


Q ss_pred             ccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          261 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      ||++.......   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....     ...........
T Consensus       163 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~  234 (321)
T 2a2a_A          163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANITSVS  234 (321)
T ss_dssp             CTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHTTC
T ss_pred             CccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcc
Confidence            99998765432   12334789999999999999999999999999999999999999854321     11111111111


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .        ...... ....+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~--------~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 Y--------DFDEEF-FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             C--------CCCHHH-HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             c--------ccChhh-hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0        000000 0113456889999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2e-43  Score=339.85  Aligned_cols=264  Identities=30%  Similarity=0.405  Sum_probs=207.1

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ...++|++.+.||+|+||.||+|.+.      ++..||+|.+... .......+.+|+.++++++||||+++++++.+.+
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            34578999999999999999999842      3678999999754 4455678899999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCC----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---CCCeE
Q 040532          185 EKILIYEYMPNKSLDFFLFDPT----KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPK  257 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~~~~k  257 (436)
                      ..++||||+++++|.+++....    ....+++..++.++.|++.||.|||+.+   ++||||||+|||++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999986432    1245889999999999999999999998   999999999999994   45699


Q ss_pred             EeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHH
Q 040532          258 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      |+|||++................||+.|+|||.+.+..++.++||||||+++|||+| |+.||.....     ... ...
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~-~~~  257 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEV-LEF  257 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHH-HHH
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----HHH-HHH
Confidence            999999976543333333334567899999999999999999999999999999998 8899854321     111 111


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      ........      ...     ..+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus       258 ~~~~~~~~------~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          258 VTSGGRMD------PPK-----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHTTCCCC------CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhcCCCCC------CCC-----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            11111110      111     1345688999999999999999999999999887653

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.8e-43  Score=337.53  Aligned_cols=264  Identities=20%  Similarity=0.231  Sum_probs=200.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++...   .....+.+.+|+.++++++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            4578999999999999999999975 5888999999754   23345778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999998543   34899999999999999999999998   9999999999999999999999999997654


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      .... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......      ........... .   .
T Consensus       186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~-~---~  254 (309)
T 2h34_A          186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAHINQAIP-R---P  254 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHHHHSCCC-C---G
T ss_pred             cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHHhccCCC-C---c
Confidence            3321 1223346899999999999999999999999999999999999998543211      11111111100 0   0


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhhccccCCC
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRP-TMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~ev~~~L~~~~~~~~~  398 (436)
                      ....     ...+..+.+++.+||+.||++|| +++++++.|++.......
T Consensus       255 ~~~~-----~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          255 STVR-----PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             GGTS-----TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             cccC-----CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence            0001     11344688899999999999999 999999999988765443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.5e-43  Score=337.28  Aligned_cols=261  Identities=20%  Similarity=0.272  Sum_probs=198.6

Q ss_pred             hccCCCCC-cccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEE
Q 040532          113 ATNTFSDT-NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       113 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ..+.|++. +.||+|+||+||+|... +++.||+|++........+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            35678774 78999999999999965 5889999999766555567889999999995 799999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC---eEEeeccCcee
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFGMARI  266 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~---~kl~DfGla~~  266 (436)
                      |||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++||||||+|||++.++.   +||+|||++..
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            9999999999998543   34889999999999999999999998   999999999999998776   99999999876


Q ss_pred             cCCCCc-----ccccccccccCCccchhhhcc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcch-------
Q 040532          267 CGGNEL-----QANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL-------  329 (436)
Q Consensus       267 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~-------  329 (436)
                      ......     ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||.........+       
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            542211     111223468999999999975     558899999999999999999999996543222110       


Q ss_pred             --hHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          330 --LGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       330 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        .............       ..+.. .....+..+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~i~~~~~-------~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          244 ACQNMLFESIQEGKY-------EFPDK-DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHHCCC-------CCCHH-HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHhccCc-------ccCch-hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              0011111111100       00000 00113457889999999999999999999987

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-43  Score=350.20  Aligned_cols=258  Identities=22%  Similarity=0.268  Sum_probs=205.0

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      .+....++|++.+.||+|+||+||+|++.. ++.||+|++....   ....+.+.+|..++..++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            345567889999999999999999999764 8899999986421   111234789999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..|+||||+++|+|.+++...    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence            999999999999999988532    3789999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      +....... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+     ............
T Consensus       216 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~  289 (410)
T 3v8s_A          216 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGTYSKIMNHK  289 (410)
T ss_dssp             EECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTHH
T ss_pred             EeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-----hhhHHHHHHhcc
Confidence            87654332 1233458999999999998765    8899999999999999999999985322     111112211111


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADD--RPTMNDVVSM  388 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~ev~~~  388 (436)
                      .........         ..+..+.+++.+||+.+|.+  ||+++|+++.
T Consensus       290 ~~~~~p~~~---------~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          290 NSLTFPDDN---------DISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHCCCCTTC---------CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ccccCCCcc---------cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            000000000         13456889999999999988  9999999874

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=331.30  Aligned_cols=266  Identities=23%  Similarity=0.326  Sum_probs=196.4

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-----hhhHHHHHHHHHHHHHc---CCCceeEEeeEEEe
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-----EQGLREMKNEASVIAKV---QHKNLVRLLGCCID  182 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~  182 (436)
                      ...++|++.+.||+|+||+||+|.+. +|+.||+|++....     ......+.+|+.+++++   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            45678999999999999999999964 58899999986321     11123556777776666   59999999999987


Q ss_pred             CC-----ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeE
Q 040532          183 KD-----EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  257 (436)
Q Consensus       183 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~k  257 (436)
                      ..     ..++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            65     4689999997 589888865332 34899999999999999999999998   99999999999999999999


Q ss_pred             EeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh
Q 040532          258 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      |+|||++.......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ...........
T Consensus       161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~  235 (308)
T 3g33_A          161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLI  235 (308)
T ss_dssp             ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH--HHHHHHHHHHH
T ss_pred             EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHh
Confidence            99999997654322   22345789999999999999999999999999999999999999854321  11111122211


Q ss_pred             hcCCcceeccCC-----ccccc------cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          338 TSNRTLELIDDP-----VLEDE------YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       338 ~~~~~~~~~~~~-----~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ............     .....      ......+..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            111100000000     00000      000113457889999999999999999999885

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.5e-43  Score=361.88  Aligned_cols=261  Identities=26%  Similarity=0.393  Sum_probs=204.2

Q ss_pred             CCCCCc-ccCCCCceeEEEEEec---CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          116 TFSDTN-KLGEGGFGPVYKGVLR---KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       116 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++.+.+ .||+|+||.||+|.++   ++..||||+++... ....+.+.+|+.+|++++||||+++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            334444 7999999999999864   35679999998653 3456789999999999999999999999876 5689999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus       415 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            999999999998643  345899999999999999999999998   999999999999999999999999999876433


Q ss_pred             Cc-ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          271 EL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       271 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      .. ........+++.|+|||++.+..++.++|||||||++|||++ |+.||......  ..    ...........    
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~----~~~i~~~~~~~----  559 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EV----MAFIEQGKRME----  559 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HH----HHHHHTTCCCC----
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HH----HHHHHcCCCCC----
Confidence            21 111222345689999999999999999999999999999998 99998643321  11    11112211111    


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCC
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP  399 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~  399 (436)
                        .+.     .++..+.+++.+||+.||++||++.++++.|+.+.......
T Consensus       560 --~p~-----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~  603 (613)
T 2ozo_A          560 --CPP-----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  603 (613)
T ss_dssp             --CCT-----TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred             --CCC-----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence              111     14457899999999999999999999999999987665443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.4e-43  Score=343.57  Aligned_cols=267  Identities=24%  Similarity=0.374  Sum_probs=192.4

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCC--c
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKD--E  185 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~  185 (436)
                      ...++|++.+.||+|+||.||+|.+. +|+.||+|++...  .......+.+|+.++.++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34578999999999999999999965 4889999998643  4455677889999999997 999999999998654  6


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .|+||||++ ++|..++..    ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            799999998 578888753    24889999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCC-------------------cccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 040532          266 ICGGNE-------------------LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD  325 (436)
Q Consensus       266 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~  325 (436)
                      ......                   ........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+. 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-  236 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-  236 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence            653211                   0111233579999999999986 6789999999999999999999999964321 


Q ss_pred             CcchhHHHHHHhhcCCccee--cc------------------CCccccccc-----------hHHHHHHHHHHHHhcccC
Q 040532          326 SLNLLGYVWDLWTSNRTLEL--ID------------------DPVLEDEYS-----------SKQVLLRYVNIALLCVQE  374 (436)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~--~~------------------~~~~~~~~~-----------~~~~~~~l~~li~~cl~~  374 (436)
                       ......+......+.....  +.                  .........           ....+..+.+++.+||+.
T Consensus       237 -~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          237 -MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             -HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             -HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence             1111111111111100000  00                  000000000           001345688999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 040532          375 SADDRPTMNDVVSM  388 (436)
Q Consensus       375 ~p~~RPs~~ev~~~  388 (436)
                      ||++|||++|+++.
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-43  Score=344.32  Aligned_cols=249  Identities=24%  Similarity=0.292  Sum_probs=200.9

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  187 (436)
                      ..++|++.+.||+|+||+||+|.... |+.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34679999999999999999999865 7889999986431   23346678899999887 8999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|..++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            999999999999998543   24899999999999999999999998   999999999999999999999999999754


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ....  ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.....     ...........       
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~-------  237 (353)
T 2i0e_A          172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEHN-------  237 (353)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC-------
T ss_pred             ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhCC-------
Confidence            3221  123345899999999999999999999999999999999999999854321     11222222111       


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT-----MNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~  387 (436)
                       ...+..     .+..+.+++.+||+.||++||+     ++++++
T Consensus       238 -~~~p~~-----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 -VAYPKS-----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -CCCCTT-----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -CCCCCC-----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             011111     3456889999999999999995     466654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.7e-43  Score=339.27  Aligned_cols=244  Identities=24%  Similarity=0.328  Sum_probs=201.2

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh--------hhHHHHHHHHHHHHHcCCCceeEEeeEEEe
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE--------QGLREMKNEASVIAKVQHKNLVRLLGCCID  182 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  182 (436)
                      ...++|++.+.||+|+||+||+|.+. +++.||+|++.....        .....+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            45678999999999999999999964 488899999875421        123457789999999999999999999999


Q ss_pred             CCccEEEEeecCCC-ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeec
Q 040532          183 KDEKILIYEYMPNK-SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  261 (436)
Q Consensus       183 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~Df  261 (436)
                      .+..++||||+.+| +|..++....   .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999877 9998886533   4899999999999999999999998   999999999999999999999999


Q ss_pred             cCceecCCCCcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      |++........   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......               
T Consensus       175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------  236 (335)
T 3dls_A          175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------  236 (335)
T ss_dssp             TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred             ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence            99987654322   223478999999999998876 88999999999999999999998532110               


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                       .......   +..     .+..+.+++.+||+.||++|||+.++++.
T Consensus       237 -~~~~~~~---~~~-----~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -VEAAIHP---PYL-----VSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -TTTCCCC---SSC-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -HhhccCC---Ccc-----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0000000   001     23468899999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.3e-43  Score=328.59  Aligned_cols=254  Identities=24%  Similarity=0.394  Sum_probs=205.0

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe--------
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID--------  182 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  182 (436)
                      ...++|++.+.||+|+||.||+|.+. +|+.||+|++....    +.+.+|+.++++++||||+++++++..        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            34567899999999999999999986 58999999997654    246789999999999999999998864        


Q ss_pred             --------CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC
Q 040532          183 --------KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  254 (436)
Q Consensus       183 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~  254 (436)
                              ....++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence                    345789999999999999985432 345899999999999999999999998   99999999999999999


Q ss_pred             CeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHH
Q 040532          255 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVW  334 (436)
Q Consensus       255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  334 (436)
                      .+||+|||++........   .....||+.|+|||.+.+..++.++||||||+++|||++|..|+...       ... .
T Consensus       160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~-~  228 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKF-F  228 (284)
T ss_dssp             EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHH-H
T ss_pred             CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHH-H
Confidence            999999999987654322   22346899999999999999999999999999999999999885210       001 1


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                      ......         .....     .+..+.+++.+||+.||++||++.|+++.|..+....+.
T Consensus       229 ~~~~~~---------~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          229 TDLRDG---------IISDI-----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             HHHHTT---------CCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             HHhhcc---------ccccc-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            111111         11111     234578899999999999999999999999988765443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.1e-43  Score=330.82  Aligned_cols=250  Identities=23%  Similarity=0.302  Sum_probs=205.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..++|++.+.||+|+||+||++.+.. ++.+|+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            45678999999999999999999764 788999998643   34456778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999999887532   34899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ....  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....     ......... ..       
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~-~~-------  231 (294)
T 2rku_A          167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLRIKK-NE-------  231 (294)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHT-TC-------
T ss_pred             cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhh-cc-------
Confidence            3221  22334789999999999998899999999999999999999999854321     111111111 11       


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ...+..     ....+.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 YSIPKH-----INPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             CCCCTT-----SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCCccc-----cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            011111     23468889999999999999999999873

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7e-43  Score=337.36  Aligned_cols=250  Identities=22%  Similarity=0.302  Sum_probs=205.5

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ...++|.+.+.||+|+||.||++.+.+ ++.+|+|++...   .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            345789999999999999999999765 788999998643   3445677899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus       118 lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             EEECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            999999999999987532   34899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      .....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....     ...........       
T Consensus       192 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~-------  257 (335)
T 2owb_A          192 EYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLRIKKNE-------  257 (335)
T ss_dssp             CSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTC-------
T ss_pred             ccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHHhcCC-------
Confidence            43221  22335789999999999999999999999999999999999999854321     11111111111       


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ......     ....+.+++.+||+.||++||++.|+++
T Consensus       258 -~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 -YSIPKH-----INPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -CCCCTT-----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -CCCCcc-----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             011111     2346788999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.5e-43  Score=338.96  Aligned_cols=248  Identities=21%  Similarity=0.264  Sum_probs=178.9

Q ss_pred             CcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEEeecCCCC
Q 040532          120 TNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKS  197 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  197 (436)
                      .+.||+|+||+||+|.+. +|+.||+|++...   ....+.+|+.++.++. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999976 4889999999643   3356789999999997 9999999999999999999999999999


Q ss_pred             hhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC---CeEEeeccCceecCCCCccc
Q 040532          198 LDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPKISDFGMARICGGNELQA  274 (436)
Q Consensus       198 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~---~~kl~DfGla~~~~~~~~~~  274 (436)
                      |.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .+||+|||++........  
T Consensus        93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--  164 (325)
T 3kn6_A           93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--  164 (325)
T ss_dssp             HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence            99998643   34899999999999999999999998   99999999999998765   799999999986543321  


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC--cchhHHHHHHhhcCCcceeccCCccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS--LNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......  .......... .....       ...
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~-------~~~  236 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDF-------SFE  236 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCC-------CCC
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCC-------CCC
Confidence            2233468999999999999999999999999999999999999996543211  1111111111 11110       000


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       .......+..+.+++.+||+.||++|||++|+++
T Consensus       237 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          237 -GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             -SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             -cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence             0001124567899999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2e-43  Score=332.00  Aligned_cols=248  Identities=25%  Similarity=0.340  Sum_probs=199.3

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..++|++.+.||+|+||+||+|.+.. +..||+|++....   ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            45678999999999999999998764 6789999986432   1224568899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            99999999999888543   34889999999999999999999988   9999999999999999999999999986543


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ..    ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....     ............        
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~--------  223 (279)
T 3fdn_A          161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVE--------  223 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTC--------
T ss_pred             cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-----HHHHHHHHHhCC--------
Confidence            22    1233478999999999999999999999999999999999999985422     111111111111        


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ...+..     .+..+.+++.+||+.||++||++.|+++.
T Consensus       224 ~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 FTFPDF-----VTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCCCTT-----SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCCCc-----CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            001111     23467899999999999999999999974

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=347.35  Aligned_cols=260  Identities=19%  Similarity=0.237  Sum_probs=204.0

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK  183 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  183 (436)
                      .+.....++|++.+.||+|+||+||+++.+ +|+.||+|++....   ....+.+.+|..++.+++||||+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            344556788999999999999999999975 58999999996421   12234578999999999999999999999999


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      +..|+||||+++|+|..++....  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence            99999999999999999986422  24889999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhc-------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYAL-------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      ++....... ......+||+.|+|||++.       +..++.++|||||||++|||++|+.||.....     .......
T Consensus       209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i  282 (412)
T 2vd5_A          209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-----AETYGKI  282 (412)
T ss_dssp             CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHH
T ss_pred             heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence            987654322 1223458999999999997       35689999999999999999999999854321     1111111


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCC---CCHHHHHH
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDR---PTMNDVVS  387 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~~ev~~  387 (436)
                      ......   ...+...     ...+..+.+++.+||+ +|.+|   |+++|+++
T Consensus       283 ~~~~~~---~~~p~~~-----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          283 VHYKEH---LSLPLVD-----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HTHHHH---CCCC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HhcccC---cCCCccc-----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            110000   0001111     1134578899999999 99998   58888875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.2e-42  Score=347.80  Aligned_cols=263  Identities=24%  Similarity=0.280  Sum_probs=195.6

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC----
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  184 (436)
                      ...++|++.+.||+|+||+||+|.+. .|+.||||++...  .....+.+.+|+.+++.++||||+++++++....    
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            34678999999999999999999865 4889999999754  4455677899999999999999999999997654    


Q ss_pred             --ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          185 --EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       185 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                        ..|+||||++++ |...+..     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       139 ~~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          139 FQDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CCEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CCeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence              459999999876 4444422     2788999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC--
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN--  340 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  340 (436)
                      +++......   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..  +....+.......  
T Consensus       210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~--~~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          210 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCP  284 (464)
T ss_dssp             CC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCH
T ss_pred             eeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCH
Confidence            998654322   223357999999999999999999999999999999999999999643211  1111111110000  


Q ss_pred             -----------------Ccce------eccCCccc-cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          341 -----------------RTLE------LIDDPVLE-DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       341 -----------------~~~~------~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                                       ....      ........ ...........+.+|+.+||+.||++|||++|+++.
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                             0000      00000000 000112235678999999999999999999999873

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=327.09  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=199.7

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      +.|.....||+|+||.||+|.+. ++..||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34555668999999999999964 47899999998766556678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-CCCeEEeeccCceecCCCCc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~~  272 (436)
                      ++++|.+++........+++..+..++.|++.||.|||+.+   ++|+||||+||+++. ++.+||+|||++....... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999876544455778899999999999999999998   999999999999997 8999999999998764322 


Q ss_pred             ccccccccccCCccchhhhccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                       .......|++.|+|||.+.+..  ++.++||||||+++|||++|+.||........   .. .......      ..+.
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~-~~~~~~~------~~~~  246 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AM-FKVGMFK------VHPE  246 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HH-HHHHHHC------CCCC
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HH-Hhhcccc------cccc
Confidence             1223347899999999998654  78999999999999999999999853221110   00 1100000      0111


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ....     .+..+.+++.+||+.||++||++.++++
T Consensus       247 ~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 IPES-----MSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCTT-----SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccc-----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111     3456889999999999999999999975

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-43  Score=333.18  Aligned_cols=254  Identities=22%  Similarity=0.311  Sum_probs=198.0

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ...++|++.+.||+|+||+||++... ++..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            45678999999999999999999975 4889999998654 233457889999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE---cCCCCeEEeeccCce
Q 040532          190 YEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMAR  265 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll---~~~~~~kl~DfGla~  265 (436)
                      |||+++|+|.+++... .....+++..+..++.|++.||+|||+.+   ++||||||+||++   +.++.+||+|||++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999998887542 22345899999999999999999999998   9999999999999   456889999999997


Q ss_pred             ecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ......   ......||+.|+|||.+. +.++.++||||||+++|||++|+.||.....     ................
T Consensus       176 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~~~~  246 (285)
T 3is5_A          176 LFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----EEVQQKATYKEPNYAV  246 (285)
T ss_dssp             C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCCC
T ss_pred             ecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----HHHHhhhccCCccccc
Confidence            654322   223347899999999875 5689999999999999999999999854321     1111111111111000


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ..    ..     .+..+.+++.+||+.||++|||+.|+++
T Consensus       247 -~~----~~-----~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          247 -EC----RP-----LTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -------CC-----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -cc----Cc-----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00    00     2346788999999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.4e-44  Score=357.09  Aligned_cols=249  Identities=22%  Similarity=0.258  Sum_probs=193.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++...   .......+.+|+.++++++||||+++++++.+.+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            4567999999999999999999965 4889999998642   23344567889999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      ||||+++|+|..++...   ..+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++..
T Consensus       226 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            99999999999888542   358999999999999999999998 77   999999999999999999999999999754


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...........       
T Consensus       300 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~-------  365 (446)
T 4ejn_A          300 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE-------  365 (446)
T ss_dssp             CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC-------
T ss_pred             cCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHHhCC-------
Confidence            3222  223345899999999999999999999999999999999999999854321     11111111111       


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                       ...+..     .+..+.+++.+||+.||++||     +++|+++
T Consensus       366 -~~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 -IRFPRT-----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -CCCCTT-----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCCCcc-----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence             011111     335688999999999999999     9999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.7e-43  Score=330.04  Aligned_cols=255  Identities=27%  Similarity=0.385  Sum_probs=200.2

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-CccEEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-DEKILI  189 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv  189 (436)
                      ....++|++.+.||+|+||+||+|..+ |+.||+|++....  ..+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             cCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            344678999999999999999999886 8899999997653  346789999999999999999999997654 478999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+++++|.+++... ....+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             ECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999999998542 2223788899999999999999999998   99999999999999999999999999875432


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      .     .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||......  ..   .... .....      
T Consensus       170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~---~~~~-~~~~~------  232 (278)
T 1byg_A          170 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DV---VPRV-EKGYK------  232 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GH---HHHH-TTTCC------
T ss_pred             c-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HH---HHHH-hcCCC------
Confidence            2     122357889999999999999999999999999999998 99998643221  11   1111 11100      


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      .....     ..+..+.+++.+||+.||++||++.|+++.|+++..
T Consensus       233 ~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          233 MDAPD-----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcc-----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            01111     134578899999999999999999999999998764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=7.3e-43  Score=335.98  Aligned_cols=261  Identities=28%  Similarity=0.374  Sum_probs=206.0

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCE--EEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDE--IAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  188 (436)
                      .++|++.+.||+|+||.||+|.+.. |..  +|+|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            3678899999999999999999754 554  499998753 334456789999999999 89999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC
Q 040532          189 IYEYMPNKSLDFFLFDPT-------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  255 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~  255 (436)
                      ||||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            999999999999986543             2346899999999999999999999998   999999999999999999


Q ss_pred             eEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHH
Q 040532          256 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVW  334 (436)
Q Consensus       256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  334 (436)
                      +||+|||++.....   ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....     .... 
T Consensus       181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~-  251 (327)
T 1fvr_A          181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELY-  251 (327)
T ss_dssp             EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHH-
T ss_pred             EEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----HHHH-
Confidence            99999999874321   112223356889999999999999999999999999999998 9999854321     1111 


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCC
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALH  397 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~  397 (436)
                      ........      .....     ..+..+.+++.+||+.||++||++.|+++.|+++.....
T Consensus       252 ~~~~~~~~------~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          252 EKLPQGYR------LEKPL-----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             HHGGGTCC------CCCCT-----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHhhcCCC------CCCCC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            11111100      00111     134568899999999999999999999999999886543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-42  Score=335.81  Aligned_cols=248  Identities=29%  Similarity=0.444  Sum_probs=198.9

Q ss_pred             hccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ..+.|+..+.||+|+||+||+|.. .+|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            345688899999999999999996 458899999986432   3345678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||++ |+|.+++...  ...+++..+..++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||++....
T Consensus       132 v~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             EEECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EEecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            999997 5676666422  235899999999999999999999998   9999999999999999999999999997653


Q ss_pred             CCCcccccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          269 GNELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      .      .....||+.|+|||++.   +..++.++|||||||++|||++|+.||....     .............    
T Consensus       206 ~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-----~~~~~~~~~~~~~----  270 (348)
T 1u5q_A          206 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNES----  270 (348)
T ss_dssp             S------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCC----
T ss_pred             C------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcCC----
Confidence            2      22347899999999985   5678999999999999999999999985322     1111222222111    


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        .......     .+..+.+++.+||+.||++|||++++++.
T Consensus       271 --~~~~~~~-----~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          271 --PALQSGH-----WSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             --CCCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --CCCCCCC-----CCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              0001111     33468899999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-42  Score=327.23  Aligned_cols=256  Identities=23%  Similarity=0.289  Sum_probs=202.5

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh------hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      .++|++.+.||+|+||+||+|... +|+.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            457889999999999999999976 489999999864321      1357889999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC----CeEEeecc
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDFG  262 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~----~~kl~DfG  262 (436)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999854   235899999999999999999999998   99999999999999877    89999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      ++.......   ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....     .............
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~  229 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-----QETLTNISAVNYD  229 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTCCC
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-----HHHHHHhHhcccC
Confidence            998764332   12234689999999999999999999999999999999999999854321     1111111111100


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhhc
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS--MLTNE  392 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~--~L~~~  392 (436)
                             .....  ....+..+.+++.+||+.||++||++.|+++  .++.+
T Consensus       230 -------~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          230 -------FDEEY--FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             -------CCHHH--HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             -------Ccchh--cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence                   00000  0113456889999999999999999999997  34443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2e-43  Score=345.53  Aligned_cols=250  Identities=22%  Similarity=0.257  Sum_probs=192.3

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHH-HHHcCCCceeEEeeEEEeCCcc
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASV-IAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      ...++|++.+.||+|+||+||+|+.+. ++.||+|++....   ......+..|..+ ++.++||||+++++++.+.+..
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence            345789999999999999999999764 7889999996532   2233456667666 4668999999999999999999


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      |+||||+++|+|..++...   ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       115 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            9999999999999988542   34788999999999999999999998   99999999999999999999999999975


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .....  ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||....     ............      
T Consensus       189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~~------  255 (373)
T 2r5t_A          189 NIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNILNKP------  255 (373)
T ss_dssp             GBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-----HHHHHHHHHHSC------
T ss_pred             cccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcc------
Confidence            32221  12344589999999999999999999999999999999999999985422     111222222111      


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        ......     .+..+.+++.+||+.||.+||++.+.++
T Consensus       256 --~~~~~~-----~~~~~~~li~~lL~~dp~~R~~~~~~~~  289 (373)
T 2r5t_A          256 --LQLKPN-----ITNSARHLLEGLLQKDRTKRLGAKDDFM  289 (373)
T ss_dssp             --CCCCSS-----SCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred             --cCCCCC-----CCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence              011111     3346888999999999999999864433

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-42  Score=345.68  Aligned_cols=196  Identities=24%  Similarity=0.418  Sum_probs=155.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-----C
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----D  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  184 (436)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||++...  .....+.+.+|+.+|++++||||+++++++...     .
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            4578999999999999999999976 4889999998653  344567889999999999999999999998543     4


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..|+||||++ ++|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence            6799999984 6888887543   34899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcc-------------------------cccccccccCCccchhhhc-cCCCCcccchhhHHHHHHHHHhC
Q 040532          265 RICGGNELQ-------------------------ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSG  315 (436)
Q Consensus       265 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg  315 (436)
                      +........                         ......+||+.|+|||++. +..++.++|||||||++|||++|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            876432110                         1223457899999999864 56799999999999999999994

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-42  Score=334.35  Aligned_cols=265  Identities=24%  Similarity=0.322  Sum_probs=206.8

Q ss_pred             CccccchhhhhccCCCCC-cccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHc-CCCceeEEe
Q 040532          103 PLFSFSSVSTATNTFSDT-NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKV-QHKNLVRLL  177 (436)
Q Consensus       103 ~~~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~  177 (436)
                      +...+.......+.|.+. +.||+|+||+||+|... +|+.||+|++...  .......+.+|+.++.++ +||||++++
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            344455566777888887 88999999999999976 4899999998753  233357789999999999 569999999


Q ss_pred             eEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---CC
Q 040532          178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DM  254 (436)
Q Consensus       178 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~~  254 (436)
                      +++.+.+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+   ++||||||+|||++.   ++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBC
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCC
Confidence            9999999999999999999999988543 2345899999999999999999999998   999999999999997   78


Q ss_pred             CeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHH
Q 040532          255 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVW  334 (436)
Q Consensus       255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  334 (436)
                      .+||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......     ....
T Consensus       172 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~  243 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-----ETYL  243 (327)
T ss_dssp             CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH
T ss_pred             cEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHH
Confidence            99999999998765332   123347999999999999999999999999999999999999998543211     1111


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      .......  . ......      ...+..+.+++.+||+.||++|||++|+++.
T Consensus       244 ~i~~~~~--~-~~~~~~------~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          244 NISQVNV--D-YSEETF------SSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHTCC--C-CCTTTT------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHHhccc--c-cCchhh------cccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            1111110  0 000000      1134568899999999999999999999763

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.1e-42  Score=341.88  Aligned_cols=252  Identities=19%  Similarity=0.258  Sum_probs=191.2

Q ss_pred             hccCCCCC-cccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHH-cCCCceeEEeeEEEe----CCc
Q 040532          113 ATNTFSDT-NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAK-VQHKNLVRLLGCCID----KDE  185 (436)
Q Consensus       113 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~  185 (436)
                      ..++|.+. +.||+|+||+||+|.+. +|+.||+|++...     ..+.+|+.++.+ .+||||+++++++..    .+.
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            34556665 68999999999999976 4889999999643     356788888754 589999999999876    556


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---CCCeEEeecc
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFG  262 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~~~~kl~DfG  262 (436)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence            899999999999999996532 235899999999999999999999998   999999999999997   7899999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCc--chhHHHHHHhhcC
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL--NLLGYVWDLWTSN  340 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~  340 (436)
                      +++......   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+    ...
T Consensus       210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~  282 (400)
T 1nxk_A          210 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMG  282 (400)
T ss_dssp             TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHT
T ss_pred             cccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcC
Confidence            998654322   22345789999999999999999999999999999999999999965432221  111111    111


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      .. . ...+..      ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       283 ~~-~-~~~~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          283 QY-E-FPNPEW------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CC-C-CCTTTT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cc-c-CCCccc------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00 0 000000      1134578899999999999999999999874

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-42  Score=327.87  Aligned_cols=247  Identities=21%  Similarity=0.325  Sum_probs=199.0

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  187 (436)
                      ...++|++.+.||+|+||+||+|.+. +++.||+|++...  .......+.+|+..+.++ +||||+++++++.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            34577899999999999999999976 5899999998754  334456788999999999 9999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC--------------
Q 040532          188 LIYEYMPNKSLDFFLFDPTK-RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--------------  252 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~--------------  252 (436)
                      +||||+++++|.+++..... ...+++..+..++.|++.||+|||+++   ++||||||+||+++.              
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999999999864321 245899999999999999999999998   999999999999984              


Q ss_pred             -----CCCeEEeeccCceecCCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 040532          253 -----DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  326 (436)
Q Consensus       253 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~  326 (436)
                           ...+||+|||++.......      ...||+.|+|||.+.+. .++.++||||||+++|||++|.+++....   
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---  235 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---  235 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred             cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence                 4479999999998765322      23589999999999876 56789999999999999999987753211   


Q ss_pred             cchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        .    ..........      ..+..     .+..+.+++.+||+.||++|||+.|+++
T Consensus       236 --~----~~~~~~~~~~------~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 --Q----WHEIRQGRLP------RIPQV-----LSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             --H----HHHHHTTCCC------CCSSC-----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --H----HHHHHcCCCC------CCCcc-----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence              0    1111111111      11111     3456889999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-42  Score=336.10  Aligned_cols=252  Identities=20%  Similarity=0.257  Sum_probs=198.8

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ..++|++.+.||+|+||.||+|.++. |+.||+|++.....    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            45679999999999999999999764 88999999975432    235688888888 7999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC----CCeEEeeccCcee
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNPKISDFGMARI  266 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~----~~~kl~DfGla~~  266 (436)
                      ||+++|+|.+++....   .+++.....++.|++.||+|||+.+   |+||||||+|||+.++    +.+||+|||++..
T Consensus        96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            9999999999886533   4899999999999999999999998   9999999999998543    3599999999987


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....+  ......... ...... . 
T Consensus       170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i-~~~~~~-~-  242 (342)
T 2qr7_A          170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARI-GSGKFS-L-  242 (342)
T ss_dssp             CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHH-HHCCCC-C-
T ss_pred             CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHH-ccCCcc-c-
Confidence            543321  223357899999999999888999999999999999999999999643221  111122221 111110 0 


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..    ...  ...+..+.+++.+||+.||++||++.|+++
T Consensus       243 ~~----~~~--~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          243 SG----GYW--NSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CS----TTT--TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             Cc----ccc--ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00    000  113457889999999999999999999886

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2e-42  Score=333.48  Aligned_cols=265  Identities=24%  Similarity=0.373  Sum_probs=199.0

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      .++|++.+.||+|+||.||+|.+.. |+.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            4678999999999999999999765 889999998654  3334566889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|..++....   .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999988875433   3899999999999999999999998   999999999999999999999999999765432


Q ss_pred             CcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHH----------HHHhhc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV----------WDLWTS  339 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----------~~~~~~  339 (436)
                      ..  ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... .+....          ...+..
T Consensus       178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHH
T ss_pred             cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhh
Confidence            21  22334789999999999875 68999999999999999999999986533211 000000          000111


Q ss_pred             CCcceeccCCccccccc----hHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          340 NRTLELIDDPVLEDEYS----SKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       340 ~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .........+.......    ....+..+.+++.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            10000000000000000    0114567899999999999999999998875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-42  Score=333.75  Aligned_cols=258  Identities=24%  Similarity=0.348  Sum_probs=195.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC-----
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  184 (436)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++...  .....+.+.+|+.++++++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            4578999999999999999999975 5899999999653  3444677899999999999999999999998753     


Q ss_pred             -ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          185 -EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       185 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                       ..++||||+ +++|.+++..    ..+++.....++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence             459999999 8899988854    24889999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      ++.....     .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.  .+....+.........
T Consensus       175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~~~~  247 (367)
T 1cm8_A          175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--LDQLKEIMKVTGTPPA  247 (367)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCH
T ss_pred             ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCH
Confidence            9875432     233478999999999987 6799999999999999999999999864321  1111111111100000


Q ss_pred             -----------------ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 -----------------LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 -----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                                       ..............  ..+..+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFASILT--NASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCT--TCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCC--CCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                             00000011111111  13457889999999999999999999987

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-42  Score=327.57  Aligned_cols=252  Identities=21%  Similarity=0.283  Sum_probs=204.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      .++|++.+.||+|+||.||+|.... +..||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            4678999999999999999999764 7789999986431   12246788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999988543   24889999999999999999999998   99999999999999999999999999976543


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ..    .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....     ...........        .
T Consensus       167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~--------~  229 (284)
T 2vgo_A          167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-----TETHRRIVNVD--------L  229 (284)
T ss_dssp             SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTC--------C
T ss_pred             cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-----hHHHHHHhccc--------c
Confidence            21    2334789999999999999999999999999999999999999864321     11111111111        0


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhhcc
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS--MLTNEA  393 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~--~L~~~~  393 (436)
                      ..+..     .+..+.+++.+||+.||++||++.++++  .+....
T Consensus       230 ~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          230 KFPPF-----LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             CCCTT-----SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             CCCCc-----CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            11111     3346889999999999999999999986  444433

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-42  Score=333.93  Aligned_cols=267  Identities=22%  Similarity=0.306  Sum_probs=195.9

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChh-----hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      ...++|++.+.||+|+||.||+|.+. +|+.||+|++......     ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999976 4889999999753211     12467899999999999999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++||||+++ +|..++....  ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 7877775432  34788889999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ......  .......||+.|+|||++.+. .++.++|||||||++|||++|..||.....  ......+...........
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--~~~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTT
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHcCCCChhh
Confidence            654322  122335789999999999764 589999999999999999999999854321  111111122111111000


Q ss_pred             ecc---------CCccccc---cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          345 LID---------DPVLEDE---YSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       345 ~~~---------~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ..+         ....+..   ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000         0000000   0001134578999999999999999999999874

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.5e-42  Score=340.67  Aligned_cols=201  Identities=24%  Similarity=0.402  Sum_probs=167.9

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-----C
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----D  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  184 (436)
                      ..++|++.+.||+|+||+||+|.+.. |+.||||++...  .....+.+.+|+.+|++++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            45789999999999999999999754 788999999753  344567889999999999999999999999876     5


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..|+||||++ ++|..++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            6899999987 5898888543   34899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcc--------------------cccccccccCCccchhhh-ccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 040532          265 RICGGNELQ--------------------ANTSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSGKKNTG  320 (436)
Q Consensus       265 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltg~~p~~  320 (436)
                      +........                    ......+||+.|+|||++ .+..++.++||||+||++|||++|..|+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            876533211                    112446899999999986 45669999999999999999998766553

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3e-42  Score=351.87  Aligned_cols=255  Identities=26%  Similarity=0.350  Sum_probs=205.9

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ...++|+..+.||+|+||.||+|... +|+.||+|++....   ......+.+|+.+|.+++||||+++++++.+.+..+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            45577999999999999999999975 58999999986431   223456889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|..++.... ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       261 lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence            9999999999999886533 334899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      .....   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +........      
T Consensus       337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~-i~~~i~~~~------  405 (576)
T 2acx_A          337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREE-VERLVKEVP------  405 (576)
T ss_dssp             CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHH-HHHHHHHCC------
T ss_pred             ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHH-HHHHhhccc------
Confidence            54322   223489999999999999899999999999999999999999996543211 1111 111111110      


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                       ......     .+..+.+++.+||+.||++||     +++|+++
T Consensus       406 -~~~p~~-----~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 -EEYSER-----FSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -CCCCTT-----SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -ccCCcc-----CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence             011111     345788999999999999999     6788875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.3e-42  Score=327.64  Aligned_cols=250  Identities=25%  Similarity=0.439  Sum_probs=205.5

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ..+.|+..+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            4467899999999999999999865 48899999997542 344678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|.+++..    ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus       100 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          100 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             ECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            99999999999853    24899999999999999999999998   999999999999999999999999999876533


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      ..  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     ....... ....      .+.
T Consensus       173 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~-~~~~------~~~  238 (303)
T 3a7i_A          173 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----MKVLFLI-PKNN------PPT  238 (303)
T ss_dssp             BC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHH-HHSC------CCC
T ss_pred             cc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----HHHHHHh-hcCC------CCC
Confidence            21  22335789999999999999999999999999999999999999854321     1111111 1111      111


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      ....     .+..+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          239 LEGN-----YSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCSS-----CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             Cccc-----cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1111     33468899999999999999999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.9e-42  Score=336.88  Aligned_cols=254  Identities=22%  Similarity=0.350  Sum_probs=202.7

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--------hhhHHHHHHHHHHHHHc-CCCceeEEeeEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--------EQGLREMKNEASVIAKV-QHKNLVRLLGCC  180 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  180 (436)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++....        ....+.+.+|+.++.++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            445577999999999999999999986 58999999986542        11245678999999999 799999999999


Q ss_pred             EeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEee
Q 040532          181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  260 (436)
Q Consensus       181 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~D  260 (436)
                      ...+..++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence            999999999999999999999853   234899999999999999999999998   99999999999999999999999


Q ss_pred             ccCceecCCCCcccccccccccCCccchhhhccC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHH
Q 040532          261 FGMARICGGNELQANTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVW  334 (436)
Q Consensus       261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  334 (436)
                      ||++........   .....||+.|+|||++.+.      .++.++|||||||++|||++|+.||.....     .....
T Consensus       244 fG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~~~~  315 (365)
T 2y7j_A          244 FGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-----ILMLR  315 (365)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred             cCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----HHHHH
Confidence            999987654322   2335799999999998743      588999999999999999999999854221     11111


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .........      ..+ ..  ...+..+.+++.+||+.||++||++.|+++
T Consensus       316 ~i~~~~~~~------~~~-~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          316 MIMEGQYQF------SSP-EW--DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHTCCCC------CHH-HH--SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhCCCCC------CCc-cc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111000      000 00  013456889999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.2e-42  Score=331.05  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=200.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ..++|.+.+.||+|+||+||++... +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            4567889999999999999999975 589999999986554445678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE---cCCCCeEEeeccCceecC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICG  268 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll---~~~~~~kl~DfGla~~~~  268 (436)
                      |+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+||++   ++++.+||+|||++....
T Consensus        87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999888542   34889999999999999999999998   9999999999999   788999999999987543


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ..    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     ....... ..... . ...
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i-~~~~~-~-~~~  228 (304)
T 2jam_A          161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKLFEKI-KEGYY-E-FES  228 (304)
T ss_dssp             CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHH-HHCCC-C-CCT
T ss_pred             CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH-HcCCC-C-CCc
Confidence            21    12234689999999999999999999999999999999999999854321     1111111 11110 0 000


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +..      ...+..+.+++.+||+.||++||++.|+++
T Consensus       229 ~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          229 PFW------DDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TTT------TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccc------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            100      113457889999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.8e-42  Score=344.41  Aligned_cols=253  Identities=23%  Similarity=0.325  Sum_probs=191.2

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC--------hhhHHHHHHHHHHHHHcCCCceeEEeeEEEe
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--------EQGLREMKNEASVIAKVQHKNLVRLLGCCID  182 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  182 (436)
                      ...++|.+.+.||+|+||+||+|.+.. ++.||+|++....        ......+.+|+.+|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            456889999999999999999999754 7899999986421        112235789999999999999999999975 


Q ss_pred             CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC---CCeEEe
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKIS  259 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~---~~~kl~  259 (436)
                      .+..++||||+++|+|.+++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.+   +.+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            45679999999999999888543   34899999999999999999999998   9999999999999754   459999


Q ss_pred             eccCceecCCCCcccccccccccCCccchhhhcc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 040532          260 DFGMARICGGNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      |||+++......   ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||....... .+..    .
T Consensus       285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~----~  356 (419)
T 3i6u_A          285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKD----Q  356 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHH----H
T ss_pred             ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHH----H
Confidence            999998764322   2234579999999999863   568899999999999999999999986433221 1111    1


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .......      ..+...  ...+..+.+++.+||+.||++||++.|+++
T Consensus       357 i~~~~~~------~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          357 ITSGKYN------FIPEVW--AEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHTTCCC------CCHHHH--TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCCCC------CCchhh--cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1111100      000000  113457889999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.1e-43  Score=332.38  Aligned_cols=254  Identities=22%  Similarity=0.407  Sum_probs=198.9

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ...++|++.+.||+|+||.||+|.+.. |+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            346789999999999999999999864 8899999998766666788999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        96 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           96 EFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             ECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999887542  234899999999999999999999998   999999999999999999999999987532111


Q ss_pred             CcccccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          271 ELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                        ........||+.|+|||.+.     +..++.++||||||+++|+|++|+.||.....     ............. ..
T Consensus       171 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-~~  242 (302)
T 2j7t_A          171 --LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSDPP-TL  242 (302)
T ss_dssp             --HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCCC-CC
T ss_pred             --ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----HHHHHHHhccCCc-cc
Confidence              11122346899999999984     56789999999999999999999999864321     1111222111110 00


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                          ...     ...+..+.+++.+||+.||++|||+.++++
T Consensus       243 ----~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 ----LTP-----SKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ----SSG-----GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ----CCc-----cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                001     113456889999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.5e-42  Score=348.00  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=203.7

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ...++|+..+.||+|+||+||+|+.+ +|+.||+|++....   ....+.+.+|..++++++||||+++++++.+.+..|
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            34578999999999999999999976 48999999996432   123467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          188 LIYEYMPNKSLDFFLFDPT-KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      +||||+++|+|..++.... ....+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVE  338 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeee
Confidence            9999999999999886543 2345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............      
T Consensus       339 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~~~------  409 (543)
T 3c4z_A          339 LKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLEQA------  409 (543)
T ss_dssp             CCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHHCC------
T ss_pred             ccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhhcc------
Confidence            654322  2233589999999999999999999999999999999999999996543211 1111222221111      


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTM  382 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  382 (436)
                        ...+..     .+..+.+++.+||+.||++||++
T Consensus       410 --~~~p~~-----~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 --VTYPDK-----FSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             --CCCCTT-----SCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             --cCCCcc-----cCHHHHHHHHHhccCCHhHCCCC
Confidence              011111     34568899999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.7e-43  Score=345.74  Aligned_cols=246  Identities=15%  Similarity=0.191  Sum_probs=190.4

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCC---CChhhHHHHHHHH---HHHHHcCCCceeEEe-----
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSG---RSEQGLREMKNEA---SVIAKVQHKNLVRLL-----  177 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~---~~l~~l~h~niv~l~-----  177 (436)
                      .....++|++.+.||+|+||+||+|.+. +|+.||||++..   ......+.+.+|+   ..+++++||||++++     
T Consensus        68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~  147 (377)
T 3byv_A           68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  147 (377)
T ss_dssp             SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred             cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence            3345678999999999999999999964 589999999863   2344567889999   555566899999998     


Q ss_pred             --eEEEeCC-----------------ccEEEEeecCCCChhhhhcCCCc----cCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 040532          178 --GCCIDKD-----------------EKILIYEYMPNKSLDFFLFDPTK----RILLDWVTRVQIIEGIAQGLLYLHQYS  234 (436)
Q Consensus       178 --~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~  234 (436)
                        +++.+.+                 ..++||||+ +|+|.+++.....    ...+++..+..++.|++.||+|||+++
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence              6655543                 278999999 6899998864211    122345888899999999999999998


Q ss_pred             CCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccC-----------CCCcccchh
Q 040532          235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-----------IFSIKSDVF  303 (436)
Q Consensus       235 ~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~  303 (436)
                         |+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||
T Consensus       227 ---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw  297 (377)
T 3byv_A          227 ---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW  297 (377)
T ss_dssp             ---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred             ---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence               99999999999999999999999999986432     2233467 999999999987           899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHH
Q 040532          304 SFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMN  383 (436)
Q Consensus       304 SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  383 (436)
                      ||||++|||++|+.||.......               ....+....  .     ..+..+.+++.+||+.||++||++.
T Consensus       298 SlG~il~elltg~~Pf~~~~~~~---------------~~~~~~~~~--~-----~~~~~~~~li~~~L~~dp~~Rpt~~  355 (377)
T 3byv_A          298 ALGLVIYWIWCADLPITKDAALG---------------GSEWIFRSC--K-----NIPQPVRALLEGFLRYPKEDRLLPL  355 (377)
T ss_dssp             HHHHHHHHHHHSSCCC------C---------------CSGGGGSSC--C-----CCCHHHHHHHHHHTCSSGGGCCCHH
T ss_pred             HHHHHHHHHHHCCCCCccccccc---------------chhhhhhhc--c-----CCCHHHHHHHHHHcCCCchhCCCHH
Confidence            99999999999999985432111               011110100  0     1345688999999999999999999


Q ss_pred             HHHH
Q 040532          384 DVVS  387 (436)
Q Consensus       384 ev~~  387 (436)
                      |+++
T Consensus       356 e~l~  359 (377)
T 3byv_A          356 QAME  359 (377)
T ss_dssp             HHHT
T ss_pred             HHhh
Confidence            9985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.5e-42  Score=361.37  Aligned_cols=251  Identities=27%  Similarity=0.374  Sum_probs=198.3

Q ss_pred             cccCCCCceeEEEEEec---CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLR---KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      +.||+|+||+||+|.+.   .++.||||+++..  .....+.+.+|+.+|++++||||+++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999653   3678999999754  3344678999999999999999999999986 4568899999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc-cc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QA  274 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~  274 (436)
                      |+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus       454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            9999999543   34899999999999999999999998   99999999999999999999999999987654322 12


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                      ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......     . +...........      .+.
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~-~~~~i~~~~~~~------~p~  595 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----E-VTAMLEKGERMG------CPA  595 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H-HHHHHHTTCCCC------CCT
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----H-HHHHHHcCCCCC------CCC
Confidence            2233356788999999999999999999999999999998 99998543221     1 111112211111      111


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                           .++..+.+++.+||+.||++||++.+|++.|+++..+
T Consensus       596 -----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          596 -----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             -----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                 1345789999999999999999999999999987654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.3e-42  Score=324.02  Aligned_cols=260  Identities=25%  Similarity=0.343  Sum_probs=198.3

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC--CC--EEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK--GD--EIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      ..++|++.+.||+|+||+||+|.+..  ++  .||+|++...   .....+.+.+|+.++++++||||+++++++.... 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            45689999999999999999998532  33  6899998754   2345678899999999999999999999987654 


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .++|+||+++++|.+++...  ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence            89999999999999988643  234889999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcc
Q 040532          266 ICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTL  343 (436)
Q Consensus       266 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  343 (436)
                      ........ .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....     ..............
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~~~  244 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKIDKEGERL  244 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTSCCCC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HHHHHHHHccCCCC
Confidence            76543321 12233467888999999999899999999999999999999 9999854321     11122221111110


Q ss_pred             eeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                            ....     ..+..+.+++.+||+.||++||++.++++.|++...
T Consensus       245 ------~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          245 ------PRPE-----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ------CCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ------CCCc-----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                  0011     134578899999999999999999999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.5e-42  Score=334.90  Aligned_cols=264  Identities=24%  Similarity=0.325  Sum_probs=202.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ..++|++.+.||+|+||+||+|.+. +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            4568999999999999999999976 5889999999765 4455678899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      ||+++++|.+++...   ..+++.....++.|++.||+|||+. +   ++||||||+|||++.++.+||+|||++.....
T Consensus       111 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             ECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999998543   2488999999999999999999985 7   99999999999999999999999999865421


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhH----------HHHHHhhc
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG----------YVWDLWTS  339 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~  339 (436)
                          .......||+.|+|||++.+..++.++||||||+++|||++|+.||............          ........
T Consensus       185 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          185 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             ----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             ----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence                1223347899999999999999999999999999999999999998653321100000          00000000


Q ss_pred             CCc--------------ceec---cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          340 NRT--------------LELI---DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       340 ~~~--------------~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...              .+..   ..... ........+..+.+++.+||+.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCC-CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCC-CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            000              0000   00000 00001113456889999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9e-42  Score=328.54  Aligned_cols=259  Identities=17%  Similarity=0.286  Sum_probs=199.1

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEe--CCccEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCCID--KDEKIL  188 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~l  188 (436)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++.....   +.+.+|+.++++++ ||||+++++++.+  ....++
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch---HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            3578999999999999999999864 588999999975443   57889999999997 9999999999988  567799


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC-CeEEeeccCceec
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARIC  267 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~-~~kl~DfGla~~~  267 (436)
                      ||||+++++|..++..      +++.....++.|++.||+|||+.+   ++||||||+|||++.++ .+||+|||++...
T Consensus       111 v~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            9999999999988742      788999999999999999999998   99999999999999776 8999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .....   .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.........+.... ...........+
T Consensus       182 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~-~~~~~~~~~~~~  257 (330)
T 3nsz_A          182 HPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA-KVLGTEDLYDYI  257 (330)
T ss_dssp             CTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH-HHHCHHHHHHHH
T ss_pred             CCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHH-HhcCCchhhhHH
Confidence            54322   233478999999999987 6789999999999999999999999843322111111110 000000000000


Q ss_pred             ---------------c---CCccc---cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          347 ---------------D---DPVLE---DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       347 ---------------~---~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                                     .   .....   ........+..+.+++.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                           0   00000   00001113567899999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.7e-42  Score=348.50  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=200.8

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCCh-------------hhHHHHHHHHHHHHHcCCCceeEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSE-------------QGLREMKNEASVIAKVQHKNLVRL  176 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l  176 (436)
                      ....++|++.+.||+|+||+||+|.... ++.||+|++.....             ...+.+.+|+.++++++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            4467889999999999999999999764 78999999865321             234678999999999999999999


Q ss_pred             eeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC--
Q 040532          177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM--  254 (436)
Q Consensus       177 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~--  254 (436)
                      ++++.+....++||||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++  
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCC
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCC
Confidence            99999999999999999999998888543   34899999999999999999999998   99999999999999776  


Q ss_pred             -CeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHH
Q 040532          255 -NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV  333 (436)
Q Consensus       255 -~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  333 (436)
                       .+||+|||++.......   ......||+.|+|||++. +.++.++||||+||++|+|++|+.||.....     ....
T Consensus       186 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~  256 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-----QDII  256 (504)
T ss_dssp             SSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred             ccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence             69999999998765432   223347999999999876 5689999999999999999999999864321     1111


Q ss_pred             HHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...........         .......+..+.+++.+||+.||.+|||+.|+++
T Consensus       257 ~~i~~~~~~~~---------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          257 KKVEKGKYYFD---------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHCCCCCC---------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCCCCC---------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            12111110000         0000113457889999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.7e-42  Score=339.28  Aligned_cols=256  Identities=9%  Similarity=0.048  Sum_probs=182.3

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHc--CCCceeEEe-------
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKV--QHKNLVRLL-------  177 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~niv~l~-------  177 (436)
                      ......|+..+.||+|+||+||+|.+. +|+.||+|++....   ....+.+.+|+.++..+  +||||++++       
T Consensus        58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~  137 (371)
T 3q60_A           58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS  137 (371)
T ss_dssp             TCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred             CCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence            334556899999999999999999965 58899999998653   23456677886555555  699988755       


Q ss_pred             eEEEeCC-----------------ccEEEEeecCCCChhhhhcCCCccCCCCHHHH------HHHHHHHHHHHHHHhhCC
Q 040532          178 GCCIDKD-----------------EKILIYEYMPNKSLDFFLFDPTKRILLDWVTR------VQIIEGIAQGLLYLHQYS  234 (436)
Q Consensus       178 ~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~  234 (436)
                      +++...+                 ..++||||++ |+|.+++.....  .+++..+      ..++.|++.||+|||+++
T Consensus       138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~  214 (371)
T 3q60_A          138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG  214 (371)
T ss_dssp             EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence            4444332                 3699999999 899999864322  2445555      788899999999999998


Q ss_pred             CCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhcc--CCCCcccchhhHHHHHHHH
Q 040532          235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEI  312 (436)
Q Consensus       235 ~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el  312 (436)
                         |+||||||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+  ..++.++|||||||++|||
T Consensus       215 ---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el  286 (371)
T 3q60_A          215 ---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV  286 (371)
T ss_dssp             ---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred             ---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence               9999999999999999999999999998754221     13356799999999987  6799999999999999999


Q ss_pred             HhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc-CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          313 VSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID-DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       313 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ++|+.||...........       .......... ....+.   ....+..+.+++.+||+.||++|||+.|+++
T Consensus       287 ltg~~Pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          287 WCLFLPFGLVTPGIKGSW-------KRPSLRVPGTDSLAFGS---CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHSSCSTTBCCTTCTTCC-------CBCCTTSCCCCSCCCTT---SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HhCCCCCCCcCcccccch-------hhhhhhhccccccchhh---ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999999965432211000       0000000000 000110   0124567899999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-41  Score=342.03  Aligned_cols=264  Identities=19%  Similarity=0.274  Sum_probs=207.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEe-cCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCC-CceeEEeeEEEeCCccEEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVL-RKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  190 (436)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++......  ..+.+|+.+++.++| +++..+..++.+.+..++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            457899999999999999999996 45899999988654332  357899999999976 56666667777788889999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE---cCCCCeEEeeccCceec
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARIC  267 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll---~~~~~~kl~DfGla~~~  267 (436)
                      ||+ +++|.+++....  ..+++..++.++.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        83 e~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            999 999999986322  24899999999999999999999998   9999999999999   68899999999999876


Q ss_pred             CCCCcc-----cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCc-chhHHHHHHhhcCC
Q 040532          268 GGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NLLGYVWDLWTSNR  341 (436)
Q Consensus       268 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~  341 (436)
                      ......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .....+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            543321     122345799999999999999999999999999999999999999965433221 11111111110010


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      ....           ...++..+.+++..||+.+|++||++.+|++.|+++...
T Consensus       237 ~~~l-----------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          237 IEAL-----------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HHHH-----------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHH-----------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            0000           011345789999999999999999999999999988654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-41  Score=321.32  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=198.5

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe----CC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCID----KD  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~  184 (436)
                      .....|.+.+.||+|+||+||+|.+. ++..||+|.+...  .....+.+.+|+.++++++||||+++++++..    ..
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            34456788889999999999999975 4778999998643  45556789999999999999999999999876    34


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-CCCCeEEeeccC
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGM  263 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-~~~~~kl~DfGl  263 (436)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+ .+++||||||+||+++ +++.+||+|||+
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             eEEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            578999999999999998542   34889999999999999999999875 3499999999999998 789999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL  343 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  343 (436)
                      +.......    .....||+.|+|||.+. +.++.++||||||+++|+|++|+.||.....    ........ ..... 
T Consensus       179 ~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~-~~~~~-  247 (290)
T 1t4h_A          179 ATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRV-TSGVK-  247 (290)
T ss_dssp             GGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHH-TTTCC-
T ss_pred             cccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc----HHHHHHHH-hccCC-
Confidence            97544322    22346899999999876 4589999999999999999999999854321    11111111 11111 


Q ss_pred             eeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                          .......     .+..+.+++.+||+.||++|||+.|+++
T Consensus       248 ----~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 ----PASFDKV-----AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----CGGGGGC-----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----ccccCCC-----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                1111111     2346889999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.5e-42  Score=325.32  Aligned_cols=252  Identities=20%  Similarity=0.248  Sum_probs=197.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC----hhhHHHHHHHHHHHHHcCCCceeEEeeEEE--eCCcc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS----EQGLREMKNEASVIAKVQHKNLVRLLGCCI--DKDEK  186 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  186 (436)
                      .++|++.+.||+|+||.||++.+. +++.||+|++....    ....+.+.+|+.++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999975 48899999996432    234577899999999999999999999985  44578


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||++++ |.+++.... ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999987 555554322 335899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCCccchhhhccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ..............||+.|+|||++.+..  ++.++||||||+++|||++|+.||....     ............    
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~i~~~~----  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFENIGKGS----  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHCC----
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHHhcCC----
Confidence            65433333334457899999999988644  4789999999999999999999986422     111111111111    


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                          ......     .+..+.+++.+||+.||++||++.|+++.
T Consensus       230 ----~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ----YAIPGD-----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----CCCCSS-----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----CCCCCc-----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                011111     33468899999999999999999999963

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.7e-42  Score=329.16  Aligned_cols=264  Identities=24%  Similarity=0.379  Sum_probs=186.6

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ....++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            345678999999999999999999965 58899999987542 3345678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcC-----CCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          189 IYEYMPNKSLDFFLFD-----PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      ||||+++++|.+++..     ......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999998853     112345899999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCc---ccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc
Q 040532          264 ARICGGNEL---QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS  339 (436)
Q Consensus       264 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  339 (436)
                      +........   ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......  .   .......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~---~~~~~~~  242 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--V---LMLTLQN  242 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--H---HHHHHTS
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--H---HHHHhcc
Confidence            876543211   111233478999999999876 568999999999999999999999986543221  1   1111111


Q ss_pred             CC--cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          340 NR--TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       340 ~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..  .............     .+..+.+++.+||+.||++||++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKK-----YGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----CCCCC-----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccchhhhh-----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            10  0111111111111     3346889999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-41  Score=325.78  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=200.9

Q ss_pred             ccccchhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcC--CCceeEEeeE
Q 040532          104 LFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQ--HKNLVRLLGC  179 (436)
Q Consensus       104 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~  179 (436)
                      .+.+..+....++|++.+.||+|+||.||++.+.+++.||+|++...  .....+.+.+|+.++.+++  ||||++++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            34555667778899999999999999999999988999999998643  4455678999999999997  5999999999


Q ss_pred             EEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEe
Q 040532          180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  259 (436)
Q Consensus       180 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~  259 (436)
                      +...+..++||| +.+++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||||+||++++ +.+||+
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEEC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEe
Confidence            999999999999 6788999998643   34889999999999999999999998   999999999999975 899999


Q ss_pred             eccCceecCCCCcccccccccccCCccchhhhcc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 040532          260 DFGMARICGGNELQANTSRIVGTYGYMSPEYALE-----------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN  328 (436)
Q Consensus       260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~  328 (436)
                      |||++................||+.|+|||.+.+           ..++.++||||||+++|||++|+.||......   
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---  245 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---  245 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---
Confidence            9999987654333222334578999999999875           46888999999999999999999998543211   


Q ss_pred             hhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          329 LLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                       ..............      .....     .+..+.+++.+||+.||++||++.|+++.
T Consensus       246 -~~~~~~~~~~~~~~------~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          246 -ISKLHAIIDPNHEI------EFPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -HHHHHHHHCTTSCC------CCCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHHHHhccccc------CCccc-----chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence             11111111111110      01111     13468899999999999999999999863

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=333.62  Aligned_cols=263  Identities=22%  Similarity=0.361  Sum_probs=193.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhh-HHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|++.+.||+|+||+||+|... +++.||+|++....... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46889999999999999999976 58899999997543221 12455799999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      ++ |+|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            98 4787777543  235889999999999999999999998   9999999999999999999999999997654322 


Q ss_pred             ccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc---eeccC
Q 040532          273 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL---ELIDD  348 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  348 (436)
                       .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....  .+....+..........   .....
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--EEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHhchhhhcc
Confidence             12233478999999999886 5689999999999999999999999864321  11222222221111100   00000


Q ss_pred             --------Ccccc---ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          349 --------PVLED---EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       349 --------~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                              +....   .......+..+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                    00000   0000113456889999999999999999999987

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.1e-42  Score=332.32  Aligned_cols=266  Identities=21%  Similarity=0.303  Sum_probs=198.3

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-------
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-------  183 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  183 (436)
                      .++|++.+.||+|+||+||+|.+. +|+.||+|++....  ......+.+|+.++++++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            467999999999999999999974 58999999986542  22245678999999999999999999999874       


Q ss_pred             -CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          184 -DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       184 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                       +..++||||+++ +|...+....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             457899999986 5655554432  23899999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCc--ccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc
Q 040532          263 MARICGGNEL--QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS  339 (436)
Q Consensus       263 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  339 (436)
                      ++........  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....  ......+......
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~  247 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGS  247 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCC
Confidence            9987653221  122334578999999999876 4589999999999999999999999864321  1111111111111


Q ss_pred             CC--cceecc---------CCcccccc-----chHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          340 NR--TLELID---------DPVLEDEY-----SSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       340 ~~--~~~~~~---------~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..  .....+         ........     ........+.+++.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            00  000000         00000000     00011345789999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.6e-42  Score=327.64  Aligned_cols=252  Identities=25%  Similarity=0.430  Sum_probs=198.4

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ...++|++.+.||+|+||.||+|.+.. |+.||+|.+....  ..+.+.+|+.++.+++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            456789999999999999999999764 8999999997543  2367899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++++|.+++..  ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999998852  2235899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      .  .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....     ............       ..
T Consensus       179 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~-------~~  244 (314)
T 3com_A          179 M--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-----MRAIFMIPTNPP-------PT  244 (314)
T ss_dssp             B--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCC-------CC
T ss_pred             c--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCCC-------cc
Confidence            2  122334789999999999998999999999999999999999999854321     111111111110       00


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..   .....+..+.+++.+||+.||++|||+.++++
T Consensus       245 ~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 FR---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CS---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00   00113456889999999999999999999976

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1e-42  Score=328.68  Aligned_cols=255  Identities=23%  Similarity=0.319  Sum_probs=186.9

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hh-hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      +...++|++.+.||+|+||+||+|.+. +|+.||+|++.... .. ..+.+.++...++.++||||+++++++.+.+..+
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            345678999999999999999999974 58899999997542 22 2334455555677889999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          188 LIYEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      +||||+++ +|.+++... .....+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.+||+|||++.
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISG  158 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence            99999985 776665431 2234589999999999999999999997 7   9999999999999999999999999997


Q ss_pred             ecCCCCcccccccccccCCccchhhh----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYA----LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      ......   ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||.......    ...........
T Consensus       159 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~  231 (290)
T 3fme_A          159 YLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF----QQLKQVVEEPS  231 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH----HHHHHHHHSCC
T ss_pred             cccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH----HHHHHHhccCC
Confidence            654332   12223689999999996    45678999999999999999999999986432211    11111111111


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      . .     ...     ...+..+.+++.+||+.||++|||+.|+++
T Consensus       232 ~-~-----~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 P-Q-----LPA-----DKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             C-C-----CCT-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C-C-----ccc-----ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            0 0     000     113456889999999999999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-42  Score=326.28  Aligned_cols=250  Identities=21%  Similarity=0.348  Sum_probs=195.5

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ...++|++.+.||+|+||.||+|.+. +|+.||+|++....   ....+.+.+|+..+++++||||+++++++.+.+..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            34578999999999999999999976 58999999986432   123467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++...
T Consensus        88 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence            999999999999998543   24889999999999999999999998   999999999999999999999999999765


Q ss_pred             CCCCcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .....   .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....     ........ ....     
T Consensus       162 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~-~~~~-----  227 (276)
T 2h6d_A          162 SDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-----VPTLFKKI-RGGV-----  227 (276)
T ss_dssp             CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH-HHCC-----
T ss_pred             CCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHh-hcCc-----
Confidence            43321   223468999999999987765 689999999999999999999985422     11111111 1111     


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        ...+..     .+..+.+++.+||+.||++|||+.|+++.
T Consensus       228 --~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 --FYIPEY-----LNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --CCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --ccCchh-----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              001111     23468889999999999999999999873

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.1e-42  Score=349.22  Aligned_cols=253  Identities=25%  Similarity=0.356  Sum_probs=198.3

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ....+.|++.+.||+|+||+||+|... .+..||+|++....  ......+.+|+.++++++||||+++++++.+.+..+
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            345567999999999999999999976 48899999987542  233567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---CCCeEEeeccCc
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMA  264 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~~~~kl~DfGla  264 (436)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       113 lv~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            999999999998887533   34889999999999999999999998   999999999999976   455999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      .......   ......||+.|+|||++. +.++.++||||+||++|+|++|+.||.....     .............  
T Consensus       187 ~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~--  255 (494)
T 3lij_A          187 AVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----QEILRKVEKGKYT--  255 (494)
T ss_dssp             EECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCC--
T ss_pred             eECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC--
Confidence            8765332   223357999999999876 5699999999999999999999999864321     1111111111110  


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ...+..      ...+..+.+++.+||+.||.+|||+.|+++
T Consensus       256 -~~~~~~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          256 -FDSPEW------KNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -CCSGGG------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CCchhc------ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence             001110      113456889999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.2e-42  Score=332.96  Aligned_cols=265  Identities=21%  Similarity=0.301  Sum_probs=192.2

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh--hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ....++|++.+.||+|+||+||+|.+. +++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            344578999999999999999999865 588999999975432  23456789999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-----CCCCeEEeecc
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-----KDMNPKISDFG  262 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-----~~~~~kl~DfG  262 (436)
                      +||||+++ +|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+|||++     +++.+||+|||
T Consensus       110 lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999985 8888885433   4899999999999999999999998   99999999999994     45569999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      ++.......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....  .+.............
T Consensus       183 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          183 LARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE--IDQLFKIFEVLGLPD  258 (329)
T ss_dssp             HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCC
T ss_pred             CccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH--HHHHHHHHHHhCCCc
Confidence            998664322  122334689999999999874 489999999999999999999999854321  111111111111100


Q ss_pred             cce---e------------ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 TLE---L------------IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~---~------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...   .            .....+... ........+.+++.+||+.||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRV-LGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHH-HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhh-cccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000   0            000000000 00113356889999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.1e-43  Score=328.56  Aligned_cols=259  Identities=23%  Similarity=0.310  Sum_probs=202.8

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe--CCccEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKIL  188 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  188 (436)
                      .++|++.+.||+|+||+||+|... +|+.||+|.+...  .....+.+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467899999999999999999976 5889999999754  34556789999999999999999999998864  567899


Q ss_pred             EEeecCCCChhhhhcCCC-ccCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          189 IYEYMPNKSLDFFLFDPT-KRILLDWVTRVQIIEGIAQGLLYLHQYS--RVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      ||||+++++|.+++.... ....+++...+.++.|++.||+|||+.+  ..+++||||||+||++++++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999986422 2345899999999999999999999876  2349999999999999999999999999997


Q ss_pred             ecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      .......  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....     ...... .......  
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~-i~~~~~~--  234 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGK-IREGKFR--  234 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-HHHTCCC--
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HHHHHH-Hhhcccc--
Confidence            6543221  12234689999999999999999999999999999999999999864321     111111 1111111  


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhh
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN  391 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~  391 (436)
                          .....     .+..+.+++.+||+.||++||++.|+++.+..
T Consensus       235 ----~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          235 ----RIPYR-----YSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             ----CCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ----cCCcc-----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                11111     34568899999999999999999999986643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3e-42  Score=349.53  Aligned_cols=253  Identities=25%  Similarity=0.315  Sum_probs=201.3

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      ...++|++.+.||+|+||+||+|.+. +++.||+|++...  .......+.+|+.++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            45678999999999999999999976 5889999998532  12235678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc---CCCCeEEeeccCce
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMAR  265 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~---~~~~~kl~DfGla~  265 (436)
                      ||||+++|+|.+.+...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++   .++.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            99999999998887543   34899999999999999999999998   99999999999995   45679999999997


Q ss_pred             ecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ......   ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....     ............... 
T Consensus       173 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~-  242 (486)
T 3mwu_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDILKRVETGKYAFD-  242 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCCSC-
T ss_pred             ECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCC-
Confidence            654332   2233479999999998875 589999999999999999999999854321     111122111111000 


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                        .+.      ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       243 --~~~------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 --LPQ------WRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             --SGG------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             --Ccc------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              000      01134578899999999999999999999873

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-42  Score=351.17  Aligned_cols=252  Identities=26%  Similarity=0.347  Sum_probs=203.9

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ...++|++.+.||+|+||+||+|... +|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45678999999999999999999976 58999999986432   334578899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE---cCCCCeEEeeccCc
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMA  264 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll---~~~~~~kl~DfGla  264 (436)
                      +||||+++|+|.+++....   .+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++
T Consensus       103 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            9999999999998886533   4899999999999999999999998   9999999999999   56789999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      .......   ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....     ...............
T Consensus       177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~  247 (484)
T 3nyv_A          177 THFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----YDILKKVEKGKYTFE  247 (484)
T ss_dssp             HHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCC
T ss_pred             EEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCCCCC
Confidence            8765432   1233479999999998875 689999999999999999999999864321     111122111111000


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                         .+.      ....+..+.+++.+||+.||++|||+.|+++
T Consensus       248 ---~~~------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 ---LPQ------WKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ---SGG------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---Ccc------cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence               000      0114457889999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-42  Score=335.59  Aligned_cols=256  Identities=22%  Similarity=0.287  Sum_probs=202.1

Q ss_pred             hccCCCCCcccCCCCceeEEEEEe----cCCCEEEEEEcCCCC----hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeC
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVL----RKGDEIAVKRLSGRS----EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  183 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  183 (436)
                      ..++|++.+.||+|+||+||+|..    .+|+.||+|++....    ....+.+.+|+.++.++ +||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            347899999999999999999997    358999999986431    12234577899999999 699999999999999


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                      +..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             ceEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence            9999999999999999998543   34889999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      ++....... .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||....... ............. 
T Consensus       206 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~-  282 (355)
T 1vzo_A          206 SKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSE-  282 (355)
T ss_dssp             EEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHCC-
T ss_pred             CeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhccC-
Confidence            987543222 222345799999999999863  47899999999999999999999986433221 1222222221111 


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVSML  389 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~~L  389 (436)
                             +.....     .+..+.+++.+||+.||++||     ++.|+++..
T Consensus       283 -------~~~~~~-----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          283 -------PPYPQE-----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -------CCCCTT-----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -------CCCCcc-----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                   111111     334678899999999999999     899998754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.8e-41  Score=329.91  Aligned_cols=266  Identities=20%  Similarity=0.269  Sum_probs=201.4

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-----C
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----D  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  184 (436)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++.+++||||+++++++...     .
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            34578999999999999999999975 4788999999754 344457789999999999999999999998765     3


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..++||||++ |+|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence            5799999997 488887743    24899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCccc-ccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          265 RICGGNELQA-NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       265 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      .......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......  +....+.........
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGILGSPSQ  253 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG--GHHHHHHHHHCSCCH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHHHhCCCCH
Confidence            8765332211 1234579999999998764 45899999999999999999999998643321  121111111111100


Q ss_pred             ce---------------eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 LE---------------LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 ~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..               ................+..+.+++.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00               0000000000000113456889999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.3e-41  Score=322.50  Aligned_cols=252  Identities=22%  Similarity=0.321  Sum_probs=202.1

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---------hhhHHHHHHHHHHHHHcC-CCceeEEeeEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---------EQGLREMKNEASVIAKVQ-HKNLVRLLGCCI  181 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  181 (436)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++....         ....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999976 48899999986542         123456789999999995 999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeec
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  261 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~Df  261 (436)
                      ..+..++||||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999854   235899999999999999999999998   999999999999999999999999


Q ss_pred             cCceecCCCCcccccccccccCCccchhhhc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 040532          262 GMARICGGNELQANTSRIVGTYGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  335 (436)
                      |++.......   ......|++.|+|||.+.      ...++.++||||||+++|||++|+.||.....     ......
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~  240 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLRM  240 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----HHHHHH
Confidence            9998765432   223347899999999986      45688999999999999999999999854321     111111


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .......   ...+..      ...+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~---~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          241 IMSGNYQ---FGSPEW------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHTCCC---CCTTTG------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HhcCCcc---cCcccc------cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1111100   000000      113457889999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.3e-41  Score=333.64  Aligned_cols=266  Identities=20%  Similarity=0.249  Sum_probs=201.1

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC--------CCceeEEeeEEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ--------HKNLVRLLGCCI  181 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~  181 (436)
                      ....++|++.+.||+|+||+||+|.+. +++.||+|++... ....+.+.+|+.++++++        |+||+++++++.
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            345688999999999999999999865 4788999999753 444577889999999985        788999999988


Q ss_pred             ----eCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecccCCCCEEEcCCC--
Q 040532          182 ----DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDM--  254 (436)
Q Consensus       182 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~i~H~Dikp~NIll~~~~--  254 (436)
                          +....++||||+.++.+..+....  ...+++..+..++.|++.||+|||++ +   |+||||||+|||++.++  
T Consensus       112 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          112 ISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEETTEEEEEEEECCCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHH
T ss_pred             ecCCCCceEEEEEeccCccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchh
Confidence                455789999999555544444332  23489999999999999999999998 7   99999999999999775  


Q ss_pred             -----------------------------------------------CeEEeeccCceecCCCCcccccccccccCCccc
Q 040532          255 -----------------------------------------------NPKISDFGMARICGGNELQANTSRIVGTYGYMS  287 (436)
Q Consensus       255 -----------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  287 (436)
                                                                     .+||+|||++......     .....||+.|+|
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a  261 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence                                                           8999999999875432     233478999999


Q ss_pred             hhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcc----hhHHHHHHhhcC---------Ccceecc-------
Q 040532          288 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN----LLGYVWDLWTSN---------RTLELID-------  347 (436)
Q Consensus       288 PE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~---------~~~~~~~-------  347 (436)
                      ||++.+..++.++|||||||++|||++|+.||.........    ............         .......       
T Consensus       262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            99999999999999999999999999999999755433221    111111111100         0000000       


Q ss_pred             --CCc--------cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 --DPV--------LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 --~~~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        ...        .............+.+|+.+||+.||++|||++|+++
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence              000        0000112346678999999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-42  Score=329.38  Aligned_cols=262  Identities=23%  Similarity=0.374  Sum_probs=199.7

Q ss_pred             CccccchhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEE
Q 040532          103 PLFSFSSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCC  180 (436)
Q Consensus       103 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  180 (436)
                      +.+.+.++....++|++.+.||+|+||.||+|.+. +|+.||+|++..... ..+.+.+|+.+++++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            34455666778899999999999999999999974 588999999875432 236788999999999 899999999999


Q ss_pred             Ee------CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC
Q 040532          181 ID------KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  254 (436)
Q Consensus       181 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~  254 (436)
                      ..      .+..++||||+++++|.+++.... ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~  166 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA  166 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence            87      457899999999999999986432 345889999999999999999999998   99999999999999999


Q ss_pred             CeEEeeccCceecCCCCcccccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 040532          255 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL  329 (436)
Q Consensus       255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~  329 (436)
                      .+||+|||++.......  .......||+.|+|||++.     +..++.++||||||+++|+|++|+.||.....     
T Consensus       167 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----  239 (326)
T 2x7f_A          167 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----  239 (326)
T ss_dssp             CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred             CEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----
Confidence            99999999987654321  1223347899999999987     56689999999999999999999999853321     


Q ss_pred             hHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          330 LGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ........... ..     ......     .+..+.+++.+||+.||++||++.++++
T Consensus       240 ~~~~~~~~~~~-~~-----~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          240 MRALFLIPRNP-AP-----RLKSKK-----WSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHHHHSC-CC-----CCSCSC-----SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhcCc-cc-----cCCccc-----cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11111111111 00     001111     2356889999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-41  Score=332.69  Aligned_cols=260  Identities=23%  Similarity=0.327  Sum_probs=184.6

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-----
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----  183 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  183 (436)
                      ...++|++.+.||+|+||.||+|.+. +|+.||+|++...  .....+.+.+|+.++++++||||+++++++...     
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            34578999999999999999999864 4889999999753  344567788999999999999999999998754     


Q ss_pred             -CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          184 -DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       184 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                       ...++|+||+ +++|..++..    ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred             CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence             5579999999 6888888753    34899999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      +++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.  .+....+........
T Consensus       178 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p~  250 (367)
T 2fst_X          178 LARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPG  250 (367)
T ss_dssp             ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCC
T ss_pred             cccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCC
Confidence            99764322     233578999999999987 6789999999999999999999999864321  111111111111110


Q ss_pred             c--c---------------eeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          342 T--L---------------ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       342 ~--~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                      .  .               ............  ......+.+|+.+||+.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVF--IGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHT--TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHC--CCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0  0               000000000000  0124568899999999999999999999863

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.2e-42  Score=332.86  Aligned_cols=267  Identities=20%  Similarity=0.271  Sum_probs=196.2

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCC-----------hhhHHHHHHHHHHHHHcCCCceeEE
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS-----------EQGLREMKNEASVIAKVQHKNLVRL  176 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~niv~l  176 (436)
                      .++....++|++.+.||+|+||.||+|.+.+|..||+|++....           ....+.+.+|+.++++++||||+++
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            45667789999999999999999999998889999999985421           2224778999999999999999999


Q ss_pred             eeEEEeCC-----ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc
Q 040532          177 LGCCIDKD-----EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  251 (436)
Q Consensus       177 ~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~  251 (436)
                      ++++...+     ..++||||++ |+|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLA  168 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred             eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEc
Confidence            99986533     4699999998 5777766543  335899999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeeccCceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 040532          252 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL  330 (436)
Q Consensus       252 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~  330 (436)
                      .++.+||+|||++.......   ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||......  ...
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~  243 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--NQL  243 (362)
T ss_dssp             TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH
T ss_pred             CCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--HHH
Confidence            99999999999997543222   2233478999999999887 67899999999999999999999998643211  111


Q ss_pred             HHHHHHhhcCCc------------------ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          331 GYVWDLWTSNRT------------------LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       331 ~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ............                  ...........  ........+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTA--VVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHH--HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHh--hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            111111111100                  00000000000  00113456889999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.4e-42  Score=327.49  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=195.5

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC--------hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS--------EQGLREMKNEASVIAKVQHKNLVRLLGCCIDK  183 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  183 (436)
                      ..++|++.+.||+|+||.||+|.+.. ++.||+|++....        ......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            45679999999999999999999764 7899999986532        12234578999999999999999999998765


Q ss_pred             CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC---eEEee
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISD  260 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~---~kl~D  260 (436)
                      + .++||||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 89999999999999988543   34899999999999999999999998   999999999999987664   99999


Q ss_pred             ccCceecCCCCcccccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh
Q 040532          261 FGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      ||++........   .....||+.|+|||++.   ...++.++|||||||++|+|++|+.||....... .+...+.   
T Consensus       161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~---  233 (322)
T 2ycf_A          161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQIT---  233 (322)
T ss_dssp             CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHH---
T ss_pred             Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHH---
Confidence            999987653321   22346899999999975   4668999999999999999999999986443221 1211111   


Q ss_pred             hcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          338 TSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       .....      ..+..  ....+..+.+++.+||+.||++||++.++++
T Consensus       234 -~~~~~------~~~~~--~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 -SGKYN------FIPEV--WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -HTCCC------CCHHH--HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -hCccc------cCchh--hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             11100      00000  0113457889999999999999999999984

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.2e-41  Score=331.38  Aligned_cols=261  Identities=23%  Similarity=0.281  Sum_probs=191.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC-----
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  184 (436)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++...  .....+.+.+|+.++++++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            3578999999999999999999865 4888999999753  3445677889999999999999999999998665     


Q ss_pred             -ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          185 -EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       185 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                       ..++||||+++ +|.+++..     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence             67999999985 57666632     3788999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHH----------
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV----------  333 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----------  333 (436)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..  .....+          
T Consensus       174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPE  248 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHC-CCCCCHH
T ss_pred             cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence            98654322   122347899999999999999999999999999999999999998643211  000000          


Q ss_pred             ---------HHHhhcCCcce------eccCCccc-cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          334 ---------WDLWTSNRTLE------LIDDPVLE-DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       334 ---------~~~~~~~~~~~------~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                               ...........      .......+ ...........+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                     00000000000      00000000 00011224667899999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.9e-41  Score=336.72  Aligned_cols=200  Identities=22%  Similarity=0.291  Sum_probs=171.8

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHc------CCCceeEEeeEEEeCC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKV------QHKNLVRLLGCCIDKD  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~  184 (436)
                      ....+|++.+.||+|+||+||+|.+.. ++.||||++... ......+.+|+.++..+      +|+||+++++++...+
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            445679999999999999999998764 789999999754 33446778888888887      5779999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC--eEEeecc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--PKISDFG  262 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~--~kl~DfG  262 (436)
                      ..++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             eEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence            9999999996 57877775432 234899999999999999999999998   999999999999999887  9999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY  322 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~  322 (436)
                      ++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       248 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          248 SSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            99765432     22347899999999999999999999999999999999999998643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.5e-41  Score=329.36  Aligned_cols=262  Identities=23%  Similarity=0.332  Sum_probs=204.0

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChh-----------------hHHHHHHHHHHHHHcCCCcee
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQ-----------------GLREMKNEASVIAKVQHKNLV  174 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~niv  174 (436)
                      ...++|++.+.||+|+||.||+|.. +|+.||+|++......                 ..+.+.+|+.++++++||||+
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            3457899999999999999999999 7999999998643111                 127889999999999999999


Q ss_pred             EEeeEEEeCCccEEEEeecCCCChhhh------hcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCC
Q 040532          175 RLLGCCIDKDEKILIYEYMPNKSLDFF------LFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASN  247 (436)
Q Consensus       175 ~l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~N  247 (436)
                      ++++++.+.+..++||||+++++|.++      +.. .....+++..+..++.|++.||.|||+ .+   ++||||||+|
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N  182 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN  182 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence            999999999999999999999999998      433 224568999999999999999999998 87   9999999999


Q ss_pred             EEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccC-CCCc-ccchhhHHHHHHHHHhCCCCCCCCCCC
Q 040532          248 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSI-KSDVFSFGVLLLEIVSGKKNTGLYRTD  325 (436)
Q Consensus       248 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlGvil~elltg~~p~~~~~~~  325 (436)
                      |+++.++.+||+|||++......    ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            99999999999999999875433    22335789999999999877 6666 999999999999999999998643321


Q ss_pred             CcchhHHHHHHhhcCCcceecc-----CCccc--cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          326 SLNLLGYVWDLWTSNRTLELID-----DPVLE--DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                          ....... ..........     .+...  ........+..+.+++.+||+.||.+||++.|+++
T Consensus       259 ----~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 ----VELFNNI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ----HHHHHHH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHHH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                1111111 1111100000     00000  00000124457889999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.2e-42  Score=327.96  Aligned_cols=269  Identities=24%  Similarity=0.384  Sum_probs=202.9

Q ss_pred             cchhhhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC
Q 040532          107 FSSVSTATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD  184 (436)
Q Consensus       107 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  184 (436)
                      ..+.....++|++.+.||+|+||.||+|.++.  .+|+|++...  .....+.+.+|+.++++++||||+++++++.+.+
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            34455667889999999999999999999863  5999998753  2223356788999999999999999999999999


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++ ++.+||+|||++
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             ceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence            9999999999999999996532  35888999999999999999999998   99999999999998 679999999998


Q ss_pred             eecCCCC---cccccccccccCCccchhhhcc---------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 040532          265 RICGGNE---LQANTSRIVGTYGYMSPEYALE---------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY  332 (436)
Q Consensus       265 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~  332 (436)
                      .......   .........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||......     ..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~  251 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----AI  251 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-----HH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH
Confidence            7653221   1122233468999999999874         35789999999999999999999998543211     11


Q ss_pred             HHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCC
Q 040532          333 VWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP  399 (436)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~  399 (436)
                      ...... .....     .....     .+..+.+++.+||+.||++|||+.++++.|+++.......
T Consensus       252 ~~~~~~-~~~~~-----~~~~~-----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~  307 (319)
T 2y4i_B          252 IWQMGT-GMKPN-----LSQIG-----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL  307 (319)
T ss_dssp             HHHHHT-TCCCC-----CCCSS-----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred             HHHhcc-CCCCC-----CCcCC-----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            112111 11100     00001     2335788999999999999999999999999988765443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.6e-41  Score=355.00  Aligned_cols=263  Identities=22%  Similarity=0.307  Sum_probs=207.5

Q ss_pred             chhhhhccCCCCCcccCCCCceeEEEEEecC----CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe
Q 040532          108 SSVSTATNTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCID  182 (436)
Q Consensus       108 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  182 (436)
                      .......++|++.+.||+|+||+||+|.+..    +..||+|++... .....+.+.+|+.++++++||||+++++++. 
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence            3445556789999999999999999998743    457999998754 4445578999999999999999999999984 


Q ss_pred             CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                      ++..++||||+++|+|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence            56789999999999999998643  234899999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      +++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.....     .+......... 
T Consensus       537 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----~~~~~~i~~~~-  609 (656)
T 2j0j_A          537 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENGE-  609 (656)
T ss_dssp             CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHHTC-
T ss_pred             CCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHcCC-
Confidence            99876543222 2223457789999999999999999999999999999997 8999854321     11111111111 


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      ..      ..+.     .++..+.+++.+||+.||++||++.++++.|+++..
T Consensus       610 ~~------~~~~-----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          610 RL------PMPP-----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             CC------CCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC------CCCc-----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            10      0111     134578899999999999999999999999998764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.1e-41  Score=336.29  Aligned_cols=264  Identities=20%  Similarity=0.291  Sum_probs=196.3

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc------
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE------  185 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------  185 (436)
                      ....+|++.+.||+|+||+||+|.+..+..+|+|++.....    ...+|+.+++.++||||+++++++...+.      
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            34567999999999999999999988777899998865432    22479999999999999999999976443      


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-CCCCeEEeeccCc
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMA  264 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-~~~~~kl~DfGla  264 (436)
                      .++||||++++.+............+++..+..++.|++.||+|||+.+   |+||||||+|||++ .++.+||+|||++
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            6899999998765544322222345899999999999999999999998   99999999999999 7999999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC--
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR--  341 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  341 (436)
                      +.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......  +....+........  
T Consensus       190 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~  264 (394)
T 4e7w_A          190 KILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSRE  264 (394)
T ss_dssp             EECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHH
T ss_pred             ccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence            87643322   2234789999999999765 5899999999999999999999998643211  11111111110000  


Q ss_pred             --------cce----eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          342 --------TLE----LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       342 --------~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                              ...    ........... ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          265 QIKTMNPNYMEHKFPQIRPHPFSKVF-RPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHCGGGSSSCCCCCCCCCHHHHS-CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHhhChhhhhhccccccCCcHHHhc-cccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                    000    00000000000 01134578999999999999999999999873

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.7e-42  Score=358.34  Aligned_cols=249  Identities=24%  Similarity=0.295  Sum_probs=201.9

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCC---ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  187 (436)
                      ..++|++.+.||+|+||+||+|.+.. ++.||+|++...   .....+.+..|..++..+ +||||+.+++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            44679999999999999999999764 788999998643   122345678899999887 7999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|..++...   ..+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999998643   34899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.     ...........       
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~-------  558 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEHN-------  558 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHSSC-------
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhCC-------
Confidence            3222  123445899999999999999999999999999999999999999854321     11222221111       


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTM-----NDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~ev~~  387 (436)
                       ...+..     .+..+.+|+.+||+.||++||++     +|+++
T Consensus       559 -~~~p~~-----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 -VAYPKS-----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -CCCCTT-----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -CCCCcc-----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence             111111     34568899999999999999997     66654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=9.3e-41  Score=324.47  Aligned_cols=264  Identities=22%  Similarity=0.316  Sum_probs=199.6

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-----C
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----D  184 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  184 (436)
                      ...++|++.+.||+|+||+||+|.+. +|+.||+|++... .......+.+|+.++++++||||+++++++...     .
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            34678999999999999999999976 4889999999754 344456788999999999999999999988764     5


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..++||||++ ++|.+++..    ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence            6799999997 588888753    24899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCccc--------ccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 040532          265 RICGGNELQA--------NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       265 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  335 (436)
                      ..........        ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......  ........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~  237 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--HQLLLIFG  237 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHH
Confidence            8765322111        1223478999999998765 67899999999999999999999998643311  11111111


Q ss_pred             HhhcCCc---ceecc---------------CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          336 LWTSNRT---LELID---------------DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       336 ~~~~~~~---~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .......   .....               ........  ...+..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMF--PRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHS--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhc--ccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1111100   00000               00000000  114457889999999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=323.86  Aligned_cols=265  Identities=22%  Similarity=0.293  Sum_probs=194.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEE----------
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI----------  181 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----------  181 (436)
                      ..++|++.+.||+|+||.||+|.+.. |+.||+|++........+.+.+|+.++++++||||+++++++.          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            45789999999999999999999875 8899999998777777788999999999999999999999874          


Q ss_pred             ----eCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-CCCCe
Q 040532          182 ----DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNP  256 (436)
Q Consensus       182 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-~~~~~  256 (436)
                          +....++||||++ |+|.+++..    ..+++.....++.|++.||+|||+.+   ++||||||+||+++ +++.+
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence                3456799999998 689888853    24889999999999999999999998   99999999999997 56799


Q ss_pred             EEeeccCceecCCCCc-ccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHH
Q 040532          257 KISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVW  334 (436)
Q Consensus       257 kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  334 (436)
                      ||+|||++........ ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......  .......
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~  238 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLIL  238 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHH
Confidence            9999999987543211 112233467899999998876 67899999999999999999999998643311  1111111


Q ss_pred             HHhhcC----------Ccce----eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          335 DLWTSN----------RTLE----LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       335 ~~~~~~----------~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ......          ....    ....+...........+..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            000000          0000    0000000000000113567899999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-40  Score=321.55  Aligned_cols=264  Identities=21%  Similarity=0.279  Sum_probs=203.0

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec--CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCC------ceeEEeeEEEe
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR--KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHK------NLVRLLGCCID  182 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~  182 (436)
                      ....++|++.+.||+|+||+||+|.+.  +++.||+|++... ....+.+.+|+.+++.++|+      +++++++++.+
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            345678999999999999999999862  4788999999753 34456788999999998765      49999999999


Q ss_pred             CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC----------
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK----------  252 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~----------  252 (436)
                      .+..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+++   ++||||||+|||++.          
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCc
Confidence            99999999999 888988885432 235889999999999999999999998   999999999999987          


Q ss_pred             ---------CCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 040532          253 ---------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  323 (436)
Q Consensus       253 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~  323 (436)
                               ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             cccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                     678999999999864422     233478999999999999999999999999999999999999986543


Q ss_pred             CCCcchhHHHHHHhhcC--------Ccceec--------------------cCCccccccchHHHHHHHHHHHHhcccCC
Q 040532          324 TDSLNLLGYVWDLWTSN--------RTLELI--------------------DDPVLEDEYSSKQVLLRYVNIALLCVQES  375 (436)
Q Consensus       324 ~~~~~~~~~~~~~~~~~--------~~~~~~--------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~  375 (436)
                      ..  .............        ......                    ..+...........+..+.+++.+||+.|
T Consensus       239 ~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          239 SK--EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             HH--HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             hH--HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            21  1111111111000        000000                    00000001112235678999999999999


Q ss_pred             CCCCCCHHHHHH
Q 040532          376 ADDRPTMNDVVS  387 (436)
Q Consensus       376 p~~RPs~~ev~~  387 (436)
                      |++|||+.|+++
T Consensus       317 P~~Rpt~~ell~  328 (339)
T 1z57_A          317 PAKRITLREALK  328 (339)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             cccccCHHHHhc
Confidence            999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.3e-41  Score=333.29  Aligned_cols=268  Identities=21%  Similarity=0.311  Sum_probs=181.3

Q ss_pred             ccCCCC-CcccCCCCceeEEEEEec---CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe--CCccE
Q 040532          114 TNTFSD-TNKLGEGGFGPVYKGVLR---KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKI  187 (436)
Q Consensus       114 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  187 (436)
                      .+.|++ .++||+|+||+||+|.+.   +++.||+|++......  ..+.+|+.+|++++||||+++++++..  ....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            344655 457999999999999965   4788999999754322  467899999999999999999999965  56789


Q ss_pred             EEEeecCCCChhhhhcC------CCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE----cCCCCeE
Q 040532          188 LIYEYMPNKSLDFFLFD------PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPK  257 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll----~~~~~~k  257 (436)
                      +||||+++ +|.+++..      ......+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999975 66655531      112234899999999999999999999998   9999999999999    6788999


Q ss_pred             EeeccCceecCCCCc-ccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCC-------cc
Q 040532          258 ISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-------LN  328 (436)
Q Consensus       258 l~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-------~~  328 (436)
                      |+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+.       .+
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999999987653221 1223345789999999999874 58999999999999999999999996443211       01


Q ss_pred             hhHHHHHHhhcCCcce--ecc-------------CCccccccchH-------HHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 040532          329 LLGYVWDLWTSNRTLE--LID-------------DPVLEDEYSSK-------QVLLRYVNIALLCVQESADDRPTMNDVV  386 (436)
Q Consensus       329 ~~~~~~~~~~~~~~~~--~~~-------------~~~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~RPs~~ev~  386 (436)
                      ....+...........  .+.             ...........       .....+.+|+.+||+.||++|||++|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            1111111111110000  000             00000000000       0134678999999999999999999998


Q ss_pred             H
Q 040532          387 S  387 (436)
Q Consensus       387 ~  387 (436)
                      +
T Consensus       333 ~  333 (405)
T 3rgf_A          333 Q  333 (405)
T ss_dssp             T
T ss_pred             c
Confidence            7

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-41  Score=333.21  Aligned_cols=264  Identities=20%  Similarity=0.276  Sum_probs=193.1

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC------
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------  183 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  183 (436)
                      ....++|++.+.||+|+||+||+|.+. +|+.||+|++.....    ...+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            455678999999999999999999964 589999999875432    234799999999999999999998543      


Q ss_pred             --------------------------------CccEEEEeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHH
Q 040532          184 --------------------------------DEKILIYEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYL  230 (436)
Q Consensus       184 --------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~L  230 (436)
                                                      ...++||||+++ +|.+.+... .....+++..+..++.|++.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            237899999984 776665421 2234589999999999999999999


Q ss_pred             hhCCCCCeEecccCCCCEEEc-CCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCC-CCcccchhhHHHH
Q 040532          231 HQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVL  308 (436)
Q Consensus       231 H~~~~~~i~H~Dikp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvi  308 (436)
                      |+.+   |+||||||+|||++ .++.+||+|||+++.......   .....+|+.|+|||.+.+.. ++.++||||+||+
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9998   99999999999998 688999999999987644332   22347899999999988754 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc---------ceeccCCccccc----cchHHHHHHHHHHHHhcccCC
Q 040532          309 LLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT---------LELIDDPVLEDE----YSSKQVLLRYVNIALLCVQES  375 (436)
Q Consensus       309 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~  375 (436)
                      +|||++|+.||.....  .+..............         .....-+.....    ......+..+.+++.+||+.|
T Consensus       232 l~ell~g~~pf~~~~~--~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          232 FGELILGKPLFSGETS--IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            9999999999864321  1111111111111000         000000000000    001113456889999999999


Q ss_pred             CCCCCCHHHHHH
Q 040532          376 ADDRPTMNDVVS  387 (436)
Q Consensus       376 p~~RPs~~ev~~  387 (436)
                      |++|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999984

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-41  Score=338.42  Aligned_cols=262  Identities=21%  Similarity=0.305  Sum_probs=191.4

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC------c
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------E  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  185 (436)
                      ...+|+..+.||+|+||.||+|.+. +|+.||||++.....    ...+|+++|++++||||+++++++....      .
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            3456899999999999999999986 489999999865432    2357999999999999999999986432      2


Q ss_pred             cEEEEeecCCCChhhhhcC-CCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC-CCeEEeeccC
Q 040532          186 KILIYEYMPNKSLDFFLFD-PTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGM  263 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~-~~~kl~DfGl  263 (436)
                      .++||||++++ +...+.. ......+++..+..++.|+++||+|||+.+   |+||||||+|||++.+ +.+||+|||+
T Consensus       128 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          128 LNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEECCCEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeehhccccc-HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchh
Confidence            57899999864 4444321 122345899999999999999999999988   9999999999999965 5689999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC--
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN--  340 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  340 (436)
                      ++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...+ ......  
T Consensus       204 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~-~~lg~p~~  278 (420)
T 1j1b_A          204 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEII-KVLGTPTR  278 (420)
T ss_dssp             CEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH-HHHCSCCH
T ss_pred             hhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HHhCCCCH
Confidence            987643322   2234789999999999765 7899999999999999999999998643211 1111111 111000  


Q ss_pred             -------CcceeccCCcccc-cc---chHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 -------RTLELIDDPVLED-EY---SSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 -------~~~~~~~~~~~~~-~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                             .......-+.... ..   .....+..+.+|+.+||+.||++||++.|+++
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                   0000000000000 00   00113457899999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.9e-41  Score=327.93  Aligned_cols=259  Identities=22%  Similarity=0.325  Sum_probs=195.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc---
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK---  186 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---  186 (436)
                      ..++|.+.+.||+|+||+||+|.+. +|+.||+|++...  .......+.+|+.++++++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            4578999999999999999999975 4889999999754  344467789999999999999999999999877655   


Q ss_pred             ---EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          187 ---ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       187 ---~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                         ++||||++ ++|..++..     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999998 577777632     2889999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      ++.....     .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......  +..............
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~  263 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGT  263 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCH
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCcH
Confidence            9764322     233478999999999987 67899999999999999999999998643211  111111111000000


Q ss_pred             --cee------------c-cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 --LEL------------I-DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 --~~~------------~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        ...            + ..+...........+..+.+++.+||+.||++|||+.|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence              000            0 00000000000113467899999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.2e-41  Score=327.79  Aligned_cols=269  Identities=17%  Similarity=0.228  Sum_probs=186.8

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc---
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE---  185 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  185 (436)
                      .....++|++.+.||+|+||+||+|.+. +|+.||||++..... ....+.+++..+..++||||+++++++...+.   
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            4455678999999999999999999975 488999999865422 22456778888999999999999999976443   


Q ss_pred             ----cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEecccCCCCEEEcC-CCCeEE
Q 040532          186 ----KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH--QYSRVRIIHRDLKASNILLDK-DMNPKI  258 (436)
Q Consensus       186 ----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~i~H~Dikp~NIll~~-~~~~kl  258 (436)
                          .++||||++++.+..+.........+++.....++.|++.||.|||  +.+   |+||||||+|||++. ++.+||
T Consensus        97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred             cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence                6899999987544333221223445889999999999999999999  777   999999999999996 899999


Q ss_pred             eeccCceecCCCCcccccccccccCCccchhhhccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHh
Q 040532          259 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW  337 (436)
Q Consensus       259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  337 (436)
                      +|||++........   .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||......  ..........
T Consensus       174 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~  248 (360)
T 3e3p_A          174 CDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIVRVL  248 (360)
T ss_dssp             CCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHH
T ss_pred             eeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHHHHc
Confidence            99999987654332   22347899999999987654 899999999999999999999998643211  1111111111


Q ss_pred             hcC------------CcceeccCCccc--cc--cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          338 TSN------------RTLELIDDPVLE--DE--YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       338 ~~~------------~~~~~~~~~~~~--~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...            ............  ..  ......+..+.+++.+||+.||.+|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            000            000000000000  00  000113567899999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.3e-41  Score=323.14  Aligned_cols=265  Identities=24%  Similarity=0.344  Sum_probs=198.5

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEe--cCCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHc---CCCceeEEeeEEE--
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVL--RKGDEIAVKRLSGRS--EQGLREMKNEASVIAKV---QHKNLVRLLGCCI--  181 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~--  181 (436)
                      ....++|++.+.||+|+||+||+|.+  .+|+.||+|++....  ......+.+|+.+++.+   +||||+++++++.  
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            34568899999999999999999997  357889999986321  11123456777777666   8999999999987  


Q ss_pred             ---eCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEE
Q 040532          182 ---DKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  258 (436)
Q Consensus       182 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl  258 (436)
                         .....++||||++ |+|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEE
Confidence               4567799999998 68988885432 234889999999999999999999998   999999999999999999999


Q ss_pred             eeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhh
Q 040532          259 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT  338 (436)
Q Consensus       259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  338 (436)
                      +|||++.......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  ......+.....
T Consensus       162 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~  236 (326)
T 1blx_A          162 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIG  236 (326)
T ss_dssp             CSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHC
T ss_pred             ecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcC
Confidence            9999997654221   22345789999999999999999999999999999999999999864321  111111111111


Q ss_pred             cCCcceec-------------cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          339 SNRTLELI-------------DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       339 ~~~~~~~~-------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ........             .........  ...+..+.+++.+||+.||++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFV--TDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTC--CSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhcc--ccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11000000             000000000  114457889999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.6e-40  Score=325.10  Aligned_cols=208  Identities=24%  Similarity=0.317  Sum_probs=173.6

Q ss_pred             ccchhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CC-----ceeEEee
Q 040532          106 SFSSVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HK-----NLVRLLG  178 (436)
Q Consensus       106 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~  178 (436)
                      .........++|++.+.||+|+||+||+|.+. +++.||||++... ......+..|+.++..++ |+     +++++.+
T Consensus        45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            34445566789999999999999999999976 4788999999753 344567788999998885 55     4999999


Q ss_pred             EEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc--CCCCe
Q 040532          179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNP  256 (436)
Q Consensus       179 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~--~~~~~  256 (436)
                      ++...+..++||||++ ++|.+++.... ...+++.....++.|++.||.|||.+ ..+|+||||||+|||++  .++.+
T Consensus       124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred             eeccCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence            9999999999999996 48888875432 23488999999999999999999953 12399999999999995  57889


Q ss_pred             EEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 040532          257 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY  322 (436)
Q Consensus       257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~  322 (436)
                      ||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       201 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999876432     22347899999999999999999999999999999999999998643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3e-41  Score=318.59  Aligned_cols=253  Identities=24%  Similarity=0.307  Sum_probs=201.0

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ....++|++.+.||+|+||+||+|... +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            345678999999999999999999976 5889999998643  2334577899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC---CCeEEeeccCc
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISDFGMA  264 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~---~~~kl~DfGla  264 (436)
                      +||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            999999999998887532   24899999999999999999999998   9999999999999754   47999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ........   .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.....     ...............
T Consensus       172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~  242 (287)
T 2wei_A          172 TCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDILKRVETGKYAFD  242 (287)
T ss_dssp             GTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCC
T ss_pred             eeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCCCCC
Confidence            76543321   223358899999998875 489999999999999999999999854321     111111111111000


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                         .+..      ...+..+.+++.+||+.||++|||+.|+++
T Consensus       243 ---~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          243 ---LPQW------RTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ---SGGG------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---chhh------hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence               0000      113456889999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.2e-40  Score=320.09  Aligned_cols=257  Identities=22%  Similarity=0.342  Sum_probs=195.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc----
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE----  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  185 (436)
                      ..++|...+.||+|+||+||+|.+. +|+.||||++...  .....+.+.+|+.++++++||||+++++++...+.    
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            3568999999999999999999975 4889999999754  34445778999999999999999999999987654    


Q ss_pred             --cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          186 --KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       186 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                        .++||||++ ++|..++..     .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence              399999997 578777632     3889999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      +......     .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....  .+..............
T Consensus       173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~  245 (353)
T 3coi_A          173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGT  245 (353)
T ss_dssp             TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--HHHHHHHHHHHCBCCH
T ss_pred             ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCH
Confidence            9764322     223478999999999887 6789999999999999999999999854321  1111111111000000


Q ss_pred             --c------------eec---cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 --L------------ELI---DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 --~------------~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        .            ..+   .........  ...+..+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLF--PRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTTTTC--TTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHHHhc--CCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0            000   000000000  113567899999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1e-40  Score=320.99  Aligned_cols=258  Identities=24%  Similarity=0.389  Sum_probs=178.3

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHH-HHHHcCCCceeEEeeEEEeCCccE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ....++|+..+.||+|+||.||+|... +|+.||+|++... .......+..|.. +++.++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            344578999999999999999999975 5889999999765 3334455566666 667779999999999999999999


Q ss_pred             EEEeecCCCChhhhhcC--CCccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          188 LIYEYMPNKSLDFFLFD--PTKRILLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      +||||+++ +|.+++..  ......+++.....++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||++
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            99999986 67666532  11234588999999999999999999998 7   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccCCccchhhh----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYA----LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      .......   ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||........        .  ..
T Consensus       174 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~--~~  240 (327)
T 3aln_A          174 GQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------Q--LT  240 (327)
T ss_dssp             CC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------C
T ss_pred             eeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--------H--HH
Confidence            7654322   12223689999999998    456789999999999999999999999864321100        0  00


Q ss_pred             CcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 RTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..... ..+...... ....+..+.+++.+||+.||++||++.++++
T Consensus       241 ~~~~~-~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          241 QVVKG-DPPQLSNSE-EREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCS-CCCCCCCCS-SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHhcC-CCCCCCCcc-cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00000 001111000 0113457889999999999999999999976

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-40  Score=316.13  Aligned_cols=253  Identities=24%  Similarity=0.388  Sum_probs=190.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe---------
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID---------  182 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  182 (436)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++.. .....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3567889999999999999999975 589999999964 34455788999999999999999999998865         


Q ss_pred             ----CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEE
Q 040532          183 ----KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  258 (436)
Q Consensus       183 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl  258 (436)
                          .+..++||||+++++|.+++....  ..+++...+.++.|++.||+|||+.+   ++||||||+||+++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                345689999999999999986432  34778899999999999999999998   999999999999999999999


Q ss_pred             eeccCceecCCCCc------------ccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 040532          259 SDFGMARICGGNEL------------QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD  325 (436)
Q Consensus       259 ~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~  325 (436)
                      +|||++........            ........||+.|+|||.+.+. .++.++||||||+++|||++   ||...   
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---  231 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---  231 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence            99999976542210            1112334689999999999864 68999999999999999998   43211   


Q ss_pred             CcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          326 SLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       .+........ .... .. . .+...     ...+..+.+++.+||+.||++|||+.++++
T Consensus       232 -~~~~~~~~~~-~~~~-~~-~-~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          232 -MERVNILKKL-RSVS-IE-F-PPDFD-----DNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -HHHHHHHHHH-HSTT-CC-C-CTTCC-----TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -hhHHHHHHhc-cccc-cc-c-Ccccc-----ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence             0111111111 1110 00 0 01111     113456889999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.3e-40  Score=332.65  Aligned_cols=254  Identities=23%  Similarity=0.292  Sum_probs=186.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .+.|...+.||+|+||+||.+...+|+.||||++....   .+.+.+|+.++.++ +||||+++++++.+.+..++||||
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            34556678899999999987766679999999986432   35678899999886 899999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccC----CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCC-------------CC
Q 040532          193 MPNKSLDFFLFDPTKRI----LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-------------MN  255 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~-------------~~  255 (436)
                      ++ |+|.+++.......    ...+...+.++.|++.||+|||+++   |+||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence            96 69999986543211    1123345789999999999999998   9999999999999754             48


Q ss_pred             eEEeeccCceecCCCCcc--cccccccccCCccchhhhcc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 040532          256 PKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTD  325 (436)
Q Consensus       256 ~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~  325 (436)
                      +||+|||++.........  .......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||+.....
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            999999999876543221  12234579999999999976       568999999999999999999 99998543211


Q ss_pred             CcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          326 SLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .   .    ..........     .. ........+..+.+++.+||+.||++|||+.|+++
T Consensus       247 ~---~----~i~~~~~~~~-----~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 E---S----NIIRGIFSLD-----EM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H---H----HHHHTCCCCC-----CC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---H----HHhcCCCCcc-----cc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1   0    1111110000     00 11122346678999999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.7e-40  Score=317.39  Aligned_cols=264  Identities=20%  Similarity=0.252  Sum_probs=198.9

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecC-C-CEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCc------eeEEeeEEEe
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRK-G-DEIAVKRLSGRSEQGLREMKNEASVIAKVQHKN------LVRLLGCCID  182 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~  182 (436)
                      ....++|++.+.||+|+||+||+|.... + ..||+|++... ....+.+.+|+.++++++|++      ++.+.+++..
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            3456889999999999999999999753 4 68999999753 344567889999999997665      9999999999


Q ss_pred             CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEE------------
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL------------  250 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll------------  250 (436)
                      .+..++||||+. +++.+++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||+            
T Consensus        94 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           94 HGHMCIAFELLG-KNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CCeEEEEEeccC-CChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccc
Confidence            999999999995 5555554332 2234899999999999999999999998   9999999999999            


Q ss_pred             -------cCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 040532          251 -------DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  323 (436)
Q Consensus       251 -------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~  323 (436)
                             +.++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                   67889999999999864322     233478999999999999999999999999999999999999996433


Q ss_pred             CCCcchhHHHHHHhhcC--------Ccceecc--------------------CCccccccchHHHHHHHHHHHHhcccCC
Q 040532          324 TDSLNLLGYVWDLWTSN--------RTLELID--------------------DPVLEDEYSSKQVLLRYVNIALLCVQES  375 (436)
Q Consensus       324 ~~~~~~~~~~~~~~~~~--------~~~~~~~--------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~  375 (436)
                      ..  .............        .......                    .+..............+.+++.+||+.|
T Consensus       244 ~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          244 NR--EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             HH--HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             HH--HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            21  1111111111000        0000000                    0000000111224567899999999999


Q ss_pred             CCCCCCHHHHHH
Q 040532          376 ADDRPTMNDVVS  387 (436)
Q Consensus       376 p~~RPs~~ev~~  387 (436)
                      |++|||+.|+++
T Consensus       322 P~~Rpt~~e~l~  333 (355)
T 2eu9_A          322 PAQRITLAEALL  333 (355)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             hhhCcCHHHHhc
Confidence            999999999974

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.9e-40  Score=323.37  Aligned_cols=264  Identities=21%  Similarity=0.282  Sum_probs=197.9

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-----------CCceeEEeeEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-----------HKNLVRLLGCC  180 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~  180 (436)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++... ....+.+.+|+.++++++           ||||+++++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            3568999999999999999999964 5889999999753 344567889999999886           89999999999


Q ss_pred             EeCC----ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecccCCCCEEEc----
Q 040532          181 IDKD----EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLD----  251 (436)
Q Consensus       181 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~i~H~Dikp~NIll~----  251 (436)
                      ...+    ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++ +   |+||||||+|||++    
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence            8654    678999999 889998886432 23488999999999999999999998 8   99999999999995    


Q ss_pred             --CCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCc--
Q 040532          252 --KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL--  327 (436)
Q Consensus       252 --~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~--  327 (436)
                        ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence              4447999999999875432     2234789999999999999999999999999999999999999975432211  


Q ss_pred             --chhHHHHHHhh------------------cCCcceeccCCc--------cccccchHHHHHHHHHHHHhcccCCCCCC
Q 040532          328 --NLLGYVWDLWT------------------SNRTLELIDDPV--------LEDEYSSKQVLLRYVNIALLCVQESADDR  379 (436)
Q Consensus       328 --~~~~~~~~~~~------------------~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~R  379 (436)
                        ...........                  .......+....        ..........+..+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence              01111111100                  000000000000        00001123467789999999999999999


Q ss_pred             CCHHHHHH
Q 040532          380 PTMNDVVS  387 (436)
Q Consensus       380 Ps~~ev~~  387 (436)
                      ||+.|+++
T Consensus       326 pt~~ell~  333 (373)
T 1q8y_A          326 ADAGGLVN  333 (373)
T ss_dssp             BCHHHHHT
T ss_pred             CCHHHHhh
Confidence            99999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.5e-40  Score=321.11  Aligned_cols=254  Identities=20%  Similarity=0.235  Sum_probs=173.6

Q ss_pred             hhccCCCCCc-ccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe----CCc
Q 040532          112 TATNTFSDTN-KLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDE  185 (436)
Q Consensus       112 ~~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~  185 (436)
                      ...++|++.+ .||+|+||+||+|.+. +|+.||+|++.... .   ...+....+..++||||+++++++..    ...
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            3567788855 6999999999999976 58999999996532 1   22233344566799999999999876    345


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---CCCeEEeecc
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFG  262 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~~~~kl~DfG  262 (436)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.   ++.+||+|||
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence            789999999999999997543 245899999999999999999999998   999999999999986   4559999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      ++.......    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..........  .........  
T Consensus       177 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~--  248 (336)
T 3fhr_A          177 FAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIRLG--  248 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhhcc--
Confidence            998654322    223478999999999988889999999999999999999999985433211100  000000000  


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                        ....+.  ...  ...+..+.+++.+||+.||++|||+.|+++
T Consensus       249 --~~~~~~--~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 --QYGFPN--PEW--SEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ----CCCT--TTS--TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --ccccCc--hhh--ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              000000  000  113457889999999999999999999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=317.80  Aligned_cols=244  Identities=21%  Similarity=0.345  Sum_probs=189.9

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh------hhHHHHHHHHHHHHHc----CCCceeEEee
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE------QGLREMKNEASVIAKV----QHKNLVRLLG  178 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~~  178 (436)
                      .....++|++.+.||+|+||.||+|.+. +++.||+|++.....      .....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3455688999999999999999999874 588999999975432      1223456799999999    8999999999


Q ss_pred             EEEeCCccEEEEee-cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-CCCCe
Q 040532          179 CCIDKDEKILIYEY-MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNP  256 (436)
Q Consensus       179 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-~~~~~  256 (436)
                      ++...+..++|+|| +++++|.+++...   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++ +++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence            99999999999999 7899999998542   34899999999999999999999998   99999999999999 88999


Q ss_pred             EEeeccCceecCCCCcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHH
Q 040532          257 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  335 (436)
                      ||+|||++.......    .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||....           .
T Consensus       180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------~  244 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----------E  244 (312)
T ss_dssp             EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------H
T ss_pred             EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------H
Confidence            999999998765432    233468999999999987766 458999999999999999999985311           0


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .....        ......     .+..+.+++.+||+.||++||++.|+++
T Consensus       245 ~~~~~--------~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ILEAE--------LHFPAH-----VSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHHTC--------CCCCTT-----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             Hhhhc--------cCCccc-----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            10100        001111     3346889999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.8e-41  Score=323.06  Aligned_cols=245  Identities=23%  Similarity=0.343  Sum_probs=197.7

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh------hhHHHHHHHHHHHHHcC--CCceeEEeeE
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE------QGLREMKNEASVIAKVQ--HKNLVRLLGC  179 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~  179 (436)
                      +.....++|++.+.||+|+||.||+|.+. +++.||+|++.....      ...+.+.+|+.++++++  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            34556788999999999999999999864 588999999864321      11245678999999996  5999999999


Q ss_pred             EEeCCccEEEEeecCC-CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-CCCCeE
Q 040532          180 CIDKDEKILIYEYMPN-KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPK  257 (436)
Q Consensus       180 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-~~~~~k  257 (436)
                      +...+..++|+|++.+ ++|.+++..   ...+++.....++.|++.||+|||+.+   ++||||||+|||++ +++.+|
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence            9999999999999986 899998854   234889999999999999999999998   99999999999999 789999


Q ss_pred             EeeccCceecCCCCcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 040532          258 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      |+|||++.......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....           ..
T Consensus       191 L~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----------~~  255 (320)
T 3a99_A          191 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EI  255 (320)
T ss_dssp             ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HH
T ss_pred             EeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------hh
Confidence            99999998765332    223468999999999987765 788999999999999999999985321           11


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .....        .....     .+..+.+++.+||+.||++||++.|+++
T Consensus       256 ~~~~~--------~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 IRGQV--------FFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHCCC--------CCSSC-----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcccc--------ccccc-----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11110        01111     3346889999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=330.07  Aligned_cols=253  Identities=21%  Similarity=0.288  Sum_probs=186.9

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  189 (436)
                      .....+|+..+.||+|+||+||.....+|+.||||++.....   ..+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            344567888999999999996655555699999999975432   2356899999999 799999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-----CCCeEEeeccCc
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-----DMNPKISDFGMA  264 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-----~~~~kl~DfGla  264 (436)
                      |||++ |+|.+++.....  .........++.|++.||+|||+.+   |+||||||+|||++.     ...+||+|||++
T Consensus        97 ~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            99996 589888865432  2344456789999999999999998   999999999999953     346889999999


Q ss_pred             eecCCCCc-ccccccccccCCccchhhhc---cCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhc
Q 040532          265 RICGGNEL-QANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTS  339 (436)
Q Consensus       265 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  339 (436)
                      +....... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||+.....      ..... ..
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~------~~~~~-~~  243 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR------QANIL-LG  243 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH------HHHHH-TT
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH------HHHHH-hc
Confidence            87653321 12233457999999999998   4567889999999999999999 88888432211      01111 11


Q ss_pred             CCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          340 NRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ....        ............+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 ACSL--------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCC--------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCc--------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1000        001111124556789999999999999999999983

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=317.42  Aligned_cols=254  Identities=23%  Similarity=0.364  Sum_probs=180.3

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhh-HHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ....++|+..+.||+|+||.||+|.+. +|+.||+|++.... ... .+.+.++..+++.++||||+++++++.+.+..+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            344567888999999999999999976 58999999997543 222 334455556778889999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      +||||+ ++++..+....  ...+++.....++.|++.||.|||+. +   ++|+||||+||+++.++.+||+|||++..
T Consensus       101 lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             EEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            999999 45555554321  23488999999999999999999985 7   99999999999999999999999999976


Q ss_pred             cCCCCcccccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      .....   ......||+.|+|||.+.     +..++.++||||||+++|||++|+.||......    ............
T Consensus       175 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~  247 (318)
T 2dyl_A          175 LVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD----FEVLTKVLQEEP  247 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH----HHHHHHHHHSCC
T ss_pred             ccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----HHHHHHHhccCC
Confidence            54322   122346899999999995     456889999999999999999999998642211    111122211111


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       .      ..+...   ..+..+.+++.+||+.||.+||++.++++
T Consensus       248 -~------~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 -P------LLPGHM---GFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -C------CCCSSS---CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -C------CCCccC---CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             0      011000   13356889999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.4e-40  Score=338.75  Aligned_cols=271  Identities=23%  Similarity=0.285  Sum_probs=202.3

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe------CC
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCID------KD  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  184 (436)
                      ..++|++.+.||+|+||+||+|.+. +|+.||+|++... .....+.+.+|+.++++++||||+++++++..      .+
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            3478999999999999999999975 4889999998764 45556789999999999999999999998765      66


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC---eEEeec
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDF  261 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~---~kl~Df  261 (436)
                      ..++||||+++|+|.+++........+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence            77999999999999999977655556888999999999999999999998   999999999999997765   999999


Q ss_pred             cCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH-----
Q 040532          262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL-----  336 (436)
Q Consensus       262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----  336 (436)
                      |++........   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....    ...|....     
T Consensus       169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~  241 (676)
T 3qa8_A          169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSN  241 (676)
T ss_dssp             CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC----
T ss_pred             ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccc
Confidence            99987654322   2335789999999999999999999999999999999999999854210    00000000     


Q ss_pred             ---hhcCCccee--ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHH-----HHHHHhhcc
Q 040532          337 ---WTSNRTLEL--IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMND-----VVSMLTNEA  393 (436)
Q Consensus       337 ---~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e-----v~~~L~~~~  393 (436)
                         .........  ...............+..+.+++.+||+.||++|||+.|     ..+.++++.
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence               000000000  000000011111225678999999999999999999977     445555544

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.8e-39  Score=305.13  Aligned_cols=236  Identities=11%  Similarity=0.088  Sum_probs=186.1

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ...++|++.+.||+|+||.||+|.+.. |+.||+|++....   ....+.+.+|+..+.+++||||+++++++.+.+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            345789999999999999999999865 8899999997542   344578899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++++|.+++...     ........++.|++.||+|||+++   |+||||||+|||++.++.+||+++|     
T Consensus       108 lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-----  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-----  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred             EEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence            999999999999998432     345578899999999999999998   9999999999999999999998543     


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                                       |++|       ++.++|||||||++|||+||+.||..........           .......
T Consensus       175 -----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-----------~~~~~~~  219 (286)
T 3uqc_A          175 -----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-----------PAERDTA  219 (286)
T ss_dssp             -----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-----------ECCBCTT
T ss_pred             -----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-----------HHHHHhc
Confidence                             3333       6889999999999999999999986533211000           0000000


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                      .............+..+.+++.+||+.||++| |+.|+++.|++.....
T Consensus       220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            10000000011245578999999999999999 9999999999987553

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.7e-39  Score=340.64  Aligned_cols=243  Identities=20%  Similarity=0.305  Sum_probs=197.2

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEec--CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc--
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLR--KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE--  185 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--  185 (436)
                      ....++|++.+.||+|+||+||+|.+.  +|+.||||++... .......+.+|+.++.+++||||+++++++.+.+.  
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            345689999999999999999999975  5889999998754 34555678999999999999999999999988766  


Q ss_pred             ---cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          186 ---KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       186 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                         .|+||||+++++|.+++..     .+++..++.++.|++.||.|||+++   |+||||||+|||++.+ .+||+|||
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecc
Confidence               6999999999999887643     4899999999999999999999998   9999999999999986 89999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      +++.....      ....||+.|+|||++.+.. +.++|||||||++|+|++|..|+.......               .
T Consensus       227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------~  284 (681)
T 2pzi_A          227 AVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------L  284 (681)
T ss_dssp             TCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------C
T ss_pred             cchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------c
Confidence            99876432      3347999999999987764 899999999999999999988864211100               0


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHhhcc
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT-MNDVVSMLTNEA  393 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~ev~~~L~~~~  393 (436)
                               ............+.+++.+||+.||++||+ ++++...|....
T Consensus       285 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          285 ---------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ---------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                     001111223457889999999999999994 677777776654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9e-38  Score=296.65  Aligned_cols=231  Identities=19%  Similarity=0.231  Sum_probs=178.0

Q ss_pred             hccCCCCC-cccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHH-HHcCCCceeEEeeEEEe----CCc
Q 040532          113 ATNTFSDT-NKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVI-AKVQHKNLVRLLGCCID----KDE  185 (436)
Q Consensus       113 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~  185 (436)
                      ..++|.+. +.||+|+||.||+|... +++.||+|++...     ..+.+|+.++ +..+||||+++++++..    ...
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            34567776 77999999999999974 5889999999643     3567888888 55699999999999987    667


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---CCCeEEeecc
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFG  262 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~~~~kl~DfG  262 (436)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.   ++.+||+|||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            899999999999999986532 235899999999999999999999998   999999999999998   7899999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT  342 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  342 (436)
                      ++....                        +..++.++|||||||++|||++|+.||.......           .....
T Consensus       166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----------~~~~~  210 (299)
T 3m2w_A          166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------ISPGM  210 (299)
T ss_dssp             TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCS
T ss_pred             cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-----------hhHHH
Confidence            986532                        2346778999999999999999999985432111           00001


Q ss_pred             ceeccCCccccc-cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          343 LELIDDPVLEDE-YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       343 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ...+........ ......+..+.+++.+||+.||++|||+.|+++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            111111100000 000124567899999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-38  Score=312.36  Aligned_cols=245  Identities=16%  Similarity=0.190  Sum_probs=178.2

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCC-Cce-----------
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQH-KNL-----------  173 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~ni-----------  173 (436)
                      .......|...+.||+|+||+||+|.+. +|+.||||++....   ....+.+.+|+.+++.++| +|.           
T Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~  152 (413)
T 3dzo_A           73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  152 (413)
T ss_dssp             SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred             CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence            3445566888899999999999999954 58999999987432   2235778999999999977 221           


Q ss_pred             ----eE------EeeEEEe-----CCccEEEEeecCCCChhhhhcC----CCccCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 040532          174 ----VR------LLGCCID-----KDEKILIYEYMPNKSLDFFLFD----PTKRILLDWVTRVQIIEGIAQGLLYLHQYS  234 (436)
Q Consensus       174 ----v~------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~  234 (436)
                          +.      +..++..     ....+++|+++ +++|.+++..    ......+++..++.++.|+++||+|||+++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  231 (413)
T 3dzo_A          153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  231 (413)
T ss_dssp             CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence                11      1111111     12345666654 6889888731    122334778899999999999999999998


Q ss_pred             CCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhh----------ccCCCCcccchhh
Q 040532          235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA----------LEGIFSIKSDVFS  304 (436)
Q Consensus       235 ~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~S  304 (436)
                         |+||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.++||||
T Consensus       232 ---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS  302 (413)
T 3dzo_A          232 ---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT  302 (413)
T ss_dssp             ---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred             ---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence               999999999999999999999999999865422     233467 999999999          4556889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 040532          305 FGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMND  384 (436)
Q Consensus       305 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e  384 (436)
                      |||++|||++|+.||........              ....+...   .     ..+..+.+++.+||+.||++||++.+
T Consensus       303 lGvil~elltg~~Pf~~~~~~~~--------------~~~~~~~~---~-----~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          303 LGLAIYWIWCADLPNTDDAALGG--------------SEWIFRSC---K-----NIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHHHHHHSSCCCCTTGGGSC--------------SGGGGSSC---C-----CCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHCCCCCCCcchhhh--------------HHHHHhhc---c-----cCCHHHHHHHHHHccCChhhCcCHHH
Confidence            99999999999999864321110              00001000   0     12356889999999999999999665


Q ss_pred             HH
Q 040532          385 VV  386 (436)
Q Consensus       385 v~  386 (436)
                      ++
T Consensus       361 ~l  362 (413)
T 3dzo_A          361 AM  362 (413)
T ss_dssp             HT
T ss_pred             HH
Confidence            53

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.4e-38  Score=305.67  Aligned_cols=242  Identities=17%  Similarity=0.159  Sum_probs=182.5

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCC--------hhhHHHHHHHHHHHHHcC---------CCceeEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS--------EQGLREMKNEASVIAKVQ---------HKNLVRL  176 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l  176 (436)
                      .++|++.+.||+|+||+||+|++ +|+.||+|++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999998 58999999997542        223467889999999886         7777777


Q ss_pred             eeEEE-----------------e-------------CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHH
Q 040532          177 LGCCI-----------------D-------------KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQG  226 (436)
Q Consensus       177 ~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~  226 (436)
                      .+++.                 +             .+..++||||+++|++.+.+.+    ..+++..+..++.|++.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            76543                 2             6788999999999976655533    347899999999999999


Q ss_pred             HHHHh-hCCCCCeEecccCCCCEEEcCCC--------------------CeEEeeccCceecCCCCcccccccccccCCc
Q 040532          227 LLYLH-QYSRVRIIHRDLKASNILLDKDM--------------------NPKISDFGMARICGGNELQANTSRIVGTYGY  285 (436)
Q Consensus       227 l~~LH-~~~~~~i~H~Dikp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  285 (436)
                      |+||| +.+   |+||||||+|||++.++                    .+||+|||+++.....       ...||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 888   99999999999999887                    8999999999865422       24799999


Q ss_pred             cchhhhccCCCCcccchhhHHHH-HHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHH
Q 040532          286 MSPEYALEGIFSIKSDVFSFGVL-LLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRY  364 (436)
Q Consensus       286 ~aPE~~~~~~~~~~~Dv~SlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  364 (436)
                      +|||++.+.. +.++||||+|++ .+++++|..||...     ..............     ..............+..+
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQM-----TFKTKCNTPAMKQIKRKI  312 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTC-----CCSSCCCSHHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhh-----ccCcccchhhhhhcCHHH
Confidence            9999998766 899999998777 77888899886210     00000111111000     000001111223477889


Q ss_pred             HHHHHhcccCCCCCCCCHHHHH
Q 040532          365 VNIALLCVQESADDRPTMNDVV  386 (436)
Q Consensus       365 ~~li~~cl~~~p~~RPs~~ev~  386 (436)
                      .+|+.+||+.|     |++|++
T Consensus       313 ~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHhccC-----CHHHHH
Confidence            99999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=4.7e-31  Score=271.03  Aligned_cols=185  Identities=16%  Similarity=0.124  Sum_probs=129.3

Q ss_pred             ccCCCCceeEEEEEe-cCCCEEEEEEcCCCC----------hhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEE
Q 040532          122 KLGEGGFGPVYKGVL-RKGDEIAVKRLSGRS----------EQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       122 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ..+.|+.|.+..+.. --|+.+++|.+....          +...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            356667766666542 238889999986431          23356799999999999 799999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||++|++|.+++....   +++..   +|+.||+.||+|+|++|   |+||||||+|||+++++++||+|||+|+....
T Consensus       321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999996533   35543   58999999999999999   99999999999999999999999999987653


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  318 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p  318 (436)
                      ...  .....+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus       392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            322  2334589999999998875 467789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.7e-28  Score=250.59  Aligned_cols=185  Identities=21%  Similarity=0.215  Sum_probs=147.0

Q ss_pred             CCCcccCCCCceeEEEEEecCCCEEEEEEcCCCC---h-----hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          118 SDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS---E-----QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       118 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ...+.||+|+||+||+|... +..+++|+.....   .     ...+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            34568999999999999655 7889999865432   1     1134589999999999999999777777788889999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+++++|.+++..           ...++.|+++||+|||+++   |+||||||+|||+++  ++||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999854           4589999999999999998   999999999999999  999999999998754


Q ss_pred             CCccc-----ccccccccCCccchhhhcc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 040532          270 NELQA-----NTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNT  319 (436)
Q Consensus       270 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~  319 (436)
                      .....     ......||+.|||||++..  ..|+..+|+||..+-..+.+.++.+|
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            32111     1234579999999999987  56888899999999999988877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=4.8e-25  Score=206.89  Aligned_cols=147  Identities=18%  Similarity=0.132  Sum_probs=119.0

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCCh------------------hhHHHHHHHHHHHHHcCCCceeE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE------------------QGLREMKNEASVIAKVQHKNLVR  175 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~  175 (436)
                      ...|++.+.||+|+||.||+|.+.+|+.||+|.++....                  .....+.+|+.++++++  | ++
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            445556699999999999999997799999999964321                  13467899999999999  4 66


Q ss_pred             EeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC
Q 040532          176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  255 (436)
Q Consensus       176 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~  255 (436)
                      +.+++. .+..++||||+++++|.+ +..         .....++.|++.||.|||+.+   |+||||||+|||++ ++.
T Consensus       166 v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~  230 (282)
T 1zar_A          166 VPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEG  230 (282)
T ss_dssp             SCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTE
T ss_pred             cCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCc
Confidence            666543 366799999999999988 421         123479999999999999998   99999999999999 999


Q ss_pred             eEEeeccCceecCCCCcccccccccccCCccchhhhcc
Q 040532          256 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE  293 (436)
Q Consensus       256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  293 (436)
                      +||+|||+++.               +..++|||.+..
T Consensus       231 vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          231 IWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             EEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             EEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            99999999853               345789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=1.4e-20  Score=174.25  Aligned_cols=136  Identities=15%  Similarity=0.156  Sum_probs=105.0

Q ss_pred             CCCCcccCCCCceeEEEEEe-cCCCE--EEEEEcCCCChh------------------------hHHHHHHHHHHHHHcC
Q 040532          117 FSDTNKLGEGGFGPVYKGVL-RKGDE--IAVKRLSGRSEQ------------------------GLREMKNEASVIAKVQ  169 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  169 (436)
                      |++.+.||+|+||.||+|.+ .+|+.  ||||+++.....                        ....+.+|+..|.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998 66888  999987543111                        1236789999999998


Q ss_pred             CCce--eEEeeEEEeCCccEEEEeecCC-C----ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEec
Q 040532          170 HKNL--VRLLGCCIDKDEKILIYEYMPN-K----SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH-QYSRVRIIHR  241 (436)
Q Consensus       170 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~i~H~  241 (436)
                      |+++  ..+++.    +..++||||+.+ |    +|.++...      .++.....++.|++.||.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            7754  333332    467999999942 4    55554421      123456789999999999999 888   9999


Q ss_pred             ccCCCCEEEcCCCCeEEeeccCceec
Q 040532          242 DLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       242 Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      ||||+|||+++  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.70  E-value=4.6e-18  Score=164.01  Aligned_cols=139  Identities=13%  Similarity=0.134  Sum_probs=101.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCC-----------------hhh-----HHHHHHHHHHHHHcCCC
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRS-----------------EQG-----LREMKNEASVIAKVQHK  171 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~-----~~~~~~e~~~l~~l~h~  171 (436)
                      ..-|++.+.||+|++|.||+|...+|+.||||+++...                 ...     .-...+|...|.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            34488999999999999999999889999999875320                 000     01123566777777544


Q ss_pred             ceeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc
Q 040532          172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  251 (436)
Q Consensus       172 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~  251 (436)
                      ++....-+.  ....++||||+++++|..+...         .....++.|++.+|.+||+.+   |+||||||.|||++
T Consensus       174 gv~vp~p~~--~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~  239 (397)
T 4gyi_A          174 GFPVPEPIA--QSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR  239 (397)
T ss_dssp             TCSCCCEEE--EETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             CCCCCeeee--ccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence            432211111  1234799999999988765421         123567899999999999998   99999999999998


Q ss_pred             CCCC----------eEEeeccCcee
Q 040532          252 KDMN----------PKISDFGMARI  266 (436)
Q Consensus       252 ~~~~----------~kl~DfGla~~  266 (436)
                      +++.          +.|+||+-+..
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCCcccccccccceEEEEeCCccc
Confidence            7763          89999997754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=5e-13  Score=123.45  Aligned_cols=143  Identities=16%  Similarity=0.119  Sum_probs=111.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      -..|+....++.|+.+.||++... ++.+++|............+.+|+.+++.+. +.++.++++++.+.+..|+||||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            346777788898999999999865 7899999986421122245889999999984 67788899998888889999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS--------------------------------------  234 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------  234 (436)
                      ++|.+|...+..        ......++.++++++..||+..                                      
T Consensus        92 i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           92 ADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             CSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             cCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            999999765321        1223477889999999999821                                      


Q ss_pred             ------------------CCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          235 ------------------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       235 ------------------~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                                        ...++|+|++|.||+++++..+.|+||+.+.
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                              1449999999999999876667799999864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=4.3e-12  Score=116.71  Aligned_cols=136  Identities=15%  Similarity=0.173  Sum_probs=100.7

Q ss_pred             CCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCc--eeEEeeEEEeCCccEEEEeec
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKN--LVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~  193 (436)
                      .+.+....+.|..+.||++...+|..+++|......   ...+.+|+.+++.+.+.+  +.+++++....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            344433334566699999987778889999976542   245788999999885444  455888887777889999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS---------------------------------------  234 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------  234 (436)
                      +|.++.  ...      .+   ...++.+++..|..||+..                                       
T Consensus        98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            998884  211      11   2356778888888888753                                       


Q ss_pred             ----------------CCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          235 ----------------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       235 ----------------~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                                      ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                            1239999999999999887667799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.16  E-value=1.8e-10  Score=111.42  Aligned_cols=141  Identities=14%  Similarity=0.259  Sum_probs=106.3

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcC--CCC-hhhHHHHHHHHHHHHHcC--CCceeEEeeEEEeC---CccEEEEe
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLS--GRS-EQGLREMKNEASVIAKVQ--HKNLVRLLGCCIDK---DEKILIYE  191 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e  191 (436)
                      .+.|+.|.++.||+.... +..+++|+..  ... ......+.+|..+++.+.  +..+.+++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            467899999999999876 5678899876  322 122356889999999996  45678888888766   34799999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS-------------------------------------  234 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------  234 (436)
                      |++|..+.+...     ..++...+..++.++++.|..||+..                                     
T Consensus       122 ~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            999988743211     12667888899999999999999731                                     


Q ss_pred             ------------------CCCeEecccCCCCEEEcCCCC--eEEeeccCcee
Q 040532          235 ------------------RVRIIHRDLKASNILLDKDMN--PKISDFGMARI  266 (436)
Q Consensus       235 ------------------~~~i~H~Dikp~NIll~~~~~--~kl~DfGla~~  266 (436)
                                        ...++|||+++.||+++.++.  +.|.||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              246999999999999997753  68999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.08  E-value=1.8e-10  Score=108.72  Aligned_cols=183  Identities=18%  Similarity=0.204  Sum_probs=120.9

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCc--eeEEeeEEEeCC---ccEEEEeec
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKN--LVRLLGCCIDKD---EKILIYEYM  193 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  193 (436)
                      .+.++.|....||+..    ..+++|....  ......+.+|..+|+.+. +..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3568999999999973    5689998653  234567899999998883 332  333444333332   348999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS---------------------------------------  234 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------  234 (436)
                      +|.++.....     ..++..++..++.+++..+..||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988864322     12566677788888888888888621                                       


Q ss_pred             ----------------CCCeEecccCCCCEEEcC--CCCeEEeeccCceecCCCCcccccccccccCCc---cchhhhcc
Q 040532          235 ----------------RVRIIHRDLKASNILLDK--DMNPKISDFGMARICGGNELQANTSRIVGTYGY---MSPEYALE  293 (436)
Q Consensus       235 ----------------~~~i~H~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~  293 (436)
                                      .+.++|+|++|.||++++  +..+.|+||+.+..-.... ...     ....+   ..|+....
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~-----~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFI-----SLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHH-----TTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHH-----HHHhhccccCHHHHHH
Confidence                            245899999999999998  4567899999987543211 000     00001   22222210


Q ss_pred             -----CC---------CCcccchhhHHHHHHHHHhCCCCC
Q 040532          294 -----GI---------FSIKSDVFSFGVLLLEIVSGKKNT  319 (436)
Q Consensus       294 -----~~---------~~~~~Dv~SlGvil~elltg~~p~  319 (436)
                           +.         .....+.|++|.++|.+.+|..++
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                 00         122368999999999999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.60  E-value=2.9e-07  Score=84.88  Aligned_cols=133  Identities=18%  Similarity=0.174  Sum_probs=96.3

Q ss_pred             cCCCCce-eEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEEeecCCCChh
Q 040532          123 LGEGGFG-PVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLD  199 (436)
Q Consensus       123 lg~G~~g-~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  199 (436)
                      +..|..| .||+..... +..+++|+-...   ....+.+|...|+.+. +-.+-++++++.+.+..++|||++++.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4445554 689887654 567899986532   3457888999998884 334667788888888999999999998886


Q ss_pred             hhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------------
Q 040532          200 FFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS---------------------------------------------  234 (436)
Q Consensus       200 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------------  234 (436)
                      +.....       ......+..+++..|..||...                                             
T Consensus       109 ~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          109 QVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            654211       1233456667777777777421                                             


Q ss_pred             ----------CCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          235 ----------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       235 ----------~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                                ...++|+|+++.||++++++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      1238999999999999988777899999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.58  E-value=5.4e-07  Score=84.81  Aligned_cols=136  Identities=20%  Similarity=0.192  Sum_probs=94.5

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCC---ceeEEeeEEE-eCCccEEEEeecCC
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHK---NLVRLLGCCI-DKDEKILIYEYMPN  195 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  195 (436)
                      .+.++.|....||+.    |..+++|+..  .......+.+|..+|+.+.+.   .+.+.+.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356788998999998    6778889853  334456789999999999642   3455565554 34557899999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------------------
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY------------------------------------------  233 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------------  233 (436)
                      ..+......     .++......++.+++..|..||+.                                          
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            888653211     123444455555555555555542                                          


Q ss_pred             ---------------CCCCeEecccCCCCEEEcC---CCC-eEEeeccCcee
Q 040532          234 ---------------SRVRIIHRDLKASNILLDK---DMN-PKISDFGMARI  266 (436)
Q Consensus       234 ---------------~~~~i~H~Dikp~NIll~~---~~~-~kl~DfGla~~  266 (436)
                                     ..+.++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2235799999999999997   455 48999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.42  E-value=7.2e-07  Score=85.75  Aligned_cols=80  Identities=9%  Similarity=0.001  Sum_probs=54.9

Q ss_pred             ccc-CCCCceeEEEEEec-------CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcC-C--CceeEEeeEEEeC---
Q 040532          121 NKL-GEGGFGPVYKGVLR-------KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQ-H--KNLVRLLGCCIDK---  183 (436)
Q Consensus       121 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~---  183 (436)
                      +.| +.|....+|+....       ++..+++|......   ......+.+|..+++.+. +  ..+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 88889999998764       26678999865422   001245678888888773 2  3566677776554   


Q ss_pred             CccEEEEeecCCCChhh
Q 040532          184 DEKILIYEYMPNKSLDF  200 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~  200 (436)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            34689999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.16  E-value=5.4e-06  Score=80.88  Aligned_cols=75  Identities=13%  Similarity=0.255  Sum_probs=49.6

Q ss_pred             CcccCCCCceeEEEEEec-CCCEEEEEEcCCCCh-------hhHHHHHHHHHHHHHcCC--Cce-eEEeeEEEeCCccEE
Q 040532          120 TNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSE-------QGLREMKNEASVIAKVQH--KNL-VRLLGCCIDKDEKIL  188 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~ni-v~l~~~~~~~~~~~l  188 (436)
                      .+.+|.|..+.||++... +++.+++|.......       ...+.+..|.++++.+..  +.. .+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999999764 368899998653211       123456778888888732  333 344433  4566789


Q ss_pred             EEeecCCC
Q 040532          189 IYEYMPNK  196 (436)
Q Consensus       189 v~e~~~~g  196 (436)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.16  E-value=6.5e-06  Score=76.58  Aligned_cols=78  Identities=17%  Similarity=0.204  Sum_probs=57.0

Q ss_pred             CCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-C--CceeEEeeEEEeCCccEEEEeec
Q 040532          117 FSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-H--KNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      ....+.+|.|..+.||+....+|+.+++|+...........+..|...|+.+. .  -.+.+++++    +..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence            34457789999999999999999999999876554333356788999998884 2  123334443    3458999999


Q ss_pred             CCCCh
Q 040532          194 PNKSL  198 (436)
Q Consensus       194 ~~g~L  198 (436)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87765

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.13  E-value=8e-06  Score=77.62  Aligned_cols=140  Identities=14%  Similarity=0.170  Sum_probs=79.4

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-----CCceeEEe-e--EEEeCCccEEEEee
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-----HKNLVRLL-G--CCIDKDEKILIYEY  192 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~  192 (436)
                      +.|+.|..+.||+....+| .+++|+.... .   ..+..|..++..+.     .|.++... |  +....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987644 5899998752 2   23334555555442     34444311 1  12345667899999


Q ss_pred             cCCCChhh-----------h---hc----CC--Cc-----cCCCCHHHH-------------------------------
Q 040532          193 MPNKSLDF-----------F---LF----DP--TK-----RILLDWVTR-------------------------------  216 (436)
Q Consensus       193 ~~~g~L~~-----------~---l~----~~--~~-----~~~l~~~~~-------------------------------  216 (436)
                      ++|..+..           .   ++    ..  ..     .....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99876530           0   11    00  00     001123211                               


Q ss_pred             HHHHHHHHHHHHHHhh----------CCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          217 VQIIEGIAQGLLYLHQ----------YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       217 ~~i~~~ia~~l~~LH~----------~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      ..+...+..++.+|+.          ..+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223445666653          123469999999999999888899999999864

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.94  E-value=7.8e-05  Score=69.99  Aligned_cols=138  Identities=17%  Similarity=0.103  Sum_probs=91.4

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC---CCceeEEeeEEEeCCccEEEEeecCCC
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIYEYMPNK  196 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  196 (436)
                      .+.|+.|....+|+.... +..+++|+....   ....+..|...|+.+.   ...+.++++++...+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            467899999999999864 678899987532   2466888999888883   356778888887778899999999998


Q ss_pred             Chhh--------h---hcCCCc-------------------cCCCCHHHHH---HHH----------------HHHHH-H
Q 040532          197 SLDF--------F---LFDPTK-------------------RILLDWVTRV---QII----------------EGIAQ-G  226 (436)
Q Consensus       197 ~L~~--------~---l~~~~~-------------------~~~l~~~~~~---~i~----------------~~ia~-~  226 (436)
                      .+..        .   ++....                   ...-+|....   ++.                ..+.. .
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            7531        0   111100                   0012454321   111                11111 1


Q ss_pred             HHHHhh-CCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          227 LLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       227 l~~LH~-~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                      ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            223422 2356799999999999999887 8899973

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.78  E-value=0.00011  Score=72.25  Aligned_cols=80  Identities=9%  Similarity=0.044  Sum_probs=47.8

Q ss_pred             CCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccC---CCCcccchhhHHHHHHH
Q 040532          235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG---IFSIKSDVFSFGVLLLE  311 (436)
Q Consensus       235 ~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~e  311 (436)
                      .+.++|||++|.|||++.++ ++++||+.+..-... .........-...|++|+.....   ......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            34599999999999999876 999999998653211 00000000001245666544311   11223556688888888


Q ss_pred             HHhCC
Q 040532          312 IVSGK  316 (436)
Q Consensus       312 lltg~  316 (436)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.73  E-value=0.00013  Score=68.06  Aligned_cols=71  Identities=13%  Similarity=0.201  Sum_probs=44.7

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeEEEeCCccEEEEeec-CCCC
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEYM-PNKS  197 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~  197 (436)
                      .+.|+.|....+|+.     ..+++|+........ .+..+|...++.+...++ .+++++  +.+..++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            678999999999998     568889886542221 123567777776632222 234433  444568999999 6655


Q ss_pred             h
Q 040532          198 L  198 (436)
Q Consensus       198 L  198 (436)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            5

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.59  E-value=0.00028  Score=66.39  Aligned_cols=143  Identities=15%  Similarity=0.101  Sum_probs=79.1

Q ss_pred             CcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-----CCceeEEe-e--EEEeCCccEEEEe
Q 040532          120 TNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-----HKNLVRLL-G--CCIDKDEKILIYE  191 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e  191 (436)
                      .+.|+.|....+|+....+| .+++|......  ..+.+..|..++..+.     -|.++... |  +....+..+++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            35677888899999987655 68899887531  1134556777777663     23333211 1  1123455689999


Q ss_pred             ecCCCChhhh--------------hc----CCCcc--CCC---CHHHHHH------------HHHHHHHHHHHHhhC---
Q 040532          192 YMPNKSLDFF--------------LF----DPTKR--ILL---DWVTRVQ------------IIEGIAQGLLYLHQY---  233 (436)
Q Consensus       192 ~~~~g~L~~~--------------l~----~~~~~--~~l---~~~~~~~------------i~~~ia~~l~~LH~~---  233 (436)
                      |++|..+...              ++    .....  ...   .|.....            +...+...+++++..   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            9998764210              11    00000  001   1221100            001134445555432   


Q ss_pred             -CCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          234 -SRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       234 -~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                       .+..++|+|+++.||+++++..+.++||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             23469999999999999987666899998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.52  E-value=0.00029  Score=67.93  Aligned_cols=141  Identities=18%  Similarity=0.201  Sum_probs=81.4

Q ss_pred             cccCCCCceeEEEEEec--------CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEEe
Q 040532          121 NKLGEGGFGPVYKGVLR--------KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      +.|..|-...+|+....        +++.+++|+.... ........+|..+++.+. +.-..++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            56777888899998864        2478999986432 223456678999988874 2222445555432    39999


Q ss_pred             ecCCCChhhh-h----------------cCC--CccCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 040532          192 YMPNKSLDFF-L----------------FDP--TKRILLD--WVTRVQIIEGIAQ-------------------GLLYL-  230 (436)
Q Consensus       192 ~~~~g~L~~~-l----------------~~~--~~~~~l~--~~~~~~i~~~ia~-------------------~l~~L-  230 (436)
                      |++|..|..- +                +..  .......  +.+..++..++..                   .+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998766421 1                111  0011122  3344444433321                   22333 


Q ss_pred             ---hhC-CCCCeEecccCCCCEEEcCC----CCeEEeeccCcee
Q 040532          231 ---HQY-SRVRIIHRDLKASNILLDKD----MNPKISDFGMARI  266 (436)
Q Consensus       231 ---H~~-~~~~i~H~Dikp~NIll~~~----~~~kl~DfGla~~  266 (436)
                         ... ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               221 23469999999999999876    7899999998753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.48  E-value=0.00059  Score=64.51  Aligned_cols=33  Identities=27%  Similarity=0.441  Sum_probs=28.1

Q ss_pred             CCCeEecccCCCCEEEcCC----CCeEEeeccCceec
Q 040532          235 RVRIIHRDLKASNILLDKD----MNPKISDFGMARIC  267 (436)
Q Consensus       235 ~~~i~H~Dikp~NIll~~~----~~~kl~DfGla~~~  267 (436)
                      ...++|||+.+.||+++.+    +.+.|+||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4469999999999999875    67999999998653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.45  E-value=0.0013  Score=61.87  Aligned_cols=142  Identities=13%  Similarity=0.113  Sum_probs=81.0

Q ss_pred             cccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCC--CceeEEeeE-----EEeCCccEEEEeec
Q 040532          121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQH--KNLVRLLGC-----CIDKDEKILIYEYM  193 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~-----~~~~~~~~lv~e~~  193 (436)
                      ..++ |....||+....+|+.+++|....... ....+..|..++..+..  -.+.+++..     ....+..+++|+|+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 788899998877777899999864311 23456678888777732  123334432     22244567899999


Q ss_pred             CCCChhh-----h---------hc----CC--CccCCCCHHHH----HHH---------------HHHHHHHHHHHhh--
Q 040532          194 PNKSLDF-----F---------LF----DP--TKRILLDWVTR----VQI---------------IEGIAQGLLYLHQ--  232 (436)
Q Consensus       194 ~~g~L~~-----~---------l~----~~--~~~~~l~~~~~----~~i---------------~~~ia~~l~~LH~--  232 (436)
                      +|..+..     +         ++    ..  ......++...    ..+               ...+...++.+..  
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            9865431     0         01    00  01111222111    000               1111122333321  


Q ss_pred             --CCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          233 --YSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       233 --~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                        .....++|||+++.||+++ + .+.++||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence              1234589999999999999 4 899999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.43  E-value=0.00038  Score=68.48  Aligned_cols=73  Identities=14%  Similarity=0.260  Sum_probs=48.9

Q ss_pred             CcccCCCCceeEEEEEecC--------CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeEEEeCCccEEEE
Q 040532          120 TNKLGEGGFGPVYKGVLRK--------GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIY  190 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  190 (436)
                      .+.|+.|....+|+....+        +..+++|+......  .+.+.+|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3568889899999998653        47899999854211  1345578888888743333 445555432    3899


Q ss_pred             eecCCCCh
Q 040532          191 EYMPNKSL  198 (436)
Q Consensus       191 e~~~~g~L  198 (436)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.38  E-value=0.00085  Score=66.41  Aligned_cols=74  Identities=12%  Similarity=0.077  Sum_probs=48.0

Q ss_pred             CcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeEEEeCCccEEEEeecCCCC
Q 040532          120 TNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEYMPNKS  197 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  197 (436)
                      .+.|+.|-...+|+....+ +..+++|+........ -+-.+|..++..+...++ .++++.+.    ..+|+||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCcc
Confidence            3568888899999998764 4788899875432211 122588889988864444 45666552    236999999865


Q ss_pred             h
Q 040532          198 L  198 (436)
Q Consensus       198 L  198 (436)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.22  E-value=0.00052  Score=65.95  Aligned_cols=73  Identities=14%  Similarity=0.160  Sum_probs=43.8

Q ss_pred             cccCCCCceeEEEEEecC---------CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCc-eeEEeeEEEeCCccEEEE
Q 040532          121 NKLGEGGFGPVYKGVLRK---------GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKN-LVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  190 (436)
                      +.++.|....+|+....+         +..+++|+....... ..+...|..+++.+...+ ..++++..    ..++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence            467788888999988653         268888887653222 123467788887774223 23455433    247899


Q ss_pred             eecCCCCh
Q 040532          191 EYMPNKSL  198 (436)
Q Consensus       191 e~~~~g~L  198 (436)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.17  E-value=0.0012  Score=62.75  Aligned_cols=32  Identities=22%  Similarity=0.402  Sum_probs=28.0

Q ss_pred             CCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          235 RVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       235 ~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ...++|+|+.+.||++++++.+.++||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34699999999999999888899999988754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.87  E-value=0.0027  Score=55.49  Aligned_cols=103  Identities=12%  Similarity=0.011  Sum_probs=65.4

Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcccc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  275 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  275 (436)
                      -+|.+.|..  .+.++++.++|.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.|.+.+ +.+.          
T Consensus        33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence            367777743  34569999999999999999877622111 1 1233457899999999998874 2111          


Q ss_pred             cccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCC
Q 040532          276 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  318 (436)
Q Consensus       276 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p  318 (436)
                          .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                1123466888653 3456888999999999999865443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.66  E-value=0.043  Score=53.47  Aligned_cols=73  Identities=12%  Similarity=0.126  Sum_probs=47.5

Q ss_pred             cccCCCCceeEEEEEecC--------CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCc-eeEEeeEEEeCCccEEEEe
Q 040532          121 NKLGEGGFGPVYKGVLRK--------GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKN-LVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  191 (436)
                      +.+..|-...+|+....+        +..+++++....... .-+..+|..+++.+...+ ..++++.+    ..++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEE
Confidence            567778889999998753        578999987544322 123357888887774222 23344432    2488999


Q ss_pred             ecCCCCh
Q 040532          192 YMPNKSL  198 (436)
Q Consensus       192 ~~~~g~L  198 (436)
                      |++|..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998765

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.62  E-value=0.015  Score=36.52  Aligned_cols=33  Identities=15%  Similarity=0.146  Sum_probs=19.8

Q ss_pred             cCCCChhhHHHHHHHHHHHHHHHHhhheeccCC
Q 040532           26 TSTPRLPLFLLSIVLAAVAILGLIFFCVRRKPG   58 (436)
Q Consensus        26 ~s~~~~~~~i~~~~~~~v~i~~~~~~~~~r~~~   58 (436)
                      +.++.++.-+++.+++++++++++++++|||+.
T Consensus         8 s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B            8 PKIPSIATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             SCSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCcceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            445556666666666666666666666665544

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=95.37  E-value=0.009  Score=37.33  Aligned_cols=20  Identities=15%  Similarity=0.230  Sum_probs=9.3

Q ss_pred             HHHHHHHHHHHhhheeccCC
Q 040532           39 VLAAVAILGLIFFCVRRKPG   58 (436)
Q Consensus        39 ~~~~v~i~~~~~~~~~r~~~   58 (436)
                      +++++++.++++++.|||+.
T Consensus        21 vll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           21 ILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHCS
T ss_pred             HHHHHHHHHHHHhheehhhh
Confidence            34444444444555555543

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=95.22  E-value=0.014  Score=36.60  Aligned_cols=26  Identities=19%  Similarity=0.024  Sum_probs=12.0

Q ss_pred             hHHHHHHHHHHHHHHHHhhheeccCC
Q 040532           33 LFLLSIVLAAVAILGLIFFCVRRKPG   58 (436)
Q Consensus        33 ~~i~~~~~~~v~i~~~~~~~~~r~~~   58 (436)
                      .-+++.+++++++++++++++|||+.
T Consensus        14 ~gVVgGv~~v~ii~~~~~~~~RRRr~   39 (44)
T 2l2t_A           14 AGVIGGLFILVIVGLTFAVYVRRKSI   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EeehHHHHHHHHHHHHHHHHhhhhhh
Confidence            33334344444444444555555443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.21  E-value=0.11  Score=50.12  Aligned_cols=29  Identities=28%  Similarity=0.430  Sum_probs=24.9

Q ss_pred             eEecccCCCCEEE------cCCCCeEEeeccCcee
Q 040532          238 IIHRDLKASNILL------DKDMNPKISDFGMARI  266 (436)
Q Consensus       238 i~H~Dikp~NIll------~~~~~~kl~DfGla~~  266 (436)
                      ++|+|+.+.|||+      +++..+.++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567799999998753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.27  E-value=1.1  Score=38.97  Aligned_cols=117  Identities=10%  Similarity=0.031  Sum_probs=76.3

Q ss_pred             cCCCceeEEeeEEEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCC
Q 040532          168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  247 (436)
Q Consensus       168 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~N  247 (436)
                      ..||+.++. .+-.+.+...+.++.-+  +...+-.    -..++...+++++.+|+....+++.     -+|--++|+|
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            368888866 45555555555555433  2222221    1236788999999999988765553     4788999999


Q ss_pred             EEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 040532          248 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG  320 (436)
Q Consensus       248 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~  320 (436)
                      ++++.++.+++.-.|+...+                   +|.     ..+...=.-.+=+++..+++++..|.
T Consensus       110 L~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999887764221                   111     01111223367788999999998863

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=86.80  E-value=0.61  Score=28.18  Aligned_cols=19  Identities=37%  Similarity=0.756  Sum_probs=8.0

Q ss_pred             HHHHHHHHHHHHHhhheec
Q 040532           37 SIVLAAVAILGLIFFCVRR   55 (436)
Q Consensus        37 ~~~~~~v~i~~~~~~~~~r   55 (436)
                      +.++++++++++++|++||
T Consensus        19 G~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A           19 GLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHeec
Confidence            3333333344444455444

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.87  E-value=0.11  Score=51.14  Aligned_cols=62  Identities=11%  Similarity=0.110  Sum_probs=18.7

Q ss_pred             CCCcccCCCCceeEEEEEecC-CCEEEE------EEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe
Q 040532          118 SDTNKLGEGGFGPVYKGVLRK-GDEIAV------KRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCID  182 (436)
Q Consensus       118 ~~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  182 (436)
                      .+.+.||   ||.||+|.+.. ..+||+      |.....  +.+....+.+|..++..++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3446676   99999999864 357888      766542  22334567889999999999999999887654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.94  E-value=1.6  Score=37.98  Aligned_cols=114  Identities=8%  Similarity=0.068  Sum_probs=73.0

Q ss_pred             cCCCceeEEeeEEEeCCccEEEEeecCCC-ChhhhhcCCCccCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeEecccCC
Q 040532          168 VQHKNLVRLLGCCIDKDEKILIYEYMPNK-SLDFFLFDPTKRILLDWVTRVQIIEGIAQGLL-YLHQYSRVRIIHRDLKA  245 (436)
Q Consensus       168 l~h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~i~H~Dikp  245 (436)
                      ..||++  -...-.+++...+.++.-+++ ++.. +      ..++...+++++.+++.... +++.     -+|--++|
T Consensus        47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P  112 (219)
T 4ano_A           47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP  112 (219)
T ss_dssp             GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred             ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence            368887  333445556666666654332 2222 2      12677888998888887666 4443     67889999


Q ss_pred             CCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCC
Q 040532          246 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT  319 (436)
Q Consensus       246 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~  319 (436)
                      +|+++|.++.+++.-.|+-..+.              |.=+.+|.+          .-++=+++..++.++..|
T Consensus       113 ~NL~f~~~~~p~i~hRGi~~~lp--------------P~e~~ee~f----------l~qyKali~all~~K~~F  162 (219)
T 4ano_A          113 ENLMFNRALEPFFLHVGVKESLP--------------PDEWDDERL----------LREVKATVLALTEGEYRF  162 (219)
T ss_dssp             GGEEECTTCCEEESCCEETTTBS--------------SCSCCHHHH----------HHHHHHHHHHHTTCSSCH
T ss_pred             ceEEEeCCCcEEEEEcCCcccCC--------------CCCCCHHHH----------HHHHHHHHHHHHcCCCCH
Confidence            99999999999999887642211              000222211          236778888899888775

>1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1

Probab=82.96  E-value=0.12  Score=30.44  Aligned_cols=18  Identities=17%  Similarity=0.346  Sum_probs=8.7

Q ss_pred             HHHHHHHHHHHhhheecc
Q 040532           39 VLAAVAILGLIFFCVRRK   56 (436)
Q Consensus        39 ~~~~v~i~~~~~~~~~r~   56 (436)
                      +++++++.+.++++.|||
T Consensus        17 lll~vii~l~~~~~iRRr   34 (35)
T 1iij_A           17 VLLFLILVVVVGILIKRR   34 (35)
T ss_dssp             HHHHHHHTTTTTHHHHHC
T ss_pred             HHHHHHHHHHhheEEeec
Confidence            333444444445555555

>2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens}

Probab=82.63  E-value=2  Score=29.00  Aligned_cols=20  Identities=30%  Similarity=0.438  Sum_probs=12.7

Q ss_pred             HHHHHHHHHHHHHHHHhh-he
Q 040532           34 FLLSIVLAAVAILGLIFF-CV   53 (436)
Q Consensus        34 ~i~~~~~~~v~i~~~~~~-~~   53 (436)
                      +++|.++.+++++++.+| |.
T Consensus        12 ivlGg~~~lll~~glcI~ccv   32 (70)
T 2klu_A           12 IVLGGVAGLLLFIGLGIFFSV   32 (70)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhHHHHHHHHHHHHHHHhh
Confidence            567777776666665555 44

>1afo_A Glycophorin A; integral membrane protein, transmembrane helix interactions, membrane protein folding; NMR {Homo sapiens} SCOP: j.35.1.1 PDB: 2kpf_A

Probab=82.42  E-value=1.2  Score=26.48  Aligned_cols=32  Identities=22%  Similarity=0.452  Sum_probs=21.5

Q ss_pred             ccCCCChhhHHHHHHHHHHHHHHHHhhheecc
Q 040532           25 LTSTPRLPLFLLSIVLAAVAILGLIFFCVRRK   56 (436)
Q Consensus        25 ~~s~~~~~~~i~~~~~~~v~i~~~~~~~~~r~   56 (436)
                      +.|.|.+.+++.+..++++..++++.+|.||-
T Consensus         6 ~fs~p~i~lII~~vmaGiIG~IllI~y~I~rl   37 (40)
T 1afo_A            6 HFSEPEITLIIFGVMAGVIGTILLISYGIRRL   37 (40)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCchhHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            34666677777776666677777777776653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	436
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-72
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-67
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-67
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-66
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-66
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-60
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-59
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-59
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-35
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-24

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 2e-72
 Identities = 70/283 (24%), Positives = 130/283 (45%), Gaps = 23/283 (8%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            ++G G FG VYKG       + +  ++  + Q L+  KNE  V+ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
               +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   IIH
Sbjct: 74  -TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIH 127

Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGIFS 297
           RDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      +  +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 298 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSS 357
            +SDV++FG++L E+++G+         ++N    +  +    R     D   +      
Sbjct: 188 FQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMV--GRGYLSPDLSKVRSNCPK 240

Query: 358 KQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPK 400
                    +   C+++  D+RP    +++ +   A +L  PK
Sbjct: 241 A-----MKRLMAECLKKKRDERPLFPQILASIELLARSL--PK 276

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 1e-67
 Identities = 83/278 (29%), Positives = 131/278 (47%), Gaps = 29/278 (10%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
            T     +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           RL       +   +I EYM N SL  FL  P   I L     + +   IA+G+ ++ + +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 294
               IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185

Query: 295 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD---PVL 351
            F+IKSDV+SFG+LL EIV+  +                +   T+   ++ ++     V 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP--------------YPGMTNPEVIQNLERGYRMVR 231

Query: 352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
            D             +  LC +E  +DRPT + + S+L
Sbjct: 232 PDNCPE-----ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 1e-67
 Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 23/289 (7%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV 174
            +     KLG+G FG V+ G       +A+K L             EA V+ K++H+ LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           +L      ++   ++ EYM   SL  FL   T + L      V +   IA G+ Y+ +  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 294
               +HRDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 295 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDE 354
            F+IKSDV+SFG+LL E+ +  +                +    +   L+ ++       
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--------------PYPGMVNREVLDQVERGYRMP- 234

Query: 355 YSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPA 403
               +      ++   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 235 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 3e-66
 Identities = 71/269 (26%), Positives = 124/269 (46%), Gaps = 23/269 (8%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            ++G G FG V+ G     D++A+K +         +   EA V+ K+ H  LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
           +++    L++E+M +  L  +L    +R L    T + +   + +G+ YL +     +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIH 124

Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL A N L+ ++   K+SDFGM R    ++   +++       + SPE      +S KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 301 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQV 360
           DV+SFGVL+ E+ S  K                ++  +++  +E I        Y  +  
Sbjct: 184 DVWSFGVLMWEVFSEGK--------------IPYENRSNSEVVEDISTG--FRLYKPRLA 227

Query: 361 LLRYVNIALLCVQESADDRPTMNDVVSML 389
                 I   C +E  +DRP  + ++  L
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (539), Expect = 3e-66
 Identities = 66/291 (22%), Positives = 121/291 (41%), Gaps = 27/291 (9%)

Query: 122 KLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
            +G+G FG V++G  R G+E+AVK  S R E+     + E      ++H+N++  +    
Sbjct: 10  SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67

Query: 182 DKDEKI----LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ----- 232
             +       L+ +Y  + SL  +L     R  +     +++    A GL +LH      
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 290
             +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 291 ALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE 344
             + I         ++D+++ G++  EI       G++    L     V    +     +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 345 LID----DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           ++      P + + + S + L     I   C   +   R T   +   L+ 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  208 bits (529), Expect = 9e-65
 Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 38/302 (12%)

Query: 105 FSFSSVSTATNTFSDT---------NKLGEGGFGPVYKGVLRKGDE----IAVKRL-SGR 150
           F+F   + A   F+             +G G FG V  G L+   +    +A+K L SG 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 151 SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRIL 210
           +E+  R+  +EAS++ +  H N++ L G        ++I E+M N SLD FL     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 211 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 270
              +  V ++ GIA G+ YL        +HRDL A NIL++ ++  K+SDFG++R    +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 271 ELQANTSRIVG---TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 327
                 +  +G      + +PE      F+  SDV+S+G+++ E++S  +          
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 328 NLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
                 +   T+   +  I+                   + L C Q+  + RP    +V+
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPP--PMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 388 ML 389
            L
Sbjct: 286 TL 287

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 3e-64
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 23/271 (8%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            +LG G FG V  G  R   ++A+K +         E   EA V+  + H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             +    +I EYM N  L  +L +   R        +++ + + + + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 123

Query: 241 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 300
           RDL A N L++     K+SDFG++R    +E  ++         +  PE  +   FS KS
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYSKFSSKS 182

Query: 301 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQV 360
           D+++FGVL+ EI S  K                ++ +T++ T E I        Y     
Sbjct: 183 DIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQG--LRLYRPHLA 226

Query: 361 LLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
             +   I   C  E AD+RPT   ++S + +
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-62
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 29/270 (10%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
             +G+G FG V  G  R G+++AVK +  +++   +    EASV+ +++H NLV+LLG  
Sbjct: 13  QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 181 IDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
           +++   + ++ EYM   SL  +L     R +L     ++    + + + YL        +
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 125

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 299
           HRDL A N+L+ +D   K+SDFG+ +     E  +          + +PE   E  FS K
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 180

Query: 300 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQ 359
           SDV+SFG+LL EI S  +                +        +  ++     D  +   
Sbjct: 181 SDVWSFGILLWEIYSFGR--------------VPYPRIPLKDVVPRVEKGYKMD--APDG 224

Query: 360 VLLRYVNIALLCVQESADDRPTMNDVVSML 389
                  +   C    A  RP+   +   L
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  201 bits (511), Expect = 4e-62
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 23/276 (8%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNL 173
              +  +KLG G +G VY+GV +K    +AVK L       + E   EA+V+ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 75

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LLG C  +    +I E+M   +L  +L +   R  +  V  + +   I+  + YL + 
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 134

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
                IHRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE    
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190

Query: 294 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED 353
             FSIKSDV++FGVLL EI +               L  V++L   +  +E  +      
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM-----SPYPGIDLSQVYELLEKDYRMERPEG----- 240

Query: 354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
                    +   +   C Q +  DRP+  ++    
Sbjct: 241 ------CPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 8e-62
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 11/206 (5%)

Query: 113 ATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQH 170
             + F   ++LG G  G V+K   +  G  +A K +    +  +R  +  E  V+ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             +V   G      E  +  E+M   SLD  L    K   +      ++   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
               + +I+HRD+K SNIL++     K+ DFG++     +      +  VGT  YMSPE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGK 316
                +S++SD++S G+ L+E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (506), Expect = 2e-61
 Identities = 68/303 (22%), Positives = 118/303 (38%), Gaps = 47/303 (15%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLS-GRSEQGLREMKNEASVIAK 167
           N       +GEG FG V++              +AVK L    S     + + EA+++A+
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRIL----------------- 210
             + N+V+LLG C       L++EYM    L+ FL   +   +                 
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 211 ----LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 266
               L    ++ I   +A G+ YL +    + +HRDL   N L+ ++M  KI+DFG++R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 326
               +             +M PE      ++ +SDV+++GV+L EI S            
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP------- 242

Query: 327 LNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
                  +        +  + D  +      +   L   N+  LC  +   DRP+   + 
Sbjct: 243 -------YYGMAHEEVIYYVRDGNILA--CPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

Query: 387 SML 389
            +L
Sbjct: 294 RIL 296

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 5e-61
 Identities = 66/278 (23%), Positives = 121/278 (43%), Gaps = 29/278 (10%)

Query: 121 NKLGEGGFGPVYKGVLRKGD----EIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVR 175
             +G G FG VY G L   D      AVK L+  ++ G + +   E  ++    H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 176 LLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
           LLG C+  +    ++  YM +  L  F+ + T    +  +    +          +   +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPEYAL 292
             + +HRDL A N +LD+    K++DFG+AR     E  +  ++        +M+ E   
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE 352
              F+ KSDV+SFGVLL E+++          ++ ++  Y+                +L+
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQ-----------GRRLLQ 255

Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
            EY    +      + L C    A+ RP+ +++VS ++
Sbjct: 256 PEYCPDPL----YEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 5e-61
 Identities = 66/276 (23%), Positives = 115/276 (41%), Gaps = 33/276 (11%)

Query: 122 KLGEGGFGPVYKGVLR---KGDEIAVKRLSGRSEQG-LREMKNEASVIAKVQHKNLVRLL 177
           +LG G FG V +GV R   K  ++A+K L   +E+    EM  EA ++ ++ +  +VRL+
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           G C   +  +L+ E      L  FL    +   +      +++  ++ G+ YL + +   
Sbjct: 76  GVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKN--- 129

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEYALEGIF 296
            +HRDL A N+LL      KISDFG+++  G ++      S       + +PE      F
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189

Query: 297 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD---PVLED 353
           S +SDV+S+GV + E +S  +                +        +  I+         
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQ--------------KPYKKMKGPEVMAFIEQGKRMECPP 235

Query: 354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
           E   +        +   C     +DRP    V   +
Sbjct: 236 ECPPE-----LYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 9e-61
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 28/280 (10%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDE-----IAVKRLS-GRSEQGLREMKNEASVIAKVQH 170
            +    +G G FG VYKG+L+         +A+K L  G +E+   +   EA ++ +  H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
            N++RL G        ++I EYM N +LD FL +  K      +  V ++ GIA G+ YL
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPE 289
                +  +HRDL A NIL++ ++  K+SDFG++R+   +     T S       + +PE
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
                 F+  SDV+SFG+++ E+++  +                +   +++  ++ I+D 
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYWELSNHEVMKAINDG 229

Query: 350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
                 +          + + C Q+    RP   D+VS+L
Sbjct: 230 FRLP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (502), Expect = 2e-60
 Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 35/278 (12%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLS---GRSEQGLREMKNEASVIAKVQHKN 172
           FSD  ++G G FG VY     +  + +A+K++S    +S +  +++  E   + K++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
            ++  GC + +    L+ EY    + D        +  L  V    +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 233 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
           +    +IHRD+KA NILL +    K+ DFG A I       A  +  VGT  +M+PE  L
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184

Query: 293 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP 349
              EG +  K DV+S G+  +E+   K    L+  ++++ L ++             + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSALYHIAQ----------NESP 232

Query: 350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
            L+  + S+       N    C+Q+   DRPT   ++ 
Sbjct: 233 ALQSGHWSEYF----RNFVDSCLQKIPQDRPTSEVLLK 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 8e-60
 Identities = 64/282 (22%), Positives = 113/282 (40%), Gaps = 35/282 (12%)

Query: 119 DTNKLGEGGFGPVYKGVLRK---GDEIAVKRLSGRSEQG--LREMKNEASVIAKVQHKNL 173
           +  +LG G FG V KG  +       +AVK L   +       E+  EA+V+ ++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           VR++G C + +  +L+ E      L+ +L        +     ++++  ++ G+ YL + 
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS-RIVGTYGYMSPEYAL 292
                +HRDL A N+LL      KISDFG+++    +E              + +PE   
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD---P 349
              FS KSDV+SFGVL+ E  S  +                +     +    +++     
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLEKGERM 229

Query: 350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
                           ++  LC     ++RP    V   L N
Sbjct: 230 GCPAGCPR-----EMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 1e-59
 Identities = 72/299 (24%), Positives = 124/299 (41%), Gaps = 46/299 (15%)

Query: 122 KLGEGGFGPVYKGVLRKGDE------IAVKRLSGRSEQGLRE-MKNEASVIAKV-QHKNL 173
            LG G FG V         +      +AVK L  +++   RE + +E  ++ ++  H+N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRI--------------------LLDW 213
           V LLG C       LI+EY     L  +L    ++                     +L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 214 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 273
              +     +A+G+ +L        +HRDL A N+L+      KI DFG+AR    +   
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV 333
                      +M+PE   EGI++IKSDV+S+G+LL EI S   N   Y    ++     
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--PYPGIPVDAN--F 276

Query: 334 WDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE 392
           + L  +   ++          Y+++++      I   C    +  RP+  ++ S L  +
Sbjct: 277 YKLIQNGFKMDQ-------PFYATEEI----YIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-59
 Identities = 75/300 (25%), Positives = 131/300 (43%), Gaps = 37/300 (12%)

Query: 121 NKLGEGGFGPVYKGVLRK------GDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNL 173
            +LG+G FG VY+GV +          +A+K ++   S +   E  NEASV+ +    ++
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRIL-------LDWVTRVQIIEGIAQG 226
           VRLLG        ++I E M    L  +L      +              +Q+   IA G
Sbjct: 86  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 227 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 286
           + YL+     + +HRDL A N ++ +D   KI DFGM R     +      + +    +M
Sbjct: 146 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202

Query: 287 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI 346
           SPE   +G+F+  SDV+SFGV+L EI +  +                +   ++ + L  +
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--------------YQGLSNEQVLRFV 248

Query: 347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP-PKQPAFS 405
            +  L D+            +  +C Q +   RP+  +++S +  E   + P  ++ +F 
Sbjct: 249 MEGGLLDK--PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE---MEPGFREVSFY 303

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 3e-59
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 32/275 (11%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLL 177
            ++G G F  VYKG+  +   E+A   L  R  ++   +  K EA ++  +QH N+VR  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 178 GCCID----KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
                    K   +L+ E M + +L  +L    +  ++           I +GL +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 234 SRVRIIHRDLKASNILL-DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
           +   IIHRDLK  NI +     + KI D G+A +   +        ++GT  +M+PE   
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-Y 185

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE 352
           E  +    DV++FG+ +LE+ + +                  +     R +     P   
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEY-----------PYSECQNAAQIYRRVTSGVKPASF 234

Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
           D+ +  +V      I   C++++ D+R ++ D+++
Sbjct: 235 DKVAIPEV----KEIIEGCIRQNKDERYSIKDLLN 265

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 7e-59
 Identities = 73/296 (24%), Positives = 128/296 (43%), Gaps = 30/296 (10%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRKGDE-----IAVKRLS-GRSEQGLREMKNEASVIAKVQH 170
           F     LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
            ++ RLLG C+    + LI + MP   L  ++ +    I       +     IA+G+ YL
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL 127

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                 R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M+ E 
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV 350
            L  I++ +SDV+S+GV + E+++                   +D   ++    +++   
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEKGE 230

Query: 351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQPAFSN 406
              +       +    I + C    AD RP   +++        A  P +      
Sbjct: 231 RLPQ--PPICTIDVYMIMVKCWMIDADSRPKFRELIIEF--SKMARDPQRYLVIQG 282

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 9e-59
 Identities = 69/297 (23%), Positives = 115/297 (38%), Gaps = 45/297 (15%)

Query: 121 NKLGEGGFGPVYKGVLRK------GDEIAVKRLSGRSEQGLRE-MKNEASVIAKV-QHKN 172
             LG G FG V +              +AVK L   +    RE + +E  V++ +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD---------------PTKRILLDWVTRV 217
           +V LLG C      ++I EY     L  FL                     + LD    +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
                +A+G+ +L        IHRDL A NILL      KI DFG+AR    +       
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW 337
                  +M+PE     +++ +SDV+S+G+ L E+ S   +                 + 
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-------------PYPGMP 252

Query: 338 TSNRTLELIDD--PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE 392
             ++  ++I +   +L  E++  ++     +I   C       RPT   +V ++  +
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEM----YDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 7e-58
 Identities = 63/271 (23%), Positives = 122/271 (45%), Gaps = 28/271 (10%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGC 179
            +LG+G FG VYK   ++     A K +  +SE+ L +   E  ++A   H N+V+LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRII 239
              ++   ++ E+    ++D  + +  +   L       + +     L YLH     +II
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD---NKII 132

Query: 240 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EG 294
           HRDLKA NIL   D + K++DFG++        + ++   +GT  +M+PE  +     + 
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDR 190

Query: 295 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDE 354
            +  K+DV+S G+ L+E+   +     +  + + +L  +      +    L         
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE--PPHHELNPMRVLLKI----AKSEPPTLAQPSRWSSN 244

Query: 355 YSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
           +  K  L +       C++++ D R T + +
Sbjct: 245 F--KDFLKK-------CLEKNVDARWTTSQL 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 8e-58
 Identities = 66/277 (23%), Positives = 114/277 (41%), Gaps = 33/277 (11%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
             +G G +G   K   +  G  +  K L     +E   + + +E +++ +++H N+VR  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 178 GCCIDKDEKIL--IYEYMPNKSLDFFLFDPTK-RILLDWVTRVQIIEGIAQGLLYLHQYS 234
              ID+    L  + EY     L   +   TK R  LD    ++++  +   L   H+ S
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 235 RV--RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 292
                ++HRDLK +N+ LD   N K+ DFG+ARI   +   A     VGT  YMSPE   
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMN 187

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI---DDP 349
              ++ KSD++S G LL E+ +                   +  ++       I      
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALM---------------PPFTAFSQKELAGKIREGKFR 232

Query: 350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVV 386
            +   YS +        I    +      RP++ +++
Sbjct: 233 RIPYRYSDE-----LNEIITRMLNLKDYHRPSVEEIL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 6e-57
 Identities = 67/270 (24%), Positives = 115/270 (42%), Gaps = 24/270 (8%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLS-GRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
             LGEG +G V   V R   + +AVK +   R+      +K E  +   + H+N+V+  G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
              + + + L  EY     L   +      I +      +    +  G++YLH      I
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GI 124

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-S 297
            HRD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184

Query: 298 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSS 357
              DV+S G++L  +++G+       +DS        +  T     + ID          
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWD-QPSDSCQEYSDWKEKKTYLNPWKKIDSAP------- 236

Query: 358 KQVLLRYVNIALLCVQESADDRPTMNDVVS 387
             +L +        + E+   R T+ D+  
Sbjct: 237 LALLHK-------ILVENPSARITIPDIKK 259

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 7e-57
 Identities = 72/278 (25%), Positives = 109/278 (39%), Gaps = 29/278 (10%)

Query: 121 NKLGEGGFGPVYKGVLR----KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNL 173
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           +RL G  +    K+ + E  P  SL   L       LL  ++R      +A+G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESK 130

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAL 292
              R IHRDL A N+LL      KI DFG+ R +   ++           + + +PE   
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE 352
              FS  SD + FGV L E+ +     G      LN    +  +      L   +D    
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTY----GQEPWIGLNGSQILHKIDKEGERLPRPED---- 239

Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT 390
                        N+ + C     +DRPT   +   L 
Sbjct: 240 -------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 9e-57
 Identities = 72/293 (24%), Positives = 119/293 (40%), Gaps = 40/293 (13%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRKGD---EIAVKRLS-GRSEQGLREMKNEASVIAKV-Q 169
           N     + +GEG FG V K  ++K     + A+KR+    S+   R+   E  V+ K+  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 170 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRILLDWVTR 216
           H N++ LLG C  +    L  EY P+ +L  FL                +    L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 217 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT 276
           +     +A+G+ YL Q    + IHRDL A NIL+ ++   KI+DFG++R           
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183

Query: 277 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL 336
           +       +M+ E     +++  SDV+S+GVLL EIVS                   +  
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------------YCG 229

Query: 337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
            T     E +      ++           ++   C +E   +RP+   ++  L
Sbjct: 230 MTCAELYEKLPQGYRLEK--PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 2e-55
 Identities = 66/273 (24%), Positives = 109/273 (39%), Gaps = 36/273 (13%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEI-AVKRLS---GRSEQGLREMKNEASVIAKVQHKNLVRL 176
             LG+G FG VY    ++   I A+K L            +++ E  + + ++H N++RL
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
            G   D     LI EY P  ++   L   +K    D       I  +A  L Y H     
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSK--- 125

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
           R+IHRD+K  N+LL      KI+DFG +     +      + + GT  Y+ PE     + 
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMH 181

Query: 297 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI--DDPVLEDE 354
             K D++S GVL  E + GK                 ++  T   T + I   +    D 
Sbjct: 182 DEKVDLWSLGVLCYEFLVGK---------------PPFEANTYQETYKRISRVEFTFPDF 226

Query: 355 YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS 387
            +         ++    ++ +   RP + +V+ 
Sbjct: 227 VTE-----GARDLISRLLKHNPSQRPMLREVLE 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 6e-55
 Identities = 63/281 (22%), Positives = 123/281 (43%), Gaps = 25/281 (8%)

Query: 106 SFSSVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASV 164
           S  SV      ++   K+G+G  G VY  +    G E+A+++++ + +     + NE  V
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 165 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIA 224
           + + ++ N+V  L   +  DE  ++ EY+   SL   + +       D      +     
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126

Query: 225 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 284
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG          Q+  S +VGT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE 344
           +M+PE      +  K D++S G++ +E++ G+                 +      R L 
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---------------PPYLNENPLRALY 226

Query: 345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
           LI      +  + +++   + +    C+    + R +  ++
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 1e-53
 Identities = 58/278 (20%), Positives = 107/278 (38%), Gaps = 34/278 (12%)

Query: 122 KLGEGGFGPVYKGVLRKGDE----IAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRL 176
            +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
           +G   + +   +I E      L  FL        LD  + +     ++  L YL      
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESK--- 127

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
           R +HRD+ A N+L+  +   K+ DFG++R    +      S+      +M+PE      F
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRF 186

Query: 297 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI---DDPVLED 353
           +  SDV+ FGV + EI+                    +    +N  +  I   +   +  
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKP--------------FQGVKNNDVIGRIENGERLPMPP 232

Query: 354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
                       ++   C       RP   ++ + L+ 
Sbjct: 233 NCPPT-----LYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 8e-53
 Identities = 70/293 (23%), Positives = 114/293 (38%), Gaps = 40/293 (13%)

Query: 121 NKLGEGGFGPVYKGVLRK------GDEIAVKRLS-GRSEQGLREMKNEASVIAK-VQHKN 172
             LG G FG V +              +AVK L  G +    R + +E  ++     H N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 173 LVRLLGCCIDKDEKILI-YEYMPNKSLDFFLF-------------DPTKRILLDWVTRVQ 218
           +V LLG C      +++  E+    +L  +L              +   +  L     + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 219 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 278
               +A+G+ +L      + IHRDL A NILL +    KI DFG+AR    +        
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 279 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWT 338
                 +M+PE   + +++I+SDV+SFGVLL EI S   +        + +         
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEFCRRLK 251

Query: 339 SNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
               +   D       Y++ ++        L C       RPT +++V  L N
Sbjct: 252 EGTRMRAPD-------YTTPEMY----QTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 5e-52
 Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 42/292 (14%)

Query: 121 NKLGEGGFGPVYKGVLR--------KGDEIAVKRL-SGRSEQGLREMKNEASVIAKV-QH 170
             LGEG FG V              +  ++AVK L S  +E+ L ++ +E  ++  + +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRIL-------------LDWVTRV 217
           KN++ LLG C       +I EY    +L  +L       L             L     V
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 218 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 277
                +A+G+ YL      + IHRDL A N+L+ +D   KI+DFG+AR     +    T+
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 278 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLW 337
                  +M+PE   + I++ +SDV+SFGVLL EI +   +   Y    +  L   + L 
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL---FKLL 250

Query: 338 TSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSML 389
                ++   +                  +   C       RPT   +V  L
Sbjct: 251 KEGHRMDKPSN-----------CTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 3e-51
 Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 10/200 (5%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRL 176
             LGEG F  V          E A+K L  R    E  +  +  E  V++++ H   V+L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                D ++      Y  N  L  ++                     A+ +  L      
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGK 127

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E   
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 297 SIKSDVFSFGVLLLEIVSGK 316
              SD+++ G ++ ++V+G 
Sbjct: 188 CKSSDLWALGCIIYQLVAGL 207

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  169 bits (429), Expect = 2e-49
 Identities = 55/269 (20%), Positives = 108/269 (40%), Gaps = 29/269 (10%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +LG G FG V++   R  G+  A K +    E     ++ E   ++ ++H  LV L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            D +E ++IYE+M    L   + D   +  +     V+ +  + +GL ++H       +H
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH---ENNYVH 147

Query: 241 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
            DLK  NI+     +   K+ DFG+       +   +     GT  + +PE A       
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGY 204

Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSS- 357
            +D++S GVL   ++SG      +  ++ +      +   + ++ +   D       S  
Sbjct: 205 YTDMWSVGVLSYILLSGLS---PFGGENDD------ETLRNVKSCDWNMDDSAFSGISED 255

Query: 358 -KQVLLRYVNIALLCVQESADDRPTMNDV 385
            K  + +        +    + R T++  
Sbjct: 256 GKDFIRK-------LLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  166 bits (420), Expect = 5e-48
 Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 11/198 (5%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           +LG G FG V++ V +  G     K ++         +KNE S++ ++ H  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
            DK E +LI E++    L   +     +  +     +  +    +GL ++H      I+H
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH---EHSIVH 150

Query: 241 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
            D+K  NI+ +       KI DFG+A     +E+         T  + +PE         
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGF 207

Query: 299 KSDVFSFGVLLLEIVSGK 316
            +D+++ GVL   ++SG 
Sbjct: 208 YTDMWAIGVLGYVLLSGL 225

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 6e-45
 Identities = 59/289 (20%), Positives = 114/289 (39%), Gaps = 20/289 (6%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHK 171
              +++ + +GEG +G V           +A+K++S    Q   +    E  ++ + +H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
           N++ +         + +   Y+    +   L+   K   L        +  I +GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEY 290
                 ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  Y +PE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 291 ALEGIFSIKS-DVFSFGVLLLEIVSGK-------------KNTGLYRTDSLNLLGYVWDL 336
            L      KS D++S G +L E++S +                G+  + S   L  + +L
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
              N  L L     +           + +++    +  +   R  +   
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (394), Expect = 1e-44
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 15/201 (7%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLS---GRSEQGLREMKNEASVIAKVQHKNLVRL 176
             LG G FG V+    R  G   A+K L        + +    +E  +++ V H  ++R+
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 177 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
            G   D  +  +I +Y+    L   L                     A+  L L      
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            II+RDLK  NILLDK+ + KI+DFG A+      +   T  + GT  Y++PE      +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY 178

Query: 297 SIKSDVFSFGVLLLEIVSGKK 317
           +   D +SFG+L+ E+++G  
Sbjct: 179 NKSIDWWSFGILIYEMLAGYT 199

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 2e-44
 Identities = 53/268 (19%), Positives = 108/268 (40%), Gaps = 28/268 (10%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
            LG G FG V++ V          K +  +       +K E S++   +H+N++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
              +E ++I+E++    +   +   T    L+    V  +  + + L +LH +    I H
Sbjct: 71  ESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125

Query: 241 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
            D++  NI+     +   KI +FG AR     +   N   +     Y +PE     + S 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVST 182

Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI-DDPVLEDEYSS 357
            +D++S G L+  ++SG                  +   T+ + +E I +     DE + 
Sbjct: 183 ATDMWSLGTLVYVLLSGI---------------NPFLAETNQQIIENIMNAEYTFDEEAF 227

Query: 358 KQVLLRYVNIALLCVQESADDRPTMNDV 385
           K++ +  ++     + +    R T ++ 
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  152 bits (384), Expect = 1e-43
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 15/212 (7%)

Query: 114 TNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLS---GRSEQGLREMKNEASVIAKVQ 169
           ++ +     LG GG   V+     +   ++AVK L     R        + EA   A + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 170 HKNLVRLLGCCIDKDEKI----LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           H  +V +      +        ++ EY+   +L   +        +     +++I    Q
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYG 284
            L + HQ     IIHRD+K +NI++      K+ DFG+AR I         T+ ++GT  
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (385), Expect = 2e-43
 Identities = 56/295 (18%), Positives = 111/295 (37%), Gaps = 28/295 (9%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLRE-MKNEASVIAKVQHKNLVRLLG 178
           + LG G F  V     ++    +A+K ++ ++ +G    M+NE +V+ K++H N+V L  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
                    LI + +    L   +    ++         ++I  +   + YLH    V  
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 298
             +        LD+D    ISDFG++++     +    S   GT GY++PE   +  +S 
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSK 188

Query: 299 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSS- 357
             D +S GV+   ++ G      +  ++         L+      E   D    D+ S  
Sbjct: 189 AVDCWSIGVIAYILLCGYP---PFYDEN------DAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 358 -KQVLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEAAALHPPKQPAFSNVRN 409
            K  +          +++  + R T    +    +  + A      Q     ++ 
Sbjct: 240 AKDFIRH-------LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKK 287

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (384), Expect = 2e-43
 Identities = 52/279 (18%), Positives = 101/279 (36%), Gaps = 26/279 (9%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           K+G G FG +Y G  +  G+E+A+K    +++    ++  E+ +   +Q    +  +  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             + +  ++   +   SL+      +++      T + + + +   + Y+H       IH
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFIH 126

Query: 241 RDLKASNIL---LDKDMNPKISDFGMARICGGNELQAN-----TSRIVGTYGYMSPEYAL 292
           RD+K  N L     K     I DFG+A+         +        + GT  Y S    L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 293 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE 352
               S + D+ S G +L+    G       +  +             +         VL 
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-----RQKYERISEKKMSTPIEVLC 241

Query: 353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
             Y S+     +      C     DD+P  + +  +  N
Sbjct: 242 KGYPSE-----FATYLNFCRSLRFDDKPDYSYLRQLFRN 275

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 3e-43
 Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 27/301 (8%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRL-----SGRSEQGLREMKNEASVIAKVQHKNLV 174
           + LGEG F  VYK   +     +A+K++     S   +   R    E  ++ ++ H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            LL     K    L++++M               ++L        +    QGL YLHQ+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 235 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE- 293
              I+HRDLK +N+LLD++   K++DFG+A+  G        +  V T  Y +PE     
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGA 175

Query: 294 GIFSIKSDVFSFGVLLLEIVSGKK-NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE 352
            ++ +  D+++ G +L E++       G    D L  +       T  +  ++   P   
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 353 DEYSSKQVLLRYVN-------IALL--CVQESADDRPTMNDVVSM--LTNEAAALHPPKQ 401
              S   + L ++        + L+      +   R T    + M   +N        + 
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295

Query: 402 P 402
           P
Sbjct: 296 P 296

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  153 bits (387), Expect = 4e-43
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 18/210 (8%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRS------EQGLREMKNEASVIAK 167
           N FS    +G GGFG VY       G   A+K L  +       E      +   S+++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 168 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGL 227
                +V +       D+   I + M    L + L    +  +            I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 228 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 287
            ++H      +++RDLK +NILLD+  + +ISD G+A      +        VGT+GYM+
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 288 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
           PE   +G+ +   +D FS G +L +++ G 
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 8e-43
 Identities = 67/285 (23%), Positives = 113/285 (39%), Gaps = 27/285 (9%)

Query: 121 NKLGEGGFGPVYKGVLRK--GDEIAVKRLS------GRSEQGLREMKNEASVIAKVQHKN 172
            ++GEG +G V+K    K  G  +A+KR+       G     +RE+      +   +H N
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLETFEHPN 71

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLD---FFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
           +VRL   C            +  + +D       D      +   T   ++  + +GL +
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 289
           LH +   R++HRDLK  NIL+      K++DFG+ARI          + +V T  Y +PE
Sbjct: 132 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPE 185

Query: 290 YALEGIFSIKSDVFSFGVLLLEIVSGKKN-TGLYRTDSLNLLGYVWDLWTSNRTLELIDD 348
             L+  ++   D++S G +  E+   K    G    D L  +  V  L         +  
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 349 PVLEDEYSSKQVLLRYVN------IALL--CVQESADDRPTMNDV 385
           P       S Q + ++V         LL  C+  +   R +    
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 64/286 (22%), Positives = 115/286 (40%), Gaps = 40/286 (13%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRL--------SGRSEQGLRE-MKNEASVIA 166
           +     LG G    V + + +    E AVK +        S    Q LRE    E  ++ 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 167 KVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           KV  H N+++L           L+++ M    L  +L   T+++ L      +I+  + +
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLE 121

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
            +  LH   ++ I+HRDLK  NILLD DMN K++DFG +      E       + GT  Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSY 175

Query: 286 MSPEYALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS 339
           ++PE     +      +  + D++S GV++  +++G      +      L+  +  + + 
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLM--LRMIMSG 230

Query: 340 NRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
           N      +     D    K ++ R        +      R T  + 
Sbjct: 231 NYQFGSPEWDDYSDTV--KDLVSR-------FLVVQPQKRYTAEEA 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-42
 Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 13/201 (6%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLS---GRSEQGLREMKNEASVIAKV-QHKNLVR 175
             LG+G FG V+    +K     A+K L       +  +     E  V++   +H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 176 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSR 235
           +      K+    + EY+    L + +    K    D          I  GL +LH    
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSK-- 122

Query: 236 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 295
             I++RDLK  NILLDKD + KI+DFGM +     + + NT    GT  Y++PE  L   
Sbjct: 123 -GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQK 179

Query: 296 FSIKSDVFSFGVLLLEIVSGK 316
           ++   D +SFGVLL E++ G+
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQ 200

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  148 bits (374), Expect = 4e-42
 Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 22/279 (7%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLLG 178
            K+GEG +G VYK     G+  A+K  RL    E        E S++ +++H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 179 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRI 238
               K   +L++E++                 L+ VT    +  +  G+ Y H     R+
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHDR---RV 121

Query: 239 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-EGIFS 297
           +HRDLK  N+L++++   KI+DFG+AR  G    +      + T  Y +P+  +    +S
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYS 179

Query: 298 IKSDVFSFGVLLLEIVSGK------KNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL 351
              D++S G +  E+V+G                   L       W +   L   D    
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 352 EDEYSSKQVLLRYVNIALL-----CVQESADDRPTMNDV 385
             E    +  L+ ++ + +      ++   + R T    
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 8e-42
 Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 31/230 (13%)

Query: 108 SSVSTATNT------------FSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQG 154
           S V+T   T            ++DT  +G G FG VY+  L   G+ +A+K++     Q 
Sbjct: 1   SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QD 56

Query: 155 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEK------ILIYEYMPNKSLDFFLFDPTKR 208
            R    E  ++ K+ H N+VRL        EK       L+ +Y+P             +
Sbjct: 57  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116

Query: 209 ILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARIC 267
             L  +     +  + + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+  
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

Query: 268 GGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
              E   +    + +  Y +PE       ++   DV+S G +L E++ G+
Sbjct: 174 VRGEPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 4e-41
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 9/203 (4%)

Query: 117 FSDTNKLGEGGFGPVYKGVLRK-GDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNL 173
           F    K+GEG +G VYK   +  G+ +A+K  RL   +E        E S++ ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 174 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY 233
           V+LL     +++  L++E++      F        I L  +        + Q L  L   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGLAFC 118

Query: 234 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 293
              R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V  +          
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 294 GIFSIKSDVFSFGVLLLEIVSGK 316
             +S   D++S G +  E+V+ +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (362), Expect = 3e-40
 Identities = 40/281 (14%), Positives = 95/281 (33%), Gaps = 28/281 (9%)

Query: 122 KLGEGGFGPVYKGV-LRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           ++GEG FG +++G  L    ++A+K    RS+    ++++E      +     +  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 181 IDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 240
             +    ++   +   SL+  L    ++      T     + +   +  +H+     +++
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHEK---SLVY 124

Query: 241 RDLKASNILLDKDMNP-----KISDFGMARICGGNELQAN-----TSRIVGTYGYMSPEY 290
           RD+K  N L+ +  +       + DFGM +       + +        + GT  YMS   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV 350
            L    S + D+ + G + +  + G           L                +      
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGS-----LPWQGLKAATNKQKYERIGEKKQSTPLRE 239

Query: 351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTN 391
           L   +  +     +          + D  P  + +  + + 
Sbjct: 240 LCAGFPEE-----FYKYMHYARNLAFDATPDYDYLQGLFSK 275

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 4e-39
 Identities = 62/275 (22%), Positives = 100/275 (36%), Gaps = 44/275 (16%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKN------EASVIAKVQ--HKN 172
            LG GGFG VY G+       +A+K +         E+ N      E  ++ KV      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 173 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ 232
           ++RLL      D  +LI E        F     T+R  L           + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128

Query: 233 YSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
                ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE+ 
Sbjct: 129 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWI 181

Query: 292 L-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV 350
                    + V+S G+LL ++V G      +  D                  E+I   V
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI---PFEHDE-----------------EIIRGQV 221

Query: 351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
              +  S +      ++   C+     DRPT  ++
Sbjct: 222 FFRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 252

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 5e-39
 Identities = 67/277 (24%), Positives = 110/277 (39%), Gaps = 38/277 (13%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRL------SGRSEQGLREMKNEASVIAKVQHKNLV 174
           +LG G F  V K   +  G + A K +      S R      +++ E S++ ++QH N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 175 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS 234
            L     +K + ILI E +    L  F     ++  L      + ++ I  G+ YLH   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF---LAEKESLTEEEATEFLKQILNGVYYLHSL- 132

Query: 235 RVRIIHRDLKASNILLDKDMNP----KISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
             +I H DLK  NI+L     P    KI DFG+A              I GT  +++PE 
Sbjct: 133 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 187

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI--DD 348
                  +++D++S GV+   ++SG                  +   T   TL  +   +
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGA---------------SPFLGDTKQETLANVSAVN 232

Query: 349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
              EDEY S        +     + +    R T+ D 
Sbjct: 233 YEFEDEYFSN-TSALAKDFIRRLLVKDPKKRMTIQDS 268

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 3e-38
 Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
            K+G+G FG V+K   RK G ++A+K++      E        E  ++  ++H+N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 178 GCCIDKDEKI--------LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLY 229
             C  K            L++++  +        +   +  L  + RV     +   L  
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRV-----MQMLLNG 129

Query: 230 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMS 287
           L+   R +I+HRD+KA+N+L+ +D   K++DFG+AR      N      +  V T  Y  
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 288 PEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 316
           PE  L E  +    D++  G ++ E+ +  
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (344), Expect = 7e-38
 Identities = 54/296 (18%), Positives = 115/296 (38%), Gaps = 28/296 (9%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVK--RLSGRSEQGLREMKNEASVIAKVQHKNLVRLL 177
            K+GEG +G V+K   R+  + +A+K  RL    E        E  ++ +++HKN+VRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 178 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
                  +  L++E+       +F            +    +   + Q L  L       
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 238 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 297
           ++HRDLK  N+L++++   K+++FG+AR   G  ++  ++ +V  +           ++S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 298 IKSDVFSFGVLLLEIVSGKK-------NTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV 350
              D++S G +  E+ +  +            +     L     + W S   L       
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 351 LEDEYSSKQVLLRYVNIALL-----CVQESADDRPTMNDVVSM--LTNEAAALHPP 399
           +    +S   ++  +N          ++ +   R +  + +     ++      PP
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD----FCPP 292

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-37
 Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 12/206 (5%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLS---GRSEQGLREMKNEASVIAKVQH 170
           N F     LG+G FG V     +  G   A+K L      ++  +     E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
             L  L       D    + EY     L F L            T  +     A+ +  L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSAL 118

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 290
                  +++RD+K  N++LDKD + KI+DFG+ +    +   A      GT  Y++PE 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176

Query: 291 ALEGIFSIKSDVFSFGVLLLEIVSGK 316
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 3e-36
 Identities = 48/271 (17%), Positives = 103/271 (38%), Gaps = 29/271 (10%)

Query: 123 LGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCI 181
           LG G  G V +   ++  ++ A+K L     +  RE++         Q  ++VR++    
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRAS---QCPHIVRIVDVYE 75

Query: 182 DKDEK----ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVR 237
           +        +++ E +    L   + D   +         +I++ I + + YLH    + 
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHS---IN 131

Query: 238 IIHRDLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 294
           I HRD+K  N+L          K++DFG A+    +           T  Y++PE     
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPE 188

Query: 295 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDE 354
            +    D++S GV++  ++ G      + ++       +     +   +   + P  E  
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLA---ISPGMKTRIRMGQYEFPNPEWS 242

Query: 355 YSSKQVLLRYVNIALLCVQESADDRPTMNDV 385
             S++V      +    ++     R T+ + 
Sbjct: 243 EVSEEV----KMLIRNLLKTEPTQRMTITEF 269

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (336), Expect = 5e-36
 Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 16/230 (6%)

Query: 92  ERSKKKEVDQLPLFSFSSVSTAT-NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSG 149
           E   K + D L  +   S +TA  + F     LG G FG V     ++ G+  A+K L  
Sbjct: 17  EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76

Query: 150 R---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT 206
           +     + +    NE  ++  V    LV+L     D     ++ EY+    +   L    
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--- 133

Query: 207 KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 266
           +               I     YLH      +I+RDLK  N+L+D+    +++DFG A+ 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190

Query: 267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
             G      T  + GT   ++PE  L   ++   D ++ GVL+ E+ +G 
Sbjct: 191 VKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 5e-35
 Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 23/212 (10%)

Query: 115 NTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRL--SGRSEQGLREMKNEASVIAKVQHK 171
             + D   +G G +G V   V  + G ++A+K+L    +SE   +    E  ++  ++H+
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 172 NLVRLLGCCIDKD------EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
           N++ LL      +      +  L+  +M             K   L       ++  + +
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 285
           GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR     +  +  +  V T  Y
Sbjct: 133 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184

Query: 286 MSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 316
            +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 5e-32
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 27/225 (12%)

Query: 107 FSSVSTATNTFSDTNK------LGEGGFGPVYKGVLRK-GDEIAVKRLS--GRSEQGLRE 157
           F SV    +TF+   +      +G G  G V           +A+K+LS   +++   + 
Sbjct: 3   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62

Query: 158 MKNEASVIAKVQHKNLVRLLGCCIDKD------EKILIYEYMPNKSLDFFLFDPTKRILL 211
              E  ++  V HKN++ LL     +       +  L+ E M          +       
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------ 116

Query: 212 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 271
           D      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + 
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173

Query: 272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           +    +  V T  Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 174 M---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 2e-31
 Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 18/207 (8%)

Query: 121 NKLGEGGFGPVYKGVLRK----GDEIAVKRLS----GRSEQGLREMKNEASVIAKVQHK- 171
             LG G +G V+          G   A+K L      +  +     + E  V+  ++   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 172 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLH 231
            LV L      + +  LI +Y+    L   L    +       T  ++   + + +L L 
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALE 143

Query: 232 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 291
              ++ II+RD+K  NILLD + +  ++DFG+++    +E +       GT  YM+P+  
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIV 202

Query: 292 LEGI--FSIKSDVFSFGVLLLEIVSGK 316
             G        D +S GVL+ E+++G 
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  118 bits (295), Expect = 2e-30
 Identities = 41/202 (20%), Positives = 91/202 (45%), Gaps = 21/202 (10%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLG 178
            KLG G +  V++ +     +++ VK L    ++   ++K E  ++  ++   N++ L  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLAD 97

Query: 179 CCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
              D   +   L++E++ N            + L D+  R   +  I + L Y H    +
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIR-FYMYEILKALDYCHS---M 148

Query: 237 RIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-G 294
            I+HRD+K  N+++D +    ++ D+G+A      +     +  V +  +  PE  ++  
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQ 205

Query: 295 IFSIKSDVFSFGVLLLEIVSGK 316
           ++    D++S G +L  ++  K
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRK 227

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 4e-29
 Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 11/200 (5%)

Query: 121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLS--GRSEQGLREMKNEASVIAKVQHKNLVRLL 177
           + +G G +G V      K G  +AVK+LS   +S    +    E  ++  ++H+N++ LL
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 178 GCCIDKDEKILI-YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRV 236
                          Y+    +   L +  K   L       +I  I +GL Y+H     
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA--- 140

Query: 237 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 296
            IIHRDLK SN+ +++D   KI DFG+AR          T  +   +            +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 196

Query: 297 SIKSDVFSFGVLLLEIVSGK 316
           +   D++S G ++ E+++G+
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (277), Expect = 9e-28
 Identities = 44/212 (20%), Positives = 84/212 (39%), Gaps = 22/212 (10%)

Query: 122 KLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCC 180
           KLG G F  V+          +A+K +    +      ++E  ++ +V   +  +     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 181 IDKDEKILIY---------------EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQ 225
            +   K+L +               E +    L        + I L +V   QI + +  
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV--KQISKQLLL 136

Query: 226 GLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYG 284
           GL Y+H+  R  IIH D+K  N+L++  D    +    +A +        + +  + T  
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 285 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 316
           Y SPE  L   +   +D++S   L+ E+++G 
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 96.8 bits (240), Expect = 4e-24
 Identities = 37/202 (18%), Positives = 68/202 (33%), Gaps = 27/202 (13%)

Query: 121 NKLGEGGFGPVYKGVLRKGDEIAVK--RLSGRS--------EQGLREMKNEASVIAKVQH 170
             +GEG    V+     K  E  VK  ++   S        + G       A   A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 171 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYL 230
           + L +L G  + K      Y +  N  L   +       +       ++++ I + +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 231 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPE 289
           +      I+H DL   N+L+  +    I DF  +   G    +    R +     Y S  
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175

Query: 290 YALEGIFSIKSDVFSFGVLLLE 311
           Y        + D+ S    +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	436
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.77
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.31
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.89
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.36
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.88
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.77

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=408.78  Aligned_cols=267  Identities=27%  Similarity=0.436  Sum_probs=208.3

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      +...++|++.+.||+|+||+||+|+++  ..||||+++..  +....+.|.+|+.+|++++|||||++++++. ++..++
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l   80 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI   80 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence            344678999999999999999999875  35999998743  4556788999999999999999999999875 457899


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++|+|.+++....  ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus        81 v~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            999999999999986533  34899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCccchhhhcc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ............||+.|||||++.+   ..++.++|||||||++|||+||+.||......     ..+.........   
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-----~~~~~~~~~~~~---  227 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----DQIIFMVGRGYL---  227 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHHTSC---
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-----HHHHHHHhcCCC---
Confidence            4443334455689999999999974   35899999999999999999999998543211     111111111111   


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCC
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALH  397 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~  397 (436)
                        .+.....  ...++..+.+++.+||+.||++|||++|+++.|+.+.+.+|
T Consensus       228 --~p~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         228 --SPDLSKV--RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             --CCCGGGS--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             --CCcchhc--cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence              0111110  11145578999999999999999999999999999887655

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-55  Score=404.38  Aligned_cols=253  Identities=25%  Similarity=0.334  Sum_probs=204.1

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            356899999999999999999975 58999999997543 2334678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++|+|.+++...   ..+++..+..++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+|+......
T Consensus        84 y~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            99999999998643   34899999999999999999999998   9999999999999999999999999998765444


Q ss_pred             cccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      ........+||+.|||||++.+..+ +.++||||+||++|||+||+.||..........    .........        
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~----~~~~~~~~~--------  225 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY----SDWKEKKTY--------  225 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH----HHHHTTCTT--------
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH----HHHhcCCCC--------
Confidence            3344455689999999999988776 678999999999999999999996543222111    111111100        


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       ...  ....+..+.+++.+||+.||++|||++|+++
T Consensus       226 -~~~--~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 -LNP--WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -STT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             000  0113456788999999999999999999865

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=400.36  Aligned_cols=256  Identities=28%  Similarity=0.403  Sum_probs=200.3

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecC
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP  194 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  194 (436)
                      ++|++.+.||+|+||+||+|.+.+++.||||+++... ...+++.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5688889999999999999999888899999997643 234679999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCccc
Q 040532          195 NKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  274 (436)
Q Consensus       195 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  274 (436)
                      +|+|.+++....  ..+++..+..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++........ 
T Consensus        84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            999999986533  35889999999999999999999998   999999999999999999999999999876543322 


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCC-CCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN-TGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                      ......||+.|+|||++.+..++.++|||||||++|||+|++.| +...     .............+.       ..+.
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~~~~~i~~~~~~-------~~p~  225 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDISTGFRL-------YKPR  225 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHHHHHHHHHTCCC-------CCCT
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHhcCCC-------CCcc
Confidence            22334789999999999999999999999999999999996544 4321     111122222111110       0011


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                           .++..+.+++.+||+.||++|||++||++.|+++.+
T Consensus       226 -----~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         226 -----LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                 134568899999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=403.00  Aligned_cols=262  Identities=32%  Similarity=0.449  Sum_probs=210.5

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      +...++|++.+.||+|+||+||+|.++++..||||++.... ...+.+.+|+.++++++|||||++++++.+ +..++||
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            34557888999999999999999999888899999997643 234679999999999999999999998754 5679999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++... ....+++..+..++.|+++||+|||+++   |+||||||+||||++++.+||+|||+++.....
T Consensus        87 Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence            999999999887543 2345899999999999999999999988   999999999999999999999999999987644


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      ... ......||+.|+|||++.++.++.++|||||||++|||+||+.|+....    ......... .....      ..
T Consensus       163 ~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~----~~~~~~~~i-~~~~~------~~  230 (272)
T d1qpca_         163 EYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----TNPEVIQNL-ERGYR------MV  230 (272)
T ss_dssp             CEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHH-HTTCC------CC
T ss_pred             ccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC----CHHHHHHHH-HhcCC------CC
Confidence            322 2334578999999999999999999999999999999999766542211    111111111 11110      11


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      .+.     .++..+.+++.+||+.||++|||++||++.|++...+
T Consensus       231 ~p~-----~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         231 RPD-----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Ccc-----cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            111     1345688999999999999999999999999987643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-54  Score=404.68  Aligned_cols=264  Identities=28%  Similarity=0.416  Sum_probs=213.8

Q ss_pred             hhhhhccCCCCCcccCCCCceeEEEEEecC-CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          109 SVSTATNTFSDTNKLGEGGFGPVYKGVLRK-GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       109 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      .++...++|++.+.||+|+||+||+|.+++ |+.||||+++... ...+++.+|+.+|++++|||||+++++|.+.+..+
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            345556788999999999999999999764 8889999997543 33567999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|..++... ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++++||+|||+++..
T Consensus        90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence            999999999999998643 2345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ...... ......|++.|+|||++.+..++.++|||||||++|||++|+.|+....    +... +......+...    
T Consensus       166 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----~~~~-~~~~i~~~~~~----  235 (287)
T d1opja_         166 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQ-VYELLEKDYRM----  235 (287)
T ss_dssp             CSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHH-HHHHHHTTCCC----
T ss_pred             CCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----hHHH-HHHHHhcCCCC----
Confidence            543322 2233468899999999999999999999999999999999877652211    1111 12222222111    


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                        ..+.     ..+..+.+++.+||+.||++|||++||++.|+.+..
T Consensus       236 --~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         236 --ERPE-----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             --CCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             --CCCc-----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence              1111     134578999999999999999999999999988754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-54  Score=401.94  Aligned_cols=250  Identities=23%  Similarity=0.381  Sum_probs=206.5

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .++|+..+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            457999999999999999999965 4899999998755444457799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      |++|+|.+++.+    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++.......
T Consensus        99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            999999988753    24899999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          273 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                        .....+||+.|+|||++.+..++.++||||+||++|||+||+.||.....     ............. .    ....
T Consensus       172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~-~----~~~~  239 (293)
T d1yhwa1         172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGTP-E----LQNP  239 (293)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHHCSC-C----CSSG
T ss_pred             --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----HHHHHHHHhCCCC-C----CCCc
Confidence              23345799999999999999999999999999999999999999853221     1111222111110 0    0001


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                           ...+..+.+++.+||+.||++|||+.|+++
T Consensus       240 -----~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         240 -----EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -----GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 113457889999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.8e-54  Score=404.63  Aligned_cols=259  Identities=27%  Similarity=0.417  Sum_probs=200.3

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC-C---CEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK-G---DEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      .++|++.+.||+|+||+||+|.++. |   ..||||++... .....+.|.+|+.+|++++|||||+++|++.+.+..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            3567888999999999999999753 3   25899998754 55566789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      |||||++|+|.+++....  ..+++..+..++.|+++||+|||+++   |+||||||+||||+.++++||+|||+++...
T Consensus       105 v~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence            999999999999886533  34899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCccc---ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          269 GNELQA---NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       269 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ......   ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.....     ....... ..+....
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~~~~~~i-~~~~~~~  253 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----QDVINAI-EQDYRLP  253 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHH-HTTCCCC
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----HHHHHHH-HcCCCCC
Confidence            432221   1222457899999999999999999999999999999998 8999854321     1111111 1111000


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                            .+     ..++..+.+++.+||+.||++|||+.||++.|+++.+
T Consensus       254 ------~~-----~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         254 ------PP-----MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             ------CC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------CC-----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                  01     1144578899999999999999999999999998875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=392.27  Aligned_cols=255  Identities=27%  Similarity=0.401  Sum_probs=211.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      .++|++.++||+|+||+||+|++++++.||||+++.... ..+++.+|+.++++++||||++++|+|.+++..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            367899999999999999999998888999999976433 3468999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++|+|..++....  ..+++..+.+++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus        82 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          82 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             TTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             CCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            9999998875533  34889999999999999999999988   999999999999999999999999999876543322


Q ss_pred             cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCccc
Q 040532          274 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLE  352 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (436)
                       ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......     +..... ......      ..+
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----~~~~~i-~~~~~~------~~p  223 (258)
T d1k2pa_         157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHI-AQGLRL------YRP  223 (258)
T ss_dssp             -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHHH-HTTCCC------CCC
T ss_pred             -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----HHHHHH-HhCCCC------CCc
Confidence             2333578999999999999999999999999999999998 79898644321     111112 221110      011


Q ss_pred             cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          353 DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       353 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                      .     ..+..+.+++.+||+.||++|||++|+++.|.++
T Consensus       224 ~-----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         224 H-----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             T-----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             c-----cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            1     1345788999999999999999999999998754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-54  Score=397.91  Aligned_cols=245  Identities=25%  Similarity=0.342  Sum_probs=203.3

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||+|+++ +|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46889999999999999999976 48899999986431   223467889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            999999999998543   34899999999999999999999998   999999999999999999999999999765432


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....     ............        ..
T Consensus       160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~--------~~  222 (263)
T d2j4za1         160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVE--------FT  222 (263)
T ss_dssp             C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTTC--------CC
T ss_pred             c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCC--------CC
Confidence            2    234579999999999999999999999999999999999999985422     111112211111        11


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .+..     .+..+.+++.+||+.||++|||++|+++
T Consensus       223 ~p~~-----~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 FPDF-----VTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCcc-----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            1111     3456889999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-54  Score=401.21  Aligned_cols=251  Identities=25%  Similarity=0.393  Sum_probs=205.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      +.|++.+.||+|+||+||+|.+. +|+.||+|++........+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56889999999999999999975 48899999998766666778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++|+|..++.+.  ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+|+......  
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            999999987542  235899999999999999999999998   9999999999999999999999999997643211  


Q ss_pred             cccccccccCCccchhhhc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          274 ANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      .......||+.|+|||++.     +..|+.++|||||||++|||+||+.||......  .   ..........       
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~---~~~~i~~~~~-------  232 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--R---VLLKIAKSEP-------  232 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--G---HHHHHHHSCC-------
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--H---HHHHHHcCCC-------
Confidence            1223457999999999984     456899999999999999999999998543221  1   1122222111       


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      +...   .....+..+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         233 PTLA---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CCCS---SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCC---ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000   01114457889999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=396.21  Aligned_cols=260  Identities=25%  Similarity=0.388  Sum_probs=208.7

Q ss_pred             ccCCCCCc-ccCCCCceeEEEEEecC---CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          114 TNTFSDTN-KLGEGGFGPVYKGVLRK---GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       114 ~~~~~~~~-~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      .++|.+.+ +||+|+||+||+|.++.   +..||||+++.. .....+.|.+|+++|++++|||||+++|++.+ +..++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            34556666 49999999999998642   457999999754 45556789999999999999999999999864 56899


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ||||+++|+|.+++....  ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 vmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence            999999999999875433  35899999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCc-ccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          269 GNEL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       269 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      .... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||......  +.    ...........  
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~----~~~i~~~~~~~--  232 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EV----MAFIEQGKRME--  232 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HH----HHHHHTTCCCC--
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HH----HHHHHcCCCCC--
Confidence            5432 223334578999999999999999999999999999999998 89998643211  11    11222221111  


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                          .+.     .++..+.+++.+||+.||++|||+.+|++.|+....++
T Consensus       233 ----~p~-----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         233 ----CPP-----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             ----CCT-----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCC-----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                111     14457889999999999999999999999998766443

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=397.07  Aligned_cols=268  Identities=28%  Similarity=0.407  Sum_probs=209.7

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ...++|++.+.||+|+||+||+|.+++++.||||++.... ...+.|.+|+.++++++|||||++++++. ++..++|||
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~E   91 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE   91 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEE
Confidence            4456899999999999999999999888899999997543 33467999999999999999999999985 466899999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++|+|..++.... ...+++..++.++.|++.||+|||+++   |+||||||+||||++++++||+|||+++......
T Consensus        92 y~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          92 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             ecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            999999998885432 235899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                      . .......||+.|+|||.+.++.++.++|||||||++|||+||+.|+.....    ........ .....      ...
T Consensus       168 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----~~~~~~~i-~~~~~------~~~  235 (285)
T d1fmka3         168 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQV-ERGYR------MPC  235 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHH-HTTCC------CCC
T ss_pred             c-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----HHHHHHHH-HhcCC------CCC
Confidence            2 222334789999999999999999999999999999999997766533221    11111111 11110      001


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCCCCC
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPPKQP  402 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~  402 (436)
                      ..     .++.++.+++.+||+.||++||++++|++.|++.....+|+..|
T Consensus       236 ~~-----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p  281 (285)
T d1fmka3         236 PP-----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  281 (285)
T ss_dssp             CT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred             Cc-----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence            11     13457899999999999999999999999999988776655444

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=396.19  Aligned_cols=261  Identities=27%  Similarity=0.410  Sum_probs=201.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecCC-----CEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRKG-----DEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ...|+..+.||+|+||+||+|.++.+     ..||||++... ......+|.+|+.++++++|||||+++|++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            35678889999999999999997642     36999999754 4455567999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||++++++.+++....  ..+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus        86 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          86 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999988775432  34899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ...... .......||+.|+|||++.++.++.++|||||||++|||++|+.|+....    ...... ........    
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----~~~~~~-~~i~~~~~----  231 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVM-KAINDGFR----  231 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHH-HHHHTTCC----
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC----CHHHHH-HHHhccCC----
Confidence            543222 22333468999999999999999999999999999999999766653211    111111 11111111    


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                        +..+.     .++..+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus       232 --~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         232 --LPTPM-----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             --CCCCT-----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --CCCch-----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence              01111     1345688999999999999999999999999988753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-53  Score=403.80  Aligned_cols=260  Identities=27%  Similarity=0.378  Sum_probs=207.7

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC-C-----CEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK-G-----DEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  183 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  183 (436)
                      ...++|++.+.||+|+||+||+|++.. +     ..||+|.+... .......+.+|+.+|.++ +|||||++++++.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            345678999999999999999998653 2     26999998754 334456789999999998 899999999999999


Q ss_pred             CccEEEEeecCCCChhhhhcCCCc--------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccc
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPTK--------------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL  243 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Di  243 (436)
                      +..++|||||++|+|.+++.....                    ...+++..++.++.|+++||+|||+++   |+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence            999999999999999999865432                    235889999999999999999999998   999999


Q ss_pred             CCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 040532          244 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLY  322 (436)
Q Consensus       244 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~  322 (436)
                      ||+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987654443333344578999999999999999999999999999999998 89998643


Q ss_pred             CCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 040532          323 RTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLT  390 (436)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~  390 (436)
                      ....     .+...........      .+.     .++..+.+|+.+||+.||++|||++||++.|.
T Consensus       271 ~~~~-----~~~~~~~~~~~~~------~p~-----~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVDA-----NFYKLIQNGFKMD------QPF-----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSH-----HHHHHHHTTCCCC------CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHH-----HHHHHHhcCCCCC------CCC-----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            3221     1122222221110      111     13457899999999999999999999999985

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-53  Score=393.28  Aligned_cols=249  Identities=27%  Similarity=0.374  Sum_probs=199.0

Q ss_pred             cccCCCCceeEEEEEecC---CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeecCC
Q 040532          121 NKLGEGGFGPVYKGVLRK---GDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN  195 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  195 (436)
                      ++||+|+||+||+|.+++   ++.||||+++..  +....+.+.+|+.+|++++|||||+++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998653   467999999653  33445789999999999999999999999864 567899999999


Q ss_pred             CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc-cc
Q 040532          196 KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QA  274 (436)
Q Consensus       196 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~  274 (436)
                      |+|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            9999998643   34899999999999999999999988   99999999999999999999999999987654332 22


Q ss_pred             ccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcccc
Q 040532          275 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVLED  353 (436)
Q Consensus       275 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (436)
                      ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....     .+ +..........      ..+.
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----~~-~~~~i~~~~~~------~~p~  233 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SE-VTAMLEKGERM------GCPA  233 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH-HHHHHHTTCCC------CCCT
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----HH-HHHHHHcCCCC------CCCc
Confidence            3334578999999999999999999999999999999998 8999864321     11 11222222111      1111


Q ss_pred             ccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          354 EYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       354 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                           .++..+.+++.+||+.||++|||+++|++.|+...
T Consensus       234 -----~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         234 -----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             -----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -----ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence                 13457889999999999999999999999998754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=396.55  Aligned_cols=254  Identities=23%  Similarity=0.329  Sum_probs=194.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe--CCccEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILI  189 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  189 (436)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|++...  ++...+.+.+|+++|++++||||+++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            56899999999999999999975 4889999998754  44556778999999999999999999999875  4567899


Q ss_pred             EeecCCCChhhhhcCC-CccCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          190 YEYMPNKSLDFFLFDP-TKRILLDWVTRVQIIEGIAQGLLYLHQYS--RVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ||||++|+|.+++... ..+..+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999988542 22346899999999999999999999865  23599999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ......  ......||+.|||||++.+..++.++|||||||++|||+||+.||.....     .+..... ......   
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~~i-~~~~~~---  232 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKI-REGKFR---  232 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHH-HHTCCC---
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHHHH-HcCCCC---
Confidence            653321  22345799999999999999999999999999999999999999854321     1111221 111111   


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                         ..+..     .+.++.+++.+||+.||++|||++|+++
T Consensus       233 ---~~~~~-----~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 ---RIPYR-----YSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---CCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCcc-----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               11111     3456889999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=398.95  Aligned_cols=249  Identities=25%  Similarity=0.312  Sum_probs=201.8

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++...   .....+.+.+|+++|++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56999999999999999999975 5889999998643   1233467899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            999999999887543   34899999999999999999999998   999999999999999999999999999987654


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      .........+||+.|+|||++.+..++.++||||+||++|||+||+.||...+     ............        ..
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~--------~~  228 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EYLIFQKIIKLE--------YD  228 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHTTC--------CC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-----HHHHHHHHHcCC--------CC
Confidence            44444445689999999999999999999999999999999999999986422     111112211111        11


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .+..     .+..+.+++.+||+.||++|||++|+++
T Consensus       229 ~p~~-----~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         229 FPEK-----FFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             CCTT-----CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CCcc-----CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            1111     3456889999999999999999998754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-53  Score=403.46  Aligned_cols=266  Identities=24%  Similarity=0.324  Sum_probs=204.0

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ...++|++.+.||+|+||+||+|++. +|+.||+|+++.. .....+.+.+|+.+|++++|||||+++++|.+.+..++|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            34678999999999999999999975 5889999999754 344457789999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      |||+++|+|.+++.+.   ..+++..+..++.|++.||.|||+. +   |+||||||+|||+++++++||+|||+|+...
T Consensus        83 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            9999999999998643   3489999999999999999999974 6   9999999999999999999999999998653


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHH--H--------HHhh
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV--W--------DLWT  338 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--~--------~~~~  338 (436)
                      .    ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..........  .        ....
T Consensus       157 ~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         157 D----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             H----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             C----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence            2    122345899999999999999999999999999999999999999965332211000000  0        0000


Q ss_pred             cCCc-cee-ccC-Cc-------------cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          339 SNRT-LEL-IDD-PV-------------LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       339 ~~~~-~~~-~~~-~~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .... ... .+. +.             ..........+.++.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            0000 000 000 00             0000000112356889999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-52  Score=395.89  Aligned_cols=264  Identities=26%  Similarity=0.399  Sum_probs=212.3

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCID  182 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  182 (436)
                      ++...++|++.+.||+|+||+||+|+++      +++.||||++... .....+++.+|+.+|++++||||++++++|.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            4445778999999999999999999864      2568999999765 34446779999999999999999999999999


Q ss_pred             CCccEEEEeecCCCChhhhhcCC---------------------CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDP---------------------TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR  241 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~---------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~  241 (436)
                      .+..+++|||+++|+|.+++...                     .....+++..++.++.|++.||+|||+++   ++||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence            99999999999999999988532                     12335889999999999999999999998   9999


Q ss_pred             ccCCCCEEEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCC-CCCC
Q 040532          242 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTG  320 (436)
Q Consensus       242 Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~-~p~~  320 (436)
                      ||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998765444333444557889999999999999999999999999999999996 5664


Q ss_pred             CCCCCCcchhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          321 LYRTDSLNLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                      ....     .+..... .......      .+.     .++.++.+++.+||+.+|++||||.||++.|+++.
T Consensus       245 ~~~~-----~e~~~~v-~~~~~~~------~p~-----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAH-----EEVIYYV-RDGNILA------CPE-----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCH-----HHHHHHH-HTTCCCC------CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCH-----HHHHHHH-HcCCCCC------CCc-----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            3221     1111221 2221111      111     13457899999999999999999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-52  Score=396.16  Aligned_cols=253  Identities=22%  Similarity=0.300  Sum_probs=190.7

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC-hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS-EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ...+.|++.+.||+|+||+||+|+++ +|+.||||++.... ......+.+|+.+|++++||||+++++++.+++..|+|
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            34577999999999999999999976 48899999997543 22345678999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc---CCCCeEEeeccCcee
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARI  266 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~---~~~~~kl~DfGla~~  266 (436)
                      ||||++|+|.+++...   ..+++.....++.|++.||+|||+++   |+||||||+|||++   +++.+||+|||+++.
T Consensus        86 mE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          86 MQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             ECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             EeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence            9999999999999653   34899999999999999999999998   99999999999995   578999999999986


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ......   ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.....     ..............   
T Consensus       160 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~i~~~~~~~---  228 (307)
T d1a06a_         160 EDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----AKLFEQILKAEYEF---  228 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHTTCCCC---
T ss_pred             ccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHhccCCCC---
Confidence            543322   2335799999999999999999999999999999999999999854221     11112221111100   


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..+..      ...+..+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~------~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 DSPYW------DDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CTTTT------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCccc------cCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            00100      113457889999999999999999999987

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.7e-52  Score=397.90  Aligned_cols=253  Identities=22%  Similarity=0.308  Sum_probs=209.0

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      -++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999975 5889999999887777778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc--CCCCeEEeeccCceecCCC
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNPKISDFGMARICGGN  270 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~--~~~~~kl~DfGla~~~~~~  270 (436)
                      |++|+|.+++....  ..+++..+..++.||+.||+|||+++   |+||||||+|||++  .++.+||+|||+++.....
T Consensus       105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999999885433  34899999999999999999999998   99999999999996  4678999999999876543


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      ..   .....||+.|||||++.+..++.++|||||||++|||++|+.||.....     .+............   ....
T Consensus       180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~---~~~~  248 (350)
T d1koaa2         180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRNVKSCDWNM---DDSA  248 (350)
T ss_dssp             SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCCS---CCGG
T ss_pred             cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCC---Cccc
Confidence            32   2335799999999999999999999999999999999999999854321     11222221111100   0000


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                            ....+..+.+++.+||+.||++|||++|+++.
T Consensus       249 ------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         249 ------FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  01134578899999999999999999999873

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=382.89  Aligned_cols=247  Identities=26%  Similarity=0.402  Sum_probs=195.5

Q ss_pred             CCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe----CCccEEE
Q 040532          117 FSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILI  189 (436)
Q Consensus       117 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv  189 (436)
                      |+..+.||+|+||+||+|.+. ++..||+|++...  .....+.+.+|+++|++++|||||++++++.+    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            356678999999999999976 4789999998643  44556789999999999999999999999875    3456899


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc-CCCCeEEeeccCceecC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICG  268 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~-~~~~~kl~DfGla~~~~  268 (436)
                      |||+++|+|.+++...   ..+++..+..++.|+++||+|||+++ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999998543   35899999999999999999999875 3599999999999997 57899999999997643


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccC
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDD  348 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (436)
                      ..    .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.....    ... ..........     .
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~-~~~~i~~~~~-----~  231 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQ-IYRRVTSGVK-----P  231 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHH-HHHHHTTTCC-----C
T ss_pred             CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----HHH-HHHHHHcCCC-----C
Confidence            22    2234589999999998865 699999999999999999999999853221    111 1111111111     1


Q ss_pred             CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          349 PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       349 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ......     .+.++.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~-----~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 ASFDKV-----AIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GGGGGC-----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCcc-----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            111111     2346889999999999999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=386.99  Aligned_cols=265  Identities=26%  Similarity=0.355  Sum_probs=203.0

Q ss_pred             hhhccCCCCCcccCCCCceeEEEEEecC------CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEe
Q 040532          111 STATNTFSDTNKLGEGGFGPVYKGVLRK------GDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCID  182 (436)
Q Consensus       111 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  182 (436)
                      +...++|++.+.||+|+||+||+|.+..      ++.||||+++.. .....+.+.+|...+.++ +|+||+.+++++.+
T Consensus         9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1           9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            3445779999999999999999998642      467999999754 444566788888888887 68999999999876


Q ss_pred             CC-ccEEEEeecCCCChhhhhcCCCc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCE
Q 040532          183 KD-EKILIYEYMPNKSLDFFLFDPTK-------------RILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  248 (436)
Q Consensus       183 ~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NI  248 (436)
                      .+ ..++|||||++|+|.+++.....             ...+++..+..++.|+++||+|||+++   |+||||||+||
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NI  165 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI  165 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccce
Confidence            54 67999999999999999854321             335889999999999999999999998   99999999999


Q ss_pred             EEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCCCc
Q 040532          249 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSL  327 (436)
Q Consensus       249 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~-~p~~~~~~~~~  327 (436)
                      |+++++++||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. .||......  
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--  243 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--  243 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--
Confidence            99999999999999998766544444445568999999999999999999999999999999999975 566433221  


Q ss_pred             chhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          328 NLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                         ..+...........      .+..     .+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       244 ---~~~~~~~~~~~~~~------~~~~-----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         244 ---EEFCRRLKEGTRMR------APDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             ---HHHHHHHHHTCCCC------CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHhcCCCCC------CCcc-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence               11222222221111      1111     34568899999999999999999999999998764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.4e-52  Score=391.16  Aligned_cols=245  Identities=29%  Similarity=0.467  Sum_probs=200.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ..|+..+.||+|+||+||+|++. +|+.||||++....   ....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45888999999999999999965 48889999987543   334567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      |||++|+|..++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..... 
T Consensus        95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            999999997766432   35899999999999999999999998   99999999999999999999999999976432 


Q ss_pred             CcccccccccccCCccchhhhcc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                           .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||....     .............      
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-----~~~~~~~i~~~~~------  231 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNES------  231 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCC------
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCC------
Confidence                 233579999999999864   458999999999999999999999985322     1111222221111      


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       +....    ...+..+.+++.+||+.||++|||++|+++
T Consensus       232 -~~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         232 -PALQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -CCCSC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -CCCCC----CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence             01111    113457889999999999999999999976

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.9e-51  Score=393.66  Aligned_cols=253  Identities=23%  Similarity=0.304  Sum_probs=208.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ..+.|++.+.||+|+||+||+|.+. +|+.||||++..........+.+|+.+|++++||||+++++++.+++..|+|||
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            3467999999999999999999975 589999999987766666788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc--CCCCeEEeeccCceecCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNPKISDFGMARICGG  269 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~--~~~~~kl~DfGla~~~~~  269 (436)
                      ||++|+|.+++...  ...+++.....++.||+.||+|||+++   |+||||||+|||++  +++.+||+|||++.....
T Consensus       107 ~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         107 FLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             cCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence            99999998877543  234899999999999999999999998   99999999999998  678999999999988754


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ...   .....||+.|+|||++.+..++.++||||+||++|||+||+.||.....     .............   ....
T Consensus       182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~~---~~~~  250 (352)
T d1koba_         182 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQNVKRCDWE---FDED  250 (352)
T ss_dssp             TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHHCCCC---CCSS
T ss_pred             CCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC---CCcc
Confidence            332   2334789999999999999999999999999999999999999854321     1111222111110   0000


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..      ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       251 ~~------~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         251 AF------SSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cc------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00      113457889999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=383.84  Aligned_cols=260  Identities=22%  Similarity=0.324  Sum_probs=199.0

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC----CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK----GDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      ...++|++.+.||+|+||+||+|.+..    +..||||.+... .....+.+.+|+.+|++++||||+++++++. .+..
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            345678999999999999999998653    346899998754 4445677999999999999999999999985 5678


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||+++|+|..++....  ..+++..+..++.|+++||+|||+++   ++||||||+||++++++.+||+|||+++.
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence            99999999999998875432  35899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCccee
Q 040532          267 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL  345 (436)
Q Consensus       267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (436)
                      ....... ......||+.|+|||.+.+..++.++|||||||++|||+| |..||......  ...   ... ....... 
T Consensus       158 ~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~---~~i-~~~~~~~-  229 (273)
T d1mp8a_         158 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVI---GRI-ENGERLP-  229 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH---HHH-HTTCCCC-
T ss_pred             ccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHH---HHH-HcCCCCC-
Confidence            6543322 2334578999999999999999999999999999999998 88888543321  121   111 1111111 


Q ss_pred             ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          346 IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                           .+.     .++..+.+++.+||+.||++|||+.||++.|+++..+
T Consensus       230 -----~~~-----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         230 -----MPP-----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -----CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCC-----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                 111     1445789999999999999999999999999887643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-51  Score=384.56  Aligned_cols=252  Identities=25%  Similarity=0.306  Sum_probs=204.7

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC------hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS------EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  185 (436)
                      ..++|++.+.||+|+||+||+|+++ +|+.||||++....      ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3567999999999999999999975 58999999986431      2235789999999999999999999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC----CeEEeec
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDF  261 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~----~~kl~Df  261 (436)
                      .|+|||||++|+|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+|++||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence            99999999999999998543   35899999999999999999999998   99999999999998776    4999999


Q ss_pred             cCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          262 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      |++........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+..........
T Consensus       162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~i~~~~~  233 (293)
T d1jksa_         162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANVSAVNY  233 (293)
T ss_dssp             TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHTTCC
T ss_pred             hhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcCC
Confidence            99987654322   2334789999999999999999999999999999999999999854221     111111111110


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                              ..... .....+..+.+++.+||+.||++|||++|+++
T Consensus       234 --------~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 --------EFEDE-YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             --------CCCHH-HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------CCCch-hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    00000 00113456889999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=389.73  Aligned_cols=257  Identities=28%  Similarity=0.441  Sum_probs=202.6

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CC----EEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GD----EIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL  188 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  188 (436)
                      .+|++.+.||+|+||+||+|.+.. |+    +||+|++... +....+.+.+|+.++++++|||||+++++|.+ +..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence            458999999999999999998753 43    5899998754 34456789999999999999999999999976 46678


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecC
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  268 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~  268 (436)
                      ++||+.+|+|.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            89999999998877543  345899999999999999999999998   9999999999999999999999999998876


Q ss_pred             CCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceecc
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELID  347 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (436)
                      ............||+.|+|||++.++.++.++|||||||++|||+| |+.||......  .+...    ...+...    
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~----i~~~~~~----  232 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI----LEKGERL----  232 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHH----HHHTCCC----
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCCCC----
Confidence            5444444444578999999999999999999999999999999999 78887543321  12111    1111110    


Q ss_pred             CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          348 DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       348 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                        ..+.     .++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       233 --~~p~-----~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         233 --PQPP-----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             --CCCT-----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCc-----ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence              0111     134578899999999999999999999999988764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=380.38  Aligned_cols=252  Identities=27%  Similarity=0.393  Sum_probs=198.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-CccEEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-DEKILIYE  191 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  191 (436)
                      .-++|++.+.||+|+||.||+|.++ |..||||+++...  ..+.+.+|++++++++||||++++|+|.+. +..++|||
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            3456788899999999999999986 8899999997543  346799999999999999999999998654 56799999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+++|+|.+++... ....+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++..... 
T Consensus        82 y~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          82 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             CCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             ccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-
Confidence            99999999998542 2234899999999999999999999988   999999999999999999999999999864322 


Q ss_pred             cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                          .....+|..|+|||++.++.++.++|||||||++|||+| |+.||.....  .+....   . ......      .
T Consensus       157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~---i-~~~~~~------~  220 (262)
T d1byga_         157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPR---V-EKGYKM------D  220 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHH---H-TTTCCC------C
T ss_pred             ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHH---H-HcCCCC------C
Confidence                223467899999999999999999999999999999998 6777654321  122211   1 111111      1


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcc
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEA  393 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~  393 (436)
                      .+..     .+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       221 ~~~~-----~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         221 APDG-----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcc-----CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1111     3457889999999999999999999999998764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=376.97  Aligned_cols=257  Identities=26%  Similarity=0.339  Sum_probs=197.5

Q ss_pred             ccCCCCCcccCCCCceeEEEEEecC--C--CEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCcc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLRK--G--DEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK  186 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  186 (436)
                      .++|++.+.||+|+||+||+|.++.  +  ..||||++...   .....++|.+|+.+|++++||||++++|++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            3568999999999999999998643  2  36899998753   33446789999999999999999999999965 567


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      ++||||+++|++.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence            8999999999998877543  234899999999999999999999988   99999999999999999999999999998


Q ss_pred             cCCCCcc-cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          267 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       267 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ....... .......|+..|+|||.+.+..++.++|||||||++|||+| |+.||....     ..+.............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-----~~~~~~~i~~~~~~~~  235 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GSQILHKIDKEGERLP  235 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTSCCCCC
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-----HHHHHHHHHhCCCCCC
Confidence            7554332 22334467889999999999999999999999999999998 899985332     1222222222221111


Q ss_pred             eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhc
Q 040532          345 LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNE  392 (436)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~  392 (436)
                            ...     ..+..+.+++.+||+.||++|||+.||.+.|++.
T Consensus       236 ------~~~-----~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 ------RPE-----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ------CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------Ccc-----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  011     1345688999999999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=382.57  Aligned_cols=263  Identities=28%  Similarity=0.389  Sum_probs=210.3

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEecC--------CCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEE
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLRK--------GDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCI  181 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  181 (436)
                      ...++|++.+.||+|+||.||+|+...        +..||||+++.. ......++.+|...+.++ +|||||+++++|.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            445788899999999999999998643        246999999765 345567889999999888 8999999999999


Q ss_pred             eCCccEEEEeecCCCChhhhhcCCC-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCE
Q 040532          182 DKDEKILIYEYMPNKSLDFFLFDPT-------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  248 (436)
Q Consensus       182 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NI  248 (436)
                      +++..++||||+++|+|.+++....             ....+++..++.++.|++.||+|||+.+   |+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence            9999999999999999999986432             1245899999999999999999999998   99999999999


Q ss_pred             EEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCCc
Q 040532          249 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSL  327 (436)
Q Consensus       249 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  327 (436)
                      |++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |..||.....   
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---  243 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  243 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence            999999999999999987765444444555678999999999999999999999999999999998 6778753221   


Q ss_pred             chhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          328 NLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                         ..+......+....      .+..     .+..+.+++.+||+.||++|||+.||++.|+++++
T Consensus       244 ---~~~~~~i~~~~~~~------~p~~-----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 ---EELFKLLKEGHRMD------KPSN-----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ---HHHHHHHHTTCCCC------CCSS-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHcCCCCC------CCcc-----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence               11222222222111      1111     34568999999999999999999999999998864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=381.94  Aligned_cols=265  Identities=25%  Similarity=0.354  Sum_probs=213.7

Q ss_pred             hhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeC
Q 040532          112 TATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK  183 (436)
Q Consensus       112 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  183 (436)
                      ...++|++.+.||+|+||.||+|++.      .++.||||+++.. .......+.+|+.++.++ +|||||+++++|.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            44578888999999999999999853      3568999999764 445566789999999999 699999999999999


Q ss_pred             CccEEEEeecCCCChhhhhcCCC---------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCE
Q 040532          184 DEKILIYEYMPNKSLDFFLFDPT---------------KRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  248 (436)
Q Consensus       184 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NI  248 (436)
                      +..++|||||++|+|.+++....               ....+++..+..++.|+++||+|||+++   ++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence            99999999999999999985432               2335889999999999999999999998   99999999999


Q ss_pred             EEcCCCCeEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCC-CCCCCCCCc
Q 040532          249 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN-TGLYRTDSL  327 (436)
Q Consensus       249 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p-~~~~~~~~~  327 (436)
                      +++.++.+|++|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|++.| +.... ...
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~-~~~  255 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-VDS  255 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-SSH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC-HHH
Confidence            9999999999999999987655444444556899999999999999999999999999999999995544 43222 111


Q ss_pred             chhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          328 NLLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      .    +......+..      +..+.     ..+..+.+|+.+||+.||++|||++||+++|++...+
T Consensus       256 ~----~~~~i~~~~~------~~~~~-----~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         256 K----FYKMIKEGFR------MLSPE-----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             H----HHHHHHHTCC------CCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H----HHHHHhcCCC------CCCcc-----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            1    1222221111      11111     1345689999999999999999999999999987654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.7e-50  Score=377.92  Aligned_cols=261  Identities=21%  Similarity=0.290  Sum_probs=203.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCc---
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE---  185 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  185 (436)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||+++..   +....+.+.+|+.++++++||||+++++++...+.   
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            3567999999999999999999965 5889999999754   34445679999999999999999999999987543   


Q ss_pred             -cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          186 -KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       186 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                       .|+||||+++++|..++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++..+++|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence             68999999999999887543   34899999999999999999999998   999999999999999999999999998


Q ss_pred             eecCCCC-cccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc
Q 040532          265 RICGGNE-LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL  343 (436)
Q Consensus       265 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  343 (436)
                      ....... ........+||+.|+|||++.+..++.++|||||||++|||+||+.||....     ...............
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~~~~~~~~~  233 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSVAYQHVREDPIP  233 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHCCCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-----HHHHHHHHHhcCCCC
Confidence            7654332 2223344579999999999999999999999999999999999999985422     122222332222111


Q ss_pred             eeccCCccccccchHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhhcc
Q 040532          344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRP-TMNDVVSMLTNEA  393 (436)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~ev~~~L~~~~  393 (436)
                      ....         ....+..+.+++.+||+.||++|| |++++++.|..+.
T Consensus       234 ~~~~---------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         234 PSAR---------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             GGGT---------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             Cchh---------ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            1000         011345788999999999999999 8999999987653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-50  Score=384.81  Aligned_cols=244  Identities=25%  Similarity=0.311  Sum_probs=202.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...   .....+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46889999999999999999975 4899999998643   1233567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|..++....   .+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999988885433   3788888999999999999999998   999999999999999999999999999876532


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                           ....+||+.|+|||++.+..|+.++||||+||++|||+||+.||...+     .............        .
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~~~--------~  219 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNAEL--------R  219 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHCCC--------C
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-----HHHHHHHHHcCCC--------C
Confidence                 233589999999999999999999999999999999999999985422     1111222222110        1


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                      .+..     .+..+.+++.+||+.||.+||     |++++++
T Consensus       220 ~p~~-----~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         220 FPPF-----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CCTT-----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCC-----CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            1111     335688999999999999996     8999876

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-51  Score=385.53  Aligned_cols=270  Identities=24%  Similarity=0.326  Sum_probs=202.9

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC----ccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----EKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  190 (436)
                      .+|...+.||+|+||+||+|+++ |+.||||++...... ......|+..+.+++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            45677789999999999999975 899999999644322 122234555556789999999999998754    468999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY-----SRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      ||+++|+|.+++...    .+++..++.++.|++.||+|||+.     +.++|+||||||+||||++++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            999999999999642    489999999999999999999974     23459999999999999999999999999998


Q ss_pred             ecCCCCc--ccccccccccCCccchhhhccCC------CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcc---------
Q 040532          266 ICGGNEL--QANTSRIVGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN---------  328 (436)
Q Consensus       266 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~---------  328 (436)
                      .......  ........||+.|+|||++.+..      ++.++|||||||++|||+||..|++........         
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            7654322  22334468999999999987643      677999999999999999999887543322111         


Q ss_pred             hhHHHHHHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhcccc
Q 040532          329 LLGYVWDLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAA  395 (436)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~  395 (436)
                      ..............     .+..+........+..+.+++.+||+.||++|||+.||++.|+++...
T Consensus       237 ~~~~~~~~~~~~~~-----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         237 SVEEMRKVVCEQKL-----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHTTSCC-----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccc-----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            11111221111111     122223333334667799999999999999999999999999988754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=377.29  Aligned_cols=258  Identities=26%  Similarity=0.394  Sum_probs=205.4

Q ss_pred             CcccCCCCceeEEEEEecCC----CEEEEEEcCC-CChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-CccEEEEeec
Q 040532          120 TNKLGEGGFGPVYKGVLRKG----DEIAVKRLSG-RSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-DEKILIYEYM  193 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~  193 (436)
                      .++||+|+||+||+|.+.++    ..||||+++. .+....++|.+|+++|++++||||++++|++.+. +..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999997542    2589999975 3566678899999999999999999999998764 5789999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      ++|+|.+++....  ...++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            9999999886543  34778889999999999999999998   999999999999999999999999999876543322


Q ss_pred             --cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCcc
Q 040532          274 --ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPVL  351 (436)
Q Consensus       274 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (436)
                        .......||+.|+|||.+.++.++.++||||||+++|||+||+.||..... ..+....+   ....+.       ..
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~~~~i---~~g~~~-------~~  255 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYL---LQGRRL-------LQ  255 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH---HTTCCC-------CC
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHHHHHH---HcCCCC-------CC
Confidence              223335789999999999999999999999999999999998888643221 11222111   111111       01


Q ss_pred             ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCC
Q 040532          352 EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHP  398 (436)
Q Consensus       352 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~  398 (436)
                      +.     .++..+.+++.+||+.||++||++.||++.|+++......
T Consensus       256 p~-----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         256 PE-----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             CT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             cc-----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence            11     1345688999999999999999999999999999875443

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=381.99  Aligned_cols=265  Identities=28%  Similarity=0.396  Sum_probs=214.8

Q ss_pred             hhhhccCCCCCcccCCCCceeEEEEEec------CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe
Q 040532          110 VSTATNTFSDTNKLGEGGFGPVYKGVLR------KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCID  182 (436)
Q Consensus       110 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  182 (436)
                      ++...++|++.+.||+|+||+||+|.++      ++..||||+++.. .......+.+|+.++++++||||+++++++..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            4445678889999999999999999864      2568999999754 44555678999999999999999999999999


Q ss_pred             CCccEEEEeecCCCChhhhhcCC-------CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCC
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDP-------TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  255 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~  255 (436)
                      .+..++||||+++|+|.+++...       .....+++..+..++.|+++||.|||+++   |+||||||+|||++++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence            99999999999999999987532       22235789999999999999999999988   999999999999999999


Q ss_pred             eEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCCCcchhHHHH
Q 040532          256 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLLGYVW  334 (436)
Q Consensus       256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~  334 (436)
                      +||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. .||...     .......
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~~  246 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLR  246 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CHHHHHH
Confidence            9999999998765444444444557899999999999999999999999999999999985 565432     2222222


Q ss_pred             HHhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccc
Q 040532          335 DLWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAA  394 (436)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~  394 (436)
                      ... ......      .+.     .++..+.+++.+||+.+|++|||+++|++.|++..+
T Consensus       247 ~i~-~~~~~~------~p~-----~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 FVM-EGGLLD------KPD-----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHH-TTCCCC------CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH-hCCCCC------Ccc-----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            221 211111      011     134579999999999999999999999999988754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=387.13  Aligned_cols=247  Identities=21%  Similarity=0.265  Sum_probs=203.4

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|++...   .....+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            56899999999999999999975 5899999998643   2233567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+++|+|..++...   ..+++..+..++.|++.||+|||+++   |+||||||+|||++++|.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            999999999988543   34889999999999999999999998   999999999999999999999999999865432


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      ..  .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+.     ......... ..       ..
T Consensus       159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~~~i~~-~~-------~~  223 (337)
T d1o6la_         159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILM-EE-------IR  223 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH-CC-------CC
T ss_pred             Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHHHHHHhc-CC-------CC
Confidence            21  23345899999999999999999999999999999999999999864321     111111111 11       11


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPT-----MNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~  387 (436)
                      .+..     .+..+.+|+.+||+.||++||+     ++|+++
T Consensus       224 ~p~~-----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 FPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCTT-----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCcc-----CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1111     3456889999999999999995     777775

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=376.76  Aligned_cols=251  Identities=19%  Similarity=0.286  Sum_probs=204.5

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      .++|++.+.||+|+||+||+|.+. +|+.||+|.++..... ...+.+|+.+|++++||||+++++++.+.+..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467999999999999999999976 4888999999865433 35688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC--CCCeEEeeccCceecCCC
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNPKISDFGMARICGGN  270 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~--~~~~kl~DfGla~~~~~~  270 (436)
                      |++|+|.+++....  ..+++.....++.||+.||+|||+++   |+||||||+|||++.  ...+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            99999999986432  34899999999999999999999998   999999999999985  458999999999876543


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                      ..   .....+|+.|+|||.+.+..++.++||||+||++|||++|+.||.....     .+...........        
T Consensus       158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----~~~~~~i~~~~~~--------  221 (321)
T d1tkia_         158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIENIMNAEYT--------  221 (321)
T ss_dssp             CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTCCC--------
T ss_pred             Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC--------
Confidence            32   2234789999999999999999999999999999999999999854321     1112222111110        


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .... .....+..+.+++.+||+.||++|||+.|+++
T Consensus       222 ~~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         222 FDEE-AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CCHH-HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CChh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000 00113456889999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=381.44  Aligned_cols=259  Identities=27%  Similarity=0.361  Sum_probs=205.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEecC-CC--EEEEEEcCCC-ChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEeCCccEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRK-GD--EIAVKRLSGR-SEQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ++|++.+.||+|+||+||+|++++ |.  .||||++... .....+.+.+|+++|.++ +||||++++++|.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678888999999999999999764 33  4788988644 344567899999999998 799999999999999999999


Q ss_pred             EeecCCCChhhhhcCC-------------CccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCe
Q 040532          190 YEYMPNKSLDFFLFDP-------------TKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  256 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~  256 (436)
                      |||+++|+|.+++...             .....+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998653             23456899999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCC-CCCCCCCCCcchhHHHHH
Q 040532          257 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK-NTGLYRTDSLNLLGYVWD  335 (436)
Q Consensus       257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~-p~~~~~~~~~~~~~~~~~  335 (436)
                      ||+|||+++......   ......||..|+|||.+.++.++.++|||||||++|||++|.. ||....     ..+....
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----~~~~~~~  238 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEK  238 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHH
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Confidence            999999997643221   2223468999999999999999999999999999999999765 553221     1111111


Q ss_pred             HhhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          336 LWTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                       ......      +..+.     ..+..+.+++.+||+.||++||||+||++.|+++....
T Consensus       239 -i~~~~~------~~~~~-----~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         239 -LPQGYR------LEKPL-----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             -GGGTCC------CCCCT-----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             -HHhcCC------CCCCc-----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence             111111      11111     13457899999999999999999999999999988643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-49  Score=383.21  Aligned_cols=244  Identities=22%  Similarity=0.277  Sum_probs=203.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC---ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR---SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  190 (436)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...   .....+.+.+|+.+|++++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999975 5899999998643   1233567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCC
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  270 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~  270 (436)
                      ||+.+|+|..++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999888543   34899999999999999999999998   999999999999999999999999999876532


Q ss_pred             CcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCCc
Q 040532          271 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDPV  350 (436)
Q Consensus       271 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (436)
                           .....||+.|||||++.+..++.++|||||||++|||+||+.||....     ............        ..
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~~--------~~  256 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIVSGK--------VR  256 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCC--------CC
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHHHHhcCC--------CC
Confidence                 233579999999999999999999999999999999999999985321     111222221111        01


Q ss_pred             cccccchHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 040532          351 LEDEYSSKQVLLRYVNIALLCVQESADDRP-----TMNDVVS  387 (436)
Q Consensus       351 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~ev~~  387 (436)
                      .+..     .+..+.+++.+||+.||.+|+     |++|+++
T Consensus       257 ~p~~-----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 FPSH-----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCTT-----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCcc-----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            1111     345688999999999999994     8999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.6e-49  Score=370.06  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=202.6

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---------hhhHHHHHHHHHHHHHcC-CCceeEEeeEEEe
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---------EQGLREMKNEASVIAKVQ-HKNLVRLLGCCID  182 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  182 (436)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++....         ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            367899999999999999999974 58899999986542         112346889999999997 9999999999999


Q ss_pred             CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                      ++..|+||||+++|+|.+++..   +..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999954   335899999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhcc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALE------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL  336 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  336 (436)
                      +++......   ......||+.|+|||.+.+      ..++.++||||+||++|||++|+.||.....     .......
T Consensus       156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-----~~~~~~i  227 (277)
T d1phka_         156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLRMI  227 (277)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH
T ss_pred             heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-----HHHHHHH
Confidence            998865432   2233579999999999973      3468899999999999999999999964321     1111111


Q ss_pred             hhcCCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          337 WTSNRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ......   ...+.      ....+.++.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~---~~~~~------~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 MSGNYQ---FGSPE------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHTCCC---CCTTT------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HhCCCC---CCCcc------cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111110   00111      1114567899999999999999999999865

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-49  Score=371.35  Aligned_cols=258  Identities=22%  Similarity=0.263  Sum_probs=193.7

Q ss_pred             CcccCCCCceeEEEEEec-CCCEEEEEEcCCCChh-----hHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEeec
Q 040532          120 TNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM  193 (436)
Q Consensus       120 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  193 (436)
                      ++.||+|+||+||+|.++ +|+.||||+++.....     ..+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            478999999999999975 4899999998654221     1246889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCcc
Q 040532          194 PNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  273 (436)
Q Consensus       194 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  273 (436)
                      +++++..+...   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        83 ~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          83 ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             SEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             cchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            99888766643   234788899999999999999999998   99999999999999999999999999976543322 


Q ss_pred             cccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec------
Q 040532          274 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI------  346 (436)
Q Consensus       274 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  346 (436)
                       .....+||+.|+|||++.+. .++.++|||||||++|||+||+.||.....  .+....+.............      
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~~l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--HHHHHHHHHhcCCCChhhccchhccc
Confidence             22334799999999998754 579999999999999999999999854321  11111122211111000000      


Q ss_pred             ---cCCccccc---cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          347 ---DDPVLEDE---YSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       347 ---~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                         ........   ......+..+.+|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence               00000000   000113457899999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.9e-49  Score=382.43  Aligned_cols=248  Identities=25%  Similarity=0.291  Sum_probs=196.0

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHH---HHHHHHHHcCCCceeEEeeEEEeCCccE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKI  187 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~  187 (436)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....   ......+.   +++.+++.++||||+++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57899999999999999999976 48999999985321   11122233   4466677778999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceec
Q 040532          188 LIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  267 (436)
Q Consensus       188 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~  267 (436)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+..
T Consensus        84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999998543   34789999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceec
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELI  346 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (436)
                      ....    .....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.......  ... +.......      
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~-~~~~~~~~------  224 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHE-IDRMTLTM------  224 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHH-HHHHSSSC------
T ss_pred             CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHHhcccC------
Confidence            5432    233479999999999975 568999999999999999999999996543222  111 11110000      


Q ss_pred             cCCccccccchHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 040532          347 DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT-----MNDVVS  387 (436)
Q Consensus       347 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~  387 (436)
                       ....+..     .+..+.+++.+||+.||++|||     ++|+++
T Consensus       225 -~~~~~~~-----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 -AVELPDS-----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -CCCCCSS-----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -CCCCCCC-----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence             0111111     3456889999999999999999     577764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-49  Score=375.04  Aligned_cols=250  Identities=18%  Similarity=0.226  Sum_probs=197.0

Q ss_pred             ccCCCCCc-ccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHc-CCCceeEEeeEEEe----CCcc
Q 040532          114 TNTFSDTN-KLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKV-QHKNLVRLLGCCID----KDEK  186 (436)
Q Consensus       114 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~  186 (436)
                      .++|.+.+ .||+|+||+||+|.+. +|+.||||+++..     ..+.+|+.++.++ +||||+++++++.+    +...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            45788775 5999999999999974 5899999999643     4567899887655 89999999999876    3567


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC---CCCeEEeeccC
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGM  263 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~---~~~~kl~DfGl  263 (436)
                      |+|||||+||+|.+++.... ...+++..+..++.|++.||+|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            99999999999999996532 245899999999999999999999998   999999999999985   56799999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL  343 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  343 (436)
                      ++.......   .....||+.|+|||++.+..|+.++|||||||++|||+||+.||.......  ....         ..
T Consensus       161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~---------~~  226 (335)
T d2ozaa1         161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPG---------MK  226 (335)
T ss_dssp             CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred             eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHH---------HH
Confidence            987654332   234579999999999999999999999999999999999999985432211  0000         00


Q ss_pred             eecc--CCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          344 ELID--DPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       344 ~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..+.  ....+. ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       227 ~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         227 TRIRMGQYEFPN-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -CCCSCSSSCCT-THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCCCCCCC-cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0110  011111 111235667899999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-50  Score=379.72  Aligned_cols=247  Identities=25%  Similarity=0.360  Sum_probs=199.6

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---hhhHHHHHHHHHHHH-HcCCCceeEEeeEEEeCCccEEE
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---EQGLREMKNEASVIA-KVQHKNLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  189 (436)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46889999999999999999976 48899999996431   223455667777665 68999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  269 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~  269 (436)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||+++   ++||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            9999999999998643   34889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcceeccCC
Q 040532          270 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLELIDDP  349 (436)
Q Consensus       270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (436)
                      ..  .......||+.|+|||++.+..++.++||||+||++|||+||+.||.....     ....... ...       .+
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i-~~~-------~~  220 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHSI-RMD-------NP  220 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH-HHC-------CC
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHH-HcC-------CC
Confidence            32  223345899999999999999999999999999999999999999954321     1111111 111       11


Q ss_pred             ccccccchHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 040532          350 VLEDEYSSKQVLLRYVNIALLCVQESADDRPTMN-DVVS  387 (436)
Q Consensus       350 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-ev~~  387 (436)
                      ..+..     .+..+.+|+.+||+.||++||++. |+++
T Consensus       221 ~~p~~-----~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 FYPRW-----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCCTT-----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCcc-----CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            11111     345688999999999999999995 6753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=367.64  Aligned_cols=270  Identities=21%  Similarity=0.315  Sum_probs=201.2

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC--hhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS--EQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...  +...+.+.+|+++|++++||||+++++++.+.+..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            47899999999999999999974 58999999996542  2235678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      |+.++.+.......  ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99876555444332  234899999999999999999999998   9999999999999999999999999998765332


Q ss_pred             cccccccccccCCccchhhhccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc-CCc--ceecc
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS-NRT--LELID  347 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~  347 (436)
                        .......||+.|+|||.+.... ++.++|+||+||++|+|++|+.||...+.  .+........... .+.  .....
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH--HHHHHHHHHhcCCCchhhcccccc
Confidence              2233347999999999887665 58899999999999999999999864321  1111111111000 000  00000


Q ss_pred             C-------Cccccc---cchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhcc
Q 040532          348 D-------PVLEDE---YSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEA  393 (436)
Q Consensus       348 ~-------~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~--L~~~~  393 (436)
                      .       +.....   ......+..+.+++.+||+.||++|||+.|+++.  ++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence            0       000000   0001134578899999999999999999999874  54443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.2e-48  Score=361.00  Aligned_cols=263  Identities=22%  Similarity=0.319  Sum_probs=200.1

Q ss_pred             cCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCCh--hhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEee
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY  192 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  192 (436)
                      ++|++.+.||+|+||+||+|++++|+.||||++.....  ...+.+.+|+.+|++++||||+++++++.+.+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57899999999999999999999899999999976432  2356789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCCc
Q 040532          193 MPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  272 (436)
Q Consensus       193 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  272 (436)
                      +.++++..+....   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+|++|||.+........
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9988877776433   34899999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCccee------
Q 040532          273 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLEL------  345 (436)
Q Consensus       273 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  345 (436)
                        ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.....  .+....+............      
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMRIFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH--HHHHHHHHHhhCCCChhhccchhhh
Confidence              22334689999999999764 569999999999999999999999854321  1111111111111000000      


Q ss_pred             ------c-cCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          346 ------I-DDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       346 ------~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                            . ..............+..+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0 00000000001113456889999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=362.16  Aligned_cols=240  Identities=23%  Similarity=0.348  Sum_probs=194.2

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCC---h---hhHHHHHHHHHHHHHcC--CCceeEEeeEEEeCC
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRS---E---QGLREMKNEASVIAKVQ--HKNLVRLLGCCIDKD  184 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~---~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~  184 (436)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++....   .   .....+.+|+.+|++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            467999999999999999999975 58999999986421   1   11234678999999996  899999999999999


Q ss_pred             ccEEEEeecCC-CChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-CCCeEEeecc
Q 040532          185 EKILIYEYMPN-KSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFG  262 (436)
Q Consensus       185 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-~~~~kl~DfG  262 (436)
                      ..++||||+.+ +++.+++..   +..+++..+..++.|++.||+|||+++   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999986 577777643   234899999999999999999999998   999999999999985 4799999999


Q ss_pred             CceecCCCCcccccccccccCCccchhhhccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC
Q 040532          263 MARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR  341 (436)
Q Consensus       263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  341 (436)
                      +++......    .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||....           ...... 
T Consensus       157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~i~~~~-  220 (273)
T d1xwsa_         157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EIIRGQ-  220 (273)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHCC-
T ss_pred             cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------HHhhcc-
Confidence            998754322    234579999999999987765 677999999999999999999985321           111111 


Q ss_pred             cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          342 TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                             ...+..     .+.++.+++.+||+.||++|||++|+++
T Consensus       221 -------~~~~~~-----~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 -------VFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -------CCCSSC-----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------cCCCCC-----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                   011111     3456889999999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=361.50  Aligned_cols=263  Identities=24%  Similarity=0.337  Sum_probs=195.0

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-C-CCEEEEEEcCCC--ChhhHHHHHHHHHHHHHc---CCCceeEEeeEEEe---
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-K-GDEIAVKRLSGR--SEQGLREMKNEASVIAKV---QHKNLVRLLGCCID---  182 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---  182 (436)
                      ..++|++.+.||+|+||+||+|++. + ++.||||++...  .......+.+|+.+|+.+   +||||++++++|..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            3578999999999999999999974 3 567999998532  222223456677776665   89999999999864   


Q ss_pred             --CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEee
Q 040532          183 --KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  260 (436)
Q Consensus       183 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~D  260 (436)
                        ....+++|||++++++.......  ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             ccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence              23568999999998876555432  334889999999999999999999998   99999999999999999999999


Q ss_pred             ccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcC
Q 040532          261 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSN  340 (436)
Q Consensus       261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  340 (436)
                      ||+++.....   .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.....  .+....+.......
T Consensus       160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~  234 (305)
T d1blxa_         160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLP  234 (305)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCC
T ss_pred             hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhhCCC
Confidence            9998764322   233445899999999999999999999999999999999999999964321  11111111111111


Q ss_pred             Cccee-------------ccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          341 RTLEL-------------IDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       341 ~~~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .....             ..........  ...+..+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFV--TDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTC--CSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhcccccccchhhhhccccccchhhcc--ccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000             0000000011  113456889999999999999999999876

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.3e-46  Score=350.68  Aligned_cols=264  Identities=21%  Similarity=0.270  Sum_probs=198.0

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCcee-EEeeEEEeCCccEEEEe
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYE  191 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e  191 (436)
                      +++|++.+.||+|+||+||+|++. +|+.||||++......  ..+..|++++++++|+|++ .+.+++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            467999999999999999999975 4889999998754322  4578899999999877654 55566677788899999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEc---CCCCeEEeeccCceecC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICG  268 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~---~~~~~kl~DfGla~~~~  268 (436)
                      |+++ ++...+...  ...+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+...
T Consensus        84 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLGP-SLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCCC-BHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcCC-chhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            9955 454444322  234899999999999999999999998   99999999999986   45579999999999765


Q ss_pred             CCCcc-----cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchh-HHHHHHhhcCCc
Q 040532          269 GNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL-GYVWDLWTSNRT  342 (436)
Q Consensus       269 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~  342 (436)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... ..........  
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--  235 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--  235 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--
Confidence            43221     223445799999999999999999999999999999999999999975443222111 0000000000  


Q ss_pred             ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccC
Q 040532          343 LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAAL  396 (436)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~  396 (436)
                            + .+.  ....++.++.+++..||+.+|++||+++++.+.|++.....
T Consensus       236 ------~-~~~--~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         236 ------P-IEV--LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ------C-HHH--HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ------C-hhH--hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                  0 000  00113457889999999999999999999999998876543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-45  Score=346.51  Aligned_cols=268  Identities=16%  Similarity=0.208  Sum_probs=209.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCC-CceeEEeeEEEeCCccEEEE
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDEKILIY  190 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  190 (436)
                      ..++|++.+.||+|+||+||+|++. +|+.||||++......  ..+.+|++.+..++| +|++.+++++.++...++||
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            3578999999999999999999975 4889999998654322  356789999999965 89999999999999999999


Q ss_pred             eecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcC-----CCCeEEeeccCce
Q 040532          191 EYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-----DMNPKISDFGMAR  265 (436)
Q Consensus       191 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~-----~~~~kl~DfGla~  265 (436)
                      ||+ +++|.+++....  ..++......++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+|+
T Consensus        81 e~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          81 DLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence            999 688888875433  34899999999999999999999998   999999999999974     5789999999998


Q ss_pred             ecCCCCcc-----cccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcc-hhHHHHHHhhc
Q 040532          266 ICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN-LLGYVWDLWTS  339 (436)
Q Consensus       266 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~  339 (436)
                      ........     .......||+.|||||++.+..++.++|||||||++|||+||+.||......... ....+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            76533211     1233457999999999999999999999999999999999999999654332211 11111111000


Q ss_pred             CCcceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhhccccCCCC
Q 040532          340 NRTLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSMLTNEAAALHPP  399 (436)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~~  399 (436)
                      ....+.           ...++.++.+++..|++.+|++||+++.+.+.|+++.......
T Consensus       235 ~~~~~l-----------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~  283 (293)
T d1csna_         235 TPLREL-----------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  283 (293)
T ss_dssp             SCHHHH-----------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CChHHh-----------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence            100000           0113456889999999999999999999999999887655443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=354.72  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=195.6

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC-----
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----  184 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  184 (436)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||+++..  +....+.+.+|+.+|++++|||||+++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3578999999999999999999975 4899999999753  4445678899999999999999999999998655     


Q ss_pred             -ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccC
Q 040532          185 -EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  263 (436)
Q Consensus       185 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGl  263 (436)
                       ..++||||+ +++|..+...    ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+|++|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence             469999999 5667666532    34899999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCC-
Q 040532          264 ARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNR-  341 (436)
Q Consensus       264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  341 (436)
                      ++.....     .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||......  .............. 
T Consensus       168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPPA  240 (346)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCH
T ss_pred             eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH--HHHHHHHhccCCCcH
Confidence            9875432     2335799999999998864 5689999999999999999999998643211  11100000000000 


Q ss_pred             ----------------cceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhhcc
Q 040532          342 ----------------TLELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM--LTNEA  393 (436)
Q Consensus       342 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~--L~~~~  393 (436)
                                      ..............  ...+..+.+|+.+||+.||++|||+.|+++.  ++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASIL--TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTC--TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhc--cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                            00000011111111  1134567899999999999999999999974  55544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=361.44  Aligned_cols=259  Identities=22%  Similarity=0.295  Sum_probs=192.7

Q ss_pred             CCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC------ccEE
Q 040532          116 TFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------EKIL  188 (436)
Q Consensus       116 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l  188 (436)
                      +|+..++||+|+||+||+|++. +|+.||||++.....    ...+|+.+|++++||||++++++|....      ..++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888899999999999999976 489999999976432    2357999999999999999999986532      3689


Q ss_pred             EEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC-CeEEeeccCceec
Q 040532          189 IYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARIC  267 (436)
Q Consensus       189 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~-~~kl~DfGla~~~  267 (436)
                      ||||++++++..+.........+++..+..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||++...
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999988765554432233445899999999999999999999988   99999999999999775 8999999999876


Q ss_pred             CCCCcccccccccccCCccchhhhcc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHH----------
Q 040532          268 GGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDL----------  336 (436)
Q Consensus       268 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----------  336 (436)
                      .....   .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......  +....+...          
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCCHHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--HHHHHHHHHhCCChHHhhh
Confidence            54332   223479999999998875 46899999999999999999999999643311  111111000          


Q ss_pred             -hhcCCcc---eeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          337 -WTSNRTL---ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       337 -~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       .......   .......... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhccccccccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000000   0000000000 001113456889999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=352.07  Aligned_cols=266  Identities=20%  Similarity=0.288  Sum_probs=195.9

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEe--------
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCID--------  182 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  182 (436)
                      -++|++.+.||+|+||+||+|++. +|+.||||++...  .......+.+|+.+|++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            368999999999999999999975 5899999998643  23334678899999999999999999999865        


Q ss_pred             CCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeecc
Q 040532          183 KDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  262 (436)
Q Consensus       183 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfG  262 (436)
                      .+..++||||++++++..+...   ...++......++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            3457899999998887765533   234788999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcc--cccccccccCCccchhhhccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhc
Q 040532          263 MARICGGNELQ--ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTS  339 (436)
Q Consensus       263 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  339 (436)
                      ++.........  ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||....  ..............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~--~~~~~~~i~~~~~~  240 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLCGS  240 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--HHHHHHHHHHhcCC
Confidence            99876543322  222335799999999999865 68999999999999999999999985422  11111112221111


Q ss_pred             C--Cccee---------ccCCcccccc-----chHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          340 N--RTLEL---------IDDPVLEDEY-----SSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       340 ~--~~~~~---------~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      .  .....         ..........     ........+.+|+.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            0  00000         0000000000     01112345678999999999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-45  Score=354.06  Aligned_cols=265  Identities=19%  Similarity=0.271  Sum_probs=197.5

Q ss_pred             hccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC-ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCC----cc
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR-SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----EK  186 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~  186 (436)
                      .+.+|++++.||+|+||+||+|.++ +|+.||||++... .....+.+.+|+.+|++++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            3467999999999999999999864 5899999999754 3445678899999999999999999999987654    23


Q ss_pred             EEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          187 ILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       187 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      +++++|+.+|+|.+++...    .+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++..
T Consensus        86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence            5666778899999998532    4899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccCCccchhhhc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcce
Q 040532          267 CGGNELQ-ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTLE  344 (436)
Q Consensus       267 ~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (436)
                      ....... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||......  +................
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGILGSPSQED  236 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH--HHHHHHhhhccCCChhh
Confidence            6543222 2234457999999999985 456789999999999999999999998543211  11111111100000000


Q ss_pred             -----------------eccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          345 -----------------LIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       345 -----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                                       ............  ..+..+.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFP--NADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCT--TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCC--CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                             000000000000  123468899999999999999999999863

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1e-44  Score=346.77  Aligned_cols=259  Identities=17%  Similarity=0.269  Sum_probs=196.1

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeC--CccEEE
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDK--DEKILI  189 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  189 (436)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++...   .+.+.+|+.+|++++ ||||+++++++...  ...++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            367999999999999999999975 58899999997544   356889999999995 99999999999854  467899


Q ss_pred             EeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCC-CeEEeeccCceecC
Q 040532          190 YEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICG  268 (436)
Q Consensus       190 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~-~~kl~DfGla~~~~  268 (436)
                      |||+++++|..+..      .+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            99999999977642      3889999999999999999999998   99999999999999655 68999999998765


Q ss_pred             CCCcccccccccccCCccchhhhccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHH--------HHHh--
Q 040532          269 GNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYV--------WDLW--  337 (436)
Q Consensus       269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~--  337 (436)
                      ...   ......+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||..............        ....  
T Consensus       182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            432   223457899999999988754 79999999999999999999999864432211110000        0000  


Q ss_pred             -hcCCcce---ec---cCCcc---ccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          338 -TSNRTLE---LI---DDPVL---EDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       338 -~~~~~~~---~~---~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                       .......   ..   .....   .........+.++.+|+.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000000   00   00000   000011123456889999999999999999999976

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-45  Score=343.66  Aligned_cols=264  Identities=20%  Similarity=0.270  Sum_probs=202.4

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeCCccEEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++..  .......+.+|+.+|++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47899999999999999999975 5888999998643  33456788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCceecCCCC
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  271 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  271 (436)
                      ++.++++..++....   .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988875433   4789999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cccccccccccCCccchhhhccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc------ce
Q 040532          272 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT------LE  344 (436)
Q Consensus       272 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~  344 (436)
                      .  ......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||-.... ..+....+.........      ..
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC-HHHHHHHHHhhcCCCChhhhhhhhh
Confidence            2  222335778899999988665 68999999999999999999999732221 11111111111111100      00


Q ss_pred             ec---cC----CccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 040532          345 LI---DD----PVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS  387 (436)
Q Consensus       345 ~~---~~----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~  387 (436)
                      ..   ..    ............+..+.+|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   00    000000011123456889999999999999999999876

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=348.37  Aligned_cols=252  Identities=21%  Similarity=0.273  Sum_probs=198.9

Q ss_pred             cCCCCCcccCCCCceeEEEEEec----CCCEEEEEEcCCC----ChhhHHHHHHHHHHHHHcCC-CceeEEeeEEEeCCc
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR----KGDEIAVKRLSGR----SEQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDE  185 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  185 (436)
                      ++|++.+.||+|+||+||+|...    +|+.||||++...    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999852    3789999998643    12234567899999999966 899999999999999


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .+++|||+.+|+|.+++....   .++......++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999985433   3678888999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccCCccchhhhccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCcc
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRTL  343 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  343 (436)
                      ........ ......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.......  ....+........  
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--~~~~i~~~~~~~~--  252 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE--  252 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCC--
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcccCC--
Confidence            76543322 23345799999999999764  46889999999999999999999996543222  1111111111110  


Q ss_pred             eeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 040532          344 ELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPT-----MNDVVS  387 (436)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~ev~~  387 (436)
                           +..+.     ..+..+.+++.+||++||++|||     ++|+++
T Consensus       253 -----~~~~~-----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 -----PPYPQ-----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -----CCCCT-----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -----CCCcc-----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                 01111     13457889999999999999994     788875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-44  Score=345.35  Aligned_cols=263  Identities=24%  Similarity=0.279  Sum_probs=191.4

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC------C
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------D  184 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  184 (436)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++...  +......+.+|+.++++++||||+++++++...      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            368999999999999999999976 4899999999754  344556789999999999999999999999643      5


Q ss_pred             ccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCc
Q 040532          185 EKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  264 (436)
Q Consensus       185 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla  264 (436)
                      ..|+||||+.++++..+.      ..+++.....++.|++.||.|||+++   |+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence            679999999877665543      13789999999999999999999998   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCcc----------------
Q 040532          265 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN----------------  328 (436)
Q Consensus       265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~----------------  328 (436)
                      +......   ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...+.....                
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            7654322   233447899999999999999999999999999999999999998543211000                


Q ss_pred             -hhHHHHHHhhcCCcc------eeccCCccc-cccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 040532          329 -LLGYVWDLWTSNRTL------ELIDDPVLE-DEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVSM  388 (436)
Q Consensus       329 -~~~~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~~  388 (436)
                       ...............      ......... ........+..+.+|+.+||+.||++|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             000001111110000      000000000 111123456778999999999999999999999753

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-44  Score=345.36  Aligned_cols=263  Identities=22%  Similarity=0.309  Sum_probs=196.8

Q ss_pred             ccCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCC--ChhhHHHHHHHHHHHHHcCCCceeEEeeEEEeC-----Cc
Q 040532          114 TNTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGR--SEQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE  185 (436)
Q Consensus       114 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  185 (436)
                      .++|++.+.||+|+||+||+|++. +|+.||||++...  +....+.+.+|+.+|++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999965 5899999999754  344556788999999999999999999998643     34


Q ss_pred             cEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          186 KILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       186 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .+++++|+.+|+|.+++...    .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            47778888999999998532    3899999999999999999999998   9999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccCCccchhhhccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCCcchhHHHHHHhhcCCc--
Q 040532          266 ICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYVWDLWTSNRT--  342 (436)
Q Consensus       266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  342 (436)
                      ....     ......||+.|+|||...+.. ++.++||||+||++|+|++|+.||...+..  .....+.........  
T Consensus       170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--~~~~~i~~~~~~~~~~~  242 (348)
T d2gfsa1         170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAEL  242 (348)
T ss_dssp             CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred             ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChHH
Confidence            5432     223357899999999877654 689999999999999999999998543211  111111111000000  


Q ss_pred             ---------------ceeccCCccccccchHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhhc
Q 040532          343 ---------------LELIDDPVLEDEYSSKQVLLRYVNIALLCVQESADDRPTMNDVVS--MLTNE  392 (436)
Q Consensus       343 ---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev~~--~L~~~  392 (436)
                                     .............  ...+..+.+|+.+||+.||++|||++|+++  .+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         243 LKKISSESARNYIQSLTQMPKMNFANVF--IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HTTCCCHHHHHHHTTSCCCCCCCHHHHS--TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhccchhhhhhhhhcccCCCcchhhhc--CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                           0000000000000  113456889999999999999999999987  45443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.8e-39  Score=312.15  Aligned_cols=264  Identities=20%  Similarity=0.229  Sum_probs=189.6

Q ss_pred             cCCCCCcccCCCCceeEEEEEec-CCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-----------CCceeEEeeEEEe
Q 040532          115 NTFSDTNKLGEGGFGPVYKGVLR-KGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-----------HKNLVRLLGCCID  182 (436)
Q Consensus       115 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~  182 (436)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++... ...+.+.+|+.++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            45999999999999999999975 58999999997643 33467788999888875           5789999998865


Q ss_pred             C--CccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEecccCCCCEEEcCCCC----
Q 040532          183 K--DEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMN----  255 (436)
Q Consensus       183 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~i~H~Dikp~NIll~~~~~----  255 (436)
                      .  ...+++++++..+..............+++.....++.|++.||+|||+ .+   |+||||||+|||++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            4  4556777777665543333333344457889999999999999999998 66   999999999999986653    


Q ss_pred             --eEEeeccCceecCCCCcccccccccccCCccchhhhccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCc-chhHH
Q 040532          256 --PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NLLGY  332 (436)
Q Consensus       256 --~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~~~  332 (436)
                        ++++|||.+.....     ......||+.|+|||++.+..++.++|+||+||+++||++|+.||........ ...+.
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              99999999976432     22335799999999999999999999999999999999999999864432111 11111


Q ss_pred             HHH---Hhhc------------------CCcceeccCCcc--------ccccchHHHHHHHHHHHHhcccCCCCCCCCHH
Q 040532          333 VWD---LWTS------------------NRTLELIDDPVL--------EDEYSSKQVLLRYVNIALLCVQESADDRPTMN  383 (436)
Q Consensus       333 ~~~---~~~~------------------~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  383 (436)
                      ...   ....                  ......+.....        ............+.+|+.+||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            100   0000                  000000000000        00111234667899999999999999999999


Q ss_pred             HHHH
Q 040532          384 DVVS  387 (436)
Q Consensus       384 ev~~  387 (436)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9976

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.5e-24  Score=189.57  Aligned_cols=163  Identities=18%  Similarity=0.173  Sum_probs=120.1

Q ss_pred             CCCcccCCCCceeEEEEEecCCCEEEEEEcCCCCh------------------hhHHHHHHHHHHHHHcCCCceeEEeeE
Q 040532          118 SDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSE------------------QGLREMKNEASVIAKVQHKNLVRLLGC  179 (436)
Q Consensus       118 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~  179 (436)
                      .+.+.||+|+||+||+|.+.+|+.||||+++....                  ........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45688999999999999988899999998753210                  112335578889999999999888765


Q ss_pred             EEeCCccEEEEeecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecccCCCCEEEcCCCCeEEe
Q 040532          180 CIDKDEKILIYEYMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  259 (436)
Q Consensus       180 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i~H~Dikp~NIll~~~~~~kl~  259 (436)
                      .    ..+++|||++++.+..+          +......++.|++.+++|||+++   |+||||||+|||+++++ ++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred             c----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence            3    34899999998765432          23345678999999999999998   99999999999999755 8999


Q ss_pred             eccCceecCCCCcccccccccccCCccch--hh---hccCCCCcccchhhHHHH
Q 040532          260 DFGMARICGGNELQANTSRIVGTYGYMSP--EY---ALEGIFSIKSDVFSFGVL  308 (436)
Q Consensus       260 DfGla~~~~~~~~~~~~~~~~gt~~y~aP--E~---~~~~~~~~~~Dv~SlGvi  308 (436)
                      |||.|.....+...          .|...  +.   .....|+.++|+||..--
T Consensus       145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            99999765422110          11111  00   123568889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.77  E-value=1e-08  Score=91.96  Aligned_cols=144  Identities=16%  Similarity=0.124  Sum_probs=99.2

Q ss_pred             hccCCCCCcccCCCCceeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC-CCceeEEeeEEEeCCccEEEEe
Q 040532          113 ATNTFSDTNKLGEGGFGPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       113 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  191 (436)
                      .-..|+..+..+.++.+.||+.... ++.+++|+...........+.+|...+..+. +--+.+++.+..+.+..++||+
T Consensus        12 ~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~   90 (263)
T d1j7la_          12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             hhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence            3345565555455555789998754 6678889886544333445678888888774 4345667777778888899999


Q ss_pred             ecCCCChhhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 040532          192 YMPNKSLDFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQYS-------------------------------------  234 (436)
Q Consensus       192 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------  234 (436)
                      ++++.++.......        .....++.++++.+..||+..                                     
T Consensus        91 ~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          91 EADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             eccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            99998886544221        122345566666777777421                                     


Q ss_pred             -------------------CCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          235 -------------------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       235 -------------------~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                                         ...++|+|+.|.||++++++.+-|.||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                               1238999999999999987767799999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.31  E-value=2e-06  Score=76.07  Aligned_cols=130  Identities=16%  Similarity=0.156  Sum_probs=87.9

Q ss_pred             ccCCCCc-eeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcC--CCceeEEeeEEEeCCccEEEEeecCCCCh
Q 040532          122 KLGEGGF-GPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQ--HKNLVRLLGCCIDKDEKILIYEYMPNKSL  198 (436)
Q Consensus       122 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L  198 (436)
                      .+..|.. +.||+....++..+++|.......   ..+..|...++.+.  .-.+.+++++..+.+..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3444543 679999988788899998765433   34677788777763  33356677777788888999999998776


Q ss_pred             hhhhcCCCccCCCCHHHHHHHHHHHHHHHHHHhhC---------------------------------------------
Q 040532          199 DFFLFDPTKRILLDWVTRVQIIEGIAQGLLYLHQY---------------------------------------------  233 (436)
Q Consensus       199 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------------------  233 (436)
                      ....        ...   ...+.+++..|.-||+.                                             
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4321        111   12233444444455421                                             


Q ss_pred             ----------CCCCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          234 ----------SRVRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       234 ----------~~~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                                ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                      12238999999999999987777899998864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.89  E-value=2.4e-05  Score=73.85  Aligned_cols=76  Identities=13%  Similarity=0.242  Sum_probs=49.1

Q ss_pred             cccCCCCceeEEEEEecC-CCEEEEEEcCCC-------ChhhHHHHHHHHHHHHHc-CC-C-ceeEEeeEEEeCCccEEE
Q 040532          121 NKLGEGGFGPVYKGVLRK-GDEIAVKRLSGR-------SEQGLREMKNEASVIAKV-QH-K-NLVRLLGCCIDKDEKILI  189 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l-~h-~-niv~l~~~~~~~~~~~lv  189 (436)
                      +.||.|....||+....+ ++.+++|.-...       -+...+....|.+.|+.+ .+ | .+.+++.  .+.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence            568999999999998765 678999975321       111234456788888776 23 2 3444444  356678899


Q ss_pred             EeecCCCCh
Q 040532          190 YEYMPNKSL  198 (436)
Q Consensus       190 ~e~~~~g~L  198 (436)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.36  E-value=0.00025  Score=64.74  Aligned_cols=135  Identities=13%  Similarity=0.094  Sum_probs=77.7

Q ss_pred             eeEEEEEecCCCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCc--eeEEe-----eEEEeCCccEEEEeecCCCChhhh
Q 040532          129 GPVYKGVLRKGDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKN--LVRLL-----GCCIDKDEKILIYEYMPNKSLDFF  201 (436)
Q Consensus       129 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~-----~~~~~~~~~~lv~e~~~~g~L~~~  201 (436)
                      -.||++...+|..+++|..+... ...+++..|...+..|....  ++..+     ..+...+..+.++++++|..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            47999999889999999987542 22356778888888774221  11111     123345567889999987554210


Q ss_pred             -----------h-------c--CCCccCCCCHH-------------------HHHHHHHHHHHHHHHHh----hCCCCCe
Q 040532          202 -----------L-------F--DPTKRILLDWV-------------------TRVQIIEGIAQGLLYLH----QYSRVRI  238 (436)
Q Consensus       202 -----------l-------~--~~~~~~~l~~~-------------------~~~~i~~~ia~~l~~LH----~~~~~~i  238 (436)
                                 +       .  ....+...+..                   ....+...+...++.+.    ...+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                       0       0  01111112211                   11112222222333332    2223468


Q ss_pred             EecccCCCCEEEcCCCCeEEeeccCcee
Q 040532          239 IHRDLKASNILLDKDMNPKISDFGMARI  266 (436)
Q Consensus       239 ~H~Dikp~NIll~~~~~~kl~DfGla~~  266 (436)
                      +|+|+.+.|||++++  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.88  E-value=0.0014  Score=61.19  Aligned_cols=72  Identities=15%  Similarity=0.283  Sum_probs=48.1

Q ss_pred             cccCCCCceeEEEEEecC--------CCEEEEEEcCCCChhhHHHHHHHHHHHHHcCCCce-eEEeeEEEeCCccEEEEe
Q 040532          121 NKLGEGGFGPVYKGVLRK--------GDEIAVKRLSGRSEQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYE  191 (436)
Q Consensus       121 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  191 (436)
                      +.|+.|-.=.+|+....+        .+.|.+++... ... ..+..+|..+++.+.-.++ .++++++.    -.+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence            568888889999998653        34566666653 222 2355688888888742333 35666653    378999


Q ss_pred             ecCCCCh
Q 040532          192 YMPNKSL  198 (436)
Q Consensus       192 ~~~~g~L  198 (436)
                      |+++..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987655

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.77  E-value=0.0025  Score=57.37  Aligned_cols=30  Identities=30%  Similarity=0.364  Sum_probs=27.0

Q ss_pred             CCeEecccCCCCEEEcCCCCeEEeeccCce
Q 040532          236 VRIIHRDLKASNILLDKDMNPKISDFGMAR  265 (436)
Q Consensus       236 ~~i~H~Dikp~NIll~~~~~~kl~DfGla~  265 (436)
                      .+++|+|+.++||+++++...-+.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            459999999999999998878999999875